PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Man, ZQ; Kondo, Y; Koga, H; Umino, H; Nakayama, K; Shin, HW				Man, Zhiqiu; Kondo, Yumika; Koga, Hiroshi; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won			Arfaptins Are Localized to the trans-Golgi by Interaction with Arl1, but Not Arfs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; NUCLEOTIDE-EXCHANGE FACTORS; INHIBITS PHOSPHOLIPASE-D; RAC1-INTERACTING PROTEIN; MEMBRANE TRAFFICKING; SHIGA-TOXIN; IN-VIVO; NETWORK; DOMAINS; BINDING	Arfaptins (arfaptin-1 and arfaptin-2/POR1) were originally identified as binding partners of the Arf small GTPases. Both proteins contain a BAR (Bin/Amphiphysin/Rvs) domain, which participates in membrane deformation. Here we show that arfaptins associate with trans-Golgi membranes. Unexpectedly, Arl1 (Arf-like 1), but not Arfs, determines the trans-Golgi association of arfaptins. We also demonstrate that arfaptins interact with Arl1 through their BAR domain-containing region and compete for Arl1 binding with golgin-97 and golgin-245/p230, both of which also bind to Arl1 through their GRIP (golgin-97/RanBP2/Imh1p/p230) domains. However, arfaptins and these golgins show only limited colocalization at the trans-Golgi. Time-lapse imaging of cells overexpressing fluorescent protein-tagged arfaptins and golgin-97 reveals that arfaptins, but not golgin-97, are included in vesicular and tubular structures emanating from the Golgi region. These observations indicate that arfaptins are recruited onto trans-Golgi membranes by interacting with Arl1, and capable of inducing membrane deformation via their BAR domains.	[Man, Zhiqiu; Kondo, Yumika; Koga, Hiroshi; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Targeted Proteins Research Program; Special Coordination Fund for Promoting Science and Technology; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Society for Promotion of Science; the Targeted Proteins Research Program; the Special Coordination Fund for Promoting Science and Technology; the Takeda Science Foundation; and the Hayashi Memorial Foundation for Female Natural Scientists.	Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Hosaka M, 1996, J BIOCHEM-TOKYO, V120, P813; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakayama K, 2005, METHOD ENZYMOL, V404, P367, DOI 10.1016/S0076-6879(05)04032-2; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Toda K, 1999, FEBS LETT, V442, P221, DOI 10.1016/S0014-5793(98)01646-9; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	48	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11569	11578		10.1074/jbc.M110.201442	http://dx.doi.org/10.1074/jbc.M110.201442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21239483	Green Published, hybrid			2022-12-25	WOS:000288797100067
J	Ha, BH; Jeon, YJ; Shin, SC; Tatsumi, K; Komatsu, M; Tanaka, K; Watson, CM; Wallis, G; Chung, CH; Kim, EE				Ha, Byung Hak; Jeon, Young Joo; Shin, Sang Chul; Tatsumi, Kanako; Komatsu, Masaaki; Tanaka, Keiji; Watson, Christopher M.; Wallis, Gillian; Chung, Chin Ha; Kim, Eunice EunKyeong			Structure of Ubiquitin-fold Modifier 1-specific Protease UfSP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; CRYSTAL-STRUCTURE; HUMAN ATG4B; MECHANISM; AUTOPHAGY; UFM1; UBIQUITIN-FOLD-MODIFIER-1; RECOGNITION; SPECIFICITY; CATALYSIS	Ubiquitin- fold modifier 1 (Ufm1)-specific protease 2 (UfSP2) is a cysteine protease that is responsible for the release of Ufm1 from Ufm1-conjugated cellular proteins, as well as for the generation of mature Ufm1 from its precursor. The 2.6A resolution crystal structure of mouse UfSP2 reveals that it is composed of two domains. The C-terminal catalytic domain is similar to UfSP1 with Cys294, Asp418, His420, Tyr282, and a regulatory loop participating in catalysis. The novel N-terminal domain shows a unique structure and plays a role in the recognition of its cellular substrate C20orf116 and thus in the recruitment of UfSP2 to the endoplasmic reticulum, where C20orf116 predominantly localizes. Mutagenesis studies were carried out to provide the structural basis for understanding the loss of catalytic activity observed in a recently identified UfSP2 mutation that is associated with an autosomal dominant form of hip dysplasia.	[Ha, Byung Hak; Jeon, Young Joo; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ha, Byung Hak; Shin, Sang Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Tatsumi, Kanako; Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Tokyo 1568506, Japan; [Watson, Christopher M.; Wallis, Gillian] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Watson, Christopher M.; Wallis, Gillian] Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Tokyo Metropolitan Institute of Medical Science; University of Manchester; University of Manchester	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	eunice@kist.re.kr; chchung@snu.ac.kr	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Watson, Christopher Mark/0000-0003-2371-1844; Jeon, Young Joo/0000-0003-1004-5336	Functional Proteomics Center [FPR08B2-280]; Korea Ministry of Science and Technology; Korea Research Foundation [KRF-2005-084-C00025]; Korea Science and Engineering Foundation [M10533010001-05N3301]	Functional Proteomics Center; Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by Functional Proteomics Center Grant FPR08B2-280, the 21C Frontier Research and Development Program of the Korea Ministry of Science and Technology, a Korea Institute of Science and Technology Institutional Program grant (to E. E. K.), Korea Research Foundation Grant KRF-2005-084-C00025, and Korea Science and Engineering Foundation Grant M10533010001-05N3301 (to C. H. C.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ha BH, 2008, BMB REP, V41, P435, DOI 10.5483/BMBRep.2008.41.6.435; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	35	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10248	10257		10.1074/jbc.M110.172171	http://dx.doi.org/10.1074/jbc.M110.172171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21228277	Green Published, hybrid			2022-12-25	WOS:000288547000042
J	Ramakrishna, S; Suresh, B; Lee, EJ; Lee, HJ; Ahn, WS; Baek, KH				Ramakrishna, Suresh; Suresh, Bharathi; Lee, Eung-Ji; Lee, Hey-Jin; Ahn, Woong-Shick; Baek, Kwang-Hyun			Lys-63-specific Deubiquitination of SDS3 by USP17 Regulates HDAC Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-PROTEASOME PATHWAY; HISTONE DEACETYLASES; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; INTEGRAL COMPONENT; PROTEIN; ACTIVATION; ENZYMES; CANCER	SDS3 is a key component of the histone deacetylase (HDAC)-dependent Sin3A co-repressor complex, serving to maintain its HDAC activity. Here, we report both exogenous and endogenous functional interaction between deubiquitinating enzyme USP17 and human SDS3 by MALDI-TOF-MS, co-immunoprecipitation assay, and GST pull-down assay. In this study, we demonstrated that SDS3 readily undergoes endogenous polyubiquitination, which is associated specifically with Lys-63-branched polyubiquitin chains and not with Lys-48-branched polyubiquitin chains. Further, we also demonstrated that USP17 specifically deubiquitinates Lys-63-linked ubiquitin chains from SDS3 and regulates its biological functions. The deubiquitinating activity of USP17 on SDS3 negatively regulates SDS3-associated HDAC activity. The constitutive expression of USP17 and its substrate SDS3 was involved in the inhibition of anchorage-independent tumor growth and blocks cell proliferation, leading to apoptosis in cervical carcinoma cells. Furthermore, we showed that USP17 and SDS3 mutually interact with each other to regulate cancer cell viability. These data support the possibility that SDS3, being a substrate of USP17, may play an important role in developing a novel therapeutic means to inhibit specific HDAC activities in cancer.	[Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Seoul 135081, South Korea; [Ahn, Woong-Shick] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul 150727, South Korea	Pochon Cha University; Catholic University of Korea	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, 606-16 Yeoksam,1 Dong, Seoul 135081, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Korea Research Foundation, Korean Government [KRF-2008-313-C00718]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [0820330]	Korea Research Foundation, Korean Government(National Research Foundation of KoreaKorean Government); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2008-313-C00718 funded by the Korean Government and by National Research and Development Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea Grant 0820330.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; David G, 2006, ONCOGENE, V25, P7354, DOI 10.1038/sj.onc.1209734; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim YS, 2006, PROTEOMICS, V6, P3445, DOI 10.1002/pmic.200500775; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lee MY, 2008, J CELL BIOCHEM, V105, P1420, DOI 10.1002/jcb.21961; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Shin JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-292; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384	40	31	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10505	10514		10.1074/jbc.M110.162321	http://dx.doi.org/10.1074/jbc.M110.162321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239494	Green Published, hybrid			2022-12-25	WOS:000288547000067
J	Pelz, C; Steininger, S; Weiss, C; Coscia, F; Vogelmann, R				Pelz, Christiane; Steininger, Sylvia; Weiss, Claudia; Coscia, Fabian; Vogelmann, Roger			A Novel Inhibitory Domain of Helicobacter pylori Protein CagA Reduces CagA Effects on Host Cell Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; APICAL-JUNCTIONAL COMPLEX; FOCAL ADHESION KINASE; VIRULENCE FACTOR CAGA; TYROSINE PHOSPHORYLATION; BETA-CATENIN; E-CADHERIN; IV SECRETION; MDCK CELLS; ACTIVATION	The Helicobacter pylori protein CagA (cytotoxin-associated gene A) is associated with an increased risk for gastric cancer formation. After attachment to epithelial cells, the bacteria inject CagA via a type IV secretion apparatus into host cells, where it exerts its biological activity. Host cell responses to intracellular CagA have been linked exclusively to signaling motifs in the C terminus of the CagA protein. Little is known about the functional role of the remaining CagA protein. Using transgenic expression of CagA mutants in epithelial cells, we were able to identify a novel CagA inhibitory domain at the N terminus consisting of the first 200 amino acids. This domain localizes to cell-cell contacts and increases the rate and strength of cell-cell adhesion in epithelial cells. Thus, it compensates for the loss of cell-cell adhesion induced by the C terminus of the CagA protein. Consistent with its stabilizing role on cell-cell adhesion, the CagA N terminus domain reduces the CagA-induced beta-catenin transcriptional activity in the nucleus. Furthermore, it inhibits apical surface constriction and cell elongations, host cell phenotypes induced by the C terminus in polarized epithelia. Therefore, our study suggests that CagA contains an intrinsic inhibitory domain that reduces host cell responses to CagA, which have been associated with the formation of cancer.	[Pelz, Christiane; Steininger, Sylvia; Weiss, Claudia; Coscia, Fabian; Vogelmann, Roger] Tech Univ Munich, Dept Internal Med 2, Klinikum Rechts Isar, D-81675 Munich, Germany; [Vogelmann, Roger] Univ Heidelberg, Dept Med 2, Univ Hosp Mannheim, D-68167 Mannheim, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg	Vogelmann, R (corresponding author), Ismaninger Str 22, D-81675 Munich, Germany.	roger.vogelmann@lrz.tum.de	Coscia, Fabian/AAD-3899-2020	Coscia, Fabian/0000-0002-2244-5081	Deutsche Krebshilfe; Max-Eder Nachwuchsgruppenprogramm [107238]; Kommission fur Klinische Forschung (KKF); Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany	Deutsche Krebshilfe(Deutsche Krebshilfe); Max-Eder Nachwuchsgruppenprogramm(Deutsche Krebshilfe); Kommission fur Klinische Forschung (KKF); Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany	This work was supported by the Deutsche Krebshilfe, Max-Eder Nachwuchsgruppenprogramm 107238, the Kommission fur Klinische Forschung (KKF) Program Klinikum rechts der Isar, and generous financial support from Roland M. Schmid (Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany).	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BLASER MJ, 1995, CANCER RES, V55, P2111; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2002, GASTROENTEROLOGY, V123, P1962, DOI 10.1053/gast.2002.37044; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Stewart A, 2002, BIOCHEM BIOPH RES CO, V299, P62, DOI 10.1016/S0006-291X(02)02547-0; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wiedemann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004754; Yokoyama K, 2005, P NATL ACAD SCI USA, V102, P9661, DOI 10.1073/pnas.0502529102	51	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8999	9008		10.1074/jbc.M110.166504	http://dx.doi.org/10.1074/jbc.M110.166504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212271	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000288247700031
J	Chiappini, F; Cunha, LL; Harris, JC; Hollenberg, AN				Chiappini, Franck; Cunha, Lucas L.; Harris, Jamie C.; Hollenberg, Anthony N.			Lack of cAMP-response Element-binding Protein 1 in the Hypothalamus Causes Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOPRESSIN GENE-EXPRESSION; TRANSCRIPTION FACTOR CREB; CENTRAL-NERVOUS-SYSTEM; BROWN ADIPOSE-TISSUE; MELANOCORTIN-4 RECEPTOR; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; ENERGY-BALANCE; MESSENGER-RNA; ADAPTIVE THERMOGENESIS	The melanocortin system in the hypothalamus controls food intake and energy expenditure. Its disruption causes severe obesity in mice and humans. cAMP-response element-binding protein 1 (CREB1) has been postulated to play an important role downstream of the melanocortin-4 receptor (MC4R), but this hypothesis has never been confirmed in vivo. To test this, we generated mice that lack CREB1 in SIM1-expressing neurons, of the paraventricular nucleus (PVN), which are known to be MC4R-positive. Interestingly, CREB1(Delta SIM1) mice developed obesity as a result of decreased energy expenditure and impairment in maintaining their core body temperature and not because of hyperphagia, defining a new role for CREB1 in the PVN. In addition, the lack of CREB1 in the PVN caused a reduction in vasopressin expression but did not affect adrenal or thyroid function. Surprisingly, MC4R function tested pharmacologically was normal in CREB1(Delta SIM1) mice, suggesting that CREB1 is not required for intact MC4R signaling. Thus CREB1 may affect other pathways that are implicated in the regulation of body weight.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hollenberg, AN (corresponding author), 330 Brookline Ave,E CLS 0728, Boston, MA 02215 USA.	thollenb@bidmc.harvard.edu	Cunha, Lucas Leite/AAK-9877-2020; Chiappini, Franck/AAB-9894-2021	Cunha, Lucas Leite/0000-0002-1513-1455; Chiappini, Franck/0000-0002-2684-1241	American Diabetes Association; NIH [R01 DK078090, NIH/5P01DK056116-10]; Takeda Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078090, P01DK056116] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Smith Family Pinnacle Award from the American Diabetes Association (to A. N. H.), NIH Grant R01 DK078090 (to A. N. H.), and a research grant from Takeda Pharmaceuticals. The comprehensive laboratory animal monitoring system is a part of the Physiological Core (Dr. Maratos-Flier, Beth Israel Deaconess Medical Center), supported by NIH Grant (NIH/5P01DK056116-10).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2006, OBESITY, V14, P222; Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Daniels D, 2003, BRAIN RES, V986, P1, DOI 10.1016/S0006-8993(03)03162-7; Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314; Duplan SM, 2009, EUR J NEUROSCI, V30, P2239, DOI 10.1111/j.1460-9568.2009.07028.x; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; GROSS DS, 1985, J HISTOCHEM CYTOCHEM, V33, P11, DOI 10.1177/33.1.2578140; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Haus-Seuffert P, 2000, MOL CELL BIOCHEM, V212, P5, DOI 10.1023/A:1007111818628; Holder JL, 2000, HUM MOL GENET, V9, P101; Hollenberg AN, 2008, THYROID, V18, P131, DOI 10.1089/thy.2007.0251; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; KISS JZ, 1984, P NATL ACAD SCI-BIOL, V81, P1854, DOI 10.1073/pnas.81.6.1854; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kuwahara S, 2003, J NEUROSCI, V23, P10231; Lechan RM, 2006, PEPTIDES, V27, P310, DOI 10.1016/j.peptides.2005.01.033; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lee EJ, 2001, EUR J BIOCHEM, V268, P582, DOI 10.1046/j.1432-1327.2001.01900.x; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mantamadiotis T, 2006, MOL ENDOCRINOL, V20, P204, DOI 10.1210/me.2005-0195; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Parlato R, 2007, DEVELOPMENT, V134, P1663, DOI 10.1242/dev.02838; Patten CS, 2007, REGUL PEPTIDES, V142, P111, DOI 10.1016/j.regpep.2007.02.005; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sugrue ML, 2010, ENDOCRINOLOGY, V151, P793, DOI 10.1210/en.2009-0976; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Vella KR, 2007, J NEUROENDOCRINOL, V19, P499, DOI 10.1111/j.1365-2826.2007.01556.x; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7	68	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8094	8105		10.1074/jbc.M110.178186	http://dx.doi.org/10.1074/jbc.M110.178186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209091	hybrid, Green Published			2022-12-25	WOS:000288013300040
J	Yu, QJ; Ghisla, S; Hirschberg, J; Mann, V; Beyer, P				Yu, Qiuju; Ghisla, Sandro; Hirschberg, Joseph; Mann, Varda; Beyer, Peter			Plant Carotene Cis-Trans Isomerase CRTISO A NEW MEMBER OF THE FAD(RED)-DEPENDENT FLAVOPROTEINS CATALYZING NON-REDOX REACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOENE DESATURATION; DIPHOSPHATE ISOMERASE; MOLECULAR-OXYGEN; BETA-CAROTENE; BIOSYNTHESIS; LYCOPENE; FLAVIN; STEREOCHEMISTRY; CHROMOPLASTS; INHIBITION	The carotene cis-trans isomerase CRTISO is a constituent of the carotene desaturation pathway as evolved in cyanobacteria and prevailing in plants, in which a tetra-cis-lycopene species, termed prolycopene, is formed. CRTISO, an evolutionary descendant of the bacterial carotene desaturase CRTI, catalyzes the cis-to-trans isomerization reactions leading to all-trans-lycopene, the substrate for the subsequent lycopene cyclization to form all-trans-alpha/beta-carotene. CRTISO and CRTI share a dinucleotide binding motif at the N terminus. Here we report that this site is occupied by FAD in CRTISO. The reduced form of this cofactor catalyzes a reaction not involving net redox changes. Results obtained with C(1)- and C(5)-deaza-FAD suggest mechanistic similarities with type II isopentenyl diphosphate: dimethylallyl diphosphate isomerase (IDI-2). CRTISO, together with lycopene cyclase CRTY and IDI-2, thus represents the third enzyme in isoprenoid metabolism belonging to the class of non-redox enzymes depending on reduced flavin for activity. The regional specificity and the kinetics of the isomerization reaction were investigated in vitro using purified enzyme and biphasic liposome-based systems carrying specific cis-configured lycopene species as substrates. The reaction proceeded from cis to trans, recognizing half-sides of the symmetrical prolycopene and was accompanied by one trans-to-cis isomerization step specific for the C(5)-C(6) double bond. Rice lycopene beta-cyclase (OsLCY-b), when additionally introduced into the biphasic in vitro system used, was found to be stereospecific for all-trans-lycopene and allowed the CRTISO reaction to proceed toward completion by modifying the thermodynamics of the overall reaction.	[Yu, Qiuju; Beyer, Peter] Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Hirschberg, Joseph; Mann, Varda] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	University of Freiburg; University of Konstanz; Hebrew University of Jerusalem	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de			German-Israel Foundation; Excellence Initiative of the German Federal and State Governments [EXC 294]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Excellence Initiative of the German Federal and State Governments	This work was supported by The German-Israel Foundation and by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Ben-Amot A., 1997, FOOD CHEM, V62, P515; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; CLOUGH JM, 1979, J CHEM SOC CHEM COMM, P616, DOI 10.1039/c39790000616; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; ECKSTEIN JW, 1993, BIOCHEMISTRY-US, V32, P404, DOI 10.1021/bi00053a004; Edmondson D, 1999, METH MOL B, V131, P157; EUGSTER CH, 1979, PURE APPL CHEM, V51, P463, DOI 10.1351/pac197951030463; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; Guo WH, 2008, J PHYS CHEM B, V112, P12158, DOI 10.1021/jp8019705; HENGARTNER U, 1992, HELV CHIM ACTA, V75, P1848, DOI 10.1002/hlca.19920750611; Hersh L B, 1980, Methods Enzymol, V66, P277; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kao YT, 2008, J AM CHEM SOC, V130, P13132, DOI 10.1021/ja8045469; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Klassen JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011257; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; Mialoundama AS, 2010, PLANT PHYSIOL, V153, P970, DOI 10.1104/pp.110.155440; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; ROMER S, 1991, PHOTOCHEM PHOTOBIOL, V53, P535, DOI 10.1111/j.1751-1097.1991.tb03666.x; SANDMANN G, 1991, ARCH MICROBIOL, V155, P229, DOI 10.1007/BF00252205; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Schulz C. E., 1992, CURR OPIN STRUC BIOL, V2, P61; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Unno H, 2009, J BIOL CHEM, V284, P9160, DOI 10.1074/jbc.M808438200; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; ZUMBRUNN A, 1985, HELV CHIM ACTA, V68, P1519, DOI 10.1002/hlca.19850680604	40	64	66	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8666	8676		10.1074/jbc.M110.208017	http://dx.doi.org/10.1074/jbc.M110.208017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209101	hybrid, Green Published			2022-12-25	WOS:000288013300092
J	Plews, JR; Li, JL; Jones, M; Moore, HD; Mason, C; Andrews, PW; Na, J				Plews, Jordan R.; Li, JianLiang; Jones, Mark; Moore, Harry D.; Mason, Chris; Andrews, Peter W.; Na, Jie			Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach	PLOS ONE			English	Article							HUMAN IPSC INDUCTION; STEM-CELLS; DENDRITIC CELLS; GENERATION; EXPRESSION; MOLECULES; IMPROVE; VECTOR	Background: Several methods have been used to induce somatic cells to re-enter the pluripotent state. Viral transduction of reprogramming genes yields higher efficiency but involves random insertions of viral sequences into the human genome. Although induced pluripotent stem (iPS) cells can be obtained with the removable PiggyBac transposon system or an episomal system, both approaches still use DNA constructs so that resulting cell lines need to be thoroughly analyzed to confirm they are free of harmful genetic modification. Thus a method to change cell fate without using DNA will be very useful in regenerative medicine. Methodology/Principal Findings: In this study, we synthesized mRNAs encoding OCT4, SOX2, cMYC, KLF4 and SV40 large T (LT) and electroporated them into human fibroblast cells. Upon transfection, fibroblasts expressed these factors at levels comparable to, or higher than those in human embryonic stem (ES) cells. Ectopically expressed OCT4 localized to the cell nucleus within 4 hours after mRNA introduction. Transfecting fibroblasts with a mixture of mRNAs encoding all five factors significantly increased the expression of endogenous OCT4, NANOG, DNMT3 beta, REX1 and SALL4. When such transfected fibroblasts were also exposed to several small molecules (valproic acid, BIX01294 and 5'-aza-2'-deoxycytidine) and cultured in human embryonic stem cell (ES) medium they formed small aggregates positive for alkaline phosphatase activity and OCT4 protein within 30 days. Conclusion/Significance: Our results demonstrate that mRNA transfection can be a useful approach to precisely control the protein expression level and short-term expression of reprogramming factors is sufficient to activate pluripotency genes in differentiated cells.	[Plews, Jordan R.; Li, JianLiang; Jones, Mark; Moore, Harry D.; Andrews, Peter W.; Na, Jie] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Plews, Jordan R.; Mason, Chris] UCL, Dept Biochem Engn, London, England; [Na, Jie] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	University of Sheffield; University of London; University College London; Tsinghua University	Plews, JR (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	P.W.Andrews@sheffield.ac.uk; JieNajie.na@tsinghua.edu.cn	Na, Jie/U-4518-2019; Na, Jie/N-3522-2018	Na, Jie/0000-0003-1820-0548; Na, Jie/0000-0003-1820-0548; Andrews, Peter/0000-0001-7215-4410	MRC; European Commission; Engineering and Physical Sciences Research Council (EPSRC); MRC [G0700785, G0500491] Funding Source: UKRI; Medical Research Council [G0500491, G0700785] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants to PWA from the MRC and from the European Commission under the Sixth Framework Programme to the ESTOOLS Integrated Project Consortium. JN was supported by an MRC Stem Cell Career Development Fellowship. JP was supported by an Engineering and Physical Sciences Research Council (EPSRC) PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bhutani N., 2009, NATURE; Boczkowski D, 2009, CANCER GENE THER, V16, P900, DOI 10.1038/cgt.2009.39; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Desponts C, 2010, METHODS MOL BIOL, V636, P207, DOI 10.1007/978-1-60761-691-7_13; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; GLOVER AB, 1987, CANCER TREAT REP, V71, P959; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu D, 2008, NAT BIOTECHNOL; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Lee J, 2008, IMMUNOLOGY, V125, P229, DOI 10.1111/j.1365-2567.2008.02833.x; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Ma DK, 2008, STEM CELLS; Mali P, 2008, STEM CELLS; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Melhem NM, 2007, EUR J IMMUNOL, V37, P2164, DOI 10.1002/eji.200636782; Papapetrou EP, 2009, MOL THER, V17, pS22; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Smits E, 2004, LEUKEMIA, V18, P1898, DOI 10.1038/sj.leu.2403463; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vierbuchen T, 2010, NATURE; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiehe JM, 2007, J CELL MOL MED, V11, P521, DOI 10.1111/j.1582-4934.2007.00038.x; Wong CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001955; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	46	69	99	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14397	10.1371/journal.pone.0014397	http://dx.doi.org/10.1371/journal.pone.0014397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209933	Green Published, gold			2022-12-25	WOS:000285793600001
J	Wang, J; Taherbhoy, AM; Hunt, HW; Seyedin, SN; Miller, DW; Miller, DJ; Huang, DT; Schulman, BA				Wang, Jing; Taherbhoy, Asad M.; Hunt, Harold W.; Seyedin, Steven N.; Miller, David W.; Miller, Darcie J.; Huang, Danny T.; Schulman, Brenda A.			Crystal Structure of UBA2(ufd)-Ubc9: Insights into E1-E2 Interactions in Sumo Pathways	PLOS ONE			English	Article							CONJUGATING ENZYME; E3 LIGASE; SUBSTRATE RECOGNITION; PROTEIN-ACTIVATION; ACTIVE-SITE; UBIQUITIN; UBC9; COMPLEX; E1; E2	Canonical ubiquitin-like proteins (UBLs) such as ubiquitin, Sumo, NEDD8, and ISG15 are ligated to targets by E1-E2-E3 multienzyme cascades. The Sumo cascade, conserved among all eukaryotes, regulates numerous biological processes including protein localization, transcription, DNA replication, and mitosis. Sumo conjugation is initiated by the heterodimeric Aos1-Uba2 E1 enzyme (in humans called Sae1-Uba2), which activates Sumo's C-terminus, binds the dedicated E2 enzyme Ubc9, and promotes Sumo C-terminal transfer between the Uba2 and Ubc9 catalytic cysteines. To gain insights into details of E1-E2 interactions in the Sumo pathway, we determined crystal structures of the C-terminal ubiquitin fold domain (ufd) from yeast Uba2 (Uba2(ufd)), alone and in complex with Ubc9. The overall structures of both yeast Uba2(ufd) and Ubc9 superimpose well on their individual human counterparts, suggesting conservation of fundamental features of Sumo conjugation. Docking the Uba2(ufd)-Ubc9 and prior full-length human Uba2 structures allows generation of models for steps in Sumo transfer from Uba2 to Ubc9, and supports the notion that Uba2 undergoes remarkable conformational changes during the reaction. Comparisons to previous structures from the NEDD8 cascade demonstrate that UBL cascades generally utilize some parallel E1-E2 interaction surfaces. In addition, the structure of the Uba2(ufd)-Ubc9 complex reveals interactions unique to Sumo E1 and E2. Comparison with a previous Ubc9-E3 complex structure demonstrates overlap between Uba2 and E3 binding sites on Ubc9, indicating that loading with Sumo and E3-catalyzed transfer to substrates are strictly separate steps. The results suggest mechanisms establishing specificity and order in Sumo conjugation cascades.	[Wang, Jing; Taherbhoy, Asad M.; Hunt, Harold W.; Seyedin, Steven N.; Miller, David W.; Miller, Darcie J.; Huang, Danny T.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Taherbhoy, Asad M.; Schulman, Brenda A.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Wang, J (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Brenda.Schulman@stjude.org	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X; Seyedin, Steven/0000-0002-6841-968X	Howard Hughes Medical Institute; NIH [R01GM069530, 5P30CA021765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077053, R01GM069530] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Howard Hughes Medical Institute. BAS is an Investigator of the Howard Hughes Medical Institute. URL: www.hhmi.org. NIH: R01GM069530 (to BAS); 5P30CA021765 (to St. Jude Cancer Center). ALSAC: http://www.stjude.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Biggins S, 2001, GENETICS, V159, P453; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Hannoun Z, 2010, POSTTRANSLATIONAL MO; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; WANG J, 2010, J BIOL CHEM; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	57	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15805	10.1371/journal.pone.0015805	http://dx.doi.org/10.1371/journal.pone.0015805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209884	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000285793600041
J	Conroy, AL; Phiri, H; Hawkes, M; Glover, S; Mallewa, M; Seydel, KB; Taylor, TE; Molyneux, ME; Kain, KC				Conroy, Andrea L.; Phiri, Happy; Hawkes, Michael; Glover, Simon; Mallewa, Mac; Seydel, Karl B.; Taylor, Terrie E.; Molyneux, Malcolm E.; Kain, Kevin C.			Endothelium-Based Biomarkers Are Associated with Cerebral Malaria in Malawian Children: A Retrospective Case-Control Study	PLOS ONE			English	Article							GROWTH-FACTOR; PLASMODIUM-FALCIPARUM; ANGIOPOIETIN-2; VEGF; RETINOPATHY; ADHESION; CELLS; COAGULATION; ACTIVATION	Background: Differentiating cerebral malaria (CM) from other causes of serious illness in African children is problematic, owing to the non-specific nature of the clinical presentation and the high prevalence of incidental parasitaemia. CM is associated with endothelial activation. In this study we tested the hypothesis that endothelium-derived biomarkers are associated with the pathophysiology of severe malaria and may help identify children with CM. Methods and Findings: Plasma samples were tested from children recruited with uncomplicated malaria (UM; n = 32), cerebral malaria with retinopathy (CM-R; n = 38), clinically defined CM without retinopathy (CM-N; n = 29), or non-malaria febrile illness with decreased consciousness (CNS; n = 24). Admission levels of angiopoietin-2 (Ang-2), Ang-1, soluble Tie-2 (sTie-2), von Willebrand factor (VWF), its propeptide (VWFpp), vascular endothelial growth factor (VEGF), soluble ICAM-1 (sICAM-1) and interferon-inducible protein 10 (IP-10) were measured by ELISA. Children with CM-R had significantly higher median levels of Ang-2, Ang-2: Ang-1, sTie-2, VWFpp and sICAM-1 compared to children with CM-N. Children with CM-R had significantly lower median levels of Ang-1 and higher median concentrations of Ang-2: Ang-1, sTie-2, VWF, VWFpp, VEGF and sICAM-1 compared to UM, and significantly lower median levels of Ang-1 and higher median levels of Ang-2, Ang-2: Ang-1, VWF and VWFpp compared to children with fever and altered consciousness due to other causes. Ang-1 was the best discriminator between UM and CM-R and between CNS and CM-R (areas under the ROC curve of 0.96 and 0.93, respectively). A comparison of biomarker levels in CM-R between admission and recovery showed uniform increases in Ang-1 levels, suggesting this biomarker may have utility in monitoring clinical response. Conclusions: These results suggest that endothelial proteins are informative biomarkers of malarial disease severity. These results require validation in prospective studies to confirm that this group of biomarkers improves the diagnostic accuracy of CM from similar conditions causing fever and altered consciousness.	[Conroy, Andrea L.; Hawkes, Michael; Kain, Kevin C.] Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada; [Phiri, Happy; Mallewa, Mac; Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glover, Simon; Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Seydel, Karl B.; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Seydel, Karl B.; Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Toronto	Conroy, AL (corresponding author), Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	, Michael/AAP-3049-2020; Conroy, Andrea/AAA-8356-2020; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Hawkes, Michael/0000-0002-4122-0937; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR) [MOP-13721]; Genome Canada through the Ontario Genomics Institute; CIHR Canada Research Chair; Defense Advanced Research Projects Agency; Wellcome Trust, United Kingdom; National Institutes of Health, United States of America [5R01AI034969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wellcome Trust, United Kingdom(Wellcome Trust); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by a Canadian Institutes of Health Research (CIHR) Team Grant in Malaria (KCK), CIHR MOP-13721 (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chair (KCK), CIHR studentship (ALC), a Defense Advanced Research Projects Agency grant (KCK) and a kind donation from Mr. D. Kirkwood. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Enrollment, clinical characterization and sampling of patients were funded by grants from The Wellcome Trust, United Kingdom, and the National Institutes of Health, United States of America (5R01AI034969).	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bridges DJ, 2009, BLOOD; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Burton M, 2004, TROP DOCT, V34, P214, DOI 10.1177/004947550403400409; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Kentaro U, 2009, BRIT J HAEMATOL, V148, P285; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kim IJ, 2002, FASEB J, V16, pA305; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Okubadejo N U, 2004, Niger Postgrad Med J, V11, P10; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Sachanonta N, 2008, ASIAN PAC J ALLERGY, V26, P37; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; WRIGHT PW, 1993, PEDIATR INFECT DIS J, V12, P37, DOI 10.1097/00006454-199301000-00009; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yuan HT, 2009, MOL CELL BIOL, P01472	43	100	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15291	10.1371/journal.pone.0015291	http://dx.doi.org/10.1371/journal.pone.0015291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209923	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200022
J	Pyo, CW; Guethlein, LA; Vu, QY; Wang, RH; Abi-Rached, L; Norman, PJ; Marsh, SGE; Miller, JS; Parham, P; Geraghty, DE				Pyo, Chul-Woo; Guethlein, Lisbeth A.; Vu, Quyen; Wang, Ruihan; Abi-Rached, Laurent; Norman, Paul J.; Marsh, Steven G. E.; Miller, Jeffrey S.; Parham, Peter; Geraghty, Daniel E.			Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SEQUENCE ALIGNMENT; ACUTE MYELOGENOUS LEUKEMIA; KIR HAPLOTYPES; GENE-CONTENT; CUTTING EDGE; HLA-C; PHYLOGENETIC ANALYSIS; ALLELIC POLYMORPHISM	The fast evolving human KIR gene family encodes variable lymphocyte receptors specific for polymorphic HLA class I determinants. Nucleotide sequences for 24 representative human KIR haplotypes were determined. With three previously defined haplotypes, this gave a set of 12 group A and 15 group B haplotypes for assessment of KIR variation. The seven gene-content haplotypes are all combinations of four centromeric and two telomeric motifs. 2DL5, 2DS5 and 2DS3 can be present in centromeric and telomeric locations. With one exception, haplotypes having identical gene content differed in their combinations of KIR alleles. Sequence diversity varied between haplotype groups and between centromeric and telomeric halves of the KIR locus. The most variable A haplotype genes are in the telomeric half, whereas the most variable genes characterizing B haplotypes are in the centromeric half. Of the highly polymorphic genes, only the 3DL3 framework gene exhibits a similar diversity when carried by A and B haplotypes. Phylogenetic analysis and divergence time estimates, point to the centromeric gene-content motifs that distinguish A and B haplotypes having emerged similar to 6 million years ago, contemporaneously with the separation of human and chimpanzee ancestors. In contrast, the telomeric motifs that distinguish A and B haplotypes emerged more recently, similar to 1.7 million years ago, before the emergence of Homo sapiens. Thus the centromeric and telomeric motifs that typify A and B haplotypes have likely been present throughout human evolution. The results suggest the common ancestor of A and B haplotypes combined a B-like centromeric region with an Alike telomeric region.	[Pyo, Chul-Woo; Vu, Quyen; Wang, Ruihan; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Guethlein, Lisbeth A.; Abi-Rached, Laurent; Norman, Paul J.; Parham, Peter] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Miller, Jeffrey S.] Univ Minnesota, Minneapolis, MN USA; [Marsh, Steven G. E.] Anthony Nolan Res Inst, London, England	Fred Hutchinson Cancer Center; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Pyo, CW (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	geraghty@fhcrc.org	Marsh, Steven GE/C-1638-2008; Abi-Rached, Laurent/H-7236-2012	Marsh, Steven GE/0000-0003-2855-4120; Miller, Jeffrey S/0000-0002-0339-4944; Norman, Paul/0000-0001-8370-7703	National Institutes of Health [CA111412, RR018669]; NATIONAL CANCER INSTITUTE [P01CA111412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R41RR018669, R42RR018669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants CA111412 to J.S.M. and RR018669 to D. E. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Beatty PG, 2000, HUM IMMUNOL, V61, P834, DOI 10.1016/S0198-8859(00)00138-5; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Du Z, 2008, GENES IMMUN, V9, P470, DOI 10.1038/gene.2008.39; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gendzekhadze K, 2009, P NATL ACAD SCI USA, V106, P18692, DOI 10.1073/pnas.0906051106; Geraghty DE, 2002, IMMUNOL REV, V190, P69, DOI 10.1034/j.1600-065X.2002.19006.x; Gomez-Lozano N, 2005, EUR J IMMUNOL, V35, P16, DOI 10.1002/eji.200425493; Gomez-Lozano N, 2003, EUR J IMMUNOL, V33, P639, DOI 10.1002/eji.200323741; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Guethlein LA, 2007, J IMMUNOL, V179, P491, DOI 10.4049/jimmunol.179.1.491; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Locatelli F, 2009, CLIN IMMUNOL, V133, P171, DOI 10.1016/j.clim.2009.04.009; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Marsh SGE, 2003, IMMUNOGENETICS, V55, P220, DOI 10.1007/s00251-003-0571-z; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Middleton D, 2007, IMMUNOGENETICS, V59, P145, DOI 10.1007/s00251-006-0181-7; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Momot T, 2004, ARTHRITIS RHEUM-US, V50, P1561, DOI 10.1002/art.20216; Moretta A, 2009, CLIN EXP IMMUNOL, V157, P325, DOI 10.1111/j.1365-2249.2009.03983.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nelson GW, 2004, J IMMUNOL, V173, P4273, DOI 10.4049/jimmunol.173.7.4273; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Norman PJ, 2002, GENES IMMUN, V3, P86, DOI 10.1038/sj.gene.6363836; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PYO CW, 2006, IMMUNOGENET IN PRESS; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sambrook JG, 2007, CURR OPIN IMMUNOL, V19, P553, DOI 10.1016/j.coi.2007.08.002; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; Smith WP, 2006, GENOMICS, V87, P561, DOI 10.1016/j.ygeno.2005.11.020; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Suzuki Y, 2004, J INVEST DERMATOL, V122, P1133, DOI 10.1111/j.0022-202X.2004.22517.x; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van der Slik AR, 2003, DIABETES, V52, P2639, DOI 10.2337/diabetes.52.10.2639; Vely F, 2001, J IMMUNOL, V166, P2487, DOI 10.4049/jimmunol.166.4.2487; Whang DH, 2005, HUM IMMUNOL, V66, P146, DOI 10.1016/j.humimm.2004.10.013; Williams F, 2003, GENES IMMUN, V4, pS1; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yawata M, 2002, IMMUNOGENETICS, V54, P543, DOI 10.1007/s00251-002-0497-x; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	73	177	181	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15115	10.1371/journal.pone.0015115	http://dx.doi.org/10.1371/journal.pone.0015115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206914	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200015
J	Leroy, Q; Lebrigand, K; Armougom, F; Barbry, P; Thiery, R; Raoult, D				Leroy, Quentin; Lebrigand, Kevin; Armougom, Fabrice; Barbry, Pascal; Thiery, Richard; Raoult, Didier			Coxiella burnetii Transcriptional Analysis Reveals Serendipity Clusters of Regulation in Intracellular Bacteria	PLOS ONE			English	Article							TROPHERYMA-WHIPPLEI; STRINGENT RESPONSE; GENOME SEQUENCE; GENE-EXPRESSION; CELL-DIVISION; RNA; PROTEINS; PPGPP; MICROARRAY; STARVATION	Coxiella burnetii, the causative agent of the zoonotic disease Q fever, is mainly transmitted to humans through an aerosol route. A spore-like form allows C. burnetii to resist different environmental conditions. Because of this, analysis of the survival strategies used by this bacterium to adapt to new environmental conditions is critical for our understanding of C. burnetii pathogenicity. Here, we report the early transcriptional response of C. burnetii under temperature stresses. Our data show that C. burnetii exhibited minor changes in gene regulation under short exposure to heat or cold shock. While small differences were observed, C. burnetii seemed to respond similarly to cold and heat shock. The expression profiles obtained using microarrays produced in-house were confirmed by quantitative RT-PCR. Under temperature stresses, 190 genes were differentially expressed in at least one condition, with a fold change of up to 4. Globally, the differentially expressed genes in C. burnetii were associated with bacterial division, (p) ppGpp synthesis, wall and membrane biogenesis and, especially, lipopolysaccharide and peptidoglycan synthesis. These findings could be associated with growth arrest and witnessed transformation of the bacteria to a spore-like form. Unexpectedly, clusters of neighboring genes were differentially expressed. These clusters do not belong to operons or genetic networks; they have no evident associated functions and are not under the control of the same promoters. We also found undescribed but comparable clusters of regulation in previously reported transcriptomic analyses of intracellular bacteria, including Rickettsia sp. and Listeria monocytogenes. The transcriptomic patterns of C. burnetii observed under temperature stresses permits the recognition of unpredicted clusters of regulation for which the trigger mechanism remains unidentified but which may be the result of a new mechanism of epigenetic regulation.	[Leroy, Quentin; Armougom, Fabrice; Raoult, Didier] Univ Mediterranee, Fac Med, CNRS IRD, Unite Rech Malad Infect & Trop Emergentes,UMR 623, Marseille, France; [Lebrigand, Kevin; Barbry, Pascal] CNRS UNSA, UMR 6079, IPMC, Sophia Antipolis, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur	Leroy, Q (corresponding author), Univ Mediterranee, Fac Med, CNRS IRD, Unite Rech Malad Infect & Trop Emergentes,UMR 623, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Barbry, Pascal/O-5021-2016; Thiery, Richard/GRR-1496-2022	RAOULT, Didier/0000-0002-0633-5974; Barbry, Pascal/0000-0001-9632-6483; Thiery, Richard/0000-0003-2049-918X	Agence National pour la Recherche, France [ANR-06-PNRA-031]	Agence National pour la Recherche, France(French National Research Agency (ANR))	This work was supported by a grant from the Agence National pour la Recherche, France (contract number: ANR-06-PNRA-031; VIACOX project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSETH G, 1995, J BACTERIOL, V177, P2946, DOI 10.1128/jb.177.10.2946-2949.1995; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Crapoulet N, 2006, J BACTERIOL, V188, P5228, DOI 10.1128/JB.00507-06; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Edgar R, 2006, MOL MICROBIOL, V59, P276, DOI 10.1111/j.1365-2958.2005.04933.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; La MV, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-349; Leroy Q, 2010, J MICROBIOL METH, V81, P81, DOI 10.1016/j.mimet.2010.02.008; Martinez-Nunez MA, 2010, MICROBIOL-SGM, V156, P14, DOI 10.1099/mic.0.033266-0; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; OGASAWARA N, 1992, MOL MICROBIOL, V6, P629, DOI 10.1111/j.1365-2958.1992.tb01510.x; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Raghavan R, 2007, J BACTERIOL, V189, P6572, DOI 10.1128/JB.00812-07; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Renesto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003681; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; Saito M, 2008, BIOSCI BIOTECH BIOCH, V72, P1394, DOI 10.1271/bbb.80093; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WIEBE ME, 1972, J BACTERIOL, V110, P368, DOI 10.1128/JB.110.1.368-377.1972; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15321	10.1371/journal.pone.0015321	http://dx.doi.org/10.1371/journal.pone.0015321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203564	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900027
J	Copeland, E; Balgobin, S; Lee, CM; Rozakis-Adcock, M				Copeland, E.; Balgobin, S.; Lee, C. M.; Rozakis-Adcock, M.			hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas	ONCOGENE			English	Article						hTid-1; molecular chaperones; c-Met receptor tyrosine kinase; renal cell carcinoma; cell migration	DROSOPHILA TUMOR-SUPPRESSOR; HUMAN DNAJ PROTEIN; HEPATOCYTE GROWTH-FACTOR; HUMAN HOMOLOG; MOLECULAR CHAPERONES; MAMMALIAN HOMOLOG; MET/HGF RECEPTOR; TYROSINE KINASE; IMAGINAL-DISCS; GENE-PRODUCT	The c-Met receptor tyrosine kinase (MetR) is frequently overexpressed and constitutively phosphorylated in a number of human malignancies. Activation of the receptor by its ligand, hepatocyte growth factor (HGF), leads to increased cell proliferation, motility, survival and disruption of adherens junctions. In this study, we show that hTid-1, a DNAJ/Hsp40 chaperone, represents a novel modulator of the MetR signaling pathway. hTid-1 is a co-chaperone of the Hsp70 family of proteins, and has been shown to regulate a number of cellular signaling proteins including several involved in tumorigenic and apoptotic pathways. In this study we demonstrate that hTid-1 binds to unphosphorylated MetR and becomes dissociated from the receptor upon HGF stimulation. Overexpression of the short form of hTid-1 (hTid-1(S)) in 786-0 renal clear cell carcinomas (RCCs) enhances MetR kinase activity leading to an increase in HGF-mediated cell migration with no discernible effect on cell proliferation. By contrast, knockdown of hTid-1 markedly impairs both the onset and amplitude of MetR phosphorylation in response to HGF without altering receptor protein levels. hTid-1-depleted cells display defective migratory properties, coincident with inhibition of ERK/MAP kinase and STAT3 pathways. Taken together, our findings denote hTid-1(S) as an essential regulatory component of MetR signaling. We propose that the binding of hTid-1(S) to MetR may stabilize the receptor in a ligand-competent state and this stabilizing function may influence conformational changes that take place during the catalytic cycle that promote kinase activation. Given the prevalence of HGF/MetR pathway activation in human cancers, targeted inhibition of hTid-1 may be a useful therapeutic in the management of MetR-dependent malignancies. Oncogene (2011) 30, 2252-2263; doi:10.1038/onc.2010.601; published online 17 January 2011	[Rozakis-Adcock, M.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Rozakis-Adcock, M (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Med Sci Bldg,1 Kings Coll Circle,Room 6238A, Toronto, ON M5S 1A8, Canada.	maria.rozakis@utoronto.ca			National Cancer Institure of Canada; Ontario Graduate Scholarship; Canadian Institutes of Health Research	National Cancer Institure of Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the National Cancer Institure of Canada (to MRA). ER was supported by an Ontario Graduate Scholarship and CML by a Canadian Institutes of Health Research Master's Award. We thank Kevin Conway for assistance with immunofluorescence microscopy.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; FERRACINI R, 1995, ONCOGENE, V10, P739; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hov H, 2004, CLIN CANCER RES, V10, P6686, DOI 10.1158/1078-0432.CCR-04-0874; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Koga F, 2007, CELL CYCLE, V6, P1393, DOI 10.4161/cc.6.11.4296; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Kurzik-Dumke U, 2007, CELL SIGNAL, V19, P1973, DOI 10.1016/j.cellsig.2007.05.008; KURZIKDUMKE U, 1992, DIFFERENTIATION, V51, P91, DOI 10.1111/j.1432-0436.1992.tb00685.x; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Lesko E, 2007, ANTI-CANCER DRUG, V18, P1173, DOI 10.1097/CAD.0b013e3282ef532d; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Maulik G, 2002, CLIN CANCER RES, V8, P620; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Peruzzi B, 2006, CELL CYCLE, V5, P2839, DOI 10.4161/cc.5.24.3581; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qian J, 2010, GASTROENTEROLOGY, V138, P1418, DOI 10.1053/j.gastro.2009.10.044; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schaaf CP, 2004, FASEB J, V18, P267, DOI 10.1096/fj.04-1558fje; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Syken J, 2003, ONCOGENE, V22, P4636, DOI 10.1038/sj.onc.1206569; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; WALL D, 1994, J BIOL CHEM, V269, P5446; Webb CP, 2000, CANCER RES, V60, P342; Yin X, 2001, GENE, V278, P201, DOI 10.1016/S0378-1119(01)00720-X; Zia MK, 2007, INT J MOL MED, V20, P605	51	13	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	19					2252	2263		10.1038/onc.2010.601	http://dx.doi.org/10.1038/onc.2010.601			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242965	Green Published, hybrid			2022-12-25	WOS:000290514600008
J	Kalamarides, M; Stemmer-Rachamimov, AO; Niwa-Kawakita, M; Chareyre, F; Taranchon, E; Han, ZY; Martinelli, C; Lusis, EA; Hegedus, B; Gutmann, DH; Giovannini, M				Kalamarides, M.; Stemmer-Rachamimov, A. O.; Niwa-Kawakita, M.; Chareyre, F.; Taranchon, E.; Han, Z-Y; Martinelli, C.; Lusis, E. A.; Hegedus, B.; Gutmann, D. H.; Giovannini, M.			Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes	ONCOGENE			English	Article						neurofibromatosis type 2; arachnoid; brain tumours	PROSTAGLANDIN-D SYNTHASE; BETA-TRACE; NATURAL-HISTORY; CHOROID-PLEXUS; SKULL BASE; NF2; EXPRESSION; MICE; LOCALIZATION; MUTATION	Meningiomas are among the most common primary central nervous system tumours in adults. Studies focused on the molecular basis for meningioma development are hampered by a lack of information with regard to the cell of origin for these brain tumours. Herein, we identify a prostaglandin D synthase-positive meningeal precursor as the cell of origin for murine meningioma, and show that neurofibromatosis type 2 (Nf2) inactivation in prostaglandin D2 synthase (PGDS) (+) primordial meningeal cells, before the formation of the three meningeal layers, accounts for the heterogeneity of meningioma histological subtypes. Using a unique PGDSCre strain, we define a critical embryonic and early postnatal developmental window in which biallelic Nf2 inactivation in PGDS (+) progenitor cells results in meningioma formation. Moreover, we identify differentially expressed markers that characterize the two major histological meningioma subtypes both in human and mouse tumours. Collectively, these findings establish the cell of origin for these common brain tumours as well as a susceptible developmental period in which signature genetic mutations culminate in meningioma formation. Oncogene (2011) 30, 2333-2344; doi: 10.1038/onc.2010.609; published online 17 January 2011	[Giovannini, M.] House Ear Res Inst, Ctr Neural Tumor Res, Los Angeles, CA 90057 USA; [Kalamarides, M.; Niwa-Kawakita, M.; Chareyre, F.; Taranchon, E.; Han, Z-Y; Martinelli, C.; Giovannini, M.] INSERM, U674, Paris, France; [Kalamarides, M.; Niwa-Kawakita, M.; Chareyre, F.; Taranchon, E.; Han, Z-Y; Martinelli, C.; Giovannini, M.] Univ Paris 07, Inst Univ Hematol, Paris, France; [Kalamarides, M.] Hop Beaujon, AP HP, Serv Neurochirurg, Clichy, France; [Stemmer-Rachamimov, A. O.] Massachusetts Gen Hosp, Mol Neurooncol & Pathol Dept, Boston, MA 02114 USA; [Stemmer-Rachamimov, A. O.] Harvard Univ, Sch Med, Boston, MA USA; [Lusis, E. A.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Hegedus, B.; Gutmann, D. H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	House Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Giovannini, M (corresponding author), House Ear Res Inst, Ctr Neural Tumor Res, 2100W 3rd St, Los Angeles, CA 90057 USA.	mgiovannini@hei.org	Hegedus, Balazs/B-6076-2008	Hegedus, Balazs/0000-0002-4341-4153; Gutmann, David/0000-0002-3127-5045; Kawakita, Michiko/0000-0002-9450-583X	US Army Medical Research and Materiel Command [DAMD17-02-1-0645]; James S McDonnell Foundation; Association Neurofibromatoses et Recklinghausen; Vincent Buono Research Fund; Inserm	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); James S McDonnell Foundation; Association Neurofibromatoses et Recklinghausen; Vincent Buono Research Fund; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank A Berns for p16<SUP>Ink4a</SUP> and p53<SUP>flox</SUP> mutant mice; S Dufour and JP Thiery for HtPACre mice; Y Urade for the PGDS genomic fragment; M Pla and staff of the Institut Universitaire d'Hematologie (IUH), Universite Paris 7, for mouse housing; N Karboul for technical assistance; and M Catala and W Van Furth for helpful discussions. This work was supported by Grants from the US Army Medical Research and Materiel Command (DAMD17-02-1-0645 to MG), James S McDonnell Foundation (to DHG and MG), Association Neurofibromatoses et Recklinghausen, the Vincent Buono Research Fund (to DHG and MG) and Inserm.	Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; ANGELOV DN, 1989, CELL TISSUE RES, V257, P207; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Catala M., 1998, Archives d'Anatomie et de Cytologie Pathologiques, V46, P153; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; da Cruz MJ, 2000, BRIT J NEUROSURG, V14, P101; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Fevre-Montange M, 2009, INT J ONCOL, V35, P1395, DOI 10.3892/ijo_00000457; Giovannini M, 2000, GENE DEV, V14, P1617; Gutmann DH, 1997, NEUROLOGY, V49, P267, DOI 10.1212/WNL.49.1.267; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hartmann C, 2006, BRAIN PATHOL, V16, P15, DOI 10.1111/j.1750-3639.2006.tb00557.x; Hoffmann A, 1996, DEV DYNAM, V207, P332, DOI 10.1002/(SICI)1097-0177(199611)207:3<332::AID-AJA10>3.0.CO;2-6; Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302; Kalamarides M, 2008, BRAIN PATHOL, V18, P62, DOI 10.1111/j.1750-3639.2007.00105.x; KAMIRYO T, 1990, ANAT RECORD, V227, P207, DOI 10.1002/ar.1092270209; Kawashima M, 2001, MODERN PATHOL, V14, P197, DOI 10.1038/modpathol.3880285; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Kros J, 2001, J PATHOL, V194, P367, DOI 10.1002/path.909; Krutilkova V, 2005, EUR J CANCER, V41, P1597, DOI 10.1016/j.ejca.2005.01.026; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Lee JH, 2006, J NEUROSURG, V105, P60, DOI 10.3171/jns.2006.105.1.60; Louis DN, 2000, PATHOLOGY GENETICS T, P176; Marino S, 2000, GENE DEV, V14, P994; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; MCLONE DG, 1975, AM J ANAT, V142, P273, DOI 10.1002/aja.1001420302; Nakamura M, 2003, NEUROSURGERY, V53, P62, DOI 10.1227/01.NEU.0000068730.76856.58; NAKASU S, 1987, SURG NEUROL, V27, P319, DOI 10.1016/0090-3019(87)90005-X; OLIVERO WC, 1995, J NEUROSURG, V83, P222, DOI 10.3171/jns.1995.83.2.0222; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Robanus-Maandag E, 2004, ONCOGENE, V23, P6541, DOI 10.1038/sj.onc.1207858; RUTTLEDGE MH, 1994, GENE CHROMOSOME CANC, V10, P122, DOI 10.1002/gcc.2870100207; SCHWECHHEIMER K, 1984, LAB INVEST, V51, P584; Stuart JE, 2010, J NEUROPATHOL EXP NE; TOHMA Y, 1992, CANCER RES, V52, P1981; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Vandenabeele F, 1996, J ANAT, V189, P417; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Yamashima T, 1997, J NEUROSCI, V17, P2376; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	44	91	92	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	20					2333	2344		10.1038/onc.2010.609	http://dx.doi.org/10.1038/onc.2010.609			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21242963	Bronze			2022-12-25	WOS:000290789200005
J	Bavencoffe, A; Kondratskyi, A; Gkika, D; Mauroy, B; Shuba, Y; Prevarskaya, N; Skryma, R				Bavencoffe, Alexis; Kondratskyi, Artem; Gkika, Dimitra; Mauroy, Brigitte; Shuba, Yaroslav; Prevarskaya, Natalia; Skryma, Roman			Complex Regulation of the TRPM8 Cold Receptor Channel ROLE OF ARACHIDONIC ACID RELEASE FOLLOWING M3 MUSCARINIC RECEPTOR STIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; PHOSPHOLIPASE A(2); EPITHELIAL-CELLS; CALCIUM-ENTRY; ACTIVATION; MECHANISM; DESENSITIZATION; PROLIFERATION; MODULATION; SENSATION	Cold/menthol-activated TRPM8 (transient receptor potential channel melastatin member 8) is primarily expressed in sensory neurons, where it constitutes the principal receptor of environmental innocuous cold. TRPM8 has been shown to be regulated by multiple influences such as phosphorylation, pH, Ca2+, and lipid messengers. One such messenger is arachidonic acid (AA), which has been shown to inhibit TRPM8 channel activity. However, the physiological pathways mediating the inhibitory effect of AA on TRPM8 still remain unknown. Here, we demonstrate that TRPM8 is regulated via M3 muscarinic acetylcholine receptor-coupled signaling cascade based on the activation of cytosolic phospholipase A2 (cPLA2) and cPLA2-catalyzed derivation of AA. Stimulation of M3 receptors heterologously co-expressed with TRPM8 in HEK-293 cells by nonselective muscarinic agonist, oxotremorine methiodide (Oxo-M), caused inhibition of TRPM8-mediated membrane current, which could be mimicked by AA and antagonized by pharmacological or siRNA-mediated cPLA2 silencing. Our results demonstrate the intracellular functional link between M3 receptor and TRPM8 channel via cPLA2/AA and suggest a novel physiological mechanism of arachidonate-mediated regulation of TRPM8 channel activity through muscarinic receptors. We also summarize the existing TRPM8 regulations and discuss their physiological and pathological significance.	[Bavencoffe, Alexis; Gkika, Dimitra; Mauroy, Brigitte; Prevarskaya, Natalia; Skryma, Roman] USTL, Inserm U1003, Equipe Labellise Ligue Natl Canc, F-59656 Villeneuve Dascq, France; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, AA Bogomolets Physiol Inst, UA-01024 Kiev, Ukraine; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Int Ctr Mol Physiol, UA-01024 Kiev, Ukraine; [Mauroy, Brigitte] Univ Catholique Lille, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; Universite Catholique de Lille	Prevarskaya, N (corresponding author), USTL, Inserm U1003, Equipe Labellise Ligue Natl Canc, F-59656 Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr; roman.skryma@univ-lille1.fr	Gkika, Dimitra/S-3054-2019; Shuba, Yaroslav/AAT-6758-2021	Gkika, Dimitra/0000-0001-8612-0836; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Kondratskyi, Artem/0000-0003-3290-0524; Prevarskaya, natacha/0000-0003-0316-197X	INSERM; La Ligue Nationale Contre le Cancer; le Ministere de l'Education Nationale; Region Nord/Pas-de-Calais; New Independent States of the Former Soviet Union [05-1000008-8223]; Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); le Ministere de l'Education Nationale; Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); New Independent States of the Former Soviet Union; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, La Ligue Nationale Contre le Cancer, le Ministere de l'Education Nationale, the Region Nord/Pas-de-Calais, and The international Association for the Promotion of Co-operation with Scientists from the New Independent States of the Former Soviet Union 05-1000008-8223.; Supported by a postdoctoral fellowship from the Institut National du Cancer.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bavencoffe A, 2010, J BIOL CHEM, V285, P9410, DOI 10.1074/jbc.M109.069377; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; De Petrocellis L, 2007, EXP CELL RES, V313, P1911, DOI 10.1016/j.yexcr.2007.01.008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GKIKA D, 2010, ONCOGENE IN PRESS; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Li Q, 2009, ONCOLOGY-BASEL, V77, P335, DOI 10.1159/000264627; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Osterhout JL, 2000, J BIOL CHEM, V275, P8248, DOI 10.1074/jbc.275.11.8248; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Shuttleworth TJ, 1998, J BIOL CHEM, V273, P32636, DOI 10.1074/jbc.273.49.32636; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Yang ZH, 2009, ASIAN J ANDROL, V11, P157, DOI 10.1038/aja.2009.1	44	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9849	9855		10.1074/jbc.M110.162016	http://dx.doi.org/10.1074/jbc.M110.162016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245133	Green Published, hybrid			2022-12-25	WOS:000288247700108
J	Chavarria, M; Santiago, C; Platero, R; Krell, T; Casasnovas, JM; de Lorenzo, V				Chavarria, Max; Santiago, Cesar; Platero, Raul; Krell, Tino; Casasnovas, Jose M.; de Lorenzo, Victor			Fructose 1-Phosphate Is the Preferred Effector of the Metabolic Regulator Cra of Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; ESCHERICHIA-COLI; LACTOSE REPRESSOR; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL ACTIVATION; PHOSPHOTRANSFERASE SYSTEM; GENE-EXPRESSION; PROTEIN; FRUR; ULTRACENTRIFUGATION	The catabolite repressor/activator (Cra) protein is a global sensor and regulator of carbon fluxes through the central metabolic pathways of Gram-negative bacteria. To examine the nature of the effector (or effectors) that signal such fluxes to the protein of Pseudomonas putida, the Cra factor of this soil microorganism has been purified and characterized and its three-dimensional structure determined. Analytical ultracentrifugation, gel filtration, and mobility shift assays showed that the effector-free Cra is a dimer that binds an operator DNA sequence in the promoter region of the fruBKA cluster. Furthermore, fructose 1-phosphate (F1P) was found to most efficiently dissociate the Cra-DNA complex. Thermodynamic parameters of the F1P-Cra-DNA interaction calculated by isothermal titration calorimetry revealed that the factor associates tightly to the DNA sequence 5'-TTAAACGTTTCA-3' (K-D = 26.3 +/- 3.1 nM) and that F1P binds the protein with an apparent stoichiometry of 1.06 +/- 0.06 molecules per Cra monomer and a K-D of 209 +/- 20 nM. Other possible effectors, like fructose 1,6-bisphosphate, did not display a significant affinity for the regulator under the assay conditions. Moreover, the structure of Cra and its co-crystal with F1P at a 2-angstrom resolution revealed that F1P fits optimally the geometry of the effector pocket. Our results thus single out F1P as the preferred metabolic effector of the Cra protein of P. putida.	[Chavarria, Max; Platero, Raul; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid 28049, Spain; [Santiago, Cesar; Casasnovas, Jose M.] CSIC, Ctr Nacl Biotecnol, Xray Crystallog Unit, Madrid 28049, Spain; [Krell, Tino] CSIC, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Campus Cantoblanco, Madrid 28049, Spain.	vdlorenzo@cnb.csic.es	Chavarria, Max/J-3940-2019; Casasnovas, Jose M/L-6299-2014; Krell, Tino/G-7296-2015; Santiago, César/K-4240-2014	Chavarria, Max/0000-0001-5901-3576; Casasnovas, Jose M/0000-0002-2873-6410; Krell, Tino/0000-0002-9040-3166; Santiago, César/0000-0002-5149-1722; Platero, Raul/0000-0001-5331-1396; de Lorenzo, Victor/0000-0002-6041-2731	Spanish Ministry of Science and Innovation; European Union; Autonomous Community of Madrid; Universidad de Costa Rica; CSIC; Centro Nacional de Biotecnologia; Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Autonomous Community of Madrid; Universidad de Costa Rica; CSIC; Centro Nacional de Biotecnologia; Consejo Superior de Investigaciones Cientificas	This work was supported by grants of the CONSOLIDER program of the Spanish Ministry of Science and Innovation, by the BACSINE and MICROME Contracts of the European Union, and by funds of the Autonomous Community of Madrid. This work was also supported by a doctoral scholarship of the Universidad de Costa Rica and the CSIC (to M.C.). C.S. was supported by the Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bledig SA, 1996, J BACTERIOL, V178, P280, DOI 10.1128/jb.178.1.280-283.1996; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHEN J, 1992, J BIOL CHEM, V267, P13843; Cole JL, 2004, METHOD ENZYMOL, V384, P212; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Daddaoua A, 2010, J BACTERIOL, V192, P4357, DOI 10.1128/JB.00520-10; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Krell T., 2007, PSEUDOMONAS MODEL SY, P255; Laue T, 1992, ULTRACENTRIFUGATION, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller J. H., 1972, EXPT MOL GENETICS, P431; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Negre D, 1998, J MOL BIOL, V276, P355, DOI 10.1006/jmbi.1997.1548; Negre D, 1996, MOL MICROBIOL, V21, P257, DOI 10.1046/j.1365-2958.1996.6341350.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Ow DSW, 2007, J BIOTECHNOL, V131, P261, DOI 10.1016/j.jbiotec.2007.07.508; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Pfluger K, 2008, J BACTERIOL, V190, P3374, DOI 10.1128/JB.02002-07; Prost JF, 1999, J BACTERIOL, V181, P893, DOI 10.1128/JB.181.3.893-898.1999; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2; SAWYER MH, 1977, ARCH MICROBIOL, V112, P49, DOI 10.1007/BF00446653; SCARABEL M, 1995, GENE, V153, P9, DOI 10.1016/0378-1119(94)00660-K; Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velazquez F, 2004, J BACTERIOL, V186, P8267, DOI 10.1128/JB.186.24.8267-8275.2004; Velazquez F, 2007, J BACTERIOL, V189, P4529, DOI 10.1128/JB.00033-07; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Wilson CJ, 2005, P NATL ACAD SCI USA, V102, P14563, DOI 10.1073/pnas.0505808102	53	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9351	9359		10.1074/jbc.M110.187583	http://dx.doi.org/10.1074/jbc.M110.187583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239488	hybrid, Green Published			2022-12-25	WOS:000288247700064
J	Chuang, TW; Peng, PJ; Tarn, WY				Chuang, Tzu-Wei; Peng, Pey-Jey; Tarn, Woan-Yuh			The Exon Junction Complex Component Y14 Modulates the Activity of the Methylosome in Biogenesis of Spliceosomal Small Nuclear Ribonucleoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSKAR MESSENGER-RNA; SM PROTEINS; BINDING PROTEIN; IMPORTIN-BETA; PRMT5; METHYLATION; CORE; SNRNPS; PICLN; GENE	The RNA-binding protein Y14 heterodimerizes with Mago as the core of the exon junction complex during precursor mRNA splicing and plays a role in mRNA surveillance in the cytoplasm. Using the Y14/Magoh heterodimer as bait in a screening for its interacting partners, we identified the protein-arginine methyltransferase PRMT5 as a candidate. We show that Y14 and Magoh, but not other factors of the exon junction complex, interact with the cytoplasmic PRMT5-containing methylosome. We further provide evidence that Y14 promoted the activity of PRMT5 in methylation of Sm proteins of the small nuclear ribonucleoprotein core, whereas knockdown of Y14 reduced their methylation level. Moreover, Y14 overexpression induced the formation of a large, active, and small nuclear ribonucleoprotein (snRNP)-associated methylosome complex. However, Y14 may only transiently associate with the snRNP assembly complex in the cytoplasm. Together, our results suggest that Y14 facilitates Sm protein methylation probably by its activity in promoting the formation or stability of the methylosome-containing complex. We hypothesize that Y14 provides a regulatory link between pre-mRNA splicing and snRNP biogenesis.	[Chuang, Tzu-Wei; Peng, Pey-Jey; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chuang, Tzu-Wei] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd Sect 2, Taipei 11529, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		Academia Sinica investigator award	Academia Sinica investigator award(Academia Sinica - Taiwan)	This work was supported by an Academia Sinica investigator award (to W.-Y.T.).	BLACK DL, 1989, MOL CELL BIOL, V9, P3350, DOI 10.1128/MCB.9.8.3350; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Mohr SE, 2001, GENE DEV, V15, P2886; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	43	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8722	8728		10.1074/jbc.M110.190587	http://dx.doi.org/10.1074/jbc.M110.190587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209085	Green Published, hybrid			2022-12-25	WOS:000288247700003
J	Costa, MJ; So, AYL; Kaasik, K; Krueger, KC; Pillsbury, ML; Fu, YH; Ptacek, LJ; Yamamoto, KR; Feldman, BJ				Costa, Maria Jose; So, Alex Y. -L.; Kaasik, Krista; Krueger, Katherine C.; Pillsbury, Marlisa L.; Fu, Ying-Hui; Ptacek, Louis J.; Yamamoto, Keith R.; Feldman, Brian J.			Circadian Rhythm Gene Period 3 Is an Inhibitor of the Adipocyte Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; INSULIN-RESISTANCE; MAMMALIAN CLOCK; PPAR-GAMMA; OBESITY; TIME; ADIPOGENESIS; OSCILLATORS; FIBROBLASTS; EXPRESSION	Glucocorticoids rapidly and robustly induce cell fate decisions in various multipotent cells, although the precise mechanisms of these important cellular events are not understood. Here we showed that glucocorticoids repressed Per3 expression and that this repression was critical for advancing mesenchymal stem cells to the adipocyte fate. Exogenous expression of Per3 inhibited adipogenesis, whereas knocking out Per3 enhanced that fate. Moreover, we found that PER3 formed a complex with PPAR gamma and inhibited PPAR gamma-mediated transcriptional activation via Ppar gamma response elements. Consistent with these findings, Per3 knock-out mice displayed alterations in body composition, with both increased adipose and decreased muscle tissue compared with wild-type mice. Our findings identify Per3 as potent mediator of cell fate that functions by altering the transcriptional activity of PPAR gamma.	[Costa, Maria Jose; Krueger, Katherine C.; Feldman, Brian J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Feldman, Brian J.] Stanford Univ, Program Regenerat Med, Stanford, CA 94305 USA; [So, Alex Y. -L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [So, Alex Y. -L.; Pillsbury, Marlisa L.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Kaasik, Krista; Fu, Ying-Hui; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Feldman, BJ (corresponding author), Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA.	feldman@stanford.edu	Costa, Maria Jose/I-7754-2013	Costa, Maria Jose/0000-0001-6111-7614	National Institutes of Health [1-DP2-OD006740, DK73697, CA20535, HL59596, T32 DK007217-35, GM 56847]; Stanford Dean's Fellowship; NATIONAL CANCER INSTITUTE [R37CA020535, R01CA020535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073697, T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Dean's Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award Program 1-DP2-OD006740 (to B. J. F.) and Grants DK73697 (to B. J. F.), CA20535 (to K. R. Y.), and HL59596 (to Y.-H. F. and L. J. P.).; Funded in part by a Stanford Dean's Fellowship award.; Funded in part by National Institutes of Health Training Grant T32 DK007217-35.; Funded in part by National Institutes of Health Training Grant GM 56847.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bae K, 2007, J BIOL RHYTHM, V22, P85, DOI 10.1177/0748730406296718; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Feldman BJ, 2009, PEDIATR RES, V65, P249, DOI 10.1203/PDR.0b013e3181989667; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Roberge C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1465, DOI 10.1152/ajpendo.00516.2007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	44	69	76	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9063	9070		10.1074/jbc.M110.164558	http://dx.doi.org/10.1074/jbc.M110.164558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228270	Green Published, hybrid			2022-12-25	WOS:000288247700037
J	Sricholpech, M; Perdivara, I; Nagaoka, H; Yokoyama, M; Tomer, KB; Yamauchi, M				Sricholpech, Marnisa; Perdivara, Irina; Nagaoka, Hideaki; Yokoyama, Megumi; Tomer, Kenneth B.; Yamauchi, Mitsuo			Lysyl Hydroxylase 3 Glucosylates Galactosylhydroxylysine Residues in Type I Collagen in Osteoblast Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; BONE-COLLAGEN; GALACTOSYL-HYDROXYLYSINE; POSTTRANSLATIONAL MODIFICATIONS; OSTEOGENESIS IMPERFECTA; LYSINE HYDROXYLATION; TRABECULAR BONE; LYSYL-HYDROXYLASE-3 LH3; BIOCHEMICAL MARKER; URINARY-EXCRETION	Lysyl hydroxylase 3 (LH3), encoded by Plod3, is the multifunctional collagen-modifying enzyme possessing LH, hydroxylysine galactosyltransferase (GT), and galactosylhydroxylysine-glucosyltransferase (GGT) activities. Although an alteration in type I collagen glycosylation has been implicated in several osteogenic disorders, the role of LH3 in bone physiology has never been investigated. To elucidate the function of LH3 in bone type I collagen modifications, we used a short hairpin RNA technology in a mouse osteoblastic cell line, MC3T3-E1; generated single cell-derived clones stably suppressing LH3 (short hairpin (Sh) clones); and characterized the phenotype. Plod3 expression and the LH3 protein levels in the Sh clones were significantly suppressed when compared with the controls, MC3T3-E1, and the clone transfected with an empty vector. In comparison with controls, type I collagen synthesized by Sh clones (Sh collagen) showed a significant decrease in the extent of glucosylgalactosylhydroxylysine with a concomitant increase of galactosylhydroxylysine, whereas the total number of hydroxylysine residues was essentially unchanged. In an in vitro fibrillogenesis assay, Sh collagen showed accelerated fibrillogenesis compared with the controls. In addition, when recombinant LH3-V5/His protein was generated in 293 cells and subjected to GGT/GT activity assay, it showed GGT but not GT activity against denatured type I collagen. The results from this study clearly indicate that the major function of LH3 in osteoblasts is to glucosylate galactosylhydroxylysine residues in type I collagen and that an impairment of this LH3 function significantly affects type I collagen fibrillogenesis.	[Sricholpech, Marnisa; Nagaoka, Hideaki; Yokoyama, Megumi; Yamauchi, Mitsuo] Univ N Carolina, NC Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yamauchi, M (corresponding author), Univ N Carolina, NC Oral Hlth Inst, Sch Dent, CB 7454, Chapel Hill, NC 27599 USA.	mitsuo_yamauchi@dentistry.unc.edu	Tomer, Kenneth B/E-8018-2013	Sricholpech, Marnisa/0000-0003-2139-0688	National Institutes of Health [R21DE019569, R01 DE10489]; NIEHS [ES050171]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21DE019569 and R01 DE10489 and Intramural Research Program NIEHS Project ES050171.	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; Al-Dehaimi AW, 1999, CLIN CHEM, V45, P676; AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; ASKENASI R, 1973, BIOCHIM BIOPHYS ACTA, V304, P375, DOI 10.1016/0304-4165(73)90256-0; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Batge B, 1997, J BIOCHEM, V122, P109; Bettica P, 1996, J CLIN ENDOCR METAB, V81, P542, DOI 10.1210/jc.81.2.542; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; CETTA G, 1983, CONNECT TISSUE RES, V11, P103, DOI 10.3109/03008208309004847; CETTA G, 1982, BIOCHEM J, V204, P61, DOI 10.1042/bj2040061; CUNNINGH.LW, 1968, J BIOL CHEM, V243, P2390; CUNNINGHAM LW, 1967, J BIOL CHEM, V242, P2570; Dominguez LJ, 2005, BIOCHEM BIOPH RES CO, V330, P1, DOI 10.1016/j.bbrc.2005.02.050; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; EYRE DR, 1973, BIOCHEM BIOPH RES CO, V52, P663, DOI 10.1016/0006-291X(73)90764-X; EYRE DR, 1973, BIOCHEM J, V135, P393, DOI 10.1042/bj1350393; Garza H, 1996, J CHROMATOGR A, V732, P385, DOI 10.1016/0021-9673(95)01296-6; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; GUITTON JD, 1981, BIOSCIENCE REP, V1, P945, DOI 10.1007/BF01114964; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; LEHMANN HW, 1995, J CANCER RES CLIN, V121, P413, DOI 10.1007/BF01212948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOU MF, 1971, CLIN CHEM, V17, P782; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; MICHALSKY M, 1995, CLIN CHIM ACTA, V234, P101, DOI 10.1016/0009-8981(94)05981-W; MICHALSKY M, 1993, BIOCHEM BIOPH RES CO, V192, P1281, DOI 10.1006/bbrc.1993.1555; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P29; MORO L, 1993, BIOCHIM BIOPHYS ACTA, V1156, P288, DOI 10.1016/0304-4165(93)90044-9; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P269; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Myers LK, 2004, J IMMUNOL, V172, P2970, DOI 10.4049/jimmunol.172.5.2970; MYLLYLA R, 1975, EUR J BIOCHEM, V58, P517, DOI 10.1111/j.1432-1033.1975.tb02400.x; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; ODELL V, 1974, J CHROMATOGR, V88, P245, DOI 10.1016/S0021-9673(00)83148-9; OIKARINEN A, 1977, BIOCHEM J, V166, P357, DOI 10.1042/bj1660357; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Pecile A, 1996, J ENDOCRINOL, V150, P383, DOI 10.1677/joe.0.1500383; PECZON BD, 1979, J CHROMATOGR, V169, P351, DOI 10.1016/0021-9673(75)85060-6; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; RAUCH F, 1995, J CLIN ENDOCR METAB, V80, P1295, DOI 10.1210/jc.80.4.1295; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; ROBINS SP, 1983, BIOCHEM J, V215, P167, DOI 10.1042/bj2150167; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TENNI R, 1993, AM J MED GENET, V45, P252, DOI 10.1002/ajmg.1320450219; TENNI R, 1984, ITAL J BIOCHEM, V33, P117; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2000, DNA CELL BIOL, V19, P71, DOI 10.1089/104454900314582; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x; Zuurmond AM, 2005, MATRIX BIOL, V24, P261, DOI 10.1016/j.matbio.2005.04.002	78	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8846	8856		10.1074/jbc.M110.178509	http://dx.doi.org/10.1074/jbc.M110.178509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220425	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000288247700015
J	Di Stefano, V; Giacca, M; Capogrossi, MC; Crescenzi, M; Martelli, F				Di Stefano, Valeria; Giacca, Mauro; Capogrossi, Maurizio C.; Crescenzi, Marco; Martelli, Fabio			Knockdown of Cyclin-dependent Kinase Inhibitors Induces Cardiomyocyte Re-entry in the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; GROWTH-FACTOR-I; CARDIAC MYOCYTES; MYOCARDIAL REGENERATION; CARDIOVASCULAR-DISEASE; ADULT CARDIOMYOCYTES; SKELETAL-MUSCLE; GENE-EXPRESSION; MICE LACKING; MAMMALIAN CARDIOMYOCYTES	Proliferation of mammalian cardiomyocytes stops rapidly after birth and injured hearts do not regenerate adequately. High cyclin-dependent kinase inhibitor (CKI) levels have been observed in cardiomyocytes, but their role in maintaining cardiomyocytes in a post-mitotic state is still unknown. In this report, it was investigated whether CKI knockdown by RNA interference induced cardiomyocyte proliferation. We found that triple transfection with p21(Waf1), p27(Kip1), and p57(Kip2) siRNAs induced both neonatal and adult cardiomyocyte to enter S phase and increased the nuclei/cardiomyocyte ratio; furthermore, a subpopulation of cardiomyocytes progressed beyond karyokynesis, as assessed by the detection of mid-body structures and by straight cardiomyocyte counting. Intriguingly, cardiomyocyte proliferation occurred in the absence of overt DNA damage and aberrant mitotic figures. Finally, CKI knockdown and DNA synthesis reactivation correlated with a dramatic change in adult cardiomyocyte morphology that may be a prerequisite for cell division. In conclusion, CKI expression plays an active role in maintaining cardiomyocyte withdrawal from the cell cycle.	[Capogrossi, Maurizio C.; Martelli, Fabio] Ist Dermopat Immacolata IRCCS, Vasc Pathol Lab, I-00167 Rome, Italy; [Di Stefano, Valeria] IRCCS Policlin San Donato, Mol Cardiol Lab, I-20097 San Donato Milanese, Italy; [Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy; [Crescenzi, Marco] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Policlinico San Donato; International Center for Genetic Engineering & Biotechnology (ICGEB); Istituto Superiore di Sanita (ISS)	Martelli, F (corresponding author), Ist Dermopat Immacolata IRCCS, Vasc Pathol Lab, Via Monti Creta 104, I-00167 Rome, Italy.	f.martelli@idi.it	Giacca, Mauro/J-9287-2016; Crescenzi, Marco/J-3603-2018; Martelli, Fabio/AAL-3788-2020	Giacca, Mauro/0000-0003-2927-7225; Crescenzi, Marco/0000-0003-0156-1494; Martelli, Fabio/0000-0002-8624-7738	Ministero della Salute [RF06, RF07, RC09-11]	Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by Ministero della Salute (RF06, RF07, and RC09-11).	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bicknell KA, 2003, J PHARM PHARMACOL, V55, P571, DOI 10.1211/002235703765344487; Bicknell KA, 2008, CURR OPIN PHARMACOL, V8, P193, DOI 10.1016/j.coph.2007.12.015; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Borges A, 1997, J MOL CELL CARDIOL, V29, P2717, DOI 10.1006/jmcc.1997.0503; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Busk PK, 2003, CELL CYCLE, V2, P91, DOI 10.4161/cc.2.2.298; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; CAPASSO JM, 1992, AM J PHYSIOL, V262, pH486, DOI 10.1152/ajpheart.1992.262.2.H486; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gowdak LHW, 2000, CIRCULATION, V102, P565; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Haley Sheila A., 2008, BMC Physiology, V8, P4, DOI 10.1186/1472-6793-8-4; Harper JW, 1997, CANCER SURV, V29, P91; Hosoda T, 2010, CIRC J, V74, P13, DOI 10.1253/circj.CJ-09-0665; Kajstura J, 2006, ANTIOXID REDOX SIGN, V8, P2125, DOI 10.1089/ars.2006.8.2125; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koh KN, 1998, J MOL CELL CARDIOL, V30, P463, DOI 10.1006/jmcc.1997.0611; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Leri A, 2008, CURR PROB CARDIOLOGY, V33, P91, DOI 10.1016/j.cpcardiol.2007.11.002; Li GM, 1998, CIRCULATION, V98, pII144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; MUHLHAUSER J, 1995, CIRC RES, V77, P1077, DOI 10.1161/01.RES.77.6.1077; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Orlandi A, 2008, AM J PHYSIOL-HEART C, V294, pH1541, DOI 10.1152/ajpheart.01285.2007; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; Schluter KD, 1999, AM J PHYSIOL-HEART C, V276, pH1655, DOI 10.1152/ajpheart.1999.276.5.H1655; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Shay JW, 2001, SCIENCE, V291, P839, DOI 10.1126/science.1058546; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stephen MJ, 2009, OPEN CARDIOVASC MED, V3, P1, DOI 10.2174/1874192400903010001; Tamamori-Adachi M, 2008, CELL CYCLE, V7, P3768, DOI 10.4161/cc.7.23.7239; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Westbury J, 2001, MECH DEVELOP, V109, P83, DOI 10.1016/S0925-4773(01)00512-3; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Williams GT, 2006, GENE THER MOL BIOL, V10B, P255; Woo YJ, 2007, J THORAC CARDIOV SUR, V133, P927, DOI 10.1016/j.jtcvs.2006.07.057; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	82	57	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8644	8654		10.1074/jbc.M110.184549	http://dx.doi.org/10.1074/jbc.M110.184549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209082	Green Published, hybrid			2022-12-25	WOS:000288013300090
J	Neutzner, A; Neutzner, M; Benischke, AS; Ryu, SW; Frank, S; Youle, RJ; Karbowski, M				Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie; Ryu, Seung-Wook; Frank, Stephan; Youle, Richard J.; Karbowski, Mariusz			A Systematic Search for Endoplasmic Reticulum (ER) Membrane-associated RING Finger Proteins Identifies Nixin/ZNRF4 as a Regulator of Calnexin Stability and ER Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; UBIQUITIN; LIGASE; DEGRADATION; PROTEOMICS; MEDIATORS; PATHWAYS; TOPOLOGY; DATABASE	To identify novel regulators of endoplasmic reticulum (ER)-linked protein degradation and ER function, we determined the entire inventory of membrane-spanning RING finger E3 ubiquitin ligases localized to the ER. We identified 24 ER membrane-anchored ubiquitin ligases and found Nixin/ZNRF4 to be central for the regulation of calnexin turnover. Ectopic expression of wild type Nixin induced a dramatic down-regulation of the ER-localized chaperone calnexin that was prevented by inactivation of the Nixin RING domain. Importantly, Nixin physically interacts with calnexin in a glycosylation-independent manner, induces calnexin ubiquitination, and p97-dependent degradation, indicating an ER-associated degradation-like mechanism of calnexin turnover.	[Neutzner, Albert; Ryu, Seung-Wook; Youle, Richard J.; Karbowski, Mariusz] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie] Univ Basel Hosp, Univ Eye Clin, CH-4031 Basel, Switzerland; [Neutzner, Melanie; Frank, Stephan] Univ Basel, Inst Pathol, Dept Neuropathol, CH-4031 Basel, Switzerland; [Ryu, Seung-Wook] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Karbowski, Mariusz] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Karbowski, Mariusz] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Basel; University of Basel; University of Basel; Korea Advanced Institute of Science & Technology (KAIST); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Neutzner, A (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	albert.neutzner@unibas.ch; mkarbowski@umaryland.edu	Neutzner, Albert/ABC-4368-2020	Neutzner, Albert/0000-0001-9254-5558	National Institutes of Health from NIGMS [RO1 GM083131]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123, ZIANS003127] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM083131 from NIGMS (to M. K.).	Ain Q, 2007, HUM GENET, V122, P445, DOI 10.1007/s00439-007-0418-z; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Fujii T, 1999, GENOMICS, V57, P94, DOI 10.1006/geno.1998.5738; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hirsch C, 2004, BBA-MOL CELL RES, V1695, P215, DOI 10.1016/j.bbamcr.2004.10.006; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Laney J. D., 2002, CURRENT PROTOCOLS PR, P1; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Oliver JD, 1996, J BIOL CHEM, V271, P13691, DOI 10.1074/jbc.271.23.13691; PIND S, 1994, J BIOL CHEM, V269, P12784; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang Q, 2009, CELL RES, V19, P348, DOI 10.1038/cr.2008.285	38	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8633	8643		10.1074/jbc.M110.197459	http://dx.doi.org/10.1074/jbc.M110.197459			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205830	hybrid, Green Published			2022-12-25	WOS:000288013300089
J	Voxeur, A; Gilbert, L; Rihouey, C; Driouich, A; Rothan, C; Baldet, P; Lerouge, P				Voxeur, Aline; Gilbert, Louise; Rihouey, Christophe; Driouich, Azeddine; Rothan, Christophe; Baldet, Pierre; Lerouge, Patrice			Silencing of the GDP-D-mannose 3,5-Epimerase Affects the Structure and Cross-linking of the Pectic Polysaccharide Rhamnogalacturonan II and Plant Growth in Tomato	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDE; BORATE ESTER; ARABIDOPSIS; MUTANT; DIMER; BIOSYNTHESIS; PATHWAYS; FUCOSE	L-Galactose (L-Gal), a monosaccharide involved in L-ascorbate and rhamnogalacturonan II (RG-II) biosynthesis in plants, is produced in the cytosol by a GDP-D-mannose 3,5-epimerase (GME). It has been recently reported that the partial inactivation of GME induced growth defects affecting both cell division and cell expansion (Gilbert, L., Alhagdow, M., Nunes-Nesi, A., Quemener, B., Guillon, F., Bouchet, B., Faurobert, M., Gouble, B., Page, D., Garcia, V., Petit, J., Stevens, R., Causse, M., Fernie, A. R., Lahaye, M., Rothan, C., and Baldet, P. (2009) Plant J. 60, 499-508). In the present study, we show that the silencing of the two GME genes in tomato leaves resulted in approximately a 60% decrease in terminal L-Gal content in the side chain A of RG-II as well as in a lower capacity of RG-II to perform in muro cross-linking. In addition, we show that unlike supplementation with L-Gal or ascorbate, supplementation of GME-silenced lines with boric acid was able to restore both the wild-type growth phenotype of tomato seedlings and an efficient in muro boron-mediated cross-linking of RG-II. Our findings suggest that developmental phenotypes in GME-deficient lines are due to the structural alteration of RG-II and further underline the crucial role of the cross-linking of RG-II in the formation of the pectic network required for normal plant growth and development.	[Voxeur, Aline; Driouich, Azeddine; Lerouge, Patrice] Univ Rouen, Inst Federatif Rech 23, Equipe Associee 4358, Lab Glycobiol & Matrice Extracellulaire Vegetale, F-76821 Mont St Aignan, France; [Rihouey, Christophe] Univ Rouen, Inst Federatif Rech 23, UMR 6270, F-76821 Mont St Aignan, France; [Gilbert, Louise; Rothan, Christophe; Baldet, Pierre] Univ Bordeaux, Inst Federatif Rech 103, Inst Natl Rech Agron, UMR Biol Fruit 619, F-33883 Villenave Dornon, France	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Lerouge, P (corresponding author), Univ Rouen, Lab Glyco MEV, UPRES EA 4358, IFRMP 23, F-76821 Mont St Aignan, France.	patrice.lerouge@univ-rouen.fr	Voxeur, Aline/O-7149-2015; Voxeur, Aline/C-1117-2011	Voxeur, Aline/0000-0001-9452-6756; Baldet, Pierre/0000-0001-7351-1803; ROTHAN, Christophe/0000-0002-6831-2823	University of Rouen	University of Rouen	This work was supported by the University of Rouen.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Doco T, 1997, CARBOHYD RES, V297, P181, DOI 10.1016/S0008-6215(96)00260-1; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Noguchi K, 1997, PLANT PHYSIOL, V115, P901, DOI 10.1104/pp.115.3.901; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; SPELLMAN MW, 1983, CARBOHYD RES, V122, P131, DOI 10.1016/0008-6215(83)88413-4; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034	23	40	43	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8014	8020		10.1074/jbc.M110.198614	http://dx.doi.org/10.1074/jbc.M110.198614			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224383	Green Published, hybrid			2022-12-25	WOS:000288013300032
J	Zhu, XD; Zhuang, Y; Ben, JJ; Qian, LL; Huang, HP; Bai, H; Sha, JH; He, ZG; Chen, Q				Zhu, Xu-Dong; Zhuang, Yan; Ben, Jing-Jing; Qian, Ling-Ling; Huang, Han-Peng; Bai, Hui; Sha, Jia-Hao; He, Zhi-Gang; Chen, Qi			Caveolae-dependent Endocytosis Is Required for Class A Macrophage Scavenger Receptor-mediated Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; CYTOPLASMIC DOMAIN; LIPID UPTAKE; PLASMA-MEMBRANE; CLATHRIN; ATHEROSCLEROSIS; INTERNALIZATION; BINDING; CHOLESTEROL	SR-A (classAmacrophage scavenger receptor) is a transmembrane receptor that can bind many different ligands, including modified lipoproteins that are relevant to the development of vascular diseases. However, the precise endocytic pathways of SR-A/mediated ligands internalization are not fully characterized. In this study, we show that the SR-A/ligand complex can be endocytosed by both clathrin-and caveolae-dependent pathways. Internalizations of SR-A-lipoprotein (such as acLDL) complexes primarily go through clathrin-dependent endocytosis. In contrast, macrophage apoptosis triggered by SR-A-fucoidan internalization requires caveolae-dependent endocytosis. The caveolae-dependent process activates p38 kinase and JNK signaling, whereas the clathrin-mediated endocytosis elicits ERK signaling. Our results suggest that different SR-A endocytic pathways have distinct functional consequences due to the activation of different signaling cascades in macrophages.	[Zhu, Xu-Dong; Zhuang, Yan; Ben, Jing-Jing; Qian, Ling-Ling; Huang, Han-Peng; Bai, Hui; Chen, Qi] Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Human Funct Genom, Nanjing 210029, Peoples R China; [Zhu, Xu-Dong; Sha, Jia-Hao; Chen, Qi] Nanjing Med Univ, Inst Reprod Med, Nanjing 210029, Peoples R China; [He, Zhi-Gang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Nanjing Medical University; Nanjing Medical University; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, Q (corresponding author), Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Human Funct Genom, Nanjing 210029, Peoples R China.	qichen@njmu.edu.cn			National Natural Science Foundation of China [30730044, 81070120, 81000118]; National Basic Research Program (973) [2011CB503900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730044 and 81070120 and National Basic Research Program (973) Grant 2011CB503900 (to Q.C.) and National Natural Science Foundation of China Grant 81000118 (to J.-J.B.).	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Ben JJ, 2009, J MOL CELL CARDIOL, V47, P646, DOI 10.1016/j.yjmcc.2009.08.011; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen Y, 2006, ARTERIOSCL THROM VAS, V26, P1317, DOI 10.1161/01.ATV.0000220171.50282.0c; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Jones NL, 2000, ARTERIOSCL THROM VAS, V20, P773, DOI 10.1161/01.ATV.20.3.773; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liao HS, 1999, ARTERIOSCL THROM VAS, V19, P1872, DOI 10.1161/01.ATV.19.8.1872; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; MOMMAASKIENHUIS AM, 1985, HISTOCHEMISTRY, V83, P29, DOI 10.1007/BF00495296; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Morimoto K, 1999, BIOL PHARM BULL, V22, P1022; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Wang XH, 2009, BBA-MOL CELL BIOL L, V1791, P76, DOI 10.1016/j.bbalip.2008.10.011; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006	49	86	87	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8231	8239		10.1074/jbc.M110.145888	http://dx.doi.org/10.1074/jbc.M110.145888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205827	hybrid, Green Published			2022-12-25	WOS:000288013300053
J	Bock, J; Fukuyo, Y; Kang, S; Phipps, ML; Alexandrov, LB; Rasmussen, KO; Bishop, AR; Rosen, ED; Martinez, JS; Chen, HT; Rodriguez, G; Alexandrov, BS; Usheva, A				Bock, Jonathan; Fukuyo, Yayoi; Kang, Sona; Phipps, M. Lisa; Alexandrov, Ludmil B.; Rasmussen, Kim O.; Bishop, Alan R.; Rosen, Evan D.; Martinez, Jennifer S.; Chen, Hou-Tong; Rodriguez, George; Alexandrov, Boian S.; Usheva, Anny			Mammalian Stem Cells Reprogramming in Response to Terahertz Radiation	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR RECEPTOR; DNA; ACTIVATION; DYNAMICS; MODEL	We report that extended exposure to broad-spectrum terahertz radiation results in specific changes in cellular functions that are closely related to DNA-directed gene transcription. Our gene chip survey of gene expression shows that whereas 89% of the protein coding genes in mouse stem cells do not respond to the applied terahertz radiation, certain genes are activated, while other are repressed. RT-PCR experiments with selected gene probes corresponding to transcripts in the three groups of genes detail the gene specific effect. The response was not only gene specific but also irradiation conditions dependent. Our findings suggest that the applied terahertz irradiation accelerates cell differentiation toward adipose phenotype by activating the transcription factor peroxisome proliferator-activated receptor gamma (PPARG). Finally, our molecular dynamics computer simulations indicate that the local breathing dynamics of the PPARG promoter DNA coincides with the gene specific response to the THz radiation. We propose that THz radiation is a potential tool for cellular reprogramming.	[Bock, Jonathan; Fukuyo, Yayoi; Kang, Sona; Alexandrov, Ludmil B.; Rosen, Evan D.; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Phipps, M. Lisa; Martinez, Jennifer S.; Chen, Hou-Tong; Rodriguez, George] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM USA; [Rasmussen, Kim O.; Bishop, Alan R.; Alexandrov, Boian S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Bock, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	Rasmussen, Kim O/B-5464-2009; Rodriguez, George/G-7571-2012; Alexandrov, Ludmil/AAS-1454-2021; Alexandrov, Boian/D-2488-2010; Chen, Hou-Tong/C-6860-2009; Alexandrov, Ludmil/B-6582-2014	Rasmussen, Kim O/0000-0002-4029-4723; Rodriguez, George/0000-0002-6044-9462; Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Boian/0000-0001-8636-4603; Chen, Hou-Tong/0000-0003-2014-7571; Alexandrov, Ludmil/0000-0003-3596-4515	U.S. Department of Energy, Office of Basic Energy Sciences [DE- AC52-06NA25396]; Sandia National Laboratories [DE- AC04-94AL85000]; NIH [R01GM73911]; Richard and Susan Smith Family Foundation [ADA 1-08-PPG-02]; NIH ARRA supplement [3R01GM73911-4S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Sandia National Laboratories(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard and Susan Smith Family Foundation; NIH ARRA supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed, in part, at the Center for Integrated Nanotechnologies, U.S. Department of Energy, Office of Basic Energy Sciences user facility at Los Alamos National Laboratory (Contract DE- AC52-06NA25396) and Sandia National Laboratories (Contract DE- AC04-94AL85000); NIH grants R01GM73911; NIH ARRA supplement (3R01GM73911-4S1); Richard and Susan Smith Family Foundation Pinnacle Award ADA 1-08-PPG-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2010, PHYS LETT A, V374, P1214, DOI 10.1016/j.physleta.2009.12.077; Alexandrov B, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034107; Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Alexandrov BS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000313; Alexandrov BS, 2009, NUCLEIC ACIDS RES, V37, P2405, DOI 10.1093/nar/gkp016; BAXA CA, 1989, BIOCHEMISTRY-US, V28, P8683, DOI 10.1021/bi00448a003; Cherkasova OP, 2009, OPT SPECTROSC+, V107, P534, DOI 10.1134/S0030400X09100063; Choi CH, 2004, BIOPHYS CHEM, V111, P9, DOI 10.1016/j.bpc.2004.03.007; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; Choi CH, 2008, BIOPHYS J, V95, P597, DOI 10.1529/biophysj.107.123471; Davies AG, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70016-6; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Kauzmann W, 1942, REV MOD PHYS, V14, P0012, DOI 10.1103/RevModPhys.14.12; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Kim KY, 2008, NAT PHOTONICS, V2, P605, DOI 10.1038/nphoton.2008.153; Korenstein-Ilan A, 2008, RADIAT RES, V170, P224, DOI 10.1667/RR0944.1; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Olshevskaya JS, 2008, 2008 IEEE REGION 8 INTERNATIONAL CONFERENCE ON COMPUTATIONAL TECHNOLOGIES IN ELECTRICAL AND ELECTRONICS ENGINEERING: SIBIRCON 2008, PROCEEDINGS, P210, DOI 10.1109/SIBIRCON.2008.4602607; Orlando AR, 2009, J INFRARED MILLIM TE, V30, P1308, DOI 10.1007/s10762-009-9561-z; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; Sherwin MS, 2004, OPPORTUNITIES THZ SC; Shiurba R, 2006, PHOTOCH PHOTOBIO SCI, V5, P799, DOI 10.1039/b601741j; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Woolard DL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051903; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	35	94	103	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15806	10.1371/journal.pone.0015806	http://dx.doi.org/10.1371/journal.pone.0015806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209821	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900036
J	Dahmani-Mardas, F; Troadec, C; Boualem, A; Leveque, S; Alsadon, AA; Aldoss, AA; Dogimont, C; Bendahmane, A				Dahmani-Mardas, Fatima; Troadec, Christelle; Boualem, Adnane; Leveque, Sylvie; Alsadon, Abdullah A.; Aldoss, Abdullah A.; Dogimont, Catherine; Bendahmane, Abdelhafid			Engineering Melon Plants with Improved Fruit Shelf Life Using the TILLING Approach	PLOS ONE			English	Article							ACC OXIDASE GENE; ISOPENICILLIN N-SYNTHASE; CUCUMIS-MELO; REVERSE GENETICS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; ETHYLENE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; CLIMACTERIC FRUIT; TRANSGENIC PLANTS	Background: Fruit ripening and softening are key traits that have an effect on food supply, fruit nutritional value and consequently, human health. Since ethylene induces ripening of climacteric fruit, it is one of the main targets to control fruit over ripening that leads to fruit softening and deterioration. The characterization of the ethylene pathway in Arabidopsis and tomato identified key genes that control fruit ripening. Methodology/Principal Findings: To engineer melon fruit with improved shelf-life, we conducted a translational research experiment. We set up a TILLING platform in a monoecious and climacteric melon line, cloned genes that control ethylene production and screened for induced mutations that lead to fruits with enhanced shelf life. Two missense mutations, L124F and G194D, of the ethylene biosynthetic enzyme, ACC oxidase 1, were identified and the mutant plants were characterized with respect to fruit maturation. The L124F mutation is a conservative mutation occurring away from the enzyme active site and thus was predicted to not affect ethylene production and thus fruit ripening. In contrast, G194D modification occurs in a highly conserved amino acid position predicted, by crystallographic analysis, to affect the enzymatic activity. Phenotypic analysis of the G194D mutant fruit showed complete delayed ripening and yellowing with improved shelf life and, as predicted, the L124F mutation did not have an effect. Conclusions/Significance: We constructed a mutant collection of 4023 melon M2 families. Based on the TILLING of 11 genes, we calculated the overall mutation rate of one mutation every 573 kb and identified 8 alleles per tilled kilobase. We also identified a TILLING mutant with enhanced fruit shelf life. This work demonstrates the effectiveness of TILLING as a reverse genetics tool to improve crop species. As cucurbits are model species in different areas of plant biology, we anticipate that the developed tool will be widely exploited by the scientific community.	[Dahmani-Mardas, Fatima; Troadec, Christelle; Boualem, Adnane; Bendahmane, Abdelhafid] UMR1165 ERL8196 INRA UEVE CNRS, Unite Rech Genom Vegetale, Evry, France; [Leveque, Sylvie; Dogimont, Catherine] INRA UR1052, Unite Genet & Ameliorat Fruits & Legumes, Montfavet, France; [Alsadon, Abdullah A.; Aldoss, Abdullah A.; Bendahmane, Abdelhafid] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; King Saud University	Dahmani-Mardas, F (corresponding author), UMR1165 ERL8196 INRA UEVE CNRS, Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021; Al-Doss, Abdullah/AAL-7883-2021; Al-Doss, Abdullah A/F-8539-2016	Boualem, Adnane/0000-0003-4428-6496; Al-Doss, Abdullah/0000-0003-3828-2384; Catherine, DOGIMONT/0000-0001-7399-768X; Bendahmane, Abdelhafid/0000-0003-3246-868X; TROADEC, Christelle/0000-0003-1927-7352	INRA-KSU Plant biotechnology network; MELRIP Plant-KBBE	INRA-KSU Plant biotechnology network; MELRIP Plant-KBBE	This work was supported by INRA-KSU Plant biotechnology network and the MELRIP Plant-KBBE program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, PLANT MOL BIOL, V54, P387, DOI 10.1023/B:PLAN.0000036371.30528.26; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boualem A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006144; BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Haritatos E, 1996, PLANTA, V198, P614, DOI 10.1007/BF00262649; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jeffrey C., 1990, BIOL UTILIZATION CUC, P3; Le Signor C, 2009, PLANT BIOTECHNOL J, V7, P430, DOI 10.1111/j.1467-7652.2009.00410.x; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Morales M, 2005, THEOR APPL GENET, V111, P914, DOI 10.1007/s00122-005-0019-y; Murray A. J., 1993, Postharvest Biology and Technology, V2, P301, DOI 10.1016/0925-5214(93)90035-2; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nunez-Palenius HG, 2006, PLANT CELL REP, V25, P198, DOI 10.1007/s00299-005-0042-0; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Perin C, 2002, PLANT PHYSIOL, V129, P300, DOI 10.1104/pp.010613; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; Silva JA, 2004, POSTHARVEST BIOL TEC, V32, P263, DOI 10.1016/j.postharvbio.2004.01.002; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van Leeuwen H, 2003, PLANT MOL BIOL, V51, P703, DOI 10.1023/A:1022573230486; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xiong AS, 2005, PLANT CELL REP, V23, P639, DOI 10.1007/s00299-004-0887-7; Zhang ZH, 2004, CHEM BIOL, V11, P1383, DOI 10.1016/j.chembiol.2004.08.012; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	68	77	78	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15776	10.1371/journal.pone.0015776	http://dx.doi.org/10.1371/journal.pone.0015776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209891	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600037
J	Porco, D; Bedos, A; Deharveng, L				Porco, David; Bedos, Anne; Deharveng, Louis			Cuticular Compounds Bring New Insight in the Post-Glacial Recolonization of a Pyrenean Area: Deutonura deficiens Deharveng, 1979 Complex, a Case Study	PLOS ONE			English	Article							CONTACT SEX-PHEROMONE; MEADOW GRASSHOPPER; HYBRID ZONE; AGGREGATION PHEROMONES; SPECIES DELIMITATION; HYDROCARBONS; COLLEMBOLA; DIVERGENCE; PATTERNS; LIPIDS	Background: In most Arthropod groups, the study of systematics and evolution rely mostly on neutral characters, in this context cuticular compounds, as non-neutral characters, represent an underexplored but potentially informative type of characters at the infraspecific level as they have been routinely proven to be involved in sexual attraction. Methods and Findings: The collembolan species complex Deutonura deficiens was chosen as a model in order to test the utility of these characters for delineating four infraspecific entities of this group. Specimens were collected for three subspecies (D.d. deficiens, D.d. meridionalis, D.d. sylvatica) and two morphotypes (D.d. sylvatica morphoype A and B) of the complex; an additional species D. monticola was added. Cuticular compounds were extracted and separated by gas chromatography for each individual. Our results demonstrate that cuticular compounds succeeded in separating the different elements of this complex. Those data allowed also the reconstruction of the phylogenetic relationships among them. Conclusions: The discriminating power of cuticular compounds is directly related to their involvement in sexual attraction and mate recognition. These findings allowed a discussion on the potential involvement of intrinsic and paleoclimatic factors in the origin and the diversification of this complex in the Pyrenean zone. This character type brings the first advance from pattern to process concerning the origin of this species complex.	[Porco, David] Univ Toulouse 3, Lab Dynam Biodiversite, F-31062 Toulouse, France; [Bedos, Anne; Deharveng, Louis] Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Museum National d'Histoire Naturelle (MNHN)	Porco, D (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	dporco@uoguelph.ca	Porco, David/D-7781-2011; Deharveng, Louis/D-7275-2012		Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS)	Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS)	This research was funded by the Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audzijonyte A, 2008, MAR BIOL, V155, P599, DOI 10.1007/s00227-008-1055-3; Austin JW, 2007, ZOOTAXA, P1; BAGINE RKN, 1994, ANN ENTOMOL SOC AM, V87, P498, DOI 10.1093/aesa/87.5.498; Baracchi D, 2010, J ZOOL SYST EVOL RES, V48, P109, DOI 10.1111/j.1439-0469.2009.00543.x; Benoit JB, 2009, J INSECT BEHAV, V22, P121, DOI 10.1007/s10905-008-9159-7; Buckley SH, 2003, BIOL J LINN SOC, V78, P193, DOI 10.1046/j.1095-8312.2003.00147.x; Buczkowski G, 2006, ANIM BEHAV, V71, P327, DOI 10.1016/j.anbehav.2005.04.012; Carlson DA, 1997, J AM MOSQUITO CONTR, V13, P103; CHAPMAN RF, 1995, BIOCHEM SYST ECOL, V23, P383, DOI 10.1016/0305-1978(95)00032-P; Clement Jean-Luc, 1998, P126; de Freitas TRO, 2006, GENETICA, V126, P227, DOI 10.1007/s10709-005-1451-2; DEHARVENG L, 1984, REV ECOL BIOL SOL, V21, P533; Deharveng L, 1998, BIOL J LINN SOC, V64, P527, DOI 10.1006/bijl.1998.0246; Driscoll DA, 2007, AUST J ZOOL, V55, P371, DOI 10.1071/ZO08020; Gava A, 2004, J MAMMAL, V85, P1201, DOI 10.1644/BEL-017.1; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Gonzalez J, 2008, J ORNITHOL, V149, P495, DOI 10.1007/s10336-008-0293-y; Guiot J, 1997, NATURE, V388, P25, DOI 10.1038/40282; Haverty MI, 2005, J CHEM ECOL, V31, P2119, DOI 10.1007/s10886-005-6081-8; Haverty MI, 1999, SOCIOBIOLOGY, V34, P1; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Higgie M, 2008, EVOLUTION, V62, P1192, DOI 10.1111/j.1558-5646.2008.00357.x; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; JOOSSE ENG, 1979, ENTOMOL EXP APPL, V26, P197, DOI 10.1111/j.1570-7458.1979.tb02917.x; Kaib M, 2002, PHYSIOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-3032.2002.00292.x; Kovats E, 1965, ADV CHROMATOGR, V1, P229; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Manica A, 2001, ENTOMOL EXP APPL, V99, P393, DOI 10.1023/A:1019227412274; Marten A, 2009, J CHEM ECOL, V35, P572, DOI 10.1007/s10886-009-9626-4; MERTENS J, 1977, BEHAV ECOL SOCIOBIOL, V2, P41, DOI 10.1007/BF00299287; Messer C, 1999, PEDOBIOLOGIA, V43, P174; Mpuru S, 2001, INSECT BIOCHEM MOLEC, V31, P139, DOI 10.1016/S0965-1748(00)00098-9; NEEMS RM, 1995, BIOL J LINN SOC, V54, P139, DOI 10.1006/bijl.1995.0008; Nelson DR, 2003, COMP BIOCHEM PHYS B, V135, P273, DOI 10.1016/S1096-4959(03)00080-0; Nojima S, 2007, J CHEM ECOL, V33, P923, DOI 10.1007/s10886-007-9266-5; Page M, 1997, J CHEM ECOL, V23, P1053, DOI 10.1023/B:JOEC.0000006388.92425.ec; Peterson MA, 2007, CHEMOECOLOGY, V17, P87, DOI 10.1007/s00049-007-0366-z; Porco D, 2004, PEDOBIOLOGIA, V48, P581, DOI 10.1016/j.pedobi.2004.05.010; Porco D, 2007, BIOCHEM SYST ECOL, V35, P160, DOI 10.1016/j.bse.2006.09.005; Porco D, 2009, PEDOBIOLOGIA, V53, P59, DOI 10.1016/j.pedobi.2009.03.003; Porco D, 2009, NATURWISSENSCHAFTEN, V96, P943, DOI 10.1007/s00114-009-0555-4; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; PURRINGTON FF, 1991, GREAT LAKES ENTOMOL, V24, P75; Rougerie R, 2006, PEDOBIOLOGIA, V50, P83, DOI 10.1016/j.pedobi.2005.09.003; Singer TL, 1998, AM ZOOL, V38, P394; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Sugeno W, 2006, APPL ENTOMOL ZOOL, V41, P269, DOI 10.1303/aez.2006.269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tregenza T, 2000, EVOLUTION, V54, P574, DOI 10.1111/j.0014-3820.2000.tb00060.x; Tregenza T, 2000, J CHEM ECOL, V26, P257, DOI 10.1023/A:1005457931869; Tregenza T, 2000, EVOLUTION, V54, P1; VERHOEF HA, 1977, J INSECT PHYSIOL, V23, P1009, DOI 10.1016/0022-1910(77)90128-7; Volobouev V, 2007, BIOL J LINN SOC, V91, P203, DOI 10.1111/j.1095-8312.2007.00773.x; WALDORF ES, 1974, ENVIRON ENTOMOL, V3, P916, DOI 10.1093/ee/3.6.916	55	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14405	10.1371/journal.pone.0014405	http://dx.doi.org/10.1371/journal.pone.0014405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21209797	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900015
J	Xiang, T; Jia, Y; Sherris, D; Li, S; Wang, H; Lu, D; Yang, Q				Xiang, T.; Jia, Y.; Sherris, D.; Li, S.; Wang, H.; Lu, D.; Yang, Q.			Targeting the Akt/mTOR pathway in Brca1-deficient cancers	ONCOGENE			English	Article						Brca1; PKB/Akt; mTOR	AKT ACTIVATION; PALOMID 529; CELL-CYCLE; MTOR; BRCA1; BREAST; EXPRESSION; GENE; INHIBITOR; GROWTH	The breast cancer susceptibility gene 1 (Brca1) has a key role in both hereditary and sporadic mammary tumorigenesis. However, the reasons why Brca1-deficiency leads to the development of cancer are not clearly understood. Activation of Akt kinase is one of the most common molecular alterations associated with human malignancy. Increased Akt kinase activity has been reported in most breast cancers. We previously found that downregulation of Brca1 expression or mutations of the Brca1 gene activate the Akt oncogenic pathway. To further investigate the role of Brca1/Akt in tumorigenesis, we analyzed Brca1/Akt expression in human breast cancer samples and found that reduced expression of Brca1 was highly correlated with increased phosphorylation of Akt. Consistent with the clinical data, knockdown of Akt1 by short-hairpin RNA inhibited cellular proliferation of Brca1 mutant cells. Importantly, depletion of Akt1 significantly reduced tumor formation induced by Brca1-deficiency in mice. The third generation inhibitor of mammalian target of rapamycin (mTOR), Palomid 529, significantly suppressed Brca1-deficient tumor growth in mice through inhibition of both Akt and mTOR signaling. Our results indicate that activation of Akt is involved in Brca1-deficiency mediated tumorigenesis and that the mTOR pathway can be used as a novel target for treatment of Brca1-deficient cancers. Oncogene (2011) 30, 2443-2450; doi:10.1038/onc.2010.603; published online 17 January 2011	[Yang, Q.] Washington Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, St Louis, MO 63108 USA; [Sherris, D.] Paloma Pharmaceut, Jamaica Plain, MA USA; [Li, S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA; [Li, S.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wang, H.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, St Louis, MO USA; [Lu, D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Cedars Sinai Medical Center; Washington University (WUSTL)	Yang, Q (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, 4511 Forest Pk, St Louis, MO 63108 USA.	qyang@wustl.edu			Susan G Komen Foundation; Siteman Cancer Center; NIH [CA129440]; NATIONAL CANCER INSTITUTE [R01CA129440] Funding Source: NIH RePORTER	Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Siteman Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Junjie Chen for providing the wild type and mutant GST-Brca1-BRCT constructs and Bing-Hua Jiang for providing Akt1-473D construct and Thomas Ludwig for providing Brca1<SUP>+/+</SUP> and Brca1<SUP>tr/tr</SUP> MEFs. We thank Buck Rogers, Andrei Laszlo and Xiaowei Wang for proof-reading. This work is supported in part by grants from the Susan G Komen Foundation (QY), Siteman Cancer Center Award (QY) and NIH CA129440 (QY).	Aaltonen K, 2009, BREAST CANCER RES TR, V113, P75, DOI 10.1007/s10549-008-9908-5; Aleskandarany M, 2010, BREAST CANC RES TREA; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brodie S G, 2001, Trends Genet, V17, pS18, DOI 10.1016/S0168-9525(01)02451-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Diaz R, 2009, BRIT J CANCER, V100, P932, DOI 10.1038/sj.bjc.6604938; Dinesh KPB, 2006, MOL CELL BIOCHEM, V287, P177, DOI 10.1007/s11010-005-9097-z; Ding SL, 2004, J BIOMED SCI, V11, P911, DOI 10.1159/000081838; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Pallares J, 2005, INT J GYNECOL PATHOL, V24, P247, DOI 10.1097/01.pgp.0000163849.37129.d4; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van der Groep P, 2009, J CLIN PATHOL, V62, P926, DOI 10.1136/jcp.2009.065524; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Xue Q, 2008, CANCER RES, V68, P9551, DOI 10.1158/0008-5472.CAN-08-2058; Yang Q, 2000, BRIT J CANCER, V82, P763, DOI 10.1054/bjoc.1999.0995	40	39	41	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2443	2450		10.1038/onc.2010.603	http://dx.doi.org/10.1038/onc.2010.603			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21242970	Green Accepted			2022-12-25	WOS:000291008000006
J	Kapoor, N; Galang, G; Marban, E; Cho, HC				Kapoor, Nidhi; Galang, Giselle; Marban, Eduardo; Cho, Hee Cheol			Transcriptional Suppression of Connexin43 by TBX18 Undermines Cell-Cell Electrical Coupling in Postnatal Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; PACEMAKER FUNCTION; CONDUCTION SYSTEM; SINOATRIAL NODE; CARDIAC-PACEMAKER; HUMAN HEART; EXPRESSION; TURNOVER; DIFFERENTIATION; HETEROGENEITY	T-box transcription factors figure prominently in embryonic cardiac cell lineage specifications. Mesenchymal precursor cells expressing Tbx18 give rise to the heart's pacemaker, the sinoatrial node (SAN). We sought to identify targets of TBX18 transcriptional regulation in the heart by forced adenoviral overexpression in postnatal cardiomyocytes. Neonatal rat cardiomyocytes (NRCMs) transduced with GFP showed sarcolemmal, punctate Cx43 expression. In contrast, TBX18-transduced NRCMs exhibited sparse Cx43 expression. Both the transcript and protein levels of Cx43 were greatly down-regulated within 2 days of TBX18 transduction. Direct injection of TBX18 in the guinea pig heart in vivo inhibited Cx43 expression. The repressor activity of TBX18 on Cx43 was highly specific; protein levels of Cx45 and Cx40, which comprise the main gap junctions in the SAN and conduction system, were unchanged by TBX18. A reporter-based promoter assay demonstrated that TBX18 directly represses the Cx43 promoter. Phenotypically, TBX18-NRCMs exhibited slowed intercellular calcein dye transfer kinetics (421 +/- 54 versus control 127 +/- 43 ms). Intracellular Ca2+ oscillations in control NRCM monolayers were highly synchronized. In contrast, TBX18 overexpression led to asynchronous Ca2+ oscillations, demonstrating reduced cell-cell coupling. Decreased coupling led to slow electrical propagation; conduction velocity in TBX18 NRCMs slowed by more than 50% relative to control (2.9 +/- 0.5 versus 14.3 +/- 0.9 cm/s). Taken together, TBX18 specifically and directly represses Cx43 transcript and protein levels. Cx43 suppression leads to significant electrical uncoupling, but the preservation of other gap junction proteins supports slow action potential propagation, recapitulating a key phenotypic hallmark of the SAN.	[Kapoor, Nidhi; Galang, Giselle; Marban, Eduardo; Cho, Hee Cheol] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Cho, HC (corresponding author), Cedars Sinai Heart Inst, 8700 Beverly Blvd,1090 Davis Bldg, Los Angeles, CA 90048 USA.	ChoHC@cshs.org	Marban, Eduardo/GWC-8514-2022		Heart Rhythm Society	Heart Rhythm Society	Supported by a fellowship from the Heart Rhythm Society.	Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; BURT JM, 1991, AM J PHYSIOL, V260, pC439, DOI 10.1152/ajpcell.1991.260.3.C439; BURT JM, 1988, P NATL ACAD SCI USA, V85, P3431, DOI 10.1073/pnas.85.10.3431; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chatterjee B, 2005, DEV DYNAM, V233, P890, DOI 10.1002/dvdy.20426; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Coppen SR, 1999, J HISTOCHEM CYTOCHEM, V47, P907, DOI 10.1177/002215549904700708; DAVIS LM, 1995, J CARDIOVASC ELECTR, V6, P813, DOI 10.1111/j.1540-8167.1995.tb00357.x; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fedorov VV, 2009, CIRC RES, V104, P915, DOI 10.1161/CIRCRESAHA.108.193193; Hoogaars WMH, 2007, CELL MOL LIFE SCI, V64, P646, DOI 10.1007/s00018-007-6518-z; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Joung Boyoung, 2009, Korean Circ J, V39, P217, DOI 10.4070/kcj.2009.39.6.217; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Leaf DE, 2008, CIRC RES, V103, P1001, DOI 10.1161/CIRCRESAHA.107.168997; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Maltsev VA, 2008, CARDIOVASC RES, V77, P274, DOI 10.1093/cvr/cvm058; McNally EM, 2009, CIRC RES, V104, P285, DOI 10.1161/CIRCRESAHA.109.193680; MOMMERSTEEG MT, 2010, CARDIOVASC RES; MORENO AP, 1995, AM J PHYSIOL-CELL PH, V268, pC356, DOI 10.1152/ajpcell.1995.268.2.C356; OKITA K, 2008, SCIENCE; Saffitz JE, 2000, CIRC RES, V87, P835, DOI 10.1161/01.RES.87.10.835; Sekar RB, 2009, CIRC RES, V104, P355, DOI 10.1161/CIRCRESAHA.108.178335; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; Valiunas V, 2002, J GEN PHYSIOL, V119, P147, DOI 10.1085/jgp.119.2.147; Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9; Vinogradova TM, 2005, ANN NY ACAD SCI, V1047, P138, DOI 10.1196/annals.1341.013; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14073	14079		10.1074/jbc.M110.185298	http://dx.doi.org/10.1074/jbc.M110.185298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21205823	Green Published, hybrid			2022-12-25	WOS:000289556200030
J	Carracedo, J; Merino, A; Briceno, C; Soriano, S; Buendia, P; Calleros, L; Rodriguez, M; Martin-Malo, A; Aljama, P; Ramirez, R				Carracedo, Julia; Merino, Ana; Briceno, Carolina; Soriano, Sagrario; Buendia, Paula; Calleros, Laura; Rodriguez, Mariano; Martin-Malo, Alejandro; Aljama, Pedro; Ramirez, Rafael			Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells	FASEB JOURNAL			English	Article						chronic kidney disease; genomic damage; premature cellular senescence; angiogenesis; atherosclerotic disease	TELOMERE; MICROINFLAMMATION; ATHEROSCLEROSIS; INFLAMMATION; MITOCHONDRIA; PROTEIN; REPAIR; UREMIA; DAMAGE; DEATH	Carbamylated low-density lipoprotein (cLDL) plays a role in atherosclerosis. In this study we evaluate the effect of uremia on LDL carbamylation and the effect of cLDL and oxidized LDL (oxLDL; 200 mu g/ml) on number, function, and genomic stability of endothelial progenitor cells (EPCs) obtained from healthy volunteers. cLDL was generated after incubation of native LDL (nLDL) with uremic serum from patients with chronic kidney disease (CKD) stages 2-4. Oxidative stress was measured by flow cytometry and fluorescent microscopy, mitochondrial depolarization by flow cytometry, senescence by beta-galactosidase activity and telomere length, and DNA damage by phosphorylated histone H2AX (gamma H2AX). The percentage of cLDL by uremic serum was related to the severity of CKD. Compared with nLDL, cLDL induced an increase in oxidative stress (62 +/- 5 vs. 8 +/- 3%, P<0.001) and cells with mitochondrial depolarization (73 +/- 7 vs. 9 +/- 5%, P<0.001), and a decrease in EPC proliferation and angiogenesis. cLDL also induced accelerated senescence (73 +/- 16 vs. 12 +/- 9%, P<0.001), which was associated with a decrease in the expression of gamma H2AX (62 +/- 9 vs. 5 +/- 3%, P<0.001). The degree of injury induced by cLDL was comparable to that observed with oxLDL. This study supports the hypothesis that cLDL triggers genomic damage in EPCs, resulting in premature senescence. We can, therefore, hypothesize that EPCs injury by cLDL contributes to an increase in atherosclerotic disease in CKD.-Carracedo, J., Merino, A., Briceno, C., Soriano, S., Buendia, P., Calleros, L., Rodriguez, M., Martin-Malo, A., Aljama, P., Ramirez, R. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J. 25, 1314-1322 (2011). www.fasebj.org	[Carracedo, Julia; Merino, Ana; Briceno, Carolina; Buendia, Paula; Rodriguez, Mariano; Aljama, Pedro; Ramirez, Rafael] Hosp Univ Reina Sofia, Unidad Invest, Inst Maimonides Invest Biomed Cordoba, Fdn Invest Biomed Cordoba, Cordoba 14004, Spain; [Soriano, Sagrario; Rodriguez, Mariano; Martin-Malo, Alejandro; Aljama, Pedro] Reina Sofia Univ Hosp, Nephrol Unit, Cordoba, Spain; [Carracedo, Julia; Merino, Ana; Briceno, Carolina; Soriano, Sagrario; Buendia, Paula; Calleros, Laura; Rodriguez, Mariano; Martin-Malo, Alejandro; Aljama, Pedro; Ramirez, Rafael] Inst Salud Carlos III, Madrid, Spain; [Calleros, Laura] Univ Alcala de Henares, Dept Fisiol, Madrid, Spain	Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario Reina Sofia - Cordoba; Instituto de Salud Carlos III; Universidad de Alcala	Ramirez, R (corresponding author), Hosp Univ Reina Sofia, Unidad Invest, Inst Maimonides Invest Biomed Cordoba, Fdn Invest Biomed Cordoba, Avda Menendez Pidal S-N, Cordoba 14004, Spain.	manuelr.ramirez.sspa@juntadeandalucia.es	Ramirez, Rafael/B-3249-2019; Carracedo, Julia/ABG-2464-2020; Carracedo, Julia/L-2012-2015; Rodriguez, teresa/H-5452-2011; Merino, Ana/L-8347-2017; Calleros, Laura/L-3122-2015	Carracedo, Julia/0000-0002-8422-812X; Carracedo, Julia/0000-0002-8422-812X; Calleros, Laura/0000-0001-7739-1319; Rafael, Ramirez/0000-0003-4598-339X; Rodriguez, Mariano/0000-0002-9380-6614	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS PI06/0724, PI06/0747, PI07/0204, PI08/1038, PS09/00836, RD06/0016/0007]; Junta de Andalucia [PI-JA0235/2009, PI-JA0227/2009, P06-CVI-02172, P08-CTS-3797]; Fundacion Nefrologica; Fundacion de Investigaciones Biomedicas de Cordoba (FIBICO);  [I3SNS]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia); Fundacion Nefrologica; Fundacion de Investigaciones Biomedicas de Cordoba (FIBICO); 	The authors are grateful to M. J. Jimenez and M. J. Montenegro for technical assistance. This work was supported by grants from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (FIS PI06/0724, PI06/0747, PI07/0204, PI08/1038, PS09/00836, RETICs Red Renal RD06/0016/0007), Junta de Andalucia (PI-JA0235/2009, PI-JA0227/2009, P06-CVI-02172, P08-CTS-3797), and Fundacion Nefrologica. J. C. was supported by a contract from Fundacion de Investigaciones Biomedicas de Cordoba (FIBICO; Programa I3SNS, Linea de estabilizacion de investigadores del Instituto de Salud Carlos III/Fundacion Progreso y Salud).	Apostolov EO, 2009, ARTERIOSCL THROM VAS, V29, P1622, DOI 10.1161/ATVBAHA.109.189795; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HORKKO S, 1992, KIDNEY INT, V41, P1175, DOI 10.1038/ki.1992.179; Ishigaki Y, 2009, CURR OPIN LIPIDOL, V20, P363, DOI 10.1097/MOL.0b013e32832fa58d; Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kipling D, 1999, NAT BIOTECHNOL, V17, P313, DOI 10.1038/7827; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; KUZUYA M, 1991, BIOCHIM BIOPHYS ACTA, V1084, P198; Merino A, 2008, CONTRIB NEPHROL, V161, P83, DOI 10.1159/000130412; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; Ramirez R, 2007, KIDNEY INT, V72, P108, DOI 10.1038/sj.ki.5002250; Ramirez R, 2009, J MOL CELL CARDIOL, V47, P781, DOI 10.1016/j.yjmcc.2009.09.005; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; Trepanier DJ, 1996, CLIN BIOCHEM, V29, P347, DOI 10.1016/0009-9120(96)00038-0; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	30	74	80	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1314	1322		10.1096/fj.10-173377	http://dx.doi.org/10.1096/fj.10-173377			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21228221				2022-12-25	WOS:000288982800020
J	Gunawardena, HP; Huang, Y; Kenjale, R; Wang, HY; Xie, L; Chen, XA				Gunawardena, Harsha P.; Huang, Yi; Kenjale, Roma; Wang, Haiyang; Xie, Ling; Chen, Xian			Unambiguous Characterization of Site-specific Phosphorylation of Leucine-rich Repeat Fli-I-interacting Protein 2 (LRRFIP2) in Toll-like Receptor 4 (TLR4)-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER DISSOCIATION; COLLISION-INDUCED DISSOCIATION; PROTEOMIC APPROACH; SEQUENCE-ANALYSIS; MASS; IDENTIFICATION; FRAGMENTATION; PATHWAYS; ACCURATE; COMPLEX	In the TLR4 signaling pathways, we previously characterized a signal regulator, LRRFIP2, that modulates the time course-dependent changes in NF-kappa B activity through its dynamic interaction with the TLR adaptor protein, MyD88. However, little is known about the driving force behind the LPS-inducible dynamics between LRRFIP2 and MyD88. We have therefore designed a multiplex label-free quantitative proteomics method to investigate dynamic changes of LRRFIP2 phosphorylation upon LPS stimulation. Given our observation that LRRFIP2 binds to MyD88 through its serine-rich domain in which most of serine residues have the propensity to be phosphorylated, we used collision-activated dissociation- and electron transfer dissociation-based methods in a complementary manner to unambiguously localize phosphorylation sites in the peptides constituting the serine-rich domain. Among 23 phosphorylation sites identified and first quantified by the label-free approach and then verified by the AACT/SILAC (amino acid-coded tagging/stable isotope labeling in cell culture)-based quantitation method, phosphorylation at serine 202 showed a significant LPS-induced dynamic change during the full-course cellular response to LPS stimulation. The substitution of serine 202 with nonphosphorylated residues by site-directed mutagenesis resulted in a weakened LRRFIP2-MyD88 interaction and a concurrently reduced activity in downstream NF-kappa B. Taking these results together, phosphorylation at serine 202 was found to regulate the dynamics of the LRRFIP2-MyD88 interaction, which in turn modulated the strength and duration of TLR4 signaling. Strategically, we have demonstrated the importance of precise identification of the biologically relevant phosphorylation site(s) using comprehensive mass spectrometry-based quantitative proteomics approaches in guiding downstream biological characterization experiments, which could otherwise be both time-and cost-consuming for a large number of phosphorylation possibilities.	[Gunawardena, Harsha P.; Chen, Xian] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Huang, Yi; Kenjale, Roma; Wang, Haiyang; Xie, Ling; Chen, Xian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chen, XA (corresponding author), Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA.	xianc@email.unc.edu			National Institutes of Health [1R01A1064806-01A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded, in whole or in part, by National Institutes of Health Grant 1R01A1064806-01A2.	AMANKWA LN, 1995, PROTEIN SCI, V4, P113; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Dai PG, 2009, J IMMUNOL, V182, P3450, DOI 10.4049/jimmunol.0802260; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; Gunawardena HP, 2006, ANAL CHEM, V78, P3788, DOI 10.1021/ac060164j; Gunawardena HP, 2005, J AM CHEM SOC, V127, P12627, DOI 10.1021/ja0526057; Hatao F, 2008, FEMS IMMUNOL MED MIC, V53, P260, DOI 10.1111/j.1574-695X.2008.00425.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kandasamy K, 2009, ANAL CHEM, V81, P7170, DOI 10.1021/ac9006107; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; Ladner RD, 1996, J BIOL CHEM, V271, P7752, DOI 10.1074/jbc.271.13.7752; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; McAlister GC, 2007, ANAL CHEM, V79, P3525, DOI 10.1021/ac070020k; Molina H, 2008, ANAL CHEM, V80, P4825, DOI 10.1021/ac8007785; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palumbo AM, 2008, ANAL CHEM, V80, P9735, DOI 10.1021/ac801768s; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; RESING KA, 1995, BIOCHEMISTRY-US, V34, P9477, DOI 10.1021/bi00029a024; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; WANG YK, 1993, J BIOL CHEM, V268, P14269; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; YIP TT, 1992, FEBS LETT, V308, P149, DOI 10.1016/0014-5793(92)81264-M; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zhu HN, 2002, ANAL CHEM, V74, P1687, DOI 10.1021/ac010853p; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k	43	19	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10897	10910		10.1074/jbc.M110.168179	http://dx.doi.org/10.1074/jbc.M110.168179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21220426	Green Published, hybrid			2022-12-25	WOS:000288797100002
J	Ivanova, MM; Luken, KH; Zimmer, AS; Lenzo, FL; Smith, RJ; Arteel, MW; Kollenberg, TJ; Mattingly, KA; Klinge, CM				Ivanova, Margarita M.; Luken, Kristen H.; Zimmer, Amber S.; Lenzo, Felicia L.; Smith, Ryan J.; Arteel, Maia W.; Kollenberg, Tara J.; Mattingly, Kathleen A.; Klinge, Carolyn M.			Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites	FASEB JOURNAL			English	Article						breast cancer; estradiol ER alpha; PGC-1 alpha; Tfam; RNA polymerase; apoptosis	CONTROLLING MITOCHONDRIAL BIOGENESIS; GROWTH-FACTOR; ER-ALPHA; FACTOR-I; RESPONSE ELEMENTS; DISTINCT CLASSES; GENE-EXPRESSION; BREAST; CANCER; MECHANISMS	Little is known about endogenous estrogen receptor beta (ER beta) gene targets in human breast cancer. We reported that estradiol (E-2) induces nuclear respiratory factor-1 (NRF-1) transcription through ER alpha in MCF-7 breast cancer cells. Here we report that 4-hydroxytamoxifen (4-OHT), with an EC50 of similar to 1.7 nM, increases NRF-1 expression by recruiting ER beta, cJun, cFos, CBP, and RNA polymerase II to and dismissing NCoR from the NRF1 promoter. Promoter deletion and transient transfection studies showed that the estrogen response element (ERE) is essential and that an adjacent AP-1 site contributes to maximal 4-OHT-induced NRF-1 transcription. siRNA knockdown of ER beta revealed that ER beta inhibits basal NRF-1 expression and is required for 4-OHT-induced NRF-1 transcription. An AP-1 inhibitor blocked 4-OHT-induced NRF-1 expression. The 4-OHT-induced increase in NRF-1 resulted in increased transcription of NRF-1 target CAPNS1 but not CYC1, CYC2, or TFAM despite increased NRF-1 coactivator PGC-1 alpha protein. The absence of TFAM induction corresponds to a lack of Akt-dependent phosphorylation of NRF-1 with 4-OHT treatment. Overexpression of NRF-1 inhibited 4-OHT-induced apoptosis and siRNA knockdown of NRF-1 increased apoptosis, indicating an antiapoptotic role for NRF-1. Overall, NRF-1 expression and activity is regulated by 4-OHT via endogenous ER beta in MCF-7 cells.-Ivanova, M. M., Luken, K. H., Zimmer, A. S., Lenzo, F. L., Smith, R. J., Arteel, M. W., Kollenberg, T. J., Mattingly, K. A., Klinge, C. M. Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites. FASEB J. 25, 1402-1416 (2011). www.fasebj.org	[Klinge, Carolyn M.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Ctr Genet & Mol Med, Louisville, KY 40292 USA; Univ Louisville, Sch Med, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Ctr Genet & Mol Med, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu	Ivanova, Margarita/AAM-4510-2021	Klinge, Carolyn/0000-0002-3358-4378; Ivanova, Margarita/0000-0002-6197-8606	U.S. National Institutes of Health (NIH) [R01 DK53220]; NIH [5T35 DK072923, 5P30ES014443]; American Recovery and Reinvestment Act supplement NIH [R01 DK53220-02S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053220, T35DK072923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act supplement NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Richard C. Scarpulla (Northwestern University Medical School, Chicago, IL, USA) for providing the pSG5NRF-1, Sumata Bhamani for her participation in H1793 experiments, and Dr. Barbara J. Clark for her suggestions to improve this manuscript. This work was supported by U.S. National Institutes of Health (NIH) grant R01 DK53220 to C.M.K. A.S.Z. and R.J.S. were supported by NIH grant 5T35 DK072923. F.L.L. and T.J.K. were supported by American Recovery and Reinvestment Act supplement NIH R01 DK53220-02S1 to C.M.K. The DNA core for the Center for Environmental Genomics and Integrative Biology is supported by NIH grant 5P30ES014443.	Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Baron S, 2007, J BIOL CHEM, V282, P11732, DOI 10.1074/jbc.M610079200; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Bourdoncle A, 2005, J MOL BIOL, V347, P921, DOI 10.1016/j.jmb.2005.01.048; Bowie ML, 2004, ONCOGENE, V23, P8743, DOI 10.1038/sj.onc.1208120; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Buck MB, 2004, MOL ENDOCRINOL, V18, P1643, DOI 10.1210/me.2003-0278; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Cheung E, 2005, P NATL ACAD SCI USA, V102, P559, DOI 10.1073/pnas.0407113102; Choi YS, 2004, ANN NY ACAD SCI, V1011, P69, DOI 10.1196/annals.1293.008; Covaleda AMS, 2008, TOXICOL SCI, V105, P303, DOI 10.1093/toxsci/kfn141; Delaunay F, 2000, MOL PHARMACOL, V58, P584, DOI 10.1124/mol.58.3.584; Duong V, 2006, ONCOGENE, V25, P1799, DOI 10.1038/sj.onc.1209102; DuSell CD, 2010, MOL ENDOCRINOL, V24, P33, DOI 10.1210/me.2009-0339; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; FISCH TM, 1989, MOL CELL BIOL, V9, P1327, DOI 10.1128/MCB.9.3.1327; Flageng MH, 2009, BRIT J CANCER, V101, P1253, DOI 10.1038/sj.bjc.6605324; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Jayachandran M, 2010, AGE, V32, P109, DOI 10.1007/s11357-009-9119-y; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; Klinge CM, 1999, MOL CELL ENDOCRINOL, V150, P99, DOI 10.1016/S0303-7207(99)00019-2; KLINGE CM, 1992, CANCER RES, V52, P1073; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kulakosky PC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290137; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levy N, 2010, MOL CELL ENDOCRINOL, V315, P201, DOI 10.1016/j.mce.2009.08.030; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Li JJ, 1997, CANCER RES, V57, P3569; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mohamood AS, 1997, J SUBMICR CYTOL PATH, V29, P1; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Nehra R, 2010, FASEB J, V24, P2040, DOI 10.1096/fj.09-138305; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; O'Malley BW, 2009, MOL ENDOCRINOL, V23, P587, DOI 10.1210/me.2009-0015; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Peekhaus NT, 2004, J MOL ENDOCRINOL, V32, P987, DOI 10.1677/jme.0.0320987; Perumal SS, 2005, CANCER CHEMOTH PHARM, V56, P105, DOI 10.1007/s00280-004-0943-6; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Sripathy SP, 2008, ONCOGENE, V27, P6376, DOI 10.1038/onc.2008.235; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Uht Rosalie M, 2004, Nucl Recept, V2, P2, DOI 10.1186/1478-1336-2-2; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Vladusic EA, 2000, ONCOL REP, V7, P157; Welboren WJ, 2009, ENDOCR-RELAT CANCER, V16, P1073, DOI 10.1677/ERC-09-0086; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoo YA, 2008, BBA-MOL CELL RES, V1783, P438, DOI 10.1016/j.bbamcr.2007.12.001; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109	72	24	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1402	1416		10.1096/fj.10-169029	http://dx.doi.org/10.1096/fj.10-169029			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21233487	Green Published			2022-12-25	WOS:000288982800029
J	Mazot, P; Cazes, A; Boutterin, MC; Figueiredo, A; Raynal, V; Combaret, V; Hallberg, B; Palmer, RH; Delattre, O; Janoueix-Lerosey, I; Vigny, M				Mazot, P.; Cazes, A.; Boutterin, M. C.; Figueiredo, A.; Raynal, V.; Combaret, V.; Hallberg, B.; Palmer, R. H.; Delattre, O.; Janoueix-Lerosey, I.; Vigny, M.			The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking	ONCOGENE			English	Article						ALK; neuroblastoma; phosphorylation; ER retention; RTK	ANAPLASTIC LYMPHOMA KINASE; TYROSINE KINASE; MONOCLONAL-ANTIBODIES; ACTIVATING MUTATIONS; NPM-ALK; NEUROBLASTOMA; GENE; IDENTIFICATION; GROWTH; PLEIOTROPHIN	Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK), which is transiently expressed during development of the central and peripheral nervous system. ALK has been recently identified as a major neuroblastoma predisposition gene and activating mutations have also been identified in a subset of sporadic neuroblastoma tumors. Two hot spots of ALK mutations have been observed at positions F1174 and R1275. Here, we studied stably transfected cell lines expressing wild-type or F1174L- or R1275Q-mutated ALK in parallel with a neuroblastoma cell line (CLB-GE) in which the allele mutated at position F1174 is amplified. We observed that the mutated ALK variants were essentially intracellular and were largely retained in the reticulum/Golgi compartments. This localization was corroborated by a defect of N-linked glycosylation. Although the mutated receptors exhibited a constitutive activation, the minor pool of receptor addressed to the plasma membrane was much more tyrosine phosphorylated than the intracellular pool. The use of antagonist monoclonal antibodies suggested that the constitutive activity of the mutated receptors did not require the dimerization of the receptor, whereas adequate dimerization triggered by agonist monoclonal antibodies increased this activity. Finally, kinase inactivation of the mutated receptors restored maturation and cell-surface localization. Our results show that constitutive activation of ALK results in its impaired maturation and intracellular retention. Furthermore, they provide a rationale for the potential use of kinase inhibitors and antibodies in ALK-dependent tumors. Oncogene (2011) 30, 2017-2025; doi:10.1038/onc.2010.595; published online 17 January 2011	[Vigny, M.] Univ Paris 06, UPMC, INSERM, UMR S839, F-75005 Paris, France; [Mazot, P.; Boutterin, M. C.; Figueiredo, A.; Vigny, M.] INSERM, UMRS 839, Paris, France; [Mazot, P.; Boutterin, M. C.; Figueiredo, A.; Vigny, M.] IFM, Paris, France; [Cazes, A.; Raynal, V.; Delattre, O.; Janoueix-Lerosey, I.] Ctr Rech, Inst Curie, Paris, France; [Combaret, V.] Ctr Leon Berard, FNCLCC, Lab Rech Translat, F-69373 Lyon, France; [Hallberg, B.; Palmer, R. H.] Umea Univ, Dept Mol Biol, Umea, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Leon Berard; Umea University	Vigny, M (corresponding author), Univ Paris 06, UPMC, INSERM, UMR S839, 17 Rue Fer Moulin, F-75005 Paris, France.	marc.vigny@inserm.fr	Janoueix-Lerosey, Isabelle/G-1758-2018; Cazes, Alex/K-9899-2019	Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; delattre, olivier/0000-0002-8730-2276; Figueiredo, Ana Leonor/0000-0003-2329-2854	Inserm [UMR-S839]; Universite Pierre et Marie Curie; Institut National du Cancer,; Nationale contre le Cancer (Equipe labellisee); Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfance et Sante	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; Institut National du Cancer,(Institut National du Cancer (INCA) France); Nationale contre le Cancer (Equipe labellisee); Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfance et Sante	Work at the Institut du Fer a Moulin UMR-S839 was supported by Inserm and Universite Pierre et Marie Curie. The U830 Inserm laboratory is supported by grants from the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee), the Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfance et Sante. We are grateful to Dr JA Girault for helpful discussions.	Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Martinelli E, 2009, CLIN EXP IMMUNOL, V158, P1, DOI 10.1111/j.1365-2249.2009.03992.x; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Mourali J, 2006, MOL CELL BIOL, V26, P6209, DOI 10.1128/MCB.01515-05; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Reiner DJ, 2008, CURR BIOL, V18, P1101, DOI 10.1016/j.cub.2008.06.060; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; Yang HL, 2007, J EXP ZOOL PART B, V308B, P269, DOI 10.1002/jez.b.21146	32	39	43	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	17					2017	2025		10.1038/onc.2010.595	http://dx.doi.org/10.1038/onc.2010.595			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21242967				2022-12-25	WOS:000289977400005
J	Sung, CK; Dahl, J; Yim, H; Rodig, S; Benjamin, TL				Sung, Chang K.; Dahl, Jean; Yim, Hyungshin; Rodig, Scott; Benjamin, Thomas L.			Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2)	FASEB JOURNAL			English	Article						TGF beta, AP4; ubiquitination; E3 ligase; polyoma	TOWNES-BROCKS-SYNDROME; EMBRYONIC STEM-CELLS; TISSUE GROWTH-FACTOR; RADIAL RAY SYNDROME; E3 LIGASE COMPLEX; OKIHIRO-SYNDROME; DROSOPHILA EMBRYO; UBIQUITIN LIGASES; POLYOMA-VIRUS; HOMEOTIC GENE	The evolutionarily conserved SALL genes encode transcription factors with roles in embryonic development. The product of the SALL2 gene was first identified as a binding partner of the mouse polyoma virus large T antigen and later shown to possess tumor suppressor-like functions. Independent studies identified SALL2 as a factor regulating the quiescent state in human fibroblasts. Here, we investigate factors that regulate the expression of SALL2 and turnover of p150(Sal2) in growing vs. resting cells. The transcription factor AP4 increases along with SALL2 in quiescent cells and positively regulates SALL2 expression. TGF beta effectively inhibits expression of SALL2 and its regulator AP4 when added to quiescent fibroblasts. TGF beta repression of SALL2 and AP4 is independent of the induction of connective tissue growth factor (CTGF) by TGF beta. p150(Sal2) disappears rapidly on restoration of serum. In both growing fibroblasts and established ovarian surface epithelial cells, p150(Sal2) undergoes polyubiquitination and proteosomal degradation. A CUL4/DDB1 E3 ligase containing RBBP7 as the p150(Sal2) receptor has been identified as mediating the destruction of p150(Sal2) as cells transition from a quiescent to an actively growing state.-Sung, C. K., Dahl, J., Yim, H., Rodig, S., Benjamin, T. L. Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2). FASEB J. 25, 1275-1283 (2011). www.fasebj.org	[Sung, Chang K.; Dahl, Jean; Yim, Hyungshin; Benjamin, Thomas L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rodig, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Benjamin, TL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Pathol NRB-939,77th Ave Louis Pasteur, Boston, MA 02115 USA.	thomas_benjamin@hms.harvard.edu	Rodig, Scott/Y-3889-2019		National Cancer Institute [RO1-CA 92520]; NATIONAL CANCER INSTITUTE [R01CA092520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. Public Health Service grant RO1-CA 92520 from the National Cancer Institute. The authors kindly thank Dr. J. Wade Harper (Harvard Medical School, Boston, MA, USA) for the DN-Cul3, DN-Cul4B, pEBB-Ub, myc-CUL4A, and myc-CUL4B constructs.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Benjamin TL, 2001, VIROLOGY, V289, P167, DOI 10.1006/viro.2001.1124; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; de Celis JF, 1999, DEVELOPMENT, V126, P2653; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 1999, AM J HUM GENET, V64, P435, DOI 10.1086/302238; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koster R, 1997, DEVELOPMENT, V124, P3147; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Li DW, 2004, MOL CELL BIOL, V24, P3885, DOI 10.1128/MCB.24.9.3885-3893.2004; Li DW, 2001, P NATL ACAD SCI USA, V98, P14619, DOI 10.1073/pnas.251447198; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Ma YP, 2001, J BIOL CHEM, V276, P48223, DOI 10.1074/jbc.M106468200; Mason RM, 2009, J CELL COMMUN SIGNAL, V3, P95, DOI 10.1007/s12079-009-0038-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nilsson Eric E, 2002, Reprod Biomed Online, V5, P254; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Pincheira R, 2009, EMBO J, V28, P261, DOI 10.1038/emboj.2008.274; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; SHIPLEY GD, 1986, CANCER RES, V46, P2068; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	51	16	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1275	1283		10.1096/fj.10-173674	http://dx.doi.org/10.1096/fj.10-173674			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21228219	Green Published			2022-12-25	WOS:000288982800016
J	Boivin, S; Hart, DJ				Boivin, Stephane; Hart, Darren J.			Interaction of the Influenza A Virus Polymerase PB2 C-terminal Region with Importin alpha Isoforms Provides Insights into Host Adaptation and Polymerase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; RNA-POLYMERASE; KARYOPHERIN ALPHA; CRYSTALLOGRAPHIC ANALYSIS; FUNCTIONAL DOMAINS; STRUCTURAL BASIS; MOLECULAR-BASIS; BINDING-SITE; SUBUNIT PB2; AVIAN-LIKE	In the adaptation of avian viruses to mammalian hosts, mutations in the viral polymerase, notably in the PB2 subunit, play an important role. A PB2 C-terminal domain rich in putative host adaptation residues has been shown to bind importin alpha nuclear import receptors. Adaptation has been proposed to involve binding of PB2 to importins of the new host. To date PB2-importin complexes have been characterized semiquantitatively with no precise measurement of binding parameters. To investigate the effects of adaptive mutations on importin interaction and selectivity, surface plasmon resonance was used to compare the binding rate constants and affinities of avian H5N1 and human H3N2 PB2 C-terminal variants with importin isoforms human alpha 1, 3, 5 and 7, and avian alpha 1. Using purified proteins eliminates host environment effects and permits measurement of intrinsic affinities and rates of complex formation and dissociation. Two effects were observed: first, adaptive mutations D701N, R702K, and S714R in the nuclear localization signal domain increased 2-4-fold the association rates with avian and human importins; second, measurement of different structural forms of the PB2 C terminus demonstrated that the upstream 627 domain reduced binding affinity, consistent with a steric clash predicted from crystal structures. From these kinetic data, structural analyses, and the data of others, a model is proposed in which an increase in charged surface residues during host adaptation increases the association rate of PB2 to cytoplasmic importins and where the C-terminal 627-nuclear localization signal domain may reorganize upon importin binding, consistent with a role in active polymerase assembly.	[Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; UJF EMBL CNRS, UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hart, DJ (corresponding author), European Mol Biol Lab, Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	hart@embl.fr	Boivin, Stephane/K-4018-2012; Hart, Darren/C-4858-2015	Hart, Darren/0000-0002-3502-2002; Boivin, Stephane/0000-0003-1460-326X	Fondation Innovations en Infectiologie (FINOVI); European Union FLUPOL [SP5B-CT-2007-044263]	Fondation Innovations en Infectiologie (FINOVI); European Union FLUPOL	This work was supported by the Fondation Innovations en Infectiologie (FINOVI) and European Union FLUPOL Contract SP5B-CT-2007-044263.	Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DELALUNA S, 1989, VIRUS RES, V13, P143, DOI 10.1016/0168-1702(89)90012-9; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Honda A, 1997, BIOL CHEM, V378, P483; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; NATH ST, 1990, MOL CELL BIOL, V10, P4139, DOI 10.1128/MCB.10.8.4139; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; ONEILL RE, 1995, VIROLOGY, V206, P116, DOI 10.1016/S0042-6822(95)80026-3; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Tworowski D, 2003, PROTEIN SCI, V12, P1247, DOI 10.1110/ps.0301203; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Zhou HX, 2005, PHYS BIOL, V2, pR1, DOI 10.1088/1478-3975/2/3/R01; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	64	59	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10439	10448		10.1074/jbc.M110.182964	http://dx.doi.org/10.1074/jbc.M110.182964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21216958	hybrid, Green Published			2022-12-25	WOS:000288547000060
J	Thibault, D; Albert, PR; Pineyro, G; Trudeau, LE				Thibault, Dominic; Albert, Paul R.; Pineyro, Graciela; Trudeau, Louis-Eric			Neurotensin Triggers Dopamine D2 Receptor Desensitization through a Protein Kinase C and beta-Arrestin1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIPSYCHOTIC-DRUGS; RAT-BRAIN; NEURONS; PHOSPHORYLATION; INTERNALIZATION; TRAFFICKING; INHIBITION; CONDUCTANCE; EXPRESSION; ISOFORMS	The peptide neurotensin (NT) is known to exert a potent excitatory effect on the dopaminergic system by inhibiting D2 dopamine (DA) receptor (D2R) function. This regulation is dependent on activation of PKC, a well known effector of the type 1 NT receptor (NTR1). Because PKC phosphorylation of the D2R has recently been shown to induce its internalization, we hypothesized that NT acts to reduce D2R function through heterologous desensitization of the D2R. In the present study, we first used HEK-293 cells to demonstrate that NT induces PKC-dependent D2R internalization. Furthermore, internalization displayed faster kinetics in cells expressing the D2R short isoform, known to act as an autoreceptor in DA neurons, than in cells expressing the long isoform, known to act as a postsynaptic D2R. In patch clamp experiments on cultured DA neurons, overexpression of a mutant D2S lacking three key PKC phosphorylation sites abrogated the ability of NT to reduce D2R-mediated cell firing inhibition. Short interfering RNA-mediated inhibition of beta-arrestin1 and dynamin2, proteins important for receptor desensitization, reduced agonist-induced desensitization of D2R function, but only the inhibition of beta-arrestin1 reduced the effect of NT on D2R function. Taken together, our data suggest that NT acutely regulates D2 autoreceptor function and DA neuron excitability through PKC-mediated phosphorylation of the D2R, leading to heterologous receptor desensitization.	[Thibault, Dominic; Pineyro, Graciela; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Thibault, Dominic; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Pineyro, Graciela; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Thibault, Dominic; Trudeau, Louis-Eric] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Pineyro, Graciela] Univ Montreal, Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Albert, Paul R.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8M5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Ottawa; Ottawa Hospital Research Institute	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Albert, Paul/E-4804-2010; Trudeau, Louis-Eric/AAE-4782-2020	Albert, Paul/0000-0002-1809-3554; Trudeau, Louis-Eric/0000-0003-4684-1377; Pineyro, Graciela/0000-0001-9709-651X	Canadian Institutes of Health Research [MOP-49591]; Ontario Mental Health Foundation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes of Health Research Grant MOP-49591 (to L.-E. T.) and a graduate studentship (to D. T.), an Ontario Mental Health Foundation grant (to P. R. A.), and an infrastructure grant from the Fonds de la Recherche en Sante du Quebec to the Groupe de Recherche sur le Systeme Nerveux Central.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BEAUREGARD M, 1992, NEUROSCIENCE, V47, P613, DOI 10.1016/0306-4522(92)90170-7; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Botto JM, 1998, BIOCHEM BIOPH RES CO, V243, P585, DOI 10.1006/bbrc.1997.8071; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; Caceda R, 2005, J NEUROSCI, V25, P11748, DOI 10.1523/JNEUROSCI.4282-05.2005; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Diaz-Cabiale Z, 2002, NEUROREPORT, V13, P763, DOI 10.1097/00001756-200205070-00006; Farkas RH, 1997, NEUROSCI LETT, V231, P21, DOI 10.1016/S0304-3940(97)00530-2; Fasano C, 2008, EUR J NEUROSCI, V28, P1480, DOI 10.1111/j.1460-9568.2008.06450.x; Fassio A, 2000, NEUROPHARMACOLOGY, V39, P1430, DOI 10.1016/S0028-3908(00)00060-5; Feifel D, 2010, NEUROPHARMACOLOGY, V58, P173, DOI 10.1016/j.neuropharm.2009.07.002; Feifel D, 2009, NEUROPSYCHOPHARMACOL, V34, P2011, DOI 10.1038/npp.2009.15; GARVER DL, 1991, AM J PSYCHIAT, V148, P484; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; JIANG ZG, 1994, J PHYSIOL-LONDON, V474, P119, DOI 10.1113/jphysiol.1994.sp020007; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Khan ZU, 1998, J COMP NEUROL, V402, P353, DOI 10.1002/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kinkead B, 2005, J PHARMACOL EXP THER, V315, P256, DOI 10.1124/jpet.105.087437; Kinkead B, 2002, CURR OPIN PHARMACOL, V2, P99, DOI 10.1016/S1471-4892(01)00128-X; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; LI XM, 1994, NEUROREPORT, V5, P1621, DOI 10.1097/00001756-199408150-00020; Li ZM, 2010, BRAIN RES, V1311, P28, DOI 10.1016/j.brainres.2009.11.048; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; LIU YF, 1992, J NEUROCHEM, V59, P2311; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mechanic JA, 2009, EUR NEUROPSYCHOPHARM, V19, P466, DOI 10.1016/j.euroneuro.2009.01.004; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nemeroff C B, 1989, J Neuropsychiatry Clin Neurosci, V1, P16; NICOT A, 1995, J NEUROSCI RES, V40, P667, DOI 10.1002/jnr.490400512; Norman C, 2008, J PSYCHOPHARMACOL, V22, P300, DOI 10.1177/0269881107083838; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Radke JM, 1998, P NATL ACAD SCI USA, V95, P11462, DOI 10.1073/pnas.95.19.11462; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; SHI WX, 1992, ANN NY ACAD SCI, V668, P129, DOI 10.1111/j.1749-6632.1992.tb27345.x; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vandenbulcke F, 2000, J CELL SCI, V113, P2963; WATSON MA, 1992, J NEUROCHEM, V59, P1967, DOI 10.1111/j.1471-4159.1992.tb11035.x; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; WU T, 1995, BRAIN RES, V683, P242, DOI 10.1016/0006-8993(95)00379-5; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	63	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9174	9184		10.1074/jbc.M110.166454	http://dx.doi.org/10.1074/jbc.M110.166454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233215	hybrid, Green Published			2022-12-25	WOS:000288247700048
J	Eyre, DR; Weis, M; Hudson, DM; Wu, JJ; Kim, L				Eyre, David R.; Weis, MaryAnn; Hudson, David M.; Wu, Jiann-Jiu; Kim, Lammy			A Novel 3-Hydroxyproline (3Hyp)-rich Motif Marks the Triple-helical C Terminus of Tendon Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; AMINO-ACID; IDENTIFICATION; DEFICIENCY; MUTATIONS; PROTEINS; RESIDUES; CLEAVAGE; FIBRILS; DECORIN	Because of its unique physical and chemical properties, rat tail tendon collagen has long been favored for crystallographic and biochemical studies of fibril structure. In studies of the distribution of 3-hydroxyproline in type I collagen of rat bone, skin, and tail tendon by mass spectrometry, the repeating sequences of Gly-Pro-Pro (GPP) triplets at the C terminus of alpha 1(I) and alpha 2(I) chains were shown to be heavily 3-hydroxylated in tendon but not in skin and bone. By isolating the tryptic peptides and subjecting them to Edman sequence analysis, the presence of repeating 3-hydroxyprolines in consecutive GPP triplets adjacent to 4-hydroxyproline was confirmed as a unique feature of the tendon collagen. A 1960s study by Piez et al. (Piez, K. A., Eigner, E. A., and Lewis, M. S. (1963) Biochemistry 2, 58-66) in which they compared the amino acid compositions of rat skin and tail tendon type I collagen chains indeed showed 3-4 residues of 3Hyp in tendon alpha 1(I) and alpha 2(I) chains but only one 3Hyp residue in skin alpha 1(I) and none in alpha 2(I). The present work therefore confirms this difference and localizes the additional 3Hyp to the GPP repeat at the C terminus of the triple-helix. We speculate on the significance in terms of a potential function in contributing to the unique assembly mechanism and molecular packing in tendon collagen fibrils and on mechanisms that could regulate 3-hydroxylation at this novel substrate site in a tissue-specific manner.	[Eyre, David R.; Weis, MaryAnn; Hudson, David M.; Wu, Jiann-Jiu; Kim, Lammy] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@u.washington.edu			NIAMS [AR37694, AR37318]; University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR037318, R01AR037318] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Washington(University of Washington); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37694 and AR37318 from the NIAMS (to D. R. E.). This work was also supported by funds from the Ernest M. Burgess Endowed Chair research program of the University of Washington.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; BRODSKY B, 1980, BIOCHIM BIOPHYS ACTA, V621, P162, DOI 10.1016/0005-2795(80)90072-0; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Garrone R., 1985, BIOL INVERTEBRATE VE, V93, P157; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KESSLER A, 1960, J BIOL CHEM, V235, P989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WU JJ, 1992, J BIOL CHEM, V267, P23007; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	31	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7732	7736		10.1074/jbc.C110.195768	http://dx.doi.org/10.1074/jbc.C110.195768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239503	Green Published, hybrid			2022-12-25	WOS:000288013300004
J	Zhou, LJ; Chavez-Gutierrez, L; Bockstael, K; Sannerud, R; Annaert, W; May, PC; Karran, E; De Strooper, B				Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; May, Patrick C.; Karran, Eric; De Strooper, Bart			Inhibition of beta-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; BRAIN DRUG-DELIVERY; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; MICE; SITE; SPECIFICITY	beta-Secretase (BACE1) is an attractive drug target for Alzheimer disease. However, the design of clinical useful inhibitors targeting its active site has been extremely challenging. To identify alternative drug targeting sites we have generated a panel of BACE1 monoclonal antibodies (mAbs) that interfere with BACE1 activity in various assays and determined their binding epitopes. mAb 1A11 inhibited BACE1 in vitro using a large APP sequence based substrate (IC50 similar to 0.76 nM), in primary neurons (EC50 similar to 1.8 nM), and in mouse brain after stereotactic injection. Paradoxically, mAb 1A11 increased BACE1 activity in vitro when a short synthetic peptide was used as substrate, indicating that mAb 1A11 does not occupy the active-site. Epitope mapping revealed that mAb 1A11 binds to adjacent loops D and F, which together with nearby helix A, distinguishes BACE1 from other aspartyl proteases. Interestingly, mutagenesis of loop F and helix A decreased or increased BACE1 activity, identifying them as enzymatic regulatory elements and as potential alternative sites for inhibitor design. In contrast, mAb 5G7 was a potent BACE1 inhibitor in cell-free enzymatic assays (IC50 similar to 0.47 nM) but displayed no inhibitory effect in primary neurons. Its epitope, a surface helix 299-312, is inaccessible in membrane-anchored BACE1. Remarkably, mutagenesis of helix 299-312 strongly reduced BACE1 ectodomain shedding, suggesting that this helix plays a role in BACE1 cellular biology. In conclusion, this study generated highly selective and potent BACE1 inhibitory mAbs, which recognize unique structural and functional elements in BACE1, and uncovered interesting alternative sites on BACE1 that could become targets for drug development.	[Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; De Strooper, Bart] KULeuven, Dept Mol & Dev Genet, VIB, B-3000 Louvain, Belgium; [Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; De Strooper, Bart] KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium; [May, Patrick C.] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; [Karran, Eric] Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Eli Lilly; Johnson & Johnson; Janssen Pharmaceuticals	De Strooper, B (corresponding author), Herestr 49,Box 602, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	De Strooper, Bart/F-6507-2012; Sannerud, Ragna/AAA-6497-2021; Chávez-Gutiérrez, Lucía/E-2657-2017	De Strooper, Bart/0000-0001-5455-5819; Sannerud, Ragna/0000-0002-6694-3154	VIB; Eli Lilly; O; SA0-FRMA; Federal Office for Scientific Affairs, Belgium (IUAP) [P6/43/]; KULeuven; Flemish Government; European Union [FZ-2007-200611]	VIB; Eli Lilly(Eli Lilly); O; SA0-FRMA; Federal Office for Scientific Affairs, Belgium (IUAP); KULeuven(KU Leuven); Flemish Government(European Commission); European Union(European Commission)	This work was supported by VIB, Eli Lilly, FWO, SA0-FRMA (grant cycle 2008/2009), the Federal Office for Scientific Affairs, Belgium (IUAP P6/43/), a Methusalem grant of the KULeuven and the Flemish Government, and Memosad (FZ-2007-200611) of the European Union.	Alam MI, 2010, EUR J PHARM SCI, V40, P385, DOI 10.1016/j.ejps.2010.05.003; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chang WP, 2007, FASEB J, V21, P3184, DOI 10.1096/fj.06-7993com; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Hong L, 2002, BIOCHEMISTRY-US, V41, P10963, DOI 10.1021/bi026232n; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Mohajeri MH, 2004, NEURODEGENER DIS, V1, P160, DOI 10.1159/000080981; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Silvestri R, 2009, MED RES REV, V29, P295, DOI 10.1002/med.20132; Simons M, 1996, J NEUROSCI, V16, P899; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Turner RT, 2005, BIOCHEMISTRY-US, V44, P105, DOI 10.1021/bi048106k; Turner RT, 2002, BIOCHEMISTRY-US, V41, P8742, DOI 10.1021/bi025926t; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang HC, 2004, J NEUROCHEM, V91, P1249, DOI 10.1111/j.1471-4159.2004.02764.x; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004	62	43	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8677	8687		10.1074/jbc.M110.194860	http://dx.doi.org/10.1074/jbc.M110.194860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209097	Green Published, hybrid			2022-12-25	WOS:000288013300093
J	Bohn, M; Heermann, DW				Bohn, Manfred; Heermann, Dieter W.			Repulsive Forces Between Looping Chromosomes Induce Entropy-Driven Segregation	PLOS ONE			English	Article							INTERPHASE CHROMOSOMES; GENE-REGULATION; MONTE-CARLO; CHROMATIN; GENOME; MODEL; CONFORMATION; ORGANIZATION; SIMULATION; POLYMERS	One striking feature of chromatin organization is that chromosomes are compartmentalized into distinct territories during interphase, the degree of intermingling being much smaller than expected for linear chains. A growing body of evidence indicates that the formation of loops plays a dominant role in transcriptional regulation as well as the entropic organization of interphase chromosomes. Using a recently proposed model, we quantitatively determine the entropic forces between chromosomes. This Dynamic Loop Model assumes that loops form solely on the basis of diffusional motion without invoking other long-range interactions. We find that introducing loops into the structure of chromatin results in a multi-fold higher repulsion between chromosomes compared to linear chains. Strong effects are observed for the tendency of a non-random alignment; the overlap volume between chromosomes decays fast with increasing loop number. Our results suggest that the formation of chromatin loops imposes both compartmentalization as well as order on the system without requiring additional energy-consuming processes.	[Bohn, Manfred; Heermann, Dieter W.] Univ Heidelberg, Inst Theoret Phys, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bohn, M (corresponding author), Univ Heidelberg, Inst Theoret Phys, Heidelberg, Germany.	bohn@tphys.uni-heidelberg.de			Landesgraduiertenfoerderung Baden-Wuerttemberg	Landesgraduiertenfoerderung Baden-Wuerttemberg	MB acknowledges funding from the Landesgraduiertenfoerderung Baden-Wuerttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Binder K, 2002, MONTE CARLO SIMULATI; Binder K., 1995, MONTE CARLO MOL DYNA; BOHN M, 2009, MACROMOLECULES UNPUB; BOHN M, 2010, J CHEM PHYS IN PRESS; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; BRANCO M, 2006, PLOS BIOL, V4, P97; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; DAUTENHAHN J, 1994, MACROMOLECULES, V27, P5399, DOI 10.1021/ma00097a021; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Diesinger PM, 2009, BIOPHYS J, V97, P2146, DOI 10.1016/j.bpj.2009.06.057; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rawdon EJ, 2008, MACROMOLECULES, V41, P8281, DOI 10.1021/ma801389c; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sokal A, 1996, MONTE CARLO METHODS; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	31	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14428	10.1371/journal.pone.0014428	http://dx.doi.org/10.1371/journal.pone.0014428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245914	Green Published, Green Submitted, gold			2022-12-25	WOS:000286510500002
J	Maxwell, CR; Spangenberg, RJ; Hoek, JB; Silberstein, SD; Oshinsky, ML				Maxwell, Christina R.; Spangenberg, Rebecca Jay; Hoek, Jan B.; Silberstein, Stephen D.; Oshinsky, Michael L.			Acetate Causes Alcohol Hangover Headache in Rats	PLOS ONE			English	Article							CUTANEOUS ALLODYNIA; ETHANOL-METABOLISM; RED WINE; MIGRAINE; BLOOD; ACETALDEHYDE; DISULFIRAM; OXIDATION; PHONOPHOBIA; INHIBITION	Background: The mechanism of veisalgia cephalgia or hangover headache is unknown. Despite a lack of mechanistic studies, there are a number of theories positing congeners, dehydration, or the ethanol metabolite acetaldehyde as causes of hangover headache. Methods: We used a chronic headache model to examine how pure ethanol produces increased sensitivity for nociceptive behaviors in normally hydrated rats. Results: Ethanol initially decreased sensitivity to mechanical stimuli on the face (analgesia), followed 4 to 6 hours later by inflammatory pain. Inhibiting alcohol dehydrogenase extended the analgesia whereas inhibiting aldehyde dehydrogenase decreased analgesia. Neither treatment had nociceptive effects. Direct administration of acetate increased nociceptive behaviors suggesting that acetate, not acetaldehyde, accumulation results in hangover-like hypersensitivity in our model. Since adenosine accumulation is a result of acetate formation, we administered an adenosine antagonist that blocked hypersensitivity. Discussion: Our study shows that acetate contributes to hangover headache. These findings provide insight into the mechanism of hangover headache and the mechanism of headache induction.	[Maxwell, Christina R.; Spangenberg, Rebecca Jay; Silberstein, Stephen D.; Oshinsky, Michael L.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Hoek, Jan B.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Maxwell, CR (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	Michael.Oshinsky@jefferson.edu		Oshinsky, Michael/0000-0002-0976-1047; Hoek, Jan/0000-0001-7127-4218	National Institutes of Health [F31-AA017852, R01-NS058695]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA017852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health (F31-AA017852 to CRM, R01-NS058695 to MLO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou AP, 2010, EXPERT REV NEUROTHER, V10, P389, DOI 10.1586/ERN.10.16; Ashkenazi A, 2009, CEPHALALGIA, V29, P1042, DOI 10.1111/j.1468-2982.2008.01834.x; Ashkenazi A, 2010, J NEUROL NEUROSUR PS, V81, P1256, DOI 10.1136/jnnp.2009.198481; Blau JN, 2005, HEADACHE, V45, P757, DOI 10.1111/j.1526-4610.2005.05143_3.x; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; BLOOM F, 1982, BRIT J PHARMACOL, V75, P251, DOI 10.1111/j.1476-5381.1982.tb08780.x; BRIDGES SR, 1992, AM J CLIN NUTR, V56, P455, DOI 10.1093/ajcn/56.2.455; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Campisi P, 1997, EUR J PHARMACOL, V325, P165, DOI 10.1016/S0014-2999(97)00124-6; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Chandra D, 2008, ALCOHOL CLIN EXP RES, V32, P10, DOI 10.1111/j.1530-0277.2007.00563.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; DEITRICH RA, 2007, NOVART FDN SYMP, V285, P40; Deitrich RA, 2007, NOVART FDN SYMP, V285, P198; Deitrich Richard A, 2007, Novartis Found Symp, V285, P23; DIAMOND SM, 1987, AM J KIDNEY DIS, V9, P3, DOI 10.1016/S0272-6386(87)80155-5; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; FEIERMAN DE, 1986, BIOCHEM J, V239, P671, DOI 10.1042/bj2390671; FERKO AP, 1978, TOXICOL APPL PHARM, V46, P235, DOI 10.1016/0041-008X(78)90154-0; FRIEDMAN HJ, 1980, PHARMACOL BIOCHEM BE, V13, P773, DOI 10.1016/0091-3057(80)90205-1; GOLDBERG L, 1969, BIOCHEM PHARMACOL, V18, P1749, DOI 10.1016/0006-2952(69)90164-6; Gonzalez D, 2008, DURAL STIMULATION IN, V369, P1; HARADA S, 1982, Substance and Alcohol Actions-Misuse, V3, P107; Helander A, 2000, LIFE SCI, V67, P799, DOI 10.1016/S0024-3205(00)00674-3; Howland J, 2008, ADDICTION, V103, P758, DOI 10.1111/j.1360-0443.2008.02181.x; Jakubowski M, 2005, HEADACHE, V45, P850, DOI 10.1111/j.1526-4610.2005.05153.x; Karamanakos PN, 2001, PHARMACOL TOXICOL, V88, P106, DOI 10.1034/j.1600-0773.2001.d01-90.x; KAUFMAN HS, 1988, LANCET, V1, P992; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Kuster GW, 2006, HEADACHE, V46, P688, DOI 10.1111/j.1526-4610.2006.00419.x; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; LITTLEWOOD JT, 1988, LANCET, V1, P558, DOI 10.1016/S0140-6736(88)91353-0; LUNDQUIST F, 1962, NATURE, V193, P579, DOI 10.1038/193579b0; Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5; Nurmi M, 1999, ALCOHOL, V19, P113, DOI 10.1016/S0741-8329(99)00022-1; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky Michael L, 2006, Curr Pain Headache Rep, V10, P225, DOI 10.1007/s11916-006-0050-y; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Panconesi A, 2008, J HEADACHE PAIN, V9, P19, DOI 10.1007/s10194-008-0006-1; POHORECKY LA, 1987, LIFE SCI, V41, P1289, DOI 10.1016/0024-3205(87)90208-6; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Rosman AS, 2000, ALCOHOL CLIN EXP RES, V24, P958, DOI 10.1097/00000374-200007000-00004; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2004, J HEADACHE PAIN, V5, P230; Sjaastad O, 2004, J HEADACHE PAIN, V5, P181; Stephens R, 2008, ALCOHOL ALCOHOLISM, V43, P163, DOI 10.1093/alcalc/agm160; Swift R, 1998, ALCOHOL HEALTH RES W, V22, P54; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101, DOI 10.1093/oxfordjournals.alcalc.a044872; Wall TL, 2000, J STUD ALCOHOL, V61, P13, DOI 10.15288/jsa.2000.61.13; WHITBY JD, 1980, ANAESTHESIA, V35, P502, DOI 10.1111/j.1365-2044.1980.tb03830.x; Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008; Wieseler J, 2010, J NEUROSCI METH, V185, P236, DOI 10.1016/j.jneumeth.2009.10.006; Wu WP, 2006, NEUROSCI LETT, V402, P164, DOI 10.1016/j.neulet.2006.03.065; Yokoyama M, 2005, ALCOHOL CLIN EXP RES, V29, P1165, DOI 10.1097/01.ALC.0000172457.62535.EE; YOURICK JJ, 1989, BIOCHEM PHARMACOL, V38, P413, DOI 10.1016/0006-2952(89)90380-8; Zimatkin SM, 2006, ALCOHOL CLIN EXP RES, V30, P1500, DOI 10.1111/j.1530-0277.2006.00181.x; Zimatkin SM, 1998, ALCOHOL CLIN EXP RES, V22, P1623, DOI 10.1111/j.1530-0277.1998.tb03958.x	61	34	35	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15963	10.1371/journal.pone.0015963	http://dx.doi.org/10.1371/journal.pone.0015963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209842	gold, Green Published, Green Submitted			2022-12-25	WOS:000285838900054
J	Strom, S; Rodriguez-Wallberg, K; Holm, F; Bergstrom, R; Eklund, L; Stromberg, AM; Hovatta, O				Strom, Susanne; Rodriguez-Wallberg, Kenny; Holm, Frida; Bergstrom, Rosita; Eklund, Linda; Stromberg, Anne-Marie; Hovatta, Outi			No Relationship between Embryo Morphology and Successful Derivation of Human Embryonic Stem Cell Lines	PLOS ONE			English	Article							SERUM REPLACEMENT MEDIUM; POOR-QUALITY EMBRYOS; MASS ISOLATION; HUMAN ZYGOTES; FEEDER CELLS; BLASTOCYST; DIFFERENTIATION; ENUCLEATION; FIBROBLASTS; EXPRESSION	Background: The large number (30) of permanent human embryonic stem cell (hESC) lines and additional 29 which did not continue growing, in our laboratory at Karolinska Institutet have given us a possibility to analyse the relationship between embryo morphology and the success of derivation of hESC lines. The derivation method has been improved during the period 2002-2009, towards fewer xeno-components. Embryo quality is important as regards the likelihood of pregnancy, but there is little information regarding likelihood of stem cell derivation. Methods: We evaluated the relationship of pronuclear zygote stage, the score based on embryo morphology and developmental rate at cleavage state, and the morphology of the blastocyst at the time of donation to stem cell research, to see how they correlated to successful establishment of new hESC lines. Results: Derivation of hESC lines succeeded from poor quality and good quality embryos in the same extent. In several blastocysts, no real inner cell mass (ICM) was seen, but permanent well growing hESC lines could be established. One tripronuclear (3PN) zygote, which developed to blastocyst stage, gave origin to a karyotypically normal hESC line. Conclusion: Even very poor quality embryos with few cells in the ICM can give origin to hESC lines.	[Strom, Susanne; Rodriguez-Wallberg, Kenny; Holm, Frida; Bergstrom, Rosita; Stromberg, Anne-Marie; Hovatta, Outi] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rodriguez-Wallberg, Kenny; Eklund, Linda] Karolinska Univ Hosp, Fertil Unit, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Strom, S (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	susanne.strom@ki.se		Rodriguez-Wallberg, Kenny A./0000-0003-4378-6181	Swedish Research Council; Karolinska Institutet; KID; R&D funding of Stockholm County	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); KID; R&D funding of Stockholm County	This study was supported by the Swedish Research Council and by Karolinska Institutet, KID-funding, and by the R&D funding of Stockholm County and Karolinska Institutet (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2006, FERTIL STERIL, V86, P1193, DOI 10.1016/j.fertnstert.2005.12.081; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Escriba MJ, 2006, FERTIL STERIL, V86, P1601, DOI 10.1016/j.fertnstert.2006.04.047; Feki A, 2008, SWISS MED WKLY, V138, P540, DOI 2008/37/smw-12385; FINN A, 2010, J REPROD BIOMED ONLI, V21, P381; Gardner David K., 2000, Hum Fertil (Camb), V3, P229, DOI 10.1080/1464727002000199051; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Ivakhnenko V, 2000, HUM REPROD, V15, P911, DOI 10.1093/humrep/15.4.911; Kattera S, 2003, HUM REPROD, V18, P1319, DOI 10.1093/humrep/deg262; Klimanskaya I, 2007, NAT PROTOC, V2, P1963, DOI 10.1038/nprot.2007.274; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Koivisto H, 2004, REPROD BIOMED ONLINE, V9, P330, DOI 10.1016/S1472-6483(10)62150-5; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Liu WQ, 2009, J GENET GENOMICS, V36, P229, DOI 10.1016/S1673-8527(08)60110-1; MOHR L R, 1985, Journal of In Vitro Fertilization and Embryo Transfer, V2, P1, DOI 10.1007/BF01130825; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Sathananthan AH, 1999, HUM REPROD UPDATE, V5, P553, DOI 10.1093/humupd/5.5.553; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stephenson EL, 2009, BJOG-INT J OBSTET GY, V116, P158, DOI 10.1111/j.1471-0528.2008.02009.x; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Stephenson EL, 2006, REGEN MED, V1, P739, DOI 10.2217/17460751.1.6.739; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Wells D, 2010, REPROD BIOMED ONLINE, V21, P274, DOI 10.1016/j.rbmo.2010.06.035; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15329	10.1371/journal.pone.0015329	http://dx.doi.org/10.1371/journal.pone.0015329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217828	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900020
J	Wierenga, CJ; Mullner, FE; Rinke, I; Keck, T; Stein, V; Bonhoeffer, T				Wierenga, Corette J.; Muellner, Fiona E.; Rinke, Ilka; Keck, Tara; Stein, Valentin; Bonhoeffer, Tobias			Molecular and Electrophysiological Characterization of GFP-Expressing CA1 Interneurons in GAD65-GFP Mice	PLOS ONE			English	Article							CAUDAL GANGLIONIC EMINENCE; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; PYRAMIDAL CELLS; MEDIAL SEPTUM; NEUROGLIAFORM CELLS; NEURONAL DIVERSITY; CEREBRAL-CORTEX; AREA	The use of transgenic mice in which subtypes of neurons are labeled with a fluorescent protein has greatly facilitated modern neuroscience research. GAD65-GFP mice, which have GABAergic interneurons labeled with GFP, are widely used in many research laboratories, although the properties of the labeled cells have not been studied in detail. Here we investigate these cells in the hippocampal area CA1 and show that they constitute similar to 20% of interneurons in this area. The majority of them expresses either reelin (70 +/- 2%) or vasoactive intestinal peptide (VIP; 15 +/- 2%), while expression of parvalbumin and somatostatin is virtually absent. This strongly suggests they originate from the caudal, and not the medial, ganglionic eminence. GFP-labeled interneurons can be subdivided according to the (partially overlapping) expression of neuropeptide Y (42 +/- 3%), cholecystokinin (25 +/- 3%), calbindin (20 +/- 2%) or calretinin (20 +/- 2%). Most of these subtypes (with the exception of calretinin-expressing interneurons) target the dendrites of CA1 pyramidal cells. GFP-labeled interneurons mostly show delayed onset of firing around threshold, and regular firing with moderate frequency adaptation at more depolarized potentials.	[Wierenga, Corette J.; Muellner, Fiona E.; Keck, Tara; Bonhoeffer, Tobias] Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiolgy, Martinsried, Germany	Max Planck Society	Wierenga, CJ (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiolgy, Martinsried, Germany.	wierenga@neuro.mpg.de	Stein, Valentin/A-8025-2008; Wierenga, Corette J./H-2749-2019; Bonhoeffer, Tobias/B-9481-2009	Stein, Valentin/0000-0003-1222-4928; Wierenga, Corette J./0000-0001-9073-4099; Bonhoeffer, Tobias/0000-0001-7897-6634; Mullner, Fiona/0000-0002-7954-7273; Keck, Tara/0000-0001-6623-1037	IEF [40528]; ERG [256284]; German National Academic Foundation; Max Planck Society; Medical Research Council [G0901899B] Funding Source: researchfish	IEF; ERG; German National Academic Foundation; Max Planck Society(Max Planck Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Marie Curie grants IEF #40528 and ERG #256284 (CJW), the German National Academic Foundation (FEM) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FROTSCHER M, 2010, NEUROSCIENCES, V33, P407; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Gulyas AI, 1996, HIPPOCAMPUS, V6, P525, DOI 10.1002/(SICI)1098-1063(1996)6:5<525::AID-HIPO5>3.0.CO;2-H; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Jinno S, 2006, NEUROSCI RES, V56, P229, DOI 10.1016/j.neures.2006.07.007; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; LEDRI M, 2010, HIPPOCAMPUS IN PRESS; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; NIU S, 2010, J NEUROSCI, V28, P10339; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Takacs VT, 2008, EUR J NEUROSCI, V28, P148, DOI 10.1111/j.1460-9568.2008.06319.x; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	49	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15915	10.1371/journal.pone.0015915	http://dx.doi.org/10.1371/journal.pone.0015915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209836	Green Submitted, gold, Green Published			2022-12-25	WOS:000285838900049
J	Casey, GJ; Jolley, D; Phuc, TQ; Tinh, TT; Tho, DH; Montresor, A; Biggs, BA				Casey, Gerard J.; Jolley, Damien; Phuc, Tran Q.; Tinh, Ta T.; Tho, Dang H.; Montresor, Antonio; Biggs, Beverley-Ann			Long-Term Weekly Iron-Folic Acid and De-Worming Is Associated with Stabilised Haemoglobin and Increasing Iron Stores in Non-Pregnant Women in Vietnam	PLOS ONE			English	Article							REPRODUCTIVE AGE; ANEMIA; SUPPLEMENTATION; ASSAY; SERUM	Background: The prevalence of anaemia and iron deficiency in women remains high worldwide. WHO recommends weekly iron-folic acid supplementation where anaemia rates in non-pregnant women of reproductive age are higher than 20%. In 2006, a demonstration project consisting of weekly iron-folic acid supplementation and regular de-worming was set up in two districts in a northern province in Vietnam where anaemia and hookworm rates were 38% and 76% respectively. In 2008 the project was expanded to all districts in the province, targeting some 250,000 women. The objectives of this study were to: 1) examine changes in haemoglobin, iron stores and soil transmitted helminth infection prevalence over three years and 2) assess women's access to and compliance with the intervention. Methods and Findings: The study was a semi-cross-sectional, semi-longitudinal panel design with a baseline survey, three impact surveys at three-, twelve- and thirty months after commencement of the intervention, and three compliance surveys after ten weeks, eighteen and thirty six months. Results: After thirty months, mean haemoglobin stabilised at 130.3 g/L, an increase of 8.2 g/L from baseline, and mean serum ferritin rose from 23.9 mu g/L to 52 mu g/L. Hookworm prevalence fell from 76% to 22% over the same period. After thirty six months, 81% of the target population were receiving supplements and 87% were taking 75% or more of the supplements they received. Conclusions: Weekly iron-folic acid supplementation and regular de-worming was effective in significantly and sustainably reducing the prevalence of anaemia and soil transmitted helminth infections and high compliance rates were maintained over three years.	[Casey, Gerard J.; Biggs, Beverley-Ann] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia; [Jolley, Damien] Monash Univ, Sch Publ Hlth Prevent Med, Alfred Ctr, Prahran, Vic, Australia; [Phuc, Tran Q.; Tinh, Ta T.] Natl Inst Malariol Parasitol & Entomol NIMPE, Hanoi, Vietnam; [Tho, Dang H.] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Montresor, Antonio] WHO, CH-1211 Geneva, Switzerland; [Biggs, Beverley-Ann] Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Monash University; World Health Organization; Royal Melbourne Hospital	Casey, GJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia.	babiggs@unimelb.edu.au	Montresor, Antonio/J-3137-2019	Montresor, Antonio/0000-0003-3103-8872; Biggs, Beverley-Ann/0000-0002-2961-9793	Atlantic Philanthropies Inc.	Atlantic Philanthropies Inc.	This project was kindly funded by Atlantic Philanthropies Inc. URL: http://www.atlanticphilanthropies.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASH LR, 2004, TRAINING MANUAL DIAG; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Cochran WG., 1963, SAMPLING TECHNIQUES; Kish L, 1995, SCI 1995; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mihrshahi S, 2009, INT J PARASITOL, V39, P1037, DOI 10.1016/j.ijpara.2009.01.013; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Phuc TQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-266; Rabe-Hesketh S, 2005, MULILEVEL LONGITUDIN; Stoltzfus RJ, 1997, NUTR REV, V55, P223, DOI 10.1111/j.1753-4887.1997.tb01609.x; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; THURNHAM DI, 1988, CLIN CHEM, V34, P377; Trinh LTT, 2007, ASIA PAC J CLIN NUTR, V16, P310; Vir SC, 2008, FOOD NUTR BULL, V29, P186, DOI 10.1177/156482650802900304; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Waterton J., 1989, PANEL SURVEYS; WHO, 2006, THAL OTH HEM REP SEC; *WHO, 1999, WHOCDSCPCSIP993; WHO/CDC, 2005, ASS IR STAT POP REP; World Health Organization (WHO), 2009, WEEKL IR FOL AC SUPP; World Health Organization (WHO), WHONHD013	24	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15691	10.1371/journal.pone.0015691	http://dx.doi.org/10.1371/journal.pone.0015691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209902	gold, Green Published			2022-12-25	WOS:000285793600029
J	Di Modugno, F; Mottolese, M; DeMonte, L; Trono, P; Balsamo, M; Conidi, A; Melucci, E; Terrenato, I; Belleudi, F; Torrisi, MR; Alessio, M; Santoni, A; Nistico, P				Di Modugno, Francesca; Mottolese, Marcella; DeMonte, Lucia; Trono, Paola; Balsamo, Michele; Conidi, Andrea; Melucci, Elisa; Terrenato, Irene; Belleudi, Francesca; Torrisi, Maria Rosaria; Alessio, Massimo; Santoni, Angela; Nistico, Paola			The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer	PLOS ONE			English	Article							CELL-LINES; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; TUMOR CELLS; EXPRESSION; ERBB3; EGFR; IDENTIFICATION; REGULATORS; PROGNOSIS	hMena and the epithelial specific isoform hMena(11a) are actin cytoskeleton regulatory proteins belonging to the Ena/VASP family. EGF treatment of breast cancer cell lines upregulates hMena/hMena(11a) expression and phosphorylates hMena(11a), suggesting cross-talk between the ErbB receptor family and hMena/hMena(11a) in breast cancer. The aim of this study was to determine whether the hMena/hMena(11a) overexpression cooperates with HER-2 signalling, thereby affecting the HER2 mitogenic activity in breast cancer. In a cohort of breast cancer tissue samples a significant correlation among hMena, HER2 overexpression, the proliferation index (high Ki67), and phosphorylated MAPK and AKT was found and among the molecular subtypes the highest frequency of hMena overexpressing tumors was found in the HER2 subtype. From a clinical viewpoint, concomitant overexpression of HER2 and hMena identifies a subgroup of breast cancer patients showing the worst prognosis, indicating that hMena overexpression adds prognostic information to HER2 overexpressing tumors. To identify a functional link between HER2 and hMena, we show here that HER2 transfection in MCF7 cells increased hMena/hMena(11a) expression and hMena(11a) phosphorylation. On the other hand, hMena/hMena(11a) knock-down reduced HER3, AKT and p44/42 MAPK phosphorylation and inhibited the EGF and NRG1-dependent HER2 phosphorylation and cell proliferation. Of functional significance, hMena/hMena(11a) knock-down reduced the mitogenic activity of EGF and NRG1. Collectively these data provide new insights into the relevance of hMena and hMena(11a) as downstream effectors of the ErbB receptor family which may represent a novel prognostic indicator in breast cancer progression, helping to stratify patients.	[Di Modugno, Francesca; Trono, Paola; Balsamo, Michele; Conidi, Andrea; Nistico, Paola] Regina Elena Inst Canc Res, Immunol Lab, Rome, Italy; [Mottolese, Marcella; Melucci, Elisa] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [DeMonte, Lucia; Alessio, Massimo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Balsamo, Michele] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Conidi, Andrea] Katholieke Univ Leuven, Dept Mol & Dev Genet, Louvain, Belgium; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Belleudi, Francesca] Azienda Osped S Andrea, Rome, Italy; [Torrisi, Maria Rosaria; Santoni, Angela] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Massachusetts Institute of Technology (MIT); KU Leuven; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome	Di Modugno, F (corresponding author), Regina Elena Inst Canc Res, Immunol Lab, Rome, Italy.	nistico@ifo.it	Di Modugno, Francesca/B-2865-2018; Nisticò, Paola/B-2862-2018; Melucci, Elisa/K-5860-2016; Alessio, Massimo/L-4518-2019; Terrenato, Irene/B-1308-2017; Balsamo, Michele/AAJ-3247-2020; Di Modugno, Francesca/ABH-9406-2020; DeMonte, Lucia/AAN-8336-2020; santoni, angela/K-8997-2016; Alessio, Massimo/K-7028-2014	Di Modugno, Francesca/0000-0003-1427-1883; Nisticò, Paola/0000-0003-4409-2261; Melucci, Elisa/0000-0003-4908-5271; Terrenato, Irene/0000-0002-0187-9323; Balsamo, Michele/0000-0002-2315-4761; Di Modugno, Francesca/0000-0003-1427-1883; santoni, angela/0000-0003-1206-7731; Alessio, Massimo/0000-0002-4133-3472; Trono, Paola/0000-0002-2053-6334; De Monte, Lucia/0000-0002-9406-7809	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Health Ricerca Finalizzata; Italian Ministry of Health [PIO-2006, 5/07]; Ludwig Fund Postdoctoral Fellowship	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy); Ludwig Fund Postdoctoral Fellowship	Associazione Italiana per la Ricerca sul Cancro (AIRC)(P.N.,M.M.); Italian Ministry of Health Ricerca Finalizzata (P.N.); Italian Ministry of Health PIO-2006 RO strategici 5/07 (M.A.). Ludwig Fund Postdoctoral Fellowship (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Conti A, 2005, PROTEOMICS, V5, P4558, DOI 10.1002/pmic.200402088; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Feldner JC, 2002, EXP CELL RES, V272, P93, DOI 10.1006/excr.2001.5385; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klapper LN, 2000, ADV CANCER RES, V77, P25; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Margadant C, 2007, J CELL SCI, V120, P66, DOI 10.1242/jcs.03301; Menard S, 2008, ANN ONCOL, V19, P1706, DOI 10.1093/annonc/mdn369; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; NISTICO P, 1994, J CLIN INVEST, V94, P1426, DOI 10.1172/JCI117479; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; TAVASSOLI FA, 2003, TUMORS BREAST; Vocaturo A, 2006, ONCOLOGIST, V11, P878, DOI 10.1634/theoncologist.11-8-878; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15852	10.1371/journal.pone.0015852	http://dx.doi.org/10.1371/journal.pone.0015852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209853	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600046
J	Drew, SC; Masters, CL; Barnham, KJ				Drew, Simon C.; Masters, Colin L.; Barnham, Kevin J.			Alzheimer's A beta Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ Coordination	PLOS ONE			English	Article							METAL-ION CATALYSIS; AMYLOID-BETA; IN-VITRO; HYDROGEN-PEROXIDE; AMIDE HYDROLYSIS; COPPER(II) IONS; SENILE PLAQUES; CORE PROTEIN; PULSE EPR; BINDING	Background: The amyloid-beta (A beta) peptide is the primary component of the extracellular senile plaques characteristic of Alzheimer's disease (AD). The metals hypothesis implicates redox-active copper ions in the pathogenesis of AD and the Cu2+ coordination of various A beta peptides has been widely studied. A number of disease-associated modifications involving the first 3 residues are known, including isomerisation, mutation, truncation and cyclisation, but are yet to be characterised in detail. In particular, A beta in plaques contain a significant amount of truncated pyroglutamate species, which appear to correlate with disease progression. Methodology/Principal Findings: We previously characterised three Cu2+/A beta 1-16 coordination modes in the physiological pH range that involve the first two residues. Based upon our finding that the carbonyl of Ala2 is a Cu2+ ligand, here we speculate on a hypothetical Cu2+-mediated intramolecular cleavage mechanism as a source of truncations beginning at residue 3. Using EPR spectroscopy and site-specific isotopic labelling, we have also examined four A beta peptides with biologically relevant N-terminal modifications, A beta 1[isoAsp]-16, A beta 1-16(A2V), A beta 3-16 and A beta 3[pE]-16. The recessive A2V mutation preserved the first coordination sphere of Cu2+/A beta, but altered the outer coordination sphere. Isomerisation of Asp1 produced a single dominant species involving a stable 5-membered Cu2+ chelate at the amino terminus. The A beta 3-16 and A beta 3[pE]-16 peptides both exhibited an equilibrium between two Cu2+ coordination modes between pH 6-9 with nominally the same first coordination sphere, but with a dramatically different pH dependence arising from differences in H-bonding interactions at the N-terminus. Conclusions/Significance: N-terminal modifications significantly influence the Cu2+ coordination of A beta, which may be critical for alterations in aggregation propensity, redox-activity, resistance to degradation and the generation of the A beta 3-6 (x = 40/42) precursor of disease-associated A beta 3[pE]-x species.	[Drew, Simon C.; Barnham, Kevin J.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Drew, Simon C.; Barnham, Kevin J.] Univ Melbourne, Natl Neuroscience Facil, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Drew, Simon C.; Masters, Colin L.; Barnham, Kevin J.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic, Australia; [Drew, Simon C.] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia; [Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of Melbourne	Drew, SC (corresponding author), Max Planck Inst Bioinorgan Chem, Mulheim, Germany.	drew@mpi-muelheim.mpg.de	Drew, Simon/ABB-8102-2021	Drew, Simon/0000-0002-1459-9865	National Health and Medical Research Council of Australia [400202]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia grant # 400202 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balland V, 2010, P NATL ACAD SCI USA, V107, P17113, DOI 10.1073/pnas.1011315107; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Blumberger J, 2007, J CHEM THEORY COMPUT, V3, P1837, DOI 10.1021/ct7000792; Bush AI, 2003, ALZ DIS ASSOC DIS, V17, P147, DOI 10.1097/00002093-200307000-00005; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; Deligiannakis Y, 2000, COORDIN CHEM REV, V204, P1, DOI 10.1016/S0010-8545(99)00218-0; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2008, J BIOL INORG CHEM, V13, P899, DOI 10.1007/s00775-008-0377-4; Drew SC, 2009, J AM CHEM SOC, V131, P8760, DOI 10.1021/ja903669a; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; DUERR BF, 1990, J CHEM SOC CHEM COMM, P1707, DOI 10.1039/c39900001707; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; FIFE TH, 1986, J AM CHEM SOC, V108, P4631, DOI 10.1021/ja00275a059; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Furlan S, 2010, J PHYS CHEM B, V114, P15119, DOI 10.1021/jp102928h; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jiang DL, 2010, J PHYS CHEM B, V114, P4896, DOI 10.1021/jp9095375; Jun S, 2009, BIOCHEMISTRY-US, V48, P10724, DOI 10.1021/bi9012935; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Kowalik-Jankowska T, 2003, J INORG BIOCHEM, V95, P270, DOI 10.1016/S0162-0134(03)00128-4; Kowalik-Jankowska T, 2004, J INORG BIOCHEM, V98, P940, DOI 10.1016/j.jinorgbio.2004.03.001; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lou YC, 2006, J MOL BIOL, V355, P409, DOI 10.1016/j.jmb.2005.10.069; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MANTLE D, 1990, J NEUROL SCI, V98, P13, DOI 10.1016/0022-510X(90)90178-P; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; MCDERMOTT JR, 1985, J NEUROCHEM, V45, P752, DOI 10.1111/j.1471-4159.1985.tb04056.x; Miura T, 2004, J INORG BIOCHEM, V98, P10, DOI 10.1016/j.jinorgbio.2003.10.008; MORI H, 1992, J BIOL CHEM, V267, P17062; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pogni R, 1999, J INORG BIOCHEM, V73, P157, DOI 10.1016/S0162-0134(99)00012-4; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; SAYRE LM, 1986, J AM CHEM SOC, V108, P1632, DOI 10.1021/ja00267a037; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schweiger A., 2001, PRINCIPLES PULSE ELE; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; SUGIURA Y, 1975, J AM CHEM SOC, V97, P5577, DOI 10.1021/ja00852a043; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Tsvetkov PO, 2008, CHEMBIOCHEM, V9, P1564, DOI 10.1002/cbic.200700784; Van Doorslaer S, 2001, J PHYS CHEM B, V105, P1631, DOI 10.1021/jp003115y; Van Doorslaer S, 1999, J MAGN RESON, V136, P152, DOI 10.1006/jmre.1998.1609; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200; Zou J, 2001, ANGEW CHEM INT EDIT, V40, P2274, DOI 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5	68	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15875	10.1371/journal.pone.0015875	http://dx.doi.org/10.1371/journal.pone.0015875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209855	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600047
J	Carrozzo, M; Moscatelli, A; Lacquaniti, F				Carrozzo, Mauro; Moscatelli, Alessandro; Lacquaniti, Francesco			Tempo Rubato: Animacy Speeds Up Time in the Brain	PLOS ONE			English	Article							NEURAL MECHANISMS; MOTOR CONTROL; PERCEPTION; MOVEMENT; ANTHROPOMORPHISM; REPRESENTATION; ATTENTION; CORTEX; REAL	Background: How do we estimate time when watching an action? The idea that events are timed by a centralized clock has recently been called into question in favour of distributed, specialized mechanisms. Here we provide evidence for a critical specialization: animate and inanimate events are separately timed by humans. Methodology/Principal Findings: In different experiments, observers were asked to intercept a moving target or to discriminate the duration of a stationary flash while viewing different scenes. Time estimates were systematically shorter in the sessions involving human characters moving in the scene than in those involving inanimate moving characters. Remarkably, the animate/inanimate context also affected randomly intermingled trials which always depicted the same still character. Conclusions/Significance: The existence of distinct time bases for animate and inanimate events might be related to the partial segregation of the neural networks processing these two categories of objects, and could enhance our ability to predict critically timed actions.	[Carrozzo, Mauro] CNR, Inst Neurosci, Rome, Italy; [Carrozzo, Mauro; Moscatelli, Alessandro; Lacquaniti, Francesco] Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Carrozzo, M (corresponding author), CNR, Inst Neurosci, Rome, Italy.	lacquaniti@caspur.it	Lacquaniti, Francesco/J-9842-2016; Moscatelli, Alessandro/L-1391-2018	Lacquaniti, Francesco/0000-0003-0896-7315; Moscatelli, Alessandro/0000-0001-6269-4536	Italian Space Agency; Italian Ministry of University and Research; Italian Ministry of Health	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	Research was supported by grants from the Italian Space Agency, the Italian Ministry of University and Research, and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymoz C, 2004, VISION RES, V44, P1547, DOI 10.1016/j.visres.2003.12.011; Bartneck C, 2009, INT J SOC ROBOT, V1, P71, DOI 10.1007/s12369-008-0001-3; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brown SW, 2008, PSYCHOLOGY OF TIME, P111, DOI 10.1016/B978-0-08046-977-5.00004-1; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Chaminade T, 2007, SOC COGN AFFECT NEUR, V2, P206, DOI 10.1093/scan/nsm017; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; Faraggi D, 2003, STAT MED, V22, P1977, DOI 10.1002/sim.1368; Georgopoulos AP, 2002, CURR OPIN NEUROBIOL, V12, P678, DOI 10.1016/S0959-4388(02)00382-3; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Merchant H, 2004, CEREB CORTEX, V14, P314, DOI 10.1093/cercor/bhg130; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Neri P, 2009, P ROY SOC B-BIOL SCI, V276, P861, DOI 10.1098/rspb.2008.1363; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Oh S, 2008, PERCEPTION, V37, P317, DOI 10.1068/p5887; Opfer JE, 2011, WILEY BLACKWELL HDB, V2nd, P213, DOI DOI 10.1002/9780470996652.CH7; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2005, NEURON, V45, P625, DOI 10.1016/j.neuron.2004.12.052; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	54	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15638	10.1371/journal.pone.0015638	http://dx.doi.org/10.1371/journal.pone.0015638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21206749	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200033
J	Torres, M; Castillo, K; Armisen, R; Stutzin, A; Soto, C; Hetz, C				Torres, Mauricio; Castillo, Karen; Armisen, Ricardo; Stutzin, Andres; Soto, Claudio; Hetz, Claudio			Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress	PLOS ONE			English	Article							AMYLOID-BETA; TRANSMEMBRANE FORM; PROTEASOMAL DEGRADATION; RETROGRADE TRANSPORT; APOPTOTIC PATHWAY; BCL-2 FAMILY; DISEASE; PRP; ACCUMULATION; PEPTIDES	Prion-related disorders (PrDs) are fatal neurodegenerative disorders characterized by progressive neuronal impairment as well as the accumulation of an abnormally folded and protease resistant form of the cellular prion protein, termed PrP RES. Altered endoplasmic reticulum (ER) homeostasis is associated with the occurrence of neurodegeneration in sporadic, infectious and familial forms of PrDs. The ER operates as a major intracellular calcium store, playing a crucial role in pathological events related to neuronal dysfunction and death. Here we investigated the possible impact of PrP misfolding on ER calcium homeostasis in infectious and familial models of PrDs. Neuro2A cells chronically infected with scrapie prions showed decreased ER-calcium content that correlated with a stronger upregulation of UPR-inducible chaperones, and a higher sensitivity to ER stress-induced cell death. Overexpression of the calcium pump SERCA stimulated calcium release and increased the neurotoxicity observed after exposure of cells to brain-derived infectious PrP RES. Furthermore, expression of PrP mutants that cause hereditary Creutzfeldt-Jakob disease or fatal familial insomnia led to accumulation of PrP RES and their partial retention at the ER, associated with a drastic decrease of ER calcium content and higher susceptibility to ER stress. Finally, similar results were observed when a transmembrane form of PrP was expressed, which is proposed as a neurotoxic intermediate. Our results suggest that alterations in calcium homeostasis and increased susceptibility to ER stress are common pathological features of both infectious and familial PrD models.	[Torres, Mauricio; Castillo, Karen; Armisen, Ricardo; Stutzin, Andres; Hetz, Claudio] Univ Chile, Fac Med, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago 7, Chile; [Torres, Mauricio; Castillo, Karen; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 7, Chile; [Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX USA; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard T.H. Chan School of Public Health	Torres, M (corresponding author), Univ Chile, Fac Med, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago 7, Chile.	claudio.soto@uth.tmc.edu; chetz@med.uchile.cl	Hetz, Claudio/ABD-7514-2021; Armisen, Ricardo/A-7409-2012; Hetz, Claudio/I-1900-2013; Stutzin, Andrés/I-7605-2013	Armisen, Ricardo/0000-0003-2567-0521; Hetz, Claudio/0000-0001-7724-1767; Stutzin, Andrés/0000-0002-7264-066X; Castillo, Karen/0000-0003-0353-7025; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044	FONDECYT [1070444, 3100112]; Millennium Nucleus [P07-048-F]; Michael J. Fox Foundation for Parkinson's Research; ICGEB; Alzheimer's Disease Foundation; FONDAP [15010006]; CONICYT; NIH [R01 NS05349]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus; Michael J. Fox Foundation for Parkinson's Research; ICGEB; Alzheimer's Disease Foundation; FONDAP; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by FONDECYT no. 1070444, Millennium Nucleus no. P07-048-F, Michael J. Fox Foundation for Parkinson's Research, and ICGEB, Alzheimer's Disease Foundation (to CH), FONDAP grant no. 15010006 (to AS and CH), FONDECYT no. 3100112 (KC), CONICYT PhD fellowship (MT); and the NIH grant R01 NS05349 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Florio T, 1996, BIOCHEM BIOPH RES CO, V228, P397, DOI 10.1006/bbrc.1996.1673; Gleason MR, 2004, DEV BIOL, V276, P441, DOI 10.1016/j.ydbio.2004.09.008; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Gu YP, 2007, J MOL NEUROSCI, V32, P90, DOI 10.1007/s12031-007-0023-6; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2003, CELL MOL LIFE SCI, V60, P133, DOI 10.1007/s000180300009; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; O'Donovan CN, 2001, J BIOL CHEM, V276, P43516, DOI 10.1074/jbc.M103894200; ONG DS, NAT CHEM BIOL, V6, P424; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PARK SW, P NATL ACAD SCI US; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Soto C, 2001, TRENDS MOL MED, V7, P109, DOI 10.1016/S1471-4914(01)01931-1; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Stewart RS, 2005, J BIOL CHEM, V280, P15855, DOI 10.1074/jbc.M412298200; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; VIDAL R, 2011, CURR MOL ME IN PRESS; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; XU K, J MOL NEUROSCI; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	66	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15658	10.1371/journal.pone.0015658	http://dx.doi.org/10.1371/journal.pone.0015658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209925	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200035
J	Narayan, V; Halada, P; Hernychova, L; Chong, YP; Zakova, J; Hupp, TR; Vojtesek, B; Ball, KL				Narayan, Vikram; Halada, Petr; Hernychova, Lenka; Chong, Yuh Ping; Zakova, Jitka; Hupp, Ted R.; Vojtesek, Borivoj; Ball, Kathryn L.			A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; TRANSCRIPTIONAL REPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; IRF FAMILY; NUCLEOPHOSMIN; DOMAIN; YB-1; P53; IDENTIFICATION	The interferon-regulated transcription factor and tumor suppressor protein IRF-1 is predicted to be largely disordered outside of the DNA-binding domain. One of the advantages of intrinsically disordered protein domains is thought to be their ability to take part in multiple, specific but low affinity protein interactions; however, relatively few IRF-1-interacting proteins have been described. The recent identification of a functional binding interface for the E3-ubiquitin ligase CHIP within the major disordered domain of IRF-1 led us to ask whether this region might be employed more widely by regulators of IRF-1 function. Here we describe the use of peptide aptamer-based affinity chromatography coupled with mass spectrometry to define a multiprotein binding interface on IRF-1 (Mf2 domain; amino acids 106-140) and to identify Mf2-binding proteins from A375 cells. Based on their function as known transcriptional regulators, a selection of the Mf2 domain-binding proteins (NPM1, TRIM28, and YB-1) have been validated using in vitro and cell-based assays. Interestingly, although NPM1, TRIM28, and YB-1 all bind to the Mf2 domain, they have differing amino acid specificities, demonstrating the degree of combinatorial diversity and specificity available through linear interaction motifs.	[Narayan, Vikram; Chong, Yuh Ping; Ball, Kathryn L.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Hupp, Ted R.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK P53 Signal Transduct Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Halada, Petr] Inst Microbiol AS CR Vvi, Prague 14220, Czech Republic; [Hernychova, Lenka; Zakova, Jitka] Univ Def, Fac Mil Hlth Sci, Hradec Kralove 50001, Czech Republic; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Dept Oncol & Expt Pathol, Brno 65653, Czech Republic	University of Edinburgh; University of Edinburgh; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Defence - Czech Republic; Masaryk Memorial Cancer Institute	Ball, KL (corresponding author), Univ Edinburgh, Edinburgh Canc Res UK Ctr, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Halada, Petr/H-3330-2014; Narayan, Vikram/AAF-3964-2020; Hernychova, Lenka/J-6714-2014	Halada, Petr/0000-0002-7229-3450; Chong, Yuh Ping/0000-0002-9596-3242; Hernychova, Lenka/0000-0002-4352-0626; Narayan, Vikram/0000-0002-6128-7944	Czech Science Foundation [P304/10/0868]; Ministry of Defense, Czech Republic [FVZ0000604]; Ministry of Education, Youth, and Sports of the Czech Republic [LC07017]; Institutional Research Concept [AV0Z50200510]; Regional Center for Applied Molecular Oncology [CZ.1.05/2.1.00/03.0101]; Cancer Research UK [C377/A6355]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Defense, Czech Republic(Czech Republic Government); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept; Regional Center for Applied Molecular Oncology; Cancer Research UK(Cancer Research UK)	This work was supported in part by Czech Science Foundation Grant P304/10/0868; Ministry of Defense, Czech Republic, Grant FVZ0000604; Ministry of Education, Youth, and Sports of the Czech Republic Grant LC07017; Institutional Research Concept AV0Z50200510; and Regional Center for Applied Molecular Oncology Grant CZ.1.05/2.1.00/03.0101 and Cancer Research UK Programme Grant C377/A6355.	Alter MD, 2008, NEURON, V60, P733, DOI 10.1016/j.neuron.2008.12.002; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bauerle M, 2002, J BIOL CHEM, V277, P32480, DOI 10.1074/jbc.M202765200; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Briers S, 2009, J CELL SCI, V122, P937, DOI 10.1242/jcs.034793; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Fujii T, 2008, CANCER RES, V68, P1504, DOI 10.1158/0008-5472.CAN-07-2362; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; HARLOW E, 1999, USING ANTIBODIES LAB, P323; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Latzer J, 2007, J MOL BIOL, V367, P262, DOI 10.1016/j.jmb.2006.12.006; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Liao GL, 2005, J VIROL, V79, P245, DOI 10.1128/JVI.79.1.245-256.2005; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lorenz P, 2001, BIOL CHEM, V382, P637, DOI 10.1515/BC.2001.075; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Marsili G, 2004, ANN NY ACAD SCI, V1030, P636, DOI 10.1196/annals.1329.074; Masumi A, 1999, MOL CELL BIOL, V19, P1810; Meani N, 2009, EXPERT REV ANTICANC, V9, P1283, DOI 10.1586/ERA.09.84; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moller A, 2010, J BIOL CHEM, V285, P38348, DOI 10.1074/jbc.M110.149476; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Park J, 2007, P NATL ACAD SCI USA, V104, P17028, DOI 10.1073/pnas.0609852104; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sigalov AB, 2010, MOL BIOSYST, V6, P451, DOI 10.1039/b916030m; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Yung Benjamin Yat Ming, 2007, Chang Gung Med J, V30, P285	71	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14291	14303		10.1074/jbc.M110.204602	http://dx.doi.org/10.1074/jbc.M110.204602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21245151	Green Published, hybrid			2022-12-25	WOS:000289556200052
J	Finan, GM; Okada, H; Kim, TW				Finan, Gina M.; Okada, Hirokazu; Kim, Tae-Wan			BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SECRETASE CYTOSOLIC DOMAIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; GGA PROTEINS; RETROMER COMPLEX; HUMAN BRAIN; CLEAVING ENZYME; RECEPTOR LR11; GROWTH-FACTOR	BACE1 (beta-site beta-amyloid precursor protein (APP)-cleaving enzyme 1) mediates the first proteolytic cleavage of APP, leading to amyloid beta-peptide (A beta) production. It has been reported that BACE1 intracellular trafficking, in particular endosome-to-TGN sorting, is mediated by adaptor complexes, such as retromer and Golgi-localized gamma-ear-containing ARF-binding proteins (GGAs). Here we investigated whether sortilin, a Vps10p domain-sorting receptor believed to participate in retromer- mediated transport of select membrane cargoes, contributes to the subcellular trafficking and activity of BACE1. Our initial studies revealed increased levels of sortilin in post-mortem brain tissue of AD patients and that overexpression of sortilin leads to increased BACE1-mediated cleavage of APP in cultured cells. In contrast, RNAi suppression of sortilin results in decreased BACE1-mediated cleavage of APP. We also found that sortilin interacts with BACE1 and that a sortilin construct lacking its cytoplasmic domain, which contains putative retromer sorting motifs, remains bound to BACE1. However, expression of this truncated sortilin redistributes BACE1 from the trans-Golgi network to the endosomes and substantially reduces the retrograde trafficking of BACE1. Site-directed mutagenesis and chimera experiments reveal that the cytoplasmic tail of sortilin, but not those from other VPS10p domain receptors (e. g. SorCs1b and SorLA), plays a unique role in BACE1 trafficking. Our studies suggest a new function for sortilin as a modulator of BACE1 retrograde trafficking and subsequent generation of A beta.	[Finan, Gina M.; Kim, Tae-Wan] Columbia Univ, Med Ctr, Grad Program Pathobiol & Mol Med, New York, NY 10032 USA; [Okada, Hirokazu; Kim, Tae-Wan] Columbia Univ, Med Ctr, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; [Finan, Gina M.; Okada, Hirokazu; Kim, Tae-Wan] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kim, Tae-Wan] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Grad Program Pathobiol & Mol Med, 630 W 168th St,P&S 12-430, New York, NY 10032 USA.	twk16@columbia.edu		Okada, Hirokazu/0000-0002-1065-2470	National Institutes of Health Alzheimer's Disease Research Center [AG08702]; American Health Assistance Foundation; National Institute of Neurological Disorders and Stroke Predoctoral National Research Service [NS051957]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS051957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health Alzheimer's Disease Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); National Institute of Neurological Disorders and Stroke Predoctoral National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health Alzheimer's Disease Research Center (AG08702, to T.-W.K.), American Health Assistance Foundation (to T.-W.K.), and the National Institute of Neurological Disorders and Stroke Predoctoral National Research Service Award (NS051957, to G. M. F.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; ARNOLD SE, 1994, ARCH NEUROL-CHICAGO, V51, P145, DOI 10.1001/archneur.1994.00540140051014; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2001, TRAFFIC, V2, P75, DOI 10.1034/j.1600-0854.2001.020201.x; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kim E, 2010, BIOCHEM BIOPH RES CO, V403, P167, DOI 10.1016/j.bbrc.2010.10.121; KOO EH, 1994, J BIOL CHEM, V269, P17386; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Nielsen MS, 2008, TRAFFIC, V9, P980, DOI 10.1111/j.1600-0854.2008.00731.x; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rezgaoui M, 2001, MECH DEVELOP, V100, P335, DOI 10.1016/S0925-4773(00)00523-2; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Van Gassen G, 2003, NEUROSCIENTIST, V9, P117, DOI 10.1177/1073858403252227; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Westergaard UB, 2005, FEBS LETT, V579, P1172, DOI 10.1016/j.febslet.2004.12.088; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	57	89	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.170217	http://dx.doi.org/10.1074/jbc.M110.170217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21245145	Green Published, hybrid			2022-12-25	WOS:000289077500072
J	Zhang, LY; Fujita, T; Wu, G; Xiao, XA; Wan, Y				Zhang, Liyong; Fujita, Takeo; Wu, George; Xiao, Xiao; Wan, Yong			Phosphorylation of the Anaphase-promoting Complex/Cdc27 Is Involved in TGF-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE CK2; MITOTIC PROGRESSION; CANCER; SNON; SKI; SMAD3; GENE; CDH1; DIFFERENTIATION	Loss of TGF-beta-induced growth inhibition is a hallmark of many human tumors. Previous studies implied that activation of the anaphase-promoting complex (APC/cyclosome) is involved in the TGF-beta signaling pathway, which facilitates the destruction of SnoN, a transcriptional co-suppressor, which leads in turn to the transactivation of TGF-beta-responsive genes for cell cycle arrest. The function of APC was demonstrated in TGF-beta signal transduction, but the mechanism by which it is activated in response to TGF-beta signaling remains unclear. We report here that phosphorylation of Cdc27, a core subunit of APC, in response to TGF-beta signaling can facilitate the activation of APC. We have demonstrated that casein kinase II (CKII) is involved in the phosphorylation of Cdc27 in response to TGF-beta signaling. Depletion of CKII by shRNA abolishes the TGF-beta-induced phosphorylation of Cdc27 and subsequent degradation of SnoN. Disruptive mutation of Cdc27 (S154A) attenuates TGF-beta-induced SnoN degradation. In addition, expression of a phosphorylation-resistant Cdc27 mutant significantly attenuates TGF-beta-induced growth inhibition. Together, the results suggest that phosphorylation of Cdc27 by CKII is involved in TGF-beta-induced activation of APC.	[Wan, Yong] Univ Pittsburgh, Hillman Canc Ctr, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15213 USA; [Zhang, Liyong; Fujita, Takeo; Wu, George; Xiao, Xiao; Wan, Yong] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Fujita, Takeo] Natl Canc Ctr Hosp, Kashiwa, Chiba 2778577, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Cancer Center - Japan	Wan, Y (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Dept Cell Biol & Physiol, Sch Med, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu		Zhang, Liyong/0000-0002-6952-7463	National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA115943, R01CA154695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Fujita T, 2008, MOL BIOL CELL, V19, P5446, DOI 10.1091/mbc.E08-03-0289; Gao Y, 2009, J VIROL, V83, P2393, DOI 10.1128/JVI.02339-08; Guo X, 2008, ONCOGENE, V27, P7235, DOI 10.1038/onc.2008.337; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Kim EK, 2009, GENE, V431, P55, DOI 10.1016/j.gene.2008.10.020; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee NY, 2009, FASEB J, V23, P3712, DOI 10.1096/fj.09-131607; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809	42	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10041	10050		10.1074/jbc.M110.205518	http://dx.doi.org/10.1074/jbc.M110.205518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209074	hybrid, Green Published			2022-12-25	WOS:000288547000018
J	Ohnsorg, PM; Rohrer, L; Perisa, D; Kateifides, A; Chroni, A; Kardassis, D; Zannis, VI; von Eckardstein, A				Ohnsorg, Pascale M.; Rohrer, Lucia; Perisa, Damir; Kateifides, Andreas; Chroni, Angeliki; Kardassis, Dimitris; Zannis, Vassilis I.; von Eckardstein, Arnold			Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR BI; CHOLESTEROL EFFLUX; CELLULAR CHOLESTEROL; SR-BI; BINDING; HDL; ABCA1; MUTATIONS; MODEL	High density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) must leave the circulation and pass the endothelium to exert their atheroprotective actions in the arterial wall. We previously demonstrated that the transendothelial transport of apoA-I involves ATP-binding cassette transporter (ABC) A1 and re-secretion of lipidated particles. Transendothelial transport of HDL is modulated by ABCG1 and the scavenger receptor BI (SR-BI). We hypothesize that apoA-I transport is started by the ABCA1-mediated generation of a lipidated particle which is then transported by ABCA1-independent pathways. To test this hypothesis we analyzed the endothelial binding and transport properties of initially lipid-free as well as prelipidated apoA-I mutants. Lipid-free apoA-I mutants with a defective carboxyl-terminal domain showed an 80% decreased specific binding and 90% decreased specific transport by aortic endothelial cells. After prior cell-free lipidation of the mutants, the resulting HDL-like particles were transported through endothelial cells by an ABCG1- and SR-BI-dependent process. ApoA-I mutants with deletions of either the amino terminus or both the amino and carboxyl termini showed dramatic increases in nonspecific binding but no specific binding or transport. Prior cell-free lipidation did not rescue these anomalies. Our findings of stringent structure-function relationships underline the specificity of transendothelial apoA-I transport and suggest that lipidation of initially lipid-free apoA-I is necessary but not sufficient for specific transendothelial transport. Our data also support the model of a two-step process for the transendothelial transport of apoA-I in which apoA-I is initially lipidated by ABCA1 and then further processed by ABCA1-independent mechanisms.	[Ohnsorg, Pascale M.; Rohrer, Lucia; Perisa, Damir; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Ohnsorg, Pascale M.; von Eckardstein, Arnold] Univ Zurich, CH-8091 Zurich, Switzerland; [Ohnsorg, Pascale M.; von Eckardstein, Arnold] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8091 Zurich, Switzerland; [Rohrer, Lucia; Perisa, Damir; von Eckardstein, Arnold] Univ Zurich, Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland; [Kateifides, Andreas; Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biol, Athens 15310, Greece; [Kateifides, Andreas; Kardassis, Dimitris; Zannis, Vassilis I.] Univ Crete, Sch Med, Dept Biochem, Div Basic Sci,Inst Mol Biol & Biotechnol, Iraklion 71201, Greece	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Boston University; National Centre of Scientific Research "Demokritos"; University of Crete	von Eckardstein, A (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.	arnold.voneckardstein@usz.ch	Perisa, Damir/I-4217-2012; Kateifides, Andreas/E-9269-2011	Chroni, Angeliki/0000-0003-3107-1189; Zannis, Vassilis/0000-0002-1295-7155	National Institutes of Health [HL48739]; Swiss National Research Foundation [3100AO-116404/1, 31003A_130836/1]; European Grant [LSHM-CT-2006-0376331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL48739. This work was also supported by Swiss National Research Foundation Grants 3100AO-116404/1, 31003A_130836/1 and European Grant LSHM-CT-2006-0376331.	Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Borhani DW, 1999, ACTA CRYSTALLOGR D, V55, P1578, DOI 10.1107/S0907444999008914; BROWN WV, 1969, J BIOL CHEM, V244, P5687; Cavelier C, 2006, CIRC RES, V99, P1060, DOI 10.1161/01.RES.0000250567.17569.b3; Chroni A, 2005, BIOCHEMISTRY-US, V44, P14353, DOI 10.1021/bi050962o; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Chroni A, 2007, BIOCHEMISTRY-US, V46, P5697, DOI 10.1021/bi602354t; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Gajdusek C. M., 1983, IN VITRO, V19, P394; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Lorenzi I, 2008, BBA-MOL CELL BIOL L, V1781, P306, DOI 10.1016/j.bbalip.2008.04.006; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8; Minshall R. D., 2006, V176, P107; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Reardon CA, 2001, BIOCHEMISTRY-US, V40, P13670, DOI 10.1021/bi011451e; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Von Eckardstein A, 2010, EXPERT REV CARDIOVAS, V8, P345, DOI 10.1586/ERC.10.6; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; Zannis V., 2007, HIGH DENSITY LIPOPRO, P237; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	45	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7744	7754		10.1074/jbc.M110.193524	http://dx.doi.org/10.1074/jbc.M110.193524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209084	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000288013300006
J	Zhao, DZ; Bakirtzi, K; Zhan, YN; Zeng, HY; Koon, HW; Pothoulakis, C				Zhao, Dezheng; Bakirtzi, Kyriaki; Zhan, Yanai; Zeng, Huiyan; Koon, Hon Wai; Pothoulakis, Charalabos			Insulin-like Growth Factor-1 Receptor Transactivation Modulates the Inflammatory and Proliferative Responses of Neurotensin in Human Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEINASE-ACTIVATED RECEPTOR-1; TUMOR-NECROSIS-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; HUMAN COLONOCYTES; SMALL-INTESTINE; INTERLEUKIN-8 EXPRESSION; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS	Neurotensin (NT) is a gastrointestinal neuropeptide that modulates intestinal inflammation and healing by binding to its high-affinity receptor NTR1. The dual role of NT in inflammation and healing is demonstrated in models of colitis induced by Clostridium difficile toxin A and dextran sulfate sodium, respectively, and involves NF-kappa B-dependent IL-8 expression and EGF receptor-mediated MAPK activation in human colonocytes. However, the detailed signaling pathways involved in these responses remain to be elucidated. We report here that NT/NTR1 coupling in human colonic epithelial NCM460 cells activates tyrosine phosphorylation of the insulin-like growth factor-1 receptor (IGF-1R) in a time-and dose-dependent manner. NT also rapidly induces Src tyrosine phosphorylation, whereas pretreatment of cells with the Src inhibitor PP2 before NT exposure decreases NT-induced IGF-1R phosphorylation. In addition, inhibition of IGF-1R activation by either its specific antagonist AG1024 or siRNA against IGF-1 significantly reduces NT-induced IL-8 expression and NF-kappa B-dependent reporter gene expression. Pretreatment with AG1024 also inhibits Akt activation and apoptosis induced by NT. Silencing of Akt expression by siRNA also substantially attenuates NT-induced IL-8 promoter activity and NF-kappa B-dependent reporter gene expression. This is the first report to indicate that NT transactivates IGF-1R and that this response is linked to Akt phosphorylation and NF-kappa B activation, contributing to both pro-inflammatory and tissue repair signaling pathways in response to NT in colonic epithelial cells. We propose that IGF-1R activation represents a previously unrecognized key pathway involved in the mechanisms by which NT and NTR1 modulate colonic inflammation and inflammatory bowel disease.	[Zhao, Dezheng; Zhan, Yanai] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA USA; [Zeng, Huiyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vasc Med,Dept Med, Boston, MA USA; [Zhao, Dezheng; Zhan, Yanai] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, Boston, MA USA; [Bakirtzi, Kyriaki; Koon, Hon Wai; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhao, DZ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, 99 Brookline Ave,RN270J, Boston, MA 02115 USA.	dzhao@bidmc.harvard.edu; cpothoulakis@mednet.ucla.edu			National Institute of Health [K01 DK064920, R21 DK080970, DK060729]; American Cancer Society [RSG-07-178-CSM]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080970, K01DK064920, R01DK060729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institute of Health Grants K01 DK064920 and R21 DK080970 (to D. Z.) and DK060729 (to C. P.). This work was also supported by American Cancer Society Research Scholar Grant RSG-07-178-CSM (to D. Z.).	AMAR S, 1986, FEBS LETT, V201, P31, DOI 10.1016/0014-5793(86)80565-8; Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Ballinger A, 2002, HORM RES, V58, P7, DOI 10.1159/000064756; BOZOU JC, 1989, BIOCHEM J, V264, P871, DOI 10.1042/bj2640871; Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004; BURAKOFF R, 1995, GASTROENTEROLOGY, V109, P348, DOI 10.1016/0016-5085(95)90320-8; CARRAWAY R, 1976, J BIOL CHEM, V251, P7045; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Castagliuolo I, 1996, P NATL ACAD SCI USA, V93, P12611, DOI 10.1073/pnas.93.22.12611; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Cenac N, 2005, INFLAMM BOWEL DIS, V11, P792, DOI 10.1097/01.mib.0000177506.71784.bd; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Ehlers RA, 1998, SURGERY, V124, P239, DOI 10.1067/msy.1998.90370; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Eivindson M, 2007, GROWTH HORM IGF RES, V17, P33, DOI 10.1016/j.ghir.2006.10.003; El Yafi F, 2005, CLIN EXP IMMUNOL, V139, P526, DOI 10.1111/j.1365-2249.2004.02724.x; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Guha S, 2003, CANCER RES, V63, P2379; Guha S, 2002, CANCER RES, V62, P1632; Gulluoglu BM, 1999, DIGEST DIS SCI, V44, P1531, DOI 10.1023/A:1026646523284; Hassan S, 2004, REGUL PEPTIDES, V120, P155, DOI 10.1016/j.regpep.2004.03.004; HEINZERIAN P, 1991, ENDOCRINOLOGY, V129, P1769, DOI 10.1210/endo-129-4-1769; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; IZUKURA M, 1992, ANN SURG, V215, P520, DOI 10.1097/00000658-199205000-00015; Katsanos KH, 2001, GROWTH HORM IGF RES, V11, P364, DOI 10.1054/ghir.2001.0248; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Koon HW, 2006, J IMMUNOL, V176, P5050, DOI 10.4049/jimmunol.176.8.5050; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Maoret JJ, 1999, INT J CANCER, V80, P448, DOI 10.1002/(SICI)1097-0215(19990129)80:3<448::AID-IJC19>3.0.CO;2-N; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Ozes ON, 1999, NATURE, V401, P82; PoinotChazel G, 1996, BIOCHEM J, V320, P145, DOI 10.1042/bj3200145; Pothoulakis C, 1998, ANN NY ACAD SCI, V840, P635, DOI 10.1111/j.1749-6632.1998.tb09602.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; REASBECK PG, 1984, GASTROENTEROLOGY, V86, P1552; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Riegler M, 2000, GASTROENTEROLOGY, V119, P348, DOI 10.1053/gast.2000.9310; Sipos Ferenc, 2006, Orvosi Hetilap, V147, P1835; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sumitomo M, 2001, CANCER RES, V61, P3294; THOR K, 1986, GASTROENTEROLOGY, V90, P27, DOI 10.1016/0016-5085(86)90070-3; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; WIKLUND B, 1984, REGUL PEPTIDES, V8, P33, DOI 10.1016/0167-0115(84)90026-0; WOOD JG, 1988, AM J PHYSIOL, V255, pG813, DOI 10.1152/ajpgi.1988.255.6.G813; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Yoshinaga K, 1992, Surg Oncol, V1, P127, DOI 10.1016/0960-7404(92)90025-G; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	59	34	39	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6092	6099		10.1074/jbc.M110.192534	http://dx.doi.org/10.1074/jbc.M110.192534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21212273	Green Published, hybrid			2022-12-25	WOS:000287476400018
J	Pillot, MH; Gautrais, J; Arrufat, P; Couzin, ID; Bon, R; Deneubourg, JL				Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Couzin, Iain D.; Bon, Richard; Deneubourg, Jean-Louis			Scalable Rules for Coherent Group Motion in a Gregarious Vertebrate	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; LEADERSHIP; INFORMATION; MOVEMENTS; BEHAVIOR	Individuals of gregarious species that initiate collective movement require mechanisms of cohesion in order to maintain advantages of group living. One fundamental question in the study of collective movement is what individual rules are employed when making movement decisions. Previous studies have revealed that group movements often depend on social interactions among individual members and specifically that collective decisions to move often follow a quorum-like response. However, these studies either did not quantify the response function at the individual scale (but rather tested hypotheses based on group-level behaviours), or they used a single group size and did not demonstrate which social stimuli influence the individual decision-making process. One challenge in the study of collective movement has been to discriminate between a common response to an external stimulus and the synchronization of behaviours resulting from social interactions. Here we discriminate between these two mechanisms by triggering the departure of one trained Merino sheep (Ovis aries) from groups containing one, three, five and seven naive individuals. Each individual was thus exposed to various combinations of already-departed and non-departed individuals, depending on its rank of departure. To investigate which individual mechanisms are involved in maintaining group cohesion under conditions of leadership, we quantified the temporal dynamic of response at the individual scale. We found that individuals' decisions to move do not follow a quorum response but rather follow a rule based on a double mimetic effect: attraction to already-departed individuals and attraction to non-departed individuals. This rule is shown to be in agreement with an adaptive strategy that is inherently scalable as a function of group size.	[Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Bon, Richard] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Bon, Richard] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Pillot, Marie-Helene; Deneubourg, Jean-Louis] Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium; [Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Princeton University	Pillot, MH (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France.	pillot@cict.fr	Gautrais, Jacques/B-4523-2008; Couzin, Iain D./Q-6862-2018	Gautrais, Jacques/0000-0002-7002-9920; Couzin, Iain D./0000-0001-8556-4558	French Agence Nationale de la Recherche [ANR-BLAN07-3_200418]; University Paul Sabatier of Toulouse; Centre National de la Recherche Scientifique [4423]; Searle Scholars Award [08-SPP-201]; DARPA [HR0011-05-1-0057]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Division Of Physics [0848755] Funding Source: National Science Foundation	French Agence Nationale de la Recherche(French National Research Agency (ANR)); University Paul Sabatier of Toulouse; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Searle Scholars Award; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Marie-Helene Pillot is supported by a PhD grant from the French Agence Nationale de la Recherche (PANURGE project ANR-BLAN07-3_200418), and by a ATUPS grant of the University Paul Sabatier of Toulouse. Jean-Louis Deneubourg is research associate from the Belgian National Funds for Scientific Research. This work was also supported by the project PICS n 4423 from the Centre National de la Recherche Scientifique and by a BQR grant of the University Paul Sabatier of Toulouse. Iain D. Couzin acknowledges support from Searle Scholars Award 08-SPP-201, DARPA Grant No. HR0011-05-1-0057, National Science Foundation Award PHY-0848755 and Office of Naval Research Award N00014-09-1-1074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Burnham KP, 2002, MULTIMODEL INFERENCE; Camazine S., 2003, SELF ORG BIOL SYSTEM; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dawkins R., 1980, SOCIOBIOLOGY NATUREN, P331; Dostalkova I, 2010, J THEOR BIOL, V263, P437, DOI 10.1016/j.jtbi.2009.12.031; Dumont B, 2005, APPL ANIM BEHAV SCI, V95, P55, DOI 10.1016/j.applanim.2005.04.005; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Giraldeau L.A., 2000, MG BEH ECOL; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOUSTON AI, 1993, TRENDS ECOL EVOL, V8, P194, DOI 10.1016/0169-5347(93)90096-8; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2010, BEHAV PROCESS, V84, P657, DOI 10.1016/j.beproc.2010.02.024; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Visscher PK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1615, DOI 10.1007/s00265-007-0393-3; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105	31	36	36	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14487	10.1371/journal.pone.0014487	http://dx.doi.org/10.1371/journal.pone.0014487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245930	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200002
J	Roggero, P; Gianni, ML; Liotto, N; Taroni, F; Orsi, A; Amato, O; Morlacchi, L; Piemontese, P; Agosti, M; Mosca, F				Roggero, Paola; Gianni, Maria L.; Liotto, Nadia; Taroni, Francesca; Orsi, Anna; Amato, Orsola; Morlacchi, Laura; Piemontese, Pasqua; Agosti, Massimo; Mosca, Fabio			Rapid Recovery of Fat Mass in Small for Gestational Age Preterm Infants after Term	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BIRTH-WEIGHT INFANTS; CATCH-UP GROWTH; BODY-COMPOSITION; POSTNATAL-GROWTH; INSULIN-RESISTANCE; ALTERED ADIPOSITY; FETAL; LIFE; ASSOCIATION	Background: Preterm small for gestational age (SGA) infants may be at risk for increased adiposity, especially when experiencing rapid postnatal weight gain. Data on the dynamic features of body weight and fat mass (FM) gain that occurs early in life is scarce. We investigated the postnatal weight and FM gain during the first five months after term in a cohort of preterm infants. Methodology/Principal Findings: Changes in growth parameters and FM were prospectively monitored in 195 infants with birth weight <= 1500 g. The infants were categorized as born adequate for gestational age (AGA) without growth retardation at term (GR-), born AGA with growth retardation at term (GR+), born SGA. Weight and FM were assessed by an air displacement plethysmography system. At five months, weight z-score was comparable between the AGA (GR+) and the AGA (GR-), whereas the SGA showed a significantly lower weight. The mean weight (g) differences (95% CI) between SGA and AGA (GR-) and between SGA and AGA (GR+) infants at 5 months were -613 (-1215; -12) and -573 (-1227; -79), respectively. At term, the AGA (GR+) and the SGA groups showed a significantly lower FM than the AGA (GR-) group. In the first three months, change in FM was comparable between the AGA (GR+) and the SGA groups and significantly higher than that of the AGA (GR-) group. The mean difference (95% CI) in FM change between SGA and AGA (GR-) and between AGA (GR+) and AGA (GR-) from term to 3 months were 38.6 (12; 65); and 37.7 (10; 65). At three months, the FM was similar in all groups. Conclusions: Our data suggests that fetal growth pattern influences the potential to rapidly correct anthropometry whereas the restoration of fat stores takes place irrespective of birth weight. The metabolic consequences of these findings need to be elucidated.	[Roggero, Paola; Gianni, Maria L.; Liotto, Nadia; Taroni, Francesca; Orsi, Anna; Amato, Orsola; Morlacchi, Laura; Piemontese, Pasqua; Agosti, Massimo; Mosca, Fabio] Univ Milan, NICU, Dept Mother & Infant Sci, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy; [Agosti, Massimo] Del Ponte Hosp, Maternal & Child Hlth Dept, AO Di Circolo Fdn Macchi, Varese, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ospedale Circolo & Fondazione Macchi	Roggero, P (corresponding author), Univ Milan, NICU, Dept Mother & Infant Sci, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy.	paola.roggero@unimi.it	Mosca, Fabio/C-5826-2017; Agosti, Massimo/Q-6222-2016; Taroni, Francesca/AAC-6481-2022; Giannì, Maria/C-2026-2017	Mosca, Fabio/0000-0001-6477-0299; Agosti, Massimo/0000-0003-1828-821X; Giannì, Maria/0000-0003-3901-9131; orsi, anna/0000-0002-5862-0371; AMATO, ORSOLA/0000-0003-4687-4654; LIOTTO, NADIA/0000-0003-0425-5046; taroni, francesca/0000-0001-7710-7795				Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; Bertino E, 2009, EARLY HUM DEV, V85, P339, DOI 10.1016/j.earlhumdev.2008.12.014; Cooke RJ, 2009, ACTA PAEDIATR, V98, P1269, DOI 10.1111/j.1651-2227.2009.01354.x; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Ellis KJ, 2007, AM J CLIN NUTR, V85, P90, DOI 10.1093/ajcn/85.1.90; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; Fenton TR, 2003, BMC PEDIATR, V16, P3; Gianni ML, 2009, ARCH DIS CHILD-FETAL, V94, pF368, DOI 10.1136/adc.2008.153163; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P17; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hay WW, 2005, ACTA PAEDIATR, V94, P37, DOI 10.1080/08035320510043547; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P925, DOI 10.1210/jc.2007-1618; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jordan IM, 2005, BIOL NEONATE, V88, P57, DOI 10.1159/000084701; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Maringhini S, 2010, J MATERN-FETAL NEO M, V23, P84, DOI 10.3109/14767058.2010.510245; Meas T, 2010, DIABETES METAB, V36, P11, DOI 10.1016/j.diabet.2009.09.001; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Mostyn A, 2009, P NUTR SOC, V68, P393, DOI 10.1017/S002966510999022X; Radmacher Paula G, 2003, J Perinatol, V23, P392, DOI 10.1038/sj.jp.7210947; ROGGERO P, 2010, PEDIAT RES IN PRESS; Roggero P, 2008, EARLY HUM DEV, V84, P555, DOI 10.1016/j.earlhumdev.2008.01.012; Roggero P, 2010, NEONATOLOGY, V97, P139, DOI 10.1159/000239767; Sauer PJJ, 2007, AM J CLIN NUTR, V85, p608S, DOI 10.1093/ajcn/85.2.608S; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; van Goudoever JB, 2000, AM J CLIN NUTR, V71, P816, DOI 10.1093/ajcn/71.3.816; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Willemsen RH, 2008, J CLIN ENDOCR METAB, V93, P452, DOI 10.1210/jc.2007-1913; Yeung MY, 2006, ACTA PAEDIATR, V95, P909, DOI 10.1080/08035250600724507	36	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14489	10.1371/journal.pone.0014489	http://dx.doi.org/10.1371/journal.pone.0014489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245927	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200003
J	Mottin, S; Panasenko, G; Ganesh, SS				Mottin, Stephane; Panasenko, Grigory; Ganesh, S. Sivaji			Multiscale Modeling of Light Absorption in Tissues: Limitations of Classical Homogenization Approach	PLOS ONE			English	Article							MULTICOMPONENT HOMOGENIZATION; DISCRETE ABSORBERS; BLOOD-VESSELS; RESPONSES; OPERATOR	In biophotonics, the light absorption in a tissue is usually modeled by the Helmholtz equation with two constant parameters, the scattering coefficient and the absorption coefficient. This classic approximation of "haemoglobin diluted everywhere" (constant absorption coefficient) corresponds to the classical homogenization approach. The paper discusses the limitations of this approach. The scattering coefficient is supposed to be constant (equal to one) while the absorption coefficient is equal to zero everywhere except for a periodic set of thin parallel strips simulating the blood vessels, where it is a large parameter omega. The problem contains two other parameters which are small: epsilon, the ratio of the distance between the axes of vessels to the characteristic macroscopic size, and delta, the ratio of the thickness of thin vessels and the period. We construct asymptotic expansion in two cases: epsilon -> 0, omega -> infinity, delta -> 0, omega delta -> infinity, epsilon(2)omega delta -> 0, and epsilon -> 0, omega -> infinity, delta -> 0, epsilon(2)omega delta(2) -> infinity and prove that in the first case the classical homogenization (averaging) of the differential equation is true while in the second case it is wrong. This result may be applied in the biomedical optics, for instance, in the modeling of the skin and cosmetics.	[Mottin, Stephane] Univ St Etienne, Univ Lyon, CNRS, UMR5516, St Etienne, France; [Panasenko, Grigory] Univ St Etienne, Univ Lyon, LAMUSE, St Etienne, France; [Ganesh, S. Sivaji] Indian Inst Technol, Bombay, Maharashtra, India	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet; Universite Jean Monnet; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Mottin, S (corresponding author), Univ St Etienne, Univ Lyon, CNRS, UMR5516, St Etienne, France.	mottin@univ-st-etienne.fr; grigory.panasenko@univ-st-etienne.fr	MOTTIN, Stéphane/F-6850-2011; Panasenko, Grigory/AAA-2618-2019; Panasenko, Grigory/J-4594-2013	MOTTIN, Stéphane/0000-0002-7088-4353; Panasenko, Grigory/0000-0003-1399-9661; Panasenko, Grigory/0000-0003-1399-9661; Sista, Sivaji Ganesh/0000-0001-8298-3546	Region Rhone-Alpes; CNRS; Russian Federal Agency on Research and Innovations [02.740.11.5091]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS)); Russian Federal Agency on Research and Innovations	The results were supported by the Program Emergence of the Region Rhone-Alpes. The theoretical part was supported by the CNRS postdoctoral grant and by the grant of the Russian Federal Agency on Research and Innovations Contract No 02.740.11.5091 "Multiscale Models in Physics, Biology and Technologies: Asymptotic and Numerical Analysis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire G, 2004, ARCH RATION MECH AN, V174, P179, DOI 10.1007/s00205-004-0332-7; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; BAKHVALOV N, 1989, MATH ITS APPL SOVIET; Bar T., 1980, ADV ANAT EMBRYOL CEL, V59, P1, DOI DOI 10.1007/978-3-642-67432-7_1; BENSOUSSAN A, 1978, STUDIES MATH ITS APP; BRADU A, 2001, 2001 JUN 19 21 MUN G, P85; Campillo F, 2001, STOCH PROC APPL, V93, P57, DOI 10.1016/S0304-4149(00)00095-8; Case K., 1967, ADDISON WESLEY SERIE; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Firbank M, 1997, PHYS MED BIOL, V42, P465, DOI 10.1088/0031-9155/42/3/002; Fleming WH, 1997, ANN PROBAB, V25, P1953, DOI 10.1214/aop/1023481117; Gibson AP, 2006, NEUROIMAGE, V30, P521, DOI 10.1016/j.neuroimage.2005.08.059; LIU H, 1995, MED PHYS, V22, P1209, DOI 10.1118/1.597520; Mottin S, 2003, J NEUROCHEM, V84, P633, DOI 10.1046/j.1471-4159.2003.01508.x; PANASENKO G, 1995, CR ACAD SCI I-MATH, V321, P1109; Panasenko G., 2005, MULTISCALE MODELLING; Panasenko GP, 2008, PHYS ATOM NUCL+, V71, P681, DOI 10.1134/S106377880804008X; PANASENKO GP, 1991, MATH USSR SB+, V69, P143, DOI 10.1070/SM1991v069n01ABEH001233; Ramstein S, 2005, APPL OPTICS, V44, P6197, DOI 10.1364/AO.44.006197; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Svaasand LO, 1995, LASER MED SCI, V10, P235, DOI 10.1007/BF02133615; Talsma A, 2001, J OPT SOC AM A, V18, P932, DOI 10.1364/JOSAA.18.000932; van Veen RLP, 2002, OPT LETT, V27, P246, DOI 10.1364/OL.27.000246; Verkruysse W, 1997, PHYS MED BIOL, V42, P51, DOI 10.1088/0031-9155/42/1/003; Vignal C, 2008, PHYS MED BIOL, V53, P2457, DOI 10.1088/0031-9155/53/10/001; WEINSTEIN MI, 1985, SIAM J APPL MATH, V45, P200, DOI 10.1137/0145011	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14350	10.1371/journal.pone.0014350	http://dx.doi.org/10.1371/journal.pone.0014350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217816	Green Published, gold			2022-12-25	WOS:000285838900002
J	Vera, PL; Wolfe, TE; Braley, AE; Meyer-Siegler, KL				Vera, Pedro L.; Wolfe, Terra E.; Braley, Alexander E.; Meyer-Siegler, Katherine L.			Thrombin Induces Macrophage Migration Inhibitory Factor Release and Upregulation in Urothelium: A Possible Contribution to Bladder Inflammation	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; RAT BLADDER; INTERSTITIAL CYSTITIS; FACTOR MIF; CELLS; MECHANISM; CANCER; HYPERSENSITIVITY; URINE; VITRO	Purpose: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine expressed by urothelial cells that mediates bladder inflammation. We investigated the effect of stimulation with thrombin, a Protease Activated Receptor-1 (PAR1) agonist, on MIF release and MIF mRNA upregulation in urothelial cells. Materials and Methods: MIF and PAR1 expression was examined in normal human immortalized urothelial cells (UROtsa) using real-time RT-PCR, Western blotting and dual immunostaining. MIF and PAR1 immunostaining was also examined in rat urothelium. The effect of thrombin stimulation (100 nM) on urothelial MIF release was examined in UROtsa cells (in vitro) and in rats (in vivo). UROtsa cells were stimulated with thrombin, culture media were collected at different time points and MIF amounts were determined by ELISA. Pentobarbital anesthetized rats received intravesical saline (control), thrombin, or thrombin +2% lidocaine (to block nerve activity) for 1 hr, intraluminal fluid was collected and MIF amounts determined by ELISA. Bladder or UROtsa MIF mRNA was measured using real time RT-PCR. Results: UROtsa cells constitutively express MIF and PAR1 and immunostaining for both was observed in these cells and in the basal and intermediate layers of rat urothelium. Thrombin stimulation of urothelial cells resulted in a concentration-and time-dependent increase in MIF release both in vitro (UROtsa; 2.8-fold increase at 1 hr) and in vivo (rat; 4.5-fold) while heat-inactivated thrombin had no effect. In rats, thrombin-induced MIF release was reduced but not abolished by intravesical lidocaine treatment. Thrombin also upregulated MIF mRNA in UROtsa cells (3.3-fold increase) and in the rat bladder (2-fold increase) where the effect was reduced (1.4-fold) by lidocaine treatment. Conclusions: Urothelial cells express both MIF and PAR1. Activation of urothelial PAR1 receptors, either by locally generated thrombin or proteases present in the urine, may mediate bladder inflammation by inducing urothelial MIF release and upregulating urothelial MIF expression.	[Vera, Pedro L.; Wolfe, Terra E.; Braley, Alexander E.; Meyer-Siegler, Katherine L.] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Vera, Pedro L.] Univ S Florida, Dept Surg, Div Urol, Tampa, FL 33620 USA; [Meyer-Siegler, Katherine L.] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Vera, PL (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021	Braley, Alexander/0000-0002-1443-1472	Department of Veterans Affairs; National Institute of Diabetes and Digestive and Kidney Disorders [DK075059]; Bay Pines Foundation; Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bay Pines Foundation; Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (PLV; KLMS). This work was also supported by the National Institute of Diabetes and Digestive and Kidney Disorders DK075059 (PLV) and the Bay Pines Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dale C, 2008, J RECEPT SIG TRANSD, V28, P29, DOI [10.1080/10799890801941913, 10.1080/10799890801941913 ]; Dattilio A, 2005, J UROLOGY, V173, P635, DOI 10.1097/01.ju.0000143191.55468.1d; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Garavilla L, 2001, BRIT J PHARMACOL, V133, P975, DOI 10.1038/sj.bjp.0704152; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gao BC, 2006, J LEUKOCYTE BIOL, V80, P359, DOI 10.1189/jlb.1205738; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Giraudoux P., 2009, PGIRMESS DATA ANAL E; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Kuromitsu S, 2008, SCAND J UROL NEPHROL, V42, P455, DOI 10.1080/00365590802025881; McHowat J, 2001, J UROLOGY, V165, P2063, DOI 10.1016/S0022-5347(05)66295-7; Meyer-Siegler KL, 2010, CANCER LETT, V290, P49, DOI 10.1016/j.canlet.2009.08.025; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; R Development Core Team, 2009, R FDN STAT COMP; Rickard A, 2002, AM J PHYSIOL-RENAL, V283, pF944, DOI 10.1152/ajprenal.00072.2002; Ritz C, 2005, J STAT SOFTW, V12, P1; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Saban Ricardo, 2007, BMC Physiology, V7, P4, DOI 10.1186/1472-6793-7-4; Shimizu T, 2004, J BIOL CHEM, V279, P13729, DOI 10.1074/jbc.M400150200; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera Pedro L, 2006, BMC Urol, V6, P24, DOI 10.1186/1471-2490-6-24; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Vera PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005835; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wadgaonkar R, 2008, J CELL BIOCHEM, V105, P1279, DOI 10.1002/jcb.21928	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15904	10.1371/journal.pone.0015904	http://dx.doi.org/10.1371/journal.pone.0015904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209875	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900047
J	Yang, CX; Tan, WJ; Whittle, C; Qiu, LH; Cao, LC; Akbarian, S; Xu, ZS				Yang, Chunxing; Tan, Weijia; Whittle, Catheryne; Qiu, Linghua; Cao, Lucheng; Akbarian, Schahram; Xu, Zuoshang			The C-Terminal TDP-43 Fragments Have a High Aggregation Propensity and Harm Neurons by a Dominant-Negative Mechanism	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; NUCLEAR FACTOR TDP-43; TRANSGENIC MICE; CFTR EXON-9; FUNCTIONAL IMPLICATIONS; CELLULAR TOXICITY; GENE-EXPRESSION; MOTOR DEFICITS	TAR DNA binding protein 43 KD (TDP-43) is an essential gene that regulates gene transcription, mRNA splicing and stability. In amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two fatal neurodegenerative diseases, TDP-43 is fragmented, generating multiple fragments that include the C-terminal fragment of similar to 25 KD. The role of these fragments in the pathogenesis of ALS and FTD is not clear. Here we investigated the aggregation propensity in various polypeptide regions of TDP-43 in mammalian cells and the effect of these fragments on cultured neurons. By expressing the full length and various TDP-43 fragments in motor neuron-derived NSC-34 cells and primary neurons, we found that both N- and C-terminal fragments of TDP-43 are prone to aggregate and the C-terminal end of RRM2 region is required, though not sufficient, for aggregation. The aggregation of the TDP-43 fragments can drive co-aggregation with the full-length TDP-43, consequently reducing the nuclear TDP-43. In addition, the TDP-43 fragments can impair neurite growth during neuronal differentiation. Importantly, overexpression of the full-length TDP-43 rescues the neurite growth phenotype whereas knockdown of the endogenous TDP-43 reproduces this phenotype. These results suggest that TDP-43 fragments, particularly the pathologically relevant C-terminal fragments, can impair neuronal differentiation by dominant-negatively interfering with the function of the full length TDP-43, thus playing a role in pathogenesis in ALS and FTD.	[Yang, Chunxing; Tan, Weijia; Qiu, Linghua; Cao, Lucheng; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Whittle, Catheryne; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Yang, CX (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Zuoshang.xu@umassmed.edu			NIH/NINDS [RO1 NS048145, R21 NS062230]; ALS Association; Robert Pachard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062230, R01NS048145] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; Robert Pachard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH/NINDS (RO1 NS048145 and R21 NS062230) ALS Association and The Robert Pachard Center for ALS Research at Johns Hopkins to ZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chiang P-M, 2010, P NATL ACAD SCI; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Sato M, 2001, MOL REPROD DEV, V60, P446, DOI 10.1002/mrd.1109; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stallings NR, 2010, NEUROBIOL DIS; Strong MJ, 2007, MOL CELL NEUROSCI; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	51	90	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15878	10.1371/journal.pone.0015878	http://dx.doi.org/10.1371/journal.pone.0015878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209826	Green Published, gold			2022-12-25	WOS:000285838900045
J	Chen, QA; Tang, MX; Mamiya, T; Im, HI; Xiong, XL; Joseph, A; Tang, YP				Chen, Qian; Tang, Mingxi; Mamiya, Takayoshi; Im, Heh-In; Xiong, Xiaoli; Joseph, Anu; Tang, Ya-Ping			Bi-Directional Effect of Cholecystokinin Receptor-2 Overexpression on Stress-Triggered Fear Memory and Anxiety in the Mouse	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARAVENTRICULAR NUCLEUS; SYNAPTIC PLASTICITY; CCK ANTAGONISTS; PANIC-DISORDER; AMYGDALA; RATS; BRAIN; TETRAPEPTIDE; ASSOCIATION	Fear, an emotional response of animals to environmental stress/threats, plays an important role in initiating and driving adaptive response, by which the homeostasis in the body is maintained. Overwhelming/uncontrollable fear, however, represents a core symptom of anxiety disorders, and may disturb the homeostasis. Because to recall or imagine certain cue(s) of stress/threats is a compulsory inducer for the expression of anxiety, it is generally believed that the pathogenesis of anxiety is associated with higher attention (acquisition) selectively to stress or mal-enhanced fear memory, despite that the actual relationship between fear memory and anxiety is not yet really established. In this study, inducible forebrain-specific cholecystokinin receptor-2 transgenic (IF-CCKR-2 tg) mice, different stress paradigms, batteries of behavioral tests, and biochemical assays were used to evaluate how different CCKergic activities drive fear behavior and hormonal reaction in response to stresses with different intensities. We found that in IF-CCKR-2 tg mice, contextual fear was impaired following 1 trial of footshock, while overall fear behavior was enhanced following 36 trials of footshock, compared to their littermate controls. In contrast to a standard Yerkes-Dodson (inverted-U shaped) stress-fear relationship in control mice, a linearized stress-fear curve was observed in CCKR-2 tg mice following gradient stresses. Moreover, compared to 1 trial, 36 trials of footshock in these transgenic mice enhanced anxiety-like behavior in other behavioral tests, impaired spatial and recognition memories, and prolonged the activation of adrenocorticotropic hormone (ACTH) and glucocorticoids (CORT) following new acute stress. Taken together, these results indicate that stress may trigger two distinctive neurobehavioral systems, depending on both of the intensity of stress and the CCKergic tone in the brain. A "threshold theory" for this two-behavior system has been suggested.	[Chen, Qian; Mamiya, Takayoshi; Im, Heh-In; Xiong, Xiaoli; Joseph, Anu; Tang, Ya-Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA; [Chen, Qian; Mamiya, Takayoshi; Joseph, Anu; Tang, Ya-Ping] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA; [Tang, Mingxi] Luzhou Med Coll, Dept Pathol, Sichun, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Southwest Medical University	Chen, QA (corresponding author), Astellas Res Inst Amer LLC, CNS, Skokie, IL USA.	ytang1@lsuhsc.edu	Tang, Ya-Ping/A-1035-2011; joseph, anu/K-4292-2019	Tang, Ya-Ping/0000-0002-0445-4072	Geraldi Norton Foundation; Christopher Eklund Family Foundation; National Institute of Mental Health/National Institutes of Health (NIMH/NIH) [MH066243, MH083530]; Alzheimer's Association [NIRG-02-4368]; National Science Foundation (NSF) [0213112]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH083530, R21MH083530, R01MH066243] Funding Source: NIH RePORTER	Geraldi Norton Foundation; Christopher Eklund Family Foundation; National Institute of Mental Health/National Institutes of Health (NIMH/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); National Science Foundation (NSF)(National Science Foundation (NSF)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HII was supported by the Geraldi Norton Foundation and Christopher Eklund Family Foundation. This work was partially conducted in the University of Chicago. This study was supported by grants from National Institute of Mental Health/National Institutes of Health (NIMH/NIH) (MH066243), NIMH/NIH (MH083530), Alzheimer's Association (NIRG-02-4368), National Science Foundation (NSF; 0213112), and National Alliance for Research on Schizophrenia and Depression (NARSAD), all to YPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; Bereza BG, 2009, CLIN THER, V31, P1279, DOI 10.1016/j.clinthera.2009.06.004; Bhatnagar S, 2000, J NEUROSCI, V20, P5564, DOI 10.1523/JNEUROSCI.20-14-05564.2000; Binkley K, 2001, J ALLERGY CLIN IMMUN, V107, P887, DOI 10.1067/mai.2001.114798; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chung L, 2009, J NEUROPHYSIOL, V102, P272, DOI 10.1152/jn.90769.2008; Cornelis MC, 2010, CURR PSYCHIAT REP, V12, P313, DOI 10.1007/s11920-010-0126-6; Damsa C, 2009, CURR OPIN PSYCHIATR, V22, P96, DOI 10.1097/YCO.0b013e328319bd10; DelBel EA, 1997, NEUROREPORT, V8, P3597, DOI 10.1097/00001756-199711100-00035; DELLAFERA MA, 1979, SCIENCE, V206, P471, DOI 10.1126/science.504989; Dere E, 2010, BEHAV BRAIN RES; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; EICHENBAUM H, 2007, ANN REV NEUROSCI; Farook JM, 2001, NEUROREPORT, V12, P2717, DOI 10.1097/00001756-200108280-00025; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Greisen MH, 2005, BEHAV BRAIN RES, V161, P204, DOI 10.1016/j.bbr.2005.02.006; Gulpinar MA, 2004, CURR PROTEIN PEPT SC, V5, P457, DOI 10.2174/1389203043379341; Handwerger K, 2009, HARVARD REV PSYCHIAT, V17, P184, DOI 10.1080/10673220902996775; Harro J, 1996, N-S ARCH PHARMACOL, V354, P59; Hattori E, 2002, AM J MED GENET, V114, P523, DOI 10.1002/ajmg.10516; Hebb ALO, 2005, PROG NEURO-PSYCHOPH, V29, P1225, DOI 10.1016/j.pnpbp.2005.08.008; Herman JP, 2008, PROG BRAIN RES, V170, P353, DOI 10.1016/S0079-6123(08)00429-9; HILL DR, 1987, J NEUROSCI, V7, P2967; Hinkelmann K, 2010, J PSYCHIAT RES; Im HI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007424; Kellner M, 2000, BIOL PSYCHIAT, V47, P107, DOI 10.1016/S0006-3223(99)00118-3; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koks S, 2000, J PSYCHIATR NEUROSCI, V25, P33; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Ma S, 2005, J NEUROENDOCRINOL, V17, P761, DOI 10.1111/j.1365-2826.2005.01372.x; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Matynia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009857; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; PAVLASEVIC S, 1993, NEUROREPORT, V5, P225, DOI 10.1097/00001756-199312000-00009; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rabinowitch I, 2006, J NEUROSCI, V26, P13474, DOI 10.1523/JNEUROSCI.4333-06.2006; Rodrigues SM, 2009, ANN REV NEUROSCI; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rotzinger S, 2010, PEPTIDES, V31, P736, DOI 10.1016/j.peptides.2009.12.015; Schneider R, 2009, PSYCHOPHARMACOLOGY, V202, P559, DOI 10.1007/s00213-008-1332-3; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sherrin T, 2009, MOL PSYCHIATR, V14, P291, DOI 10.1038/sj.mp.4002121; Shindo S, 2005, FORENSIC SCI INT, V150, P85, DOI 10.1016/j.forsciint.2004.10.001; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tahara T, 2009, HEPATO-GASTROENTEROL, V56, P1245; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tiwari AK, 2010, PROG NEUROPSYCHOPHAR; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Wang Z, 2002, AM J MED GENET, V114, P479, DOI 10.1002/ajmg.10408; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; WETTSTEIN JG, 1994, PHARMACOL THERAPEUT, V62, P267, DOI 10.1016/0163-7258(94)90047-7; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yokoyama F, 2009, PSYCHOPHARMACOLOGY, V205, P177, DOI 10.1007/s00213-009-1528-1; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	65	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15999	10.1371/journal.pone.0015999	http://dx.doi.org/10.1371/journal.pone.0015999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209861	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600054
J	Andrews, JR; Shah, NS; Weissman, D; Moll, AP; Friedland, G; Gandhi, NR				Andrews, Jason R.; Shah, N. Sarita; Weissman, Darren; Moll, Anthony P.; Friedland, Gerald; Gandhi, Neel R.			Predictors of Multidrug- and Extensively Drug-Resistant Tuberculosis in a High HIV Prevalence Community	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SOUTH-AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; TRANSMISSION; THERAPY; POPULATION; RUSSIA; IMPACT; PERU	Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) have emerged in high-HIV-prevalence settings, which generally lack laboratory infrastructure for diagnosing TB drug resistance. Even where available, inherent delays with current drug-susceptibility testing (DST) methods result in clinical deterioration and ongoing transmission of MDR and XDR-TB. Identifying clinical predictors of drug resistance may aid in risk stratification for earlier treatment and infection control. Methods: We performed a retrospective case-control study of patients with MDR (cases), XDR (cases) and drug-susceptible (controls) TB in a high-HIV-prevalence setting in South Africa to identify clinical and demographic risk factors for drug-resistant TB. Controls were selected in a 1: 1: 1 ratio and were not matched. We calculated odds ratios (OR) and performed multivariate logistic regression to identify independent predictors. Results: We enrolled 116, 123 and 139 patients with drug-susceptible, MDR, and XDR-TB. More than 85% in all three patient groups were HIV-infected. In multivariate analysis, MDR and XDR-TB were each strongly associated with history of TB treatment failure (adjusted OR 51.7 [CI 6.6-403.7] and 51.5 [CI 6.4-414.0], respectively) and hospitalization more than 14 days (aOR 3.8 [CI 1.1-13.3] and 6.1 [CI 1.8-21.0], respectively). Prior default from TB treatment was not a risk factor for MDR or XDR-TB. HIV was a risk factor for XDR (aOR 8.2, CI 1.3-52.6), but not MDR-TB. Comparing XDR with MDR-TB patients, the only significant risk factor for XDR-TB was HIV infection (aOR 5.3, CI 1.0-27.6). Discussion: In this high-HIV-prevalence and drug-resistant TB setting, a history of prolonged hospitalization and previous TB treatment failure were strong risk factors for both MDR and XDR-TB. Given high mortality observed among patients with HIV and drug-resistant TB co-infection, previously treated and hospitalized patients should be considered for empiric secondline TB therapy while awaiting confirmatory DST results in settings with a high-burden of MDR/XDR-TB.	[Andrews, Jason R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Shah, N. Sarita; Weissman, Darren; Gandhi, Neel R.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Shah, N. Sarita; Gandhi, Neel R.] Albert Einstein Coll Med, Dept Epidemiol & Publ Hlth, New York, NY USA; [Shah, N. Sarita; Weissman, Darren; Gandhi, Neel R.] Montefiore Med Ctr, New York, NY USA; [Moll, Anthony P.] Philanjalo & Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Friedland, Gerald] Yale Univ, Sch Med, AIDS Program, New Haven, CT USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Yeshiva University; Yeshiva University; Montefiore Medical Center; Yale University	Andrews, JR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	neelgandhi@alumni.williams.edu	alzahrani, saud hamed/C-2014-2012	Andrews, Jason/0000-0002-5967-251X	Doris Duke Charitable Foundation [NRG 2007070, NSS 2007071, 2007018]; Gilead Foundation; Irene Diamond Fund [R05130]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087465, R01AI089349] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Gilead Foundation(Gilead Sciences); Irene Diamond Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NRG and NSS are both recipients of the Doris Duke Charitable Foundation Clinical Scientist Development Award (NRG 2007070, NSS 2007071; www.ddcf.org). GF is also supported by the Doris Duke Charitable Foundation (2007018), the Gilead Foundation (www.gilead.com/Gilead_Foundation), and The Irene Diamond Fund (R05130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P433; Costello C, 2005, JAIDS-J ACQ IMM DEF, V39, P242; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; Hassim S, 2010, CLIN INFECT DIS, V50, P1053, DOI 10.1086/651119; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kliiman K, 2009, ANN INTERN MED, V150, P766, DOI 10.7326/0003-4819-150-11-200906020-00004; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; PATEL KB, 1995, NEW ENGL J MED, V332, P336, DOI 10.1056/NEJM199502023320518; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; Schreiber YS, 2009, INT J TUBERC LUNG D, V13, P1274; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; South African Department of Health, 2004, S AFR NAT TUB CONTR; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; *WHO, 2009, GLOB TUB CONTR SHORT	39	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15735	10.1371/journal.pone.0015735	http://dx.doi.org/10.1371/journal.pone.0015735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209951	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200047
J	Shi, WF; Lei, FM; Zhu, CD; Sievers, F; Higgins, DG				Shi, Weifeng; Lei, Fumin; Zhu, Chaodong; Sievers, Fabian; Higgins, Desmond G.			A Complete Analysis of HA and NA Genes of Influenza A Viruses	PLOS ONE			English	Article							AVIAN INFLUENZA; WILD BIRDS; H5N1; TRANSMISSION; SWINE; EVOLUTION; INFECTION; DUCKS; PHYLOGENIES; GENERATION	Background: More and more nucleotide sequences of type A influenza virus are available in public databases. Although these sequences have been the focus of many molecular epidemiological and phylogenetic analyses, most studies only deal with a few representative sequences. In this paper, we present a complete analysis of all Haemagglutinin (HA) and Neuraminidase (NA) gene sequences available to allow large scale analyses of the evolution and epidemiology of type A influenza. Methodology/Principal Findings: This paper describes an analysis and complete classification of all HA and NA gene sequences available in public databases using multivariate and phylogenetic methods. Conclusions/Significance: We analyzed 18975 HA sequences and divided them into 280 subgroups according to multivariate and phylogenetic analyses. Similarly, we divided 11362 NA sequences into 202 subgroups. Compared to previous analyses, this work is more detailed and comprehensive, especially for the bigger datasets. Therefore, it can be used to show the full and complex phylogenetic diversity and provides a framework for studying the molecular evolution and epidemiology of type A influenza virus. For more than 85% of type A influenza HA and NA sequences into GenBank, they are categorized in one unambiguous and unique group. Therefore, our results are a kind of genetic and phylogenetic annotation for influenza HA and NA sequences. In addition, sequences of swine influenza viruses come from 56 HA and 45 NA subgroups. Most of these subgroups also include viruses from other hosts indicating cross species transmission of the viruses between pigs and other hosts. Furthermore, the phylogenetic diversity of swine influenza viruses from Eurasia is greater than that of North American strains and both of them are becoming more diverse. Apart from viruses from human, pigs, birds and horses, viruses from other species show very low phylogenetic diversity. This might indicate that viruses have not become established in these species. Based on current evidence, there is no simple pattern of inter-hemisphere transmission of avian influenza viruses and it appears to happen sporadically. However, for H6 subtype avian influenza viruses, such transmissions might have happened very frequently and multiple and bidirectional transmission events might exist.	[Shi, Weifeng; Sievers, Fabian; Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Lei, Fumin; Zhu, Chaodong] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	University College Dublin; Chinese Academy of Sciences; Institute of Zoology, CAS	Shi, WF (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland.	weifeng.shi@ucd.ie	Sievers, Fabian/AAG-2021-2020; ZHU, Chao-Dong/E-5961-2011; Higgins, des g/J-6314-2012	Sievers, Fabian/0000-0002-7885-6867; ZHU, Chao-Dong/0000-0002-9347-3178; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland [07/IN.1/B1783]; CAS [KSCX2-YW-N-063]; NSFC [30925008]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This study was mainly supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). FL was funded by CAS Innovation Program (KSCX2-YW-N-063) and NSFC (No. 30925008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belongie S, 2002, LECT NOTES COMPUT SC, V2352, P531; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Chen JM, 2007, VIRUS GENES, V35, P33, DOI 10.1007/s11262-006-0025-4; Chen JM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-137; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Cheng MC, 2010, AVIAN DIS, V54, P885, DOI 10.1637/9208-120609-Reg.1; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gagnon CA, 2009, J CLIN MICROBIOL, V47, P796, DOI 10.1128/JCM.01228-08; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P15; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lee DH, 2011, INFECT GENET EVOL, V11, P232, DOI 10.1016/j.meegid.2010.09.012; Leschnik M, 2007, EMERG INFECT DIS, V13, P243, DOI 10.3201/eid1302.060608; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Ma HC, 2007, VIRUS GENES, V34, P283, DOI 10.1007/s11262-006-0018-3; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Normile D, 2006, SCIENCE, V311, P1225, DOI 10.1126/science.311.5765.1225; Normile D, 2005, SCIENCE, V310, P426, DOI 10.1126/science.310.5747.426; Okamatsu M, 2007, VET MICROBIOL, V124, P35, DOI 10.1016/j.vetmic.2007.04.025; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2010, VIRUS RES, V148, P44, DOI 10.1016/j.virusres.2009.12.002; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Qi X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004682; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; YANG ZB, 1994, J MOL EVOL, V39, P105; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	73	27	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14454	10.1371/journal.pone.0014454	http://dx.doi.org/10.1371/journal.pone.0014454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209922	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200010
J	Wu, J; Zhang, FW; Wang, MR; Xu, CQ; Song, JD; Zhou, JF; Lin, XJ; Zhang, YH; Wu, XB; Tan, WJ; Lu, JA; Zhao, HL; Gao, JM; Zhao, P; Lu, JX; Wang, Y				Wu, Jia; Zhang, Fengwei; Wang, Maorong; Xu, Chunqiong; Song, Jingdong; Zhou, Jianfang; Lin, Xiaojing; Zhang, Yonghui; Wu, Xiaobing; Tan, Wenjie; Lu, Jian; Zhao, Honglan; Gao, Jimin; Zhao, Ping; Lu, Jianxin; Wang, Yue			Characterization of Neuraminidases from the Highly Pathogenic Avian H5N1 and 2009 Pandemic H1N1 Influenza A Viruses	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; STALK LENGTH; HEMAGGLUTININ; PROTEIN; FUSION; CELLS	To study the precise role of the neuraminidase (NA), and its stalk region in particular, in the assembly, release, and entry of influenza virus, we deleted the 20-aa stalk segment from 2009 pandemic H1N1 NA (09N1) and inserted this segment, now designated 09s60, into the stalk region of a highly pathogenic avian influenza (HPAI) virus H5N1 NA (AH N1). The biological characterization of these wild-type and mutant NAs was analyzed by pseudotyped particles (pseudoparticles) system. Compared with the wild-type AH N1, the wild-type 09N1 exhibited higher NA activity and released more pseudoparticles. Deletion/insertion of the 09s60 segment did not alter this relationship. The infectivity of pseudoparticles harboring NA in combination with the hemagglutinin from HPAI H5N1 (AH H5) was decreased by insertion of 09s60 into AH N1 and was increased by deletion of 09s60 from 09N1. When isolated from the wild-type 2009H1N1 virus, 09N1 existed in the forms (in order of abundance) dimer>>tetramer>monomer, but when isolated from pseudoparticles, 09N1 existed in the forms dimer>monomer>>>tetramer. After deletion of 09s60, 09N1 existed in the forms monomer>>>dimer. AH N1 from pseudoparticles existed in the forms monomer>>dimer, but after insertion of 09s60, it existed in the forms dimer>>monomer. Deletion/insertion of 09s60 did not alter the NA glycosylation pattern of 09N1 or AH N1. The 09N1 was more sensitive than the AH N1 to the NA inhibitor oseltamivir, suggesting that the infectivity-enhancing effect of oseltamivir correlates with robust NA activity.	[Wu, Jia; Zhang, Fengwei; Xu, Chunqiong; Gao, Jimin; Lu, Jianxin] Wenzhou Med Coll, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Minist Educ,Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Wang, Maorong] 81st Hosp PLA, Liver Dis Ctr PLA, Nanjing, Peoples R China; [Xu, Chunqiong] NingXia Med Univ, Sch Clin Sci, Yinchuang, Peoples R China; [Wu, Jia; Zhang, Fengwei; Song, Jingdong; Zhou, Jianfang; Lin, Xiaojing; Zhang, Yonghui; Wu, Xiaobing; Tan, Wenjie; Lu, Jian; Zhao, Honglan; Wang, Yue] China Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhao, Ping] Second Mil Med Univ, Dept Microbiol, Shanghai Key Lab Med Biodef, Shanghai, Peoples R China	Wenzhou Medical University; Ningxia Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Naval Medical University	Wu, J (corresponding author), Wenzhou Med Coll, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Minist Educ,Sch Lab Med & Life Sci, Wenzhou, Peoples R China.	pnzhao@163.com; jxlu313@163.com; euy-tokyo@umin.ac.jp		Wu, Xiaobing/0000-0002-2823-2634	863 Hi-Tech Research and Development Program of the People's Republic of China [2007AA02Z157]; State Special Key Program on Infectious Diseases of China [2009ZX10004-711]; National Natural Science Foundation of China (NSFC) [30970159]; Natural Science Foundation of Zhejiang Province [Y2101159]	863 Hi-Tech Research and Development Program of the People's Republic of China(National High Technology Research and Development Program of China); State Special Key Program on Infectious Diseases of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the 863 Hi-Tech Research and Development Program of the People's Republic of China (#2007AA02Z157), the State Special Key Program on Infectious Diseases of China (#2009ZX10004-711), the National Natural Science Foundation of China (NSFC#30970159), and the Natural Science Foundation of Zhejiang Province (Y2101159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Bian T, 2009, BIOCHEM BIOPH RES CO, V378, P118, DOI 10.1016/j.bbrc.2008.11.024; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Knipe DM, 2007, FIELD VIROLOGY, V5th; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Liu YA, 2010, VACCINE, V29, P183, DOI 10.1016/j.vaccine.2010.10.059; LUO GX, 1993, VIRUS RES, V29, P141; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; *WHO, 2009, PAND HINI; World Health Organization, CONF HUM CAS AV INFL; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	30	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15825	10.1371/journal.pone.0015825	http://dx.doi.org/10.1371/journal.pone.0015825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209916	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200061
J	Shields, DJ; Murphy, EA; Desgrosellier, JS; Mielgo, A; Lau, SKM; Barnes, LA; Lesperance, J; Huang, M; Schmedt, C; Tarin, D; Lowy, AM; Cheresh, DA				Shields, D. J.; Murphy, E. A.; Desgrosellier, J. S.; Mielgo, A.; Lau, S. K. M.; Barnes, L. A.; Lesperance, J.; Huang, M.; Schmedt, C.; Tarin, D.; Lowy, A. M.; Cheresh, D. A.			Oncogenic Ras/Src cooperativity in pancreatic neoplasia	ONCOGENE			English	Article						pancreatic cancer; Src; Ras; oncogenic cooperativity	EPIDERMAL-GROWTH-FACTOR; SRC FAMILY KINASES; DUCTAL ADENOCARCINOMA; TYROSINE KINASE; C-SRC; HUMAN CANCER; INTRAEPITHELIAL NEOPLASIA; TUMOR PROGRESSION; TRANSGENIC MICE; MOUSE MODEL	Pancreas cancer is one of the most lethal malignancies and is characterized by activating mutations of Kras, present in 95% of patients. More than 60% of pancreatic cancers also display increased c-Src activity, which is associated with poor prognosis. Although loss of tumor suppressor function (for example, p16, p53, Smad4) combined with oncogenic Kras signaling has been shown to accelerate pancreatic duct carcinogenesis, it is unclear whether elevated Src activity contributes to Kras-dependent tumorigenesis or is simply a biomarker of disease progression. Here, we demonstrate that in the context of oncogenic Kras, activation of c-Src through deletion of C-terminal Src kinase (CSK) results in the development of invasive pancreatic ductal adenocarcinoma (PDA) by 5-8 weeks. In contrast, deletion of CSK alone fails to induce neoplasia, while oncogenic Kras expression yields PDA at low frequency after a latency of 12 months. Analysis of cell lines derived from Ras/Src-induced PDA's indicates that oncogenic Ras/Src cooperativity may lead to genomic instability, yet Ras/Src-driven tumor cells remain dependent on Src signaling and as such, Src inhibition suppresses growth of Ras/Src-driven tumors. These findings demonstrate that oncogenic Ras/Src cooperate to accelerate PDA onset and support further studies of Src-directed therapies in pancreatic cancer. Oncogene (2011) 30, 2123-2134; doi:10.1038/onc.2010.589; published online 17 January 2011	[Shields, D. J.; Murphy, E. A.; Desgrosellier, J. S.; Mielgo, A.; Lau, S. K. M.; Barnes, L. A.; Lesperance, J.; Huang, M.; Tarin, D.; Cheresh, D. A.] Moores UCSD Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Schmedt, C.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Lowy, A. M.] Moores UCSD Canc Ctr, Dept Surg, La Jolla, CA 92093 USA	Novartis	Cheresh, DA (corresponding author), Moores UCSD Canc Ctr, Dept Pathol, Room 2344,3855 Hlth Sci Dr,MC 0803, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	Desgrosellier, Jay S/A-8756-2008	Huang, Miller/0000-0002-3371-0100; Lau, Steven/0000-0002-6433-8735	NIH [R21CA104898, P01-CA078045]; Moores UCSD Cancer Center; NATIONAL CANCER INSTITUTE [T32CA121938, P01CA078045, P01CA104898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moores UCSD Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Charles Yi and Dana Wu for excellent technical assistance. We acknowledge Richard Aspinall, Lisette Acevedo, Josh Greenberg and David Tuveson for valuable discussions, Greg Boivin for histological analysis, as well as Richard Levenson and Kristin Lane for NuBrio imaging. This work was supported by NIH grants R21CA104898, P01-CA078045 (DAC) and Collaborative Translational Research grants from Moores UCSD Cancer Center (DAC, DJS and AML).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; BARTON CM, 1991, J PATHOL, V163, P111, DOI 10.1002/path.1711630206; Billadeau DD, 2006, J GASTROINTEST CANC, V37, P110, DOI 10.1007/s12029-007-0011-7; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Broome MA, 2000, ONCOGENE, V19, P2867, DOI 10.1038/sj.onc.1203608; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Grimm J, 2003, INT J CANCER, V106, P806, DOI 10.1002/ijc.11281; HALL PA, 1990, J PATHOL, V161, P195, DOI 10.1002/path.1711610305; Hernandez-Munoz I, 2008, PANCREATOLOGY, V8, P462, DOI 10.1159/000151537; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kabil A, 2008, CARCINOGENESIS, V29, P1862, DOI 10.1093/carcin/bgn138; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kline CLB, 2008, INT J CANCER, V122, P2665, DOI 10.1002/ijc.23445; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Maddalena AS, 1999, BRAIN PATHOL, V9, P627; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Matsumoto T, 2004, MOL CARCINOGEN, V40, P189, DOI 10.1002/mc.20027; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vitali R, 2009, INT J CANCER, V125, P2547, DOI 10.1002/ijc.24606; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yezhelyev MV, 2004, CLIN CANCER RES, V10, P8028, DOI 10.1158/1078-0432.CCR-04-0621	51	53	58	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	18					2123	2134		10.1038/onc.2010.589	http://dx.doi.org/10.1038/onc.2010.589			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21242978	Green Accepted			2022-12-25	WOS:000290249600004
J	Gupta, R; Asomugha, CO; Srivastava, OP				Gupta, Ratna; Asomugha, Chinwe O.; Srivastava, Om P.			The Common Modification in alpha A-Crystallin in the Lens, N101D, Is Associated with Increased Opacity in a Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; POSTERIOR SUBCAPSULAR CATARACTS; OPTICAL-QUALITY; B-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; CELL-DIFFERENTIATION; PROTEIN INTERACTIONS; MASS-SPECTROMETRY; EPITHELIAL-CELLS; PLASMA-MEMBRANE	To elucidate the morphological and cellular changes due to introduction of a charge during development and the possible mechanism that underlies cataract development in humans as a consequence of an additional charge, we generated a transgenic mouse model mimicking deamidation of Asn at position 101. The mouse model expresses a human alpha A-crystallin gene in which Asn-101 was replaced with Asp, which is referred to as alpha AN101D-transgene and is considered to be "deamidated" in this study. Mice expressing alpha AN101D-transgene are referred to here CRYAA(N101D) mice. All of the lines showed the expression of alpha AN101D-transgene. Compared with the lenses of mice expressing wild-type (WT) alpha A-transgene (referred to as CRYAA(WT) mice), the lenses of CRYAA(N101D) mice showed (a) altered alpha A-crystallin membrane protein (aquaporin-0 (AQP0), a specific lens membrane protein) interaction, (b) extracellular spaces between outer cortical fiber cells, (c) attenuated denucleation during confocal microscopic examination, (d) disrupted normal fiber cell organization and structure during scanning electron microscopic examination, (e) distorted posterior suture lines by bright field microscopy, and (f) development of a mild anterior lens opacity in the superior cortical region during the optical coherence tomography scan analysis. Relative to lenses with WT alpha A-crystallin, the lenses containing the deamidated alpha A-crystallin also showed an aggregation of alpha A-crystallin and a higher level of water-insoluble proteins, suggesting that the morphological and cellular changes in these lenses are due to the N101D mutation. This study provides evidence for the first time that expression of deamidated alpha A-crystallin caused disruption of fiber cell structural integrity, protein aggregation, insolubilization, and mild cortical lens opacity.	[Gupta, Ratna; Asomugha, Chinwe O.; Srivastava, Om P.] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama, Dept Vis Sci, Worrell Bldg,924 S 18th St, Birmingham, AL 35294 USA.	srivasta@uab.edu			National Institutes of Health [EY06400, P30-EY03039]; National Institutes of Health, NCRR [S10RR026887]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026887] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003039, R01EY006400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY06400 and P30-EY03039 and National Institutes of Health, NCRR, Grant S10RR026887 (for the purchase of the Bioptigen SDOCT system).	Al-Ghoul KJ, 1998, EXP EYE RES, V67, P163, DOI 10.1006/exer.1998.0505; Al-Khudari Samer, 2007, BMC Ophthalmol, V7, P19, DOI 10.1186/1471-2415-7-19; AlGhoul KJ, 1996, EXP EYE RES, V62, P237, DOI 10.1006/exer.1996.0029; Andersson M, 2003, EXP EYE RES, V76, P175, DOI 10.1016/S0014-4835(02)00283-X; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-4; Beebe D, 2004, INT J DEV BIOL, V48, P845, DOI 10.1387/ijdb.041869db; Blankenship TN, 2001, INVEST OPHTH VIS SCI, V42, P735; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boyle Daniel L, 2003, BMC Ophthalmol, V3, P3, DOI 10.1186/1471-2415-3-3; Boyle DL, 2000, MOL VIS, V6, P63; BROWN NAP, 1989, EYE, V3, P597, DOI 10.1038/eye.1989.93; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chaves JM, 2008, BIOCHEMISTRY-US, V47, P10069, DOI 10.1021/bi8001902; Chung J, 2007, EXP EYE RES, V84, P513, DOI 10.1016/j.exer.2006.11.004; Clark JI, 1999, EYE, V13, P417, DOI 10.1038/eye.1999.116; Clark JI, 2000, INT REV CYTOL, V192, P171; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; DUNIA I, 1990, EUR J CELL BIOL, V53, P59; Freel Christopher D, 2003, BMC Ophthalmol, V3, P1, DOI 10.1186/1471-2415-3-1; GOPALAKRISHNAN S, 1992, CURR EYE RES, V11, P929, DOI 10.3109/02713689209033490; Grey AC, 2003, EXP EYE RES, V77, P567, DOI 10.1016/S0014-4835(03)00192-1; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Kim YH, 2002, BIOCHEMISTRY-US, V41, P14076, DOI 10.1021/bi026288h; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; KUSZAK JR, 1991, INVEST OPHTH VIS SCI, V32, P2119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Ponce A, 2006, MOL VIS, V12, P879; RAMAEKERS FCS, 1982, P NATL ACAD SCI-BIOL, V79, P3208, DOI 10.1073/pnas.79.10.3208; Sandilands A, 2003, EXP EYE RES, V76, P385, DOI 10.1016/S0014-4835(02)00330-5; SIVAK JG, 1994, EXP EYE RES, V59, P505, DOI 10.1006/exer.1994.1137; Song SH, 2008, MOL VIS, V14, P1282; SRIVASTAVA OP, 1994, EXP EYE RES, V58, P595, DOI 10.1006/exer.1994.1054; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takemoto L, 2000, MOL VIS, V6, P164; Takemoto LJ, 1998, CURR EYE RES, V17, P247, DOI 10.1076/ceyr.17.3.247.5218; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; West-Mays JA, 2002, DEV BIOL, V245, P13, DOI 10.1006/dbio.2002.0624; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Wong AL, 2009, BRIT J OPHTHALMOL, V93, P61, DOI 10.1136/bjo.2008.137653; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Yu XS, 2004, J CELL SCI, V117, P871, DOI 10.1242/jcs.00945; Zillig M, 2005, INVEST OPHTH VIS SCI, V46, P223, DOI 10.1167/iovs.04-0988	60	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11579	11592		10.1074/jbc.M110.148627	http://dx.doi.org/10.1074/jbc.M110.148627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245144	hybrid, Green Published			2022-12-25	WOS:000288797100068
J	Rauch, A; Gossye, V; Bracke, D; Gevaert, E; Jacques, P; Van Beneden, K; Vandooren, B; Rauner, M; Hofbauer, LC; Haegeman, G; Elewaut, D; Tuckermann, JP; De Bosscher, K				Rauch, Alexander; Gossye, Valerie; Bracke, Debby; Gevaert, Elien; Jacques, Peggy; Van Beneden, Katrien; Vandooren, Bernard; Rauner, Martina; Hofbauer, Lorenz C.; Haegeman, Guy; Elewaut, Dirk; Tuckermann, Jan P.; De Bosscher, Karolien			An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation	FASEB JOURNAL			English	Article						GR; osteoporosis; interleukin 11	FACTOR-KAPPA-B; SUPPRESS BONE-FORMATION; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION; SYNOVIAL FIBROBLASTS; GENE REPRESSION; PLANT-ORIGIN; CATHEPSIN-K; CELLS; MECHANISMS	Glucocorticoids (GCs) are in widespread use to treat inflammatory bone diseases, such as rheumatoid arthritis (RA). Their anti-inflammatory efficacy, however, is accompanied by deleterious effects on bone, leading to GC-induced osteoporosis (GIO). These effects include up-regulation of the receptor activator of NF-kappa B ligand/osteoprotegerin (RANKL/OPG) ratio to promote bone-resorbing osteoclasts and include inhibition of bone-forming osteoblasts. We previously identified suppression of osteoblast differentiation by the monomer glucocorticoid receptor (GR) via the inhibition of Il11 expression as a crucial mechanism for GIO. Here we show that the GR-modulating substance compound A (CpdA), which does not induce GR dimerization, still suppresses proinflammatory cytokines in fibroblast-like synovial cells from patients with RA and in osteoblasts. In contrast to the full GR agonist dexamethasone, it does not unfavorably alter the RANKL/OPG ratio and does not affect Il11 expression and subsequent STAT3 phosphorylation in these cells. Notably, while dexamethasone inhibits osteoblast differentiation, CpdA does not affect osteoblast differentiation in vitro and in vivo. We describe here for the first time that selective GR modulators can act against inflammation, while not impairing osteoblast differentiation.-Rauch, A., Gossye, V., Bracke, D., Gevaert, E., Jacques, P., Van Beneden, K., Vandooren, B., Rauner, M., Hofbauer, L. C., Haegeman, G., Elewaut, D., Tuckermann, J. P., De Bosscher, K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB J. 25, 1323-1332 (2011). www.fasebj.org	[Rauch, Alexander; Tuckermann, Jan P.] Fritz Lipmann Inst, Leibniz Inst Age Res, Grp Tissue Specif Hormone Act, D-07745 Jena, Germany; [Gossye, Valerie; Bracke, Debby; Gevaert, Elien; Haegeman, Guy; De Bosscher, Karolien] Univ Ghent, Dept Physiol, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; [Jacques, Peggy; Van Beneden, Katrien; Vandooren, Bernard; Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium; [Rauner, Martina; Hofbauer, Lorenz C.] Tech Univ Dresden, Med Ctr, Dresden, Germany; [Rauner, Martina; Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, Dresden, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ghent University; Ghent University; Ghent University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Tuckermann, JP (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Grp Tissue Specif Hormone Act, Beutenbergstr 11, D-07745 Jena, Germany.	jan@fli-leibniz.de; karolien.debosscher@vib-ugent.be	Elewaut, Dirk/K-6831-2014; Rauch, Alexander/AAY-5235-2021; Rauner, Martina/A-1665-2015; Hofbauer, Lorenz C/G-2490-2010	Rauch, Alexander/0000-0002-9429-7356; Hofbauer, Lorenz C/0000-0002-8691-8423; De Bosscher, Karolien/0000-0001-5059-9718; Jacques, Peggy/0000-0001-9227-257X	Deutsche Forschungsgemeinschaft [SP1468, Tu220/6-1, HO1875/8-1]; Boehringer Ingelheim Stiftung; FWO-Vlaanderen; IWT-Vlaanderen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Stiftung(Boehringer Ingelheim); FWO-Vlaanderen(FWO); IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The authors thank Susanne Ostermay for excellent technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft by the priority program SP1468 (Tu220/6-1 to J.P.T. and HO1875/8-1 to L. C. H. and M. R.), the Boehringer Ingelheim Stiftung (to J.P.T.), the FWO-Vlaanderen (to K. D. B), and the IWT-Vlaanderen (to V. G.). The authors declare no competing financial interests.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Berris Karen Koenig, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P446, DOI 10.1097/MED.0b013e3282f15407; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Gossye V, 2010, ANN RHEUM DIS, V69, P291, DOI 10.1136/ard.2008.102871; Gossye V, 2008, FRONT BIOSCI-LANDMRK, V13, P4122, DOI 10.2741/2997; Gossye V, 2009, ARTHRITIS RHEUM-US, V60, P3241, DOI 10.1002/art.24963; Hofbauer LC, 1999, EUR J ENDOCRINOL, V140, P376, DOI 10.1530/eje.0.1400376; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Humphrey EL, 2006, BONE, V38, P652, DOI 10.1016/j.bone.2005.10.004; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459; Kalak R, 2009, BONE, V45, P61, DOI 10.1016/j.bone.2009.03.673; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Kondo T, 2008, J CELL BIOCHEM, V103, P335, DOI 10.1002/jcb.21414; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Muller-Ladner U, 2000, CURR OPIN RHEUMATOL, V12, P186, DOI 10.1097/00002281-200005000-00005; MULLERLADNER, 1996, AM J PATHOL, V149, P1607; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rauner M, 2011, ENDOCRINOLOGY, V152, P103, DOI 10.1210/en.2010-0456; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Schacke H, 2008, EXPERT OPIN THER PAT, V18, P339, DOI 10.1517/13543776.18.3.339; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schett G, 2010, ANN RHEUM DIS, V69, P1415, DOI 10.1136/ard.2010.135061; SEITZ M, 1994, BRIT J RHEUMATOL, V33, P613; Shigeyama Y, 2000, ARTHRITIS RHEUM, V43, P2523, DOI 10.1002/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; Swanson C, 2006, ENDOCRINOLOGY, V147, P3613, DOI 10.1210/en.2005-0717; Tohjima E, 2003, J BONE MINER RES, V18, P1461, DOI 10.1359/jbmr.2003.18.8.1461; Trepicchio WL, 1998, ANN NY ACAD SCI, V856, P12, DOI 10.1111/j.1749-6632.1998.tb08308.x; VANLOO G, 2009, MOL ENDOCRINOL, V24, P1; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	47	58	58	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1323	1332		10.1096/fj.10-173393	http://dx.doi.org/10.1096/fj.10-173393			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21233489				2022-12-25	WOS:000288982800021
J	Wu, SM; Huang, YH; Yeh, CT; Tsai, MM; Liao, CH; Cheng, WL; Chen, WJ; Lin, KH				Wu, S-M; Huang, Y-H; Yeh, C-T; Tsai, M-M; Liao, C-H; Cheng, W-L; Chen, W-J; Lin, K-H			Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells	ONCOGENE			English	Article						cysteine proteases; receptors; migration; hepatocellular carcinoma	LYSOSOMAL CYSTEINE PROTEASES; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS; PITUITARY-TUMOR; MOUSE MODEL; B ACTIVITY; V-ERBA; CANCER; EXPRESSION	Thyroid hormone, 3, 3', 5-triiodo-L-thyronine (T-3), mediates cell growth, development and differentiation by binding to its nuclear receptors (TRs). The role of TRs in cancer is still undefined. Notably, hyperthyroxinemia has been reported to influence the rate of colon cancer in an experimental model of carcinogenesis in rats. Previous microarray analysis revealed that cathepsin H (CTSH) is upregulated by T-3 in HepG2-TR cells. We verified that mRNA and protein expression of CTSH are induced by T3 in HepG2-TR cells and in thyroidectomized rats following administration of T-3. The possible thyroid hormone-responsive elements of the CTSH promoter localized to the nucleotides -2038 to -1966 and -1565 to -1501 regions. An in vitro functional assay showed that CTSH can increase metastasis. J7 cells overexpressing CTSH were inoculated into severe combined immune-deficient mice and these J7-CTSH mice displayed a greater metastatic potential than did J7-control mice. The clinicopathologic significance of CTSH expression in hepatocellular carcinoma (HCC) was also investigated. The CTSH overexpressing in HCC was associated with the presence of microvascular invasion (P = 0.037). The microvascular invasion characteristic is closely related to our in vitro characterization of CTSH function. Our results show that T-3-mediated upregulation of CTSH led to matrix metallopeptidase or extracellular signal-regulated kinase activation and increased cell migration. This study demonstrated that CTSH overexpression in a subset hepatoma may be TR dependent and suggests that this overexpression has an important role in hepatoma progression. Oncogene (2011) 30, 2057-2069; doi:10.1038/onc.2010.585; published online 10 January 2011	[Wu, S-M; Tsai, M-M; Liao, C-H; Cheng, W-L; Lin, K-H] Chang Gung Univ, Sch Med, Dept Biochem, Tao Yuan 333, Taiwan; [Huang, Y-H] Chang Gung Mem Hosp, Med Res Ctr, Tao Yuan, Taiwan; [Yeh, C-T] Chang Gung Med Ctr, Liver Res Unit, Taipei, Taiwan; [Tsai, M-M] Chang Gung Inst Technol, Dept Nursing, Tao Yuan, Taiwan; [Chen, W-J] Chang Gung Mem Hosp, Cardiovasc Div 1, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital	Lin, KH (corresponding author), Chang Gung Univ, Sch Med, Dept Biochem, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	khlin@mail.cgu.edu.tw		Liao, Hsiang-Ruei/0000-0003-0843-4375	Chang-Gung University, Taoyuan, Taiwan [CMRPD 34013, NMRP 140511]; National Science Council of the Republic of China [NSC 94-2320-B-182-052]	Chang-Gung University, Taoyuan, Taiwan; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang-Gung University, Taoyuan, Taiwan (CMRPD 34013, NMRP 140511) and from the National Science Council of the Republic of China (NSC 94-2320-B-182-052).	Ando S, 2001, MOL ENDOCRINOL, V15, P1529, DOI 10.1210/me.15.9.1529; Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Chamba A, 1996, J CLIN ENDOCR METAB, V81, P360, DOI 10.1210/jc.81.1.360; Chen RN, 2008, ENDOCRINOLOGY, V149, P3817, DOI 10.1210/en.2007-0989; Chen RN, 2008, CANCER RES, V68, P1697, DOI 10.1158/0008-5472.CAN-07-5492; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; del Re EC, 2000, BRIT J CANCER, V82, P1317; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; GABRIJELCIC D, 1992, EUR J CLIN CHEM CLIN, V30, P69; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Hall LC, 2008, J STEROID BIOCHEM, V109, P57, DOI 10.1016/j.jsbmb.2007.12.008; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang YH, 2010, J CELL PHYSIOL, V222, P347, DOI 10.1002/jcp.21959; Huang Ya-Hui, 2008, Chang Gung Med J, V31, P325; Huang YH, 2006, ENDOCRINOLOGY, V147, P2481, DOI 10.1210/en.2005-1166; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Kos J, 1997, CLIN CANCER RES, V3, P1815; Kress E, 2010, GASTROENTEROLOGY, V138, P1863, DOI 10.1053/j.gastro.2010.01.041; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liao CS, 2009, MOL CELL ENDOCRINOL, V307, P109, DOI 10.1016/j.mce.2009.04.013; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Lin KH, 2001, ENDOCRINOLOGY, V142, P653, DOI 10.1210/en.142.2.653; Martinez-Iglesias O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006428; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nelson D, 2006, J LEUKOCYTE BIOL, V80, P685, DOI 10.1189/jlb.1105646; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Rosen MD, 2009, MOL ENDOCRINOL, V23, P1183, DOI 10.1210/me.2009-0126; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Shih CH, 2004, ENDOCRINOLOGY, V145, P2804, DOI 10.1210/en.2003-1372; Sivaparvathi M, 1996, CANCER LETT, V104, P121, DOI 10.1016/0304-3835(96)04242-5; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Teranishi S, 2009, INVEST OPHTH VIS SCI, V50, P5646, DOI 10.1167/iovs.08-2534; Thormeyer D, 1999, INT J MOL MED, V4, P351; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; TSUSHIMA H, 1991, INT J CANCER, V48, P726, DOI 10.1002/ijc.2910480516; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Wilson TJ, 2008, BBA-REV CANCER, V1785, P85, DOI 10.1016/j.bbcan.2007.11.001; Wu SM, 2010, CELL MOL LIFE SCI, V67, P1831, DOI 10.1007/s00018-010-0281-2; Yang H, 1999, ENDOCRINOLOGY, V140, P43, DOI 10.1210/en.140.1.43; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; YEN PM, 1994, J BIOL CHEM, V269, P903; Zhu XG, 2010, ONCOGENE, V29, P1909, DOI 10.1038/onc.2009.476	52	29	30	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2057	2069		10.1038/onc.2010.585	http://dx.doi.org/10.1038/onc.2010.585			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21217776				2022-12-25	WOS:000289977400009
J	Carvajal-Yepes, M; Himmelsbach, K; Schaedler, S; Ploen, D; Krause, J; Ludwig, L; Weiss, T; Klingel, K; Hildt, E				Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Ploen, Daniela; Krause, Janis; Ludwig, Leopold; Weiss, Thomas; Klingel, Karin; Hildt, Eberhard			Hepatitis C Virus Impairs the Induction of Cytoprotective Nrf2 Target Genes by Delocalization of Small Maf Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCYTES; OXIDATIVE STRESS; VIRAL-HEPATITIS; NS5A; REPLICATION; ACTIVATION; DEGRADATION; EXPRESSION; INFECTION; APOPTOSIS	The expression of a variety of cytoprotective genes is regulated by short cis-acting elements in their promoters, called antioxidant response elements (AREs). A central regulator of ARE-mediated gene expression is the NF-E2-related factor 2 (Nrf2). Nrf2/ARE-regulated genes are crucial for the maintenance of cellular integrity. Hepatitis C virus inhibits the induction of ARE-regulated genes, but neither induction nor inhibition of ARE-regulated gene expression affects HCV replication directly. In HCV-replicating cells the core protein triggers the delocalization of sMaf proteins from the nucleus to the replicon complex. Here sMafs bind to NS3. The extranuclear sMaf proteins prevent Nrf2 from entry in the nucleus and thereby inhibit the induction of Nrf2/ARE-regulated genes. This results in the decreased expression of cytoprotective genes. Consistent with this finding, the elimination of ROI is impaired in HCV-replicating cells as demonstrated by elevated protein oxidation or 8-OH-dG formation, reflecting DNA damage. In conclusion, these data identified a novel mechanism of Nrf2 regulation and suggest that the HCV-dependent inhibition of Nrf2/ARE-regulated genes confers to the HCV-associated pathogenesis by elevation of intracellular ROI that affect integrity of the host genome and regenerative processes.	[Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Ploen, Daniela; Hildt, Eberhard] Univ Kiel, Inst Infect Med, D-24105 Kiel, Germany; [Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Krause, Janis; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Carvajal-Yepes, Monica; Schaedler, Stephanie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, D-72076 Tubingen, Germany; [Ludwig, Leopold] Tech Univ Munich, Dept Med 2, D-81675 Munich, Germany; [Weiss, Thomas] Univ Regensburg, Ctr Liver Cell Res, D-93053 Regensburg, Germany	University of Kiel; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Technical University of Munich; University of Regensburg	Hildt, E (corresponding author), Paul Ehrlich Inst, Div Virol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	hileb@pei.de	Hildt, Eberhard/A-1040-2015; Weiss, Thomas S./G-3989-2012	Weiss, Thomas S./0000-0003-0336-0581; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Bender, Daniela/0000-0002-8991-126X				Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Himmelsbach K, 2009, GUT, V58, P1644, DOI 10.1136/gut.2009.182212; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jung T, 2007, ARCH BIOCHEM BIOPHYS, V462, P231, DOI 10.1016/j.abb.2007.01.030; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; Sauter D, 2009, J HEPATOL, V50, P861, DOI 10.1016/j.jhep.2008.11.024; Schaedler S, 2010, J BIOL CHEM, V285, P41074, DOI 10.1074/jbc.M110.145862; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	43	80	83	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8941	8951		10.1074/jbc.M110.186684	http://dx.doi.org/10.1074/jbc.M110.186684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216956	Green Published, hybrid			2022-12-25	WOS:000288247700026
J	Chen, WT; Liao, YH; Yu, HM; Cheng, IH; Chen, YR				Chen, Wei-Ting; Liao, Yi-Hung; Yu, Hui-Ming; Cheng, Irene H.; Chen, Yun-Ru			Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-beta Stability, Oligomerization, and Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; COPPER-BINDING; SYNAPTIC ZINC; METAL-IONS; PROTEIN; PEPTIDE; PRECURSOR; INSIGHTS; ALUMINUM	Abnormally high concentrations of Zn2+, Cu2+, and Fe3+ are present along with amyloid-beta (A beta) in the senile plaques in Alzheimer disease, where Al3+ is also detected. A beta aggregation is the key pathogenic event in Alzheimer disease, where A beta oligomers are the major culprits. The fundamental mechanism of these metal ions on A beta remains elusive. Here, we employ 4,4'-Bis(1-anilinonaphthalene 8-sulfonate) and tyrosine fluorescence, CD, stopped flow fluorescence, guanidine hydrochloride denaturation, and photo-induced cross-linking to elucidate the effect of Zn2+, Cu2+, Fe3+, and Al3+ on A beta at the early stage of the aggregation. Furthermore, thioflavin T assay, dot blotting, and transmission electron microscopy are utilized to examine A beta aggregation. Our results show that Al3+ and Zn2+, but not Cu2+ and Fe3+, induce larger hydrophobic exposures of A beta conformation, resulting in its significant destabilization at the early stage. The metal ion binding induces A beta conformational changes with micromolar binding affinities and millisecond binding kinetics. Cu2+ and Zn2+ induce similar assembly of transiently appearing A beta oligomers at the early state. During the aggregation, we found that Zn2+ exclusively promotes the annular protofibril formation without undergoing a nucleation process, whereas Cu2+ and Fe3+ inhibit fibril formation by prolonging the nucleation phases. Al3+ also inhibits fibril formation; however, the annular oligomers co-exist in the aggregation pathway. In conclusion, Zn2+, Cu2+, Fe3+, and Al3+ adopt distinct folding and aggregation mechanisms to affect A beta, where A beta destabilization promotes annular protofibril formation. Our study facilitates the understanding of annular A beta oligomer formation upon metal ion binding.	[Liao, Yi-Hung] Acad Sinica, Genom Res Ctr, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 11574, Taiwan; [Chen, Wei-Ting; Cheng, Irene H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 11221, Taiwan; [Liao, Yi-Hung] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014; CHEN, WEI-TING/AFL-9663-2022	Chen, Yun-Ru/0000-0002-6596-6338; CHEN, WEI-TING/0000-0003-2730-9529	Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan) [98-2320-B-001-020-MY3, 96-2113-M-001-030-MY2, 97-2320-B-010-027-MY3]; National Health Research Institute [NHRI-EX98-9816NC]	Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan)(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by Grants 98-2320-B-001-020-MY3, 96-2113-M-001-030-MY2, and 97-2320-B-010-027-MY3 from the Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan) and National Health Research Institute Grant NHRI-EX98-9816NC.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bibl M, 2007, J NEUROCHEM, V103, P467, DOI 10.1111/j.1471-4159.2007.04763.x; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Chen YR, 2004, PROTEIN SCI, V13, P2196, DOI 10.1110/ps.03521504; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Drago D, 2008, INT J BIOCHEM CELL B, V40, P731, DOI 10.1016/j.biocel.2007.10.014; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawahara M, 2001, BRAIN RES BULL, V55, P211, DOI 10.1016/S0361-9230(01)00475-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stellato F, 2006, EUR BIOPHYS J BIOPHY, V35, P340, DOI 10.1007/s00249-005-0041-7; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Yumoto S, 2009, J INORG BIOCHEM, V103, P1579, DOI 10.1016/j.jinorgbio.2009.07.023; Zatta P, 2009, TRENDS PHARMACOL SCI, V30, P346, DOI 10.1016/j.tips.2009.05.002	67	157	162	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9646	9656		10.1074/jbc.M110.177246	http://dx.doi.org/10.1074/jbc.M110.177246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216965	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000288247700089
J	Greenough, MA; Volitakis, I; Li, QX; Laughton, K; Evin, G; Ho, M; Dalziel, AH; Camakaris, J; Bush, AI				Greenough, Mark A.; Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Evin, Genevieve; Ho, Michael; Dalziel, Andrew H.; Camakaris, James; Bush, Ashley I.			Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Copper Chaperone of SOD1-dependent Copper/Zinc Superoxide Dismutase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; A-BETA; SYNAPTIC ZINC; TRANSPORTER; ACTIVATION; EXPRESSION; ABSENCE; CELLS; BRAIN; MOUSE	Dyshomeostasis of extracellular zinc and copper has been implicated in beta-amyloid aggregation, the major pathology associated with Alzheimer disease. Presenilin mediates the proteolytic cleavage of the beta-amyloid precursor protein to release beta-amyloid, and mutations in presenilin can cause familial Alzheimer disease. We tested whether presenilin expression affects copper and zinc transport. Studying murine embryonic fibroblasts (MEFs) from presenilin knock-out mice or RNA interference of presenilin expression in HEK293T cells, we observed a marked decrease in saturable uptake of radiolabeled copper and zinc. Measurement of basal metal levels in 6-month-old presenilin 1 heterozygous knock-out (PS1(+/-)) mice revealed significant deficiencies of copper and zinc in several tissues, including brain. Copper/zinc superoxide dismutase (SOD1) activity was significantly decreased in both presenilin knock-out MEFs and brain tissue of presenilin 1 heterozygous knock-out mice. In the MEFs and PS1(+/-) brains, copper chaperone of SOD1 (CCS) levels were decreased. Zinc-dependent alkaline phosphatase activity was not decreased in the PS null MEFs. These data indicate that presenilins are important for cellular copper and zinc turnover, influencing SOD1 activity, and having the potential to indirectly impact beta-amyloid aggregation through metal ion clearance.	[Greenough, Mark A.; Volitakis, Irene; Dalziel, Andrew H.; Bush, Ashley I.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Greenough, Mark A.; Dalziel, Andrew H.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Evin, Genevieve; Ho, Michael; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Mental Hlth Res Inst, 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Bush, Ashley I/A-1186-2007; Greenough, Mark/AAK-1615-2021; Bush, Ashley/Y-2457-2019; Evin, Genevieve M/E-5891-2013	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X; Greenough, Mark/0000-0001-6767-0584	Australian Research Council; National Health & Medical Research Council; Australian Institute of Nuclear Science Engineering; Australian National Health & Medical Research Council [567171]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Institute of Nuclear Science Engineering; Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from the Australian Research Council and the National Health & Medical Research Council. <SUP>64</SUP>Cu was obtained via a grant from the Australian Institute of Nuclear Science & Engineering.; Supported by Australian National Health & Medical Research Council Biomedical Research Scholarship 567171.	Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; BUSH AI, 1994, J BIOL CHEM, V269, P12152; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; de Hoef DLV, 2009, GENESIS, V47, P246, DOI 10.1002/dvg.20485; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; GETZ J, 2010, ARCH BIOCHEM BIOPHYS, V417, P227; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leutner S, 2000, NEUROSCI LETT, V292, P87, DOI 10.1016/S0304-3940(00)01449-X; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Ris L, 2003, J BIOL CHEM, V278, P44393, DOI 10.1074/jbc.M300971200; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang DS, 2002, NEUROSCI LETT, V328, P117, DOI 10.1016/S0304-3940(02)00498-6; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	57	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9776	9786		10.1074/jbc.M110.163964	http://dx.doi.org/10.1074/jbc.M110.163964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239495	Green Published, hybrid			2022-12-25	WOS:000288247700100
J	Hasan, A; Pokeza, N; Shaw, L; Lee, HS; Lazzaro, D; Chintala, H; Rosenbaum, D; Grant, MB; Chaqour, B				Hasan, Adeel; Pokeza, Nataliya; Shaw, Lynn; Lee, Hyun-Seung; Lazzaro, Douglas; Chintala, Hemabindu; Rosenbaum, Daniel; Grant, Maria B.; Chaqour, Brahim			The Matricellular Protein Cysteine-rich Protein 61 (CCN1/Cyr61) Enhances Physiological Adaptation of Retinal Vessels and Reduces Pathological Neovascularization Associated with Ischemic Retinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; PROGENITOR CELLS; MECHANICAL REGULATION; VASCULAR DEVELOPMENT; ANGIOGENESIS; CYR61; GENE	Retinal vascular damages are the cardinal hallmarks of retinopathy of prematurity (ROP), a leading cause of vision impairment and blindness in childhood. Both angiogenesis and vasculogenesis are disrupted in the hyperoxia-induced vaso-obliteration phase, and recapitulated, although aberrantly, in the subsequent ischemia-induced neovessel formation phase of ROP. Yet, whereas the histopathological features of ROP are well characterized, many key modulators with a therapeutic potential remain unknown. The CCN1 protein also known as cysteine-rich protein 61 (Cyr61) is a dynamically expressed, matricellular protein required for proper angiogenesis and vasculogenesis during development. The expression of CCN1 becomes abnormally reduced during the hyperoxic and ischemic phases of ROP modeled in the mouse eye with oxygen-induced retinopathy (OIR). Lentivirus-mediated re-expression of CCN1 enhanced physiological adaptation of the retinal vasculature to hyperoxia and reduced pathological angiogenesis following ischemia. Remarkably, injection into the vitreous of OIR mice of hematopoietic stem cells (HSCs) engineered to express CCN1 harnessed ischemia-induced neovessel outgrowth without adversely affecting the physiological adaptation of retinal vessels to hyperoxia. In vitro exposure of HSCs to recombinant CCN1 induced integrin-dependent cell adhesion, migration, and expression of specific endothelial cell markers as well as many components of the Wnt signaling pathway including Wnt ligands, their receptors, inhibitors, and downstream targets. CCN1-induced Wnt signaling mediated, at least in part, adhesion and endothelial differentiation of cultured HSCs, and inhibition of Wnt signaling interfered with normalization of the retinal vasculature induced by CCN1-primed HSCs in OIR mice. These newly identified functions of CCN1 suggest its possible therapeutic utility in ischemic retinopathy.	[Lazzaro, Douglas; Chaqour, Brahim] Suny Downstate Med Ctr, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Hasan, Adeel; Pokeza, Nataliya; Lee, Hyun-Seung; Chintala, Hemabindu; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Lazzaro, Douglas; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, SUNY Eye Inst, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	National Institutes of Health [EY019387-01A1]; NATIONAL EYE INSTITUTE [R01EY012601, R21EY019387, P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY019387-01A1 (to B. C.).	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Asahara T, 2005, E SCHERING RES FDN W, V54, P111; Asahara T, 2007, YAKUGAKU ZASSHI, V127, P841, DOI 10.1248/yakushi.127.841; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bhatwadekar AD, 2009, INVEST OPHTH VIS SCI, V50, P4967, DOI 10.1167/iovs.09-3616; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davies M, 2006, MOL VIS, V12, P467; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Fataccioli V, 2002, HUM GENE THER, V13, P1461, DOI 10.1089/10430340260185094; Francischetti IMB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009356; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guthrie SM, 2005, BLOOD, V105, P1916, DOI 10.1182/blood-2004-09-3415; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hubert KE, 2009, AM J PATHOL, V175, P2697, DOI 10.2353/ajpath.2009.090099; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; LANG R, 1994, DEVELOPMENT, V120, P3395; Liu BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008611; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; McLeod DS, 2006, DEV DYNAM, V235, P3336, DOI 10.1002/dvdy.20988; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pollan C, 2009, NEONATAL NETW, V28, P93, DOI 10.1891/0730-0832.28.2.93; Rayssac A, 2009, MOL THER, V17, P2010, DOI 10.1038/mt.2009.211; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Uno K, 2007, DEV DYNAM, V236, P981, DOI 10.1002/dvdy.21122; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008; Yoshida Y, 2007, BIOCHEM BIOPH RES CO, V355, P611, DOI 10.1016/j.bbrc.2007.01.195; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004	59	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9542	9554		10.1074/jbc.M110.198689	http://dx.doi.org/10.1074/jbc.M110.198689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212276	Green Published, hybrid			2022-12-25	WOS:000288247700080
J	Kim, CH; Leung, A; Huh, YH; Yang, E; Kim, DJ; Leblanc, P; Ryu, H; Kim, K; Kim, DW; Garland, EM; Raj, SR; Biaggioni, I; Robertson, D; Kim, KS				Kim, Chun-Hyung; Leung, Amanda; Huh, Yang Hoon; Yang, Eungi; Kim, Deog-Joong; Leblanc, Pierre; Ryu, Hoon; Kim, Kyungjin; Kim, Dong-Wook; Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David; Kim, Kwang-Soo			Norepinephrine Deficiency Is Caused by Combined Abnormal mRNA Processing and Defective Protein Trafficking of Dopamine beta-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULE BIOGENESIS; MOUSE FETAL DEVELOPMENT; HUMAN-DISEASE; GENE; CHAPERONES; MUTATIONS; CATECHOLAMINES; NORADRENALINE; FAILURE; STORAGE	Human norepinephrine (NE) deficiency (or dopamine beta-hydroxylase (DBH) deficiency) is a rare congenital disorder of primary autonomic failure, in which neurotransmitters NE and epinephrine are undetectable. Although potential pathogenic mutations, such as a common splice donor site mutation (IVS1 + 2T -> C) and various missense mutations, in NE deficiency patients were identified, molecular mechanisms underlying this disease remain unknown. Here, we show that the IVS1 + 2T -> C mutation results in a non-detectable level of DBH protein production and that all three missense mutations tested lead to the DBH protein being trapped in the endoplasmic reticulum (ER). Supporting the view that mutant DBH induces an ER stress response, exogenous expression of mutant DBH dramatically induced expression of BiP, a master ER chaperone. Furthermore, we found that a pharmacological chaperone, glycerol, significantly rescued defective trafficking of mutant DBH proteins. Taken together, we propose that NE deficiency is caused by the combined abnormal processing of DBH mRNA and defective protein trafficking and that this disease could be treated by a pharmacological chaperone(s).	[Kim, Chun-Hyung; Leung, Amanda; Yang, Eungi; Kim, Deog-Joong; Leblanc, Pierre; Kim, Kwang-Soo] Harvard Univ, Sch Med, Mol Neurobiol Lab, McLean Hosp, Belmont, MA 02478 USA; [Huh, Yang Hoon] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David] Vanderbilt Univ, Auton Dysfunct Ctr, Nashville, TN 37232 USA; [Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David] Vanderbilt Univ, Dept Clin Pharmacol, Nashville, TN 37232 USA	Harvard University; McLean Hospital; Boston Biomedical Research Institute; Boston University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Vanderbilt University; Vanderbilt University	Kim, CH (corresponding author), Harvard Univ, Sch Med, Mol Neurobiol Lab, McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	chkim@mclean.harvard.edu; kskim@mclean.harvard.edu	Leblanc, Pierre/AAB-3554-2020	Leblanc, Pierre/0000-0001-8756-2396; Ryu, Hoon/0000-0001-6544-3732	National Institutes of Health [MH48866, MH087903, P01 HL056693, HL071784, UL1 RR024975D]; Brain Research Center; Dongyang Corporation Co. in the Republic of Korea; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002497, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693, R01HL071784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087903, R21MH087903, R01MH048866, R29MH048866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Center; Dongyang Corporation Co. in the Republic of Korea; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH48866 (to K.-S.K.), MH087903 (to K.-S.K.), P01 HL056693 (to D. R.), HL071784 (to D. R.), and UL1 RR024975D. This work was also supported by international grants from the Brain Research Center and the Dongyang Corporation Co. in the Republic of Korea.	Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; AXELROD J, 1972, NEW ENGL J MED, V287, P237, DOI 10.1056/NEJM197208032870508; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Deinum J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009282; Garland EM, 2002, ANN NY ACAD SCI, V971, P506, DOI 10.1111/j.1749-6632.2002.tb04515.x; Goldstein DS, 2006, CARDIOVASC DRUG REV, V24, P189, DOI 10.1111/j.1527-3466.2006.00189.x; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Hendershot LM, 2004, MT SINAI J MED, V71, P289; INTVELD AJM, 1987, LANCET, V1, P183; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; MATHIAS CJ, 1990, Q J MED, V75, P617; NAGATSU T, 1972, CLIN CHEM, V18, P980; OCONNOR DT, 1994, CLIN SCI, V86, P149, DOI 10.1042/cs0860149; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Oyarce AM, 2000, J BIOL CHEM, V275, P3270, DOI 10.1074/jbc.275.5.3270; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; ROBERTSON D, 1986, NEW ENGL J MED, V314, P1494, DOI 10.1056/NEJM198606053142307; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; WEINSHILBOUM RM, 1971, SCIENCE, V174, P1349, DOI 10.1126/science.174.4016.1349; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	32	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9196	9204		10.1074/jbc.M110.192351	http://dx.doi.org/10.1074/jbc.M110.192351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209083	Green Published, hybrid			2022-12-25	WOS:000288247700050
J	Ufret-Vincenty, CA; Klein, RM; Hua, L; Angueyra, J; Gordon, SE				Ufret-Vincenty, Carmen A.; Klein, Rebecca M.; Hua, Li; Angueyra, Juan; Gordon, Sharona E.			Localization of the PIP2 Sensor of TRPV1 Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; PROTEIN; DESENSITIZATION; SENSITIZATION; ACTIVATION; INHIBITION; BRADYKININ; NEURONS; SITE	Although a large number of ion channels are now believed to be regulated by phosphoinositides, particularly phosphoinositide 4,5-bisphosphate (PIP2), the mechanisms involved in phosphoinositide regulation are unclear. For the TRP superfamily of ion channels, the role and mechanism of PIP2 modulation has been especially difficult to resolve. Outstanding questions include: is PIP2 the endogenous regulatory lipid; does PIP2 potentiate all TRPs or are some TRPs inhibited by PIP2; where does PIP2 interact with TRP channels; and is the mechanism of modulation conserved among disparate subfamilies? We first addressed whether the PIP2 sensor resides within the primary sequence of the channel itself, or, as recently proposed, within an accessory integral membrane protein called Pirt. Here we show that Pirt does not alter the phosphoinositide sensitivity of TRPV1 in HEK-293 cells, that there is no FRET between TRPV1 and Pirt, and that dissociated dorsal root ganglion neurons from Pirt knock-out mice have an apparent affinity for PIP2 indistinguishable from that of their wild-type littermates. We followed by focusing on the role of the C terminus of TRPV1 in sensing PIP2. Here, we show that the distal C-terminal region is not required for PIP2 regulation, as PIP2 activation remains intact in channels in which the distal C-terminal has been truncated. Furthermore, we used a novel in vitro binding assay to demonstrate that the proximal C-terminal region of TRPV1 is sufficient for PIP2 binding. Together, our data suggest that the proximal C-terminal region of TRPV1 can interact directly with PIP2 and may play a key role in PIP2 regulation of the channel.	[Ufret-Vincenty, Carmen A.; Klein, Rebecca M.; Hua, Li; Angueyra, Juan; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Box 357290,1959 NE Pacific St, Seattle, WA 98195 USA.	seg@u.washington.edu	Angueyra, Juan/HCI-8722-2022	Angueyra, Juan/0000-0002-9217-3069	National Institutes of Health [R01EY17564, T32EY007031, T32NS007332]; National Eye Institute [P30EY01730]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017564, T32EY007031, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY17564 (to S. E. G.), T32EY007031 (to R. M. K.), T32NS007332 (to C. A. U.-V.), and National Eye Institute Core Grant for Vision Research P30EY01730.	Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lee SY, 2005, ARCH PHARM RES, V28, P405, DOI 10.1007/BF02977669; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zheng Jie, 2006, V337, P65; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	38	95	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9688	9698		10.1074/jbc.M110.192526	http://dx.doi.org/10.1074/jbc.M110.192526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224382	Green Published, hybrid			2022-12-25	WOS:000288247700093
J	Yang, Y; Shi, WW; Chen, XF; Cui, NR; Konduru, AS; Shi, Y; Trower, TC; Zhang, SA; Jiang, C				Yang, Yang; Shi, Weiwei; Chen, Xianfeng; Cui, Ningren; Konduru, Anuhya S.; Shi, Yun; Trower, Timothy C.; Zhang, Shuang; Jiang, Chun			Molecular Basis and Structural Insight of Vascular K-ATP Channel Gating by S-Glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; PROTEIN-KINASE-C; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; I-TASSER; KIR6.1/SUR2B CHANNEL; STRUCTURE PREDICTION; PHYSIOLOGICAL ROLES; DISULFIDE BOND; KAPPA-B	The vascular ATP-sensitive K+ (K-ATP) channel is targeted by a variety of vasoactive substances, playing an important role in vascular tone regulation. Our recent studies indicate that the vascular K-ATP channel is inhibited in oxidative stress via S-glutathionylation. Here we show evidence for the molecular basis of the S-glutathionylation and its structural impact on channel gating. By comparing the oxidant responses of the Kir6.1/SUR2B channel with the Kir6.2/SUR2B channel, we found that the Kir6.1 subunit was responsible for oxidant sensitivity. Oxidant screening of Kir6.1-Kir6.2 chimeras demonstrated that the N terminus and transmembrane domains of Kir6.1 were crucial. Systematic mutational analysis revealed three cysteine residues in these domains: Cys(43), Cys(120), and Cys(176). Among them, Cys(176) was prominent, contributing to > 80% of the oxidant sensitivity. The Kir6.1-C176A/SUR2B mutant channel, however, remained sensitive to both channel opener and inhibitor, which indicated that Cys(176) is not a general gating site in Kir6.1, in contrast to its counterpart (Cys(166)) in Kir6.2. A protein pull-down assay with biotinylated glutathione ethyl ester showed that mutation of Cys(176) impaired oxidant-induced incorporation of glutathione (GSH) into the Kir6.1 subunit. In contrast to Cys(176), Cys(43) had only a modest contribution to S-glutathionylation, and Cys(120) was modulated by extracellular oxidants but not intracellular GSSG. Simulation modeling of Kir6.1 S-glutathionylation suggested that after incorporation to residue 176, the GSH moiety occupied a space between the slide helix and two transmembrane helices. This prevented the inner transmembrane helix from undergoing conformational changes necessary for channel gating, retaining the channel in its closed state.	[Yang, Yang; Shi, Weiwei; Chen, Xianfeng; Cui, Ningren; Konduru, Anuhya S.; Shi, Yun; Trower, Timothy C.; Zhang, Shuang; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 100 Piedmont Ave, Atlanta, GA 30302 USA.	cjiang@gsu.edu	Shi, Yun/B-5623-2009; Shi, Yun S/T-8845-2018; SHI, WEIWEI/B-3477-2008; Yang, Yang/B-3440-2008; Chen, Xianfeng/ABG-8256-2021; Konduru, Anuhya S/J-4765-2019	Shi, Yun/0000-0002-8842-9818; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0003-4275-0515; Konduru, Anuhya S/0000-0002-6347-9464; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD060959. This work was also supported by American Heart Association Grant 09GRNT2010037.	Akao M, 1997, J CLIN INVEST, V100, P3053, DOI 10.1172/JCI119860; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Cao K, 2002, BIOCHEM BIOPH RES CO, V296, P463, DOI 10.1016/S0006-291X(02)00892-6; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker B, 2007, NAT GENET, V39, P1453, DOI 10.1038/ng.2007.25; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Erdos B, 2004, STROKE, V35, P964, DOI 10.1161/01.STR.0000119753.05670.F1; Farzaneh T, 2008, CARDIOVASC RES, V79, P621, DOI 10.1093/cvr/cvn138; HARRISON RW, 1994, PROTEIN ENG, V7, P1353, DOI 10.1093/protein/7.11.1353; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; Miura H, 2003, CIRC RES, V92, P151, DOI 10.1161/01.RES.0000052671.53256.49; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Ross J, 2003, AM J PHYSIOL-REG I, V285, pR149, DOI 10.1152/ajpregu.00003.2003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi WW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.058313; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1982, DOI 10.1111/j.1471-4159.2007.04883.x; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Tokube K, 1998, PFLUG ARCH EUR J PHY, V437, P155, DOI 10.1007/s004240050760; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578; Yokoshiki H, 1998, AM J PHYSIOL-CELL PH, V274, pC25, DOI 10.1152/ajpcell.1998.274.1.C25; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	57	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9298	9307		10.1074/jbc.M110.195123	http://dx.doi.org/10.1074/jbc.M110.195123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216949	hybrid, Green Published			2022-12-25	WOS:000288247700060
J	Zhang, T; Yao, SH; Wang, P; Yin, CR; Xiao, C; Qian, ML; Liu, DH; Zheng, LM; Meng, WT; Zhu, HY; Liu, J; Xu, H; Mo, XM				Zhang, Ting; Yao, Shaohua; Wang, Ping; Yin, Chaoran; Xiao, Chun; Qian, Meilin; Liu, Donghui; Zheng, Lemin; Meng, Wentong; Zhu, Hongyan; Liu, Jin; Xu, Hong; Mo, Xianming			ApoA-II Directs Morphogenetic Movements of Zebrafish Embryo by Preventing Chromosome Fusion during Nuclear Division in Yolk Syncytial Layer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN A-II; EEL ANGUILLA-JAPONICA; MYOCARDIAL MIGRATION; INSULIN-RESISTANCE; MULTIGENE FAMILY; E GENE; CELL; EXPRESSION; ORGANIZATION; GASTRULATION	The high density lipoprotein (HDL) represents a class of lipid- and protein-containing particles and consists of two major apolipoproteins apoA-I and apoA-II. ApoA-II has been shown to be involved in the pathogenesis of insulin resistance, adiposity, diabetes, and metabolic syndrome. In embryo, apoa2 mRNAs are abundant in the liver, brain, lung, placenta, and in fish yolk syncytial layer (YSL), suggesting that apoa2 may perform a function during embryonic development. Here we find out that apoa2 modulates zebrafish embryonic development by regulating the organization of YSL. Disruption of apoa2 function in zebrafish caused chromosome fusing, which strongly blocked YSL nuclear division, inducing disorders in YSL organization and finally disturbing the embryonic epiboly. Purified native human apoA-II was able specifically to rescue the defects and induced nuclear division in zebrafish embryos and in human HeLa cells. The C terminus of apoA-II was required for the proper chromosome separation during nuclear division of YSL in zebrafish embryos and in human HeLa cells. Our data indicate that organization of YSL is required for blastoderm patterning and morphogenesis and suggest that apolipoprotein apoA-II is a novel factor of nuclear division in YSL involved in the regulation of early zebrafish embryonic morphogenesis and in mammalian cells for proliferation.	[Zhang, Ting; Yao, Shaohua; Wang, Ping; Yin, Chaoran; Xiao, Chun; Qian, Meilin; Meng, Wentong; Zhu, Hongyan; Liu, Jin; Xu, Hong; Mo, Xianming] Sichuan Univ, Lab Stem Cell Biol, State Key Lab Biotherapy, W China Hosp,W China Med Sch, Chengdu 610041, Peoples R China; [Liu, Donghui; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Liu, Donghui; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Sichuan University; Peking University; Peking University	Xu, H (corresponding author), Keyuan 4 Lu, Chengdu 610041, Peoples R China.	xuhongm@yahoo.com; xmingmo@scu.edu.cn	Mo, Xianming/AAM-2167-2021	Donghui, Liu/0000-0001-6568-5424; Zhang, Ting/0000-0002-8645-581X; Yin, Chaoran/0000-0002-4193-7022; Yao, Shaohua/0000-0002-0191-4889	National Basic Research Program of China [2009CB941200]; Nature Science Foundation of China [30771228, 30771227]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB941200) and the Nature Science Foundation of China (to H. X. (30771228) and to X. M. (30771227)).	Ando S, 2005, BIOSCI BIOTECH BIOCH, V69, P2258, DOI 10.1271/bbb.69.2258; Carvalho L, 2009, DEVELOPMENT, V136, P1305, DOI 10.1242/dev.026922; Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Chen SR, 2000, DEVELOPMENT, V127, P4681; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; Cooper MS, 2007, J EXP ZOOL PART B, V308B, P591, DOI 10.1002/jez.b.21142; D'Amico LA, 2001, DEV DYNAM, V222, P611, DOI 10.1002/dvdy.1216; Ebert AM, 2008, P NATL ACAD SCI USA, V105, P198, DOI 10.1073/pnas.0707948105; Fan X, 2007, DEV BIOL, V310, P363, DOI 10.1016/j.ydbio.2007.08.008; Gingerich JL, 2006, DEV DYNAM, V235, P2749, DOI 10.1002/dvdy.20918; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Havel R J, 1975, Adv Exp Med Biol, V63, P37; Hirata T, 2000, BIOCHEM BIOPH RES CO, V271, P603, DOI 10.1006/bbrc.2000.2672; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Ishida M, 2007, J REPROD DEVELOP, V53, P69, DOI 10.1262/jrd.18002; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1985, DEV BIOL, V108, P86, DOI 10.1016/0012-1606(85)90011-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondo H, 2005, GENE, V346, P257, DOI 10.1016/j.gene.2004.11.015; Kondo H, 2001, BBA-MOL CELL BIOL L, V1531, P132, DOI 10.1016/S1388-1981(01)00099-3; Lange PH, 2005, NAT CLIN PRACT UROL, V2, P151, DOI 10.1038/ncpuro0149; LI WH, 1988, J LIPID RES, V29, P245; Li Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-117; Mizuno T, 1999, MECH DEVELOP, V81, P51, DOI 10.1016/S0925-4773(98)00202-0; Monnot MJ, 1999, DEV DYNAM, V214, P207, DOI 10.1002/(SICI)1097-0177(199903)214:3<207::AID-AJA4>3.0.CO;2-5; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Paolucci M, 1998, COMP BIOCHEM PHYS B, V119, P647, DOI 10.1016/S0305-0491(98)00040-6; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; Provost PR, 2009, J ENDOCRINOL, V200, P321, DOI 10.1677/JOE-08-0238; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trinh LA, 2004, DEV CELL, V6, P371; TRINKAUS JP, 1993, J EXP ZOOL, V265, P258, DOI 10.1002/jez.1402650308; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilkins SJ, 2008, DEV BIOL, V314, P12, DOI 10.1016/j.ydbio.2007.10.050; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527; Zhou L, 2005, COMP BIOCHEM PHYS B, V142, P432, DOI 10.1016/j.cbpb.2005.09.007	44	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9514	9525		10.1074/jbc.M110.134908	http://dx.doi.org/10.1074/jbc.M110.134908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212265	Green Published, hybrid			2022-12-25	WOS:000288247700078
J	Doi, S; Zou, YL; Togao, O; Pastor, JV; John, GB; Wang, L; Shiizaki, K; Gotschall, R; Schiavi, S; Yorioka, N; Takahashi, M; Boothman, DA; Kuro-o, M				Doi, Shigehiro; Zou, Yonglong; Togao, Osamu; Pastor, Johanne V.; John, George B.; Wang, Lei; Shiizaki, Kazuhiro; Gotschall, Russell; Schiavi, Susan; Yorioka, Noriaki; Takahashi, Masaya; Boothman, David A.; Kuro-o, Makoto			Klotho Inhibits Transforming Growth Factor-beta 1 (TGF-beta 1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; UNILATERAL URETERAL OBSTRUCTION; FIBROBLAST GROWTH FACTOR-23; TGF-BETA; FUNCTIONAL VARIANT; TRPV5 CHANNEL; BREAST-CANCER; FGF RECEPTOR; DISEASE; MECHANISMS	Fibrosis is a pathological process characterized by infiltration and proliferation of mesenchymal cells in interstitial space. A substantial portion of these cells is derived from residing non-epithelial and/or epithelial cells that have acquired the ability to migrate and proliferate. The mesenchymal transition is also observed in cancer cells to confer the ability to metastasize. Here, we show that renal fibrosis induced by unilateral ureteral obstruction and metastasis of human cancer xenografts are suppressed by administration of secreted Klotho protein to mice. Klotho is a single-pass transmembrane protein expressed in renal tubular epithelial cells. The extracellular domain of Klotho is secreted by ectodomain shedding. Secreted Klotho protein directly binds to the type-II TGF-beta receptor and inhibits TGF-beta 1 binding to cell surface receptors, thereby inhibiting TGF-beta 1 signaling. Klotho suppresses TGF-beta 1-induced epithelial-to-mesenchymal transition (EMT) responses in cultured cells, including decreased epithelial marker expression, increased mesenchymal marker expression, and/or increased cell migration. In addition to TGF-beta 1 signaling, secreted Klotho has been shown to inhibit Wnt and IGF-1 signaling that can promote EMT. These results have raised the possibility that secreted Klotho may function as an endogenous anti-EMT factor by inhibiting multiple growth factor signaling pathways simultaneously.	[Zou, Yonglong; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Dept Oncol, Dallas, TX 75390 USA; [Doi, Shigehiro; Pastor, Johanne V.; John, George B.; Wang, Lei; Shiizaki, Kazuhiro; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Togao, Osamu; Takahashi, Masaya] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Gotschall, Russell; Schiavi, Susan] Genzyme Corp, Cambridge, MA 02142 USA; [Yorioka, Noriaki] Grad Sch Biomed Sci, Dept Adv Nephrol, Minami Ku, Hiroshima 7348551, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sanofi-Aventis; Genzyme Corporation	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	david.boothman@utsouthwestern.edu; makoto.kuro-o@utsouthwestern.edu	Togao, Osamu/AAE-4702-2022; Boothman, David/Q-7776-2019; Doi, Shigehiro/AAQ-2655-2020	Gotschall, Robert Russell/0000-0002-5050-1386	National Institutes of Health [R01AG019712, R01CA102792, R01CA129011]; Dept. of Energy [DE-FG02-09ER64789]; Genzyme; Philips Japan; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA129011, U24CA126608, P30CA142543, R01CA139217] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Energy; Genzyme(Sanofi-AventisGenzyme Corporation); Philips Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part by Grants R01AG019712 (to M. K.), R01CA102792 (to D. A. B.), R01CA129011 (to M. T.), and R21EB009147 (to M. T.) from the National Institutes of Health. This work was also supported by the Dept. of Energy (DE-FG02-09ER64789, to D. A. B.), Genzyme (Genzyme Renal Innovations Program, to M. K.), and Philips Japan (Cooperative Research Grant, to M. T.). R. G. and S. S. are employees of Genzyme Corporation.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DasGupta R, 1999, DEVELOPMENT, V126, P4557; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xu YF, 2007, J MAGN RESON IMAGING, V26, P678, DOI 10.1002/jmri.20979; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	51	385	424	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8655	8665		10.1074/jbc.M110.174037	http://dx.doi.org/10.1074/jbc.M110.174037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209102	Green Published, hybrid			2022-12-25	WOS:000288013300091
J	Zhang, QC; Yeh, TL; Leyva, A; Frank, LG; Miller, J; Kim, YE; Langen, R; Finkbeiner, S; Amzel, ML; Ross, CA; Poirier, MA				Zhang, Qi Charles; Yeh, Tzu-lan; Leyva, Alfonso; Frank, Leslie G.; Miller, Jason; Kim, Yujin E.; Langen, Ralf; Finkbeiner, Steven; Amzel, Mario L.; Ross, Christopher A.; Poirier, Michelle A.			A Compact beta Model of huntingtin Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG REPEAT LENGTH; MUTANT HUNTINGTIN; MONOCLONAL-ANTIBODIES; CLINICAL PROGRESSION; POLYGLUTAMINE LENGTH; NEURONAL DEATH; DISEASE; AGGREGATION; FRAGMENTS; OLIGOMERS	Huntington disease results from an expanded polyglutamine region in the N terminus of the huntingtin protein. HD pathology is characterized by neuronal degeneration and protein inclusions containing N-terminal fragments of mutant huntingtin. Structural information is minimal, though it is believed that mutant huntingtin polyglutamine adopts beta structure upon conversion to a toxic form. To this end, we designed mammalian cell expression constructs encoding compact beta variants of Htt exon 1 N-terminal fragment and tested their ability to aggregate and induce toxicity in cultured neuronal cells. In parallel, we performed molecular dynamics simulations, which indicate that constructs with expanded polyglutamine beta-strands are stabilized by main-chain hydrogen bonding. Finally, we found a correlation between the reactivity to 3B5H10, an expanded polyglutamine antibody that recognizes a compact beta rich hairpin structure, and the ability to induce cell toxicity. These data are consistent with an important role for a compact beta structure in mutant huntingtin-induced cell toxicity.	[Ross, Christopher A.; Poirier, Michelle A.] Childrens Med Surg Ctr, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA; [Yeh, Tzu-lan; Leyva, Alfonso; Amzel, Mario L.] Johns Hopkins Univ, Sch Med, Dept Biochem & Biophys, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Miller, Jason] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Miller, Jason; Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biochem, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Biol, Los Angeles, CA 90089 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; University of Southern California	Poirier, MA (corresponding author), Childrens Med Surg Ctr, Div Neurobiol, Dept Psychiat, 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	mpoirie1@jhmi.edu	Nucifora, Leslie/X-2716-2019; Ross, Christopher A/H-8395-2013; Kim, Yujin/P-4270-2014	Kim, Yujin/0000-0003-4290-0974; Amzel, L. Mario/0000-0002-0129-9572; Miller, Jason/0000-0002-2784-9560	National Institutes of Health [R01NS053679, P01NS16375, 2NS45091, AG027936]; DOE [DE-FG02-04ER25626]; National Institutes of Health-NIGMS; University of California at San Francisco Hillblom Center for the Biology of Aging; Huntington Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053679, R01NS045091, P01NS016375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California at San Francisco Hillblom Center for the Biology of Aging(University of California System); Huntington Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS053679 (to M. A. P.), P01NS16375 (to C. A. R.), 2NS45091 (to S. F.), AG027936 (to R. L.), and DOE DE-FG02-04ER25626 (to M. L. A.), the National Institutes of Health-NIGMS UCSF Medical Scientist Training Program (to J. M.), and a fellowship from the University of California at San Francisco Hillblom Center for the Biology of Aging (to J. M.). This work was also supported by the Huntington Disease Society of America Coalition for the Cure and by CHDI, Inc.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Rosenblatt A, 2006, NEUROLOGY, V66, P1016, DOI 10.1212/01.wnl.0000204230.16619.d9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8188	8196		10.1074/jbc.M110.192013	http://dx.doi.org/10.1074/jbc.M110.192013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209075	hybrid, Green Published			2022-12-25	WOS:000288013300049
J	Barria, MA; Telling, GC; Gambetti, P; Mastrianni, JA; Soto, C				Barria, Marcelo A.; Telling, Glenn C.; Gambetti, Pierluigi; Mastrianni, James A.; Soto, Claudio			Generation of a New Form of Human PrPSc in Vitro by Interspecies Transmission from Cervid Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; PROTEIN; ELK; REPLICATION; DEER; PROPAGATION; ADAPTATION	Prion diseases are infectious neurodegenerative disorders that affect humans and animals and that result from the conversion of normal prion protein (PrPC) into the misfolded prion protein (PrPSc). Chronic wasting disease (CWD) is a prion disorder of increasing prevalence within the United States that affects a large population of wild and captive deer and elk. Determining the risk of transmission of CWD to humans is of utmost importance, considering that people can be infected by animal prions, resulting in new fatal diseases. To study the possibility that human PrPC can be converted into the misfolded form by CWD PrPSc, we performed experiments using the protein mis-folding cyclic amplification technique, which mimics in vitro the process of prion replication. Our results show that cervid PrPSc can induce the conversion of human PrPC but only after the CWD prion strain has been stabilized by successive passages in vitro or in vivo. Interestingly, the newly generated human PrPSc exhibits a distinct biochemical pattern that differs from that of any of the currently known forms of human PrPSc. Our results also have profound implications for understanding the mechanisms of the prion species barrier and indicate that the transmission barrier is a dynamic process that depends on the strain and moreover the degree of adaptation of the strain. If our findings are corroborated by infectivity assays, they will imply that CWD prions have the potential to infect humans and that this ability progressively increases with CWD spreading.	[Barria, Marcelo A.; Soto, Claudio] Univ Texas Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Microbiol, Lexington, KY 40506 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Immunol, Lexington, KY 40506 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Mol Genet & Neurol, Lexington, KY 40506 USA; [Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Texas System; University of Texas Health Science Center Houston; University of Kentucky; University of Kentucky; University of Kentucky; Case Western Reserve University; University of Chicago	Soto, C (corresponding author), Univ Texas Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, 6431 Fannin St, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805; Barria Matus, Marcelo/0000-0003-4789-7401	National Institutes of Health [R01NS049173, P01AI77774, P01AG14359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049173, P01AI77774, and P01AG14359. Dr. Soto is the inventor of several patents related to PMCA technology and is currently Founder, Chief Scientific Officer, and Vice President of Amprion Inc., a biotechnological company focusing on the commercial exploitation of PMCA for prion diagnosis.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Belay ED, 2001, ARCH NEUROL-CHICAGO, V58, P1673, DOI 10.1001/archneur.58.10.1673; Bosque Patrick J, 2002, Curr Neurol Neurosci Rep, V2, P488, DOI 10.1007/s11910-002-0034-1; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Jones M, 2008, NEUROREPORT, V19, P1783, DOI 10.1097/WNR.0b013e328318edfa; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Moore RA, 2005, ARCH VIROL, P187; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Xie ZL, 2006, J BIOL CHEM, V281, P4199, DOI 10.1074/jbc.M509052200	37	79	79	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7490	7495		10.1074/jbc.M110.198465	http://dx.doi.org/10.1074/jbc.M110.198465			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209079	hybrid, Green Published			2022-12-25	WOS:000287737300063
J	Horvath, B; Lenzser, G; Benyo, B; Nemeth, T; Benko, R; Iring, A; Herman, P; Komjati, K; Lacza, Z; Sandor, P; Benyo, Z				Horvath, Bela; Lenzser, Gabor; Benyo, Balazs; Nemeth, Tamas; Benko, Rita; Iring, Andras; Herman, Peter; Komjati, Katalin; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan			Hypersensitivity to Thromboxane Receptor Mediated Cerebral Vasomotion and CBF Oscillations during Acute NO-Deficiency in Rats	PLOS ONE			English	Article							OXIDE SYNTHASE BLOCKADE; SMOOTH-MUSCLE; PROTEIN-KINASE; NITRIC-OXIDE; BLOOD-FLOW; LASER-DOPPLER; SUBARACHNOID HEMORRHAGE; PROSTAGLANDIN I-2; IN-VIVO; PHOSPHORYLATION	Background: Low frequency (4-12 cpm) spontaneous fluctuations of the cerebrovascular tone (vasomotion) and oscillations of the cerebral blood flow (CBF) have been reported in diseases associated with endothelial dysfunction. Since endothelium-derived nitric oxide (NO) suppresses constitutively the release and vascular effects of thromboxane A(2) (TXA(2)), NO-deficiency is often associated with activation of thromboxane receptors (TP). In the present study we hypothesized that in the absence of NO, overactivation of the TP-receptor mediated cerebrovascular signaling pathway contributes to the development of vasomotion and CBF oscillations. Methodology/Principal Findings: Effects of pharmacological modulation of TP-receptor activation and its downstream signaling pathway have been investigated on CBF oscillations (measured by laser-Doppler flowmetry in anesthetized rats) and vasomotion (measured by isometric tension recording in isolated rat middle cerebral arteries, MCAs) both under physiological conditions and after acute inhibition of NO synthesis. Administration of the TP-receptor agonist U-46619 (1 mu g/kg iv.) to control animals failed to induce any changes of the systemic or cerebral circulatory parameters. Inhibition of the NO synthesis by nitro-L-arginine methyl esther (L-NAME, 100 mg/kg iv.) resulted in increased mean arterial blood pressure and a decreased CBF accompanied by appearance of CBF-oscillations with a dominant frequency of 148+/-2 mHz. U-46619 significantly augmented the CBF-oscillations induced by L-NAME while inhibition of endogenous TXA(2) synthesis by ozagrel (10 mg/kg iv.) attenuated it. In isolated MCAs U-46619 in a concentration of 100 nM, which induced weak and stable contraction under physiological conditions, evoked sustained vasomotion in the absence of NO, which effect could be completely reversed by inhibition of Rho-kinase by 10 mu M Y-27632. Conclusion/Significance: These results suggest that hypersensitivity of the TP-receptor - Rho-kinase signaling pathway contributes to the development of low frequency cerebral vasomotion which may propagate to vasospasm in pathophysiological states associated with NO-deficiency.	[Horvath, Bela; Lenzser, Gabor; Nemeth, Tamas; Benko, Rita; Iring, Andras; Herman, Peter; Komjati, Katalin; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary; [Horvath, Bela] NIAAA, NIH, Bethesda, MD USA; [Lenzser, Gabor] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Benyo, Balazs] Budapest Univ Technol & Econ, Dept Control Engn & Informat Technol, H-1117 Budapest, Hungary; [Herman, Peter] Yale Univ, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA	Semmelweis University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Pecs; Budapest University of Technology & Economics; Yale University	Horvath, B (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary.	bela.horvath@nih.gov	Horvath, Bela/A-7368-2009; Benyó, Balázs/H-6208-2012; Herman, Peter/E-7028-2010; Benyó, Balázs/AAR-4275-2021; Iring, Andras/F-7092-2010; Benko, Rita/I-9646-2017	Benyó, Balázs/0000-0003-2770-9127; Benyó, Balázs/0000-0003-2770-9127; Iring, Andras/0000-0002-3087-4337; Herman, Peter/0000-0003-2218-9652; Benko, Rita/0000-0001-7740-9128; Benyo, Zoltan/0000-0001-6015-0359	EFSD) European Foundation for the Study of Diabetes/Servier; Hungarian Scientific Research Fund (OTKA) [K 62375, K82066]; NKTH National Office for Research and Technology [OMFB-00770/2009, ALAP1-01298/2009]; ESZCSM Health Science Council (ETT) [427/2009]; Tarsadalmi Megujulas Operativ Program (TAMOP) [4.2.2-08/1/KMR-2008-004, 4.2.1/B-09/1/KMR-2010-000]; NKTH-OTKA-EU [MB08-A 80238]	EFSD) European Foundation for the Study of Diabetes/Servier(Servier); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NKTH National Office for Research and Technology(National Office for Research and Technology); ESZCSM Health Science Council (ETT); Tarsadalmi Megujulas Operativ Program (TAMOP); NKTH-OTKA-EU(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by an (EFSD) European Foundation for the Study of Diabetes/Servier grant as well as by grants from the The Hungarian Scientific Research Fund (Hungarian abbreviation: OTKA) (K 62375, K82066), NKTH National Office for Research and Technology (OMFB-00770/2009, ALAP1-01298/2009), ESZCSM Health Science Council (ETT)(427/2009) and Tarsadalmi Megujulas Operativ Program (TAMOP) (4.2.2-08/1/KMR-2008-004, 4.2.1/B-09/1/KMR-2010-000). Dr. Horvath was supported by an NKTH-OTKA-EU Fellowship (MB08-A 80238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Ansar S, 2010, BRAIN RES, V1316, P163, DOI 10.1016/j.brainres.2009.12.031; Benyo Z, 1998, J CEREBR BLOOD F MET, V18, P616, DOI 10.1097/00004647-199806000-00003; BENYO Z, 1995, NEUROSCI LETT, V198, P127, DOI 10.1016/0304-3940(95)11981-2; Biswal B, 1997, J CEREBR BLOOD F MET, V17, P301, DOI 10.1097/00004647-199703000-00007; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; DAVIES PW, 1957, FED PROC, V16, P689; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; DORA E, 1981, ACTA PHYSIOL HUNG, V57, P261; DUHAMEL P, 1990, SIGNAL PROCESS, V19, P259, DOI 10.1016/0165-1684(90)90158-U; FASANO VA, 1988, ACTA NEUROCHIR, V95, P40, DOI 10.1007/BF01793081; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Frigo M, 1998, INT CONF ACOUST SPEE, P1381; FUNK W, 1983, INT J MICROCIRC, V2, P11; Hudetz AG, 1998, ADV EXP MED BIOL, V454, P551; HUDETZ AG, 1992, J CEREBR BLOOD F MET, V12, P491, DOI 10.1038/jcbfm.1992.67; Ichikawa K, 1999, PHARMACOLOGY, V59, P257, DOI 10.1159/000028328; Lacza Z, 2000, NEUROSCI LETT, V291, P65, DOI 10.1016/S0304-3940(00)01341-0; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Lan C, 2004, AM J PHYSIOL-HEART C, V286, pH165, DOI 10.1152/ajpheart.00664.2003; LEFER DJ, 1990, MICROVASC RES, V39, P129, DOI 10.1016/0026-2862(90)90065-Y; Leszl-Ishiguro M, 2007, NEUROREPORT, V18, P1193, DOI 10.1097/WNR.0b013e3282202459; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Miyamoto A, 2007, VASC PHARMACOL, V46, P85, DOI 10.1016/j.vph.2006.06.018; MORITATSUZUKI Y, 1992, ACTA PHYSIOL SCAND, V146, P431, DOI 10.1111/j.1748-1716.1992.tb09444.x; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OSOL G, 1988, AM J PHYSIOL, V254, pH28, DOI 10.1152/ajpheart.1988.254.1.H28; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; ROSENBLUM BR, 1987, J NEUROSURG, V66, P396, DOI 10.3171/jns.1987.66.3.0396; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Turalska M, 2008, ACTA NEUROCHIR SUPPL, V102, P43, DOI 10.1007/978-3-211-85578-2_9; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wade ML, 1997, ARCH BIOCHEM BIOPHYS, V347, P174, DOI 10.1006/abbi.1997.0348; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Westermaier T, 2009, J NEUROSURG, V110, P996, DOI 10.3171/2008.8.JNS08591; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Xavier FE, 2009, BRIT J PHARMACOL, V158, P1787, DOI 10.1111/j.1476-5381.2009.00459.x	42	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14477	10.1371/journal.pone.0014477	http://dx.doi.org/10.1371/journal.pone.0014477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217826	gold, Green Submitted, Green Published			2022-12-25	WOS:000285838900006
J	Liu, WJ; Zong, WJ; Wu, G; Fujita, T; Li, WQ; Wu, J; Wan, Y				Liu, Weijun; Zong, Wenjun; Wu, George; Fujita, Takeo; Li, Wenqi; Wu, Judy; Wan, Yong			Turnover of BRCA1 Involves in Radiation-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PROTEASOME-MEDIATED DEGRADATION; NUCLEOTIDE EXCISION-REPAIR; CANCER CELL-LINE; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; BREAST-CANCER; GENOTOXIC STRESS; SPORADIC BREAST; IN-VITRO	Background: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susceptibility to tumorigenesis. The function of BRCA1 is to regulate critical cellular processes, including cell cycle progression, genomic integrity, and apoptosis. Studies on the regulation of BRCA1 have focused intensely on transcription and phosphorylation mechanisms. Proteolytic regulation of BRCA1 in response to stress signaling remains largely unknown. The manuscript identified a novel mechanism by which BRCA1 is regulated by the ubiquitin-dependent degradation in response to ionization. Methodology/Principal Findings: Here, we report that severe ionization triggers rapid degradation of BRCA1, which in turn results in the activation of apoptosis. Ionization-induced BRCA1 turnover is mediated via an ubiquitin-proteasomal pathway. The stabilization of BRCA1 significantly delays the onset of ionization-induced apoptosis. We have mapped the essential region on BRCA1, which mediates its proteolysis in response to ionization. Moreover, we have demonstrated that BRCA1 protein is most sensitive to degradation when ionization occurs during G2/M and S phase. Conclusions/Significance: Our results suggest that ubiquitin-proteasome plays an important role in regulating BRCA1 during genotoxic stress. Proteolytic regulation of BRCA1 involves in ionization-induced apoptosis.	[Liu, Weijun] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, WJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	yow4@pitt.edu	Liu, Weijun/D-5291-2017; Liu, Weijun/B-5896-2008	Liu, Weijun/0000-0002-4426-6148	National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA115943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA115943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Boulton SJ, 2006, CELL CYCLE, V5, P1481, DOI 10.4161/cc.5.14.2930; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen YM, 1996, CANCER RES, V56, P3168; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi YH, 2001, INT J ONCOL, V19, P687; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Deng CX, 2000, BIOESSAYS, V22, P728; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jacquemont C, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S10; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Quinn JE, 2003, CANCER RES, V63, P6221; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 2001, EXP CELL RES, V264, P67, DOI 10.1006/excr.2000.5132; Setlow RB, 2002, MUTAT RES-REV MUTAT, V511, P1, DOI 10.1016/S1383-5742(02)00004-2; Sylvain V, 2002, INT J ONCOL, V20, P845; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang Q, 2000, ONCOGENE, V19, P6152, DOI 10.1038/sj.onc.1203974; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang Y, 2000, GENE DEV, V14, P927; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14484	10.1371/journal.pone.0014484	http://dx.doi.org/10.1371/journal.pone.0014484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217819	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000285838900013
J	Chuang-Smith, ON; Wells, CL; Henry-Stanley, MJ; Dunny, GM				Chuang-Smith, Olivia N.; Wells, Carol L.; Henry-Stanley, Michelle J.; Dunny, Gary M.			Acceleration of Enterococcus faecalis Biofilm Formation by Aggregation Substance Expression in an Ex Vivo Model of Cardiac Valve Colonization	PLOS ONE			English	Article							EXPERIMENTAL BACTERIAL-ENDOCARDITIS; HIGH-RESOLUTION VISUALIZATION; SCANNING-ELECTRON-MICROSCOPY; SEX-PHEROMONE; INFECTIVE ENDOCARDITIS; STREPTOCOCCUS-FAECALIS; GENETIC-DETERMINANTS; FUNCTIONAL DOMAINS; HUMAN NEUTROPHILS; TERMINAL DOMAIN	Infectious endocarditis involves formation of a microbial biofilm in vivo. Enterococcus faecalis Aggregation Substance (Asc10) protein enhances the severity of experimental endocarditis, where it has been implicated in formation of large vegetations and in microbial persistence during infection. In the current study, we developed an ex vivo porcine heart valve adherence model to study the initial interactions between Asc10(+) and Asc10(-) E. faecalis and valve tissue, and to examine formation of E. faecalis biofilms on a relevant tissue surface. Scanning electron microscopy of the infected valve tissue provided evidence for biofilm formation, including growing masses of bacterial cells and the increasing presence of exopolymeric matrix over time; accumulation of adherent biofilm populations on the cardiac valve surfaces during the first 2-4 h of incubation was over 10-fold higher than was observed on abiotic membranes incubated in the same culture medium. Asc10 expression accelerated biofilm formation via aggregation between E. faecalis cells; the results also suggested that in vivo adherence to host tissue and biofilm development by E. faecalis can proceed by Asc10-dependent or Asc10-independent pathways. Mutations in either of two Asc10 subdomains previously implicated in endocarditis virulence reduced levels of adherent bacterial populations in the ex vivo system. Interference with the molecular interactions involved in adherence and initiation of biofilm development in vivo with specific inhibitory compounds could lead to more effective treatment of infectious endocarditis.	[Chuang-Smith, Olivia N.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Wells, Carol L.; Henry-Stanley, Michelle J.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chuang-Smith, ON (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	dunny001@umn.edu			National Heart and Lung Institute [HL51987]; National Institute of Allergy and Infectious Disease [AI 58134]; National Institute of Dental and Craniofacial Research [T32DE07288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058134, R56AI058134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095553] Funding Source: NIH RePORTER	National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grants HL51987 (from the National Heart and Lung Institute), AI 58134 (National Institute of Allergy and Infectious Disease) and MinnCResT training fellowship T32DE07288 from the National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; BEHNKE O, 1970, J ULTRA MOL STRUCT R, V31, P424, DOI 10.1016/S0022-5320(70)90159-0; Chandler JR, 2005, P NATL ACAD SCI USA, V102, P15617, DOI 10.1073/pnas.0505545102; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; CREMIEUX AC, 1989, J INFECT DIS, V159, P938, DOI 10.1093/infdis/159.5.938; DUNNY G, 1982, J BACTERIOL, V151, P855, DOI 10.1128/JB.151.2.855-859.1982; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; DURACK DT, 1975, J PATHOL, V115, P81, DOI 10.1002/path.1711150204; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; KAYE D, 2004, INFECT DIS, P569; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; McCormick, 2000, Curr Infect Dis Rep, V2, P315, DOI 10.1007/s11908-000-0009-9; McCormick JK, 2002, J INFECT DIS, V185, P994, DOI 10.1086/339604; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; OLMSTED SB, 1993, J BACTERIOL, V175, P6229, DOI 10.1128/JB.175.19.6229-6237.1993; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rakita RM, 1999, INFECT IMMUN, V67, P6067, DOI 10.1128/IAI.67.11.6067-6075.1999; Rantz LA, 1943, ARCH INTERN MED, V71, P516, DOI 10.1001/archinte.1943.00210040075008; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Schlievert PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013194; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Vanek NN, 1999, FEMS IMMUNOL MED MIC, V26, P49, DOI 10.1016/S0928-8244(99)00120-0; Veltrop MHAM, 1999, INFECT IMMUN, V67, P6130, DOI 10.1128/IAI.67.11.6130-6138.1999; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; Waters CM, 2001, J BACTERIOL, V183, P5659, DOI 10.1128/JB.183.19.5659-5667.2001; WIRTH R, 1994, EUR J BIOCHEM, V222, P235, DOI 10.1111/j.1432-1033.1994.tb18862.x	32	73	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15798	10.1371/journal.pone.0015798	http://dx.doi.org/10.1371/journal.pone.0015798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209892	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600040
J	Du, J; Sun, CQ; Hu, ZZ; Yang, Y; Zhu, YC; Zheng, DT; Gu, L; Lu, XA				Du, Jun; Sun, Chongqi; Hu, Zhenzhen; Yang, Yu; Zhu, Yichao; Zheng, Datong; Gu, Luo; Lu, Xiang			Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ERK ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOSKELETAL REORGANIZATION; P21-ACTIVATED KINASES; BIOLOGICAL-ACTIVITIES; ENDOTHELIAL-CELLS; REGULATED KINASE; BONE METASTASES; STEM-CELLS	Background: Enhanced motility of cancer cells is a critical step in promoting tumor metastasis. Lysophosphatidic acid (LPA), representing the major mitogenic activity in serum, stimulates migration in various types of cancer cells. However, the underlying signaling mechanisms for LPA-induced motility of cancer cells remain to be elucidated. Methodology/Principal Findings: In this study, we found that LPA dose-dependently stimulated migration of MDA-MB-231 breast cancer cells, with 10 mu M being the most effective. LPA also increased ERK activity and the MEK inhibitor U0126 could block LPA-induced ERK activity and cell migration. In addition, LPA induced PAK1 activation while ERK activation and cell migration were inhibited by ectopic expression of an inactive mutant form of PAK1 in MDA-MB-231 cells. Furthermore, LPA increased PI3K activity, and the PI3K inhibitor LY294002 inhibited both LPA-induced PAK1/ERK activation and cell migration. Moreover, in the breast cancer cell, LPA treatment resulted in remarkable production of reactive oxygen species (ROS), while LPA-induced ROS generation, PI3K/PAK1/ERK activation and cell migration could be inhibited by N-acetyl-L-Cysteine, a scavenger of ROS. Conclusions/Significance: Taken together, this study identifies a PI3K/PAK1/ERK signaling pathway for LPA-stimulated breast cancer cell migration. These data also suggest that ROS generation plays an essential role in the activation of LPA-stimulated PI3K/PAK1/ERK signaling and breast cancer cell migration. These findings may provide a basis for designing future therapeutic strategy for blocking breast cancer metastasis.	[Du, Jun; Hu, Zhenzhen; Yang, Yu] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Sun, Chongqi] Nanjing Med Univ, Kangda Coll, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zheng, Datong; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China.	lgu@njmu.edu.cn; uxiang66@njmu.edu.cn			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (No 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to L.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cechin SR, 2005, NEUROCHEM RES, V30, P603, DOI 10.1007/s11064-005-2747-4; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Gadalla SM, 2009, BRIT J CANCER, V100, P817, DOI 10.1038/sj.bjc.6604906; Hess AR, 2003, CANCER RES, V63, P4757; Huang Q, 2005, CELL MOL LIFE SCI, V62, P1167, DOI 10.1007/s00018-005-5050-2; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Karagiosis SA, 2009, J CELL PHYSIOL, V219, P716, DOI 10.1002/jcp.21720; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lee MJ, 2008, J CELL BIOCHEM, V104, P499, DOI 10.1002/jcb.21641; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mehdi MZ, 2007, CELL BIOCHEM BIOPHYS, V47, P1; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; Schmitz U, 2002, BIOCHEM BIOPH RES CO, V291, P687, DOI 10.1006/bbrc.2002.6493; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Turbov JM, 2002, J SURG ONCOL, V79, P17, DOI 10.1002/jso.10033; Vadlamudi Ratna K, 2004, Cancer Treat Res, V119, P77; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang JR, 2009, EUR J CELL BIOL, V88, P103, DOI 10.1016/j.ejcb.2008.05.003; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r; Wu WS, 2006, MOL CANCER RES, V4, P747, DOI 10.1158/1541-7786.MCR-06-0096; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200; Zhang HS, 2006, FREE RADICAL BIO MED, V40, P1664, DOI 10.1016/j.freeradbiomed.2006.01.003; Zugasti O, 2001, MOL CELL BIOL, V21, P6706, DOI 10.1128/MCB.21.19.6706-6717.2001	58	78	83	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15940	10.1371/journal.pone.0015940	http://dx.doi.org/10.1371/journal.pone.0015940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209852	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600051
J	Keren, H; Donyo, M; Zeevi, D; Maayan, C; Pupko, T; Ast, G				Keren, Hadas; Donyo, Maya; Zeevi, David; Maayan, Channa; Pupko, Tal; Ast, Gil			Phosphatidylserine Increases IKBKAP Levels in Familial Dysautonomia Cells	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; ELONGATOR COMPLEX; MESSENGER-RNA; SPLICING DEFECT; LIFE-SPAN; EXPRESSION; KINETIN; GENE; IKAP; TOCOTRIENOLS	Familial Dysautonomia (FD) is an autosomal recessive congenital neuropathy that results from abnormal development and progressive degeneration of the sensory and autonomic nervous system. The mutation observed in almost all FD patients is a point mutation at position 6 of intron 20 of the IKBKAP gene; this gene encodes the IkB kinase complex-associated protein (IKAP). The mutation results in a tissue-specific splicing defect: Exon 20 is skipped, leading to reduced IKAP protein expression. Here we show that phosphatidylserine (PS), an FDA-approved food supplement, increased IKAP mRNA levels in cells derived from FD patients. Long-term treatment with PS led to a significant increase in IKAP protein levels in these cells. A conjugate of PS and an omega-3 fatty acid also increased IKAP mRNA levels. Furthermore, PS treatment released FD cells from cell cycle arrest and up-regulated a significant number of genes involved in cell cycle regulation. Our results suggest that PS has potential for use as a therapeutic agent for FD. Understanding its mechanism of action may reveal the mechanism underlying the FD disease.	[Keren, Hadas; Donyo, Maya; Ast, Gil] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Ramat Aviv, Israel; [Zeevi, David; Pupko, Tal] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Maayan, Channa] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Hebrew University of Jerusalem	Keren, H (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Ramat Aviv, Israel.	gilast@post.tau.ac.il	Pupko, Tal/HGF-1353-2022	Zeevi, David/0000-0002-6492-6078; Pupko, Tal/0000-0001-9463-2575	FD Hope; FD Foundation; Israel FD Foundation; Israel Science Foundation [ISF 61/09]	FD Hope; FD Foundation; Israel FD Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by FD Hope, FD Foundation, Israel FD Foundation, and Israel Science Foundation (ISF 61/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Anderson SL, 2005, BIOCHEM BIOPH RES CO, V336, P150, DOI 10.1016/j.bbrc.2005.08.054; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Axelrod FB, 2006, CLIN AUTON RES, V16, P90, DOI 10.1007/s10286-006-0326-7; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; CROOK T, 1998, TREATMENT AGE RELATE, P20; CROOK TH, 1991, NEUROLOGY, V41, P644, DOI 10.1212/WNL.41.5.644; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fares F, 2008, PRENATAL DIAG, V28, P236, DOI 10.1002/pd.1943; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Guillard J, 2007, BIOORG MED CHEM LETT, V17, P1934, DOI 10.1016/j.bmcl.2007.01.033; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jorissen BL, 2002, NUTR NEUROSCI, V5, P337, DOI 10.1080/1028415021000033802; Kidd P., 1996, ALTERN MED REV, V1, P70; Kingsley M, 2006, SPORTS MED, V36, P657, DOI 10.2165/00007256-200636080-00003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lehavi O, 2003, GENET TEST, V7, P139, DOI 10.1089/109065703322146830; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Moreno MD, 2003, CLIN THER, V25, P178; Nakamura H, 2001, FOOD CHEM TOXICOL, V39, P799, DOI 10.1016/S0278-6915(01)00025-4; NGUYEN L, TRENDS MOL MED, V16, P1; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Ohkubo T, 2010, J OLEO SCI, V59, P247, DOI 10.5650/jos.59.247; Pepeu G, 1996, PHARMACOL RES, V33, P73, DOI 10.1006/phrs.1996.0013; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Rattan SIS, 2002, J ANTI-AGING MED, V5, P113, DOI 10.1089/109454502317629336; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Sampalis Fotini, 2003, Altern Med Rev, V8, P171; Schreiber S, 2000, ISRAEL J PSYCHIAT, V37, P302; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; SHARMA SP, 1995, BIOCHEM BIOPH RES CO, V216, P1067, DOI 10.1006/bbrc.1995.2729; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Storim J, 2001, EXP CELL RES, V267, P233, DOI 10.1006/excr.2001.5250; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Vaisman N, 2008, AM J CLIN NUTR, V87, P1170, DOI 10.1093/ajcn/87.5.1170; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072	60	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15884	10.1371/journal.pone.0015884	http://dx.doi.org/10.1371/journal.pone.0015884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209961	gold, Green Published			2022-12-25	WOS:000285793200065
J	Lin, ZF; Wu, Z; Yin, XJ; Liu, YL; Yan, XX; Lin, SQ; Xiao, JA; Wang, XJ; Feng, WK; Li, XK				Lin, Zhuofeng; Wu, Zhen; Yin, Xiaojing; Liu, Yanlong; Yan, Xinxin; Lin, Shaoqiang; Xiao, Jian; Wang, Xiaojie; Feng, Wenke; Li, Xiaokun			Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile	PLOS ONE			English	Article							GROWTH-FACTOR 21; RESISTANCE SYNDROME PREDICTS; INSULIN SENSITIVITY; CHINESE SUBJECTS; PPAR-ALPHA; FIBROBLAST; OBESITY; MICE; FIBROBLAST-GROWTH-FACTOR-21; CHOLESTEROL	Background: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and lipid metabolism in animal models. The relationship between plasma levels of FGF-21 and coronary heart disease (CHD) in unknown. Methodology/Principal Findings: This study aimed to investigate the correlation of serum FGF-21 levels and lipid metabolism in the patients with coronary heart disease. We performed a logistic regression analysis of the relation between serum levels of FGF-21 and CHD patients with and without diabetes and hypertension. This study was conducted in the Departments of Endocrinology and Cardiovascular Diseases at two University Hospitals. Participants consisted of one hundred and thirty-five patients who have been diagnosed to have CHD and sixty-one control subjects. Serum FGF-21 level and levels of fasting blood glucose; triglyceride; apolipoprotein B100; HOMA-IR; insulin; total cholesterol; HDL-cholesterol; LDL-cholesterol; and C-reactive protein were measured. We found that median serum FGF-21 levels were significantly higher in CHD than that of control subjects (P<0.0001). Serum FGF-21 levels in CHD patients with diabetes, hypertension, or both were higher than that of patients without these comorbidities. Serum FGF-21 levels correlated positively with triglycerides, fasting blood glucose, apolipoprotein B100, insulin and HOMA-IR but negatively with HDL-C and apolipoprotein A1 after adjusting for BMI, diabetes and hypertension. Logistic regression analysis demonstrated that FGF-21 showed an independent association with triglyceride and apolipoprotein A1. Conclusions/Significance: High levels of FGF-21 are associated with adverse lipid profiles in CHD patients. The paradoxical increase of serum FGF-21 in CHD patients may indicate a compensatory response or resistance to FGF-21.	[Lin, Zhuofeng; Liu, Yanlong; Yan, Xinxin; Lin, Shaoqiang; Xiao, Jian; Feng, Wenke; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Wu, Zhen] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Xiaojing] Sun Yat Sen Univ, Dept Cardiovasc Dis, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yanlong; Feng, Wenke] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Wang, Xiaojie; Li, Xiaokun] Jilin Agr Univ, Bioreator Engn Res Ctr, Changchun, Peoples R China; [Lin, Zhuofeng; Li, Xiaokun] Jilin Univ, Key Lab Pathobiol, Minist Educ, Norman Bethune Coll Med, Changchun 130023, Peoples R China	Wenzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Louisville; Jilin Agricultural University; Jilin University	Lin, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China.	wenke.feng@louisville.edu; xiaokunli@163.net	Lin, Zhuofeng/K-2431-2013		Scientific Projects of Guangzhou; Science and Technology Project of Guangdong Province; Changjiang Scholars and Innovative Group Program, China [30971515]; Zhejiang Natural Science Foundation [R2090550, Y2100048]	Scientific Projects of Guangzhou; Science and Technology Project of Guangdong Province; Changjiang Scholars and Innovative Group Program, China; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported, in part, by grants from "Scientific Projects of Guangzhou" [Z. Lin], "Science and Technology Project of Guangdong Province" [Z. Wu], "Changjiang Scholars and Innovative Group Program [X. Li], China (30971515) and the Zhejiang Natural Science Foundation (R2090550, Y2100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; FU XB, 1995, CHINESE MED J-PEKING, V108, P209; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Fu Xiaobing, 1996, Wound Repair and Regeneration, V4, P297, DOI 10.1046/j.1524-475X.1996.40219.x; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kuusisto J, 2001, DIABETES CARE, V24, P1629, DOI 10.2337/diacare.24.9.1629; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2005, WORLD J GASTROENTERO, V11, P5492, DOI 10.3748/wjg.v11.i35.5492; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	30	142	152	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15534	10.1371/journal.pone.0015534	http://dx.doi.org/10.1371/journal.pone.0015534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206918	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200026
J	Mikalova, L; Strouhal, M; Cejkova, D; Zobanikova, M; Pospisilova, P; Norris, SJ; Sodergren, E; Weinstock, GM; Smajs, D				Mikalova, Lenka; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Pospisilova, Petra; Norris, Steven J.; Sodergren, Erica; Weinstock, George M.; Smajs, David			Genome Analysis of Treponema pallidum subsp. pallidum and subsp. pertenue Strains: Most of the Genetic Differences Are Localized in Six Regions	PLOS ONE			English	Article							REPEAT PROTEIN-K; ESCHERICHIA-COLI; MULTIPLE ALLELES; TPRK GENE; LATE YAWS; SYPHILIS; SEQUENCE; DNA; IDENTIFICATION; HYPOTHESIS	The genomes of eight treponemes including T. p. pallidum strains (Nichols, SS14, DAL-1 and Mexico A), T. p. pertenue strains (Samoa D, CDC-2 and Gauthier), and the Fribourg-Blanc isolate, were amplified in 133 overlapping amplicons, and the restriction patterns of these fragments were compared. The approximate sizes of the genomes investigated based on this whole genome fingerprinting (WGF) analysis ranged from 1139.3-1140.4 kb, with the estimated genome sequence identity of 99.57-99.98% in the homologous genome regions. Restriction target site analysis, detecting the presence of 1773 individual restriction sites found in the reference Nichols genome, revealed a high genome structure similarity of all strains. The unclassified simian Fribourg-Blanc isolate was more closely related to T. p. pertenue than to T. p. pallidum strains. Most of the genetic differences between T. p. pallidum and T. p. pertenue strains were accumulated in six genomic regions. These genome differences likely contribute to the observed differences in pathogenicity between T. p. pallidum and T. p. pertenue strains. These regions of sequence divergence could be used for the molecular detection and discrimination of syphilis and yaws strains.	[Mikalova, Lenka; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Pospisilova, Petra; Smajs, David] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Norris, Steven J.] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	Masaryk University Brno; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL)	Mikalova, L (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.	dsmajs@med.muni.cz	Mikalová, Lenka/AAM-1068-2020; Weinstock, George M/C-6314-2013; Pospisilova, Petra/L-8212-2018; Smajs, David/I-3479-2016; Cejkova, Darina/AAA-5820-2022; Norris, Steven James/K-6586-2019	Weinstock, George M/0000-0002-2997-4592; Cejkova, Darina/0000-0002-6989-6330; Norris, Steven James/0000-0002-2501-8034	U.S. Public Health Service [R01 DE12488, R01 DE13759, R01 AI49252, R03 AI69107]; Grant Agency of the Czech Republic [310/04/0021, 310/07/0321]; Ministry of Health of the Czech Republic [NR8967-4/2006]; Ministry of Education of the Czech Republic [VZ MSM0021622415]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069107, R01AI049252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488, R01DE013759] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the U.S. Public Health Service to G. M. W. (R01 DE12488 and R01 DE13759) and S.J.N. (R01 AI49252 and R03 AI69107), and by the grants of the Grant Agency of the Czech Republic (310/04/0021 and 310/07/0321), the grant of the Ministry of Health of the Czech Republic (NR8967-4/2006), and that of the Ministry of Education of the Czech Republic (VZ MSM0021622415) to D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; BAKER BJ, 1988, CURR ANTHROPOL, V29, P703, DOI 10.1086/203691; BASEMAN JB, 1974, INFECT IMMUN, V10, P1062, DOI 10.1128/IAI.10.5.1062-1067.1974; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Calendini F., 2005, PAUPUP V1 0 3 1 FREE; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; Citti C, 1997, INFECT IMMUN, V65, P1773, DOI 10.1128/IAI.65.5.1773-1785.1997; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; FRIBOURG-BLANC A., 1963, BULL SOC PATHOL EXOTIQUE, V56, P474; GASTINEL P, 1963, Ann Dermatol Syphiligr (Paris), V90, P155; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; HACKETT CJ, 1963, B WORLD HEALTH ORGAN, V29, P7; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; HOLLANDER D. H., 1954, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V38, P489; HOLLANDER DH, 1981, SEX TRANSM DIS, V8, P34; HUDSON EH, 1965, B WORLD HEALTH ORGAN, V32, P735; Julvez J, 1998, Med Trop (Mars), V58, P38; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levrero F, 2007, AM J PHYS ANTHROPOL, V132, P568, DOI 10.1002/ajpa.20560; LISKA SL, 1982, CURR MICROBIOL, V7, P41, DOI 10.1007/BF01570978; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; LIVINGSTONE FB, 1991, CURR ANTHROPOL, V32, P587, DOI 10.1086/204004; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; Medina R, 1963, 6364 WHOVDTRES; Morgan CA, 2003, INFECT IMMUN, V71, P5605, DOI 10.1128/IAI.71.10.5605-5612.2003; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; Morgan CA, 2002, INFECT IMMUN, V70, P6811, DOI 10.1128/IAI.70.12.6811-6816.2002; Nichols HJ, 1913, J AMER MED ASSOC, V60, P108, DOI 10.1001/jama.1913.04340020016005; NOORDHOEK GT, 1990, INFECT IMMUN, V58, P2011, DOI 10.1128/IAI.58.6.2011-2013.1990; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; SMITH JL, 1971, BRIT J VENER DIS, V47, P223; STAMM LV, 1983, INFECT IMMUN, V41, P709, DOI 10.1128/IAI.41.2.709-721.1983; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Turner TB, 1957, BIOL TREPONEMATOSES; WALKER EM, 1995, J BACTERIOL, V177, P1797, DOI 10.1128/jb.177.7.1797-1804.1995; Weinstock G.M., 2000, VIRULENCE MECH BACTE, V3rd, P251; WENDEL GD, 1991, OBSTET GYNECOL, V78, P890; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; WILSON J, 1973, NEW ZEAL MED J, V77, P384	57	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15713	10.1371/journal.pone.0015713	http://dx.doi.org/10.1371/journal.pone.0015713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209953	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200041
J	Drafahl, KA; McAndrew, CW; Meyer, AN; Haas, M; Donoghue, DJ				Drafahl, Kristine A.; McAndrew, Christopher W.; Meyer, April N.; Haas, Martin; Donoghue, Daniel J.			The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROSTATE-CANCER PROGRESSION; B-KINASE; EPIDERMAL-GROWTH; IKK-BETA; POTENTIAL TARGET; TUMOR-GROWTH; CELL-DEATH; ACTIVATION; PHOSPHORYLATION	Background: NF kappa B signaling is of paramount importance in the regulation of apoptosis, proliferation, and inflammatory responses during human development and homeostasis, as well as in many human cancers. Receptor Tyrosine Kinases (RTKs), including the Fibroblast Growth Factor Receptors (FGFRs) are also important in development and disease. However, a direct relationship between growth factor signaling pathways and NFkB activation has not been previously described, although FGFs have been known to antagonize TNF alpha-induced apoptosis. Methodology/Principal Findings: Here, we demonstrate an interaction between FGFR4 and IKKb (Inhibitor of NF kappa B Kinase beta subunit), an essential component in the NF kappa B pathway. This novel interaction was identified utilizing a yeast two-hybrid screen [1] and confirmed by coimmunoprecipitation and mass spectrometry analysis. We demonstrate tyrosine phosphorylation of IKKb in the presence of activated FGFR4, but not kinase-dead FGFR4. Following stimulation by TNF alpha (Tumor Necrosis Factor a) to activate NF kappa B pathways, FGFR4 activation results in significant inhibition of NF kappa B signaling as measured by decreased nuclear NF kappa B localization, by reduced NFkB transcriptional activation in electophoretic mobility shift assays, and by inhibition of IKK beta kinase activity towards the substrate GST-I kappa B alpha in in vitro assays. FGF19 stimulation of endogenous FGFR4 in TNF alpha-treated DU145 prostate cancer cells also leads to a decrease in IKKb activity, concomitant reduction in NF kappa B nuclear localization, and reduced apoptosis. Microarray analysis demonstrates that FGF19 + TNF alpha treatment of DU145 cells, in comparison with TNFa alone, favors proliferative genes while downregulating genes involved in apoptotic responses and NF kappa B signaling. Conclusions/Significance: These results identify a compelling link between FGFR4 signaling and the NF kappa B pathway, and reveal that FGFR4 activation leads to a negative effect on NF kappa B signaling including an inhibitory effect on proapoptotic signaling. We anticipate that this interaction between an RTK and a component of NF kappa B signaling will not be limited to FGFR4 alone.	[Drafahl, Kristine A.; McAndrew, Christopher W.; Meyer, April N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haas, Martin; Donoghue, Daniel J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Drafahl, KA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			National Institutes of Health (NIH) [5 R01 CA090900]; University of California Cancer Research Coordinating Committee; University of California Breast Cancer Research [14IB-0065]; Ruth L. Kirschstein Institutional National Research Service [5 T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA090900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); University of California Breast Cancer Research; Ruth L. Kirschstein Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) #5 R01 CA090900, the University of California Cancer Research Coordinating Committee, and the University of California Breast Cancer Research Program #14IB-0065 to DJD; a Ruth L. Kirschstein Institutional National Research Service Award #5 T32 CA009523 to KAD; the Achievement Rewards for College Scientists Foundation, and the UCSD Chancellor's Interdisciplinary Collaboratories Fellowship to CWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2007, J MOL BIOL, V366, P563, DOI 10.1016/j.jmb.2006.11.057; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Chandler LA, 1999, INT J CANCER, V81, P451, DOI 10.1002/(SICI)1097-0215(19990505)81:3<451::AID-IJC20>3.3.CO;2-8; Chaudhari BR, 2006, IMMUNOL RES, V35, P249, DOI 10.1385/IR:35:3:249; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Guo GZ, 2004, ONCOGENE, V23, P535, DOI 10.1038/sj.onc.1207149; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang J, 2006, J PHARMACOL SCI, V102, P305, DOI 10.1254/jphs.FPJ06004X; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; KORHONEN J, 1992, INT J DEV BIOL, V36, P323; Koumakpayi IH, 2010, BRIT J CANCER, V102, P1163, DOI 10.1038/sj.bjc.6605571; Kwak YT, 2000, J BIOL CHEM, V275, P14752, DOI 10.1074/jbc.M001039200; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Murphy T, 2010, J PATHOL, V220, P452, DOI 10.1002/path.2657; Nikolaidis NM, 2010, SHOCK, V33, P197, DOI 10.1097/SHK.0b013e3181ae8155; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; ROIDL A, 2009, FGFR4 Y367C MUTANT I; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Rokhlin OW, 2002, J BIOL CHEM, V277, P33213, DOI 10.1074/jbc.M204612200; Sahadevan K, 2007, J PATHOL, V213, P82, DOI 10.1002/path.2205; Sarkar FH, 2008, FRONT BIOSCI-LANDMRK, V13, P2950, DOI 10.2741/2900; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; STARK KL, 1991, DEVELOPMENT, V113, P641; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Taghiyev AF, 2005, CANCER BIOL THER, V4, P382; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Vandermoere F, 2005, ONCOGENE, V24, P5482, DOI 10.1038/sj.onc.1208713; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Woodworth CD, 2005, MOL CANCER THER, V4, P650, DOI 10.1158/1535-7163.MCT-04-0238; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	67	49	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14412	10.1371/journal.pone.0014412	http://dx.doi.org/10.1371/journal.pone.0014412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203561	Green Submitted, Green Published, gold			2022-12-25	WOS:000285578000015
J	Sopko, NA; Turturice, BA; Becker, ME; Brown, CR; Dong, F; Popovic, ZB; Penn, MS				Sopko, Nikolai A.; Turturice, Benjamin A.; Becker, Mitchell E.; Brown, Chase R.; Dong, Feng; Popovic, Zoran B.; Penn, Marc S.			Bone Marrow Support of the Heart in Pressure Overload Is Lost with Aging	PLOS ONE			English	Article							CARDIAC STEM-CELLS; PROGENITOR CELLS; ISCHEMIC CARDIOMYOPATHY; HYPERTROPHY; EXPRESSION; STRESS; MICE; ANGIOGENESIS; REGENERATION; ACTIVATION	Rationale: Exogenous stem cell delivery is under investigation to prevent and treat cardiac dysfunction. It is less studied as to the extent endogenous bone marrow derived stem cells contribute to cardiac homeostais in response to stress and the affects of aging on this stress response. Objective: To determine the role of bone marrow (BM) derived stem cells on cardiac homeostasis in response to pressure overload (PO) and how this response is altered by aging. Methods and Results: Young (8 weeks) and old (>40 weeks) C57/b6 mice underwent homo-and heterochronic BM transplantation prior to transverse aortic constriction (TAC). We found that older BM is associated with decreased cardiac function following TAC. This decreased function is associated with decrease in BM cell engraftment, increased myocyte apoptosis, decreased myocyte hypertrophy, increased myocardial fibrosis and decreased cardiac function. Additionally, there is a decrease in activation of resident cells within the heart in response to PO in old mice. Interestingly, these effects are not due to alterations in vascular density or inflammation in response to PO or differences in ex vivo stem cell migration between young and old mice. Conclusions: BM derived stem cells are activated in response to cardiac PO, and the recruitment of BM derived cells are involved in cardiac myocyte hypertrophy and maintenance of function in response to PO which is lost with aging.	[Sopko, Nikolai A.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Sopko, Nikolai A.; Turturice, Benjamin A.; Becker, Mitchell E.; Brown, Chase R.; Dong, Feng; Penn, Marc S.] Cleveland Clin, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44106 USA; [Sopko, Nikolai A.; Dong, Feng; Penn, Marc S.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Popovic, Zoran B.; Penn, Marc S.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sopko, NA (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	pennm@ccf.org	Sopko, Nikolai/AAL-2036-2020; Turturice, Benjamin/AAF-6819-2019	Sopko, Nikolai/0000-0003-4913-0570; Turturice, Benjamin/0000-0001-9382-4612; popovic, zoran/0000-0001-5692-2299	Skirball Foundation; American Heart Association; National Institutes of Health [T32 GM07250]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Skirball Foundation; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Skirball Foundation. NAS was a recipient of an American Heart Association Great Rivers Pre-Doctoral Fellowship and National Institutes of Health grant T32 GM07250. The funders had no role in study design, data collection, and analysis, decision to publish or preperation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bian J, 2007, CIRC RES, V100, P1626, DOI 10.1161/01.RES.0000269778.75877.68; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; Dimmeler S, 2004, J AM COLL CARDIOL, V44, P464, DOI 10.1016/j.jacc.2004.06.001; Dong F, 2010, CIRC RES, V106, P601, DOI 10.1161/CIRCRESAHA.109.208967; Faggiano Pompilio, 2006, Cardiovasc Ultrasound, V4, P27, DOI 10.1186/1476-7120-4-27; FAN M, EFFECT AGE EFFICACY; FAU KC, RECIPIENT AGE DETERM; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Haq S, 2001, CIRCULATION, V103, P670; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Higashiyama H, 2007, INT J EXP PATHOL, V88, P31, DOI 10.1111/j.1365-2613.2006.00514.x; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kimura TE, 2010, CIRC RES; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livi U, 1992, G Ital Cardiol, V22, P1405; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Moens AL, 2008, CIRCULATION, V117, P2626, DOI 10.1161/CIRCULATIONAHA.107.737031; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; MULLER P, 2007, CARDIOVASCULAR RES; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Peng Y, 2009, AM J PHYSIOL-HEART C, V297, pH811, DOI 10.1152/ajpheart.00385.2009; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	42	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15187	10.1371/journal.pone.0015187	http://dx.doi.org/10.1371/journal.pone.0015187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203577	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900018
J	Zrimi, J; Ling, AN; Arifin, EGR; Feverati, G; Lesieur, C				Zrimi, Jihad; Ling, Alicia Ng; Arifin, Ernawati Giri-Rachman; Feverati, Giovanni; Lesieur, Claire			Cholera Toxin B Subunits Assemble into Pentamers - Proposition of a Fly-Casting Mechanism	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; REASSEMBLY-COMPETENT; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; FOLDING FUNNELS; MOLECULAR-BASIS; IN-VITRO; BINDING	The cholera toxin B pentamer (CtxB(5)), which belongs to the AB(5) toxin family, is used as a model study for protein assembly. The effect of the pH on the reassembly of the toxin was investigated using immunochemical, electrophoretic and spectroscopic methods. Three pH-dependent steps were identified during the toxin reassembly: (i) acquisition of a fully assembly-competent fold by the CtxB monomer, (ii) association of CtxB monomer into oligomers, (iii) acquisition of the native fold by the CtxB pentamer. The results show that CtxB5 and the related heat labile enterotoxin LTB5 have distinct mechanisms of assembly despite sharing high sequence identity (84%) and almost identical atomic structures. The difference can be pinpointed to four histidines which are spread along the protein sequence and may act together. Thus, most of the toxin B amino acids appear negligible for the assembly, raising the possibility that assembly is driven by a small network of amino acids instead of involving all of them.	[Zrimi, Jihad; Feverati, Giovanni; Lesieur, Claire] Univ Savoie, LAPTH, CNRS, Annecy Le Vieux, France; [Ling, Alicia Ng; Lesieur, Claire] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Arifin, Ernawati Giri-Rachman] Sch Life Sci & Technol, ITB, Bandung, Indonesia; [Lesieur, Claire] Univ Grenoble 1, CNRS, CEA, IRTSV,LBBSI, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; National University of Singapore; Institute Technology of Bandung; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zrimi, J (corresponding author), Univ Savoie, LAPTH, CNRS, Annecy Le Vieux, France.	lesieur@lapp.in2p3.fr	Feverati, Giovanni/L-8248-2013	Giri-Rachman, Ernawati/0000-0002-1661-9073	CNRS (Centre National de Recherche Scientifique)	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	The CNRS (Centre National de Recherche Scientifique) has supported the work (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BHAKUNI V, 1991, BIOCHEMISTRY-US, V30, P5055, DOI 10.1021/bi00234a031; CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1618, DOI 10.1021/bi035499z; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1609, DOI 10.1021/bi0354987; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; DEWOLF M, 1985, BIOCHIM BIOPHYS ACTA, V832, P165, DOI 10.1016/0167-4838(85)90328-0; DEWOLF MJS, 1987, BIOCHEMISTRY-US, V26, P3799, DOI 10.1021/bi00387a010; FINKELSTEIN RA, 1974, J IMMUNOL, V113, P145; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRST TR, 1984, P NATL ACAD SCI-BIOL, V81, P7752, DOI 10.1073/pnas.81.24.7752; HIRST TR, 1995, BACTERIAL TOXINS VIR, P123; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KING J, 1973, J MOL BIOL, V75, P339, DOI 10.1016/0022-2836(73)90025-9; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722; Lesieur C, 2002, J BIOL CHEM, V277, P16697, DOI 10.1074/jbc.M110561200; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Luke K, 2006, J MOL BIOL, V363, P729, DOI 10.1016/j.jmb.2006.08.058; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Perham M, 2005, J AM CHEM SOC, V127, P16402, DOI 10.1021/ja055574o; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; RUDDOCK LW, 1995, J BIOL CHEM, V270, P29953; Ruddock LW, 1996, BIOCHEMISTRY-US, V35, P16069, DOI 10.1021/bi961865l; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SIXMA TK, 1992, NATURE, V355, P561, DOI 10.1038/355561a0; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zhuravlev PI, 2010, CURR OPIN STRUC BIOL, V20, P16, DOI 10.1016/j.sbi.2009.12.010	48	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15347	10.1371/journal.pone.0015347	http://dx.doi.org/10.1371/journal.pone.0015347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203571	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900029
J	Ban, J; Jug, G; Mestdagh, P; Schwentner, R; Kauer, M; Aryee, DNT; Schaefer, KL; Nakatani, F; Scotlandi, K; Reiter, M; Strunk, D; Speleman, F; Vandesompele, J; Kovar, H				Ban, J.; Jug, G.; Mestdagh, P.; Schwentner, R.; Kauer, M.; Aryee, D. N. T.; Schaefer, K-L; Nakatani, F.; Scotlandi, K.; Reiter, M.; Strunk, D.; Speleman, F.; Vandesompele, J.; Kovar, H.			Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma	ONCOGENE			English	Article						Ewing's sarcoma; microRNA; mir-145; EWS-FLI1	CELL-GROWTH; MIR-145; EWS-FLI1; EXPRESSION; P53; DIFFERENTIATION	EWS-FLI1 is a chromosome translocation-derived chimeric transcription factor that has a central and rate-limiting role in the pathogenesis of Ewing's sarcoma. Although the EWS-FLI1 transcriptomic signature has been extensively characterized on the mRNA level, information on its impact on non-coding RNA expression is lacking. We have performed a genome-wide analysis of microRNAs affected by RNAi-mediated silencing of EWS-FLI1 in Ewing's sarcoma cell lines, and differentially expressed between primary Ewing's sarcoma and mesenchymal progenitor cells. Here, we report on the identification of hsa-mir-145 as the top EWS-FLI1-repressed microRNA. Upon knockdown of EWS-FLI1, hsa-mir-145 expression dramatically increases in all Ewing's sarcoma cell lines tested. Vice versa, ectopic expression of the microRNA in Ewing's sarcoma cell lines strongly reduced EWS-FLI1 protein, whereas transfection of an anti-mir to hsa-mir-145 increased the EWS-FLI1 levels. Reporter gene assays revealed that this modulation of EWS-FLI1 protein was mediated by the microRNA targeting the FLI1 3'-untranslated region. Mutual regulations of EWS-FLI1 and hsa-mir-145 were mirrored by an inverse correlation between their expression levels in four of the Ewing's sarcoma cell lines tested. Consistent with the role of EWS-FLI1 in Ewing's sarcoma growth regulation, forced hsa-mir-145 expression halted Ewing's sarcoma cell line growth. These results identify feedback regulation between EWS-FLI1 and hsa-mir-145 as an important component of the EWS-FLI1-mediated Ewing's sarcomagenesis that may open a new avenue to future microRNA-mediated therapy of this devastating malignant disease. Oncogene (2011) 30, 2173-2180; doi:10.1038/onc.2010.581; published online 10 January 2011	[Ban, J.; Jug, G.; Schwentner, R.; Kauer, M.; Aryee, D. N. T.; Reiter, M.; Kovar, H.] St Anna Childrens Hosp, Childrens Canc Res Inst, St Anna Kinderkrebsforschung, A-1090 Vienna, Austria; [Mestdagh, P.; Speleman, F.; Vandesompele, J.] Univ Med Ctr, Ctr Med Genet, Ghent, Belgium; [Schaefer, K-L] Univ Dusseldorf, Inst Pathol, Fac Med, Dusseldorf, Germany; [Nakatani, F.; Scotlandi, K.] CRS Dev Biomol Therapies, Expt Oncol Lab, Ist Ortoped Rizzoli, Bologna, Italy; [Strunk, D.] Med Univ, Div Hematol, Graz, Austria	Saint Anna Children's Hospital; Ghent University; Heinrich Heine University Dusseldorf; IRCCS Istituto Ortopedico Rizzoli; Medical University of Graz	Kovar, H (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, St Anna Kinderkrebsforschung, Zimmermannpl 10, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at	Vandesompele, Jo/W-3411-2018; Strunk, Dirk/V-4598-2017; Scotlandi, Katia/J-9009-2016; speleman, frank/AAR-5184-2020	Vandesompele, Jo/0000-0001-6274-0184; Strunk, Dirk/0000-0003-1810-867X; Scotlandi, Katia/0000-0001-6114-9499; speleman, frank/0000-0002-6628-8559; Mestdagh, Pieter/0000-0001-7821-9684; Schwentner, Raphaela/0000-0001-6839-0322; Kovar, Heinrich/0000-0001-6873-9109	Austrian Research Fund FWF [P20665-B12]; European Commission [LSHC-CT-2006-037260]; Ghent University [BOF 01D31406]	Austrian Research Fund FWF(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Ghent University(Ghent University)	We thank Aykut Uren for help in the analysis of the PDGF/mir-145 axis and Stephan Baldus for supplying primary tumor tissue, and Karin Muhlbacher for technical assistance. This study was supported by grants from the Austrian Research Fund FWF (P20665-B12) and the European Commission (EET-pipeline, LSHC-CT-2006-037260). PM is supported by the Ghent University research fund (BOF 01D31406).	Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Kano M, 2010, INT J CANC; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; KOVAR H, 1993, ONCOGENE, V8, P2683; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; LESSNICK SL, 1995, ONCOGENE, V10, P423; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sartipy P, 2009, IDRUGS, V12, P492; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Torchia EC, 2003, CANCER RES, V63, P3464; Uren A, 2003, ONCOGENE, V22, P2334, DOI 10.1038/sj.onc.1206330; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106	38	69	73	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	18					2173	2180		10.1038/onc.2010.581	http://dx.doi.org/10.1038/onc.2010.581			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21217773	Green Accepted			2022-12-25	WOS:000290249600008
J	Meyer, RD; Husain, D; Rahimi, N				Meyer, R. D.; Husain, D.; Rahimi, N.			c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLC gamma 1	ONCOGENE			English	Article						VEGFR-2; PLC gammal; c-Cbl; angiogenesis; ubiquitination	ENDOTHELIAL-CELL PROLIFERATION; PHOSPHOLIPASE C-GAMMA-1; CHOROIDAL NEOVASCULARIZATION; NEGATIVE REGULATION; T-CELLS; MICE; VEGFR-2; PROTEINS; VASCULOGENESIS; RECEPTOR-2	Angiogenesis is regulated by highly coordinated function of various proteins with pro- and anti-angiogenic functions. Among the many cytoplasmic signaling proteins that are activated by VEGFR-2, activation of PLC gamma 1 is considered to have a pivotal role in angiogenic signaling. In previous study we have identified c-Cbl as a negative regulator of PLC gamma 1 in endothelial cells, the biochemical and biological significance of c-Cbl, however, in angiogenesis in vivo and molecular mechanisms involved were remained elusive. In this study, we report that genetic inactivation of c-Cbl in mice results in enhanced tumor angiogenesis and retinal neovascularization. Endothelial cells derived from c-Cbl null mice displayed elevated cell proliferation and tube formation in response to VEGF stimulation. Loss of c-Cbl also resulted in robust activation of PLC gamma 1 and increased intracellular calcium release. c-Cbl-dependent ubiquitination selectively inhibited tyrosine phosphorylation of PLC gamma 1 and mostly refrained from ubiquitin-mediated degradation. Hence, we propose c-Cbl as an angiogenic suppressor protein where upon activation it uniquely modulates PLC gamma 1 activation by ubiquitination and subsequently inhibits VEGF-driven angiogenesis. Oncogene (2011) 30, 2198-2206; doi:10.1038/onc.2010.597; published online 17 January 2011	[Meyer, R. D.; Rahimi, N.] Boston Univ, Dept Pathol, Boston, MA 02118 USA; [Husain, D.; Rahimi, N.] Boston Univ, Dept Ophthalmol, Boston, MA 02118 USA	Boston University; Boston University	Rahimi, N (corresponding author), Boston Univ, Dept Pathol, Med Campus,670 Albany St,Room 429, Boston, MA 02118 USA.	nrahimi@bu.edu		Husain, Deeba/0000-0002-8494-0950; Rahimi, Nader/0000-0002-6745-1725	National Institutes of Health (NIH/NEI); Department of Ophthalmology; BU; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Ophthalmology; BU(Bogazici University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants from the National Institutes of Health (NIH/NEI) to NR and Massachusetts Lions Foundation grant to Department of Ophthalmology, and also by BU CTSI grant (NR). The c-Cbl knockout mice were generously provided by Jeffrey Chiang (National Cancer Institute, Frederick, MD).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Funakoshi T, 2006, EXP EYE RES, V83, P1102, DOI 10.1016/j.exer.2006.05.016; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Graham LJ, 2003, ONCOGENE, V22, P2493, DOI 10.1038/sj.onc.1206318; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Meyer RD, 2004, ONCOGENE, V23, P5523, DOI 10.1038/sj.onc.1207712; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teckchandani AM, 2005, EXP CELL RES, V307, P247, DOI 10.1016/j.yexcr.2005.03.010; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	37	22	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	19					2198	2206		10.1038/onc.2010.597	http://dx.doi.org/10.1038/onc.2010.597			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242968	Green Accepted			2022-12-25	WOS:000290514600003
J	Haldar, S; Saini, A; Nanda, JS; Saini, S; Singh, J				Haldar, Swati; Saini, Ashok; Nanda, Jagpreet Singh; Saini, Sharanjot; Singh, Jagmohan			Role of Swi6/HP1 Self-association-mediated Recruitment of Clr4/Suv39 in Establishment and Maintenance of Heterochromatin in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-9 METHYLATION; HISTONE H3; SHADOW DOMAIN; HP1 PROTEINS; TRANSCRIPTION; COMPLEX; RNAI; METHYLTRANSFERASE; CHROMODOMAIN; DIMERIZATION	Swi6/HP1, an evolutionarily conserved protein, is critical for heterochromatin assembly in fission yeast and higher eukaryotes. In fission yeast, histone deacetylation by histone deacetylases is thought to be followed by H3-Lys-9 methylation by the histone methyltransferase Clr4/Suv39H1.H3-Lys-9-Me2 interacts with the chromodomain of Swi6/HP1. Swi6/HP1 is thought to act downstream of Clr4/Suv39, and further self-association of Swi6/HP1 is assumed to stabilize the heterochromatin structure. Here, we show that the self-association-defective mutant of Swi6 does not interact with Clr4. It not only fails to localize to heterochromatin loci but also interferes with heterochromatic localization of H3-Lys-9-Me2 (and thereby Clr4) and the endogenous Swi6 in a dominant negative manner. Thus, self-association of Swi6/HP1 helps in binding to and recruitment of Clr4 and thereby in establishment and maintenance of heterochromatin by a concerted rather than a sequential mechanism.	[Haldar, Swati; Saini, Ashok; Nanda, Jagpreet Singh; Saini, Sharanjot; Singh, Jagmohan] Inst Microbial Technol, Sector 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	jag@imtech.res.in	Haldar, Swati/AAH-5388-2021	saini, ashok/0000-0001-6530-4281; Haldar, Swati/0000-0002-1566-1907; Nanda, Jagpreet Singh/0000-0002-8096-7654	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by intramural support from the Council of Scientific and Industrial Research, New Delhi, India.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Arney KL, 2002, INT J DEV BIOL, V46, P317; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dubey RN, 2009, J BIOL CHEM, V284, P7165, DOI 10.1074/jbc.M806461200; EKWALL K, 1999, CHROMOSOME STRUCTURA, P38; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Klar AJS, 2007, ANNU REV GENET, V41, P213, DOI 10.1146/annurev.genet.39.073103.094316; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Norwood LE, 2006, J BIOL CHEM, V281, P18668, DOI 10.1074/jbc.M512454200; Pidoux AL, 2000, J CELL SCI, V113, P4177; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	34	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9308	9320		10.1074/jbc.M110.143198	http://dx.doi.org/10.1074/jbc.M110.143198			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224386	hybrid, Green Published			2022-12-25	WOS:000288247700061
J	Pisani, F; Mastrototaro, M; Rossi, A; Nicchia, GP; Tortorella, C; Ruggieri, M; Trojano, M; Frigeri, A; Svelto, M				Pisani, Francesco; Mastrototaro, Mauro; Rossi, Andrea; Nicchia, Grazia Paola; Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Frigeri, Antonio; Svelto, Maria			Identification of Two Major Conformational Aquaporin-4 Epitopes for Neuromyelitis Optica Autoantibody Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; ARRAY-FORMATION; PROTEIN; DISTINCTION; TRANSPORT; MECHANISM; ANTIBODY; LESIONS; MARKER	Neuromyelitis optica (NMO) is an autoimmune demyelinating disease characterized by the presence of anti-aquaporin-4 (AQP4) antibodies in the patient sera. We recently reported that these autoantibodies are able to bind AQP4 when organized in the supramolecular structure called the orthogonal array of particles (OAP). To map the antigenic determinants, we produced a series of AQP4 mutants based on multiple alignment sequence analysis between AQP4 and other OAP-forming AQPs. Mutations were introduced in the three extracellular loops (A, C, and E), and the binding capacity of NMO sera was tested on AQP4 mutants. Results indicate that one group of sera was able to recognize a limited portion of loop C containing the amino acid sequence (146)GVT(T/M)V-150. A second group of sera was characterized by a predominant role of loop A. Deletion of four AQP4-specific amino acids ((61)G(S/T)E(N/K)(64)) in loop A substantially affected the binding of this group of sera. However, the binding capacity was further reduced when amino acids in loop A were mutated together with those in loop E or when those in loop C were mutated in combination with loop E. Finally, a series of AQP0 mutants were produced in which the extracellular loops were progressively changed to make them identical to AQP4. Results showed that none of the mutants was able to reproduce in AQP0 the NMO-IgG epitopes, indicating that the extracellular loop sequence by itself was not sufficient to determine the rearrangement required to create the epitopes. Although our data highlight the complexity of the disease, this study identifies key immunodominant epitopes and provides direct evidence that the transition from AQP4 tetramers to AQP4-OAPs involves conformational changes of the extracellular loops.	[Pisani, Francesco; Mastrototaro, Mauro; Rossi, Andrea; Nicchia, Grazia Paola; Frigeri, Antonio; Svelto, Maria] Univ Bari, Dept Gen & Environm Physiol, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria] Univ Bari, Dept Neurol & Psychiat Sci, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Frigeri, A (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Ctr Excellence Comparat Genom, I-70126 Bari, Italy.	a.frigeri@biologia.uniba.it	PISANI, Francesco/AAC-1749-2019; Tortorella, Carla/J-2557-2012; frigeri, Antonio/AAC-6336-2022; Svelto, Maria/P-6186-2014	PISANI, Francesco/0000-0001-8511-117X; Tortorella, Carla/0000-0001-9037-7300; Frigeri, Antonio/0000-0002-5284-2934; Rossi, Andrea/0000-0001-5863-6448; Trojano, Maria/0000-0002-6329-8946; Svelto, Maria/0000-0002-5584-9541	Apulia Region [PS124]; Rete Nazionale di Proteomica [RBRN07BMCT_009]	Apulia Region; Rete Nazionale di Proteomica	This work was supported by the Apulia Region Grant Progetto Strategico APQ Ricerca PS124 (Neurobiotech) and Rete Nazionale di Proteomica Project RBRN07BMCT_009.	Correale J, 2004, NEUROLOGY, V63, P2363, DOI 10.1212/01.WNL.0000148481.80152.BF; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; FRIGERI A, 1995, J CELL SCI, V108, P2993; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Haase CG, 2001, NEUROSCI LETT, V307, P131, DOI 10.1016/S0304-3940(01)01949-8; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Lalive PH, 2006, NEUROLOGY, V67, P176, DOI 10.1212/01.wnl.0000223346.09426.34; LeCaherec F, 1996, J CELL SCI, V109, P1285; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Marnetto F, 2009, J NEUROIMMUNOL, V217, P74, DOI 10.1016/j.jneuroim.2009.10.002; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Saikali P, 2009, AUTOIMMUN REV, V9, P132, DOI 10.1016/j.autrev.2009.04.004; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tani T, 2009, J NEUROIMMUNOL, V211, P110, DOI 10.1016/j.jneuroim.2009.04.001	26	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9216	9224		10.1074/jbc.M110.123000	http://dx.doi.org/10.1074/jbc.M110.123000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212277	Green Published, hybrid			2022-12-25	WOS:000288247700052
J	Im, CH; Hwang, SM; Son, YS; Heo, JB; Bang, WY; Suwastika, IN; Shiina, T; Bahk, JD				Im, Chak Han; Hwang, Sung Min; Son, Young Sim; Heo, Jae Bok; Bang, Woo Young; Suwastika, I. Nengah; Shiina, Takashi; Bahk, Jeong Dong			Nuclear/Nucleolar GTPase 2 Proteins as a Subfamily of YlqF/YawG GTPases Function in Pre-60S Ribosomal Subunit Maturation of Mono- and Dicotyledonous Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS GTPASE; ESCHERICHIA-COLI; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; NUCLEOTIDE-BINDING; NUCLEAR EXPORT; PRE-RIBOSOMES; RNA; BIOGENESIS	The YlqF/YawG families are important GTPases involved in ribosome biogenesis, cell proliferation, or cell growth, however, no plant homologs have yet to be characterized. Here we isolated rice (Oryza sativa) and Arabidopsis nuclear/nucleolar GTPase 2 (OsNug2 and AtNug2, respectively) that belong to the YawG subfamily and characterized them for pre-60S ribosomal subunit maturation. They showed typical intrinsic YlqF/YawG family GTPase activities in bacteria and yeasts with k(cat) values 0.12 +/- 0.007 min(-1) (n = 6) and 0.087 +/- 0.002 min(-1) (n = 4), respectively, and addition of 60S ribosomal subunits stimulated their activities in vitro. In addition, OsNug2 rescued the lethality of the yeast nug2 null mutant through recovery of 25S pre-rRNA processing. By yeast two-hybrid screening five clones, including a putative one of 60S ribosomal proteins, OsL10a, were isolated. Subcellular localization and pulldown assays resulted in that the N-terminal region of OsNug2 is sufficient for nucleolar/nuclear targeting and association with OsL10a. OsNug2 is physically associated with pre-60S ribosomal complexes highly enriched in the 25S, 5.8S, and 5S rRNA, and its interaction was stimulated by exogenous GTP. Furthermore, the AtNug2 knockdown mutant constructed by the RNAi method showed defective growth on the medium containing cycloheximide. Expression pattern analysis revealed that the distribution of AtNug2 mainly in the meristematic region underlies its potential role in active plant growth. Finally, it is concluded that Nug2/Nog2p GTPase from mono-and didicoty-ledonous plants is linked to the pre-60S ribosome complex and actively processed 27S into 25S during the ribosomal large subunit maturation process, i.e. prior to export to the cytoplasm.	[Im, Chak Han; Hwang, Sung Min; Son, Young Sim; Heo, Jae Bok; Bang, Woo Young; Bahk, Jeong Dong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21, Jinju 660701, South Korea; [Suwastika, I. Nengah] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Shiina, Takashi] Kyoto Prefectural Univ, Grad Sch Human & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Gyeongsang National University; Kyoto University; Kyoto Prefectural University	Bahk, JD (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21, Jinju 660701, South Korea.	jdbahk@gnu.ac.kr	Suwastika, I Nengah/R-7439-2019	Suwastika, I Nengah/0000-0001-5648-3169	Ministry of Education and Science Technology of Korea; Gyeongsang National University of Korea, Jinju, Korea; Gyeongsang National University of Korea; Grants-in-Aid for Scientific Research [22370022] Funding Source: KAKEN	Ministry of Education and Science Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeongsang National University of Korea, Jinju, Korea; Gyeongsang National University of Korea; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the BK21 program of the Ministry of Education and Science Technology of Korea.; Graduate student supported by the BK21 program, Gyeongsang National University of Korea, Jinju, Korea.; Postdoctoral student supported by the BK21 program, Gyeongsang National University of Korea.	BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Daigle DM, 2002, BIOCHEMISTRY-US, V41, P11109, DOI 10.1021/bi020355q; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Dutca LM, 2005, MOL CELL, V20, P497, DOI 10.1016/j.molcel.2005.11.006; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Furukawa T, 1998, PLANT CELL PHYSIOL, V39, P43, DOI 10.1093/oxfordjournals.pcp.a029287; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Heo JB, 2005, PLANT CELL PHYSIOL, V46, P2005, DOI 10.1093/pcp/pci215; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Jain N, 2009, BIOCHEM BIOPH RES CO, V379, P201, DOI 10.1016/j.bbrc.2008.12.072; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; McIntosh KB, 2005, GENOME, V48, P443, DOI [10.1139/g05-007, 10.1139/G05-007]; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Muench SP, 2006, P NATL ACAD SCI USA, V103, P12359, DOI 10.1073/pnas.0602585103; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Pontvianne F, 2007, MOL BIOL CELL, V18, P369, DOI 10.1091/mbc.E06-08-0751; Popescu SC, 2004, PLANT J, V39, P29, DOI 10.1111/j.1365-313X.2004.02109.x; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sayed A, 1999, BIOCHEM BIOPH RES CO, V264, P51, DOI 10.1006/bbrc.1999.1471; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Seo HS, 1997, EUR J BIOCHEM, V249, P293, DOI 10.1111/j.1432-1033.1997.00293.x; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Wood AJ, 2000, J EXP BOT, V51, P1655, DOI 10.1093/jexbot/51.351.1655; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	55	17	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8620	8632		10.1074/jbc.M110.200816	http://dx.doi.org/10.1074/jbc.M110.200816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205822	hybrid, Green Published			2022-12-25	WOS:000288013300088
J	Arthur, JW; Reichardt, JKV				Arthur, Jonathan W.; Reichardt, Juergen K. V.			Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses	PLOS ONE			English	Article							TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; KETO REDUCTASE SUPERFAMILY; 3-DIMENSIONAL STRUCTURES; STRUCTURE VALIDATION; CRYSTAL-STRUCTURES; PROSTATE-CANCER; BINDING; IDENTIFICATION; PROTEINS; ANDROGEN	Enzymes encoded by the AKR1C1 and AKR1C2 genes are responsible for the metabolism of progesterone and 5 alpha-dihydrotestosterone (DHT), respectively. The effect of amino acid substitutions, resulting from single nucleotide polymorphisms (SNPs) in the AKR1C2 gene, on the enzyme kinetics of the AKR1C2 gene product were determined experimentally by Takashi et al. In this paper, we used homology modeling to predict and analyze the structure of AKR1C1 and AKR1C2 genetic variants. The experimental reduction in enzyme activity in the AKR1C2 variants F46Y and L172Q, as determined by Takahashi et al., is predicted to be due to increased instability in cofactor binding, caused by disruptions to the hydrogen bonds between NADP and AKR1C2, resulting from the insertion of polar residues into largely non-polar environments near the site of cofactor binding. Other AKR1C2 variants were shown to involve either conservative substitutions or changes taking place on the surface of the molecule and distant from the active site, confirming the experimental finding of Takahashi et al. that these variants do not result in any statistically significant reduction in enzyme activity. The AKR1C1 R258C variant is predicted to have no effect on enzyme activity for similar reasons. Thus, we provide further insight into the molecular mechanism of the enzyme kinetics of these proteins. Our data also highlight previously reported difficulties with online databases.	[Arthur, Jonathan W.] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Reichardt, Juergen K. V.] Univ Sydney, Sydney Med Sch, Plunkett Chair Mol Biol Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Arthur, JW (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia.	jonathan.arthur@sydney.edu.au	Arthur, Jonathan/A-5367-2009	Arthur, Jonathan/0000-0003-3615-7352; Reichardt, Juergen/0000-0001-6458-2773	National Cancer Institute [P01 CA108964]; NATIONAL CANCER INSTITUTE [P01CA108964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (www.cancer.gov) grant P01 CA108964 (project 1) to JKVR who is also a Medical Foundation Fellow at the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bauman DR, 2006, ENDOCRINOLOGY, V147, P5806, DOI 10.1210/en.2006-0627; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Couture JF, 2005, PROTEIN SCI, V14, P1485, DOI 10.1110/ps.051353205; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day INM, 2010, HUM MUTAT, V31, P2, DOI 10.1002/humu.21149; Faucher F, 2007, J MOL BIOL, V369, P525, DOI 10.1016/j.jmb.2007.03.058; Faucher F, 2006, J MOL BIOL, V364, P747, DOI 10.1016/j.jmb.2006.09.030; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Musumeci L, 2010, HUM MUTAT, V31, P67, DOI 10.1002/humu.21137; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Takahashi RH, 2009, J PHARMACOL EXP THER, V329, P1032, DOI 10.1124/jpet.109.150995; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; XU Q, 2011, NUCL ACIDS IN PRESS	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15604	10.1371/journal.pone.0015604	http://dx.doi.org/10.1371/journal.pone.0015604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217827	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000285838900023
J	Mason, E; Tronc, G; Nones, K; Matigian, N; Kim, J; Aronow, BJ; Wolfinger, RD; Wells, C; Gibson, G				Mason, Elizabeth; Tronc, Graham; Nones, Katia; Matigian, Nick; Kim, Jinhee; Aronow, Bruce J.; Wolfinger, Russell D.; Wells, Christine; Gibson, Greg			Maternal Influences on the Transmission of Leukocyte Gene Expression Profiles in Population Samples from Brisbane, Australia	PLOS ONE			English	Article							THRIFTY PHENOTYPE HYPOTHESIS; UMBILICAL-CORD BLOOD; DEVELOPMENTAL ORIGINS; ADULT DISEASE; LYMPHOCYTES; EPIGENETICS; RECEPTORS; HEALTH; LINK	Two gene expression profiling studies designed to identify maternal influences on development of the neonate immune system and to address the population structure of the leukocyte transcriptome were carried out in Brisbane, Australia. In the first study, a comparison of 19 leukocyte samples obtained from mothers in the last three weeks of pregnancy with 37 umbilical cord blood samples documented differential expression of 7,382 probes at a false discovery rate of 1%, representing approximately half of the expressed transcriptome. An even larger component of the variation involving 8,432 probes, notably enriched for Vitamin E and methotrexate-responsive genes, distinguished two sets of individuals, with perfect transmission of the two profile types between each of 16 mother-child pairs in the study. A minor profile of variation was found to distinguish the gene expression profiles of obese mothers and children of gestational diabetic mothers from those of children born to obese mothers. The second study was of adult leukocyte profiles from a cross-section of Red Cross blood donors sampled throughout Brisbane. The first two axes in this study are related to the third and fourth axes of variation in the first study and also reflect variation in the abundance of CD4 and CD8 transcripts. One of the profiles associated with the third axis is largely excluded from samples from the central portion of the city. Despite enrichment of insulin signaling and aspects of central metabolism among the differentially expressed genes, there was little correlation between leukocyte expression profiles and body mass index overall. Our data is consistent with the notion that maternal health and cytokine milieu directly impact gene expression in fetal tissues, but that there is likely to be a complex interplay between cultural, genetic, and other environmental factors in the programming of gene expression in leukocytes of newborn children.	[Mason, Elizabeth; Gibson, Greg] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Tronc, Graham] Wesley Med Ctr, Auchenflower, Australia; [Nones, Katia; Matigian, Nick; Wells, Christine] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Kim, Jinhee; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Computat Med Ctr, Cincinnati, OH USA; [Wolfinger, Russell D.] SAS Inst Inc, Cary, NC USA	University of Queensland; Wesley Hospital; Griffith University; University System of Georgia; Georgia Institute of Technology; Cincinnati Children's Hospital Medical Center; SAS Institute Inc	Mason, E (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	greg.gibson@biology.gatech.edu	Nones, Katia/AAX-6453-2021; Mason, Elizabeth A/C-6193-2012; Aronow, Bruce J/F-8438-2012; Mason, Elizabeth/AAH-6851-2020; Matigian, Nicholas/AAF-9390-2020; Matigian, Nicholas A/A-4935-2009; Mason, Elizabeth A/N-2345-2014; Wells, Christine A/A-5071-2010	Nones, Katia/0000-0003-1925-5196; Mason, Elizabeth A/0000-0002-8823-0024; Matigian, Nicholas/0000-0001-7735-9415; Matigian, Nicholas A/0000-0001-7735-9415; Wells, Christine A/0000-0003-3133-3628	University of Queensland, Australia; Australian Research Council (ARC) [DP0880204]	University of Queensland, Australia(University of Queensland); Australian Research Council (ARC)(Australian Research Council)	This study was funded by the University of Queensland, Australia, and salary support for GG and EM was provided by the Australian Research Council (ARC DP0880204). RW is an employee of SAS Institute Inc., and was involved in data analysis as a long-term collaborator with the senior author, GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANDRA RK, 1975, AM J DIS CHILD, V129, P450, DOI 10.1001/archpedi.1975.02120410038013; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Colao A, 2008, EUR J ENDOCRINOL, V159, P389, DOI 10.1530/EJE-08-0201; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; Durand EF, 2007, J COMMUN HEALTH NURS, V24, P167, DOI 10.1080/07370010701429579; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Joss-Moore LA, 2009, CURR OPIN PEDIATR, V21, P230, DOI 10.1097/MOP.0b013e328326773b; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012; Merkerova M, 2009, EUR J HAEMATOL, V83, P183, DOI 10.1111/j.1600-0609.2009.01281.x; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Montano M, 2006, GENES IMMUN, V7, P298, DOI 10.1038/sj.gene.6364297; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Thewissen M, 2008, CRIT REV IMMUNOL, V28, P363, DOI 10.1615/CritRevImmunol.v28.i5.10; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14479	10.1371/journal.pone.0014479	http://dx.doi.org/10.1371/journal.pone.0014479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217831	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000285838900008
J	Schwarz, RF; Fletcher, W; Forster, F; Merget, B; Wolf, M; Schultz, J; Markowetz, F				Schwarz, Roland F.; Fletcher, William; Foerster, Frank; Merget, Benjamin; Wolf, Matthias; Schultz, Joerg; Markowetz, Florian			Evolutionary Distances in the Twilight Zone-A Rational Kernel Approach	PLOS ONE			English	Article							MULTIPLE-SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD ALIGNMENT; PROFILE DISTANCES; DNA-SEQUENCES; PHYLOGENY; TREES; INFERENCE; RECONSTRUCTION; CHLOROPHYCEAE; CONSTRUCTION	Phylogenetic tree reconstruction is traditionally based on multiple sequence alignments (MSAs) and heavily depends on the validity of this information bottleneck. With increasing sequence divergence, the quality of MSAs decays quickly. Alignment-free methods, on the other hand, are based on abstract string comparisons and avoid potential alignment problems. However, in general they are not biologically motivated and ignore our knowledge about the evolution of sequences. Thus, it is still a major open question how to define an evolutionary distance metric between divergent sequences that makes use of indel information and known substitution models without the need for a multiple alignment. Here we propose a new evolutionary distance metric to close this gap. It uses finite-state transducers to create a biologically motivated similarity score which models substitutions and indels, and does not depend on a multiple sequence alignment. The sequence similarity score is defined in analogy to pairwise alignments and additionally has the positive semi-definite property. We describe its derivation and show in simulation studies and real-world examples that it is more accurate in reconstructing phylogenies than competing methods. The result is a new and accurate way of determining evolutionary distances in and beyond the twilight zone of sequence alignments that is suitable for large datasets.	[Schwarz, Roland F.; Markowetz, Florian] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England; [Fletcher, William] UCL, Dept Genet Evolut & Environm, London, England; [Fletcher, William] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Foerster, Frank; Merget, Benjamin; Wolf, Matthias; Schultz, Joerg] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; University of London; University College London; University of Wurzburg	Schwarz, RF (corresponding author), Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England.	rfs32@cam.ac.uk; florian.markowetz@cancer.org.uk	Förster, Frank/A-2181-2010; Markowetz, Florian/H-6883-2019; Wolf, Matthias/A-5580-2008	Förster, Frank/0000-0003-4166-5423; Markowetz, Florian/0000-0002-2784-5308; Wolf, Matthias/0000-0003-2004-1806; Schwarz, Roland/0000-0001-9155-4268	Cancer Research UK; Deutsche Forschungsgemeinschaft (DFG) [Mu-2831/1-1]; Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre; University of Cambridge; Hutchison Whampoa Limited	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Cambridge(University of Cambridge); Hutchison Whampoa Limited	This work was partially funded by Cancer Research UK. Further support was provided by the Deutsche Forschungsgemeinschaft (DFG) grant (Mu-2831/1-1). WF is financially supported by an Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Bemm F, 2009, FEBS LETT, V583, P3589, DOI 10.1016/j.febslet.2009.10.029; BISHOP MJ, 1986, J MOL BIOL, V190, P159, DOI 10.1016/0022-2836(86)90289-5; Buchheim MA, 2001, J PHYCOL, V37, P819, DOI 10.1046/j.1529-8817.2001.00162.x; Cortes C., 2004, J MACH LERN RES, V1, P1; DASKALAKIS C, 2010, ALIGNMENT FREE PHYLO; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOOLITTLE RF, 1987, URFS ORFS PRIMER ANA; DROSTE M, HDB WEIGHTED AUTOMAT, P1; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Goldman N, 1998, BIOESSAYS, V20, P287, DOI 10.1002/(SICI)1521-1878(199804)20:4<287::AID-BIES4>3.0.CO;2-N; Hein J, 2003, P NATL ACAD SCI USA, V100, P14960, DOI 10.1073/pnas.2036252100; HIGHAM NJ, 1988, LINEAR ALGEBRA APPL, V103, P103, DOI 10.1016/0024-3795(88)90223-6; Hohl M, 2006, EVOL BIOINFORM, V2, P359; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Keller A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-218; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mailund T, 2004, BIOINFORMATICS, V20, P1636, DOI 10.1093/bioinformatics/bth097; Mohri M., 2003, International Journal of Foundations of Computer Science, V14, P957, DOI 10.1142/S0129054103002114; Mohri M., 1996, Natural Language Engineering, V2, P61, DOI 10.1017/S135132499600126X; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Roch S, 2010, SCIENCE, V327, P1376, DOI 10.1126/science.1182300; Scholkopf B, 2001, LEARNING KERNELS SUP; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THORNE JL, 1992, J MOL EVOL, V34, P3, DOI 10.1007/BF00163848; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; WANG LS, 2009, IMPACT MULTIPLE PROT; WATERMAN MS, 1977, J THEOR BIOL, V64, P199, DOI 10.1016/0022-5193(77)90351-4; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wolf M, 2002, PLANT SYST EVOL, V230, P161, DOI 10.1007/s006060200002; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15788	10.1371/journal.pone.0015788	http://dx.doi.org/10.1371/journal.pone.0015788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209825	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000285838900033
J	Tegethoff, M; Greene, N; Olsen, J; Meyer, AH; Meinlschmidt, G				Tegethoff, Marion; Greene, Naomi; Olsen, Jorn; Meyer, Andrea H.; Meinlschmidt, Gunther			Maternal Psychosocial Stress during Pregnancy and Placenta Weight: Evidence from a National Cohort Study	PLOS ONE			English	Article							PLASMA PROTEIN-A; BIRTH-WEIGHT; HUMAN FIBROBLASTS; PRENATAL STRESS; NEWBORN-INFANT; GROWTH-HORMONE; FETAL-GROWTH; FOLLOW-UP; IN-UTERO; LIFE	Background: To study in a large-scale cohort with prospective data the associations between psychosocial stress during pregnancy and placenta weight at birth. Animal data suggest that the placenta is involved in stress-related fetal programming. Methodology/Principal Findings: We defined a priori two types of psychosocial stress during pregnancy, life stress (perceived burdens in major areas of life) and emotional symptoms (e. g. anxiety). We estimated the associations of maternal stress during pregnancy with placenta weight at birth, controlled for length of gestation, by predicting gestational age-and sex-specific z-scores of placenta weight through multiple regression analysis, adjusted for potential confounders (N = 78017 singleton pregnancies). Life stress (per increase in stress score by 1, range: 0-18) during pregnancy was associated with increased placenta weight at birth (z-score, reported in 10(-3); B, 14.33; CI, 10.12-18.54). In contrast, emotional symptoms during pregnancy were not associated with placenta weight at birth. Conclusions/Significance: Maternal life stress but not emotional symptoms during pregnancy was associated with increased placenta weight at birth; yet, the association-estimate was rather small. Our results may contribute to a better understanding of the role of the placenta in the regulation of intrauterine processes in response to maternal stress.	[Tegethoff, Marion; Meyer, Andrea H.; Meinlschmidt, Gunther] Univ Basel, Dept Psychol, Div Clin Psychol & Psychotherapy, Basel, Switzerland; [Tegethoff, Marion] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Greene, Naomi; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Olsen, Jorn] Univ Aarhus, Inst Publ Hlth, Danish Epidemiol Sci Ctr, Dept Epidemiol, Aarhus, Denmark; [Meyer, Andrea H.] Univ Basel, Dept Psychol, Dept Appl Stat Life Sci, Basel, Switzerland; [Meinlschmidt, Gunther] Natl Ctr Competence Res Swiss Etiol Study Adjustm, Basel, Switzerland	University of Basel; Universitat Trier; University of California System; University of California Los Angeles; Aarhus University; University of Basel	Tegethoff, M (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Psychotherapy, Basel, Switzerland.	gunther.meinlschmidt@unibas.ch	Meinlschmidt, Gunther/AAD-3618-2019	Meinlschmidt, Gunther/0000-0002-3488-193X	Danish National Research Foundation; German National Academic Foundation; Swiss National Science Foundation (SNSF) [51A240-104890]	Danish National Research Foundation(Danmarks Grundforskningsfond); German National Academic Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this Foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. This project was financed by the German National Academic Foundation (to MT), and the Swiss National Science Foundation (SNSF), project no. 51A240-104890, (to GM). Validation of the stress scores was undertaken in part with data from the National Centre of Competence in Research 'Swiss Etiological Study of Adjustment and Mental Health (sesam)', funded by the Swiss National Science Foundation (SNSF), project no. 51A240-104890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Bland JM, 2002, BRIT MED J, V324, P606, DOI 10.1136/bmj.324.7337.606; Carter FA, 2005, AUST NZ J PSYCHIAT, V39, P255, DOI 10.1111/j.1440-1614.2005.01562.x; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Coall DA, 2008, PEDIAT DEV PATHOL, P1; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Coussons-Read ME, 2005, PSYCHOSOM MED, V67, P625, DOI 10.1097/01.psy.0000170331.74960.ad; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Fatayerji N, 1996, ALCOHOL CLIN EXP RES, V20, P94, DOI 10.1111/j.1530-0277.1996.tb01051.x; Figueras F, 2002, EUR J OBSTET GYN R B, V105, P25, DOI 10.1016/S0301-2115(02)00141-0; Fink P, 2004, J PSYCHOSOM RES, V56, P371, DOI 10.1016/S0022-3999(03)00071-0; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Fuglsang J, 2006, GROWTH HORM IGF RES, V16, P67, DOI 10.1016/j.ghir.2006.03.010; Glorio-Bottini F, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-38; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kramer MS, 2010, PAEDIATR PERINAT EP, V24, P390, DOI 10.1111/j.1365-3016.2010.01127.x; KRUGER H, 1970, AM J OBSTET GYNECOL, V106, P586; Kucuk M, 2009, J DIABETES COMPLICAT, V23, P25, DOI 10.1016/j.jdiacomp.2007.04.002; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lumey LH, 1998, PLACENTA, V19, P105; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; MILLS NC, 1986, MOL BIOL REP, V11, P231, DOI 10.1007/BF00419602; Mittal P, 2007, J MATERN-FETAL NEO M, V20, P651, DOI 10.1080/14767050701463571; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; NORBECK JS, 1984, RES NURS HEALTH, V7, P61, DOI 10.1002/nur.4770070110; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen J, 2008, EPIDEMIOLOGY, V19, P635, DOI 10.1097/EDE.0b013e3181773494; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Resch ZT, 2006, ENDOCRINOLOGY, V147, P885, DOI 10.1210/en.2005-0908; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Roberts CT, 2003, PLACENTA, V24, pS94, DOI 10.1053/plac.2002.0949; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; de Paula CFS, 2008, J ULTRAS MED, V27, P1583, DOI 10.7863/jum.2008.27.11.1583; Sondergaard C, 2003, ACTA PAEDIATR, V92, P811, DOI 10.1080/08035250310003857; Taricco E, 2003, PLACENTA, V24, P343, DOI 10.1053/plac.2002.0913; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; USUI T, 1988, MOL ENDOCRINOL, V2, P871, DOI 10.1210/mend-2-9-871; Wadhwa P D, 2001, Matern Child Health J, V5, P119, DOI 10.1023/A:1011353216619; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; WARREN WB, 1990, J PERINAT MED, V18, P39, DOI 10.1515/jpme.1990.18.1.39; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	61	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14478	10.1371/journal.pone.0014478	http://dx.doi.org/10.1371/journal.pone.0014478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217829	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000285838900007
J	Thao, S; Chen, CS; Zhu, H; Escalante-Semerena, JC				Thao, Sandy; Chen, Chien-Sheng; Zhu, Heng; Escalante-Semerena, Jorge C.			N-epsilon-Lysine Acetylation of a Bacterial Transcription Factor Inhibits Its DNA-Binding Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; ERWINIA-AMYLOVORA; CAPSULE SYNTHESIS; RCS PHOSPHORELAY; COA SYNTHETASE; COLANIC ACID; RECOMBINANT PROTEINS; EXPRESSION; REGULATOR; SYSTEM	Evidence suggesting that eukaryotes and archaea use reversible N-epsilon-lysine (N-epsilon-Lys) acetylation to modulate gene expression has been reported, but evidence for bacterial use of N-epsilon-Lys acetylation for this purpose is lacking. Here, we report data in support of the notion that bacteria can control gene expression by modulating the acetylation state of transcription factors (TFs). We screened the E. coli proteome for substrates of the bacterial Gcn5-like protein acetyltransferase (Pat). Pat acetylated four TFs, including the RcsB global regulatory protein, which controls cell division, and capsule and flagellum biosynthesis in many bacteria. Pat acetylated residue Lys180 of RcsB, and the NAD+-dependent Sir2 (sirtuin)-like protein deacetylase (CobB) deacetylated acetylated RcsB (RcsB(Ac)), demonstrating that N-epsilon-Lys acetylation of RcsB is reversible. Analysis of RcsB(Ac) and variant RcsB proteins carrying substitutions at Lys180 provided biochemical and physiological evidence implicating Lys180 as a critical residue for RcsB DNA-binding activity. These findings further the likelihood that reversible N-epsilon-Lys acetylation of transcription factors is a mode of regulation of gene expression used by all cells.	[Thao, Sandy; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Chen, Chien-Sheng; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Chen, Chien-Sheng; Zhu, Heng] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD USA; [Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University; National Central University	Thao, S (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	escalante@bact.wisc.edu	Chen, Chien-Sheng/ACO-7414-2022		USPHS [R01-GM62203, U54 RR 020839]; NRSA [F31-GM083668]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083668, R01GM062203] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	USPHS R01-GM62203 to JCE-S, USPHS U54 RR 020839 to HZ, NRSA Predoctoral Fellowship F31-GM083668 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BRILL JA, 1988, J BACTERIOL, V170, P2599, DOI 10.1128/jb.170.6.2599-2611.1988; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Davalos-Garcia M, 2001, J BACTERIOL, V183, P5870, DOI 10.1128/JB.183.20.5870-5876.2001; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Ebel W, 1997, J BACTERIOL, V179, P6858, DOI 10.1128/jb.179.21.6858-6861.1997; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gupte G, 1997, J BACTERIOL, V179, P4328, DOI 10.1128/jb.179.13.4328-4335.1997; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Huang YH, 2006, RES MICROBIOL, V157, P206, DOI 10.1016/j.resmic.2005.11.005; Joos T, 2009, FRONT BIOSCI-LANDMRK, V14, P4376, DOI 10.2741/3534; Kelley WL, 1997, MOL MICROBIOL, V25, P913, DOI 10.1111/j.1365-2958.1997.mmi527.x; Kelm O, 1997, MOL GEN GENET, V256, P72, DOI 10.1007/s004380050547; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Li R, 2010, MOL MICROBIOL, V76, P1162, DOI 10.1111/j.1365-2958.2010.07125.x; Liarzi O, 2010, MOL MICROBIOL, V76, P932, DOI 10.1111/j.1365-2958.2010.07148.x; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Miller JH., 1972, EXPT MOL GENETICS; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; TORRESCABASSA AS, 1987, J BACTERIOL, V169, P981, DOI 10.1128/jb.169.3.981-989.1987; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	53	114	120	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15123	10.1371/journal.pone.0015123	http://dx.doi.org/10.1371/journal.pone.0015123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217812	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900014
J	Choi, KJ; Grass, S; Paek, S; St Geme, JW; Yeo, HJ				Choi, Kyoung-Jae; Grass, Susan; Paek, Seonghee; St. Geme, Joseph W., III; Yeo, Hye-Jeong			The Actinobacillus pleuropneumoniae HMW1C-Like Glycosyltransferase Mediates N-Linked Glycosylation of the Haemophilus influenzae HMW1 Adhesin	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; MYCOBACTERIUM-TUBERCULOSIS; TETRATRICOPEPTIDE REPEATS; SUBSTRATE-SPECIFICITY; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; PROTEINS; GLUCOSYLTRANSFERASE; FAMILY; DOMAIN	The Haemophilus influenzae HMW1 adhesin is an important virulence exoprotein that is secreted via the two-partner secretion pathway and is glycosylated at multiple asparagine residues in consensus N-linked sequons. Unlike the heavily branched glycans found in eukaryotic N-linked glycoproteins, the modifying glycan structures in HMW1 are mono-hexoses or di-hexoses. Recent work demonstrated that the H. influenzae HMW1C protein is the glycosyltransferase responsible for transferring glucose and galactose to the acceptor sites of HMW1. An Actinobacillus pleuropneumoniae protein designated ApHMW1C shares high-level homology with HMW1C and has been assigned to the GT41 family, which otherwise contains only O-glycosyltransferases. In this study, we demonstrated that ApHMW1C has N-glycosyltransferase activity and is able to transfer glucose and galactose to known asparagine sites in HMW1. In addition, we found that ApHMW1C is able to complement a deficiency of HMW1C and mediate HMW1 glycosylation and adhesive activity in whole bacteria. Initial structure-function studies suggested that ApHMW1C consists of two domains, including a 15-kDa N-terminal domain and a 55-kDa C-terminal domain harboring glycosyltransferase activity. These findings suggest a new subfamily of HMW1C-like glycosyltransferases distinct from other GT41 family O-glycosyltransferases.	[Choi, Kyoung-Jae; Paek, Seonghee; Yeo, Hye-Jeong] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Grass, Susan; St. Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Grass, Susan; St. Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	University of Houston System; University of Houston; Duke University; Duke University	Choi, KJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	hyeo@uh.edu		Choi, Kyoungjae/0000-0001-9541-4182	National Institutes of Health (NIH) [RO1-AI068943, RO1-DC02873]; Welch Foundation [E-1616]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grant RO1-AI068943 and Grant E-1616 from the Welch Foundation to HJY and by NIH grant RO1-DC02873 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kirkpatrick AS, 2009, BIOCHEM BIOPH RES CO, V380, P407, DOI 10.1016/j.bbrc.2009.01.115; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Marceau M, 1999, J BACTERIOL, V181, P656, DOI 10.1128/JB.181.2.656-661.1999; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; St Geme JW, 1998, INFECT IMMUN, V66, P364; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Yokoyama T, 2008, J MOL BIOL, V384, P364, DOI 10.1016/j.jmb.2008.09.036; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	44	54	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15888	10.1371/journal.pone.0015888	http://dx.doi.org/10.1371/journal.pone.0015888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209858	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600049
J	Youngsteadt, E; Bustios, PG; Schal, C				Youngsteadt, Elsa; Guerra Bustios, Patricia; Schal, Coby			Divergent Chemical Cues Elicit Seed Collecting by Ants in an Obligate Multi-Species Mutualism in Lowland Amazonia	PLOS ONE			English	Article							ESSENTIAL OIL; DUFOUR GLAND; GARDENS; PHEROMONE; EPIPHYTES; HYMENOPTERA; ELAIOSOMES; SECRETIONS; DISPERSAL; BEHAVIOR	In lowland Amazonian rainforests, specific ants collect seeds of several plant species and cultivate them in arboreal carton nests, forming species-specific symbioses called ant-gardens (AGs). In this obligate mutualism, ants depend on the plants for nest stability and the plants depend on ant nests for substrate and nutrients. AG ants and plants are abundant, dominant members of lowland Amazonian ecosystems, but the cues ants use to recognize the seeds are poorly understood. To address the chemical basis of the ant-seed interaction, we surveyed seed chemistry in nine AG species and eight non-AG congeners. We detected seven phenolic and terpenoid volatiles common to seeds of all or most of the AG species, but a blend of the shared compounds was not attractive to the AG ant Camponotus femoratus. We also analyzed seeds of three AG species (Anthurium gracile, Codonanthe uleana, and Peperomia macrostachya) using behavior-guided fractionation. At least one chromatographic fraction of each seed extract elicited retrieval behavior in C. femoratus, but the active fractions of the three plant species differed in polarity and chemical composition, indicating that shared compounds alone did not explain seed-carrying behavior. We suggest that the various AG seed species must elicit seed-carrying with different chemical cues.	[Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Guerra Bustios, Patricia] Univ Nacl San Antonio Abad Cusco, Fac Ciencias Biol, Cuzco, Peru	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Universidad Nacional de San Antonio Abad del Cusco	Youngsteadt, E (corresponding author), Sigma Xi, Durham, NC USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Youngsteadt, Elsa/0000-0003-2032-9674	Amazon Conservation Association; National Science Foundation; United States Department of Education Graduate Assistance in Areas of National Need (GAANN); North Carolina State University; Blanton J. Whitmire Endowment	Amazon Conservation Association; National Science Foundation(National Science Foundation (NSF)); United States Department of Education Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); North Carolina State University; Blanton J. Whitmire Endowment	This work was funded by an Amazon Conservation Association graduate research fellowship, a National Science Foundation predoctoral fellowship, a United States Department of Education Graduate Assistance in Areas of National Need (GAANN) biotechnology fellowship, a North Carolina State University Internationalization Seed Grant, and the Blanton J. Whitmire Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie Andrew J., 2002, P211; Belin-Depoux M., 1987, Revue de Cytologie et de Biologie Vegetales le Botaniste, V10, P185; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; Bertsch A, 2004, Z NATURFORSCH C, V59, P701; BESTMANN HJ, 1995, NATURWISSENSCHAFTEN, V82, P334; Blum MS, 1987, COMP BIOCH PHYSL B; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bluthgen N, 2001, J TROP ECOL, V17, P887, DOI 10.1017/S0266467401001651; BOOS DD, 1995, STAT PROBABIL LETT, V23, P183, DOI 10.1016/0167-7152(94)00112-L; BREW CR, 1989, OECOLOGIA, V80, P490, DOI 10.1007/BF00380071; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; DAVIDSON DW, 1990, J CHEM ECOL, V16, P2993, DOI 10.1007/BF00979490; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Gammans N, 2005, OECOLOGIA, V146, P43, DOI 10.1007/s00442-005-0154-9; Greenberg L, 2007, J CHEM ECOL, V33, P935, DOI 10.1007/s10886-007-9269-2; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Howard RW, 2003, ARCH INSECT BIOCHEM, V54, P95, DOI 10.1002/arch.10104; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Javidnia K, 2007, J ESSENT OIL RES, V19, P430, DOI 10.1080/10412905.2007.9699944; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; Kaufmann E, 2002, SE ASIAN ANT GARDENS; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Kleinfeldt S.E., 1986, P283; Kohl E, 2000, NATURWISSENSCHAFTEN, V87, P320, DOI 10.1007/s001140050730; Limberger RP, 2003, FLAVOUR FRAG J, V18, P144, DOI 10.1002/ffj.1122; Longhurst C, 1980, J INSECT PHYSL, V26; Madison M., 1979, SELBYANA, V5, P107; Nieder J, 2000, BIOTROPICA, V32, P385, DOI 10.1111/j.1744-7429.2000.tb00485.x; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Orivel J, 1999, ECOSCIENCE, V6, P51, DOI 10.1080/11956860.1999.11952205; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Quintana A, 2003, J CHEM ECOL, V29, P639, DOI 10.1023/A:1022868603108; Raina VK, 2006, FLAVOUR FRAG J, V21, P140, DOI 10.1002/ffj.1547; *SAS I, 2002, SAS ONL DOC VERS 9 1; Schmit-Neuerburg Viviane, 2007, Ecotropica-Bonn, V13, P93; SEIDEL JL, 1990, J CHEM ECOL, V16, P1791, DOI 10.1007/BF01020495; Ule E, 1901, ENGLERS BOT JB, V68, P45; WILSON EO, 1987, BIOTROPICA, V19, P245, DOI 10.2307/2388342; Youngsteadt E, 2008, THESIS N CAROLINA ST; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; Youngsteadt E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004335; YU DW, 1994, BIOTROPICA, V26, P222, DOI 10.2307/2388813; Zrira S, 2008, J ESSENT OIL BEAR PL, V11, P30, DOI 10.1080/0972060X.2008.10643593	43	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15822	10.1371/journal.pone.0015822	http://dx.doi.org/10.1371/journal.pone.0015822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209898	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793600043
J	Bashiri, G; Rehan, AM; Greenwood, DR; Dickson, JMJ; Baker, EN				Bashiri, Ghader; Rehan, Aisyah M.; Greenwood, David R.; Dickson, James M. J.; Baker, Edward N.			Metabolic Engineering of Cofactor F-420 Production in Mycobacterium smegmatis	PLOS ONE			English	Article							SECONDARY ALCOHOL-DEHYDROGENASE; REDUCED COENZYME F-420; F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; PHOTOREACTIVATING ENZYME; ARCHAEOGLOBUS-FULGIDUS; CRYSTAL-STRUCTURES; PURIFICATION; TUBERCULOSIS; SYSTEM; EXPRESSION	Cofactor F-420 is a unique electron carrier in a number of microorganisms including Archaea and Mycobacteria. It has been shown that F-420 has a direct and important role in archaeal energy metabolism whereas the role of F-420 in mycobacterial metabolism has only begun to be uncovered in the last few years. It has been suggested that cofactor F-420 has a role in the pathogenesis of M. tuberculosis, the causative agent of tuberculosis. In the absence of a commercial source for F-420, M. smegmatis has previously been used to provide this cofactor for studies of the F-420-dependent proteins from mycobacterial species. Three proteins have been shown to be involved in the F420 biosynthesis in Mycobacteria and three other proteins have been demonstrated to be involved in F-420 metabolism. Here we report the over-expression of all of these proteins in M. smegmatis and testing of their importance for F-420 production. The results indicate that co-expression of the F-420 biosynthetic proteins can give rise to a much higher F-420 production level. This was achieved by designing and preparing a new T7 promoter-based co-expression shuttle vector. A combination of co-expression of the F-420 biosynthetic proteins and fine-tuning of the culture media has enabled us to achieve F-420 production levels of up to 10 times higher compared with the wild type M. smegmatis strain. The high levels of the F-420 produced in this study provide a suitable source of this cofactor for studies of F-420-dependent proteins from other microorganisms and for possible biotechnological applications.	[Bashiri, Ghader; Rehan, Aisyah M.; Dickson, James M. J.; Baker, Edward N.] Univ Auckland, Struct Biol Lab, Sch Biol Sci, Auckland 1, New Zealand; [Bashiri, Ghader; Rehan, Aisyah M.; Greenwood, David R.; Dickson, James M. J.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Sch Biol Sci, Auckland 1, New Zealand; [Greenwood, David R.] Univ Auckland, Ctr Genom & Prote, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Bashiri, G (corresponding author), Univ Auckland, Struct Biol Lab, Sch Biol Sci, Auckland 1, New Zealand.	g.bashiri@auckland.ac.nz	Rehan, Aisyah/A-9495-2011; Greenwood, David R/D-2375-2016; Rehan, Aisyah Mohamed/N-6806-2019; Bashiri, Ghader/R-4957-2017	Greenwood, David R/0000-0001-5280-042X; Rehan, Aisyah Mohamed/0000-0001-7841-1705; Bashiri, Ghader/0000-0002-5092-3749; Baker, Edward/0000-0003-2456-7661	New Zealand Lottery Grants Board (Health); Maurice & Phyllis Paykel Trust; Allan Wilson Centre for Molecular Ecology and Evolution; Health research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; Ministry of Higher Education, Malaysia; International Islamic University Malaysia	New Zealand Lottery Grants Board (Health); Maurice & Phyllis Paykel Trust; Allan Wilson Centre for Molecular Ecology and Evolution; Health research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); International Islamic University Malaysia	The authors would like to thank New Zealand Lottery Grants Board (Health), the Maurice & Phyllis Paykel Trust and the Allan Wilson Centre for Molecular Ecology and Evolution for funding to purchase the EnVision Multilabel plate reader. This research was supported by the Health research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand. A. M. R. is a recipient of a PhD scholarship from the IPTA Academic Training Scheme from The Ministry of Higher Education, Malaysia and International Islamic University Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Ceh K, 2009, BIOCHEMISTRY-US, V48, P10098, DOI 10.1021/bi901104d; Chang Y, 2009, PROTEIN SCI, V18, P2316, DOI 10.1002/pro.242; CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Cirillo JD, 1993, EFFICIENT ELECTROTRA; COATS JH, 1989, J ANTIBIOT, V42, P472, DOI 10.7164/antibiotics.42.472; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COUSINS FB, 1960, BIOCHIM BIOPHYS ACTA, V40, P532, DOI 10.1016/0006-3002(60)91396-2; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; DEPPENMEIER U, 1990, FEBS LETT, V261, P199, DOI 10.1016/0014-5793(90)80670-E; DEPPENMEIER U, 1990, P NATL ACAD SCI USA, V87, P9449, DOI 10.1073/pnas.87.23.9449; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ebert S, 1999, J BACTERIOL, V181, P2669, DOI 10.1128/JB.181.9.2669-2674.1999; EIRICH LD, 1978, BIOCHEMISTRY-US, V17, P4583, DOI 10.1021/bi00615a002; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; EKER APM, 1990, J BIOL CHEM, V265, P8009; FUCHS G, 1982, ZBL BAKT MIK HYG I C, V3, P277, DOI 10.1016/S0721-9571(82)80041-0; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graupner M, 2003, J BACTERIOL, V185, P4662, DOI 10.1128/JB.185.15.4662-4665.2003; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Harth G, 2004, MICROBIOL-SGM, V150, P2143, DOI 10.1099/mic.0.27113-0; HARTZELL PL, 1985, BIOCHEM BIOPH RES CO, V133, P884, DOI 10.1016/0006-291X(85)91218-5; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KIENER A, 1985, ARCH MICROBIOL, V143, P147, DOI 10.1007/BF00411038; KUNOW J, 1994, EUR J BIOCHEM, V223, P503, DOI 10.1111/j.1432-1033.1994.tb19019.x; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; MA K, 1990, EUR J BIOCHEM, V191, P187, DOI 10.1111/j.1432-1033.1990.tb19109.x; MCCORMICK JRD, 1982, J AM CHEM SOC, V104, P4014, DOI 10.1021/ja00378a044; Nocek B, 2007, J MOL BIOL, V372, P456, DOI 10.1016/j.jmb.2007.06.063; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; RHODES PM, 1981, J GEN MICROBIOL, V124, P329; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Seedorf H, 2004, ARCH MICROBIOL, V182, P126, DOI 10.1007/s00203-004-0675-3; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUTTON WB, 1964, BIOCHEM BIOPH RES CO, V15, P414, DOI 10.1016/0006-291X(64)90477-2; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZENG SF, 1975, J BACTERIOL, V121, P184, DOI 10.1128/JB.121.1.184-191.1975; TZENG SF, 1975, J BACTERIOL, V121, P192, DOI 10.1128/JB.121.1.192-196.1975; VERMEIJ P, 1994, EUR J BIOCHEM, V226, P185, DOI 10.1111/j.1432-1033.1994.tb20040.x; VERMEIJ P, 1995, EUR J BIOCHEM, V234, P592, DOI 10.1111/j.1432-1033.1995.592_b.x; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; WIDDEL F, 1989, ARCH MICROBIOL, V152, P322, DOI 10.1007/BF00425168; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	62	95	99	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15803	10.1371/journal.pone.0015803	http://dx.doi.org/10.1371/journal.pone.0015803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209917	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200057
J	Hong, SB; Oh, H; Valera, VA; Baba, M; Schmidt, LS; Linehan, WM				Hong, Seung-Beom; Oh, HyoungBin; Valera, Vladimir A.; Baba, Masaya; Schmidt, Laura S.; Linehan, W. Marston			Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization	PLOS ONE			English	Article							HOGG-DUBE-SYNDROME; RENAL-CELL CARCINOMA; MELANOMA PROTEIN-B; BHD GENE; THERAPEUTIC TARGET; MTOR ACTIVATION; BREAST-CANCER; AURISTATIN-E; MITF; MICROPHTHALMIA	Background: Germline mutations in a tumor suppressor gene FLCN lead to development of fibrofolliculomas, lung cysts and renal cell carcinoma (RCC) in Birt-Hogg-Dube syndrome. TFE3 is a member of the MiTF/TFE transcription factor family and Xp11.2 translocations found in sporadic RCC involving TFE3 result in gene fusions and overexpression of chimeric fusion proteins that retain the C-terminal DNA binding domain of TFE3. We found that GPNMB expression, which is regulated by MiTF, was greatly elevated in renal cancer cells harboring either TFE3 translocations or FLCN inactivation. Since TFE3 is implicated in RCC, we hypothesized that elevated GPNMB expression was due to increased TFE3 activity resulting from the inactivation of FLCN. Methodology/Principal Findings: TFE3 knockdown reduced GPNMB expression in renal cancer cells harboring either TFE3 translocations or FLCN inactivation. Moreover, FLCN knockdown induced GPNMB expression in FLCN-restored renal cancer cells. Conversely, wildtype FLCN suppressed GPNMB expression in FLCN-null cells. FLCN inactivation was correlated with increased TFE3 transcriptional activity accompanied by its nuclear localization as revealed by elevated GPNMB mRNA and protein expression, and predominantly nuclear immunostaining of TFE3 in renal cancer cells, mouse embryo fibroblast cells, mouse kidneys and mouse and human renal tumors. Nuclear localization of TFE3 was associated with TFE3 post-translational modifications including decreased phosphorylation. Conclusions/Significance: Increased TFE3 activity is a downstream event induced by FLCN inactivation and is likely to be important for renal tumor development. This study provides an important novel mechanism for induction of TFE3 activity in addition to TFE3 overexpression resulting from Xp11.2 translocations, suggesting that TFE3 may be more broadly involved in tumorigenesis.	[Hong, Seung-Beom; Oh, HyoungBin; Valera, Vladimir A.; Baba, Masaya; Schmidt, Laura S.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Schmidt, Laura S.] NCI, Basic Sci Program, SAIC Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hong, SB (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	linehanm@mail.nih.gov	Baba, Masaya/ABE-4893-2020; Baba, Masaya/L-7490-2013	Baba, Masaya/0000-0002-5308-6683; Hong, Seung-Beom/0000-0002-4928-2091	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NCI-Frederick; NATIONAL CANCER INSTITUTE [ZIABC011028, Z01BC011043, Z01BC011023, ZIABC011043, Z01BC011028] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-Frederick; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. This project has been funded with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Heath and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SAIC-Frederick is the Operation and Technical Support contractor to the National Cancer Institute at Frederick (NCI-Frederick), a federal laboratory. SAIC-Frederick, as the contractor, is the recipient of NCI-Frederick funding and has not independently funded this research.	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armah HB, 2010, ARCH PATHOL LAB MED, V134, P124, DOI 10.1043/2008-0391-RSR.1; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Mathur M, 2007, ONCOGENE, V26, P277, DOI 10.1038/sj.onc.1209783; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Schwarz T, 2010, BIOCHEM BIOPH RES CO, V394, P890, DOI 10.1016/j.bbrc.2010.03.034; Selim AA, 2009, MED SCI MONITOR, V15, pMT19; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Verastegui C, 2000, MOL ENDOCRINOL, V14, P449, DOI 10.1210/me.14.3.449; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010	43	100	104	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15793	10.1371/journal.pone.0015793	http://dx.doi.org/10.1371/journal.pone.0015793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209915	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200054
J	Lambert, TJ; Storm, DR; Sullivan, JM				Lambert, Talley J.; Storm, Daniel R.; Sullivan, Jane M.			MicroRNA132 Modulates Short-Term Synaptic Plasticity but Not Basal Release Probability in Hippocampal Neurons	PLOS ONE			English	Article							ASYNCHRONOUS RELEASE; TRANSMISSION; SYNAPSES; EXPRESSION; VESICLES; BRAIN; CALYX; MICE; POOL; CREB	MicroRNAs play important regulatory roles in a broad range of cellular processes including neuronal morphology and long-term synaptic plasticity. MicroRNA-132 (miR132) is a CREB-regulated miRNA that is induced by neuronal activity and neurotrophins, and plays a role in regulating neuronal morphology and cellular excitability. Little is known about the effects of miR132 expression on synaptic function. Here we show that overexpression of miR132 increases the paired-pulse ratio and decreases synaptic depression in cultured mouse hippocampal neurons without affecting the initial probability of neurotransmitter release, the calcium sensitivity of release, the amplitude of excitatory postsynaptic currents or the size of the readily releasable pool of synaptic vesicles. These findings are the first to demonstrate that microRNAs can regulate short-term plasticity in neurons.	[Lambert, Talley J.; Storm, Daniel R.; Sullivan, Jane M.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sullivan, Jane M.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lambert, TJ (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA.	jmsull@u.washington.edu	Lambert, Talley/B-4024-2015; Lambert, Talley/V-7602-2019	Lambert, Talley/0000-0002-2409-0181; Lambert, Talley/0000-0002-2409-0181	National Institutes of Health [MH073601, NS020498, PHS NRSA T32-GM07270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (www.nih.gov) grants MH073601 and NS020498 (Daniel R. Storm). Talley J. Lambert was supported in part by NIH grant PHS NRSA T32-GM07270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional funding that supported this study.	Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Scheuber A, 2004, J NEUROSCI, V24, P10402, DOI 10.1523/JNEUROSCI.1664-04.2004; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Smalheiser NR, 2009, NEUROMOL MED, V11, P133, DOI 10.1007/s12017-009-8065-2; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	24	64	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15182	10.1371/journal.pone.0015182	http://dx.doi.org/10.1371/journal.pone.0015182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206919	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200019
J	Mai, Y; Gao, GX				Mai, Yun; Gao, Guangxia			Expression of IMP1 Enhances Production of Murine Leukemia Virus Vector by Facilitating Viral Genomic RNA Packaging	PLOS ONE			English	Article							GROWTH-FACTOR-II; MESSENGER-RNA; RETROVIRAL VECTORS; BINDING PROTEINS; REVERSE-TRANSCRIPTASE; ENVELOPE PROTEIN; ACTINOMYCIN-D; GENE-THERAPY; IN-VITRO; CELLS	Murine leukemia virus (MLV)-based retroviral vector is widely used for gene transfer. Efficient packaging of the genomic RNA is critical for production of high-titer virus. Here, we report that expression of the insulin-like growth factor II mRNA binding protein 1 (IMP1) enhanced the production of infectious MLV vector. Overexpression of IMP1 increased the stability of viral genomic RNA in virus producer cells and packaging of the RNA into progeny virus in a dose-dependent manner. Downregulation of IMP1 in virus producer cells resulted in reduced production of the retroviral vector. These results indicate that IMP1 plays a role in regulating the packaging of MLV genomic RNA and can be used for improving production of retroviral vectors.	[Mai, Yun; Gao, Guangxia] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Mai, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	gaogx@moon.ibp.ac.cn			Ministry of Science and Technology of China [2006CB504302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (to G. G.) from Ministry of Science and Technology of China (973 Program 2006CB504302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Butsch M, 2002, J VIROL, V76, P3089, DOI 10.1128/jvi.76.7.3089-3094.2002; Carmo M, 2009, J GENE MED, V11, P670, DOI 10.1002/jgm.1353; Coroadinha AS, 2006, BIOTECHNOL BIOENG, V94, P24, DOI 10.1002/bit.20778; Dorman N, 2000, J VIROL, V74, P11413, DOI 10.1128/JVI.74.23.11413-11417.2000; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; DUESBERG PH, 1968, P NATL ACAD SCI USA, V59, P930, DOI 10.1073/pnas.59.3.930; Flynn JA, 2006, VIROLOGY, V344, P391, DOI 10.1016/j.virol.2005.09.002; Flynn JA, 2004, J VIROL, V78, P12129, DOI 10.1128/JVI.78.22.12129-12139.2004; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Gao GX, 1998, J VIROL, V72, P5905, DOI 10.1128/JVI.72.7.5905-5911.1998; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Higashikawa F, 2001, VIROLOGY, V280, P124, DOI 10.1006/viro.2000.0743; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; KOTANI H, 1994, HUM GENE THER, V5, P19, DOI 10.1089/hum.1994.5.1-19; Kuznetsov YG, 2004, VIROLOGY, V323, P189, DOI 10.1016/j.virol.2004.02.023; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Le Doux JM, 1999, BIOTECHNOL BIOENG, V63, P654, DOI 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lei P, 2005, BIOTECHNOL BIOENG, V90, P781, DOI 10.1002/bit.20468; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; LEVIN JG, 1974, J VIROL, V14, P152, DOI 10.1128/JVI.14.1.152-161.1974; LEVIN JG, 1976, P NATL ACAD SCI USA, V73, P1154, DOI 10.1073/pnas.73.4.1154; McTaggart S, 2001, BIOTECHNOL BIOENG, V76, P52, DOI 10.1002/bit.1025; MESSER LI, 1981, J VIROL, V40, P683, DOI 10.1128/JVI.40.3.683-690.1981; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ogert RA, 1996, J VIROL, V70, P3834, DOI 10.1128/JVI.70.6.3834-3843.1996; OLSEN JC, 1995, HUM GENE THER, V6, P1195, DOI 10.1089/hum.1995.6.9-1195; PAGES JC, 1995, GENE THER, V2, P547; PASKIND MP, 1975, VIROLOGY, V67, P242, DOI 10.1016/0042-6822(75)90421-3; Rodrigues T, 2008, J SEP SCI, V31, P3509, DOI 10.1002/jssc.200800195; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Shen BQCM, 1996, CYTOTECHNOLOGY, V22; SHIELDS A, 1978, CELL, V14, P601, DOI 10.1016/0092-8674(78)90245-3; Smith CM, 1997, VIROLOGY, V229, P437, DOI 10.1006/viro.1997.8454; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhou YD, 2008, J VIROL, V82, P5683, DOI 10.1128/JVI.00189-08	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15881	10.1371/journal.pone.0015881	http://dx.doi.org/10.1371/journal.pone.0015881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209918	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200062
J	Ramgolam, VS; DeGregorio, SD; Rao, GK; Collinge, M; Subaran, SS; Markovic-Plese, S; Pardi, R; Bender, JR				Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Markovic-Plese, Silva; Pardi, Ruggero; Bender, Jeffrey R.			T Cell LFA-1 Engagement Induces HuR-Dependent Cytokine mRNA Stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 Signaling Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; BINDING-PROTEIN; INTEGRIN LFA-1; ADHESION; RAC2; UROKINASE; PHOSPHORYLATION; INHIBITOR; STABILITY	Background: Engagement of the beta 2 integrin, lymphocyte function-associated antigen-1 (LFA-1), results in stabilization of T cell mRNA transcripts containing AU-rich elements (AREs) by inducing rapid nuclear-to-cytosolic translocation of the RNA-stabilizing protein, HuR. However, little is known regarding integrin-induced signaling cascades that affect mRNA catabolism. This study examines the role of the GTPases, Rac 1 and Rac 2, and their downstream effectors, in the LFA-1-induced effects on mRNA. Methodology/Principal Findings: Engagement of LFA-1 to its ligand, ICAM-1, in human peripheral T cells resulted in rapid activation of Rac1 and Rac2. siRNA-mediated knockdown of either Rac1 or Rac2 prevented LFA-1-stimulated stabilization of the labile transcripts encoding IFN-gamma and TNF-alpha, and integrin mediated IFN-gamma mRNA stabilization was absent in T cells obtained from Rac2 gene-deleted mice. LFA-1 engagement-induced translocation of HuR and stabilization of TNF-alpha mRNA was lost in Jurkat cells deficient in the Rac guanine nucleotide exchange factor Vav-1 (J.Vav1). The transfection of J.Vav1 cells with constitutively active Rac1 or Rac2 stabilized a labile beta-globin reporter mRNA, in a HuR-dependent manner. Furthermore, LFA-1-mediated mRNA stabilization and HuR translocation in mouse splenic T cells was dependent on the phosphorylation of the mitogen-activated protein kinase kinase, MKK3, and its target MAP kinase p38MAPK, and lost in T cells obtained from MKK3 gene-deleted mice. Conclusions/Significance: Collectively, these results demonstrate that LFA-1-induced stabilization of ARE-containing mRNAs in T cells is dependent on HuR, and occurs through the Vav-1, Rac1/2, MKK3 and p38MAPK signaling cascade. This pathway constitutes a molecular switch that enhances immune and pro-inflammatory gene expression in T cells undergoing adhesion at sites of activation and effector function.	[Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Raymond & Beverly Sackler Fdn, Cardiovasc Lab,Dept Med Cardiovasc Med, New Haven, CT 06520 USA; [Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Immunobiol, Vasc Biol & Therapeut Program, New Haven, CT USA; [Markovic-Plese, Silva] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Pardi, Ruggero] Univ Vita Salute, Sch Med, Dept Mol Pathol, San Raffaele Sci Inst, Milan, Italy	Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ramgolam, VS (corresponding author), Yale Univ, Sch Med, Raymond & Beverly Sackler Fdn, Cardiovasc Lab,Dept Med Cardiovasc Med, New Haven, CT 06520 USA.	jeffrey.bender@yale.edu			National Institutes of Health [HL43331]; Raymond and Beverly Sackler Foundation; Associazione Italiana per la Ricerca sul Cancro; Telethon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant HL43331 and a Raymond and Beverly Sackler Foundation Award (to J.R.B.) and by grants from Associazione Italiana per la Ricerca sul Cancro and Telethon (to R. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bianchi E, 1996, J CLIN INVEST, V98, P1133, DOI 10.1172/JCI118896; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PARDI R, 1989, J IMMUNOL, V143, P3157; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; REIBEL L, 1991, BIOCHEM BIOPH RES CO, V175, P451, DOI 10.1016/0006-291X(91)91585-Z; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Soede RDM, 1999, J IMMUNOL, V163, P4253; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wang GJ, 1998, P NATL ACAD SCI USA, V95, P6296, DOI 10.1073/pnas.95.11.6296; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; WELDER CA, 1993, J IMMUNOL, V150, P2203; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; YUI K, 1990, P NATL ACAD SCI USA, V87, P7135, DOI 10.1073/pnas.87.18.7135	40	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14450	10.1371/journal.pone.0014450	http://dx.doi.org/10.1371/journal.pone.0014450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206905	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200006
J	Sun, F; Cho, H; Jeong, DW; Li, CL; He, CA; Bae, T				Sun, Fei; Cho, Hoonsik; Jeong, Do-Won; Li, Chunling; He, Chuan; Bae, Taeok			Aureusimines in Staphylococcus aureus Are Not Involved in Virulence	PLOS ONE			English	Article							SAE LOCUS; IN-VITRO; SIGNAL-TRANSDUCTION; REGULATORY SYSTEM; GLOBAL REGULATOR; AGR DYSFUNCTION; EXPRESSION; GENE; MUTATION; SEQUENCE	Background: Recently, dipeptide aureusimines were reported to activate expression of staphylococcal virulence genes, such as alpha-hemolysin, and increase S. aureus virulence. Surprisingly, most of the virulence genes affected by aureusimines form part of the regulon of the SaeRS two component system (TCS), raising the possibility that SaeRS might be directly or indirectly involved in the aureusimine-dependent signaling process. Methodology/Principal Findings: Using HPLC analyses, we confirmed that a transposon mutant of ausA, the gene encoding the aureusimine dipeptide synthesis enzyme, does not produce dipeptides. However, the transposon mutant showed normal hemolysis activity and alpha-hemolysin/SaeP production. Furthermore, the P1 promoter of the sae operon, one of the targets of the SaeRS TCS, showed normal transcription activity. Moreover, in contrast to the original report, the ausA transposon mutant did not exhibit attenuated virulence in an animal infection model. DNA sequencing revealed that the ausA deletion mutant used in the original study has an 83 nt-duplication in saeS. Hemolysis activity of the original mutant was restored by a plasmid carrying the sae operon. A mutant of the sae operon showed elevated resistance to chloramphenicol and erythromycin, two antibiotics widely used during staphylococcal mutagenesis. At 43 degrees C in the presence of erythromycin and aeration, the conditions typically employed for staphylococcal mutagenesis, an saeR transposon mutant grew much faster than a control mutant and the saeR mutant was highly enriched in a mixed culture experiment. Conclusions/Significance: Our results show that the previously reported roles of aureusimines in staphylococcal gene regulation and virulence were due to an unintended mutation in saeS, which was likely selected due to elevated resistance of the mutant to environmental stresses. Thus, there is no evidence indicating that the dipeptide aureusimines play a role in sae-mediated virulence factor production or contribute to staphylococcal virulence.	[Sun, Fei; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Sun, Fei; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Cho, Hoonsik; Jeong, Do-Won; Li, Chunling; Bae, Taeok] Indiana Univ Sch Med NW, Dept Microbiol & Immunol, Gary, IN USA	University of Chicago; University of Chicago; Indiana University System; Indiana University Northwest	Sun, F (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu; tbae@iun.edu		Bae, Taeok/0000-0002-0576-2851; Jeong, Do-Won/0000-0001-6586-748X	American Heart Association [0835158N]; National Institute of Allergy and Infectious Diseases [AI077564, AI074658]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077564, R01AI074658] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by a Scientist Development Grant 0835158N from the American Heart Association (T. B.), AI077564 from the National Institute of Allergy and Infectious Diseases (T. B), AI074658 (C. H.), and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (C. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200; Chen J, 2007, MICROBIOL-SGM, V153, P1604, DOI 10.1099/mic.0.2007/006247-0; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Garvis S, 2002, MICROBIOL-SGM, V148, P3235, DOI 10.1099/00221287-148-10-3235; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; GIRAUDO AT, 1994, CAN J MICROBIOL, V40, P677, DOI 10.1139/m94-107; Giraudo AT, 2003, CURR MICROBIOL, V46, P246, DOI 10.1007/s00284-002-3853-z; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; JOHNSON M, 2010, INT J MED M IN PRESS; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Lovmar M, 2009, EMBO J, V28, P736, DOI 10.1038/emboj.2009.17; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Shopsin B, 2008, J INFECT DIS, V198, P1171, DOI 10.1086/592051; SMELTZER MS, 1993, INFECT IMMUN, V61, P919, DOI 10.1128/IAI.61.3.919-925.1993; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zeng YB, 2005, BIOORG MED CHEM LETT, V15, P3034, DOI 10.1016/j.bmcl.2005.04.031	40	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15703	10.1371/journal.pone.0015703	http://dx.doi.org/10.1371/journal.pone.0015703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209955	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200039
J	Pilon, G; Charbonneau, A; White, PJ; Dallaire, P; Perreault, M; Kapur, S; Marette, A				Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre			Endotoxin Mediated-iNOS Induction Causes Insulin Resistance via ONOO- Induced Tyrosine Nitration of IRS-1 in Skeletal Muscle	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; RECEPTOR SUBSTRATE-1; TARGETED DISRUPTION; OXIDATIVE STRESS; S-NITROSYLATION; CARBON-DIOXIDE; PROTEIN-KINASE; PEROXYNITRITE; MECHANISM	Background: It is believed that the endotoxin lipopolysaccharide (LPS) is implicated in the metabolic perturbations associated with both sepsis and obesity (metabolic endotoxemia). Here we examined the role of inducible nitric oxide synthase (iNOS) in skeletal muscle insulin resistance using LPS challenge in rats and mice as in vivo models of endotoxemia. Methodology/Principal Findings: Pharmacological (aminoguanidine) and genetic strategies (iNOS(-/-) mice) were used to counter iNOS induction in vivo. In vitro studies using peroxynitrite (ONOO 2) or inhibitors of the iNOS pathway, 1400 W and EGCG were conducted in L6 myocytes to determine the mechanism by which iNOS mediates LPS-dependent insulin resistance. In vivo, both pharmacological and genetic invalidation of iNOS prevented LPS-induced muscle insulin resistance. Inhibition of iNOS also prevented insulin resistance in myocytes exposed to cytokine/LPS while exposure of myocytes to ONOO 2 fully reproduced the inhibitory effect of cytokine/LPS on both insulin-stimulated glucose uptake and PI3K activity. Importantly, LPS treatment in vivo and iNOS induction and ONOO 2 treatment in vitro promoted tyrosine nitration of IRS-1 and reduced insulin-dependent tyrosine phosphorylation. Conclusions/Significance: Our work demonstrates that iNOS-mediated tyrosine nitration of IRS-1 is a key mechanism of skeletal muscle insulin resistance in endotoxemia, and presents nitrosative modification of insulin signaling proteins as a novel therapeutic target for combating muscle insulin resistance in inflammatory settings.	[Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre] Laval Hosp, Dept Med, Quebec Heart & Lung Inst, Ste Foy, PQ, Canada; [Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre] Laval Univ Hosp, Res Ctr, Ste Foy, PQ, Canada	Quebec Heart & Lung Institute; Laval University	Pilon, G (corresponding author), Laval Hosp, Dept Med, Quebec Heart & Lung Inst, Ste Foy, PQ, Canada.	andre.marette@criucpq.ulaval.ca	White, Phillip J/H-3048-2019; Marette, Andre/E-9342-2013	White, Phillip J/0000-0002-0957-425X; Marette, Andre/0000-0003-3950-5973	Canadian Institute of Health Research (CIHR); Canadian Diabetes Association; CIHR; Fonds de la Recherche en Sante du Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant (no. 151431 to A.M.) from the Canadian Institute of Health Research (CIHR) and by postdoctoral fellowships to A.C. from the Canadian Diabetes Association and the CIHR obesity training grant. P.J.W. is the recipient of a PhD studentship from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238; Frayn KN, 2008, DIABETOLOGIA, V51, P394, DOI 10.1007/s00125-007-0901-z; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Gorg B, 2007, FEBS LETT, V581, P84, DOI 10.1016/j.febslet.2006.11.081; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; HAUSCHILDT S, 1990, BIOCHEM J, V270, P351, DOI 10.1042/bj2700351; He CY, 2010, AM J PATHOL, V176, P2542, DOI 10.2353/ajpath.2010.090783; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kapur S, 1999, AM J PHYSIOL-ENDOC M, V276, pE635, DOI 10.1152/ajpendo.1999.276.4.E635; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; MARI A, 1992, AM J PHYSIOL, V263, pE400, DOI 10.1152/ajpendo.1992.263.2.E400; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Nomiyama T, 2004, BIOCHEM BIOPH RES CO, V320, P639, DOI 10.1016/j.bbrc.2004.06.019; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Pilon G, 2000, HORM METAB RES, V32, P480, DOI 10.1055/s-2007-978674; Roberts ES, 1998, CHEM RES TOXICOL, V11, P1067, DOI 10.1021/tx980099b; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Wahl SM, 2003, CELLS TISSUES ORGANS, V174, P26, DOI 10.1159/000070572; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	41	49	56	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15912	10.1371/journal.pone.0015912	http://dx.doi.org/10.1371/journal.pone.0015912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21206533	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500043
J	Kellermayer, R; Dowd, SE; Harris, RA; Balasa, A; Schaible, TD; Wolcott, RD; Tatevian, N; Szigeti, R; Li, ZJ; Versalovic, J; Smith, CW				Kellermayer, Richard; Dowd, Scot E.; Harris, R. Alan; Balasa, Alfred; Schaible, Tiffany D.; Wolcott, Randy D.; Tatevian, Nina; Szigeti, Reka; Li, Zhijie; Versalovic, James; Smith, C. Wayne			Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice	FASEB JOURNAL			English	Article						metagenomics; inflammatory bowel diseases; metabolic syndrome; epigenetics; Tlr2	INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; METABOLIC SYNDROME; GUT MICROBIOTA; GROWTH-FACTOR; TLR2; EXPRESSION; BACTERIA; COLITIS; COMMUNICATION	The connection between intestinal microbiota and host physiology is increasingly becoming recognized. The details of this dynamic interaction, however, remain to be explored. Toll-like receptor 2 (Tlr2) is important for its role in bacterial recognition, intestinal inflammation, and obesity-related metabolic changes. Therefore, we sought to determine the epigenomic and metagenomic consequences of Tlr2 deficiency in the colonic mucosa of mice to gain insights into biological pathways that shape the interface between the gut microbiota and the mammalian host. Colonic mucosa from wild type (WT) and Tlr2(-/-) C57BL/6 mice was interrogated by microarrays specific for DNA methylation and gene expression. The mucosal microbiome was studied by next-generation pyrosequencing of bacterial 16S rRNA. The expression of genes involved in immune processes was significantly modified by the absence of Tlr2, a number of which correlated with DNA methylation changes. The epigenomic and transcriptomic modifications associated with alteration in mucosal microbial composition. Several bacterial species, including members of the Firmicutes were significantly different in abundance between WT and Tlr2(-/-) animals. This manuscript highlights the intimate interrelationships between expression of immune-related genes and immunity pathways in the host with compositional and functional differences of the mammalian microbiome.-Kellermayer, R., Dowd, S. E., Harris, R. A., Balasa, A., Schaible, T. D., Wolcott, R. D., Tatevian, N., Szigeti, R., Li, Z., Versalovic, J., Smith, C. W. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 25, 1449-1460 (2011). www.fasebj.org	[Kellermayer, Richard] Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, Houston, TX 77030 USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Szigeti, Reka; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Dowd, Scot E.; Wolcott, Randy D.] Res & Testing Lab, Lubbock, TX USA; [Tatevian, Nina] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA; [Smith, C. Wayne] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor University; United States Department of Agriculture (USDA)	Kellermayer, R (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, 6621 Fannin St,CC1010-00, Houston, TX 77030 USA.	kellerma@bcm.edu	Harris, R. Alan/AAI-2784-2020; Dowd, Scot E/M-5386-2017	Harris, R. Alan/0000-0002-7333-4752; Dowd, Scot E/0000-0002-6296-1427	Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition [CCFA 2426]; Broad Medical Research Program; Broad Foundation [IBD-0252]; U.S. Department of Agriculture/Agriculture Research Service Child Health Research Center [6250-51000-055]; National Human Genome Research Initiative ENCODE [U54HG004592]; National Institute of Diabetes, Digestive, and Kidney Disease [R01 DK065075, UH3 DK083990, P30 DK56338]; National Center for Complementary and Alternative Medicine [R01 AT004326]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004326] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065075, P30DK056338, UH3DK083990] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition; Broad Medical Research Program; Broad Foundation; U.S. Department of Agriculture/Agriculture Research Service Child Health Research Center(United States Department of Agriculture (USDA)); National Human Genome Research Initiative ENCODE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes, Digestive, and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Stefi Lee for her outstanding technical support. R. K. was supported by a young investigator joint award from the Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA 2426), and the Broad Medical Research Program, the Broad Foundation (IBD-0252). C. W. S. was supported by a U.S. Department of Agriculture/Agriculture Research Service Child Health Research Center, Current Research Information System Project grant (6250-51000-055). DNaseI mapping data were funded through a National Human Genome Research Initiative ENCODE grant (U54HG004592) to John A. Stamatoyannopoulos (University of Washington, Seattle, WA, USA). J.V. was supported by the National Institute of Diabetes, Digestive, and Kidney Disease (R01 DK065075, UH3 DK083990, and P30 DK56338) and the National Center for Complementary and Alternative Medicine (R01 AT004326). The authors declare no conflicts of interest.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Andoh A, 2007, INFLAMM BOWEL DIS, V13, P955, DOI 10.1002/ibd.20151; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Balasa A, 2010, INT J COLORECTAL DIS, V25, P553, DOI 10.1007/s00384-010-0874-0; Barnett M, 2010, MUTAT RES-FUND MOL M, V690, P71, DOI 10.1016/j.mrfmmm.2010.02.006; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; CHESA PG, 1986, AM J SURG PATHOL, V10, P829, DOI 10.1097/00000478-198612000-00001; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Ey B, 2009, J BIOL CHEM, V284, P22332, DOI 10.1074/jbc.M901619200; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kim H, 2007, GASTROENTEROLOGY, V133, P875, DOI 10.1053/j.gastro.2007.06.063; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Lees Charlie W, 2009, Expert Rev Gastroenterol Hepatol, V3, P513, DOI 10.1586/egh.09.45; Loh G, 2008, ENVIRON MICROBIOL, V10, P709, DOI 10.1111/j.1462-2920.2007.01493.x; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McMahon LA, 2010, VET IMMUNOL IMMUNOP, V135, P158, DOI 10.1016/j.vetimm.2009.11.012; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Mowat AM, 2010, EUR J IMMUNOL, V40, P318, DOI 10.1002/eji.200940232; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Paclik D, 2008, J MOL MED, V86, P1395, DOI 10.1007/s00109-007-0290-2; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Sepulveda AR, 2010, GASTROENTEROLOGY, V138, P1836, DOI 10.1053/j.gastro.2009.12.042; Shiraga T, 2005, EXP CELL RES, V308, P41, DOI 10.1016/j.yexcr.2005.04.008; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Wolcott R D, 2009, J Wound Care, V18, P317; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yoshioka T, 2001, J INT MED RES, V29, P409, DOI 10.1177/147323000102900505; Zhang SS, 2009, EUR J GASTROEN HEPAT, V21, P1145, DOI 10.1097/MEG.0b013e32830edb29; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	65	100	102	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1449	1460		10.1096/fj.10-172205	http://dx.doi.org/10.1096/fj.10-172205			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21228220	Green Published			2022-12-25	WOS:000290023800004
J	Neumann, M; Klar, S; Wilisch-Neumann, A; Hollenbach, E; Kavuri, S; Leverkus, M; Kandolf, R; Brunner-Weinzierl, MC; Klingel, K				Neumann, M.; Klar, S.; Wilisch-Neumann, A.; Hollenbach, E.; Kavuri, S.; Leverkus, M.; Kandolf, R.; Brunner-Weinzierl, M. C.; Klingel, K.			Glycogen synthase kinase-3 beta is a crucial mediator of signal-induced RelB degradation	ONCOGENE			English	Article						RelB; NF-kappa B; GSK-3 beta; proteasomal degradation	NF-KAPPA-B; LIVER DEGENERATION; MICE LACKING; KINASE; PHOSPHORYLATION; GLYCOGEN-SYNTHASE-KINASE-3-BETA; TRANSCRIPTION; REQUIREMENT; INHIBITION; GSK-3-BETA	The immediate early transcription factor nuclear factor (I kappa Bs) kappa B (NF-kappa B) is crucially involved in the regulation of numerous physiological or pathophysiological processes such as inflammation and tumourigenesis. Therefore, the control of NF-kappa B activity, which is mainly regulated by signal-induced degradation of cytoplasmic inhibitors of NF-kappa B (I kappa Bs), is of high relevance. One known alternative pathway of NF-kappa B regulation is the stimulus-induced proteasomal degradation of RelB, a component of the NF-kappa B dimer. Here, we identified the serine/threonine protein kinase glycogen synthase kinase-3 beta (GSK-3 beta) as a critical signalling component leading to RelB degradation. In Jurkat leukaemic T cells as well as in primary human T cells, tetradecanoylphorbolacetate/ionomycinand CD3/CD28-induced RelB degradation were impaired by a GSK-3 beta-specific pharmacological inhibitor, an ectopically expressed dominant-negative GSK-3 beta mutant and by small-interfering RNA-mediated silencing of GSK-3 beta expression. Furthermore, a physical interaction between RelB and GSK-3 beta was shown by co-immunoprecipitation, which was already notable in unstimulated cells. Most importantly, as demonstrated by in vitro kinase assays, human RelB is inducibly phosphorylated by GSK-3 beta, indicating a direct substrate-enzyme relationship. The serine residue 552 is a target of GSK-3 beta-mediated phosphorylation in vitro and in vivo. We conclude that GSK-3 beta is a crucial regulator of RelB degradation, stressing the relevant linkage between the NF-kappa B system and GSK-3 beta. Oncogene (2011) 30, 2485-2492; doi:10.1038/onc.2010.580; published online 10 January 2011	[Neumann, M.; Kandolf, R.; Klingel, K.] Univ Tubingen, Univ Hosp, Inst Pathol, Dept Mol Pathol, D-72076 Tubingen, Germany; [Klar, S.] Robert Koch Inst, D-1000 Berlin, Germany; [Wilisch-Neumann, A.] Otto von Guericke Univ, Inst Neuropathol, Magdeburg, Germany; [Hollenbach, E.] Univ Leipzig, Univ Hosp, Intens Care Unit, Leipzig, Germany; [Kavuri, S.; Leverkus, M.] Univ Heidelberg, Med Fac Mannheim, Dept Dermatol Venereol & Allergol, Mol Dermatol Sect, Heidelberg, Germany; [Brunner-Weinzierl, M. C.] Otto von Guericke Univ, Dept Pediat, Magdeburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Robert Koch Institute; Otto von Guericke University; Leipzig University; Ruprecht Karls University Heidelberg; Otto von Guericke University	Neumann, M (corresponding author), Univ Tubingen, Univ Hosp, Inst Pathol, Dept Mol Pathol, Liebermeisterstr 8, D-72076 Tubingen, Germany.	manfred.neumann@med.uni-tuebingen.de	Brunner-Weinzierl, Monika/AAB-8813-2019	Brunner-Weinzierl, Monika/0000-0002-6838-3568; Klar, Stefanie/0000-0001-5852-5692	Deutsche Forschungsgemeinschaft [NE608/3-2, LE953/5-1]; DFG [SFB-TR19]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (NE608/3-2 to MN; LE953/5-1 to ML) and by DFG grant SFB-TR19 (to KK and RK). We thank Sandra Bundschuh, Beatrix Kramer and Konstantin Klein for their excellent technical assistance.	Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; DEGROOT RP, 1993, ONCOGENE, V8, P841; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Vincent T, 2008, ONCOGENE, V27, P5254, DOI 10.1038/onc.2008.152; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	28	18	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	21					2485	2492		10.1038/onc.2010.580	http://dx.doi.org/10.1038/onc.2010.580			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21217772				2022-12-25	WOS:000291008000010
J	Stocki, P; Wang, XN; Morris, NJ; Dickinson, AM				Stocki, Pawel; Wang, Xiao N.; Morris, Nicholas J.; Dickinson, Anne M.			HSP70 Natively and Specifically Associates with an N-terminal Dermcidin-derived Peptide That Contains an HLA-A*03 Antigenic Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SURVIVAL; CELLS; IDENTIFICATION; EXPRESSION; STRESS; APOPTOSIS; CONFERS	Tumor cells very often have elevated expression of HSP70, the anti-apoptotic properties of which contribute to overall tumor survival. Independent of its anti-apoptotic properties, HSP70 was also suggested to be involved in the antigen presentation process by chaperoning cytosolic peptides, thus protecting them from rapid degradation and securing the peptide pool for further processing. In this study, we identified a 33-amino acid N-terminal dermcidin (DCD)-derived peptide from the repertoire of in vivo HSP70-associated peptides isolated from a leukemic cell line, K562. The DCD peptide has been previously shown to be involved in tumorigenesis, to increase tumor survival rate, to improve tumor stress resistance, and to aid growth. We show that HSP70 is a specific binding partner for the DCD prosurvival peptide and define an ATP-dependent DCD-binding site (GNPCH). We also identify an HLA-A*03 antigenic epitope within the DCD peptide, which follows and partially overlaps the HSP70-binding site (CHEASAAQK). This study describes the interaction between HSP70 and the DCD-derived prosurvival peptide, an interaction that may direct the peptide toward antigen presentation and independently contribute to the prosurvival mechanism mediated by DCD.	[Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Morris, Nicholas J.] Newcastle Univ, Sch Biomed Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Dickinson, AM (corresponding author), Newcastle Univ, Inst Cellular Med, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.m.dickinson@ncl.ac.uk		Morris, Nicholas/0000-0002-8389-7508	Leukemia Research Fund [04070]; Tyneside Leukaemia Research Fund; European Commission [MRTN-CT-2004-512253]	Leukemia Research Fund; Tyneside Leukaemia Research Fund; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Grant 04070 from the Leukemia Research Fund, a grant from the Tyneside Leukaemia Research Fund, and Trans-Net Grant MRTN-CT-2004-512253 from the European Commission.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2002, EXP NEUROL, V177, P32, DOI 10.1006/exnr.2002.7979; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li ZH, 2005, CLIN CANCER RES, V11, P4460, DOI 10.1158/1078-0432.CCR-05-0250; Lowrie AG, 2006, BRIT J CANCER, V94, P1663, DOI 10.1038/sj.bjc.6603148; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Peng P, 1997, J IMMUNOL METHODS, V204, P13, DOI 10.1016/S0022-1759(97)00017-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sato K, 2001, BLOOD, V98, P1852, DOI 10.1182/blood.V98.6.1852; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Stewart GD, 2007, PROSTATE, V67, P1308, DOI 10.1002/pros.20618; Stocki P, 2010, CELL STRESS CHAPERON, V15, P729, DOI 10.1007/s12192-010-0184-z; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Todorov PT, 1996, CANCER RES, V56, P1256; Todorov PT, 1997, J BIOL CHEM, V272, P12279, DOI 10.1074/jbc.272.19.12279; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546	30	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.179630	http://dx.doi.org/10.1074/jbc.M110.179630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21216960	Green Published, hybrid			2022-12-25	WOS:000289077500091
J	Milagro, FI; Campion, J; Cordero, P; Goyenechea, E; Gomez-Uriz, AM; Abete, I; Zulet, MA; Martinez, JA				Milagro, Fermin I.; Campion, Javier; Cordero, Paul; Goyenechea, Estibaliz; Gomez-Uriz, Ana M.; Abete, Itziar; Zulet, Maria A.; Alfredo Martinez, J.			A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss	FASEB JOURNAL			English	Article						CD44; ATP10A; WT1; PBMC; microarray	HIGH-FAT DIET; GENE-EXPRESSION; ADIPOSE-TISSUE; RESTRICTION; INFLAMMATION; EPIGENETICS; MECHANISMS; OXIDATION; RESPONSES; PATHWAYS	Epigenetics could help to explain individual differences in weight loss after an energy-restriction intervention. Here, we identify novel potential epigenetic biomarkers of weight loss, comparing DNA methylation patterns of high and low responders to a hypocaloric diet. Twenty-five overweight or obese men participated in an 8-wk caloric restriction intervention. DNA was isolated from peripheral blood mononuclear cells and treated with bisulfite. The basal and endpoint epigenetic differences between high and low responders were analyzed by methylation microarray, which was also useful in comparing epigenetic changes due to the nutrition intervention. Subsequently, MALDI-TOF mass spectrometry was used to validate several relevant CpGs and the surrounding regions. DNA methylation levels in several CpGs located in the ATP10A and CD44 genes showed statistical baseline differences depending on the weight-loss outcome. At the treatment endpoint, DNA methylation levels of several CpGs on the WT1 promoter were statistically more methylated in the high than in the low responders. Finally, different CpG sites from WT1 and ATP10A were significantly modified as a result of the intervention. In summary, hypocaloric-diet-induced weight loss in humans could alter DNA methylation status of specific genes. Moreover, baseline DNA methylation patterns may be used as epigenetic markers that could help to predict weight loss.-Milagro, F. I., Campion, J., Cordero, P., Goyenechea, E., Gomez-Uriz, A. M., Abete, I., Zulet, M. A., Martinez, J. A. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 25, 1378-1389 (2011). www.fasebj.org	[Milagro, Fermin I.; Campion, Javier; Cordero, Paul; Gomez-Uriz, Ana M.; Abete, Itziar; Zulet, Maria A.; Alfredo Martinez, J.] Univ Navarra, Dept Nutr & Food Sci Physiol & Toxicol, Pamplona 31008, Spain; [Goyenechea, Estibaliz] Hosp Donostia, Dept Neurol, San Sebastian, Spain	University of Navarra; University Hospital Donostia	Martinez, JA (corresponding author), Univ Navarra, Dept Nutr & Food Sci Physiol & Toxicol, C Irunlarrea 1, Pamplona 31008, Spain.	jalfmtz@unav.es	Zulet, M. Angeles/H-1317-2017; Milagro, Fermin/F-2315-2015; Abete, Itziar/H-4827-2017; Martinez Hernandez, J Alfredo/K-8709-2014	Zulet, M. Angeles/0000-0002-3926-0892; Milagro, Fermin/0000-0002-3228-9916; ESTIBALIZ, GOYENECHEA/0000-0001-7990-5192; Campion, Javier/0000-0002-6522-8271; Abete, Itziar/0000-0002-6475-5387; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	Asociacion de Amigos de la Universidad de Navarra; Basque Department of Education, Universities, and Research; Linea Especial (University of Navarra) [LE/97]; Spanish Ministerio de Ciencia e Innovacion [SAF2010-16887]; Navarra Department of Health (RESMENA-S); Department of Education	Asociacion de Amigos de la Universidad de Navarra; Basque Department of Education, Universities, and Research; Linea Especial (University of Navarra); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Navarra Department of Health (RESMENA-S); Department of Education(US Department of Education)	The technical assistance of A. Lorente, V. Fernandez, and J. A. Ayala is gratefully acknowledged. P.C. and A.M.G.-U. have fellowships from the Asociacion de Amigos de la Universidad de Navarra. E.G. had a fellowship from the Basque Department of Education, Universities, and Research. The authors thank the Linea Especial (University of Navarra; LE/97), the Spanish Ministerio de Ciencia e Innovacion (SAF2010-16887), and the Navarra Department of Health (RESMENA-S) and Department of Education for financial support. The authors thank all the volunteers who participated in this study. The authors also thank Enrique Buso [Unidad Central de Investigacion de la Facultad de Medicina (UCIM), University of Valencia, Spain] for his expert support and feedback. The authors declare no conflicts of interest.	Abete I, 2008, J HUM NUTR DIET, V21, P591, DOI 10.1111/j.1365-277X.2008.00902.x; Abete I, 2009, J MED FOOD, V12, P100, DOI 10.1089/jmf.2007.0700; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Campion J, 2010, PROG MOL BIOL TRANSL, V94, P291, DOI 10.1016/S1877-1173(10)94011-8; Campion J, 2009, OBESITY, V17, P1293, DOI 10.1038/oby.2008.679; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Dhar M, 2002, OBES RES, V10, P695, DOI 10.1038/oby.2002.94; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; DuBose AJ, 2010, NEUROGENETICS, V11, P145, DOI 10.1007/s10048-009-0226-9; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Gallou-Kabani C, 2007, CLIN CHEM LAB MED, V45, P321, DOI 10.1515/CCLM.2007.081; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Konstantinidou V, 2010, FASEB J, V24, P2546, DOI 10.1096/fj.09-148452; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Lomba A, 2010, MOL GENET METAB, V101, P273, DOI 10.1016/j.ymgme.2010.07.017; MacLean PS, 2009, AM J PHYSIOL-REG I, V297, pR793, DOI 10.1152/ajpregu.00192.2009; Margulies KB, 2009, CLIN CHEM, V55, P1897, DOI 10.1373/clinchem.2009.131649; Marti A, 2010, WORLD REV NUTR DIET, V101, P21, DOI 10.1159/000314508; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Mutch DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001344; Ostergaard M, 2004, BRIT J HAEMATOL, V125, P590, DOI 10.1111/j.1365-2141.2004.04952.x; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Redinger Richard N, 2009, J Ky Med Assoc, V107, P211; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Satoh T, 2000, J GASTROEN HEPATOL, V15, P402, DOI 10.1046/j.1440-1746.2000.02164.x; Sigurdsson MI, 2009, EPIGENETICS-US, V4, P43, DOI 10.4161/epi.4.1.7603; Steege A, 2008, KIDNEY INT, V74, P458, DOI 10.1038/ki.2008.194; Thompson RF, 2010, EXP GERONTOL, V45, P255, DOI 10.1016/j.exger.2009.12.013; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tremblay A, 2005, INT J OBESITY, V29, P1295, DOI 10.1038/sj.ijo.0803019; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; Wang CF, 2010, AM J PHYSIOL-REG I, V298, pR1320, DOI 10.1152/ajpregu.00844.2009; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yang J, 2009, ANN NY ACAD SCI, V1177, P185, DOI 10.1111/j.1749-6632.2009.05027.x; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624	50	161	167	1	50	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1378	1389		10.1096/fj.10-170365	http://dx.doi.org/10.1096/fj.10-170365			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21209057				2022-12-25	WOS:000288982800027
J	Fumagalli, M; Daniele, S; Lecca, D; Lee, PR; Parravicini, C; Fields, RD; Rosa, P; Antonucci, F; Verderio, C; Trincavelli, ML; Bramanti, P; Martini, C; Abbracchio, MP				Fumagalli, Marta; Daniele, Simona; Lecca, Davide; Lee, Philip R.; Parravicini, Chiara; Fields, R. Douglas; Rosa, Patrizia; Antonucci, Flavia; Verderio, Claudia; Trincavelli, M. Letizia; Bramanti, Placido; Martini, Claudia; Abbracchio, Maria P.			Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-expressing Neural Precursor Cells during Oligodendrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2Y-LIKE RECEPTOR GPR17; ADENOSINE; MYELINATION; EXPRESSION; RAT; DESENSITIZATION; DERIVATIVES; ANTAGONISTS; ASTROCYTES; CULTURES	The developing and mature central nervous system contains neural precursor cells expressing the proteoglycan NG2. Some of these cells continuously differentiate to myelin-forming oligodendrocytes; knowledge of the destiny of NG2(+) precursors would benefit from the characterization of new key functional players. In this respect, the G protein-coupled membrane receptor GPR17 has recently emerged as a new timer of oligodendrogliogenesis. Here, we used purified oligodendrocyte precursor cells (OPCs) to fully define the immunophenotype of the GPR17-expressing cells during OPC differentiation, unveil its native signaling pathway, and assess the functional consequences of GPR17 activation by its putative endogenous ligands, uracil nucleotides and cysteinyl leukotrienes (cysLTs). GPR17 presence was restricted to very early differentiation stages and completely segregated from that of mature myelin. Specifically, GPR17 decorated two subsets of slowly proliferating NG2(+) OPCs: (i) morphologically immature cells expressing other early proteins like Olig2 and PDGF receptor-alpha, and (ii) ramified preoligodendrocytes already expressing more mature factors, like O4 and O1. Thus, GPR17 is a new marker of these transition stages. In OPCs, GPR17 activation by either uracil nucleotides or cysLTs resulted in potent inhibition of intracellular cAMP formation. This effect was counteracted by GPR17 antagonists and receptor silencing with siRNAs. Finally, uracil nucleotides promoted and GPR17 inhibition, by either antagonists or siRNAs, impaired the normal program of OPC differentiation. These data have implications for the in vivo behavior of NG2(+) OPCs and point to uracil nucleotides and cysLTs as main extrinsic local regulators of these cells under physiological conditions and during myelin repair.	[Fumagalli, Marta; Lecca, Davide; Parravicini, Chiara; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, I-20133 Milan, Italy; [Daniele, Simona; Trincavelli, M. Letizia; Martini, Claudia] Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, I-56126 Pisa, Italy; [Lee, Philip R.; Fields, R. Douglas] NIH, Nervous Syst Dev & Plast Sect, Bethesda, MD 20817 USA; [Rosa, Patrizia; Antonucci, Flavia; Verderio, Claudia] CNR, Dept Med Pharmacol, Inst Neurosci, I-20129 Milan, Italy; [Bramanti, Placido] Ctr Neurolesi Bonino Pulejo, I-98121 Messina, Italy	University of Milan; University of Pisa; National Institutes of Health (NIH) - USA; Consiglio Nazionale delle Ricerche (CNR); IRCCS Bonino Pulejo	Abbracchio, MP (corresponding author), Univ Milan, Dept Pharmacol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, Via Balzaretti 9, I-20133 Milan, Italy.	mariapia.abbracchio@unimi.it	Abbracchio, Maria Pia/B-9342-2014; Lecca, Davide/A-8850-2010; Messier, Claude/A-2322-2008; Bramanti, Placido/K-5117-2016; Daniele, Simona/AAB-8888-2019; Martini, Claudia/AAC-4089-2019; Verderio, Claudia/K-4415-2016; Fumagalli, Marta/AEP-4117-2022; Trincavelli, Maria Letizia/M-1921-2015	Abbracchio, Maria Pia/0000-0002-7833-3388; Lecca, Davide/0000-0002-3258-363X; Messier, Claude/0000-0002-4791-1763; Daniele, Simona/0000-0001-7391-3087; Martini, Claudia/0000-0001-9379-3027; Verderio, Claudia/0000-0001-7216-5873; Antonucci, Flavia/0000-0002-0198-4529; Rosa, Patrizia/0000-0002-2590-6955; Trincavelli, Maria Letizia/0000-0001-8124-977X; Fumagalli, Marta/0000-0002-0158-842X	NICHD, National Institutes of Health; Italian Ministero della Salute [RF-CNM-2007-662855]; PRIN-COFIN Project [2006059022, 2008XFMEA3]; FISM, Fondazione Italiana Sclerosi Multipla [COD. 2010/R/2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Italian Ministero della Salute(Ministry of Health, Italy); PRIN-COFIN Project; FISM, Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the NICHD, National Institutes of Health. This work was also supported by Italian Ministero della Salute RF-CNM-2007-662855 and PRIN-COFIN Project Prot. 2006059022 and 2008XFMEA3 and by FISM, Fondazione Italiana Sclerosi Multipla COD. 2010/R/2.	Andres-Barquin PJ, 1999, EXP CELL RES, V247, P347, DOI 10.1006/excr.1998.4360; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Cai Y, 2006, NEUROSCIENCE, V138, P133, DOI 10.1016/j.neuroscience.2005.11.041; Calleri E, 2010, J MED CHEM, V53, P3489, DOI 10.1021/jm901691y; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Colotta V, 2008, BIOORGAN MED CHEM, V16, P6086, DOI 10.1016/j.bmc.2008.04.039; Cosimelli B, 2008, J MED CHEM, V51, P1764, DOI 10.1021/jm701159t; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Temporini C, 2009, ANAL BIOCHEM, V384, P123, DOI 10.1016/j.ab.2008.09.010; Trincavelli ML, 2008, J CELL BIOCHEM, V104, P150, DOI 10.1002/jcb.21611; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216	29	135	143	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10593	10604		10.1074/jbc.M110.162867	http://dx.doi.org/10.1074/jbc.M110.162867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209081	hybrid, Green Published			2022-12-25	WOS:000288547000074
J	Huang, CJ; Chang, A				Huang, Chunjuan; Chang, Amy			pH-dependent Cargo Sorting from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; VACUOLAR H+-ATPASE; YEAST SACCHAROMYCES-CEREVISIAE; CELL-SURFACE STABILITY; V-ATPASE; SECRETORY PATHWAY; BINDING-PROTEIN; QUALITY-CONTROL; PROTON PUMPS; GGA PROTEINS	The vacuolar proton-translocating ATPase (V-ATPase) plays a major role in organelle acidification and works together with other ion transporters to maintain pH homeostasis in eukaryotic cells. We analyzed a requirement for V-ATPase activity in protein trafficking in the yeast secretory pathway. Deficiency of V-ATPase activity caused by subunit deletion or glucose deprivation results in missorting of newly synthesized plasma membrane proteins Pma1 and Can1 directly from the Golgi to the vacuole. Vacuolar mislocalization of Pma1 is dependent on Gga adaptors although no Pma1 ubiquitination was detected. Proper cell surface targeting of Pma1 was rescued in V-ATPase-deficient cells by increasing the pH of the medium, suggesting that missorting is the result of aberrant cytosolic pH. In addition to mislocalization of the plasma membrane proteins, Golgi membrane proteins Kex2 and Vrg4 are also missorted to the vacuole upon loss of V-ATPase activity. Because the missorted cargos have distinct trafficking routes, we suggest a pH dependence for multiple cargo sorting events at the Golgi.	[Huang, Chunjuan; Chang, Amy] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chang, A (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	amychang@umich.edu	Chang, Amy/AAS-5491-2020	Chang, Amy/0000-0003-3682-6456	National Institutes of Health [GM 58212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058212, R01GM058212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 58212.	Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ayscough KR, 2005, PROTOPLASMA, V226, P81, DOI 10.1007/s00709-005-0107-5; Babst M, 2004, NAT CELL BIOL, V6, P175, DOI 10.1038/ncb0304-175; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chang A, 2002, METHOD ENZYMOL, V351, P339; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; KLIONSKY DJ, 1992, J EXP BIOL, V172, P83; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MORANO KA, 1994, J CELL SCI, V107, P2813; Mullins C, 2001, MOL CELL BIOL, V21, P7981, DOI 10.1128/MCB.21.23.7981-7994.2001; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Perzov N, 2002, J EXP BIOL, V205, P1209; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rose M. D., 1990, METHODS YEAST GENETI, P198; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Sherman F., 1986, METHODS YEAST GENETI, P523; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Spelbrink RG, 1999, MOL BIOL CELL, V10, P4263, DOI 10.1091/mbc.10.12.4263; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; YAVER DS, 1993, J BIOL CHEM, V268, P10564; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643	66	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10058	10065		10.1074/jbc.M110.197889	http://dx.doi.org/10.1074/jbc.M110.197889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239492	Green Published, hybrid			2022-12-25	WOS:000288547000020
J	Sugiyama, R; Nishitsuji, H; Furukawa, A; Katahira, M; Habu, Y; Takeuchi, H; Ryo, A; Takaku, H				Sugiyama, Ryuichi; Nishitsuji, Hironori; Furukawa, Ayako; Katahira, Masato; Habu, Yuichiro; Takeuchi, Hiroaki; Ryo, Akihide; Takaku, Hiroshi			Heat Shock Protein 70 Inhibits HIV-1 Vif-mediated Ubiquitination and Degradation of APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; CYTIDINE DEAMINASE; REVERSE TRANSCRIPTION; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; MESSENGER-RNA; SOCS-BOX; PROTEIN; DNA	The cytidine deaminase APOBEC3G, which is incorporated into nascent virus particles, possesses potent antiviral activity and restricts Vif-deficient HIV-1 replication at the reverse transcription step through deamination-dependent and -independent effects. HIV-1 Vif counteracts the antiviral activity of APOBEC3G by inducing APOBEC3G polyubiquitination and its subsequent proteasomal degradation. In this study, we show that overexpression of heat shock protein 70 (HSP70) blocked the degradation of APOBEC3G in the ubiquitin-proteasome pathway by HIV-1 Vif, rendering the viral particles non-infectious. In addition, siRNA targeted knock-down of HSP70 expression enhanced the Vif-mediated degradation of APOBEC3G. A co-immunoprecipitation study revealed that overexpression of HSP70 inhibited APOBEC3G binding to HIV-1 Vif. Thus, we provide evidence for a host protein-mediated suppression of HIV-1 replication in an APOBEC3G-dependent manner.	[Sugiyama, Ryuichi; Nishitsuji, Hironori; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Chiba 2750016, Japan; [Furukawa, Ayako; Katahira, Masato] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Habu, Yuichiro] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Takeuchi, Hiroaki] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Chiba Institute of Technology; Kyoto University; Colorado State University; University of Tokyo; Yokohama City University	Takaku, H (corresponding author), 2-17-1 Tsudanuma, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp	Furukawa, Ayako/CAH-2120-2022; Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858	Ministry of Education, Science, Sports, and Culture of Japan [09309011]; Ministry of Health, Labor, and Welfare, Japan; MEXT [21370047 22121517]; JST-SENTAN; Naito Foundation; YCU-AMRC; Grants-in-Aid for Scientific Research [21370047] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-SENTAN(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); YCU-AMRC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for High Technology Research (No. 09309011) from the Ministry of Education, Science, Sports, and Culture of Japan and by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare, Japan.; Supported by Grants from MEXT (21370047 & 22121517), JST-SENTAN, Naito Foundation, and YCU-AMRC.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Babaahmady K, 2007, J VIROL, V81, P3354, DOI 10.1128/JVI.02320-06; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Kremer M, 2005, VIROLOGY, V337, P175, DOI 10.1016/j.virol.2005.04.006; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	51	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10051	10057		10.1074/jbc.M110.166108	http://dx.doi.org/10.1074/jbc.M110.166108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21228271	hybrid, Green Published			2022-12-25	WOS:000288547000019
J	Ozawa, D; Hasegawa, K; Lee, YH; Sakurai, K; Yanagi, K; Ookoshi, T; Goto, Y; Naiki, H				Ozawa, Daisaku; Hasegawa, Kazuhiro; Lee, Young-Ho; Sakurai, Kazumasa; Yanagi, Kotaro; Ookoshi, Tadakazu; Goto, Yuji; Naiki, Hironobu			Inhibition of beta(2)-Microglobulin Amyloid Fibril Formation by alpha(2)-Macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CHAPERONE CLUSTERIN; NEUTRAL PH; PROTEINS; ALPHA-2-MACROGLOBULIN; BETA-2-MICROGLOBULIN; HEMODIALYSIS; NUCLEATION; COMPLEX; DISSOCIATION; AGGREGATION	The relationship between various amyloidoses and chaperones is gathering attention. In patients with dialysis-related amyloidosis, alpha(2)-macroglobulin (alpha 2M), an extracellular chaperone, forms a complex with beta(2)-microglobulin (beta 2-m), a major component of amyloid fibrils, but the molecular mechanisms and biological implications of the complex formation remain unclear. Here, we found that alpha 2M substoichiometrically inhibited the beta 2-m fibril formation at a neutral pH in the presence of SDS, a model for anionic lipids. Binding analysis showed that the binding affinity between alpha 2M and beta 2-m in the presence of SDS was higher than that in the absence of SDS. Importantly, SDS dissociated tetrameric alpha 2M into dimers with increased surface hydrophobicity. Western blot analysis revealed that both tetrameric and dimeric alpha 2M interacted with SDS-denatured beta 2-m. At a physiologically relevant acidic pH and in the presence of heparin, alpha 2M was also dissociated into dimers, and both tetrameric and dimeric alpha 2M interacted with beta 2-m, resulting in the inhibition of fibril growth reaction. These results suggest that under conditions where native beta 2-m is denatured, tetrameric alpha 2M is also converted to dimeric form with exposed hydrophobic surfaces to favor the hydrophobic interaction with denatured beta 2-m, thus dimeric alpha 2M as well as tetrameric alpha 2M may play an important role in controlling beta 2-m amyloid fibril formation.	[Ozawa, Daisaku; Hasegawa, Kazuhiro; Ookoshi, Tadakazu; Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan; [Lee, Young-Ho; Sakurai, Kazumasa; Yanagi, Kotaro; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	University of Fukui; Osaka University	Naiki, H (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan.	naiki@u-fukui.ac.jp	Naiki, Hironobu/G-5599-2014		Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid for scientific research (B) (H. N.), scientific research on priority area "protein community" (H. N.), and scientific research (C) (K. H.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and for research on specific diseases (H. N.) from the Ministry of Health, Labour and Welfare, Japan.	ARGILES A, 1989, CLIN SCI, V76, P547, DOI 10.1042/cs0760547; Calabrese MF, 2007, J MOL BIOL, V367, P1, DOI 10.1016/j.jmb.2006.12.034; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2010, J BIOL CHEM, V285, P5827, DOI 10.1074/jbc.M109.061168; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gouin-Charnet A, 2000, CLIN SCI, V98, P427, DOI 10.1042/CS19990234; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JENSEN PEH, 1993, BIOCHIM BIOPHYS ACTA, V1164, P152, DOI 10.1016/0167-4838(93)90242-J; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kolodziej SJ, 2002, J BIOL CHEM, V277, P28031, DOI 10.1074/jbc.M202714200; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; LIU D, 1987, Biochemistry, V26, P5221, DOI 10.1021/bi00391a001; Motomiya Y, 2003, KIDNEY INT, V64, P2244, DOI 10.1046/j.1523-1755.2003.00315.x; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; OKUBO H, 1984, INFLAMMATION, V8, P171, DOI 10.1007/BF00916092; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; PAP S, 1990, EUR J BIOCHEM, V191, P41, DOI 10.1111/j.1432-1033.1990.tb19091.x; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x; REDDY VY, 1994, J BIOL CHEM, V269, P4683; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Shanbhag VP, 1997, EUR J BIOCHEM, V244, P694, DOI 10.1111/j.1432-1033.1997.00694.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt AR, 2010, J BIOL CHEM, V285, P3532, DOI 10.1074/jbc.M109.079566; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	47	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9668	9676		10.1074/jbc.M110.167965	http://dx.doi.org/10.1074/jbc.M110.167965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216953	Green Published, hybrid			2022-12-25	WOS:000288247700091
J	Xu, XF; Lee, YJ; Holm, JB; Terry, MD; Oswald, RE; Horne, WA				Xu, Xingfu; Lee, Yoon J.; Holm, Johanna B.; Terry, Mark D.; Oswald, Robert E.; Horne, William A.			The Ca2+ Channel beta 4c Subunit Interacts with Heterochromatin Protein 1 via a PXVXL Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESTIBULAR NUCLEUS NEURONS; INTRINSIC EXCITABILITY; CALCIUM-CHANNELS; STRUCTURAL BASIS; BETA(4) SUBUNIT; ALPHA-SUBUNIT; DOMAIN; HP1; COMPLEX; SYSTEM	The beta subunits of voltage-gated Ca2+ channels are best known for their roles in regulating surface expression and gating of voltage-gated Ca2+ channel alpha(1) subunits. Recent evidence, however, indicates that these proteins have a variety of Ca2+ channel-independent functions. For example, on the molecular level, they regulate gene expression, and on the whole animal level, they regulate early cell movements in zebrafish development. In the present study, an alternatively spliced, truncated beta 4 subunit (beta 4c) is identified in the human brain and shown to be highly expressed in nuclei of vestibular neurons. Pull-down assays, nuclear magnetic resonance, and isothermal titration calorimetry demonstrate that the protein interacts with the chromo shadow domain (CSD) of heterochromatin protein 1 gamma. Site-directed mutagenesis reveals that the primary CSD interaction occurs through a beta 4c C-terminal PXVXL consensus motif, adding the beta 4c subunit to a growing PXVXL protein family with epigenetic responsibilities. These proteins have multiple nuclear functions, including transcription regulation (TIF1 alpha) and nucleosome assembly (CAF1). An NMR-based two-site docking model of beta 4c in complex with dimerized CSD is presented. Possible roles for the interaction are discussed.	[Horne, William A.] Cornell Univ, Ctr Vet Med, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Oswald, Robert E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Terry, Mark D.; Horne, William A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA	Cornell University; Cornell University; Colorado State University	Horne, WA (corresponding author), Cornell Univ, Ctr Vet Med, Coll Vet Med, Dept Clin Sci, Box 32, Ithaca, NY 14853 USA.	wah27@cornell.edu	Xu, Xingfu/A-1359-2015	Xu, Xingfu/0000-0001-6231-269X; Holm, Johanna/0000-0002-7646-4085	National Institutes of Health [NS42600]; National Science Foundation [IOS 0719242]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42600 (to W. A. H.). This work was also supported by National Science Foundation Grant IOS 0719242 (to W. A. H.).	Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Broussard DM, 2004, LEARN MEMORY, V11, P127, DOI 10.1101/lm.65804; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Cavanagh J., 2006, PROTEIN NMR SPECTROS, P613; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ebert AM, 2008, P NATL ACAD SCI USA, V105, P198, DOI 10.1073/pnas.0707948105; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Gray AC, 2007, CELL CALCIUM, V42, P409, DOI 10.1016/j.ceca.2007.04.003; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Helton TD, 2002, J NEUROSCI, V22, P1573, DOI 10.1523/JNEUROSCI.22-05-01573.2002; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Khan Z, 2002, J NEUROSCI, V22, P8193; KNELLER DG, 1993, J CELL BIOCHEM, P254; Kobayashi T, 2007, BIOCHEM BIOPH RES CO, V360, P679, DOI 10.1016/j.bbrc.2007.06.112; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; van Rootselaar Anne-Fleur, 2009, Pract Neurol, V9, P102, DOI 10.1136/jnnp.2009.172213; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Vendel AC, 2006, PROTEIN SCI, V15, P378, DOI 10.1110/ps.051894506; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	39	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9677	9687		10.1074/jbc.M110.187864	http://dx.doi.org/10.1074/jbc.M110.187864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220418	hybrid, Green Published			2022-12-25	WOS:000288247700092
J	Barzi, M; Kostrz, D; Menendez, A; Pons, S				Barzi, Mercedes; Kostrz, Dorota; Menendez, Anghara; Pons, Sebastian			Sonic Hedgehog-induced Proliferation Requires Specific G alpha Inhibitory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PRIMARY CILIUM; ADENYLYL-CYCLASE; MEDIATED PROLIFERATION; BETA-TRCP; CEREBELLUM; ACTIVATION; PHOSPHORYLATION; DROSOPHILA; GRADIENT	Proliferation of cerebellar granular neuronal precursors (CGNPs) is mediated by Sonic Hedgehog (Shh), which activates the Patched and Smoothened (Smo) receptor complex. Although its protein sequence suggests that Smo is a G protein coupled receptor (GPCR), the evidence that this receptor utilizes heterotrimeric G proteins as downstream effectors is controversial. In Drosophila, G alpha(i) is required for Hedgehog (Hh) activity, but the involvement of heterotrimeric G proteins in vertebrate Shh signaling has not yet been established. Here, we show that Shh-induced proliferation of rat CGNPs is enhanced strongly by the expression of the active forms of G alpha(i/o) proteins (G alpha(i1), G alpha(i2), G alpha(i3), and G alpha(o)) but not by members of another class (G alpha(12)) of heterotrimeric G proteins. Additionally, the mRNAs of these different G alpha(i) members display specific expression patterns in the developing cerebellum; only G alpha(i2) and G alpha(i3) are substantially expressed in the outer external granular layer, where CGNPs proliferate. Consistent with this, Shh-induced proliferation of CGNPs is reduced significantly by knockdowns of G alpha(i2) and G alpha(i3) but not by silencing of other members of the G alpha(i/o) class. Finally, our results demonstrate that G alpha(i2) and G alpha(i3) locate to the primary cilium when expressed in CGNP cultures. In summary, we conclude that the proliferative effects of Shh on CGNPs are mediated by the combined activity of G alpha(i2) and G alpha(i3) proteins.	[Pons, Sebastian] IDIBAPS, CSIC, IIBB, Dept Cell Death & Proliferat,Inst Biomed Res Barc, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pons, S (corresponding author), IDIBAPS, CSIC, IIBB, Dept Cell Death & Proliferat,Inst Biomed Res Barc, Rosello 161,6th Floor, Barcelona 08036, Spain.	spfnqi@iibb.csic.es	Pons, Sebastian/K-7794-2014	Pons, Sebastian/0000-0003-1027-0621; Menendez, Anghara/0000-0001-6513-0584	Spanish Ministry of Education [BFU2008-02424/BFI]	Spanish Ministry of Education(Spanish Government)	This work was supported by Spanish Ministry of Education Grant BFU2008-02424/BFI.	Altman J, 1997, DEV CEREBELLAR SYSTE; Barzi M, 2010, J CELL SCI, V123, P62, DOI 10.1242/jcs.060020; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boehlke C, 2010, J CELL SCI, V123, P1460, DOI 10.1242/jcs.058883; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Megason SG, 2002, DEVELOPMENT, V129, P2087; Milenkovic L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3117pe14; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEMS N; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ruiz-Gomez A, 2007, BBA-BIOMEMBRANES, V1768, P901, DOI 10.1016/j.bbamem.2006.09.020; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200	38	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8067	8074		10.1074/jbc.M110.178772	http://dx.doi.org/10.1074/jbc.M110.178772			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209076	Green Published, hybrid			2022-12-25	WOS:000288013300037
J	Mittelstaet, J; Konevega, AL; Rodnina, MV				Mittelstaet, Joerg; Konevega, Andrey L.; Rodnina, Marina V.			Distortion of tRNA upon Near-cognate Codon Recognition on the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; GTP HYDROLYSIS; CRYSTAL-STRUCTURE; ACTIVE-ROLE; EF-TU; SELECTION; TRANSLATION; ACTIVATION; FIDELITY	The accurate decoding of the genetic information by the ribosome relies on the communication between the decoding center of the ribosome, where the tRNA anticodon interacts with the codon, and the GTPase center of EF-Tu, where GTP hydrolysis takes place. In the A/T state of decoding, the tRNA undergoes a large conformational change that results in a more open, distorted tRNA structure. Here we use a real-time transient fluorescence quenching approach to monitor the timing and the extent of the tRNA distortion upon reading cognate or near-cognate codons. The tRNA is distorted upon codon recognition and remains in that conformation until the tRNA is released from EF-Tu, although the extent of distortion gradually changes upon transition from the pre- to the post-hydrolysis steps of decoding. The timing and extent of the rearrangement is similar on cognate and near-cognate codons, suggesting that the tRNA distortion alone does not provide a specific switch for the preferential activation of GTP hydrolysis on the cognate codon. Thus, although the tRNA plays an active role in signal transmission between the decoding and GTPase centers, other regulators of signaling must be involved.	[Mittelstaet, Joerg; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; McClory SP, 2010, RNA, V16, P1925, DOI 10.1261/rna.2228510; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan D, 2008, J BIOL CHEM, V283, P18431, DOI 10.1074/jbc.M801560200; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; ROBERTSON JM, 1981, J MOL BIOL, V151, P57, DOI 10.1016/0022-2836(81)90221-7; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1075, DOI 10.1016/j.biochi.2006.07.002; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; SCHULTZ DW, 1994, J MOL BIOL, V235, P1381, DOI 10.1006/jmbi.1994.1095; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Vorstenbosch E, 1996, EMBO J, V15, P6766, DOI 10.1002/j.1460-2075.1996.tb01066.x; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; WINTERMEYER W, 1979, EUR J BIOCHEM, V98, P465; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	41	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8158	8164		10.1074/jbc.M110.210021	http://dx.doi.org/10.1074/jbc.M110.210021			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212264	Green Published, hybrid			2022-12-25	WOS:000288013300046
J	Guabiraba, R; Marques, RE; Besnard, AG; Fagundes, CT; Souza, DG; Ryffel, B; Teixeira, MM				Guabiraba, Rodrigo; Marques, Rafael Elias; Besnard, Anne-Gaelle; Fagundes, Caio T.; Souza, Danielle G.; Ryffel, Bernhard; Teixeira, Mauro M.			Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS-INFECTION; ANTIBODY-RESPONSE; PLASMA LEAKAGE; INFLAMMATION; EXPRESSION; DISEASE; SYSTEM; CLASSIFICATION; INTERLEUKIN-8	Dengue virus (DENV), a mosquito-borne flavivirus, is a public health problem in many tropical countries. Recent clinical data have shown an association between levels of different chemokines in plasma and severity of dengue. We evaluated the role of CC chemokine receptors CCR1, CCR2 and CCR4 in an experimental model of DENV-2 infection in mice. Infection of mice induced evident clinical disease and tissue damage, including thrombocytopenia, hemoconcentration, lymphopenia, increased levels of transaminases and pro-inflammatory cytokines, and lethality in WT mice. Importantly, infected WT mice presented increased levels of chemokines CCL2/JE, CCL3/MIP-1 alpha and CCL5/RANTES in spleen and liver. CCR1(-/-) mice had a mild phenotype with disease presentation and lethality similar to those of WT mice. In CCR2(-/-) mice, lethality, liver damage, levels of IL-6 and IFN-gamma, and leukocyte activation were attenuated. However, thrombocytopenia, hemoconcentration and systemic TNF-alpha levels were similar to infected WT mice. Infection enhanced levels of CCL17/TARC, a CCR4 ligand. In CCR4(-/-) mice, lethality, tissue injury and systemic inflammation were markedly decreased. Despite differences in disease presentation in CCR-deficient mice, there was no significant difference in viral load. In conclusion, activation of chemokine receptors has discrete roles in the pathogenesis of dengue infection. These studies suggest that the chemokine storm that follows severe primary dengue infection associates mostly to development of disease rather than protection.	[Guabiraba, Rodrigo; Marques, Rafael Elias; Fagundes, Caio T.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guabiraba, Rodrigo; Besnard, Anne-Gaelle; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Guabiraba, Rodrigo; Besnard, Anne-Gaelle; Ryffel, Bernhard] CNRS, UMR 6218, F-45071 Orleans, France; [Souza, Danielle G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Universidade Federal de Minas Gerais	Guabiraba, R (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	mmtex@icb.ufmg.br	souza, danielle/D-3378-2014; Fagundes, Caio/AAK-9336-2020; Marques, Rafael Elias/R-4890-2016; R, Guabiraba/F-1396-2010; Teixeira, Mauro M/A-4587-2008	Fagundes, Caio/0000-0002-6747-5233; Marques, Rafael Elias/0000-0002-6949-0947; R, Guabiraba/0000-0003-4005-1753; Teixeira, Mauro M/0000-0002-6944-3008	Fondation pour la Recherche Medicale en France (FRM); Centre Nationale de la Recherche Scientifique (CNRS, France); Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil)	Fondation pour la Recherche Medicale en France (FRM)(Fondation pour la Recherche Medicale); Centre Nationale de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received financial support from Fondation pour la Recherche Medicale en France (FRM), Centre Nationale de la Recherche Scientifique (CNRS, France) and Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Conceicao TM, J INFECT, V60, P65; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Glass WG, 2003, CURR OPIN ALLERGY CL, V3, P467, DOI 10.1097/01.all.0000104448.09202.91; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Horuk Richard, 2009, Front Biosci (Elite Ed), V1, P209; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Luster AD, 2001, CURR OPIN ALLERGY CL, V1, P561, DOI 10.1097/00130832-200112000-00012; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mantovani A, 1999, Chem Immunol, V72, P1, DOI 10.1159/000058734; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Nouri-Aria KT, 2002, EUR J IMMUNOL, V32, P1933, DOI 10.1002/1521-4141(200207)32:7<1933::AID-IMMU1933>3.0.CO;2-R; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Schuh JM, 2002, FASEB J, V16, pA331; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Sierra B, CYTOKINE; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Souza DG, 2003, J IMMUNOL, V170, P4759, DOI 10.4049/jimmunol.170.9.4759; Spain-Santana TA, 2001, J MED VIROL, V65, P324, DOI 10.1002/jmv.2037; Speyer CL, 2004, AM J PATHOL, V165, P2187, DOI 10.1016/S0002-9440(10)63268-3; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	70	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15680	10.1371/journal.pone.0015680	http://dx.doi.org/10.1371/journal.pone.0015680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206747	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000285793200036
J	Huang, ES; Strate, LL; Ho, WW; Lee, SS; Chan, AT				Huang, Edward S.; Strate, Lisa L.; Ho, Wendy W.; Lee, Salina S.; Chan, Andrew T.			A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; URGENT COLONOSCOPY; PRIMARY PREVENTION; PHYSICAL-ACTIVITY; BLOOD-FLOW; OMEPRAZOLE; ULCERS; COMPLICATIONS	Background and Aims: Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleeding are conflicting. Methods: We conducted a prospective cohort study of 32,989 men enrolled in the Health Professionals Follow-up Study (HPFS) in 1994 who provided biennial aspirin data. We estimated relative risk of major gastrointestinal bleeding requiring hospitalization or a blood transfusion. Results: During 14 years of follow-up, 707 men reported an episode of major gastrointestinal bleeding over 377,231 person-years. After adjusting for risk factors, regular aspirin use (>= 2 times/week) had a multivariate relative risk (RR) of gastrointestinal bleeding of 1.32 (95% confidence interval [CI], 1.12-1.55) compared to non-regular use. The association was particularly evident for upper gastrointestinal bleeding (multivariate RR, 1.49; 95% CI, 1.16-1.92). Compared to men who denied any aspirin use, multivariate RRs of upper gastrointestinal bleeding were 1.05 (95% CI 0.71-1.52) for men who used 0.5-1.5 standard tablets/week, 1.31 (95% CI 0.88-1.95) for 2-5 aspirin/week, 1.63 (95% CI, 1.15-2.32) for 6-14 aspirin/week and 2.40 (95% CI, 1.10-5.22) for >14 aspirin/week (P-trend < 0.001). The relative risk also appeared to be dose-dependent among short-term users (>= 5 years; P-trend<.001) and long-term users (>= 5 years; P-trend = 0.015). In contrast, after controlling for dose, increasing duration of use did not appear to be associated with risk (P-trend = 0.749). Conclusions: Regular aspirin use increases the risk of gastrointestinal bleeding, especially from the upper tract. However, risk of bleeding appears to be more strongly related to dose than to duration of use. Risk of bleeding should be minimized by using the lowest effective dose among short-term and long-term aspirin users.	[Huang, Edward S.; Chan, Andrew T.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Boston, MA 02114 USA; [Huang, Edward S.; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Strate, Lisa L.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA USA; [Ho, Wendy W.] Univ Calif Los Angeles, Dept Med, Div Digest Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Lee, Salina S.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital	Huang, ES (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Boston, MA 02114 USA.	eshuang@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767	Foundation for Digestive Health and Nutrition; American Gastroenterology Association; NATIONAL CANCER INSTITUTE [R01CA137178, P01CA055075, K07CA107412, P01CA087969] Funding Source: NIH RePORTER	Foundation for Digestive Health and Nutrition; American Gastroenterology Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Foundation for Digestive Health and Nutrition Pilot Research Award for this work. Dr. Chan is a Damon Runyon Clinical Investigator. Dr. Huang is supported by the American Gastroenterology Association Fellow to Faculty Transition Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IB, 2000, EPIDEMIOLOGY, V11, P434; Arora G, 2009, CLIN GASTROENTEROL H, V7, P725, DOI 10.1016/j.cgh.2009.03.015; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Brzozowski T, 2008, J PHYSIOL PHARMACOL, V59, P89; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cole AT, 1999, ALIMENT PHARM THERAP, V13, P187; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; EASTWOOD GL, 1982, GASTROENTEROLOGY, V82, P852; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HENRY D, 1993, GASTROENTEROLOGY, V105, P1078, DOI 10.1016/0016-5085(93)90952-9; Huang ES, 2010, LONG TERM USE ASPIRI; Javid G, 2001, AM J MED, V111, P280, DOI 10.1016/S0002-9343(01)00812-9; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Khuroo MS, 1997, NEW ENGL J MED, V336, P1054, DOI 10.1056/NEJM199704103361503; KONTUREK JW, 1994, GUT, V35, P1197, DOI 10.1136/gut.35.9.1197; KONTUREK SJ, 1994, GUT, V35, P1189, DOI 10.1136/gut.35.9.1189; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Meade TW, 1998, LANCET, V351, P233; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; OLIVERO JJ, 1992, SCAND J GASTROENTERO, V27, P53, DOI 10.3109/00365529209096006; PAHOR M, 1994, JAMA-J AM MED ASSOC, V272, P595, DOI 10.1001/jama.272.8.595; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; PENSTON JG, 1992, ALIMENT PHARM THERAP, V6, P629; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Serrano P, 2002, ALIMENT PHARM THER, V16, P1945, DOI 10.1046/j.1365-2036.2002.01355.x; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Strate LL, 2009, AM J GASTROENTEROL, V104, P1221, DOI 10.1038/ajg.2009.121; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; Zanchetti A, 1999, LANCET, V353, P149, DOI 10.1016/S0140-6736(05)76187-0	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15721	10.1371/journal.pone.0015721	http://dx.doi.org/10.1371/journal.pone.0015721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209949	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200042
J	Yuan, HP; Zhang, XY; Huang, XQ; Lu, YG; Tang, WQ; Man, Y; Wang, S; Xi, JZ; Li, JA				Yuan, Huiping; Zhang, Xiaoyong; Huang, Xiuqing; Lu, Yonggang; Tang, Weiqing; Man, Yong; Wang, Shu; Xi, Jianzhong; Li, Jian			NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-Induced Dysfunction and Apoptosis of beta-Cells via JNK, p38 MAPK and p53 Pathways	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; HUMAN PANCREATIC-ISLETS; LONG-TERM EXPOSURE; FREE FATTY-ACIDS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR PDX-1; OXIDATIVE STRESS; GENE-EXPRESSION; DIABETES-MELLITUS; RAT ISLETS	Dysfunction of beta-cell is one of major characteristics in the pathogenesis of type 2 diabetes. The combination of obesity and type 2 diabetes, characterized as 'diabesity', is associated with elevated plasma free fatty acids (FFAs). Oxidative stress has been implicated in the pathogenesis of FFA-induced beta-cell dysfunction. However, molecular mechanisms linking between reactive oxygen species (ROS) and FFA-induced beta-cell dysfunction and apoptosis are less clear. In the present study, we test the hypothesis that NOX2-derived ROS may play a critical role in dysfunction and apoptosis of beta-cells induced by FFA. Our results show that palmitate and oleate (0.5 mmol/L, 48 h) induced JNK activation and AKT inhibition which resulted in decreased phosphorylation of FOXO1 following nuclear localization and the nucleocytoplasmic translocation of PDX-1, leading to the reducing of insulin and ultimately dysfunction of pancreatic NIT-1 cells. We also found that palmitate and oleate stimulated apoptosis of NIT-1 cells through p38MAPK, p53 and NF-kappa B pathway. More interestingly, our data suggest that suppression of NOX2 may restore FFA-induced dysfunction and apoptosis of NIT-1 cells. Our findings provide a new insight of the NOX2 as a potential new therapeutic target for preservation of beta-cell mass and function.	[Yuan, Huiping; Xi, Jianzhong] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China; [Yuan, Huiping; Huang, Xiuqing; Tang, Weiqing; Man, Yong; Wang, Shu; Li, Jian] Peking Univ, Sch Clin Med 5, Beijing Hosp, Beijing 100871, Peoples R China; [Zhang, Xiaoyong; Lu, Yonggang; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhang, Xiaoyong; Lu, Yonggang; Li, Jian] Chinese Acad Med Sci, Beijing 100037, Peoples R China	Peking University; Beijing Hospital; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Yuan, HP (corresponding author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.	jzxi@pku.edu.cn; lijian@bjhmoh.cn	LI, RUIJIAN/GYJ-0470-2022; Xi, Jianzhong/J-1420-2014		National Basic Research Program of China [2006CB503910]; National Natural Science Foundation of China [81070634]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (2006CB503910) and National Natural Science Foundation of China (81070634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bikopoulos G, 2008, J ENDOCRINOL, V196, P455, DOI 10.1677/JOE-07-0174; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Manna P, 2010, TOXICOL APPL PHARM, V244, P114, DOI 10.1016/j.taap.2009.12.024; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Mason TM, 1999, DIABETES, V48, P524, DOI 10.2337/diabetes.48.3.524; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; RANDLE PJ, 1963, LANCET, V1, P785; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yang JY, 2005, J BIOL CHEM, V280, P32835, DOI 10.1074/jbc.M504058200; Zhang Y, 2007, J MOL ENDOCRINOL, V38, P651, DOI 10.1677/JME-06-0048; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	42	92	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15726	10.1371/journal.pone.0015726	http://dx.doi.org/10.1371/journal.pone.0015726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209957	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200043
J	Neff, CP; Ndolo, T; Tandon, A; Habu, Y; Akkina, R				Neff, C. Preston; Ndolo, Thomas; Tandon, Apurva; Habu, Yuichiro; Akkina, Ramesh			Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; IMMUNE-RESPONSES; MICE; INFECTION; MACAQUES; CHALLENGES; INHIBITOR; ANTAGONIST; PREVENTION	Sexual HIV-1 transmission by vaginal route is the most predominant mode of viral transmission, resulting in millions of new infections every year. In the absence of an effective vaccine, there is an urgent need to develop other alternative methods of pre-exposure prophylaxis (PrEP). Many novel drugs that are currently approved for clinical use also show great potential to prevent viral sexual transmission when administered systemically. A small animal model that permits rapid preclinical evaluation of potential candidates for their systemic PrEP efficacy will greatly enhance progress in this area of investigation. We have previously shown that RAG-hu humanized mouse model permits HIV-1 mucosal transmission via both vaginal and rectal routes and displays CD4 T cell loss typical to that seen in the human. Thus far systemic PrEP studies have been primarily limited to RT inhibitors exemplified by tenofovir and emtricitabine. In these proof-of-concept studies we evaluated two new classes of clinically approved drugs with different modes of action namely, an integrase inhibitor raltegravir and a CCR5 inhibitor maraviroc as potential systemically administered chemo-prophylactics. Our results showed that oral administration of either of these drugs fully protects against vaginal HIV-1 challenge in the RAG-hu mouse model. Based on these results both these drugs show great promise for further development as orally administered PrEPs.	[Neff, C. Preston; Ndolo, Thomas; Tandon, Apurva; Habu, Yuichiro; Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Neff, CP (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	akkina@colostate.edu			National Institutes of Health [AI057066, AI073255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057066, R01AI073255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work reported here was supported by National Institutes of Health RO1 grants AI057066 and AI073255 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; *CLIN, FEM PREP TRU STUD AS; D'Cruz OJ, 2007, AM J REPROD IMMUNOL, V57, P353, DOI 10.1111/j.1600-0897.2007.00478.x; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton Paul W, 2009, Curr HIV/AIDS Rep, V6, P13, DOI 10.1007/s11904-009-0003-2; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/00002030-200307250-00003; Di Fabio S, 2001, AIDS, V15, pS19, DOI 10.1097/00002030-200102001-00020; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; *JOINT UN HIV AIDS, 2008, REP GLOB AIDS EP; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Polhemus ME, 2008, ANTIMICROB AGENTS CH, V52, P1493, DOI 10.1128/AAC.01367-07; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; *US FDA, 2009, ANT DRUGS US TREATM; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Van Rompay KKA, 1998, AIDS, V12, pF79, DOI 10.1097/00002030-199809000-00001; Van Rompay KKA, 2006, JAIDS-J ACQ IMM DEF, V43, P6, DOI 10.1097/01.qai.0000224972.60339.7c; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	45	87	91	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15257	10.1371/journal.pone.0015257	http://dx.doi.org/10.1371/journal.pone.0015257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203568	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900024
J	Park, E; Lee, GJ; Choi, S; Choi, SK; Chae, SJ; Kang, SW; Pak, YK; Park, HK				Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Choi, Seok-Keun; Chae, Su-Jin; Kang, Sung-Wook; Pak, Youngmi Kim; Park, Hun-Kuk			The Role of Glutamate Release on Voltage-Dependent Anion Channels (VDAC)-Mediated Apoptosis in an Eleven Vessel Occlusion Model in Rats	PLOS ONE			English	Article							BILATERAL HEMISPHERIC ISCHEMIA; NEURONAL CELL-DEATH; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; MICRODIALYSIS; BRAIN; VDAC; PROTEINS; INJURY; DAMAGE	Voltage-dependent anion channel (VDAC) is the main protein in mitochondria-mediated apoptosis, and the modulation of VDAC may be induced by the excessive release of extracellular glutamate. This study examined the role of glutamate release on VDAC-mediated apoptosis in an eleven vessel occlusion model in rats. Male Sprague-Dawley rats (250-350 g) were used for the 11 vessel occlusion ischemic model, which were induced for a 10-min transient occlusion. During the ischemic and initial reperfusion episode, the real-time monitoring of the extracellular glutamate concentration was measured using an amperometric microdialysis biosensor and the cerebral blood flow (CBF) was monitored by laser-Doppler flowmetry. To confirm neuronal apoptosis, the brains were removed 72 h after ischemia to detect the neuron-specific nuclear protein and pro-apoptotic proteins (cleaved caspase-3, VDAC, p53 and BAX). The changes in the mitochondrial morphology were measured by atomic force microscopy. A decrease in the % of CBF was observed, and an increase in glutamate release was detected after the onset of ischemia, which continued to increase during the ischemic period. A significantly higher level of glutamate release was observed in the ischemia group. The increased glutamate levels in the ischemia group resulted in the activation of VDAC and pro-apoptotic proteins in the hippocampus with morphological alterations to the mitochondria. This study suggests that an increase in glutamate release promotes VDAC-mediated apoptosis in an 11 vessel occlusion ischemic model.	[Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Chae, Su-Jin; Kang, Sung-Wook; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Chae, Su-Jin; Kang, Sung-Wook; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Coll Med, Seoul, South Korea; [Park, Eunkuk] Kyung Hee Univ, Dept Med Zool, Coll Med, Seoul, South Korea; [Choi, Seok-Keun] Kyung Hee Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea; [Pak, Youngmi Kim] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Park, E (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	sigmoidus@khu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Lee, Gi-Ja/AAH-9998-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Choi, Samjin/0000-0003-3498-0652	Korea government (MEST) [2009-0092562]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2009-0092562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; Benveniste H, 2009, ANESTHESIOLOGY, V110, P422, DOI 10.1097/ALN.0b013e318194b620; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Caragine LP, 1998, BRAIN RES, V793, P255, DOI 10.1016/S0006-8993(98)00182-6; Chi OZ, 2009, NEUROCHEM RES, V34, P1249, DOI 10.1007/s11064-008-9902-7; CHOI SK, 2008, KOR J INTEGRA MED, V3, P11; Choi YS, 2005, ANN NY ACAD SCI, V1042, P88, DOI 10.1196/annals.1338.009; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Groebe K, 2010, EXP GERONTOL, V45, P632, DOI 10.1016/j.exger.2010.02.006; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Kirino T, 1989, Rinsho Shinkeigaku, V29, P1522; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Landolt H, 1998, J CLIN NEUROSCI, V5, P193, DOI 10.1016/S0967-5868(98)90037-6; Lee GJ, 2009, CURR APPL PHYS, V9, pS25, DOI 10.1016/j.cap.2008.08.031; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Lee GJ, 2009, BIOCHIP J, V3, P82; Lee GJ, 2009, KOREAN J PHYSIOL PHA, V13, P23, DOI 10.4196/kjpp.2009.13.1.23; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; Ogawa S, 2007, ANTIOXID REDOX SIGN, V9, P573, DOI 10.1089/ars.2006.1516; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Park E, 2010, BRAIN RES, V1342, P160, DOI 10.1016/j.brainres.2010.04.054; Poleszak E, 2008, PHARMACOL REP, V60, P655; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; SUGIO K, 1988, STROKE, V19, P922, DOI 10.1161/str.19.7.922a; Takagi N, 2010, EUR J PHARMACOL, V644, P96, DOI 10.1016/j.ejphar.2010.07.026; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; TODD NV, 1986, ACTA NEUROL SCAND, V74, P269; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V128, P9, DOI 10.1111/j.1748-1716.1986.tb07943.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Yao T, 2001, ANAL SCI, V17, P703, DOI 10.2116/analsci.17.703; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhao H, 1998, NEUROREPORT, V9, P3183, DOI 10.1097/00001756-199810050-00011	43	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15192	10.1371/journal.pone.0015192	http://dx.doi.org/10.1371/journal.pone.0015192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203570	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900019
J	Fu, Y; Westenbroek, RE; Yu, FH; Clark, JP; Marshall, MR; Scheuer, T; Catterall, WA				Fu, Ying; Westenbroek, Ruth E.; Yu, Frank H.; Clark, John P., III; Marshall, Misty R.; Scheuer, Todd; Catterall, William A.			Deletion of the Distal C Terminus of Ca(V)1.2 Channels Leads to Loss of beta-Adrenergic Regulation and Heart Failure in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; HUMAN VENTRICULAR MYOCYTES; CARDIAC ALPHA(1) SUBUNIT; 2 SIZE FORMS; CALCIUM-CHANNEL; CA2+ CHANNELS; CARBOXYL-TERMINUS; SKELETAL-MUSCLE; ION CHANNELS; DEVELOPMENTAL-CHANGES	L-type calcium currents conducted by Ca(V)1.2 channels initiate excitation-contraction coupling in cardiac and vascular smooth muscle. In the heart, the distal portion of the C terminus (DCT) is proteolytically processed in vivo and serves as a noncovalently associated autoinhibitor of Ca(V)1.2 channel activity. This autoinhibitory complex, with A-kinase anchoring protein- 15 (AKAP15) bound to the DCT, is hypothesized to serve as the substrate for beta-adrenergic regulation in the fight-or-flight response. Mice expressing Ca(V)1.2 channels with the distal C terminus deleted (DCT-/-) develop cardiac hypertrophy and die prematurely after E15. Cardiac hypertrophy and survival rate were improved by drug treatments that reduce peripheral vascular resistance and hypertension, consistent with the hypothesis that Ca(V)1.2 hyperactivity in vascular smooth muscle causes hypertension, hypertrophy, and premature death. However, in contrast to expectation, L-type Ca2+ currents in cardiac myocytes from DCT-/- mice were dramatically reduced due to decreased cell-surface expression of Ca(V)1.2 protein, and the voltage dependence of activation and the kinetics of inactivation were altered. Ca(V)1.2 channels in DCT-/- myocytes fail to respond to activation of adenylyl cyclase by forskolin, and the localized expression of AKAP15 is reduced. Therefore, we conclude that the DCT of Ca(V)1.2 channels is required in vivo for normal vascular regulation, cell-surface expression of Ca(V)1.2 channels in cardiac myocytes, and beta-adrenergic stimulation of L-type Ca2+ currents in the heart.	[Fu, Ying; Westenbroek, Ruth E.; Yu, Frank H.; Clark, John P., III; Marshall, Misty R.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.	wcatt@uw.edu	Marshall, Misty R/E-5833-2016; Fu, Ying/E-5655-2012	Marshall, Misty R/0000-0002-1073-3131; Yu, Frank/0000-0001-9306-1731	National Institutes of Health [T32 GM07750, T32 NS07332, P01 HL44948, R01 HL85372]; American Heart Association [10POST2630160]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948, R01HL085372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606, T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 GM07750 (to M. R. M.) and T32 NS07332 (to J. P. C.) and Research Grants P01 HL44948 and R01 HL85372 (to W. A. C.). This work was also supported by American Heart Association Postdoctoral Research Fellowship 10POST2630160 (to Y. F.).	An RH, 1996, CIRC RES, V78, P371, DOI 10.1161/01.RES.78.3.371; Anderson JR, 2010, CARDIOL REV, V18, P148, DOI 10.1097/CRD.0b013e3181d4e921; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BROGDEN RN, 1995, DRUGS, V49, P618, DOI 10.2165/00003495-199549040-00009; Brunet S, 2009, J GEN PHYSIOL, V134, P81, DOI 10.1085/jgp.200910209; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XW, 2002, CIRC RES, V91, P517, DOI 10.1161/01.RES.0000033988.13062.7C; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; DEEDWANIA PC, 1997, AM J HYPERTENS, V280, pS280; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fernandez-Tenorio M, 2010, CIRC RES, V106, P1285, DOI 10.1161/CIRCRESAHA.109.213967; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; HADLEY RW, 1992, AM J PHYSIOL, V262, pH472, DOI 10.1152/ajpheart.1992.262.2.H472; HADLEY RW, 1991, J GEN PHYSIOL, V98, P265, DOI 10.1085/jgp.98.2.265; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; HELL JW, 1993, J BIOL CHEM, V268, P19451; HESCHELER J, 1988, J PHYSIOL-LONDON, V404, P259, DOI 10.1113/jphysiol.1988.sp017289; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2004, J MOL CELL CARDIOL, V37, P625, DOI 10.1016/j.yjmcc.2004.04.014; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Luo ZY, 1998, NAT MED, V4, P1092, DOI 10.1038/2578; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Mikala G, 2003, MOL CELL BIOCHEM, V250, P81, DOI 10.1023/A:1024910605389; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Momma K, 2005, PEDIATR RES, V58, P42, DOI 10.1203/01.PDR.0000156370.50874.3C; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NORMAN RI, 1994, BIOCHEM SOC T, V22, P492, DOI 10.1042/bst0220492; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; REUTER H, 1979, ANNU REV PHYSIOL, V41, P413, DOI 10.1146/annurev.ph.41.030179.002213; REUTER H, 1977, J PHYSIOL-LONDON, V264, P17, DOI 10.1113/jphysiol.1977.sp011656; SCHACHTER M, 1991, J CLIN PHARM THER, V16, P79, DOI 10.1111/j.1365-2710.1991.tb00288.x; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SPERELAKIS N, 1976, AM J CARDIOL, V37, P1079, DOI 10.1016/0002-9149(76)90428-8; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Toyoshima K, 2006, BIOL NEONATE, V89, P251, DOI 10.1159/000089954; TSIEN RW, 1972, NATURE-NEW BIOL, V240, P181, DOI 10.1038/newbio240181a0; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; WEI XY, 1994, J BIOL CHEM, V269, P1635; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P	66	62	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.175307	http://dx.doi.org/10.1074/jbc.M110.175307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21216955	Green Published, hybrid			2022-12-25	WOS:000289077500073
J	Khrapunovich-Baine, M; Menon, V; Yang, CPH; Northcote, PT; Miller, JH; Angeletti, RH; Fiser, A; Horwitz, SB; Xiao, H				Khrapunovich-Baine, Marina; Menon, Vilas; Yang, Chia-Ping Huang; Northcote, Peter T.; Miller, John H.; Angeletti, Ruth Hogue; Fiser, Andras; Horwitz, Susan Band; Xiao, Hui			Hallmarks of Molecular Action of Microtubule Stabilizing Agents EFFECTS OF EPOTHILONE B, IXABEPILONE, PELORUSIDE A, AND LAULIMALIDE ON MICROTUBULE CONFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III BETA-TUBULIN; TAXOID SITE; ELECTRON CRYSTALLOGRAPHY; CELLS RESISTANT; BINDING AGENTS; CANCER-CELLS; BOVINE BRAIN; IN-VITRO; PACLITAXEL; DYNAMICS	Microtubule stabilizing agents (MSAs) comprise a class of drugs that bind to microtubule (MT) polymers and stabilize them against disassembly. Several of these agents are currently in clinical use as anticancer drugs, whereas others are in various stages of development. Nonetheless, there is insufficient knowledge about the molecular modes of their action. Recent studies from our laboratory utilizing hydrogen-deuterium exchange in combination with mass spectrometry (MS) provide new information on the conformational effects of Taxol and discodermolide on microtubules isolated from chicken erythrocytes (CET). We report here a comprehensive analysis of the effects of epothilone B, ixabepilone (IXEMPRA (TM)), laulimalide, and peloruside A on CET conformation. The results of our comparative hydrogen-deuterium exchange MS studies indicate that all MSAs have significant conformational effects on the C-terminal H12 helix of alpha-tubulin, which is a likely molecular mechanism for the previously observed modulations of MT interactions with microtubule-associated and motor proteins. More importantly, the major mode of MT stabilization by MSAs is the tightening of the longitudinal interactions between two adjacent alpha beta-tubulin heterodimers at the interdimer interface. In contrast to previous observations reported with bovine brain tubulin, the lateral interactions between the adjacent protofilaments in CET are particularly strongly stabilized by peloruside A and laulimalide, drugs that bind outside the taxane site. This not only highlights the significance of tubulin isotype composition in modulating drug effects on MT conformation and stability but also provides a potential explanation for the synergy observed when combinations of taxane and alternative site binding drugs are used.	[Khrapunovich-Baine, Marina; Yang, Chia-Ping Huang; Horwitz, Susan Band] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Menon, Vilas; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Angeletti, Ruth Hogue; Xiao, Hui] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Northcote, Peter T.; Miller, John H.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Victoria University Wellington	Horwitz, SB (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	susan.horwitz@einstein.yu.edu	Baine, Marina/GPC-8924-2022; Menon, Vilas/AAG-4109-2021	Baine, Marina/0000-0003-4939-6491; Menon, Vilas/0000-0002-4096-8601	National Institutes of Health [CA124898 (NCI)]; National Foundation for Cancer Research; PhRMA Foundation; NATIONAL CANCER INSTITUTE [R01CA124898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096041, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124898 (NCI) (to S. B. H.). This work was also supported by the National Foundation for Cancer Research (to S. B. H.).; Supported by a predoctoral fellowship in pharmacology/toxicology from the PhRMA Foundation.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; BANERJEE A, 1992, J BIOL CHEM, V267, P5625; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Bode CJ, 2002, BIOCHEMISTRY-US, V41, P3870, DOI 10.1021/bi0121611; BOLLAG DM, 1995, CANCER RES, V55, P2325; Clark EA, 2006, MOL PHARMACEUT, V3, P457, DOI 10.1021/mp060016h; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Field JJ, 2009, J MED CHEM, V52, P7328, DOI 10.1021/jm901249g; Gaitanos TN, 2004, CANCER RES, V64, P5063, DOI 10.1158/0008-5472.CAN-04-0771; Ganesh T, 2004, P NATL ACAD SCI USA, V101, P10006, DOI 10.1073/pnas.0403459101; Gapud EJ, 2004, MOL PHARMACOL, V66, P113, DOI 10.1124/mol.66.1.113; Geney R, 2005, CHEM BIOL, V12, P339, DOI 10.1016/j.chembiol.2005.01.004; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Hamel E, 2006, MOL PHARMACOL, V70, P1555, DOI 10.1124/mol.106.027847; Huzil JT, 2008, J MOL BIOL, V378, P1016, DOI 10.1016/j.jmb.2008.03.026; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Kar S, 2003, FEBS LETT, V539, P34, DOI 10.1016/S0014-5793(03)00181-9; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Katsetos CD, 2009, J CELL PHYSIOL, V221, P505, DOI 10.1002/jcp.21870; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Khrapunovich-Baine M, 2009, BIOCHEMISTRY-US, V48, P11664, DOI 10.1021/bi901351q; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; Lee KM, 2007, HISTOPATHOLOGY, V51, P539, DOI 10.1111/j.1365-2559.2007.02792.x; Li YK, 2000, BIOCHEMISTRY-US, V39, P281, DOI 10.1021/bi991936r; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LU Q, 1994, J BIOL CHEM, V269, P2041; LU Q, 1993, CELL STRUCT FUNCT, V18, P173, DOI 10.1247/csf.18.173; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; MURPHY DB, 1983, J BIOL CHEM, V258, P8357; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pineda O, 2004, BIOORG MED CHEM LETT, V14, P4825, DOI 10.1016/j.bmcl.2004.07.053; Pryor DE, 2002, BIOCHEMISTRY-US, V41, P9109, DOI 10.1021/bi020211b; Rowinsky EK, 1997, ANNU REV MED, V48, P353; RUDIGER M, 1993, EUR J BIOCHEM, V218, P107, DOI 10.1111/j.1432-1033.1993.tb18357.x; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y; Wilmes A, 2007, MOL PHARM, V4, P269, DOI 10.1021/mp060101p; Xia SJ, 2006, BIOCHEMISTRY-US, V45, P11762, DOI 10.1021/bi060497a; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	52	54	55	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11765	11778		10.1074/jbc.M110.162214	http://dx.doi.org/10.1074/jbc.M110.162214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245138	Green Published, hybrid			2022-12-25	WOS:000288797100084
J	Cooper, TH; Bailey-Hill, K; Leifert, WR; McMurchie, EJ; Asgari, S; Glatz, RV				Cooper, Tamara H.; Bailey-Hill, Kelly; Leifert, Wayne R.; McMurchie, Edward J.; Asgari, Sassan; Glatz, Richard V.			Identification of an in Vitro Interaction between an Insect Immune Suppressor Protein (CrV2) and G alpha Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; HETEROTRIMERIC G-PROTEIN; TRANSIENT EXPRESSION; HEMOCYTE INACTIVATION; ANTIMICROBIAL PEPTIDE; RUBECULA BRACOVIRUS; GALLERIA-MELLONELLA; ENDOPARASITOID WASP; POLYDNAVIRUS GENES; SPREADING BEHAVIOR	The protein CrV2 is encoded by a polydnavirus integrated into the genome of the endoparasitoid Cotesia rubecula (Hymenoptera: Braconidae:Microgastrinae) and is expressed in host larvae with other gene products of the polydnavirus to allow successful development of the parasitoid. CrV2 expression has previously been associated with immune suppression, although the molecular basis for this was not known. Here, we have used time-resolved Forster resonance energy transfer (TR-FRET) to demonstrate high affinity binding of CrV2 to G alpha subunits (but not the G beta gamma dimer) of heterotrimeric G-proteins. Signals up to 5-fold above background were generated, and an apparent dissociation constant of 6.2 nM was calculated. Protease treatment abolished the TR-FRET signal, and the presence of unlabeled CrV2 or G alpha proteins also reduced the TR-FRET signal. The activation state of the G alpha subunit was altered with aluminum fluoride, and this decreased the affinity of the interaction with CrV2. It was also demonstrated that CrV2 preferentially bound to Drosophila G alpha(o) compared with rat G alpha(i1). In addition, three CrV2 homologs were detected in sequences derived from polydnaviruses from Cotesia plutellae and Cotesia congregata (including the immune-related early expressed transcript, EP2). These data suggest a potential mode-of-action of immune suppressors not previously reported, which in addition to furthering our understanding of insect immunity may have practical benefits such as facilitating development of novel controls for pest insect species.	[Cooper, Tamara H.; Bailey-Hill, Kelly; Glatz, Richard V.] S Australian Res & Dev Inst, Urrbrae, SA 5064, Australia; [Cooper, Tamara H.; Bailey-Hill, Kelly; Leifert, Wayne R.; McMurchie, Edward J.; Glatz, Richard V.] Commonwealth Sci & Ind Res Org, Div Mol & Hlth Technol, Adelaide, SA 5000, Australia; [Leifert, Wayne R.] Commonwealth Sci & Ind Res Org, Div Human Nutr, Adelaide, SA 5000, Australia; [Asgari, Sassan] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Glatz, RV (corresponding author), GPO Box 397, Adelaide, SA 5001, Australia.	richard.glatz@sa.gov.au	Leifert, Wayne/H-4623-2013; Cooper, Tamara/F-3702-2013; Glatz, Richard/AAF-9483-2019; Asgari, Sassan/G-2678-2011	Leifert, Wayne/0000-0003-0535-7327; Glatz, Richard/0000-0001-8889-3701; Asgari, Sassan/0000-0001-7885-6544	OzNano2Life research initiative of the Australian Department of Education, Science, and Technology; CSIRO Emerging Science Area for Nanotechnology funding scheme; Australian Research Council [F09943013]; University of Queensland; Horticulture Australia Ltd. [VG08048]	OzNano2Life research initiative of the Australian Department of Education, Science, and Technology; CSIRO Emerging Science Area for Nanotechnology funding scheme; Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); Horticulture Australia Ltd.(Horticulture Australia Limited)	This work was supported by the OzNano2Life research initiative of the Australian Department of Education, Science, and Technology, CSIRO Emerging Science Area for Nanotechnology funding scheme, Australian Research Council Grant F09943013, a University of Queensland grant (to S. A.), and a Horticulture Australia Ltd. Grant VG08048 (to R. G.).	Asgari S, 1996, J GEN VIROL, V77, P2653, DOI 10.1099/0022-1317-77-10-2653; Asgari S, 1997, J GEN VIROL, V78, P3061, DOI 10.1099/0022-1317-78-11-3061; Barandoc KP, 2009, COMP BIOCHEM PHYS D, V4, P218, DOI 10.1016/j.cbd.2009.03.003; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beckage NE, 1998, BIOSCIENCE, V48, P305, DOI 10.2307/1313357; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cytrynska M, 2006, J INSECT PHYSIOL, V52, P744, DOI 10.1016/j.jinsphys.2006.04.002; Dowal L, 2001, BIOCHEMISTRY-US, V40, P414, DOI 10.1021/bi001923+; Gad W, 2008, J GEN VIROL, V89, P931, DOI 10.1099/vir.0.83585-0; Gitau CW, 2007, J INSECT PHYSIOL, V53, P676, DOI 10.1016/j.jinsphys.2007.04.008; Glatz R, 2004, J GEN VIROL, V85, P2873, DOI 10.1099/vir.0.80307-0; Glatz R, 2003, J BIOL CHEM, V278, P19743, DOI 10.1074/jbc.M301396200; Glatz RV, 2004, TRENDS MICROBIOL, V12, P545, DOI 10.1016/j.tim.2004.10.004; HARWOOD SH, 1994, INSECT BIOCHEM MOLEC, V24, P685, DOI 10.1016/0965-1748(94)90056-6; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; Ibrahim AMA, 2008, NATURWISSENSCHAFTEN, V95, P25, DOI 10.1007/s00114-007-0290-7; Knight PJK, 2004, ARCH INSECT BIOCHEM, V57, P142, DOI 10.1002/arch.20018; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kroemer JA, 2006, J VIROL, V80, P12219, DOI 10.1128/JVI.01187-06; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Leifert WR, 2006, ANAL BIOCHEM, V355, P201, DOI 10.1016/j.ab.2006.04.042; Lentschat A, 2005, J IMMUNOL, V174, P4252, DOI 10.4049/jimmunol.174.7.4252; Malagoli D, 2000, PEPTIDES, V21, P175, DOI 10.1016/S0196-9781(99)00203-X; Marin D, 2005, J INSECT PHYSIOL, V51, P575, DOI 10.1016/j.jinsphys.2005.02.010; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Nalini M, 2008, J INSECT PHYSIOL, V54, P1125, DOI 10.1016/j.jinsphys.2008.04.023; Nalini M, 2007, J INSECT PHYSIOL, V53, P1283, DOI 10.1016/j.jinsphys.2007.07.004; NISHIOKA T, 2007, BIOMEMS BIOMEDICAL N, V3, P437; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ozaki A, 2005, FEBS J, V272, P3863, DOI 10.1111/j.1742-4658.2005.04800.x; Raftos DA, 2004, DEV COMP IMMUNOL, V28, P181, DOI 10.1016/S0145-305X(03)00136-8; Roda A, 2009, ANAL BIOANAL CHEM, V393, P109, DOI 10.1007/s00216-008-2435-8; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shia M, 2008, VIROLOGY, V375, P374, DOI 10.1016/j.virol.2008.02.027; Solon E, 1996, DEV COMP IMMUNOL, V20, P307, DOI 10.1016/S0145-305X(96)00022-5; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; STOLTZ DB, 1993, PARASITES PATHOGENS, P80; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Teramato T, 2003, J INSECT PHYSIOL, V49, P463, DOI 10.1016/S0022-1910(03)00063-5; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; WEBB BA, 2005, 8 INT COMM TAX VIR, P255; WEBB BA, 2005, COMPREHENSIVE MOL IN, P260	54	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10466	10475		10.1074/jbc.M110.214726	http://dx.doi.org/10.1074/jbc.M110.214726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233205	Green Published, hybrid			2022-12-25	WOS:000288547000063
J	Bush, DJ; Kirillova, O; Clark, SA; Davulcu, O; Fabiola, F; Xie, Q; Somasundaram, T; Ellington, WR; Chapman, MS				Bush, D. Jeffrey; Kirillova, Olga; Clark, Shawn A.; Davulcu, Omar; Fabiola, Felcy; Xie, Qing; Somasundaram, Thayumanasamy; Ellington, W. Ross; Chapman, Michael S.			The Structure of Lombricine Kinase IMPLICATIONS FOR PHOSPHAGEN KINASE CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE KINASE; CREATINE-KINASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; INDUCED-FIT; REFINEMENT; SYSTEM; CONSEQUENCES; GLYCOCYAMINE; MUTAGENESIS	Lombricine kinase is a member of the phosphagen kinase family and a homolog of creatine and arginine kinases, enzymes responsible for buffering cellular ATP levels. Structures of lombricine kinase from the marine worm Urechis caupo were determined by x-ray crystallography. One form was crystallized as a nucleotide complex, and the other was substrate-free. The two structures are similar to each other and more similar to the substrate-free forms of homologs than to the substrate-bound forms of the other phosphagen kinases. Active site specificity loop 309-317, which is disordered in substrate-free structures of homologs and is known from the NMR of arginine kinase to be inherently dynamic, is resolved in both lombricine kinase structures, providing an improved basis for understanding the loop dynamics. Phosphagen kinases undergo a segmented closing on substrate binding, but the lombricine kinase ADP complex is in the open form more typical of substrate-free homologs. Through a comparison with prior complexes of intermediate structure, a correlation was revealed between the overall enzyme conformation and the substrate interactions of His(178). Comparative modeling provides a rationale for the more relaxed specificity of these kinases, of which the natural substrates are among the largest of the phosphagen substrates.	[Bush, D. Jeffrey; Clark, Shawn A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Kirillova, Olga; Davulcu, Omar; Xie, Qing; Chapman, Michael S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, Portland, OR 97239 USA; [Fabiola, Felcy; Somasundaram, Thayumanasamy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Ellington, W. Ross] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; Oregon Health & Science University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Chapman, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med L224, Portland, OR 97239 USA.	chapmami@ohsu.edu		Somasundaram, Thayumanasamy/0000-0002-3629-5117; Chapman, Michael/0000-0001-8525-8585	National Institutes of Health [GM55837, GM77643, GM78538, RR-01646]; American Heart Association [0315101B]; National Science Foundation [DMR 0225180]; U. S. Department of Energy [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078538, R01GM077643, R01GM055837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55837, GM77643, and GM78538 (to M.S.C.). This work was also supported by Predoctoral Fellowship 0315101B from the American Heart Association (to D.J.B.).; Diffraction data were collected at the Cornell High Energy Synchrotron Source and its MacCHESS resource, supported by the National Science Foundation (DMR 0225180) and the National Institutes of Health (RR-01646) and also at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, supported by the U. S. Department of Energy (W-31-109-Eng-38).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLETHEN SL, 1972, ARCH BIOCHEM BIOPHYS, V149, P244, DOI 10.1016/0003-9861(72)90319-0; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BOYER R, 1998, CONCEPTS BIOCH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chapman MS., 2006, CREATINE KINASE, P69; Chen LH, 1996, BIOCHEMISTRY-US, V35, P7895, DOI 10.1021/bi952798i; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davulcu O, 2009, STRUCTURE, V17, P1356, DOI 10.1016/j.str.2009.08.014; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Ellington WR, 2002, BIOCHEM BIOPH RES CO, V291, P939, DOI 10.1006/bbrc.2002.6539; Ellington WR, 1998, BIOL BULL-US, V195, P264, DOI 10.2307/1543138; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Forstner M, 1997, PROTEIN SCI, V6, P331; Forstner M, 1998, BIOPHYS J, V75, P1016, DOI 10.1016/S0006-3495(98)77590-3; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; FURTER R, 1993, BIOCHEMISTRY-US, V32, P7022, DOI 10.1021/bi00078a030; Gattis JL, 2004, BIOCHEMISTRY-US, V43, P8680, DOI 10.1021/bi049793i; GERSTEIN M, 1991, J MOL BIOL, V220, P133, DOI 10.1016/0022-2836(91)90387-L; Grosse-Kunstleve RW, 2001, ACTA CRYSTALLOGR D, V57, P1390, DOI 10.1107/S090744490101246X; HANSEN DE, 1981, J BIOL CHEM, V256, P5967; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hosfield D, 2003, J STRUCT BIOL, V142, P207, DOI 10.1016/S1047-8477(03)00051-0; HOWLIN B, 1989, ACTA CRYSTALLOGR A, V45, P851, DOI 10.1107/S0108767389009177; Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509; Jourden MJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1519, DOI 10.1016/j.bbapap.2007.10.001; Kirillova O, 2006, BIOINFORMATICS, V22, P1660, DOI 10.1093/bioinformatics/btl152; KLEYWEGT GJ, 1996, CCP4 ESF EACBM NEWSL, V32, P32; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MAGGIO ET, 1977, J BIOL CHEM, V252, P1202; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MURALI N, 1993, BIOCHEMISTRY-US, V32, P12941, DOI 10.1021/bi00210a049; MURALI N, 1994, BIOCHEMISTRY-US, V33, P14227, DOI 10.1021/bi00251a035; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; Novak WRP, 2004, BIOCHEMISTRY-US, V43, P13766, DOI 10.1021/bi049060y; Ohren JF, 2007, ACTA CRYSTALLOGR D, V63, P381, DOI 10.1107/S0907444906056204; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; RAO BDN, 1976, J BIOL CHEM, V251, P6981; Rao JK, 1998, FEBS LETT, V439, P133; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlattner U, 1998, MOL CELL BIOCHEM, V184, P125, DOI 10.1023/A:1006851330913; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Suzuki T, 2000, J BIOL CHEM, V275, P23884, DOI 10.1074/jbc.M002926200; Suzuki T, 1999, BIOCHEM J, V340, P671, DOI 10.1042/0264-6021:3400671; Suzuki T, 2009, COMP BIOCHEM PHYS B, V152, P60, DOI 10.1016/j.cbpb.2008.09.087; Szebenyi DME, 1997, J SYNCHROTRON RADIAT, V4, P128, DOI 10.1107/S0909049597000204; Tanaka K, 2004, FEBS LETT, V573, P78, DOI 10.1016/j.febslet.2004.07.061; Tisi D, 2001, ACTA CRYSTALLOGR D, V57, P187, DOI 10.1107/S0907444900015614; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu XA, 2010, FASEB J, V24, P242, DOI 10.1096/fj.09-140194; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Yousef MS, 2002, ACTA CRYSTALLOGR D, V58, P2009, DOI 10.1107/S0907444902014683; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449	76	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9338	9350		10.1074/jbc.M110.202796	http://dx.doi.org/10.1074/jbc.M110.202796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212263	Green Published, hybrid			2022-12-25	WOS:000288247700063
J	Park, R; Wang'ondu, R; Heston, L; Shedd, D; Miller, G				Park, Richard; Wang'ondu, Ruth; Heston, Lee; Shedd, Duane; Miller, George			Efficient Induction of Nuclear Aggresomes by Specific Single Missense Mutations in the DNA-binding Domain of a Viral AP-1 Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; ZEBRA PROTEIN; TRANSCRIPTIONAL ACTIVATION; EXPANDED POLYGLUTAMINE; HUNTINGTONS-DISEASE; ZTA TRANSACTIVATOR; CRYSTAL-STRUCTURE; INCLUSION-BODIES; GENE-EXPRESSION; BODY FORMATION	Nuclear aggresomes induced by proteins containing an expanded polyglutamine (polyQ) tract are pathologic hallmarks of certain neurodegenerative diseases. Some GFP fusion proteins lacking a polyQ tract may also induce nuclear aggresomes in cultured cells. Here we identify single missense mutations within the basic DNA recognition region of Bam HI Z E B virus replication activator (ZEBRA), an Epstein-Barr virus (EBV)-encoded basic zipper protein without a polyQ tract, that efficiently induced the formation of nuclear aggresomes. Wild-type (WT) ZEBRA was diffusely distributed within the nucleus. Four non-DNA-binding mutants, Z(R179E), Z(R183E), Z(R190E), and Z(K178D) localized to the periphery of large intranuclear spheres, to discrete nuclear aggregates, and to the cytoplasm. Other non-DNA-binding mutants, Z(N182K), Z(N182E), and Z(S186E), did not exhibit this phenotype. The interior of the spheres contained promyelocytic leukemia and HSP70 proteins. ZEBRA mutants directly induced the nuclear aggresome pathway in cells with and without EBV. Specific cellular proteins (SC35 and HDAC6) and viral proteins (WT ZEBRA, Rta, and BMLF1) but not other cellular or viral proteins were recruited to nuclear aggresomes. Co-transfection of WT ZEBRA with aggresome-inducing mutants Z(R183E) and Z(R179E) inhibited late lytic viral protein expression and lytic viral DNA amplification. This is the first reported instance in which nuclear aggresomes are induced by single missense mutations in a viral or cellular protein. We discuss conformational changes in the mutant viral AP-1 proteins that may lead to formation of nuclear aggresomes.	[Heston, Lee; Shedd, Duane; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Park, Richard; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wang'ondu, Ruth] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,420 LSOG,POB 208064, New Haven, CT 06520 USA.	George.Miller@yale.edu		wangondu, ruth/0000-0002-4586-8933	National Institutes of Health [CA12055, CA16038]; Medical Scientist Training Program [2T32GM07205]; NATIONAL CANCER INSTITUTE [R37CA012055, P01CA016038, R01CA012055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA12055 and CA16038 and Training Grant 2T32GM07205 from the Medical Scientist Training Program (to R. W.).	Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bell P, 2000, J VIROL, V74, P11800, DOI 10.1128/JVI.74.24.11800-11810.2000; Bertrand L, 2010, J VIROL, V84, P109, DOI 10.1128/JVI.01428-09; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; Chen L, 2001, VIROLOGY, V288, P119, DOI 10.1006/viro.2001.1057; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dovey CL, 2004, J PATHOL, V203, P877, DOI 10.1002/path.1604; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; El-Guindy AS, 2004, J VIROL, V78, P7634, DOI 10.1128/JVI.78.14.7634-7644.2004; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRAHAM FL, 1974, NATURE, V251, P687, DOI 10.1038/251687a0; Heston L, 2006, J VIROL, V80, P9115, DOI 10.1128/JVI.00909-06; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lehman AM, 1998, J BIOL CHEM, V273, P932, DOI 10.1074/jbc.273.2.932; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lymberopoulos MH, 2007, VIROLOGY, V363, P397, DOI 10.1016/j.virol.2007.01.028; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Miranker AD, 2005, NATURE, V437, P197, DOI 10.1038/437197a; Moran DM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-32; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park R, 2008, VIROLOGY, V382, P145, DOI 10.1016/j.virol.2008.09.009; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Schelcher C, 2007, J VIROL, V81, P7149, DOI 10.1128/JVI.00215-07; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TOKUYASU KT, 1983, J CELL BIOL, V97, P562, DOI 10.1083/jcb.97.2.562; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	63	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9748	9762		10.1074/jbc.M110.198325	http://dx.doi.org/10.1074/jbc.M110.198325			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233201	Green Published, hybrid			2022-12-25	WOS:000288247700098
J	Tsvetkov, P; Adamovich, Y; Elliott, E; Shaul, Y				Tsvetkov, Peter; Adamovich, Yaarit; Elliott, Evan; Shaul, Yosef			E3 Ligase STUB1/CHIP Regulates NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Accumulation in Aged Brain, a Process Impaired in Certain Alzheimer Disease Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PROTEASOMAL DEGRADATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXIDATIVE STRESS; DT-DIAPHORASE; PHOSPHORYLATED TAU; CHIP; POLYMORPHISM; ASSOCIATION; P53	NAD(P) H: quinone oxidoreductase 1 (NQO1) is a flavoenzyme that is important in maintaining the cellular redox state and regulating protein degradation. The NQO1 polymorphism C609T has been associated with increased susceptibility to various age-related pathologies. We show here that NQO1 protein level is regulated by the E3 ligase STUB1/CHIP (C terminus of Hsc70-interacting protein). NQO1 binds STUB1 via the Hsc70-interacting domain (tetratricopeptide repeat domain) and undergoes ubiquitination and degradation. We demonstrate here that the product of the C609T polymorphism (P187S) is a stronger STUB1 interactor with increased susceptibility to ubiquitination by the E3 ligase STUB1. Furthermore, age-dependent decrease of STUB1 correlates with increased NQO1 accumulation. Remarkably, examination of hippocampi from Alzheimer disease patients revealed that in half of the cases examined the NQO1 protein level was undetectable due to C609T polymorphism, suggesting that the age-dependent accumulation of NQO1 is impaired in certain Alzheimer disease patients.	[Tsvetkov, Peter; Adamovich, Yaarit; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Elliott, Evan] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Tsvetkov, Peter/D-6458-2011; Tsvetkov, Peter/J-9878-2019	Tsvetkov, Peter/0000-0002-7577-2342; Elliott, Evan/0000-0002-1630-969X; Adamovich, Yaarit/0000-0001-9583-0338	Israel Science Foundation [1040/03-18.2]; Federal German Ministry for Education and Research; Minerva Foundation	Israel Science Foundation(Israel Science Foundation); Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Minerva Foundation	This work was supported by Grant 1040/03-18.2 from the Israel Science Foundation and a grant from the Minerva Foundation with funding from the Federal German Ministry for Education and Research.	Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Anwar A, 2002, J BIOL CHEM, V277, P14060, DOI 10.1074/jbc.M111576200; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bian JT, 2008, J MOL NEUROSCI, V34, P235, DOI 10.1007/s12031-008-9036-z; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Chen HW, 1999, CANCER RES, V59, P3045; Cheng XR, 2007, NEUROBIOL AGING, V28, P497, DOI 10.1016/j.neurobiolaging.2006.02.004; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Elliott E, 2009, J NEUROCHEM, V109, P1168, DOI 10.1111/j.1471-4159.2009.06047.x; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gaedigk A, 1998, PHARMACOGENETICS, V8, P305, DOI 10.1097/00008571-199808000-00004; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Lafuente MJ, 2000, CARCINOGENESIS, V21, P1813, DOI 10.1093/carcin/21.10.1813; Loffek S, 2010, HUM MUTAT, V31, P466, DOI 10.1002/humu.21222; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Moran JL, 1999, P NATL ACAD SCI USA, V96, P8150, DOI 10.1073/pnas.96.14.8150; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Raina AK, 1999, REDOX REP, V4, P23, DOI 10.1179/135100099101534701; Ross D, 2004, METHOD ENZYMOL, V382, P115; SantaCruz KS, 2004, NEUROBIOL AGING, V25, P63, DOI 10.1016/S0197-4580(03)00117-9; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, EMBO REP, V10, P65, DOI 10.1038/embor.2008.218; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Talalay P, 2004, METHOD ENZYMOL, V382, P355; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Wang BB, 2006, NEUROSCI LETT, V409, P179, DOI 10.1016/j.neulet.2006.09.042; Wiemels JL, 1999, CANCER RES, V59, P4095	57	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8839	8845		10.1074/jbc.M110.193276	http://dx.doi.org/10.1074/jbc.M110.193276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220432	Green Published, hybrid			2022-12-25	WOS:000288247700014
J	Hutchinson, JA; Shanware, NP; Chang, HY; Tibbetts, RS				Hutchinson, John A.; Shanware, Naval P.; Chang, Haeyoon; Tibbetts, Randal S.			Regulation of Ribosomal Protein S6 Phosphorylation by Casein Kinase 1 and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SIZE; IDENTIFICATION; TRANSLATION; ACTIVATION; INITIATION; INSULIN; SERUM	Ribosomal protein S6 (rpS6) is a critical component of the 40 S ribosomal subunit that mediates translation initiation at the 5'-m7GpppG cap of mRNA. In response to mitogenic stimuli, rpS6 undergoes ordered C-terminal phosphorylation by p70 S6 kinases and p90 ribosomal S6 kinases on four conserved Ser residues (Ser-235, Ser-236, Ser-240, and Ser-244) whose modification potentiates rpS6 cap binding activity. A fifth site, Ser-247, is also known to be phosphorylated, but its function and regulation are not well characterized. In this study, we employed phospho-specific antibodies to show that Ser-247 is a target of the casein kinase 1 (CK1) family of protein kinases. CK1-dependent phosphorylation of Ser-247 was induced by mitogenic stimuli and required prior phosphorylation of upstream S6 kinase/ribosomal S6 kinase residues. CK1-mediated phosphorylation of Ser-247 also enhanced the phosphorylation of upstream sites, which implies that bidirectional synergy between C-terminal phospho-residues is required to sustain rpS6 phosphorylation. Consistent with this idea, CK1-dependent phosphorylation of rpS6 promotes its association with the mRNA cap-binding complex in vitro. Additionally, we show that protein phosphatase 1 (PP1) antagonizes rpS6 C terminus phosphorylation and cap binding in intact cells. These findings further our understanding of rpS6 phospho-regulation and define a direct link between CK1 and translation initiation.	[Hutchinson, John A.; Shanware, Naval P.; Chang, Haeyoon; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hutchinson, John A.; Tibbetts, Randal S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shanware, Naval P.; Tibbetts, Randal S.] Univ Wisconsin, Mol & Cellular Pharmacol Program, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722]; National Institutes of Health through the NIEHS [T32ES007015]; American Cancer Society; Greater Milwaukee Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIEHS; American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722 (to R. S. T.) and National Institutes of Health Grant T32ES007015 through the NIEHS (to J. A. H.). This work was also supported by grants from the American Cancer Society and a Shaw Scientist Award from the Greater Milwaukee Foundation (to R. S. T.) and an American Heart Association Predoctoral Fellowship (to N. P. S.).	BELANDIA B, 1994, MOL CELL BIOL, V14, P200, DOI 10.1128/MCB.14.1.200; BURKHARD SJ, 1983, J BIOL CHEM, V258, P4003; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DUNCAN R, 1982, EUR J BIOCHEM, V123, P535; Gao ZH, 2000, BIOCHEM BIOPH RES CO, V268, P562, DOI 10.1006/bbrc.2000.2168; HAAS DW, 1991, ARCH BIOCHEM BIOPHYS, V284, P84, DOI 10.1016/0003-9861(91)90267-M; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; KRIEG J, 1988, J BIOL CHEM, V263, P11473; MARTINPEREZ J, 1983, P NATL ACAD SCI-BIOL, V80, P926, DOI 10.1073/pnas.80.4.926; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; OLIVIER AR, 1988, P NATL ACAD SCI USA, V85, P4720, DOI 10.1073/pnas.85.13.4720; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; WETTENHALL REH, 1992, J BIOL CHEM, V267, P9021	21	69	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8688	8696		10.1074/jbc.M110.141754	http://dx.doi.org/10.1074/jbc.M110.141754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233202	hybrid, Green Published			2022-12-25	WOS:000288013300094
J	Konig, J; Wyllie, S; Wells, G; Stevens, MF; Wyatt, PG; Fairlamb, AH				Koenig, Janine; Wyllie, Susan; Wells, Geoffrey; Stevens, Malcolm F.; Wyatt, Paul G.; Fairlamb, Alan H.			Antitumor Quinol PMX464 Is a Cytocidal Anti-trypanosomal Inhibitor Targeting Trypanothione Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-SENSITIVE OLIGOMERIZATION; CANCER CELL-LINES; TRYPANOSOMA-BRUCEI; TRYPAREDOXIN PEROXIDASES; CRITHIDIA-FASCICULATA; AFRICAN TRYPANOSOMES; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; THIOREDOXIN INHIBITOR	Better drugs are urgently needed for the treatment of African sleeping sickness. We tested a series of promising anticancer agents belonging to the 4-substituted 4-hydroxycyclohexa-2,5-dienones class ("quinols") and identified several with potent trypanocidal activity (EC50 < 100 nM). In mammalian cells, quinols are proposed to inhibit the thioredoxin/thioredoxin reductase system, which is absent from trypanosomes. Studies with the prototypical 4-benzothiazole-substituted quinol, PMX464, established that PMX464 is rapidly cytocidal, similar to the arsenical drug, melarsen oxide. Cell lysis by PMX464 was accelerated by addition of sublethal concentrations of glucose oxidase implicating oxidant defenses in the mechanism of action. Whole cells treated with PMX464 showed a loss of trypanothione (T(SH)(2)), a unique dithiol in trypanosomes, and tryparedoxin peroxidase (TryP), a 2-Cys peroxiredoxin similar to mammalian thioredoxin peroxidase. Enzyme assays revealed that T(SH)(2), TryP, and a glutathione peroxidase- like tryparedoxin-dependent peroxidase were inhibited in time-and concentration-dependent manners. The inhibitory activities of various quinol analogues against these targets showed a good correlation with growth inhibition of Trypanosoma brucei. The monothiols glutathione and L-cysteine bound in a 2: 1 ratio with PMX464 with K-d values of 6 and 27 mu M, respectively, whereas T(SH)(2) bound more tightly in a 1: 1 ratio with a K-d value of 430 nM. Overexpression of trypanothione synthetase in T. brucei decreased sensitivity to PMX464 indicating that the key metabolite T(SH)(2) is a target for quinols. Thus, the quinol pharmacophore represents a novel lead structure for the development of a new drug against African sleeping sickness.	[Koenig, Janine; Wyllie, Susan; Wyatt, Paul G.; Fairlamb, Alan H.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Wells, Geoffrey; Stevens, Malcolm F.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Dundee; University of Nottingham	Fairlamb, AH (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyatt, Paul/0000-0002-0397-245X; Wyllie, Susan/0000-0001-8810-5605; Wells, Geoffrey/0000-0002-0253-911X	Wellcome Trust [WT 079838, WT 077705, WT 083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants WT 079838, WT 077705, and WT 083481.	ABOAGYEKWARTENG T, 1992, MOL MICROBIOL, V6, P3089, DOI 10.1111/j.1365-2958.1992.tb01766.x; Alphey MS, 2008, BIOCHEM J, V414, P375, DOI 10.1042/BJ20080889; Alphey MS, 2003, J BIOL CHEM, V278, P25919, DOI 10.1074/jbc.M301526200; Alphey MS, 1999, J BIOL CHEM, V274, P25613, DOI 10.1074/jbc.274.36.25613; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Augustyns K, 2001, CURR PHARM DESIGN, V7, P1117, DOI 10.2174/1381612013397564; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P783, DOI 10.2471/BLT.06.031955; Balasegaram M, 2009, T ROY SOC TROP MED H, V103, P280, DOI 10.1016/j.trstmh.2008.09.005; Berry JM, 2005, J MED CHEM, V48, P639, DOI 10.1021/jm040859h; Bond CS, 1999, STRUCTURE, V7, P81, DOI 10.1016/S0969-2126(99)80011-2; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Callister ME, 2008, BRIT J PHARMACOL, V155, P661, DOI 10.1038/bjp.2008.258; Chew EH, 2008, FASEB J, V22, P2072, DOI 10.1096/fj.07-101477; Chew EH, 2006, BIOCHEM BIOPH RES CO, V346, P242, DOI 10.1016/j.bbrc.2006.05.106; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; CUNNINGHAM ML, 1994, EUR J BIOCHEM, V221, P285, DOI 10.1111/j.1432-1033.1994.tb18740.x; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; GETHING MJH, 1972, EUR J BIOCHEM, V30, P352; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; HENDERSON GB, 1987, MOL BIOCHEM PARASIT, V24, P39, DOI 10.1016/0166-6851(87)90113-7; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lion CJ, 2006, BIOORG MED CHEM LETT, V16, P5005, DOI 10.1016/j.bmcl.2006.07.072; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; Mortimer CG, 2006, J MED CHEM, V49, P179, DOI 10.1021/jm050942k; Mukherjee A, 2005, BRIT J CANCER, V92, P350, DOI 10.1038/sj.bjc.6602338; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Pallis M, 2003, BIOCHEM PHARMACOL, V66, P1695, DOI 10.1016/S0006-2952(03)00471-4; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Wells G, 2003, J MED CHEM, V46, P532, DOI 10.1021/jm020984y; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	56	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8523	8533		10.1074/jbc.M110.214833	http://dx.doi.org/10.1074/jbc.M110.214833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212280	Green Published, hybrid			2022-12-25	WOS:000288013300079
J	Zhang, JH; Fukuhara, S; Sako, K; Takenouchi, T; Kitani, H; Kume, T; Koh, GY; Mochizuki, N				Zhang, Jianghui; Fukuhara, Shigetomo; Sako, Keisuke; Takenouchi, Takato; Kitani, Hiroshi; Kume, Tsutomu; Koh, Gou Young; Mochizuki, Naoki			Angiopoietin-1/Tie2 Signal Augments Basal Notch Signal Controlling Vascular Quiescence by Inducing Delta-Like 4 Expression through AKT-mediated Activation of beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS TUMOR-GROWTH; TIE2 RECEPTOR; CELL-CELL; VESSEL FORMATION; ANGIOGENESIS; LIGAND; PATHWAY; DLL4; MATRIX; VEGF	Angiopoietin-1 (Ang1) regulates both vascular quiescence and angiogenesis through the receptor tyrosine kinase Tie2. We and another group previously showed that Ang1 and Tie2 form distinct signaling complexes at cell-cell and cell-matrix contacts. We further demonstrated that the former up-regulates Notch ligand delta-like 4 (Dll4) only in the presence of cell-cell contacts. Because Dll4/Notch signal restricts sprouting angiogenesis and promotes vascular stabilization, we investigated the mechanism of how the Ang1/Tie2 signal induces Dll4 expression to clarify the role of the Dll4/Notch signal in Ang1/Tie2 signal-mediated vascular quiescence. Under confluent endothelial cells, the basal Notch signal was observed. Ang1, moreover, induced Dll4 expression and production of the Notch intracellular domain (NICD). Ang1 stimulated transcriptional activity of beta-catenin through phosphoinositide 3-kinase (PI3K)/AKT-mediated phosphorylation of glycogen synthase kinase 3 beta (GSK3 beta). Correspondingly, the GSK3 beta inhibitor up-regulated Dll4, whereas depletion of beta-catenin by siRNA blocked Ang1-induced Dll4 expression, indicating the indispensability of beta-catenin in Ang1-mediated up-regulation of Dll4. In addition, Dll4 expression by the GSK3 beta inhibitor was only observed in confluent cells, and was impeded by DAPT, a gamma-secretase inhibitor, implying requirement of the Notch signal in beta-catenin-dependent Dll4 expression. Consistently, we found that either Ang1 or NICD up-regulates Dll4 through the RBP-J binding site within intron 3 of the DLL4 gene and that beta-catenin forms a complex with NICD/RBP-J to enhance Dll4 expression. Ang1 induced the deposition of extracellular matrix that is preferable for basement membrane formation through Dll4/Notch signaling. Collectively, the Ang1/Tie2 signal potentiates basal Notch signal controlling vascular quiescence by up-regulating Dll4 through AKT-mediated activation of beta-catenin.	[Zhang, Jianghui; Fukuhara, Shigetomo; Sako, Keisuke; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Osaka 5658565, Japan; [Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Transgenic Anim Res Ctr, Ibaraki 3058634, Japan; [Takenouchi, Takato] Tokyo Metropolitan Inst Neurosci, Lab Chem & Metab, Tokyo 1838526, Japan; [Kume, Tsutomu] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	National Cerebral & Cardiovascular Center - Japan; National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Northwestern University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Fukuhara, S (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Koh, Gou Young/C-1615-2011	sako, keisuke/0000-0002-6453-8075	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labor, and Welfare of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Naito Foundation; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Novartis Foundation (Japan) for the Promotion of Science; Senri Life Science Foundation; Mitsubishi Foundation; AstraZeneca; Grants-in-Aid for Scientific Research [22113009, 22390040] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074121] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Senri Life Science Foundation; Mitsubishi Foundation; AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (to S. F. and N. M.), the Ministry of Health, Labor, and Welfare of Japan (to N. M.), and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to S. F. and N. M.), grants from the Naito Foundation (to S. F.), Takeda Science Foundation (to S. F. and N. M.), the Sagawa Foundation for Promotion of Cancer Research (to S. F.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (to S. F.), Kowa Life Science Foundation (to S. F.), Kanae Foundation for the Promotion of Medical Science (to S. F.), The Novartis Foundation (Japan) for the Promotion of Science (to S. F.), Senri Life Science Foundation (to S. F.), the Mitsubishi Foundation (to N. M.), and a AstraZeneca Research Grant (to N. M.).	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gridley T, 1997, MOL CELL NEUROSCI, V9, P103, DOI 10.1006/mcne.1997.0610; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Machein MR, 2004, AM J PATHOL, V165, P1557, DOI 10.1016/S0002-9440(10)63413-X; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	50	83	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8055	8066		10.1074/jbc.M110.192641	http://dx.doi.org/10.1074/jbc.M110.192641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212269	Green Published, hybrid			2022-12-25	WOS:000288013300036
J	Dluzen, D; Li, GF; Tacelosky, D; Moreau, M; Liu, DX				Dluzen, Douglas; Li, Guangfu; Tacelosky, Diana; Moreau, Matthew; Liu, David X.			BCL-2 Is a Downstream Target of ATF5 That Mediates the Prosurvival Function of ATF5 in a Cell Type-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ATF5; NEURAL PROGENITOR CELLS; EPITHELIAL-CELLS; EXPRESSION; GENE; APOPTOSIS; PROMOTER; SURVIVAL; PROTEIN; FAMILY	ATF5 loss of function has been shown previously to cause apoptotic cell death in glioblastoma and breast cancer cells but not in non-transformed astrocytes and human breast epithelial cells. The mechanism for the cell type-dependent survival function of ATF5 is unknown. We report here that the anti-apoptotic factor BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in C6 glioma cells and MCF-7 breast cancer cells. ATF5 binds to an ATF5-specific regulatory element that is downstream of and adjacent to the negative regulatory element in the BCL-2 P2 promoter, stimulating BCL-2 expression. Highlighting the critical role of BCL-2 in ATF5-dependent cancer cell survival, expression of BCL-2 blocks death of C6 and MCF-7 cells induced by dominant-negative ATF5, and depletion of BCL-2 impairs ATF5-promoted cell survival. Moreover, we found that BCL-2 expression is not regulated by ATF5 in non-transformed rat astrocytes, mouse embryonic fibroblasts, and human breast epithelial cells, where expression of BCL-2 but not ATF5 is required for cell survival. These findings identify BCL-2 as an essential mediator for the cancer-specific cell survival function of ATF5 in glioblastoma and breast cancer cells and provide direct evidence that the cell type-specific function of ATF5 derives from differential regulation of downstream targets by ATF5 in different types of cells.	[Dluzen, Douglas; Li, Guangfu; Tacelosky, Diana; Moreau, Matthew; Liu, David X.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, DX (corresponding author), Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA.	dliu@psu.edu		Li, Guangfu/0000-0002-9817-568X; Dluzen, Douglas/0000-0002-9426-5071	American Cancer Society; United States Department of Defense	American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported in part by grants from the American Cancer Society and United States Department of Defense.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; CHEN HM, 1995, MOL CELL BIOL, V15, P3840; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cole R, 2001, PROTOCOLS NEURAL CEL, P117, DOI [10.1385/1-59259-207-4:117, DOI 10.1385/1-59259-207-4:117]; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Heckman CA, 2003, ONCOGENE, V22, P7891, DOI 10.1038/sj.onc.1206639; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; MIYASHITA T, 1994, CANCER RES, V54, P3131; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; NOVACK DV, 1994, AM J PATHOL, V145, P61; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Wang H, 2007, CELL BIOL INT, V31, P1309, DOI 10.1016/j.cellbi.2007.05.002; Wei YY, 2006, BIOCHEM BIOPH RES CO, V339, P591, DOI 10.1016/j.bbrc.2005.11.054; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686	32	60	65	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7705	7713		10.1074/jbc.M110.207639	http://dx.doi.org/10.1074/jbc.M110.207639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21212266	Green Published, hybrid			2022-12-25	WOS:000287737300083
J	Nageshan, RK; Roy, N; Hehl, AB; Tatu, U				Nageshan, Rishi Kumar; Roy, Nainita; Hehl, Adrian B.; Tatu, Utpal			Post-transcriptional Repair of a Split Heat Shock Protein 90 Gene by mRNA trans-Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIARDIA-LAMBLIA; GENOME SEQUENCE; DRUG TARGET; HSP90; EXPRESSION; EVOLUTION; GROWTH; HEAT-SHOCK-PROTEIN-90; CAPACITOR; PARASITE	Heat shock protein 90 participates in diverse biological processes ranging from protein folding, cell cycle, signal transduction and development to evolution in all eukaryotes. It is also critically involved in regulating growth of protozoa such as Dictyostelium discoideum, Leishmania donovani, Plasmodium falciparum, Trypanosoma cruzi, and Trypanosoma evansi. Selective inhibition of Hsp90 has also been explored as an intervention strategy against important human diseases such as cancer, malaria, or trypanosomiasis. Giardia lamblia, a simple protozoan parasite of humans and animals, is an important cause of diarrheal disease with significant morbidity and some mortality in tropical countries. Here we show that the G. lamblia cytosolic hsp90 ( glhsp90) is split in two similar sized fragments located 777 kb apart on the same scaffold. Intrigued by this unique arrangement, which appears to be specific for the Giardiinae, we have investigated the biosynthesis of GlHsp90. We used genome sequencing to confirm the split nature of the giardial hsp90. However, a specific antibody raised against the peptide detected a product with a mass of about 80 kDa, suggesting a post-transcriptional rescue of the genomic defect. We show evidence for the joining of the two independent Hsp90 transcripts in-trans to one long mature mRNA presumably by RNA splicing. The splicing junction carries hallmarks of classical cis-spliced introns, suggesting that the regular cis-splicing machinery may be sufficient for repair of the open reading frame. A complementary 26-nt sequence in the "intron" regions adjacent to the splice sites may assist in positioning the two pre-mRNAs for processing. This is the first example of post-transcriptional rescue of a split gene by trans-splicing.	[Hehl, Adrian B.] Univ Zurich, Inst Parasitol, CH-8046 Zurich, Switzerland; [Nageshan, Rishi Kumar; Roy, Nainita; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	University of Zurich; Indian Institute of Science (IISC) - Bangalore	Hehl, AB (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8046 Zurich, Switzerland.	adrian.hehl@access.uzh.ch; tatu@biochem.iisc.ernet.in	Bhowmick, Nainita Roy/AAS-2908-2021	Tatu, Utpal/0000-0003-0404-8872; Hehl, Adrian/0000-0002-2110-4445; Nageshan, Rishi Kumar/0000-0003-1592-4452	Department of Science and Technology, New Delhi; Department of Biotechnology, New Delhi, India; MALSIG; Council of Scientific and Industrial Research; Swiss National Science Foundation [31003A125389]; United Grants Commission, New Delhi, India	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); MALSIG; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United Grants Commission, New Delhi, India	This work was supported by grants from the Department of Science and Technology, New Delhi, the Department of Biotechnology, New Delhi, India, and MALSIG, by a Junior Research Fellowship from the Council of Scientific and Industrial Research and United Grants Commission, New Delhi, India (to R. K. N and N. R.), and by Swiss National Science Foundation Grant 31003A125389 (to A. B. H.).	Adam RD, 2000, INT J PARASITOL, V30, P475, DOI 10.1016/S0020-7519(99)00191-5; Ahn HJ, 2003, BIOCHEM BIOPH RES CO, V311, P654, DOI 10.1016/j.bbrc.2003.10.045; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen B, 2005, INSECT MOL BIOL, V14, P697, DOI 10.1111/j.1365-2583.2005.00602.x; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Echeverria PC, 2005, J MOL BIOL, V350, P723, DOI 10.1016/j.jmb.2005.05.031; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; HANNON GJ, 1992, SCIENCE, V258, P1775, DOI 10.1126/science.1465612; Harris JC, 2000, MICROBIOL-SGM, V146, P3119, DOI 10.1099/00221287-146-12-3119; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nakai H, 2000, NAT BIOTECHNOL, V18, P527, DOI 10.1038/75390; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pan F, 2000, J EXP ZOOL, V287, P199, DOI 10.1002/1097-010X(20000801)287:3&lt;199::AID-JEZ2&gt;3.0.CO;2-3; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sawarkar R, 2008, J MOL BIOL, V383, P24, DOI 10.1016/j.jmb.2008.08.006; Simpson AGB, 2002, CURR BIOL, V12, pR691, DOI 10.1016/S0960-9822(02)01207-1; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; YEE J, 1992, J BIOL CHEM, V267, P7539	29	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7116	7122		10.1074/jbc.C110.208389	http://dx.doi.org/10.1074/jbc.C110.208389			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209094	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000287737300028
J	Fisher, MA; McKinley, KL; Bradley, LH; Viola, SR; Hecht, MH				Fisher, Michael A.; McKinley, Kara L.; Bradley, Luke H.; Viola, Sara R.; Hecht, Michael H.			De Novo Designed Proteins from a Library of Artificial Sequences Function in Escherichia Coli and Enable Cell Growth	PLOS ONE			English	Article							NONPOLAR AMINO-ACIDS; COMBINATORIAL LIBRARY; GENOME; SUPERFAMILY; POLAR; K-12	A central challenge of synthetic biology is to enable the growth of living systems using parts that are not derived from nature, but designed and synthesized in the laboratory. As an initial step toward achieving this goal, we probed the ability of a collection of > 10(6) de novo designed proteins to provide biological functions necessary to sustain cell growth. Our collection of proteins was drawn from a combinatorial library of 102-residue sequences, designed by binary patterning of polar and nonpolar residues to fold into stable 4-helix bundles. We probed the capacity of proteins from this library to function in vivo by testing their abilities to rescue 27 different knockout strains of Escherichia coli, each deleted for a conditionally essential gene. Four different strains - Delta serB, Delta gltA, Delta ilvA, and Delta fes - were rescued by specific sequences from our library. Further experiments demonstrated that a strain simultaneously deleted for all four genes was rescued by co-expression of four novel sequences. Thus, cells deleted for similar to 0.1% of the E. coli genome (and similar to 1% of the genes required for growth under nutrient-poor conditions) can be sustained by sequences designed de novo.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Fisher, MA (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	hecht@princeton.edu		Bradley, Luke/0000-0003-1870-0796; Hecht, Michael/0000-0002-5538-9813; McKinley, Kara/0000-0001-6283-9168	NSF [MCB-0817651]; Direct For Biological Sciences [0817651, 1050510] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by NSF grant MCB-0817651 (URL: http://www.nsf.gov/div/index.jsp?div = MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beasley JR, 1997, J BIOL CHEM, V272, P2031, DOI 10.1074/jbc.272.4.2031; Bradley LH, 2005, PROTEIN ENG DES SEL, V18, P201, DOI 10.1093/protein/gzi020; BRADLEY LH, DESIGNED ARTIF UNPUB; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Go A, 2008, PROTEIN SCI, V17, P821, DOI 10.1110/ps.073377908; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Morett E, 2008, J MOL BIOL, V376, P839, DOI 10.1016/j.jmb.2007.12.017; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Patrick WM, 2008, J MOL BIOL, V377, P323, DOI 10.1016/j.jmb.2008.01.043; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; Pereto Juli, 2007, Biology Theory, V2, P128, DOI 10.1162/biot.2007.2.2.128; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; UMBARGER HE, 1957, J BACTERIOL, V73, P105, DOI 10.1128/JB.73.1.105-112.1957; Wei YN, 2003, P NATL ACAD SCI USA, V100, P13270, DOI 10.1073/pnas.1835644100; Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003; XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349	25	76	76	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e15364	10.1371/journal.pone.0015364	http://dx.doi.org/10.1371/journal.pone.0015364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245923	gold, Green Published, Green Submitted			2022-12-25	WOS:000286510500006
J	Azzi, S; Parissi, V; Maroun, RG; Eid, P; Mauffret, O; Fermandjian, S				Azzi, Sandy; Parissi, Vincent; Maroun, Richard G.; Eid, Pierre; Mauffret, Olivier; Fermandjian, Serge			The HIV-1 Integrase alpha 4-Helix Involved in LTR-DNA Recognition Is also a Highly Antigenic Peptide Element	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHOTO-CROSS-LINKING; C-TERMINAL DOMAIN; IN-VITRO; TYPE-1 INTEGRASE; VIRAL-DNA; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; ACTIVE-SITE; MONOCLONAL-ANTIBODY	Monoclonal antibodies (MAbas) constitute remarkable tools to analyze the relationship between the structure and the function of a protein. By immunizing a mouse with a 29mer peptide (K159) formed by residues 147 to 175 of the HIV-1 integrase (IN), we obtained a monoclonal antibody (MAba4) recognizing an epitope lying in the N-terminal portion of K159 (residues 147-166 of IN). The boundaries of the epitope were determined in ELISA assays using peptide truncation and amino acid substitutions. The epitope in K159 or as a free peptide (pep-a4) was mostly a random coil in solution, while in the CCD (catalytic core domain) crystal, the homologous segment displayed an amphipathic helix structure (alpha 4-helix) at the protein surface. Despite this conformational difference, a strong antigenic crossreactivity was observed between pep-a4 and the protein segment, as well as K156, a stabilized analogue of pep-a4 constrained into helix by seven helicogenic mutations, most of them involving hydrophobic residues. We concluded that the epitope is freely accessible to the antibody inside the protein and that its recognition by the antibody is not influenced by the conformation of its backbone and the chemistry of amino acids submitted to helicogenic mutations. In contrast, the AA -> Glu mutations of the hydrophilic residues Gln148, Lys156 and Lys159, known for their interactions with LTRs (long terminal repeats) and inhibitors (5 CITEP, for instance), significantly impaired the binding of K156 to the antibody. Moreover, we found that in competition ELISAs, the processed and unprocessed LTR oligonucleotides interfered with the binding of MAba4 to IN and K156, confirming that the IN alpha 4-helix uses common residues to interact with the DNA target and the MAba4 antibody. This also explains why, in our standard in vitro concerted integration assays, MAba4 strongly impaired the IN enzymatic activity.	[Azzi, Sandy; Mauffret, Olivier; Fermandjian, Serge] CNRS, ENS Cachan, LBPA, Cachan, France; [Azzi, Sandy; Eid, Pierre] Univ Paris 11, INSERM, U1014, Villejuif, France; [Parissi, Vincent] Univ Bordeaux 2, CNRS, UMR 5234, Lab Microbiol Cellulaire & Mol & Pathogenicite, F-33076 Bordeaux, France; [Maroun, Richard G.] Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, CST Mar Roukoz, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Saint Joseph University Beirut	Azzi, S (corresponding author), CNRS, ENS Cachan, LBPA, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020	Maroun, Richard/0000-0002-0697-2535	Centre National de la Recherche Scientifique (CNRS)-France [A/18-1/01251]; Conseil National de la Recherche Scientifique (CNRS)-Lebanon; Conseil de la Recherche de l'Universite Saint Joseph [09 S F 24/L 45]; Association Arc en ciel-Lebanon	Centre National de la Recherche Scientifique (CNRS)-France(Centre National de la Recherche Scientifique (CNRS)); Conseil National de la Recherche Scientifique (CNRS)-Lebanon(Centre National de la Recherche Scientifique (CNRS)); Conseil de la Recherche de l'Universite Saint Joseph; Association Arc en ciel-Lebanon	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was funded by the Centre National de la Recherche Scientifique (CNRS)-France, Sidaction (Ref: A/18-1/01251), the Conseil National de la Recherche Scientifique (CNRS)-Lebanon, the Conseil de la Recherche de l'Universite Saint Joseph and the Program CEDRE (09 S F 24/L 45). S.A. was supported by Association Arc en ciel-Lebanon.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Camacho LH, 2008, EXPERT OPIN INV DRUG, V17, P371, DOI [10.1517/13543784.17.3.371, 10.1517/13543784.17.3.371 ]; Caumont A, 1999, FEBS LETT, V455, P154, DOI 10.1016/S0014-5793(99)00859-5; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Drake RR, 1998, P NATL ACAD SCI USA, V95, P4170, DOI 10.1073/pnas.95.8.4170; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hobaika Z, 2010, NEUROCHEM RES, V35, P888, DOI 10.1007/s11064-009-0098-2; Hobaika Z, 2009, NUCLEIC ACIDS RES, V37, P7691, DOI 10.1093/nar/gkp824; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Johnson AA, 2006, J BIOL CHEM, V281, P32428, DOI 10.1074/jbc.M605101200; KATAYANAGI K, 1993, J BIOL CHEM, V268, P22092; KOSHLAND ME, 1966, BIOCHEMISTRY-US, V5, P641, DOI 10.1021/bi00866a034; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mahler M, 2003, J MOL MED-JMM, V81, P194, DOI 10.1007/s00109-003-0423-1; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Maroun RG, 1999, EUR J BIOCHEM, V260, P145, DOI 10.1046/j.1432-1327.1999.00130.x; Maroun RG, 1999, J BIOL CHEM, V274, P34174, DOI 10.1074/jbc.274.48.34174; Merad H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004081; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Moreau K, 2009, VIROLOGY, V392, P94, DOI 10.1016/j.virol.2009.06.031; Mould DR, 2007, CURR OPIN DRUG DISC, V10, P84; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Queffelec C, 2008, EUR J MED CHEM, V43, P2268, DOI 10.1016/j.ejmech.2007.12.013; Ramcharan J, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-34; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Routsias JG, 2006, CRIT REV CL LAB SCI, V43, P203, DOI 10.1080/10408360500523837; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Sourgen F, 1996, EUR J BIOCHEM, V240, P765, DOI 10.1111/j.1432-1033.1996.0765h.x; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; TANESE N, 1988, DNA-J MOLEC CELL BIO, V7, P407, DOI 10.1089/dna.1.1988.7.407; Yi JZ, 2000, J BIOL CHEM, V275, P38739, DOI 10.1074/jbc.M005499200; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200	67	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16001	10.1371/journal.pone.0016001	http://dx.doi.org/10.1371/journal.pone.0016001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209864	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600056
J	Gu, B; Zhang, JR; Wang, W; Mo, LJ; Zhou, Y; Chen, LB; Liu, YS; Zhang, M				Gu, Bin; Zhang, Jiarong; Wang, Wei; Mo, Lijuan; Zhou, Yang; Chen, Liangbiao; Liu, Yusen; Zhang, Ming			Global Expression of Cell Surface Proteins in Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; HEMATOPOIETIC STEM; MEMBRANE-PROTEINS; MOUSE; DIFFERENTIATION; CHROMATIN; TRANSCRIPTION; LIF; PROLIFERATION; GENES	Background: Recent studies have shown that embryonic stem (ES) cells globally express most genes in the genome at the mRNA level; however, it is unclear whether this global expression is propagated to the protein level. Cell surface proteins could perform critical functions in ES cells, so determining whether ES cells globally express cell surface proteins would have significant implications for ES cell biology. Methods and Principal Findings: The surface proteins of mouse ES cells were purified by biotin labeling and subjected to proteomics analysis. About 1000 transmembrane or secreted cell surface proteins were identified. These proteins covered a large variety if functional categories including signal transduction, adhesion and transporting. More over, mES cells promiscuously expressed a wide variety of tissue specific surface proteins. And many surface proteins were expressed heterogeneously on mES cells. We also find that human ES cells express a wide variety of tissue specific surface proteins. Conclusions/Significance: Our results indicate that global gene expression is not simply a result of leaky gene expression, which could be attributed to the loose chromatin structure of ES cells; it is also propagated to the functional level. ES cells may use diverse surface proteins to receive signals from the diverse extracellular stimuli that initiate differentiation. Moreover, the promiscuous expression of tissue specific surface proteins illuminate new insights into the strategies of cell surface marker screening.	[Gu, Bin; Zhang, Jiarong; Wang, Wei; Mo, Lijuan; Zhou, Yang; Zhang, Ming] Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Liangbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Liu, Yusen] Ohio State Univ, Dept Pediat, Ctr Perinatal Res, Res Inst,Nationwide Childrens Hosp,Coll Med, Columbus, OH 43210 USA	Zhejiang University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Gu, B (corresponding author), Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangming_ls@zju.edu.cn	Liu, Yusen/E-3527-2011	Liu, Yusen/0000-0002-0994-0109; Gu, Bin/0000-0002-5594-2463; , liangbiao/0000-0002-0717-8536	Ministry of Science and Technology of China; National Key Scientific Research Program of China [2007947804]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Scientific Research Program of China	This work was supported by the Ministry of Science and Technology of China and the National Key Scientific Research Program of China (2007947804, http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gu B, 2010, BIOCHEM BIOPH RES CO, V394, P418, DOI 10.1016/j.bbrc.2010.03.042; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2007, J INFRARED MILLIM W, V26, P26; [姜祖韵 Jiang Zuyun], 2005, [浙江大学学报. 理学版, Journal of Zhejiang University], V32, P574; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Son YS, 2005, STEM CELLS, V23, P1502, DOI 10.1634/stemcells.2004-0307; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Taylor T, 2010, STEM CELLS DEV, V19, P1333, DOI 10.1089/scd.2009.0484; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	52	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15795	10.1371/journal.pone.0015795	http://dx.doi.org/10.1371/journal.pone.0015795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209962	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200055
J	Reynolds, AM; Reynolds, DR; Smith, AD; Chapman, JW				Reynolds, Andy M.; Reynolds, Don R.; Smith, Alan D.; Chapman, Jason W.			Orientation Cues for High-Flying Nocturnal Insect Migrants: Do Turbulence-Induced Temperature and Velocity Fluctuations Indicate the Mean Wind Flow?	PLOS ONE			English	Article							HIGH-ALTITUDE; PARTICLE ACCELERATIONS; VERTICAL-DISTRIBUTION; PASSIVE SCALARS; LOCAL ISOTROPY; FLIGHT; RADAR; MIGRATION; LAYER; MOTION	Migratory insects flying at high altitude at night often show a degree of common alignment, sometimes with quite small angular dispersions around the mean. The observed orientation directions are often close to the downwind direction and this would seemingly be adaptive in that large insects could add their self-propelled speed to the wind speed, thus maximising their displacement in a given time. There are increasing indications that high-altitude orientation may be maintained by some intrinsic property of the wind rather than by visual perception of relative ground movement. Therefore, we first examined whether migrating insects could deduce the mean wind direction from the turbulent fluctuations in temperature. Within the atmospheric boundary-layer, temperature records show characteristic ramp-cliff structures, and insects flying downwind would move through these ramps whilst those flying crosswind would not. However, analysis of vertical-looking radar data on the common orientations of nocturnally migrating insects in the UK produced no evidence that the migrants actually use temperature ramps as orientation cues. This suggests that insects rely on turbulent velocity and acceleration cues, and refocuses attention on how these can be detected, especially as small-scale turbulence is usually held to be directionally invariant (isotropic). In the second part of the paper we present a theoretical analysis and simulations showing that velocity fluctuations and accelerations felt by an insect are predicted to be anisotropic even when the small-scale turbulence (measured at a fixed point or along the trajectory of a fluid-particle) is isotropic. Our results thus provide further evidence that insects do indeed use turbulent velocity and acceleration cues as indicators of the mean wind direction.	[Reynolds, Andy M.; Reynolds, Don R.; Smith, Alan D.; Chapman, Jason W.] Rothamsted Res, Harpenden, Herts, England; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Greenwich	Reynolds, AM (corresponding author), Rothamsted Res, Harpenden, Herts, England.	andy.reynolds@bbsrc.ac.uk	Reynolds, Donald R/C-7361-2013; Chapman, Jason/H-8236-2012	Chapman, Jason/0000-0002-7475-4441; Reynolds, Donald/0000-0001-8749-7491	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant aided support from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIA RA, 1982, BOUND-LAY METEOROL, V23, P395, DOI 10.1007/BF00116268; Ayyalasomayajula S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.144507; Chapman JW, 2008, CURR BIOL, V18, pR908, DOI 10.1016/j.cub.2008.08.014; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2006, ECOL ENTOMOL, V31, P378, DOI 10.1111/j.1365-2311.2006.00797.x; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, ECOL ENTOMOL, V27, P641, DOI 10.1046/j.1365-2311.2002.00472.x; Fung JCH, 2003, P ROY SOC A-MATH PHY, V459, P445, DOI 10.1098/rspa.2002.1023; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; GIBSON CH, 1977, PHYS FLUIDS, V20, pS156, DOI 10.1063/1.861725; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; La Porta A, 2001, NATURE, V409, P1017, DOI 10.1038/35059027; MAXEY MR, 1987, PHYS FLUIDS, V30, P1915, DOI 10.1063/1.866206; MESTAYER PG, 1976, PHYS FLUIDS, V19, P1279, DOI 10.1063/1.861649; PHONGANANT D, 1980, J GEOPHYS RES-OCEANS, V85, P424, DOI 10.1029/JC085iC01p00424; Reynolds AM, 2009, J R SOC INTERFACE, V6, P87, DOI 10.1098/rsif.2008.0173; Reynolds AM, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/058; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; Reynolds DR, 2008, B ENTOMOL RES, V98, P35, DOI 10.1017/S0007485307005470; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Riley J.R., 1986, P71; RILEY JR, 1975, NATURE, V253, P113, DOI 10.1038/253113a0; RILEY JR, 1989, C ROYAL I NAV CARD 6; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Schaefer G.W., 1976, Symposia Royal Ent Soc Lond, V7, P157; Schaefer G.W., 1969, P ROYAL ENTOMOLOGICA, V34, P39; SCHAEFER GW, 1969, P ROY ENTOMOL SOC  C, V34, P33; SREENIVASAN KR, 1979, J FLUID MECH, V94, P745, DOI 10.1017/S0022112079001270; SREENIVASAN KR, 1991, P ROY SOC LOND A MAT, V434, P165, DOI 10.1098/rspa.1991.0087; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; Voth GA, 2002, J FLUID MECH, V469, P121, DOI 10.1017/S0022112002001842; Warhaft Z, 2000, ANNU REV FLUID MECH, V32, P203, DOI 10.1146/annurev.fluid.32.1.203; Webb B, 2007, CURR BIOL, V17, pR124, DOI 10.1016/j.cub.2006.12.008; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843	40	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15758	10.1371/journal.pone.0015758	http://dx.doi.org/10.1371/journal.pone.0015758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209956	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000285793200052
J	Swetnam, J; Shmelkov, E; Zolla-Pazner, S; Cardozo, T				Swetnam, James; Shmelkov, Evgeny; Zolla-Pazner, Susan; Cardozo, Timothy			Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; PBL-SCID MICE; V3 LOOP; PASSIVE-IMMUNIZATION; CD4-BINDING SITE; TYPE-1 NEUTRALIZATION; GENETIC SUBTYPES; IMMUNE-RESPONSE; SOLUBLE CD4	Although the sequence variable loops of the human immunodeficiency virus' (HIV-1) surface envelope glycoprotein (gp120) can exhibit good immunogenicity, characterizing conserved (invariant) cross-strain neutralization epitopes within these loops has proven difficult. We recently developed a method to derive sensitive and specific signature motifs for the three-dimensional (3D) shapes of the HIV-1 neutralization epitopes in the third variable (V3) loop of gp120 that are recognized by human monoclonal antibodies (mAbs). We used the signature motif method to estimate the conservation of these epitopes across circulating worldwide HIV-1 strains. The epitope targeted by the anti-V3 loop neutralizing mAb 3074 is present in 87% of circulating strains, distributed nearly evenly among all subtypes. The results for other anti-V3 Abs are: 3791, present in 63% of primarily non-B subtypes; 2219, present in 56% of strains across all subtypes; 2557, present in 52% across all subtypes; 447-52D, present in 11% of primarily subtype B strains; 537-10D, present in 9% of primarily subtype B strains; and 268-D, present in 5% of primarily subtype B strains. The estimates correlate with in vitro tests of these mAbs against diverse viral panels. The mAb 3074 thus targets an epitope that is nearly completely conserved among circulating HIV-1 strains, demonstrating the presence of an invariant structure hidden in the dynamic and sequence-variable V3 loop in gp120. Since some variable loop regions are naturally immunogenic, designing immunogens to mimic their conserved epitopes may be a promising vaccine discovery approach. Our results suggest one way to quantify and compare the magnitude of the conservation.	[Swetnam, James; Shmelkov, Evgeny; Cardozo, Timothy] New York Univ Sch Med, Dept Pharmacol, New York, NY USA; [Zolla-Pazner, Susan] New York Univ Sch Med, Dept Pathol, New York, NY USA; [Zolla-Pazner, Susan] New York Vet Affairs Med Ctr, New York, NY USA	New York University; New York University	Swetnam, J (corresponding author), New York Univ Sch Med, Dept Pharmacol, New York, NY USA.	cardot01@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	Bill and Melinda Gates Foundation [38631]; National Institutes of Health [DPOD004631]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Bill and Melinda Gates Foundation (#38631 to SZP; http://www.gatesfoundation.org/Pages/home.aspx) and the National Institutes of Health (DPOD004631 to TC; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Gorny MK, 1997, J IMMUNOL, V159, P5114; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; HO DD, 1991, J VIROL, V65, P489, DOI 10.1128/JVI.65.1.489-493.1991; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Israel ZR, 1997, AIDS, V11, P128; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Mbah HA, 2001, J VIROL, V75, P7785, DOI 10.1128/JVI.75.16.7785-7788.2001; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; PINTER A, 1993, AIDS RES HUM RETROV, V9, P985, DOI 10.1089/aid.1993.9.985; Ruprecht Ruth M., 2009, V525, P559, DOI 10.1007/978-1-59745-554-1_31; SAFRIT JT, 1993, AIDS, V7, P15, DOI 10.1097/00002030-199301000-00002; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; VOGEL T, 1994, J IMMUNOL, V153, P1895; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039; ZOLLAPAZNER S, 2009, VIROLOGY; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	48	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15994	10.1371/journal.pone.0015994	http://dx.doi.org/10.1371/journal.pone.0015994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209919	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200078
J	Dalvai, M; Mondesert, O; Bourdon, JC; Ducommun, B; Dozier, C				Dalvai, M.; Mondesert, O.; Bourdon, J-C; Ducommun, B.; Dozier, C.			Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors	ONCOGENE			English	Article						Cdc25B; p53; Sp1; NF-Y	CELL-CYCLE REGULATION; WILD-TYPE P53; BREAST-CANCER; DNA-DAMAGE; EXPRESSION; ACTIVATION; PHOSPHATASE; APOPTOSIS; GENES; TRIGGERS	Cdc25B phosphatases function as key players in G2/M cell cycle progression by activating the CDK1-cyclinB1 complexes. They also have an essential role in recovery from the G2/M checkpoint activated in response to DNA damage. Overexpression of Cdc25B results in bypass of the G2/M checkpoint and illegitimate entry into mitosis, and also causes replicative stress, leading to genomic instability. Thus, fine-tuning of Cdc25B expression level is critical for correct cell cycle progression and G2 checkpoint recovery. However, the transcriptional regulation of Cdc25B remains largely unknown. Earlier studies have shown that the tumor suppressor p53 overexpression transcriptionally represses Cdc25B; however, the molecular mechanism of this repression has not yet been elucidated, although it was suggested to occur through the induction of p21. Here we show that Cdc25B is downregulated by the basal level of p53 in multiple cell types. This downregulation also occurs in p21-/- cell lines, indicating that p21 is not required for p53-mediated regulation of Cdc25B. Deletion and mutation analyses of the Cdc25B promoter revealed that downregulation by p53 is dependent on the presence of functional Sp1/Sp3 and NF-Y binding sites. Furthermore, chromatin immuno-precipitation analyses show that p53 binds to the Cdc25B promoter and mediates transcriptional attenuation through the Sp1 and NF-Y transcription factors. Our results suggest that the inability to downregulate Cdc25B after loss of p53 might contribute to tumorigenesis. Oncogene (2011) 30, 2282-2288; doi:10.1038/onc.2010.588; published online 17 January 2011	[Dalvai, M.; Mondesert, O.; Ducommun, B.; Dozier, C.] Univ Toulouse, CNRS, LBCMCP, UMR 5088, F-31062 Toulouse, France; [Bourdon, J-C] Univ Dundee, Dept Surg & Mol Oncol, European Associated Lab, INSERM,U858,Coll Med, Dundee, Scotland; [Ducommun, B.] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Dundee; CHU de Toulouse	Dozier, C (corresponding author), Univ Toulouse, CNRS, LBCMCP, UMR 5088, Bat 4R3B1,118 Route Narbonne, F-31062 Toulouse, France.	dozier@cict.fr	DOZIER, Christine/P-1539-2014; DUCOMMUN, Bernard/B-3208-2008; JC, Bourdon/A-4439-2008	JC, Bourdon/0000-0003-4623-9386; DUCOMMUN, Bernard/0000-0002-7126-8368	CNRS (Centre National de la Recherche Scientifique); Universite Paul Sabatier; CNRS, Universite Paul Sabatier, la region Midi-Pyrenees, l'Institut National du Cancer; Canceropole; la Ligue Nationale Contre le Cancer	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; CNRS, Universite Paul Sabatier, la region Midi-Pyrenees, l'Institut National du Cancer(Region Occitanie); Canceropole(Region Ile-de-France); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	We thank Dr Bert Vogelstein (Howard Hughes Medical Institute, Baltimore USA) for providing the WT, p53-/- and p21-/- HCT116 cells. MD was a recipient of a postdoctoral fellowship from the CNRS (Centre National de la Recherche Scientifique). This work was supported by CNRS, Universite Paul Sabatier, la region Midi-Pyrenees, l'Institut National du Cancer, the Canceropole Grand Sud-Ouest and la Ligue Nationale Contre le Cancer (Equipe labellisee 2008).	Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Baldin V, 1997, ONCOGENE, V14, P2485, DOI 10.1038/sj.onc.1201063; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bocangel D, 2009, ANTICANCER RES, V29, P3741; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Brosh R, 2010, MOL BIOSYST, V6, P17, DOI 10.1039/b911416e; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bugler B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-29; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Essafi-Benkhadir K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004478; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Jin W, 2008, J BIOL CHEM, V283, P29671, DOI 10.1074/jbc.M802785200; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Miyata H, 2001, CANCER RES, V61, P3188; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Torgeman A, 2001, VIROLOGY, V281, P10, DOI 10.1006/viro.2000.0779; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Varmeh S, 2009, J BIOL CHEM, V284, P9475, DOI 10.1074/jbc.M900037200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200	39	35	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	19					2282	2288		10.1038/onc.2010.588	http://dx.doi.org/10.1038/onc.2010.588			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242964				2022-12-25	WOS:000290514600011
J	Rovillain, E; Mansfield, L; Caetano, C; Alvarez-Fernandez, M; Caballero, OL; Medema, RH; Hummerich, H; Jat, PS				Rovillain, E.; Mansfield, L.; Caetano, C.; Alvarez-Fernandez, M.; Caballero, O. L.; Medema, R. H.; Hummerich, H.; Jat, P. S.			Activation of nuclear factor-kappa B signalling promotes cellular senescence	ONCOGENE			English	Article						cellular senescence; conditional immortalisation; senescence bypass; differential expression, NF-kappa B signalling	HUMAN MAMMARY FIBROBLASTS; TELOMERASE ACTIVITY; CANCER; FOXM1; CELLS; NETWORK; PROLIFERATION; PROGRESSION; PATHWAYS; GENES	Cellular senescence is a programme of irreversible cell cycle arrest that normal cells undergo in response to progressive shortening of telomeres, changes in telomeric structure, oncogene activation or oxidative stress. The underlying signalling pathways, of major clinicopathological relevance, are unknown. We combined genome-wide expression profiling with genetic complementation to identify genes that are differentially expressed when conditionally immortalised human fibroblasts undergo senescence upon activation of the p16-pRB and p53-p21 tumour suppressor pathways. This identified 816 up and 961 downregulated genes whose expression was reversed when senescence was bypassed. Overlay of this data set with the meta-signatures of genes upregulated in cancer showed that nearly 50% of them were downregulated upon senescence showing that even though overcoming senescence may only be one of the events required for malignant transformation, nearly half of the genes upregulated in cancer are related to it. Moreover 65 of the up and 26 of the downregulated genes are known downstream targets of nuclear factor (NF)-kappa B suggesting that senescence was associated with activation of the NF-kappa B pathway. Direct perturbation of this pathway bypasses growth arrest indicating that activation of NF-kappa B signalling has a causal role in promoting senescence. Oncogene (2011) 30, 2356-2366; doi: 10.1038/onc.2010.611; published online 17 January 2011	[Rovillain, E.; Mansfield, L.; Caetano, C.; Jat, P. S.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Alvarez-Fernandez, M.; Medema, R. H.] Univ Med Ctr, Dept Med Oncol, Utrecht, Netherlands; [Caballero, O. L.] Ludwig Inst Canc Res Ltd, New York, NY USA; [Hummerich, H.] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England	University of London; University College London; Utrecht University; Utrecht University Medical Center; Ludwig Institute for Cancer Research; University of London; University College London	Jat, PS (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	p.jat@prion.ucl.ac.uk	Medema, Rene H/E-2981-2013; Fernández, Mónica Alvarez/C-5972-2009	Fernández, Mónica Alvarez/0000-0002-6454-5128; Medema, Rene/0000-0002-6754-0381	Wellcome Trust [078305]; Brain Research Trust; Medical Research Council [MC_U123160651] Funding Source: researchfish; MRC [MC_U123160651] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Brain Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are indebted to AM Neville, A Baldwin, P Meier, M Resnicoff and N Perkins for advice, helpful discussions and critical reading of the manuscript. We thank J Downward, X Lu, P Meier, G Towers and C King (the UCL shRNA library core facility) for providing reagents. We are grateful to E Ortenberg and J White of Biotrove Inc. for the qPCR analysis, S Shah and A Grigoriadis for bioinformatic analysis and R Young for graphics. PSJ gratefully acknowledges financial support from the Wellcome Trust (078305) and an equipment grant from the Brain Research Trust.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; AGGARWAL BB, 1995, EXP CELL RES, V218, P381, DOI 10.1006/excr.1995.1169; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Batsi C, 2009, MECH AGEING DEV, V130, P409, DOI 10.1016/j.mad.2009.04.002; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Besnier C, 2003, J VIROL, V77, P13403, DOI 10.1128/JVI.77.24.13403-13406.2003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DIMRI GP, 1994, EXP CELL RES, V212, P132, DOI 10.1006/excr.1994.1127; Dodeller F, 2008, J BIOL CHEM, V283, P21487, DOI 10.1074/jbc.M801908200; Gonos ES, 1996, MOL CELL BIOL, V16, P5127; GORMAN SD, 1985, J CELL PHYSIOL, V125, P122, DOI 10.1002/jcp.1041250116; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kriete Andres, 2008, Immun Ageing, V5, P5, DOI 10.1186/1742-4933-5-5; Kriete A, 2009, EXP GERONTOL, V44, P250, DOI 10.1016/j.exger.2008.12.005; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; MANSFIELD LV, 2006, THESIS U LONDON LOND; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Penzo M, 2009, J CELL PHYSIOL, V218, P215, DOI 10.1002/jcp.21596; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	54	118	124	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	20					2356	2366		10.1038/onc.2010.611	http://dx.doi.org/10.1038/onc.2010.611			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21242976	Green Accepted			2022-12-25	WOS:000290789200007
J	Mizrachy-Schwartz, S; Cohen, N; Klein, S; Kravchenko-Balasha, N; Levitzki, A				Mizrachy-Schwartz, Sarit; Cohen, Noam; Klein, Shoshana; Kravchenko-Balasha, Nataly; Levitzki, Alexander			Up-regulation of AMP-activated Protein Kinase in Cancer Cell Lines Is Mediated through c-Src Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; PHOSPHOLIPASE-C; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; MAMMALIAN TARGET; GROWTH; HYPOXIA; ENERGY; INVASION; RECEPTOR	We report that the activation level of AMP-dependent protein kinase AMPK is elevated in cancer cell lines as a hallmark of their transformed state. In OVCAR3 and A431 cells, c-Src signals through protein kinase C alpha, phospholipase C gamma, and LKB1 to AMPK. AMPK controls internal ribosome entry site (IRES) dependent translation in these cells. We suggest that AMPK activation via PKC might be a general mechanism to regulate IRES-dependent translation in cancer cells.	[Mizrachy-Schwartz, Sarit; Cohen, Noam; Klein, Shoshana; Kravchenko-Balasha, Nataly; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Safra Campus, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	Deutsches Krebsforschungszentrum; Israel Ministry of Science and Technology	Deutsches Krebsforschungszentrum; Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum and the Israel Ministry of Science and Technology.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; LIN PH, 1995, ONCOGENE, V10, P401; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; Nozawa H, 2008, CLIN CANCER RES, V14, P4336, DOI 10.1158/1078-0432.CCR-07-4857; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Shah K, 2005, MOL BIOL CELL, V16, P5418, DOI 10.1091/mbc.e05-03-0263; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang J, 2009, ARTERIOSCL THROM VAS, V29, P202, DOI 10.1161/ATVBAHA.108.174391; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	43	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15268	15277		10.1074/jbc.M110.211813	http://dx.doi.org/10.1074/jbc.M110.211813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21245141	Green Published, hybrid			2022-12-25	WOS:000289788300058
J	Marshall, MR; Clark, JP; Westenbroek, R; Yu, FH; Scheuer, T; Catterall, WA				Marshall, Misty R.; Clark, John Patrick, III; Westenbroek, Ruth; Yu, Frank H.; Scheuer, Todd; Catterall, William A.			Functional Roles of a C-terminal Signaling Complex of Ca(v)1 Channels and A-kinase Anchoring Protein 15 in Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SUBCELLULAR-LOCALIZATION; CALCIUM-ANTAGONIST RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; CA2+ CHANNEL; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; ALPHA(1) SUBUNIT; PHOSPHORYLATION; TRANSCRIPTION	Regulation of Ca(V)1.2 channels in cardiac myocytes by the beta-adrenergic pathway requires a signaling complex in which the proteolytically processed distal C-terminal domain acts as an autoinhibitor of channel activity and mediates up-regulation by the beta-adrenergic receptor and PKA bound to A-kinase anchoring protein 15 (AKAP15). We examined the significance of this distal C-terminal signaling complex for Ca(V)1.2 and Ca(V)1.3 channels in neurons. AKAP15 co-immunoprecipitates with Ca(V)1.2 and Ca(V)1.3 channels. AKAP15 has overlapping localization with Ca(V)1.2 and Ca(V)1.3 channels in cell bodies and proximal dendrites and is closely co-localized with Ca(V)1.2 channels in punctate clusters. The neuronal AKAP MAP2B, which also interacts with Ca(V)1.2 and Ca(V)1.3 channels, has complementary localization to AKAP15, suggesting different functional roles in calcium channel regulation. Studies with mice that lack the distal C-terminal domain of Ca(V)1.2 channels (Ca(V)1.2 Delta DCT) reveal that AKAP15 interacts with neuronal Ca(V)1.2 channels via their C terminus in vivo and is co-localized in punctate clusters of Ca(V)1.2 channels via that interaction. Ca(V)1.2 Delta DCT neurons have reduced L-type calcium current, indicating that the distal C-terminal domain is required for normal functional expression in vivo. Deletion of the distal C-terminal domain impairs calcium- dependent signaling from Ca(V)1.2 channels to the nucleus, as shown by reduction in phosphorylation of the cAMP response element-binding protein. Our results define AKAP signaling complexes of Ca(V)1.2 and Ca(V)1.3 channels in brain and reveal three previously unrecognized functional roles for the distal C terminus of neuronal Ca(V)1.2 channels in vivo: increased functional expression, anchoring of AKAP15 and PKA, and initiation of excitation-transcription coupling.	[Marshall, Misty R.; Clark, John Patrick, III; Westenbroek, Ruth; Yu, Frank H.; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Marshall, Misty R/E-5833-2016	Marshall, Misty R/0000-0002-1073-3131; Yu, Frank/0000-0001-9306-1731	National Institutes of Health [T32 GM07750, T3207332, P01 HL44948, R01 HL85372, R01 NS22625]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085372, P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grants T32 GM07750 (to M. R. M.) and T3207332 (to J. P. C.) and Research Grants P01 HL44948, R01 HL85372, and R01 NS22625 (to W. A. C.).	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Endoh T, 2006, BRIT J PHARMACOL, V147, P391, DOI 10.1038/sj.bjp.0706623; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; FU Y, 2011, J BIOL CHEM, P286; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HELL JW, 1993, J BIOL CHEM, V268, P19451; HOSEY MM, 1987, BIOCHEM BIOPH RES CO, V147, P1137; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KLOCKNER U, 1995, J BIOL CHEM, V270, P17306, DOI 10.1074/jbc.270.29.17306; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; REUTER H, 1967, J PHYSIOL-LONDON, V192, P479, DOI 10.1113/jphysiol.1967.sp008310; REUTER H, 1979, ANNU REV PHYSIOL, V41, P413, DOI 10.1146/annurev.ph.41.030179.002213; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; WEI XY, 1994, J BIOL CHEM, V269, P1635; Weick JP, 2003, J NEUROSCI, V23, P3446; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Zhou J, 2005, NEUROENDOCRINOLOGY, V81, P294, DOI 10.1159/000088448	54	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.175257	http://dx.doi.org/10.1074/jbc.M110.175257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21224388	Green Published, hybrid			2022-12-25	WOS:000289077500074
J	Hoek, M; Myers, MP; Stillman, B				Hoek, Maarten; Myers, Michael P.; Stillman, Bruce			An Analysis of CAF-1-interacting Proteins Reveals Dynamic and Direct Interactions with the KU Complex and 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN ASSEMBLY FACTOR-1; DNA-REPLICATION; FACTOR-I; SACCHAROMYCES-CEREVISIAE; HISTONE CHAPERONE; HUMAN-CELLS; STRUCTURAL BASIS; P150 SUBUNIT; HUMAN ASF1; BINDING	CAF-1 is essential in human cells for the de novo deposition of histones H3 and H4 at the DNA replication fork. Depletion of CAF-1 from various cell lines causes replication fork arrest, activation of the intra-S phase checkpoint, and global defects in chromatin structure. CAF-1 is also involved in coordinating inheritance of states of gene expression and in chromatin assembly following DNA repair. In this study, we generated cell lines expressing RNAi-resistant versions of CAF-1 and showed that the N-terminal 296 amino acids are dispensable for essential CAF-1 function in vivo. N-terminally truncated CAF-1 p150 was deficient in proliferating cell nuclear antigen (PCNA) binding, reinforcing the existence of two PCNA binding sites in human CAF-1, but the defect in PCNA binding had no effect on the recruitment of CAF-1 to chromatin after DNA damage or to resistance to DNA-damaging agents. Tandem affinity purification of CAF-1-interacting proteins under mild conditions revealed that CAF-1 was directly associated with the KU70/80 complex, part of the DNA-dependent protein kinase, and the phosphoserine/threonine-binding protein 14-3-3 zeta. CAF-1 was a substrate for DNA-dependent protein kinase, and the 14-3-3 interaction in vitro is dependent on DNA-dependent protein kinase phosphorylation. These results highlight that CAF-1 has prominent interactions with theDNArepair machinery but that the N terminus is dispensable for the role of CAF-1 in DNA replication-and repair-coupled chromatin assembly.	[Hoek, Maarten; Myers, Michael P.; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091	National Institutes of Health, NCI [CA13016]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13016 from the NCI.	Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Alekseev OM, 2005, PROTEINS, V61, P1, DOI 10.1002/prot.20600; Arosio D, 2002, J BIOL CHEM, V277, P9741, DOI 10.1074/jbc.M111916200; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Ebrahimi H, 2008, GENE DEV, V22, P3363, DOI 10.1101/gad.486208; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Jiao R, 2007, ONCOGENE, V26, P3811, DOI 10.1038/sj.onc.1210150; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Keller C, 2000, J BIOL CHEM, V275, P35512, DOI 10.1074/jbc.M003073200; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lottersberger F, 2003, GENETICS, V165, P1717; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; Patterson EE, 2008, GENETICS, V180, P771, DOI 10.1534/genetics.108.091710; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SMITH S, 1991, J BIOL CHEM, V266, P12041; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tie F, 2001, DEVELOPMENT, V128, P275; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Vandre CL, 2008, GENETICS, V180, P1407, DOI 10.1534/genetics.108.094490; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 2000, GENE DEV, V14, P1430; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	64	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10876	10887		10.1074/jbc.M110.217075	http://dx.doi.org/10.1074/jbc.M110.217075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209461	Green Published, hybrid			2022-12-25	WOS:000288547000101
J	Harris, J; Hartman, M; Roche, C; Zeng, SJG; O'Shea, A; Sharp, FA; Lambe, EM; Creagh, EM; Golenbock, DT; Tschopp, J; Kornfeld, H; Fitzgerald, KA; Lavelle, EC				Harris, James; Hartman, Michelle; Roche, Caitrionna; Zeng, Shijuan G.; O'Shea, Amy; Sharp, Fiona A.; Lambe, Eimear M.; Creagh, Emma M.; Golenbock, Douglas T.; Tschopp, Jurg; Kornfeld, Hardy; Fitzgerald, Katherine A.; Lavelle, Ed C.			Autophagy Controls IL-1 beta Secretion by Targeting Pro-IL-1 beta for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; DENDRITIC CELLS; CUTTING EDGE; ACTIVATION; RECOGNITION; MECHANISM; CYTOKINES; ADJUVANTS; CRYSTALS	Autophagy is a key regulator of cellular homeostasis that can be activated by pathogen-associated molecules and recently has been shown to influence IL-1 beta secretion by macrophages. However, the mechanisms behind this are unclear. Here, we describe a novel role for autophagy in regulating the production of IL-1 beta in antigen-presenting cells. After treatment of macrophages with Toll-like receptor ligands, pro-IL-1 beta was specifically sequestered into autophagosomes, whereas further activation of autophagy with rapamycin induced the degradation of pro-IL-1 beta and blocked secretion of the mature cytokine. Inhibition of autophagy promoted the processing and secretion of IL-1 beta by antigen-presenting cells in an NLRP3- and TRIF-dependent manner. This effect was reduced by inhibition of reactive oxygen species but was independent of NOX2. Induction of autophagy in mice in vivo with rapamycin reduced serum levels of IL-1 beta in response to challenge with LPS. These data demonstrate that autophagy controls the production of IL-1 beta through at least two separate mechanisms: by targeting pro-IL-1 beta for lysosomal degradation and by regulating activation of the NLRP3 inflammasome.	[Harris, James; Roche, Caitrionna; Zeng, Shijuan G.; O'Shea, Amy; Sharp, Fiona A.; Lambe, Eimear M.; Lavelle, Ed C.] Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Harris, James; Lavelle, Ed C.] Trinity Coll Dublin, Immunol Res Ctr, Sch Biochem & Immunol, Dublin 2, Ireland; [Creagh, Emma M.] Trinity Coll Dublin, Cytokine Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Hartman, Michelle; Golenbock, Douglas T.; Kornfeld, Hardy; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester; University of Lausanne	Harris, J (corresponding author), Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland.	jaharris@tcd.ie	Kornfeld, Hardy/AAS-2903-2021; Creagh, Emma/AAX-1064-2021; Fitzgerald, Katherine/ABE-6317-2020	Creagh, Emma/0000-0001-7631-4370; Harris, James/0000-0002-5634-9637	Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster [07/SRC/B1144]; National Institutes of Health [RO1 HL064884]; Irish Research Council for Science, Engineering and Technology (IRCSET); Science Foundation of Ireland [08/RFP/BMT1363, 07/RFP/BICF537]; Enterprise Ireland [IP 2007 0451]; Meningitis Research Foundation [0610.0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER	Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster(Science Foundation Ireland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Science Foundation of Ireland(Science Foundation Ireland); Enterprise Ireland; Meningitis Research Foundation(Meningitis Research Foundation (MRF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster (07/SRC/B1144). To whom correspondence should be addressed: Adjuvant Research Group, School of Biochemistry and Immunology, Trinity College Dublin, College Green, Dublin 2, Ireland. Tel.: 353-1-8963575; Fax: 353-1-6772400; E-mail: jaharris@tcd.ie.; Supported by National Institutes of Health Grant RO1 HL064884 (principal investigator, H. Kornfeld).; Supported by the Irish Research Council for Science, Engineering and Technology (IRCSET).; Supported by the Science Foundation of Ireland (08/RFP/BMT1363, 07/RFP/BICF537), Enterprise Ireland (IP 2007 0451), and the Meningitis Research Foundation (0610.0).	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Harris J, 2009, CURR PROTOC IMMUNOL; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Monastyrska Iryna, 2006, Molecular Aspects of Medicine, V27, P483, DOI 10.1016/j.mam.2006.08.004; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; NAKAHIRA K, 2010, NAT IMMUNOL IN PRESS; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhou R, 2010, NATURE	43	597	616	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9587	9597		10.1074/jbc.M110.202911	http://dx.doi.org/10.1074/jbc.M110.202911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228274	Green Published, hybrid			2022-12-25	WOS:000288247700084
J	Lin, HV; Accili, D				Lin, Hua V.; Accili, Domenico			Reconstitution of Insulin Action in Muscle, White Adipose Tissue, and Brain of Insulin Receptor Knock-out Mice Fails to Rescue Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; FORKHEAD PROTEIN FOXO1; METABOLIC SYNDROME; OB/OB MICE; RESISTANCE; GLUT4; COMPENSATION; SENSITIVITY	Type 2 diabetes results from an impairment of insulin action. The first demonstrable abnormality of insulin signaling is a decrease of insulin-dependent glucose disposal followed by an increase in hepatic glucose production. In an attempt to dissect the relative importance of these two changes in disease progression, we have employed genetic knock-outs/knock-ins of the insulin receptor. Previously, we demonstrated that insulin receptor knock-out mice (Insr(-/-)) could be rescued from diabetes by reconstitution of insulin signaling in liver, brain, and pancreatic beta cells (L1 mice). In this study, we used a similar approach to reconstitute insulin signaling in tissues that display insulin-dependent glucose uptake. Using GLUT4-Cre mice, we restored InsR expression in muscle, fat, and brain of Insr(-/-) mice (GIRKI (Glut4-insulin receptor knock-in line 1) mice). Unlike L1 mice, GIRKI mice failed to thrive and developed diabetes, although their survival was modestly extended when compared with Insr(-/-). The data underscore the role of developmental factors in the presentation of murine diabetes. The broader implication of our findings is that diabetes treatment should not necessarily target the same tissues that are responsible for disease pathogenesis.	[Lin, Hua V.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Lin, Hua/0000-0001-5001-5567	National Institutes of Health [DK58282, DK57539]; Berrie Fellowship Award; Columbia University Diabetes and Endocrinology Research Center [DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058282, P30DK063608, R01DK058282, R01DK057539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Berrie Fellowship Award; Columbia University Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58282 and DK57539 (to D. A.). This work was also supported by the Berrie Fellowship Award (to H. V. L.) and by Grant DK63608 from the Columbia University Diabetes and Endocrinology Research Center.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2002, J BIOL CHEM, V277, P36740, DOI 10.1074/jbc.M206314200; Kitamura T, 2004, J CLIN INVEST, V113, P209, DOI 10.1172/JCI200417810; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Komori T, 2005, BRAIN RES, V1049, P34, DOI 10.1016/j.brainres.2005.04.079; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; LIN HV, 2011, DIABETES IN PRESS; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Okamoto H, 2003, J BIOL CHEM, V278, P28359, DOI 10.1074/jbc.R300009200; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	46	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9797	9804		10.1074/jbc.M110.210807	http://dx.doi.org/10.1074/jbc.M110.210807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239487	Green Published, hybrid			2022-12-25	WOS:000288247700102
J	Mishra, NK; Peleg, Y; Cirri, E; Belogus, T; Lifshitz, Y; Voelker, DR; Apell, HJ; Garty, H; Karlish, SJD				Mishra, Neeraj Kumar; Peleg, Yoav; Cirri, Erica; Belogus, Talya; Lifshitz, Yael; Voelker, Dennis R.; Apell, Hans-Juergen; Garty, Haim; Karlish, Steven J. D.			FXYD Proteins Stabilize Na,K-ATPase AMPLIFICATION OF SPECIFIC PHOSPHATIDYLSERINE-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; PHOSPHOLEMMAN-LIKE PROTEIN; ION-TRANSPORT REGULATORS; SODIUM-POTASSIUM PUMP; GAMMA-SUBUNIT; PICHIA-PASTORIS; FUNCTIONAL INTERACTION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	FXYD proteins are a family of seven small regulatory proteins, expressed in a tissue-specific manner, that associate with Na,K-ATPase as subsidiary subunits and modulate kinetic properties. This study describes an additional property of FXYD proteins as stabilizers of Na, K-ATPase. FXYD1 (phospholemman), FXYD2 (gamma subunit), and FXYD4 (CHIF) have been expressed in Escherichia coli and purified. These FXYD proteins associate spontaneously in vitro with detergent-soluble purified recombinant human Na, K-ATPase (alpha 1 beta 1) to form alpha 1 beta 1FXYD complexes. Compared with the control (alpha 1 beta 1), all three FXYD proteins strongly protect Na, K-ATPase activity against inactivation by heating or excess detergent (C12E8), with effectiveness FXYD1 > FXYD2 >= FXYD4. Heating also inactivates E-1 <-> E-2 conformational changes and cation occlusion, and FXYD1 protects strongly. Incubation of alpha 1 beta 1 or alpha 1 beta 1FXYD complexes with guanidinium chloride (up to 6 M) causes protein unfolding, detected by changes in protein fluorescence, but FXYD proteins do not protect. Thus, general protein denaturation is not the cause of thermally mediated or detergent-mediated inactivation. By contrast, the experiments show that displacement of specifically bound phosphatidylserine is the primary cause of thermally mediated or detergent-mediated inactivation, and FXYD proteins stabilize phosphatidylserine-Na,K-ATPase interactions. Phosphatidylserine probably binds near trans-membrane segments M9 of the alpha subunit and the FXYD protein, which are in proximity. FXYD1, FXYD2, and FXYD4 co-expressed in HeLacells with rat alpha 1 protect strongly against thermal inactivation. Stabilization of Na, K-ATPase by three FXYD proteins in a mammalian cell membrane, as well the purified recombinant Na, K-ATPase, suggests that stabilization is a general property of FXYD proteins, consistent with a significant biological function.	[Mishra, Neeraj Kumar; Belogus, Talya; Lifshitz, Yael; Garty, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Cirri, Erica; Apell, Hans-Juergen] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Konstanz; National Jewish Health	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il		Mishra, Neeraj/0000-0002-6762-1747	German-Israel Foundation [922-165.9]; National Institutes of Health [5R37-GM32453, GM081461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R01GM081461] Funding Source: NIH RePORTER	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by German-Israel Foundation Grant 922-165.9 (to S. J. D. K., H. G., and H.-J. A.) and in part by National Institutes of Health Grants 5R37-GM32453 and GM081461 (to D. R. V.).	ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Babavali M, 2009, BIOCHEMISTRY-US, V48, P9022, DOI 10.1021/bi901124j; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blostein R, 2003, ANN NY ACAD SCI, V986, P420, DOI 10.1111/j.1749-6632.2003.tb07224.x; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Cairo ER, 2009, J MEMBRANE BIOL, V231, P117, DOI 10.1007/s00232-009-9210-4; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2003, P NATL ACAD SCI USA, V100, P6428, DOI 10.1073/pnas.1130871100; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Capasso JM, 2006, AM J PHYSIOL-RENAL, V291, pF1142, DOI 10.1152/ajprenal.00077.2006; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2007, BIOCHEMISTRY-US, V46, P2371, DOI 10.1021/bi062239j; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Krebs MP, 2004, TRENDS BIOCHEM SCI, V29, P648, DOI 10.1016/j.tibs.2004.10.009; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; Lindzen M, 2003, J BIOL CHEM, V278, P18738, DOI 10.1074/jbc.M213253200; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pedersen M, 2002, J MEMBRANE BIOL, V185, P221, DOI 10.1007/s00232-001-0125-y; Peleg Yoav, 2008, V426, P197, DOI 10.1007/978-1-60327-058-8_12; Pihakaski-Maunsbach K, 2006, AM J PHYSIOL-RENAL, V291, pF1033, DOI 10.1152/ajprenal.00086.2006; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Pu HX, 2002, J BIOL CHEM, V277, P20270, DOI 10.1074/jbc.M201009200; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Sweadner KJ, 2003, ANN NY ACAD SCI, V986, P382, DOI 10.1111/j.1749-6632.2003.tb07218.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yamaguchi F, 2001, MOL BRAIN RES, V86, P189, DOI 10.1016/S0169-328X(00)00213-8; Zouzoulas A, 2005, J MEMBRANE BIOL, V204, P49, DOI 10.1007/s00232-005-0746-7	63	66	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9699	9712		10.1074/jbc.M110.184234	http://dx.doi.org/10.1074/jbc.M110.184234			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228272	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000288247700094
J	Rougier, JS; Albesa, M; Abriel, H; Viard, P				Rougier, Jean-Sebastien; Albesa, Maxime; Abriel, Hugues; Viard, Patricia			Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-1 (NEDD4-1) Controls the Sorting of Newly Synthesized Ca(V)1.2 Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN LIGASE; BETA-SUBUNIT; PLASMA-MEMBRANE; PROTEIN-KINASE; NA+ CHANNEL; ENDOCYTOSIS; SURFACE; MOUSE; TRAFFICKING	Neuronal precursor cell-expressed developmentally down-regulated 4 (Nedd4) proteins are ubiquitin ligases, which attach ubiquitin moieties to their target proteins, a post-translational modification that is most commonly associated with protein degradation. Nedd4 ubiquitin ligases have been shown to down-regulate both potassium and sodium channels. In this study, we investigated whether Nedd4 ubiquitin ligases also regulate Ca-v calcium channels. We expressed three Nedd4 family members, Nedd4-1, Nedd4-2, and WWP2, together with Ca(v)1.2 channels in tsA-201 cells. We found that Nedd4-1 dramatically decreased Ca-v whole-cell currents, whereas Nedd4-2 and WWP2 failed to regulate the current. Surface biotinylation assays revealed that Nedd4-1 decreased the number of channels inserted at the plasma membrane. Western blots also showed a concomitant decrease in the total expression of the channels. Surprisingly, however, neither the Ca-v pore-forming alpha 1 subunit nor the associated Ca-v beta and Ca-v alpha(2)delta subunits were ubiquitylated by Nedd4-1. The proteasome inhibitor MG132 prevented the degradation of Ca-v channels, whereas monodansylcadaverine and chloroquine partially antagonized the Nedd4-1-induced regulation of Ca-v currents. Remarkably, the effect of Nedd4-1 was fully prevented by brefeldin A. These data suggest that Nedd4-1 promotes the sorting of newly synthesized Ca-v channels for degradation by both the proteasome and the lysosome. Most importantly, Nedd4-1-induced regulation required the co-expression of Ca-v beta subunits, known to antagonize the retention of the channels in the endoplasmic reticulum. Altogether, our results suggest that Nedd4-1 interferes with the chaperon role of Ca-v beta at the endoplasmic reticulum/Golgi level to prevent the delivery of Ca-v channels at the plasma membrane.	[Rougier, Jean-Sebastien; Viard, Patricia] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Rougier, Jean-Sebastien; Albesa, Maxime; Abriel, Hugues] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of London; University College London; University of Bern	Viard, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	p.viard@ucl.ac.uk	Abriel, Hugues/B-9800-2009; Rougier, Jean-Sébastien/AAX-5038-2021	Abriel, Hugues/0000-0003-0465-5138; ROUGIER, Jean-Sebastien/0000-0002-8710-0260	Wellcome Trust; Swiss National Science Foundation [310030_120707]	Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Wellcome Trust (to J.-S. R. and P. V.) and Swiss National Science Foundation Grant 310030_120707 (to H. A.).	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Chen YH, 2009, FEBS LETT, V583, P1969, DOI 10.1016/j.febslet.2009.05.001; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Fitzgerald EM, 2002, J PHYSIOL-LONDON, V543, P425, DOI 10.1113/jphysiol.2002.022822; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Luini A, 2008, HISTOCHEM CELL BIOL, V129, P153, DOI 10.1007/s00418-007-0365-8; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; MING Z, 1994, J MOL CELL CARDIOL, V26, P1133, DOI 10.1006/jmcc.1994.1132; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puri TS, 1997, BIOCHEMISTRY-US, V36, P9605, DOI 10.1021/bi970500d; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300	41	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8829	8838		10.1074/jbc.M110.166520	http://dx.doi.org/10.1074/jbc.M110.166520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220429	hybrid, Green Published			2022-12-25	WOS:000288247700013
J	Spencer, NY; Yan, ZY; Boudreau, RL; Zhang, YL; Luo, MH; Li, QA; Tian, X; Shah, AM; Davisson, RL; Davidson, B; Banfi, B; Engelhardt, JF				Spencer, Netanya Y.; Yan, Ziying; Boudreau, Ryan L.; Zhang, Yulong; Luo, Meihui; Li, Qiang; Tian, Xin; Shah, Ajay M.; Davisson, Robin L.; Davidson, Beverly; Banfi, Botond; Engelhardt, John F.			Control of Hepatic Nuclear Superoxide Production by Glucose 6-Phosphate Dehydrogenase and NADPH Oxidase-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED NOXO1 ISOFORMS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; LIVER NUCLEI; GENERATION; DEFICIENCY; ACTIVATION	Redox-regulated signal transduction is coordinated by spatially controlled production of reactive oxygen species within subcellular compartments. The nucleus has long been known to produce superoxide (O-2(radical anion)); however, the mechanisms that control this function remain largely unknown. We have characterized molecular features of a nuclear superoxide-producing system in the mouse liver. Using electron paramagnetic resonance, we investigated whether several NADPH oxidases (NOX1, 2, and 4) and known activators of NOX(Rac1, Rac2, p22(phox), and p47(phox)) contribute to nuclear O-2(radical anion) production in isolated hepatic nuclei. Our findings demonstrate that NOX4 most significantly contributes to hepatic nuclear O-2(radical anion) production that utilizes NADPH as an electron donor. Although NOX4 protein immunolocalized to both nuclear membranes and intranuclear inclusions, fluorescent detection of NADPH-dependent nuclear O-2(radical anion) predominantly localized to the perinuclear space. Interestingly, NADP(+) and G6P also induced nuclear O-2(radical anion) production, suggesting that intranuclear glucose-6-phosphate dehydrogenase (G6PD) can control NOX4 activity through nuclear NADPH production. Using G6PD mutant mice and G6PD shRNA, we confirmed that reductions in nuclear G6PD enzyme decrease the ability of hepatic nuclei to generate O-2(radical anion) in response to NADP(+) and G6P. NOX4 and G6PD protein were also observed in overlapping microdomains within the nucleus. These findings provide new insights on the metabolic pathways for substrate regulation of nuclear O-2(radical anion) production by NOX4.	[Spencer, Netanya Y.; Yan, Ziying; Zhang, Yulong; Luo, Meihui; Li, Qiang; Tian, Xin; Banfi, Botond; Engelhardt, John F.] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Boudreau, Ryan L.; Davidson, Beverly; Banfi, Botond; Engelhardt, John F.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zhang, Yulong; Davidson, Beverly; Engelhardt, John F.] Univ Iowa, Coll Med, Ctr Gene Therapy Cyst Fibrosis & Other Genet Dis, Iowa City, IA 52242 USA; [Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, London SE5 9NU, England; [Davisson, Robin L.] Cornell Univ, Dept Biomed Sci, Coll Vet Med & Cell & Dev Biol, Weill Cornell Med Coll, New York, NY 10065 USA	University of Iowa; University of Iowa; University of Iowa; University of London; King's College London; Cornell University	Engelhardt, JF (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu	Spencer, Netanya/AAS-7999-2020	Spencer, Netanya/0000-0003-1010-5458; Banfi, Botond/0000-0001-9273-1318; Yan, Ziying/0000-0001-8210-5567; Engelhardt, John/0000-0003-2389-9277; Shah, Ajay/0000-0002-6547-0631; Boudreau, Ryan/0000-0002-9800-5349	National Institutes of Health [R01 DK051315, K01 DK083429]; British Heart Foundation [RG/08/011/25922]; Center for Gene Therapy [P30 DK54759]; Roy J. Carver Chair in Molecular Medicine; University of Iowa ESR Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759, K01DK083429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Center for Gene Therapy(Ohio State University); Roy J. Carver Chair in Molecular Medicine; University of Iowa ESR Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK051315 and K01 DK083429. This work was also supported by British Heart Foundation Grant RG/08/011/25922 (to A. M. S.), the Vector Core funded through Center for Gene Therapy Grant P30 DK54759, and the Roy J. Carver Chair in Molecular Medicine.; We gratefully acknowledge the support of the University of Iowa ESR Facility and the advice from Dr. Garry Buettner. We thank Dr. David A. Williams for the kind gift of the Rac KO mice. We appreciate the help of Dr. Martin Fray at the Mary Lyon Centre (Medical Research Council, Harwell, UK) with the rederivation of the G6PD mutant mice from cryopreserved embryos. We appreciate the assistance of Jian Shao and Randy Nessler of the University of Iowa Central Microscopy Core for help with processing and imaging of TEM samples.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; BARTOLI GM, 1977, BIOCHIM BIOPHYS ACTA, V497, P622, DOI 10.1016/0304-4165(77)90219-7; BEREZNEY R, 1970, BIOCHEM BIOPH RES CO, V38, P93, DOI 10.1016/0006-291X(70)91088-0; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; DICKER E, 1991, BIOCHEM PHARMACOL, V42, P529, DOI 10.1016/0006-2952(91)90315-V; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Im JY, 2006, FREE RADICAL BIO MED, V41, P960, DOI 10.1016/j.freeradbiomed.2006.06.001; KRISHNA CM, 1992, ARCH BIOCHEM BIOPHYS, V294, P98, DOI 10.1016/0003-9861(92)90142-J; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Opitz N, 2007, FREE RADICAL BIO MED, V42, P175, DOI 10.1016/j.freeradbiomed.2006.11.003; PATTON SE, 1980, MOL PHARMACOL, V18, P588; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Peterson JR, 2009, HYPERTENSION, V54, P1106, DOI 10.1161/HYPERTENSIONAHA.109.140087; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; PUNTARULO S, 1992, BIOCHIM BIOPHYS ACTA, V1116, P17, DOI 10.1016/0304-4165(92)90122-B; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; TAKAHASHI T, 1978, BIOCHIM BIOPHYS ACTA, V524, P262, DOI 10.1016/0005-2744(78)90163-8; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Ueyama T, 2007, FREE RADICAL BIO MED, V42, P180, DOI 10.1016/j.freeradbiomed.2006.08.024; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; VARTANYAN L S, 1989, Biokhimiya, V54, P1020; Venkataraman S, 2000, FREE RADICAL BIO MED, V29, P580, DOI 10.1016/S0891-5849(00)00404-4; Wang P, 2007, PHARMACOL RES, V55, P408, DOI 10.1016/j.phrs.2007.01.016; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; YUSA T, 1984, BIOCHIM BIOPHYS ACTA, V798, P167, DOI 10.1016/0304-4165(84)90299-X; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zwacka RM, 1998, HEPATOLOGY, V28, P1022, DOI 10.1002/hep.510280417	62	80	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8977	8987		10.1074/jbc.M110.193821	http://dx.doi.org/10.1074/jbc.M110.193821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212270	Green Published, hybrid			2022-12-25	WOS:000288247700029
J	Tiwari, M; Lopez-Cruzan, M; Morgan, WW; Herman, B				Tiwari, Meenakshi; Lopez-Cruzan, Marisa; Morgan, William W.; Herman, Brian			Loss of Caspase-2-dependent Apoptosis Induces Autophagy after Mitochondrial Oxidative Stress in Primary Cultures of Young Adult Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PERMEABILITY TRANSITION; CYTOCHROME-C; CASPASE-2; SUPEROXIDE; PROTEINS; DYSFUNCTION; ACTIVATION; MECHANISMS; UPSTREAM	Mitochondrial dysfunctions have been associated with neuronal apoptosis and are characteristic of neurodegenerative conditions. Caspases play a central role in apoptosis; however, their involvement in mitochondrial dysfunction-induced neuronal apoptosis remains elusive. In the present report using rotenone, a complex I inhibitor that causes mitochondrial dysfunction, we determined the initiator caspase and its role in cell death in primary cultures of cortical neurons from young adult mice (1-2 months old). By pretreating the cells with a cell-permeable, biotinylated pan-caspase inhibitor that irreversibly binds to and traps the active caspase, we identified caspase-2 as an initiator caspase activated in rotenone-treated primary neurons. Loss of caspase-2 inhibited rotenone-induced apoptosis; however, these neurons underwent a delayed cell death by necrosis. We further found that caspase-2 acts upstream of mitochondria to mediate rotenone-induced apoptosis in neurons. The loss of caspase-2 significantly inhibited rotenone-induced activation of Bid and Bax and the release of cytochrome c and apoptosis inducing factor from mitochondria. Rotenone-induced down-stream activation of caspase-3 and caspase-9 were also inhibited in the neurons lacking caspase-2. Autophagy was enhanced in caspase-2 knock-out neurons after rotenone treatment, and this response was important in prolonging neuronal survival. In summary, the present study identifies a novel function of caspase-2 in mitochondrial oxidative stress-induced apoptosis in neurons cultured from young adult mice.	[Tiwari, Meenakshi; Lopez-Cruzan, Marisa; Morgan, William W.; Herman, Brian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Herman, B (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	hermanb@uthscsa.edu		Lopez-Cruzan, Marisa/0000-0003-0285-1012	National Institutes of Health [5 R37 AG007218-21, P30 CA54174, P30 AG013319, P01 AG19316]; University of Texas Health Science Center-San Antonio; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG007218, P30AG013319, P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center-San Antonio; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R37 AG007218-21.; We thank Dr. Junying Yuan of Harvard University and Dr. Carol Troy of Columbia University for providing the casp2<SUP>-/-</SUP> mice and Dr. Muniswamy Madesh of Temple University for providing bax<SUP>-/-</SUP>, bak<SUP>-/-</SUP>, and bax<SUP>-/-</SUP> bak<SUP>-/-</SUP> DKO MEFs. We thank Dr. Victoria Centonze-Frohlich for contributions and guidance on the microscopy experiments. Images were generated in the Core Optical Imaging Facility, which is supported by University of Texas Health Science Center-San Antonio and National Institutes of Health Grants P30 CA54174 (NCI; to the San Antonio Cancer Institute), P30 AG013319 (NIA; to the Nathan Shock Center), and P01 AG19316 (NIA). We also thank Dr. Christie Jones and Sonya Karbach for help in preparation of the manuscript and Michelle Bendele for assistance in mouse breeding.	Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee JJ, 2008, BIOCHEM BIOPH RES CO, V371, P33, DOI 10.1016/j.bbrc.2008.03.149; Lee JA, 2009, BMB REP, V42, P324, DOI 10.5483/BMBRep.2009.42.6.324; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Pei W, 2003, FASEB J, V17, P520, DOI 10.1096/fj.02-0653fje; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shaw CA, 2008, NEUROMOL MED, V10, P1, DOI 10.1007/s12017-007-8016-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takai Y, 2007, APOPTOSIS, V12, P791, DOI 10.1007/s10495-006-0022-z; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Troy CM, 1997, J NEUROSCI, V17, P1911; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Troy CM, 2000, J NEUROSCI, V20, P1386; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	63	54	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8493	8506		10.1074/jbc.M110.163824	http://dx.doi.org/10.1074/jbc.M110.163824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216964	Green Published, hybrid			2022-12-25	WOS:000288013300077
J	Lange, C; Brunswig-Spickenheier, B; Cappallo-Obermann, H; Eggert, K; Gehling, UM; Rudolph, C; Schlegelberger, B; Cornils, K; Zustin, J; Spiess, AN; Zander, AR				Lange, Claudia; Brunswig-Spickenheier, Baerbel; Cappallo-Obermann, Heike; Eggert, Katharina; Gehling, Ursula M.; Rudolph, Cornelia; Schlegelberger, Brigitte; Cornils, Kerstin; Zustin, Jozef; Spiess, Andrej-Nikolai; Zander, Axel R.			Radiation Rescue: Mesenchymal Stromal Cells Protect from Lethal Irradiation	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; HEMATOPOIETIC RECONSTITUTION; MULTIORGAN FAILURE; THERAPY; MURINE; TRANSPLANTATION; RECOVERY; TISSUES; DISEASE	Background: Successful treatment of acute radiation syndromes relies on immediate supportive care. In patients with limited hematopoietic recovery potential, hematopoietic stem cell (HSC) transplantation is the only curative treatment option. Because of time consuming donor search and uncertain outcome we propose MSC treatment as an alternative treatment for severely radiation-affected individuals. Methods and Findings: Mouse mesenchymal stromal cells (mMSCs) were expanded from bone marrow, retrovirally labeled with eGFP (bulk cultures) and cloned. Bulk and five selected clonal mMSCs populations were characterized in vitro for their multilineage differentiation potential and phenotype showing no contamination with hematopoietic cells. Lethally irradiated recipients were i.v. transplanted with bulk or clonal mMSCs. We found a long-term survival of recipients with fast hematopoietic recovery after the transplantation of MSCs exclusively without support by HSCs. Quantitative PCR based chimerism analysis detected eGFP-positive donor cells in peripheral blood immediately after injection and in lungs within 24 hours. However, no donor cells in any investigated tissue remained long-term. Despite the rapidly disappearing donor cells, microarray and quantitative RT-PCR gene expression analysis in the bone marrow of MSC-transplanted animals displayed enhanced regenerative features characterized by (i) decreased proinflammatory, ECM formation and adhesion properties and (ii) boosted anti-inflammation, detoxification, cell cycle and anti-oxidative stress control as compared to HSC-transplanted animals. Conclusions: Our data revealed that systemically administered MSCs provoke a protective mechanism counteracting the inflammatory events and also supporting detoxification and stress management after radiation exposure. Further our results suggest that MSCs, their release of trophic factors and their HSC-niche modulating activity rescue endogenous hematopoiesis thereby serving as fast and effective first-line treatment to combat radiation-induced hematopoietic failure.	[Lange, Claudia; Brunswig-Spickenheier, Baerbel; Eggert, Katharina; Cornils, Kerstin; Zander, Axel R.] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Dept Cell & Gene Therapy, Hamburg, Germany; [Cappallo-Obermann, Heike; Spiess, Andrej-Nikolai] Univ Med Ctr Hamburg Eppendorf, Dept Androl, Hamburg, Germany; [Gehling, Ursula M.] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany; [Rudolph, Cornelia; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Inst Osteopathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lange, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Dept Cell & Gene Therapy, Hamburg, Germany.	cllange@uke.uni-hamburg.de	Spiess, Andrej-Nikolai/A-2941-2015	Spiess, Andrej-Nikolai/0000-0002-9630-4724	Federal Ministry of Education and Research, Germany [13N8904 (HyCelex)]; German Research Foundation (DFG)	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research, Germany (http://www.bmbf.de/en/index.php), grant number 13N8904 (HyCelex) and German Research Foundation (DFG, http://www.dfg.de/index.jsp) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006-0762; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cornils K, 2009, MOL THER, V17, P131, DOI 10.1038/mt.2008.238; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; DEXTER M, 1992, NATURE, V360, P709, DOI 10.1038/360709a0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drouet M, 2005, BONE MARROW TRANSPL, V35, P1201, DOI 10.1038/sj.bmt.1704970; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Fliedner TM, 2009, STEM CELLS, V27, P1205, DOI 10.1002/stem.16; Fliedner TM., 2001, MED MANAGEMENT RAD A; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Lange C, 1999, J HEMATOTH STEM CELL, V8, P335, DOI 10.1089/152581699320090; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remberger M, 2004, HAEMATOLOGICA, V89, P710; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rudolph Cornelia, 2009, V506, P453, DOI 10.1007/978-1-59745-409-4_30; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Togel FE, 2010, NAT REV NEPHROL, V6, P179, DOI 10.1038/nrneph.2009.229; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	48	78	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14486	10.1371/journal.pone.0014486	http://dx.doi.org/10.1371/journal.pone.0014486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245929	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200001
J	Maniti, O; Alves, I; Trugnan, G; Ayala-Sanmartin, J				Maniti, Ofelia; Alves, Isabel; Trugnan, Germain; Ayala-Sanmartin, Jesus			Distinct Behaviour of the Homeodomain Derived Cell Penetrating Peptide Penetratin in Interaction with Different Phospholipids	PLOS ONE			English	Article							POLYMORPHIC PHASE-BEHAVIOR; WAVE-GUIDE RESONANCE; SOLID-STATE NMR; LIPID-BILAYERS; ANTENNAPEDIA HOMEODOMAIN; MODEL MEMBRANES; 3RD HELIX; TRYPTOPHAN FLUORESCENCE; DEPENDENT TRANSLOCATION; ANTIMICROBIAL PEPTIDES	Background: Penetratin is a protein transduction domain derived from the homeoprotein Antennapedia. Thereby it is currently used as a cell penetrating peptide to introduce diverse molecules into eukaryotic cells, and it could also be involved in the cellular export of transcription factors. Moreover, it has been shown that it is able to act as an antimicrobial agent. The mechanisms involved in all these processes are quite controversial. Methodology/Principal Findings: In this article, we report spectroscopic, calorimetric and biochemical data on the penetratin interaction with three different phospholipids: phosphatidylcholine (PC) and phosphatidylethanolamine (PE) to mimic respectively the outer and the inner leaflets of the eukaryotic plasma membrane and phosphatidylglycerol (PG) to mimic the bacterial membrane. We demonstrate that with PC, penetratin is able to form vesicle aggregates with no major change in membrane fluidity and presents no well defined secondary structure organization. With PE, penetratin aggregates vesicles, increases membrane rigidity and acquires an alpha-helical structure. With PG membranes, penetratin does not aggregate vesicles but decreases membrane fluidity and acquires a structure with both alpha-helical and beta-sheet contributions. Conclusions/Significance: These data from membrane models suggest that the different penetratin actions in eukaryotic cells (membrane translocation during export and import) and on prokaryotes may result from different peptide and lipid structural arrangements. The data suggest that, for eukaryotic cell penetration, penetratin does not acquire classical secondary structure but requires a different conformation compared to that in solution.	[Maniti, Ofelia; Alves, Isabel; Ayala-Sanmartin, Jesus] CNRS, UMR 7203, Lab Biomol, Grp NJ Conte, Paris, France; [Maniti, Ofelia; Alves, Isabel; Trugnan, Germain; Ayala-Sanmartin, Jesus] Univ Paris 06, Paris, France; [Maniti, Ofelia; Alves, Isabel; Ayala-Sanmartin, Jesus] Ecole Normale Super, Dept Chim, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Maniti, O (corresponding author), CNRS, UMR 7203, Lab Biomol, Grp NJ Conte, Paris, France.	jesus.ayala-sanmartin@upmc.fr	Maniti, Ofélia/AAQ-5624-2021; Alves, Isabel D/R-9613-2016	Alves, Isabel D/0000-0003-3193-2436	ANR/Probdom; CNRS	ANR/Probdom(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Funding was provided by ANR/Probdom and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2009, J PEPT SCI, V15, P200, DOI 10.1002/psc.1070; Andrushchenko VV, 2007, BBA-BIOMEMBRANES, V1768, P2447, DOI 10.1016/j.bbamem.2007.05.015; AYALA J, 1990, NEURON, V4, P797, DOI 10.1016/0896-6273(90)90206-U; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Bagatolli LA, 1999, PHOTOCHEM PHOTOBIOL, V70, P557, DOI 10.1562/0031-8655(1999)070<0557:AMFTIO>2.3.CO;2; Barcelo F, 2007, BIOPHYS J, V93, P2530, DOI 10.1529/biophysj.106.101196; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; Binder H, 2004, BIOPHYS J, V87, P332, DOI 10.1529/biophysj.103.034025; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; Gray C, 1996, BIOPHYS J, V70, pWP269; Henriques ST, 2007, MOL MEMBR BIOL, V24, P282, DOI 10.1080/09687860601142936; Illien F, 2010, BBA-BIOMEMBRANES, V1798, P1790, DOI 10.1016/j.bbamem.2010.05.001; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Laird DJ, 2009, BIOPHYS CHEM, V145, P72, DOI 10.1016/j.bpc.2009.09.002; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamaziere A, 2010, BBA-BIOMEMBRANES, V1798, P2223, DOI 10.1016/j.bbamem.2009.12.024; Lamaziere Antonin, 2009, Commun Integr Biol, V2, P223; LEWIS RNAH, 1993, BIOPHYS J, V64, P1081, DOI 10.1016/S0006-3495(93)81474-7; LEWIS RNAH, 1994, BIOPHYS J, V67, P2367, DOI 10.1016/S0006-3495(94)80723-4; LONG FA, 1960, ANN NY ACAD SCI, V84, P596, DOI 10.1111/j.1749-6632.1960.tb39092.x; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Magzoub M, 2002, BBA-BIOMEMBRANES, V1563, P53, DOI 10.1016/S0005-2736(02)00373-5; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; PARASASSI T, 1990, BIOPHYS J, V57, pA272; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PEREZ F, 1994, MOL ENDOCRINOL, V8, P1278, DOI 10.1210/me.8.9.1278; Persson D, 2004, BBA-BIOMEMBRANES, V1665, P142, DOI 10.1016/j.bbamem.2004.07.008; Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d; Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Salamon Z, 1997, BIOPHYS J, V73, P2791, DOI 10.1016/S0006-3495(97)78308-5; Salamon Z, 2004, BIOPHYS J, V86, P2508, DOI 10.1016/S0006-3495(04)74306-4; Salamon Z, 2003, BIOPHYS J, V84, P1796, DOI 10.1016/S0006-3495(03)74987-X; Shanmukh S, 2005, BIOPHYS CHEM, V113, P233, DOI 10.1016/j.bpc.2004.09.009; Su YC, 2008, J MOL BIOL, V381, P1133, DOI 10.1016/j.jmb.2008.06.007; Su Y, 2008, J AM CHEM SOC, V130, P8856, DOI 10.1021/ja802383t; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; ZHANG YP, 1995, BIOPHYS J, V68, P847, DOI 10.1016/S0006-3495(95)80261-4; Zhu WL, 2009, CHEM BIOL DRUG DES, V73, P209, DOI 10.1111/j.1747-0285.2008.00769.x; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	59	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15819	10.1371/journal.pone.0015819	http://dx.doi.org/10.1371/journal.pone.0015819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209890	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793600042
J	Sobotnik, J; Bourguignon, T; Hanus, R; Sillam-Dusses, D; Pflegerova, J; Weyda, F; Kutalova, K; Vytiskova, B; Roisin, Y				Sobotnik, Jan; Bourguignon, Thomas; Hanus, Robert; Sillam-Dusses, David; Pflegerova, Jitka; Weyda, Frantisek; Kutalova, Katerina; Vytiskova, Blahoslava; Roisin, Yves			Not Only Soldiers Have Weapons: Evolution of the Frontal Gland in Imagoes of the Termite Families Rhinotermitidae and Serritermitidae	PLOS ONE			English	Article							PRORHINOTERMES-SIMPLEX; MOLECULAR PHYLOGENY; ISOPTERA; MITOCHONDRIAL; SECRETIONS	Background: The frontal gland is a unique adaptation of advanced termite families. It has been intensively studied in soldiers with respect to its anatomy and chemistry, with numerous novel compounds being discovered within the tremendous richness of identified products. At the same time, the presence of the frontal gland in non-soldier castes received only negligible attention in the past. Principal Findings: Here, we report on the development of the frontal gland in alate imagoes of 10 genera and 13 species of Rhinotermitidae and Serritermitidae, in order to shed light on the evolution and function of this gland in imagoes. All investigated species possess a frontal gland. In most cases, it is well-developed and equipped with a sac-like reservoir, located in the postero-dorsal part of cranium, but reaching as far as the seventh abdominal segment in some Rhinotermitinae. The only exception is the genus Psammotermes, in which the gland is very small and devoid of the reservoir. Conclusions: Our direct observations and comparisons with soldiers suggest a defensive role of the gland in imagoes of all studied species. This functional analogy, along with the anatomic homology between the frontal gland in soldiers and imagoes, make it likely that the gland appeared once during the early evolution of rhinotermitid ancestors, and remained as a defensive organ of prime importance in both, soldiers and imagoes.	[Sobotnik, Jan; Hanus, Robert; Sillam-Dusses, David; Kutalova, Katerina] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Res Team Infochem, Prague, Czech Republic; [Bourguignon, Thomas; Roisin, Yves] Univ Libre Bruxelles, Brussels, Belgium; [Pflegerova, Jitka; Weyda, Frantisek] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Dept Physiol, CR-37005 Ceske Budejovice, Czech Republic; [Kutalova, Katerina] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Vytiskova, Blahoslava] Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Game Management, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Sobotnik, J (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Res Team Infochem, Prague, Czech Republic.	robert@uochb.cas.cz	Hanus, Robert/D-4765-2013; Sillam-Dussès, David/AAI-5942-2021	Hanus, Robert/0000-0002-7054-1975; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977; Sillam-Dusses, David/0000-0001-5027-8703	Czech Science Foundation [P506/10/1570]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague [Z4 055 0506]; National Fund for Scientific Research (F.R.S.-FNRS, Belgium); FRIA; French "Centre National de la Recherche Scientifique" [2ID]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague(Czech Academy of Sciences); National Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA(Fonds de la Recherche Scientifique - FNRS); French "Centre National de la Recherche Scientifique"(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the Czech Science Foundation (project No. P506/10/1570, www.gacr.cz), by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague (project No. Z4 055 0506, www.uochb.cas.cz), by the National Fund for Scientific Research (F.R.S.-FNRS, Belgium, www.fnrs.be) through several travelling grants and a FRIA predoctoral fellowship to TB, and by the "Programme Amazonie II" of the French "Centre National de la Recherche Scientifique" (project 2ID, www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordereau C, 1997, INSECT SOC, V44, P289, DOI 10.1007/s000400050049; Bugnion E., 1913, Revue Suisse de Zoologie, V21; Deligne J., 1981, SOCIAL INSECTS, VII, P1; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; EVANS DA, 1976, CHEM ECOLOGY ODOUR C, P213; Feytaud J., 1912, Archives d'Anatomie Microscopique, V13; HARE L, 1937, ANN ENTOMOLOGICAL SO, V30, P459; Holmgren N., 1909, KUNGLIGA SVENSKA VET, V44, P1; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Kuldova J, 1999, J CHEM ECOL, V25, P657, DOI 10.1023/A:1020918323678; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; LELIS AT, 1993, J MORPHOL, V217, P239, DOI 10.1002/jmor.1052170211; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; MILL AE, 1983, PHYSIOL ENTOMOL, V8, P413, DOI 10.1111/j.1365-3032.1983.tb00375.x; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Noirot Ch., 1969, P89; Nutting WL, 1969, BIOLOGY TERMITES, VI, P233; Ohkuma M, 2004, MOL PHYLOGENET EVOL, V31, P701, DOI 10.1016/j.ympev.2003.09.009; Piskorski R, 2009, BIOL J LINN SOC, V98, P384, DOI 10.1111/j.1095-8312.2009.01286.x; PRESTWICH GD, 1984, J CHEM ECOL, V10, P1219, DOI 10.1007/BF00988550; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Quennedy A., 1984, P151; Seid MA, 2008, CURR BIOL, V18, pR1049, DOI 10.1016/j.cub.2008.09.033; Sobotnik J, 2004, EUR J ENTOMOL, V101, P153, DOI 10.14411/eje.2004.020; Sobotnik Jan, 2003, Acta Societatis Zoologicae Bohemicae, V67, P83; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012; Sobotnik J, 2010, NATURWISSENSCHAFTEN, V97, P495, DOI 10.1007/s00114-010-0664-0; Sobotnik J, 2010, BIOL J LINN SOC, V99, P839, DOI 10.1111/j.1095-8312.2010.01392.x	29	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15761	10.1371/journal.pone.0015761	http://dx.doi.org/10.1371/journal.pone.0015761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209882	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793600034
J	Buchanan, J; Mihaylova, B; Gray, A; White, N				Buchanan, James; Mihaylova, Borislava; Gray, Alastair; White, Nicholas			Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; SEVERE PNEUMONIA; RANDOMIZED-TRIAL; NEUROLOGICAL SEQUELAE; CEREBRAL MALARIA; RISK-FACTORS; CHILDREN; MORTALITY; AFRICA; ARTESUNATE	Background: Malaria and bacterial infections account for most infectious disease deaths in developing countries. Prompt treatment saves lives, but rapid deterioration often prevents the use of oral therapies; delays in reaching health facilities providing parenteral interventions are common. Rapidly and reliably absorbed antimalarial/antibacterial rectal formulations used in the community could prevent deaths and disabilities. Rectal antimalarial treatments are currently available; rectal antibacterial treatments are yet to be developed. Assessment of the likely cost-effectiveness of these interventions will inform research priorities and implementation. Methods and Findings: The burden of malaria and bacterial infections worldwide and in Sub-Saharan and Southern Africa (SSA) and South and South-East Asia (SEA) was summarised using published data. The additional healthcare costs (US$) per death and per Disability Adjusted Life Year (DALY) avoided following pre-referral treatment of severe febrile illness with rectal antimalarials, antibacterials or combined antimalarial/antibacterials in populations at malaria risk in SSA/SEA were assessed. 46 million severe malaria and bacterial infections and 5 million deaths occur worldwide each year, mostly in SSA/SEA. At annual delivery costs of $0.02/capita and 100% coverage, rectal antimalarials ($2 per dose) would avert 240,000 deaths in SSA and 7,000 deaths in SEA at $5 and $177 per DALY avoided, respectively; rectal antibacterials ($2 per dose) would avert 130,000 deaths in SSA and 27,000 deaths in SEA at $19 and $97 per DALY avoided, respectively. Combined rectal formulations ($2.50 per dose) would avert 370,000 deaths in SSA and 33,000 deaths in SEA at $8 and $79 per DALY avoided, respectively, and are a cost-effective alternative to rectal antimalarials or antibacterials alone. Conclusions: Antimalarial, antibacterial and combined rectal formulations are likely to be cost-effective interventions for severe febrile illness in the community. Attention should focus on developing effective rectal antibacterials and ensuring that these lifesaving treatments are used in a cost-effective manner.	[Buchanan, James; Mihaylova, Borislava; Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [White, Nicholas] Mahidol Univ, Fac Trop Med, Oxford, England; [White, Nicholas] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Buchanan, J (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England.	boby.mihaylova@dphpc.ox.ac.uk	White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Buchanan, James/H-7157-2019	White, Nick/0000-0002-1897-1978; Buchanan, James/0000-0003-2528-0638; Mihaylova, Borislava/0000-0002-0951-1304	Wellcome Trust [085242]; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by a technology transfer grant (085242) from the Wellcome Trust: Reducing childhood mortality in the tropics; development of a combined antimalarial-antibacterial rectal formulation for community use. Preliminary scoping excercise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB BURD DIS 2004 U; [Anonymous], SECR WORLD POP PROSP; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Beyrer C, 2006, PLOS MED, V3, P1733, DOI 10.1371/journal.pmed.0030393; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; Department of Economic and Social Affairs, 2006, DEM YB; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Faiz MA, 2005, LANCET, V366, P717; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Goodman C, 2000, EC ANAL MALARIA CONT; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Goodman CA, 2001, HEALTH ECON, V10, P731, DOI 10.1002/hec.621; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; International Monetary Fund, 2009, WORLD EC OUTL SURV S; Jeena P, 2006, B WORLD HEALTH ORGAN, V84, P269; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kenya Medical Supplies Agency, 2008, TEND PRIC; Lim Y-W, 2006, TECHNICAL SUPPLEMENT; Lim Yee-Wei, 2006, Nature, V444 Suppl 1, P9, DOI 10.1038/nature05442; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Neeraj D, 2010, LANCET; Njau JD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-4; Noedl H, 2009, TRENDS PARASITOL, V25, P540, DOI 10.1016/j.pt.2009.09.001; PrayGod G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-210; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P81; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Sinha A, LANCET, V369, P389; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; *US DEP LAB, 2009, CONS PRIC IND; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, INT MAN CHILDH ILLN; WHO, 2012, MAN SEV MAL PRACT HD, V3; 2004, SOURC PRIC SEL PROD; WHO UNICEF, 2004, MAN PNEUM COMM SETT; *WORLD BANK, 1993, WORLD DEV REP; World Health Organisation, 2009, AC RESP INF CHILDR; World Health Organisation, 2009, WHO CHOICE; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 1996, INV HLTH RES DEV REP; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2008, WORLD MAL REP	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14446	10.1371/journal.pone.0014446	http://dx.doi.org/10.1371/journal.pone.0014446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206901	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200004
J	Lieber, DS; Elemento, O; Tavazoie, S				Lieber, Daniel S.; Elemento, Olivier; Tavazoie, Saeed			Large-Scale Discovery and Characterization of Protein Regulatory Motifs in Eukaryotes	PLOS ONE			English	Article							LINEAR MOTIFS; GLOBAL ANALYSIS; SEQUENCE REQUIREMENTS; SYSTEMATIC DISCOVERY; INTERACTION NETWORKS; MASS-SPECTROMETRY; BUDDING YEAST; SITES; PHOSPHORYLATION; PEPTIDES	The increasing ability to generate large-scale, quantitative proteomic data has brought with it the challenge of analyzing such data to discover the sequence elements that underlie systems-level protein behavior. Here we show that short, linear protein motifs can be efficiently recovered from proteome-scale datasets such as sub-cellular localization, molecular function, half-life, and protein abundance data using an information theoretic approach. Using this approach, we have identified many known protein motifs, such as phosphorylation sites and localization signals, and discovered a large number of candidate elements. We estimate that similar to 80% of these are novel predictions in that they do not match a known motif in both sequence and biological context, suggesting that post-translational regulation of protein behavior is still largely unexplored. These predicted motifs, many of which display preferential association with specific biological pathways and non-random positioning in the linear protein sequence, provide focused hypotheses for experimental validation.	[Lieber, Daniel S.; Elemento, Olivier; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University	Lieber, DS (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ole2001@med.cornell.edu; tavazoie@genomics.princeton.edu			NSF [2R01HG003219]; NIGMS [P50 GM071508]; NIH [1DP10D003787-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ST was supported by grants from the NSF Career Award NHGRI (2R01HG003219), NIGMS (P50 GM071508), and the NIH Director's Pioneer Award (1DP10D003787-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1990, IDENTIFICATION PROTE; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Diella F, 2009, BIOINFORMATICS, V25, P1, DOI 10.1093/bioinformatics/btn594; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HURT EC, 1987, J BIOL CHEM, V262, P1420; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; SUBRAMANI S, 1992, J MEMBRANE BIOL, V125, P99; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	50	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14444	10.1371/journal.pone.0014444	http://dx.doi.org/10.1371/journal.pone.0014444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206902	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200002
J	Morgan, SG; Cunningham, CM; Hanley, GE				Morgan, Steven G.; Cunningham, Colleen M.; Hanley, Gillian E.			Individual and Contextual Determinants of Regional Variation in Prescription Drug Use: An Analysis of Administrative Data from British Columbia	PLOS ONE			English	Article							HEALTH-CARE; GEOGRAPHIC-VARIATION; BEHAVIORAL-MODEL; UNITED-STATES; MEDICAL-CARE; CANADA	Background: Increasing attention is being paid to variations in the use of prescription drugs because their role in health care has grown to the point where their use can be considered a proxy for health system performance. Studies have shown that prescription drug use varies across regions in the US, UK, and Canada by more than would be predicted based on age and health status alone. In this paper, we explore the determinants of variations in the use of prescription drugs, drawing on health services theories of access to care. Methods: We conducted a cross-sectional analysis using population-based administrative health care data for British Columbia (BC), Canada. We used logistic and hierarchical regressions to analyze the effects of individual-and area-level determinants of use of prescriptions overall and rates of purchase of prescriptions from five therapeutic categories representing a range of indications: antihypertensives, statins, acid reducing drugs, opioid drugs, and antidepressants. To indicate the relative scale of regional variations and the importance of individual-and area-level variables in explaining them, we computed standardized rates of utilization for 49 local health areas in BC. Results: We found that characteristics of individuals and the areas in which they live affect likelihood of prescription drug purchase. Individual-level factors influenced prescription drug purchases in ways generally consistent with behavioral models of health services use. Contextual variables exerted influences that differed by type of drug studied. Population health, education levels, and ethnic composition of local areas were associated with significant differences in the likelihood of purchasing medications. Relatively modest regional variations remained after both individual-level and area-level determinants were taken into account. Conclusions: The results of this study suggest that individual-and area-level factors should be considered when studying variations in the use of prescription drugs. Some sources of such variations, including individual-and area-level socioeconomic status, warrant further investigation and possible intervention to address inequities.	[Morgan, Steven G.; Cunningham, Colleen M.; Hanley, Gillian E.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Morgan, Steven G.; Hanley, Gillian E.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Morgan, SG (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	morgan@chspr.ubc.ca	Cunningham, Colleen/AAY-4357-2021; Morgan, Steven/J-8814-2015	Hanley, Gillian/0000-0001-9594-0545; Morgan, Steven/0000-0002-7529-0028	British Columbia Ministry of Health Services; Canadian Institutes of Health Research	British Columbia Ministry of Health Services; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was made possible through the financial support of the British Columbia Ministry of Health Services and an operating research grant from the Canadian Institutes of Health Research (www.CIHR.ca). The construction of the research database was supported, in part, by contributions of the Ministry of Health Services to the University of British Columbia Centre for Health Services and Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; *BC STATS, 2010, BC GDP IND; *BC STATS, 2009, PROF IMM; Birch S, 1993, Health Econ, V2, P87, DOI 10.1002/hec.4730020203; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; *CIHI, 2010, DRUG EXP CAN 1985 20; Cox ER, 2003, PEDIATRICS, V111, P237, DOI 10.1542/peds.111.2.237; Dubois RW, 2002, HEALTH AFFAIR, V21, P240, DOI 10.1377/hlthaff.21.1.240; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Goyder Elizabeth, 2006, Int J Equity Health, V5, P4, DOI 10.1186/1475-9276-5-4; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; LIPSITZ SR, 1994, BIOMETRICS, V50, P270, DOI 10.2307/2533218; Morgan S, 2004, CAN MED ASSOC J, V170, P329; Morgan S., 2005, CANADIAN RX ATLAS; MORGAN S, 2008, CANADIAN RX ATLAS; MORGAN S, 2005, BC RX ATLAS; MORGAN S, 2009, BC RX ATLAS; NEWBOLD KB, 1995, SOC SCI MED, V40, P1181, DOI 10.1016/0277-9536(94)00229-M; Phillips KA, 1998, HEALTH SERV RES, V33, P571; ROOS NP, 1986, AM J PUBLIC HEALTH, V76, P45, DOI 10.2105/AJPH.76.1.45; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Ward Paul R, 2007, Int J Equity Health, V6, P2, DOI 10.1186/1475-9276-6-2; Watson D, 2009, ROAD RENEWAL MAPPING; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; ZHANG Y, 2010, NEW ENGLAND J MED	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15883	10.1371/journal.pone.0015883	http://dx.doi.org/10.1371/journal.pone.0015883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209960	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200064
J	Schwend, T; Loucks, EJ; Ahlgren, SC				Schwend, Tyler; Loucks, Evyn J.; Ahlgren, Sara C.			Visualization of Gli Activity in Craniofacial Tissues of Hedgehog-Pathway Reporter Transgenic Zebrafish	PLOS ONE			English	Article							DROSOPHILA CUBITUS INTERRUPTUS; FINGER TRANSCRIPTION FACTOR; CRANIAL NEURAL CREST; SONIC HEDGEHOG; INDIAN-HEDGEHOG; FLOOR PLATE; KRUPPEL FAMILY; GENE ENCODES; PROTEIN; EXPRESSION	Background: The Hedgehog (Hh)-signaling pathway plays a crucial role in the development and maintenance of multiple vertebrate and invertebrate organ systems. Gli transcription factors are regulated by Hh-signaling and act as downstream effectors of the pathway to activate Hh-target genes. Understanding the requirements for Hh-signaling in organisms can be gained by assessing Gli activity in a spatial and temporal fashion. Methodology/Principal Findings: We have generated a Gli-dependent (Gli-d) transgenic line, Tg(Gli-d: mCherry), that allows for rapid and simple detection of Hh-responding cell populations in both live and fixed zebrafish. This transgenic line expresses a mCherry reporter under the control of a Gli responsive promoter, which can be followed by using fluorescent microscopy and in situ hybridization. Expression of the mCherry transgene reporter during embryogenesis and early larval development faithfully replicated known expression domains of Hh-signaling in zebrafish, and abrogating Hh-signaling in transgenic fish resulted in the suppression of reporter expression. Moreover, ectopic shh expression in Tg(Glid: mCherry) fish led to increased transgene production. Using this transgenic line we investigated the nature of Hh-pathway response during early craniofacial development and determined that the neural crest skeletal precursors do not directly respond to Hh-signaling prior to 48 hours post fertilization, suggesting that earlier requirements for pathway activation in this population of facial skeleton precursors are indirect. Conclusion/Significance: We have determined that early Hh-signaling requirements in craniofacial development are indirect. We further demonstrate the Tg(Gli-d: mCherry) fish are a highly useful tool for studying Hh-signaling dependent processes during embryogenesis and larval stages.	[Schwend, Tyler] Northwestern Univ, Feinberg Sch Med, Integrated Grad Program, Chicago, IL 60611 USA; [Ahlgren, Sara C.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Schwend, Tyler; Loucks, Evyn J.; Ahlgren, Sara C.] Childrens Mem Res Ctr, Dev Biol Program, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Schwend, T (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	s-ahlgren@northwestern.edu			NRSA (NIH-NIDCR) [F31DE019604]; National Institutes of Health [AA13596]; State of Illinois; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE019604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA013596] Funding Source: NIH RePORTER	NRSA (NIH-NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Illinois; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Ruth L. Kirschtein predoctoral NRSA F31DE019604 (NIH-NIDCR) to T. S. as well as grants from National Institutes of Health (AA13596) and the State of Illinois to S. C. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Brand M, 1996, DEVELOPMENT, V123, P129; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Devine CA, 2009, DEV BIOL, V326, P143, DOI 10.1016/j.ydbio.2008.11.006; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Ke ZY, 2008, MOL CELL NEUROSCI, V37, P388, DOI 10.1016/j.mcn.2007.10.013; Ke ZY, 2005, DEV DYNAM, V232, P479, DOI 10.1002/dvdy.20242; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis KE, 1999, DEVELOPMENT, V126, P2397; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; Methot N, 2001, DEVELOPMENT, V128, P733; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Vanderlaan G, 2005, DEV BIOL, V282, P550, DOI 10.1016/j.ydbio.2005.04.010; Varga ZM, 2001, DEVELOPMENT, V128, P3497; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; WALTERHOUSE D, 1993, DEV DYNAM, V196, P91, DOI 10.1002/aja.1001960203; Wang QT, 1999, DEVELOPMENT, V126, P5097; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang HB, 2009, J BIOL CHEM, V284, P20876, DOI 10.1074/jbc.M807648200	73	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14396	10.1371/journal.pone.0014396	http://dx.doi.org/10.1371/journal.pone.0014396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203590	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900011
J	el Azzouzi, H; Leptidis, S; Bourajjaj, M; Armand, AS; van der Nagel, R; van Bilsen, M; Martins, PAD; De Windt, LJ				el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel; van Bilsen, Marc; Martins, Paula A. Da Costa; De Windt, Leon J.			Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPAR alpha Target Gene in Cardioprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEART-FAILURE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CONTRACTILE DYSFUNCTION; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; EXPRESSION; DELTA; GAMMA; MICE	Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family of ligand-activated transcription factors and consist of the three isoforms, PPAR alpha, PPAR beta/delta, and PPAR gamma. Considerable evidence indicates the importance of PPARs in cardiovascular lipid homeostasis and diabetes, yet the isoform-dependent cardiac target genes remain unknown. Here, we constructed murine ventricular clones allowing stable expression of siRNAs to achieve specifically knockdown for each of the PPAR isoforms. By combining gene profiling and computational peroxisome proliferator response element analysis following PPAR isoform activation in normal versus PPAR isoform-deficient cardiomyocyte-like cells, we have, for the first time, determined PPAR isoform-specific endogenous target genes in the heart. Electromobility shift and chromatin immunoprecipitation assays demonstrated the existence of an evolutionary conserved peroxisome proliferator response element consensus-binding site in an insulin-like growth factor-1 (igf-1) enhancer. In line, Wy-14643-mediated PPAR alpha activation in the wild-type mouse heart resulted in up-regulation of igf-1 transcript abundance and provided protection against cardiomyocyte apoptosis following ischemia/reperfusion or biomechanical stress. Taken together, these data confirm igf-1 as an in vivo target of PPAR alpha and the involvement of a PPAR alpha/IGF-1 signaling pathway in the protection of cardiomyocytes under ischemic and hemodynamic loading conditions.	[el Azzouzi, Hamid; Leptidis, Stefanos; Martins, Paula A. Da Costa; De Windt, Leon J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6200 MD Maastricht, Netherlands; [van Bilsen, Marc] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6200 MD Maastricht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3584 CS Utrecht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Armand, Anne-Sophie; van der Nagel, Roel] Royal Netherlands Acad Sci, Hubrecht Inst, NL-3584 CS Utrecht, Netherlands	Maastricht University; Maastricht University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	De Windt, LJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6200 MD Maastricht, Netherlands.	l.dewindt@maastrichtuniversity.nl	Leptidis, Stefanos/D-1455-2016; van Bilsen, Marc/E-8342-2016; de Windt, Leon/AAO-6395-2020	Leptidis, Stefanos/0000-0003-0172-4193; de Windt, Leon/0000-0002-7793-2856; el Azzouzi, Hamid/0000-0003-1242-9691	The Netherlands Organization for Health Research and Development (ZonMW) [912-04-054, 912-04-017]; VIDI [917-863-72]; The Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-2005-018833/EUGeneHeart]	The Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); VIDI(Netherlands Organization for Scientific Research (NWO)); The Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMW) Grants 912-04-054 and 912-04-017 and VIDI Award 917-863-72, The Netherlands Heart Foundation Grant NHS2007B167, and the European Union Contract LSHM-CT-2005-018833/EUGeneHeart (to L. J. D. W.).	Baldan A, 2004, NUCLEIC ACIDS RES, V32, P4742, DOI 10.1093/nar/gkh806; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; BUERKE M, 1995, CIRCULATION, V91, P393, DOI 10.1161/01.CIR.91.2.393; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chevillotte E, 2001, J BIOL CHEM, V276, P10853, DOI 10.1074/jbc.M008010200; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Labinskyy V, 2007, J PHARMACOL EXP THER, V321, P165, DOI 10.1124/jpet.106.116871; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Rybkin II, 2003, J BIOL CHEM, V278, P15927, DOI 10.1074/jbc.M213102200; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Smeets PJH, 2007, ACTA PHYSIOL, V191, P171, DOI 10.1111/j.1748-1716.2007.01752.x; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Yeh CH, 2005, J CARDIOVASC PHARM, V45, P301, DOI 10.1097/01.fjc.0000155385.41479.b3; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	47	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14598	14607		10.1074/jbc.M111.220525	http://dx.doi.org/10.1074/jbc.M111.220525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21245137	Green Published, hybrid			2022-12-25	WOS:000289556200079
J	Hollander, MC; Maier, CR; Hobbs, EA; Ashmore, AR; Linnoila, RI; Dennis, PA				Hollander, M. C.; Maier, C. R.; Hobbs, E. A.; Ashmore, A. R.; Linnoila, R. I.; Dennis, P. A.			Akt1 deletion prevents lung tumorigenesis by mutant K-ras	ONCOGENE			English	Article						Akt1; Akt3; K-ras; lung	PLECKSTRIN HOMOLOGY DOMAIN; GLUCOSE-HOMEOSTASIS; ONCOGENIC MUTATION; THERAPEUTIC TARGET; TUMOR-DEVELOPMENT; MICE LACKING; ACTIVATION; CANCER; IDENTIFICATION; GROWTH	K-ras mutations are associated with smoking-induced lung cancer and poor clinical outcomes. In mice, K-ras mutations are sufficient to induce lung tumors, which require phosphoinoside-3-kinase (PI3K) and further downstream, mammalian target of rapamycin (mTOR) activation. However, the roles of individual Akt isoforms that link PI3K and mTOR are unknown. Here, we show that deletion of Akt1 but not Akt2 or Akt3 prevents lung tumorigenesis in a tobacco carcinogen-induced model and a genetic model. Akt1 deletion prevented tumor initiation as well as tumor progression, coincident with decreased Akt signaling in tumor tissues. In contrast, deletion of Akt3 increased tumor multiplicity in the carcinogen model and increased tumor size in the genetic model. Fibroblasts lacking Akt1 are resistant to transformation by mutant K-ras and stimulation by epidermal growth factor. Human lung cancer cells with mutant K-ras and diminished Akt1 levels fail to grow in vivo. These data suggest that Akt1 is the primary Akt isoform activated by mutant K-ras in lung tumors, and that Akt3 may oppose Akt1 in lung tumorigenesis and lung tumor progression. Given that Akt inhibitors in clinical development as cancer therapeutics are not isoform selective, these studies support specific targeting of Akt1 to mitigate the effects of mutant K-ras in lung cancer. Oncogene (2011) 30, 1812-1821; doi:10.1038/onc.2010.556; published online 17 January 2011	[Hollander, M. C.; Maier, C. R.; Hobbs, E. A.; Ashmore, A. R.; Dennis, P. A.] NCI, Med Oncol Branch, NIH, Bethesda, MD 20889 USA; [Linnoila, R. I.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20889 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dennis, PA (corresponding author), NCI, Med Oncol Branch, NIH, NNMC8-5101,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	pdennis@mail.nih.gov			NIH; NATIONAL CANCER INSTITUTE [ZIASC010292, ZIABC010450, ZIASC000167, ZIABC010748, P30CA006973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded through the NIH intramural research program.	Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; BELINSKY SA, 1989, CANCER RES, V49, P5305; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; Dannemann N, 2010, INT J CANCER, V127, P239, DOI 10.1002/ijc.25012; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; DiRenzo J, 2002, CANCER RES, V62, P89; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Granville CA, 2007, CLIN CANCER RES, V13, P2281, DOI 10.1158/1078-0432.CCR-06-2570; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hollander MC, 2008, NEOPLASIA, V10, P866, DOI 10.1593/neo.08406; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; John LCH, 2001, BRIT J BIOMED SCI, V58, P159; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Lin L, 1998, EXP LUNG RES, V24, P481, DOI 10.3109/01902149809087382; Macdonald JS, 2005, INVEST NEW DRUG, V23, P485, DOI 10.1007/s10637-005-2908-y; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Ruiz MIG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001722; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; West KA, 2004, CANCER RES, V64, P446, DOI 10.1158/0008-5472.CAN-03-3241; WITSCHI HP, 1981, TOXICOLOGY, V21, P95, DOI 10.1016/0300-483X(81)90120-7; Xu CX, 2008, AM J RESP CRIT CARE, V178, P60, DOI 10.1164/rccm.200707-1022OC; Zilberman DE, 2009, CANCER GENET CYTOGEN, V191, P34, DOI 10.1016/j.cancergencyto.2009.01.009	49	48	49	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	15					1812	1821		10.1038/onc.2010.556	http://dx.doi.org/10.1038/onc.2010.556			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21242979	Green Accepted			2022-12-25	WOS:000289512200008
J	Walker, MP; Zhang, M; Le, TP; Wu, P; Laine, M; Greene, GL				Walker, M. P.; Zhang, M.; Le, T. P.; Wu, P.; Laine, M.; Greene, G. L.			RAC3 is a pro-migratory co-activator of ER alpha	ONCOGENE			English	Article						transcription; estrogen receptor; RAC3; breast cancer	ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; RHO GTPASES; PROTEIN; TRANSCRIPTION; METASTASIS; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; EXPRESSION	Estrogen receptor alpha (ER alpha) is a ligand-dependent nuclear receptor that is important in breast cancer genesis, behavior and response to hormone-based therapies. A T7 phage display screen against full-length human ER alpha, coupled with genome-wide exon arrays, was used to identify RAC3 as a putative ER alpha co-regulator. RAC3 is a Rho family small GTPase that is associated with cytoskeletal rearrangement. We demonstrate a novel role for nuclear RAC3 as an ER alpha transcriptional activator, with prognostic implications for metastatic disease. Through in vitro and cell-based studies, RAC3 was shown to exist in a GTP-bound state and act as a ligand specific ER alpha co-activator of E2-induced transcription. Overexpression of RAC3 induced pro-growth and pro-migratory genes that resulted in increased migration of ER alpha-positive breast cancer cells. Chemical inhibition and genetic knockdown of RAC3 antagonized E2-induced cell proliferation, cell migration and ER alpha mediated gene expression, indicating that RAC3 is necessary for full ER alpha transcriptional activity. In agreement with the molecular and cellular data, RAC3 overexpression in ER alpha-positive breast cancers correlated with a significant decrease in recurrence free survival and a significant increase in the odds ratio of metastasis. In conclusion, RAC3 is a novel ER alpha a co-activator that promotes cell migration and has prognostic value for ER alpha-positive breast cancer metastasis. RAC3 may also be a useful therapeutic target for ER alpha-positive breast cancers. Oncogene (2011) 30, 1984-1994; doi:10.1038/onc.2010.583; published online 10 January 2011	[Zhang, M.; Wu, P.; Laine, M.; Greene, G. L.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Walker, M. P.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Le, T. P.] Univ Chicago, Comm Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Greene, GL (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 57th St GCIS, Chicago, IL 60637 USA.	ggreene@uchicago.edu		Wu, Patricia/0000-0003-3134-3789	NCI [2-RO1-CA089489]; Department of Defense [W81XWH-04-1-0791]; Ludwig Foundation; Cancer Center [5P30-CA01459935]; NIH [5T32GM007183-35]; NATIONAL CANCER INSTITUTE [R01CA089489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Ludwig Foundation; Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI 2-RO1-CA089489 (GLG), Department of Defense W81XWH-04-1-0791 (GLG) and a gift from the Ludwig Foundation (GLG). Core services were supported in part by a 5P30-CA01459935 Cancer Center grant. MPW was partially supported by NIH grant 5T32GM007183-35.	Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chang CY, 2003, METHOD ENZYMOL, V364, P118; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; Kumar R, 2005, CLIN CANCER RES, V11, P2822, DOI 10.1158/1078-0432.CCR-04-1276; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Leong HY, 2005, MOL ENDOCRINOL, V19, P2930, DOI 10.1210/me.2005-0178; Leung K, 2003, CELLS TISSUES ORGANS, V175, P72, DOI 10.1159/000073751; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muramatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P1, DOI 10.1006/bbrc.2000.2214; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Oesterreich S, 2001, CANCER RES, V61, P5771; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Pike ACW, 2006, BEST PRACT RES CL EN, V20, P1, DOI 10.1016/j.beem.2005.09.002; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Talukder AH, 2006, ONCOGENE, V25, P1311, DOI 10.1038/sj.onc.1209172; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Xie JW, 2008, BREAST CANCER RES TR, V110, P257, DOI 10.1007/s10549-007-9719-0	40	23	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	17					1984	1994		10.1038/onc.2010.583	http://dx.doi.org/10.1038/onc.2010.583			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21217774	Green Accepted			2022-12-25	WOS:000289977400002
J	Ong, HB; Sienkiewicz, N; Wyllie, S; Fairlamb, AH				Ong, Han B.; Sienkiewicz, Natasha; Wyllie, Susan; Fairlamb, Alan H.			Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PHENYLALANINE-HYDROXYLASE; DIHYDROFOLATE-REDUCTASE; TETRAHYDROBIOPTERIN BIOSYNTHESIS; METHOTREXATE RESISTANCE; THYMIDYLATE SYNTHASE; CYTOCHROME-C; ENZYME; OXIDATION; SYSTEM	Leishmania parasites are pteridine auxotrophs that use an NADPH-dependent pteridine reductase 1 (PTR1) and NADH-dependent quinonoid dihydropteridine reductase (QDPR) to salvage and maintain intracellular pools of tetrahydrobiopterin (H4B). However, the African trypanosome lacks a credible candidate-QDPR in its genome despite maintaining apparent QDPR activity. Here we provide evidence that the NADH-dependent activity previously reported by others is an assay artifact. Using an HPLC-based enzyme assay, we demonstrate that there is an NADPH-dependent QDPR activity associated with both TbPTR1 and LmPTR1. The kinetic properties of recombinant PTR1s are reported at physiological pH and ionic strength and compared with LmQDPR. Specificity constants (k(cat)/K-m) for LmPTR1 are similar with dihydrobiopterin (H2B) and quinonoid dihydrobiopterin (qH(2)B) as substrates and about 20-fold lower than LmQDPR with qH(2)B. In contrast, TbPTR1 shows a 10-fold higher k(cat)/K-m for H2B over qH(2)B. Analysis of Trypanosoma brucei isolated from infected rats revealed that H4B (430 nM, 98% of total biopterin) was the predominant intracellular pterin, consistent with a dual role in the salvage and regeneration of H4B. Gene knock-out experiments confirmed this: PTR1-nulls could only be obtained from lines overexpressing LmQDPR with H4B as a medium supplement. These cells grew normally with H4B, which spontaneously oxidizes to qH(2)B, but were unable to survive in the absence of pterin or with either biopterin or H2B in the medium. These findings establish that PTR1 has an essential and dual role in pterin metabolism in African trypanosomes and underline its potential as a drug target.	[Ong, Han B.; Sienkiewicz, Natasha; Wyllie, Susan; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Dundee	Fairlamb, AH (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyllie, Susan/0000-0001-8810-5605; Ong, Han/0000-0003-3369-8196	Wellcome Trust [WT079838, WT083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (WT079838 and WT083481).	BECK JT, 1990, MOL BIOCHEM PARASIT, V43, P221, DOI 10.1016/0166-6851(90)90147-E; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; BRUN R, 1979, ACTA TROP, V36, P289; Copeland R. A, 2005, EVALUATION ENZYME IN, P77; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; CURTIUS HC, 1985, EUR J BIOCHEM, V148, P413, DOI 10.1111/j.1432-1033.1985.tb08855.x; DAVIS MD, 1988, EUR J BIOCHEM, V173, P345, DOI 10.1111/j.1432-1033.1988.tb14004.x; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gourley DG, 1999, ACTA CRYSTALLOGR D, V55, P1608, DOI 10.1107/S0907444999008999; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; HASEGAWA H, 1978, J BIOCHEM-TOKYO, V84, P499, DOI 10.1093/oxfordjournals.jbchem.a132153; HUANG CY, 1973, J BIOL CHEM, V248, P4242; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; KAUFMAN S, 1967, J BIOL CHEM, V242, P3934; KAUFMAN S, 1961, J BIOL CHEM, V236, P804; KAUFMAN S, 1990, BIOCHIM BIOPHYS ACTA, V1040, P19, DOI 10.1016/0167-4838(90)90141-2; Keita M, 2000, EXP PARASITOL, V95, P19, DOI 10.1006/expr.2000.4505; KIDDER GW, 1958, J GEN MICROBIOL, V18, P621, DOI 10.1099/00221287-18-3-621; Kirsch M, 2003, J BIOL CHEM, V278, P24481, DOI 10.1074/jbc.M211779200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; KWON NS, 1989, J BIOL CHEM, V264, P20496; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LAZARUS RA, 1981, BIOCHEMISTRY-US, V20, P6834, DOI 10.1021/bi00527a015; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Lye LF, 2002, J BIOL CHEM, V277, P38245, DOI 10.1074/jbc.M206543200; Lye LF, 2011, MOL BIOCHEM PARASIT, V175, P58, DOI 10.1016/j.molbiopara.2010.09.004; Ma DQ, 1996, BIOCHEM BIOPH RES CO, V227, P885, DOI 10.1006/bbrc.1996.1600; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Nare B, 2009, CURR GENET, V55, P287, DOI 10.1007/s00294-009-0244-z; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; PFLEIDERER W, 1985, CHEM BIOCH PTERINS, P43; SCOTT DA, 1995, BIOCHEM J, V310, P789, DOI 10.1042/bj3100789; Shanks EJ, 2010, ANAL BIOCHEM, V396, P194, DOI 10.1016/j.ab.2009.09.003; SHIOTA T, 1964, J BIOL CHEM, V239, P2259; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sienkiewicz N, 2010, MOL MICROBIOL, V77, P658, DOI 10.1111/j.1365-2958.2010.07236.x; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; TIETZ A, 1964, J BIOL CHEM, V239, P4081; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Wang JY, 1997, ARCH BIOCHEM BIOPHYS, V342, P197, DOI 10.1006/abbi.1997.0126; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yoshida S, 2001, RESPIRATION, V68, P299, DOI 10.1159/000050514	51	35	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10429	10438		10.1074/jbc.M110.209593	http://dx.doi.org/10.1074/jbc.M110.209593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239486	Green Published, hybrid			2022-12-25	WOS:000288547000059
J	Sattlegger, E; Barbosa, JARG; Moraes, MCS; Martins, RM; Hinnebusch, AG; Castilho, BA				Sattlegger, Evelyn; Barbosa, Joao A. R. G.; Moraes, Maria Carolina S.; Martins, Rafael M.; Hinnebusch, Alan G.; Castilho, Beatriz A.			Gcn1 and Actin Binding to Yih1 IMPLICATIONS FOR ACTIVATION OF THE eIF2 KINASE GCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR 1A; PROTEIN-KINASE GCN2; INTRINSICALLY UNSTRUCTURED PROTEIN; AMINO-ACID CONTROL; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION; GI DOMAIN; GENE; ORGANIZATION; CYTOSKELETON	Yeast Yih1 protein and its mammalian ortholog IMPACT, abundant in neurons, are inhibitors of Gcn2, a kinase involved in amino acid homeostasis, stress response, and memory formation. Like Gcn2, Yih1/IMPACT harbors an N-terminal RWD domain that mediates binding to the Gcn2 activator Gcn1. Yih1 competes with Gcn2 for Gcn1 binding, thus inhibiting Gcn2. Yih1 also binds G-actin. Here, we show that Yih1-actin interaction is independent of Gcn1 and that Yih1-Gcn1 binding does not require actin. The Yih1 RWD (residues 1-132) was sufficient for Gcn2 inhibition and Gcn1 binding, but not for actin binding, showing that actin binding is dispensable for inhibiting Gcn2. Actin binding required Yih1 residues 68-258, encompassing part of the RWD and the C-terminal "ancient domain"; however, residues Asp-102 and Glu-106 in helix3 of the RWD were essential for Gcn1 binding and Gcn2 inhibition but dispensable for actin binding. Thus, the Gcn1- and actin-binding sites overlap in the RWD but have distinct binding determinants. Unexpectedly, Yih1 segment 68-258 was defective for inhibiting Gcn2 even though it binds Gcn1 at higher levels than does full-length Yih1. This and other results suggest that Yih1 binds with different requirements to distinct populations of Gcn1 molecules, and its ability to disrupt Gcn1-Gcn2 complexes is dependent on a complete RWD and hindered by actin binding. Modeling of the ancient domain on the bacterial protein YigZ showed peculiarities to the eukaryotic and prokaryotic lineages, suggesting binding sites for conserved cellular components. Our results support a role for Yih1 in a cross-talk between the cytoskeleton and translation.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Auckland 0745, New Zealand; [Moraes, Maria Carolina S.; Martins, Rafael M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Sattlegger, Evelyn; Hinnebusch, Alan G.] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Barbosa, Joao A. R. G.] Brazilian Synchrotron Light Lab, Ctr Struct Mol Biol, BR-13083970 Campinas, Brazil	Massey University; Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Laboratorio Nacional de Luz Sincrotron (LNLS)	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Private Bag 102 904, Auckland 0745, New Zealand.	e.sattlegger@massey.ac.nz	Barbosa, João Alexandre/E-2261-2012; Moraes, Maria Carolina Strano/AAS-7557-2021; Barbosa, João/GVT-7916-2022; Castilho, Beatriz A/C-2503-2012	Barbosa, João Alexandre/0000-0002-0534-481X; Moraes, Maria Carolina Strano/0000-0003-4032-5101; Castilho, Beatriz A/0000-0003-4509-5237; miyazawa martins, rafael/0000-0001-7449-0696	National Institutes of Health; Health Research Council of New Zealand; Auckland Medical Research Foundation; Massey University; Maurice and Phyllis Paykel Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Massey University; Maurice and Phyllis Paykel Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program. This work was also supported in part by the Health Research Council of New Zealand Emerging Researcher First Grant, Auckland Medical Research Foundation, Massey University Research and Technician's Fund, Maurice and Phyllis Paykel Trust (to E. S.), and a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to B. A. C.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves VS, 2005, BIOCHEM BIOPH RES CO, V332, P450, DOI 10.1016/j.bbrc.2005.04.151; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Cutler P, 1996, Methods Mol Biol, V59, P255; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kandl KA, 2002, MOL GENET GENOMICS, V268, P10, DOI 10.1007/s00438-002-0726-x; Kang N, 2008, CELL MOL IMMUNOL, V5, P333, DOI 10.1038/cmi.2008.41; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; MUNN A, 2009, AUST BIOCH, V40, P9; Munshi R, 2001, GENETICS, V157, P1425; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park F, 2004, PROTEINS, V55, P775, DOI 10.1002/prot.20087; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wout PK, 2009, EUKARYOT CELL, V8, P1061, DOI 10.1128/EC.00356-08	53	24	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10341	10355		10.1074/jbc.M110.171587	http://dx.doi.org/10.1074/jbc.M110.171587			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239490	hybrid, Green Published			2022-12-25	WOS:000288547000051
J	Yang, YK; Qu, H; Gao, D; Di, W; Chen, HW; Guo, X; Zhai, ZH; Chen, DY				Yang, Yong-Kang; Qu, Hong; Gao, Dong; Di, Wei; Chen, Hai-Wei; Guo, Xin; Zhai, Zhong-He; Chen, Dan-Ying			ARF-like Protein 16 (ARL16) Inhibits RIG-I by Binding with Its C-terminal Domain in a GTP-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; E3 UBIQUITIN LIGASE; NF-KAPPA-B; ADAPTER PROTEIN; SWISS-MODEL; ENDOPLASMIC-RETICULUM; RNA HELICASE; FAMILY; RECOGNITION; REGULATOR	Retinoic acid-inducible gene I (RIG-I) recognizes RNA virus-derived nucleic acids, which leads to the production of type I interferon (IFN) in most cell types. Tight regulation of RIG-I activity is important to prevent ultra-immune responses. In this study, we identified an ARF-like (ARL) family member, ARL16, as a protein that interacts with RIG-I. Overexpression of ARL16, but not its homologous proteins ARL1 and ARF1, inhibited RIG-I-mediated downstream signaling and antiviral activity. Knockdown of endogenous ARL16 by RNAi potentiated Sendai virus-induced IFN-beta expression and vesicular stomatitis virus replication. ARL16 interacted with the C-terminal domain (CTD) of RIG-I to suppress the association between RIG-I and RNA. ARL16 (T37N) and ARL16 Delta 45-54, which were restricted to the GTP-disassociated form, did not interact with RIG-I and also lost the inhibitory function. Furthermore, we suggest that endogenous ARL16 changes to GTP binding status upon viral infection and binds with the RIG-I CTD to negatively control its signaling activity. These findings suggested a novel innate immune function for an ARL family member, and a GTP-dependent model in which RIG-I is regulated.	[Yang, Yong-Kang; Qu, Hong; Gao, Dong; Di, Wei; Chen, Hai-Wei; Zhai, Zhong-He; Chen, Dan-Ying] Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Guo, Xin] China Agr Univ, Key Lab Zoonosis, Minist Agr, Beijing 100083, Peoples R China	Peking University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Chen, DY (corresponding author), Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	dychen@pku.edu.cn	YANG, YONGKANG/AEP-2772-2022	YANG, YONGKANG/0000-0002-0333-7712; Gao, Dong/0000-0003-1821-2741	National Natural Science Foundation of China [30421004, 30871288]; China 973 Program [2010CB911801]; Foundation for Authors of National Excellent Doctoral Dissertations of PR China; National Key Technology RD Program [2008BAI64B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 973 Program(National Basic Research Program of China); Foundation for Authors of National Excellent Doctoral Dissertations of PR China; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (30421004 and 30871288), the China 973 Program (2010CB911801), the Foundation for Authors of National Excellent Doctoral Dissertations of PR China, and the National Key Technology R&D Program (2008BAI64B01).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Lu L, 2001, J CELL SCI, V114, P4543; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748	65	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10568	10580		10.1074/jbc.M110.206896	http://dx.doi.org/10.1074/jbc.M110.206896			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233210	hybrid, Green Published			2022-12-25	WOS:000288547000072
J	Song, QJ; Pallikkuth, S; Bossuyt, J; Bers, DM; Robia, SL				Song, Qiujing; Pallikkuth, Sandeep; Bossuyt, Julie; Bers, Donald M.; Robia, Seth L.			Phosphomimetic Mutations Enhance Oligomerization of Phospholemman and Modulate Its Interaction with the Na/K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENCE FLUCTUATION SPECTROSCOPY; BETA-ADRENERGIC STIMULATION; PHOTON-COUNTING HISTOGRAM; RAT CARDIAC MYOCYTES; PROTEIN-KINASE-C; PHOSPHOLAMBAN OLIGOMERIZATION; CONFORMATIONAL-CHANGES; PUMP REGULATION; LIVING CELLS	Na/K-ATPase (NKA) activity is dynamically regulated by an inhibitory interaction with a small transmembrane protein, phospholemman (PLM). Inhibition is relieved upon PLM phosphorylation. Phosphorylation may alter how PLM interacts with NKA and/or itself, but details of these interactions are unknown. To address this, we quantified FRET between PLM and its regulatory target NKA in live cells. Phosphorylation of PLM was mimicked by mutation S63E (PKC site), S68E (PKA/PKC site), or S63E/S68E. The dependence of FRET on protein expression in live cells yielded information about the structure and binding affinity of the PLM-NKA regulatory complex. PLM phosphomimetic mutations altered the quaternary structure of the regulatory complex and reduced the apparent affinity of the PLM-NKA interaction. The latter effect was likely due to increased oligomerization of PLM phosphomimetic mutants, as suggested by PLM-PLM FRET measurements. Distance constraints obtained by FRET suggest that phosphomimetic mutations slightly alter the oligomer quaternary conformation. Photon-counting histogram measurements revealed that the major PLM oligomeric species is a tetramer. We conclude that phosphorylation of PLM increases its oligomerization into tetramers, decreases its binding to NKA, and alters the structures of both the tetramer and NKA regulatory complex.	[Song, Qiujing; Pallikkuth, Sandeep; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Loyola University Chicago; University of California System; University of California Davis	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL092321, EB006061]; American Heart Association [0720098Z]; McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL030077, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092321 and EB006061 (to S. L. R.). This work was also supported by American Heart Association Fellowship 0720098Z (to Q. S.) and the McCormick Foundation (to the Department of Cell and Molecular Physiology Multiphoton Imaging Facility).	Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Beevers AJ, 2007, J BIOL CHEM, V282, P32742, DOI 10.1074/jbc.M703676200; Bell JR, 2008, AM J PHYSIOL-HEART C, V294, pH613, DOI 10.1152/ajpheart.01332.2007; BERS DM, 2002, EXCITATION CONTRACTI, P90; Bers DM, 2009, TRENDS CARDIOVAS MED, V19, P111, DOI 10.1016/j.tcm.2009.07.001; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; COLVIN RA, 1985, BIOCHIM BIOPHYS ACTA, V812, P601, DOI 10.1016/0005-2736(85)90253-6; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornelius F, 2003, ANN NY ACAD SCI, V986, P579, DOI 10.1111/j.1749-6632.2003.tb07256.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Dobretsov M, 1998, J PHYSIOL-LONDON, V507, P527, DOI 10.1111/j.1469-7793.1998.527bt.x; Faller LD, 2008, ARCH BIOCHEM BIOPHYS, V476, P12, DOI 10.1016/j.abb.2008.05.017; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Marcaggi P, 2009, P NATL ACAD SCI USA, V106, P11388, DOI 10.1073/pnas.0901290106; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Verdonck F, 2003, J MOL CELL CARDIOL, V35, P5, DOI 10.1016/S0022-2828(02)00280-8; Wong A, 2008, SOLID STATE NUCL MAG, V33, P72, DOI 10.1016/j.ssnmr.2008.04.003; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	41	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9120	9126		10.1074/jbc.M110.198036	http://dx.doi.org/10.1074/jbc.M110.198036			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220422	Green Published, hybrid			2022-12-25	WOS:000288247700042
J	Hassan, BH; Cronan, JE				Hassan, Bachar H.; Cronan, John E.			Protein-Protein Interactions in Assembly of Lipoic Acid on the 2-Oxoacid Dehydrogenases of Aerobic Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; MULTI-ENZYME COMPLEX; ESCHERICHIA-COLI; POSTTRANSLATIONAL MODIFICATION; THERMOPLASMA-ACIDOPHILUM; MULTIENZYME COMPLEXES; OCTANOYL SUBSTRATE; REACTION-MECHANISM; MOLECULAR-CLONING; ELEMENTARY STEPS	Lipoic acid is a covalently attached cofactor essential for the activity of 2-oxoacid dehydrogenases and the glycine cleavage system. In the absence of lipoic acid modification, the dehydrogenases are inactive, and aerobic metabolism is blocked. In Escherichia coli, two pathways for the attachment of lipoic acid exist, a de novo biosynthetic pathway dependent on the activities of the LipB and LipA proteins and a lipoic acid scavenging pathway catalyzed by the LplA protein. LipB is responsible for octanoylation of the E2 components of 2-oxoacid dehydrogenases to provide the substrates of LipA, an S-adenosyl-L-methionine radical enzyme that inserts two sulfur atoms into the octanoyl moiety to give the active lipoylated dehydrogenase complexes. We report that the intact pyruvate and 2-oxoglutarate dehydrogenase complexes specifically copurify with both LipB and LipA. Proteomic, genetic, and dehydrogenase activity data indicate that all of the 2-oxoacid dehydrogenase components are present. In contrast, LplA, the lipoate protein ligase enzyme of lipoate salvage, shows no interaction with the 2-oxoacid dehydrogenases. The interaction is specific to the dehydrogenases in that the third lipoic acid-requiring enzyme of Escherichia coli, the glycine cleavage system H protein, does not copurify with either LipA or LipB. Studies of LipB interaction with engineered variants of the E2 subunit of 2-oxoglutarate dehydrogenase indicate that binding sites for LipB reside both in the lipoyl domain and catalytic core sequences. We also report that LipB forms a very tight, albeit noncovalent, complex with acyl carrier protein. These results indicate that lipoic acid is not only assembled on the dehydrogenase lipoyl domains but that the enzymes that catalyze the assembly are also present "on site."	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Hassan, Bachar H.; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health, NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from the NIAID.	AKIYAMA SK, 1980, BIOCHEMISTRY-US, V19, P4208, DOI 10.1021/bi00559a011; AKIYAMA SK, 1981, BIOCHEMISTRY-US, V20, P1491, DOI 10.1021/bi00509a013; ALI ST, 1990, MOL MICROBIOL, V4, P943, DOI 10.1111/j.1365-2958.1990.tb00667.x; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bryant P, 2006, ANAL BIOCHEM, V351, P44, DOI 10.1016/j.ab.2006.01.023; Busby RW, 1999, J AM CHEM SOC, V121, P4706, DOI 10.1021/ja990134g; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHANG YY, 1988, J BACTERIOL, V170, P3937, DOI 10.1128/jb.170.9.3937-3945.1988; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Jordan SW, 1997, METHOD ENZYMOL, V279, P176; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Lengyel JS, 2008, STRUCTURE, V16, P93, DOI 10.1016/j.str.2007.10.017; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; PACKMAN LC, 1991, BIOCHEM J, V277, P153, DOI 10.1042/bj2770153; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Phillips GJ, 2000, BIOTECHNIQUES, V28, P400, DOI 10.2144/00283bm02; PRATT KJ, 1989, BIOCHEM J, V258, P749, DOI 10.1042/bj2580749; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; SMITH MW, 1983, J BACTERIOL, V156, P81, DOI 10.1128/JB.156.1.81-88.1983; Stadtman E., 1954, MECHANISM ENZYME ACT, P581; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; VANAMAN TC, 1968, J BIOL CHEM, V243, P6409; VANAMAN TC, 1968, J BIOL CHEM, V243, P6420; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	46	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8263	8276		10.1074/jbc.M110.194191	http://dx.doi.org/10.1074/jbc.M110.194191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209092	hybrid, Green Published			2022-12-25	WOS:000288013300056
J	Manickam, B; Jha, P; Matta, B; Liu, JA; Bora, PS; Bora, NS				Manickam, Balasubramanian; Jha, Purushottam; Matta, Bharati; Liu, Juan; Bora, Puran S.; Bora, Nalini S.			Inhibition of Complement Alternative Pathway Suppresses Experimental Autoimmune Anterior Uveitis by Modulating T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-ASSOCIATED ANTIGEN; INDUCED CHOROIDAL NEOVASCULARIZATION; COLLAGEN-INDUCED ARTHRITIS; ISCHEMIA/REPERFUSION INJURY; REGULATORY PROTEINS; ADAPTIVE IMMUNITY; PRESENTING CELLS; FACTOR-B; ACTIVATION; INDUCTION	The objective of the current study was to delineate the pathway of complement activation that is crucial for the induction of experimental autoimmune anterior uveitis (EAAU). We studied the development of EAAU in melanin-associated antigen (MAA)-sensitized Lewis rats treated with antibody against C4 or factor B. Control animals received isotype IgG control. Antibody against C4 had no effect on EAAU, and all of the animals developed EAAU similar to those injected with control IgG. In contrast, EAAU was completely inhibited in all MAA-sensitized Lewis rats injected with factor B antibody. Treatment with anti-factor B antibody resulted in suppression of ocular complement activation. Adoptive transfer of T lymphocytes harvested from draining lymph nodes of donor animals treated with anti-factor B did not transfer EAAU to naive syngenic rats. Anti-factor B antibody inhibited the ability of MAA-specific CD4(+) T cells to proliferate (in vitro) in response to MAA in a dose-dependent manner. Level of TNF-alpha and IFN-gamma decreased in the presence of anti-factor B. Collectively, our results provide the novel finding that complement activation via the alternative pathway contributes to intraocular inflammation in EAAU, and anti-factor B-mediated inhibition of EAAU is due to diminished antigen-specific CD4(+) T cell responses to MAA. Our findings explain the interactions between the complement system and T cells that are critical for the induction of EAAU and may lead to the development of therapy for idiopathic anterior uveitis based on selective blockade of the alternative pathway.	[Manickam, Balasubramanian; Jha, Purushottam; Matta, Bharati; Liu, Juan; Bora, Puran S.; Bora, Nalini S.] Univ Arkansas Med Sci, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Dept Ophthalmol, 4301 W Markham,Mail Slot 523, Little Rock, AR 72205 USA.	nbora@uams.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY018812, EY014623]; Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR); NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018812 and EY014623. This work was also supported by grants from the Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR).	Abbas AK, 2003, CELLULAR MOL IMMUNOL; An FQ, 2009, INVEST OPHTH VIS SCI, V50, P3778, DOI 10.1167/iovs.08-3264; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Bora Nalini S, 2007, Chem Immunol Allergy, V92, P213, DOI 10.1159/000099272; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2004, J IMMUNOL, V172, P7086, DOI 10.4049/jimmunol.172.11.7086; Bora NS, 1997, INVEST OPHTH VIS SCI, V38, P2171; BORA NS, 1995, INVEST OPHTH VIS SCI, V36, P1056; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; BROEKHUYSE RM, 1991, EXP EYE RES, V52, P465, DOI 10.1016/0014-4835(91)90044-F; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Clark A, 2008, MOL IMMUNOL, V45, P3125, DOI 10.1016/j.molimm.2008.03.008; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; GAEDE KI, 1995, INFECT IMMUN, V63, P3697, DOI 10.1128/IAI.63.9.3697-3701.1995; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; JACQUIERSARLIN MR, 1995, IMMUNOLOGY, V84, P164; Jha P, 2006, INVEST OPHTH VIS SCI, V47, P1030, DOI 10.1167/iovs.05-1062; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651; Jha P, 2006, J IMMUNOL, V176, P7221, DOI 10.4049/jimmunol.176.12.7221; Jha P, 2009, J BIOL CHEM, V284, P31401, DOI 10.1074/jbc.M109.033381; Kaya Z, 2001, NAT IMMUNOL, V2, P739, DOI 10.1038/90686; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kerekes K, 1998, INT IMMUNOL, V10, P1923, DOI 10.1093/intimm/10.12.1923; KIM MC, 1995, CURR EYE RES, V14, P703, DOI 10.3109/02713689508998498; Manickam B, 2010, MOL IMMUNOL, V48, P231, DOI 10.1016/j.molimm.2010.08.006; Matta B, 2008, AM J PATHOL, V173, P1440, DOI 10.2353/ajpath.2008.080150; Matta B, 2010, IMMUNOL CELL BIOL, V88, P187, DOI 10.1038/icb.2009.83; Mihai S, 2007, J IMMUNOL, V178, P6514, DOI 10.4049/jimmunol.178.10.6514; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Morgan BP., 1999, COMPLEMENT REGULATOR; Pasinetti GM, 1996, NEUROBIOL AGING, V17, P707, DOI 10.1016/0197-4580(96)00113-3; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Tsokos G. C., 2004, COMPLEMENT AUTOIMMUN; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; Vriesendorp FJ, 1998, ACTA NEUROPATHOL, V95, P297, DOI 10.1007/s004010050801; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048	49	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8472	8480		10.1074/jbc.M110.197616	http://dx.doi.org/10.1074/jbc.M110.197616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216963	hybrid, Green Published			2022-12-25	WOS:000288013300075
J	Xiong, YB; Qiu, F; Piao, WJ; Song, C; Wahl, LM; Medvedev, AE				Xiong, Yanbao; Qiu, Fu; Piao, Wenji; Song, Chang; Wahl, Larry M.; Medvedev, Andrei E.			Endotoxin Tolerance Impairs IL-1 Receptor-Associated Kinase (IRAK) 4 and TGF-beta-activated Kinase 1 Activation, K63-linked Polyubiquitination and Assembly of IRAK1, TNF Receptor-associated Factor 6, and I kappa B Kinase gamma and Increases A20 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTOR; TUMOR-NECROSIS-FACTOR; INTESTINAL EPITHELIAL-CELLS; SIGNALING PATHWAY; NEGATIVE REGULATOR; INNATE IMMUNITY; LYS63-LINKED POLYUBIQUITINATION; COMPLEX-FORMATION; GENE-EXPRESSION; DOWN-REGULATION	Endotoxin tolerance reprograms Toll-like receptor 4 responses by impairing LPS-elicited production of pro-inflammatory cytokines without inhibiting expression of anti-inflammatory or anti-microbial mediators. In septic patients, Toll-like receptor tolerance is thought to underlie decreased pro-inflammatory cytokine expression in response to LPS and increased incidence of microbial infections. The impact of endotoxin tolerance on recruitment, post-translational modifications and signalosome assembly of IL-1 receptor-associated kinase (IRAK) 4, IRAK1, TNF receptor-associated factor (TRAF) 6, TGF-beta-activated kinase (TAK) 1, and I kappa B kinase (IKK) gamma is largely unknown. We report that endotoxin tolerization of THP1 cells and human monocytes impairs LPS-mediated receptor recruitment and activation of IRAK4, ablates K63-linked polyubiquitination of IRAK1 and TRAF6, compromises assembly of IRAK1-TRAF6 and IRAK1-IKK gamma platforms, and inhibits TAK1 activation. Deficiencies in these signaling events in LPS-tolerant cells coincided with increased expression of A20, an essential deubiquitination enzyme, and sustained A20-IRAK1 associations. Overexpression of A20 inhibited LPS-induced activation of NF-kappa B and ablated NF-kappa B reporter activation driven by ectopic expression of MyD88, IRAK1, IRAK2, TRAF6, and TAK1/TAB1, while not affecting the responses induced by IKK beta and p65. A20 shRNA knockdown abolished LPS tolerization of THP1 cells, mechanistically linking A20 and endotoxin tolerance. Thus, deficient LPS-induced activation of IRAK4 and TAK1, K63-linked polyubiquitination of IRAK1 and TRAF6, and disrupted IRAK1-TRAF6 and IRAK1-IKK gamma assembly associated with increased A20 expression and A20-IRAK1 interactions are new determinants of endotoxin tolerance.	[Xiong, Yanbao; Qiu, Fu; Piao, Wenji; Song, Chang; Medvedev, Andrei E.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Wahl, Larry M.] NIDCR, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Medvedev, AE (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Sch Med, 685 W Baltimore St,HSF-1 Bldg,Rm 380, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu			National Institutes of Health [AI-059524]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-059524 (to A. E. M.).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Berglund M, 2008, SCAND J IMMUNOL, V67, P473, DOI 10.1111/j.1365-3083.2008.02096.x; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shnyra A, 1998, J IMMUNOL, V160, P3729; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG767, DOI 10.1152/ajpgi.00447.2006; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Zetoune FS, 2001, CYTOKINE, V15, P282, DOI 10.1006/cyto.2001.0921; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	75	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7905	7916		10.1074/jbc.M110.182873	http://dx.doi.org/10.1074/jbc.M110.182873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220427	hybrid, Green Published			2022-12-25	WOS:000288013300021
J	Luo, YZ; Zhang, MH				Luo, Yuzhou; Zhang, Minghua			Environmental Modeling and Exposure Assessment of Sediment-Associated Pyrethroids in an Agricultural Watershed	PLOS ONE			English	Article							SAN-JOAQUIN VALLEY; CALIFORNIA; PESTICIDES; TOXICITY; SYSTEMS; RUNOFF; USA	Synthetic pyrethroid insecticides have generated public concerns due to their increasing use and potential effects on aquatic ecosystems. A modeling system was developed in this study for simulating the transport processes and associated sediment toxicity of pyrethroids at coupled field/watershed scales. The model was tested in the Orestimba Creek watershed, an agriculturally intensive area in California' Central Valley. Model predictions were satisfactory when compared with measured suspended solid concentration (R-2 = 0.536), pyrethroid toxic unit (0.576), and cumulative mortality of Hyalella azteca (0.570). The results indicated that sediment toxicity in the study area was strongly related to the concentration of pyrethroids in bed sediment. Bifenthrin was identified as the dominant contributor to the sediment toxicity in recent years, accounting for 50-85% of predicted toxicity units. In addition, more than 90% of the variation on the annual maximum toxic unit of pyrethroids was attributed to precipitation and prior application of bifenthrin in the late irrigation season. As one of the first studies simulating the dynamics and spatial variability of pyrethroids in fields and instreams, the modeling results provided useful information on new policies to be considered with respect to pyrethroid regulation. This study suggested two potential measures to efficiently reduce sediment toxicity by pyrethroids in the study area: [1] limiting bifenthrin use immediately before rainfall season; and [2] implementing conservation practices to retain soil on cropland.	[Luo, Yuzhou; Zhang, Minghua] Wenzhou Med Coll, Wenzhou, Peoples R China; [Luo, Yuzhou; Zhang, Minghua] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Wenzhou Medical University; University of California System; University of California Davis	Luo, YZ (corresponding author), Wenzhou Med Coll, Wenzhou, Peoples R China.	yzluo@ucdavis.edu; mhzhang@ucdavis.edu	Luo, Yuzhou/A-7223-2010	Luo, Yuzhou/0000-0003-0879-9622	Coalition for Urban/Rural Environmental Stewardship; California State Water Quality Control Board; Zhejiang and Wenzhou [2008C03009, 20082780125]	Coalition for Urban/Rural Environmental Stewardship; California State Water Quality Control Board; Zhejiang and Wenzhou	The authors would like to acknowledge funding support from the Coalition for Urban/Rural Environmental Stewardship and California State Water Quality Control Board. This work was also supported by the 2005 to 2006 Consolidate Grants-Proposition 50 Agricultural Water Quality Grant Program, State of California, as well as the support from Zhejiang and Wenzhou (2008C03009, 20082780125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amweg EL, 2005, ENVIRON TOXICOL CHEM, V24, P966, DOI 10.1897/04-146R1.1; *CDWR, 2010, CAL LAND WAT US SURV; *CEPA, 2010, PEST US REP PUR; Chapra S. C., 2008, QUAL2K MODELING FRAM; *CVRWQCB, 2005, COND WAIV IRR AGR MO; Domagalski JL, 2010, ENVIRON TOXICOL CHEM, V29, P813, DOI 10.1002/etc.106; ENSMINGER M, 2009, PESTICIDE CONCENTRAT; Epstein L, 2003, ANNU REV PHYTOPATHOL, V41, P351, DOI 10.1146/annurev.phyto.41.052002.095612; *FOOTPRINT, 2010, FOOTPRINT PEST PROP; Hladik ML, 2009, J AGR FOOD CHEM, V57, P9079, DOI 10.1021/jf9020448; Laskowski Dennis A., 2002, V174, P49; LEONARD RA, 1987, T ASAE, V30, P1403; Luo YZ, 2007, J ENVIRON MANAGE, V83, P44, DOI 10.1016/j.jenvman.2006.01.017; Luo YZ, 2009, ENVIRON POLLUT, V157, P3370, DOI 10.1016/j.envpol.2009.06.024; Luo YZ, 2009, J ENVIRON QUAL, V38, P664, DOI 10.2134/jeq2008.0216; Luo YZ, 2008, ENVIRON POLLUT, V156, P1171, DOI 10.1016/j.envpol.2008.04.005; Ma QL, 2004, PEST MANAG SCI, V60, P267, DOI 10.1002/ps.846; MCKONE TE, 2003, CALTOX 4 0 MULTIMEDI; MEADOWS R, 2005, CALIF AGR, V59, P5; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Neitsch S.L., 2005, SOIL WATER ASSESSMEN; Olivera F, 1999, WATER RESOUR RES, V35, P1155, DOI 10.1029/1998WR900104; OLIVERA F, 1996, SPATIALLY DISTRIBUTE; Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228; Spencer J, 2006, REV ENVIRON CONTAM T, V186, P57, DOI 10.1007/0-387-32883-1_2; United States Environmental Protection Agency (US EPA), 2006, ORG PEST REV CUM RIS; *USEPA, 2006, EPA600R05111 CTR EXP; *USEPA, 2008, USEPA TIER 2 CROP SC; *USEPA, 2000, EPA600R99064 OFF RES; *USEPA, 2010, PEST ROOT ZON MOD PR; USGS, 2010, NAT WAT INF SYST WEB; Weston DP, 2008, ENVIRON TOXICOL CHEM, V27, P953, DOI 10.1897/07-449.1; Weston DP, 2004, ENVIRON SCI TECHNOL, V38, P2752, DOI 10.1021/es0352193; WILLIAMS WM, 2004, RIVWQ CHEM TRANSPORT	34	17	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15794	10.1371/journal.pone.0015794	http://dx.doi.org/10.1371/journal.pone.0015794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246035	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511200014
J	Piepho, M; Martin-Creuzburg, D; Wacker, A				Piepho, Maike; Martin-Creuzburg, Dominik; Wacker, Alexander			Simultaneous Effects of Light Intensity and Phosphorus Supply on the Sterol Content of Phytoplankton	PLOS ONE			English	Article							KEYSTONE SPECIES DAPHNIA; ESSENTIAL LIPIDS; ISOPRENOID BIOSYNTHESIS; PLANT STEROLS; FOOD QUALITY; GROWTH; MAGNA; AVAILABILITY; CONSEQUENCES; ALLOCATION	Sterol profiles of microalgae and their change with environmental conditions are of great interest in ecological food web research and taxonomic studies alike. Here, we investigated effects of light intensity and phosphorus supply on the sterol content of phytoplankton and assessed potential interactive effects of these important environmental factors on the sterol composition of algae. We identified sterol contents of four common phytoplankton genera, Scenedesmus, Chlamydomonas, Cryptomonas and Cyclotella, and analysed the change in sterol content with varying light intensities in both a high-phosphorus and a low-phosphorus approach. Sterol contents increased significantly with increasing light in three out of four species. Phosphorus-limitation reversed the change of sterol content with light intensity, i.e., sterol content decreased with increasing light at low phosphorus supply. Generally sterol contents were lower in low-phosphorus cultures. In conclusion, both light and phosphorus conditions strongly affect the sterol composition of algae and hence should be considered in ecological and taxonomic studies investigating the biochemical composition of algae. Data suggest a possible sterol limitation of growth and reproduction of herbivorous crustacean zooplankton during summer when high light intensities and low phosphorus supply decrease sterol contents of algae.	[Piepho, Maike; Wacker, Alexander] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Martin-Creuzburg, Dominik] Univ Constance, Inst Limnol, D-7750 Constance, Germany	University of Potsdam; University of Konstanz	Piepho, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	piepho@uni-potsdam.de	Wacker, Alexander/I-8277-2012; Martin-Creuzburg, Dominik/C-6361-2011	Wacker, Alexander/0000-0001-9687-6477; Martin-Creuzburg, Dominik/0000-0002-4248-0730	German Research Foundation (DFG) [WA 2445/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG WA 2445/4-1, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behmer S. T., 2003, INSECT STEROL NUTR P; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Disch A, 1998, BIOCHEM J, V333, P381, DOI 10.1042/bj3330381; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502, DOI 10.1128/AEM.59.2.502-507.1993; GLADU PK, 1990, COMP BIOCHEM PHYS B, V97, P491, DOI 10.1016/0305-0491(90)90149-N; GLADU PK, 1991, PHYTOCHEMISTRY, V30, P2301, DOI 10.1016/0031-9422(91)83634-W; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; GOAD LJ, 1983, PHYTOCHEMISTRY, V22, P475, DOI 10.1016/0031-9422(83)83028-3; Gordillo FJL, 1998, J APPL PHYCOL, V10, P135, DOI 10.1023/A:1008067022973; GrandmouginFerjani A, 1997, PLANT PHYSIOL, V113, P163, DOI 10.1104/pp.113.1.163; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Martin-Creuzburg D, 2005, AQUAT MICROB ECOL, V41, P271, DOI 10.3354/ame041271; Martin-Creuzburg D, 2005, OECOLOGIA, V144, P362, DOI 10.1007/s00442-005-0090-8; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Martin-Creuzburg D, 2010, LIMNOL OCEANOGR, V55, P2597, DOI 10.4319/lo.2010.55.6.2597; Martin-Creuzburg D, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P43, DOI 10.1007/978-0-387-89366-2_3; Martin-Creuzburg D, 2009, P R SOC B, V276, P1805, DOI 10.1098/rspb.2008.1540; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; PARRISH CC, 1994, MAR CHEM, V48, P71, DOI 10.1016/0304-4203(94)90063-9; Patterson G. W., 1991, PHYSL BIOCH STEROLS, V5, P118; PATTERSON GW, 1994, PHYTOCHEMISTRY, V35, P1233, DOI 10.1016/S0031-9422(00)94826-X; PRAHL FG, 1984, SCIENCE, V224, P1235, DOI 10.1126/science.224.4654.1235; SCHULER I, 1991, P NATL ACAD SCI USA, V88, P6926, DOI 10.1073/pnas.88.16.6926; Sperfeld E, 2009, J EXP BIOL, V212, P3051, DOI 10.1242/jeb.031401; Thompson GA, 1996, BBA-LIPID LIPID MET, V1302, P17, DOI 10.1016/0005-2760(96)00045-8; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wacker A, 2007, FUNCT ECOL, V21, P738, DOI 10.1111/j.1365-2435.2007.01274.x	31	43	45	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15828	10.1371/journal.pone.0015828	http://dx.doi.org/10.1371/journal.pone.0015828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209879	gold, Green Submitted, Green Published			2022-12-25	WOS:000285838900039
J	Bohr, W; Kupper, M; Hoffmann, K; Weiskirchen, R				Bohr, Wilhelm; Kupper, Michael; Hoffmann, Kurt; Weiskirchen, Ralf			Recombinant Expression, Purification, and Functional Characterisation of Connective Tissue Growth Factor and Nephroblastoma-Overexpressed Protein	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TGF-BETA; FACTOR CTGF/CCN2; LIVER FIBROSIS; CCN3 NOV; SCLERODERMA FIBROBLASTS; GENE-EXPRESSION; CTGF EXPRESSION; FAMILY; PROLIFERATION	The CCN family of proteins, especially its prominent member, the Connective tissue growth factor (CTGF/CCN2) has been identified as a possible biomarker for the diagnosis of fibrotic diseases. As a downstream mediator of TGF-beta 1 signalling, it is involved in tissue scarring, stimulates interstitial deposition of extracellular matrix proteins, and promotes proliferation of several cell types. Another member of this family, the Nephroblastoma-Overexpressed protein (NOV/CCN3), has growth-inhibiting properties. First reports further suggest that these two CCN family members act opposite to each other in regulating extracellular matrix protein expression and reciprocally influence their own expression when over-expressed. We have established stable HEK and Flp-In-293 clones as productive sources for recombinant human CCN2/CTGF. In addition, we generated an adenoviral vector for recombinant expression of rat NOV and established protocols to purify large quantities of these CCN proteins. The identity of purified human CCN2/CTGF and rat CCN3/NOV was proven by In-gel digest followed by ESI-TOF/MS mass spectrometry. The biological activity of purified proteins was demonstrated using a Smad3-sensitive reporter gene and BrdU proliferation assay in permanent cell line EA.hy 926 cells. We further demonstrate for the first time that both recombinant CCN proteins are N-glycosylated.	[Bohr, Wilhelm; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Kupper, Michael; Hoffmann, Kurt] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Bohr, W (corresponding author), RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Kupper, Michael/AAW-1780-2021; Hoffmann, Kurt/P-2539-2014; Weiskirchen, Ralf/O-1734-2018	Hoffmann, Kurt/0000-0002-7991-423X; Weiskirchen, Ralf/0000-0003-3888-0931; Kupper, Michael/0000-0002-0010-9570	Deutsche Forschungsgemeinschaft [SFB/TRR57 P13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB/TRR57 P13). This is the official German support foundation for German science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Borkham-Kamphorst E, 2004, BIOCHEM BIOPH RES CO, V317, P451, DOI 10.1016/j.bbrc.2004.03.064; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7; Gressner OA, 2007, J HEPATOL, V47, P699, DOI 10.1016/j.jhep.2007.05.015; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Kunzmann S, 2008, INT ARCH ALLERGY IMM, V147, P152, DOI 10.1159/000137284; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Sin WC, 2009, J BIOL CHEM, V284, P29935, DOI 10.1074/jbc.M109.042630; SORET J, 1989, J VIROL, V63, P1803, DOI 10.1128/JVI.63.4.1803-1807.1989; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; van Roeyen CRC, 2008, KIDNEY INT, V73, P86, DOI 10.1038/sj.ki.5002584; Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16000	10.1371/journal.pone.0016000	http://dx.doi.org/10.1371/journal.pone.0016000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209863	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793600055
J	Wei, CL; Rowe, GT; Escobar-Briones, E; Boetius, A; Soltwedel, T; Caley, MJ; Soliman, Y; Huettmann, F; Qu, FY; Yu, ZS; Pitcher, CR; Haedrich, RL; Wicksten, MK; Rex, MA; Baguley, JG; Sharma, J; Danovaro, R; MacDonald, IR; Nunnally, CC; Deming, JW; Montagna, P; Levesque, M; Weslawski, JM; Wlodarska-Kowalczuk, M; Ingole, BS; Bett, BJ; Billett, DSM; Yool, A; Bluhm, BA; Iken, K; Narayanaswamy, BE				Wei, Chih-Lin; Rowe, Gilbert T.; Escobar-Briones, Elva; Boetius, Antje; Soltwedel, Thomas; Caley, M. Julian; Soliman, Yousria; Huettmann, Falk; Qu, Fangyuan; Yu, Zishan; Pitcher, C. Roland; Haedrich, Richard L.; Wicksten, Mary K.; Rex, Michael A.; Baguley, Jeffrey G.; Sharma, Jyotsna; Danovaro, Roberto; MacDonald, Ian R.; Nunnally, Clifton C.; Deming, Jody W.; Montagna, Paul; Levesque, Melanie; Weslawski, Jan Marcin; Wlodarska-Kowalczuk, Maria; Ingole, Baban S.; Bett, Brian J.; Billett, David S. M.; Yool, Andrew; Bluhm, Bodil A.; Iken, Katrin; Narayanaswamy, Bhavani E.			Global Patterns and Predictions of Seafloor Biomass Using Random Forests	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; COMMUNITY STRUCTURE; CONTINENTAL-MARGIN; BACTERIAL BIOMASS; ORGANIC-MATTER; STANDING STOCK; WATER DEPTH; NE ATLANTIC; DEEP; SEDIMENT	A comprehensive seafloor biomass and abundance database has been constructed from 24 oceanographic institutions worldwide within the Census of Marine Life (CoML) field projects. The machine-learning algorithm, Random Forests, was employed to model and predict seafloor standing stocks from surface primary production, water-column integrated and export particulate organic matter (POM), seafloor relief, and bottom water properties. The predictive models explain 63% to 88% of stock variance among the major size groups. Individual and composite maps of predicted global seafloor biomass and abundance are generated for bacteria, meiofauna, macrofauna, and megafauna (invertebrates and fishes). Patterns of benthic standing stocks were positive functions of surface primary production and delivery of the particulate organic carbon (POC) flux to the seafloor. At a regional scale, the census maps illustrate that integrated biomass is highest at the poles, on continental margins associated with coastal upwelling and with broad zones associated with equatorial divergence. Lowest values are consistently encountered on the central abyssal plains of major ocean basins The shift of biomass dominance groups with depth is shown to be affected by the decrease in average body size rather than abundance, presumably due to decrease in quantity and quality of food supply. This biomass census and associated maps are vital components of mechanistic deep-sea food web models and global carbon cycling, and as such provide fundamental information that can be incorporated into evidence-based management.	[Wei, Chih-Lin; Qu, Fangyuan; Nunnally, Clifton C.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Rowe, Gilbert T.] Univ Texas Galveston, Dept Marine Biol, Galveston, TX 77555 USA; [Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Boetius, Antje; Soltwedel, Thomas] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Soliman, Yousria] Qatar Univ, Doha, Qatar; [Huettmann, Falk] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Qu, Fangyuan; Yu, Zishan] Ocean Univ Qingdao, Coll Marine Life Sci, Qingdao 266003, Peoples R China; [Pitcher, C. Roland] CSIRO Marine & Atmospher Res, Cleveland, Qld, Australia; [Haedrich, Richard L.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Wicksten, Mary K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rex, Michael A.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Baguley, Jeffrey G.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Sharma, Jyotsna] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Danovaro, Roberto] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy; [MacDonald, Ian R.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Deming, Jody W.] Univ Washington, Dept Oceanog, Seattle, WA 98195 USA; [Montagna, Paul] Texas A&M Univ Corpus Christi, Harte Res Inst, Corpus Christi, TX USA; [Levesque, Melanie] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Weslawski, Jan Marcin; Wlodarska-Kowalczuk, Maria] Polish Acad Sci, Inst Oceanol, Sopot, Poland; [Ingole, Baban S.] Natl Inst Oceanog, Panaji, Goa, India; [Bett, Brian J.; Billett, David S. M.; Yool, Andrew] Natl Oceanog Ctr, Southampton, Hants, England; [Bluhm, Bodil A.; Iken, Katrin] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Medical Branch Galveston; Universidad Nacional Autonoma de Mexico; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Australian Institute of Marine Science; Qatar University; University of Alaska System; University of Alaska Fairbanks; Ocean University of China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Memorial University Newfoundland; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Boston; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Texas System; University of Texas at San Antonio (UTSA); Marche Polytechnic University; State University System of Florida; Florida State University; University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University Corpus Christi; University of Quebec; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); NERC National Oceanography Centre; University of Alaska System; University of Alaska Fairbanks; UHI Millennium Institute	Wei, CL (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	weic@tamug.edu	Boetius, Antje/D-5459-2013; Weslawski, Jan M/F-4075-2012; Montagna, Paul A./J-8208-2017; Ingole, Baban Shravan/GLR-9722-2022; Yool, Andrew/B-4799-2012; Pitcher, C. Roland/A-2368-2012; Wlodarska-kowalczuk, Maria/K-4325-2012; Soltwedel, Thomas/P-1852-2016; Bluhm, Bodil/E-7165-2015; Caley, Julian/A-4042-2008	Boetius, Antje/0000-0003-2117-4176; Montagna, Paul A./0000-0003-4199-3312; Yool, Andrew/0000-0002-9879-2776; Soltwedel, Thomas/0000-0002-8214-5937; Bluhm, Bodil/0000-0002-4584-7796; Caley, Julian/0000-0001-5739-749X; Narayanaswamy, Bhavani/0000-0002-5810-9127; MacDonald, Ian R/0000-0001-9717-7926; Ingole, Baban/0000-0001-6096-6980; Weslawski, Jan-Marcin/0000-0001-8434-5927; WEI, CHIH-LIN/0000-0001-9430-0060; Escobar Briones, Elva/0000-0002-8485-7495; Soliman, Yousria/0000-0001-5062-6640	Census of Marine Life (CoML); Sloan Foundation; NERC [dml010007, noc010010, noc010009] Funding Source: UKRI; Natural Environment Research Council [dml010007, noc010009, noc010010] Funding Source: researchfish	Census of Marine Life (CoML); Sloan Foundation(Alfred P. Sloan Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a grant from the Census of Marine Life (CoML) and the Sloan Foundation to G. T. Rowe and E. Escobar-Briones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, ETOPO1 ARC MINUTE GL, DOI DOI 10.7289/V5C8276M; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BETT BJ, 1994, MAR ECOL PROG SER, V104, P197, DOI 10.3354/meps104197; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; Bivand RS, 2008, USE R, P1; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; BOETIUS A, 1994, MAR ECOL PROG SER, V104, P299, DOI 10.3354/meps104299; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Cutler A, 2006, METHOD ENZYMOL, V411, P422, DOI 10.1016/S0076-6879(06)11023-X; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Danovaro R, 2002, DEEP-SEA RES PT I, V49, P843, DOI 10.1016/S0967-0637(01)00084-X; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Leo FC, 2010, P ROYAL S B IN PRESS; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Deming J. W., 1993, ORGANIC GEOCHEMISTRY, P119; Deming JW, 2008, DEEP-SEA RES PT II, V55, P2597, DOI 10.1016/j.dsr2.2008.07.009; Deming JW, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P147; DEMING JW, 1992, NATO ADV SCI I C-MAT, V360, P11; DEMING JW, 1985, APPL ENVIRON MICROB, V50, P1002, DOI 10.1128/AEM.50.4.1002-1006.1985; Dixon JL, 2000, HYDROBIOLOGIA, V440, P217, DOI 10.1023/A:1004127312756; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002907; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Heip CHR, 2001, DEEP-SEA RES PT II, V48, P3223, DOI 10.1016/S0967-0645(01)00038-8; Ho CK, 2010, AM NAT, V175, P269, DOI 10.1086/649583; Holme N, 1971, IBP HDB; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; LOCHTE K, 1992, NATO ADV SCI I C-MAT, V360, P1; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; Oppel S, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P151, DOI 10.1007/978-4-431-87771-4_8; PACE ML, 1987, NATURE, V325, P803, DOI 10.1038/325803a0; Patching JW, 1997, DEEP-SEA RES PT I, V44, P1655, DOI 10.1016/S0967-0637(97)00040-X; Petersen CG., 1913, REPORT DANISH BIOL S, V21, P1; PETERSEN CGJ, 1918, REP DAN BIOL STN, V25, P1; Pfannkuche O, 2000, DEEP-SEA RES PT II, V47, P2615, DOI 10.1016/S0967-0645(00)00041-2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher CR, EXPLORING ROLE UNPUB; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Queric NV, 2004, J MICROBIOL METH, V57, P351, DOI 10.1016/j.mimet.2004.02.005; Quiroga E, 2005, ESTUAR COAST SHELF S, V62, P217, DOI 10.1016/j.ecss.2004.08.020; R Core Team, 2021, R LANG ENV STAT COMP; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; ROWE G, 1991, MAR ECOL PROG SER, V79, P99, DOI 10.3354/meps079099; Rowe G.T., 1979, Ambio Special Report, P19, DOI 10.2307/25099603; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2686, DOI 10.1016/j.dsr2.2008.07.018; ROWE GT, 1994, DEEP-SEA RES PT II, V41, P657, DOI 10.1016/0967-0645(94)90039-6; Rowe GT, 1997, J MARINE SYST, V10, P497, DOI 10.1016/S0924-7963(96)00065-6; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; Rowe GT, MARINE BIOL RE UNPUB; ROWE GT, 1992, DEEP SEA FOOD CHAINS; Rowe GT, BIODIVERSITY D UNPUB; Rowe GT, 1983, SEA, P97; SMITH CR, 1992, NATO ADV SCI I C-MAT, V360, P375; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; Smith CR, 1998, DEEP-SEA RES PT II, V45, P335, DOI 10.1016/S0967-0645(97)00043-X; Smith K. L., 1983, SEA, P331; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Soliman Y, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1389.3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; THIEL H, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P575; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; Vetter YA, 1998, MICROBIAL ECOL, V36, P75, DOI 10.1007/s002489900095; Vinogradov M.E., 1983, DEEP SEA BIOL, V8, P123; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Williams RG, 2003, GLO CH IGBP, P19; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Xu P., 2004, P 2004 C EMP METH NA; Yool A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004792	90	244	250	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15323	10.1371/journal.pone.0015323	http://dx.doi.org/10.1371/journal.pone.0015323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209928	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600017
J	Buchold, GM; Coarfa, C; Kim, J; Milosavljevic, A; Gunaratne, PH; Matzuk, MM				Buchold, Gregory M.; Coarfa, Cristian; Kim, Jong; Milosavljevic, Aleksandar; Gunaratne, Preethi H.; Matzuk, Martin M.			Analysis of MicroRNA Expression in the Prepubertal Testis	PLOS ONE			English	Article							GERM-CELL TUMORS; EMBRYONIC STEM-CELLS; RNA-BINDING PROTEIN; MESSENGER-RNA; CHROMATOID BODY; GENE-EXPRESSION; ADAR DEAMINASES; EDITING SITES; LIN28; PRECURSOR	Only thirteen microRNAs are conserved between D. melanogaster and the mouse; however, conditional loss of miRNA function through mutation of Dicer causes defects in proliferation of premeiotic germ cells in both species. This highlights the potentially important, but uncharacterized, role of miRNAs during early spermatogenesis. The goal of this study was to characterize on postnatal day 7, 10, and 14 the content and editing of murine testicular miRNAs, which predominantly arise from spermatogonia and spermatocytes, in contrast to prior descriptions of miRNAs in the adult mouse testis which largely reflects the content of spermatids. Previous studies have shown miRNAs to be abundant in the mouse testis by postnatal day 14; however, through Next Generation Sequencing of testes from a B6;129 background we found abundant earlier expression of miRNAs and describe shifts in the miRNA signature during this period. We detected robust expression of miRNAs encoded on the X chromosome in postnatal day 14 testes, consistent with prior studies showing their resistance to meiotic sex chromosome inactivation. Unexpectedly, we also found a similar positional enrichment for most miRNAs on chromosome 2 at postnatal day 14 and for those on chromosome 12 at postnatal day 7. We quantified in vivo developmental changes in three types of miRNA variation including 5' heterogeneity, editing, and 3' nucleotide addition. We identified eleven putative novel pubertal testis miRNAs whose developmental expression suggests a possible role in early male germ cell development. These studies provide a foundation for interpretation of miRNA changes associated with testicular pathology and identification of novel components of the miRNA editing machinery in the testis.	[Buchold, Gregory M.; Gunaratne, Preethi H.; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Buchold, Gregory M.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kim, Jong; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Buchold, GM (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	mmatzuk@tmc.bcm.edu		Buchold, Greg/0000-0003-0710-7866	National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) [5R01HD057880, 5T32HD007165]; National Institutes of Health, Epigenomics Roadmap Initiative from National Institute on Drug Abuse (NIH-NIDA) [5U01DA025956]; National Institutes of Health, Epigenomics Roadmap Initiative from National Human Genome Research Institute (NIH-NHGRI) [5R01HG4009]	National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, Epigenomics Roadmap Initiative from National Institute on Drug Abuse (NIH-NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health, Epigenomics Roadmap Initiative from National Human Genome Research Institute (NIH-NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) 5R01HD057880 (to M. M. M); National Institutes of Health, Epigenomics Roadmap Initiative grant from National Institute on Drug Abuse (NIH-NIDA) 5U01DA025956 and National Human Genome Research Institute (NIH-NHGRI) 5R01HG4009 (to A. M.), and National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) 5T32HD007165 (to G. M. B.). The authors also thank the Cullen Foundation for their generous support of the University of Houston's Institute for Molecular Design (IMD) Illumina/Solexa Sequencer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Carthew RW, 2006, SCIENCE, V313, P305, DOI 10.1126/science.1131186; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Eisenberg E, 2005, NUCLEIC ACIDS RES, V33, P4612, DOI 10.1093/nar/gki771; Ferras C, 2007, FERTIL STERIL, V88, P1681, DOI 10.1016/j.fertnstert.2007.01.063; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Habig JW, 2007, MOL CELL, V25, P792, DOI 10.1016/j.molcel.2007.03.010; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kleene KC, 2003, CYTOGENET GENOME RES, V103, P217, DOI 10.1159/000076807; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Looijenga LHJ, 2007, INT J ANDROL, V30, P304, DOI 10.1111/j.1365-2605.2007.00765.x; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Novotny GW, 2007, INT J ANDROL, V30, P316, DOI 10.1111/j.1365-2605.2007.00773.x; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Pires-daSilva A, 2001, DEV BIOL, V233, P319, DOI 10.1006/dbio.2001.0169; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; SCHUMACHER JM, 1995, J CELL BIOL, V129, P1023, DOI 10.1083/jcb.129.4.1023; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	53	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15317	10.1371/journal.pone.0015317	http://dx.doi.org/10.1371/journal.pone.0015317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206922	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793200024
J	Burdet, J; Zotta, E; Cella, M; Franchi, AM; Ibarra, C				Burdet, Juliana; Zotta, Elsa; Cella, Maximiliano; Franchi, Ana M.; Ibarra, Cristina			Role of Nitric Oxide in Shiga Toxin-2-Induced Premature Delivery of Dead Fetuses in Rats	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; TOXIN; MODEL	Shiga toxin-producing Escherichia coli (STEC) infections could be one of the causes of fetal morbimortality in pregnant women. The main virulence factors of STEC are Shiga toxin type 1 and/or 2 (Stx1, Stx2). We previously reported that intraperitoneal (i.p.) injection of rats in the late stage of pregnancy with culture supernatant from recombinant E. coli expressing Stx2 and containing lipopolysaccharide (LPS) induces premature delivery of dead fetuses. It has been reported that LPS may combine with Stx2 to facilitate vascular injury, which may in turn lead to an overproduction of nitric oxide (NO). The aim of this study was to evaluate whether NO is involved in the effects of Stx2 on pregnancy. Pregnant rats were i.p. injected with culture supernatant from recombinant E. coli containing Stx2 and LPS (sStx2) on day 15 of gestation. In addition, some rats were injected with aminoguanidine (AG), an inducible isoform inhibitor of NO synthase (iNOS), 24 h before and 4 h after sStx2 injection. NO production was measured by NOS activity and iNOS expression by Western blot analysis. A significant increase in NO production and a high iNOS expression was observed in placental tissues from rats injected with sStx2 containing 0.7 ng and 2 ng Stx2/g body weight and killed 12 h after injection. AG caused a significant reduction of sStx2 effects on the feto-maternal unit, but did not prevent premature delivery. Placental tissues from rats treated with AG and sStx2 presented normal histology that was indistinguishable from the controls. Our results reveal that Stx2-induced placental damage and fetus mortality is mediated by an increase in NO production and that AG is able to completely reverse the Stx2 damages in placental tissues, but not to prevent premature delivery, thus suggesting other mechanisms not yet determined could be involved.	[Burdet, Juliana; Zotta, Elsa; Ibarra, Cristina] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] Univ Buenos Aires, CEFYBO CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Burdet, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina.	ibarra@fmed.uba.ar	Ibarra, Cristina/D-6242-2016	zotta, elsa/0000-0002-8763-5046	Buenos Aires University; CONICET;  [UBACYT-M030];  [CONICET-PIP 5587];  [ANPCYT-PICT 26224]	Buenos Aires University(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ; ; 	This study received financial support from Buenos Aires University, UBACYT-M030, CONICET-PIP 5587, ANPCYT-PICT 26224. J Burdet has a scholarship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Burdet J, 2009, PLACENTA, V30, P491, DOI 10.1016/j.placenta.2009.03.012; Cella M, 2010, BRIT J PHARMACOL, V161, P844, DOI 10.1111/j.1476-5381.2010.00911.x; Dedeoglu IO, 1996, PEDIATR NEPHROL, V10, P812; Dran GI, 2002, KIDNEY INT, V62, P1338, DOI 10.1046/j.1523-1755.2002.00554.x; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Gordjani N, 1997, SEMIN THROMB HEMOST, V23, P281, DOI 10.1055/s-2007-996101; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; HADDAD EK, 1995, J EXP MED, V182, P1143, DOI 10.1084/jem.182.4.1143; Kaper JB, 1998, CURR OPIN MICROBIOL, V1, P103, DOI 10.1016/S1369-5274(98)80149-5; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1995, INFECT IMMUN, V63, P2766, DOI 10.1128/IAI.63.7.2766-2769.1995; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Matsunaga T, 1999, BIOCHEM BIOPH RES CO, V260, P813, DOI 10.1006/bbrc.1999.0990; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Noris M, 1996, AM J KIDNEY DIS, V27, P790, DOI 10.1016/S0272-6386(96)90515-6; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2008, EMERG INFECT DIS, V14, P763, DOI 10.3201/eid1405.071050; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Siegler RL, 2005, RENAL FAILURE, V27, P635, DOI 10.1080/08860220500200841; te Loo DM, 2006, PEDIATR NEPHROL, V21, P1815, DOI 10.1007/s00467-006-0232-1; TESH VL, 1994, INFECT IMMUN, V62, P5085, DOI 10.1128/IAI.62.11.5085-5094.1994; Zotta E, 2008, PEDIATR NEPHROL, V23, P559, DOI 10.1007/s00467-007-0727-4	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15127	10.1371/journal.pone.0015127	http://dx.doi.org/10.1371/journal.pone.0015127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206910	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200016
J	Yu, F; Li, J; Chen, H; Fu, J; Ray, S; Huang, S; Zheng, H; Ai, W				Yu, F.; Li, J.; Chen, H.; Fu, J.; Ray, S.; Huang, S.; Zheng, H.; Ai, W.			Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion	ONCOGENE			English	Article						KLF4; cancer stem cell; breast cancer; migration; invasion	EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; SELF-RENEWAL; TUMOR-SUPPRESSOR; GENE-EXPRESSION; DIFFERENTIATION; IDENTIFICATION; P53; TUMORIGENICITY; TRANSFORMATION	Kruppel-like factor 4 (KLF4) is highly expressed in more than 70% of breast cancers and functions as an oncogene. However, an exact mechanism by which KLF4 enhances tumorigenesis of breast cancer remains unknown. In this study, we show that KLF4 was highly expressed in cancer stem cell (CSC)-enriched populations in mouse primary mammary tumor and breast cancer cell lines. Knockdown of KLF4 in breast cancer cells (MCF-7 and MDA-MB-231) decreased the proportion of stem/progenitor cells as demonstrated by expression of stem cell surface markers such as aldehyde dehydrogenase 1, side population and by in vitro mammosphere assay. Consistently KLF4 overexpression led to an increase of the cancer stem cell population. KLF4 knockdown also suppressed cell migration and invasion in MCF-7 and MDA-MB-231 cells. Furthermore, knockdown of KLF4 reduced colony formation in vitro and inhibited tumorigenesis in immunocompromised non-obese diabetic/severe combined immunodeficiency mice, supporting an oncogenic role for KLF4 in breast cancer development. Further mechanistic studies revealed that the Notch signaling pathway was required for KLF4-mediated cell migration and invasion, but not for CSC maintenance. Taken together, our study provides evidence that KLF4 has a potent oncogenic role in mammary tumorigenesis likely by maintaining stem cell-like features and by promoting cell migration and invasion. Thus, targeting KLF4 may provide an effective therapeutic approach to suppress tumorigenicity in breast cancer. Oncogene (2011) 30, 2161-2172; doi:10.1038/onc.2010.591; published online 17 January 2011	[Yu, F.; Li, J.; Ray, S.; Zheng, H.; Ai, W.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Li, J.; Huang, S.] Huazhong Univ Sci & Technol, Ctr Stem Cell Res & Applicat, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, H.; Fu, J.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Huazhong University of Science & Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ai, W (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd,Bldg 2,RM B18, Columbia, SC 29208 USA.	Walden.Ai@uscmed.sc.edu	chen, hexin/F-1714-2011		NIH/NIDDK [1K01DK069489]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR060987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK069489] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Plasmids containing KLF4 specific shRNA (siKLF4), the control vector (siCon), KLF4 overexpression vector (KLF4-N) and the control vector (Control) were kindly provided by Daniel S Peeper at the Netherlands Cancer Institute. IAP reporter construct was provided by Dr Chunming Liu at the University of Texas Medical Branch. This work was partially supported by an NIH/NIDDK grant to WA (1K01DK069489).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Choi BJ, 2006, PATHOL RES PRACT, V202, P585, DOI 10.1016/j.prp.2006.05.001; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Garvey SM, 2010, J PHARMACOL EXP THER, V333, P34, DOI 10.1124/jpet.109.163949; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miller KA, 2001, J BIOL CHEM, V276, P42863, DOI 10.1074/jbc.M108130200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang H, 2004, J BIOL CHEM, V279, P22674, DOI 10.1074/jbc.M401257200; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	58	320	334	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	18					2161	2172		10.1038/onc.2010.591	http://dx.doi.org/10.1038/onc.2010.591			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21242971	Green Accepted			2022-12-25	WOS:000290249600007
J	Camarota, LM; Woollett, LA; Howles, PN				Camarota, Lisa M.; Woollett, Laura A.; Howles, Philip N.			Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice	FASEB JOURNAL			English	Article						HDL metabolism; bile; fecal sterols; liver; macrophage	SCAVENGER RECEPTOR BI; APOLIPOPROTEIN-A-I; TRANSFER PROTEIN-INHIBITION; LOW-DENSITY-LIPOPROTEIN; SELECTIVE UPTAKE; SR-BI; STEROL EXCRETION; ACID SYNTHESIS; OVEREXPRESSION; MACROPHAGES	Mechanisms to increase reverse cholesterol transport (RCT) and biliary sterol disposal are currently sought to prevent atherosclerosis. Previous work with HepG2 cells and primary hepatocytes showed that carboxyl ester lipase (CEL), a broad-spectrum lipase secreted by pancreas and liver, plays an important role in hydrolysis of high-density lipoprotein (HDL) cholesteryl esters (CEs) after selective uptake by hepatocytes. The effect of CEL on RCT of HDL cholesterol was assessed by measuring biliary and fecal disposal of radiolabeled HDL-CE in control and Cel(-/-) mice. Radiolabeled CE was increased 3-fold in hepatic bile of Cel(-/-) mice, and the mass of CE in gall bladder bile was elevated. Total radiolabeled transport from plasma to hepatic bile was more rapid in Cel(-/-) mice. Fecal disposal of radiolabel from HDL-CE, as well as total sterol mass, was markedly elevated for Cel(-/-) mice, primarily due to more CE. RCT of macrophage CE was also increased in Cel(-/-) mice, as measured by excretion of radiolabel from injected J774 cells. Increased sterol loss was compensated by increased cholesterol synthesis in Cel(-/-) mice. Together, the data demonstrate significantly increased RCT in the absence of CEL and suggest a novel mechanism by which to manipulate plasma cholesterol flux.-Camarota, L. M., Woollett, L. A., Howles, P. N. Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice. FASEB J. 25, 1370-1377 (2011). www.fasebj.org	[Camarota, Lisa M.; Woollett, Laura A.; Howles, Philip N.] Univ Cincinnati, Dept Pathol, Metab Dis Inst, Coll Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Howles, PN (corresponding author), Univ Cincinnati, Dept Pathol, Metab Dis Inst, Coll Med, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	philip.howles@uc.edu			National Institutes of Health [R01 HL078900]; American Heart Association [AHA SW-97-16-B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Ronald Jandacek (University of Cincinnati College of Medicine) for the generous use of the OX700 Biological Oxidizer to measure radiolabeled bile acids in feces, Katie Burke for technical assistance with sterol synthesis assays, and Dr. David Y. Hui for many helpful discussions. This work was supported by grants from the National Institutes of Health (R01 HL078900) and the American Heart Association (AHA SW-97-16-B). Some of the data in this manuscript were previously published in abstract form (45).	Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bengtsson-Ellmark SH, 2004, EUR J HUM GENET, V12, P627, DOI 10.1038/sj.ejhg.5201204; BRODTEPPLEY J, 1995, BBA-MOL BASIS DIS, V1272, P69, DOI 10.1016/0925-4439(95)00083-G; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; CUTCHEL M, 2006, CIRCULATION, V113, P2548; Forrester JS, 2005, CIRCULATION, V111, P1847, DOI 10.1161/01.CIR.0000160860.36911.BD; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051; Ghosh S, 1998, AM J PHYSIOL-GASTR L, V274, pG662, DOI 10.1152/ajpgi.1998.274.4.G662; Harder CJ, 2007, J BIOL CHEM, V282, P1445, DOI 10.1074/jbc.M604627200; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; HARRISON EH, 1988, BIOCHIM BIOPHYS ACTA, V963, P28, DOI 10.1016/0005-2760(88)90334-7; Howles P., 2001, INTESTINAL LIPID MET, P119; Howles P, 2008, ARTERIOSCL THROM VAS, V28, pE61; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; Huang ZH, 2003, BIOCHEMISTRY-US, V42, P3949, DOI 10.1021/bi0269207; Huggins KW, 2003, J BIOL CHEM, V278, P42899, DOI 10.1074/jbc.M303422200; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Mizoguchi T, 2004, J LIPID RES, V45, P396, DOI 10.1194/jlr.D300024-JLR200; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760; PIETERS MN, 1991, BIOCHEM J, V280, P359, DOI 10.1042/bj2800359; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Post SM, 2003, ARTERIOSCL THROM VAS, V23, P892, DOI 10.1161/01.ATV.0000067702.22390.20; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; SCHEIBNER J, 1994, J LIPID RES, V35, P690; Schwarz M, 1998, J LIPID RES, V39, P1833; Sehayek E, 2003, J LIPID RES, V44, P1605, DOI 10.1194/jlr.M200488-JLR200; SEWELL RB, 1983, J LIPID RES, V24, P391; Tchoua U, 2008, CARDIOVASC RES, V77, P732, DOI 10.1093/cvr/cvm087; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhao B, 2005, PHYSIOL GENOMICS, V23, P304, DOI 10.1152/physiolgenomics.00187.2005; Zhao B, 2008, J LIPID RES, V49, P2212, DOI 10.1194/jlr.M800277-JLR200; Zhao B, 2007, AM J PHYSIOL-CELL PH, V292, pC405, DOI 10.1152/ajpcell.00306.2006	45	10	13	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1370	1377		10.1096/fj.10-169680	http://dx.doi.org/10.1096/fj.10-169680			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21212359	Green Published			2022-12-25	WOS:000288982800026
J	Jimenez, E; Zafra, F; Perez-Sen, R; Delicado, EG; Miras-Portugal, MT; Aragon, C; Lopez-Corcuera, B				Jimenez, Esperanza; Zafra, Francisco; Perez-Sen, Raquel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Maria; Aragon, Carmen; Lopez-Corcuera, Beatriz			P2Y Purinergic Regulation of the Glycine Neurotransmitter Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED CHROMAFFIN CELLS; NITRIC-OXIDE PRODUCTION; RAT SPINAL-CORD; NEUROPATHIC PAIN; CYCLIC-GMP; SYNAPTIC-TRANSMISSION; SEROTONIN TRANSPORTER; MOLECULAR-MECHANISMS; ADENOSINE TRANSPORT; RECEPTORS	The sodium-and chloride-coupled glycine neurotransmitter transporters (GLYTs) control the availability of glycine at glycine-mediated synapses. The mainly glial GLYT1 is the key regulator of the glycine levels in glycinergic and glutamatergic pathways, whereas the neuronal GLYT2 is involved in the recycling of synaptic glycine from the inhibitory synaptic cleft. In this study, we report that stimulation of P2Y purinergic receptors with 2-methylthioadenosine 5'-diphosphate in rat brainstem/spinal cord primary neuronal cultures and adult rat synaptosomes leads to the inhibition of GLYT2 and the stimulation of GLYT1 by a paracrine regulation. These effects are mainly mediated by the ADP-preferring subtypes P2Y(1) and P2Y(13) because the effects are partially reversed by the specific antagonists N-6-methyl-2'-deoxyadenosine-3',5'-bisphosphate and pyridoxal-5'-phosphate-6-azo(2chloro-5-nitrophenyl)-2,4-disulfonate and are totally blocked by suramin. P2Y(12) receptor is additionally involved in GLYT1 stimulation. Using pharmacological approaches and siRNA-mediated protein knockdown methodology, we elucidate the molecular mechanisms of GLYT regulation. Modulation takes place through a signaling cascade involving phospholipase C activation, inositol 1,4,5-trisphosphate production, intracellular Ca2+ mobilization, protein kinase C stimulation, nitric oxide formation, cyclic guanosine monophosphate production, and protein kinase G-I (PKG-I) activation. GLYT1 and GLYT2 are differentially sensitive to NO/cGMP/PKG-I both in brain-derived preparations and in heterologous systems expressing the recombinant transporters and P2Y(1) receptor. Sensitivity to 2-methylthioadenosine 5'-diphosphate by GLYT1 and GLYT2 was abolished by small interfering RNA (siRNA)-mediated knockdown of nitric-oxide synthase. Our data may help define the role of GLYTs in nociception and pain sensitization.	[Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Dept Mol Biol, E-28049 Madrid, Spain; [Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Jimenez, Esperanza; Zafra, Francisco; Aragon, Carmen; Lopez-Corcuera, Beatriz] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28049, Spain; [Perez-Sen, Raquel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Maria] Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Complutense University of Madrid	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, Dept Mol Biol, E-28049 Madrid, Spain.	blopez@cbm.uam.es	Aragon, Carmen/K-9783-2014; Corcuera, Beatriz López/D-5188-2009; Delicado, Esmerilda G./L-6992-2014; Miras-Portugal, Maria Teresa/L-7137-2014; Zafra, Francisco/A-6121-2008; Perez-Sen, Raquel/L-6975-2014	Aragon, Carmen/0000-0001-8287-9386; Corcuera, Beatriz López/0000-0002-0383-4241; Zafra, Francisco/0000-0003-3801-3109; Perez-Sen, Raquel/0000-0001-6213-3376; Pintor, Jesus/0000-0002-9191-7679	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica [BFU2005-05931/BMC, BIO2005-05786]; Ministerio de Ciencia e Innovacion [SAF2008-05436]; Comunidad Autonoma de Madrid [11/BCB/010, S-SAL-0253/2006]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia, Spain; European Regional Development Fund [BFU2007-30688-E/BFI]	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Regional Development Fund(European Commission)	This work was supported in part by the Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica Grants BFU2005-05931/BMC and BIO2005-05786, Ministerio de Ciencia e Innovacion Grant SAF2008-05436, Comunidad Autonoma de Madrid Grants 11/BCB/010 and S-SAL-0253/2006, and by an institutional grant from the Fundacion Ramon Areces.; Member of the Network for Cooperative Research on Membrane Transport Proteins, co-funded by the Ministerio de Educacion y Ciencia, Spain, and the European Regional Development Fund Grant BFU2007-30688-E/BFI.	Abbracchio Maria P, 2006, Purinergic Signal, V2, P595, DOI 10.1007/s11302-006-9016-0; Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Ando RD, 2010, BRIT J PHARMACOL, V159, P1106, DOI 10.1111/j.1476-5381.2009.00596.x; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Atterbury-Thomas AE, 2008, NEUROSCI LETT, V435, P190, DOI 10.1016/j.neulet.2008.02.034; Bardoni R, 1997, J NEUROSCI, V17, P5297; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Bradaia A, 2004, J PHYSIOL-LONDON, V559, P169, DOI 10.1113/jphysiol.2004.068858; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Caulfield WL, 2001, J MED CHEM, V44, P2679, DOI 10.1021/jm0011272; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Chhatriwala M, 2004, J PHARMACOL EXP THER, V311, P1038, DOI 10.1124/jpet.104.068650; Chizh BA, 2001, PHARMACOL REV, V53, P553; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Csolle C, 2008, J NEUROCHEM, V106, P347, DOI 10.1111/j.1471-4159.2008.05391.x; Cubelos B, 2005, NEUROPHARMACOLOGY, V49, P935, DOI 10.1016/j.neuropharm.2005.07.021; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; DELICADO EG, 1990, J NEUROCHEM, V54, P1941, DOI 10.1111/j.1471-4159.1990.tb04895.x; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; Dohi T, 2009, PHARMACOL THERAPEUT, V123, P54, DOI 10.1016/j.pharmthera.2009.03.018; Ferrero R, 1999, BRIT J PHARMACOL, V127, P779, DOI 10.1038/sj.bjp.0702607; Florenzano F, 2008, PROG NEUROBIOL, V84, P40, DOI 10.1016/j.pneurobio.2007.10.004; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Freire MAM, 2009, FRONT NEUROSCI-SWITZ, V3, P175, DOI 10.3389/neuro.01.024.2009; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hermanns H, 2008, NEUROSCI LETT, V445, P214, DOI 10.1016/j.neulet.2008.09.012; Howard A, 2010, J PHYSIOL-LONDON, V588, P995, DOI 10.1113/jphysiol.2009.186262; Hussl S, 2006, PFLUG ARCH EUR J PHY, V452, P538, DOI 10.1007/s00424-006-0063-8; Inoue K, 2007, PURINERG SIGNAL, V3, P135, DOI 10.1007/s11302-006-9045-8; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kittner H, 2003, NEUROPSYCHOPHARMACOL, V28, P435, DOI 10.1038/sj.npp.1300043; Lechner Stefan G, 2004, Purinergic Signal, V1, P31, DOI 10.1007/s11302-004-4746-3; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; LIU QR, 1993, J BIOL CHEM, V268, P22802; Lopez-Corcuera B, 2001, BIOCHEM SOC T, V29, P742, DOI 10.1042/0300-5127:0290742; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Moore D, 2000, J COMP NEUROL, V421, P374, DOI 10.1002/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nishikawa Y, 2010, J PHARMACOL SCI, V112, P352, DOI 10.1254/jphs.09351FP; Nunez E, 2005, NEUROPHARMACOLOGY, V49, P922, DOI 10.1016/j.neuropharm.2005.07.010; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ohnishi T, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-40; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; REISER G, 1995, J NEUROCHEM, V64, P61; Ruan HZ, 2003, HISTOCHEM CELL BIOL, V120, P415, DOI 10.1007/s00418-003-0579-3; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Selden NR, 2007, NEUROSCIENCE, V146, P1808, DOI 10.1016/j.neuroscience.2007.03.044; SEN RP, 1993, J NEUROCHEM, V60, P613, DOI 10.1111/j.1471-4159.1993.tb03192.x; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Tanabe M, 2008, ANESTHESIOLOGY, V108, P929, DOI 10.1097/ALN.0b013e31816c9044; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zeilhofer HU, 2008, INT IMMUNOPHARMACOL, V8, P182, DOI 10.1016/j.intimp.2007.07.009; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	78	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10712	10724		10.1074/jbc.M110.167056	http://dx.doi.org/10.1074/jbc.M110.167056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245148	hybrid, Green Published			2022-12-25	WOS:000288547000085
J	Seymour, LM; Falconer, L; Deutscher, AT; Minion, FC; Padula, MP; Dixon, NE; Djordjevic, SP; Walker, MJ				Seymour, Lisa M.; Falconer, Linda; Deutscher, Ania T.; Minion, F. Chris; Padula, Matthew P.; Dixon, Nicholas E.; Djordjevic, Steven P.; Walker, Mark J.			Mhp107 Is a Member of the Multifunctional Adhesin Family of Mycoplasma hyopneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; FIBRONECTIN-BINDING PROTEINS; ELONGATION-FACTOR TU; PLASMINOGEN-BINDING; STREPTOCOCCUS-PYOGENES; CILIUM ADHESIN; MAMMALIAN-CELLS; POTENTIAL ROLE; ALPHA-ENOLASE; ADHERENCE	Mycoplasma hyopneumoniae is the causative pathogen of porcine enzootic pneumonia, an economically significant disease that disrupts the mucociliary escalator in the swine respiratory tract. Expression of Mhp107, a P97 paralog encoded by the gene mhp107, was confirmed using ESI-MS/MS. To investigate the function of Mhp107, three recombinant proteins, F1(Mhp107), F2(Mhp107), and F3(Mhp107), spanning the N-terminal, central, and C-terminal regions of Mhp107 were constructed. Colonization of swine by M. hyopneumoniae requires adherence of the bacterium to ciliated cells of the respiratory tract. Recent studies have identified a number of M. hyopneumoniae adhesins that bind heparin, fibronectin, and plasminogen. F1(Mhp107) was found to bind porcine heparin (K-D similar to 90 nM) in a dose-dependent and saturable manner, whereas F3(Mhp107) bound fibronectin (K-D similar to 180 nM) at physiologically relevant concentrations. F1(Mhp107) also bound porcine plasminogen (K-D = 24 nM) in a dose-dependent and physiologically relevant manner. Microspheres coated with F3(Mhp107) mediate adherence to porcine kidney epithelial-like (PK15) cells, and all three recombinant proteins (F1(Mhp107)-F3(Mhp107)) bound swine respiratory cilia. Together, these findings indicate that Mhp107 is a member of the multifunctional M. hyopneumoniae adhesin family of surface proteins and contributes to both adherence to the host and pathogenesis.	[Seymour, Lisa M.; Deutscher, Ania T.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Falconer, Linda; Deutscher, Ania T.; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Ind & Investment NSW, Menangle, NSW 2567, Australia; [Minion, F. Chris] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Padula, Matthew P.; Djordjevic, Steven P.] Univ Sydney, Ithree Inst, Sydney, NSW 2006, Australia; [Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Wollongong; NSW Department of Primary Industries; Iowa State University; University of Sydney; University of Technology Sydney; University of Wollongong; University of Queensland; University of Queensland	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	mark.walker@uq.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013; Minion, Chris/A-2955-2015; Padula, Matthew P/R-6150-2016; Walker, Mark J./F-6940-2011; Dixon, Nicholas E/A-1226-2008	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Minion, Chris/0000-0003-4876-8396; Padula, Matthew P/0000-0002-8283-0643; Dixon, Nicholas E/0000-0002-5958-6945; Deutscher, Ania/0000-0002-5917-9223; Walker, Mark/0000-0001-7423-2769	Australian Postgraduate Award; Australian Research Council [LP776771]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by the Australian Postgraduate Award (to L. M. S.) and an Australian Research Council Linkage Project grant (LP776771).	Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseggio N, 1996, MICROBIOL-SGM, V142, P1429, DOI 10.1099/13500872-142-6-1429; BEREITER M, 1990, VET MICROBIOL, V25, P177, DOI 10.1016/0378-1135(90)90075-7; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Delvecchio A, 2002, EPIDEMIOL INFECT, V128, P391, DOI 10.1017/S0950268802006787; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; ERLINGER R, 1995, CELL TISSUE RES, V281, P473, DOI 10.1007/BF00417864; Giron JA, 1996, INFECT IMMUN, V64, P197; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; Hsu T, 1998, GENE, V214, P13, DOI 10.1016/S0378-1119(98)00247-9; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Madsen ML, 2007, J BACTERIOL, V189, P7977, DOI 10.1128/JB.01068-07; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Minion FC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1410, DOI 10.2741/minion; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Ramachandran V, 2004, J BACTERIOL, V186, P7601, DOI 10.1128/JB.186.22.7601-7609.2004; Razin S, 1999, BIOSCIENCE REP, V19, P367, DOI 10.1023/A:1020204020545; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wilton JL, 1998, MICROBIOL-UK, V144, P1931, DOI 10.1099/00221287-144-7-1931; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; WISE KS, 1987, J BACTERIOL, V169, P5546, DOI 10.1128/jb.169.12.5546-5555.1987; Yavlovich A, 2001, INFECT IMMUN, V69, P1977, DOI 10.1128/IAI.69.4.1977-1982.2001; Yavlovich A, 2007, FEMS MICROBIOL LETT, V266, P158, DOI 10.1111/j.1574-6968.2006.00534.x; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZHANG QJ, 1994, INFECT IMMUN, V62, P4367, DOI 10.1128/IAI.62.10.4367-4373.1994; ZIELINSKI GC, 1990, AM J VET RES, V51, P339	59	40	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10097	10104		10.1074/jbc.M110.208140	http://dx.doi.org/10.1074/jbc.M110.208140			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245147	Green Published, hybrid			2022-12-25	WOS:000288547000024
J	Huang, X; Rezaie, AR; Broze, GJ; Olson, ST				Huang, Xin; Rezaie, Alireza R.; Broze, George J., Jr.; Olson, Steven T.			Heparin Is a Major Activator of the Anticoagulant Serpin, Protein Z-dependent Protease Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITHROMBIN-FACTOR XA; KINETIC CHARACTERIZATION; PROTHROMBOTIC PHENOTYPE; Z DEFICIENCY; COFACTOR-II; THROMBIN; BINDING; ACCELERATION; MECHANISM; SULFATE	Protein Z-dependent protease inhibitor (ZPI) is a recently identified member of the serpin superfamily that functions as a cofactor-dependent regulator of blood coagulation factors Xa and XIa. Here we provide evidence that, in addition to the established cofactors, protein Z, lipid, and calcium, heparin is an important cofactor of ZPI anticoagulant function. Heparin produced 20-100-fold accelerations of ZPI reactions with factor Xa and factor XIa to yield second order rate constants approaching the physiologically significant diffusion limit (k(a) = 10(6) to 10(7) M-1 s(-1)). The dependence of heparin accelerating effects on heparin concentration was bell-shaped for ZPI reactions with both factors Xa and XIa, consistent with a template-bridging mechanism of heparin rate enhancement. Maximal accelerations of ZPI-factor Xa reactions required calcium, which augmented the heparin acceleration by relieving Gla domain inhibition as previously shown for heparin bridging of the antithrombin-factor Xa reaction. Heparin acceleration of both ZPI-protease reactions was optimal at heparin concentrations and heparin chain lengths comparable with those that produce physiologically significant rate enhancements of other serpin-protease reactions. Protein Z binding to ZPI minimally affected heparin rate enhancements, indicating that heparin binds to a distinct site on ZPI and activates ZPI in its physiologically relevant complex with protein Z. Taken together, these results suggest that whereas protein Z, lipid, and calcium cofactors promote ZPI inhibition of membrane-associated factor Xa, heparin activates ZPI to inhibit free factor Xa as well as factor XIa and therefore may play a physiologically and pharmacologically important role in ZPI anticoagulant function.	[Huang, Xin; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Rezaie, Alireza R.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Broze, George J., Jr.] Washington Univ, Med Ctr, Barnes Jewish Hosp, Div Hematol, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University; Barnes-Jewish Hospital; Washington University (WUSTL)	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C, Chicago, IL 60612 USA.	stolson@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL78827, HL39888, HL-62565]; American Heart Association [0920029G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R29HL039888, R01HL078827, R01HL039888, R01HL062565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78827 and HL39888 (to S. T. O.) and HL-62565 (to A. R. R.). This work was also supported by American Heart Association Fellowship 0920029G (to X. H.).	BOYD J, 1980, J MOL BIOL, V137, P175, DOI 10.1016/0022-2836(80)90324-1; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; HURST RE, 1983, J CLIN INVEST, V72, P1042, DOI 10.1172/JCI111028; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Riewald M, 2002, TRENDS CARDIOVAS MED, V12, P149, DOI 10.1016/S1050-1738(02)00153-6; SCULLY MF, 1988, FEBS LETT, V241, P11, DOI 10.1016/0014-5793(88)81020-2; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; TOLLEFSEN DM, 2006, HEMOSTASIS THROMBOSI, P271; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yang LK, 2009, BIOCHEMISTRY-US, V48, P1517, DOI 10.1021/bi802298r; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	37	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8740	8751		10.1074/jbc.M110.188375	http://dx.doi.org/10.1074/jbc.M110.188375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220417	Green Published, hybrid			2022-12-25	WOS:000288247700005
J	Iyer, AS; Morales, JL; Huang, WS; Ojo, F; Ning, G; Wills, E; Baines, JD; August, A				Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; Ning, Gang; Wills, Elizabeth; Baines, Joel D.; August, Avery			Absence of Tec Family Kinases Interleukin-2 Inducible T cell Kinase (Itk) and Bruton's Tyrosine Kinase (Btk) Severely Impairs Fc epsilon RI-dependent Mast Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; ACTIVATION; INHIBITOR; DEGRANULATION; MODELS	Mast cells are critical effector cells in the pathophysiology of allergic asthma and other IgE-mediated diseases. The Tec family of tyrosine kinases Itk and Btk serve as critical signal amplifiers downstream of antigen receptors. Although both kinases are expressed and activated in mast cells following Fc epsilon RI stimulation, their individual contributions are not clear. To determine whether these kinases play unique and/or complementary roles in Fc epsilon RI signaling and mast cell function, we generated Itk and Btk double knock-out mice. Analyses of these mice show decreased mast cell granularity and impaired passive systemic anaphylaxis responses. This impaired response is accompanied by a significant elevation in serum IgE in Itk/Btk double knockout mice. In vitro analyses of bone marrow-derived mast cells (BMMCs) indicated that Itk/Btk double knock-out BMMCs are defective in degranulation and cytokine secretion responses downstream to Fc epsilon RI activation. These responses were accompanied by a significant reduction in PLC gamma 2 phosphorylation and severely impaired calcium responses in these cells. This defect also results in altered NFAT1 nuclear localization in double knock-out BMMCs. Network analysis suggests that although they may share substrates, Itk plays both positive and negative roles, while Btk primarily plays a positive role in mast cell Fc epsilon RI-induced cytokine secretion.	[August, Avery] Cornell Univ, Dept Microbiol & Immunol, Coll Vet Med, Ithaca, NY 14853 USA; [Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Iyer, Archana S.] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Electron Microscopy Facil, Huck Inst Life Sci, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Coll Vet Med, C5 117 VMC, Ithaca, NY 14853 USA.	averyaugust@cornell.edu	Huang, Weishan/J-3127-2014	Huang, Weishan/0000-0002-1330-1131	National Institutes of Health [AI051626, AI065566, AI051626-S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065566, R01AI051626, R01AI052341, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051626 and AI065566 (to A. A.), and AI051626-S1 (to A. A.) (for J. L. M.).	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Denyer J, 2009, DRUG NEWS PERSPECT, V22, P146, DOI 10.1358/dnp.2009.22.3.1354124; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Ferrell JE, 2009, MOL CELL, V36, P724, DOI 10.1016/j.molcel.2009.11.032; Forssell J, 2005, AM J RESP CELL MOL, V32, P511, DOI 10.1165/rcmb.2004-0348OC; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Iyer AS, 2008, J IMMUNOL, V180, P7869, DOI 10.4049/jimmunol.180.12.7869; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Kawakami Y, 1999, P NATL ACAD SCI USA, V96, P2227, DOI 10.1073/pnas.96.5.2227; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Koranteng RD, 2004, CLIN EXP IMMUNOL, V137, P81, DOI 10.1111/j.1365-2249.2004.02510.x; Kovarova M, 2004, CURR MED CHEM, V11, P2083, DOI 10.2174/0929867043364801; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; Setoguchi R, 1998, IMMUNOL LETT, V64, P109, DOI 10.1016/S0165-2478(98)00086-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Vihinen M, 2000, FRONT BIOSCI-LANDMRK, V5, pD917, DOI 10.2741/vihinen	30	38	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9503	9513		10.1074/jbc.M110.165613	http://dx.doi.org/10.1074/jbc.M110.165613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212279	hybrid, Green Published			2022-12-25	WOS:000288247700077
J	Wang, F; Yamauchi, M; Muramatsu, M; Osawa, T; Tsuchida, R; Shibuya, M				Wang, Feng; Yamauchi, Mai; Muramatsu, Masashi; Osawa, Tsuyoshi; Tsuchida, Rika; Shibuya, Masabumi			RACK1 Regulates VEGF/Flt1-mediated Cell Migration via Activation of a PI3K/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; RECEPTOR-INTERACTING PROTEIN; TYROSINE KINASE; SIGNAL-TRANSDUCTION; BONE-MARROW; VASCULAR DEVELOPMENT; HUMAN MONOCYTES; VEGF RECEPTORS; BINDING-SITE	Vascular endothelial growth factor (VEGF) is vital to physiological as well as pathological angiogenesis, and regulates a variety of cellular functions, largely by activating its 2 receptors, fms-like tyrosine kinase (Flt1) and kinase domain receptor (KDR). KDR plays a critical role in the proliferation of endothelial cells by controlling VEGF-induced phospholipase C gamma-protein kinase C (PLC gamma-PKC) signaling. The function of Flt1, however, remains to be clarified. Recent evidence has indicated that Flt1 regulates the VEGF-triggered migration of endothelial cells and macrophages. Here, we show that RACK1, a ubiquitously expressed scaffolding protein, functions as an important regulator of this process. We found that RACK1 (receptor for activated protein kinase C 1) binds to Flt1 in vitro. When the endogenous expression of RACK1 was attenuated by RNA interference, the VEGF-driven migration was remarkably suppressed whereas the proliferation was unaffected in a stable Flt1-expressing cell line, AG1-G1-Flt1. Further, we demonstrated that the VEGF/Flt-mediated migration of AG1-G1-Flt1 cells occurred mainly via the activation of the PI3 kinase (PI3K)/Akt and Rac1 pathways, and that RACK1 plays a crucial regulatory role in promoting PI3K/Akt-Rac1 activation.	[Wang, Feng; Muramatsu, Masashi; Osawa, Tsuyoshi; Tsuchida, Rika; Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med & Dent, Bunkyo Ku, Tokyo 1138519, Japan; [Yamauchi, Mai] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1080071, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Shibuya, M (corresponding author), Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med & Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	shibuya@ims.u-tokyo.ac.jp	Wang, Feng/Q-7386-2017		Ministry of Education, Culture, Sports, Science and Technology of Japan [17014020]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid Special Project Research on Cancer-Bioscience 17014020 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; del Valle-Perez B, 2010, J BIOL CHEM, V285, P10748, DOI 10.1074/jbc.M109.062984; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ishizaki H, 2006, CLIN CANCER RES, V12, P5841, DOI 10.1158/1078-0432.CCR-06-0750; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Krysiak O, 2005, CIRC RES, V97, P1253, DOI 10.1161/01.RES.0000194324.29363.82; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Muramatsu M, 2010, CANCER RES, V70, P8211, DOI 10.1158/0008-5472.CAN-10-0202; Orlichenko L, 2010, J BIOL CHEM, V285, P19153, DOI 10.1074/jbc.M109.099382; Podar K, 2004, BLOOD, V103, P3474, DOI 10.1182/blood-2003-10-3527; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RON D, 1994, J BIOL CHEM, V269, P21395; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; SEETHARAM L, 1995, ONCOGENE, V10, P135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; SHIBUYA M, 1990, ONCOGENE, V5, P519; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; TERMAN BI, 1991, ONCOGENE, V6, P1677; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006	48	81	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9097	9106		10.1074/jbc.M110.165605	http://dx.doi.org/10.1074/jbc.M110.165605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212275	Green Published, hybrid			2022-12-25	WOS:000288247700040
J	Chan, SW; Lim, CJ; Chong, YF; Pobbati, AV; Huang, CX; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Chong, Yaan Fun; Pobbati, Ajaybabu V.; Huang, Caixia; Hong, Wanjin			Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; WW DOMAIN; ONCOGENIC TRANSFORMATION; GROWTH-CONTROL; TRANSCRIPTION; BINDING; CANCER	The Hippo pathway restricts the activity of transcriptional co-activators TAZ and YAP by phosphorylating them for cytoplasmic sequestration or degradation. In this report, we describe an independent mechanism for the cell to restrict the activity of TAZ and YAP through interaction with angiomotin (Amot) and angiomotin-like 1 (AmotL1). Amot and AmotL1 were robustly co-immunoprecipitated with FLAG-tagged TAZ, and their interaction is dependent on the WW domain of TAZ and the PPXY motif in the N terminus of Amot. Amot and AmotL1 also interact with YAP via the first WW domain of YAP. Overexpression of Amot and AmotL1 caused cytoplasmic retention of TAZ and suppressed its transcriptional outcome such as the expression of CTGF and Cyr61. Hippo refractory TAZ mutant (S89A) is also negatively regulated by Amot and AmotL1. HEK293 cells express the highest level of Amot and AmotL1 among nine cell lines examined, and silencing the expression of endogenous Amot increased the expression of CTGF and Cyr61 either at basal levels or upon overexpression of exogenous S89A. These results reveal a novel mechanism to restrict the activity of TAZ and YAP through physical interaction with Amot and AmotL1.	[Chan, Siew Wee; Lim, Chun Jye; Chong, Yaan Fun; Pobbati, Ajaybabu V.; Huang, Caixia; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Hong, Wanjin] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Hong, WJ (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg	HONG, Wanjin/E-9927-2010		Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Agency for Science, Technology and Research (A*STAR), Singapore.	Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; CHAN SW, 2010, ONCOGENE        1025, DOI DOI 10.1038/ONC.2010.438; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; XU MZ, 2010, ONCOGENE        1115, DOI DOI 10.1038/ONC.2010.518; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	36	285	290	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7018	7026		10.1074/jbc.C110.212621	http://dx.doi.org/10.1074/jbc.C110.212621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21224387	Green Published, hybrid			2022-12-25	WOS:000287737300018
J	Fakiola, M; Mishra, A; Rai, M; Singh, SP; O'Leary, RA; Ball, S; Francis, RW; Firth, MJ; Radford, BT; Miller, EN; Sundar, S; Blackwell, JM				Fakiola, Michaela; Mishra, Anshuman; Rai, Madhukar; Singh, Shri Prakash; O'Leary, Rebecca A.; Ball, Stephen; Francis, Richard W.; Firth, Martin J.; Radford, Ben T.; Miller, E. Nancy; Sundar, Shyam; Blackwell, Jenefer M.			Classification and Regression Tree and Spatial Analyses Reveal Geographic Heterogeneity in Genome Wide Linkage Study of Indian Visceral Leishmaniasis	PLOS ONE			English	Article							SIB-PAIR METHOD; KALA-AZAR; GENETIC SUSCEPTIBILITY; CELL-DIFFERENTIATION; NORTHEASTERN BRAZIL; DONOVANI INFECTION; MUSLIM POPULATIONS; MAJOR INFECTION; EASTERN SUDAN; ENDEMIC AREA	Background: Genome wide linkage studies (GWLS) have provided evidence for loci controlling visceral leishmaniasis on Chromosomes 1p22, 6q27, 22q12 in Sudan and 6q27, 9p21, 17q11-q21 in Brazil. Genome wide studies from the major focus of disease in India have not previously been reported. Methods and Findings: We undertook a GWLS in India in which a primary similar to 10 cM (515 microsatellites) scan was carried out in 58 multicase pedigrees (74 nuclear families; 176 affected, 353 total individuals) and replication sought in 79 pedigrees (102 nuclear families; 218 affected, 473 total individuals). The primary scan provided evidence (>= 2 adjacent markers allele-sharing LOD >= 0.59; nominal P <= 0.05) for linkage on Chromosomes 2, 5, 6, 7, 8, 10, 11, 20 and X, with peaks at 6p25.3-p24.3 and 8p23.1-p21.3 contributed to largely by 31 Hindu families and at Xq21.1-q26.1 by 27 Muslim families. Refined mapping confirmed linkage across all primary scan families at 2q12.2-q14.1 and 11q13.2-q23.3, but only 11q13.2-q23.3 replicated (combined LOD = 1.59; P = 0.0034). Linkage at 6p25.3-p24.3 and 8p23.1-p21.3, and at Xq21.1-q26.1, was confirmed by refined mapping for primary Hindu and Muslim families, respectively, but only Xq21.1-q26.1 replicated across all Muslim families (combined LOD 1.49; P = 0.0045). STRUCTURE and SMARTPCA did not identify population genetic substructure related to religious group. Classification and regression tree, and spatial interpolation, analyses confirm geographical heterogeneity for linkages at 6p25.3-p24.3, 8p23.1-p21.3 and Xq21.1-q26.1, with specific clusters of families contributing LOD scores of 2.13 (P = 0.0009), 1.75 (P = 0.002) and 1.84 (P = 0.001), respectively. Conclusions: GWLS has identified novel loci that show geographical heterogeneity in their influence on susceptibility to VL in India.	[Fakiola, Michaela; Francis, Richard W.; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Fakiola, Michaela; Francis, Richard W.; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Mishra, Anshuman; Rai, Madhukar; Singh, Shri Prakash; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [O'Leary, Rebecca A.; Ball, Stephen; Francis, Richard W.; Firth, Martin J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Radford, Ben T.] Univ Western Australia, UWA Oceans Inst, Australian Inst Marine Sci, Crawley, Australia	University of Cambridge; University of Cambridge; Banaras Hindu University (BHU); Telethon Kids Institute; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Fakiola, M (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England.	jblackwell@ichr.uwa.edu.au	trivedi, kruti/H-5242-2011; Francis, Richard/K-2812-2019; Blackwell, Jenefer M/H-3015-2015	Francis, Richard/0000-0003-1580-7934; Firth, Martin/0000-0002-7471-0860; Mishra, Anshuman/0000-0002-9390-9971; Fakiola, Michaela/0000-0001-9071-4709	Wellcome Trust, United Kingdom; National Institutes for Health, United States of America, Tropical Medicine Research Centre [1P50AI074321-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076233, P50AI074321] Funding Source: NIH RePORTER	Wellcome Trust, United Kingdom(Wellcome Trust); National Institutes for Health, United States of America, Tropical Medicine Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by The Wellcome Trust, United Kingdom, and the National Institutes for Health, United States of America, Tropical Medicine Research Centre grant 1P50AI074321-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2003, J IMMUNOL, V170, P1995, DOI 10.4049/jimmunol.170.4.1995; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; BALGIR RS, 1988, AM J PHYS ANTHROPOL, V75, P391, DOI 10.1002/ajpa.1330750310; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhattacharyya NP, 1999, GENOME RES, V9, P711; Bittles AH, 2000, ANN HUM BIOL, V27, P163; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; BREIMAN L., 1984, CRC PRESS; BROWN DL, 1994, AM J HUM GENET, V54, P544; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CHATTERJEE M, 1995, INDIAN J MED RES, V102, P165; Eaaswarkhanth M, 2009, HUM BIOL, V81, P427, DOI 10.3378/027.081.0403; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; FRANKENBURG S, 1990, J IMMUNOL, V145, P4284; Gauzzi MC, 2005, J LEUKOCYTE BIOL, V77, P944, DOI 10.1189/jlb.0205090; Genin E, 1996, AM J HUM GENET, V59, P1149; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gutala R, 2006, HUM GENET, V120, P543, DOI 10.1007/s00439-006-0234-x; Hatzigeorgiou DE, 1996, P NATL ACAD SCI USA, V93, P14708, DOI 10.1073/pnas.93.25.14708; HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Khalil EAG, 2002, TROP MED INT HEALTH, V7, P35, DOI 10.1046/j.1365-3156.2002.00832.x; Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lehtonen A, 2003, CYTOKINE, V24, P81, DOI 10.1016/j.cyto.2003.07.001; Leutenegger AL, 2002, GENET EPIDEMIOL, V23, P413, DOI 10.1002/gepi.10190; Lohoff M, 2004, J EXP MED, V200, P247, DOI 10.1084/jem.20040182; Malhotra KC, 1993, HUMAN POPULATION GEN; Manna M, 2005, MED SCI MONITOR, V11, pBR220; Mason NJ, 2004, IMMUNOL REV, V201, P48, DOI 10.1111/j.0105-2896.2004.00189.x; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977; Mullen AB, 2006, IMMUNOLOGY, V119, P348, DOI 10.1111/j.1365-2567.2006.02438.x; Murray HW, 2006, INFECT IMMUN, V74, P4370, DOI 10.1128/IAI.00422-06; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'sullivan D., 2003, GEOGRAPHIC INFORM AN; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; REINER NE, 1990, J CLIN INVEST, V85, P1914, DOI 10.1172/JCI114654; SACKS DL, 1987, J IMMUNOL, V138, P908; Salotra P, 2001, BRIT J DERMATOL, V145, P630, DOI 10.1046/j.1365-2133.2001.04434.x; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Speirs K, 2002, J IMMUNOL, V168, P4406, DOI 10.4049/jimmunol.168.9.4406; Sundar S, 2001, AM J TROP MED HYG, V65, P193, DOI 10.4269/ajtmh.2001.65.193; Sundar Shyam, 2003, J Assoc Physicians India, V51, P195; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P156, DOI 10.1016/S0035-9203(00)90255-4; Thakur CP, 2001, T ROY SOC TROP MED H, V95, P187, DOI 10.1016/S0035-9203(01)90160-9; Therneau T. M., 1997, 61 DEP HLTH SCI RES; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Wei XQ, 2004, IMMUNOL LETT, V94, P35, DOI 10.1016/j.imlet.2004.04.001; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	73	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15807	10.1371/journal.pone.0015807	http://dx.doi.org/10.1371/journal.pone.0015807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209823	gold, Green Submitted, Green Published			2022-12-25	WOS:000285838900037
J	Padhukasahasram, B; Halperin, E; Wessel, J; Thomas, DJ; Silver, E; Trumbower, H; Cargill, M; Stephan, DA				Padhukasahasram, Badri; Halperin, Eran; Wessel, Jennifer; Thomas, Daryl J.; Silver, Elana; Trumbower, Heather; Cargill, Michele; Stephan, Dietrich A.			Presymptomatic Risk Assessment for Chronic Non-Communicable Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; COMPLEX DISEASES; GENETIC RISK; SUSCEPTIBILITY; VARIANTS; POLYMORPHISMS; POPULATION	The prevalence of common chronic non-communicable diseases (CNCDs) far overshadows the prevalence of both monogenic and infectious diseases combined. All CNCDs, also called complex genetic diseases, have a heritable genetic component that can be used for pre-symptomatic risk assessment. Common single nucleotide polymorphisms (SNPs) that tag risk haplotypes across the genome currently account for a non-trivial portion of the germ-line genetic risk and we will likely continue to identify the remaining missing heritability in the form of rare variants, copy number variants and epigenetic modifications. Here, we describe a novel measure for calculating the lifetime risk of a disease, called the genetic composite index (GCI), and demonstrate its predictive value as a clinical classifier. The GCI only considers summary statistics of the effects of genetic variation and hence does not require the results of large-scale studies simultaneously assessing multiple risk factors. Combining GCI scores with environmental risk information provides an additional tool for clinical decision-making. The GCI can be populated with heritable risk information of any type, and thus represents a framework for CNCD pre-symptomatic risk assessment that can be populated as additional risk information is identified through next-generation technologies.	[Padhukasahasram, Badri; Halperin, Eran; Wessel, Jennifer; Thomas, Daryl J.; Silver, Elana; Trumbower, Heather; Cargill, Michele; Stephan, Dietrich A.] Navigenics, Foster City, CA USA; [Stephan, Dietrich A.] Inst Individualized Hlth, Palo Alto, CA USA; [Stephan, Dietrich A.] Canc Genome Inst, Philadelphia, PA USA; [Stephan, Dietrich A.] Childrens Hosp Boston, Childrens Hosp Informat Program, Boston, MA USA	Harvard University; Boston Children's Hospital	Padhukasahasram, B (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	bpadhuka@ucdavis.edu		Wessel, Jennifer/0000-0002-7031-0085	Navigenics Inc.	Navigenics Inc.	This project was funded by only in that all the authors were employees of Navigenics when this study was carried out. No other company funded this study. The study was carried out at Navigenics Inc. and the methodology used in this paper was initially developed for genetic risk calculations for customers using their genotype data in the product that is offered by Navigenics Inc. The research in this article was conducted to validate this methodology and its assumptions using real and simulated data. The funders had a role in study design, data collection and in the decision to publish this manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kempthorne O, 1957, INTRO GENETIC STAT; King R. A., 2002, GENETIC BASIS COMMON, V2; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; LUSTED LB, 1971, SCIENCE, V171, P1217, DOI 10.1126/science.171.3977.1217; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; 2001, NATURE, V409, P934; 2007, NATURE, V449, P851	28	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14338	10.1371/journal.pone.0014338	http://dx.doi.org/10.1371/journal.pone.0014338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217814	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900001
J	Robert-Moreno, A; Naranjo, S; de la Calle-Mustienes, E; Gomez-Skarmeta, JL; Alsina, B				Robert-Moreno, Alex; Naranjo, Silvia; de la Calle-Mustienes, Elisa; Luis Gomez-Skarmeta, Jose; Alsina, Berta			Characterization of New Otic Enhancers of the Pou3f4 Gene Reveal Distinct Signaling Pathway Regulation and Spatio-Temporal Patterns	PLOS ONE			English	Article							X-LINKED DEAFNESS; INNER-EAR DEVELOPMENT; PLACODE INDUCTION; PROSENSORY PATCHES; SONIC HEDGEHOG; HEARING-LOSS; HAIR-CELLS; FGF3; ZEBRAFISH; EXPRESSION	POU3F4 is a member of the POU-homedomain transcription factor family with a prominent role in inner ear development. Mutations in the human POU3F4 coding unit leads to X-linked deafness type 3 (DFN3), characterized by conductive hearing loss and progressive sensorineural deafness. Microdeletions found 1 Mb 5' upstream of the coding region also displayed the same phenotype, suggesting that cis-regulatory elements might be present in that region. Indeed, we and others have recently identified several enhancers at the 1 Mb 59 upstream interval of the pou3f4 locus. Here we characterize the spatio-temporal patterns of these regulatory elements in zebrafish transgenic lines. We show that the most distal enhancer (HCNR 81675) is activated earlier and drives GFP reporter expression initially to a broad ear domain to progressively restrict to the sensory patches. The proximal enhancer (HCNR 82478) is switched later during development and promotes expression, among in other tissues, in sensory patches from its onset. The third enhancer (HCNR 81728) is also active at later stages in the otic mesenchyme and in the otic epithelium. We also characterize the signaling pathways regulating these enhancers. While HCNR 81675 is regulated by very early signals of retinoic acid, HCNR 82478 is regulated by Fgf activity at a later stage and the HCNR 81728 enhancer is under the control of Hh signaling. Finally, we show that Sox2 and Pax2 transcription factors are bound to HCNR 81675 genomic region during otic development and specific mutations to these transcription factor binding sites abrogates HCNR 81675 enhancer activity. Altogether, our results suggest that pou3f4 expression in inner ear might be under the control of distinct regulatory elements that fine-tune the spatio-temporal activity of this gene and provides novel data on the signaling mechanisms controlling pou3f4 function.	[Robert-Moreno, Alex; Alsina, Berta] Univ Pompeu Fabra Parc Recerca Biomed Barcelona, Dept Expt & Hlth Sci, Barcelona, Spain; [Naranjo, Silvia; de la Calle-Mustienes, Elisa; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Robert-Moreno, A (corresponding author), Univ Pompeu Fabra Parc Recerca Biomed Barcelona, Dept Expt & Hlth Sci, Barcelona, Spain.	berta.alsina@upf.edu	Naranjo, Silvia/P-9845-2016; Gomez-Skarmeta, Jose Luis/B-5268-2014; Robert-Moreno, Alex/K-8640-2014; Alsina, Berta/A-2632-2010	Naranjo, Silvia/0000-0002-4529-3332; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Robert-Moreno, Alex/0000-0001-9042-1316; Alsina, Berta/0000-0002-6997-1249; de la Calle-Mustienes, Elisa/0000-0002-8975-6503	MICINN [BFU 2008-00714, BFU2007-60042/BMC, Petri PET2007_0158, CSD2007-00008]; Junta de Andalucia [CVI-3488]; Juan de la Cierva postdoctoral fellowship	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); Juan de la Cierva postdoctoral fellowship(Instituto de Salud Carlos III)	This work has been supported by grants from MICINN to BA (BFU 2008-00714) and JLG-S (BFU2007-60042/BMC, Petri PET2007_0158, CSD2007-00008), a grant from the Junta de Andalucia to JLG-S (Proyecto de Excelencia CVI-3488) and a Juan de la Cierva postdoctoral fellowship to ARM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; Arnold JS, 2006, HUM MOL GENET, V15, P1629, DOI 10.1093/hmg/ddl084; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; BITNERGLINDZICZ M, 1995, HUM MOL GENET, V4, P1467, DOI 10.1093/hmg/4.8.1467; Braunstein EM, 2008, JARO-J ASSOC RES OTO, V9, P33, DOI 10.1007/s10162-008-0110-6; Brown KK, 2010, HUM GENET, V127, P19, DOI 10.1007/s00439-009-0736-4; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Cremers FPM, 2000, ADV OTO-RHINO-LARYNG, V56, P184; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Dupe V, 1999, DEVELOPMENT, V126, P5051; Gale E, 1999, MECH DEVELOP, V89, P43, DOI 10.1016/S0925-4773(99)00202-6; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Guerrero L, 2010, DEV BIOL, V337, P16, DOI 10.1016/j.ydbio.2009.10.006; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; LEFEBVRE PP, 1993, SCIENCE, V260, P692, DOI 10.1126/science.8480180; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285, DOI 10.1073/pnas.89.8.3285; Liu W, 2003, DEV DYNAM, V226, P427, DOI 10.1002/dvdy.10258; Maroon H, 2002, DEVELOPMENT, V129, P2099; Naranjo S, 2010, HUM GENET, V128, P411, DOI 10.1007/s00439-010-0864-x; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Phippard D, 2000, HUM MOL GENET, V9, P79, DOI 10.1093/hmg/9.1.79; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Raz Y, 1997, SEMIN CELL DEV BIOL, V8, P257, DOI 10.1006/scdb.1997.0148; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903	58	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15907	10.1371/journal.pone.0015907	http://dx.doi.org/10.1371/journal.pone.0015907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209840	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900048
J	Fuentes, JL; Strayer, MS; Matera, AG				Fuentes, Jennifer L.; Strayer, Molly S.; Matera, A. Gregory			Molecular Determinants of Survival Motor Neuron (SMN) Protein Cleavage by the Calcium-Activated Protease, Calpain	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; DETERMINING GENE-PRODUCT; MYOBLAST FUSION; TUDOR DOMAIN; MU-CALPAIN; CELL-DEATH; RIBONUCLEOPROTEIN BIOGENESIS; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; SNRNP PROTEINS	Spinal muscular atrophy (SMA) is a leading genetic cause of childhood mortality, caused by reduced levels of survival motor neuron (SMN) protein. SMN functions as part of a large complex in the biogenesis of small nuclear ribonucleoproteins (snRNPs). It is not clear if defects in snRNP biogenesis cause SMA or if loss of some tissue-specific function causes disease. We recently demonstrated that the SMN complex localizes to the Z-discs of skeletal and cardiac muscle sarcomeres, and that SMN is a proteolytic target of calpain. Calpains are implicated in muscle and neurodegenerative disorders, although their relationship to SMA is unclear. Using mass spectrometry, we identified two adjacent calpain cleavage sites in SMN, S192 and F193. Deletion of small motifs in the region surrounding these sites inhibited cleavage. Patient-derived SMA mutations within SMN reduced calpain cleavage. SMN(D44V), reported to impair Gemin2 binding and amino-terminal SMN association, drastically inhibited cleavage, suggesting a role for these interactions in regulating calpain cleavage. Deletion of A188, a residue mutated in SMA type I (A188S), abrogated calpain cleavage, highlighting the importance of this region. Conversely, SMA mutations that interfere with self-oligomerization of SMN, Y272C and SMN Delta 7, had no effect on cleavage. Removal of the recently-identified SMN degron (Delta 268-294) resulted in increased calpain sensitivity, suggesting that the C-terminus of SMN is important in dictating availability of the cleavage site. Investigation into the spatial determinants of SMN cleavage revealed that endogenous calpains can cleave cytosolic, but not nuclear, SMN. Collectively, the results provide insight into a novel aspect of the post-translation regulation of SMN.	[Fuentes, Jennifer L.] Univ N Carolina, Program Mol Biol & Biotechnol, Dept Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fuentes, JL (corresponding author), Univ N Carolina, Program Mol Biol & Biotechnol, Dept Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	matera@unc.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Matera, A. Gregory/0000-0002-6406-0630	National Institutes of Health (USA) [R01-NS41617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041617] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the National Institutes of Health (USA), grant number R01-NS41617. URL: http://projectreporter.nih.gov/reporter.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2004, LAB INVEST, V84, P1271, DOI 10.1038/labinvest.3700163; Baki A, 1996, BIOCHEM J, V318, P897, DOI 10.1042/bj3180897; BALCERZAK D, 1995, J CELL SCI, V108, P2077; Barnoy S, 2005, BIOCHEM BIOPH RES CO, V332, P697, DOI 10.1016/j.bbrc.2005.05.010; Barth S, 2003, J VIROL, V77, P5008, DOI 10.1128/JVI.77.8.5008-5013.2003; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2008, MOL CELL BIOL; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dourdin N, 1999, EXP CELL RES, V246, P433, DOI 10.1006/excr.1998.4325; duVerle David, 2010, V22, P202; EBISUI C, 1994, BIOCHEM MOL BIOL INT, V32, P515; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gil-Parrado S, 2003, J BIOL CHEM, V278, P16336, DOI 10.1074/jbc.M208657200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; HIRAO T, 1984, J BIOCHEM-TOKYO, V96, P775, DOI 10.1093/oxfordjournals.jbchem.a134895; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kerr DA, 2000, P NATL ACAD SCI USA, V97, P13312, DOI 10.1073/pnas.230364197; Kim S, 2000, J NEUROBIOL, V42, P22, DOI 10.1002/(SICI)1097-4695(200001)42:1<22::AID-NEU3>3.0.CO;2-#; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; KWAK KB, 1993, FEBS LETT, V323, P151, DOI 10.1016/0014-5793(93)81468-F; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Murachi T, 1980, Adv Enzyme Regul, V19, P407; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Ono F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe3; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Renvoise B, 2006, J CELL SCI, V119, P680, DOI 10.1242/jcs.02782; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Scheffer H, 2001, EUR J HUM GENET, V9, P484, DOI 10.1038/sj.ejhg.5200667; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Vaisid T, 2008, J NEUROSCI RES, V86, P2314, DOI 10.1002/jnr.21670; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Vyas S, 2002, HUM MOL GENET, V11, P2751, DOI 10.1093/hmg/11.22.2751; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Wirth B, 2006, PROG MOLEC, V44, P109; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2003, MOL BRAIN RES, V119, P37, DOI 10.1016/j.molbrainres.2003.08.011; Zapletalova E, 2007, NEUROMUSCULAR DISORD, V17, P476, DOI 10.1016/j.nmd.2007.03.003; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	125	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15769	10.1371/journal.pone.0015769	http://dx.doi.org/10.1371/journal.pone.0015769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209906	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600035
J	Kadiyala, CSR; Tomechko, SE; Miyagi, M				Kadiyala, Chandra Sekhar Rao; Tomechko, Sara E.; Miyagi, Masaru			Perfluorooctanoic Acid for Shotgun Proteomics	PLOS ONE			English	Article							MASS-SPECTROMETRY; ENZYMATIC DIGESTION; MEMBRANE-PROTEINS; OUTER SEGMENT; SURFACTANT; DETERGENTS; STRATEGIES; EXCHANGE; REMOVAL; TRYPSIN	Here, we describe the novel use of a volatile surfactant, perfluorooctanoic acid (PFOA), for shotgun proteomics. PFOA was found to solubilize membrane proteins as effectively as sodium dodecyl sulfate (SDS). PFOA concentrations up to 0.5% (w/v) did not significantly inhibit trypsin activity. The unique features of PFOA allowed us to develop a single-tube shotgun proteomics method that used all volatile chemicals that could easily be removed by evaporation prior to mass spectrometry analysis. The experimental procedures involved: 1) extraction of proteins in 2% PFOA; 2) reduction of cystine residues with triethyl phosphine and their S-alkylation with iodoethanol; 3) trypsin digestion of proteins in 0.5% PFOA; 4) removal of PFOA by evaporation; and 5) LC-MS/MS analysis of the resulting peptides. The general applicability of the method was demonstrated with the membrane preparation of photoreceptor outer segments. We identified 75 proteins from 1 mu g of the tryptic peptides in a single, 1-hour, LC-MS/MS run. About 67% of the proteins identified were classified as membrane proteins. We also demonstrate that a proteolytic (18)O labeling procedure can be incorporated after the PFOA removal step for quantitative proteomic experiments. The present method does not require sample clean-up devices such as solid-phase extractions and membrane filters, so no proteins/peptides are lost in any experimental steps. Thus, this single-tube shotgun proteomics method overcomes the major drawbacks of surfactant use in proteomic experiments.	[Kadiyala, Chandra Sekhar Rao; Tomechko, Sara E.; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kadiyala, CSR (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu			National Institutes of Health [P30EY-11373]; Juvenile Diabetes Research Foundation [39-2009-643]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health grant P30EY-11373 (Visual Sciences Research Center of Case Western Reserve University) and Juvenile Diabetes Research Foundation grant 39-2009-643. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns DC, 2008, ENVIRON SCI TECHNOL, V42, P9283, DOI 10.1021/es802047v; Capelo JL, 2010, TALANTA, V80, P1476, DOI 10.1016/j.talanta.2009.04.053; Eckel-Passow JE, 2006, BIOINFORMATICS, V22, P2739, DOI 10.1093/bioinformatics/btl464; Fenselau C, 2009, J PROTEOME RES, V8, P2140, DOI 10.1021/pr8009879; Hajkova D, 2010, J PROTEOME RES, V9, P1173, DOI 10.1021/pr900819k; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Ishihama Y, 2000, ANAL BIOCHEM, V287, P45, DOI 10.1006/abio.2000.4836; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiser JZ, 2009, J PROTEOME RES, V8, P1810, DOI 10.1021/pr8004919; Loo RRO, 2007, ANAL CHEM, V79, P1115, DOI 10.1021/ac061916c; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Negri S, 2008, G Ital Med Lav Ergon, V30, P61; Norris JL, 2003, ANAL CHEM, V75, P6642, DOI 10.1021/ac034802z; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Pezeshki A, 2009, J PHARMACEUT BIOMED, V49, P607, DOI 10.1016/j.jpba.2008.12.003; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Vissers JPC, 1996, J CHROMATOGR B, V686, P119, DOI 10.1016/S0378-4347(96)00213-7; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yao XD, 2003, J PROTEOME RES, V2, P147, DOI 10.1021/pr025572s; Yu YQ, 2004, RAPID COMMUN MASS SP, V18, P711, DOI 10.1002/rcm.1374; Yu YQ, 2003, ANAL CHEM, V75, P6023, DOI 10.1021/ac0346196; Zaikin VG, 2005, EUR J MASS SPECTROM, V11, P611, DOI 10.1255/ejms.773	24	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15332	10.1371/journal.pone.0015332	http://dx.doi.org/10.1371/journal.pone.0015332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209883	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600018
J	Xu, JH; Yang, ZY; Tsien, JZ				Xu, Jinhua; Yang, Zhiyong; Tsien, Joe Z.			Emergence of Visual Saliency from Natural Scenes via Context-Mediated Probability Distributions Coding	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CELL RECEPTIVE-FIELDS; CORTEX; ATTENTION; MODEL; STATISTICS; PERCEPTION; ELEMENTS; NEURONS; FILTERS	Visual saliency is the perceptual quality that makes some items in visual scenes stand out from their immediate contexts. Visual saliency plays important roles in natural vision in that saliency can direct eye movements, deploy attention, and facilitate tasks like object detection and scene understanding. A central unsolved issue is: What features should be encoded in the early visual cortex for detecting salient features in natural scenes? To explore this important issue, we propose a hypothesis that visual saliency is based on efficient encoding of the probability distributions (PDs) of visual variables in specific contexts in natural scenes, referred to as context-mediated PDs in natural scenes. In this concept, computational units in the model of the early visual system do not act as feature detectors but rather as estimators of the context-mediated PDs of a full range of visual variables in natural scenes, which directly give rise to a measure of visual saliency of any input stimulus. To test this hypothesis, we developed a model of the context-mediated PDs in natural scenes using a modified algorithm for independent component analysis (ICA) and derived a measure of visual saliency based on these PDs estimated from a set of natural scenes. We demonstrated that visual saliency based on the context-mediated PDs in natural scenes effectively predicts human gaze in free-viewing of both static and dynamic natural scenes. This study suggests that the computation based on the context-mediated PDs of visual variables in natural scenes may underlie the neural mechanism in the early visual cortex for detecting salient features in natural scenes.	[Xu, Jinhua; Yang, Zhiyong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Xu, Jinhua] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China; [Yang, Zhiyong] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Xu, JH (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@mcg.edu; jtsien@mcg.edu			National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG fund; Georgia Research Alliance	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG fund; Georgia Research Alliance	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; [Anonymous], 2006, NIPS; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Gao D, 2007, BOTTOM UP SALIENCY D; Gao DS, 2009, IEEE T PATTERN ANAL, V31, P989, DOI 10.1109/TPAMI.2009.27; Gao DS, 2009, NEURAL COMPUT, V21, P239, DOI 10.1162/neco.2009.11-06-391; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Hoyer PO, 2000, NETWORK-COMP NEURAL, V11, P191, DOI 10.1088/0954-898X/11/3/302; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kayser C, 2003, NEURAL COMPUT, V15, P1751, DOI 10.1162/08997660360675026; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Olmos A., 2004, MCGILL CALIBRATED CO; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Seo HJ, 2009, J VISION, V9, DOI 10.1167/9.12.15; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; Wolfe J. M., 2007, INTEGRATED MODELS CO, V10, P99, DOI [DOI 10.1093/ACPROF:OSO/9780195189193.003.0008, 10.1093/acprof:oso/9780195189193.003.0008]; Zhang L., 2009, P 31 ANN COGN SCI C, P2944; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15796	10.1371/journal.pone.0015796	http://dx.doi.org/10.1371/journal.pone.0015796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209963	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200056
J	Zhang, T; Black, S; Hao, CL; Ding, YF; Ji, W; Chen, R; Lin, YZ; Eskola, J; Shinefield, H; Knoll, MD; Zhao, GM				Zhang, Tao; Black, Steven; Hao, Chuangli; Ding, Yunfang; Ji, Wei; Chen, Rong; Lin, Yuzun; Eskola, Juhani; Shinefield, Henry; Knoll, Maria Delorian; Zhao, Genming			The Blind NasoTracheal Aspiration Method Is Not a Useful Tool for Pathogen Detection of Pneumonia in Children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; PEDIATRIC-PATIENTS; URINE SAMPLES; ANTIGEN; CULTURE; CATARRHALIS; INFECTIONS; DIAGNOSIS	Background: Acute lower respiratory infection (ALRI) is a major cause of hospitalization for children in China, while the etiological diagnosis of ALRI remains a challenge. This study was performed to evaluate the utility of the blind Nasotracheal aspiration (NTA) in the pathogen detection in ALRI through an evaluation of the test's specificity. Methodology/Principal Findings: A hospital-based study of children <= 3 years was carried out from March 2006 through March 2007 in Suzhou University Affiliated Children's Hospital, including 379 cases with ALRI from the respiratory wards, and 394 controls receiving elective surgery. Nasopharyngeal swabs (NPS) and NTA specimens were taken on admission. S. pneumoniae was isolated from 10.3% of NTA samples from ALRI children, H. influenzae from 15.3%, and M. catarrhalis from 4.7%. The false positive rate-the strains from NTA in control group children-was 8.4% (95% CI: 5.8%-11.4%) for S. pneumoniae, 27.2% (95% CI: 22.7-31.5%) for H. influenzae, and 22.1% (95% CI: 18.0%-26.2%) for M. catarrhalis. The agreement between NPS and NTA in the control group was over 70%. Conclusion/Significance: The blind NTA test is not a useful test for etiologic diagnosis of ALRI.	[Zhang, Tao; Chen, Rong; Lin, Yuzun; Zhao, Genming] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA; [Hao, Chuangli; Ding, Yunfang; Ji, Wei] Suzhou Univ, Childrens Hosp, Suzhou 215006, Peoples R China; [Eskola, Juhani] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Shinefield, Henry] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Knoll, Maria Delorian] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Fudan University; Cincinnati Children's Hospital Medical Center; Soochow University - China; Finland National Institute for Health & Welfare; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, T (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China.	gmzhao@shmu.edu.cn		Deloria Knoll, Maria/0000-0001-9041-2671	Johns Hopkins University; Glaxo Smith Kline; Shanghai Leading Academic Discipline Project [B118]	Johns Hopkins University(Johns Hopkins University); Glaxo Smith Kline(GlaxoSmithKline); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was funded by a grant from the Pneumo ADIP program of Johns Hopkins University and by an unrestricted grant from Glaxo Smith Kline. This research was supported by Shanghai Leading Academic Discipline Project as well, the Project Number: B118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekmann SE, 2005, INT J ANTIMICROB AG, V25, P148, DOI 10.1016/j.ijantimicag.2004.09.016; Che DD., 2004, CHIN J CONT PEDIAT, V6, P136; Clements H, 1996, BRIT MED J, V313, P757; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; HUA CZ, 2006, CHIN J CONT PEDIAT, V8, P365; LENTINO JR, 1987, J CLIN MICROBIOL, V25, P758, DOI 10.1128/JCM.25.5.758-762.1987; LI H, 2006, J CHINESE PHYS, V18; Michelow IC, 2002, CLIN INFECT DIS, V34, pE1, DOI 10.1086/324358; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Perera Antoinette, 1998, Ceylon Medical Journal, V43, P200; QIN M, 2005, JIANGSU MED J, V35, P330; Roson B, 2004, CLIN INFECT DIS, V38, P222, DOI 10.1086/380639; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; SHENG CK, 2004, J CLIN PEDIAT, V22, P94; TANG LX, 2006, GUANGXI MED J, V28, P1926; VONGRAEVENITZ A, 1981, SOUTHERN MED J, V74, P1095, DOI 10.1097/00007611-198109000-00021; ZHAO GC, 2003, CHIN J INFECT CHEMOT, V3, P134; Zhao GM, 2003, PEDIATR INFECT DIS J, V22, P739, DOI 10.1097/01.inf.0000078373.54515.40; ZHAO GM, 2006, 5 INT S PNEUM PNEUM	20	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15885	10.1371/journal.pone.0015885	http://dx.doi.org/10.1371/journal.pone.0015885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209964	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200066
J	Wang, YQ; Buell, AK; Wang, XY; Welland, ME; Dobson, CM; Knowles, TPJ; Perrett, S				Wang, Yi-Qian; Buell, Alexander K.; Wang, Xin-Yu; Welland, Mark E.; Dobson, Christopher M.; Knowles, Tuomas P. J.; Perrett, Sarah			Relationship between Prion Propensity and the Rates of Individual Molecular Steps of Fibril Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; SACCHAROMYCES-CEREVISIAE; AMYLOID FIBRILS; PROTEIN URE2; YEAST URE2P; SEEDING SPECIFICITY; ALZHEIMERS-DISEASE; SPECIES BARRIERS; NUCLEATION; DOMAIN	Peptides and proteins possess an inherent propensity to self-assemble into generic fibrillar nanostructures known as amyloid fibrils, some of which are involved in medical conditions such as Alzheimer disease. In certain cases, such structures can self-propagate in living systems as prions and transmit characteristic traits to the host organism. The mechanisms that allow certain amyloid species but not others to function as prions are not fully understood. Much progress in understanding the prion phenomenon has been achieved through the study of prions in yeast as this system has proved to be experimentally highly tractable; but quantitative understanding of the biophysics and kinetics of the assembly process has remained challenging. Here, we explore the assembly of two closely related homologues of the Ure2p protein from Saccharomyces cerevisiae and Saccharomyces paradoxus, and by using a combination of kinetic theory with solution and biosensor assays, we are able to compare the rates of the individual microscopic steps of prion fibril assembly. We find that for these proteins the fragmentation rate is encoded in the structure of the seed fibrils, whereas the elongation rate is principally determined by the nature of the soluble precursor protein. Our results further reveal that fibrils that elongate faster but fracture less frequently can lose their ability to propagate as prions. These findings illuminate the connections between the in vitro aggregation of proteins and the in vivo proliferation of prions, and provide a framework for the quantitative understanding of the parameters governing the behavior of amyloid fibrils in normal and aberrant biological pathways.	[Buell, Alexander K.; Welland, Mark E.; Knowles, Tuomas P. J.] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England; [Wang, Yi-Qian; Wang, Xin-Yu; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Xin-Yu] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Dobson, Christopher M.; Knowles, Tuomas P. J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Wang, Yi-Qian] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	University of Cambridge; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; University of Cambridge; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Knowles, TPJ (corresponding author), Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England.	tpjk2@cam.ac.uk; sarah.perrett@cantab.net	Buell, Alexander/B-4155-2013; Knowles, Tuomas/C-6663-2009; 王, 新宇/B-1043-2012; Perrett, Sarah/AAS-9483-2020; Wang, Xin/AAN-8435-2021	Buell, Alexander/0000-0003-1161-3622; Knowles, Tuomas/0000-0002-7879-0140; 王, 新宇/0000-0002-2681-4614; Perrett, Sarah/0000-0003-0137-0997; Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [30620130109, 30670428, 30870482, 31070656]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]; IRC in Nanotechnology; Wellcome and Leverhulme Trusts; St John's College, Cambridge; Science and Innovation Section of the Foreign & Commonwealth Office; Royal Society; Medical Research Council [MC_G1000734] Funding Source: researchfish; MRC [MC_G1000734] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); IRC in Nanotechnology; Wellcome and Leverhulme Trusts; St John's College, Cambridge; Science and Innovation Section of the Foreign & Commonwealth Office; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the National Natural Science Foundation of China (30620130109, 30670428, 30870482, 31070656), the Chinese Ministry of Science and Technology (2006CB500703, 2006CB910903) and the Chinese Academy of Sciences (KSCX2-YW-R-119, KSCX2-YW-R-256) (to S. P.), as well as support from the IRC in Nanotechnology (to M. E. W. and A. K. B.), the Wellcome and Leverhulme Trusts (to C. M. D.), and St John's College, Cambridge (to T. P. J. K.). The initial stages of this work were supported by a "UK China Partners in Science II"' fund award from the Science and Innovation Section of the Foreign & Commonwealth Office (to T. P. J. K.). This work was facilitated by a Royal Society International Joint Project Grant (to Laura Itzhaki and S. P.).	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Crapeau M, 2009, MOL BIOL CELL, V20, P2286, DOI 10.1091/mbc.E08-11-1097; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fay N, 2003, J BIOL CHEM, V278, P30199, DOI 10.1074/jbc.M303000200; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hovgaard MB, 2007, BIOPHYS J, V93, P2162, DOI 10.1529/biophysj.107.109686; Immel F, 2007, J BIOL CHEM, V282, P7912, DOI 10.1074/jbc.M608652200; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2007, P NATL ACAD SCI USA, V104, P10016, DOI 10.1073/pnas.0610659104; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kunes KC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051915; Lian HY, 2006, BBA-PROTEINS PROTEOM, V1764, P535, DOI 10.1016/j.bbapap.2005.11.016; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Masel J, 2004, BIOPHYS J, V87, P728, DOI 10.1529/biophysj.104.039867; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poschel T, 2003, BIOPHYS J, V85, P3460, DOI 10.1016/S0006-3495(03)74767-5; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Talarek N, 2005, GENETICS, V171, P23, DOI 10.1534/genetics.105.043489; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; White DA, 2009, FEBS LETT, V583, P2587, DOI 10.1016/j.febslet.2009.06.008; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zhang ZR, 2009, J BIOL CHEM, V284, P14058, DOI 10.1074/jbc.M901189200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	56	27	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208934	http://dx.doi.org/10.1074/jbc.M110.208934			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21233211	Green Published, hybrid			2022-12-25	WOS:000289077500025
J	Esser, J; Gehrmann, U; Salvado, MD; Wetterholm, A; Haeggstrom, JZ; Samuelsson, B; Gabrielsson, S; Scheynius, A; Radmark, O				Esser, Julia; Gehrmann, Ulf; Salvado, M. Dolores; Wetterholm, Anders; Haeggstrom, Jesper Z.; Samuelsson, Bengt; Gabrielsson, Susanne; Scheynius, Annika; Radmark, Olof			Zymosan suppresses leukotriene C-4 synthase activity in differentiating monocytes: antagonism by aspirin and protein kinase inhibitors	FASEB JOURNAL			English	Article						acetylsalicylic acid; eicosanoids; macrophages; Toll-like receptor 2	REGULATES 5-LIPOXYGENASE ACTIVITY; COLONY-STIMULATING FACTOR; GROWTH-FACTOR-BETA; TRANSCELLULAR BIOSYNTHESIS; CYSTEINYL-LEUKOTRIENES; DENDRITIC CELLS; IN-VIVO; PERITONEAL-MACROPHAGES; EICOSANOID GENERATION; PHOSPHOLIPASE A(2)	Cysteinyl leukotrienes (cysLTs) are potent proinflammatory mediators with particular relevance for asthma. However, control of cysLT biosynthesis in the time period after onset of acute inflammation has not been extensively studied. As a model for later phases of inflammation, we investigated regulation of leukotriene (LT) C-4 synthase (LTC4S) in differentiating monocytes, exposed for several days to fungal zymosan. Incubations with LTA(4) revealed 20-fold increased LTC4S activity during differentiation of monocytic Mono Mac 6 (MM6) cells, which was reduced by 80% in the presence of zymosan (25 mu g/ml, 96 h). Zymosan (48 h) similarly attenuated LTC4S activity of primary human monocyte-derived macrophages and dendritic cells. Several findings indicate phosphoregulation of LTC4S: increased activity during MM6 cell differentiation correlated with reduced phosphorylation of 70-kDa ribosomal protein S6 kinase (p70S6K), which could phosphorylate purified LTC4S; the p70S6K inhibitor rapamycin (20 nM) doubled LTC4S activity of undifferentiated MM6 cells, and protein kinase A and C inhibitors (H-89, CGP-53353, and staurosporine) reversed the zymosan-induced suppression of LTC4S activity. Finally, zymosan (48 h) up-regulated PGE(2) biosynthesis, and aspirin (10 mu M) or prostaglandin E-2 (PGE(2)) receptor antagonists counteracted the zymosan effect. Our results suggest a late PGE(2)-mediated phosphoregulation of LTC4S during microbial exposure, which may contribute to resolution of inflammation, with implications for aspirin hypersensitivity.-Esser, J., Gehrmann, U., Salvado, M. D., Wetterholm, A., Haeggstrom, J. Z., Samuelsson, B., Gabrielsson, S., Scheynius, A., Radmark, O. Zymosan suppresses leukotriene C-4 synthase activity in differentiating monocytes: antagonism by aspirin and protein kinase inhibitors. FASEB J. 25, 1417-1427 (2011). www.fasebj.org	[Esser, Julia; Salvado, M. Dolores; Wetterholm, Anders; Haeggstrom, Jesper Z.; Samuelsson, Bengt; Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden; [Gehrmann, Ulf; Gabrielsson, Susanne; Scheynius, Annika] Karolinska Inst, Clin Allergy Res Unit, Dept Med Solna, S-17177 Stockholm, Sweden; [Gehrmann, Ulf; Gabrielsson, Susanne; Scheynius, Annika] Univ Hosp Solna, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Radmark, O (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden.	olof.radmark@ki.se	Gabrielsson, S./E-4145-2014; Sobrido, Maria/D-6697-2016	Gabrielsson, S./0000-0003-1771-1346; Sobrido, Maria/0000-0003-2060-4410; Esser-von Bieren, Julia/0000-0003-1898-9382	Swedish Research Council; European Union [FP7-Health-201668]; Vardal Foundation; Centre for Allergy Research at Karolinska Institutet; Vinnova consortium [2007-01999]; Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Swedish Heart-Lung Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Vardal Foundation; Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); Vinnova consortium(Vinnova); Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet)	The authors thank Gudrun Tibbelin (Karolinska Institutet, Stockholm, Sweden) for providing purified LTC<INF>4</INF>S. This work was supported by grants from the Swedish Research Council, European Union (FP7-Health-201668), the Vardal Foundation, the Centre for Allergy Research at Karolinska Institutet, the Vinnova consortium (2007-01999), the Swedish Asthma and Allergy Association's Research Foundation, the Cancer and Allergy Foundation, and the Swedish Heart-Lung Foundation and by Karolinska Institutet. The authors have no conflicting financial interests.	ALI A, 1994, J IMMUNOL, V153, P776; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Brock TG, 2003, PROSTAG OTH LIPID M, V71, P131, DOI 10.1016/S1098-8823(03)00036-4; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Buentke E, 2001, CLIN EXP ALLERGY, V31, P1583, DOI 10.1046/j.1365-2222.2001.01199.x; COFFEY M, J LIPID MEDIAT, V6, P43; CZOP JK, 1985, P NATL ACAD SCI USA, V82, P2751, DOI 10.1073/pnas.82.9.2751; DAHLEN SE, 1986, RESPIRATION, V50, P22, DOI 10.1159/000195097; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Farooque SP, 2009, ANNU REV PHYSIOL, V71, P465, DOI 10.1146/annurev.physiol.010908.163114; FAULER J, 1994, ARTHRITIS RHEUM-US, V37, P93, DOI 10.1002/art.1780370114; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge Helen S., 2008, V183, P87; Gupta N, 1999, FEBS LETT, V449, P66, DOI 10.1016/S0014-5793(99)00397-X; Hackstein H, 2001, J IMMUNOL, V166, P7053, DOI 10.4049/jimmunol.166.12.7053; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Harizi H, 2003, J IMMUNOL, V170, P139, DOI 10.4049/jimmunol.170.1.139; Harizi H, 2011, IMMUNOL CELL BIOL, V89, P275, DOI 10.1038/icb.2010.94; Heberden C, 1998, GEN PHARMACOL-VASC S, V30, P145, DOI 10.1016/S0306-3623(97)00271-1; KARGMAN S, 1994, MOL PHARMACOL, V45, P1043; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Martelli AM, 2010, HISTOL HISTOPATHOL, V25, P669, DOI 10.14670/HH-25.669; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Peiretti F, 2001, J BIOL CHEM, V276, P32214, DOI 10.1074/jbc.M103357200; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Planaguma A, 2002, FASEB J, V16, P1937, DOI 10.1096/fj.02-0224fje; Riddick CA, 1999, J IMMUNOL, V162, P1101; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Sala A, 1997, J PHYSIOL PHARMACOL, V48, P665; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schaloske RH, 2005, BBA-MOL CELL BIOL L, V1687, P64, DOI 10.1016/j.bbalip.2004.11.005; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sjolinder M, 1995, FEBS LETT, V377, P87, DOI 10.1016/0014-5793(95)01303-2; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Thivierge M, 2009, J IMMUNOL, V183, P6778, DOI 10.4049/jimmunol.0901800; TORNHAMRE S, 1995, EUR J BIOCHEM, V234, P513, DOI 10.1111/j.1432-1033.1995.513_b.x; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Werz O, 2001, BLOOD, V97, P2487, DOI 10.1182/blood.V97.8.2487; Wetterholm A, 2008, PROTEIN EXPRES PURIF, V60, P1, DOI 10.1016/j.pep.2008.03.005; WILLIAMS JD, 1985, J IMMUNOL, V134, P2624; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	62	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1417	1427		10.1096/fj.10-175828	http://dx.doi.org/10.1096/fj.10-175828			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21228223				2022-12-25	WOS:000288982800030
J	Huang, M; Whang, P; Chodaparambil, JV; Pollyea, DA; Kusler, B; Xu, LW; Felsher, DW; Mitchell, BS				Huang, Min; Whang, Patrick; Chodaparambil, Jayanth V.; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.			Reactive Oxygen Species Regulate Nucleostemin Oligomerization and Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; REDOX REGULATION; C-MYC; DNA-DAMAGE; GENETIC INSTABILITY; OXIDATIVE STRESS; MOLECULAR-BASIS; ROS PRODUCTION; MECHANISM; PROGRESSION	Nucleostemin (NS) is a nucleolar-nucleoplasmic shuttle protein that regulates cell proliferation, binds p53 and Mdm2, and is highly expressed in tumor cells. We have identified NS as a target of oxidative regulation in transformed hematopoietic cells. NS oligomerization occurs in HL-60 leukemic cells and Raji B lymphoblasts that express high levels of c-Myc and have high intrinsic levels of reactive oxygen species (ROS); reducing agents dissociate NS into monomers and dimers. Exposure of U2OS osteosarcoma cells with low levels of intrinsic ROS to hydrogen peroxide (H2O2) induces thiol-reversible disulfide bond-mediated oligomerization of NS. Increased exposure to H2O2 impairs NS degradation, immobilizes the protein within the nucleolus, and results in detergent-insoluble NS. The regulation of NS by ROS was validated in a murine lymphoma tumor model in which c-Myc is overexpressed and in CD34+ cells from patients with chronic myelogenous leukemia in blast crisis. In both instances, increased ROS levels were associated with markedly increased expression of NS protein and thiol-reversible oligomerization. Site-directed mutagenesis of critical cysteine-containing regions of nucleostemin altered both its intracellular localization and its stability. MG132, a potent proteasome inhibitor and activator of ROS, markedly decreased degradation and increased nucleolar retention of NS mutants, whereas N-acetyl-L-cysteine largely prevented the effects of MG132. These results indicate that NS is a highly redox-sensitive protein. Increased intracellular ROS levels, such as those that result from oncogenic transformation in hematopoietic malignancies, regulate the ability of NS to oligomerize, prevent its degradation, and may alter its ability to regulate cell proliferation.	[Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Chodaparambil, Jayanth V.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University	Mitchell, BS (corresponding author), Stanford Univ, Sch Med, Stanford Canc Ctr, LLSC Res Bldg SIM1,Rm 2167,265 Campus Dr, Stanford, CA 94305 USA.	bmitchell@stanford.edu	Chodaparambil, Jayanth V/F-3229-2015	Chodaparambil, Jayanth/0000-0002-4217-8355	Leukemia and Lymphoma Society; American Heart Association	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association)	This work was supported by a SCOR Award and a Translational Award from the Leukemia and Lymphoma Society. This work was also supported by a Western States Postdoctoral Fellowship from the American Heart Association (to J. V. C.).	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cerimele F, 2005, P NATL ACAD SCI USA, V102, P175, DOI 10.1073/pnas.0408381102; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Herrmann JM, 2008, BBA-MOL CELL RES, V1783, P519, DOI 10.1016/j.bbamcr.2008.03.002; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Singh Raj K, 2009, Hematol Oncol Stem Cell Ther, V2, P285; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Reyk DM, 2001, FREE RADICAL BIO MED, V30, P82, DOI 10.1016/S0891-5849(00)00449-4; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	49	12	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11035	11046		10.1074/jbc.M110.208470	http://dx.doi.org/10.1074/jbc.M110.208470			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21242306	hybrid, Green Published			2022-12-25	WOS:000288797100015
J	Zhou, J; Yang, Z; Tsuji, T; Gong, J; Xie, J; Chen, C; Li, W; Amar, S; Luo, Z				Zhou, J.; Yang, Z.; Tsuji, T.; Gong, J.; Xie, J.; Chen, C.; Li, W.; Amar, S.; Luo, Z.			LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth	ONCOGENE			English	Article						AMPK; LITAF; TNFSF15; p53; tumor suppressor; tumorigenesis	TNF-ALPHA FACTOR; ACTIVATED PROTEIN-KINASE; PROSTATE-CANCER CELLS; MARIE-TOOTH-DISEASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; SIMPLE MUTATION; CYTOKINE	Lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF) a factor (LITAF) is a multiple functional molecule whose sequence is identical to the small integral membrane protein of the lysosome/ late endosome. LITAF was initially identified as a transcription factor that activates transcription of proinflammatory cytokine in macrophages in response to LPS. Mutations of the LITAF gene are associated with a genetic disease, called Charcot-Marie-Tooth syndrome. Recently, we have reported that mRNA levels of LITAF and TNF superfamily member 15 (TNFSF15) are upregulated by 50 adenosine monophosphate (AMP)-activated protein kinase (AMPK). The present study further assesses their biological functions. Thus, we show that 5-aminoimidazole4- carboxamide ribonucleoside (AICAR), a pharmacological activator of AMPK, increases the abundance of LITAF and TNFSF15 in LNCaP and C4-2 prostate cancer cells, which is abrogated by small hairpin RNA (shRNA) or the dominant-negative mutant of AMPK a1 subunit. Our data further demonstrate that AMPK activation upregulates the transcription of LITAF. Intriguingly, silencing LITAF by shRNA enhances proliferation, anchorageindependent growth of these cancer cells and tumor growth in the xenograft model. In addition, our study reveals that LITAF mediates the effect of AMPK by binding to a specific sequence in the promoter region. Furthermore, we show that TNFSF15 remarkably inhibits the growth of prostate cancer cells and bovine aortic endothelial cells in vitro, with a more potent effect toward the latter. In conjuncture, intratumoral injection of TNFSF15 significantly reduces the size of tumors and number of blood vessels and induces changes that are characteristic of tumor cell differentiation. Therefore, our studies for the first time establish the regulatory axis of AMPK-LITAF-TNFSF15 and also suggest that LITAF may function as a tumor suppressor. Oncogene (2011) 30, 1892-1900; doi: 10.1038/onc.2010.575; published online 10 January 2011	[Zhou, J.; Gong, J.; Xie, J.; Li, W.; Luo, Z.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Yang, Z.] Shaanxi Normal Univ, Coll Life Sci, Dept Biochem & Mol Biol, Xian, Peoples R China; [Tsuji, T.; Chen, C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA; [Amar, S.] Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA	Boston University; Shaanxi Normal University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Luo, Z (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,Evans 645, Boston, MA 02118 USA.	zluo@bu.edu	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Amar, Salomon/0000-0002-0017-5930	NIH [R01 CA118918, R01 DE014079, CA124490]; NATIONAL CANCER INSTITUTE [R01CA124490, R01CA118918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by NIH grants (R01 CA118918 to ZL, R01 DE014079 to SA and CA124490 to CC). We thank Dr Zhixiong Xiao (BUMC) for providing p53 shRNA pSuperRetro construct as a generous gift. We are also thankful to Miss Siu Wong for her assistance in animal dissection, to Dr Wen Guo for helping us with confirmatory qPCR analysis and to Dr Mengwei Zang for her advice on statistical analysis.	Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Beauvais K, 2006, NEUROMUSCULAR DISORD, V16, P14, DOI 10.1016/j.nmd.2005.09.008; Bennett CL, 2004, ANN NEUROL, V55, P713, DOI 10.1002/ana.20094; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Haridas V, 1999, ONCOGENE, V18, P6496, DOI 10.1038/sj.onc.1203059; Hong YH, 2006, DEV COMP IMMUNOL, V30, P919, DOI 10.1016/j.dci.2005.12.007; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Latour P, 2006, J PERIPHER NERV SYST, V11, P148, DOI 10.1111/j.1085-9489.2006.00080.x; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Pan X, 2004, WORLD J GASTROENTERO, V10, P1409; Parr Christian, 2006, Angiogenesis, V9, P73, DOI 10.1007/s10456-006-9033-1; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Sethi G, 2009, ADV EXP MED BIOL, V647, P207, DOI 10.1007/978-0-387-89520-8_15; Stucchi A, 2006, INFLAMM BOWEL DIS, V12, P581, DOI 10.1097/01.MIB.0000225338.14356.d5; Tang XR, 2007, CANCER RES, V67, P1308, DOI 10.1158/0008-5472.CAN-06-1600; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200; Young HA, 2006, P NATL ACAD SCI USA, V103, P8303, DOI 10.1073/pnas.0602655103; Yue TL, 1999, J BIOL CHEM, V274, P1479, DOI 10.1074/jbc.274.3.1479; Zhai YF, 1999, INT J CANCER, V82, P131, DOI 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.3.CO;2-F; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	33	54	59	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	16					1892	1900		10.1038/onc.2010.575	http://dx.doi.org/10.1038/onc.2010.575			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21217782	Green Accepted			2022-12-25	WOS:000289777700005
J	Haneburger, I; Eichinger, A; Skerra, A; Jung, K				Haneburger, Ina; Eichinger, Andreas; Skerra, Arne; Jung, Kirsten			New Insights into the Signaling Mechanism of the pH-responsive, Membrane-integrated Transcriptional Activator CadC of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE DECARBOXYLASE; ACID INDUCTION; HOST STRAINS; PROTEIN; OPERON; DOMAIN; APOPTOSIS; GENE; DISSOCIATION; POLYMERASE	The membrane-integrated transcriptional regulator CadC of Escherichia coli activates expression of the cadBA operon at low external pH with concomitantly available lysine, providing adaptation to mild acidic stress. CadC is a representative of the ToxR-like proteins that combine sensory, signal transduction, and DNA-binding activities within a single polypeptide. Although several ToxR-like regulators such as CadC, as well as the main regulator of Vibrio cholerae virulence, ToxR itself, which activate gene expression at acidic pH, have been intensively investigated, their molecular activation mechanism is still unclear. In this study, a structure-guided mutational analysis was performed to elucidate the mechanism by which CadC detects acidification of the external milieu. Thus, a cluster of negatively charged amino acids (Asp-198, Asp-200, Glu-461, Glu-468, and Asp-471) was found to be crucial for pH detection. These amino acids form a negatively charged patch on the surface of the periplasmic domain of CadC that stretches across its two subdomains. The results of different combinations of amino acid replacements within this patch indicated that the N-terminal subdomain integrates and transduces the signals coming from both subdomains to the transmembrane domain. Alterations in the phospholipid composition did not influence pH-dependent cadBA expression, and therefore, interplay of the acidic surface patch with the negatively charged headgroups is unlikely. Models are discussed according to which protonation of these acidic amino acid side chains reduces repulsive forces between the two subdomains and/or between two monomers within a CadC dimer and thereby enables receptor activation upon lowering of the environmental pH.	[Jung, Kirsten] Univ Munich, Dept Biol 1, Biozentrum, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany; [Haneburger, Ina; Jung, Kirsten] Univ Munich, Dept Microbiol, D-82152 Martinsried, Germany; [Eichinger, Andreas; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany	University of Munich; University of Munich; Technical University of Munich	Jung, K (corresponding author), Univ Munich, Dept Biol 1, Biozentrum, Ctr Integrated Prot Sci Munich, Grosshadernerstr 2-4, D-82152 Martinsried, Germany.	jung@lmu.de	Skerra, Arne/A-2269-2013	Skerra, Arne/0000-0002-5717-498X	Deutsche Forschungsgemeinschaft [JU270/5-1, Exc114/1]; Elitenetzwerk Bayern research scholarship (BayEFG)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern research scholarship (BayEFG)	This work was supported by Deutsche Forschungsgemeinschaft Grants JU270/5-1 and Exc114/1 and by an Elitenetzwerk Bayern research scholarship (BayEFG) (to I.H.).	AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023; Dawson JE, 2009, P NATL ACAD SCI USA, V106, P8543, DOI 10.1073/pnas.0809138106; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DELL CL, 1994, MOL MICROBIOL, V14, P7, DOI 10.1111/j.1365-2958.1994.tb01262.x; EICHINGER A, 2011, PROTEIN SCI IN PRESS; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; HEACOCK PN, 1989, J BIOL CHEM, V264, P14972; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kuper C, 2005, J MOL MICROB BIOTECH, V10, P26, DOI 10.1159/000090346; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Miller JH., 1992, EXPT MOL GENETICS; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; Muller S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006930; NEELY MN, 1994, J BACTERIOL, V176, P3278, DOI 10.1128/jb.176.11.3278-3285.1994; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOZAKI Y, 1967, J BIOL CHEM, V242, P4731; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; PHAN APH, 1982, ANAL BIOCHEM, V120, P193, DOI 10.1016/0003-2697(82)90336-0; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Sambrook J, 1989, MOL CLONING LABORATO; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; WATSON N, 1992, J BACTERIOL, V174, P530, DOI 10.1128/jb.174.2.530-540.1992; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909	41	42	42	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10681	10689		10.1074/jbc.M110.196923	http://dx.doi.org/10.1074/jbc.M110.196923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21216950	Green Published, hybrid			2022-12-25	WOS:000288547000082
J	Sakami, S; Maeda, T; Bereta, G; Okano, K; Golczak, M; Sumaroka, A; Roman, AJ; Cideciyan, AV; Jacobson, SG; Palczewski, K				Sakami, Sanae; Maeda, Tadao; Bereta, Grzegorz; Okano, Kiichiro; Golczak, Marcin; Sumaroka, Alexander; Roman, Alejandro J.; Cideciyan, Artur V.; Jacobson, Samuel G.; Palczewski, Krzysztof			Probing Mechanisms of Photoreceptor Degeneration in a New Mouse Model of the Common Form of Autosomal Dominant Retinitis Pigmentosa due to P23H Opsin Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC RAT MODEL; XENOPUS-LAEVIS MODEL; LIGHT-INDUCED DAMAGE; RETINAL DEGENERATION; RHODOPSIN MUTATIONS; DISK MORPHOGENESIS; OUTER SEGMENT; MONOCLONAL-ANTIBODIES; DISEASE PROGRESSION; MOLECULAR-GENETICS	Rhodopsin, the visual pigment mediating vision under dim light, is composed of the apoprotein opsin and the chromophore ligand 11-cis-retinal. A P23H mutation in the opsin gene is one of the most prevalent causes of the human blinding disease, autosomal dominant retinitis pigmentosa. Although P23H cultured cell and transgenic animal models have been developed, there remains controversy over whether they fully mimic the human phenotype; and the exact mechanism by which this mutation leads to photoreceptor cell degeneration remains unknown. By generating P23H opsin knock-in mice, we found that the P23H protein was inadequately glycosylated with levels 1-10% that of wild type opsin. Moreover, the P23H protein failed to accumulate in rod photoreceptor cell endoplasmic reticulum but instead disrupted rod photoreceptor disks. Genetically engineered P23H mice lacking the chromophore showed accelerated photoreceptor cell degeneration. These results indicate that most synthesized P23H protein is degraded, and its retinal cytotoxicity is enhanced by lack of the 11-cis-retinal chromophore during rod outer segment development.	[Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Vis Sci, Cleveland, OH 44106 USA; [Sumaroka, Alexander; Roman, Alejandro J.; Cideciyan, Artur V.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Case Western Reserve University; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Imanishi, Sanae/0000-0001-9884-2123; Jacobson, Samuel/0000-0003-2122-169X	National Institutes of Health [K08EY019880, EY019031, EY009339, R24 EY021126, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, K08EY019031, K08EY019880, R24EY021126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019880, K08EY019880, EY019031, EY009339, R24 EY021126, and P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; COHEN AI, 1960, AM J ANAT, V107, P23, DOI 10.1002/aja.1001070103; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Iannaccone A, 2004, INVEST OPHTH VIS SCI, V45, P784, DOI 10.1167/iovs.03-0906; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; John SK, 2000, MOL VIS, V6, P204; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu XR, 1997, J CELL SCI, V110, P2589; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; MASSOF R, 1987, 2 STAGE HYPOTHESIS N, V62, P29; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Sakami S, 2008, MECH DEVELOP, V125, P106, DOI 10.1016/j.mod.2007.10.001; Saliba RS, 2002, J CELL SCI, V115, P2907; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; STONE EM, 1991, OPHTHALMOLOGY, V98, P1806; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SZEL A, 1993, INVEST OPHTH VIS SCI, V34, P3641; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2010, INVEST OPHTH VIS SCI, V51, P1327, DOI 10.1167/iovs.09-4123; To K, 2002, AM J OPHTHALMOL, V134, P290, DOI 10.1016/S0002-9394(02)01545-3; VAUGHAN DK, 1989, INVEST OPHTH VIS SCI, V30, P339; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Walsh N, 2004, BRAIN RES, V1013, P194, DOI 10.1016/j.brainres.2004.04.030; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	92	173	184	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10551	10567		10.1074/jbc.M110.209759	http://dx.doi.org/10.1074/jbc.M110.209759			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21224384	Green Published, hybrid			2022-12-25	WOS:000288547000071
J	Chen, S; Wei, HM; Lv, WW; Wang, DL; Sun, FL				Chen, Su; Wei, Hui-Min; Lv, Wen-Wen; Wang, Da-Liang; Sun, Fang-Lin			E2 Ligase dRad6 Regulates DMP53 Turnover in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; TUMOR-SUPPRESSOR P53; HISTONE H2B MONOUBIQUITINATION; DAMAGE-INDUCED RESPONSE; DNA-BINDING PROTEIN; REPAIR GENE RAD6; ACTIVITY IN-VIVO; YEAST RAD6; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION	The turnover of tumor suppressor p53 is critical for its role in various cellular events. However, the pathway that regulates the turnover of the Drosophila melanogaster DMP53 is largely unknown. Here, we provide evidence for the first time that the E2 ligase, Drosophila homolog of Rad6 (dRad6/Dhr6), plays an important role in the regulation of DMP53 turnover. Depletion of dRad6 results in DMP53 accumulation, whereas overexpression of dRad6 causes enhanced DMP53 degradation. We show that dRad6 specifically interacts with DMP53 at the transcriptional activation domain and regulates DMP53 ubiquitination. Loss of dRad6 function in transgenic flies leads to lethalities and altered morphogenesis. The dRad6-induced defects in cell proliferation and apoptosis are found to be DMP53-dependent. The loss of dRad6 induces an accumulation of DMP53 that enhances the activation of apoptotic genes and leads to apoptosis in the presence of stress stimuli. In contrast to that, the E3 ligase is the primary factor that regulates p53 turnover in mammals, and this work demonstrates that the E2 ligase dRad6 is critical for the control of DMP53 degradation in Drosophila.	[Chen, Su; Wei, Hui-Min; Lv, Wen-Wen; Wang, Da-Liang; Sun, Fang-Lin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Sun, Fang-Lin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Sun, FL (corresponding author), Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Med Sci Bldg C-315, Beijing 100084, Peoples R China.	sfl@tsinghua.edu.cn	Chen, Su/J-5130-2012		Chinese National Science Foundation [30625017]; Ministry of Science and Technology [2011CB965300, 2007CB948101, 2009CB825603]; Yu-Yuan Foundation; Wu-Shun-De Foundation of Tsinghua University	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Yu-Yuan Foundation; Wu-Shun-De Foundation of Tsinghua University	This work was supported by National Grant "Jie-Chu-Qing-Nian-Ke-Xue Fund" from the Chinese National Science Foundation 30625017, National "973" Grants from the Ministry of Science and Technology 2011CB965300, 2007CB948101, and 2009CB825603, and a start-up grant from the Yu-Yuan Foundation and the Wu-Shun-De Foundation of Tsinghua University.	Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Arama E, 2006, NAT PROTOC, V1, P1725, DOI 10.1038/nprot.2006.235; Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brooks CL, 2004, CELL CYCLE, V3, P895; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; KASTAN MB, 1991, CANCER RES, V51, P4279; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lane David P., 1992, Current Biology, V2, P581, DOI 10.1016/0960-9822(92)90154-3; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KY, 2008, MOL CELLS, V26, P5; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Nordstrom W, 2000, CELL DEATH DIFFER, V7, P1035, DOI 10.1038/sj.cdd.4400766; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Steller H, 2000, NAT CELL BIOL, V2, pE100, DOI 10.1038/35014093; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	81	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9020	9030		10.1074/jbc.M110.190314	http://dx.doi.org/10.1074/jbc.M110.190314			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21205821	Green Published, hybrid			2022-12-25	WOS:000288247700033
J	Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S				Cuomo, Maria Emanuela; Platt, Georgina M.; Pearl, Laurence H.; Mittnacht, Sibylle			Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; 68 V-CYCLIN; STRUCTURAL BASIS; CELL-CYCLE; CDK INHIBITOR; CRYSTAL-STRUCTURE; RETINOBLASTOMA PROTEIN; RECRUITMENT PEPTIDES; INK4 INHIBITORS; VIRAL CYCLIN	Cyclin/cyclin-dependent kinase (CDK) complexes are critical regulators of cellular proliferation. A complex network of regulatory mechanisms has evolved to control their activity, including activating and inactivating phosphorylation of the catalytic CDK subunit and inhibition through specific regulatory proteins. Primate herpesviruses, including the oncogenic Kaposi sarcoma herpesvirus, encode cyclin D homologues. Viral cyclins have diverged from their cellular progenitor in that they elicit holoenzyme activity independent of activating phosphorylation by the CDK-activating kinase and resistant to inhibition by CDK inhibitors. Using sequence comparison and site-directed mutagenesis, we performed molecular analysis of the cellular cyclin D and the Kaposi sarcoma herpesvirus-cyclin to delineate the molecular mechanisms behind their different behavior. This provides evidence that a surface recognized for its involvement in the docking of CIP/KIP inhibitors is required and sufficient to modulate cyclin-CDK response to a range of regulatory cues, including INK4 sensitivity and CDK-activating kinase dependence. Importantly, amino acids in this region are critically linked to substrate selection, suggesting that a mutational drift in this surface simultaneously affects function and regulation. Together our work provides novel insight into the molecular mechanisms governing cyclin-CDK function and regulation and defines the biological forces that may have driven evolution of viral cyclins.	[Cuomo, Maria Emanuela; Platt, Georgina M.; Mittnacht, Sibylle] Inst Canc Res, Sect Cell & Mol Biol, London SW3 6JB, England; [Pearl, Laurence H.] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Cuomo, ME (corresponding author), UCL Canc Inst, 72 Huntley St, London WC1E 6BT, England.	m.cuomo@ucl.ac.uk		Pearl, Laurence/0000-0002-6910-1809	Cancer Research UK; Institute of Cancer Research	Cancer Research UK(Cancer Research UK); Institute of Cancer Research	This work was supported by Cancer Research UK (to S. M. and G. M. P.).; Recipient of an Institute of Cancer Research Ph.D. scholarship. To whom correspondence should be addressed: UCL Cancer Institute, 72 Huntley St., WC1E 6BT London, United Kingdom. Tel.: 44-207-1535140; Fax: 44-207-6796817; E-mail: m.cuomo@ucl.ac.uk.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Alba MM, 2001, GENOME RES, V11, P43, DOI 10.1101/gr.149801; Archambault V, 2005, CELL CYCLE, V4, P125, DOI 10.4161/cc.4.1.1402; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; Cuomo ME, 2005, J BIOL CHEM, V280, P35844, DOI 10.1074/jbc.M503877200; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Ellis M, 1999, EMBO J, V18, P644, DOI 10.1093/emboj/18.3.644; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Ferrer JL, 2006, CELL CYCLE, V5, P2760, DOI 10.4161/cc.5.23.3506; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Hoge AT, 2000, J VIROL, V74, P7016, DOI 10.1128/JVI.74.15.7016-7023.2000; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kaldis P, 2001, MOL BIOL CELL, V12, P3987, DOI 10.1091/mbc.12.12.3987; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lairmore MD, 2000, P NATL ACAD SCI USA, V97, P6114, DOI 10.1073/pnas.110024497; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Laman H, 2000, CURR OPIN GENET DEV, V10, P70, DOI 10.1016/S0959-437X(99)00045-3; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Mittnacht S, 2000, REV MED VIROL, V10, P175, DOI 10.1002/(SICI)1099-1654(200005/06)10:3<175::AID-RMV283>3.0.CO;2-F; Moore PS, 1998, TRENDS GENET, V14, P144, DOI 10.1016/S0168-9525(98)01408-5; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Schulze-Gahmen U, 2002, NAT STRUCT BIOL, V9, P177, DOI 10.1038/nsb756; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Van Dyk LF, 1999, J VIROL, V73, P5110, DOI 10.1128/JVI.73.6.5110-5122.1999; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	59	1	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9713	9725		10.1074/jbc.M110.173872	http://dx.doi.org/10.1074/jbc.M110.173872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233209	Green Published, hybrid			2022-12-25	WOS:000288247700095
J	Hussack, G; Arbabi-Ghahroudi, M; van Faassen, H; Songer, JG; Ng, KKS; MacKenzie, R; Tanha, J				Hussack, Greg; Arbabi-Ghahroudi, Mehdi; van Faassen, Henk; Songer, J. Glenn; Ng, Kenneth K. -S.; MacKenzie, Roger; Tanha, Jamshid			Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE IMMUNOGLOBULIN CONCENTRATE; HEAVY-CHAIN ANTIBODIES; MOUSE MONOCLONAL-ANTIBODIES; PHAGE-DISPLAY LIBRARIES; INTRAVENOUS IMMUNOGLOBULIN; PASSIVE-IMMUNIZATION; NONSPECIFIC-BINDING; CRYSTAL-STRUCTURE; IN-VIVO; FRAGMENTS	Clostridium difficile is a leading cause of nosocomial infection in North America and a considerable challenge to healthcare professionals in hospitals and nursing homes. The Gram-positive bacterium produces two high molecular weight exotoxins, toxin A (TcdA) and toxin B (TcdB), which are the major virulence factors responsible for C. difficile-associated disease and are targets for C. difficile-associated disease therapy. Here, recombinant single-domain antibody fragments (V(H)Hs), which specifically target the cell receptor binding domains of TcdA or TcdB, were isolated from an immune llama phage display library and characterized. Four V(H)Hs (A4.2, A5.1, A20.1, and A26.8), all shown to recognize conformational epitopes, were potent neutralizers of the cytopathic effects of toxin A on fibroblast cells in an in vitro assay. The neutralizing potency was further enhanced when V(H)Hs were administered in paired or triplet combinations at the same overall VHH concentration, suggesting recognition of nonoverlapping TcdA epitopes. Biacore epitope mapping experiments revealed that some synergistic combinations consisted of V(H)Hs recognizing overlapping epitopes, an indication that factors other than mere epitope blocking are responsible for the increased neutralization. Further binding assays revealed TcdA-specific V(H)Hs neutralized toxin A by binding to sites other than the carbohydrate binding pocket of the toxin. With favorable characteristics such as high production yield, potent toxin neutralization, and intrinsic stability, these V(H)Hs are attractive systemic therapeutics but are more so as oral therapeutics in the destabilizing environment of the gastrointestinal tract.	[Hussack, Greg; Arbabi-Ghahroudi, Mehdi; van Faassen, Henk; MacKenzie, Roger; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Hussack, Greg; Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Arbabi-Ghahroudi, Mehdi] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Songer, J. Glenn] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ 85721 USA; [Ng, Kenneth K. -S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Ng, Kenneth K. -S.] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Dept Environm Sci, Guelph, ON N1G 2W1, Canada	National Research Council Canada; University of Ottawa; Carleton University; University of Arizona; University of Calgary; University of Calgary; University of Guelph	Tanha, J (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Jamshid.Tanha@nrc-cnrc.gc.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Dow Agro Sciences	Dow Agro Sciences	This work was supported by Dow Agro Sciences. This is National Research Council Canada Publication Number 50010.	Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Cooke DL, 1998, INFECT IMMUN, V66, P1981, DOI 10.1128/IAI.66.5.1981-1984.1998; CORTHIER G, 1991, INFECT IMMUN, V59, P1192, DOI 10.1128/IAI.59.3.1192-1195.1991; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DEMAREST SJ, 2010, MABS, V2, P1; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Giannasca PJ, 1999, INFECT IMMUN, V67, P527, DOI 10.1128/IAI.67.2.527-538.1999; Goldman ER, 2008, ANAL CHEM, V80, P8583, DOI 10.1021/ac8014774; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2009, APPL MICROBIOL BIOT, V84, P1087, DOI 10.1007/s00253-009-2029-1; Harmsen MM, 2009, VACCINE, V27, P1904, DOI 10.1016/j.vaccine.2009.01.110; Hassoun Ali, 2007, Am J Geriatr Pharmacother, V5, P48, DOI 10.1016/j.amjopharm.2007.03.001; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Johal SS, 2004, J CLIN PATHOL, V57, P973, DOI 10.1136/jcp.2003.015875; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Juang P, 2007, AM J INFECT CONTROL, V35, P131, DOI 10.1016/j.ajic.2006.06.007; Katchar K, 2007, CLIN GASTROENTEROL H, V5, P707, DOI 10.1016/j.cgh.2007.02.025; Keel MK, 2007, VET PATHOL, V44, P814, DOI 10.1354/vp.44-6-814; Kelly CP, 1997, ANTIMICROB AGENTS CH, V41, P236, DOI 10.1128/AAC.41.2.236; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly CP, 1996, ANTIMICROB AGENTS CH, V40, P373, DOI 10.1128/AAC.40.2.373; KELLY CP, 1992, GASTROENTEROLOGY, V102, P35, DOI 10.1016/0016-5085(92)91781-X; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Koide A, 2007, J MOL BIOL, V373, P941, DOI 10.1016/j.jmb.2007.08.027; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; Leffler DA, 2009, GASTROENTEROLOGY, V136, P1899, DOI 10.1053/j.gastro.2008.12.070; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; Liu JL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-78; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1989, CURR MICROBIOL, V19, P303, DOI 10.1007/BF01570105; LYERLY DM, 1991, INFECT IMMUN, V59, P2215, DOI 10.1128/IAI.59.6.2215-2218.1991; LYERLY DM, 1990, CURR MICROBIOL, V21, P29, DOI 10.1007/BF02090096; LYERLY DM, 1986, INFECT IMMUN, V54, P70, DOI 10.1128/IAI.54.1.70-76.1986; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McPherson S, 2006, DIS COLON RECTUM, V49, P640, DOI 10.1007/s10350-006-0511-8; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Ochsner UA, 2009, J ANTIMICROB CHEMOTH, V63, P964, DOI 10.1093/jac/dkp042; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; Salnikova MS, 2008, J PHARM SCI-US, V97, P3735, DOI 10.1002/jps.21261; Songer J. Glenn, 2004, Animal Health Research Reviews, V5, P321, DOI 10.1079/AHR200492; Stewart CS, 2007, TOXICON, V49, P699, DOI 10.1016/j.toxicon.2006.11.023; Stone E, 2007, MOL IMMUNOL, V44, P2487, DOI 10.1016/j.molimm.2006.10.020; Tanha Jamshid, 2003, Methods Mol Med, V89, P435; Teh YHA, 2010, TRANSGENIC RES, V19, P575, DOI 10.1007/s11248-009-9338-0; Thomassen YE, 2005, J BIOTECHNOL, V118, P270, DOI 10.1016/j.jbiotec.2005.05.010; TJELLSTROM B, 1993, LANCET, V341, P701, DOI 10.1016/0140-6736(93)90477-X; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Ward SJ, 1999, INFECT IMMUN, V67, P5124, DOI 10.1128/IAI.67.10.5124-5132.1999; Warny M, 1999, GUT, V44, P212, DOI 10.1136/gut.44.2.212; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17	97	93	118	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8961	8976		10.1074/jbc.M110.198754	http://dx.doi.org/10.1074/jbc.M110.198754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216961	Green Published, hybrid			2022-12-25	WOS:000288247700028
J	An, S; Yeo, KJ; Jeon, YH; Song, JJ				An, Sojin; Yeo, Kwon Joo; Jeon, Young Ho; Song, Ji-Joon			Crystal Structure of the Human Histone Methyltransferase ASH1L Catalytic Domain and Its Implications for the Regulatory Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITHORAX-GROUP PROTEIN; SET DOMAIN; METHYLATION; KINASE; GENES; PRODUCT; REGION; H3	Absent, small, or homeotic disc1 (Ash1) is a trithorax group histone methyltransferase that is involved in gene activation. Although there are many known histone methyltransferases, their regulatory mechanisms are poorly understood. Here, we present the crystal structure of the human ASH1L catalytic domain, showing its substrate binding pocket blocked by a loop from the post-SET domain. In this configuration, the loop limits substrate access to the active site. Mutagenesis of the loop stimulates ASH1L histone methyltransferase activity, suggesting that ASH1L activity may be regulated through the loop from the post-SET domain. In addition, we show that human ASH1L specifically methylates histone H3 Lys-36. Our data implicate that there may be a regulatory mechanism of ASH1L histone methyltransferases.	[An, Sojin; Song, Ji-Joon] World Class Univ, Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, KI BioCentury,Dept Biol Sci,Struct Biol Lab Epige, Taejon 305701, South Korea; [Yeo, Kwon Joo; Jeon, Young Ho] KBSI, Div Magnet Resonance, Ochang 363883, Chungbuk, South Korea; [Yeo, Kwon Joo; Jeon, Young Ho] Univ Sci & Technol, Ochang 363883, Chungbuk, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI)	Song, JJ (corresponding author), World Class Univ, Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, KI BioCentury,Dept Biol Sci,Struct Biol Lab Epige, 335 Gwahangno, Taejon 305701, South Korea.	songj@kaist.ac.kr	Jeon, Young Ho/F-4483-2011; Song, Ji-Joon/C-1721-2011	Song, Ji-Joon/0000-0001-7120-6311	Korea Ministry of Education, Science and Technology; World Class University (WCU) [R31-2008-000-10071-0]; Ministry of Health, Welfare and Family Affairs [A100525]; Ministry of Education, Science and Technology;  [KRF-2010-007869];  [KRF-2010-0016263]	Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University (WCU); Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); ; 	This work was supported by the Brain Korea 21 (BK21) program from the Korea Ministry of Education, Science and Technology (to S. A.). This work was partially supported by the World Class University (WCU) program Grant R31-2008-000-10071-0 (to J.-J. S.), a grant from the Korea Healthcare Technology R&D project of the Ministry of Health, Welfare and Family Affairs (Grant A100525) and Grants KRF-2010-007869 and KRF-2010-0016263 (to J.-J. S.), and a grant from the High Field NMR Research Program (to Y. H. J.) awarded through the National Research Foundation of Korea and funded by the Ministry of Education, Science and Technology.	Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; LAJEUNESSE D, 1995, MECH DEVELOP, V53, P123, DOI 10.1016/0925-4773(95)00430-0; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1999, METH MOL B, V119, P1; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Simpson R. J., 2006, COLD SPRING HARB PRO; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tripoulas N, 1996, GENETICS, V143, P913; Yokoyama N, 2005, J BIOL CHEM, V280, P8893, DOI 10.1074/jbc.M412623200	25	89	95	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8369	8374		10.1074/jbc.M110.203380	http://dx.doi.org/10.1074/jbc.M110.203380			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239497	Green Published, hybrid			2022-12-25	WOS:000288013300065
J	Bradley, HJ; Baldwin, JM; Goli, GR; Johnson, B; Zou, J; Sivaprasadarao, A; Baldwin, SA; Jiang, LH				Bradley, Helen J.; Baldwin, Jocelyn M.; Goli, G. Ranjan; Johnson, Brian; Zou, Jie; Sivaprasadarao, Asipu; Baldwin, Stephen A.; Jiang, Lin-Hua			Residues 155 and 348 Contribute to the Determination of P2X(7) Receptor Function via Distinct Mechanisms Revealed by Single-nucleotide Polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; AMINO-ACID-RESIDUES; GAIN-OF-FUNCTION; P2X7 RECEPTOR; MICROGLIAL ACTIVATION; PURINERGIC RECEPTOR; ALA POLYMORPHISM; HUMAN MONOCYTES; ATP RECEPTOR; ION-CHANNEL	P2X(7) receptors are important in mediating the physiological functions of extracellular ATP, and altered receptor expression and function have a causative role in the disease pathogenesis. Here, we investigated the mechanisms determining the P2X(7) receptor function by following two human single-nucleotide polymorphism (SNP) mutations that replace His-155 and Ala-348 in the human (h) P2X(7) receptor with the corresponding residues, Tyr-155 and Thr-348, in the rat (r) P2X(7) receptor. H155Y and A348T mutations in the hP2X(7) receptor increased ATP-induced currents, whereas the reciprocal mutations, Y155H and T348A, in the rP2X(7) receptor caused the opposite effects. Such a functional switch is a compelling indication that these residues are critical for P2X(7) receptor function. Additional mutations of His-155 and Ala-348 in the hP2X(7) receptor to residues with diverse side chains revealed a different dependence on the side chain properties, supporting the specificity of these two residues. Substitutions of the residues surrounding His-155 and Ala-348 in the hP2X(7) receptor with the equivalent ones in the rP2X(7) receptor also affected ATP-induced currents but were not fully reminiscent of the H155Y and A348T effects. Immunofluorescence imaging and biotin labeling assays showed that H155Y in the hP2X(7) receptor increased and Y155H in the rP2X(7) receptor decreased cell-surface expression. Such contrasting effects were not obvious with the reciprocal mutations of residue 348. Taken together, our results suggest that residues at positions 155 and 348 contribute to P2X(7) receptor function via determining the surface expression and the single-channel function, respectively. Such interpretations are consistent with the locations of the residues in the structural model of the hP2X(7) receptor.	[Bradley, Helen J.; Baldwin, Jocelyn M.; Goli, G. Ranjan; Johnson, Brian; Zou, Jie; Sivaprasadarao, Asipu; Baldwin, Stephen A.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Jiang, Lin-Hua/D-2030-2010; Jiang, Lin-Hua/AAU-1078-2020	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Sivaprasadarao, Asipu/0000-0002-6755-3502	Biotechnology and Biological Science Research Council; Biotechnology and Biological Sciences Research Council [BB/D524875/1, BB/C517317/1] Funding Source: researchfish; BBSRC [BB/D524875/1, BB/C517317/1] Funding Source: UKRI	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Science Research Council.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Adriouch S, 2009, PURINERG SIGNAL, V5, P151, DOI 10.1007/s11302-009-9134-6; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Gorodeski GI, 2009, EXPERT OPIN THER TAR, V13, P1313, DOI 10.1517/14728220903277249; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; Hille B., 1992, IONIC CHANNELS EXCIT; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Moore SF, 2008, BIOCHEM PHARMACOL, V76, P1740, DOI 10.1016/j.bcp.2008.09.015; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Sluyter R, 2007, AM J PHYSIOL-REG I, V293, pR2090, DOI 10.1152/ajpregu.00166.2007; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Worthington RA, 2002, FEBS LETT, V512, P43, DOI 10.1016/S0014-5793(01)03311-7; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Young MT, 2006, BRIT J PHARMACOL, V149, P261, DOI 10.1038/sj.bjp.0706880; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200	84	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8176	8187		10.1074/jbc.M110.211284	http://dx.doi.org/10.1074/jbc.M110.211284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205829	Green Published, hybrid			2022-12-25	WOS:000288013300048
J	Jiang, LY; Rong, R; Sheikh, MS; Huang, Y				Jiang, Lingyan; Rong, Rong; Sheikh, M. Saeed; Huang, Ying			Cullin-4A.DNA Damage-binding Protein 1 E3 Ligase Complex Targets Tumor Suppressor RASSF1A for Degradation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-CHROMOSOME 3P21.3; CELL-CYCLE; EPIGENETIC INACTIVATION; UBIQUITIN LIGASE; MICROTUBULE STABILITY; DNA-REPLICATION; BREAST CANCERS; CDK INHIBITOR; GENE; LUNG	Tumor suppressor RASSF1A (RAS association domain family 1, isoform A) is known to play an important role in regulation of mitosis; however, little is known about how RASSF1A is regulated during the mitotic phase of the cell cycle. In the present study, we have identified Cullin-4A (CUL4A) as a novel E3 ligase for RASSF1A. Our results demonstrate that DNA damage-binding protein 1 (DDB1) functions as a substrate adaptor that directly interacts with RASSF1A and bridges RASSF1A to the CUL4A E3 ligase complex. Depletion of DDB1 also diminishes intracellular interactions between RASSF1A and CUL4A. Our results also show that RASSF1A interacts with DDB1 via a region containing amino acids 165-200, and deletion of this region abolishes RASSF1A and DDB1 interactions. We have found that CUL4A depletion results in increased levels of RASSF1A protein due to increased half-life; whereas overexpression of CUL4A and DDB1 markedly enhances RASSF1A protein ubiquitination resulting in reduced RASSF1A levels. We further show that CUL4A-mediated RASSF1A degradation occurs during mitosis, and depletion of CUL4A markedly reverses mitotic-phase-stimulated RASSF1A degradation. We also note that overexpression of CUL4A antagonizes the ability of RASSF1A to induce M-phase cell cycle arrest. Thus, our present study demonstrates that the CUL4A.DDB1 E3 complex is important for regulation of RASSF1A during mitosis, and it may contribute to inactivation of RASSF1A and promoting cell cycle progression.	[Jiang, Lingyan; Rong, Rong; Sheikh, M. Saeed; Huang, Ying] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	huangy@upstate.edu			National Institutes of Health [CA113868, CA128096]; U.S. Department of Defense [BC073479]; NATIONAL CANCER INSTITUTE [R03CA128096, R21CA113868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA113868 and CA128096 (to Y. H.).; Supported by a predoctoral fellowship (BC073479) from the U.S. Department of Defense.	Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971; Chen LC, 1998, CANCER RES, V58, P3677; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Kuzmin I, 2002, CANCER RES, V62, P3498; Lerman MI, 2000, CANCER RES, V60, P6116; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2008, ONCOGENE, V27, P3176, DOI 10.1038/sj.onc.1210971; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Song SJ, 2009, CANCER RES, V69, P8540, DOI 10.1158/0008-5472.CAN-09-1554; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tomizawa Y, 2002, CLIN CANCER RES, V8, P2362; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Verma SK, 2008, FEBS LETT, V582, P2270, DOI 10.1016/j.febslet.2008.05.028; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yu MY, 2003, INT J CANCER, V105, P204, DOI 10.1002/ijc.11051; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	42	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6971	6978		10.1074/jbc.M110.186494	http://dx.doi.org/10.1074/jbc.M110.186494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21205828	Green Published, hybrid			2022-12-25	WOS:000287737300013
J	Lasher, CD; Rajagopalan, P; Murali, TM				Lasher, Christopher D.; Rajagopalan, Padmavathy; Murali, T. M.			Discovering Networks of Perturbed Biological Processes in Hepatocyte Cultures	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; IDENTIFYING FUNCTIONAL MODULES; COA DESATURASE 1; GENE-EXPRESSION; X-RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; LXR-ALPHA; TRANSCRIPTIONAL ACTIVATION; LIPOPROTEIN METABOLISM; SANDWICH CONFIGURATION	The liver plays a vital role in glucose homeostasis, the synthesis of bile acids and the detoxification of foreign substances. Liver culture systems are widely used to test adverse effects of drugs and environmental toxicants. The two most prevalent liver culture systems are hepatocyte monolayers (HMs) and collagen sandwiches (CS). Despite their wide use, comprehensive transcriptional programs and interaction networks in these culture systems have not been systematically investigated. We integrated an existing temporal transcriptional dataset for HM and CS cultures of rat hepatocytes with a functional interaction network of rat genes. We aimed to exploit the functional interactions to identify statistically significant linkages between perturbed biological processes. To this end, we developed a novel approach to compute Contextual Biological Process Linkage Networks (CBPLNs). CBPLNs revealed numerous meaningful connections between different biological processes and gene sets, which we were successful in interpreting within the context of liver metabolism. Multiple phenomena captured by CBPLNs at the process level such as regulation, downstream effects, and feedback loops have well described counterparts at the gene and protein level. CBPLNs reveal high-level linkages between pathways and processes, making the identification of important biological trends more tractable than through interactions between individual genes and molecules alone. Our approach may provide a new route to explore, analyze, and understand cellular responses to internal and external cues within the context of the intricate networks of molecular interactions that control cellular behavior.	[Lasher, Christopher D.] Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Murali, T. M.] Virginia Polytech Inst & State Univ, Dept Comp Sci, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy; Murali, T. M.] Virginia Polytech Inst & State Univ, ICTAS Ctr Syst Biol Engineered Tissues, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lasher, CD (corresponding author), Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA 24061 USA.	murali@cs.vt.edu			National Science Foundation [CBET-0933225]; Institute for Critical Technology and Applied Sciences at Virginia Polytechnic Institute and State University; Virginia Polytechnic Institute and State University; Div Of Chem, Bioeng, Env, & Transp Sys [0933225] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Critical Technology and Applied Sciences at Virginia Polytechnic Institute and State University; Virginia Polytechnic Institute and State University; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors gratefully acknowledge financial support from the National Science Foundation (CBET-0933225, PR and TMM) and the Institute for Critical Technology and Applied Sciences (PR and TMM) at Virginia Polytechnic Institute and State University. CDL was partly supported by a 2010 Fellowship from Virginia Polytechnic Institute and State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; ARIAS IM, 2001, LIVER BIOL PATHOBIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLOTIN E, 2010, HEPATOLOGY; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Crestani M, 1998, J LIPID RES, V39, P2192; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; ENOCH HG, 1978, BIOCHEMISTRY-US, V17, P4927, DOI 10.1021/bi00616a011; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang SSC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000350; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; KIM Y, 2010, TISSUE ENG C; KIM Y, 2010, TISSUE ENG A; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; LIU Q, 1993, MOL ENDOCRINOL, V7, P651, DOI 10.1210/me.7.5.651; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Marrapodi M, 2000, J LIPID RES, V41, P514; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDermott NB, 2002, J BIOL CHEM, V277, P36839, DOI 10.1074/jbc.M203689200; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Milo R., 2003, CONDMAT0312028 ARXIV; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Murali TM, 2008, J COMPUT BIOL, V15, P829, DOI 10.1089/cmb.2007.0139; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pandey J, 2007, BIOINFORMATICS, V23, pI377, DOI 10.1093/bioinformatics/btm203; Pandey Jayesh, 2008, Pac Symp Biocomput, P153; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Post SM, 2001, ARTERIOSCL THROM VAS, V21, P1840, DOI 10.1161/hq1101.098228; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SMYTH GK, BIOINFORMATICS COMPU, P397; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A., 2005, P NATL ACAD SCI US; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; WU KJ, 1994, J BIOL CHEM, V269, P1177; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	74	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15247	10.1371/journal.pone.0015247	http://dx.doi.org/10.1371/journal.pone.0015247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245926	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511200005
J	Brown, MTC; Bellone, C; Mameli, M; Labouebe, G; Bocklisch, C; Balland, B; Dahan, L; Lujan, R; Deisseroth, K; Luscher, C				Brown, Matthew T. C.; Bellone, Camilla; Mameli, Manuel; Labouebe, Gwenael; Bocklisch, Christina; Balland, Benedicte; Dahan, Lionel; Lujan, Rafael; Deisseroth, Karl; Luescher, Christian			Drug-Driven AMPA Receptor Redistribution Mimicked by Selective Dopamine Neuron Stimulation	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; IN-VIVO; EXTRACELLULAR DOPAMINE; SYNAPTIC PLASTICITY; SUBSTANTIA-NIGRA; COCAINE REWARD; TRANSPORTER; MIDBRAIN	Background: Addictive drugs have in common that they cause surges in dopamine (DA) concentration in the mesolimbic reward system and elicit synaptic plasticity in DA neurons of the ventral tegmental area (VTA). Cocaine for example drives insertion of GluA2-lacking AMPA receptors (AMPARs) at glutamatergic synapes in DA neurons. However it remains elusive which molecular target of cocaine drives such AMPAR redistribution and whether other addictive drugs (morphine and nicotine) cause similar changes through their effects on the mesolimbic DA system. Methodology/Principal Findings: We used in vitro electrophysiological techniques in wild-type and transgenic mice to observe the modulation of excitatory inputs onto DA neurons by addictive drugs. To observe AMPAR redistribution, post-embedding immunohistochemistry for GluA2 AMPAR subunit was combined with electron microscopy. We also used a double-floxed AAV virus expressing channelrhodopsin together with a DAT Cre mouse line to selectively express ChR2 in VTA DA neurons. We find that in mice where the effect of cocaine on the dopamine transporter (DAT) is specifically blocked, AMPAR redistribution was absent following administration of the drug. Furthermore, addictive drugs known to increase dopamine levels cause a similar AMPAR redistribution. Finally, activating DA VTA neurons optogenetically is sufficient to drive insertion of GluA2-lacking AMPARs, mimicking the changes observed after a single injection of morphine, nicotine or cocaine. Conclusions/Significance: We propose the mesolimbic dopamine system as a point of convergence at which addictive drugs can alter neural circuits. We also show that direct activation of DA neurons is sufficient to drive AMPAR redistribution, which may be a mechanism associated with early steps of non-substance related addictions.	[Brown, Matthew T. C.; Bellone, Camilla; Mameli, Manuel; Labouebe, Gwenael; Bocklisch, Christina; Balland, Benedicte; Dahan, Lionel; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; Stanford University; Stanford University; University of Geneva	Brown, MTC (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Core, Vector/CAF-4832-2022; Lüscher, Christian/A-2496-2011; Dahan, Lionel/C-2760-2009; Lujan, Rafael/G-2555-2015	Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964; Brown, Matthew/0000-0001-6983-962X; Dahan, Lionel/0000-0001-7810-6233; Lujan Miras, Rafael/0000-0003-2001-9545; bellone, camilla/0000-0002-6774-6275	National Institute on Drug Abuse [DA019022]; Swiss National Science Foundation; Systems X Initiative (NeuroChoice); Ministerio de Ciencia e Innovacion; Junta de Comunidades de Castilla-La Mancha; NIH; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X Initiative (NeuroChoice); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institute on Drug Abuse (DA019022; C. L., P. S.), the Swiss National Science Foundation, the Systems X Initiative (NeuroChoice), the Ministerio de Ciencia e Innovacion and Junta de Comunidades de Castilla-La Mancha and the NIH Pioneer Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; BRADBERRY CW, 1989, NEUROSCI LETT, V103, P97, DOI 10.1016/0304-3940(89)90492-8; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; CHEN NH, 1994, J PHARMACOL EXP THER, V271, P1597; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Dong Y, 2009, J MOL NEUROSCI; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Frank ST, 2008, SYNAPSE, V62, P243, DOI 10.1002/syn.20489; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Lodge DJ, 2005, J PHARMACOL EXP THER, V314, P201, DOI 10.1124/jpet.105.084913; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tilley MR, 2009, NEUROREPORT, V20, P9, DOI 10.1097/WNR.0b013e32831b9ce4; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Zhang D, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-57; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	47	94	96	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15870	10.1371/journal.pone.0015870	http://dx.doi.org/10.1371/journal.pone.0015870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209835	gold, Green Published			2022-12-25	WOS:000285838900044
J	Sendagire, I; Van der Loeff, MS; Mubiru, M; Konde-Lule, J; Cobelens, F				Sendagire, Ibrahim; Van der Loeff, Maarten Schim; Mubiru, Mesach; Konde-Lule, Joseph; Cobelens, Frank			Long Delays and Missed Opportunities in Diagnosing Smear-Positive Pulmonary Tuberculosis in Kampala, Uganda: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH-SERVICE DELAY; PATIENT; SPUTUM; MICROSCOPY	Background: Early detection and treatment of tuberculosis cases are the hallmark of successful tuberculosis control. We conducted a cross-sectional study at public primary health facilities in Kampala city, Uganda to quantify diagnostic delay among pulmonary tuberculosis (PTB) patients, assess associated factors, and describe trajectories of patients' health care seeking. Methodology/Principal Findings: Semi-structured interviews with new smear-positive PTB patients (>= 15 years) registered for treatment. Between April 2007 and April 2008, 253 patients were studied. The median total delay was 8 weeks (IQR 4-12), median patient delay was 4 weeks (inter-quartile range [IQR] 1-8) and median health service delay was 4 weeks (IQR 2-8). Long total delay (>14 weeks) was observed for 61/253 (24.1%) of patients, long health service delay (>6 weeks) for 71/242 (29.3%) and long patient delay (>8 weeks) for 47/242 (19.4%). Patients who knew that TB was curable were less likely to have long total delay (adjusted Odds Ratio [aOR] 0.28; 95%CI 0.11-0.73) and long patient delay (aOR 0.36; 95%CI 0.13-0.97). Being female (aOR 1.98; 95%CI 1.06-3.71), staying for more than 5 years at current residence (aOR 2.24 95%CI 1.18-4.27) and having been tested for HIV before (aOR 3.72; 95%CI 1.42-9.75) was associated with long health service delay. Health service delay contributed 50% of the total delay. Ninety-one percent (231) of patients had visited one or more health care providers before they were diagnosed, for an average (median) of 4 visits (range 1-30). All but four patients had systemic symptoms by the time the diagnosis of TB was made. Conclusions/Significance: Diagnostic delay among tuberculosis patients in Kampala is common and long. This reflects patients waiting too long before seeking care and health services waiting until systemic symptoms are present before examining sputum smears; this results in missed opportunities for diagnosis.	[Sendagire, Ibrahim; Mubiru, Mesach] Kampala City Council, Dept Publ Hlth, Kampala, Uganda; [Van der Loeff, Maarten Schim; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Municipal Hlth Serv, Dept Res, Amsterdam, Netherlands; [Konde-Lule, Joseph] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Dept Res, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Makerere University	Sendagire, I (corresponding author), Kampala City Council, Dept Publ Hlth, Kampala, Uganda.	f.cobelens@amc-cpcd.org		Cobelens, Frank/0000-0002-4367-1133	Netherlands Organization for Scientific Research - WOTRO Science for Global Development [NACCAP W 07.05.20100]	Netherlands Organization for Scientific Research - WOTRO Science for Global Development	This work was done as part of the Infectious Diseases Network for Treatment and Research in Africa (INTERACT), and financially supported by the Netherlands Organization for Scientific Research - WOTRO Science for Global Development (www.nwo.nl), grant NACCAP W 07.05.20100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuo P O, 2008, East Afr Med J, V85, P263; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Bustamante-Montes LP, 2000, INT J TUBERC LUNG D, V4, P208; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Mfinanga G S, 2007, Tanzan Health Res Bull, V9, P164; Ministry of Health [Uganda], 1999, UG NAT HLTH POL; Ozkutuk A, 2007, JPN J INFECT DIS, V60, P73; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; Wei XL, 2009, INT J TUBERC LUNG D, V13, P514; World Bank, 2007, SOC DIFF HLTH NUTR P; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2009, GLOB TUB CONTR EP ST; MERK MANUALS ONLINE	25	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14459	10.1371/journal.pone.0014459	http://dx.doi.org/10.1371/journal.pone.0014459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206746	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200012
J	Kurahashi, S; Hayakawa, F; Miyata, Y; Yasuda, T; Minami, Y; Tsuzuki, S; Abe, A; Naoe, T				Kurahashi, S.; Hayakawa, F.; Miyata, Y.; Yasuda, T.; Minami, Y.; Tsuzuki, S.; Abe, A.; Naoe, T.			PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML	ONCOGENE			English	Article						PAX5; PML; nuclear body; DNA binding; apoptosis; arsenic trioxide	ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL DEVELOPMENT; ARSENIC-TRIOXIDE; RAR-ALPHA; MEDIATED APOPTOSIS; NUCLEAR-BODIES; FUSION GENES; DNA-DAMAGE; BSAP PAX-5	PAX5 is a transcription factor required for B-cell development and maintenance. PML is a tumor suppressor and a pro-apoptotic factor. A fusion gene, PAX5-PML, was found in acute lymphoblastic leukemia (ALL) with chromosomal translocation t(9;15)(p13;q24), but no functional analysis has been reported. Here, we demonstrate that PAX5-PML had a dominant-negative effect on both PAX5 and PML. PAX5-PML dominant negatively inhibited PAX5 transcriptional activity in the luciferase reporter assay and suppressed the expression of the PAX5 transcriptional targets in B-lymphoid cell line. Surprisingly, PAX5-PML hardly showed DNA-binding activity in vitro although it retained the DNA-binding domain of PAX5. Additional experiments, including chromatin immunoprecipitation (ChIP) assay, suggested that PAX5-PML bound to the promoter through the association with PAX5 on the promoter. On the other hand, coexpression of PAX5-PML inhibited PML sumoylation, disrupted PML nuclear bodies (NBs), and conferred apoptosis resistance on HeLa cells. Furthermore, treatment with arsenic trioxide (ATO) induced PML sumoylation and reconstitution of PML NBs, and overcame the anti-apoptotic effect of PAX5-PML in HeLa cells. These data suggest the possible involvement of this fusion protein in the leukemogenesis of B-ALL in a dual dominant-negative manner and the possibility that ALL with PAX5-PML can be treated with ATO. Oncogene (2011) 30, 1822-1830; doi:10.1038/onc.2010.554; published online 10 January 2011	[Hayakawa, F.] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Tsuzuki, S.] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan	Nagoya University; Aichi Cancer Center	Hayakawa, F (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	bun-hy@med.nagoya-u.ac.jp	Yasuda, Takahiko/AGQ-5448-2022; Hayakawa, Fumihiko/I-7288-2014; Naoe, Tomoki/I-1888-2012	Yasuda, Takahiko/0000-0002-4686-0976; Tsuzuki, Shinobu/0000-0002-3209-3550	Kyowa Hakko Kirin Co., Ltd.; Wyeth; Chugai Pharmaceutical Co., Ltd.; National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Wyeth(Wyeth); Chugai Pharmaceutical Co., Ltd.; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Dr Naoe received research funding from Kyowa Hakko Kirin Co., Ltd, Wyeth, and Chugai Pharmaceutical Co., Ltd. The remaining authors declare no conflict of interest.; We thank Dr Martin L Privalsky (University of California at Davis, CA, USA), Dr Masayuki Yamamoto (Tohoku University) and Dr Stefano Rivella (Memorial Sloan-Kettering Cancer Center) for kindly providing vectors. We are very grateful to Ryouhei Tanizaki, Yuka Nomura and Chika Wakamatsu for their technical assistance. This work was supported by Grants-in-Aid from the National Institute of Biomedical Innovation and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Atsumi A, 2006, BIOCHEM BIOPH RES CO, V345, P1471, DOI 10.1016/j.bbrc.2006.05.047; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Chen GQ, 1997, BLOOD, V89, P3345; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Familiades J, 2009, LEUKEMIA, V23, P1989, DOI 10.1038/leu.2009.135; Fazio G, 2008, CANCER RES, V68, P181, DOI 10.1158/0008-5472.CAN-07-2778; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Iida S, 1996, BLOOD, V88, P1787; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Miller WH, 2002, CANCER RES, V62, P3893; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Nutt S L, 2001, Int Rev Immunol, V20, P65, DOI 10.3109/08830180109056723; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	43	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	15					1822	1830		10.1038/onc.2010.554	http://dx.doi.org/10.1038/onc.2010.554			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21217775				2022-12-25	WOS:000289512200009
J	Poburko, D; Santo-Domingo, J; Demaurex, N				Poburko, Damon; Santo-Domingo, Jaime; Demaurex, Nicolas			Dynamic Regulation of the Mitochondrial Proton Gradient during Cytosolic Calcium Elevations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION PORE; FLUORESCENT PROTEIN MUTANT; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ELECTROCHEMICAL GRADIENT; ADENOSINE-TRIPHOSPHATASE; BUFFERING POWER; INNER MEMBRANE; PH DIFFERENCE	Mitochondria extrude protons across their inner membrane to generate the mitochondrial membrane potential (Delta Psi(m)) and pH gradient (Delta pH(m)) that both power ATP synthesis. Mitochondrial uptake and efflux of many ions and metabolites are driven exclusively by Delta pH(m), whose in situ regulation is poorly characterized. Here, we report the first dynamic measurements of Delta pH(m) in living cells, using a mitochondrially targeted, pH-sensitive YFP (SypHer) combined with a cytosolic pH indicator (5-(and 6)-carboxy-SNARF-1). The resting matrix pH (similar to 7.6) and Delta pH(m) (similar to 0.45) of HeLa cells at 37 degrees C were lower than previously reported. Unexpectedly, mitochondrial pH and Delta pH(m) decreased during cytosolic Ca2+ elevations. The drop in matrix pH was due to cytosolic acid generated by plasma membrane Ca2+-ATPases and transmitted to mitochondria by P-i/H+ symport and K+/H+ exchange, whereas the decrease in Delta pH(m) reflected the low H+-buffering power of mitochondria (similar to 5mM, pH 7.8) compared with the cytosol (similar to 20 mM, pH 7.4). Upon agonist washout and restoration of cytosolic Ca2+ and pH, mitochondria alkalinized and Delta pH(m) increased. In permeabilized cells, a decrease in bath pH from 7.4 to 7.2 rapidly decreased mitochondrial pH, whereas the addition of 10 mu M Ca2+ caused a delayed and smaller alkalinization. These findings indicate that the mitochondrial matrix pH and Delta pH(m) are regulated by opposing Ca2+-dependent processes of stimulated mitochondrial respiration and cytosolic acidification.	[Poburko, Damon; Santo-Domingo, Jaime; Demaurex, Nicolas] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Sch Med, Dept Cell Physiol & Metab, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch	Domingo, Jaime Santo/AAA-4995-2020	Domingo, Jaime Santo/0000-0001-5501-0482; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [31-068317]; Canadian Natural Sciences and Engineering Research Council	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Swiss National Foundation Grant 31-068317 (to N. D.).; Supported in part by the Canadian Natural Sciences and Engineering Research Council.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bednarczyk P, 2008, BBA-BIOENERGETICS, V1777, P540, DOI 10.1016/j.bbabio.2008.04.018; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; BERNARDI P, 1983, EUR J BIOCHEM, V134, P377, DOI 10.1111/j.1432-1033.1983.tb07578.x; Bolshakov AP, 2008, CELL CALCIUM, V43, P602, DOI 10.1016/j.ceca.2007.10.005; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRAND MD, 1984, BIOCHEM J, V217, P453, DOI 10.1042/bj2170453; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Durand T, 1999, CRYOBIOLOGY, V38, P68, DOI 10.1006/cryo.1999.2152; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Gover TD, 2007, CELL CALCIUM, V41, P389, DOI 10.1016/j.ceca.2006.08.014; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1969, EUR J BIOCHEM, V7, P471, DOI 10.1111/j.1432-1033.1969.tb19633.x; MITCHELL P, 1965, NATURE, V208, P147, DOI 10.1038/208147a0; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; NIGGLI V, 1982, J BIOL CHEM, V257, P2350; Niggli V, 2008, TRENDS BIOCHEM SCI, V33, P156, DOI 10.1016/j.tibs.2007.12.005; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROTTENBERG H, 1974, BIOCHEMISTRY-US, V13, P4811, DOI 10.1021/bi00720a020; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Talbot J, 2007, J PHYSIOL-LONDON, V579, P783, DOI 10.1113/jphysiol.2006.126383; Thomas RC, 2009, J PHYSIOL-LONDON, V587, P315, DOI 10.1113/jphysiol.2008.162453; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vale-Gonzalez C, 2006, J NEUROSCI RES, V84, P326, DOI 10.1002/jnr.20878; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V425, P429, DOI 10.1113/jphysiol.1990.sp018112; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	68	231	232	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11672	11684		10.1074/jbc.M110.159962	http://dx.doi.org/10.1074/jbc.M110.159962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21224385	hybrid, Green Published			2022-12-25	WOS:000288797100075
J	Zhang, ZY; Kelemen, O; van Santen, MA; Yelton, SM; Wendlandt, AE; Sviripa, VM; Bollen, M; Beullens, M; Urlaub, H; Luhrmann, R; Watt, DS; Stamm, S				Zhang, Zhaiyi; Kelemen, Olga; van Santen, Maria A.; Yelton, Sharon M.; Wendlandt, Alison E.; Sviripa, Vitaliy M.; Bollen, Mathieu; Beullens, Monique; Urlaub, Henning; Luehrmann, Reinhard; Watt, David S.; Stamm, Stefan			Synthesis and Characterization of Pseudocantharidins, Novel Phosphatase Modulators That Promote the Inclusion of Exon 7 into the SMN (Survival of Motoneuron) pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; PROTEIN PHOSPHATASE-1; NORCANTHARIDIN ANALOGS; ANTICANCER ACTIVITY; CANTHARIDIN ANALOGS; CELL LINES; CERAMIDE; RECOGNITION; INHIBITION; COMPLEXES	Alternative pre-mRNA splicing is a central element of eukaryotic gene expression. Its deregulation can lead to disease, and methods to change splice site selection are developed as potential therapies. Spinal muscular atrophy is caused by the loss of the SMN1 (survival of motoneuron 1) gene. A therapeutic avenue for spinal muscular atrophy treatment is to promote exon 7 inclusion of the almost identical SMN2 (survival of motoneuron 2) gene. The splicing factor tra2-beta1 promotes inclusion of this exon and is antagonized by protein phosphatase (PP) 1. To identify new compounds that promote exon 7 inclusion, we synthesized analogs of cantharidin, an inhibitor of PP1, and PP2A. Three classes of compounds emerged from these studies. The first class blocks PP1 and PP2A activity, blocks constitutive splicing in vitro, and promotes exon 7 inclusion in vivo. The second class has no measurable effect on PP1 activity but activates PP2A. This class represents the first compounds described with these properties. These compounds cause a dephosphorylation of Thr-33 of tra2-beta1, which promotes exon 7 inclusion. The third class had no detectable effect on phosphatase activity and could promote exon 7 via allosteric effects. Our data show that subtle changes in similar compounds can turn a phosphatase inhibitor into an activator. These chemically related compounds influence alternative splicing by distinct mechanisms.	[Zhang, Zhaiyi; Kelemen, Olga; Yelton, Sharon M.; Wendlandt, Alison E.; Sviripa, Vitaliy M.; Watt, David S.; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [van Santen, Maria A.; Urlaub, Henning; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Bollen, Mathieu; Beullens, Monique] Catholic Univ Louvain, Dept Mol Cell Biol, Lab Biosignaling & Therapeut, B-3000 Louvain, Belgium	University of Kentucky; Max Planck Society; Universite Catholique Louvain	Stamm, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, B283 Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net		Sviripa, Vitaliy/0000-0002-7272-373X	National Institutes of Health [P20 RR020171]; Center of Biomedical Research Excellence in the Molecular Basis of Human Disease [P20 RR020171]; Muscular Dystrophy Association; EURASNET; Office of the Vice President for Research of the University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence in the Molecular Basis of Human Disease; Muscular Dystrophy Association(Muscular Dystrophy Association); EURASNET; Office of the Vice President for Research of the University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Research Resources Grant P20 RR020171 (to the University of Kentucky Center for Structural Biology Protein Core Facility) and Center of Biomedical Research Excellence in the Molecular Basis of Human Disease Grant P20 RR020171 (to the Organic Synthesis Core Facility). This work was also supported by the Muscular Dystrophy Association and EURASNET.; Supported by the Office of the Vice President for Research of the University of Kentucky.	Baba Y, 2003, J AM CHEM SOC, V125, P9740, DOI 10.1021/ja034694y; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOCKSTAHLER ER, 1966, Patent No. 3261845; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Hart ME, 2004, BIOORG MED CHEM LETT, V14, P1969, DOI 10.1016/j.bmcl.2004.01.093; Hill TA, 2007, BIOORGAN MED CHEM, V15, P6126, DOI 10.1016/j.bmc.2007.06.034; Hill TA, 2007, BIOORG MED CHEM LETT, V17, P3392, DOI 10.1016/j.bmcl.2007.03.093; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; JOLIVET J, 1960, ANN CHIM, V5, P1165; Kok SHL, 2006, INT J MOL MED, V17, P945; Kok SHL, 2006, INT J MOL MED, V17, P151; Kok SHL, 2007, BIOORG MED CHEM LETT, V17, P1155, DOI 10.1016/j.bmcl.2006.12.039; Kok SHL, 2006, INT J MOL MED, V18, P1217; Leoni LM, 1998, BIOCHEM PHARMACOL, V55, P1105, DOI 10.1016/S0006-2952(97)00685-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; McCluskey A, 2003, BIOORG CHEM, V31, P68, DOI 10.1016/S0045-2068(02)00524-2; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakatani T, 2004, CHEM PHARM BULL, V52, P807, DOI 10.1248/cpb.52.807; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pang SK, 2007, BIOCHEM BIOPH RES CO, V363, P235, DOI 10.1016/j.bbrc.2007.08.172; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Politis JK, 2001, J AM CHEM SOC, V123, P2537, DOI 10.1021/ja003588i; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Singh RN, 2007, RNA BIOL, V4, P7, DOI 10.4161/rna.4.1.4535; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stewart SG, 2007, BIOORGAN MED CHEM, V15, P7301, DOI 10.1016/j.bmc.2007.08.028; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814	51	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10126	10136		10.1074/jbc.M110.183970	http://dx.doi.org/10.1074/jbc.M110.183970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21220421	Green Published, hybrid			2022-12-25	WOS:000288547000027
J	Shimano, M; Ouchi, N; Nakamura, K; Oshima, Y; Higuchi, A; Pimentel, DR; Panse, KD; Lara-Pezzi, E; Lee, SJ; Sam, F; Walsh, K				Shimano, Masayuki; Ouchi, Noriyuki; Nakamura, Kazuto; Oshima, Yuichi; Higuchi, Akiko; Pimentel, David R.; Panse, Kalyani D.; Lara-Pezzi, Enrique; Lee, Se-Jin; Sam, Flora; Walsh, Kenneth			Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; HEART-FAILURE; ACTIVIN-A; MYOSTATIN; PROTEINS; BINDING; CARDIOMYOCYTES; ACTIVATION; APOPTOSIS	Transforming growth factor-beta family cytokines have diverse actions in the maintenance of cardiac homeostasis. Follistatinlike 3 (Fstl3) is an extracellular regulator of certain TGF-beta family members, including activin A. The aim of this study was to examine the role of Fstl3 in cardiac hypertrophy. Cardiac myocyte-specific Fstl3 knock-out (KO) mice and control mice were subjected to pressure overload induced by transverse aortic constriction (TAC). Cardiac hypertrophy was assessed by echocardiography and histological and biochemical methods. KO mice showed reduced cardiac hypertrophy, pulmonary congestion, concentric LV wall thickness, LV dilatation, and LV systolic dysfunction after TAC compared with control mice. KO mice displayed attenuated increases in cardiomyocyte cell surface area and interstitial fibrosis following pressure overload. Although activin A was similarly up-regulated in KO and control mice after TAC, a significant increase in Smad2 phosphorylation only occurred in KO mice. Knockdown of Fstl3 in cultured cardiomyocytes inhibited PE-induced cardiac hypertrophy. Conversely, adenovirus-mediated Fstl3 overexpression blocked the inhibitory action of activin A on hypertrophy and Smad2 activation. Transduction with Smad7, a negative regulator of Smad2 signaling, blocked the antihypertrophic actions of activin A stimulation or Fstl3 ablation. These findings identify Fstl3 as a stress-induced regulator of hypertrophy that controls myocyte size via regulation of Smad signaling.	[Shimano, Masayuki; Ouchi, Noriyuki; Nakamura, Kazuto; Oshima, Yuichi; Higuchi, Akiko; Pimentel, David R.; Lara-Pezzi, Enrique; Sam, Flora; Walsh, Kenneth] Boston Univ, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Panse, Kalyani D.] Univ London Imperial Coll Sci Technol & Med, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Lara-Pezzi, Enrique] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain; [Lee, Se-Jin] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Boston University; Imperial College London; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Johns Hopkins University	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Med Campus,700 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Lara-Pezzi, Enrique/E-2350-2015; OUCHI, Noriyuki/I-7306-2014	Lara-Pezzi, Enrique/0000-0002-2743-1033; Sam, Flora/0000-0001-8442-9362; Pimentel, David/0000-0002-0537-7195; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG015052, AG034972, HL068758, HL102874, DK089875, AR060636]; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102874, P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R01AG034972, R37AG015052] Funding Source: NIH RePORTER; British Heart Foundation [PG/08/084/25827] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants AG015052, AG034972, HL068758, HL102874, and DK089875 (to K. W.) and AR060636 (to S.-J. L.).; Supported by the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Chen YG, 2006, EXP BIOL MED, V231, P534; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Florholmen G, 2006, J MOL CELL CARDIOL, V41, P689, DOI 10.1016/j.yjmcc.2006.07.009; Frost RJA, 2007, CIRCULATION, V116, P1768, DOI 10.1161/CIRCULATIONAHA.107.696468; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Heger J, 2009, J CELL PHYSIOL, V220, P515, DOI 10.1002/jcp.21805; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; Lara-Pezzi E, 2008, ENDOCRINOLOGY, V149, P5822, DOI 10.1210/en.2008-0151; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mahmoudabady M, 2008, J CARD FAIL, V14, P703, DOI 10.1016/j.cardfail.2008.05.003; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Oshima Y, 2009, CIRCULATION, V120, P1606, DOI 10.1161/CIRCULATIONAHA.109.872200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Schneyer A, 2004, MOL CELL ENDOCRINOL, V225, P25, DOI 10.1016/j.mce.2004.02.009; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41	36	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9840	9848		10.1074/jbc.M110.197079	http://dx.doi.org/10.1074/jbc.M110.197079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245136	hybrid, Green Published			2022-12-25	WOS:000288247700107
J	Waithe, D; Ferron, L; Page, KM; Chaggar, K; Dolphin, AC				Waithe, Dominic; Ferron, Laurent; Page, Karen M.; Chaggar, Kanchan; Dolphin, Annette C.			beta-Subunits Promote the Expression of Ca(V)2.2 Channels by Reducing Their Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM-CHANNEL; GATED CA2+ CHANNELS; RAT TAIL ARTERY; I-II LINKER; ENDOPLASMIC-RETICULUM; PROTEIN-SYNTHESIS; NORADRENALINE RELEASE; TRUNCATED CONSTRUCTS; SYMPATHETIC NEURONS; NEUROPATHIC PAIN	The beta-subunits of voltage-gated calcium channels regulate their functional expression and properties. Two mechanisms have been proposed for this, an effect on gating and an enhancement of expression. With respect to the effect on expression, beta-subunits have been suggested to enhance trafficking by masking an unidentified endoplasmic reticulum (ER) retention signal. Here we have investigated whether, and how, beta-subunits affect the level of Ca(V)2.2 channels within somata and neurites of cultured sympathetic neurons. We have used YFP-Ca(V)2.2 containing a mutation (W391A), that prevents binding of beta-subunits to its I-II linker and found that expression of this channel was much reduced compared with WT CFP-Ca(V)2.2 when both were expressed in the same neuron. This effect was particularly evident in neurites and growth cones. The difference between the levels of YFP-Ca(V)2.2(W391A) and CFP-Ca(V)2.2(WT) was lost in the absence of co-expressed beta-subunits. Furthermore, the relative reduction of expression of Ca(V)2.2(W391A) compared with the WT channel was reversed by exposure to two proteasome inhibitors, MG132 and lactacystin, particularly in the somata. In further experiments in tsA-201 cells, we found that proteasome inhibition did not augment the cell surface Ca(V)2.2(W391A) level but resulted in the observation of increased ubiquitination, particularly of mutant channels. In contrast, we found no evidence for selective retention of Ca(V)2.2(W391A) in the ER, in either the soma or growth cones. In conclusion, there is a marked effect of beta-subunits on Ca(V)2.2 expression, particularly in neurites, but our results point to protection from proteasomal degradation rather than masking of an ER retention signal.	[Waithe, Dominic; Ferron, Laurent; Page, Karen M.; Chaggar, Kanchan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Dolphin, AC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.dolphin@ucl.ac.uk	Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856; Waithe, Dominic/0000-0003-2685-4226	British Heart Foundation; Wellcome Trust [077883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077883] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a British Heart Foundation Ph.D. studentship (to D. W.) and Wellcome Trust Grant 077883.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; ALTIER C, 2009, SOC NEUR ABS; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Brock JA, 1999, BRIT J PHARMACOL, V126, P11, DOI 10.1038/sj.bjp.0702256; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; CLASBRUMMEL B, 1989, BRIT J PHARMACOL, V96, P101, DOI 10.1111/j.1476-5381.1989.tb11789.x; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Ding QX, 2006, FASEB J, V20, P1055, DOI 10.1096/fj.05-5495com; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Maximov A, 2002, J NEUROSCI, V22, P6939; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	54	84	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9598	9611		10.1074/jbc.M110.195909	http://dx.doi.org/10.1074/jbc.M110.195909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233207	Green Published, hybrid			2022-12-25	WOS:000288247700085
J	Frischauf, I; Schindl, R; Bergsmann, J; Derler, I; Fahrner, M; Muik, M; Fritsch, R; Lackner, B; Groschner, K; Romanin, C				Frischauf, Irene; Schindl, Rainer; Bergsmann, Judith; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Lackner, Barbara; Groschner, Klaus; Romanin, Christoph			Cooperativeness of Orai Cytosolic Domains Tunes Subtype-specific Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; MOLECULAR DETERMINANTS; CA2+ CHANNELS; STIM1; SELECTIVITY; CALMODULIN; ACTIVATION	Activation of immune cells is triggered by the Ca2+ release-activated Ca2+ current, which is mediated via channels of the Orai protein family. A key gating process of the three Orai channel isoforms to prevent Ca2+ overload is fast inactivation, most pronounced in Orai3. A subsequent reactivation is a unique gating characteristic of Orai1 channels, whereas Orai2 and Orai3 currents display a second, slow inactivation phase. Employing a chimeric approach by sequential swapping of respective intra- and extracellular regions between Orai1 and Orai3, we show here that Orai1 specific proline/arginine-rich domains in the N terminus mediate reactivation, whereas the second, intracellular loop modulates fast and slow gating processes. Swapping C-terminal strands lacks a significant impact. However, simultaneous transfer of Orai3 N terminus and its second loop or C terminus in an Orai1 chimera substantially increases fast inactivation centered between wild-type channels. Concomitant swap of all three cytosolic strands from Orai3 onto Orai1 fully conveys Orai3-like gating characteristics, in a strongly cooperative manner. In conclusion, Orai subtype-specific gating requires a cooperative interplay of all three cytosolic domains.	[Frischauf, Irene; Schindl, Rainer; Bergsmann, Judith; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Lackner, Barbara; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Schindl, R (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/V-4205-2019; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Groschner, Klaus/A-2550-2010; Schindl, Rainer/E-3959-2013; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X; Schindl, Rainer/0000-0003-0896-8887; Frischauf, Irene/0000-0003-0661-2932; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation (FWF) [P22747, P211925, P21118]; Hertha-Firnberg Scholarship [T442, T466]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 22747, P 21925] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Hertha-Firnberg Scholarship(Austrian Science Fund (FWF)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Foundation (FWF) Projects P22747 (to R. S.), P211925 (to K. G.), and P21118 (to C. R.).; Recipient of Hertha-Firnberg Scholarship T442.; Recipient of a scholarship from the Austrian Academy of Sciences.; Recipient of Hertha-Firnberg Scholarship T466.	Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	21	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8577	8584		10.1074/jbc.M110.187179	http://dx.doi.org/10.1074/jbc.M110.187179			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220423	hybrid, Green Published			2022-12-25	WOS:000288013300084
J	Vina-Vilaseca, A; Bender-Sigel, J; Sorkina, T; Closs, EI; Sorkin, A				Vina-Vilaseca, Arnau; Bender-Sigel, Julia; Sorkina, Tatiana; Closs, Ellen Ildicho; Sorkin, Alexander			Protein Kinase C-dependent Ubiquitination and Clathrin-mediated Endocytosis of the Cationic Amino Acid Transporter CAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; LIGASE NEDD4-2; POSTTRANSLATIONAL REGULATION; NOREPINEPHRINE TRANSPORTER; ARGININE UPTAKE; PHOSPHORYLATION; ACTIVATION; INTERNALIZATION; MEMBRANE; DEGRADATION	Cationic amino acid transporter 1 (CAT-1) is responsible for the bulk of the uptake of cationic amino acids in most mammalian cells. Activation of protein kinase C (PKC) leads to down-regulation of the cell surface CAT-1. To examine the mechanisms of PKC-induced down-regulation of CAT-1, a functional mutant of CAT-1 (CAT-1-HA-GFP) was generated in which a hemagglutinin antigen (HA) epitope tag was introduced into the second extracellular loop and GFP was attached to the carboxyl terminus. CAT-1-HA-GFP was stably expressed in porcine aorthic endothelial and human epithelial kidney (HEK) 293 cells. Using the HA antibody internalization assay we have demonstrated that PKC-dependent endocytosis was strongly inhibited by siRNA depletion of clathrin heavy chain, indicating that CAT-1-HA-GFP internalization requires clathrin-coated pits. Internalized CAT-1-HA-GFP was accumulated in early, recycling, and late endosomes. PKC activation also resulted in ubiquitination of CAT-1. CAT-1 ubiquitination and endocytosis in phorbol ester-stimulated porcine aorthic endothelial and HEK293 cells were inhibited by siRNA knockdown of NEDD4-2 and NEDD4-1 E3 ubiquitin ligases, respectively. In contrast, ubiquitination and endocytosis of the dopamine transporter was dependent on NEDD4-2 in all cell types tested. Altogether, our data suggest that ubiquitination mediated by NEDD4-2 or NEDD4-1 leading to clathrin-mediated endocytosis is the common mode of regulation of various transporter proteins by PKC.	[Sorkina, Tatiana; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Vina-Vilaseca, Arnau; Sorkin, Alexander] Univ Colorado Denver, Dept Pharmacol, Anschutz Med Ctr, Aurora, CO 80010 USA; [Bender-Sigel, Julia; Closs, Ellen Ildicho] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55101 Mainz, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Johannes Gutenberg University of Mainz	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 Biomed Sci Tower S,3500 Terrace St, Pittsburgh, PA 15261 USA.	sorkin@pitt.edu	Closs, Ellen/ABD-5217-2020; Vina-Vilaseca, Arnau/O-1779-2015	Closs, Ellen/0000-0002-9505-2289; Vina-Vilaseca, Arnau/0000-0003-0447-5268; Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health from NIDA [DA014204]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	National Institutes of Health from NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA014204 from the NIDA.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Cui ZQ, 2005, GENOMICS, V85, P352, DOI 10.1016/j.ygeno.2004.11.006; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kizhatil K, 2002, AM J PHYSIOL-CELL PH, V283, pC1784, DOI 10.1152/ajpcell.00061.2002; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Krotova KY, 2003, AM J PHYSIOL-LUNG C, V284, pL1037, DOI 10.1152/ajplung.00308.2002; Lee SY, 1999, J VIROL, V73, P5994, DOI 10.1128/JVI.73.7.5994-6005.1999; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu XB, 2002, J VIROL, V76, P6701, DOI 10.1128/JVI.76.13.6701-6709.2002; McDonald KK, 1997, J BIOL CHEM, V272, P31213, DOI 10.1074/jbc.272.50.31213; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Racke K, 1998, J PHYSIOL-LONDON, V511, P813, DOI 10.1111/j.1469-7793.1998.813bg.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Reshef R, 2008, AM J PHYSIOL-HEART C, V294, pH1156, DOI 10.1152/ajpheart.01051.2007; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rotmann A, 2006, BIOCHEM J, V395, P117, DOI 10.1042/BJ20051558; Rotmann A, 2004, J BIOL CHEM, V279, P54185, DOI 10.1074/jbc.M409556200; Schwartz IF, 2007, ATHEROSCLEROSIS, V194, P357, DOI 10.1016/j.atherosclerosis.2006.10.039; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	56	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8697	8706		10.1074/jbc.M110.186858	http://dx.doi.org/10.1074/jbc.M110.186858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212261	Green Published, hybrid			2022-12-25	WOS:000288013300095
J	Carnahan, RH; Rokas, A; Gaucher, EA; Reynolds, AB				Carnahan, Robert H.; Rokas, Antonis; Gaucher, Eric A.; Reynolds, Albert B.			The Molecular Evolution of the p120-Catenin Subfamily and Its Functional Associations	PLOS ONE			English	Article							RHO-FAMILY GTPASES; BAYESIAN PHYLOGENETIC INFERENCE; CELL-ADHESION MOLECULES; E-CADHERIN FUNCTION; P120 CATENIN; DELTA-CATENIN; BETA-CATENIN; ADHERENS JUNCTION; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR	Background: p120-catenin (p120) is the prototypical member of a subclass of armadillo-related proteins that includes delta-catenin/NPRAP, ARVCF, p0071, and the more distantly related plakophilins 1-3. In vertebrates, p120 is essential in regulating surface expression and stability of all classical cadherins, and directly interacts with Kaiso, a BTB/ZF family transcription factor. Methodology/Principal Findings: To clarify functional relationships between these proteins and how they relate to the classical cadherins, we have examined the proteomes of 14 diverse vertebrate and metazoan species. The data reveal a single ancient delta-catenin-like p120 family member present in the earliest metazoans and conserved throughout metazoan evolution. This single p120 family protein is present in all protostomes, and in certain early-branching chordate lineages. Phylogenetic analyses suggest that gene duplication and functional diversification into "p120-like" and "delta-catenin-like" proteins occurred in the urochordate-vertebrate ancestor. Additional gene duplications during early vertebrate evolution gave rise to the seven vertebrate p120 family members. Kaiso family members (i.e., Kaiso, ZBTB38 and ZBTB4) are found only in vertebrates, their origin following that of the p120-like gene lineage and coinciding with the evolution of vertebrate-specific mechanisms of epigenetic gene regulation by CpG island methylation. Conclusions/Significance: The p120 protein family evolved from a common delta-catenin-like ancestor present in all metazoans. Through several rounds of gene duplication and diversification, however, p120 evolved in vertebrates into an essential, ubiquitously expressed protein, whereas loss of the more selectively expressed delta-catenin, p0071 and ARVCF are tolerated in most species. Together with phylogenetic studies of the vertebrate cadherins, our data suggest that the p120-like and delta-catenin-like genes co-evolved separately with non-neural (E-and P-cadherin) and neural (N-and R-cadherin) cadherin lineages, respectively. The expansion of p120 relative to delta-catenin during vertebrate evolution may reflect the pivotal and largely disproportionate role of the non-neural cadherins with respect to evolution of the wide range of somatic morphology present in vertebrates today.	[Carnahan, Robert H.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Gaucher, Eric A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Vanderbilt University; Vanderbilt University; University System of Georgia; Georgia Institute of Technology	Carnahan, RH (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA.	al.reynolds@vanderbilt.edu	Gaucher, Eric/I-7313-2013; Carnahan, Robert H/N-7429-2013; Rokas, Antonis/A-9775-2008	Carnahan, Robert H/0000-0001-5230-1532; Rokas, Antonis/0000-0002-7248-6551	Searle Scholars Program; National Science Foundation [DEB-0844968]; Vanderbilt Antibody and Protein Resource; Vanderbilt Cancer Center Support Grant [P30 CA068485]; Vanderbilt GI SPORE [50 CA95103];  [RO1 CA055724];  [RO1 CA111947]; NATIONAL CANCER INSTITUTE [R01CA111947, P50CA095103, R01CA055724, P30CA068485] Funding Source: NIH RePORTER	Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Vanderbilt Antibody and Protein Resource; Vanderbilt Cancer Center Support Grant; Vanderbilt GI SPORE; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in Antonis Rokas' laboratory is supported by the Searle Scholars Program and the National Science Foundation (DEB-0844968). Robert Carnahan is supported by the Vanderbilt Antibody and Protein Resource and RO1 CA055724 to Albert Reynolds. This work is supported in part by the Vanderbilt Cancer Center Support Grant (P30 CA068485), RO1 CA111947 (Albert Reynolds), and the Vanderbilt GI SPORE 50 CA95103 (Robert Coffey/Albert Reynolds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Gallin WJ, 1998, MOL BIOL EVOL, V15, P1099, DOI 10.1093/oxfordjournals.molbev.a026017; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Grosheva I, 2001, J CELL SCI, V114, P695; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Ho C, 2000, J COMP NEUROL, V420, P261; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mariner DJ, 2000, J CELL SCI, V113, P1481; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mo YY, 1996, CANCER RES, V56, P2633; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Natarajan L, 2001, GENETICS, V159, P159; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OAS RG, 2010, CIRCULATION RES; OHKUBO T, 2004, J CELL SCI PT; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roura S, 2004, BIOCHEM BIOPH RES CO, V320, P435, DOI 10.1016/j.bbrc.2004.05.186; RUZOV A, 2009, INTERACTION XKAISO X; SALEMI M, 2009, PHYLOGENETIC HDB PRA, pR16; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; SMALLEYFREED WG, J CLIN INVEST, V120, P1824; SOBOLIKDELMAIRE T, J INVEST DERMATOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; YANAGISAWA M, 2008, J BIOL CHEM; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	72	51	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15747	10.1371/journal.pone.0015747	http://dx.doi.org/10.1371/journal.pone.0015747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209830	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900029
J	Portillo, JAC; Okenka, G; Reed, E; Subauste, A; Van Grol, J; Gentil, K; Komatsu, M; Tanaka, K; Landreth, G; Levine, B; Subauste, CS				Portillo, Jose-Andres C.; Okenka, Genevieve; Reed, Erin; Subauste, Angela; Van Grol, Jennifer; Gentil, Katrin; Komatsu, Masaaki; Tanaka, Keiji; Landreth, Gary; Levine, Beth; Subauste, Carlos S.			The CD40-Autophagy Pathway Is Needed for Host Protection Despite IFN-Gamma-Dependent Immunity and CD40 Induces Autophagy via Control of P21 Levels	PLOS ONE			English	Article							INDUCIBLE NITRIC-OXIDE; TOXOPLASMA-GONDII; TNF-ALPHA; IN-VIVO; T-CELLS; ANTIMICROBIAL ACTIVITY; LIGAND INTERACTION; MAMMALIAN-CELLS; UP-REGULATION; INFECTION	Autophagy degrades pathogens in vitro. The autophagy gene Atg5 has been reported to be required for IFN-gamma-dependent host protection in vivo. However, these protective effects occur independently of autophagosome formation. Thus, the in vivo role of classic autophagy in protection conferred by adaptive immunity and how adaptive immunity triggers autophagy are incompletely understood. Employing biochemical, genetic and morphological studies, we found that CD40 upregulates the autophagy molecule Beclin 1 in microglia and triggers killing of Toxoplasma gondii dependent on the autophagy machinery. Infected CD40(-/-) mice failed to upregulate Beclin 1 in microglia/macrophages in vivo. Autophagy-deficient Beclin 1(+/-) mice, mice with deficiency of the autophagy protein Atg7 targeted to microglia/macrophages as well as CD40(-/-) mice exhibited impaired killing of T. gondii and were susceptible to cerebral and ocular toxoplasmosis. Susceptibility to toxoplasmosis occurred despite upregulation of IFN-gamma, TNF-alpha and NOS2, preservation of IFN-gamma-induced microglia/macrophage anti-T. gondii activity and the generation of anti-T. gondii T cell immunity. CD40 upregulated Beclin 1 and triggered killing of T. gondii by decreasing protein levels of p21, a molecule that degrades Beclin 1. These studies identified CD40-p21-Beclin 1 as a pathway by which adaptive immunity stimulates autophagy. In addition, they support that autophagy is a mechanism through which CD40-dependent immunity mediates in vivo protection and that the CD40-autophagic machinery is needed for host resistance despite IFN-gamma.	[Portillo, Jose-Andres C.; Okenka, Genevieve; Van Grol, Jennifer; Gentil, Katrin; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Portillo, Jose-Andres C.; Okenka, Genevieve; Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Reed, Erin; Landreth, Gary] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Subauste, Angela] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 113, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Microbiol, Dept Internal Med, Dallas, TX 75390 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University; Tokyo Metropolitan Institute of Medical Science; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Portillo, JAC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	carlos.subauste@case.edu	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Subauste, Carlos/0000-0002-5602-1439	National Institutes of Health (NIH) [EY018341, AI48406]; American Heart Association Ohio Valley Affiliate, NIH [P30 EY11373]; Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH [AI36219]; Ohio Lions Eye Research Foundation; Prevent Blindness Ohio;  [T32 EY007157-07]; NATIONAL EYE INSTITUTE [T32EY007157, P30EY011373, R01EY018341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048406, P30AI036219] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate, NIH(American Heart AssociationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH; Ohio Lions Eye Research Foundation; Prevent Blindness Ohio; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants EY018341 (C. S. S) and AI48406 (C. S. S), the American Heart Association Ohio Valley Affiliate (C. S. S), NIH grant P30 EY11373, and Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH grant AI36219. J-A.P. is a recipient of a post-doctoral fellowship from the Ohio Lions Eye Research Foundation. J.V.G. is a recipient of a pre-doctoral fellowship from Prevent Blindness Ohio. J.V.G. was supported by T32 EY007157-07. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RM, 2005, INFECT IMMUN, V73, P3115, DOI 10.1128/IAI.73.5.3115-3123.2005; Andrade RM, 2003, J IMMUNOL, V171, P6750, DOI 10.4049/jimmunol.171.12.6750; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bot I, 2005, BLOOD, V106, P1147, DOI 10.1182/blood-2004-12-4839; BRETAGNE S, 1993, J INFECT DIS, V168, P1585, DOI 10.1093/infdis/168.6.1585; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Deckert-Schluter M, 1998, J IMMUNOL, V160, P3427; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; GAZZINELLI RT, 1993, J IMMUNOL, V151, P3672; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hollmann CA, 2002, EXP CELL RES, V280, P201, DOI 10.1006/excr.2002.5640; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Johnson LL, 2004, VACCINE, V22, P4054, DOI 10.1016/j.vaccine.2004.03.056; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lazarevic V, 2003, IMMUNITY, V19, P823, DOI 10.1016/S1074-7613(03)00324-8; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Leib DA, 2009, J VIROL, V83, P12164, DOI 10.1128/JVI.01676-09; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; NONOYAMA S, 1995, J CLIN INVEST, V95, P66, DOI 10.1172/JCI117677; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Subauste CS, 2006, INFECT IMMUN, V74, P1573, DOI 10.1128/IAI.74.3.1573-1579.2006; Subauste CS, 1999, J IMMUNOL, V162, P6690; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Wu M, 1998, J EXP MED, V187, P1671, DOI 10.1084/jem.187.10.1671; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yap GS, 1998, J IMMUNOL, V160, P1340; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YL, 2007, INFECT IMMUN, V75, P4799, DOI 10.1128/IAI.00738-07; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	65	53	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14472	10.1371/journal.pone.0014472	http://dx.doi.org/10.1371/journal.pone.0014472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217818	gold, Green Published, Green Submitted			2022-12-25	WOS:000285838900003
J	Zeki, S; Romaya, JP				Zeki, Semir; Romaya, John Paul			The Brain Reaction to Viewing Faces of Opposite- and Same-Sex Romantic Partners	PLOS ONE			English	Article							DOPAMINE; ACTIVATION; SEROTONIN; NOREPINEPHRINE; CEREBELLUM; STIMULI; AROUSAL; REWARD; LOVE	We pursued our functional magnetic resonance imaging (fMRI) studies of the neural correlates of romantic love in 24 subjects, half of whom were female (6 heterosexual and 6 homosexual) and half male (6 heterosexual and 6 homosexual). We compared the pattern of activity produced in their brains when they viewed the faces of their loved partners with that produced when they viewed the faces of friends of the same sex to whom they were romantically indifferent. The pattern of activation and de-activation was very similar in the brains of males and females, and heterosexuals and homosexuals. We could therefore detect no difference in activation patterns between these groups.	[Zeki, Semir; Romaya, John Paul] UCL, Wellcome Lab Neurobiol, London, England	University of London; University College London	Zeki, S (corresponding author), UCL, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020	Romaya, John/0000-0002-4857-3997	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	This work was supported by the Wellcome Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; CORTES R, 1989, NEUROSCIENCE, V28, P263, DOI 10.1016/0306-4522(89)90178-4; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kim W, 2009, PSYCHIAT INVEST, V6, P19, DOI 10.4306/pi.2009.6.1.19; Kinsey AC, SEXUAL BEHAV HUMAN M; Lauzon NM, 2010, BEHAV BRAIN RES, V208, P12, DOI 10.1016/j.bbr.2009.11.037; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Marazziti D, 1999, PSYCHOL MED, V29, P741, DOI 10.1017/S0033291798007946; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Messer K, 1999, P 2 C AUD VID BIOM P; Parsons LM, 2000, P NATL ACAD SCI USA, V97, P2332, DOI 10.1073/pnas.040555497; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Penny W, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P166, DOI 10.1016/B978-012372560-8/50013-9; Penny WD, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P156, DOI 10.1016/B978-012372560-8/50012-7; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Rupp HA, 2009, EVOL HUM BEHAV, V30, P1, DOI 10.1016/j.evolhumbehav.2008.08.006; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Safron A, 2007, BEHAV NEUROSCI, V121, P237, DOI 10.1037/0735-7044.121.2.237; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Zeki S, SPLENDORS MISERIES B; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	37	56	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15802	10.1371/journal.pone.0015802	http://dx.doi.org/10.1371/journal.pone.0015802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209829	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900035
J	Glas, J; Seiderer, J; Tillack, C; Pfennig, S; Beigel, F; Jurgens, M; Olszak, T; Laubender, RP; Weidinger, M; Muller-Myhsok, B; Goke, B; Ochsenkuhn, T; Lohse, P; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Juergens, Matthias; Olszak, Torsten; Laubender, Ruediger P.; Weidinger, Maria; Mueller-Myhsok, Bertram; Goeke, Burkhard; Ochsenkuehn, Thomas; Lohse, Peter; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALPHA-DEFENSIN EXPRESSION; GENOME-WIDE ASSOCIATION; CARD15/NOD2 MUTATIONS; FRAMESHIFT MUTATION; DENDRITIC CELLS; PATHOGENESIS; TOLL; PHENOTYPE; ATG16L1	Background: The aims were to analyze two novel NOD2 variants (rs2066843 and rs2076756) in a large cohort of patients with inflammatory bowel disease and to elucidate phenotypic consequences. Methodology/Principal Findings: Genomic DNA from 2700 Caucasians including 812 patients with Crohn's disease (CD), 442 patients with ulcerative colitis (UC), and 1446 healthy controls was analyzed for the NOD2 SNPs rs2066843 and rs2076756 and the three main CD-associated NOD2 variants p. Arg702Trp (rs2066844), p. Gly908Arg (rs2066847), and p.Leu1007fsX1008 (rs2066847). Haplotype and genotype-phenotype analyses were performed. The SNPs rs2066843 (p = 3.01x10(-5), OR 1.48, [95% CI 1.23-1.78]) and rs2076756 (p = 4.01x10(-6); OR 1.54, [95% CI 1.28-1.86]) were significantly associated with CD but not with UC susceptibility. Haplotype analysis revealed a number of significant associations with CD susceptibility with omnibus p values <10(-10). The SNPs rs2066843 and rs2076756 were in linkage disequilibrium with each other and with the three main CD-associated NOD2 mutations (D'>0.9). However, in CD, SNPs rs2066843 and rs2076756 were more frequently observed than the other three common NOD2 mutations (minor allele frequencies for rs2066843 and rs2076756: 0.390 and 0.380, respectively). In CD patients homozygous for these novel NOD2 variants, genotype-phenotype analysis revealed higher rates of a penetrating phenotype (rs2076756: p = 0.015) and fistulas (rs2076756: p = 0.015) and significant associations with CD-related surgery (rs2076756: p = 0.003; rs2066843: p = 0.015). However, in multivariate analysis only disease localization (p<2x10(-16)) and behaviour (p = 0.02) were significantly associated with the need for surgery. Conclusion/Significance: The NOD2 variants rs2066843 and rs2076756 are novel and common CD susceptibility gene variants.	[Glas, Juergen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Juergens, Matthias; Olszak, Torsten; Weidinger, Maria; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Juergens, Matthias] Katholieke Univ Leuven, Div Gastroenterol, Louvain, Belgium; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Sch Med, Boston, MA 02115 USA; [Laubender, Ruediger P.] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Mueller-Myhsok, Bertram; Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lohse, Peter] Univ Munich, Inst Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Munich; Max Planck Society; University of Munich	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; German Research Council (Deutsche Forschungsgemeinschaft, DFG); DFG [BR 1912/5-1]; DCCV e.V.; Ludwig-Maximilians-University Munich (Excellence Initiative); Else Kroener-Exzellenzstipendium [2010_EKES.32]	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung; German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DCCV e.V.; Ludwig-Maximilians-University Munich (Excellence Initiative); Else Kroener-Exzellenzstipendium	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J.S. and Promotionsstipendium to J.D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroener-Fresenius-Stiftung (81/08//EKMS08/01). T. Olszak was supported by a grant from the German Research Council (Deutsche Forschungsgemeinschaft, DFG). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroener-Fresenius-Stiftung (Else Kroener Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62 and the Else Kroener-Exzellenzstipendium 2010_EKES.32), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoeFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, GASTROENTEROLOGY, V129, P1302, DOI 10.1053/j.gastro.2005.08.028; Aldhous MC, 2003, GUT, V52, P1533, DOI 10.1136/gut.52.11.1533; Alvarez-Lobos M, 2005, ANN SURG, V242, P693, DOI 10.1097/01.sla.0000186173.14696.ea; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cho Judy, 2006, Curr Treat Options Gastroenterol, V9, P191, DOI 10.1007/s11938-006-0038-z; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Dambacher J, 2007, INFLAMM BOWEL DIS, V13, P71, DOI 10.1002/ibd.20008; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS1, DOI 10.1097/01.MIB.0000195388.04021.56; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kim YG, 2008, J IMMUNOL, V181, P4340, DOI 10.4049/jimmunol.181.6.4340; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kucharzik T, 2006, INFLAMM BOWEL DIS, V12, P1068, DOI 10.1097/01.mib.0000235827.21778.d5; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leon F, 2006, ADV EXP MED BIOL, V579, P117; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; Wang YF, 2007, J DIGEST DIS, V8, P121, DOI 10.1111/j.1443-9573.2007.00296.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14466	10.1371/journal.pone.0014466	http://dx.doi.org/10.1371/journal.pone.0014466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209938	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793600009
J	Rauch, DA; Hurchla, MA; Harding, JC; Deng, HJ; Shea, LK; Eagleton, MC; Niewiesk, S; Lairmore, MD; Piwnica-Worms, D; Rosol, TJ; Weber, JD; Ratner, L; Weilbaecher, KN				Rauch, Daniel A.; Hurchla, Michelle A.; Harding, John C.; Deng, Hongju; Shea, Lauren K.; Eagleton, Mark C.; Niewiesk, Stefan; Lairmore, Michael D.; Piwnica-Worms, David; Rosol, Thomas J.; Weber, Jason D.; Ratner, Lee; Weilbaecher, Katherine N.			The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice	PLOS ONE			English	Article							CONTAINING BISPHOSPHONATES INHIBIT; ZOLEDRONIC ACID; IN-VIVO; NEUROFIBROMATOSIS TYPE-1; DEFICIENT MICE; GENE; P53; RETINOBLASTOMA; OSTEOCLAST; PATHWAY	The ARF tumor suppressor regulates p53 as well as basic developmental processes independent of p53, including osteoclast activation, by controlling ribosomal biogenesis. Here we provide evidence that ARF is a master regulator of bone remodeling and osteosarcoma (OS) development in mice. Arf(-/-) mice displayed increased osteoblast (OB) and osteoclast (OC) activity with a significant net increase in trabecular bone volume. The long bones of Arf(-/-) mice had increased expression of OB genes while Arf(-/-) OB showed enhanced differentiation in vitro. Mice transgenic for the Tax oncogene develop lymphocytic tumors with associated osteolytic lesions, while Tax+Arf(-/-) mice uniformly developed spontaneous OS by 7 months of age. Tax+Arf(-/-) tumors were well differentiated OS characterized by an abundance of new bone with OC recruitment, expressed OB markers and displayed intact levels of p53 mRNA and reduced Rb transcript levels. Cell lines established from OS recapitulated characteristics of the primary tumor, including the expression of mature OB markers and ability to form mineralized tumors when transplanted. Loss of heterozygosity in OS tumors arising in Tax+Arf(+/-) mice emphasized the necessity of ARF-loss in OS development. Hypothesizing that inhibition of ARF-regulated bone remodeling would repress development of OS, we demonstrated that treatment of Tax+Arf(-/-) mice with zoledronic acid, a bisphosphonate inhibitor of OC activity and repressor of bone turnover, prevented or delayed the onset of OS. These data describe a novel role for ARF as a regulator of bone remodeling through effects on both OB and OC. Finally, these data underscore the potential of targeting bone remodeling as adjuvant therapy or in patients with genetic predispositions to prevent the development of OS.	[Rauch, Daniel A.; Hurchla, Michelle A.; Harding, John C.; Deng, Hongju; Shea, Lauren K.; Eagleton, Mark C.; Weber, Jason D.; Ratner, Lee; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; [Niewiesk, Stefan; Lairmore, Michael D.; Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Niewiesk, Stefan; Lairmore, Michael D.] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol,Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL)	Rauch, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.	KWEILBAE@WUSTL.EDU	Rosol, Thomas/G-9585-2011	Rosol, Thomas/0000-0003-3737-1190; Ratner, Lee/0000-0003-2744-7294; Weber, Jason/0000-0002-1069-6983	National Institutes of Health [T32 CA113275, P01 CA100730, P50 CA94056, R01 CA120436, CA10521, CA63417]; St. Louis Mens' Group Against Cancer; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA120436, T32CA113275, P50CA094056, R01CA063417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Mens' Group Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by grants from the National Institutes of Health to MAH (T32 CA113275), MDL (P01 CA100730), DP-W (P50 CA94056), TJR (P01 CA100730), JDW (R01 CA120436), LR (CA10521, CA63417, P01 CA100730), KNW, MAH, HD, LKS, MCE (P01 CA100730) and from the St. Louis Mens' Group Against Cancer to KNW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT R, LANCET ONCOL, V11, P421; Akiyama T, 2008, MOL CANCER THER, V7, P3461, DOI 10.1158/1535-7163.MCT-08-0530; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Brown HK, 2009, CURR CANCER DRUG TAR, V9, P807, DOI 10.2174/156800909789760339; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Chirgwin JM, 2007, J CELL BIOCHEM, V102, P1333, DOI 10.1002/jcb.21556; Chowdhry M, 2009, J BONE JOINT SURG BR, V91B, P1223, DOI 10.1302/0301-620X.91B9.22299; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Cinamon U, 2002, EUR ARCH OTO-RHINO-L, V259, P540, DOI 10.1007/s00405-002-0497-3; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2002, CANCER RES, V62, P2184; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; Hapidin H, 2007, J BONE MINER METAB, V25, P93, DOI 10.1007/s00774-006-0733-9; Hirbe AC, 2009, BONE, V44, P908, DOI 10.1016/j.bone.2009.01.010; Horiuchi K, 2003, J RHEUMATOL, V30, P1799; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; O'Day K, 2009, EXPERT REV ANTICANC, V9, P511, DOI [10.1586/era.09.7, 10.1586/ERA.09.7]; Oh JH, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000188063.56091.69; PICARDA G, CLIN CANC RES, V16, P2363; Portis T, 2001, J VIROL, V75, P2185, DOI 10.1128/JVI.75.5.2185-2193.2001; Rauch D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-116; Rauch D, 2009, BLOOD, V113, P1493, DOI 10.1182/blood-2008-07-166462; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Tiffee JC, 1999, CALCIFIED TISSUE INT, V65, P53, DOI 10.1007/s002239900657; van Beek E, 1999, BIOCHEM BIOPH RES CO, V255, P491, DOI 10.1006/bbrc.1999.0224; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Xu ZQ, 2009, J BIOL CHEM, V284, P4658, DOI 10.1074/jbc.M804812200; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zhou ZC, 2005, CANCER-AM CANCER SOC, V104, P1713, DOI 10.1002/cncr.21383; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zucchini C, 2008, INT J ONCOL, V32, P17	61	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15755	10.1371/journal.pone.0015755	http://dx.doi.org/10.1371/journal.pone.0015755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209895	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600032
J	Wardlaw, JM; von Kummer, R; Farrall, AJ; Chappell, FM; Hill, M; Perry, D				Wardlaw, Joanna M.; von Kummer, Ruediger; Farrall, Andrew J.; Chappell, Francesca M.; Hill, Michael; Perry, David			A Large Web-Based Observer Reliability Study of Early Ischaemic Signs on Computed Tomography. The Acute Cerebral CT Evaluation of Stroke Study (ACCESS)	PLOS ONE			English	Article							ARTERY OCCLUSION; BRAIN; MR; THROMBOLYSIS; INFARCTION; DIFFUSION	Background: Early signs of ischaemic stroke on computerised tomography (CT) scanning are subtle but CT is the most widely available diagnostic test for stroke. Scoring methods that code for the extent of brain ischaemia may improve stroke diagnosis and quantification of the impact of ischaemia. Methodology and Principal Findings: We showed CT scans from patients with acute ischaemic stroke (n = 32, with different patient characteristics and ischaemia signs) to doctors in stroke-related specialties world-wide over the web. CT scans were shown twice, randomly and blindly. Observers entered their scan readings, including early ischaemic signs by three scoring methods, into the web database. We compared observers' scorings to a reference standard neuroradiologist using area under receiver operator characteristic curve (AUC) analysis, Cronbach's alpha and logistic regression to determine the effect of scales, patient, scan and observer variables on detection of early ischaemic changes. Amongst 258 readers representing 33 nationalities and six specialties, the AUCs comparing readers with the reference standard detection of ischaemic signs were similar for all scales and both occasions. Being a neuroradiologist, slower scan reading, more pronounced ischaemic signs and later time to CT all improved detection of early ischaemic signs and agreement on the rating scales. Scan quality, stroke severity and number of years of training did not affect agreement. Conclusions: Large-scale observer reliability studies are possible using web-based tools and inform routine practice. Slower scan reading and use of CT infarct rating scales improve detection of acute ischaemic signs and should be encouraged to improve stroke diagnosis.	[Wardlaw, Joanna M.; Farrall, Andrew J.; Chappell, Francesca M.; Perry, David] Univ Edinburgh, SINAPSE Collaborat, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [von Kummer, Ruediger] Tech Univ Dresden, Univ Hosp, Dept Neuroradiol, Dresden, Germany; [Hill, Michael] Univ Calgary, Stroke Unit, Dept Neurosci, Foothills Med Ctr, Calgary, AB, Canada	University of Edinburgh; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Calgary	Wardlaw, JM (corresponding author), Univ Edinburgh, SINAPSE Collaborat, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.	Joanna.wardlaw@ed.ac.uk	von Kummer, Rüdiger/AAA-4478-2019; Hernandez, María/GYU-3543-2022; Hill, Michael D/C-9073-2012; Wardlaw, Joanna M/Y-3456-2019	von Kummer, Rüdiger/0000-0003-0119-4604; Hill, Michael D/0000-0002-6269-1543; Wardlaw, Joanna M/0000-0002-9812-6642	Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE); Chest Heart Stroke Scotland [RES000/7]; Royal College of Radiologists; DesAcc, Inc, 801 W Adams St, Chicago, IL; Health Foundation [2268/1282]; Chest Heart Stroke Scotland	Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE); Chest Heart Stroke Scotland; Royal College of Radiologists; DesAcc, Inc, 801 W Adams St, Chicago, IL; Health Foundation; Chest Heart Stroke Scotland	Scottish Funding Council (SFC, http://www.sfc.ac.uk/) and Chief Scientist Office of the Scottish Executive (http://www.cso.scot.nhs.uk/) for JMW through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration (www.sinapse.ac.uk); Chest Heart Stroke Scotland (RES000/7) (http://www.chss.org.uk/) and Royal College of Radiologists (www.rcr.ac.uk) for AJF; DesAcc, Inc, 801 W Adams St, Chicago, IL 60607 for scan management software Digital Jacket (http://www.desacc.com/); The Health Foundation (2268/1282) (this agency no longer exists) supported IST-3 and with Chest Heart Stroke Scotland, also supported a scan management technician for the study; The Stroke Association (TSA 93) supported MAST-I from which some CT scans were obtained (http://www.stroke.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bossuyt PM, 2003, CLIN RADIOL, V58, P575, DOI 10.1016/S0009-9260(03)00258-7; CANDELISE L, 1995, LANCET, V346, P1509; Dorfman DD, 1998, ACAD RADIOL, V5, P591, DOI 10.1016/S1076-6332(98)80294-8; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; HOSSMANN KA, 1980, STROKE, V11, P583, DOI 10.1161/01.STR.11.6.583; Kane I, 2008, CEREBROVASC DIS, V25, P375, DOI 10.1159/000120688; Kharitonova T, 2009, CEREBROVASC DIS, V27, P51, DOI 10.1159/000172634; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; Na DG, 2005, RADIOLOGY, V235, P992, DOI 10.1148/radiol.2353040571; SANDERCOCK P, 2008, 3 INT STROKE TRIAL I; Silver B, 2001, CAN J NEUROL SCI, V28, P113, DOI 10.1017/S031716710005277X; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; von Kummer R, 1998, NEUROLOGY, V51, pS50, DOI 10.1212/WNL.51.3_Suppl_3.S50; von Kummer R, 2009, CLIN NEURORADIOL, V19, P105, DOI 10.1007/s00062-009-1002-9; vonKummer R, 1996, AM J NEURORADIOL, V17, P1743; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; WARDLAW JM, 1994, AM J NEURORADIOL, V15, P1933; Wardlaw JM, 2007, STROKE, V38, P1250, DOI 10.1161/01.STR.0000259715.53166.25; Warren RML, 2005, RADIOLOGY, V236, P779, DOI 10.1148/radiol.2363040735	23	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15757	10.1371/journal.pone.0015757	http://dx.doi.org/10.1371/journal.pone.0015757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209901	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600033
J	Franklin, J; Steadman, DW				Franklin, Janet; Steadman, David W.			Forest Plant and Bird Communities in the Lau Group, Fiji	PLOS ONE			English	Article							IGUANA BRACHYLOPHUS-VITIENSIS; TROPICAL RAIN-FOREST; HABITAT RELATIONSHIPS; SPECIES COMPOSITION; AMERICAN-SAMOA; NEW-GUINEA; VEGETATION; ISLAND; DIVERSITY; ABUNDANCE	Background: We examined species composition of forest and bird communities in relation to environmental and human disturbance gradients on Lakeba (55.9 km(2)), Nayau (18.4 km(2)), and Aiwa Levu (1.2 km(2)), islands in the Lau Group of Fiji, West Polynesia. The unique avifauna of West Polynesia (Fiji, Tonga, Samoa) has been subjected to prehistoric human-caused extinctions but little was previously known about this topic in the Lau Group. We expected that the degree of human disturbance would be a strong determinant of tree species composition and habitat quality for surviving landbirds, while island area would be unrelated to bird diversity. Methodology/Principal Findings: All trees >5 cm diameter were measured and identified in 23 forest plots of 500 m(2) each. We recognized four forest species assemblages differentiated by composition and structure: coastal forest, dominated by widely distributed species, and three forest types with differences related more to disturbance history (stages of secondary succession following clearing or selective logging) than to environmental gradients (elevation, slope, rockiness). Our point counts (73 locations in 1 or 2 seasons) recorded 18 of the 24 species of landbirds that exist on the three islands. The relative abundance and species richness of birds were greatest in the forested habitats least disturbed by people. These differences were due mostly to increased numbers of columbid frugivores and passerine insectivores in forests on Lakeba and Aiwa Levu. Considering only forested habitats, the relative abundance and species richness of birds were greater on the small but completely forested (and uninhabited) island of Aiwa Levu than on the much larger island of Lakeba. Conclusions/Significance: Forest disturbance history is more important than island area in structuring both tree and landbird communities on remote Pacific islands. Even very small islands may be suitable for conservation reserves if they are protected from human disturbance.	[Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA; [Franklin, Janet] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Steadman, David W.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of Florida	Franklin, J (corresponding author), Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	Janet.Franklin@asu.edu			San Diego State University Research Foundation; U.S. National Science Foundation [EAR-9714819]	San Diego State University Research Foundation; U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by San Diego State University Research Foundation (JF) and U.S. National Science Foundation grant EAR-9714819 (DWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding for this research.	Athens J. S., 1997, HIST ECOLOGY PACIFIC, P248; Best SB, 2002, NZ ARCHAEOLOGICAL SO, P24; Burley DV, 2001, P NATL ACAD SCI USA, V98, P11829, DOI 10.1073/pnas.181335398; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Clunie F, 1984, BIRDS FIJI BUSH; Coblentz BE, 1978, BIOL CONSERV, V41, P253; Drake DR, 1996, NEW ZEAL J BOT, V34, P65; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fall PL, 2005, QUATERNARY RES, V64, P451, DOI 10.1016/j.yqres.2005.08.003; FLENLEY JR, 1969, J ECOL, V57, P465, DOI 10.2307/2258393; FRANKLIN J, 1992, J VEG SCI, V3, P3, DOI 10.2307/3235991; Franklin J, 1999, J VEG SCI, V10, P51, DOI 10.2307/3237160; Franklin J, 2006, J VEG SCI, V17, P233, DOI 10.1111/j.1654-1103.2006.tb02442.x; Franklin J, 2003, NEW ZEAL J BOT, V41, P669, DOI 10.1080/0028825X.2003.9512877; Franklin J, 2004, J TROP ECOL, V20, P409, DOI 10.1017/S0266467404001543; FRANKLIN J, 1991, CONSERV BIOL, V5, P506, DOI 10.1111/j.1523-1739.1991.tb00358.x; Franklin J, 2007, AUSTRAL ECOL, V32, P789, DOI 10.1111/j.1442-9993.2007.01766.x; Franklin Janet, 2008, Micronesica, V40, P169; Franklin J, 2008, OIKOS, V117, P1885, DOI 10.1111/j.1600-0706.2008.16922.x; Freifeld HB, 1999, J BIOGEOGR, V26, P1191, DOI 10.1046/j.1365-2699.1999.00349.x; Garnock-Jones PJ, 1978, ROYAL SOC NZ B, V17, P95; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Grubb PJ, 1996, FUNCT ECOL, V10, P512, DOI 10.2307/2389944; Harlow PS, 2007, ORYX, V41, P44, DOI 10.1017/S0030605307001639; Harlow PS, 2001, BIOL CONSERV, V98, P223, DOI 10.1016/S0006-3207(00)00157-9; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hjerpe J, 2001, BIOTROPICA, V33, P249, DOI 10.1111/j.1744-7429.2001.tb00176.x; HOPKINS MS, 1983, BIOTROPICA, V15, P90, DOI 10.2307/2387950; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HYNDMAN DC, 1990, J BIOGEOGR, V17, P241, DOI 10.2307/2845122; Jones S, 2007, J ISL COAST ARCHAEOL, V2, P72, DOI DOI 10.1080/15564890701219966; Keppel G, 2007, NEW ZEAL J BOT, V45, P545, DOI 10.1080/00288250709509738; Keppel G, 2006, NEW ZEAL J BOT, V44, P273, DOI 10.1080/0028825X.2006.9513024; Keppel Gunnar, 2005, Pacific Science, V59, P175, DOI 10.1353/psc.2005.0021; Keppel G, 2010, J ECOL, V98, P87, DOI 10.1111/j.1365-2745.2009.01595.x; KIRCH PV, 1994, ANTIQUITY, V68, P310, DOI 10.1017/S0003598X00046615; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Koopman Karl F., 1995, American Museum Novitates, V3125, P1; Kuehler C., 1997, Bird Conservation International, V7, P69; Ladd HS, 1945, BERNICE P BISH MUS B, V181, p2N; Lasky JR, 2010, J TROP ECOL, V26, P67, DOI 10.1017/S0266467409990368; Latham M, 1983, 3 UNESCOUNFPA; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Morrison C, 2007, AUST J ZOOL, V55, P341, DOI 10.1071/ZO07062; Morrison C, 2009, PAC SCI, V63, P223, DOI 10.2984/049.063.0205; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Nunn P., 1994, OCEANIC ISLANDS; O'Day SJ, 2004, NZ J ARCHAEOLOGY, V25, P31; Palmer MW, 1991, ECOLOGY, V71, P1195; Pratt H. D., 1987, FIELD GUIDE BIRDS HA; Pregill Gregory K., 1993, Pacific Science, V47, P101; R Development Core Team, 2007, R LANG ENV STAT COMP; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Robertson HA, 2006, BIRD CONSERV INT, V16, P197, DOI 10.1017/S0959270906000268; Simons TR, 2007, AUK, V124, P986, DOI 10.1642/0004-8038(2007)124[986:EAOTAD]2.0.CO;2; Steadman David W., 1999, Pacific Conservation Biology, V5, P191; Steadman David W., 1998, Pacific Science, V52, P14; Steadman David W., 1999, Ecotropica, V5, P13; Steadman DW, 1998, CONDOR, V100, P609, DOI 10.2307/1369743; Steadman DW, 2000, EMU, V100, P227, DOI 10.1071/MU9934; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Steadman DW, 2002, P NATL ACAD SCI USA, V99, P3673, DOI 10.1073/pnas.072079299; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Straatmans W, 1964, MICRONESICA, V1, P113; Ter Braak C. J. F., 1995, P91; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Van Tongeren O. F. R., 1995, P174; Watling D, 2001, GUIDE BIRDS FIJI W P; Watling D, 1982, BIRDS FIJI TONGA SAM; Webb EL, 2006, PAC SCI, V60, P333, DOI 10.1353/psc.2006.0019; Webb EL, 1999, PLANT ECOL, V144, P257, DOI 10.1023/A:1009862618250; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Whistler WA, 1980, ALLERTONIA, V2, P45; Wiser SK, 2002, J BIOGEOGR, V29, P767, DOI 10.1046/j.1365-2699.2002.00723.x	78	11	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15685	10.1371/journal.pone.0015685	http://dx.doi.org/10.1371/journal.pone.0015685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206753	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200037
J	Wernery, U; Liu, CH; Baskar, V; Guerineche, Z; Khazanehdari, KA; Saleem, S; Kinne, J; Wernery, R; Griffin, DK; Chang, IK				Wernery, Ulrich; Liu, Chunhai; Baskar, Vijay; Guerineche, Zhor; Khazanehdari, Kamal A.; Saleem, Shazia; Kinne, Joerg; Wernery, Renate; Griffin, Darren K.; Chang, Il-Kuk			Primordial Germ Cell-Mediated Chimera Technology Produces Viable Pure-Line Houbara Bustard Offspring: Potential for Repopulating an Endangered Species	PLOS ONE			English	Article							CHICKEN; QUAIL; GENERATION; BIRDS	Background: The Houbara bustard (Chlamydotis undulata) is a wild seasonal breeding bird populating arid sandy semi-desert habitats in North Africa and the Middle East. Its population has declined drastically during the last two decades and it is classified as vulnerable. Captive breeding programmes have, hitherto, been unsuccessful in reviving population numbers and thus radical technological solutions are essential for the long term survival of this species. The purpose of this study was to investigate the use of primordial germ cell-mediated chimera technology to produce viable Houbara bustard offspring. Methodology/Principal Findings: Embryonic gonadal tissue was dissected from Houbara bustard embryos at eight days post-incubation. Subsequently, Houbara tissue containing gonadal primordial germ cells (gPGCs) was injected into White Leghorn chicken (Gallus gallus domesticus) embryos, producing 83/138 surviving male chimeric embryos, of which 35 chimeric roosters reached sexual maturity after 5 months. The incorporation and differentiation of Houbara gPGCs in chimeric chicken testis were assessed by PCR with Houbara-specific primers and 31.3% (5/16) gonads collected from the injected chicken embryos showed the presence of donor Houbara cells. A total of 302 semen samples from 34 chimeric roosters were analyzed and eight were confirmed as germline chimeras. Semen samples from these eight roosters were used to artificially inseminate three female Houbara bustards. Subsequently, 45 Houbara eggs were obtained and incubated, two of which were fertile. One egg hatched as a male live born Houbara; the other was female but died before hatching. Genotyping confirmed that the male chick was a pure-line Houbara derived from a chimeric rooster. Conclusion: This study demonstrates for the first time that Houbara gPGCs can migrate, differentiate and eventually give rise to functional sperm in the chimeric chicken testis. This approach may provide a promising tool for propagation and conservation of endangered avian species that cannot breed in captivity.	[Wernery, Ulrich; Liu, Chunhai; Baskar, Vijay; Guerineche, Zhor; Khazanehdari, Kamal A.; Saleem, Shazia; Kinne, Joerg; Wernery, Renate; Chang, Il-Kuk] Cent Vet Res Lab, Dubai, U Arab Emirates; [Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent	Wernery, U (corresponding author), Cent Vet Res Lab, Dubai, U Arab Emirates.	d.k.griffin@kent.ac.uk	Khazanehdari, Kamal/AAN-1572-2021		Biotechnology and Biological Sciences Research Council [BB/E024211/1]; International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco; Houbara bustard Breeding Centre; BBSRC [BB/E024211/1, BB/E010652/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010652/1, G19438/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco; Houbara bustard Breeding Centre; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by H.H. Sheikh Mohammed bin Rashid Al Maktoum, the Ruler of Dubai and Vice President of the United Arab Emirates, and Dr. Ali Redha, Administrative Director of Central Veterinary Research Laboratory. DKG is supported by Biotechnology and Biological Sciences Research Council Career Development Fellowship BB/E024211/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco for their support. Many thanks go to Dr. Jurgen Sasse, Mr. Jahabar Ali, Mr. Lahcen Ben Kamel, Mr. Chris Dumatol and Dr. Fatima Hakimuddin for their excellent work. Furthermore we thank the staff of CVRL's chicken house as well as the Houbara bustard Breeding Centre for their support.	[Anonymous], 1914, AM J ANAT, V15, P483; CHANG IK, 1995, CELL BIOL INT, V19, P143, DOI 10.1006/cbir.1995.1055; Chang IK, 1997, CELL BIOL INT, V21, P495, DOI 10.1006/cbir.1997.0173; CITES, CONV INT TRAD END SP; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; GINSBURG M, 1986, J EMBRYOL EXP MORPH, V95, P53; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; Kim JN, 2010, BIOL REPROD, V82, P257, DOI 10.1095/biolreprod.109.079723; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P308, DOI 10.2141/jpsa.38.308; Li ZD, 2002, POULTRY SCI, V81, P1360, DOI 10.1093/ps/81.9.1360; Liu CH, 2007, ANIM REPROD SCI, V101, P344, DOI 10.1016/j.anireprosci.2006.12.021; Nakamura Y, 2008, REPROD FERT DEVELOP, V20, P900, DOI 10.1071/RD08138; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Park TS, 2008, MOL REPROD DEV, V75, P274, DOI 10.1002/mrd.20821; Pitra C, 2000, MOL ECOL, V9, P1165, DOI 10.1046/j.1365-294x.2000.00983.x; Saint-Jalme M, 1995, PROPAGATION HOUBARA, P70; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Tajima A, 1998, J EXP ZOOL, V280, P265, DOI 10.1002/(SICI)1097-010X(19980215)280:3&lt;265::AID-JEZ8&gt;3.0.CO;2-L; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; The IUCN Red List,, IUCN RED LIST THREAT; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Yamamoto Y, 2007, BIOL REPROD, V77, P115, DOI 10.1095/biolreprod.107.061200; YASUDA Y, 1992, J REPROD FERTIL, V96, P521, DOI 10.1530/jrf.0.0960521; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	26	38	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15824	10.1371/journal.pone.0015824	http://dx.doi.org/10.1371/journal.pone.0015824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209914	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000285793200060
J	Whelan, KF; Lu, JP; Fridman, E; Wolf, A; Honig, A; Paulin, G; Klotz, L; Pinthus, JH				Whelan, Kaitlyn F.; Lu, Jian-Ping; Fridman, Eduard; Wolf, Alex; Honig, Alon; Paulin, Gregory; Klotz, Laurence; Pinthus, Jehonathan H.			What Can Surrogate Tissues Tell Us about the Oxidative Stress Status of the Prostate? A Hypothesis-Generating In-Vivo Study	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; HUMAN HAIR FOLLICLE; ANDROGEN RECEPTOR; SUBMANDIBULAR-GLAND; SEXUAL-DIMORPHISM; CANCER; MOUSE; SERUM; PREVENTION; EXPRESSION	Background: Prostatic oxidative stress (OS) is androgen-regulated and a key event in the development of prostate cancer (PC). Thus, reducing prostatic OS is an attractive target for PC prevention strategies. We sought to determine if the individual's prostatic OS status can be determined by examining the OS in surrogate androgen regulated tissues from the same host. Methodology/Principal Findings: Adult male rats were divided equally into three groups: (A-) underwent bilateral orchiectomy, (A+) received continuous testosterone supplementation or (C) were eugonadal. Serum testosterone, 8hydroxy-2-deoxyguanosine (8-OHdG) and anti-oxidative capacity (AOC) were determined after 72 hrs and the prostate, salivary glands and the hair follicles' Dermal Papillary Cells (DPC) from each animal were harvested, embedded into tissue microarray and examined for the expression of 8-OHdG by immuno-staining. Multi-variate regression was used to analyze inter-individual differences in OS staining within each androgen group and if there was a correlation between serum testosterone, 8-OHdG or AOC and Prostatic OS in tissues of same host. At the group level, 8-OHdG staining intensity directly correlated with serum testosterone levels in all three target tissues (p>0.01, Mann-Whitney Test). Although different levels of prostatic OS were noted between rats with similar serum testosterone levels and similar systemic OS measurements (p<0.01), there were no intra-individual differences between the OS status of the prostate and DPC (p<0.05). Conclusions/Significance: The level of prostatic OS is correlated with the OS of hair follicles and salivary glands, but not systemic OS. Moreover, systemic AOC negatively correlates with both prostatic and hair follicle OS. This suggests that hair follicle and salivary gland OS can serve as surrogate markers for the efficiency of OS reduction. This has tremendous potential for the rational evaluation of patient response to prevention strategies.	[Whelan, Kaitlyn F.; Lu, Jian-Ping; Fridman, Eduard; Wolf, Alex; Honig, Alon; Paulin, Gregory; Pinthus, Jehonathan H.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Klotz, Laurence] Univ Toronto, Dept Surg, Toronto, ON, Canada	McMaster University; University of Toronto	Whelan, KF (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	Jehonathan.pinthus@jcc.hhsc.ca	Pinthus, Jehonathan/AAQ-1667-2021	Paulin, Gregory/0000-0001-8752-0102; Fridman, Eddie/0000-0002-0317-7085				ANDREWS EJ, 1972, ANAT REC, V174, P361, DOI 10.1002/ar.1091740307; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Canakci CF, 2009, ARCH IMMUNOL THER EX, V57, P205, DOI 10.1007/s00005-009-0026-9; CEFALU WT, 1986, J CLIN ENDOCR METAB, V63, P20, DOI 10.1210/jcem-63-1-20; Cerbon MA, 1996, J COMP PHYSIOL A, V178, P351; Chen WC, 2004, ARCH DERMATOL RES, V296, P245, DOI 10.1007/s00403-004-0514-z; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeWeese TL, 2001, UROLOGY, V57, P137, DOI 10.1016/S0090-4295(00)00959-6; FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; George J, 2001, J CLIN PHARM THER, V26, P231, DOI 10.1046/j.1365-2710.2001.00354.x; Hoque A, 2010, CANCER PREV RES, V3, P478, DOI 10.1158/1940-6207.CAPR-09-0201; Inui S, 2007, J INVEST DERMATOL, V127, P2302, DOI 10.1038/sj.jid.5700883; Jave-Suarez LF, 2004, J INVEST DERMATOL, V122, P555, DOI 10.1111/j.0022-202X.2004.22336.x; JAYASINGHE NR, 1990, J ANAT, V172, P115; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Klein EA, 2006, UROLOGY, V68, P1145, DOI 10.1016/j.urology.2006.08.1074; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; KYAKUMOTO S, 1986, J ENDOCRINOL, V108, P267, DOI 10.1677/joe.0.1080267; LAINE M, 1993, ARCH ORAL BIOL, V38, P299, DOI 10.1016/0003-9969(93)90136-A; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; MIN KW, 1980, UROLOGY, V16, P95, DOI 10.1016/0090-4295(80)90346-5; Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001; Miyake H, 2004, J UROLOGY, V171, P1533, DOI 10.1097/01.ju.0000116617.32728.ca; MIZUKI N, 1992, MOL CELL ENDOCRINOL, V89, P25, DOI 10.1016/0303-7207(92)90207-M; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Pinthus JH, 2004, J UROLOGY, V172, P1644, DOI 10.1097/01.ju.0000140139.91993.a0; RANDALL VA, 1994, SKIN PHARMACOL, V7, P20; Reznick AZ, 2006, ARCH ORAL BIOL, V51, P640, DOI 10.1016/j.archoralbio.2006.02.004; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ryo K, 2006, PATHOBIOLOGY, V73, P252, DOI 10.1159/000098211; SAWADA K, 1991, ACTA ANAT, V140, P97; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; SIMSSAMPSON G, 1984, ANAT RECORD, V210, P53, DOI 10.1002/ar.1092100109; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Yasuda M, 2008, J SEX MED, V5, P1482, DOI 10.1111/j.1743-6109.2008.00821.x; YOSSEPOWITCH O, 2007, J UROLOGY, V178, P1243; Zitzmann M, 2009, FRONT HORM RES, V37, P52, DOI 10.1159/000175843	41	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15880	10.1371/journal.pone.0015880	http://dx.doi.org/10.1371/journal.pone.0015880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209941	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500040
J	Ogiwara, H; Ui, A; Otsuka, A; Satoh, H; Yokomi, I; Nakajima, S; Yasui, A; Yokota, J; Kohno, T				Ogiwara, H.; Ui, A.; Otsuka, A.; Satoh, H.; Yokomi, I.; Nakajima, S.; Yasui, A.; Yokota, J.; Kohno, T.			Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors	ONCOGENE			English	Article						non-homologous end joining; DNA double-strand break; DNA repair; chromatin; histone acetyltransferase	DNA-DAMAGE; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; DISTINCT ROLES; TUMOR-CELLS; REPAIR; PROTEIN; ACETYLTRANSFERASE; CANCER; GAMMA-H2AX	Non-homologous end joining (NHEJ) is a major repair pathway for DNA double-strand breaks (DSBs) generated by ionizing radiation (IR) and anti-cancer drugs. Therefore, inhibiting the activity of proteins involved in this pathway is a promising way of sensitizing cancer cells to both radiotherapy and chemotherapy. In this study, we developed an assay for evaluating NHEJ activity against DSBs in chromosomal DNA in human cells to identify the chromatin modification/remodeling proteins involved in NHEJ. We showed that ablating the activity of the homologous histone acetyltransferases, CBP and p300, using inhibitors or small interfering RNAs-suppressed NHEJ. Ablation of CBP or p300 impaired IR-induced DSB repair and sensitized lung cancer cells to IR and the anti-cancer drug, etoposide, which induces DSBs that are repaired by NHEJ. The CBP/p300 proteins were recruited to sites of DSBs and their ablation suppressed acetylation of lysine 18 within histone H3, and lysines 5, 8, 12, and 16 within histone H4, at the DSB sites. This then suppressed the recruitment of KU70 and KU80, both key proteins for NHEJ, to the DSB sites. Ablation of CBP/p300 also impaired the recruitment of BRM, a catalytic subunit of the SWI/SNF complex involved in chromatin remodeling at DSB sites. These results indicate that CBP and p300 function as histone H3 and H4 acetyltransferases at DSB sites in NHEJ and facilitate chromatin relaxation. Therefore, inhibition CBP and p300 activity may sensitize cancer cells to radiotherapy and chemotherapy. Oncogene (2011) 30, 2135-2146; doi:10.1038/onc.2010.592; published online 10 January 2011	[Ogiwara, H.; Ui, A.; Otsuka, A.; Kohno, T.] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 1040045, Japan; [Ui, A.; Otsuka, A.; Yokota, J.] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Tokyo 1040045, Japan; [Ui, A.; Nakajima, S.; Yasui, A.] Tohoku Univ, Div Dynam Proteome Aging & Canc, Dept Mol Genet, Inst Dev, Sendai, Miyagi, Japan; [Satoh, H.; Yokomi, I.] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Tumor Cell Biol, Tokyo, Japan; [Yokomi, I.] St Marianna Univ, Sch Med, Dept Pharmacol, Kanagawa, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tohoku University; University of Tokyo; Saint Marianna University	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tkkohno@ncc.go.jp	Ui, Ayako/GON-4666-2022	Ui, Ayako/0000-0001-6698-7168; Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Institute of Biomedical Innovation (NiBio)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	We thank Dr Maria Jasin of the Memorial Sloan-Kettering Cancer Center, USA, for the pCBASce plasmid, Dr Marc Tini of the University of Western Ontario for the yellow fluorescent protein-Cbp plasmid and Dr Kazunori Aoki of the National Cancer Center Research Institute for the pAD-TK plasmid. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas; from the Ministry of Health, Labor and Welfare of Japan for the 3rd-term Comprehensive 10-year Strategy for Cancer Control and for Cancer Research (19-9); and from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Downs JA, 2007, ONCOGENE, V26, P7765, DOI 10.1038/sj.onc.1210874; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Javvadi P, 2008, MOL PHARMACOL, V73, P1491, DOI 10.1124/mol.107.043554; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Khafif A, 2005, OTOLARYNG HEAD NECK, V132, P317, DOI 10.1016/j.otohns.2004.09.006; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Yoshida S, 2001, CYTOGENET CELL GENET, V94, P88, DOI 10.1159/000048791; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	44	208	216	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	18					2135	2146		10.1038/onc.2010.592	http://dx.doi.org/10.1038/onc.2010.592			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21217779				2022-12-25	WOS:000290249600005
J	Szabo, R; Rasmussen, AL; Moyer, AB; Kosa, P; Schafer, JM; Molinolo, AA; Gutkind, JS; Bugge, TH				Szabo, R.; Rasmussen, A. L.; Moyer, A. B.; Kosa, P.; Schafer, J. M.; Molinolo, A. A.; Gutkind, J. S.; Bugge, T. H.			c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase	ONCOGENE			English	Article						hepatocyte growth factor; head and neck carcinoma; mTor; protease-activated signaling; cell surface proteases	HEPATOCYTE GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; PLASMINOGEN-ACTIVATOR; IN-VIVO; FACTOR/SCATTER FACTOR; BARRIER FUNCTION; CANCER; MICE; RAPAMYCIN; RECEPTOR	The progression and negative outcome of a variety of human carcinomas are intimately associated with aberrant activity of the c-Met oncogene. The underlying cause of this dysregulation, however, remains a subject of discussion, as the majority of cancer patients do not present with activating mutations in c-Met receptor itself. In this study, we show that the oncogenic protease matriptase is ubiquitously co-expressed with the c-Met in human squamous cell carcinomas and amplifies migratory and proliferative responses of primary epithelial cells to the cognate ligand for c-Met, pro-hepatocyte growth factor/scatter factor (proHGF/SF), through c-Met and Gab1 signaling. Furthermore, the selective genetic ablation of c-Met from matriptase-expressing keratinocytes completely negates the oncogenic potential of matriptase. In addition, matriptase-dependent carcinoma formation could be blocked by the pharmacological inhibition of the Akt-mammalian target of Rapamycin (mTor) pathway. Our data identify matriptase as an initiator of c-Met-Akt-mTor-dependent signaling axis in tumors and reveal mTor activation as an essential component of matriptase/ c-Met-induced carcinogenesis. The study provides a specific example of how epithelial transformation can be promoted by epigenetic acquisition of the capacity to convert a widely available paracrine growth factor precursor to its signaling competent state. Oncogene (2011) 30, 2003-2016; doi:10.1038/onc.2010.586; published online 10 January 2011	[Szabo, R.; Rasmussen, A. L.; Moyer, A. B.; Kosa, P.; Schafer, J. M.; Molinolo, A. A.; Gutkind, J. S.; Bugge, T. H.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bugge, TH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000551, ZIADE000699] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Snorri Thorgeirsson for floxed Hgfr mice. Supported by NIDCR Intramural Research Program. We thank Dr Mary Jo Danton for critically reviewing this manuscript.	Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartmann G, 1998, CURR BIOL, V8, P125, DOI 10.1016/S0960-9822(98)70059-4; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Itoh H, 2004, GASTROENTEROLOGY, V127, P1423, DOI 10.1053/j.gastro.2004.08.027; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Kang JY, 2003, CANCER RES, V63, P1101; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Ma H, 2009, KIDNEY INT, V76, P868, DOI 10.1038/ki.2009.304; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Owen KA, 2010, BIOCHEM J, V426, P219, DOI 10.1042/BJ20091448; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Raimondi AR, 2009, CANCER RES, V69, P4159, DOI 10.1158/0008-5472.CAN-08-4645; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shanmukhappa K, 2009, J BIOL CHEM, V284, P12917, DOI 10.1074/jbc.M807313200; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617; Zhou HM, 2000, EMBO J, V19, P4817, DOI 10.1093/emboj/19.17.4817	50	76	77	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2003	2016		10.1038/onc.2010.586	http://dx.doi.org/10.1038/onc.2010.586			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21217780	Green Accepted			2022-12-25	WOS:000289977400004
J	Hisa, I; Inoue, Y; Hendy, GN; Canaff, L; Kitazawa, R; Kitazawa, S; Komori, T; Sugimoto, T; Seino, S; Kaji, H				Hisa, Itoko; Inoue, Yoshifumi; Hendy, Geoffrey N.; Canaff, Lucie; Kitazawa, Riko; Kitazawa, Sohei; Komori, Toshihisa; Sugimoto, Toshitsugu; Seino, Susumu; Kaji, Hiroshi			Parathyroid Hormone-responsive Smad3-related Factor, Tmem119, Promotes Osteoblast Differentiation and Interacts with the Bone Morphogenetic Protein-Runx2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ALKALINE-PHOSPHATASE ACTIVITY; TRANSCRIPTION FACTOR; CLEIDOCRANIAL DYSPLASIA; GENE-EXPRESSION; ANABOLIC ACTION; MC3T3-E1 CELLS; CBFA1; SMAD3; RUNX2	The mechanisms whereby the parathyroid hormone (PTH) exerts its anabolic action on bone are incompletely understood. We previously showed that inhibition of ERK1/2 enhanced Smad3-induced bone anabolic action in osteoblasts. These findings suggested the hypothesis that changes in gene expression associated with the altered Smad3-induced signaling brought about by an ERK1/2 inhibitor would identify novel bone anabolic factors in osteoblasts. We therefore performed a comparative DNA microarray analysis between empty vector-transfected mouse osteoblastic MC3T3-E1 cells and PD98059-treated stable Smad3-overexpressing MC3T3-E1 cells. Among the novel factors, Tmem119 was selected on the basis of its rapid induction by PTH independent of later increases in endogenous TGF-beta. The levels of Tmem119 increased with time in cultures of MC3T3-E1 cells and mouse mesenchymal ST-2 cells committed to the osteoblast lineage by BMP-2. PTH stimulated Tmem119 levels within 1 h as determined by Western blot analysis and immunocytochemistry in MC3T3-E1 cells. MC3T3-E1 cells stably overexpressing Tmem119 exhibited elevated levels of Runx2, osteocalcin, alkaline phosphatase, and beta-catenin, whereas Tmem119 augmented BMP-2-induced Runx2 levels in mesenchymal cells. Tmem119 interacted with Runx2, Smad1, and Smad5 in C2C12 cells. In conclusion, we identified a Smad3-related factor, Tmem119, that is induced by PTH and promotes differentiation in mouse osteoblastic cells. Tmem119 is an important molecule in the pathway downstream of PTH and Smad3 signaling in osteoblasts.	[Hisa, Itoko; Inoue, Yoshifumi; Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Physiol, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; [Kitazawa, Riko; Kitazawa, Sohei] Kobe Univ, Grad Sch Med, Div Diagnost Mol Pathol, Kobe, Hyogo 6500017, Japan; [Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Unit Basic Med Sci, Nagasaki 852, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan; [Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Physiol & Cellular Biol, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan	Kobe University; McGill University; McGill University; McGill University; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Kobe University; Nagasaki University; Shimane University; Kobe University	Kaji, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hiroshik@med.kobe-u.ac.jp	Kitazawa, Sohei/E-5602-2010; Kaji, Hiroshi/AAI-5628-2020	Kitazawa, Sohei/0000-0002-7466-7356; 	Mitsui Life Social Welfare Foundation; Ministry of Science, Education, and Culture of Japan [17590961, 21591179]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Canadian Institutes of Health Research [MOP-9315]; Kidney Foundation of Canada; Research Institute of the McGill University Health Centre; Grants-in-Aid for Scientific Research [21591179] Funding Source: KAKEN	Mitsui Life Social Welfare Foundation; Ministry of Science, Education, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Research Institute of the McGill University Health Centre; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Mitsui Life Social Welfare Foundation (to H. K.), Grants-in-aid 17590961 and 21591179 from the Ministry of Science, Education, and Culture of Japan (to H. K.), the Global COE Program F11 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Canadian Institutes of Health Research Grant MOP-9315 (to G. N. H.).r Supported by a Kidney Foundation of Canada Biomedical Fellowship and a fellowship from the Research Institute of the McGill University Health Centre.	Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Kaji H, 1999, CANCER RES, V59, P5097; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Rosen CJ, 2001, J CLIN ENDOCR METAB, V86, P957, DOI 10.1210/jc.86.3.957; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	40	52	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9787	9796		10.1074/jbc.M110.179127	http://dx.doi.org/10.1074/jbc.M110.179127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239498	hybrid, Green Published			2022-12-25	WOS:000288247700101
J	Lelouvier, B; Puertollano, R				Lelouvier, Benjamin; Puertollano, Rosa			Mucolipin-3 Regulates Luminal Calcium, Acidification, and Membrane Fusion in the Endosomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARITINT-WADDLER PHENOTYPE; CONSTITUTIVE ACTIVITY; MUTATION; MOUSE; MICE; ORGANELLES; DEAFNESS; LEADS; CA2+	Mucolipin-3 (MCOLN3) is a pH-regulated Ca2+ channel that localizes to the endosomal pathway. Gain-of-function mutation in MCOLN3 causes the varitint-waddler (Va) phenotype in mice, which is characterized by hearing loss, vestibular dysfunction, and coat color dilution. The Va phenotype results from a punctual mutation (A419P) in the pore region of MCOLN3 that locks the channel in an open conformation causing massive entry of Ca2+ inside cells and inducing cell death by apoptosis. Overexpression of wild-type MCOLN3 produces severe alterations of the endosomal pathway, including enlargement and clustering of endosomes, delayed EGF receptor degradation, and impaired autophagosome maturation, thus suggesting that MCOLN3 plays an important role in the regulation of endosomal function. To understand better the physiological role of MCOLN3, we inhibited MCOLN3 function by expression of a channel-dead dominant negative mutant (458DD/KK) or by knockdown of endogenous MCOLN3. Remarkably, we found that impairment of MCOLN3 activity caused a significant accumulation of luminal Ca2+ in endosomes. This accumulation led to severe defects in endosomal acidification as well as to increased endosomal fusion. Our findings reveal a prominent role for MCOLN3 in regulating Ca2+ homeostasis at the endosomal pathway and confirm the importance of luminal Ca2+ for proper acidification and membrane fusion.	[Lelouvier, Benjamin; Puertollano, Rosa] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov			NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006075] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the NHLBI, National Institutes of Health.	Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dunn Kenneth, 2003, Methods Cell Biol, V72, P389, DOI 10.1016/S0091-679X(03)72019-6; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-8; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yan Q, 2004, J BIOL CHEM, V279, P18270, DOI 10.1074/jbc.M400093200; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587	24	54	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9826	9832		10.1074/jbc.M110.169185	http://dx.doi.org/10.1074/jbc.M110.169185			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245134	hybrid, Green Published			2022-12-25	WOS:000288247700105
J	Liu, TF; Yoza, BK; El Gazzar, M; Vachharajani, VT; Mccall, CE				Liu, Tie Fu; Yoza, Barbara K.; El Gazzar, Mohamed; Vachharajani, Vidula T.; Mccall, Charles E.			NAD(+)-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL BIOGENESIS; CHROMATIN; HISTONE; ACTIVATION; INDUCTION; ALPHA; TRANSCRIPTION; METABOLISM; MODULATION; EXPRESSION	Gene-selective epigenetic reprogramming and shifts in cellular bioenergetics develop when Toll-like receptors (TLR) recognize and respond to systemic life-threatening infections. Using a human monocyte cell model of endotoxin tolerance and human leukocytes from acute systemic inflammation with sepsis, we report that energy sensor sirtuin 1 (SIRT1) coordinates the epigenetic and bioenergy shifts. After TLR4 signaling, SIRT1 rapidly accumulated at the promoters of TNF-alpha and IL-beta, but not I kappa B alpha; SIRT1 promoter binding was dependent on its co-factor, NAD(+). During this initial process, SIRT1 deacetylated RelA/p65 lysine 310 and nucleosomal histone H4 lysine 16 to promote termination of NF kappa B-dependent transcription. SIRT1 then remained promoter bound and recruited de novo induced RelB, which directed assembly of the mature transcription repressor complex that generates endotoxin tolerance. SIRT1 also promoted de novo expression of RelB. During sustained endotoxin tolerance, nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for endogenous production of NAD(+), and SIRT1 expression increased. The elevation of SIRT1 required protein stabilization and enhanced translation. To support the coordination of bioenergetics in human sepsis, we observed elevated NAD(+) levels concomitant with SIRT1 and RelB accumulation at the TNF-alpha promoter of endotoxin tolerant sepsis blood leukocytes. We conclude that TLR4 stimulation and human sepsis activate pathways that couple NAD(+) and its sensor SIRT1 with epigenetic reprogramming.	[Liu, Tie Fu; Yoza, Barbara K.; El Gazzar, Mohamed; Mccall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Surg, Winston Salem, NC 27157 USA; [Vachharajani, Vidula T.] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Mccall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tliu@wfubmc.edu; chmccall@wfubmc.edu	Vachharajani, Vidula/AAX-3640-2021	Vachharajani, Vidula/0000-0002-0892-7084	National Institutes of Health [RO1 AI-065791, R01 AI-079144]; Wake Forest University General Clinical Research Center [MO-1RR 007122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI-065791 (to C. E. M.), R01 AI-079144 (to C. E. M.), and MO-1RR 007122 (Wake Forest University General Clinical Research Center). The research on human participants was endorsed by Wake Forest University IRB Protocol BG174.	AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hasmann M, 2003, CANCER RES, V63, P7436; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Irizar A, 2010, NUCLEIC ACIDS RES, V38, P4675, DOI 10.1093/nar/gkq242; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482	36	178	185	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9856	9864		10.1074/jbc.M110.196790	http://dx.doi.org/10.1074/jbc.M110.196790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245135	Green Published, hybrid			2022-12-25	WOS:000288247700109
J	Marion, V; Sankaranarayanan, S; de Theije, C; van Dijk, P; Lindsey, P; Lamers, MC; Harding, HP; Ron, D; Lamers, WH; Kohler, SE				Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lindsey, Patrick; Lamers, Marinus C.; Harding, Heather P.; Ron, David; Lamers, Wouter H.; Kohler, S. Eleonore			Arginine Deficiency Causes Runting in the Suckling Period by Selectively Activating the Stress Kinase GCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; TRANSLATIONAL CONTROL; SKELETAL-MUSCLE; IGF-I; MOLECULAR-MECHANISMS; INSULIN-SECRETION; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MOUSE INTESTINE; GENE-EXPRESSION	Suckling "F/A2" mice, which overexpress arginase-I in their enterocytes, develop a syndrome (hypoargininemia, reduced hair and muscle growth, impaired B-cell maturation) that resembles IGF1 deficiency. The syndrome may result from an impaired function of the GH-IGF1 axis, activation of the stress-kinase GCN2, and/or blocking of the mTORC1-signaling pathway. Arginine deficiency inhibited GH secretion and decreased liver Igf1 mRNA and plasma IGF1 concentration, but did not change muscle IGF1 concentration. GH supplementation induced Igf1 mRNA synthesis, but did not restore growth, ruling out direct involvement of the GH-IGF1 axis. In C2C12 muscle cells, arginine withdrawal activated GCN2 signaling, without impacting mTORC1 signaling. In F/A2 mice, the reduction of plasma and tissue arginine concentrations to similar to 25% of wild-type values activated GCN2 signaling, but mTORC1-mediated signaling remained unaffected. Gcn2-deficient F/A2 mice suffered from hypoglycemia and died shortly after birth. Because common targets of all stress kinases (eIF2 alpha phosphorylation, Chop mRNA expression) were not increased in these mice, the effects of arginine deficiency were solely mediated by GCN2.	[Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Dept Anat & Embryol, NL-6200 MD Maastricht, Netherlands; [Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands; [Lindsey, Patrick] Maastricht Univ, Dept Populat Genet Genom & Bioinformat, NL-6200 MD Maastricht, Netherlands; [Lamers, Marinus C.] Max Planck Inst Immunobiol, D-79011 Freiburg, Germany; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Lamers, Marinus C.] Univ Amsterdam, Acad Med Ctr, AMC Liver Ctr, NL-1100 DD Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Max Planck Society; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Kohler, SE (corresponding author), Maastricht Univ, Dept Anat & Embryol, POB 616, NL-6200 MD Maastricht, Netherlands.	leo.koehler@maastrichtuniversity.nl	Lindsey, Patrick/AAD-8100-2021; Marion, Vincent/H-9730-2016; Lamers, Wouter H./D-2965-2012; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; Harding, Heather P/0000-0002-7359-7974; Marion, Vincent/0000-0002-8271-7376; Ron, David/0000-0002-3014-5636	graduate school NUTRIM; Medical Research Council [G0600717B] Funding Source: researchfish	graduate school NUTRIM; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the graduate school NUTRIM.	Adriao M, 2004, NEUROENDOCRINOLOGY, V79, P26, DOI 10.1159/000076043; Akaike H., 1973, 2 INT S INF THEOR AK; ALBAROTH J, 1988, J CLIN ENDOCR METAB, V67, P1186, DOI 10.1210/jcem-67-6-1186; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Barbosa TD, 2009, ENDOCRINOLOGY, V150, P2080, DOI 10.1210/en.2008-1487; Bertolo RFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE915, DOI 10.1152/ajpendo.00269.2002; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; de Jonge WJ, 2001, J NUTR, V131, P2732, DOI 10.1093/jn/131.10.2732; Deldicque L, 2008, AMINO ACIDS, V35, P147, DOI 10.1007/s00726-007-0607-z; Deval C, 2008, BIOCHIMIE, V90, P1716, DOI 10.1016/j.biochi.2008.07.004; Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; Illnerova H, 1965, Biol Neonat, V9, P197; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim H, 2005, ENDOCRINOLOGY, V146, P1772, DOI 10.1210/en.2004-0906; Kwikkers KL, 2005, BRIT J NUTR, V93, P183, DOI 10.1079/BJN20051334; LANDRETH KS, 1992, BLOOD, V80, P1207; LARON Z, 1995, DRUGS, V50, P595, DOI 10.2165/00003495-199550040-00002; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Liu JL, 2000, ENDOCRINOLOGY, V141, P4436, DOI 10.1210/en.141.12.4436; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu Ya-Li, 2005, Shengli Xuebao, V57, P254; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nakajo T, 2005, BIOCHEM BIOPH RES CO, V326, P174, DOI 10.1016/j.bbrc.2004.11.015; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; RIBY JE, 1990, PEDIATR RES, V28, P261, DOI 10.1203/00006450-199009000-00022; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sakuma K, 2000, ACTA NEUROPATHOL, V99, P169, DOI 10.1007/PL00007421; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010; Sumita K, 2005, J PHARMACOL SCI, V97, P408, DOI 10.1254/jphs.FPJ04054X; Tsutsui M, 2006, J PHARMACOL SCI, V102, P147, DOI 10.1254/jphs.CPJ06015X; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; VANHAEFTEN TW, 1988, DIABETES RES CLIN EX, V9, P187; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; VISEK WJ, 1986, J NUTR, V116, P36, DOI 10.1093/jn/116.1.36; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	66	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8866	8874		10.1074/jbc.M110.216119	http://dx.doi.org/10.1074/jbc.M110.216119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239484	Green Published, hybrid			2022-12-25	WOS:000288247700017
J	Cariolato, L; Cavin, S; Diviani, D				Cariolato, Luca; Cavin, Sabrina; Diviani, Dario			A-Kinase Anchoring Protein (AKAP)-Lbc Anchors a PKN-based Signaling Complex Involved in alpha(1)-Adrenergic Receptor-induced p38 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CARDIAC-HYPERTROPHY; DBL FAMILY; RHO; SCAFFOLD; PATHWAYS; PHOSPHORYLATION; EXPRESSION; INDUCTION; APOPTOSIS	The mitogen-activated protein kinases (MAPKs) pathways are highly organized signaling systems that transduce extracellular signals into a variety of intracellular responses. In this context, it is currently poorly understood how kinases constituting these signaling cascades are assembled and activated in response to receptor stimulation to generate specific cellular responses. Here, we show that AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific guanine nucleotide exchange factor activity, is critically involved in the activation of the p38 alpha MAPK downstream of alpha(1b)-adrenergic receptors (alpha(1b)-ARs). Our results indicate that AKAP-Lbc can assemble a novel transduction complex containing the RhoA effector PKN alpha, MLTK, MKK3, and p38 alpha, which integrates signals from alpha(1b)-ARs to promote RhoA-dependent activation of p38 alpha. In particular, silencing of AKAP-Lbc expression or disrupting the formation of the AKAP-Lbc.p38 alpha signaling complex specifically reduces alpha(1)-AR-mediated p38 alpha activation without affecting receptor-mediated activation of other MAPK pathways. These findings provide a novel mechanistic hypothesis explaining how assembly of macromolecular complexes can specify MAPK signaling downstream of alpha(1)-ARs.	[Cariolato, Luca; Cavin, Sabrina; Diviani, Dario] Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	University of Lausanne	Diviani, D (corresponding author), Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Dario.diviani@unil.ch	Cavin, Sabrina/AAE-9866-2019	Diviani, Dario/0000-0003-4375-3718	Fonds National Suisse de la Recherche Scientifique [3100A0-122020]	Fonds National Suisse de la Recherche Scientifique	This work was supported by Grant 3100A0-122020 of the Fonds National Suisse de la Recherche Scientifique (to D. D.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clerk A, 1999, AM J CARDIOL, V83, p64H; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb; Zhang H, 2001, CIRC RES, V89, P815, DOI 10.1161/hh2101.098379; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	40	44	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7925	7937		10.1074/jbc.M110.185645	http://dx.doi.org/10.1074/jbc.M110.185645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224381	Green Published, hybrid			2022-12-25	WOS:000288013300023
J	Gazi, U; Rosas, M; Singh, S; Heinsbroek, S; Haq, I; Johnson, S; Brown, GD; Williams, DL; Taylor, PR; Martinez-Pomares, L				Gazi, Umut; Rosas, Marcela; Singh, Sonali; Heinsbroek, Sigrid; Haq, Imran; Johnson, Simon; Brown, Gordon D.; Williams, David L.; Taylor, Philip R.; Martinez-Pomares, Luisa			Fungal Recognition Enhances Mannose Receptor Shedding through Dectin-1 Engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN DENDRITIC CELLS; BETA-GLUCAN RECEPTOR; CYSTEINE-RICH DOMAIN; PHOSPHATIDYLINOSITOL-3 KINASE; CRYPTOCOCCUS-NEOFORMANS; INFLAMMATORY RESPONSES; ANTIFUNGAL IMMUNITY; MURINE MACROPHAGES; SOLUBLE FORM	The mannose receptor (MR) is an endocytic type I membrane molecule with a broad ligand specificity that is involved in both hemostasis and pathogen recognition. Membrane-anchored MR is cleaved by a metalloproteinase into functional soluble MR (sMR) composed of the extracellular domains of intact MR. Although sMR production was initially considered a constitutive process, enhanced MR shedding has been observed in response to the fungal pathogen Pneumocystis carinii. In this work, we have investigated the mechanism mediating enhanced MR shedding in response to fungi. We show that other fungal species, including Candida albicans and Aspergillus fumigatus, together with zymosan, a preparation of the cell wall of Saccharomyces cerevisiae, mimic the effect of P. carinii on sMR production and that this effect takes place mainly through beta-glucan recognition. Additionally, we demonstrate that MR cleavage in response to C. albicans and bioactive particulate beta-glucan requires expression of dectin-1. Our data, obtained using specific inhibitors, are consistent with the canonical Syk-mediated pathway triggered by dectin-1 being mainly responsible for inducing MR shedding, with Raf-1 being partially involved. As in the case of steady-state conditions, MR shedding in response to C. albicans and beta-glucan particles requires metalloprotease activity. The induction of MR shedding by dectin-1 has clear implications for the role of MR in fungal recognition, as sMR was previously shown to retain the ability to bind fungal pathogens and can interact with numerous host molecules, including lysosomal hydrolases. Thus, MR cleavage could also impact on the magnitude of inflammation during fungal infection.	[Gazi, Umut; Singh, Sonali; Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2UH, England; [Haq, Imran; Johnson, Simon] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Gazi, Umut; Singh, Sonali; Haq, Imran; Johnson, Simon; Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Resp Biomed Res Unit, Nottingham NG7 2UH, England; [Rosas, Marcela; Taylor, Philip R.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Heinsbroek, Sigrid] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen AB24 3FX, Scotland; [Williams, David L.] E Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA	University of Nottingham; University of Nottingham; University of Nottingham; Cardiff University; University of Amsterdam; Academic Medical Center Amsterdam; University of Aberdeen; East Tennessee State University	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2UH, England.	luisa.martinez-pomares@nottingham.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; brown, gordon/B-4249-2012	Taylor, Philip/0000-0003-0163-1421; brown, gordon/0000-0002-0287-5383; Johnson, Simon/0000-0002-9837-2763; Martinez-Pomares, Luisa/0000-0002-2331-127X; Singh, Sonali/0000-0003-0600-9084	Mizutani Foundation for Glycoscience (Japan); Cancer Research UK; Medical Research Council; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	Mizutani Foundation for Glycoscience (Japan); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Mizutani Foundation for Glycoscience (Japan) and Cancer Research UK.; Recipient of a Medical Research Council Doctoral Training Account Ph.D. fellowship.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dan JM, 2008, INFECT IMMUN, V76, P2362, DOI 10.1128/IAI.00095-08; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Fraser IP, 2000, MICROBES INFECT, V2, P1305, DOI 10.1016/S1286-4579(00)01283-1; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hiller G, 2000, BBA-MOL CELL BIOL L, V1485, P163, DOI 10.1016/S1388-1981(00)00037-8; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jordens R, 1999, INT IMMUNOL, V11, P1775, DOI 10.1093/intimm/11.11.1775; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee JY, 2008, J MICROBIOL BIOTECHN, V18, P355; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; McCann F, 2005, INFECT IMMUN, V73, P6340, DOI 10.1128/IAI.73.10.6340-6349.2005; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Olsson Sandra, 2006, J Inflamm (Lond), V3, P8, DOI 10.1186/1476-9255-3-8; Olsson S, 2007, MOL IMMUNOL, V44, P1509, DOI 10.1016/j.molimm.2006.09.004; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; Scheid MP, 2000, CURR BIOL, V10, pR191, DOI 10.1016/S0960-9822(00)00349-3; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Stamenkovic I, 2009, J INVEST DERMATOL, V129, P1321, DOI 10.1038/jid.2009.13; Sutor SL, 1999, J BIOL CHEM, V274, P7002, DOI 10.1074/jbc.274.11.7002; Swain SD, 2003, INFECT IMMUN, V71, P6213, DOI 10.1128/IAI.71.11.6213-6221.2003; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004	53	43	49	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7822	7829		10.1074/jbc.M110.185025	http://dx.doi.org/10.1074/jbc.M110.185025			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205820	Green Published, hybrid			2022-12-25	WOS:000288013300013
J	Luo, SS; Blom, AM; Rupp, S; Hipler, UC; Hube, B; Skerka, C; Zipfel, PF				Luo, Shanshan; Blom, Anna M.; Rupp, Steffen; Hipler, Uta-Christina; Hube, Bernhard; Skerka, Christine; Zipfel, Peter F.			The pH-regulated Antigen 1 of Candida albicans Binds the Human Complement Inhibitor C4b-binding Protein and Mediates Fungal Complement Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H; SERUM RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-GONORRHOEAE; SURFACE-PROTEINS; MOLECULAR-MECHANISM; ALTERNATIVE PATHWAY; ALPHA-CHAIN; FLUID-PHASE; C4BP	Candida albicans binds and utilizes human complement inhibitors, such as C4b-binding protein (C4BP), Factor H, and FHL-1 for immune evasion. Here, we identify Candida pH-regulated antigen 1 (Pra1) as the first fungal C4BP-binding protein. Recombinant Pra1 binds C4BP, as shown by ELISA and isothermal titration calorimetry, and the Pra1-C4BP interaction is ionic in nature. The Pra1 binding domains within C4BP were localized to the complement control protein domain 4 (CCP4), CCP7, and CCP8. C4BP bound to Pra1 maintains complement-inhibitory activity. C4BP and Factor H bind simultaneously to Candida Pra1 and do not compete for binding at physiological levels. A Pra1-overexpressing C. albicans strain, which had about 2-fold Pra1 levels at the surface acquired also about 2-fold C4BP to the surface, compared with the wild type strain CAI4. A Pra1 knock-out strain showed similar to 22% reduced C4BP binding. C4BP captured by C. albicans from human serum inhibits C4b and C3b surface deposition and also maintains cofactor activity. In summary, Candida Pra1 represents the first fungal C4BP-binding surface protein. Pra1, via binding to C4BP, mediates human complement control, thereby favoring the immune and complement evasion of C. albicans.	[Luo, Shanshan; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogenic Mech, D-07745 Jena, Germany; [Blom, Anna M.] Lund Univ, Dept Lab Med, Sect Med Prot Chem, S-20502 Malmo, Sweden; [Rupp, Steffen] Fraunhofer Inst Interfacial Engn, D-70569 Stuttgart, Germany; [Hipler, Uta-Christina] Univ Jena, Dermatol Clin, D-07743 Jena, Germany; [Zipfel, Peter F.] Univ Jena, Dept Infect Biol, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Lund University; Fraunhofer Gesellschaft; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenberg Str 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Hube, Bernhard/0000-0002-6028-0425	International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication; Deutsche Forschungsgemeinschaft [Zi 432, Ru 608]; Zi 432, Ru 608), and the Swedish Research Council; Swedish Foundation for Strategic Research; Foundation of Osterlund; Foundation of King Gustav V's 80th Anniversary; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg	International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zi 432, Ru 608), and the Swedish Research Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Osterlund; Foundation of King Gustav V's 80th Anniversary; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg	This work was supported by the International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication, Priority Program 1160 of the Deutsche Forschungsgemeinschaft (Zi 432, Ru 608), and the Swedish Research Council, Swedish Foundation for Strategic Research, and Foundations of Osterlund, King Gustav V's 80th Anniversary, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg. The data for this work were presented in part at the XXIII International Complement Workshop in New York in 2010.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Berggard K, 1997, INFECT IMMUN, V65, P3638; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Blom AM, 2009, ANN RHEUM DIS, V68, P136, DOI 10.1136/ard.2007.085753; Blom AM, 2000, MOL IMMUNOL, V37, P445, DOI 10.1016/S0161-5890(00)00059-6; Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; CASANOVA M, 1992, INFECT IMMUN, V60, P4221, DOI 10.1128/IAI.60.10.4221-4229.1992; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; FONZI WA, 1993, GENETICS, V134, P717; Friese MA, 1999, MOL IMMUNOL, V36, P809, DOI 10.1016/S0161-5890(99)00101-7; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; GIGLI I, 1985, J IMMUNOL, V135, P440; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2007, J IMMUNOL, V179, P540, DOI 10.4049/jimmunol.179.1.540; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Marcil A, 2008, INFECT IMMUN, V76, P4345, DOI 10.1128/IAI.00588-07; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; PEREZCASAL J, 1995, MOL MICROBIOL, V15, P907, DOI 10.1111/j.1365-2958.1995.tb02360.x; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; SEPULVEDA P, 1995, INFECT IMMUN, V63, P2173; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; THERN A, 1995, J IMMUNOL, V154, P375; Zhang MX, 1998, INFECT IMMUN, V66, P4845, DOI 10.1128/IAI.66.10.4845-4850.1998; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2007, ADV EXP MED BIOL, V598, P80; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	56	42	44	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8021	8029		10.1074/jbc.M110.130138	http://dx.doi.org/10.1074/jbc.M110.130138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212281	Green Published, hybrid			2022-12-25	WOS:000288013300033
J	Tebbi, A; Guittet, O; Cottet, MH; Vesin, MF; Lepoivre, M				Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel			TAp73 Induction by Nitric Oxide REGULATION BY CHECKPOINT KINASE 1 (CHK1) AND PROTECTION AGAINST APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTIONS; EXPRESSING WILD-TYPE; DNA-DAMAGE; RIBONUCLEOTIDE REDUCTASE; UP-REGULATION; P53 FAMILY; IN-VIVO; RADIOSENSITIZING AGENT; ANTIOXIDANT FUNCTION; SYNTHASE EXPRESSION	Nitric oxide (NO) is a potent activator of the p53 tumor suppressor protein, thereby inducing cell cycle arrest and apoptosis. However, little is known about the regulation of the two other p53-family members, p63 and p73, by nitrogen oxides. We report here an up-regulation of p73 by NO in p53-null K-562 leukemia cells. Chemical NO prodrugs or macrophage iNOS activity induced an accumulation of the TAp73 alpha isoform in these cells, whereas macrophages from iNOS(-/-) mice did not. NO also up-regulated TAp73 mRNA expression, suggesting a transcriptional regulation. The checkpoint kinases Chk1 and Chk2 can regulate TAp73 induction after DNA damage. We show that these kinases were rapidly phosphorylated upon NO treatment. Genetic silencing or pharmacological inhibition of Chk1 impaired NO-mediated accumulation of TAp73 alpha. Because NO is known to block DNA synthesis through ribonucleotide reductase inhibition, the up-regulation of TAp73 alpha might be caused by DNA damage induced by an arrest of DNA replication forks. In support of this hypothesis, DNA replication inhibitors such as hydroxyurea and aphidicolin similarly enhanced TAp73 alpha expression and Chk1 phosphorylation. Moreover, inhibition of Chk1 also prevented TAp73 alpha accumulation in response to replication inhibitors. The knockdown of TAp73 with siRNA sensitized K-562 cells to apoptosis induced by a nitrosative (NO) or oxidative (H2O2) injury. Therefore, TAp73 alpha has an unusual cytoprotective role in K-562 cells, contrasting with its pro-apoptotic functions in many other cell models. In conclusion, NO upregulates several p53 family members displaying pro-and anti-apoptotic effects, suggesting a complex network of interactions and cross-regulations between NO production and p53-related proteins.	[Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel] Univ Paris 11, Inst Mol & Cellular Biochem & Biophys, UMR 8619, F-91405 Orsay, France; [Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel] CNRS, F-91405 Orsay, France; [Tebbi, Ali] Univ Utah, Sch Med, Dept Mol Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84112 USA	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Utah System of Higher Education; University of Utah	Lepoivre, M (corresponding author), Univ Paris 11, UMR CNRS 8619, IBBMC, F-91405 Orsay, France.	michel.lepoivre@u-psud.fr	Lepoivre, Michel/J-8578-2013; Guittet, Olivier/J-8642-2013		Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France; l'Association pour la Recherche sur le Cancer	Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France; l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by a grant from the Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France (to M. L.).; Supported by a fellowship from l'Association pour la Recherche sur le Cancer.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Ambs S, 1998, P NATL ACAD SCI USA, V95, P8823, DOI 10.1073/pnas.95.15.8823; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Berendji D, 1999, FREE RADICAL BIO MED, V27, P773, DOI 10.1016/S0891-5849(99)00123-9; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Busby EC, 2000, CANCER RES, V60, P2108; Cano CE, 2009, CANCER RES, V69, P219, DOI 10.1158/0008-5472.CAN-08-2320; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; Guittet O, 2008, NITRIC OXIDE-BIOL CH, V19, P84, DOI 10.1016/j.niox.2008.04.011; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MESSMER UK, 1994, FEBS LETT, V355, P23; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Ozaki T, 1999, CANCER RES, V59, P5902; Petit JF, 1996, BIOCHEM PHARMACOL, V52, P205, DOI 10.1016/0006-2952(96)00177-3; POTSCH S, 1994, MOL PHARMACOL, V45, P792; Roy B, 2004, FREE RADICAL BIO MED, V36, P507, DOI 10.1016/j.freeradbiomed.2003.11.028; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Stiewe T, 2003, J BIOL CHEM, V278, P14230, DOI 10.1074/jbc.M300357200; Tao YG, 2009, CELL CYCLE, V8, P1196, DOI 10.4161/cc.8.8.8203; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	58	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7873	7884		10.1074/jbc.M110.184879	http://dx.doi.org/10.1074/jbc.M110.184879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212274	hybrid, Green Published			2022-12-25	WOS:000288013300018
J	Cotter, DG; d'Avignon, DA; Wentz, AE; Weber, ML; Crawford, PA				Cotter, David G.; d'Avignon, D. Andre; Wentz, Anna E.; Weber, Mary L.; Crawford, Peter A.			Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA TRANSFERASE SCOT; RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; KETOGENIC DIET; SUCCINYL-COA; ENERGY-METABOLISM; PIG-HEART; AUTOPHAGY; INSULIN; BRAIN	To compensate for the energetic deficit elicited by reduced carbohydrate intake, mammals convert energy stored in ketone bodies to high energy phosphates. Ketone bodies provide fuel particularly to brain, heart, and skeletal muscle in states that include starvation, adherence to low carbohydrate diets, and the neonatal period. Here, we use novel Oxct1(-/-) mice, which lack the ketolytic enzyme succinyl-CoA:3-oxo-acid CoA-transferase (SCOT), to demonstrate that ketone body oxidation is required for postnatal survival in mice. Although Oxct1(-/-) mice exhibit normal prenatal development, all develop ketoacidosis, hypoglycemia, and reduced plasma lactate concentrations within the first 48 h of birth. In vivo oxidation of C-13-labeled beta-hydroxybutyrate in neonatal Oxct1(-/-) mice, measured using NMR, reveals intact oxidation to acetoacetate but no contribution of ketone bodies to the tricarboxylic acid cycle. Accumulation of acetoacetate yields a markedly reduced beta-hydroxybutyrate:acetoacetate ratio of 1:3, compared with 3:1 in Oxct1(+) littermates. Frequent exogenous glucose administration to actively suckling Oxct1(-/-) mice delayed, but could not prevent, lethality. Brains of newborn SCOT-deficient mice demonstrate evidence of adaptive energy acquisition, with increased phosphorylation of AMP-activated protein kinase alpha, increased autophagy, and 2.4-fold increased in vivo oxidative metabolism of [C-13] glucose. Furthermore, [C-13] lactate oxidation is increased 1.7-fold in skeletal muscle of Oxct1(-/-) mice but not in brain. These results indicate the critical metabolic roles of ketone bodies in neonatal metabolism and suggest that distinct tissues exhibit specific metabolic responses to loss of ketone body oxidation.	[Cotter, David G.; Wentz, Anna E.; Weber, Mary L.; Crawford, Peter A.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Sch Med, Campus Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426; Wentz, Anna/0000-0002-3585-8379	National Institutes of Health [DK020579, DK073282]; Diabetic Cardiovascular Disease Center at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073282, R01DK091538, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Cardiovascular Disease Center at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK020579 and DK073282. This work was also supported by a pilot and feasibility grant from the Diabetic Cardiovascular Disease Center at Washington University.	AFIFI AK, 2005, FUNCTIONAL NEUROANAT, P326; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; ALLEN JC, 1991, AM J CLIN NUTR, V54, P69, DOI 10.1093/ajcn/54.1.69; BARNETT SA, 1971, J REPROD FERTIL, V26, P39, DOI 10.1530/jrf.0.0260039; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bateman KS, 2002, BIOCHEMISTRY-US, V41, P14455, DOI 10.1021/bi020568f; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; Best TH, 2000, NEUROLOGY, V54, P2328, DOI 10.1212/WNL.54.12.2328; BOUGNERES PF, 1986, J CLIN INVEST, V77, P42, DOI 10.1172/JCI112299; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CHAUSSAIN JL, 1977, J PEDIATR-US, V91, P711, DOI 10.1016/S0022-3476(77)81020-2; Chen TY, 2006, LANCET, V367, P958, DOI 10.1016/S0140-6736(06)68394-3; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DENNE SC, 1986, AM J PHYSIOL, V251, pE71, DOI 10.1152/ajpendo.1986.251.1.E71; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; FERRE P, 1978, BIOCHEM J, V176, P759, DOI 10.1042/bj1760759; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Fukao T, 2000, GENOMICS, V68, P144, DOI 10.1006/geno.2000.6282; Fukao T, 2006, MOL GENET METAB, V89, P280, DOI 10.1016/j.ymgme.2006.04.014; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1973, J CLIN INVEST, V52, P3190, DOI 10.1172/JCI107519; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; HAWDON JM, 1992, ARCH DIS CHILD-FETAL, V67, P357, DOI 10.1136/adc.67.4_Spec_No.357; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; JENNESS R, 1979, SEMIN PERINATOL, V3, P225; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; Kayer Michael A, 2006, Mol Genet Metab, V87, P281; KREBS H. A., 1967, NAT CANCER INST MONGR, V27, P331; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Longo N, 2004, J INHERIT METAB DIS, V27, P691, DOI 10.1023/B:BOLI.0000043023.57321.18; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; MCGARRY JD, 1977, ARCH INTERN MED, V137, P495, DOI 10.1001/archinte.137.4.495; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MITCHELL GA, 2000, ONLINE METABOLIC MOL; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Nehlig A, 1999, EPILEPSY RES, V37, P211, DOI 10.1016/S0920-1211(99)00073-X; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Owen D, 2008, INTENS CARE MED, V34, P971, DOI 10.1007/s00134-007-0950-2; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; QUANT PA, 1991, EUR J BIOCHEM, V195, P449, DOI 10.1111/j.1432-1033.1991.tb15724.x; QUANT PA, 1989, BIOCHEM SOC T, V17, P1089, DOI 10.1042/bst0171089; QUANT PA, 1993, BIOCHIM BIOPHYS ACTA, V1156, P135, DOI 10.1016/0304-4165(93)90128-U; REICHARD GA, 1979, J CLIN INVEST, V63, P619, DOI 10.1172/JCI109344; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; SAUDUBRAY JM, 1987, ENZYME, V38, P80, DOI 10.1159/000469194; Soeters MR, 2009, OBESITY, V17, P1326, DOI 10.1038/oby.2008.678; Takahashi M, 1997, J LAB CLIN MED, V129, P72, DOI 10.1016/S0022-2143(97)90163-3; Tammam SD, 2007, BIOCHEMISTRY-US, V46, P10852, DOI 10.1021/bi700828h; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; YANG SY, 1987, J BIOL CHEM, V262, P13027; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	64	72	73	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6902	6910		10.1074/jbc.M110.192369	http://dx.doi.org/10.1074/jbc.M110.192369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209089	hybrid, Green Published			2022-12-25	WOS:000287737300005
J	Liao, YL; Kristiansen, AM; Oksvold, CP; Tuvnes, FA; Gu, N; Runden-Pran, E; Ruth, P; Sausbier, M; Storm, JF				Liao, Yiliu; Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Ruth, Peter; Sausbier, Matthias; Storm, Johan F.			Neuronal Ca2+-Activated K+ Channels Limit Brain Infarction and Promote Survival	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; HIPPOCAMPAL PYRAMIDAL CELLS; CEREBRAL-ARTERY OCCLUSION; TRANSMITTER RELEASE; SLICE CULTURES; SPIKE REPOLARIZATION; DNA FRAGMENTATION; GLUTAMATE RELEASE; LARGE-CONDUCTANCE; NERVE-TERMINALS	Neuronal calcium-activated potassium channels of the BK type are activated by membrane depolarization and intracellular Ca2+ ions. It has been suggested that these channels may play a key neuroprotective role during and after brain ischemia, but this hypothesis has so far not been tested by selective BK-channel manipulations in vivo. To elucidate the in vivo contribution of neuronal BK channels in acute focal cerebral ischemia, we performed middle cerebral artery occlusion (MCAO) in mice lacking BK channels (homozygous mice lacking the BK channel alpha subunit, BK-/-). MCAO was performed in BK-/- and WT mice for 90 minutes followed by a 7-hour-reperfusion period. Coronal 1 mm thick sections were stained with 2,3,5-triphenyltetrazolium chloride to reveal the infarction area. We found that transient focal cerebral ischemia by MCAO produced larger infarct volume, more severe neurological deficits, and higher post-ischemic mortality in BK-/- mice compared to WT littermates. However, the regional cerebral blood flow was not significantly different between genotypes as measured by Laser Doppler (LD) flowmetry pre-ischemically, intra-ischemically, and post-ischemically, suggesting that the different impact of MCAO in BK-/- vs. WT was not due to vascular BK channels. Furthermore, when NMDA was injected intracerebrally in non-ischemic mice, NMDA-induced neurotoxicity was found to be larger in BK-/- mice compared to WT. Whole-cell patch clamp recordings from CA1 pyramidal cells in organotypic hippocampal slice cultures revealed that BK channels contribute to rapid action potential repolarization, as previously found in acute slices. When these cultures were exposed to ischemia-like conditions this induced significantly more neuronal death in BK-/- than in WT cultures. These results indicate that neuronal BK channels are important for protection against ischemic brain damage.	[Liao, Yiliu; Ruth, Peter; Sausbier, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Storm, Johan F.] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Storm, Johan F.] Univ Oslo, Inst Basal Med Sci, Oslo, Norway	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo; University of Oslo	Liao, YL (corresponding author), Huazhong Univ Sci & Technol, Div Trauma, Dept Surg, Tongji Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China.	Hmatthias.sausbier@uni-tuebingen.de; Hjstorm@basalmed.uio.no	Rundén-Pran, Elise/AAN-2490-2020; Rundén-Pran, Elise/AAE-6290-2019	Rundén-Pran, Elise/0000-0002-5541-4513; 	European Union; Deutsche Forschungsgemeinschaft [SFB773]; Norwegian Research Council	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the European Union Biomed Project, Glutamate Receptor Interacting Proteins as Neuroprotective Targets, Deutsche Forschungsgemeinschaft (SFB773), and the Norwegian Research Council (Norwegian Centre of Excellence Program/Funksjonell Genomforsking). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2004, STROKE, V35, P1720, DOI 10.1161/01.STR.0000129653.22241.d7; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; COWAN AI, 1992, J PHYSIOL-LONDON, V455, P89, DOI 10.1113/jphysiol.1992.sp019292; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Diez-Sampedro A, 2006, J NEUROPHYSIOL, V96, P1507, DOI 10.1152/jn.00461.2006; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Dupuis DS, 2002, EUR J PHARMACOL, V437, P129, DOI 10.1016/S0014-2999(02)01287-6; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Gu N, 2006, SOC NEUR ABSTR; Gu N, 2007, ANN M SCAND PHYS SOC; Gu N, 2002, SOC NEUR ABSTR, P35; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Haddad JJ, 2005, PROG NEUROBIOL, V77, P252, DOI 10.1016/j.pneurobio.2005.10.008; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Knaus HG, 1996, J NEUROSCI, V16, P955; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lawson K, 1996, CLIN SCI, V91, P651, DOI 10.1042/cs0910651; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liao Y, 2009, SOC NEUR ABSTR; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; OJCIUS DM, 1991, EXP CELL RES, V197, P43, DOI 10.1016/0014-4827(91)90477-C; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Popescu G, 2005, CELL MOL LIFE SCI, V62, P2100, DOI 10.1007/s00018-005-5227-8; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Schroder RL, 2003, PFLUG ARCH EUR J PHY, V446, P607, DOI 10.1007/s00424-003-1116-x; Schroder RL, 2001, NEUROPHARMACOLOGY, V40, P888, DOI 10.1016/S0028-3908(01)00029-6; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Wieloch T, 2001, IUBMB LIFE, V52, P247, DOI 10.1080/15216540152846064; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010	62	37	39	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15601	10.1371/journal.pone.0015601	http://dx.doi.org/10.1371/journal.pone.0015601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209897	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793600022
J	Tsuang, DW; Millard, SP; Ely, B; Chi, P; Wang, KN; Raskind, WH; Kim, S; Brkanac, Z; Yu, CE				Tsuang, Debby W.; Millard, Steven P.; Ely, Benjamin; Chi, Peter; Wang, Kenneth; Raskind, Wendy H.; Kim, Sulgi; Brkanac, Zoran; Yu, Chang-En			The Effect of Algorithms on Copy Number Variant Detection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; GENETIC-VARIATION; SCHIZOPHRENIA; RISK; MAP	Background: The detection of copy number variants (CNVs) and the results of CNV-disease association studies rely on how CNVs are defined, and because array-based technologies can only infer CNVs, CNV-calling algorithms can produce vastly different findings. Several authors have noted the large-scale variability between CNV-detection methods, as well as the substantial false positive and false negative rates associated with those methods. In this study, we use variations of four common algorithms for CNV detection (PennCNV, QuantiSNP, HMMSeg, and cnvPartition) and two definitions of overlap (any overlap and an overlap of at least 40% of the smaller CNV) to illustrate the effects of varying algorithms and definitions of overlap on CNV discovery. Methodology and Principal Findings: We used a 56 K Illumina genotyping array enriched for CNV regions to generate hybridization intensities and allele frequencies for 48 Caucasian schizophrenia cases and 48 age-, ethnicity-, and gender-matched control subjects. No algorithm found a difference in CNV burden between the two groups. However, the total number of CNVs called ranged from 102 to 3,765 across algorithms. The mean CNV size ranged from 46 kb to 787 kb, and the average number of CNVs per subject ranged from 1 to 39. The number of novel CNVs not previously reported in normal subjects ranged from 0 to 212. Conclusions and Significance: Motivated by the availability of multiple publicly available genome-wide SNP arrays, investigators are conducting numerous analyses to identify putative additional CNVs in complex genetic disorders. However, the number of CNVs identified in array-based studies, and whether these CNVs are novel or valid, will depend on the algorithm(s) used. Thus, given the variety of methods used, there will be many false positives and false negatives. Both guidelines for the identification of CNVs inferred from high-density arrays and the establishment of a gold standard for validation of CNVs are needed.	[Tsuang, Debby W.; Wang, Kenneth; Raskind, Wendy H.; Brkanac, Zoran] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Tsuang, Debby W.; Millard, Steven P.; Ely, Benjamin; Chi, Peter; Raskind, Wendy H.] VISN 20 Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Seattle, WA USA; [Raskind, Wendy H.; Kim, Sulgi; Yu, Chang-En] Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; [Yu, Chang-En] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Tsuang, DW (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	dwt1@uw.edu	Tsuang, Debby/L-7234-2016	Tsuang, Debby/0000-0002-4716-1894	VA Puget Sound Health Care System, Seattle, Washington; NIH/NIMH [RO1 MH065558]; VA Merit Review [VISN-20 MIRECC]; University of Washington Alzheimer's Disease Research Center NIH/NIA [P50 AG05136]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	VA Puget Sound Health Care System, Seattle, Washington; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); VA Merit Review(US Department of Veterans Affairs); University of Washington Alzheimer's Disease Research Center NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This material is the result of work supported by resources from the VA Puget Sound Health Care System, Seattle, Washington. Funding provided by NIH/NIMH RO1 MH065558 (www.nimh.nih.gov), VA Merit Review, VISN-20 MIRECC (www.va.gov), and University of Washington Alzheimer's Disease Research Center NIH/NIA P50 AG05136 (www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calkins ME, 2007, SCHIZOPHRENIA BULL, V33, P33, DOI 10.1093/schbul/sbl044; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; *ILL, 2010, DNA COP NUMB LOSS HE; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Khoury MJ, 2009, AM J EPIDEMIOL, V170, P269, DOI 10.1093/aje/kwp119; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Maxwell M., 1992, FAMILY INTERVIEW GEN; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; PEIFFER DA, 2006, ANAL COPY NUMBER VAR; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Team RDC, 2019, R LANG ENV STAT COMP; *TOR U, DAT GEN VAR; Tsuang D, 1996, J AM GERIATR SOC, V44, P704, DOI 10.1111/j.1532-5415.1996.tb01836.x; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; ZHANG D, 2009, 17 WORLD C PSYCH GEN	33	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14456	10.1371/journal.pone.0014456	http://dx.doi.org/10.1371/journal.pone.0014456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209939	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600003
J	Friedli, M; Barde, I; Arcangeli, M; Verp, S; Quazzola, A; Zakany, J; Lin-Marq, N; Robyr, D; Attanasio, C; Spitz, F; Duboule, D; Trono, D; Antonarakis, SE				Friedli, Marc; Barde, Isabelle; Arcangeli, Melanie; Verp, Sonia; Quazzola, Alexandra; Zakany, Jozsef; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Spitz, Francois; Duboule, Denis; Trono, Didier; Antonarakis, Stylianos E.			A Systematic Enhancer Screen Using Lentivector Transgenesis Identifies Conserved and Non-Conserved Functional Elements at the Olig1 and Olig2 Locus	PLOS ONE			English	Article							NON-GENIC SEQUENCES; HUMAN GENOME; IN-VIVO; EXPRESSION ATLAS; HUMAN-CHROMOSOME-21; TRANSCRIPTION; CELLS; CHROMATIN; SCHIZOPHRENIA; ORGANIZATION	Finding sequences that control expression of genes is central to understanding genome function. Previous studies have used evolutionary conservation as an indicator of regulatory potential. Here, we present a method for the unbiased in vivo screen of putative enhancers in large DNA regions, using the mouse as a model. We cloned a library of 142 overlapping fragments from a 200 kb-long murine BAC in a lentiviral vector expressing LacZ from a minimal promoter, and used the resulting vectors to infect fertilized murine oocytes. LacZ staining of E11 embryos obtained by first using the vectors in pools and then testing individual candidates led to the identification of 3 enhancers, only one of which shows significant evolutionary conservation. In situ hybridization and 3C/4C experiments suggest that this enhancer, which is active in the neural tube and posterior diencephalon, influences the expression of the Olig1 and/or Olig2 genes. This work provides a new approach for the large-scale in vivo screening of transcriptional regulatory sequences, and further demonstrates that evolutionary conservation alone seems too limiting a criterion for the identification of enhancers.	[Friedli, Marc; Arcangeli, Melanie; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Friedli, Marc; Arcangeli, Melanie; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Barde, Isabelle; Verp, Sonia; Quazzola, Alexandra; Duboule, Denis; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Zakany, Jozsef; Spitz, Francois; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva, Switzerland; [Friedli, Marc; Barde, Isabelle; Arcangeli, Melanie; Verp, Sonia; Quazzola, Alexandra; Zakany, Jozsef; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Spitz, Francois; Duboule, Denis; Trono, Didier; Antonarakis, Stylianos E.] Frontiers Genet Natl Ctr Competence Res, Bern, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Friedli, M (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	denis.duboule@unige.ch; didier.trono@epfl.ch; stylianos.antonarakis@unige.ch	attanasio, catia/D-5042-2017; Antonarakis, Stylianos E/N-8866-2014	attanasio, catia/0000-0001-8077-5719; Antonarakis, Stylianos E/0000-0001-8907-5823; duboule, denis/0000-0001-9961-2960	National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school; NCCR; Swiss National Science Foundation; Childcare Foundation; European program "Crescendo"; European program "CONSERT"; European program "AnEUploidy"	National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school(Swiss National Science Foundation (SNSF)); NCCR(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Childcare Foundation; European program "Crescendo"; European program "CONSERT"; European program "AnEUploidy"	MF is supported by a fellowship from the National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school. This work was supported by grants from the NCCR "Frontiers in Genetics" (to DD, DT, SEA), the Swiss National Science Foundation (to DD, DT, SEA), the Childcare Foundation (to SEA), and the European programs "Crescendo" (to DD), "CONSERT" (to DT) and "AnEUploidy" (to SEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2004, HUM MOL GENET, V13, pR261, DOI 10.1093/hmg/ddh229; Attanasio C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r168; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Chen CTL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003946; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Heintzman N. D, 2009, NATURE; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lin YW, 2005, CANCER RES, V65, P7151, DOI 10.1158/0008-5472.CAN-05-1400; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Parker SC, 2009, SCIENCE; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2008, ADV GENET, V61, P175, DOI 10.1016/S0065-2660(07)00006-5; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Visel A, 2009, NATURE; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang QF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r1; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhang X, 2008, STEM CELLS, V26, P1841, DOI 10.1634/stemcells.2007-0902; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	50	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15741	10.1371/journal.pone.0015741	http://dx.doi.org/10.1371/journal.pone.0015741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206754	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200048
J	Lei, HY; Fukushige, T; Niu, W; Sarov, M; Reinke, V; Krause, M				Lei, Haiyan; Fukushige, Tetsunari; Niu, Wei; Sarov, Mihail; Reinke, Valerie; Krause, Michael			A Widespread Distribution of Genomic CeMyoD Binding Sites Revealed and Cross Validated by ChIP-Chip and ChIP-Seq Techniques	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; MUSCLE DEVELOPMENT; GENE-EXPRESSION; PROTEIN; MYOD; TRANSCRIPTION; REGULATOR; FAMILY; HLH-1	Identifying transcription factor binding sites genome-wide using chromatin immunoprecipitation (ChIP)-based technology is becoming an increasingly important tool in addressing developmental questions. However, technical problems associated with factor abundance and suitable ChIP reagents are common obstacles to these studies in many biological systems. We have used two completely different, widely applicable methods to determine by ChIP the genome-wide binding sites of the master myogenic regulatory transcription factor HLH-1 (CeMyoD) in C. elegans embryos. The two approaches, ChIP-seq and ChIP-chip, yield strongly overlapping results revealing that HLH-1 preferentially binds to promoter regions of genes enriched for E-box sequences (CANNTG), known binding sites for this well-studied class of transcription factors. HLH-1 binding sites were enriched upstream of genes known to be expressed in muscle, consistent with its role as a direct transcriptional regulator. HLH-1 binding was also detected at numerous sites unassociated with muscle gene expression, as has been previously described for its mouse homolog MyoD. These binding sites may reflect several additional functions for HLH-1, including its interactions with one or more co-factors to activate (or repress) gene expression or a role in chromatin organization distinct from direct transcriptional regulation of target genes. Our results also provide a comparison of ChIP methodologies that can overcome limitations commonly encountered in these types of studies while highlighting the complications of assigning in vivo functions to identified target sites.	[Lei, Haiyan; Fukushige, Tetsunari; Krause, Michael] NIDDK, NIH, Bethesda, MD 20892 USA; [Niu, Wei] Yale Univ, Dept Mol, New Haven, CT USA; [Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University; Max Planck Society; Yale University	Lei, HY (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	mwkrause@helix.nih.gov	NUI, WEI/B-8300-2011	Krause, Michael/0000-0001-6127-3940	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute [U01HG004267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036131] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Support also came from the Model Organism Encylopedia of DNA Elements (modENCODE) project funded by grant U01HG004267 from the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cesaroni M, 2008, BIOINFORMATICS, V24, P2918, DOI 10.1093/bioinformatics/btn542; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent JA, 1998, MECH DEVELOP, V72, P179, DOI 10.1016/S0925-4773(98)00026-4; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hikita T, 2005, BIOCHEM BIOPH RES CO, V335, P139, DOI 10.1016/j.bbrc.2005.07.068; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Krause M, 1997, DEVELOPMENT, V124, P2179; Lei H, 2009, DEVELOPMENT, V136, P1241, DOI 10.1242/dev.030668; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee James D, 2007, WormBook, P1; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Milne CA, 1999, CURR BIOL, V9, P1243, DOI 10.1016/S0960-9822(99)80504-1; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; OKKEMA PG, 1993, GENETICS, V135, P385; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Praitis V, 2001, GENETICS, V157, P1217; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wang Y, 2006, P NATL ACAD SCI USA, V103, P10450, DOI 10.1073/pnas.0602073103; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15898	10.1371/journal.pone.0015898	http://dx.doi.org/10.1371/journal.pone.0015898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209968	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200070
J	Oonincx, DGAB; van Itterbeeck, J; Heetkamp, MJW; van den Brand, H; van Loon, JJA; van Huis, A				Oonincx, Dennis G. A. B.; van Itterbeeck, Joost; Heetkamp, Marcel J. W.; van den Brand, Henry; van Loon, Joop J. A.; van Huis, Arnold			An Exploration on Greenhouse Gas and Ammonia Production by Insect Species Suitable for Animal or Human Consumption	PLOS ONE			English	Article							PACHNODA-EPHIPPIATA COLEOPTERA; NITROUS-OXIDE; OXYGEN-CONSUMPTION; METABOLIC-RATE; CARBON-DIOXIDE; WEANED PIGS; EMISSIONS; METHANE; RESPIRATION; BUILDINGS	Background: Greenhouse gas (GHG) production, as a cause of climate change, is considered as one of the biggest problems society is currently facing. The livestock sector is one of the large contributors of anthropogenic GHG emissions. Also, large amounts of ammonia (NH3), leading to soil nitrification and acidification, are produced by livestock. Therefore other sources of animal protein, like edible insects, are currently being considered. Methodology/Principal Findings: An experiment was conducted to quantify production of carbon dioxide (CO2) and average daily gain (ADG) as a measure of feed conversion efficiency, and to quantify the production of the greenhouse gases methane (CH4) and nitrous oxide (N2O) as well as NH3 by five insect species of which the first three are considered edible: Tenebrio molitor, Acheta domesticus, Locusta migratoria, Pachnoda marginata, and Blaptica dubia. Large differences were found among the species regarding their production of CO2 and GHGs. The insects in this study had a higher relative growth rate and emitted comparable or lower amounts of GHG than described in literature for pigs and much lower amounts of GHG than cattle. The same was true for CO2 production per kg of metabolic weight and per kg of mass gain. Furthermore, also the production of NH3 by insects was lower than for conventional livestock. Conclusions/Significance: This study therefore indicates that insects could serve as a more environmentally friendly alternative for the production of animal protein with respect to GHG and NH3 emissions. The results of this study can be used as basic information to compare the production of insects with conventional livestock by means of a life cycle analysis.	[Oonincx, Dennis G. A. B.; van Itterbeeck, Joost; van Loon, Joop J. A.; van Huis, Arnold] Wageningen Univ, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands; [Heetkamp, Marcel J. W.; van den Brand, Henry] Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands.	dennis.oonincx@wur.nl	van Loon, Joop J.A./B-3744-2009	van Loon, Joop J.A./0000-0002-4260-0501; Van Itterbeeck, Joost/0000-0002-0431-001X; Oonincx, Dennis/0000-0002-6728-4859	Wageningen University, Wageningen, The Netherlands	Wageningen University, Wageningen, The Netherlands(Netherlands Government)	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	AARNINK AJA, 1995, J AGR ENG RES, V62, P105, DOI 10.1006/jaer.1995.1069; Agutter P. S., 2004, THEORETICAL BIOL MED, V1; AIDLEY DJ, 1976, PHYSIOL ENTOMOL, V1, P73, DOI 10.1111/j.1365-3032.1976.tb00890.x; ARMSTRONG G, 1985, PHYSIOL ENTOMOL, V10, P353, DOI 10.1111/j.1365-3032.1985.tb00057.x; AXELSSON B, 1979, ENTOMOL EXP APPL, V25, P260, DOI 10.1111/j.1570-7458.1979.tb02878.x; BAILEY CG, 1977, CAN ENTOMOL, V109, P687, DOI 10.4039/Ent109687-5; Beauchemin KA, 2005, J ANIM SCI, V83, P653; Beets WC, 1997, ECOL FOOD NUTR, V36, P237, DOI 10.1080/03670244.1997.9991518; Blanes-Vidal V, 2008, AGR ECOSYST ENVIRON, V124, P237, DOI 10.1016/j.agee.2007.10.002; Bruins E., 2001, GEILLUSTREERDE TERRA; Cabaraux JF, 2009, AGR ECOSYST ENVIRON, V130, P86, DOI 10.1016/j.agee.2008.11.016; Casey JW, 2006, J ENVIRON QUAL, V35, P231, DOI 10.2134/jeq2005.0121; Chadwick DR, 1999, ATMOS ENVIRON, V33, P3345, DOI 10.1016/S1352-2310(98)00379-3; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Cole NA, 2005, J ANIM SCI, V83, P722; Collavo A, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P519; da Silva JKL, 2006, PHYS LIFE REV, V3, P229, DOI 10.1016/j.plrev.2006.08.001; De Boer IJM, 2008, COMMUNICATION; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Demmers TGM, 1999, ATMOS ENVIRON, V33, P217, DOI 10.1016/S1352-2310(98)00150-2; Demmers TGM, 2001, J AGR ENG RES, V79, P107, DOI 10.1006/jaer.2000.0678; Duncan FD, 2002, J EXP BIOL, V205, P791; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Emekci M, 2004, J STORED PROD RES, V40, P27, DOI 10.1016/S0022-474X(02)00076-0; Emekci M, 2002, J STORED PROD RES, V38, P413, DOI 10.1016/S0022-474X(01)00045-5; Fabbri C, 2007, BIOSYST ENG, V97, P441, DOI 10.1016/j.biosystemseng.2007.03.036; Faulkner WB, 2008, ATMOS ENVIRON, V42, P6567, DOI 10.1016/j.atmosenv.2008.04.021; Friedrich U., 2004, BREEDING FOOD ANIMAL; Gouveia SM, 2000, PHYSIOL ENTOMOL, V25, P88, DOI 10.1046/j.1365-3032.2000.00168.x; Greenlee KJ, 2004, J EXP BIOL, V207, P497, DOI 10.1242/jeb.00767; Guiziou F, 2005, BIORESOURCE TECHNOL, V96, P203, DOI 10.1016/j.biortech.2004.05.009; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P10; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; Harper LA, 2009, J DAIRY SCI, V92, P2326, DOI 10.3168/jds.2008-1753; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; IPCC, 2007, CLIM CHANG 2007 PHYS; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Kroon LJM, 2009, INLEIDING ATMOSFEER; Lacey RE, 2002, 2002 ASAE ANN INT M; Lemke R, 2002, COMMUN SOIL SCI PLAN, V33, P2705, DOI 10.1081/CSS-120014474; Li XZ, 2007, PLANT SOIL, V301, P233, DOI 10.1007/s11104-007-9440-0; LIGHTON JRB, 1995, PHYSIOL ZOOL, V68, P43, DOI 10.1086/physzool.68.1.30163917; MAY ML, 1986, PHYSIOL ENTOMOL, V11, P171, DOI 10.1111/j.1365-3032.1986.tb00403.x; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; Nicks B, 2003, ANIM RES, V52, P299, DOI 10.1051/animres:2003017; PROTHERO JW, 1979, COMP BIOCHEM PHYS A, V64, P463, DOI 10.1016/0300-9629(79)90572-3; Ramos-Elorduy J, 2008, ECOL FOOD NUTR, V47, P280, DOI 10.1080/03670240701805074; SLANSKY F, 1985, ENTOMOL EXP APPL, V39, P47, DOI 10.1007/BF00338524; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Terblanche JS, 2007, PHYSIOL ENTOMOL, V32, P175, DOI 10.1111/j.1365-3032.2006.00549.x; Thorne PS, 2007, ENVIRON HEALTH PERSP, V115, P296, DOI 10.1289/ehp.8831; Van Loon JJA, 2005, OIKOS, V108, P194, DOI 10.1111/j.0030-1299.2005.13079.x; Verstegen M.W.A., 1987, ENERGY METABOLISM FA, P21; Volkova VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006403; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wathes CM, 1997, BRIT POULTRY SCI, V38, P14, DOI 10.1080/00071669708417936; Wheeler EF, 2003, AMMONIA EMISSIONS 3; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7	59	363	378	11	197	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14445	10.1371/journal.pone.0014445	http://dx.doi.org/10.1371/journal.pone.0014445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206900	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200003
J	Patel, GB; Zhou, HY; Ponce, A; Harris, G; Chen, WX				Patel, Girishchandra B.; Zhou, Hongyan; Ponce, Amalia; Harris, Greg; Chen, Wangxue			Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; T-CELLS; GAMMA-INTERFERON; IMMUNE-RESPONSES; IMMUNOGLOBULIN-A; INFECTION; MICE; ANTIBODIES; TULAREMIA; NEUTROPHILS	Archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) is a safe mucosal adjuvant that elicits long lasting and memory boostable mucosal and systemic immune responses to model antigens such as ovalbumin. In this study, we evaluated the potential of the AMVAD system for eliciting protective immunity against mucosal bacterial infections, using a mouse model of intranasal Francisella tularensis LVS (LVS) challenge. Intranasal immunization of mice with cell free extract of LVS (LVSCE) adjuvanted with the AMVAD system (LVSCE/AMVAD) induced F. tularensis-specific antibody responses in sera and bronchoalveolar lavage fluids, as well as antigen-specific splenocyte proliferation and IL-17 production. More importantly, the AMVAD vaccine partially protected the mice against a lethal intranasal challenge with LVS. Compared to LVSCE immunized and naive mice, the LVSCE/AMVAD immunized mice showed substantial to significant reduction in pathogen burdens in the lungs and spleens, reduced serum and pulmonary levels of proinflammatory cytokines/chemokines, and longer mean time to death as well as significantly higher survival rates (p<0.05). These results suggest that the AMVAD system is a promising mucosal adjuvant and vaccine delivery technology, and should be explored further for its applications in combating mucosal infectious diseases.	[Patel, Girishchandra B.; Zhou, Hongyan; Ponce, Amalia; Harris, Greg; Chen, Wangxue] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Patel, GB (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	girish.patel@nrc-cnrc.gc.ca			Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada)	Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada)	This research was funded from the A-base budget of the Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; CHOQUET CG, 1994, APPL MICROBIOL BIOT, V42, P375, DOI 10.1007/s002530050266; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; Jakobsen H, 2003, SCAND J IMMUNOL, V58, P119, DOI 10.1046/j.1365-3083.2003.01292.x; Kemble G, 2003, VACCINE, V21, P1789, DOI 10.1016/S0264-410X(03)00074-4; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; KuoLee R, 2007, EXPERT OPIN THER PAT, V17, P267, DOI 10.1517/13543776.17.3.267; Lemoine D, 1998, STP PHARMA SCI, V8, P5; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Mestecky J, 1997, J CONTROL RELEASE, V48, P243, DOI 10.1016/S0168-3659(97)00036-9; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Patel GB, 2008, INT J TOXICOL, V27, P329, DOI 10.1080/10915810802352703; Patel GB, 2008, J LIPOSOME RES, V18, P127, DOI [10.1080/08982100802129232, 10.1080/08982100802129232 ]; Patel GB, 2007, VACCINE, V25, P8622, DOI 10.1016/j.vaccine.2007.09.042; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Sjostedt A, 1996, MICROBIOL-UK, V142, P1369, DOI 10.1099/13500872-142-6-1369; Sprott GD, 2003, METHOD ENZYMOL, V373, P155; Stenmark S, 2004, J MED MICROBIOL, V53, P501, DOI 10.1099/jmm.0.05352-0; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15574	10.1371/journal.pone.0015574	http://dx.doi.org/10.1371/journal.pone.0015574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206916	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200027
J	Taves, MD; Schmidt, KL; Ruhr, IM; Kapusta, K; Prior, NH; Soma, KK				Taves, Matthew D.; Schmidt, Kim L.; Ruhr, Ilan M.; Kapusta, Katarzyna; Prior, Nora H.; Soma, Kiran K.			Steroid Concentrations in Plasma, Whole Blood and Brain: Effects of Saline Perfusion to Remove Blood Contamination from Brain	PLOS ONE			English	Article							ACUTE STRESS; RAT-BRAIN; CEREBRAL-ISCHEMIA; SONGBIRD PLASMA; IMMUNE ORGANS; ZEBRA FINCHES; CORTICOSTERONE; CORTISOL; DEHYDROEPIANDROSTERONE; ESTRADIOL	The brain and other organs locally synthesize steroids. Local synthesis is suggested when steroid levels are higher in tissue than in the circulation. However, measurement of both circulating and tissue steroid levels are subject to methodological considerations. For example, plasma samples are commonly used to estimate circulating steroid levels in whole blood, but steroid levels in plasma and whole blood could differ. In addition, tissue steroid measurements might be affected by blood contamination, which can be addressed experimentally by using saline perfusion to remove blood. In Study 1, we measured corticosterone and testosterone (T) levels in zebra finch (Taeniopygia guttata) plasma, whole blood, and red blood cells (RBC). We also compared corticosterone in plasma, whole blood, and RBC at baseline and after 60 min restraint stress. In Study 2, we quantified corticosterone, dehydroepiandrosterone (DHEA), T, and 17 beta-estradiol (E-2) levels in the brains of sham-perfused or saline-perfused subjects. In Study 1, corticosterone and T concentrations were highest in plasma, significantly lower in whole blood, and lowest in RBC. In Study 2, saline perfusion unexpectedly increased corticosterone levels in the rostral telencephalon but not other regions. In contrast, saline perfusion decreased DHEA levels in caudal telencephalon and diencephalon. Saline perfusion also increased E-2 levels in caudal telencephalon. In summary, when comparing local and systemic steroid levels, the inclusion of whole blood samples should prove useful. Moreover, blood contamination has little or no effect on measurement of brain steroid levels, suggesting that saline perfusion is not necessary prior to brain collection. Indeed, saline perfusion itself may elevate and lower steroid concentrations in a rapid, region-specific manner.	[Taves, Matthew D.; Schmidt, Kim L.; Prior, Nora H.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Taves, Matthew D.; Ruhr, Ilan M.; Prior, Nora H.; Soma, Kiran K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Schmidt, Kim L.; Soma, Kiran K.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Kapusta, Katarzyna] Univ Strasbourg, Dept Life Sci, Strasbourg, France	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Taves, MD (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	taves@zoology.ubc.ca	ruhr, ilan/U-4266-2019; Taves, Matthew Donald/AAW-3148-2020; Soma, Kiran K/B-9772-2012	ruhr, ilan/0000-0001-9243-7055; Taves, Matthew Donald/0000-0002-4841-059X; Soma, Kiran K/0000-0003-2169-8092; Schmidt, Kim/0000-0003-2311-9285; Prior, Nora/0000-0002-3271-4409	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Michael Smith Foundation for Health Research to K. K. S. M. D. T. received a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship, and K. L. S. received Natural Sciences and Engineering Research Council of Canada CGS-M and CGS-D Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; BELANGER A, 1990, ANN NY ACAD SCI, V595, P251, DOI 10.1111/j.1749-6632.1990.tb34299.x; Bradbury MWB, 1979, CONCEPT BLOOD BRAIN; Breuner CW, 2006, HORM METAB RES, V38, P260, DOI 10.1055/s-2006-925347; Brummelte S, 2010, DEV NEUROBIOL, V70, P714, DOI 10.1002/dneu.20805; Charlier TD, 2010, GEN COMP ENDOCR, V167, P18, DOI 10.1016/j.ygcen.2010.02.002; Charlier TD, 2009, HORM BEHAV, V56, P339, DOI 10.1016/j.yhbeh.2009.06.012; Cohen J., 1988, STAT POWER ANAL BEHA; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Drabkin DL, 1932, J BIOL CHEM, V98, P719; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; GomezSanchez CE, 1997, ENDOCRINOLOGY, V138, P3369, DOI 10.1210/en.138.8.3369; Goodson JL, 2005, HORM BEHAV, V48, P461, DOI 10.1016/j.yhbeh.2005.04.005; Granger DA, 1999, PSYCHONEUROENDOCRINO, V24, P567, DOI 10.1016/S0306-4530(99)00013-X; Granger DA, 1999, HORM BEHAV, V35, P18, DOI 10.1006/hbeh.1998.1492; HIRAMATSU R, 1983, CLIN CHIM ACTA, V134, P143; HIRAMATSU R, 1987, J CLIN ENDOCR METAB, V64, P1224, DOI 10.1210/jcem-64-6-1224; HIRAMATSU R, 1991, J STEROID BIOCHEM, V38, P383, DOI 10.1016/0960-0760(91)90111-H; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; HOLTKAMP HC, 1975, CLIN CHIM ACTA, V59, P41, DOI 10.1016/0009-8981(75)90216-8; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Little HJ, 2008, NEUROSCIENCE, V156, P1017, DOI 10.1016/j.neuroscience.2008.08.029; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Newman AEM, 2008, ENDOCRINOLOGY, V149, P2537, DOI 10.1210/en.2007-1363; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Newman AEM, 2009, EUR J NEUROSCI, V29, P1905, DOI 10.1111/j.1460-9568.2009.06748.x; Payne RS, 2003, BRAIN RES, V971, P9, DOI 10.1016/S0006-8993(03)02276-5; Pradhan DS, 2008, J NEUROCHEM, V104, P244, DOI 10.1111/j.1471-4159.2007.04953.x; Pradhan DS, 2010, J NEUROCHEM, V115, P667, DOI 10.1111/j.1471-4159.2010.06954.x; Pradhan DS, 2010, HORM BEHAV, V57, P381, DOI 10.1016/j.yhbeh.2010.01.008; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2010, J CHEM NEUROANAT, V39, P72, DOI 10.1016/j.jchemneu.2009.06.009; Roberts JR, 1998, J COMP PHYSIOL B, V168, P25, DOI 10.1007/s003600050117; Romero LM, 1998, AM J PHYSIOL-REG I, V274, pR1338; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saleh Tarek M, 2004, J Stroke Cerebrovasc Dis, V13, P24, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.003; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Schmidt KL, 2008, AM J PHYSIOL-REG I, V295, pR103, DOI 10.1152/ajpregu.00002.2008; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; Schmidt KL, 2009, AM J PHYSIOL-REG I, V297, pR42, DOI 10.1152/ajpregu.90964.2008; Soma KK, 2004, ENDOCRINOLOGY, V145, P1668, DOI 10.1210/en.2003-0883; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Wagner EC, 2008, J EXP BIOL, V211, P400, DOI 10.1242/jeb.011205; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109	53	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15727	10.1371/journal.pone.0015727	http://dx.doi.org/10.1371/journal.pone.0015727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206751	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200044
J	Bulusu, V; Jayaraman, V; Balaram, H				Bulusu, Vinay; Jayaraman, Vijay; Balaram, Hemalatha			Metabolic Fate of Fumarate, a Side Product of the Purine Salvage Pathway in the Intraerythrocytic Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-DIOXIDE FIXATION; DIHYDROOROTATE DEHYDROGENASE; ASPARTATE-AMINOTRANSFERASE; ENERGY-METABOLISM; NUCLEOTIDE CYCLE; MALATE-QUINONE; MALARIA; LOCALIZATION; MITOCHONDRIA; SPECIFICITY	In aerobic respiration, the tricarboxylic acid cycle is pivotal to the complete oxidation of carbohydrates, proteins, and lipids to carbon dioxide and water. Plasmodium falciparum, the causative agent of human malaria, lacks a conventional tricarboxylic acid cycle and depends exclusively on glycolysis for ATP production. However, all of the constituent enzymes of the tricarboxylic acid cycle are annotated in the genome of P. falciparum, which implies that the pathway might have important, yet unidentified biosynthetic functions. Here we show that fumarate, a side product of the purine salvage pathway and a metabolic intermediate of the tricarboxylic acid cycle, is not a metabolic waste but is converted to aspartate through malate and oxaloacetate. P. falciparum-infected erythrocytes and free parasites incorporated [2,3-C-14] fumarate into the nucleic acid and protein fractions. C-13 NMR of parasites incubated with [2,3-C-13] fumarate showed the formation of malate, pyruvate, lactate, and aspartate but not citrate or succinate. Further, treatment of free parasites with atovaquone inhibited the conversion of fumarate to aspartate, thereby indicating this pathway as an electron transport chain-dependent process. This study, therefore, provides a biosynthetic function for fumarate hydratase, malate quinone oxidoreductase, and aspartate aminotransferase of P. falciparum.	[Bulusu, Vinay; Jayaraman, Vijay; Balaram, Hemalatha] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Balaram, H (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	hb@jncasr.ac.in		Bulusu, Vinay/0000-0002-6006-8766	Department of Science and Technology, India; University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR); CSIR	Department of Science and Technology, India(Department of Science & Technology (India)); University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, India.; Supported by a University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR) senior research fellowship.; Supported by a CSIR junior research fellowship.	Aragon J J, 1981, Curr Top Cell Regul, V18, P131; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; Berger LC, 2001, J BACTERIOL, V183, P4421, DOI 10.1128/JB.183.15.4421-4434.2001; BLUM JJ, 1984, J PROTOZOOL, V31, P167, DOI 10.1111/j.1550-7408.1984.tb04310.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; BRYANT C, 1964, AM J TROP MED HYG, V13, P515, DOI 10.4269/ajtmh.1964.13.515; Bulusu V, 2009, BBA-PROTEINS PROTEOM, V1794, P642, DOI 10.1016/j.bbapap.2008.11.021; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; FRYDMAN B, 1990, EUR J BIOCHEM, V192, P363, DOI 10.1111/j.1432-1033.1990.tb19235.x; Hodges M, 2005, MOL BIOCHEM PARASIT, V143, P29, DOI 10.1016/j.molbiopara.2005.05.004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kather B, 2000, J BACTERIOL, V182, P3204, DOI 10.1128/JB.182.11.3204-3209.2000; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; KRUNGKRAI J, 1995, BBA-GEN SUBJECTS, V1243, P351, DOI 10.1016/0304-4165(94)00158-T; Laloi M, 1999, CELL MOL LIFE SCI, V56, P918, DOI 10.1007/s000180050484; Lian LY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-38; Mather MW, 2005, J BIOL CHEM, V280, P27458, DOI 10.1074/jbc.M502319200; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Pradhan A, 2009, MOL CELL BIOCHEM, V325, P141, DOI 10.1007/s11010-009-0028-2; Raman J, 2004, MOL BIOCHEM PARASIT, V138, P1, DOI 10.1016/j.molbiopara.2004.06.013; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; SHERMAN IW, 1966, NATURE, V212, P1387, DOI 10.1038/2121387a0; SHERMAN IW, 1968, COMP BIOCHEM PHYSIOL, V24, P639, DOI 10.1016/0010-406X(68)91018-9; Storm J, 2010, MALAR J S2, V9, pP49; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uyemura SA, 2004, J BIOL CHEM, V279, P385, DOI 10.1074/jbc.M307264200; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; WINTER HC, 1989, PLANT PHYSIOL, V89, P1122, DOI 10.1104/pp.89.4.1122; Wrenger C, 2003, EUR J BIOCHEM, V270, P1775, DOI 10.1046/j.1432-1033.2003.03536.x; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018	43	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9236	9245		10.1074/jbc.M110.173328	http://dx.doi.org/10.1074/jbc.M110.173328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209090	hybrid, Green Published			2022-12-25	WOS:000288247700054
J	Fulton, S; Thibault, D; Mendez, JA; Lahaie, N; Tirotta, E; Borrelli, E; Bouvier, M; Tempel, BL; Trudeau, LE				Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Lahaie, Nicolas; Tirotta, Emanuele; Borrelli, Emiliana; Bouvier, Michel; Tempel, Bruce L.; Trudeau, Louis-Eric			Contribution of Kv1.2 Voltage-gated Potassium Channel to D2 Autoreceptor Regulation of Axonal Dopamine Overflow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC K+ CHANNELS; SUBSTANTIA-NIGRA; DEPENDENT REGULATION; RECEPTORS COUPLE; XENOPUS OOCYTES; ALPHA-SUBUNITS; MICE LACKING; G-PROTEINS; IN-VIVO; NEURONS	Impairments in axonal dopamine release are associated with neurological disorders such as schizophrenia and attention deficit hyperactivity disorder and pathophysiological conditions promoting drug abuse and obesity. The D2 dopamine autoreceptor (D2-AR) exerts tight regulatory control of axonal dopamine (DA) release through a mechanism suggested to involve K+ channels. To evaluate the contribution of Kv1 voltage-gated potassium channels of the Shaker gene family to the regulation of axonal DA release by the D2-AR, the present study employed expression analyses, real time measurements of striatal DA overflow, K+ current measurements and immunoprecipitation assays. Kv1.1, -1.2, -1.3, and -1.6 mRNA and protein were detected in midbrain DA neurons purified by fluorescence-activated cell sorting and in primary DA neuron cultures. In addition, Kv1.1, -1.2, and -1.6 were localized to DA axonal processes in the dorsal striatum. By means of fast scan cyclic voltammetry in striatal slice preparations, we found that the inhibition of stimulation-evoked DA overflow by a D2 agonist was attenuated by Kv1.1, -1.2, and -1.6 toxin blockers. A particular role for the Kv1.2 subunit in the process whereby axonal D2-AR inhibits DA overflow was established with the use of a selective Kv1.2 blocker and Kv1.2 knock-out mice. Moreover, we demonstrate the ability of D2-AR activation to increase Kv1.2 currents in co-transfected cells and its reliance on G beta gamma subunit signaling along with the physical coupling of D2-AR and Kv1.2-containing channels in striatal tissue. These findings underline the contribution of Kv1.2 in the regulation of nigrostriatal DA release by the D2-AR and thereby offer a novel mechanism by which DA release is regulated.	[Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Trudeau, Louis-Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Trudeau, Louis-Eric] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92617 USA; [Tempel, Bruce L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98915 USA; [Tempel, Bruce L.] Univ Washington, Dept Pharmacol, Seattle, WA 98915 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trudeau, LE (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020; Bouvier, Michel/H-2758-2014; Mendez, J Alfredo/E-2031-2015; Borrelli, Emiliana/M-8994-2018	Trudeau, Louis-Eric/0000-0003-4684-1377; Bouvier, Michel/0000-0003-1128-0100; Mendez, J Alfredo/0000-0002-2859-7086; 	National Institutes of Health [RO1-DC002739, DA024689]; Canadian Institutes of Health Research [MOP-49591, MOP-10501]; Fonds de la Recherche en Sante du Quebec; Faculty of Graduate studies of Universite de Montreal; National Science and Engineering Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Faculty of Graduate studies of Universite de Montreal; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DC002739 (to B.L.T.) and DA024689 (to E.B.), Canadian Institutes of Health Research Grant MOP-49591 and a Fonds de la Recherche en Sante du Quebec infrastructure grant to the Groupe de Recherche sur le Systeme Nerveux Central (to L.-E.T.), Canadian Institutes of Health Research Grant MOP-10501 (to M.B.), a studentship from the Canadian Institutes of Health Research and grant from the Faculty of Graduate studies of Universite de Montreal (to N.L.), and a National Science and Engineering Research Council postdoctoral fellowship (to S.F.).	BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bath BD, 2000, ANAL CHEM, V72, P5994, DOI 10.1021/ac000849y; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; CASS WA, 1991, J NEUROCHEM, V57, P147, DOI 10.1111/j.1471-4159.1991.tb02109.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Congar P, 2002, J NEUROPHYSIOL, V87, P1046, DOI 10.1152/jn.00459.2001; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; Davila V, 2003, J NEUROSCI, V23, P5693; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Dodson PD, 2003, J PHYSIOL-LONDON, V550, P27, DOI 10.1113/jphysiol.2003.046250; FASANO C, 2008, CURR PROTOC NEUROSCI, V44; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Geiger BM, 2008, FASEB J, V22, P2740, DOI 10.1096/fj.08-110759; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GONON FG, 1985, NEUROSCIENCE, V14, P765, DOI 10.1016/0306-4522(85)90141-1; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Inanobe A, 1999, J NEUROSCI, V19, P1006; JOHN CE, 2006, ELECTROCHEMICAL METH, P49; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Pillai G, 1998, NEUROPHARMACOLOGY, V37, P983, DOI 10.1016/S0028-3908(98)00092-6; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rasband W., 2006, IMAGEJ; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Southan AP, 1998, BRIT J PHARMACOL, V125, P1375, DOI 10.1038/sj.bjp.0702218; Tirotta E, 2008, CELL CYCLE, V7, P2241, DOI 10.4161/cc.7.14.6307; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Wang FC, 1999, EUR J BIOCHEM, V263, P222, DOI 10.1046/j.1432-1327.1999.00494.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Werner P, 1996, MOL PHARMACOL, V49, P656; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523	59	35	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9360	9372		10.1074/jbc.M110.153262	http://dx.doi.org/10.1074/jbc.M110.153262			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233214	hybrid, Green Published			2022-12-25	WOS:000288247700065
J	Haithcock, J; Billington, N; Choi, K; Fordham, J; Sellers, JR; Stafford, WF; White, H; Forgacs, E				Haithcock, Jessica; Billington, Neil; Choi, Kevin; Fordham, Jennifer; Sellers, James R.; Stafford, Walter F.; White, Howard; Forgacs, Eva			The Kinetic Mechanism of Mouse Myosin VIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTOR; USHER-SYNDROME; SEDIMENTATION-VELOCITY; TRYPTOPHAN RESIDUE; DROSOPHILA; DEAFNESS; DOMAIN; MUTATIONS; PROTEIN; COEFFICIENTS	Myosin VIIa is crucial in hearing and visual processes. We examined the kinetic and association properties of the baculovirus expressed, truncated mouse myosin VIIa construct containing the head, all 5IQ motifs and the putative coiled coil domain (myosin VIIa-5IQ). The construct appears to be monomeric as determined by analytical ultracentrifugation experiments, and only single headed molecules were detected by negative stain electron microscopy. The relatively high basal steady-state rate of 0.18 s(-1) is activated by actin only by similar to 3.5-fold resulting in a V-max of 0.7 s(-1) and a K-ATPase of 11.5 mu M. There is no single rate-limiting step of the ATP hydrolysis cycle. The ATP hydrolysis step (M.T reversible arrow M.D.P) is slow (12 s(-1)) and the equilibrium constant (K-H) of 1 suggests significant reversal of hydrolysis. In the presence of actin ADP dissociates with a rate constant of 1.2 s(-1). Phosphate dissociation is relatively fast (> 12 s(-1)), but the maximal rate could not be experimentally obtained at actin concentrations <= 50 mu M because of the weak binding of the myosin VIIa-ADP-P-i complex to actin. At higher actin concentrations the rate of attached hydrolysis (0.4 s(-1)) becomes significant and partially rate-limiting. Our findings suggest that the myosin VIIa is a "slow", monomeric molecular motor with a duty ratio of 0.6.	[White, Howard; Forgacs, Eva] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Fordham, Jennifer] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Billington, Neil; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Stafford, Walter F.] Boston Biomed Res Inst, Integrat Prot Biol Program, Watertown, MA 02472 USA	Eastern Virginia Medical School; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Biomedical Research Institute	Forgacs, E (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	forgace@evms.edu	Stafford, Walter/ABC-6553-2020	Billington, Neil/0000-0003-2306-0228	National Institutes of Health [DC009335, NIH/EB00209]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant DC009335 (to E. F.) and NIH/EB00209 (to H. W.).	Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillespie PG, 2002, NAT NEUROSCI, V5, P3, DOI 10.1038/nn0102-3; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1999, CURR BIOL, V9, pR838, DOI 10.1016/S0960-9822(00)80040-8; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Kuroda TS, 2005, J BIOL CHEM, V280, P28015, DOI 10.1074/jbc.M501465200; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Maniak M, 2001, CURR BIOL, V11, pR315, DOI 10.1016/S0960-9822(01)00173-7; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mooseker MS, 2008, MYOS SUP MOL MOT, P1; Odronitz F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-103; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Titus MA, 1999, CURR BIOL, V9, P1297, DOI 10.1016/S0960-9822(00)80051-2; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Udovichenko IP, 2002, J CELL SCI, V115, P445; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P9505, DOI 10.1021/bi8007142; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	49	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8819	8828		10.1074/jbc.M110.163592	http://dx.doi.org/10.1074/jbc.M110.163592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212272	Green Published, hybrid			2022-12-25	WOS:000288247700012
J	Kanno, Y; Ishisaki, A; Kawashita, E; Chosa, N; Nakajima, K; Nishihara, T; Toyoshima, K; Okada, K; Ueshima, S; Matsushita, K; Matsuo, O; Matsuno, H				Kanno, Yosuke; Ishisaki, Akira; Kawashita, Eri; Chosa, Naoyuki; Nakajima, Keiichi; Nishihara, Tatsuji; Toyoshima, Kuniaki; Okada, Kiyotaka; Ueshima, Shigeru; Matsushita, Kenji; Matsuo, Osamu; Matsuno, Hiroyuki			Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; ACTIVATOR INHIBITOR-1; RECEPTOR ACTIVATOR; TGF-BETA; EXPRESSION; GROWTH; MICE; PLASMIN; ALPHA-2-ANTIPLASMIN; OSTEOPROTEGERIN	The contribution of plasminogen (Plg)/plasmin, which have claimed to be the main fibrinolytic regulators in the bone metabolism, remains unclear. This study evaluated how the absence of Plg affects the function of osteoblast (OB) and osteoclast (OC). There was a larger population of pre-OCs in bone marrow-derived cells from the Plg(-/-) mice than the population of that from the WT mice. In addition, the absence of Plg suppressed the expression of osteoprotegerin in OBs. Moreover, an exogenous plasmin clearly induced the osteoprotegerin expression in Plg(-/-) OBs. The osteoclastogenesis of RAW264.7 mouse monocyte/macrophage lineage cells in co-culture with OBs from the Plg(-/-) mice was significantly accelerated in comparison with that in co-culture with OBs from the WT mice. Intriguingly, the accelerated OC differentiation of RAW264.7 cells co-cultured with Plg(-/-) OBs was clearly suppressed by the treatment of an exogenous plasmin. Consequently, Plg(-/-) mice display decreased bone mineral density. These findings could eventually lead to the development of new clinical therapies for bone disease caused by a disorder of the fibrinolytic system.	[Kanno, Yosuke; Kawashita, Eri; Matsuno, Hiroyuki] Doshisha Womens Coll Liberal Arts, Dept Clin Pathol Biochem, Fac Pharmaceut Sci, Kyoto 6100395, Japan; [Ishisaki, Akira; Chosa, Naoyuki] Iwate Med Univ, Sch Dent, Dept Biochem, Morioka, Iwate 0208505, Japan; [Nakajima, Keiichi] Natl Agr Res Ctr Hokkaido Reg, Dept Anim Prod & Grassland, Sapporo, Hokkaido 0628555, Japan; [Nishihara, Tatsuji] Kyushu Dent Coll, Div Infect & Mol Biol, Dept Hlth Promot, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Toyoshima, Kuniaki] Kyushu Dent Coll, Div Oral Histol & Neurobiol, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Okada, Kiyotaka; Ueshima, Shigeru; Matsuo, Osamu] Kinki Univ, Sch Med, Dept Physiol 2, Osaka 5898511, Japan; [Ueshima, Shigeru] Kinki Univ, Sch Agr, Dept Food Sci & Nutr, Nara 6318505, Japan; [Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Lab Oral Dis Res, Natl Inst Longev Sci, Aichi 4748522, Japan	Iwate Medical University; National Agriculture & Food Research Organization - Japan; Kyushu Dental University; Kyushu Dental University; Kindai University (Kinki University); Kindai University (Kinki University); National Center for Geriatrics & Gerontology	Kanno, Y (corresponding author), Doshisha Womens Coll Liberal Arts, Dept Clin Pathol Biochem, Fac Pharmaceut Sci, 97-1 Kodo Kyo Tanabe, Kyoto 6100395, Japan.	ykanno@dwc.doshisha.ac.jp	Chosa, Naoyuki/G-5538-2014; MATSUO, OSAMU/AAM-9703-2020	Chosa, Naoyuki/0000-0002-5399-2061; Matsuo, Osamu/0000-0002-9806-2204; Ishisaki, Akira/0000-0001-6704-4436	Ministry of Education, Culture, Sports, Science and Technology [21790097]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23590291] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Young Scientists B: 21790097 (to Y.K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, and Grant-in-aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014.	BRAATEN JV, 1993, BLOOD, V81, P1290; Carmeliet Peter, 1996, Seminars in Thrombosis and Hemostasis, V22, P525, DOI 10.1055/s-2007-999055; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004; Furlan F, 2007, J BONE MINER RES, V22, P1387, DOI 10.1359/JBMR.070516; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Kanazawa S, 2006, P NATL ACAD SCI USA, V103, P14465, DOI 10.1073/pnas.0606450103; Kanno Y, 2007, J THROMB HAEMOST, V5, P2266, DOI 10.1111/j.1538-7836.2007.02745.x; Kanno Y, 2006, J THROMB HAEMOST, V4, P1602, DOI 10.1111/j.1538-7836.2006.01978.x; Kanno Y, 2008, J INVEST DERMATOL, V128, P2792, DOI 10.1038/jid.2008.157; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Kanno Y, 2010, AM J PATHOL, V176, P238, DOI 10.2353/ajpath.2010.090150; Kanno Y, 2008, THROMB RES, V123, P336, DOI 10.1016/j.thromres.2008.05.004; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Majumdar M, 2004, J BIOL CHEM, V279, P37528, DOI 10.1074/jbc.M401372200; Matsuno H, 2003, BLOOD, V102, P3621, DOI 10.1182/blood-2003-03-0700; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Suda T, 1997, METHOD ENZYMOL, V282, P223; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007	26	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8952	8960		10.1074/jbc.M110.152181	http://dx.doi.org/10.1074/jbc.M110.152181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239499	Green Published, hybrid			2022-12-25	WOS:000288247700027
J	Kristiansen, GK; Andersen, MD				Kristiansen, Gunhild Klarskov; Andersen, Mette Dahl			Reversible Activation of Cellular Factor XIII by Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XIII; HUMAN-BLOOD PLATELETS; MALDI-TOF MS; CROSS-LINKING; TISSUE TRANSGLUTAMINASE; BINDING; FIBRINOGEN; THROMBIN; PEPTIDE; MOUSE	Factor XIII (FXIII) is a pro-transglutaminase found in the plasma as well as intracellularly in platelets and macrophages. Plasma FXIII is activated by thrombin cleavage (FXIIIa*) and acts in the final stages of blood coagulation cascade. In contrast, the function and activation of cellular FXIII are less characterized. Cellular FXIII relies on a conformational activation of the protein. The nonproteolytic activation of FXIII to FXIIIa degrees induced by Ca2+ alone is well known, but up until now it has been discussed under which conditions the process can be induced and whether it can be reversed. Here, we study the nature of the Ca2+ -induced FXIII activation. Previously used methods to evaluate FXIII activity detect both FXIIIa* and FXIIIa degrees because they rely on occurrence of enzyme activity or on active site Cys-314 solvent accessibility. Therefore, an analytical HPLC method was developed that separates zymogen recombinant FXIII (rFXIII) from rFXIIIa degrees. The data demonstrate that nonproteolytic activation and deactivation are highly dependent on Ca2+ concentration, buffer, and salt components. Moreover, it is established that Ca2+ activation of rFXIII is fully reversible, and only 2-5 mM CaCl2 is sufficient to retain full rFXIIIa degrees activity. However, below 2 mM CaCl2 the rFXIIIa degrees molecule deactivates. The deactivated molecule can subsequently undergo a new activation round. Furthermore, it is demonstrated that thermal stress of freeze-dried rFXIII can induce a new predisposed form that activates faster than nonstressed rFXIII.	[Kristiansen, Gunhild Klarskov] Novo Nordisk AS, Dept Prot Characterizat, DK-2760 Malov, Denmark; [Andersen, Mette Dahl] Novo Nordisk AS, Dept Prot Struct & Biophys, DK-2760 Malov, Denmark	Novo Nordisk; Novo Nordisk	Kristiansen, GK (corresponding author), Novo Nordisk AS, Dept Prot Characterizat, Novo Nordisk Pk, DK-2760 Malov, Denmark.	GKK@novonordisk.com						AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; Ambrus A, 2001, J BIOMOL STRUCT DYN, V19, P59, DOI 10.1080/07391102.2001.10506720; ANDERSEN MD, 2002, EMBO J, V21, P2055; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; ASIJEE GM, 1988, BIOCHIM BIOPHYS ACTA, V954, P303, DOI 10.1016/0167-4838(88)90085-4; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; CREDO RB, 1978, P NATL ACAD SCI USA, V75, P4234, DOI 10.1073/pnas.75.9.4234; DEBACKERROYER C, 1992, INT J BIOCHEM, V24, P91, DOI 10.1016/0020-711X(92)90234-R; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; HORNYAK TJ, 1992, BIOCHEMISTRY-US, V31, P423, DOI 10.1021/bi00117a017; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; KIM IG, 1993, J BIOL CHEM, V268, P12682; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1571, DOI 10.1152/ajpheart.01035.2001; LEWIS BA, 1978, BIOCHEM J, V169, P397, DOI 10.1042/bj1690397; LI LW, 1995, CELL GROWTH DIFFER, V6, P1171; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LOPACIUK S, 1976, THROMB RES, V8, P453, DOI 10.1016/0049-3848(76)90223-1; LORAND L, 1981, METHOD ENZYMOL, V80, P333; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; LORAND L, 1976, P NATL ACAD SCI USA, V73, P4479, DOI 10.1073/pnas.73.12.4479; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LORAND L, 1980, MEMBRANE TRANSPORT E, P285; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; MUSZBEK L, 1995, THROMB HAEMOSTASIS, V73, P702; MUSZBEK L, 1993, THROMB HAEMOSTASIS, V69, P282; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Muszbek L, 2007, J THROMB HAEMOST, V5, P181, DOI 10.1111/j.1538-7836.2006.02182.x; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Oertel K, 2007, ANAL BIOCHEM, V367, P152, DOI 10.1016/j.ab.2007.05.011; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; POCH E, 1995, NEPHROL DIAL TRANSPL, V10, P366; POLGAR J, 1990, BIOCHEM J, V267, P557, DOI 10.1042/bj2670557; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; Sabo TM, 2007, BIOCHEMISTRY-US, V46, P10089, DOI 10.1021/bi700579z; Serrano K, 2002, THROMB HAEMOSTASIS, V88, P315; SIEFRING GE, 1978, BIOCHEMISTRY-US, V17, P2598, DOI 10.1021/bi00606a022; SIXMA JJ, 1984, THROMB HAEMOSTASIS, V51, P388; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Turner BT, 2002, BIOCHEMISTRY-US, V41, P7947, DOI 10.1021/bi025630n; Weiss MS, 1998, FEBS LETT, V423, P291, DOI 10.1016/S0014-5793(98)00098-2; YEE VC, 1995, THROMB RES, V78, P389, DOI 10.1016/0049-3848(95)00072-Y; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	49	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9833	9839		10.1074/jbc.M110.174128	http://dx.doi.org/10.1074/jbc.M110.174128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245142	hybrid, Green Published			2022-12-25	WOS:000288247700106
J	Pulinilkunnil, T; He, HM; Kong, D; Asakura, K; Peroni, OD; Lee, A; Kahn, BB				Pulinilkunnil, Thomas; He, Huamei; Kong, Dong; Asakura, Kenji; Peroni, Odile D.; Lee, Anna; Kahn, Barbara B.			Adrenergic Regulation of AMP-activated Protein Kinase in Brown Adipose Tissue in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDIDYMAL FAT-CELLS; PERIPHERAL-TISSUES; SKELETAL-MUSCLE; ACID OXIDATION; FOOD-INTAKE; RAT; HEART; EXPRESSION; INSULIN; PHOSPHORYLATION	AMP-activated protein kinase (AMPK), an evolutionarily conserved serine-threonine kinase that senses cellular energy status, is activated by stress and neurohumoral stimuli. We investigated the mechanisms by which adrenergic signaling alters AMPK activation in vivo. Brown adipose tissue (BAT) is highly enriched in sympathetic innervation, which is critical for regulation of energy homeostasis. We performed unilateral denervation of BAT in wild type (WT) mice to abolish neural input. Six days post-denervation, UCP-1 protein levels and AMPK alpha 2 protein and activity were reduced by 45%. In beta(1,2,3)-adrenergic receptor knock-out mice, unilateral denervation led to a 25-45% decrease in AMPK activity, protein expression, and Thr(172) phosphorylation. In contrast, acute alpha -or beta-adrenergic blockade in WT mice resulted in increased AMPK alpha Thr(172) phosphorylation and AMPK alpha 1 and alpha 2 activity in BAT. But short term blockade of alpha-adrenergic signaling in beta(1,2,3)-adrenergic receptor knock-out mice resulted in decreased AMPK activity in BAT, which strongly correlated with enhanced phosphorylation of AMPK on Ser(485/491), a site associated with inhibition of AMPK activity. Both PKA and AKT inhibitors attenuated AMPK Ser(485/491) phosphorylation resulting from alpha-adrenergic blockade and prevented decreases in AMPK activity. In vitro mechanistic studies in BAT explants showed that the effects of alpha-adrenergic blockade appeared to be secondary to inhibition of oxygen consumption. In conclusion, adrenergic pathways regulate AMPK activity in vivo acutely via alterations in Thr(172) phosphorylation and chronically through changes in the alpha catalytic subunit protein levels. Furthermore, AMPK alpha Ser(485/491) phosphorylation may be a novel mechanism to inhibit AMPK activity in vivo and alter its biological effects.	[Pulinilkunnil, Thomas; Kong, Dong; Asakura, Kenji; Peroni, Odile D.; Lee, Anna; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [He, Huamei] Brigham & Womens Hosp, Dept Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Pulinilkunnil, Thomas/H-4387-2019; Pulinilkunnil, Thomas C/L-5511-2016	Pulinilkunnil, Thomas/0000-0003-1228-893X; Pulinilkunnil, Thomas C/0000-0003-1228-893X	National Institutes of Health [P01 DK56116]; Heart and Stroke Foundation of Canada and Canadian Diabetes Association;  [P30 DK57521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P01DK056116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada and Canadian Diabetes Association; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK56116 and the Physiology Core of P30 DK57521 (both to B. B. K.).; Supported by fellowships from the Heart and Stroke Foundation of Canada and Canadian Diabetes Association.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BAK MI, 1994, J CLIN INVEST, V93, P40, DOI 10.1172/JCI116974; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BORST SE, 1994, GEN PHARMACOL-VASC S, V25, P1703, DOI 10.1016/0306-3623(94)90375-1; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Clerk A, 1999, AM J CARDIOL, V83, p64H; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Funahashi K, 2009, PROSTAG OTH LIPID M, V88, P31, DOI 10.1016/j.prostaglandins.2008.09.002; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Hutchinson DS, 2005, DIABETOLOGIA, V48, P2386, DOI 10.1007/s00125-005-1936-7; Jaswal JS, 2006, AM J PHYSIOL-HEART C, V291, pH1883, DOI 10.1152/ajpheart.01147.2005; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Langfort J, 2003, SCAND J MED SCI SPOR, V13, P169, DOI 10.1034/j.1600-0838.2003.20120.x; LEFKOWITZ RJ, 1993, ADV SEC MESS PHOSPH, V28, P1; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA SWY, 1984, CAN J PHYSIOL PHARM, V62, P949, DOI 10.1139/y84-159; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Steinberg GR, 2003, AM J PHYSIOL-ENDOC M, V284, pE648, DOI 10.1152/ajpendo.00318.2002; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Xu Ming, 2007, Shengli Xuebao, V59, P175; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08	42	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8798	8809		10.1074/jbc.M111.218719	http://dx.doi.org/10.1074/jbc.M111.218719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209093	Green Published, hybrid			2022-12-25	WOS:000288247700010
J	Sarangapani, KK; Marshall, BT; McEver, RP; Zhu, C				Sarangapani, Krishna K.; Marshall, Bryan T.; McEver, Rodger P.; Zhu, Cheng			Molecular Stiffness of Selectins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; GLYCOPROTEIN LIGAND-1; SINGLE-MOLECULE; MECHANICAL STABILITY; DNA MECHANICS; CELL-ADHESION; ELASTICITY; ENDOGLYCAN; DOMAINS; SHEAR	During inflammation, selectin-ligand interactions provide forces for circulating leukocytes to adhere to vascular surfaces, which stretch the interacting molecules, suggesting that mechanical properties may be pertinent to their biological function. From mechanical measurements with atomic force microscopy, we analyzed the molecular characteristics of selectins complexed with ligands and antibodies. Respective stiffness of L-, E-, and P-selectins (4.2, 1.4, and 0.85 piconewton/nm) correlated inversely with the number (2, 6, and 9) of consensus repeats in the selectin structures that acted as springs in series to dominate their compliance. After reconstitution into a lipid bilayer, purified membrane P-selectin remained a dimer, capable of forming dimeric bonds with P-selectin glycoprotein ligand (PSGL)-1, endoglycan-Ig, and a dimeric form of a glycosulfopeptide modeled after the N terminus of PSGL-1. By comparison, purified membrane L- and E-selectin formed only monomeric bonds under identical conditions. Ligands and antibodies were much less stretchable than selectins. The length of endoglycan-Ig was found to be 51 +/- 12 nm. These results provide a comprehensive characterization of the molecular stiffness of selectins and illustrate how mechanical measurements can be utilized for molecular analysis, e.g. evaluating the multimericity of selectins and determining the molecular length of endoglycan.	Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Marshall, Bryan T.; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg,Rm 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Zhu, Cheng/A-5724-2011		National Institutes of Health [AI77343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343, R56AI077343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI77343.	Barkalow FJ, 2000, BLOOD, V96, P3070; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sassetti C, 2000, J BIOL CHEM, V275, P9001, DOI 10.1074/jbc.275.12.9001; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	27	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9567	9576		10.1074/jbc.M110.196485	http://dx.doi.org/10.1074/jbc.M110.196485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216951	Green Published, hybrid			2022-12-25	WOS:000288247700082
J	Wang, YQ; Guan, SH; Acharya, P; Koop, DR; Liu, Y; Liao, MX; Burlingame, AL; Correia, MA				Wang, YongQiang; Guan, Shenheng; Acharya, Poulomi; Koop, Dennis R.; Liu, Yi; Liao, Mingxiang; Burlingame, Alma L.; Correia, Maria Almira			Ubiquitin-dependent Proteasomal Degradation of Human Liver Cytochrome P450 2E1 IDENTIFICATION OF SITES TARGETED FOR PHOSPHORYLATION AND UBIQUITINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; RETICULUM-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; RAT HEPATOCYTES; HETEROLOGOUS EXPRESSION; MEDIATED DEGRADATION; CYP2E1 DEGRADATION; MASS-SPECTROMETRY	Human liver CYP2E1 is a monotopic, endoplasmic reticulum-anchored cytochrome P450 responsible for the biotransformation of clinically relevant drugs, low molecular weight xenobiotics, carcinogens, and endogenous ketones. CYP2E1 substrate complexation converts it into a stable slow-turnover species degraded largely via autophagic lysosomal degradation. Substrate decomplexation/withdrawal results in a fast turnover CYP2E1 species, putatively generated through its futile oxidative cycling, that incurs endoplasmic reticulum-associated ubiquitin-dependent proteasomal degradation (UPD). CYP2E1 thus exhibits biphasic turnover in the mammalian liver. We now show upon heterologous expression of human CYP2E1 in Saccharomyces cerevisiae that its autophagic lysosomal degradation and UPD pathways are evolutionarily conserved, even though its potential for futile catalytic cycling is low due to its sluggish catalytic activity in yeast. This suggested that other factors (i.e. post-translational modifications or "degrons") contribute to its UPD. Indeed, in cultured human hepatocytes, CYP2E1 is detectably ubiquitinated, and this is enhanced on its mechanism-based inactivation. Studies in Ubc7p and Ubc5p genetically deficient yeast strains versus corresponding isogenic wild types identified these ubiquitin-conjugating E2 enzymes as relevant to CYP2E1 UPD. Consistent with this, in vitro functional reconstitution analyses revealed that mammalian UBC7/gp78 and UbcH5a/CHIP E2-E3 ubiquitin ligases were capable of ubiquitinating CYP2E1, a process enhanced by protein kinase (PK) A and/or PKC inclusion. Inhibition of PKA or PKC blocked intracellular CYP2E1 ubiquitination and turnover. Here, through mass spectrometric analyses, we identify some CYP2E1 phosphorylation/ubiquitination sites in spatially associated clusters. We propose that these CYP2E1 phosphorylation clusters may serve to engage each E2-E3 ubiquitination complex in vitro and intracellularly.	[Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Guan, Shenheng; Burlingame, Alma L.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Koop, Dennis R.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Mission Bay Campus,Genentech Hall,N572F,Box 2280,, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [GM44037, DK26506, NCRRRR 01614]; NIDDK, National Institutes of Health [P30DK26743]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK026506, R01DK026506, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 (to M.A.C.), DK26506 (to M.A.C.), and NCRRRR 01614 (to A.L.B.).; We sincerely thank Dr. Todd Porter (University of Kentucky, Lexington) for the human CYP2E1 cDNA and Drs. Randy Hampton (University of California, San Diego) and Mark Hochstrasser (Yale University) for the yeast strains; Dr. A. M. Weissman (NCI, National Institutes of Health) for the UBC7 and gp78C expression plasmids; Dr. Cam Patterson (University of North Carolina) for the CHIP expression plasmid; Dr. Lucy Waskell (University of Michigan) for the b<INF>5</INF> expression plasmid; and Dr. Charles Kasper (University of Wisconsin) for the OR expression plasmid. We also thank Dr. Ed LeCluyse and Rachel Whisnant (CellzDirect, Invitrogen) for the human hepatocytes, and Chris Her (University of California, San Francisco, Liver Center Cell and Tissue Biology Core Facility; Dr. J. J. Maher, Director) for rat hepatocyte isolation. We also acknowledge the University of California, San Francisco, Liver Center Core on Cell and Tissue Biology, supported by National Institutes of Health Grant P30DK26743 from NIDDK.	Acharya P, 2011, J BIOL CHEM, V286, P3815, DOI 10.1074/jbc.M110.186981; Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Balgley BM, 2007, MOL CELL PROTEOMICS, V6, P1599, DOI 10.1074/mcp.M600469-MCP200; Banerjee A, 2000, DRUG METAB DISPOS, V28, P118; Bardag-Gorce F, 2002, FREE RADICAL BIO MED, V32, P17, DOI 10.1016/S0891-5849(01)00768-7; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Correia M. A., 2005, CYTOCHROME P450 STRU, P619; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; CORREIA MA, 1991, METHOD ENZYMOL, V206, P315; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FREEMAN JE, 1994, BIOCHEMISTRY-US, V33, P13963, DOI 10.1021/bi00251a002; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; Goasduff T, 2000, ARCH BIOCHEM BIOPHYS, V379, P321, DOI 10.1006/abbi.2000.1870; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Huan JY, 2004, TOXICOL APPL PHARM, V199, P332, DOI 10.1016/j.taap.2003.12.019; Huan JY, 1999, DRUG METAB DISPOS, V27, P549; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kalgutkar AS, 2007, CURR DRUG METAB, V8, P407; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Klotz K, 2009, EXP CELL RES, V315, P1832, DOI 10.1016/j.yexcr.2008.11.017; KOOP DR, 1984, MOL PHARMACOL, V25, P494; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; Masimirembwa CM, 1999, DRUG METAB DISPOS, V27, P1117; MENEZ JF, 1993, ALCOHOL ALCOHOLISM, V28, P445; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Murray BP, 2002, MOL PHARMACOL, V61, P1146, DOI 10.1124/mol.61.5.1146; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Olsen BB, 2008, MOL CELL BIOCHEM, V316, P115, DOI 10.1007/s11010-008-9817-2; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Paine MF, 2006, AM J CLIN NUTR, V83, P1097, DOI 10.1093/ajcn/83.5.1097; Pearce RE, 2008, DRUG METAB DISPOS, V36, P1637, DOI 10.1124/dmd.107.019562; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; Redlich G, 2008, J PROTEOME RES, V7, P4678, DOI 10.1021/pr800231w; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; SOHN DH, 1991, BIOCHEM BIOPH RES CO, V179, P449, DOI 10.1016/0006-291X(91)91391-O; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; UMENO M, 1988, BIOCHEMISTRY-US, V27, P9006, DOI 10.1021/bi00425a019; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; WATKINS PB, 1986, J BIOL CHEM, V261, P6264; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Yang MX, 1997, ARCH BIOCHEM BIOPHYS, V341, P25, DOI 10.1006/abbi.1997.9907; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453; ZHUKOV A, 1993, BIOCHEM BIOPH RES CO, V197, P221, DOI 10.1006/bbrc.1993.2464	103	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9443	9456		10.1074/jbc.M110.176685	http://dx.doi.org/10.1074/jbc.M110.176685			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209460	hybrid, Green Published			2022-12-25	WOS:000288247700072
J	Ahmad, H; Gubbels, R; Ehlers, E; Meyer, F; Waterbury, T; Lin, RT; Zhang, LW				Ahmad, Humera; Gubbels, Rachel; Ehlers, Erica; Meyer, Florencia; Waterbury, Thomas; Lin, Rongtuan; Zhang, Luwen			Kaposi Sarcoma-associated Herpesvirus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing beta-Interferon (TRIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; DOUBLE-STRANDED-RNA; MICROVASCULAR ENDOTHELIAL-CELLS; UBIQUITIN-PROTEASOME PATHWAY; RTA PROMOTES DEGRADATION; LYTIC SWITCH PROTEIN; RBP-J-KAPPA; REGULATORY FACTOR; GENE-EXPRESSION; I INTERFERON	Kaposi sarcoma-associated herpesvirus (KSHV) is a human gamma-herpesvirus associated with several human malignancies. The replication and transcription activator (RTA) is necessary and sufficient for the switch from KSHV latency to lytic replication. Toll-interleukin-1 receptor (TIR) domain-containing adaptor-inducing beta-interferon (TRIF, also called TIR-domain-containing adaptor molecule-1 (TICAM-1)) is a signaling adaptor molecule that is critically involved in the Toll-like receptor 3 (TLR-3) and TLR-4 signaling pathways for type I interferon (IFN) production, a key component of innate immunity against microbial infection. In this report, we find a new mechanism by which RTA blocks innate immunity by targeting cellular TRIF. RTA specifically degrades TRIF by shortening the half-life of TRIF protein. This RTA-mediated degradation is at least partially mediated through the ubiquitin-proteasome pathway because proteasome inhibitors as well as knockdown of cellular ubiquitin expression alleviate the degradation. RTA may not directly interact with TRIF and may activate TRIF degradation indirectly through an unknown mediator(s). RTA targets multiple regions of TRIF and may use its ubiquitin ligase domain for the degradation. In addition, physiological levels of TRIF protein are down-regulated during KSHV lytic replication when RTA is expressed. Finally, RTA down-regulates double-stranded RNA-initiated activation of TLR-3 pathway, in the absence of degradation of IFN regulatory factor 7 (IRF-7). Taken together, these data suggest that KSHV employs a novel mechanism to block the innate immunity by degrading TRIF protein. This work may contribute to our understandings on how KSHV evades host immunity for its survival in vivo.	[Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Ahmad, Humera; Gubbels, Rachel; Ehlers, Erica; Meyer, Florencia; Waterbury, Thomas; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Lin, Rongtuan] McGill Univ, Dept Med, Lady Davis Inst Med Res, Montreal, PQ H3A 2T5, Canada	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Lady Davis Institute; McGill University	Zhang, LW (corresponding author), Univ Nebraska, Nebraska Ctr Virol, 238 Morrison Ctr,4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unlnotes.unl.edu	Meyer, Florencia/V-3406-2019; Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503	National Center for Research Resources (NCRR) [CA138213, CA108951, RR15635]; NATIONAL CANCER INSTITUTE [R01CA138213, R01CA108951] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138213 and CA108951 and COBRA Grant RR15635 from the National Center for Research Resources (NCRR) (to L. Z.).	Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cirone M, 2007, IMMUNOL LETT, V113, P40, DOI 10.1016/j.imlet.2007.07.013; Cloutier N, 2010, J BIOL CHEM, V285, P7208, DOI 10.1074/jbc.M109.018838; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krug LT, 2004, J VIROL, V78, P8359, DOI 10.1128/jvi.78.15.8359-8371.2004; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liang YY, 2003, P NATL ACAD SCI USA, V100, P8490, DOI 10.1073/pnas.1432843100; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Monini P, 1999, J VIROL, V73, P4029, DOI 10.1128/JVI.73.5.4029-4041.1999; Moore P., 2001, VIROLOGY, P2803; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Papugani A, 2008, VIRUS RES, V131, P1, DOI 10.1016/j.virusres.2007.07.019; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Pozharskaya VP, 2004, J GEN VIROL, V85, P2779, DOI 10.1099/vir.0.80214-0; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanchez DJ, 2008, J VIROL, V82, P2208, DOI 10.1128/JVI.01718-07; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Saveliev AK, 2002, VIROLOGY, V299, P301, DOI 10.1006/viro.2002.1561; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2000, MOL BIOTECHNOL, V14, P73, DOI 10.1385/MB:14:1:73; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	71	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7865	7872		10.1074/jbc.M110.191452	http://dx.doi.org/10.1074/jbc.M110.191452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212282	Green Published, hybrid			2022-12-25	WOS:000288013300017
J	Dennis, MD; Baum, JI; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Baum, Jamie I.; Kimball, Scot R.; Jefferson, Leonard S.			Mechanisms Involved in the Coordinate Regulation of mTORC1 by Insulin and Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES PROTEIN-SYNTHESIS; MESSENGER-RNA TRANSLATION; GTP-BINDING PROTEINS; MAMMALIAN TARGET; SKELETAL-MUSCLE; CELL-GROWTH; RAG GTPASES; LIVER; KINASE; DEFICIENCY	In this study, we explored the coordinate regulation of mTORC1 by insulin and amino acids. Rat livers were perfused with medium containing various concentrations of insulin and/or amino acids. At fasting (1x) or 2x (2 x AA) concentrations of amino acids, insulin maximally stimulated Akt phosphorylation but had no effect on global rates of protein synthesis. In the absence of insulin, 4 x AA produced a moderate stimulation of protein synthesis and activation of mTORC1. The combination of 4 x AA and insulin produced a maximal stimulation of protein synthesis and activation of mTORC1. These effects were accompanied by decreases in raptor and PRAS40 and an increase in RagC associated with mTOR (mammalian target of rapamycin). The studies were extended to a cell culture model in which mTORC1 activity was repressed by deprivation of leucine and serum, and resupplementation with the amino acid and insulin acted in an additive manner to restore mTORC1 activation. In deprived cells, mTORC1 was activated by expressing either constitutively active (ca) Rheb or a caRagB.caRagC complex, and coexpression of the constructs had an additive effect. Notably, resupplementation with leucine in cells expressing caRheb or with insulin in cells expressing the caRagB.caRagC complex was as effective as resupplementation with both leucine and insulin in non-transfected cells. Moreover, changes in mTORC1 activity correlated directly with altered association of mTOR with RagB/RagC, Rheb, raptor, and PRAS40. Overall, the results suggest that amino acids signal through the Rag complex and insulin through Rheb to achieve coordinate activation of mTORC1.	[Dennis, Michael D.; Baum, Jamie I.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK15658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499, R37DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 and DK15658 (to L. S. J.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimball SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1080, DOI 10.1152/ajpendo.2000.279.5.E1080; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; MADER S, 1995, MOL CELL BIOL, V15, P4990; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Connor PMJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE994, DOI 10.1152/ajpendo.00391.2003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814	29	76	83	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8287	8296		10.1074/jbc.M110.209171	http://dx.doi.org/10.1074/jbc.M110.209171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239491	Green Published, hybrid			2022-12-25	WOS:000288013300058
J	Tam, JM; Castro, CE; Heath, RJW; Cardenas, ML; Xavier, RJ; Lang, MJ; Vyas, JM				Tam, Jenny M.; Castro, Carlos E.; Heath, Robert J. W.; Cardenas, Michael L.; Xavier, Ramnik J.; Lang, Matthew J.; Vyas, Jatin M.			Control and Manipulation of Pathogens with an Optical Trap for Live Cell Imaging of Intercellular Interactions	PLOS ONE			English	Article							ATTRIBUTABLE MORTALITY; T-CELLS; PHAGOCYTOSIS; PARTICLES; TWEEZERS; FORCE; ACTIVATION; CANDIDEMIA; MICROSCOPY; SYNAPSES	The application of live cell imaging allows direct visualization of the dynamic interactions between cells of the immune system. Some preliminary observations challenge long-held beliefs about immune responses to microorganisms; however, the lack of spatial and temporal control between the phagocytic cell and microbe has rendered focused observations into the initial interactions of host response to pathogens difficult. This paper outlines a method that advances live cell imaging by integrating a spinning disk confocal microscope with an optical trap, also known as an optical tweezer, in order to provide exquisite spatial and temporal control of pathogenic organisms and place them in proximity to host cells, as determined by the operator. Polymeric beads and live, pathogenic organisms (Candida albicans and Aspergillus fumigatus) were optically trapped using non-destructive forces and moved adjacent to living cells, which subsequently phagocytosed the trapped particle. High resolution, transmitted light and fluorescence-based movies established the ability to observe early events of phagocytosis in living cells. To demonstrate the broad applicability of this method to immunological studies, anti-CD3 polymeric beads were also trapped and manipulated to form synapses with T cells in vivo, and time-lapse imaging of synapse formation was also obtained. By providing a method to exert fine control of live pathogens with respect to immune cells, cellular interactions can be captured by fluorescence microscopy with minimal perturbation to cells and can yield powerful insight into early responses of innate and adaptive immunity.	[Tam, Jenny M.; Cardenas, Michael L.; Vyas, Jatin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Castro, Carlos E.; Lang, Matthew J.] MIT, Cambridge, MA 02139 USA; [Heath, Robert J. W.; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Tam, JM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	jvyas@partners.org	Vyas, Jatin/Q-1627-2016; Castro, Carlos E/D-8756-2016	Vyas, Jatin/0000-0002-9985-9565; Castro, Carlos E/0000-0001-7023-6105; Heath, Robert/0000-0001-6675-7573	Massachusetts General Hospital Department of Medicine; National Institute of Biomedical Imaging and Bioengineering [T32EB006348]; Massachusetts General Hospital's Center for Computational and Integrative Biology [AI062773]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [AI057999];  [DK83756];  [DK 043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI057999, R01AI092084, R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, R01DK083756] Funding Source: NIH RePORTER	Massachusetts General Hospital Department of Medicine; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Massachusetts General Hospital's Center for Computational and Integrative Biology; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Massachusetts General Hospital Department of Medicine Internal Funds (J.M.T. and J.M.V.), National Institute of Biomedical Imaging and Bioengineering grant T32EB006348 (C. E. C.), Massachusetts General Hospital's Center for Computational and Integrative Biology development fund and AI062773 (R.J.H.). grants AI062773, DK83756 and DK 043351 (R.J.X.), and National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) AI057999 (J.M.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2006, P NATL ACAD SCI USA, V103, P15945, DOI 10.1073/pnas.0607528103; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Blander JM, 2008, ANN RHEUM DIS, V67, P44, DOI 10.1136/ard.2008.097964; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Goksor M, 2004, APPL OPTICS, V43, P4831, DOI 10.1364/AO.43.004831; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Han SW, 2005, BIOSENS BIOELECTRON, V20, P2120, DOI 10.1016/j.bios.2004.08.023; Heinrich M, 2010, P NATL ACAD SCI US; Hoffmann A, 2000, APPL PHYS B-LASERS O, V71, P747, DOI 10.1007/s003400000454; Hultgren A, 2003, J APPL PHYS, V93, P7554, DOI 10.1063/1.1556204; Ionescu-Zanetti C, 2005, P NATL ACAD SCI USA, V102, P9112, DOI 10.1073/pnas.0503418102; Ke PC, 1999, APPL OPTICS, V38, P160, DOI 10.1364/AO.38.000160; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kress H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061927; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; McNerney GP, 2010, J BIOPHOTONICS, V3, P216, DOI 10.1002/jbio.200900102; Mohanty SK, 2005, OPT EXPRESS, V13, P4745, DOI 10.1364/OPEX.13.004745; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Oddos S, 2008, BIOPHYS J, V95, pL66, DOI 10.1529/biophysj.108.143198; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; SCHROEDER F, 1983, J BIOCHEM BIOPH METH, V8, P15, DOI 10.1016/0165-022X(83)90017-9; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811	43	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15215	10.1371/journal.pone.0015215	http://dx.doi.org/10.1371/journal.pone.0015215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217821	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900016
J	French, DA; Badamdorj, D; Kleene, SJ				French, Donald A.; Badamdorj, Dorjsuren; Kleene, Steven J.			Spatial Distribution of Calcium-Gated Chloride Channels in Olfactory Cilia	PLOS ONE			English	Article							FROG; TRANSDUCTION; RAT; LOCALIZATION; CONDUCTANCE; MECHANISM; MOUSE; CA	Background: In vertebrate olfactory receptor neurons, sensory cilia transduce odor stimuli into changes in neuronal membrane potential. The voltage changes are primarily caused by the sequential openings of two types of channel: a cyclic-nucleotide-gated (CNG) cationic channel and a calcium-gated chloride channel. In frog, the cilia are 25 to 200 mu m in length, so the spatial distributions of the channels may be an important determinant of odor sensitivity. Principal Findings: To determine the spatial distribution of the chloride channels, we recorded from single cilia as calcium was allowed to diffuse down the length of the cilium and activate the channels. A computational model of this experiment allowed an estimate of the spatial distribution of the chloride channels. On average, the channels were concentrated in a narrow band centered at a distance of 29% of the ciliary length, measured from the base of the cilium. This matches the location of the CNG channels determined previously. This non-uniform distribution of transduction proteins is consistent with similar findings in other cilia. Conclusions: On average, the two types of olfactory transduction channel are concentrated in the same region of the cilium. This may contribute to the efficient detection of weak stimuli.	[French, Donald A.; Badamdorj, Dorjsuren] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Kleene, Steven J.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA	University of Cincinnati; University of Cincinnati	French, DA (corresponding author), Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu			National Science Foundation (Division of Mathematical Sciences) [DMS-0515989]; College of Medicine Dean's Bridge Funding Program; University Research Council of the University of Cincinnati	National Science Foundation (Division of Mathematical Sciences)(National Science Foundation (NSF)); College of Medicine Dean's Bridge Funding Program; University Research Council of the University of Cincinnati	This work was supported by research grant DMS-0515989 from the National Science Foundation (Division of Mathematical Sciences), the College of Medicine Dean's Bridge Funding Program, and the University Research Council of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Badamdorj D, 2008, MATH METHOD APPL SCI, V31, P1860, DOI 10.1002/mma.1007; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Berezhkovskii AM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3271998; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Flannery RJ, 2006, BIOPHYS J, V91, P179, DOI 10.1529/biophysj.105.079046; French DA, 2006, MATH COMPUT MODEL, V43, P945, DOI 10.1016/j.mcm.2005.11.010; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Frings S, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P413; Fujiu K, 2009, CURR BIOL, V19, P133, DOI 10.1016/j.cub.2008.11.068; GETCHELL TV, 1980, BIOPHYS J, V29, P397, DOI 10.1016/S0006-3495(80)85142-3; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; HARTZELL LB, 1993, EXP CELL RES, V208, P148, DOI 10.1006/excr.1993.1232; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Jack JJB, 1983, ELECTRIC CURRENT FLO, P518; Kalinay P, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031143; kandel, 1977, NERVOUS SYSTEM, V1; KLEENE SJ, 1994, BRIT J PHARMACOL, V111, P469, DOI 10.1111/j.1476-5381.1994.tb14760.x; KLEENE SJ, 1992, PFLUG ARCH EUR J PHY, V421, P374, DOI 10.1007/BF00374226; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; Lee J, 2010, PLOS ONE, V8; LIDOW MS, 1984, J ULTRA MOL STRUCT R, V86, P18, DOI 10.1016/S0022-5320(84)90092-3; Lohret TA, 1998, MOL BIOL CELL, V9, P1195, DOI 10.1091/mbc.9.5.1195; Matsuzaki O, 1999, NEUROSCIENCE, V94, P131, DOI 10.1016/S0306-4522(99)00228-6; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1992, NEURON, V8, P441, DOI 10.1016/0896-6273(92)90272-F; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Pifferi S, 2009, NEUROBIOLOGY OLFACTI, P203; Quarmby L, 2009, CURR BIOL, V19, pR158, DOI 10.1016/j.cub.2008.12.038; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schwarzenbacher K, 2005, HISTOCHEM CELL BIOL, V123, P419, DOI 10.1007/s00418-005-0790-5; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Takeuchi H, 2009, J GEN PHYSIOL, V133, P583, DOI 10.1085/jgp.200810085	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15676	10.1371/journal.pone.0015676	http://dx.doi.org/10.1371/journal.pone.0015676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209888	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793600026
J	Akgul, B; Lin, KW; Yang, HMO; Chen, YH; Lu, TH; Chen, CH; Kikuchi, T; Chen, YT; Tu, CPD				Akgul, Bunyamin; Lin, Kai-Wei; Yang, Hui-Mei Ou; Chen, Yen-Hui; Lu, Tzu-Huan; Chen, Chien-Hsiun; Kikuchi, Tateki; Chen, Yuan-Tsong; Tu, Chen-Pei D.			Garlic Accelerates Red Blood Cell Turnover and Splenic Erythropoietic Gene Expression in Mice: Evidence for Erythropoietin-Independent Erythropoiesis	PLOS ONE			English	Article							CARBON-MONOXIDE; HEME OXYGENASE; BILIRUBIN; ENZYME; ANTIOXIDANT; INDUCTION; PROMOTER; SULFUR; MAPK	Garlic (Allium sativum) has been valued in many cultures both for its health effects and as a culinary flavor enhancer. Garlic's chemical complexity is widely thought to be the source of its many health benefits, which include, but are not limited to, anti-platelet, procirculatory, anti-inflammatory, anti-apoptotic, neuro-protective, and anti-cancer effects. While a growing body of scientific evidence strongly upholds the herb's broad and potent capacity to influence health, the common mechanisms underlying these diverse effects remain disjointed and relatively poorly understood. We adopted a phenotype-driven approach to investigate the effects of garlic in a mouse model. We examined RBC indices and morphologies, spleen histochemistry, RBC half-lives and gene expression profiles, followed up by qPCR and immunoblot validation. The RBCs of garlic-fed mice register shorter half-lives than the control. But they have normal blood chemistry and RBC indices. Their spleens manifest increased heme oxygenase 1, higher levels of iron and bilirubin, and presumably higher CO, a pleiotropic gasotransmitter. Heat shock genes and those critical for erythropoiesis are elevated in spleens but not in bone marrow. The garlic-fed mice have lower plasma erythropoietin than the controls, however. Chronic exposure to CO of mice on garlic-free diet was sufficient to cause increased RBC indices but again with a lower plasma erythropoietin level than air-treated controls. Furthermore, dietary garlic supplementation and CO treatment showed additive effects on reducing plasma erythropoietin levels in mice. Thus, garlic consumption not only causes increased energy demand from the faster RBC turnover but also increases the production of CO, which in turn stimulates splenic erythropoiesis by an erythropoietin-independent mechanism, thus completing the sequence of feedback regulation for RBC metabolism. Being a pleiotropic gasotransmitter, CO may be a second messenger for garlic's other physiological effects.	[Akgul, Bunyamin; Lin, Kai-Wei; Yang, Hui-Mei Ou; Chen, Yen-Hui; Lu, Tzu-Huan; Chen, Chien-Hsiun; Kikuchi, Tateki; Chen, Yuan-Tsong; Tu, Chen-Pei D.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Akgul, Bunyamin] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Yang, Hui-Mei Ou; Lu, Tzu-Huan; Chen, Chien-Hsiun; Chen, Yuan-Tsong] Acad Sinica, Natl Genotyping Ctr, Taipei 115, Taiwan; [Chen, Yen-Hui; Kikuchi, Tateki] Acad Sinica, Taiwan Mouse Clin, Natl Phenotyping Ctr, Taipei 115, Taiwan; [Tu, Chen-Pei D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Academia Sinica - Taiwan; Izmir Institute of Technology; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Akgul, B (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	unh@psu.edu	Akgül, Bünyamin/AAY-2958-2020; Chen, Chien Hsiun/Q-3826-2018	Akgül, Bünyamin/0000-0001-9877-9689; 	National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core) [NSC-95-3112-B-001-011]; Academia Sinica; National Science Council (Taiwan Authority)	National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core)(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Science Council (Taiwan Authority)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core, NSC-95-3112-B-001-011 to YTC), and the Genomics and Proteomics Program, Academia Sinica. C-PDT was supported by Academia Sinica and the National Science Council (Taiwan Authority) during residence in Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2006, J NUTR, V136, p716S; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Coburn RF, 1965, J CLIN INVEST, V43, P1098; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dehari H, 2009, MOL REPROD DEV, V76, P379, DOI 10.1002/mrd.20976; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; El-Bayoumy K, 2006, J NUTR, V136, p864S, DOI 10.1093/jn/136.3.864S; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Gibbons JD, 1992, NONPARAMETRIC STAT I; Gill PR, 1981, PRACTICAL OPTIMIZATI, P136, DOI DOI 10.1137/1025065; Gomori G, 1952, MICROSCOPIC HISTOCHE, P189; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; HOFFMANNFEZER G, 1991, ANN HEMATOL, V63, P214, DOI 10.1007/BF01703446; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Landaw S, 1991, HEMATOLOGY BASIC PRI, P274; LANDAW SA, 1970, J CLIN INVEST, V49, P914, DOI 10.1172/JCI106311; MAINES MD, 1986, J BIOL CHEM, V261, P411; Matsuura H, 2001, J NUTR, V131, p1000S, DOI 10.1093/jn/131.3.1000S; Miron T, 2008, J NUTR BIOCHEM, V19, P524, DOI 10.1016/j.jnutbio.2007.06.009; Munday R, 2003, FREE RADICAL BIO MED, V34, P1200, DOI 10.1016/S0891-5849(03)00144-8; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Oboh G, 2004, J MED FOOD, V7, P498, DOI 10.1089/jmf.2004.7.498; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; PARMLEY RT, 1988, J HISTOCHEM CYTOCHEM, V36, P433, DOI 10.1177/36.4.2450121; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; SHERPA AK, 1989, J APPL PHYSIOL, V67, P1383, DOI 10.1152/jappl.1989.67.4.1383; Sherrod PH, 2000, NONLINEAR REGRESSION; SHIBAHARA S, 1978, ARCH BIOCHEM BIOPHYS, V188, P243, DOI 10.1016/S0003-9861(78)80006-X; Simpson LO, 2001, J ORTHOMOL MED, V16, P157; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YEH YY, 1994, LIPIDS, V29, P189, DOI 10.1007/BF02536728	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15358	10.1371/journal.pone.0015358	http://dx.doi.org/10.1371/journal.pone.0015358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206920	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200025
J	Mandle, L; Warren, DL; Hoffmann, MH; Peterson, AT; Schmitt, J; von Wettberg, EJ				Mandle, Lisa; Warren, Dan L.; Hoffmann, Matthias H.; Peterson, A. Townsend; Schmitt, Johanna; von Wettberg, Eric J.			Conclusions about Niche Expansion in Introduced Impatiens walleriana Populations Depend on Method of Analysis	PLOS ONE			English	Article							POTENTIAL DISTRIBUTION; NORTH-AMERICA; ALIEN PLANT; SPECIES INVASIONS; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATISM; RANGES; SHIFT; RISK	Determining the degree to which climate niches are conserved across plant species' native and introduced ranges is valuable to developing successful strategies to limit the introduction and spread of invasive plants, and also has important ecological and evolutionary implications. Here, we test whether climate niches differ between native and introduced populations of Impatiens walleriana, globally one of the most popular horticultural species. We use approaches based on both raw climate data associated with occurrence points and ecological niche models (ENMs) developed with Maxent. We include comparisons of climate niche breadth in both geographic and environmental spaces, taking into account differences in available habitats between the distributional areas. We find significant differences in climate envelopes between native and introduced populations when comparing raw climate variables, with introduced populations appearing to expand into wetter and cooler climates. However, analyses controlling for differences in available habitat in each region do not indicate expansion of climate niches. We therefore cannot reject the hypothesis that observed differences in climate envelopes reflect only the limited environments available within the species' native range in East Africa. Our results suggest that models built from only native range occurrence data will not provide an accurate prediction of the potential for invasiveness if applied to areas containing a greater range of environmental combinations, and that tests of niche expansion may overestimate shifts in climate niches if they do not control carefully for environmental differences between distributional areas.	[Mandle, Lisa; Schmitt, Johanna] Brown Univ, Providence, RI 02912 USA; [Mandle, Lisa] Univ Hawaii, Dept Bot, Honolulu, HI 96822 USA; [Warren, Dan L.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Hoffmann, Matthias H.] Univ Halle Wittenberg, Inst Geobot & Bot Garten, Halle, Saale, Germany; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [von Wettberg, Eric J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA	Brown University; University of Hawaii System; University of Texas System; University of Texas Austin; Martin Luther University Halle Wittenberg; University of Kansas; State University System of Florida; Florida International University	Mandle, L (corresponding author), Brown Univ, Providence, RI 02912 USA.	evonwettberg@fairchildgarden.org	Peterson, A. Townsend/I-5697-2013; Warren, Dan/B-3821-2010; Mandle, Lisa/G-6380-2011; von Wettberg, Eric/C-1115-2016	Peterson, A. Townsend/0000-0003-0243-2379; Warren, Dan/0000-0002-8747-2451; von Wettberg, Eric/0000-0002-2724-0317; Mandle, Lisa/0000-0002-1420-8529	US Environmental Protection Agency; US National Science Foundation [0408015]; US NSF Division of Environmental Biology [0129018]; NSF; Microsoft Research; Microsoft Research Foundation	US Environmental Protection Agency(United States Environmental Protection Agency); US National Science Foundation(National Science Foundation (NSF)); US NSF Division of Environmental Biology; NSF(National Science Foundation (NSF)); Microsoft Research(Microsoft); Microsoft Research Foundation(Microsoft)	This work was funded by an US Environmental Protection Agency Science To Achieve Results graduate fellowship (to EVW, http://www.epa.gov/ncerqa/fellow/), US National Science Foundation Doctoral Dissertation Improvement Grant 0408015 (to EVW and JS, www.nsf.gov), US NSF Division of Environmental Biology 0129018 (to JS, including an REU supplement to LM, www.nsf.gov), and NSF Graduate Research Fellowship Program (to LM, www.nsf.gov), and Microsoft Research (to ATP, http://research.microsoft.com/en-us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding received did not entail employment, consultation, patents, marketing or commercial software development, or any other financial obligation. Funding does not alter the authors' adherence to PLOS ONE data sharing and materials guidelines.; The authors have declared that no competing interests exist. ATP has received academic grants from the Microsoft Research Foundation. These awards are for basic research, and come with no commercial or finanacial dimensions. They do not involve employment, consultation on microsoft products, commercial software development, patents, or advocacy for microsoft. They also do not affect our adherence to PLOS ONE policies on data sharing or materials.	ADREER H, 1890, SEED CATALOG 1 N WAT; *AGR USDO, 1998, 1998 CENS HORT SPEC; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; BirdLife International, 2009, IMP BIRD AR FACTSH; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Cain S.A., 1944, FDN PLANT GEOGRAPHY; CARNES BA, 1982, ECOLOGY, V63, P888, DOI 10.2307/1937227; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; ESPENAK F, 1999, TOTAL SOLAR ECLIPSE; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Grey-Wilson C., 1982, FLORA TROPICAL E AFR; Grey-Wilson C, 1980, IMPATIENS AFRICA MOR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Hoffmann MH, 2001, FLORA, V196, P395, DOI 10.1016/S0367-2530(17)30076-2; Hutchinson G.E., 1978, INTRO POPULATION ECO; KRAMER IN, 2000, SEED CATALOG, P225; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; LAUNERT E, 1963, FLORA ZAMBESIACA; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEVINS RICHARD, 1968; *LIV SEED CO, 1900, SEED CAT COLUMBUSOH; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; PANETTA FD, 1991, WEED RES, V31, P273, DOI 10.1111/j.1365-3180.1991.tb01767.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PERRINS J, 1993, J BIOGEOGR, V20, P33, DOI 10.2307/2845737; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; PETERSON AT, 2010, ECOLOGICAL NICHES GE; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; *PLANTS DAT, 2010, NAT RES CONS SERV US; Polhill D, 1988, FLORA TROPICAL E AFR; R Development Core Team, 2009, R FDN STAT COMP; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rogg H., 2003, EXPERIENCES LIMITATI, P117; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; STOKES J, 1890, SEED CATALOG MARKET; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; *US BUR CENS, 2002, CENS 2000 US GAZ; *US BUR CENS, 2001, HYDR EL DER DAT; *USDA, 1995, IMP BAL REP HERB ORN; VICKERY RK, 1974, ECOLOGY, V55, P796, DOI 10.2307/1934415; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WARREN DL, ECOLOGICAL IN PRESS; Welk E, 2002, DIVERS DISTRIB, V8, P219, DOI 10.1046/j.1472-4642.2002.00144.x; WIENS JJ, 2005, NICHE CONSERVATISM I; WILLIAMSON MH, BIOL INVASIONS; Woodward F.I., 1987, CLIMATE PLANT DISTRI	61	58	58	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15297	10.1371/journal.pone.0015297	http://dx.doi.org/10.1371/journal.pone.0015297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206912	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200023
J	Nelson, DM; Cann, IKO; Mackie, RI				Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.			Response of Archaeal Communities in the Rhizosphere of Maize and Soybean to Elevated Atmospheric CO2 Concentrations	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; MULTIPLE SEQUENCE ALIGNMENT; SOIL MICROBIAL COMMUNITIES; AMMONIA-OXIDIZING ARCHAEA; ENRICHMENT FACE; ZEA-MAYS; HYDROGEN EVOLUTION; NITROGEN-FIXATION; DIVERSITY; PHOTOSYNTHESIS	Background: Archaea are important to the carbon and nitrogen cycles, but it remains uncertain how rising atmospheric carbon dioxide concentrations ([CO2]) will influence the structure and function of soil archaeal communities. Methodology/Principal Findings: We measured abundances of archaeal and bacterial 16S rRNA and amoA genes, phylogenies of archaeal 16S rRNA and amoA genes, concentrations of KCl-extractable soil ammonium and nitrite, and potential ammonia oxidation rates in rhizosphere soil samples from maize and soybean exposed to ambient (similar to 385 ppm) and elevated (550 ppm) [CO2] in a replicated and field-based study. There was no influence of elevated [CO2] on copy numbers of archaeal or bacterial 16S rRNA or amoA genes, archaeal community composition, KCl-extractable soil ammonium or nitrite, or potential ammonia oxidation rates for samples from maize, a model C-4 plant. Phylogenetic evidence indicated decreased relative abundance of crenarchaeal sequences in the rhizosphere of soybean, a model leguminous-C-3 plant, at elevated [CO2], whereas quantitative PCR data indicated no changes in the absolute abundance of archaea. There were no changes in potential ammonia oxidation rates at elevated [CO2] for soybean. Ammonia oxidation rates were lower in the rhizosphere of maize than soybean, likely because of lower soil pH and/or abundance of archaea. KCl-extractable ammonium and nitrite concentrations were lower at elevated than ambient [CO2] for soybean. Conclusion: Plant-driven shifts in soil biogeochemical processes in response to elevated [CO2] affected archaeal community composition, but not copy numbers of archaeal genes, in the rhizosphere of soybean. The lack of a treatment effect for maize is consistent with the fact that the photosynthesis and productivity of maize are not stimulated by elevated [CO2] in the absence of drought.	[Nelson, David M.] Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA; [Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University System of Maryland; University of Maryland Center for Environmental Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nelson, DM (corresponding author), Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA.	dmnelson@al.umces.edu	Nelson, David/AAP-9412-2020; Nelson, David M/D-5596-2009	Nelson, David/0000-0003-2755-5535; Nelson, David M/0000-0003-2755-5535	United States Department of Agriculture National Institute of Food and Agriculture [2008-35107-05854]; U.S. Department of Energy; Illinois Council for Food and Agricultural Research; Archer Daniels Midland Company; U.S. Department of Agriculture Agricultural Research Service; Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University [DE-FC02-06ER64158]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); U.S. Department of Energy(United States Department of Energy (DOE)); Illinois Council for Food and Agricultural Research; Archer Daniels Midland Company; U.S. Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University(United States Department of Energy (DOE))	This project was supported by competitive grant no. 2008-35107-05854 from the United States Department of Agriculture National Institute of Food and Agriculture (D.M.N.). Funding for SoyFACE was provided by the U.S. Department of Energy, Illinois Council for Food and Agricultural Research, Archer Daniels Midland Company, and U.S. Department of Agriculture Agricultural Research Service. Department of Energy support was through the Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University, under Award Number DE-FC02-06ER64158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Austin EE, 2009, SOIL BIOL BIOCHEM, V41, P514, DOI 10.1016/j.soilbio.2008.12.010; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bernacchi CJ, 2005, PLANTA, V220, P434, DOI 10.1007/s00425-004-1320-8; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CRUSH JR, 1993, NEW ZEAL J AGR RES, V36, P177; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Drigo B, 2008, BIOL FERT SOILS, V44, P667, DOI 10.1007/s00374-008-0277-3; Drigo B, 2009, ISME J, V3, P1204, DOI 10.1038/ismej.2009.65; Endres TJ, 2001, SOIL SURVEY CHAMPAIG; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hendershot W.H., 1993, SOIL SAMPLING METHOD, P141; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Inubushi K, 2003, GLOBAL CHANGE BIOL, V9, P1458, DOI 10.1046/j.1365-2486.2003.00665.x; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Janus LR, 2005, MICROB ECOL, V50, P102, DOI 10.1007/s00248-004-0120-9; Jossi M, 2006, FEMS MICROBIOL ECOL, V55, P339, DOI 10.1111/j.1574-6941.2005.00040.x; Kassem II, 2008, J INTEGR PLANT BIOL, V50, P1406, DOI 10.1111/j.1744-7909.2008.00752.x; Klamer M, 2002, APPL ENVIRON MICROB, V68, P4370, DOI 10.1128/AEM.68.9.4370-4376.2002; Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2004, GLOBAL CHANGE BIOL, V10, P951, DOI 10.1111/j.1529-8817.2003.00767.x; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lesaulnier C, 2008, ENVIRON MICROBIOL, V10, P926, DOI 10.1111/j.1462-2920.2007.01512.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Morgan PB, 2005, GLOBAL CHANGE BIOL, V11, P1856, DOI 10.1111/j.1365-2486.2005.001017.x; Nadelhoffer KJ, 2004, FOREST ECOL MANAG, V196, P89, DOI 10.1016/j.foreco.2004.03.014; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Peoples MB, 2008, PLANT SOIL, V307, P67, DOI 10.1007/s11104-008-9582-8; Peralta AL, 2008, PLANT SOIL, V303, P69, DOI 10.1007/s11104-007-9474-3; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Rodriguez V, 2004, SOYBEAN ROOT PRODUCT; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rogers A, 2006, PLANT CELL ENVIRON, V29, P1651, DOI 10.1111/j.1365-3040.2006.01549.x; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; Schinner F., 1996, METHODS SOIL BIOL; SCHUBERT KR, 1976, P NATL ACAD SCI USA, V73, P1207, DOI 10.1073/pnas.73.4.1207; Simon HM, 2005, APPL ENVIRON MICROB, V71, P4751, DOI 10.1128/AEM.71.8.4751-4760.2005; Sliwinski MK, 2004, APPL ENVIRON MICROB, V70, P1821, DOI 10.1128/AEM.70.3.1821-1826.2004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zheng XH, 2006, GLOBAL CHANGE BIOL, V12, P1717, DOI 10.1111/j.1365-2486.2006.01199.x	69	15	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15897	10.1371/journal.pone.0015897	http://dx.doi.org/10.1371/journal.pone.0015897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209969	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793200069
J	Tapirdamaz, O; Mancham, S; van der Laan, LJW; Kazemier, G; Thielemans, K; Metselaar, HJ; Kwekkeboom, J				Tapirdamaz, Ozlem; Mancham, Shanta; van der Laan, Luc J. W.; Kazemier, Geert; Thielemans, Kris; Metselaar, Herold J.; Kwekkeboom, Jaap			Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay	PLOS ONE			English	Article							ALLOREACTIVE T-CELLS; IMMUNOSORBENT SPOT ASSAY; ANTIGEN-PRESENTING CELLS; CD40-ACTIVATED B-CELLS; DENDRITIC CELLS; PRECURSOR FREQUENCIES; GRAFT FUNCTION; IN-VIVO; ENDOTHELIAL-CELLS; CLONAL EXPANSION	Conventional assays for quantification of allo-reactive T-cell precursor frequencies (PF) are relatively insensitive. We present a robust assay for quantification of PF of T-cells with direct donor-specificity, and establish the kinetics of circulating donor-specific T cells after liver transplantation (LTx). B cells from donor splenocytes were differentiated into professional antigen-presenting cells by CD40-engagement (CD40-B cells). CFSE-labelled PBMC from LTx-recipients obtained before and at several time points after LTx, were stimulated with donor-derived or 3(rd) party CD40-B cells. PF of donor-specific T cells were calculated from CFSE-dilution patterns, and intracellular IFN-gamma was determined after re-stimulation with CD40-B cells. Compared to splenocytes, stimulations with CD40-B cells resulted in 3 to 5-fold higher responding T-cell PF. Memory and naive T-cell subsets responded equally to allogeneic CD40-B cell stimulation. Donor-specific CD4(+) and CD8(+) T-cell PF ranged from 0.5 to 19% (median: 5.2%). One week after LTx, PF of circulating donor-specific CD4(+) and CD8(+) T cells increased significantly, while only a minor increase in numbers of T cells reacting to 3(rd) party allo-antigens was observed. One year after LTx numbers of CD4(+) and CD8(+) T cells reacting to donor antigens, as well as those reacting to 3(rd) party allo-antigens, were slightly lower compared to pre-transplant values. Moreover, CD4(+) and CD8(+) T cells responding to donor-derived, as well as those reacting to 3(rd) party CD40-B cells, produced less IFN-gamma. In conclusion, our alternative approach enables detection of allo-reactive human T cells at high frequencies, and after application we conclude that donor-specific T-cell PF increase immediately after LTx. However, no evidence for a specific loss of circulating T-cells recognizing donor allo-antigens via the direct pathway up to 1 year after LTx was obtained, underscoring the relative insensitiveness of previous assays.	[Tapirdamaz, Ozlem; Mancham, Shanta; Metselaar, Herold J.; Kwekkeboom, Jaap] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van der Laan, Luc J. W.; Kazemier, Geert] Erasmus MC Univ, Dept Surg, Med Ctr, Rotterdam, Netherlands; [Thielemans, Kris] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Brussels, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Brussel	Tapirdamaz, O (corresponding author), Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	j.kwekkeboom@erasmusmc.nl		van der Laan, Luc/0000-0002-0651-5334	Dutch Organization of Scientific Research (NWO) [017.003.031]	Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was financially supported by a Mozaiek Grant of the Dutch Organization of Scientific Research (NWO, 017.003.031 to O.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; ATKINS RC, 1975, J EXP MED, V141, P664, DOI 10.1084/jem.141.3.664; Baker RJ, 2001, J IMMUNOL, V167, P7199, DOI 10.4049/jimmunol.167.12.7199; Baker RJ, 2001, TRANSPLANTATION, V72, P480, DOI 10.1097/00007890-200108150-00020; Benichou G, 1999, J IMMUNOL, V162, P352; Bercovici N, 2003, J IMMUNOL METHODS, V276, P5, DOI 10.1016/S0022-1759(03)00059-0; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bosma BM, 2010, LIVER TRANSPLANT, V16, P12, DOI 10.1002/lt.21961; Brennan TV, 2009, AM J TRANSPLANT, V9, P709, DOI 10.1111/j.1600-6143.2009.02578.x; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; de Haan A, 2000, TRANSPLANTATION, V69, P1434, DOI 10.1097/00007890-200004150-00038; de Haan A, 2002, TRANSPLANTATION, V74, P562, DOI 10.1097/00007890-200208270-00023; de Haan A, 2001, TRANSPLANTATION, V71, P785, DOI 10.1097/00007890-200103270-00017; de Haan A, 2000, TRANSPLANTATION, V69, P1637; Dengler TJ, 2001, J IMMUNOL, V166, P3846, DOI 10.4049/jimmunol.166.6.3846; Game DS, 2003, J AM SOC NEPHROL, V14, P1652, DOI 10.1097/01.ASN.0000067411.03024.A9; Gebauer BS, 2002, AM J TRANSPLANT, V2, P857, DOI 10.1034/j.1600-6143.2002.20908.x; Givan AL, 1999, J IMMUNOL METHODS, V230, P99, DOI 10.1016/S0022-1759(99)00136-2; Givan Alice L, 2004, Methods Mol Biol, V263, P109; Godoy-Ramirez K, 2005, CYTOM PART A, V68A, P71, DOI 10.1002/cyto.a.20189; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Kusaka S, 2000, J IMMUNOL, V164, P2240, DOI 10.4049/jimmunol.164.4.2240; LARSEN CP, 1990, TRANSPLANTATION, V50, P294, DOI 10.1097/00007890-199008000-00025; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; LINDAHL KF, 1977, J EXP MED, V145, P500, DOI 10.1084/jem.145.3.500; LOMBARDI G, 1990, INT IMMUNOL, V2, P9, DOI 10.1093/intimm/2.1.9; Macedo C, 2009, AM J TRANSPLANT, V9, P2057, DOI 10.1111/j.1600-6143.2009.02742.x; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Matesic D, 1998, TRANSPLANTATION, V65, P906, DOI 10.1097/00007890-199804150-00008; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nather BJ, 2006, TRANSPL IMMUNOL, V16, P232, DOI 10.1016/j.trim.2006.09.026; Ng WF, 2002, J AM SOC NEPHROL, V13, P2983, DOI 10.1097/01.ASN.0000042163.73539.D4; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; NISBET NW, 1969, J EXP MED, V129, P459, DOI 10.1084/jem.129.3.459; Noorchashm H, 1999, TRANSPLANTATION, V67, P1281, DOI 10.1097/00007890-199905150-00015; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; Saiki T, 2001, TRANSPLANTATION, V71, P1806, DOI 10.1097/00007890-200106270-00017; Saiki T, 2001, J LEUKOCYTE BIOL, V69, P705; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Schultze JL, 2004, TRENDS IMMUNOL, V25, P659, DOI 10.1016/j.it.2004.09.016; Smyth LA, 2006, TRANSPLANTATION, V82, pS15, DOI 10.1097/01.tp.0000231347.06149.ca; Song HK, 1999, TRANSPLANTATION, V68, P297, DOI 10.1097/00007890-199907270-00024; Stax AM, 2008, J IMMUNOL METHODS, V335, P46, DOI 10.1016/j.jim.2008.02.013; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Ueta H, 2008, HEPATOLOGY, V47, P1352, DOI 10.1002/hep.22161; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; van Besouw NM, 2005, TRANSPLANTATION, V79, P1062, DOI 10.1097/01.TP.0000161222.03635.86; van der Mast BJ, 2001, TRANSPLANTATION, V72, P873, DOI 10.1097/00007890-200109150-00023; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; von Bergwelt-Baildon M, 2006, BLOOD, V107, P2786, DOI 10.1182/blood-2004-01-0113; von Bergwelt-Baildon M, 2004, ANN ONCOL, V15, P853, DOI 10.1093/annonc/mdh213; von Bergwelt-Baildon M, 2007, EXPERT REV VACCINES, V6, P667, DOI 10.1586/14760584.6.5.667; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Zand MS, 2005, AM J TRANSPLANT, V5, P76, DOI 10.1111/j.1600-6143.2003.00637.x	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14452	10.1371/journal.pone.0014452	http://dx.doi.org/10.1371/journal.pone.0014452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206923	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200008
J	Waters, J				Waters, Jack			The Concentration of Soluble Extracellular Amyloid-beta Protein in Acute Brain Slices from CRND8 Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; IN-VIVO; INTERSTITIAL FLUID; SECRETED OLIGOMERS; PEPTIDE; DEPOSITION; DISRUPTION; CLEARANCE	Background: Many recent studies of the effects of amyloid-beta protein (A beta) on brain tissue from amyloid precursor protein (APP) overexpressing mice have concluded that A beta oligomers in the extracellular space can profoundly affect synaptic structure and function. As soluble proteins, oliomers of A beta can diffuse through brain tissue and can presumably exit acute slices, but the rate of loss of A beta species by diffusion from brain slices and the resulting reduced concentrations of A beta species in brain slices are unknown. Methodology/Principal Findings: Here I combine measurements of A beta 1-42 diffusion and release from acute slices and simple numerical models to measure the concentration of A beta 1-42 in intact mice (in vivo) and in acute slices from CRND8 mice. The in vivo concentration of diffusible A beta 1-42 in CRND8 mice was 250 pM at 6 months of age and 425 pM at 12 months of age. The concentration of A beta 1-42 declined rapidly after slice preparation, reaching a steady-state concentration within one hour. 50 mm from the surface of an acute slice the steady-state concentration of A beta was 15-30% of the concentration in intact mice. In more superficial regions of the slice, where synaptic physiology is generally studied, the remaining A beta is less than 15%. Hence the concentration of A beta 1-42 in acute slices from CRND8 mice is less than 150 pM. Conclusions/Significance: A beta affects synaptic plasticity in the picomolar concentration range. Some of the effects of A beta may therefore be lost or altered after slice preparation, as the extracellular A beta concentration declines from the high picomolar to the low picomolar range. Hence loss of A beta by diffusion may complicate interpretation of the effects of A beta in experiments on acute slices from APP overexpressing mice.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Waters, J (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	jackwaters@northwestern.edu			Alzheimer's Association [NIRG-06-25509]; National Institute on Aging [AG029282]; NATIONAL INSTITUTE ON AGING [R21AG029282] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Alzheimer's Association (NIRG-06-25509) and the National Institute on Aging (AG029282).	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Ambree O, 2006, NEUROBIOL AGING, V27, P955, DOI 10.1016/j.neurobiolaging.2005.05.009; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Jolas T, 2002, NEUROBIOL DIS, V11, P394, DOI 10.1006/nbdi.2002.0557; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Koch Christof, 1999, P1; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saxton Michael J., 2007, V400, P295; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271	43	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15709	10.1371/journal.pone.0015709	http://dx.doi.org/10.1371/journal.pone.0015709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209950	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200040
J	Johnston, APW; Baker, J; Bellamy, LM; McKay, BR; De Lisio, M; Parise, G				Johnston, Adam P. W.; Baker, Jeff; Bellamy, Leeann M.; McKay, Bryon R.; De Lisio, Michael; Parise, Gianni			Regulation of Muscle Satellite Cell Activation and Chemotaxis by Angiotensin II	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ADULT SKELETAL-MUSCLE; GENE-EXPRESSION; INDUCED MIGRATION; LEADING-EDGE; STEM-CELLS; TGF-BETA; IN-VITRO; HYPERTENSION; MYOBLASTS	The role of angiotensin II (Ang II) in skeletal muscle is poorly understood. We report that pharmacological inhibition of Ang II signaling or ablation of the AT1a receptor significantly impaired skeletal muscle growth following myotrauma, in vivo, likely due to impaired satellite cell activation and chemotaxis. In vitro experiments demonstrated that Ang II treatment activated quiescent myoblasts as evidenced by the upregulation of myogenic regulatory factors, increased number of beta-gal+, Myf5-LacZ myoblasts and the acquisition of cellular motility. Furthermore, exogenous treatment with Ang II significantly increased the chemotactic capacity of C2C12 and primary cells while AT1a(-/-) myoblasts demonstrated a severe impairment in basal migration and were not responsive to Ang II treatment. Additionally, Ang II interacted with myoblasts in a paracrine-mediated fashion as 4 h of cyclic mechanical stimulation resulted in Ang II-induced migration of cocultured myoblasts. Ang II-induced chemotaxis appeared to be regulated by multiple mechanisms including reorganization of the actin cytoskeleton and augmentation of MMP2 activity. Collectively, these results highlight a novel role for Ang II and ACE inhibitors in the regulation of skeletal muscle growth and satellite cell function.	[Johnston, Adam P. W.; Baker, Jeff; Bellamy, Leeann M.; McKay, Bryon R.; De Lisio, Michael; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Johnston, APW (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca			Natural Science and Engineering Research Council [327071-06]	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council Discovery Grant (# 327071-06) awarded to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHEN Y, 2010, PHYSL GENOMICS; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263; El Fahime E, 2000, EXP CELL RES, V258, P279, DOI 10.1006/excr.2000.4962; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hawke TJ, 2005, EXERC SPORT SCI REV, V33, P63, DOI 10.1097/00003677-200504000-00002; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HEIT B, 2003, SCI STKE, pPL5; Hlaing M, 2002, J BIOL CHEM, V277, P23794, DOI 10.1074/jbc.M201980200; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Inagami T, 2000, BRAZ J MED BIOL RES, V33, P619, DOI 10.1590/S0100-879X2000000600002; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; JOHNSTON A, 2010, J RENIN ANG IN PRESS; KAMI K, 1995, CELL TISSUE RES, V280, P11, DOI 10.1007/BF00304506; Kawamura K, 2004, J BIOL CHEM, V279, P54862, DOI 10.1074/jbc.M408057200; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Lafreniere JF, 2006, EXP CELL RES, V312, P1127, DOI 10.1016/j.yexcr.2006.01.002; Lijnen P, 1999, J MOL CELL CARDIOL, V31, P949, DOI 10.1006/jmcc.1999.0934; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Montiel M, 2005, BIOCHEM BIOPH RES CO, V327, P971, DOI 10.1016/j.bbrc.2004.12.110; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Shin EY, 2009, EXP MOL MED, V41, P387, DOI 10.3858/emm.2009.41.6.044; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	49	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15212	10.1371/journal.pone.0015212	http://dx.doi.org/10.1371/journal.pone.0015212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203566	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900020
J	Chait, R; Shrestha, S; Shah, AK; Michel, JB; Kishony, R				Chait, Remy; Shrestha, Shreya; Shah, Aakash Kaushik; Michel, Jean-Baptiste; Kishony, Roy			A Differential Drug Screen for Compounds That Select Against Antibiotic Resistance	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; BACTERIAL-RESISTANCE; NATURAL ENVIRONMENTS; GENES	Antibiotics increase the frequency of resistant bacteria by providing them a competitive advantage over sensitive strains. Here, we develop a versatile assay for differential chemical inhibition of competing microbial strains, and use it to identify compounds that preferentially inhibit tetracycline-resistant relative to sensitive bacteria, thus "inverting" selection for resistance. Our assay distinguishes compounds selecting directly against specific resistance mechanisms and compounds whose selection against resistance is based on their physiological interaction with tetracycline and is more general with respect to resistance mechanism. We find that both types of selection-inverting compounds are secreted by soil microbes, indicating that nature has evolved a repertoire of chemicals that counteracts antibiotic resistance. Finally, we show that our assay can more generally permit simple, direct screening for drugs based on their differential activity against different strains or targets.	[Chait, Remy; Michel, Jean-Baptiste; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Shrestha, Shreya; Shah, Aakash Kaushik] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Chait, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Michel, Jean-Baptiste/AAH-9336-2020	Chait, Remy/0000-0003-0876-3187	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; National Institutes of Health [R01 GM081617]; FAS (Faculty of Arts and Sciences) Center for Systems Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, P50GM068763] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAS (Faculty of Arts and Sciences) Center for Systems Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative, National Institutes of Health grant R01 GM081617, and the FAS (Faculty of Arts and Sciences) Center for Systems Biology Undergraduate Summer Research Internship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; CAMPBELL AH, 1960, BRIT MED BULL, V16, P82, DOI 10.1093/oxfordjournals.bmb.a069798; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; COLEMAN K, 1994, J ANTIMICROB CHEMOTH, V33, P1091, DOI 10.1093/jac/33.6.1091; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Djapa LY, 2007, MOL BIOCHEM PARASIT, V156, P89, DOI 10.1016/j.molbiopara.2007.07.009; Li Q, 2002, ANTIMICROB AGENTS CH, V46, P1262, DOI 10.1128/AAC.46.5.1262-1268.2002; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lorian V., 2005, ANTIBIOTICS LAB MED; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; WAKSMAN SA, 1961, PERSPECT BIOL MED, V4, P271; Whittle G, 2003, APPL ENVIRON MICROB, V69, P4151, DOI 10.1128/AEM.69.7.4151-4158.2003; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	20	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15179	10.1371/journal.pone.0015179	http://dx.doi.org/10.1371/journal.pone.0015179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21209699	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100025
J	Yu, F; Sun, L; Courjaret, R; Machaca, K				Yu, Fang; Sun, Lu; Courjaret, Raphael; Machaca, Khaled			Role of the STIM1 C-terminal Domain in STIM1 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; CA2+ STORE DEPLETION; FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; XENOPUS OOCYTE MATURATION; MAMMALIAN-CELL LINES; PLASMA-MEMBRANE; CRAC CHANNELS; ORAI CHANNELS; I-CRAC	Store-operated Ca2+ entry (SOCE) represents a ubiquitous Ca2+ influx pathway activated by the filling state of intracellular Ca2+ stores. SOCE is mediated by coupling of STIM1, the endoplasmic reticulum Ca2+ sensor, to the Orai1 channel. SOCE inactivates during meiosis, partly because of the inability of STIM1 to cluster in response to store depletion. STIM1 has several functional domains, including the Orai1 interaction domain (STIM1 Orai Activating Region (SOAR) or CRAC Activation Domain (CAD)) and STIM1 homomerization domain. When Ca2+ stores are full, these domains are inactive to prevent constitutive Ca2+ entry. Here we show, using the Xenopus oocyte as an expression system, that the C-terminal 200 residues of STIM1 are important to maintain STIM1 in an inactive state when Ca2+ stores are full, through predicted intramolecular shielding of the active STIM1 domains (SOAR/CAD and STIM1 homomerization domain). Interestingly, our data argue that the C-terminal 200 residues accomplish this through a steric hindrance mechanism because they can be substituted by GFP or mCherry while maintaining all aspects of STIM1 function. We further show that STIM1 clustering inhibition during meiosis is independent of the C-terminal 200 residues.	[Yu, Fang; Sun, Lu; Courjaret, Raphael; Machaca, Khaled] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha 24144, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar	Machaca, K (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, POB 24144, Doha 24144, Qatar.	khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019	Machaca, Khaled/0000-0001-6215-2411	Qatar National Research Fund [NPRP08-395-3-088, NPRP08-138-3-050]; Weill Cornell Medical College; Qatar Foundation	Qatar National Research Fund(Qatar National Research Fund (QNRF)); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was supported by Qatar National Research Fund Grants NPRP08-395-3-088 and NPRP08-138-3-050 and the Biomedical Research Program funds at Weill Cornell Medical College, a program funded by the Qatar Foundation.	Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; Machaca K, 1999, J GEN PHYSIOL, V113, P249, DOI 10.1085/jgp.113.2.249; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	35	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8375	8384		10.1074/jbc.M110.188789	http://dx.doi.org/10.1074/jbc.M110.188789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220431	Green Published, hybrid			2022-12-25	WOS:000288013300066
J	Anupam, R; Datta, A; Kesic, M; Green-Church, K; Shkriabai, N; Kvaratskhelia, M; Lairmore, MD				Anupam, Rajaneesh; Datta, Antara; Kesic, Matthew; Green-Church, Kari; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Lairmore, Michael D.			Human T-lymphotropic Virus Type 1 p30 Interacts with REG gamma and Modulates ATM (Ataxia Telangiectasia Mutated) to Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME ACTIVATOR PA28-GAMMA; INFECTIVITY IN-VIVO; READING FRAME II; DNA-DAMAGE; HISTONE ACETYLTRANSFERASE; HTLV-1 TAX; LEUKEMIA; PROTEIN; REPLICATION; P30(II)	Human T-lymphotropic virus type 1 (HTLV-1) is a causative agent of adult T cell leukemia/lymphoma and a variety of inflammatory disorders. HTLV-1 encodes a nuclear localizing protein, p30, that selectively alters viral and cellular gene expression, activates G(2)-M cell cycle checkpoints, and is essential for viral spread. Here, we used immunoprecipitation and affinity pulldown of ectopically expressed p30 coupled with mass spectrometry to identify cellular binding partners of p30. Our data indicate that p30 specifically binds to cellular ATM (ataxia telangiectasia mutated) and REG gamma (a nuclear 20 S proteasome activator). Under conditions of genotoxic stress, p30 expression was associated with reduced levels of ATM and increased cell survival. Knockdown or overexpression of REG gamma paralleled p30 expression, suggesting an unexpected enhancement of p30 expression in the presence of REG gamma. Finally, size exclusion chromatography revealed the presence of p30 in a high molecular mass complex along with ATM and REG gamma. On the basis of our findings, we propose that HTLV-1 p30 interacts with ATM and REG gamma to increase viral spread by facilitating cell survival.	[Lairmore, Michael D.] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Green-Church, Kari] Ohio State Univ, Mass Spectrometry & Prote Facil, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Lairmore, Michael D.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Lairmore, Michael D.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lairmore, MD (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	lairmore.1@osu.edu	Green, Kari B/H-3541-2011		National Institutes of Health, NCI [P01 CA100730]; NATIONAL CANCER INSTITUTE [P01CA100730] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 CA100730 from NCI (to M. D. L.).	Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Awasthi S, 2005, MOL CELL BIOL, V25, P6178, DOI 10.1128/MCB.25.14.6178-6198.2005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartoe JT, 2000, J VIROL, V74, P1094, DOI 10.1128/JVI.74.3.1094-1100.2000; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Chen YMA, 1997, INT J CANCER, V71, P196, DOI 10.1002/(SICI)1097-0215(19970410)71:2&lt;196::AID-IJC12&gt;3.0.CO;2-G; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Collins ND, 1998, BLOOD, V91, P4701, DOI 10.1182/blood.V91.12.4701.412k23_4701_4707; Datta A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-49; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ghorbel S, 2006, J BIOL CHEM, V281, P37150, DOI 10.1074/jbc.M603981200; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Hiraragi H, 2006, J VIROL, V80, P3469, DOI 10.1128/JVI.80.7.3469-3476.2006; KORALNIK IJ, 1993, J VIROL, V67, P2360, DOI 10.1128/JVI.67.4.2360-2366.1993; Lairmore M. D., 2007, FIELDS VIROLOGY, P2071; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; MA CP, 1992, J BIOL CHEM, V267, P10515; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Michael B, 2006, VIROLOGY, V354, P225, DOI 10.1016/j.virol.2006.07.002; Michael Bindhu, 2004, Retrovirology, V1, P39, DOI 10.1186/1742-4690-1-39; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Pique C, 2000, J EXP MED, V191, P567, DOI 10.1084/jem.191.3.567; Pise-Masison CA, 2005, ARCH IMMUNOL THER EX, V53, P283; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1; Silverman LR, 2004, J VIROL, V78, P3837, DOI 10.1128/JVI.78.8.3837-3845.2004; Sinha-Datta U, 2007, J BIOL CHEM, V282, P14608, DOI 10.1074/jbc.M611219200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Taylor JM, 2009, J VIROL, V83, P11467, DOI 10.1128/JVI.00952-09; Tichy Ales, 2010, Acta Medica (Hradec Kralove), V53, P13; Valeri VW, 2010, BLOOD, V116, P3809, DOI 10.1182/blood-2010-05-284141; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yoshida M, 2005, ONCOGENE, V24, P5931, DOI 10.1038/sj.onc.1208981; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Younis I, 2004, J VIROL, V78, P11077, DOI 10.1128/JVI.78.20.11077-11083.2004; Zhang WQ, 2001, J VIROL, V75, P9885, DOI 10.1128/JVI.75.20.9885-9895.2001; Zhang WQ, 2000, J VIROL, V74, P11270, DOI 10.1128/JVI.74.23.11270-11277.2000; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhou PB, 2006, CELL, V124, P256, DOI 10.1016/j.cell.2006.01.003	50	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7661	7668		10.1074/jbc.M110.176354	http://dx.doi.org/10.1074/jbc.M110.176354			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21216954	hybrid, Green Published			2022-12-25	WOS:000287737300079
J	Overstreet, MG; Chen, YC; Cockburn, IA; Tse, SW; Zavala, F				Overstreet, Michael G.; Chen, Yun-Chi; Cockburn, Ian A.; Tse, Sze-Wah; Zavala, Fidel			CD4(+) T Cells Modulate Expansion and Survival but Not Functional Properties of Effector and Memory CD8(+) T Cells Induced by Malaria Sporozoites	PLOS ONE			English	Article							LIVER-STAGES; CD8-T-CELL MEMORY; HIV-1 INFECTION; CD4-T-CELL HELP; DENDRITIC CELL; LYMPHOCYTES-T; IN-VIVO; RESPONSES; GENERATION; VIRUS	CD4(+) helper T cells are critical orchestrators of immune responses to infection and vaccination. During primary responses, naive CD8(+) T cells may need "CD4 help'' for optimal development of memory populations. The immunological factors attributed to CD4 help depend on the context of immunization and vary depending on the priming system. In response to immunization with radiation-attenuated Plasmodium yoelii sporozoites, CD8(+) T cells in BALB/c mice fail to generate large numbers of effector cells without help from CD4(+) T cells - a defect not observed in most systems. Given this unique early dependence on CD4 help, we evaluated the effects of CD4(+) cells on the development of functional properties of CD8(+) T cells and on their ability to abolish infection. First, we determined that this effect was not mediated by CD4(+) non-T cells and did not involve CD1d-restricted NKT cells. We found that CD8(+) T cells induced by sporozoites without CD4 help formed memory populations severely reduced in magnitude that could not limit parasite development in the liver. The inability of these "helpless'' memory T cells to protect is not a result of defects in effector function, as their capacity to produce cytokines and undergo cytotoxic degranulation was indistinguishable from control memory T cells. These data indicate that CD4(+) T help may not be necessary to develop the functional attributes of CD8(+) T cells; however they are crucial to ensure the survival of effector and memory cells induced in primary responses.	[Overstreet, Michael G.; Chen, Yun-Chi; Cockburn, Ian A.; Tse, Sze-Wah; Zavala, Fidel] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Overstreet, MG (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	fzavala@jhsph.edu		Cockburn, Ian/0000-0001-8220-9294; Overstreet, Michael/0000-0001-7450-7929; Chen, Yun-Chi/0000-0003-2787-1247	NIH [AI44375]; Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044375, R01AI044375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant number AI44375 to FZ (http://www.nih.gov). MGO and IAC were supported by fellowships from the Malaria Research Institute. The authors are grateful for the support of the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHMIDT N, 2008, P NATL ACAD SCI US; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	42	36	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e15948	10.1371/journal.pone.0015948	http://dx.doi.org/10.1371/journal.pone.0015948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245909	Green Submitted, Green Published, gold			2022-12-25	WOS:000286510500007
J	Erlandsson, L; Nielsen, LP; Fomsgaard, A				Erlandsson, Lena; Nielsen, Lars Peter; Fomsgaard, Anders			Amp-PCR: Combining a Random Unbiased Phi29-Amplification with a Specific Real-Time PCR, Performed in One Tube to Increase PCR Sensitivity	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; WHOLE-GENOME AMPLIFICATION; PHI-29 DNA-POLYMERASE; VIRUS; SAMPLES; FLUID; JC	In clinical situations where a diagnostic real-time PCR assay is not sensitive enough, leading to low or falsely negative results, or where detection earlier in a disease progression would benefit the patient, an unbiased pre-amplification prior to the real-time PCR could be beneficial. In Amp-PCR, an unbiased random Phi29 pre-amplification is combined with a specific real-time PCR reaction. The two reactions are separated physically by a wax-layer (AmpliWax (R)) and are run in sequel in the same sealed tube. Amp-PCR can increase the specific PCR signal at least 100x10(6)-fold and make it possible to detect positive samples normally under the detection limit of the specific real-time PCR. The risk of contamination is eliminated and Amp-PCR could replace nested-PCR in situations where increased sensitivity is needed e. g. in routine PCR diagnostic analysis. We show Amp-PCR to work on clinical samples containing circular and linear viral dsDNA genomes, but can work well on DNA of any origin, both from non-cellular (virus) and cellular sources (bacteria, archae, eukaryotes).	[Erlandsson, Lena; Nielsen, Lars Peter] Statens Serum Inst, Dept Virol, Influenza Lab, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Erlandsson, L (corresponding author), Statens Serum Inst, Dept Virol, Influenza Lab, DK-2300 Copenhagen, Denmark.	lao@ssi.dk		Erlandsson, Lena/0000-0003-4350-5909; Fomsgaard, Anders/0000-0003-4304-0603				Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bustin SA, 2004, A Z QUANTITATIVE PCR; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Giardina E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-159; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Koralnik IJ, 2004, CURR OPIN NEUROL, V17, P365, DOI 10.1097/00019052-200406000-00019; Landry ML, 2008, J CLIN VIROL, V43, P247, DOI 10.1016/j.jcv.2008.07.003; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; MacKenzie J, 2003, J NATL CANCER I, V95, P1001, DOI 10.1093/jnci/95.13.1001; Perrott P, 2009, J APPL MICROBIOL, V106, P1438, DOI 10.1111/j.1365-2672.2008.04119.x; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schloss L, 2003, J CLIN VIROL, V28, P175, DOI 10.1016/S1386-6532(03)00003-9; VOSBERG HP, 1989, HUM GENET, V83, P1, DOI 10.1007/BF00274139	19	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15719	10.1371/journal.pone.0015719	http://dx.doi.org/10.1371/journal.pone.0015719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209824	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900028
J	Feng, QP; Jiang, L; Berg, RL; Antonik, M; MacKinney, E; Gunnell-Santoro, J; McCarty, CA; Wilke, RA				Feng, Qiping; Jiang, Lan; Berg, Richard L.; Antonik, Melissa; MacKinney, Erin; Gunnell-Santoro, Jennifer; McCarty, Catherine A.; Wilke, Russell A.			A Common CNR1 (Cannabinoid Receptor 1) Haplotype Attenuates the Decrease in HDL Cholesterol That Typically Accompanies Weight Gain	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; FOOD FREQUENCY QUESTIONNAIRES; DIET HISTORY QUESTIONNAIRE; BODY-MASS INDEX; PHYSICAL-ACTIVITY; GENETIC-VARIATION; CB1 RECEPTOR; RISK-FACTORS; ASSOCIATION; POPULATION	We have previously shown that genetic variability in CNR1 is associated with low HDL dyslipidemia in a multigenerational obesity study cohort of Northern European descent (209 families, median = 10 individuals per pedigree). In order to assess the impact of CNR1 variability on the development of dyslipidemia in the community, we genotyped this locus in all subjects with class III obesity (body mass index.40 kg/m(2)) participating in a population-based biobank of similar ancestry. Twenty-two haplotype tagging SNPs, capturing the entire CNR1 gene locus plus 15 kb upstream and 5 kb downstream, were genotyped and tested for association with clinical lipid data. This biobank contains data from 645 morbidly obese study subjects. In these subjects, a common CNR1 haplotype (H3, frequency 21.1%) is associated with fasting TG and HDL cholesterol levels (p = 0.031 for logTG; p = 0.038 for HDL-C; p = 0.00376 for log[TG/HDL-C]). The strength of this relationship increases when the data are adjusted for age, gender, body mass index, diet and physical activity. Mean TG levels were 160 +/- 70, 155 +/- 70, and 120 +/- 60 mg/dL for subjects with 0, 1, and 2 copies of the H3 haplotype. Mean HDL-C levels were 45 +/- 10, 47 +/- 10, and 48 +/- 9 mg/dL, respectively. The H3 CNR1 haplotype appears to exert a protective effect against development of obesity-related dyslipidemia.	[Feng, Qiping; Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37203 USA; [Jiang, Lan] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN USA; [Berg, Richard L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Antonik, Melissa; MacKinney, Erin; Gunnell-Santoro, Jennifer] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA	Vanderbilt University; Vanderbilt University; Medical College of Wisconsin	Feng, QP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37203 USA.	russell.a.wilke@Vanderbilt.Edu	Feng, Qiping/F-7941-2013	McCarty, Catherine/0000-0003-1089-0142	Eagles Max Bauer Heart Fund;  [U01HG004608];  [R01DK080007]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER	Eagles Max Bauer Heart Fund; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly funded by U01HG004608 (McCarty) (http://www.genome.gov/) and R01DK080007 (Wilke)(http://www2.niddk.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We thank all PMRP participants, and the Eagles Max Bauer Heart Fund (C.A. McCarty).	Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye TM, 2008, PHARMACOGENOMICS, V9, P1647, DOI 10.2217/14622416.9.11.1647; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEGOTTARDI A, 2010, LIVER INT; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; *DHHS, 2000, BOD MASS IND; Flood A, 2006, J AM DIET ASSOC, V106, P393, DOI 10.1016/j.jada.2005.12.008; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gazzerro P, 2007, INT J OBESITY, V31, P908, DOI 10.1038/sj.ijo.0803510; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GREENBERG I, 1976, PSYCHOPHARMACOLOGY, V49, P79; Greenlee RT, 2005, J AGRIC SAF HEALTH, V11, P211, DOI 10.13031/2013.18188; Greenlee Robert T, 2002, WMJ, V101, P46; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jaeger JP, 2008, DIS MARKERS, V25, P67, DOI 10.1155/2008/841490; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lieb W, 2009, OBESITY, V17, P755, DOI 10.1038/oby.2008.608; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Margetts BM, 1991, DESIGN CONCEPTS NUTR; MCCARTY CA, 2005, PERSONALIZED MED, V2; McCarty CA, 2008, PERS MED, V5, P529, DOI 10.2217/17410541.5.5.529; McCarty CA, 2010, PHARMACOGENOMICS, V11, P637, DOI [10.2217/pgs.10.13, 10.2217/PGS.10.13]; Millen AE, 2006, AM J EPIDEMIOL, V163, P279, DOI 10.1093/aje/kwj031; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Osei-Hyiaman D, 2006, INT J OBESITY, V30, pS33, DOI 10.1038/sj.ijo.0803276; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Scheen AJ, 2009, BEST PRACT RES CL EN, V23, P103, DOI 10.1016/j.beem.2008.09.001; Schleinitz D, 2010, PHARMACOGENOMICS, V11, P693, DOI [10.2217/pgs.10.42, 10.2217/PGS.10.42]; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; SUBAR AF, 1995, J AM DIET ASSOC, V95, P781, DOI 10.1016/S0002-8223(95)00217-0; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Subar AF, 2001, AM J EPIDEMIOL, V153, P404, DOI 10.1093/aje/153.4.404; Sugamura K, 2010, J ATHEROSCLER THROMB, V17, P141, DOI 10.5551/jat.2865; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; *US NIH, 2007, DIET HIST QUEST DIET; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wilke Russell A, 2010, Prev Cardiol, V13, P63, DOI 10.1111/j.1751-7141.2009.00055.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLET WC, 1990, NUTR EPIDEMIOLOGY; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zhang Y, 2009, PHARMACOGENOMICS, V10, P1929, DOI [10.2217/pgs.09.122, 10.2217/PGS.09.122]	58	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15779	10.1371/journal.pone.0015779	http://dx.doi.org/10.1371/journal.pone.0015779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209828	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900032
J	Hartman, NW; Carpentino, JE; LaMonica, K; Mor, DE; Naegele, JR; Grabel, L				Hartman, Nathaniel W.; Carpentino, Joseph E.; LaMonica, Kristi; Mor, Danielle E.; Naegele, Janice R.; Grabel, Laura			CXCL12-Mediated Guidance of Migrating Embryonic Stem Cell-Derived Neural Progenitors Transplanted into the Hippocampus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; ACID-INDUCED SEIZURES; ADULT-RAT BRAIN; DENTATE GYRUS; KAINIC ACID; MESSENGER-RNA; PRECURSOR CELLS; IN-VITRO; NEUROGENESIS	Stem cell therapies for neurodegenerative disorders require accurate delivery of the transplanted cells to the sites of damage. Numerous studies have established that fluid injections to the hippocampus can induce lesions in the dentate gyrus (DG) that lead to cell death within the upper blade. Using a mouse model of temporal lobe epilepsy, we previously observed that embryonic stem cell-derived neural progenitors (ESNPs) survive and differentiate within the granule cell layer after stereotaxic delivery to the DG, replacing the endogenous cells of the upper blade. To investigate the mechanisms for ESNP migration and repair in the DG, we examined the role of the chemokine CXCL12 in mice subjected to kainic acid-induced seizures. We now show that ESNPs transplanted into the DG show extensive migration through the upper blade, along the septotemporal axis of the hippocampus. Seizures upregulate CXCL12 and infusion of the CXCR4 antagonist AMD3100 by osmotic minipump attenuated ESNP migration. We also demonstrate that seizures promote the differentiation of transplanted ESNPs toward neuronal rather than astrocyte fates. These findings suggest that ESNPs transplanted into the adult rodent hippocampus migrate in response to cytokine-mediated signals.	[Hartman, Nathaniel W.; Carpentino, Joseph E.; LaMonica, Kristi; Mor, Danielle E.; Naegele, Janice R.; Grabel, Laura] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Naegele, Janice R.] Wesleyan Univ, Neurosci & Behav Program, Middletown, CT 06459 USA	Wesleyan University; Wesleyan University	Hartman, NW (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	nathaniel.hartman@yale.edu	; Hartman, Nathaniel/P-7654-2014	Naegele, Janice Rae/0000-0001-5151-0543; Mor, Danielle/0000-0003-3851-5010; Hartman, Nathaniel/0000-0003-4976-5525	Connecticut Stem Cell Initiative; McKnight Foundation	Connecticut Stem Cell Initiative; McKnight Foundation	Connecticut Stem Cell Initiative (Grabel). McKnight Foundation Brain Disorders Award (Naegele). Connecticut Stem Cell Initiative ( Naegele). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bagri A, 2002, DEVELOPMENT, V129, P4249; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; CASSEL JC, 1993, NEUROSCI LETT, V150, P89, DOI 10.1016/0304-3940(93)90115-2; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; DUGICHDJORDJEVIC MM, 1992, NEUROSCIENCE, V47, P303, DOI 10.1016/0306-4522(92)90246-X; Einstein O, 2009, J NEUROSCI, V29, P15694, DOI 10.1523/JNEUROSCI.3364-09.2009; Elliott RC, 2003, J NEUROSCI, V23, P2218; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gabriel S, 2004, J NEUROSCI, V24, P10416, DOI 10.1523/JNEUROSCI.2074-04.2004; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Jung KH, 2009, EPILEPSIA, V50, P537, DOI 10.1111/j.1528-1167.2008.01718.x; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Maisano X, 2009, NEUROTHERAPEUTICS, V6, P263, DOI 10.1016/j.nurt.2009.01.011; Mathern GW, 2002, PROG BRAIN RES, V135, P237; MORGAN TE, 1993, EXP NEUROL, V120, P291, DOI 10.1006/exnr.1993.1063; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Neema M, 2005, HIPPOCAMPUS, V15, P1057, DOI 10.1002/hipo.20123; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pierce JP, 2007, NEUROSCI LETT, V422, P136, DOI 10.1016/j.neulet.2007.06.016; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Ruschenschmidt T, 2005, EPILEPSIA, V46, P174, DOI 10.1111/j.1528-1167.2005.01028.x; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; VIETJE BP, 1989, EXP NEUROL, V106, P275, DOI 10.1016/0014-4886(89)90160-X; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang S, 2009, J NEUROSCI RES, V87, P1135, DOI 10.1002/jnr.21941	64	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15856	10.1371/journal.pone.0015856	http://dx.doi.org/10.1371/journal.pone.0015856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209827	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900042
J	Seemanapalli, SV; Xu, QL; McShan, K; Liang, FT				Seemanapalli, Sunita V.; Xu, Qilong; McShan, Kristy; Liang, Fang Ting			Outer Surface Protein C Is a Dissemination-Facilitating Factor of Borrelia burgdorferi during Mammalian Infection	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; IMMUNE EVASION; OSPC; LIPOPOLYSACCHARIDE; LIPOPROTEINS; EXPRESSION; TICKS	Background: The Lyme disease spirochete Borrelia burgdorferi dramatically upregulates outer surface protein C (OspC) in response to fresh bloodmeal during transmission from the tick vector to a mammal, and abundantly produces the antigen during early infection. As OspC is an effective immune target, to evade the immune system B. burgdorferi downregulates the antigen once the anti-OspC humoral response has developed, suggesting an important role for OspC during early infection. Methodology/Principal Findings: In this study, a borrelial mutant producing an OspC antigen with a 5-amino-acid deletion was generated. The deletion didn't significantly increase the 50% infectious dose or reduce the tissue bacterial burden during infection of the murine host, indicating that the truncated OspC can effectively protect B. burgdorferi against innate elimination. However, the deletion greatly impaired the ability of B. burgdorferi to disseminate to remote tissues after inoculation into mice. Conclusions/Significance: The study indicates that OspC plays an important role in dissemination of B. burgdorferi during mammalian infection.	[Seemanapalli, Sunita V.; Xu, Qilong; McShan, Kristy; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Seemanapalli, SV (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [AI077733, AR053338, RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR053338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by AI077733, AR053338, and RR020159 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Downie AB, 2004, J EXP BOT, V55, P961, DOI 10.1093/jxb/erh112; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Fingerle V, 2007, INT J MED MICROBIOL, V297, P97, DOI 10.1016/j.ijmm.2006.11.003; FUNG BP, 1994, INFECT IMMUN, V62, P3213, DOI 10.1128/IAI.62.8.3213-3221.1994; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Kumaran D, 2001, ACTA CRYSTALLOGR D, V57, P298, DOI 10.1107/S0907444900017546; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005	34	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15830	10.1371/journal.pone.0015830	http://dx.doi.org/10.1371/journal.pone.0015830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209822	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900040
J	van der Helden, J; van Schie, HT; Rombouts, C				van der Helden, Jurjen; van Schie, Hein T.; Rombouts, Christiaan			Observational Learning of New Movement Sequences Is Reflected in Fronto-Parietal Coherence	PLOS ONE			English	Article							PARIETAL AREAS; HAND ACTIONS; MU-RHYTHM; MOTOR; EEG; IMITATION; MODULATION; MECHANISMS; PREMOTOR; DESYNCHRONIZATION	Mankind is unique in her ability for observational learning, i.e. the transmission of acquired knowledge and behavioral repertoire through observation of others' actions. In the present study we used electrophysiological measures to investigate brain mechanisms of observational learning. Analysis investigated the possible functional coupling between occipital (alpha) and motor (mu) rhythms operating in the 10Hz frequency range for translating "seeing" into "doing". Subjects observed movement sequences consisting of six consecutive left or right hand button presses directed at one of two target-buttons for subsequent imitation. Each movement sequence was presented four times, intervened by short pause intervals for sequence rehearsal. During a control task subjects observed the same movement sequences without a requirement for subsequent reproduction. Although both alpha and mu rhythms desynchronized during the imitation task relative to the control task, modulations in alpha and mu power were found to be largely independent from each other over time, arguing against a functional coupling of alpha and mu generators during observational learning. This independence was furthermore reflected in the absence of coherence between occipital and motor electrodes overlaying alpha and mu generators. Instead, coherence analysis revealed a pair of symmetric fronto-parietal networks, one over the left and one over the right hemisphere, reflecting stronger coherence during observation of movements than during pauses. Individual differences in fronto-parietal coherence were furthermore found to predict imitation accuracy. The properties of these networks, i.e. their fronto-parietal distribution, their ipsilateral organization and their sensitivity to the observation of movements, match closely with the known properties of the mirror neuron system (MNS) as studied in the macaque brain. These results indicate a functional dissociation between higher order areas for observational learning (i.e. parts of the MNS as reflected in 10Hz coherence measures) and peripheral structures (i.e. lateral occipital gyrus for alpha; central sulcus for mu) that provide low-level support for observation and motor imagery of action sequences.	[van der Helden, Jurjen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van der Helden, Jurjen; Rombouts, Christiaan] Univ Twente, Dept Cognit Psychol & Ergon, NL-7500 AE Enschede, Netherlands; [van Schie, Hein T.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen	van der Helden, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	J.vanderHelden@donders.ru.nl	van Schie, Hein T/D-2281-2010		European Union [FP6-IST2-003747]	European Union(European Commission)	HvS was supported by the European Union Integrated Project JAST (Joint Action Science and Technology), grant FP6-IST2-003747. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew C, 1996, MED BIOL ENG COMPUT, V34, P232, DOI 10.1007/BF02520079; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Byrne R. W., 2005, PERSPECTIVES IMITATI, V1, P225; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Classen J, 1998, J NEUROPHYSIOL, V79, P1567, DOI 10.1152/jn.1998.79.3.1567; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gomarus HK, 2006, CLIN NEUROPHYSIOL, V117, P871, DOI 10.1016/j.clinph.2005.12.008; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hummel F, 2005, CEREB CORTEX, V15, P670, DOI 10.1093/cercor/bhh170; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Muthukumaraswamy SD, 2006, BRAIN RES, V1071, P105, DOI 10.1016/j.brainres.2005.11.053; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G., 2005, PERSPECTIVES IMITATI, V1, P55, DOI DOI 10.1146/ANNUREV.NEURO.27.070203.144230; SMYTH MM, 1990, Q J EXP PSYCHOL-A, V42, P291, DOI 10.1080/14640749008401223; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Elk M, 2008, NEUROIMAGE, V43, P808, DOI 10.1016/j.neuroimage.2008.07.057; van Schie HT, 2008, SOC NEUROSCI-UK, V3, P213, DOI 10.1080/17470910701414364; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005	51	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14482	10.1371/journal.pone.0014482	http://dx.doi.org/10.1371/journal.pone.0014482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217815	Green Published, gold			2022-12-25	WOS:000285838900011
J	Wu, J; Xia, J; Lei, W; Wang, BP				Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping			Superhydrophobic Surface Based on a Coral-Like Hierarchical Structure of ZnO	PLOS ONE			English	Article							SUPER-HYDROPHOBIC SURFACE; LOTUS; FILMS; CONTACT	Background: Fabrication of superhydrophobic surfaces has attracted much interest in the past decade. The fabrication methods that have been studied are chemical vapour deposition, the sol-gel method, etching technique, electrochemical deposition, the layer-by-layer deposition, and so on. Simple and inexpensive methods for manufacturing environmentally stable superhydrophobic surfaces have also been proposed lately. However, work referring to the influence of special structures on the wettability, such as hierarchical ZnO nanostructures, is rare. Methodology: This study presents a simple and reproducible method to fabricate a superhydrophobic surface with micro-scale roughness based on zinc oxide (ZnO) hierarchical structure, which is grown by the hydrothermal method with an alkaline aqueous solution. Coral-like structures of ZnO were fabricated on a glass substrate with a micro-scale roughness, while the antennas of the coral formed the nano-scale roughness. The fresh ZnO films exhibited excellent superhydrophilicity (the apparent contact angle for water droplet was about 0 degrees), while the ability to be wet could be changed to superhydrophobicity after spin-coating Teflon (the apparent contact angle greater than 168 degrees). The procedure reported here can be applied to substrates consisting of other materials and having various shapes. Results: The new process is convenient and environmentally friendly compared to conventional methods. Furthermore, the hierarchical structure generates the extraordinary solid/gas/liquid three-phase contact interface, which is the essential characteristic for a superhydrophobic surface.	[Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping] Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China	Southeast University - China	Wu, J (corresponding author), Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China.	xiajun@seu.edu.cn	Xia, Jun/A-1240-2011		National High Technology Research and Development Program of China [2007AA01Z303]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is supported by the National High Technology Research and Development Program of China (2007AA01Z303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2000, APPL PHYS LETT, V76, P3257, DOI 10.1063/1.126599; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bormashenko E, 2006, LANGMUIR, V22, P9982, DOI 10.1021/la061622m; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Han JT, 2005, J PHYS CHEM B, V109, P20773, DOI 10.1021/jp052691x; Hikita M, 2005, LANGMUIR, V21, P7299, DOI 10.1021/la050901r; Huang L, 2005, J PHYS CHEM B, V109, P7746, DOI 10.1021/jp046549s; Kim H, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/9/095002; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Li GP, 2008, APPL PHYS LETT, V17, P92; Li XH, 2006, POLYMER, V47, P506, DOI 10.1016/j.polymer.2005.08.097; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Ma M, 2008, J ADHES SCI TECHNOL, V11, P193; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; Ming W, 2005, NANO LETT, V5, P2298, DOI 10.1021/nl0517363; Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142; Niu JJ, 2009, J PHYS CHEM B, V113, P2909, DOI 10.1021/jp808322e; Okamoto K, 2004, NANO LETT, V4, P233, DOI 10.1021/nl034954+; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Qu AL, 2007, APPL SURF SCI, V253, P9430, DOI 10.1016/j.apsusc.2007.06.002; Rosario R, 2004, J PHYS CHEM B, V108, P12640, DOI 10.1021/jp0473568; Sarkar DK, 2008, MATER LETT, V62, P1226, DOI 10.1016/j.matlet.2007.08.051; SCHMIDT DL, 1994, NATURE, V368, P39, DOI 10.1038/368039a0; Service RE, 1997, SCIENCE, V276, P895, DOI 10.1126/science.276.5314.895; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Su CH, 2006, APPL SURF SCI, V253, P2633, DOI 10.1016/j.apsusc.2006.05.038; Wang CH, 2006, SURF SCI, V600, pL38, DOI 10.1016/j.susc.2005.12.013; Wang J, 2009, MATER CHEM PHYS, V117, P183, DOI 10.1016/j.matchemphys.2009.05.033; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Xi JM, 2008, APPL PHYS LETT, V5, P92; Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b; Zhang Z, 2007, J ELECTRON MATER, V36, P895, DOI 10.1007/s11664-007-0126-4	35	24	26	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14475	10.1371/journal.pone.0014475	http://dx.doi.org/10.1371/journal.pone.0014475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209931	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600013
J	Raman, R; Rajanikanth, V; Palaniappan, RUM; Lin, YP; He, HX; McDonough, SP; Sharma, Y; Chang, YF				Raman, Rajeev; Rajanikanth, V.; Palaniappan, Raghavan U. M.; Lin, Yi-Pin; He, Hongxuan; McDonough, Sean P.; Sharma, Yogendra; Chang, Yung-Fu			Big Domains Are Novel Ca2+-Binding Modules: Evidences from Big Domains of Leptospira Immunoglobulin-Like (Lig) Proteins	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; CALCIUM-BINDING; SURFACE PROTEIN; INTERROGANS; SUPERFAMILY; CRYSTALLINS; MUTAGENESIS; EXPRESSION; LIPL32; MOTIF	Background: Many bacterial surface exposed proteins mediate the host-pathogen interaction more effectively in the presence of Ca2+. Leptospiral immunoglobulin-like (Lig) proteins, LigA and LigB, are surface exposed proteins containing Bacterial immunoglobulin like (Big) domains. The function of proteins which contain Big fold is not known. Based on the possible similarities of immunoglobulin and beta gamma-crystallin folds, we here explore the important question whether Ca2+ binds to a Big domains, which would provide a novel functional role of the proteins containing Big fold. Principal Findings: We selected six individual Big domains for this study (three from the conserved part of LigA and LigB, denoted as Lig A3, Lig A4, and LigBCon5; two from the variable region of LigA, i.e., 9(th) (Lig A9) and 10(th) repeats (Lig A10); and one from the variable region of LigB, i.e., LigBCen2. We have also studied the conserved region covering the three and six repeats (LigBCon1-3 and LigCon). All these proteins bind the calcium-mimic dye Stains-all. All the selected four domains bind Ca2+ with dissociation constants of 2-4 mu M. Lig A9 and Lig A10 domains fold well with moderate thermal stability, have beta-sheet conformation and form homodimers. Fluorescence spectra of Big domains show a specific doublet (at 317 and 330 nm), probably due to Trp interaction with a Phe residue. Equilibrium unfolding of selected Big domains is similar and follows a two-state model, suggesting the similarity in their fold. Conclusions: We demonstrate that the Lig are Ca2+-binding proteins, with Big domains harbouring the binding motif. We conclude that despite differences in sequence, a Big motif binds Ca2+. This work thus sets up a strong possibility for classifying the proteins containing Big domains as a novel family of Ca2+-binding proteins. Since Big domain is a part of many proteins in bacterial kingdom, we suggest a possible function these proteins via Ca2+ binding.	[Raman, Rajeev; Rajanikanth, V.; Sharma, Yogendra] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Palaniappan, Raghavan U. M.; Lin, Yi-Pin; He, Hongxuan; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [He, Hongxuan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Cornell University; Cornell University; Chinese Academy of Sciences; Institute of Zoology, CAS	Raman, R (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	yogendra@ccmb.res.in; yc42@cornell.edu	Vangipurapu, Rajanikanth/AAM-6841-2020	Vangipurapu, Rajanikanth/0000-0003-0676-3140	Biotechnology Research and Development Corporation (BRDC); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; Department of Biotechnology, Government of India	Biotechnology Research and Development Corporation (BRDC); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Biotechnology Research and Development Corporation (BRDC), the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT). DBT as well as DST are supported by the Government of India. RR is supported by a senior research fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. VR acknowledges Department of Biotechnology, Government of India, for a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; CRABBE MJC, 1995, COMPUT CHEM, V19, P343, DOI 10.1016/0097-8485(95)90316-X; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dardanelli M, 2003, CAN J MICROBIOL, V49, P399, DOI 10.1139/w03-054; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Gopalan V, 1997, J MOL BIOL, V267, P765, DOI 10.1006/jmbi.1997.0907; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Izutsu KT, 1996, FEMS MICROBIOL LETT, V144, P145, DOI 10.1111/j.1574-6968.1996.tb08521.x; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; Sharma Y, 1991, NOVEL CALCIUM BINDIN, P51; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940	48	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14377	10.1371/journal.pone.0014377	http://dx.doi.org/10.1371/journal.pone.0014377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206924	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200001
J	Wang, Q; Frolova, AI; Purcell, S; Adastra, K; Schoeller, E; Chi, MM; Schedl, T; Moley, KH				Wang, Qiang; Frolova, Antonina I.; Purcell, Scott; Adastra, Katie; Schoeller, Erica; Chi, Maggie M.; Schedl, Tim; Moley, Kelle H.			Mitochondrial Dysfunction and Apoptosis in Cumulus Cells of Type I Diabetic Mice	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOS; VITRO FERTILIZATION; GRANULOSA-CELLS; PARACRINE REGULATION; GLUCOSE-METABOLISM; MEIOTIC REGULATION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; OOCYTE QUALITY	Impaired oocyte quality has been demonstrated in diabetic mice; however, the potential pathways by which maternal diabetes exerts its effects on the oocyte are poorly understood. Cumulus cells are in direct contact with the oocyte via gap junctions and provide essential nutrients to support oocyte development. In this study, we investigated the effects of maternal diabetes on the mitochondrial status in cumulus cells. We found an increased frequency of fragmented mitochondria, a decreased transmembrane potential and an aggregated distribution of mitochondria in cumulus cells from diabetic mice. Furthermore, while mitochondrial biogenesis in cumulus cells was induced by maternal diabetes, their metabolic function was disrupted as evidenced by lower ATP and citrate levels. Moreover, we present evidence suggesting that the mitochondrial impairments induced by maternal diabetes, at least in part, lead to cumulus cell apoptosis through the release of cytochrome c. Together the deleterious effects on cumulus cells may disrupt trophic and signaling interactions with the oocyte, contributing to oocyte incompetence and thus poor pregnancy outcomes in diabetic females.	[Wang, Qiang; Frolova, Antonina I.; Purcell, Scott; Adastra, Katie; Schoeller, Erica; Chi, Maggie M.; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Wang, Qiang; Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wang, Q (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wustl.edu	Frolova, Antonina/ABC-1994-2020	Frolova, Antonina/0000-0002-6491-6910	National Institutes of Health [NIH-UO1 HD044691, HD040390, NIH-R01 GM085150]; American Diabetes Association; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040390] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD044691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following agencies: The National Institutes of Health (http://www.nih.gov/), The American Diabetes Association (http://www.diabetes.org/), and the March of Dimes (http://www.marchofdimes.com/). The National Institutes of Health grant numbers and grantees are as follows: NIH-UO1 HD044691 and HD040390 (KHM) and NIH-R01 GM085150 (TS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Chan CCW, 2006, FERTIL STERIL, V85, P780, DOI 10.1016/j.fertnstert.2005.08.042; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chi MMY, 2002, AM J PHYSIOL-ENDOC M, V283, pE226, DOI 10.1152/ajpendo.00046.2002; Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444; Colton SA, 2003, BIOL REPROD, V69, P761, DOI 10.1095/biolreprod.102.013649; Colton SA, 2002, BIOL REPROD, V67, P220, DOI 10.1095/biolreprod67.1.220; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Doblado Manuel, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P488, DOI 10.1097/MED.0b013e3282f1cb92; DOWNS SM, 1995, DEV BIOL, V167, P502, DOI 10.1006/dbio.1995.1044; ETHELL DW, 2002, APOPTOSIS TECHNIQUES, P21; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier AE, 2006, BIOL CHEM, V387, P1551, DOI 10.1515/BC.2006.193; Frolova A, 2009, ENDOCRINOLOGY, V150, P1512, DOI 10.1210/en.2008-1081; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greene MF, 1999, SEMIN REPROD ENDOCR, V17, P127, DOI 10.1055/s-2007-1016220; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; Hutt KJ, 2007, REPROD BIOMED ONLINE, V14, P758, DOI 10.1016/S1472-6483(10)60679-7; Idil M, 2004, EUR J OBSTET GYN R B, V112, P182, DOI 10.1016/S0301-2115(03)00365-8; Jansen S, 2009, REPRODUCTION, V138, P493, DOI 10.1530/REP-09-0038; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P580, DOI 10.1023/A:1026439409584; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj.onc.1205187; Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Nakahara K, 1997, FERTIL STERIL, V68, P312, DOI 10.1016/S0015-0282(97)81521-X; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Park DW, 2003, FERTIL STERIL, V80, P993, DOI 10.1016/S0015-0282(03)01118-X; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seifer DB, 2002, FERTIL STERIL, V78, P1046, DOI 10.1016/S0015-0282(02)04214-0; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VERCHEVAL M, 1990, DIABETOLOGIA, V33, P187, DOI 10.1007/BF00404794; Voet D, 2006, FUNDAMENTALS BIOCH; Wadia JS, 1998, J NEUROSCI, V18, P932; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; WYLLIE AH, 1981, HISTOCHEM J, V13, P681, DOI 10.1007/BF01002719; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	83	61	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15901	10.1371/journal.pone.0015901	http://dx.doi.org/10.1371/journal.pone.0015901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209947	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500041
J	Jourd'heuil, FL; Lowery, AM; Melton, EM; Mnaimneh, S; Bryan, NS; Fernandez, BO; Park, JH; Ha, CE; Bhagavan, NV; Feelisch, M; Jourd'heuil, D				Jourd'heuil, Frances L.; Lowery, Anthony M.; Melton, Elaina M.; Mnaimneh, Sanie; Bryan, Nathan S.; Fernandez, Bernadette O.; Park, Joo-Ho; Ha, Chung-Eun; Bhagavan, Nadhipuram V.; Feelisch, Martin; Jourd'heuil, David			Redox-Sensitivity and Site-Specificity of S- and N-Denitrosation in Proteins	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; FAMILIAL DYSALBUMINEMIC HYPERTHYROXINEMIA; NITRIC-OXIDE; NITROSOTRYPTOPHAN DERIVATIVES; TRYPTOPHAN DERIVATIVES; SUPEROXIDE-DISMUTASE; THYROXINE-BINDING; THIYL RADICALS; IN-VIVO; NITROSYLATION	Background: S-nitrosation - the formation of S-nitrosothiols (RSNOs) at cysteine residues in proteins - is a posttranslational modification involved in signal transduction and nitric oxide (NO) transport. Recent studies would also suggest the formation of N-nitrosamines (RNNOs) in proteins in vivo, although their biological significance remains obscure. In this study, we characterized a redox-based mechanism by which N-nitroso-tryptophan residues in proteins may be denitrosated. Methodology/Principal Findings: The denitrosation of N-acetyl-nitroso Trp (NANT) by glutathione (GSH) required molecular oxygen and was inhibited by superoxide dismutase (SOD). Transnitrosation to form S-nitrosoglutathione (GSNO) was observed only in the absence of oxygen or presence of SOD. Protein denitrosation by GSH was studied using a set of mutant recombinant human serum albumin (HSA). Trp-214 and Cys-37 were the only two residues nitrosated by NO under aerobic conditions. Nitroso-Trp-214 in HSA was insensitive to denitrosation by GSH or ascorbate while denitrosation at Cys-37 was evident in the presence of GSH but not ascorbate. GSH-dependent denitrosation of Trp-214 was restored in a peptide fragment of helix II containing Trp-214. Finally, incubation of cell lysates with NANT revealed a pattern of protein nitrosation distinct from that observed with GSNO. Conclusions: We propose that the denitrosation of nitrosated Trp by GSH occurs through homolytic cleavage of nitroso Trp to NO and a Trp aminyl radical, driven by the formation of superoxide derived from the oxidation of GSH to GSSG. Overall, the accessibility of Trp residues to redox-active biomolecules determines the stability of protein-associated nitroso species such that in the case of HSA, N-nitroso-Trp-214 is insensitive to denitrosation by low-molecular-weight antioxidants. Moreover, RNNOs can generate free NO and transfer their NO moiety in an oxygen-dependent fashion, albeit site-specificities appear to differ markedly from that of RSNOs.	[Jourd'heuil, Frances L.; Lowery, Anthony M.; Melton, Elaina M.; Jourd'heuil, David] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Mnaimneh, Sanie; Bryan, Nathan S.; Feelisch, Martin] Louisiana State Univ, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Bryan, Nathan S.; Fernandez, Bernadette O.; Feelisch, Martin] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Park, Joo-Ho] R&D Planning Dept, Inchon, South Korea; [Ha, Chung-Eun] Univ Hawaii Manoa, John A Burns Sch Med, Dept Native Hawaiian Hlth, Honolulu, HI 96822 USA; [Bhagavan, Nadhipuram V.] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA	Albany Medical College; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Boston University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Jourd'heuil, FL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.	jourdhd@mail.amc.edu	Fernandez, Bernadette/AAG-7202-2020; Feelisch, Martin/C-3042-2008	Fernandez, Bernadette/0000-0001-6337-0381; Feelisch, Martin/0000-0003-2320-1158; Jourd'heuil, David/0000-0002-6555-5061; Melton, Elaina/0000-0002-4030-7766	National Institutes of Health [CA89366, HL 69029]; Albany Medical College; NATIONAL CANCER INSTITUTE [R01CA089366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany Medical College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by Grants CA89366 (to D.J.) and HL 69029 (to M. F.) from the National Institutes of Health, and support from Albany Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; De Biase PM, 2005, J ORG CHEM, V70, P5790, DOI 10.1021/jo047720z; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Harohalli K, 2002, J BIOMED SCI, V9, P47, DOI 10.1007/BF02256578; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; Ishima Y, 2007, BIOCHEM BIOPH RES CO, V364, P790, DOI 10.1016/j.bbrc.2007.10.094; Ishima Y, 2008, J BIOL CHEM, V283, P34966, DOI 10.1074/jbc.M807009200; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; Kirsch M, 2003, J BIOL CHEM, V278, P11931, DOI 10.1074/jbc.M300237200; Kirsch M, 2007, ORG BIOMOL CHEM, V5, P3889, DOI 10.1039/b713377b; Kytzia A, 2006, CHEM-EUR J, V12, P8786, DOI 10.1002/chem.200600405; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Madej E, 2008, FREE RADICAL BIO MED, V44, P2013, DOI 10.1016/j.freeradbiomed.2008.02.015; MAGEE PN, 1956, BR J CANC; MEYER TA, 1982, J CHEM SOC PERK T 2, P1383, DOI 10.1039/p29820001383; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Pelaez D, 2007, J ORG CHEM, V72, P4741, DOI 10.1021/jo070399a; Petersen CE, 1999, CLIN CHEM, V45, P1248; Petersen CE, 1996, J BIOL CHEM, V271, P19110, DOI 10.1074/jbc.271.32.19110; Petersen CE, 1997, BIOCHEMISTRY-US, V36, P7012, DOI 10.1021/bi970225v; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Rassaf T, 2002, FREE RADICAL BIO MED, V33, P1590, DOI 10.1016/S0891-5849(02)01183-8; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Romeo AA, 2003, J AM CHEM SOC, V125, P14370, DOI 10.1021/ja0289752; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Suntsova TP, 2002, IUBMB LIFE, V54, P281, DOI 10.1080/15216540215677; Tsikas D, 2001, J CHROMATOGR A, V915, P107, DOI 10.1016/S0021-9673(01)00634-3; WANG X, 2008, FREE RADIC BIOL MED; WARDMAN P, 1995, METHOD ENZYMOL, V251, P31, DOI 10.1016/0076-6879(95)51108-3; Williams D. L. H., 1988, NITROSATION; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14400	10.1371/journal.pone.0014400	http://dx.doi.org/10.1371/journal.pone.0014400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203591	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000285576900014
J	Hanashiro, K; Brancaccio, M; Fukasawa, K				Hanashiro, K.; Brancaccio, M.; Fukasawa, K.			Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification	ONCOGENE			English	Article						CDK2; cyclin E; nucleophosmin; ROCK II; centrosome; morgana/chp-1	RHO-ASSOCIATED KINASE; CYCLIN-E; PHOSPHORYLATION; MYOSIN; NUCLEOPHOSMIN/B23; GTPASES; TARGET; ROLES	Initiation of centrosome duplication and DNA replication is coupled, which is primarily achieved by the late G1 phase-specific activation of cyclin-dependent kinase 2 (CDK2)-cyclin E, which triggers both centrosome duplication and DNA replication. Uncoupling of these two events contributes to overduplication of centrosomes, resulting in the presence of more than two centrosomes (centrosome amplification). Centrosome amplification, which is frequently observed in cancers, contributes to tumor development through destabilizing genomes. Nucleophosmin (NPM/B23) is one of the phosphorylation targets of CDK2-cyclin E for the initiation of centrosome duplication. It has been found that NPM/B23 phosphorylated on Thr199 by CDK2-cyclin E acquires a high binding affinity to ROCK II kinase. The Thr199-phosphorylated NPM/B23 physically interacts with and super-activates the centrosomally localized ROCK II, which is a critical event for centrosomes to initiate duplication. Here, we provide direct evidence for the activation of ROCK II as a primary and sufficient downstream event of CDK2-cyclin E for the initiation of centrosome duplication and for the induction of centrosome amplification. Oncogene (2011) 30, 2188-2197; doi:10.1038/onc.2010.607; published online 17 January 2011	[Hanashiro, K.; Fukasawa, K.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Brancaccio, M.] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Turin	Fukasawa, K (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	kenji.fukasawa@moffitt.org			National Institutes of Health [CA90522, GM87328, AIRC2008]; NATIONAL CANCER INSTITUTE [R01CA090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087328] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Cyclin E <SUP>/</SUP> MEFs lacking functional p53 were provided by Dr P Sicinski (Harvard Medical School), and p53 <SUP>/</SUP> MEFs from Dr Donehower (Baylor College of Medicine). We thank M Crow, B Nepon-Sixt and M Rowland for technical assistance, and M Lloyd and J Johnson for technical assistance on microscopic analysis. This research is supported by the grants from the National Institutes of Health (CA90522 and GM87328) to KF and from AIRC2008 to MB.	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Leung T, 1996, MOL CELL BIOL, V16, P5313; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005	33	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	19					2188	2197		10.1038/onc.2010.607	http://dx.doi.org/10.1038/onc.2010.607			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242972				2022-12-25	WOS:000290514600002
J	Yeung, CLA; Tsang, TY; Yau, PL; Kwok, TT				Yeung, C. L. Au; Tsang, T. Y.; Yau, P. L.; Kwok, T. T.			Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway	ONCOGENE			English	Article						HPV-16 E6; p53; miR-23b; uPA; cervical cancer	DIFFERENTIAL REGULATION; MICRORNA EXPRESSION; GENE-EXPRESSION; UROKINASE; CARCINOMA; MIR-34A; P53; TRANSCRIPTION; LESIONS; SYSTEM	Deregulation of microRNA (miRNA or miR) expression in human cervical cancer is associated frequently with human papillomavirus (HPV) integration. miR-23b is often downregulated in HPV-associated cervical cancer. Interestingly, urokinase-type plasminogen activator (uPA), the miR-23b target, is detected in cervical cancer, but not in normal cervical tissues. Thus, the importance of miR-23b and uPA in HPV-associated cervical cancer development is investigated. In this study, the high-risk subtype HPV-16 E6 oncoprotein was found to decrease the expression of miR-23b, increase the expression of uPA, and thus induce the migration of human cervical carcinoma SiHa and CaSki cells. uPA is the target gene for miR-23b as the miR repressed uPA expression and interacted with the 30-untranslated region of uPA mRNA. The tumor suppressor p53 is known to be inactivated by HPV-16 E6. A consensus p53 binding site is detected in the promoter region of miR-23b, whereas p53 trans-activated and also interacted with the miR's promoter. Therefore, p53 is believed to mediate the HPV-16 E6 downregulation of miR-23b. From the above, miR-23b/uPA are confirmed to be involved in HPV-16 E6-associated cervical cancer development. Oncogene (2011) 30, 2401-2410; doi:10.1038/onc.2010.613; published online 17 January 2011	[Yeung, C. L. Au; Tsang, T. Y.; Yau, P. L.; Kwok, T. T.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Ctr Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Kwok, TT (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Ctr Sci, Room 177, Shatin, Hong Kong, Peoples R China.	kwok2020@cuhk.edu.hk			Hong Kong Research Grants; Council Earmarked [466908, 467609]	Hong Kong Research Grants(Hong Kong Research Grants Council); Council Earmarked	The study is supported by grants from Hong Kong Research Grants and Council Earmarked Grants 466908, 467609.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bai L, 2006, INT J GYNECOL CANCER, V16, P718, DOI 10.1111/j.1525-1438.2006.00380.x; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Riethdorf L, 1999, J PATHOL, V189, P245, DOI 10.1002/(SICI)1096-9896(199910)189:2<245::AID-PATH427>3.0.CO;2-Z; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Scaria V, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-82; Shetty P, 2008, AM J RESP CELL MOL, V39, P364, DOI 10.1165/rcmb.2007-0406OC; Soliman PT, 2004, DRUG DISCOV TODAY, V1, P253; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; TURNER MA, 1995, CLIN EXP METASTAS, V13, P260, DOI 10.1007/BF00133481; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zuna RE, 2004, MODERN PATHOL, V17, P1314, DOI 10.1038/modpathol.3800223; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	96	98	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2401	2410		10.1038/onc.2010.613	http://dx.doi.org/10.1038/onc.2010.613			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21242962				2022-12-25	WOS:000291008000002
J	Anderton, JA; Bose, S; Vockerodt, M; Vrzalikova, K; Wei, W; Kuo, M; Helin, K; Christensen, J; Rowe, M; Murray, PG; Woodman, CB				Anderton, J. A.; Bose, S.; Vockerodt, M.; Vrzalikova, K.; Wei, W.; Kuo, M.; Helin, K.; Christensen, J.; Rowe, M.; Murray, P. G.; Woodman, C. B.			The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma	ONCOGENE			English	Article						KDM6B; histone demethylase; Epstein-Barr virus; latent membrane protein-1; Hodgkins lymphoma	REED-STERNBERG CELLS; JMJD3 CONTRIBUTES; GENE-EXPRESSION; HISTONE; DIFFERENTIATION; INHIBITION; ACTIVATION; ROLES; UTX	There is now evidence for both increased and decreased activity of the enzymes controlling the methylation of lysine 27 on histone 3 (H3K27) in cancer. One of these enzymes, KDM6B formally known as JMJD3, a histone demethylase, which removes the trimethyl mark from H3K27, is required for the lineage commitment and terminal differentiation of neural stem cells and of keratinocytes. Our results suggest that KDM6B may also have a role in antigen-driven B-cell differentiation. KDM6B expression increases in B-cell subsets with increasing stage of differentiation, and gene expression profiling shows that KDM6B transcriptional targets in germinal centre B (GC B) cells are significantly enriched for those differentially expressed during memory and plasma cell differentiation. Our results also suggest that aberrant expression of KDM6B may contribute to the pathogenesis of Hodgkin's Lymphoma (HL), an Epstein-Barr virus (EBV) associated malignancy. KDM6B is over-expressed in primary HL and induced by the EBV oncogene, latent membrane protein (LMP1) in GC B cells, the presumptive progenitors of HL. Consistent with these observations, we found that KDM6B transcriptional targets in GC B cells are enriched for genes differentially expressed in HL, and that KDM6B depletion can restore the tri-methylation of H3K27 on these genes. Oncogene (2011) 30, 2037-2043; doi:10.1038/onc.2010.579; published online 17 January 2011	[Anderton, J. A.; Bose, S.; Vockerodt, M.; Vrzalikova, K.; Wei, W.; Rowe, M.; Murray, P. G.; Woodman, C. B.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Kuo, M.] Birmingham Childrens Hosp, Dept Paediat Otolaryngol, Birmingham, W Midlands, England; [Helin, K.; Christensen, J.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Helin, K.; Christensen, J.] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark	University of Birmingham; University of Birmingham; University of Copenhagen; University of Copenhagen	Woodman, CB (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	c.b.woodman@bham.ac.uk	Helin, Kristian/HDM-8306-2022; Rowe, Martin/B-2880-2009; Helin, Kristian/K-2526-2019; Vockerodt, Martina/L-4465-2014	Helin, Kristian/0000-0003-1975-6097; Rowe, Martin/0000-0003-4139-7326; Vockerodt, Martina/0000-0001-7761-5829; Wei, Wenbin/0000-0003-1288-6999	Leukaemia and Lymphoma Research Fund; Medical Research Council [G9818340B] Funding Source: researchfish	Leukaemia and Lymphoma Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Leukaemia and Lymphoma Research Fund.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Aldinucci D, 2010, J PATHOL, V221, P248, DOI 10.1002/path.2711; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Dai JP, 2010, J CELL BIOCHEM, V110, P1457, DOI 10.1002/jcb.22703; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; HAAFTEN GV, 2010, FUNDERS GROUP HUMAN, V41, P521; Hellerbrand C, 1998, HEPATOLOGY, V27, P1285, DOI 10.1002/hep.510270514; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Mainou-Fowler T, 2004, LEUKEMIA RES, V28, P159, DOI 10.1016/S0145-2126(03)00216-9; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; SANDVEJ KB, 1993, LEUKEMIA LYMPHOMA, V9, P95, DOI 10.3109/10428199309148510; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shannon-Lowe C, 2005, J GEN VIROL, V86, P3009, DOI 10.1099/vir.0.81153-0; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vockerodt M, 2008, J PATHOL, V216, P83, DOI 10.1002/path.2384	32	104	110	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2037	2043		10.1038/onc.2010.579	http://dx.doi.org/10.1038/onc.2010.579			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21242977				2022-12-25	WOS:000289977400007
J	Good, CH; Hoffman, AF; Hoffer, BJ; Chefer, VI; Shippenberg, TS; Backman, CM; Larsson, NG; Olson, L; Gellhaar, S; Galter, D; Lupica, CR				Good, Cameron H.; Hoffman, Alexander F.; Hoffer, Barry J.; Chefer, Vladimir I.; Shippenberg, Toni S.; Baeckman, Cristina M.; Larsson, Nils-Goeran; Olson, Lars; Gellhaar, Sandra; Galter, Dagmar; Lupica, Carl R.			Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease	FASEB JOURNAL			English	Article						dopamine; patch clamp; striatum; substantia nigra pars compacta	ACTIVATED CATION CURRENT; SUBSTANTIA-NIGRA NEURONS; MIDBRAIN DOPAMINERGIC-NEURONS; CURRENT I-H; NUCLEUS-ACCUMBENS; PHYSIOLOGICAL-FUNCTION; DNA DELETIONS; HCN CHANNELS; RAT; MICRODIALYSIS	Parkinson's disease (PD) involves progressive loss of nigrostriatal dopamine (DA) neurons over an extended period of time. Mitochondrial damage may lead to PD, and neurotoxins affecting mitochondria are widely used to produce degeneration of the nigrostriatal circuitry. Deletion of the mitochondrial transcription factor A gene (Tfam) in C57BL6 mouse DA neurons leads to a slowly progressing parkinsonian phenotype in which motor impairment is first observed at similar to 12 wk of age. L-DOPA treatment improves motor dysfunction in these "MitoPark" mice, but this declines when DA neuron loss is more complete. To investigate early neurobiological events potentially contributing to PD, we compared the neurochemical and electrophysiological properties of the nigrostriatal circuit in behaviorally asymptomatic 6- to 8-wk-old MitoPark mice and age-matched control littermates. Release, but not uptake of DA, was impaired in MitoPark mouse striatal brain slices, and nigral DA neurons lacked characteristic pacemaker activity compared with control mice. Also, hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channel function was reduced in MitoPark DA neurons, although HCN messenger RNA was unchanged. This study demonstrates altered nigrostriatal function that precedes behavioral parkinsonian symptoms in this genetic PD model. A full understanding of these presymptomatic cellular properties may lead to more effective early treatments of PD.-Good, C. H., Hoffman, A. F., Hoffer, B. J., Chefer, V. I., Shippenberg, T. S., Backman, C. M., Larsson, N.-G., Olson, L., Gellhaar, S., Galter, D., Lupica, C. R. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J. 25, 1333-1344 (2011). www.fasebj.org	[Good, Cameron H.; Hoffman, Alexander F.; Lupica, Carl R.] NIDA, NIH, IRP, Electrophys Res Sect,US Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Good, Cameron H.; Hoffman, Alexander F.; Hoffer, Barry J.; Baeckman, Cristina M.; Lupica, Carl R.] NIDA, Cellular Neurobiol Branch, Intramural Res Program, NIH,US Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Chefer, Vladimir I.; Shippenberg, Toni S.] NIDA, Behav Neurosci Res Branch, Integrat Neurosci Sect, Intramural Res Program,NIH,US Dept Hlth & Human, Baltimore, MD 21224 USA; [Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Cologne, Germany; [Olson, Lars; Gellhaar, Sandra; Galter, Dagmar] Karolinska Inst Stockholm, Dept Neurosci, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Max Planck Society; Karolinska Institutet	Lupica, CR (corresponding author), NIDA, NIH, IRP, Electrophys Res Sect,US Dept Hlth & Human Serv, 333 Cassell Dr, Baltimore, MD 21224 USA.	clupica@mail.nih.gov	Larsson, Nils-Göran/GVS-5578-2022; Hoffman, Alex/H-3035-2012; Galter, Dagmar/C-4826-2011; backman, cristina/C-1276-2013; Hoffman, Alex/AIF-4544-2022; Lupica, Carl/AAY-3193-2021	Larsson, Nils-Göran/0000-0001-5100-996X; Hoffman, Alex/0000-0002-2676-0628; Galter, Dagmar/0000-0001-6485-6244; Hoffman, Alex/0000-0002-2676-0628; Lupica, Carl/0000-0002-5375-3263	U.S. National Institutes of Health, the National Institute on Drug Abuse; Swedish Research Council; Swedish Brain Foundation; Hallsten's Foundation; Swedish Parkinson's Foundation; Swedish Brain Power; Michael J. Fox Foundation; Karolinska Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000588, ZIADA000519, ZIADA000518, ZIADA000560, ZIADA000516, ZIADA000517, ZIADA000538] Funding Source: NIH RePORTER	U.S. National Institutes of Health, the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Hallsten's Foundation; Swedish Parkinson's Foundation; Swedish Brain Power; Michael J. Fox Foundation; Karolinska Institute(Karolinska Institutet); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work supported by the U.S. National Institutes of Health, the National Institute on Drug Abuse Intramural Research Program, the Swedish Research Council, the Swedish Brain Foundation, Hallsten's Foundation, the Swedish Parkinson's Foundation, Swedish Brain Power, the Michael J. Fox Foundation, and the Karolinska Institute. N.-G. L. and L.O. are co-owners of a company owning commercial rights to the MitoPark mice.	AGID Y, 1991, LANCET, V337, P1321, DOI 10.1016/0140-6736(91)92989-F; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Bonci A, 1998, J NEUROSCI, V18, P6693; CASTANEDA E, 1990, J NEUROSCI, V10, P1847; Chefer VI, 2006, J NEUROSCI METH, V155, P187, DOI 10.1016/j.jneumeth.2005.12.018; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, pR22; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Garris PA, 1997, BRAIN RES, V753, P225, DOI 10.1016/S0006-8993(97)00003-6; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Guatteo E, 2005, NEUROTOXICOLOGY, V26, P857, DOI 10.1016/j.neuro.2005.01.013; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; HOLLERMAN JR, 1990, BRAIN RES, V533, P203, DOI 10.1016/0006-8993(90)91341-D; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; JIANG ZG, 1993, J PHYSIOL-LONDON, V462, P753, DOI 10.1113/jphysiol.1993.sp019580; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEENDERS KL, 1990, ARCH NEUROL-CHICAGO, V47, P1290, DOI 10.1001/archneur.1990.00530120034007; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MERCURI NB, 1994, NEUROSCIENCE, V63, P757, DOI 10.1016/0306-4522(94)90520-7; MERCURI NB, 1994, J NEUROPHYSIOL, V71, P1165, DOI 10.1152/jn.1994.71.3.1165; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; MIZUNO Y, 1987, J NEUROCHEM, V48, P1787, DOI 10.1111/j.1471-4159.1987.tb05737.x; PARSONS LH, 1991, J NEUROSCI METH, V40, P139, DOI 10.1016/0165-0270(91)90063-6; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; SMITH AD, 1994, J NEUROSCI METH, V54, P75, DOI 10.1016/0165-0270(94)90161-9; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; STACHOWIAK MK, 1987, J NEUROSCI, V7, P1648; Svoboda KR, 1998, J NEUROSCI, V18, P7084; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Watabe M, 2008, MOL PHARMACOL, V74, P933, DOI 10.1124/mol.108.048546; Watts AE, 1996, J NEUROPHYSIOL, V76, P2262, DOI 10.1152/jn.1996.76.4.2262; Westerlund M, 2010, PROG NEUROBIOL, V90, P146, DOI 10.1016/j.pneurobio.2009.11.001; ZIGMOND MJ, 1973, SCIENCE, V182, P717, DOI 10.1126/science.182.4113.717; ZIGMOND MJ, 1989, MOL CHEM NEUROPATHOL, V10, P185, DOI 10.1007/BF03159728; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	57	84	85	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1333	1344		10.1096/fj.10-173625	http://dx.doi.org/10.1096/fj.10-173625			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21233488	Green Published			2022-12-25	WOS:000288982800022
J	Smith, MA; Wright, G; Wu, JA; Tailor, P; Ozato, K; Chen, XH; Wei, S; Piskurich, JF; Ting, JPY; Wright, KL				Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Tailor, Prafullakumar; Ozato, Keiko; Chen, Xianghong; Wei, Sheng; Piskurich, Janet F.; Ting, Jenny P. -Y.; Wright, Kenneth L.			Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; IFN-GAMMA; B-LYMPHOCYTES; MICE LACKING; DEVELOPMENTAL REGULATION; RECEPTOR EXPRESSION; BINDING-PROTEIN; DOWN-REGULATION; PROMOTER-III; GENES	Dendritic cells (DCs) are key mediators of immune function through robust and tightly regulated presentation of antigen in the context of the MHC Class II. MHC Class II expression is controlled by the transactivator CIITA. CIITA expression in conventional DCs is uniquely dependent on an uncharacterized myeloid cell-specific promoter, CIITApI. We now identify in vivo the promoter structure and factors regulating CIITApI. In immature DCs transcription requires binding of PU.1, IRF8, NF kappa B, and Sp1 to the promoter. PU.1 binds independently at one site and in a required heterodimer with IRF8 at a composite element. DCs from IRF8-null mice have an unoccupied CIITApI promoter that can be rescued by reconstitution with IRF8 in vitro. Furthermore, mutation of either PU.1 site or the IFR8 site inhibits transcriptional activation. In vivo footprinting and chromatin immunoprecipitation reveals that DC maturation induces complete disassociation of the bound activators paralleled by recruitment of PRDM1/Blimp-1 to the promoter. PRDM1 is a transcriptional repressor with essential roles in B cells, T cells, NK cells, and DCs. We show that PRDM1 co-repressors, G9a and HDAC2, are recruited to CIITApI, leading to a loss of histone acetylation and acquisition of histone H3K9 dimethylation and heterochromatin protein 1 gamma (HP1 gamma). PRDM1 binding also blocks IRF8-mediated activation dependent on the PU.1/IRF composite element. Together these findings reveal the mechanisms regulating CIITA and, thus, antigen presentation in DCs, demonstrating that PRDM1 and IRF8/PU.1 counter-regulate expression. The activity of PRDM1 in silencing all three cell type-specific CIITA promoters places it as a central regulator of antigen presentation.	[Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Chen, Xianghong; Wei, Sheng; Wright, Kenneth L.] Univ S Florida, Dept Mol Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Chen, Xianghong; Wei, Sheng; Wright, Kenneth L.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Tailor, Prafullakumar; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Piskurich, Janet F.] Texas Tech Univ Hlth Sci Ctr, Dept Med Educ, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Texas Tech University System; Texas Tech University Health Science Center; University of North Carolina; University of North Carolina Chapel Hill	Wright, KL (corresponding author), Univ S Florida, Dept Mol Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,MRC 4 E, Tampa, FL 33612 USA.	ken.wright@moffitt.org			National Institutes of Health [CA114504, CA080990, AI029564]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA114504, R01CA080990, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029564, R01AI029564, R37AI029564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA114504 and CA080990 (to K. L. W.) and AI029564.	Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chen H, 2007, MOL IMMUNOL, V44, P1461, DOI 10.1016/j.molimm.2006.04.026; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Desai S, 2010, MOL CANCER RES, V8, P907, DOI 10.1158/1541-7786.MCR-10-0131; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Ghosh N, 1999, J BIOL CHEM, V274, P32342, DOI 10.1074/jbc.274.45.32342; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; LopezRodriguez C, 1995, EUR J IMMUNOL, V25, P3496, DOI 10.1002/eji.1830251243; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pantano S, 2006, EXP CELL RES, V312, P1312, DOI 10.1016/j.yexcr.2005.12.020; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tooze RM, 2006, J IMMUNOL, V177, P4584, DOI 10.4049/jimmunol.177.7.4584; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; van der Stoep N, 2002, J IMMUNOL, V169, P5061, DOI 10.4049/jimmunol.169.9.5061; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; WEISZ A, 1992, J BIOL CHEM, V267, P25589; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	68	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7893	7904		10.1074/jbc.M110.165431	http://dx.doi.org/10.1074/jbc.M110.165431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216962	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000288013300020
J	Xiao, L; Chen, YH; Ji, M; Dong, JX				Xiao, Ling; Chen, Yuanhong; Ji, Ming; Dong, Jixin			KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; CELL CONTACT INHIBITION; WW DOMAIN; YAP ONCOPROTEIN; GROWTH-CONTROL; PATHWAY; PROTEIN; PROLIFERATION; DROSOPHILA; APOPTOSIS	The Hippo pathway controls tissue growth and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. Recent genetic studies in Drosophila identified Kibra as a novel regulator of Hippo signaling. Human KIBRA has been associated with memory performance and cell migration. However, it is unclear whether or how KIBRA is connected to the Hippo pathway in mammalian cells. Here, we show that KIBRA associates with and activates Lats (large tumor suppressor) 1 and 2 kinases by stimulating their phosphorylation on the hydrophobic motif. KIBRA overexpression stimulates the phosphorylation of Yes-associated protein (YAP), the Hippo pathway effector. Conversely, depletion of KIBRA by RNA interference reduces YAP phosphorylation. Furthermore, KIBRA stabilizes Lats2 by inhibiting its ubiquitination. We also found that KIBRA mRNA is induced by YAP overexpression in both murine and human cells, suggesting the evolutionary conservation of KIBRA as a transcriptional target of the Hippo signaling pathway. Thus, our study revealed a new connection between KIBRA and mammalian Hippo signaling.	[Xiao, Ling; Chen, Yuanhong; Ji, Ming; Dong, Jixin] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu			National Center for Research Resources [5P20-RR018759-07]; Nebraska Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health Grant 5P20-RR018759-07 from the National Center for Research Resources and a grant from the Nebraska Department of Health and Human Services (to J. D.).	Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	43	136	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7788	7796		10.1074/jbc.M110.173468	http://dx.doi.org/10.1074/jbc.M110.173468			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233212	hybrid, Green Published			2022-12-25	WOS:000288013300010
J	Hu, W; Hossain, M; Lux, R; Wang, J; Yang, Z; Li, YZ; Shi, WY				Hu, Wei; Hossain, Muhaiminu; Lux, Renate; Wang, Jing; Yang, Zhe; Li, Yuezhong; Shi, Wenyuan			Exopolysaccharide-Independent Social Motility of Myxococcus xanthus	PLOS ONE			English	Article							FRUITING BODY FORMATION; GLIDING MOTILITY; IV PILUS; MULTICELLULAR DEVELOPMENT; TWITCHING MOTILITY; POLYSACCHARIDE PRODUCTION; PSEUDOMONAS-AERUGINOSA; CHEMOTAXIS HOMOLOGS; O-ANTIGEN; MYXOBACTERIA	Social motility (S motility), the coordinated movement of large cell groups on agar surfaces, of Myxococcus xanthus requires type IV pili (TFP) and exopolysaccharides (EPS). Previous models proposed that this behavior, which only occurred within cell groups, requires cycles of TFP extension and retraction triggered by the close interaction of TFP with EPS. However, the curious observation that M. xanthus can perform TFP-dependent motility at a single-cell level when placed onto polystyrene surfaces in a highly viscous medium containing 1% methylcellulose indicated that "S motility" is not limited to group movements. In an apparent further challenge of the previous findings for S motility, mutants defective in EPS production were found to perform TFP-dependent motility on polystyrene surface in methylcellulose-containing medium. By exploring the interactions between pilin and surface materials, we found that the binding of TFP onto polystyrene surfaces eliminated the requirement for EPS in EPS- cells and thus enabled TFP-dependent motility on a single cell level. However, the presence of a general anchoring surface in a viscous environment could not substitute for the role of cell surface EPS in group movement. Furthermore, EPS was found to serve as a self-produced anchoring substrate that can be shed onto surfaces to enable cells to conduct TFP-dependent motility regardless of surface properties. These results suggested that in certain environments, such as in methylcellulose solution, the cells could bypass the need for EPS to anchor their TPF and conduct single-cell S motility to promote exploratory movement of colonies over new specific surfaces.	[Hu, Wei; Lux, Renate; Wang, Jing; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hossain, Muhaiminu; Yang, Zhe; Shi, Wenyuan] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Hu, Wei; Wang, Jing; Li, Yuezhong] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shandong University	Hu, W (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	wenyuan@ucla.edu	SHI, wen/GPW-9531-2022; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	United States National Institutes of Health [GM54666]; Chinese National Natural Science Foundation [30870020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054666] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grant GM54666 (to W.S.) and Chinese National Natural Science Foundation Grant 30870020 (to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; CHANG BY, 1994, J BACTERIOL, V176, P7190, DOI 10.1128/JB.176.23.7190-7196.1994; Chavira M, 2007, J BACTERIOL, V189, P169, DOI 10.1128/JB.00792-06; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Cordelieres F, 2005, MANUAL TRACKING PLUG; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; Harlow E., 1988, ANTIBODIES LAB MANUA; HARTZELL P, 2008, GLIDING MOTILITY MYX; HIGGS P, 2008, MYXOCOCCUS XANTHUS C; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; HODGKIN J, 1979, MOL GEN GENET, V171, P167, DOI 10.1007/BF00270003; Jelsbak L, 2000, CURR OPIN MICROBIOL, V3, P637, DOI 10.1016/S1369-5274(00)00153-3; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; KAISER D, 1983, CELL MOTILITY, V3, P18; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Leonardy S, 2008, MOL BIOSYST, V4, P1009, DOI 10.1039/b806640j; Li YN, 2005, MICROBIOL-SGM, V151, P353, DOI 10.1099/mic.0.27614-0; Li YZ, 2002, J MICROBIOL METH, V50, P205, DOI 10.1016/S0167-7012(02)00029-5; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Lux R., 2004, BIOFILMS, V1, P293; MACNEIL SD, 1994, MOL MICROBIOL, V14, P785, DOI 10.1111/j.1365-2958.1994.tb01315.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MCBRIDE M, 1993, MOTILITY TACTIC BEHA; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Rasband W, IMAGEJ; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reichenbach H, 1993, BIOL MYXOBACTERIA EC; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Shi WY, 2002, INFECT IMMUN, V70, P1, DOI 10.1128/IAI.70.1.1-4.2002; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Shi WY, 1996, P NATL ACAD SCI USA, V93, P4142, DOI 10.1073/pnas.93.9.4142; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Ward MJ, 1999, CURR OPIN MICROBIOL, V2, P624, DOI 10.1016/S1369-5274(99)00032-6; Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542	55	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16102	10.1371/journal.pone.0016102	http://dx.doi.org/10.1371/journal.pone.0016102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245931	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511200034
J	Berecki, G; Wilders, R; de Jonge, B; van Ginneken, ACG; Verkerk, AO				Berecki, Geza; Wilders, Ronald; de Jonge, Berend; van Ginneken, Antoni C. G.; Verkerk, Arie O.			Re-Evaluation of the Action Potential Upstroke Velocity as a Measure of the Na+ Current in Cardiac Myocytes at Physiological Conditions	PLOS ONE			English	Article							AVAILABLE SODIUM CONDUCTANCE; VOLTAGE CLAMP MEASUREMENTS; RABBIT PURKINJE-FIBERS; BRUGADA-SYNDROME; HEART-FAILURE; VENTRICULAR MYOCYTES; TEMPERATURE-DEPENDENCE; CHANNEL MUTATIONS; PATCH-CLAMP; V-MAX	Background: The SCN5A encoded sodium current (I-Na) generates the action potential (AP) upstroke and is a major determinant of AP characteristics and AP propagation in cardiac myocytes. Unfortunately, in cardiac myocytes, investigation of kinetic properties of I-Na with near-physiological ion concentrations and temperature is technically challenging due to the large amplitude and rapidly activating nature of I-Na, which may seriously hamper the quality of voltage control over the membrane. We hypothesized that the alternating voltage clamp-current clamp (VC/CC) technique might provide an alternative to traditional voltage clamp (VC) technique for the determination of I-Na properties under physiological conditions. Principal Findings: We studied I-Na under close-to-physiological conditions by VC technique in SCN5A cDNA-transfected HEK cells or by alternating VC/CC technique in both SCN5A cDNA-transfected HEK cells and rabbit left ventricular myocytes. In these experiments, peak I-Na during a depolarizing VC step or maximal upstroke velocity, dV/dt(max), during VC/CC served as an indicator of available I-Na. In HEK cells, biophysical properties of I-Na, including current density, voltage dependent (in) activation, development of inactivation, and recovery from inactivation, were highly similar in VC and VC/CC experiments. As an application of the VC/CC technique we studied I-Na in left ventricular myocytes isolated from control or failing rabbit hearts. Conclusions: Our results demonstrate that the alternating VC/CC technique is a valuable experimental tool for I-Na measurements under close-to-physiological conditions in cardiac myocytes.	[Berecki, Geza; Wilders, Ronald; de Jonge, Berend; van Ginneken, Antoni C. G.; Verkerk, Arie O.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Berecki, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	A.O.Verkerk@amc.uva.nl	Berecki, Geza/T-5016-2017	Verkerk, Arie/0000-0003-2140-834X				Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Baartscheer A, 2008, BRIT J PHARMACOL, V154, P1266, DOI 10.1038/bjp.2008.189; Berecki G, 2006, J PHYSIOL-LONDON, V570, P237, DOI 10.1113/jphysiol.2005.096578; CALLEWAERT G, 1984, J PHYSIOL-LONDON, V349, P643, DOI 10.1113/jphysiol.1984.sp015179; CARMELIET E, 1991, EUR J PHARMACOL, V196, P53, DOI 10.1016/0014-2999(91)90408-I; Cascio WE, 2001, J CARDIOVASC ELECTR, V12, P726, DOI 10.1046/j.1540-8167.2001.00726.x; Casini S, 2009, CARDIOVASC RES, V81, P72, DOI 10.1093/cvr/cvn274; CLARKSON CW, 1984, AM J PHYSIOL, V247, pH645, DOI 10.1152/ajpheart.1984.247.4.H645; COHEN CJ, 1984, CIRC RES, V54, P636, DOI 10.1161/01.RES.54.6.636; COHEN IS, 1985, CIRC RES, V57, P482, DOI 10.1161/01.RES.57.3.482; COLATSKY TJ, 1979, NATURE, V278, P265, DOI 10.1038/278265a0; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; de Groot JR, 2003, CARDIOVASC RES, V59, P705, DOI 10.1016/S0008-6363(03)00460-7; DECARVALHO AP, 1969, J GEN PHYSIOL, V54, P607, DOI 10.1085/jgp.54.5.607; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Fozzard HA, 2005, CURR PHARM DESIGN, V11, P2671, DOI 10.2174/1381612054546833; GELBAND H, 1972, CIRC RES, V30, P293, DOI 10.1161/01.RES.30.3.293; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han CY, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-3; HANCK DA, 1992, AM J PHYSIOL, V262, pH1197, DOI 10.1152/ajpheart.1992.262.4.H1197; HONDEGHEM LM, 1985, CIRC RES, V57, P192; HONDEGHEM LM, 1978, BIOPHYS J, V23, P147, DOI 10.1016/S0006-3495(78)85439-3; JOHNS JA, 1989, J CARDIOVASC PHARM, V13, P826, DOI 10.1097/00005344-198906000-00004; Kleber AG, 2005, CIRC RES, V97, P204, DOI 10.1161/01.RES.0000177922.62341.f2; Kleber AG, 1997, BASIC RES CARDIOL, V92, P111, DOI 10.1007/BF00794075; Milburn T, 1995, RECEPTOR CHANNEL, V3, P201; MURRAY KT, 1990, BIOPHYS J, V57, P607, DOI 10.1016/S0006-3495(90)82576-5; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Petitprez S, 2008, CARDIOVASC RES, V78, P494, DOI 10.1093/cvr/cvn023; Postema PG, 2009, HEART RHYTHM, V6, P1335, DOI 10.1016/j.hrthm.2009.07.002; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; ROBERGE FA, 1987, COMPUT BIOMED RES, V20, P351, DOI 10.1016/0010-4809(87)90049-8; ROSEN MR, 1974, AM HEART J, V88, P380, DOI 10.1016/0002-8703(74)90475-X; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; SAIKAWA T, 1982, PFLUG ARCH EUR J PHY, V394, P90, DOI 10.1007/BF01108313; SAKAKIBARA Y, 1993, AM J PHYSIOL, V265, pH1301, DOI 10.1152/ajpheart.1993.265.4.H1301; SHEETS MF, 1988, CIRC RES, V63, P386, DOI 10.1161/01.RES.63.2.386; Sherman AJ, 1999, BIOPHYS J, V77, P2590, DOI 10.1016/S0006-3495(99)77093-1; Sperelakis N, 1968, J Electrocardiol, V1, P31; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Verkerk AO, 2005, CARDIOVASC RES, V68, P441, DOI 10.1016/j.cardiores.2005.06.027; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Verkerk AO, 2008, EUROPACE, V10, P257, DOI 10.1093/europace/eum267; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Verkerk AO, 2011, INT J CARDIOL, V148, P154, DOI 10.1016/j.ijcard.2009.10.047; VERMEULEN JT, 1994, CARDIOVASC RES, V28, P1547, DOI 10.1093/cvr/28.10.1547; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WEIDMANN S, 1955, J PHYSIOL-LONDON, V127, P213, DOI 10.1113/jphysiol.1955.sp005250; Wiegerinck RF, 2006, CIRCULATION, V113, P806, DOI 10.1161/CIRCULATIONAHA.105.565804; YAMAOKA K, 1987, JPN J PHYSIOL, V37, P585, DOI 10.2170/jjphysiol.37.585	59	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15772	10.1371/journal.pone.0015772	http://dx.doi.org/10.1371/journal.pone.0015772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217835	Green Published, gold			2022-12-25	WOS:000285838900031
J	Morran, LT; Ohdera, AH; Phillips, PC				Morran, Levi T.; Ohdera, Aki H.; Phillips, Patrick C.			Purging Deleterious Mutations under Self Fertilization: Paradoxical Recovery in Fitness with Increasing Mutation Rate in Caenorhabditis elegans	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; COMPENSATORY MUTATIONS; INBREEDING DEPRESSION; POPULATIONS; RECOMBINATION; SELECTION; MUTAGENESIS; EXTINCTION; ADVANTAGE; GENETICS	Background: The accumulation of deleterious mutations can drastically reduce population mean fitness. Self-fertilization is thought to be an effective means of purging deleterious mutations. However, widespread linkage disequilibrium generated and maintained by self-fertilization is predicted to reduce the efficacy of purging when mutations are present at multiple loci. Methodology/Principal Findings: We tested the ability of self-fertilizing populations to purge deleterious mutations at multiple loci by exposing obligately self-fertilizing populations of Caenorhabditis elegans to a range of elevated mutation rates and found that mutations accumulated, as evidenced by a reduction in mean fitness, in each population. Therefore, purging in obligate selfing populations is overwhelmed by an increase in mutation rate. Surprisingly, we also found that obligate and predominantly self-fertilizing populations exposed to very high mutation rates exhibited consistently greater fitness than those subject to lesser increases in mutation rate, which contradicts the assumption that increases in mutation rate are negatively correlated with fitness. The high levels of genetic linkage inherent in self-fertilization could drive this fitness increase. Conclusions: Compensatory mutations can be more frequent under high mutation rates and may alleviate a portion of the fitness lost due to the accumulation of deleterious mutations through epistatic interactions with deleterious mutations. The prolonged maintenance of tightly linked compensatory and deleterious mutations facilitated by self-fertilization may be responsible for the fitness increase as linkage disequilibrium between the compensatory and deleterious mutations preserves their epistatic interaction.	[Morran, Levi T.; Ohdera, Aki H.; Phillips, Patrick C.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Morran, LT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	pphil@uoregon.edu			National Science Foundation [DEB-0236180, DEB-0710386, DEB-0641066]; National Institutes of Health; NIH National Center for Research Resources (NCRR)	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by National Science Foundation grants DEB-0236180, DEB-0710386, DEB-0641066, and an National Institutes of Health Genetics Fellowship awarded to LTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Y.L. Lee, M. Parmenter, S. Scholz, and J. Chiem for logistical help and J. Thornton for use of lab space and equipment. We would also like to thank the members of the Phillips lab and two anonymous reviewers for helpful comments and discussion pertaining to this work. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anderson P, 1995, METHOD CELL BIOL, V48, P31; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; BARTON NH, 1995, GENETICS, V140, P821; BRENNER S, 1974, GENETICS, V77, P71; Burch CL, 1999, GENETICS, V151, P921; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Davis BH, 2009, P R SOC B, V276, P1823, DOI 10.1098/rspb.2008.1846; Denver DR, 2010, GENOME RES, V20, P1663, DOI 10.1101/gr.108191.110; Drake JW, 1998, GENETICS, V148, P1667; Estes S, 2003, EVOLUTION, V57, P1022, DOI 10.1111/j.0014-3820.2003.tb00313.x; Estes S, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P135; FELSENSTEIN J, 1974, GENETICS, V78, P737; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; HASTINGS A, 1984, P NATL ACAD SCI-BIOL, V81, P4596, DOI 10.1073/pnas.81.14.4596; HELLER J, 1972, GENET RES, V8, P269; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; JOHNS V, 1978, MOL GEN GENET, V167, P197, DOI 10.1007/BF00266913; Keightley PD, 1999, GENETICS, V153, P515; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kimura M., 1985, POPULATION GENETICS, P19; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lande R, 1998, GENETICA, V102-3, P21, DOI 10.1023/A:1017018405648; Lynch M., 1995, EVOLUTION, V47, P1744; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; MUKAI T, 1964, GENETICS, V50, P1; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; PARK EC, 1986, GENETICS, V113, P821; Phillips PC, 2000, EPISTATIS EVOLUTIONA; ROSENBLUTH RE, 1983, MUTAT RES, V110, P39, DOI 10.1016/0027-5107(83)90016-7; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Schultz ST, 1997, EVOLUTION, V51, P1363, DOI [10.1111/j.1558-5646.1997.tb01459.x, 10.2307/2411188]; SIDDIQI BA, 1973, HEREDITAS, V73, P311; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Stiernagle T, 2006, COMMUNITY TCER; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Whitlock MC, 1999, TRENDS ECOL EVOL, V14, P295, DOI 10.1016/S0169-5347(99)01662-6; Wright S, 1931, GENETICS, V16, P0097	48	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14473	10.1371/journal.pone.0014473	http://dx.doi.org/10.1371/journal.pone.0014473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217820	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900004
J	Jang, KJ; Kim, MS; Feltrin, D; Jeon, NL; Suh, KY; Pertz, O				Jang, Kyung-Jin; Kim, Min Sung; Feltrin, Daniel; Jeon, Noo Li; Suh, Kahp-Yang; Pertz, Olivier			Two Distinct Filopodia Populations at the Growth Cone Allow to Sense Nanotopographical Extracellular Matrix Cues to Guide Neurite Outgrowth	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MYOSIN-II; AXONAL OUTGROWTH; TIME-LAPSE; GUIDANCE; ACTIN; DIFFERENTIATION; MECHANISMS; FIBERS; NANOFIBERS	Background: The process of neurite outgrowth is the initial step in producing the neuronal processes that wire the brain. Current models about neurite outgrowth have been derived from classic two-dimensional (2D) cell culture systems, which do not recapitulate the topographical cues that are present in the extracellular matrix (ECM) in vivo. Here, we explore how ECM nanotopography influences neurite outgrowth. Methodology/Principal Findings: We show that, when the ECM protein laminin is presented on a line pattern with nanometric size features, it leads to orientation of neurite outgrowth along the line pattern. This is also coupled with a robust increase in neurite length. The sensing mechanism that allows neurite orientation occurs through a highly stereotypical growth cone behavior involving two filopodia populations. Non-aligned filopodia on the distal part of the growth cone scan the pattern in a lateral back and forth motion and are highly unstable. Filopodia at the growth cone tip align with the line substrate, are stabilized by an F-actin rich cytoskeleton and enable steady neurite extension. This stabilization event most likely occurs by integration of signals emanating from non-aligned and aligned filopodia which sense different extent of adhesion surface on the line pattern. In contrast, on the 2D substrate only unstable filopodia are observed at the growth cone, leading to frequent neurite collapse events and less efficient outgrowth. Conclusions/Significance: We propose that a constant crosstalk between both filopodia populations allows stochastic sensing of nanotopographical ECM cues, leading to oriented and steady neurite outgrowth. Our work provides insight in how neuronal growth cones can sense geometric ECM cues. This has not been accessible previously using routine 2D culture systems.	[Jang, Kyung-Jin; Suh, Kahp-Yang] Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea; [Kim, Min Sung; Jeon, Noo Li; Suh, Kahp-Yang] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Feltrin, Daniel; Pertz, Olivier] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland	Seoul National University (SNU); Seoul National University (SNU); University of Basel	Jang, KJ (corresponding author), Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea.	sky4u@snu.ac.kr; olivier.pertz@unibas.ch		pertz, olivier/0000-0001-8579-4919	Swiss National Science Foundation [114853]; World Class University [R31-2008-000-10083-0]; Korea Research Foundation [KRF-J03003]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); World Class University; Korea Research Foundation(National Research Foundation of Korea)	This work was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch) to Olivier Pertz (grant 114853). This work was supported in part by a World Class University Program (http://www.mrs.org/s_mrs/doc.asp?CID = 1653&DID = 214385) to Kahp-Yang Suh and Noo Li Jeon (grant R31-2008-000-10083-0) and a Korea Research Foundation Grant (http://hero2.krf.or.kr/KHPapp/eng/maina.jsp) to Kahp-Yang Suh (grant KRF-J03003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CLARK P, 1993, J CELL SCI, V105, P203; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Hwang SY, 2010, ANAL CHEM, V82, P3016, DOI 10.1021/ac100107z; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI 10.1016/j.biomaterials.2005.07.047; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mason CA, 1997, J NEUROSCI, V17, P1086; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Reynolds M L, 1993, Curr Opin Neurobiol, V3, P683, DOI 10.1016/0959-4388(93)90139-P; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771; Tsiper MV, 2002, J CELL SCI, V115, P1005; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013	38	71	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15966	10.1371/journal.pone.0015966	http://dx.doi.org/10.1371/journal.pone.0015966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209862	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793600052
J	Tang, SM; Juusola, M				Tang, Shiming; Juusola, Mikko			Intrinsic Activity in the Fly Brain Gates Visual Information during Behavioral Choices	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FRUIT-FLY; LOBULA PLATE; BINOCULAR INTERACTION; COROLLARY DISCHARGE; RESPONSE PROPERTIES; FLIGHT ORIENTATION; NEURAL MECHANISMS; FINE-STRUCTURE; YAW TORQUE	The small insect brain is often described as an input/output system that executes reflex-like behaviors. It can also initiate neural activity and behaviors intrinsically, seen as spontaneous behaviors, different arousal states and sleep. However, less is known about how intrinsic activity in neural circuits affects sensory information processing in the insect brain and variability in behavior. Here, by simultaneously monitoring Drosophila's behavioral choices and brain activity in a flight simulator system, we identify intrinsic activity that is associated with the act of selecting between visual stimuli. We recorded neural output (multiunit action potentials and local field potentials) in the left and right optic lobes of a tethered flying Drosophila, while its attempts to follow visual motion (yaw torque) were measured by a torque meter. We show that when facing competing motion stimuli on its left and right, Drosophila typically generate large torque responses that flip from side to side. The delayed onset (0.1-1 s) and spontaneous switch-like dynamics of these responses, and the fact that the flies sometimes oppose the stimuli by flying straight, make this behavior different from the classic steering reflexes. Drosophila, thus, seem to choose one stimulus at a time and attempt to rotate toward its direction. With this behavior, the neural output of the optic lobes alternates; being augmented on the side chosen for body rotation and suppressed on the opposite side, even though the visual input to the fly eyes stays the same. Thus, the flow of information from the fly eyes is gated intrinsically. Such modulation can be noise-induced or intentional; with one possibility being that the fly brain highlights chosen information while ignoring the irrelevant, similar to what we know to occur in higher animals.	[Tang, Shiming; Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tang, Shiming] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Beijing Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Sheffield	Tang, SM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	tangshm@sun5.ibp.ac.cn; m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330	NSFC (National Science Foundation of China) [30525016, 90408030, 30810103906]; Chinese Academy of Sciences; Gatsby Foundation; Royal Society; BBSRC [BBF0120711, BBD0019001]; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012071/1, BB/D001900/1] Funding Source: researchfish	NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Gatsby Foundation; Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the NSFC (National Science Foundation of China) Outstanding Young Researcher Award (30525016), the NSFC project (90408030) and the Knowledge Innovation Project of the Chinese Academy of Sciences (S.T.); the NSFC project (30810103906: S.T. & M.J.); the Gatsby Foundation (M.J.), the Royal Society (M.J.) and BBSRC (BBF0120711: M.J. and BBD0019001: M.J. and S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLONDEAU J, 1981, J EXP BIOL, V92, P143; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRANCESCHINI N, 1997, P 25 GOTT NEUR C 199, V2; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; GEIGER G, 1981, NATURE, V293, P398, DOI 10.1038/293398a0; GEIGER G, 1982, BIOL CYBERN, V44, P141, DOI 10.1007/BF00317974; Goodhill GJ, 2007, NEURON, V56, P301, DOI 10.1016/j.neuron.2007.09.027; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hausen K., 1989, P391; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; HEISENBERG M, 1984, SELECTIVE ATTENTION, P183; HENGSTENBERG R, 1971, BIOL CYBERN, V9, P56; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KARA P, 2009, NATURE; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LI ZP, 1994, NETWORK-COMP NEURAL, V5, P157, DOI 10.1088/0954-898X/5/2/003; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; LOWNE BT, 1890, ANATOMY PHYSL MORPHO; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Miller SM, 2000, CURR BIOL, V10, P383, DOI 10.1016/S0960-9822(00)00416-4; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nordstrom K, 2009, TRENDS NEUROSCI, V32, P383, DOI 10.1016/j.tins.2009.03.004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PATTERSON J, 1973, J EXP BIOL, V58, P565; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; ROSSEL S, 1983, NATURE, V302, P821, DOI 10.1038/302821a0; Rossel S, 1996, P NATL ACAD SCI USA, V93, P13229, DOI 10.1073/pnas.93.23.13229; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Tammero LF, 2002, J EXP BIOL, V205, P2785; Tammero LF, 2002, J EXP BIOL, V205, P327; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	81	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14455	10.1371/journal.pone.0014455	http://dx.doi.org/10.1371/journal.pone.0014455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209935	Green Published, Green Accepted, gold			2022-12-25	WOS:000285793600002
J	Noonin, C; Jiravanichpaisal, P; Soderhall, I; Merino, S; Tomas, JM; Soderhall, K				Noonin, Chadanat; Jiravanichpaisal, Pikul; Soderhall, Irene; Merino, Susana; Tomas, Juan M.; Soderhall, Kenneth			Melanization and Pathogenicity in the Insect, Tenebrio molitor, and the Crustacean, Pacifastacus leniusculus, by Aeromonas hydrophila AH-3	PLOS ONE			English	Article							III SECRETION SYSTEM; INDUCED MELANIN SYNTHESIS; CLINICAL ISOLATE; LATERAL FLAGELLA; POLAR FLAGELLUM; CDNA CLONING; LIPOPOLYSACCHARIDE; PHENOLOXIDASE; EXPRESSION; RESISTANCE	Aeromonas hydrophila is the most common Aeromonas species causing infections in human and other animals such as amphibians, reptiles, fish and crustaceans. Pathogenesis of Aeromonas species have been reported to be associated with virulence factors such as lipopolysaccharides (LPS), bacterial toxins, bacterial secretion systems, flagella, and other surface molecules. Several mutant strains of A. hydrophila AH-3 were initially used to study their virulence in two animal species, Pacifastacus leniusculus (crayfish) and Tenebrio molitor larvae (mealworm). The AH-3 strains used in this study have mutations in genes involving the synthesis of flagella, LPS structures, secretion systems, and some other factors, which have been reported to be involved in A. hydrophila pathogenicity. Our study shows that the LPS (O-antigen and external core) is the most determinant A. hydrophila AH-3 virulence factor in both animals. Furthermore, we studied the immune responses of these hosts to infection of virulent or non-virulent strains of A. hydrophila AH-3. The AH-3 wild type (WT) containing the complete LPS core is highly virulent and this bacterium strongly stimulated the prophenoloxidase activating system resulting in melanization in both crayfish and mealworm. In contrast, the Delta waaE mutant which has LPS without O-antigen and external core was non-virulent and lost ability to stimulate this system and melanization in these two animals. The high phenoloxidase activity found in WT infected crayfish appears to result from a low expression of pacifastin, a prophenoloxidase activating enzyme inhibitor, and this gene expression was not changed in the Delta waaE mutant infected animal and consequently phenoloxidase activity was not altered as compared to non-infected animals. Therefore we show that the virulence factors of A. hydrophila are the same regardless whether an insect or a crustacean is infected and the O-antigen and external core is essential for activation of the proPO system and as virulence factors for this bacterium.	[Noonin, Chadanat; Jiravanichpaisal, Pikul; Soderhall, Irene; Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden; [Jiravanichpaisal, Pikul] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Merino, Susana; Tomas, Juan M.] Univ Barcelona, Dept Microbiol, Fac Biol, Barcelona, Spain	Uppsala University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Barcelona	Noonin, C (corresponding author), Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden.	kenneth.soderhall@ebc.uu.se	Tomas, Juan M/L-1398-2015; Noonin, Chadanat/AAD-6269-2022; Merino, Susana/D-4342-2014; Soderhall, Irene/AAS-5433-2020	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; 	Swedish Science Research Council; Swedish Research Council Formas; Swedish Foundation for International Cooperation in Research and Higher Education; Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain; Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Foundation for International Cooperation in Research and Higher Education; Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work has been supported by the Swedish Science Research Council (K. S.), The Swedish Research Council Formas (K. S.) and The Swedish Foundation for International Cooperation in Research and Higher Education (K. S. and P.J.). Part of this work was supported by Plan Nacional de I+D and FIS grants (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia) to J.M.T.. The funders had no role in study design, data collection and analysis, decision of publish, or preparation of the manuscript.	Akinbowale AL, 2007, INT J ANTIMICROB AG, V30, P177, DOI 10.1016/j.ijantimicag.2007.03.012; Alagappan K.M., 2009, World Journal of Fish and Marine Sciences, V1, P185; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Daskalov H, 2006, FOOD CONTROL, V17, P474, DOI 10.1016/j.foodcont.2005.02.009; Edberg SC, 2007, CRIT REV MICROBIOL, V33, P89, DOI 10.1080/10408410601172180; Erova TE, 2007, FEMS MICROBIOL LETT, V275, P301, DOI 10.1111/j.1574-6968.2007.00895.x; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; Jiravanichpaisal P, 2009, J INVERTEBR PATHOL, V101, P56, DOI 10.1016/j.jip.2009.02.002; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kirov SM, 2003, FEMS MICROBIOL LETT, V224, P151, DOI 10.1016/S0378-1097(03)00445-2; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; MASSAD G, 1991, J GEN MICROBIOL, V137, P237, DOI 10.1099/00221287-137-2-237; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; MERINO S, 1991, J GEN MICROBIOL, V137, P1583, DOI 10.1099/00221287-137-7-1583; Merino S, 1995, INT J FOOD MICROBIOL, V28, P157, DOI 10.1016/0168-1605(95)00054-2; MUNN CB, 1982, INFECT IMMUN, V36, P1069, DOI 10.1128/IAI.36.3.1069-1075.1982; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Nogueras MM, 2000, INFECT IMMUN, V68, P1849, DOI 10.1128/IAI.68.4.1849-1854.2000; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Sahoo PK, 2008, FISH SHELLFISH IMMUN, V25, P163, DOI 10.1016/j.fsi.2008.04.003; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sierra JC, 2007, MICROB PATHOGENESIS, V43, P147, DOI 10.1016/j.micpath.2007.05.003; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Stintzi A, 2000, J BIOL INORG CHEM, V5, P57, DOI 10.1007/PL00010655; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; van der Marel M, 2008, J FISH DIS, V31, P321, DOI 10.1111/j.1365-2761.2008.00902.x; Vilches S, 2004, APPL ENVIRON MICROB, V70, P6914, DOI 10.1128/AEM.70.11.6914-6919.2004; Vilches S, 2009, APPL ENVIRON MICROB, V75, P6382, DOI 10.1128/AEM.00222-09; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	46	25	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15728	10.1371/journal.pone.0015728	http://dx.doi.org/10.1371/journal.pone.0015728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206752	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793200045
J	Ganapathy, S; Chen, QH; Singh, KP; Shankar, S; Srivastava, RK				Ganapathy, Suthakar; Chen, Qinghe; Singh, Karan P.; Shankar, Sharmila; Srivastava, Rakesh K.			Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR-KAPPA-B; CHEMOTHERAPEUTIC DRUGS; MOLECULAR-MECHANISMS; DOWN-REGULATION; CELL-SURVIVAL; IN-VITRO; APOPTOSIS; EXPRESSION; STRESS; LIGAND	Background: Resveratrol (3, 49, 5 tri-hydroxystilbene), a naturally occurring polyphenol, exhibits anti-inflammatory, antioxidant, cardioprotective and antitumor activities. We have recently shown that resveratrol can enhance the apoptosis-inducing potential of TRAIL in prostate cancer cells through multiple mechanisms in vitro. Therefore, the present study was designed to validate whether resveratrol can enhance the apoptosis-inducing potential of TRAIL in a xenograft model of prostate cancer. Methodology/Principal Findings: Resveratrol and TRAIL alone inhibited growth of PC-3 xenografts in nude mice by inhibiting tumor cell proliferation (PCNA and Ki67 staining) and inducing apoptosis (TUNEL staining). The combination of resveratrol and TRAIL was more effective in inhibiting tumor growth than single agent alone. In xenografted tumors, resveratrol upregulated the expressions of TRAIL-R1/DR4, TRAIL-R2/DR5, Bax and p27/(K IP1), and inhibited the expression of Bcl-2 and cyclin D1. Treatment of mice with resveratrol and TRAIL alone inhibited angiogenesis (as demonstrated by reduced number of blood vessels, and VEGF and VEGFR2 positive cells) and markers of metastasis (MMP-2 and MMP-9). The combination of resveratrol with TRAIL further inhibited number of blood vessels in tumors, and circulating endothelial growth factor receptor 2-positive endothelial cells than single agent alone. Furthermore, resveratrol inhibited the cytoplasmic phosphorylation of FKHRL1 resulting in its enhanced activation as demonstrated by increased DNA binding activity. Conclusions/Significance: These data suggest that resveratrol can enhance the apoptosis-inducing potential of TRAIL by activating FKHRL1 and its target genes. The ability of resveratrol to inhibit tumor growth, metastasis and angiogenesis, and enhance the therapeutic potential of TRAIL suggests that resveratrol alone or in combination with TRAIL can be used for the management of prostate cancer.	[Ganapathy, Suthakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, Div Radiat Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Chen, Qinghe] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Singh, Karan P.] Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Biostat, Ft Worth, TX USA; [Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA	University of Texas System; University of Texas Health San Antonio; Virginia Polytechnic Institute & State University; University of North Texas System; University of North Texas Health Science Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Ganapathy, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, Div Radiat Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	rsrivastava@kumc.edu	Ganapathy, Suthakar/C-1266-2013	Ganapathy, Suthakar/0000-0003-3828-5382				Alex D, 2010, J CELL BIOCHEM, V109, P339, DOI 10.1002/jcb.22405; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Brito PM, 2009, ATHEROSCLEROSIS, V205, P126, DOI 10.1016/j.atherosclerosis.2008.11.011; Brosens JJ, 2009, ADV EXP MED BIOL, V665, P227; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen XF, 2003, CANCER RES, V63, P1059; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Fabbrocini G, 2010, EXP DERMATOL; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fukuoka M, 2003, INT J MOL MED, V12, P503; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang Jingting, 2010, Mol Cell Pharmacol, V2, P1, DOI 10.2174/1874467210902010001; Kalantari H, 2010, BIOFACTORS, V36, P401, DOI 10.1002/biof.100; Kim EJ, 2001, INT J ONCOL, V18, P187; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pal S. K., 2010, EXPERT OPIN INVESTIG; Paul S, 2010, EUR J MED CHEM, V45, P3702, DOI 10.1016/j.ejmech.2010.05.019; Puig O, 2010, ANTIOXID REDOX SIGN; Queen Brannon L, 2010, Curr Aging Sci, V3, P34; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Shankar S, 2005, INT J MOL MED, V16, P1125; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Shankar S, 2004, PROSTATE, V61, P35, DOI 10.1002/pros.20069; Shankar S, 2004, INT J ONCOL, V24, P1133; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shankar Sharmila, 2007, J Mol Signal, V2, P7, DOI 10.1186/1750-2187-2-7; Shankar Sharmila, 2007, J Mol Signal, V2, P10, DOI 10.1186/1750-2187-2-10; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Shankar S, 2007, CARCINOGENESIS, V28, P1277, DOI 10.1093/carcin/bgm024; Shankar S, 2007, INT J ONCOL, V30, P905; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Singh TR, 2003, CANCER RES, V63, P5390; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2010, ANTIOXID REDOX SIGN; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Wu HH, 2010, ONCOGENE, V29, P4330, DOI 10.1038/onc.2010.178; Xie G, 2010, BRIT J PHARMACOL, V159, P689, DOI 10.1111/j.1476-5381.2009.00577.x; Yoshida T, 2004, VITAM HORM, V67, P35; Zykova TA, 2008, MOL CARCINOGEN, V47, P797, DOI 10.1002/mc.20437	71	92	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15627	10.1371/journal.pone.0015627	http://dx.doi.org/10.1371/journal.pone.0015627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209944	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500033
J	Hong, JA; Hu, YF; Li, CM; Jia, ZC; Xia, B; Jin, CW				Hong, Jiang; Hu, Yunfei; Li, Congmin; Jia, Zongchao; Xia, Bin; Jin, Changwen			NMR Characterizations of the Ice Binding Surface of an Antifreeze Protein	PLOS ONE			English	Article							GROUP HYDROGEN-EXCHANGE; CHEMICAL-SHIFTS; SPRUCE BUDWORM; FREEZING RESISTANCE; TEMPERATURE; DYNAMICS; RELAXATION; WATER; RECOGNITION; POLYPEPTIDE	Antifreeze protein (AFP) has a unique function of reducing solution freezing temperature to protect organisms from ice damage. However, its functional mechanism is not well understood. An intriguing question concerning AFP function is how the high selectivity for ice ligand is achieved in the presence of free water of much higher concentration which likely imposes a large kinetic barrier for protein-ice recognition. In this study, we explore this question by investigating the property of the ice binding surface of an antifreeze protein using NMR spectroscopy. An investigation of the temperature gradient of amide proton chemical shift and its correlation with chemical shift deviation from random coil was performed for CfAFP-501, a hyperactive insect AFP. A good correlation between the two parameters was observed for one of the two Thr rows on the ice binding surface. A significant temperature-dependent protein-solvent interaction is found to be the most probable origin for this correlation, which is consistent with a scenario of hydrophobic hydration on the ice binding surface. In accordance with this finding, rotational correlation time analyses combined with relaxation dispersion measurements reveals a weak dimer formation through ice binding surface at room temperature and a population shift of dimer to monomer at low temperature, suggesting hydrophobic effect involved in dimer formation and hence hydrophobic hydration on the ice binding surface of the protein. Our finding of hydrophobic hydration on the ice binding surface provides a test for existing simulation studies. The occurrence of hydrophobic hydration on the ice binding surface is likely unnecessary for enhancing protein-ice binding affinity which is achieved by a tight H-bonding network. Subsequently, we speculate that the hydrophobic hydration occurring on the ice binding surface plays a role in facilitating protein-ice recognition by lowering the kinetic barrier as suggested by some simulation studies.	[Hong, Jiang; Hu, Yunfei; Li, Congmin; Xia, Bin; Jin, Changwen] Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Xia, Bin; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Li, Congmin; Xia, Bin; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Peking University; Peking University; Peking University; Queens University - Canada	Hong, JA (corresponding author), Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China.	changwen@pku.edu.cn		Hong, Jiang/0000-0003-4068-0779	National Natural Science Foundation of China [30325010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30325010) to C.J (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NH, 1997, J AM CHEM SOC, V119, P8547, DOI 10.1021/ja963250h; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Daley ME, 2004, BIOCHEMISTRY-US, V43, P13012, DOI 10.1021/bi0488092; Daley ME, 2004, J BIOMOL NMR, V29, P139, DOI 10.1023/B:JNMR.0000019250.02229.a8; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Li CM, 2005, J BIOMOL NMR, V32, P251, DOI 10.1007/s10858-005-8206-3; Li CM, 2004, J BIOMOL NMR, V30, P101, DOI 10.1023/B:JNMR.0000042949.59771.69; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Madura JD, 2000, J MOL RECOGNIT, V13, P101, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<101::AID-JMR493>3.0.CO;2-9; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; OHNISHI M, 1969, BIOCHEM BIOPH RES CO, V36, P194, DOI 10.1016/0006-291X(69)90314-3; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Smolin N, 2008, J PHYS CHEM B, V112, P6193, DOI 10.1021/jp710546e; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wierzbicki A, 2007, BIOPHYS J, V93, P1442, DOI 10.1529/biophysj.107.105189; Yang C, 2005, PROTEINS, V59, P266, DOI 10.1002/prot.20429; Yang C, 2004, BIOPHYS CHEM, V109, P137, DOI 10.1016/j.bpc.2003.10.024; Yang ZY, 2003, BIOPHYS J, V85, P2599, DOI 10.1016/S0006-3495(03)74682-7; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806	37	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15682	10.1371/journal.pone.0015682	http://dx.doi.org/10.1371/journal.pone.0015682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209943	gold, Green Submitted, Green Published			2022-12-25	WOS:000285792500036
J	Ross, FA; Rafferty, JN; Dallas, ML; Ogunbayo, O; Ikematsu, N; McClafferty, H; Tian, LJ; Widmer, H; Rowe, ICM; Wyatt, CN; Shipston, MJ; Peers, C; Hardie, DG; Evans, AM				Ross, Fiona A.; Rafferty, J. Nicole; Dallas, Mark L.; Ogunbayo, Oluseye; Ikematsu, Naoko; McClafferty, Heather; Tian, Lijun; Widmer, Helene; Rowe, Iain C. M.; Wyatt, Christopher N.; Shipston, Michael J.; Peers, Chris; Hardie, D. Grahame; Evans, A. Mark			Selective Expression in Carotid Body Type I Cells of a Single Splice Variant of the Large Conductance Calcium- and Voltage-activated Potassium Channel Confers Regulation by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CURRENTS; PHOSPHORYLATION; HYPOXIA; INHIBITION; SENSITIVITY; MECHANISM; SUBSTRATE; ENERGY; ALPHA; CA	Inhibition of large conductance calcium-activated potassium (BKCa) channels mediates, in part, oxygen sensing by carotid body type I cells. However, BKCa channels remain active in cells that do not serve to monitor oxygen supply. Using a novel, bacterially derived AMP-activated protein kinase (AMPK), we show that AMPK phosphorylates and inhibits BKCa channels in a splice variant-specific manner. Inclusion of the stress-regulated exon within BKCa channel alpha subunits increased the stoichiometry of phosphorylation by AMPK when compared with channels lacking this exon. Surprisingly, however, the increased phosphorylation conferred by the stress-regulated exon abolished BKCa channel inhibition by AMPK. Point mutation of a single serine (Ser-657) within this exon reduced channel phosphorylation and restored channel inhibition by AMPK. Significantly, RT-PCR showed that rat carotid body type I cells express only the variant of BKCa that lacks the stress-regulated exon, and intracellular dialysis of bacterially expressed AMPK markedly attenuated BKCa currents in these cells. Conditional regulation of BKCa channel splice variants by AMPK may therefore determine the response of carotid body type I cells to hypoxia.	[Rafferty, J. Nicole; Ogunbayo, Oluseye; McClafferty, Heather; Tian, Lijun; Rowe, Iain C. M.; Shipston, Michael J.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Ross, Fiona A.; Ikematsu, Naoko; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Dallas, Mark L.; Peers, Chris] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Widmer, Helene] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Wyatt, Christopher N.] Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA	University of Edinburgh; University of Dundee; University of Leeds; Glasgow Caledonian University; University System of Ohio; Wright State University Dayton	Evans, AM (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk	Shipston, Mike/C-7309-2013; Dallas, Mark L/A-6654-2013; Hardie, David/Z-1979-2019	Shipston, Mike/0000-0001-7544-582X; Peers, Chris/0000-0002-8354-346X; Hardie, Grahame/0000-0002-8373-7379; Rowe, Iain C M/0000-0002-0148-5332; Dallas, Mark/0000-0002-5190-0522	Wellcome Trust [81195, 080982, 082407]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grants 81195 (to A. M. E., C. P., and D. G. H.), 080982 (to D. G. H.), and 082407 (to M. J. S.).	Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Lai GJ, 2002, P NATL ACAD SCI USA, V99, P7722, DOI 10.1073/pnas.112619799; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Lopez-Barneo J, 2008, EUR RESPIR J, V32, P1386, DOI 10.1183/09031936.00056408; McCartney CE, 2005, P NATL ACAD SCI USA, V102, P17870, DOI 10.1073/pnas.0505270102; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; PEERS C, 1991, J PHYSIOL-LONDON, V437, P589, DOI 10.1113/jphysiol.1991.sp018613; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.189779	http://dx.doi.org/10.1074/jbc.M110.189779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21209098	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000289077500006
J	Heijink, DM; Fehrmann, RSN; de Vries, EGE; Koornstra, JJ; Oosterhuis, D; van der Zee, AGJ; Kleibeuker, JH; de Jong, S				Heijink, D. M.; Fehrmann, R. S. N.; de Vries, E. G. E.; Koornstra, J. J.; Oosterhuis, D.; van der Zee, A. G. J.; Kleibeuker, J. H.; de Jong, S.			A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer	ONCOGENE			English	Article						pathways; microarray; gene set enrichment; adenoma; chemoprevention	DEPENDENT KINASE INHIBITOR; GENE-EXPRESSION; PROTEIN-KINASE; EARLY EVENT; DNA-DAMAGE; RB-PATHWAY; CYCLIN D1; COLON; ADENOMAS; DASATINIB	Comparing normal colorectal mucosa and adenomas focusing on deregulated pathways obtains insight into the biological processes of early colorectal carcinogenesis. Publicly available microarray expression data from 26 normal mucosa and 47 adenoma samples were analyzed. Biological pathways enriched in adenomas were identified with Gene Set Enrichment Analysis (GSEA). The analysis revealed 10, 11 and 16 gene sets distinguishing adenomas from normal mucosa according to Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Map Annotator and Pathway Profiler (GenMAPP) and Biocarta databases, respectively. Biological pathways known to be involved in colon carcinogenesis such as cell cycle (P = 0.002) and Wnt signaling (P = 0.007) were enriched in adenomas. In addition, we found enrichment of novel pathways such as retinoblastoma (Rb) pathway (P = 0.002), Src pathway (P = 0.004), folate biosynthesis (P = 0.019) and Hedgehog signaling (P = 0.037) in adenomas. Microarray results for Rb and Src pathway genes were validated by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) on mRNA isolated from an independent set of adenoma and normal colon samples. A high correlation between microarray data and qRT-PCR expression data was found. The relevance of targeting of identified pathways was shown using the Rb pathway inhibitors roscovitine and PD-0332991 and the Src pathway inhibitor dasatinib. All inhibitors used induced cell growth reduction in adenoma cells. This study shows a bioinformatical and functional approach leading to potentially new options for chemoprevention of colorectal cancer. Oncogene (2011) 30, 2026-2036; doi:10.1038/onc.2010.578; published online 10 January 2011	[Heijink, D. M.; Fehrmann, R. S. N.; de Vries, E. G. E.; Oosterhuis, D.; de Jong, S.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 GZ Groningen, Netherlands; [Heijink, D. M.; Koornstra, J. J.; Kleibeuker, J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 GZ Groningen, Netherlands; [Fehrmann, R. S. N.; van der Zee, A. G. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, NL-9713 GZ Groningen, Netherlands; [Fehrmann, R. S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	de Vries, EGE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	e.g.e.de.vries@int.umcg.nl	Fehrmann, Rudolf/E-2551-2011; Pillay, Nischalan/F-9536-2012	Fehrmann, Rudolf/0000-0002-7516-315X; de Vries, Elisabeth/0000-0002-8949-7425	Dutch Cancer Society [RUG 2005-3361]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by Grant RUG 2005-3361 from the Dutch Cancer Society.	Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Arber N, 2008, GASTROENTEROLOGY, V134, P1224, DOI 10.1053/j.gastro.2008.02.012; Arhel NJ, 2003, INT J CANCER, V106, P364, DOI 10.1002/ijc.11257; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Bartkova J, 2001, GASTROENTEROLOGY, V120, P1680, DOI 10.1053/gast.2001.24880; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Boquoi A, 2009, CANCER PREV RES, V2, P800, DOI 10.1158/1940-6207.CAPR-09-0053; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; Chen R, 2009, BLOOD, V113, P4637, DOI 10.1182/blood-2008-12-190256; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Crijns APG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-232; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du W, 2009, CURR DRUG TARGETS, V10, P581, DOI 10.2174/138945009788680392; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einspahr JG, 2006, CANCER EPIDEM BIOMAR, V15, P1443, DOI 10.1158/1055-9965.EPI-06-0144; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Hao XP, 1998, VIRCHOWS ARCH, V433, P523, DOI 10.1007/s004280050284; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Imazeki F, 1996, GASTROENTEROLOGY, V110, P362, DOI 10.1053/gast.1996.v110.pm8566581; Jalving M, 2006, CLIN CANCER RES, V12, P4350, DOI 10.1158/1078-0432.CCR-05-2487; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kantarjian H, 2007, BLOOD, V109, P5143, DOI 10.1182/blood-2006-11-056028; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Koornstra JJ, 2004, HISTOPATHOLOGY, V44, P9, DOI 10.1111/j.1365-2559.2004.01739.x; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Kwong LN, 2008, ONCOGENE, V27, P1013, DOI 10.1038/sj.onc.1210708; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; RENCHER A, 1998, MUTIVARIATE STAT INT; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; van Geelen CMM, 2003, BRIT J CANCER, V89, P363, DOI 10.1038/sj.bjc.6601065; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wesierska-Gadek J, 2011, J CELL PHYSIOL, V226, P341, DOI 10.1002/jcp.22426; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhao P, 2006, WORLD J GASTROENTERO, V12, P6391, DOI 10.3748/wjg.v12.i39.6391	62	18	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2026	2036		10.1038/onc.2010.578	http://dx.doi.org/10.1038/onc.2010.578			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21217777				2022-12-25	WOS:000289977400006
J	Rousselet, E; Benjannet, S; Marcinkiewicz, E; Asselin, MC; Lazure, C; Seidah, NG				Rousselet, Estelle; Benjannet, Suzanne; Marcinkiewicz, Edwidge; Asselin, Marie-Claude; Lazure, Claude; Seidah, Nabil G.			Proprotein Convertase PC7 Enhances the Activation of the EGF Receptor Pathway through Processing of the EGF Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; IN-VITRO; SERINE-PROTEASE; POSTTRANSLATIONAL MODIFICATIONS; TYROSINE PHOSPHORYLATION; PROHORMONE CONVERTASES; SUBSTRATE-SPECIFICITY; POTENT INHIBITORS; MESSENGER-RNA; CELL-SURFACE	Although the processing profile of the membrane-bound epidermal growth factor precursor (pro-EGF) is tissue-specific, it has not been investigated at the cellular level nor have the cognate proteinases been defined. Among the proprotein convertases (PCs), only the membrane-bound PC7, the most ancient and conserved basic amino acid-specific PC family member, induces the processing of pro-EGF into an similar to 115-kDa transmembrane form (EGF-115) at an unusual VHPR290 down arrow A motif. Because site-directed mutagenesis revealed that Arg(290) is not critical, the generation of EGF-115 by PC7 is likely indirect. This was confirmed by testing a wide range of protease inhibitors, which revealed that the production of EGF-115 is most probably achieved via the activation by PC7 of a latent serine and/or cysteine protease(s). EGF-115 is more abundant at the cell surface than pro-EGF and is associated with a stronger EGF receptor (EGFR) activation, as evidenced by higher levels of phosphorylated ERK1/2. This suggests that the generation of EGF-115 represents a regulatory mechanism of juxtacrine EGFR activation. Thus, PC7 is distinct from the other PCs in its ability to enhance the activation of the cell surface EGFR.	[Rousselet, Estelle; Benjannet, Suzanne; Marcinkiewicz, Edwidge; Asselin, Marie-Claude; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Lazure, Claude] Clin Res Inst Montreal, Lab Neuropeptide Struct & Metab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, and a Canada Chair Grant 216684.	Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BREYER JA, 1990, J BIOL CHEM, V265, P16564; Canaff L, 1999, ENDOCRINOLOGY, V140, P3633, DOI 10.1210/en.140.8.3633; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; FREY P, 1979, P NATL ACAD SCI USA, V76, P6294, DOI 10.1073/pnas.76.12.6294; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Geraghty P, 2008, THORAX, V63, P621, DOI 10.1136/thx.2007.088559; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Iwashita K, 2003, J AM SOC NEPHROL, V14, P11, DOI 10.1097/01.ASN.0000043900.39397.48; Janciauskiene S, 2008, AM J RESP CELL MOL, V39, P631, DOI 10.1165/rcmb.2008-0015RC; JORGENSEN PE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P284, DOI 10.1016/0304-4165(91)90165-D; JORGENSEN PE, 1994, GROWTH FACTORS, V11, P113, DOI 10.3109/08977199409001053; Journe F, 1997, BBA-MOL CELL RES, V1357, P18, DOI 10.1016/S0167-4889(97)00012-8; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KING ICL, 1986, BIOCHEM BIOPH RES CO, V140, P837, DOI 10.1016/0006-291X(86)90710-2; Kwan RWP, 1999, INT J ONCOL, V15, P281; Le Gall SM, 2004, REGUL PEPTIDES, V122, P119, DOI 10.1016/j.regpep.2004.06.008; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0; Marechal H, 1999, AM J PHYSIOL-CELL PH, V276, pC734, DOI 10.1152/ajpcell.1999.276.3.C734; Meerabux J, 1996, CANCER RES, V56, P448; MENTLEIN R, 1994, J NEUROCHEM, V62, P27; Mishima Y, 2007, CANCER SCI, V98, P364, DOI 10.1111/j.1349-7006.2007.00393.x; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; RAAB G, 1994, BIOCHEM BIOPH RES CO, V204, P592, DOI 10.1006/bbrc.1994.2500; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; SCOTT J, 1985, J CELL SCI, P19; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Valcarce C, 1999, EUR J BIOCHEM, V260, P200, DOI 10.1046/j.1432-1327.1999.00156.x; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Wouters S, 1999, FEBS LETT, V456, P97, DOI 10.1016/S0014-5793(99)00938-2; Zelvyte I, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-7; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	73	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9185	9195		10.1074/jbc.M110.189936	http://dx.doi.org/10.1074/jbc.M110.189936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209099	Green Published, hybrid			2022-12-25	WOS:000288247700049
J	Sun, XL; Wu, YL; Chen, B; Zhang, ZH; Zhou, WH; Tong, YG; Yuan, JY; Xia, K; Gronemeyer, H; Flavell, RA; Song, WH				Sun, Xiulian; Wu, Yili; Chen, Bin; Zhang, Zhuohua; Zhou, Weihui; Tong, Yigang; Yuan, Junying; Xia, Kun; Gronemeyer, Hinrich; Flavell, Richard A.; Song, Weihong			Regulator of Calcineurin 1 (RCAN1) Facilitates Neuronal Apoptosis through Caspase-3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; ALZHEIMERS-DISEASE; DOWN-SYNDROME; CELL-DEATH; PRECURSOR PROTEIN; DSCR1 ADAPT78; TRANSCRIPTIONAL REGULATION; INHIBITS CALCINEURIN; STRIATED-MUSCLES; OXIDATIVE STRESS	Individuals with Down syndrome (DS) will inevitably develop Alzheimer disease (AD) neuropathology sometime after middle age, which may be attributable to genes triplicated in individuals with DS. The characteristics of AD neuropathology include neuritic plaques, neurofibrillary tangles, and neuronal loss in various brain regions. The mechanism underlying neurodegeneration in AD and DS remains elusive. Regulator of calcineurin 1 (RCAN1) has been implicated in the pathogenesis of DS. Our data show that RCAN1 expression is elevated in the cortex of DS and AD patients. RCAN1 expression can be activated by the stress hormone dexamethasone. A functional glucocorticoid response element was identified in the RCAN1 isoform 1 (RCAN1-1) promoter region, which is able to mediate the up-regulation of RCAN1 expression. Here we show that overexpression of RCAN1-1 in primary neurons activates caspase-9 and caspase-3 and subsequently induces neuronal apoptosis. Furthermore, we found that the neurotoxicity of RCAN1-1 is inhibited by knock-out of caspase-3 in caspase-3(-/-) neurons. Our study provides a novel mechanism by which RCAN1 functions as a mediator of stress- and A beta-induced neuronal death, and overexpression of RCAN1 due to an extra copy of the RCAN1 gene on chromosome 21 contributes to AD pathogenesis in DS.	[Sun, Xiulian; Wu, Yili; Chen, Bin; Zhou, Weihui; Tong, Yigang; Song, Weihong] Univ British Columbia, Townsend Family Labs, Dept Psychiat, Brain Res Ctr,Grad Program Neurosci, Vancouver, BC V6T 1Z3, Canada; [Sun, Xiulian] Shandong Univ, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Zhang, Zhuohua] Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; [Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Xia, Kun] Cent S Univ, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; [Gronemeyer, Hinrich] CU Strasbourg, Dept Cell Biol & Signal Transduct, Inst Genet & Biol Mol & Cellulaire, CNRS INSERM ULP, F-67404 Illkirch Graffenstaden, France; [Flavell, Richard A.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of British Columbia; Shandong University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Central South University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yale University	Song, WH (corresponding author), 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@exchange.ubc.ca	Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/H-7002-2016; Song, Weihong/O-7623-2017; Gronemeyer, Hinrich/AAH-5575-2019; XIA, KUN/AAO-3525-2020	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Song, Weihong/0000-0001-9928-889X; Gronemeyer, Hinrich/0000-0001-9454-2449; wu, yili/0000-0002-2369-6974; Tong, Yigang/0000-0002-8503-8045	Canadian Institutes of Health Research; Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research; National Natural Science Foundation of China [30528015]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Canadian Institutes of Health Research, the Jack Brown and Family Alzheimer's Research Foundation, the Michael Smith Foundation for Health Research, and the National Natural Science Foundation of China (Distinguished Young Scholars (Oversea) Fund Grant 30528015) (to W. S.).	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Alzheimer A, 1906, NEUROLOGISCHES CENTR, V23, P1129; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; Down J.L., 1866, OBSERVATION ETHNIC C, DOI DOI 10.1038/HDY.1966.69; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Hampton T, 2005, JAMA-J AM MED ASSOC, V293, P284, DOI 10.1001/jama.293.3.284; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; JACOBS PA, 1959, LANCET, V1, P710; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kang SJ, 2003, J NEUROSCI, V23, P5455; Kawata M, 1998, J STEROID BIOCHEM, V65, P273, DOI 10.1016/S0960-0760(98)00026-0; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Kluetzman KS, 2005, BIOCHEM BIOPH RES CO, V337, P595, DOI 10.1016/j.bbrc.2005.09.069; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Newcomer JW, 1998, PSYCHONEUROENDOCRINO, V23, P65, DOI 10.1016/S0306-4530(97)00081-4; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Pomara Nunzio, 2003, Psychopharmacol Bull, V37, P120; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Sousa N, 1999, NEUROSCIENCE, V89, P1079, DOI 10.1016/S0306-4522(98)00311-X; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Su JH, 1997, J NEUROPATH EXP NEUR, V56, P86, DOI 10.1097/00005072-199701000-00009; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	84	89	97	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9049	9062		10.1074/jbc.M110.177519	http://dx.doi.org/10.1074/jbc.M110.177519			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216952	Green Published, hybrid			2022-12-25	WOS:000288247700036
J	Zhou, XH; Keller, R; Volkmer, R; Krauss, N; Scheerer, P; Hunke, S				Zhou, Xiaohui; Keller, Rebecca; Volkmer, Rudolf; Krauss, Norbert; Scheerer, Patrick; Hunke, Sabine			Structural Basis for Two-component System Inhibition and Pilus Sensing by the Auxiliary CpxP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE STRESS-RESPONSE; COMPLETE GENOME SEQUENCE; SIGNAL-TRANSDUCTION; CHAPERONE FUNCTION; MODEL; CRYSTALLOGRAPHY; BIOGENESIS; EXPRESSION; SUBSTRATE; PATHWAY	Bacteria are equipped with two-component systems to cope with environmental changes, and auxiliary proteins provide response to additional stimuli. The Cpx two-component system is the global modulator of cell envelope stress in Gram-negative bacteria that integrates very different signals and consists of the kinase CpxA, the regulator CpxR, and the dual function auxiliary protein CpxP. CpxP both inhibits activation of CpxA and is indispensable for the quality control system of P pili that are crucial for uropathogenic Escherichia coli during kidney colonization. How these two essential biological functions of CpxP are linked is not known. Here, we report the crystal structure of CpxP at 1.45 angstrom resolution with two monomers being interdigitated like "left hands" forming a cap-shaped dimer. Our combined structural and functional studies suggest that CpxP inhibits the kinase CpxA through direct interaction between its concave polar surface and the negatively charged sensor domain on CpxA. Moreover, an extended hydrophobic cleft on the convex surface suggests a potent substrate recognition site for misfolded pilus subunits. Altogether, the structural details of CpxP provide a first insight how a periplasmic two-component system inhibitor blocks its cognate kinase and is released from it.	[Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Zhou, Xiaohui; Keller, Rebecca; Hunke, Sabine] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Scheerer, Patrick] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany	University of London; Queen Mary University London; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krauss, N (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	n.krauss@qmul.ac.uk; patrick.scheerer@charite.de; sabine.hunke@hu-berlin.de	Hunke, Sabine/B-7169-2011	Volkmer, Rudolf/0000-0003-4710-1143; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft [Hu1011/1-3]; Yousef Jameel Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Yousef Jameel Foundation(American University Cairo)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Hu1011/1-3) and the Yousef Jameel Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunke S, 2003, MOL MICROBIOL, V50, P1579, DOI 10.1046/j.1365-2958.2003.03785.x; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; Keller RF, 2009, RES MICROBIOL, V160, P396, DOI 10.1016/j.resmic.2009.07.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kwon E, 2010, PROTEIN SCI, V19, P2252, DOI 10.1002/pro.489; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller JH, 1992, SHORT COURSE BACTERI, V2; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; SABLONNIERE B, 1987, J CHROMATOGR, V403, P183, DOI 10.1016/S0021-9673(00)96352-0; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; SWIDERSKY UE, 1992, EUR J BIOCHEM, V207, P803, DOI 10.1111/j.1432-1033.1992.tb17111.x; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; van Stelten J, 2009, SCIENCE, V325, P753, DOI 10.1126/science.1172221; VOLKMERENGERT R, 1994, LETT PEPT SCI, V1, P243; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T	61	53	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9805	9814		10.1074/jbc.M110.194092	http://dx.doi.org/10.1074/jbc.M110.194092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239493	Green Published, hybrid			2022-12-25	WOS:000288247700103
J	Schuijt, TJ; Narasimhan, S; Daffre, S; DePonte, K; Hovius, JWR; van't Veer, C; van der Poll, T; Bakhtiari, K; Meijers, JCM; Boder, ET; van Dam, AP; Fikrig, E				Schuijt, Tim J.; Narasimhan, Sukanya; Daffre, Sirlei; DePonte, Kathleen; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom; Bakhtiari, Kamran; Meijers, Joost C. M.; Boder, Eric T.; van Dam, Alje P.; Fikrig, Erol			Identification and Characterization of Ixodes scapularis Antigens That Elicit Tick Immunity Using Yeast Surface Display	PLOS ONE			English	Article							SALIVARY PROTEIN; BORRELIA-BURGDORFERI; RICINUS L; RESISTANCE; COMPLEMENT; SALP15; SERUM; TRANSMISSION; INFESTATION; ANTIBODIES	Repeated exposure of rabbits and other animals to ticks results in acquired resistance or immunity to subsequent tick bites and is partially elicited by antibodies directed against tick antigens. In this study we demonstrate the utility of a yeast surface display approach to identify tick salivary antigens that react with tick-immune serum. We constructed an Ixodes scapularis nymphal salivary gland yeast surface display library and screened the library with nymph-immune rabbit sera and identified five salivary antigens. Four of these proteins, designated P8, P19, P23 and P32, had a predicted signal sequence. We generated recombinant (r) P8, P19 and P23 in a Drosophila expression system for functional and immunization studies. rP8 showed anti-complement activity and rP23 demonstrated anti-coagulant activity. Ixodes scapularis feeding was significantly impaired when nymphs were fed on rabbits immunized with a cocktail of rP8, rP19 and rP23, a hall mark of tick-immunity. These studies also suggest that these antigens may serve as potential vaccine candidates to thwart tick feeding.	[Schuijt, Tim J.; Narasimhan, Sukanya; Daffre, Sirlei; DePonte, Kathleen; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Schuijt, Tim J.; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Bakhtiari, Kamran; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schuijt, Tim J.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands; [Daffre, Sirlei] Univ Sao Paulo, Dept Parasitol, Sao Paulo, Brazil; [Boder, Eric T.] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN USA; [van Dam, Alje P.] Onze Lieve Vrouw Hosp, Dept Med Microbiol, Amsterdam, Netherlands	Yale University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade de Sao Paulo; University of Tennessee System; University of Tennessee Knoxville; Onze Lieve Vrouwe Gasthuis Hospital	Schuijt, TJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	T.J.Schuijt@amc.uva.nl	Meijers, J.C.M./S-5981-2019; Boder, Eric T./E-9635-2015; Schuijt, Tim J/S-6440-2017; Hovius, Joppe/GZL-6894-2022; Daffre, Sirlei/M-4233-2013	Meijers, J.C.M./0000-0002-4198-6780; Boder, Eric T./0000-0003-4095-5680; Schuijt, Tim J/0000-0002-4799-225X; Hovius, Joppe/0000-0003-0066-2437; Daffre, Sirlei/0000-0002-9966-0433; Van Dam, Alje/0000-0003-3967-550X	National Institutes of Health [41440, 49200, 32947]; OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam); National Institute of Allergy and Infectious Diseases/NIH; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam); National Institute of Allergy and Infectious Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants 41440, 49200 and 32947 from the National Institutes of Health (E. F.). E. F. is an Investigator of the Howard Hughes Medical Institute. T.J.S. is supported by a grant from the OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam) research fund, and S.N. is supported by an Exploratory Research grant from the National Institute of Allergy and Infectious Diseases/NIH. S. D. is supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P92, DOI 10.1017/CBO9780511551802.005; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; ASKENASE PW, 1982, IMMUNOLOGY, V45, P501; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; BELL JF, 1979, AM J TROP MED HYG, V28, P876, DOI 10.4269/ajtmh.1979.28.876; Bidlingmaier S, 2006, MOL CELL PROTEOMICS, V5, P533, DOI 10.1074/mcp.M500309-MCP200; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BROSSARD M, 1979, EXPERIENTIA, V35, P1395, DOI 10.1007/BF01964030; BROSSARD M, 1982, PARASITOLOGY, V85, P583, DOI 10.1017/S0031182000056365; Burke GS, 2005, EMERG INFECT DIS, V11, P36; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Decrem Y, 2008, INT J PARASITOL, V38, P549, DOI 10.1016/j.ijpara.2007.09.003; Decrem Y, 2009, J EXP MED, V206, P2381, DOI 10.1084/jem.20091007; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gao JL, 2009, VACCINE, V27, P483, DOI 10.1016/j.vaccine.2008.10.067; Goodman J., 2005, TICK BORNE DIS HUMAN; Hannier S, 2004, IMMUNOLOGY, V113, P401, DOI 10.1111/j.1365-2567.2004.01975.x; HOFFMANN A, 1991, PHARMAZIE, V46, P209; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Hu RJ, 2000, J MED ENTOMOL, V37, P198, DOI 10.1603/0022-2585-37.1.198; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Prevot PP, 2006, J BIOL CHEM, V281, P26361, DOI 10.1074/jbc.M604197200; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; SCHUIJT TJ, 2010, TRENDS PARASITOL; SHAPIRO SZ, 1987, J MED ENTOMOL, V24, P147, DOI 10.1093/jmedent/24.2.147; TRAGER WILLIAM, 1939, JOUR PARASITOL, V25, P57, DOI 10.2307/3272160; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Vancova I, 2010, VET PARASITOL, V167, P274, DOI 10.1016/j.vetpar.2009.09.029; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Wadle A, 2005, INT J CANCER, V117, P104, DOI 10.1002/ijc.21147; Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019; Walsh C., 2006, POSTTRANSLATIONAL MO; WANG H, 1994, PARASITOLOGY, V109, P525, DOI 10.1017/S0031182000080781; Wikel SK, 1997, INFECT IMMUN, V65, P335, DOI 10.1128/IAI.65.1.335-338.1997; You M, 2001, INSECT BIOCHEM MOLEC, V32, P67, DOI 10.1016/S0965-1748(01)00081-9	51	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15926	10.1371/journal.pone.0015926	http://dx.doi.org/10.1371/journal.pone.0015926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246036	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511200025
J	Askoxylakis, V; Garcia-Boy, R; Rana, S; Kramer, S; Hebling, U; Mier, W; Altmann, A; Markert, A; Debus, J; Haberkorn, U				Askoxylakis, Vasileios; Garcia-Boy, Regine; Rana, Shoaib; Kraemer, Susanne; Hebling, Ulrike; Mier, Walter; Altmann, Annette; Markert, Annette; Debus, Juergen; Haberkorn, Uwe			A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; TUMOR HYPOXIA; POOR-PROGNOSIS; LUNG-CANCER; NECK-CANCER; EXPRESSION; MARKER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; THERAPEUTICS	Carbonic anhydrase IX (CAIX) is a transmembrane enzyme found to be overexpressed in various tumors and associated with tumor hypoxia. Ligands binding this target may be used to visualize hypoxia, tumor manifestation or treat tumors by endoradiotherapy. Methods: Phage display was performed with a 12 amino acid phage display library by panning against a recombinant extracellular domain of human carbonic anhydrase IX. The identified peptide CaIX-P1 was chemically synthesized and tested in vitro on various cell lines and in vivo in Balb/c nu/nu mice carrying subcutaneously transplanted tumors. Binding, kinetic and competition studies were performed on the CAIX positive human renal cell carcinoma cell line SKRC 52, the CAIX negative human renal cell carcinoma cell line CaKi 2, the human colorectal carcinoma cell line HCT 116 and on human umbilical vein endothelial cells (HUVEC). Organ distribution studies were carried out in mice, carrying SKRC 52 tumors. RNA expression of CAIX in HCT 116 and HUVEC cells was investigated by quantitative real time PCR. Results: In vitro binding experiments of (125)I-labeled-CaIX-P1 revealed an increased uptake of the radioligand in the CAIX positive renal cell carcinoma cell line SKRC 52. Binding of the radioligand in the colorectal carcinoma cell line HCT 116 increased with increasing cell density and correlated with the mRNA expression of CAIX. Radioligand uptake was inhibited up to 90% by the unlabeled CaIX-P1 peptide, but not by the negative control peptide octreotide at the same concentration. No binding was demonstrated in CAIX negative CaKi 2 and HUVEC cells. Organ distribution studies revealed a higher accumulation in SKRC 52 tumors than in heart, spleen, liver, muscle, intestinum and brain, but a lower uptake compared to blood and kidney. Conclusions: These data indicate that CaIX-P1 is a promising candidate for the development of new ligands targeting human carbonic anhydrase IX.	[Askoxylakis, Vasileios; Debus, Juergen] Univ Heidelberg, Dept Radiooncol & Radiat Therapy, Heidelberg, Germany; [Garcia-Boy, Regine; Rana, Shoaib; Kraemer, Susanne; Hebling, Ulrike; Mier, Walter; Haberkorn, Uwe] Univ Heidelberg, Dept Nucl Med, Heidelberg, Germany; [Altmann, Annette; Markert, Annette; Haberkorn, Uwe] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Askoxylakis, V (corresponding author), Univ Heidelberg, Dept Radiooncol & Radiat Therapy, Heidelberg, Germany.	vasileios.askoxylakis@med.uni-heidelberg.de			Tumorzentrum Heidelberg/Mannheim; Medical Faculty at the University of Heidelberg	Tumorzentrum Heidelberg/Mannheim; Medical Faculty at the University of Heidelberg	This project has been financially supported by the Tumorzentrum Heidelberg/Mannheim. Vasileios Askoxylakis received support from the PostDoc fellowship of the Medical Faculty at the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JKJ, 2009, BRIT J CANCER, V101, P645, DOI 10.1038/sj.bjc.6605200; Askoxylakis V, 2005, CLIN CANCER RES, V11, P6705, DOI 10.1158/1078-0432.CCR-05-0432; Askoxylakis V, 2006, J NUCL MED, V47, P981; BAKKER WH, 1990, J NUCL MED, V31, P1501; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363; Brouwers AH, 2005, CLIN CANCER RES, V11, p7178S, DOI 10.1158/1078-0432.CCR-1004-0010; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Crim JW, 2002, PEPTIDES, V23, P2045, DOI 10.1016/S0196-9781(02)00192-4; Demir R, 2009, PATHOL ONCOL RES, V15, P417, DOI 10.1007/s12253-008-9140-y; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hulikova A, 2009, FEBS LETT, V583, P3563, DOI 10.1016/j.febslet.2009.10.060; Jubb AM, 2004, J CLIN PATHOL, V57, P504, DOI 10.1136/jcp.2003.012963; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Lee SH, 2005, BIOCONJUGATE CHEM, V16, P377, DOI 10.1021/bc049735+; Li GR, 2001, CLIN CANCER RES, V7, P89; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; Mees G, 2009, EUR J NUCL MED MOL I, V36, P1674, DOI 10.1007/s00259-009-1195-9; Mier W, 2007, J NUCL MED, V48, P1545, DOI 10.2967/jnumed.106.036707; Niemela AM, 2007, CANCER EPIDEM BIOMAR, V16, P1760, DOI 10.1158/1055-9965.EPI-07-0080; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Rofstad EK, 2000, BRIT J CANCER, V83, P354, DOI 10.1054/bjoc.2000.1266; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Sun X, 2006, APPL RADIAT ISOTOPES, V64, P645, DOI 10.1016/j.apradiso.2005.12.019; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Thorwarth D, 2006, RADIOTHER ONCOL, V80, P151, DOI 10.1016/j.radonc.2006.07.033; Winum JY, 2008, MED RES REV, V28, P445, DOI 10.1002/med.20112; Wykoff CC, 2000, CANCER RES, V60, P7075; Zimny M, 2006, EUR J NUCL MED MOL I, V33, P1426, DOI 10.1007/s00259-006-0175-6	35	28	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15962	10.1371/journal.pone.0015962	http://dx.doi.org/10.1371/journal.pone.0015962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209841	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900053
J	Heinemann, LV; Rahm, B; Kaiser, J; Gaese, BH; Altmann, CF				Heinemann, Linda V.; Rahm, Benjamin; Kaiser, Jochen; Gaese, Bernhard H.; Altmann, Christian F.			Repetition Enhancement for Frequency-Modulated but Not Unmodulated Sounds: A Human MEG Study	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; FORMANT TRANSITIONS; NORMAL READERS; SENSITIVITY; SELECTIVITY; DIRECTION; STIMULI; NEURONS; ADAPTATION; RESPONSES	Background: Decoding of frequency-modulated (FM) sounds is essential for phoneme identification. This study investigates selectivity to FM direction in the human auditory system. Methodology/Principal Findings: Magnetoencephalography was recorded in 10 adults during a two-tone adaptation paradigm with a 200-ms interstimulus-interval. Stimuli were pairs of either same or different frequency modulation direction. To control that FM repetition effects cannot be accounted for by their on-and offset properties, we additionally assessed responses to pairs of unmodulated tones with either same or different frequency composition. For the FM sweeps, N1m event-related magnetic field components were found at 103 and 130 ms after onset of the first (S1) and second stimulus (S2), respectively. This was followed by a sustained component starting at about 200 ms after S2. The sustained response was significantly stronger for stimulation with the same compared to different FM direction. This effect was not observed for the non-modulated control stimuli. Conclusions/Significance: Low-level processing of FM sounds was characterized by repetition enhancement to stimulus pairs with same versus different FM directions. This effect was FM-specific; it did not occur for unmodulated tones. The present findings may reflect specific interactions between frequency separation and temporal distance in the processing of consecutive FM sweeps.	[Heinemann, Linda V.; Rahm, Benjamin; Kaiser, Jochen; Altmann, Christian F.] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany; [Rahm, Benjamin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mainz, Germany; [Gaese, Bernhard H.] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany; [Altmann, Christian F.] Kyoto Univ, Grad Sch Med, Int Young Scientists Career Dev Org, Kyoto, Japan; [Altmann, Christian F.] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan	Goethe University Frankfurt; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Kyoto University; Kyoto University	Heinemann, LV (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany.	heinemann@med.uni-frankfurt.de	Kaiser, Jochen/T-9184-2017	Kaiser, Jochen/0000-0001-6740-5000; Gaese, Bernhard/0000-0002-6410-2626; Altmann, Christian/0000-0003-0958-1238	Deutsche Forschungsgemeinschaft (DFG) [AL 1074/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Christian Friedrich Altmann and Jochen Kaiser were supported by Deutsche Forschungsgemeinschaft (DFG AL 1074/2-1), http://www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Behne N, 2005, J NEUROPHYSIOL, V93, P414, DOI 10.1152/jn.00568.2004; Brimijoin WO, 2005, HEARING RES, V210, P63, DOI 10.1016/j.heares.2005.07.005; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 2003, NEURAL REPRESENTATIO; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Cheung SW, 2005, J NEUROSCI, V25, P2490, DOI 10.1523/JNEUROSCI.5289-04.2005; DAVIS H, 1966, ELECTROEN CLIN NEURO, V21, P105, DOI 10.1016/0013-4694(66)90118-0; Doehrmann O, 2008, NEUROPSYCHOLOGIA, V46, P2776, DOI 10.1016/j.neuropsychologia.2008.05.011; Efron B., 1994, INTRO BOOTSTRAP; GARDNER RB, 1979, J ACOUST SOC AM, V66, P704, DOI 10.1121/1.383220; Godey B, 2005, J NEUROPHYSIOL, V94, P1299, DOI 10.1152/jn.00950.2004; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; HARI R, 1982, ELECTROEN CLIN NEURO, V54, pP43; HEIL P, 1992, HEARING RES, V63, P108, DOI 10.1016/0378-5955(92)90080-7; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LINDBLOM BE, 1967, J ACOUST SOC AM, V42, P830, DOI 10.1121/1.1910655; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; LOVELESS NE, 1993, BIOL PSYCHOL, V35, P1, DOI 10.1016/0301-0511(93)90088-P; Luo H, 2007, HEARING RES, V224, P75, DOI 10.1016/j.heares.2006.11.007; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; MOODY DB, 1984, J ACOUST SOC AM, V76, P1076, DOI 10.1121/1.391399; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; PARDO PJ, 1993, NEUROSCI LETT, V159, P43, DOI 10.1016/0304-3940(93)90794-L; Poeppel D, 2004, NEUROPSYCHOLOGIA, V42, P183, DOI 10.1016/j.neuropsychologia.2003.07.010; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Solis MM, 1997, J NEUROSCI, V17, P6447; STEVENS KN, 1974, J ACOUST SOC AM, V55, P653, DOI 10.1121/1.1914578; Stoodley CJ, 2006, BRAIN RES, V1121, P190, DOI 10.1016/j.brainres.2006.08.095; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; Wang AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003929; Weisz N, 2004, HEARING RES, V191, P49, DOI 10.1016/j.heares.2004.01.012; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Witton C, 2002, J COGNITIVE NEUROSCI, V14, P866, DOI 10.1162/089892902760191090; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15548	10.1371/journal.pone.0015548	http://dx.doi.org/10.1371/journal.pone.0015548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217825	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900021
J	Hu, LL; Niu, S; Huang, T; Wang, K; Shi, XH; Cai, YD				Hu, Le-Le; Niu, Shen; Huang, Tao; Wang, Kai; Shi, Xiao-He; Cai, Yu-Dong			Prediction and Analysis of Protein Hydroxyproline and Hydroxylysine	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; AMINO-ACID-COMPOSITION; CORE-SPECIFIC LECTIN; INTRINSIC DISORDER; POSTTRANSLATIONAL MODIFICATIONS; FEATURE-SELECTION; PROLINE HYDROXYLATION; LYSINE HYDROXYLATION; CROSS-LINKING; IDENTIFICATION	Background: Hydroxylation is an important post-translational modification and closely related to various diseases. Besides the biotechnology experiments, in silico prediction methods are alternative ways to identify the potential hydroxylation sites. Methodology/Principal Findings: In this study, we developed a novel sequence-based method for identifying the two main types of hydroxylation sites - hydroxyproline and hydroxylysine. First, feature selection was made on three kinds of features consisting of amino acid indices (AAindex) which includes various physicochemical properties and biochemical properties of amino acids, Position-Specific Scoring Matrices (PSSM) which represent evolution information of amino acids and structural disorder of amino acids in the sliding window with length of 13 amino acids, then the prediction model were built using incremental feature selection method. As a result, the prediction accuracies are 76.0% and 82.1%, evaluated by jackknife cross-validation on the hydroxyproline dataset and hydroxylysine dataset, respectively. Feature analysis suggested that physicochemical properties and biochemical properties and evolution information of amino acids contribute much to the identification of the protein hydroxylation sites, while structural disorder had little relation to protein hydroxylation. It was also found that the amino acid adjacent to the hydroxylation site tends to exert more influence than other sites on hydroxylation determination. Conclusions/Significance: These findings may provide useful insights for exploiting the mechanisms of hydroxylation.	[Hu, Le-Le; Wang, Kai; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Niu, Shen; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Shi, Xiao-He] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiao-He] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		WANG, kai/0000-0002-6194-0480; cai, yudong/0000-0001-5664-7979				Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auer M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S1; Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A; BAXEVANIS AD, 2006, CURR PROTOC BIOINFOR, pCH1; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; CHOPRA RK, 1982, P NATL ACAD SCI-BIOL, V79, P7180, DOI 10.1073/pnas.79.23.7180; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; COLLEY KJ, 1987, J BIOL CHEM, V262, P10296; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KIVIRIKK.KI, 1967, P NATL ACAD SCI USA, V57, P782, DOI 10.1073/pnas.57.3.782; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Ostell J M, 2001, Methods Biochem Anal, V43, P19; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Salnikow K, 2005, ENVIRON HEALTH PERSP, V113, P577, DOI 10.1289/ehp.7605; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shi MG, 2008, PROTEIN PEPTIDE LETT, V15, P692, DOI 10.2174/092986608785133627; Sigalov AB, 2010, MOL BIOSYST, V6, P451, DOI 10.1039/b916030m; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wu G, 2008, PROTEIN PEPTIDE LETT, V15, P144, DOI 10.2174/092986608783489571; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yang ZR, 2009, J COMPUT BIOL, V16, P691, DOI 10.1089/cmb.2008.0167; Zhou J, 2007, BIOINFORMATICS, V23, P589, DOI 10.1093/bioinformatics/btl680	61	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15917	10.1371/journal.pone.0015917	http://dx.doi.org/10.1371/journal.pone.0015917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209839	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900050
J	Jensen, VL; Simonsen, KT; Lee, YH; Park, D; Riddle, DL				Jensen, Victor L.; Simonsen, Karina T.; Lee, Yu-Hui; Park, Donha; Riddle, Donald L.			RNAi Screen of DAF-16/FOXO Target Genes in C. elegans Links Pathogenesis and Dauer Formation	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; LIFE-SPAN; LONGEVITY; RECEPTOR; LARVA; IDENTIFICATION; EXPRESSION; BACTERIA; DIAPAUSE	The DAF-16/FOXO transcription factor is the major downstream output of the insulin/IGF1R signaling pathway controlling C. elegans dauer larva development and aging. To identify novel downstream genes affecting dauer formation, we used RNAi to screen candidate genes previously identified to be regulated by DAF-16. We used a sensitized genetic background [eri-1(mg366); sdf-9(m708)], which enhances both RNAi efficiency and constitutive dauer formation (Daf-c). Among 513 RNAi clones screened, 21 displayed a synthetic Daf-c (SynDaf) phenotype with sdf-9. One of these genes, srh-100, was previously identified to be SynDaf, but twenty have not previously been associated with dauer formation. Two of the latter genes, lys-1 and cpr-1, are known to participate in innate immunity and six more are predicted to do so, suggesting that the immune response may contribute to the dauer decision. Indeed, we show that two of these genes, lys-1 and clc-1, are required for normal resistance to Staphylococcus aureus. clc-1 is predicted to function in epithelial cohesion. Dauer formation exhibited by daf-8(m85), sdf-9(m708), and the wild-type N2 (at 27 degrees C) were all enhanced by exposure to pathogenic bacteria, while not enhanced in a daf-22(m130) background. We conclude that knockdown of the genes required for proper pathogen resistance increases pathogenic infection, leading to increased dauer formation in our screen. We propose that dauer larva formation is a behavioral response to pathogens mediated by increased dauer pheromone production.	[Jensen, Victor L.; Riddle, Donald L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jensen, Victor L.; Lee, Yu-Hui; Park, Donha; Riddle, Donald L.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Simonsen, Karina T.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of British Columbia; University of British Columbia; University of Southern Denmark	Jensen, VL (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	driddle@msl.ubc.ca		Jensen, Victor/0000-0002-9039-4319	Canadian Institute of Health Research [MOP-79458]; Natural Science and Engineering Research Council; Michael Smith Foundation for Health Research; National Institutes of Health - National Center for Research Resources	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Canadian Institute of Health Research Operating Grant to D. L. R. #MOP-79458 (www.cihr.ca), the Natural Science and Engineering Research Council Scholarship to V.L.J. (www.nserc-crsng.gc.ca), and the Michael Smith Foundation for Health Research Scholarship to V.L.J. (www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Caenorhabditis Genetics Center (funded by the National Institutes of Health - National Center for Research Resources) for strains, Dr. Donald Moerman for the RNAi clones, and Nigel O'Neil and Marco Gallo for constructive discussions.	Ailion M, 2000, GENETICS, V156, P1047; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Ailion M, 2003, GENETICS, V165, P127; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Antebi A, 2000, GENE DEV, V14, P1512; Asano A, 2003, CURR BIOL, V13, P1042, DOI 10.1016/S0960-9822(03)00395-6; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Darby Creg, 2005, WormBook, P1; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hu P.J., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Jensen VL, 2007, GENETICS, V177, P661, DOI 10.1534/genetics.107.076703; Jensen VL, 2006, EXP GERONTOL, V41, P922, DOI 10.1016/j.exger.2006.06.058; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; LARSEN PL, 1995, GENETICS, V139, P1567; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu Tao, 2004, BMC Developmental Biology, V4; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Matsuura T, 2005, ZOOL SCI, V22, P1095, DOI 10.2108/zsj.22.1095; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ohkura K, 2003, DEVELOPMENT, V130, P3237, DOI 10.1242/dev.00540; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki Y, 2006, GENE DEV, V20, P423, DOI 10.1101/gad.1378906; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tewari M, 2004, MOL CELL, V13, P469, DOI 10.1016/S1097-2765(04)00033-4; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; THOMAS JH, 1993, GENETICS, V134, P1105; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	71	17	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15902	10.1371/journal.pone.0015902	http://dx.doi.org/10.1371/journal.pone.0015902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209831	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900046
J	McCluney, KE; Sabo, JL				McCluney, Kevin E.; Sabo, John L.			Tracing Water Sources of Terrestrial Animal Populations with Stable Isotopes: Laboratory Tests with Crickets and Spiders	PLOS ONE			English	Article							NATURAL-ABUNDANCE; CARBON-DIOXIDE; FOOD WEBS; HYDROGEN; RATIOS; TEMPERATURE; OXYGEN; DEUTERIUM; STREAM; HAIR	Fluxes of carbon, nitrogen, and water between ecosystem components and organisms have great impacts across levels of biological organization. Although much progress has been made in tracing carbon and nitrogen, difficulty remains in tracing water sources from the ecosystem to animals and among animals (the "water web"). Naturally occurring, non-radioactive isotopes of hydrogen and oxygen in water provide a potential method for tracing water sources. However, using this approach for terrestrial animals is complicated by a change in water isotopes within the body due to differences in activity of heavy and light isotopes during cuticular and transpiratory water losses. Here we present a technique to use stable water isotopes to estimate the mean mix of water sources in a population by sampling a group of sympatric animals over time. Strong correlations between H and O isotopes in the body water of animals collected over time provide linear patterns of enrichment that can be used to predict a mean mix of water sources useful in standard mixing models to determine relative source contribution. Multiple temperature and humidity treatment levels do not greatly alter these relationships, thus having little effect on our ability to estimate this population-level mix of water sources. We show evidence for the validity of using multiple samples of animal body water, collected across time, to estimate the isotopic mix of water sources in a population and more accurately trace water sources. The ability to use isotopes to document patterns of animal water use should be a great asset to biologists globally, especially those studying drylands, droughts, streamside areas, irrigated landscapes, and the effects of climate change.	[McCluney, Kevin E.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	McCluney, KE (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	Kevin.McCluney@colostate.edu		McCluney, Kevin/0000-0002-3574-0354	EPA [FP-91649201]; National Science Foundation [DEB-0808537]; Brian Daniel Corrigan Foundation; Direct For Biological Sciences [0842410] Funding Source: National Science Foundation	EPA(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); Brian Daniel Corrigan Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by EPA STAR grant FP-91649201 and National Science Foundation DDIG grant DEB-0808537 to K. McCluney and by the Brian Daniel Corrigan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Clark I., 1997, ENV ISOTOPES HYDROLO; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P377, DOI 10.1016/0016-7037(94)90471-5; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; CRAIG H, 1963, J GEOPHYS RES, V68, P5079, DOI 10.1029/JZ068i017p05079; Currie WS, 1999, ECOSYSTEMS, V2, P4, DOI 10.1007/s100219900054; Davis JR, 2006, INTEGR COMP BIOL, V46, pE31; DAWSON TE, 1991, NATURE, V350, P335, DOI 10.1038/350335a0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; EPSTEIN S, 1976, EARTH PLANET SC LETT, V30, P241, DOI 10.1016/0012-821X(76)90251-X; ESTEP MF, 1980, SCIENCE, V209, P1537, DOI 10.1126/science.209.4464.1537; FLANAGAN LB, 1991, PLANT PHYSIOL, V97, P298, DOI 10.1104/pp.97.1.298; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; IPCC, 2007, AR4 SYNTHESIS REPORT; LIFSON N, 1955, J APPL PHYSIOL, V7, P704, DOI 10.1152/jappl.1955.7.6.704; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; McCluney KE, 2010, IMPACTS ALTERED WATE; McCluney KE, 2009, ECOLOGY, V90, P1463, DOI 10.1890/08-1626.1; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; Middleton NJ, WORLD ATLAS DESERTIF; NAGY KA, 1972, J COMP PHYSIOL, V79, P39, DOI 10.1007/BF00693617; Sabo JL, 2008, ECOL MONOGR, V78, P615, DOI 10.1890/07-1382.1; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Soykan C, 2007, THESIS ARIZONA STATE; TATNER P, 1988, J THEOR BIOL, V133, P267, DOI 10.1016/S0022-5193(88)80321-7; West AG, 2006, RAPID COMMUN MASS SP, V20, P1317, DOI 10.1002/rcm.2456; Wolf BO, 2002, ECOLOGY, V83, P1286, DOI 10.1890/0012-9658(2002)083[1286:SIRTSF]2.0.CO;2; Zar JH, 1999, BIOSTATISTICAL ANAL	40	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15696	10.1371/journal.pone.0015696	http://dx.doi.org/10.1371/journal.pone.0015696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209877	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900027
J	Chittenden, TW; Pak, J; Rubio, R; Cheng, HL; Holton, K; Prendergast, N; Glinskii, V; Cai, Y; Culhane, A; Bentink, S; Schwede, M; Mar, JC; Howe, EA; Aryee, M; Sultana, R; Lanahan, AA; Taylor, JM; Holmes, C; Hahn, WC; Zhao, JJ; Iglehart, JD; Quackenbush, J				Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Cheng, Hailing; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Aryee, Martin; Sultana, Razvan; Lanahan, Anthony A.; Taylor, Jennifer M.; Holmes, Chris; Hahn, William C.; Zhao, Jean J.; Iglehart, J. Dirk; Quackenbush, John			Therapeutic Implications of GIPC1 Silencing in Cancer	PLOS ONE			English	Article							GENE-EXPRESSION-DATA; PDZ DOMAIN PROTEIN; TGF-BETA RECEPTOR; INTERACTING PROTEIN; MOLECULAR SUBTYPES; CYTOPLASMIC DOMAIN; BREAST-CANCER; SYNECTIN; GROWTH; PATHWAY	GIPC1 is a cytoplasmic scaffold protein that interacts with numerous receptor signaling complexes, and emerging evidence suggests that it plays a role in tumorigenesis. GIPC1 is highly expressed in a number of human malignancies, including breast, ovarian, gastric, and pancreatic cancers. Suppression of GIPC1 in human pancreatic cancer cells inhibits in vivo tumor growth in immunodeficient mice. To better understand GIPC1 function, we suppressed its expression in human breast and colorectal cancer cell lines and human mammary epithelial cells (HMECs) and assayed both gene expression and cellular phenotype. Suppression of GIPC1 promotes apoptosis in MCF-7, MDA-MD231, SKBR-3, SW480, and SW620 cells and impairs anchorage-independent colony formation of HMECs. These observations indicate GIPC1 plays an essential role in oncogenic transformation, and its expression is necessary for the survival of human breast and colorectal cancer cells. Additionally, a GIPC1 knock-down gene signature was used to interrogate publically available breast and ovarian cancer microarray datasets. This GIPC1 signature statistically correlates with a number of breast and ovarian cancer phenotypes and clinical outcomes, including patient survival. Taken together, these data indicate that GIPC1 inhibition may represent a new target for therapeutic development for the treatment of human cancers.	[Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Sultana, Razvan; Quackenbush, John] Dana Farber Canc Inst, Funct Genom & Computat Biol Grp, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Sultana, Razvan; Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chittenden, Thomas W.; Culhane, Aedin; Bentink, Stefan; Mar, Jessica C.; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Chittenden, Thomas W.; Howe, Eleanor A.; Holmes, Chris] Univ Oxford, Dept Stat, Oxford Ctr Gene Funct, Oxford OX1 3TG, England; [Cheng, Hailing; Zhao, Jean J.; Iglehart, J. Dirk] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Aryee, Martin] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Aryee, Martin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Lanahan, Anthony A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Taylor, Jennifer M.] CSIRO Plant Ind, Canberra, ACT, Australia; [Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Chittenden, TW (corresponding author), Dana Farber Canc Inst, Funct Genom & Computat Biol Grp, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu	Aryee, Martin/AAC-8113-2020; Culhane, Aedin/AAG-8490-2019; Taylor, Jennifer M/A-1686-2010	Culhane, Aedin/0000-0002-1395-9734; Taylor, Jennifer M/0000-0003-4231-0181; Quackenbush, John/0000-0002-2702-5879; Mar, Jessica/0000-0002-5147-9299	Dana-Farber Strategic Fund Initiative; Claudia Adams Barr Foundation; National Library of Medicine of the United States National Institutes of Health [R01LM010129]; NATIONAL CANCER INSTITUTE [R01CA134502] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010129] Funding Source: NIH RePORTER; Medical Research Council [G0500115, MC_UP_A390_1107] Funding Source: researchfish; MRC [G0500115, MC_UP_A390_1107] Funding Source: UKRI	Dana-Farber Strategic Fund Initiative; Claudia Adams Barr Foundation; National Library of Medicine of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.W.C, A.C., J.Q., J.P., R.R., K.H., N.P., V.G., Y.C., S.B., M.S., J.C.M., E.A.H., M.A., and R.S. were supported by funds from the Dana-Farber Strategic Fund Initiative and the Claudia Adams Barr Foundation. J.Q. and J.C.M were supported in part by a grant from the National Library of Medicine (R01LM010129) of the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Cai HB, 1999, J NEUROSCI, V19, P6519; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Goeman JJ, 2005, BIOINFORMATICS, V21, P1950, DOI 10.1093/bioinformatics/bti267; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Katoh M, 2002, INT J MOL MED, V9, P585; KELLERPINTER A, 2010, CELL MOL LIFE SCI; Kirikoshi H, 2002, INT J MOL MED, V9, P509; Kirikoshi H, 2002, INT J ONCOL, V20, P1183; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Muders M H, 2007, Verh Dtsch Ges Pathol, V91, P286; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Rudchenko S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-248; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Tan C, 2001, DEVELOPMENT, V128, P3665; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yavelsky V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-247; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	36	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15581	10.1371/journal.pone.0015581	http://dx.doi.org/10.1371/journal.pone.0015581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209904	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600021
J	Jorgensen, KW; Buus, S; Nielsen, M				Jorgensen, Kasper Winther; Buus, Soren; Nielsen, Morten			Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes	PLOS ONE			English	Article							T-CELL RECOGNITION; ANTIGEN	Major Histocompatibility class II (MHC-II) molecules sample peptides from the extracellular space allowing the immune system to detect the presence of foreign microbes from this compartment. Prediction of MHC class II ligands is complicated by the open binding cleft of the MHC class II molecule, allowing binding of peptides extending out of the binding groove. Furthermore, only a few HLA-DR alleles have been characterized with a sufficient number of peptides (100-200 peptides per allele) to derive accurate description of their binding motif. Little work has been performed characterizing structural properties of MHC class II ligands. Here, we perform one such large-scale analysis. A large set of SYFPEITHI MHC class II ligands covering more than 20 different HLA-DR molecules was analyzed in terms of their secondary structure and surface exposure characteristics in the context of the native structure of the corresponding source protein. We demonstrated that MHC class II ligands are significantly more exposed and have significantly more coil content than other peptides in the same protein with similar predicted binding affinity. We next exploited this observation to derive an improved prediction method for MHC class II ligands by integrating prediction of MHC- peptide binding with prediction of surface exposure and protein secondary structure. This combined prediction method was shown to significantly outperform the state-of-the-art MHC class II peptide binding prediction method when used to identify MHC class II ligands. We also tried to integrate N- and O-glycosylation in our prediction methods but this additional information was found not to improve prediction performance. In summary, these findings strongly suggest that local structural properties influence antigen processing and/or the accessibility of peptides to the MHC class II molecule.	[Jorgensen, Kasper Winther; Nielsen, Morten] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Jorgensen, KW (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Buus, Soren/0000-0001-8363-1999	National Institutes of Health [HHSN272200900045C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant (contract no. HHSN272200900045C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; BERZOFSKY JA, 1983, SURV IMMUNOL RES, V2, P223; Brodsky F M, 1992, Trends Cell Biol, V2, P109, DOI 10.1016/0962-8924(92)90015-F; Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014; Dengjel J, 2005, J MASS SPECTROM, V40, P100, DOI 10.1002/jms.780; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; GalliStampino L, 1997, CANCER RES, V57, P3214; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; OZAKI S, 1987, J IMMUNOL, V138, P4133; Paul B, 2008, FUNDAMENTAL IMMUNOLO; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15877	10.1371/journal.pone.0015877	http://dx.doi.org/10.1371/journal.pone.0015877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209859	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600048
J	Khurana, S; Li, WK; Atkinson, NS				Khurana, Sukant; Li, Wen-Ke; Atkinson, Nigel S.			Image Enhancement for Tracking the Translucent Larvae of Drosophila melanogaster	PLOS ONE			English	Article							SENSORY INPUT; REAL-TIME; BEHAVIOR; SYSTEM; MODEL; TASTE	Drosophila melanogaster larvae are model systems for studies of development, synaptic transmission, sensory physiology, locomotion, drug discovery, and learning and memory. A detailed behavioral understanding of larvae can advance all these fields of neuroscience. Automated tracking can expand fine-grained behavioral analysis, yet its full potential remains to be implemented for the larvae. All published methods are unable to track the larvae near high contrast objects, including the petri-dish edges encountered in many behavioral paradigms. To alleviate these issues, we enhanced the larval contrast to obtain complete tracks. Our method employed a dual approach of optical-contrast boosting and post-hoc image processing for contrast enhancement. We reared larvae on black food media to enhance their optical contrast through darkening of their digestive tracts. For image processing we performed Frame Averaging followed by Subtraction then Thresholding (FAST). This algorithm can remove all static objects from the movie, including petri-dish edges prior to processing by the image-tracking module. This dual approach for contrast enhancement also succeeded in overcoming fluctuations in illumination caused by the alternating current power source. Our tracking method yields complete tracks, including at the edges of the behavioral arena and is computationally fast, hence suitable for high-throughput fine-grained behavioral measurements.	[Khurana, Sukant] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Khurana, S (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	sukant@mail.utexas.edu		Khurana, Sukant/0000-0002-6665-6892	NSF [IOS-0641370]	NSF(National Science Foundation (NSF))	NSF grant IOS-0641370 to N.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cole BJ, 1996, AM NAT, V148, P1, DOI 10.1086/285908; Dukas R, 1999, BEHAV ECOL SOCIOBIOL, V45, P195, DOI 10.1007/s002650050553; Fontaine Ebraheem, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3716; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; HASEGAWA K, 1988, PHYSIOL BEHAV, V42, P397, DOI 10.1016/0031-9384(88)90282-X; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hoy JB, 1996, J NEUROSCI METH, V64, P157, DOI 10.1016/0165-0270(95)00121-2; Hussaini A, 2003, CURR SCI INDIA, V85, P857; Khurana Sukant, 2003, Drosophila Information Service, V86, P151; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Shapiro L.G., 2001, COMPUTER VISION, P137; Stilwell GE, 2006, EUR J NEUROSCI, V24, P2211, DOI 10.1111/j.1460-9568.2006.05075.x; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Tsen C, 2008, J MED CHEM, V51, P324, DOI 10.1021/jm701198s	29	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15259	10.1371/journal.pone.0015259	http://dx.doi.org/10.1371/journal.pone.0015259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209929	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600016
J	Xi, JF; Wang, YF; Zhang, P; He, LJ; Nan, X; Yue, W; Pei, XT				Xi, Jiafei; Wang, Yunfang; Zhang, Peng; He, Lijuan; Nan, Xue; Yue, Wen; Pei, Xuetao			Human Fetal Liver Stromal Cells That Overexpress bFGF Support Growth and Maintenance of Human Embryonic Stem Cells	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; II IGF-II; SELF-RENEWAL; CULTURE-CONDITIONS; FEEDER LAYERS; DEFINED CONDITIONS; HUMAN BLASTOCYSTS; IN-VITRO; DIFFERENTIATION; LINES	In guiding hES cell technology toward the clinic, one key issue to be addressed is to culture and maintain hES cells much more safely and economically in large scale. In order to avoid using mouse embryonic fibroblasts (MEFs) we isolated human fetal liver stromal cells (hFLSCs) from 14 weeks human fetal liver as new human feeder cells. hFLSCs feeders could maintain hES cells for 15 passages (about 100 days). Basic fibroblast growth factor (bFGF) is known to play an important role in promoting self-renewal of human embryonic stem (hES) cells. So, we established transgenic hFLSCs that stably express bFGF by lentiviral vectors. These transgenic human feeder cells - bFGF-hFLSCs maintained the properties of H9 hES cells without supplementing with any exogenous growth factors. H9 hES cells culturing under these conditions maintained all hES cell features after prolonged culture, including the developmental potential to differentiate into representative tissues of all three embryonic germ layers, unlimited and undifferentiated proliferative ability, and maintenance of normal karyotype. Our results demonstrated that bFGF-hFLSCs feeder cells were central to establishing the signaling network among bFGF, insulin-like growth factor 2 (IGF-2), and transforming growth factor beta (TGF-beta), thereby providing the framework in which hES cells were instructed to self-renew or to differentiate. We also found that the conditioned medium of bFGF-hFLSCs could maintain the H9 hES cells under feeder-free conditions without supplementing with bFGF. Taken together, bFGF-hFLSCs had great potential as feeders for maintaining pluripotent hES cell lines more safely and economically.	[Xi, Jiafei; Wang, Yunfang; Zhang, Peng; He, Lijuan; Nan, Xue; Yue, Wen; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China		Xi, JF (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China.	wenyue26@yahoo.com; peixt@nic.bmi.ac.cn	Zhang, Peng/B-6898-2014	Zhang, Peng/0000-0001-5574-0899; Yue, Wen/0000-0002-3935-360X	National High Technology Research and Development Program of China [2006AA02A107]; Major State Basic Research Program of China [2009CB941102, 2011CB964804]; Project of Beijing Municipal Science & Technology Commission [D07050701350702]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by National High Technology Research and Development Program of China (No: 2006AA02A107 to X.T.P.), the Major State Basic Research Program of China (No: 2009CB941102 to W.Y. and No: 2011CB964804 to W.Y.), and the Project of Beijing Municipal Science & Technology Commission (No: D07050701350702 to X.T.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Braam SR, 2008, NAT PROTOC, V3, P1435, DOI 10.1038/nprot.2008.140; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Choo A, 2008, METHOD CELL BIOL, V86, P15, DOI 10.1016/S0091-679X(08)00002-2; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; GABBITAS B, 1994, ENDOCRINOLOGY, V135, P284, DOI 10.1210/en.135.1.284; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Ji L, 2009, J CELL PHYSIOL, V221, P54, DOI 10.1002/jcp.21826; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Miyamoto K, 2004, STEM CELLS, V22, P433, DOI 10.1634/stemcells.22-4-433; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; NEWMANSMITH ED, 1995, DEVELOPMENT, V121, P2069; O'Dell SD, 1998, INT J BIOCHEM CELL B, V30, P767, DOI 10.1016/S1357-2725(98)00048-X; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; PONS S, 1992, ENDOCRINOLOGY, V131, P2271, DOI 10.1210/en.131.5.2271; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saxena S, 2008, MOL REPROD DEV, V75, P1523, DOI 10.1002/mrd.20895; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; TAKAHASHI A, 1995, J VET MED SCI, V57, P553, DOI 10.1292/jvms.57.553; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xi JF, 2007, PROG BIOCHEM BIOPHYS, V34, P207; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhou HS, 2008, DIFFERENTIATION, V76, P923, DOI 10.1111/j.1432-0436.2008.00280.x	46	21	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14457	10.1371/journal.pone.0014457	http://dx.doi.org/10.1371/journal.pone.0014457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209880	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600004
J	Zhang, HY; Mao, XG; Wang, CS; Jing, RL				Zhang, Hongying; Mao, Xinguo; Wang, Chengshe; Jing, Ruilian			Overexpression of a Common Wheat Gene TaSnRK2.8 Enhances Tolerance to Drought, Salt and Low Temperature in Arabidopsis	PLOS ONE			English	Article							SNF1-RELATED PROTEIN-KINASES; ABSCISIC-ACID; HYPEROSMOTIC STRESS; SIGNAL-TRANSDUCTION; ENCODES; IDENTIFICATION; METABOLISM; ACTIVATION; EXPRESSION; CALCIUM	Drought, salinity and low temperatures are major factors limiting crop productivity and quality. Sucrose non-fermenting1-related protein kinase 2 (SnRK2) plays a key role in abiotic stress signaling in plants. In this study, TaSnRK2.8, a SnRK2 member in wheat, was cloned and its functions under multi-stress conditions were characterized. Subcellular localization showed the presence of TaSnRK2.8 in the cell membrane, cytoplasm and nucleus. Expression pattern analyses in wheat revealed that TaSnRK2.8 was involved in response to PEG, NaCl and cold stresses, and possibly participates in ABA-dependent signal transduction pathways. To investigate its role under various environmental stresses, TaSnRK2.8 was transferred to Arabidopsis under control of the CaMV-35S promoter. Overexpression of TaSnRK2.8 resulted in enhanced tolerance to drought, salt and cold stresses, further confirmed by longer primary roots and various physiological characteristics, including higher relative water content, strengthened cell membrane stability, significantly lower osmotic potential, more chlorophyll content, and enhanced PSII activity. Meanwhile, TaSnRK2.8 plants had significantly lower total soluble sugar levels under normal growing conditions, suggesting that TaSnRK2.8 might be involved in carbohydrate metabolism. Moreover, the transcript levels of ABA biosynthesis (ABA1, ABA2), ABA signaling (ABI3, ABI4, ABI5), stress-responsive genes, including two ABA-dependent genes (RD20A, RD29B) and three ABA-independent genes (CBF1, CBF2, CBF3), were generally higher in TaSnRK2.8 plants than in WT/GFP controls under normal/stress conditions. Our results suggest that TaSnRK2.8 may act as a regulatory factor involved in a multiple stress response pathways.	[Zhang, Hongying; Wang, Chengshe] NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Zhang, Hongying; Mao, Xinguo; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, HY (corresponding author), NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National Key Technologies RD Program [2009ZX08002-012B]; National Science Foundation [NSF31040089]	National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Key Technologies R&D Program (2009ZX08002-012B) and the National Science Foundation (NSF31040089). The funders had no role in study design, data collection and analysis, decision to publish.	ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong DM, 2002, PLANT PHYSIOL, V130, P256, DOI 10.1104/pp.004507; Granier C, 1999, PLANT PHYSIOL, V119, P609, DOI 10.1104/pp.119.2.609; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hrabak EM, PLANT PHYSL, V132, P666; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Huai JL, 2008, PLANT CELL REP, V27, P1861, DOI 10.1007/s00299-008-0608-8; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Takahashi S, 2001, PLANT CELL PHYSIOL, V42, P214, DOI 10.1093/pcp/pce028; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu W, 2000, PLANT BREEDING, V119, P365, DOI 10.1046/j.1439-0523.2000.00506.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zheng ZF, 2010, PLANT PHYSIOL, V153, P99, DOI 10.1104/pp.109.150789; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	58	123	143	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16041	10.1371/journal.pone.0016041	http://dx.doi.org/10.1371/journal.pone.0016041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209856	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600059
J	Zeng, HQ; Jia, JP; Liu, AM				Zeng, Huiqing; Jia, Jinping; Liu, Aimin			Coordinated Translocation of Mammalian Gli Proteins and Suppressor of Fused to the Primary Cilium	PLOS ONE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; INTRAFLAGELLAR TRANSPORT PROTEINS; PALLISTER-HALL SYNDROME; NEGATIVE REGULATOR; REPRESSOR FUNCTIONS; VERTEBRATE LIMB; SENSORY CILIA; DROSOPHILA; MOUSE; ACTIVATOR	Intracellular transduction of Hedgehog (Hh) signals in mammals requires functional primary cilia. The Hh signaling effectors, the Gli family of transcription factors, and their negative regulator, Suppressor of Fused (Sufu), accumulate at the tips of cilia; however, the molecular mechanism regulating this localization remains elusive. In the current study, we show that the ciliary localization of mammalian Gli proteins depends on both their N-terminal domains and a central region lying C-terminal to the zinc-finger DNA-binding domains. Invertebrate Gli homologs Ci and Tra1, when over-expressed in ciliated mouse fibroblasts, fail to localize to the cilia, suggesting the lack of a vertebrate-specific structural feature required for ciliary localization. We further show that activation of protein kinase A (PKA) efficiently inhibits ciliary localization of Gli2 and Gli3, but only moderately affects the ciliary localization of Gli1. Interestingly, variants of Gli2 mimicking the phosphorylated or non-phosphorylated states of Gli2 are both localized to the cilia, and their ciliary localizations are subjected to the inhibitory effect of PKA activation, suggesting a likely indirect mechanism underlying the roles of PKA in Gli ciliary localization. Finally, we show that ciliary localization of Sufu is dependent on ciliary-localized Gli proteins, and is inhibited by PKA activation, suggesting a coordinated mechanism for the ciliary translocation of Sufu and Gli proteins.	[Zeng, Huiqing; Jia, Jinping; Liu, Aimin] Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA; [Liu, Aimin] Penn State Univ, Ctr Cellular Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zeng, HQ (corresponding author), Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA.	AXL25@psu.edu		Liu, Aimin/0000-0003-0099-0879	National Science Foundation [0949877]; Penn State University; Direct For Biological Sciences [0949877] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Penn State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation 0949877 and The Penn State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Burglin TR., 2006, HOMOLOGS HH SIGNALLI, P1, DOI [10.1895/wormbook.1.76.1, DOI 10.1895/WORMBOOK.1.76.1]; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; Methot N, 2000, DEVELOPMENT, V127, P4001; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PREAT T, 1992, GENETICS, V132, P725; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sisson BE, 2006, DEV BIOL, V294, P258, DOI 10.1016/j.ydbio.2006.02.050; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182	49	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15900	10.1371/journal.pone.0015900	http://dx.doi.org/10.1371/journal.pone.0015900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209912	gold, Green Published, Green Submitted			2022-12-25	WOS:000285793200071
J	Zhu, F; Wang, P; Lee, NH; Goldring, MB; Konstantopoulos, K				Zhu, Fei; Wang, Pu; Lee, Norman H.; Goldring, Mary B.; Konstantopoulos, Konstantinos			Prolonged Application of High Fluid Shear to Chondrocytes Recapitulates Gene Expression Profiles Associated with Osteoarthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; NITRIC-OXIDE; IN-VITRO; FUNCTIONAL ANNOTATION; POSSIBLE INVOLVEMENT; MICROARRAY ANALYSIS; SYNOVIAL TISSUE; CANDIDATE GENES; DOWN-REGULATION; CARTILAGE	Background: Excessive mechanical loading of articular cartilage producing hydrostatic stress, tensile strain and fluid flow leads to irreversible cartilage erosion and osteoarthritic (OA) disease. Since application of high fluid shear to chondrocytes recapitulates some of the earmarks of OA, we aimed to screen the gene expression profiles of shear-activated chondrocytes and assess potential similarities with OA chondrocytes. Methodology/Principal Findings: Using a cDNA microarray technology, we screened the differentially-regulated genes in human T/C-28a2 chondrocytes subjected to high fluid shear (20 dyn/cm(2)) for 48 h and 72 h relative to static controls. Confirmation of the expression patterns of select genes was obtained by qRT-PCR. Using significance analysis of microarrays with a 5% false discovery rate, 71 and 60 non-redundant transcripts were identified to be >= 2-fold up-regulated and <= 0.6-fold down-regulated, respectively, in sheared chondrocytes. Published data sets indicate that 42 of these genes, which are related to extracellular matrix/degradation, cell proliferation/differentiation, inflammation and cell survival/death, are differentially-regulated in OA chondrocytes. In view of the pivotal role of cyclooxygenase-2 (COX-2) in the pathogenesis and/or progression of OA in vivo and regulation of shear-induced inflammation and apoptosis in vitro, we identified a collection of genes that are either up-or down-regulated by shear-induced COX-2. COX-2 and L-prostaglandin D synthase (L-PGDS) induce reactive oxygen species production, and negatively regulate genes of the histone and cell cycle families, which may play a critical role in chondrocyte death. Conclusions/Significance: Prolonged application of high fluid shear stress to chondrocytes recapitulates gene expression profiles associated with osteoarthritis. Our data suggest a potential link between exposure of chondrocytes/cartilage to abnormal mechanical loading and the pathogenesis/progression of OA.	[Zhu, Fei; Wang, Pu; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Goldring, Mary B.] Hosp Special Surg, New York, NY 10021 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA	Johns Hopkins University; George Washington University; Johns Hopkins University; Johns Hopkins University	Zhu, F (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health [RO1 AR053358, R01 AG022021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants RO1 AR053358 (KK)(http://www.niams.nih.gov) and R01 AG022021 (MBG)(http://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 1997, ARTHRITIS RHEUM, V40, P562, DOI 10.1002/art.1780400323; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Ali K, 2008, ATHEROSCLEROSIS, V196, P201, DOI 10.1016/j.atherosclerosis.2007.03.038; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Backman JT, 1998, VIRCHOWS ARCH, V433, P153, DOI 10.1007/s004280050230; Bramlage CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1923; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Dunn S, 2009, MOD RHEUMATOL, V19, P151, DOI 10.1007/s10165-008-0136-y; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Gobezie R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2172; Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Greim H, 2003, TOXICOL LETT, V138, P1, DOI 10.1016/S0378-4274(02)00408-3; Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953; Hansen IB, 2006, J RHEUMATOL, V33, P1754; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hsieh YS, 2007, J RHEUMATOL, V34, P785; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung N, 2000, SCAND J RHEUMATOL, V29, P222; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim SR, 2008, MECH AGEING DEV, V129, P706, DOI 10.1016/j.mad.2008.09.003; Kitamura T, 2005, AM J PHYSIOL-CELL PH, V289, pC82, DOI 10.1152/ajpcell.00486.2004; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Lee MS, 2003, J CELL BIOCHEM, V90, P80, DOI 10.1002/jcb.10611; Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Mahr S, 2006, AM J HUM GENET, V78, P793, DOI 10.1086/503849; Mahr Sandra, 2007, Genomic Med, V1, P125, DOI 10.1007/s11568-007-9012-7; Martin JA, 2006, BIORHEOLOGY, V43, P517; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Pattoli MA, 2005, J PHARMACOL EXP THER, V315, P382, DOI 10.1124/jpet.105.087569; Pfander D, 2005, INT ORTHOP, V29, P6, DOI 10.1007/s00264-004-0618-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Siow HC, 2004, CEPHALALGIA, V24, P414, DOI 10.1111/j.1468-2982.2003.00695.x; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Tardif G, 2004, ARTHRITIS RHEUM-US, V50, P2521, DOI 10.1002/art.20441; Tiku ML, 2000, J BIOL CHEM, V275, P20069, DOI 10.1074/jbc.M907604199; Trifan OC, 1999, J BIOL CHEM, V274, P34141, DOI 10.1074/jbc.274.48.34141; Ullrich O, 2001, FREE RADICAL BIO MED, V31, P887, DOI 10.1016/S0891-5849(01)00672-4; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Yamane S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-5; Yatsugi N, 2000, J Orthop Sci, V5, P150, DOI 10.1007/s007760050142; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zayed N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2581; Zhang QY, 2009, ARTHRITIS RHEUM-US, V60, P3602, DOI 10.1002/art.24999; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13	70	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15174	10.1371/journal.pone.0015174	http://dx.doi.org/10.1371/journal.pone.0015174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209926	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200018
J	Guggenhuber, S; Monory, K; Lutz, B; Klugmann, M				Guggenhuber, Stephan; Monory, Krisztina; Lutz, Beat; Klugmann, Matthias			AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; ENDOCANNABINOID SYSTEM; ADENOASSOCIATED VIRUS; SYNAPTIC-TRANSMISSION; PRINCIPAL NEURONS; KAINIC ACID; EXPRESSION; MICE; FOREBRAIN	The CB1 cannabinoid receptor is the most abundant G-protein coupled receptor in the brain and a key regulator of neuronal excitability. There is strong evidence that CB1 receptor on glutamatergic hippocampal neurons is beneficial to alleviate epileptiform seizures in mouse and man. Therefore, we hypothesized that experimentally increased CB1 gene dosage in principal neurons would have therapeutic effects in kainic acid (KA)-induced hippocampal pathogenesis. Here, we show that virus-mediated conditional overexpression of CB1 receptor in pyramidal and mossy cells of the hippocampus is neuroprotective and moderates convulsions in the acute KA seizure model in mice. We introduce a recombinant adeno-associated virus (AAV) genome with a short stop element flanked by loxP sites, for highly efficient attenuation of transgene expression on the transcriptional level. The presence of Cre-recombinase is strictly necessary for expression of reporter proteins or CB1 receptor in vitro and in vivo. Transgenic CB1 receptor immunoreactivity is targeted to glutamatergic neurons after stereotaxic delivery of AAV to the dorsal hippocampus of the driver mice NEX-cre. Increased CB1 receptor protein levels in hippocampal lysates of AAV-treated Cre-mice is paralleled by enhanced cannabinoid-induced G-protein activation. KA-induced seizure severity and mortality is reduced in CB1 receptor overexpressors compared with AAV-treated control animals. Neuronal damage in the hippocampal CA3 field is specifically absent from AAV-treated Cre-transgenics, but evident throughout cortical areas of both treatment groups. Our data provide further evidence for a role of increased CB1 signaling in pyramidal hippocampal neurons as a safeguard against the adverse effects of excessive excitatory network activity.	[Guggenhuber, Stephan; Monory, Krisztina; Lutz, Beat; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Guggenhuber, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany.	blutz@uni-mainz.de; m.klugmann@unsw.edu.au	Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022		Deutsche Forschungsgemeinschaft [LU 775/3-1, LU 775/4-1]; European Leukodystrophy association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Leukodystrophy association	This work was supported by the Deutsche Forschungsgemeinschaft Grants LU 775/3-1 and LU 775/4-1 (in the context of FOR926) (to B.L. and K.M.) and in part by a project grant of the European Leukodystrophy association (ELA) to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coomber B, 2008, SYNAPSE, V62, P746, DOI 10.1002/syn.20547; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; During Matthew J, 2003, Methods Mol Med, V76, P221; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klugmann M, 2006, MOL CELL NEUROSCI, V31, P303, DOI 10.1016/j.mcn.2005.09.019; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morozov YM, 2009, CEREB CORTEX, V19, pI78, DOI 10.1093/cercor/bhp028; Naderi N, 2008, J NEURAL TRANSM, V115, P1501, DOI 10.1007/s00702-008-0076-x; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010	37	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15707	10.1371/journal.pone.0015707	http://dx.doi.org/10.1371/journal.pone.0015707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203567	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900035
J	Mongan, MA; Dunn, RT; Vonderfecht, S; Everds, N; Chen, GA; Su, C; Higgins-Garn, M; Chen, YA; Afshari, CA; Williamson, TL; Carlock, L; DiPalma, C; Moss, S; Bussiere, J; Qualls, C; He, YD; Hamadeh, HK				Mongan, M. Ann; Dunn, Robert T., II; Vonderfecht, Steven; Everds, Nancy; Chen, Guang; Su, Cheng; Higgins-Garn, Marnie; Chen, Yuan; Afshari, Cynthia A.; Williamson, Toni L.; Carlock, Linda; DiPalma, Christopher; Moss, Suzanne; Bussiere, Jeanine; Qualls, Charles, Jr.; He, Yudong D.; Hamadeh, Hisham K.			A Novel Statistical Algorithm for Gene Expression Analysis Helps Differentiate Pregnane X Receptor-Dependent and Independent Mechanisms of Toxicity	PLOS ONE			English	Article							DRUG DISCOVERY; BETA-SECRETASE; MICROARRAY; REPRODUCIBILITY; ELEMENT; BIOLOGY; STRESS; BACE	Genome-wide gene expression profiling has become standard for assessing potential liabilities as well as for elucidating mechanisms of toxicity of drug candidates under development. Analysis of microarray data is often challenging due to the lack of a statistical model that is amenable to biological variation in a small number of samples. Here we present a novel non-parametric algorithm that requires minimal assumptions about the data distribution. Our method for determining differential expression consists of two steps: 1) We apply a nominal threshold on fold change and platform p-value to designate whether a gene is differentially expressed in each treated and control sample relative to the averaged control pool, and 2) We compared the number of samples satisfying criteria in step 1 between the treated and control groups to estimate the statistical significance based on a null distribution established by sample permutations. The method captures group effect without being too sensitive to anomalies as it allows tolerance for potential non-responders in the treatment group and outliers in the control group. Performance and results of this method were compared with the Significant Analysis of Microarrays (SAM) method. These two methods were applied to investigate hepatic transcriptional responses of wild-type (PXR(+/+)) and pregnane X receptor-knockout (PXR(-/-)) mice after 96 h exposure to CMP013, an inhibitor of beta-secretase (beta-site of amyloid precursor protein cleaving enzyme 1 or BACE1). Our results showed that CMP013 led to transcriptional changes in hallmark PXR-regulated genes and induced a cascade of gene expression changes that explained the hepatomegaly observed only in PXR(+/+) animals. Comparison of concordant expression changes between PXR(+/+) and PXR(-/-) mice also suggested a PXR-independent association between CMP013 and perturbations to cellular stress, lipid metabolism, and biliary transport.	[Mongan, M. Ann; Dunn, Robert T., II; Vonderfecht, Steven; Everds, Nancy; Higgins-Garn, Marnie; Chen, Yuan; Afshari, Cynthia A.; Williamson, Toni L.; Carlock, Linda; DiPalma, Christopher; Moss, Suzanne; Bussiere, Jeanine; Qualls, Charles, Jr.; He, Yudong D.; Hamadeh, Hisham K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Chen, Guang; Su, Cheng] Amgen Inc, Res & Translat Sci Biostat, Seattle, WA USA	Amgen; Amgen	Mongan, MA (corresponding author), Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA.	thuyv@amgen.com			Amgen	Amgen(Amgen)	All authors are employed by Amgen. This employment does not alter the authors' adherence to PLoS ONE policies on sharing data and materials. This study is funded by Amgen as part of the company's business. The fund source does not compromise the objectivity or validity of the research, analyses, and interpretations presented in the paper.	Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017; Citron Martin, 2001, Expert Opin Ther Targets, V5, P341, DOI 10.1517/14728222.5.3.341; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Gant TW, 2009, CURR OPIN DRUG DISC, V12, P72; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Mongan A, 2008, BIOTECHNIQUES, V45, P283, DOI 10.2144/000112914; Reed SI, 1997, CANCER SURV, V29, P7; Searfoss GH, 2005, CURR MOL MED, V5, P53, DOI 10.2174/1566524053152825; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walker MS, 2008, INT J MOL MED, V21, P13; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15595	10.1371/journal.pone.0015595	http://dx.doi.org/10.1371/journal.pone.0015595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203578	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900034
J	Penfold, S; Hill, Z; Mrisho, M; Manzi, F; Tanner, M; Mshinda, H; Schellenberg, D; Schellenberg, JRMA				Penfold, Suzanne; Hill, Zelee; Mrisho, Mwifadhi; Manzi, Fatuma; Tanner, Marcel; Mshinda, Hassan; Schellenberg, David; Schellenberg, Joanna R. M. Armstrong			A Large Cross-Sectional Community-Based Study of Newborn Care Practices in Southern Tanzania	PLOS ONE			English	Article							NEONATAL-MORTALITY; RURAL GHANA; SURVIVAL; TRANSMISSION; INITIATION; INFECTION; PROGRAM; NEPAL; RISK	Despite recent improvements in child survival in sub-Saharan Africa, neonatal mortality rates remain largely unchanged. This study aimed to determine the frequency of delivery and newborn-care practices in southern Tanzania, where neonatal mortality is higher than the national average. All households in five districts of Southern Tanzania were approached to participate. Of 213,220 female residents aged 13-49 years, 92% participated. Cross-sectional, retrospective data on childbirth and newborn care practices were collected from 22,243 female respondents who had delivered a live baby in the preceding year. Health facility deliveries accounted for 41% of births, with nearly all non-facility deliveries occurring at home (57% of deliveries). Skilled attendants assisted 40% of births. Over half of women reported drying the baby and over a third reported wrapping the baby within 5 minutes of delivery. The majority of mothers delivering at home reported that they had made preparations for delivery, including buying soap (84%) and preparing a cloth for drying the child (85%). Although 95% of these women reported that the cord was cut with a clean razor blade, only half reported that it was tied with a clean thread. Furthermore, out of all respondents 10% reported that their baby was dipped in cold water immediately after delivery, around two-thirds reported bathing their babies within 6 hours of delivery, and 28% reported putting something on the cord to help it dry. Skin-to-skin contact between mother and baby after delivery was rarely practiced. Although 83% of women breastfed within 24 hours of delivery, only 18% did so within an hour. Fewer than half of women exclusively breastfed in the three days after delivery. The findings suggest a need to promote and facilitate health facility deliveries, hygienic delivery practices for home births, delayed bathing and immediate and exclusive breastfeeding in Southern Tanzania to improve newborn health.	[Penfold, Suzanne; Schellenberg, David; Schellenberg, Joanna R. M. Armstrong] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Hill, Zelee] UCL, Inst Child Hlth, London, England; [Mrisho, Mwifadhi; Manzi, Fatuma] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Basel, Switzerland; [Mshinda, Hassan] COSTECH, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Penfold, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Suzanne.penfold@lshtm.ac.uk		Schellenberg, David/0000-0001-8222-0186; Schellenberg, Joanna/0000-0002-0708-3676	Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium; Saving Newborn Lives program of Save the Children [NCT00152204]	Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium; Saving Newborn Lives program of Save the Children	The study was funded by the Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium (www.ipti-malaria.org) and the Saving Newborn Lives program of Save the Children (www.savethechildren.org/programs/health/saving-newborn-lives/), clinical trial number NCT00152204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TECHN WORK GROUP M N; [Anonymous], 2005, POVERTY HUMAN DEV RE; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Edmond KM, 2007, AM J CLIN NUTR, V86, P1126, DOI 10.1093/ajcn/86.4.1126; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Hill Z., 2009, REPORT FORMATIVE RES; Hill Z, 2010, PEDIATR INFECT DIS J, V29, P1004, DOI 10.1097/INF.0b013e3181f5ddb1; Hill Z, 2010, TROP MED INT HEALTH, V15, P1118, DOI 10.1111/j.1365-3156.2010.02593.x; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, INT J EPIDEMIOL S1, V39, pi144; Manji K., 2009, SITUATION ANAL NEWBO; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mbuyita S, 2008, NEONATAL CARE PRACTI; Mrisho M, 2008, T ROY SOC TROP MED H, V102, P669, DOI 10.1016/j.trstmh.2008.04.029; NBS, TANZ DEM HLTH SURV 2; Osrin D, 2002, BMJ-BRIT MED J, V325, P1063, DOI 10.1136/bmj.325.7372.1063; Rhee V, 2008, ARCH PEDIAT ADOL MED, V162, P603, DOI 10.1001/archpedi.162.7.603; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Shirima K, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-5; *STAT CORP LP, 2007, STAT STAT SOFTW REL; Syed U, 2008, J PERINATOL, V28, pS9, DOI 10.1038/jp.2008.165; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Waiswa P, BMC PREGNANCY CHILDB, V10, P9; White E, 2008, PRINCIPLES EXPOSURE; World Health Organization, 1994, ESS NEWB CAR REP TEC	29	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15593	10.1371/journal.pone.0015593	http://dx.doi.org/10.1371/journal.pone.0015593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203574	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000285576900033
J	Yang, Y; Tse, AKW; Li, P; Ma, Q; Xiang, S; Nicosia, SV; Seto, E; Zhang, X; Bai, W				Yang, Y.; Tse, A. K-W; Li, P.; Ma, Q.; Xiang, S.; Nicosia, S. V.; Seto, E.; Zhang, X.; Bai, W.			Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation	ONCOGENE			English	Article						androgen receptor; androgens; HDAC4; prostate cancer; SUMOylation; SUMO E3 ligase	PROSTATE-CANCER CELLS; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION; HDAC4 DEACETYLASE; COMPLEMENTARY-DNA; SUPERFAMILY; ACTIVATION; PHOSPHORYLATION; ACETYLATION; APOPTOSIS	The transcriptional activity of the androgen receptor (AR) is regulated by both ligand binding and post-translational modifications, including acetylation and small ubiquitin-like modifier (SUMO)ylation. Histone deacetylases (HDACs) are known to catalyze the removal of acetyl groups from both histones and non-histone proteins. In this study, we report that HDAC4 binds to and inhibits the activity of the AR. This inhibition was found to depend on the SUMOylation, instead of deacetylation, of the AR. Consistently, HDAC4 increases the level of AR SUMOylation in both whole-cell and cell-free assay systems, raising the possibility that the deacetylase may act as an E3 ligase for AR SUMOylation. Knock down of HDAC4 increases the activity of endogenous AR and androgen induction of prostate-specific antigen expression and prostate cancer cell growth, which is associated with decreased SUMOylation of the receptor. Overall, the studies identify HDAC4 as a positive regulator for AR SUMOylation, revealing a deacetylase-independent mechanism of HDAC action in prostate cancer cells. Oncogene (2011) 30, 2207-2218; doi:10.1038/onc.2010.600; published online 17 January 2011	[Yang, Y.; Tse, A. K-W; Li, P.; Ma, Q.; Xiang, S.; Nicosia, S. V.; Zhang, X.; Bai, W.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33612 USA; [Nicosia, S. V.; Seto, E.; Zhang, X.; Bai, W.] Univ S Florida, Dept Oncol Sci, Coll Med, Tampa, FL 33612 USA; [Seto, E.; Zhang, X.; Bai, W.] Univ S Florida, H Lee Moffitt Canc Ctr, Programs Mol Oncol, Tampa, FL 33682 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Bai, W (corresponding author), Univ S Florida, Dept Pathol & Cell Biol, Coll Med, 12901 Bruce B Downs Blvd,MDC 11, Tampa, FL 33612 USA.	wbai@health.usf.edu	XIANG, SHENGYAN/C-3176-2013; Bai, Wenlong/A-8977-2013	XIANG, SHENGYAN/0000-0002-6940-3559; Bai, Wenlong/0000-0002-9536-0556	Public Health Service [CA93666, CA111334]; DOD [DAMD17-02-1-0140]; Florida Department of Health [09KT-03, 06BCBG1]; NATIONAL CANCER INSTITUTE [R01CA093666, R01CA111334] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); DOD(United States Department of Defense); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs XJ Yang for HDAC4 vector, RJ Matusik for probasin-based AR reporter genes, PR Rennie for the PSA-based reporter gene, G Jenster for GST-AR-NT construct, JJ Palvimo for AR SUMOylation mutants and AP Lieberman for AR acetylation mutants. The work was supported by the Public Health Service Grants CA93666 and CA111334 (WB), a DOD Prostate Cancer Grant DAMD17-02-1-0140 (WB) and Grants 09KT-03 and 06BCBG1 (W.B) from the Florida Department of Health.	Bai WL, 1996, J BIOL CHEM, V271, P12801, DOI 10.1074/jbc.271.22.12801; Blok LJ, 1996, ENDOCR RES, V22, P197, DOI 10.3109/07435809609030508; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2004, BIOCHEM PHARMACOL, V68, P1199, DOI 10.1016/j.bcp.2004.05.037; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kasper S, 1999, J MOL ENDOCRINOL, V22, P313, DOI 10.1677/jme.0.0220313; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; ONATE SA, 1995, SCIENCE, V270, P1354; Pan Y, 2005, BIOCHEM BIOPH RES CO, V332, P702, DOI 10.1016/j.bbrc.2005.05.012; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Snoek R, 1998, PROSTATE, V36, P256; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	39	53	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	19					2207	2218		10.1038/onc.2010.600	http://dx.doi.org/10.1038/onc.2010.600			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242980	Green Accepted			2022-12-25	WOS:000290514600004
J	Rul, F; Ben-Yahia, L; Chegdani, F; Wrzosek, L; Thomas, S; Noordine, ML; Gitton, C; Cherbuy, C; Langella, P; Thomas, M				Rul, Francoise; Ben-Yahia, Leila; Chegdani, Fatima; Wrzosek, Laura; Thomas, Stephane; Noordine, Marie-Louise; Gitton, Christophe; Cherbuy, Claire; Langella, Philippe; Thomas, Muriel			Impact of the Metabolic Activity of Streptococcus thermophilus on the Colon Epithelium of Gnotobiotic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE DIGESTIVE-TRACT; CELL-CYCLE; LACTOBACILLUS-PLANTARUM; SMALL-INTESTINE; GASTROINTESTINAL-TRACT; LACTOSE-INTOLERANCE; LACTOCOCCUS-LACTIS; HEALTHY-VOLUNTEERS; ESCHERICHIA-COLI; HUMAN GUT	The thermophilic lactic acid bacterium Streptococcus thermophilus is widely and traditionally used in the dairy industry. Despite the vast level of consumption of S. thermophilus through yogurt or probiotic functional food, very few data are available about its physiology in the gastrointestinal tract (GIT). The objective of the present work was to explore both the metabolic activity and host response of S. thermophilus in vivo. Our study profiles the protein expression of S. thermophilus after its adaptation to the GIT of gnotobiotic rats and describes the impact of S. thermophilus colonization on the colonic epithelium. S. thermophilus colonized progressively the GIT of germ-free rats to reach a stable population in 30 days (10(8) cfu/g of feces). This progressive colonization suggested that S. thermophilus undergoes an adaptation process within GIT. Indeed, we showed that the main response of S. thermophilus in the rat's GIT was the massive induction of the glycolysis pathway, leading to formation of lactate in the cecum. At the level of the colonic epithelium, the abundance of monocarboxylic acid transporter mRNAs (SLC16A1 and SLC5A8) and a protein involved in the cell cycle arrest (p27(kip1)) increased in the presence of S. thermophilus compared with germ-free rats. Based on different mono-associated rats harboring two different strains of S. thermophilus (LMD-9 or LMG18311) or weak lactate-producing commensal bacteria (Bacteroides thetaiotaomicron and Ruminococcus gnavus), we propose that lactate could be a signal produced by S. thermophilus and modulating the colon epithelium.	[Rul, Francoise; Ben-Yahia, Leila; Chegdani, Fatima; Wrzosek, Laura; Thomas, Stephane; Noordine, Marie-Louise; Gitton, Christophe; Cherbuy, Claire; Langella, Philippe; Thomas, Muriel] INRA, MICALIS UMR 1319, F-78352 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rul, F (corresponding author), INRA, MICALIS UMR 1319, Domaine Vilvert, F-78352 Jouy En Josas, France.	francoise.rul@jouy.inra.fr; muriel.thomas@jouy.inra.fr	thomas, muriel/HDO-3887-2022; Chegdani, Fatima/AAW-9322-2021; Langella, Philippe/N-8368-2017	Chegdani, Fatima/0000-0002-2473-0302; Langella, Philippe/0000-0001-5960-4341; Rul, Francoise/0000-0002-7093-3098	Syndifrais-CNIEL (Paris, France)	Syndifrais-CNIEL (Paris, France)	This work was supported by Syndifrais-CNIEL (Paris, France).	ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Alpert C, 2009, ENVIRON MICROBIOL, V11, P751, DOI 10.1111/j.1462-2920.2008.01798.x; Beganovic J, 2010, J PROTEOME RES, V9, P677, DOI 10.1021/pr9000866; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Chiaramonte F, 2009, APPL ENVIRON MICROB, V75, P4498, DOI 10.1128/AEM.02868-08; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Derzelle S, 2005, APPL ENVIRON MICROB, V71, P8597, DOI 10.1128/AEM.71.12.8597-8605.2005; Drouault S, 2002, APPL ENVIRON MICROB, V68, P938, DOI 10.1128/AEM.68.2.938-941.2002; Druesne N, 2004, CARCINOGENESIS, V25, P1227, DOI 10.1093/carcin/bgh123; Elli M, 2006, APPL ENVIRON MICROB, V72, P5113, DOI 10.1128/AEM.02950-05; Firmesse O, 2008, INT J FOOD MICROBIOL, V125, P176, DOI 10.1016/j.ijfoodmicro.2008.03.044; Frank H, 2008, J BIOL CHEM, V283, P24729, DOI 10.1074/jbc.M802681200; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Guarner F, 2005, BRIT J NUTR, V93, pS61, DOI 10.1079/BJN20041345; He T, 2008, EUR J CLIN INVEST, V38, P541, DOI 10.1111/j.1365-2362.2008.01966.x; Herve-Jimenez L, 2008, PROTEOMICS, V8, P4273, DOI 10.1002/pmic.200700489; Higashikawa F, 2010, NUTRITION, V26, P367, DOI 10.1016/j.nut.2009.05.008; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; HOVE H, 1995, DIGEST DIS SCI, V40, P1372, DOI 10.1007/BF02065554; HOVE H, 1993, GUT, V34, P625, DOI 10.1136/gut.34.5.625; Hsiao YP, 2009, J DERMATOL SCI, V54, P175, DOI 10.1016/j.jdermsci.2009.02.012; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Mater DDG, 2005, FEMS MICROBIOL LETT, V250, P185, DOI 10.1016/j.femsle.2005.07.006; Mater DDG, 2006, BRIT J NUTR, V96, P177, DOI 10.1079/BJN20061724; MOREAU MC, 1986, REPROD NUTR DEV, V26, P745, DOI 10.1051/rnd:19860429; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rabot S, 2010, J NUTR, V140, p677S, DOI 10.3945/jn.109.113738; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Roy K, 2008, PROTEOMICS, V8, P1661, DOI 10.1002/pmic.200700698; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Shima T, 2008, FEMS IMMUNOL MED MIC, V52, P69, DOI 10.1111/j.1574-695X.2007.00344.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Zheng Y, 2008, CANCER BIOL THER, V7, P873, DOI 10.4161/cbt.7.6.5868	55	37	39	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10288	10296		10.1074/jbc.M110.168666	http://dx.doi.org/10.1074/jbc.M110.168666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239485	Green Published, hybrid			2022-12-25	WOS:000288547000046
J	Dassau, L; Conti, LR; Radeke, CM; Ptacek, LJ; Vandenberg, CA				Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Ptacek, Louis J.; Vandenberg, Carol A.			Kir2.6 Regulates the Surface Expression of Kir2.x Inward Rectifier Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; SELECTIVE GOLGI EXPORT; RECTIFYING K+ CHANNEL; ANDERSENS-SYNDROME; PERIODIC PARALYSIS; FUNCTIONAL EXPRESSION; TUBULAR SYSTEM; DISULFIDE BOND; CURRENT I-K1; ER EXPORT	Precise trafficking, localization, and activity of inward rectifier potassium Kir2 channels are important for shaping the electrical response of skeletal muscle. However, how coordinated trafficking occurs to target sites remains unclear. Kir2 channels are tetrameric assemblies of Kir2. x subunits. By immunocytochemistry we show that endogenous Kir2.1 and Kir2.2 are localized at the plasma membrane and T-tubules in rodent skeletal muscle. Recently, a new subunit, Kir2.6, present in human skeletal muscle, was identified as a gene in which mutations confer susceptibility to thyrotoxic hypokalemic periodic paralysis. Here we characterize the trafficking and interaction of wild type Kir2.6 with other Kir2. x in COS-1 cells and skeletal muscle in vivo. Immunocytochemical and electrophysiological data demonstrate that Kir2.6 is largely retained in the endoplasmic reticulum, despite high sequence identity with Kir2.2 and conserved endoplasmic reticulum and Golgi trafficking motifs shared with Kir2.1 and Kir2.2. We identify amino acids responsible for the trafficking differences of Kir2.6. Significantly, we show that Kir2.6 subunits can coassemble with Kir2.1 and Kir2.2 in vitro and in vivo. Notably, this interaction limits the surface expression of both Kir2.1 and Kir2.2. We provide evidence that Kir2.6 functions as a dominant negative, in which incorporation of Kir2.6 as a subunit in a Kir2 channel heterotetramer reduces the abundance of Kir2 channels on the plasma membrane.	[Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Vandenberg, Carol A.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Vandenberg, Carol A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Vandenberg, CA (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	vandenbe@lifesci.ucsb.edu			American Heart Association Western Affiliate [0655234Y]; Muscular Dystrophy Association [4137]; Cottage Hospital	American Heart Association Western Affiliate(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Cottage Hospital	This work was supported by grants from American Heart Association Western Affiliate Grant 0655234Y, the Muscular Dystrophy Association Grant 4137, and the Cottage Hospital Research Program (to C. A. V.).	ALMERS W, 1972, J PHYSIOL-LONDON, V225, P57, DOI 10.1113/jphysiol.1972.sp009929; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; ASHCROFT FM, 1985, J PHYSIOL-LONDON, V359, P269, DOI 10.1113/jphysiol.1985.sp015585; Bendahhou S, 2005, J PHYSIOL-LONDON, V565, P731, DOI 10.1113/jphysiol.2004.081620; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Christe G, 1999, J MOL CELL CARDIOL, V31, P2207, DOI 10.1006/jmcc.1999.1034; Clark RB, 2001, J PHYSIOL-LONDON, V537, P979; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; Fontaine B, 2008, ADV GENET, V63, P3, DOI 10.1016/S0065-2660(08)01001-8; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; Kaisto T, 2003, EXP CELL RES, V289, P47, DOI 10.1016/S0014-4827(03)00231-3; Kristensen M, 2006, AM J PHYSIOL-REG I, V290, pR766, DOI 10.1152/ajpregu.00534.2004; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Namba N, 1996, FEBS LETT, V386, P211, DOI 10.1016/0014-5793(96)00445-0; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Olsen O, 2002, AM J PHYSIOL-CELL PH, V282, pC183, DOI 10.1152/ajpcell.00249.2001; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Panama BK, 2010, PFLUG ARCH EUR J PHY, V460, P839, DOI 10.1007/s00424-010-0864-7; Percival JM, 2007, TRAFFIC, V8, P184, DOI 10.1111/j.1600-0854.2006.00523.x; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sacconi S, 2009, AM J PHYSIOL-CELL PH, V297, pC876, DOI 10.1152/ajpcell.00519.2008; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; SCHNEIDER MF, 1976, J GEN PHYSIOL, V67, P125, DOI 10.1085/jgp.67.2.125; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; STANDEN NB, 1979, J PHYSIOL-LONDON, V294, P497, DOI 10.1113/jphysiol.1979.sp012943; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Struyk AF, 2008, MUSCLE NERVE, V37, P326, DOI 10.1002/mus.20928; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Wallinga W, 1999, EUR BIOPHYS J BIOPHY, V28, P317, DOI 10.1007/s002490050214; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; Wong SHA, 2005, NEUROMUSCULAR DISORD, V15, P630, DOI 10.1016/j.nmd.2005.04.008; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	57	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9526	9541		10.1074/jbc.M110.170597	http://dx.doi.org/10.1074/jbc.M110.170597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209095	Green Published, hybrid			2022-12-25	WOS:000288247700079
J	Midzak, A; Akula, N; Lecanu, L; Papadopoulos, V				Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent; Papadopoulos, Vassilios			Novel Androstenetriol Interacts with the Mitochondrial Translocator Protein and Controls Steroidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; LEYDIG TUMOR-CELLS; PERIPHERAL BENZODIAZEPINE-RECEPTOR; CHOLESTEROL-RICH DOMAINS; IN-VITRO; STEROID-BIOSYNTHESIS; ADRENAL-CORTEX; BINDING-SITES; DRUG DESIGN; SIDE-CHAIN	Steroid hormones are metabolically derived from multiple enzymatic transformations of cholesterol. The controlling step in steroid hormone biogenesis is the delivery of cholesterol from intracellular stores to the cytochrome P450 enzyme CYP11A1 in the mitochondrial matrix. The 18-kDa translocator protein (TSPO) plays an integral part in this mitochondrial cholesterol transport. Consistent with its role in intracellular cholesterol movement, TSPO possesses a cholesterol recognition/interaction amino acid consensus (CRAC) motif that has been demonstrated to bind cholesterol. To further investigate the TSPO CRAC motif, we performed molecular modeling studies and identified a novel ligand, 3,17,19-androsten-5-triol (19-Atriol) that inhibits cholesterol binding at the CRAC motif. 19-Atriol could bind a synthetic CRAC peptide and rapidly inhibited hormonally induced steroidogenesis in MA-10 mouse Leydig tumor cells and constitutive steroidogenesis in R2C rat Leydig tumor cells at low micromolar concentrations. Inhibition at these concentrations was not due to toxicity or inhibition of the CYP11A1 enzyme and was reversed upon removal of the compound. In addition, 19-Atriol was an even more potent inhibitor of PK 11195-stimulated steroidogenesis, with activity in the high nanomolar range. This was accomplished without affecting PK 11195 binding or basal steroidogenesis. Finally, 19-Atriol inhibited mitochondrial import and processing of the steroidogenic acute regulatory protein without any effect on TSPO protein levels. In conclusion, we have identified a novel androstenetriol that can interact with the CRAC domain of TSPO, can control hormonal and constitutive steroidogenesis, and may prove to be a useful tool in the therapeutic control of diseases of excessive steroid formation.	[Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent; Papadopoulos, Vassilios] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Midzak, Andrew; Lecanu, Laurent; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568; lecanu, laurent/0000-0001-6935-1384	National Institutes of Health [ES007747, HD037031]; Canadian Institutes of Health Research [MOP102647, TGF36110]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES007747 and HD037031. This work was also supported by Canadian Institutes of Health Research Grant MOP102647 and a Canada Research Chair in Biochemical Pharmacology (to V.P.). The Research Institute of the McGill University Health Centre was supported by a Center grant from Le Fonds de la Recherche en Sante du Quebec. Drs. Akula, Lecanu, and Papadopoulos are named inventors in a patent pertaining to the work described here. The patent has been licensed to Samaritan Pharmaceuticals. Drs. Lecanu and Papadopoulos served in the past (until 2006) as consultants of Samaritan Pharmaceuticals.; Supported in part by Canadian Institutes of Health Research Postdoctoral Fellowship TGF36110.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bornstein SR, 1999, ANN INTERN MED, V130, P759, DOI 10.7326/0003-4819-130-9-199905040-00017; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Christenson LK, 2000, BBA-MOL CELL BIOL L, V1529, P175, DOI 10.1016/S1388-1981(00)00147-5; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clark BJ, 2001, MOL CELL ENDOCRINOL, V173, P183, DOI 10.1016/S0303-7207(00)00410-X; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Follesa P, 2006, PSYCHOPHARMACOLOGY, V186, P267, DOI 10.1007/s00213-005-0126-0; FREEMAN DA, 1986, ENDOCR REV, V7, P204, DOI 10.1210/edrv-7-2-204; GARNIER M, 1994, MOL PHARMACOL, V45, P201; Gavish M, 1999, PHARMACOL REV, V51, P629; Gazouli M, 2002, J PHARMACOL EXP THER, V303, P627, DOI 10.1124/jpet.102.039388; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P120, DOI 10.1113/expphysiol.2009.048900; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Hardwick M, 1999, CANCER RES, V59, P831; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; KING SR, 1995, ENDOCRINOLOGY, V136, P5165, DOI 10.1210/en.136.11.5165; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; LEFUR G, 1983, LIFE SCI, V32, P1839, DOI 10.1016/0024-3205(83)90062-0; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; MARTIN YC, 1992, J MED CHEM, V35, P2145, DOI 10.1021/jm00090a001; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; PIKULEVA IA, 1995, ARCH BIOCHEM BIOPHYS, V322, P189, DOI 10.1006/abbi.1995.1451; PON LA, 1986, J BIOL CHEM, V261, P6594; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Shalet S, 2008, CURR OPIN ENDOCRINOL, V15, P234, DOI 10.1097/MED.0b013e3282fc7025; SHIN SI, 1968, ENDOCRINOLOGY, V82, P614, DOI 10.1210/endo-82-3-614; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; STOCCO DM, 1988, BIOCHEM J, V249, P95, DOI 10.1042/bj2490095; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711	70	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9875	9887		10.1074/jbc.M110.203216	http://dx.doi.org/10.1074/jbc.M110.203216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209087	Green Published, hybrid			2022-12-25	WOS:000288247700111
J	Ram, S; Lewis, LA; Agarwal, S				Ram, Sanjay; Lewis, Lisa A.; Agarwal, Sarika			Meningococcal Group W-135 and Y Capsular Polysaccharides Paradoxically Enhance Activation of the Alternative Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H BINDING; B NEISSERIA-MENINGITIDIS; SIALIC-ACID; SERUM RESISTANCE; SEROGROUP-B; NULL LOCUS; CRYPTOCOCCUS-NEOFORMANS; PATHOGENIC NEISSERIAE; BACTERICIDAL ACTIVITY; PROPERDIN DEFICIENCY	Although capsular polysaccharide (CPS) is critical for meningococcal virulence, the molecular basis of alternative complement pathway (AP) regulation by meningococcal CPSs remains unclear. Using serum with only the AP active, the ability of strains to generate C3a (a measure of C3 activation) and subsequently deposit C3 fragments on bacteria was studied in encapsulated group A, B, C, W-135, and Y strains and their isogenic unencapsulated mutants. To eliminate confounding AP regulation by membrane-bound factor H(fH; AP inhibitor) and lipooligosaccharide sialic acid, the meningococcal fH ligands (fHbp and NspA) and lipooligosaccharide sialylation were deleted in all strains. Group A CPS expression did not affect C3a generation or C3 deposition. C3a generated by encapsulated and unencapsulated group B and C strains was similar, but CPS expression was associated with reduced C3 deposition, suggesting that these CPSs blocked C3 deposition on membrane targets. Paradoxically, encapsulated W-135 and Y strains (including the wild-type parent strains) enhanced C3 activation and showed marked C3 deposition as early as 10 min; at this time point C3 was barely activated by the unencapsulated mutants. W-135 and Y CPSs themselves served as a site for C3 deposition; this observation was confirmed using immobilized purified CPSs. Purified CPSs bound to unencapsulated meningococci, simulated findings with naturally encapsulated strains. These data highlight the heterogeneity of AP activation on the various meningococcal serogroups that may contribute to differences in their pathogenic mechanisms.	[Ram, Sanjay] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ram, S (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Lazare Res Bldg,Rm 322,364 Plantat St, Worcester, MA 01605 USA.	sanjay.ram@umassmed.edu			National Institutes of Health [AI054544, AI 084048, AI32725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084048, R01AI032725, R56AI032725, R37AI032725, R01AI054544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054544, AI 084048, and AI32725.	Alper C. A., 1970, NEW ENGL J MED, V282, P350; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; BARBA GMR, 1994, CLIN IMMUNOL IMMUNOP, V72, P83, DOI 10.1006/clin.1994.1110; Biesma DH, 2001, J CLIN INVEST, V108, P233, DOI 10.1172/JCI12023; CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154, DOI 10.1128/JCM.30.1.154-159.1992; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; CZOP JK, 1985, J IMMUNOL, V135, P3388; DENSEN P, 1987, NEW ENGL J MED, V316, P922, DOI 10.1056/NEJM198704093161506; Edwards JL, 2002, CELL MICROBIOL, V4, P585, DOI 10.1046/j.1462-5822.2002.00212.x; EDWARDS MS, 1982, J IMMUNOL, V128, P1278; EDWARDS MS, 1980, J EXP MED, V151, P1275, DOI 10.1084/jem.151.5.1275; ELLISON RT, 1983, NEW ENGL J MED, V308, P913, DOI 10.1056/NEJM198304213081601; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; FIJEN CAP, 1989, LANCET, V2, P585; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Frosch M., 2006, HDB MENINGOCOCCAL DI, P145, DOI DOI 10.1002/3527608508.CH8; Gudlavalleti SK, 2004, J BIOL CHEM, V279, P42765, DOI 10.1074/jbc.M313552200; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; IIDA K, 1987, IMMUNOLOGY, V62, P413; INGWER I, 1978, J LAB CLIN MED, V92, P211; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; JARVIS GA, 1994, INFECT IMMUN, V62, P1755, DOI 10.1128/IAI.62.5.1755-1760.1994; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; KOZEL TR, 1991, INFECT IMMUN, V59, P3101, DOI 10.1128/IAI.59.9.3101-3110.1991; KOZEL TR, 1977, INFECT IMMUN, V16, P99, DOI 10.1128/IAI.16.1.99-106.1977; Law SKA, 1997, PROTEIN SCI, V6, P263; LEHNER PJ, 1992, LANCET, V340, P1379, DOI 10.1016/0140-6736(92)92561-S; Lewis LA, 2008, INFECT IMMUN, V76, P339, DOI 10.1128/IAI.00613-07; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; LIM D, 1976, J PEDIATR-US, V89, P42, DOI 10.1016/S0022-3476(76)80924-9; Madico G, 2007, J IMMUNOL, V178, P4489, DOI 10.4049/jimmunol.178.7.4489; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; McQuillen DP, 1999, J INFECT DIS, V179, P124, DOI 10.1086/314545; MORRIS JT, 1992, SOUTHERN MED J, V85, P1030, DOI 10.1097/00007611-199210000-00027; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; PETERSEN BH, 1976, J CLIN INVEST, V57, P283, DOI 10.1172/JCI108279; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; ROSEN MS, 1988, ARCH INTERN MED, V148, P1441, DOI 10.1001/archinte.148.6.1441; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998; SAHU A, 1995, MOL IMMUNOL, V32, P711, DOI 10.1016/0161-5890(95)98933-F; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Selander B, 2000, J CLIN IMMUNOL, V20, P138, DOI 10.1023/A:1006638631581; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2009, INFECT IMMUN, V77, P2094, DOI 10.1128/IAI.01561-08; SIM E, 1981, FEBS LETT, V132, P55, DOI 10.1016/0014-5793(81)80426-7; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SODERSTROM C, 1989, SCAND J INFECT DIS, V21, P259, DOI 10.3109/00365548909035695; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; VARKI A, 1980, J EXP MED, V152, P532, DOI 10.1084/jem.152.3.532; VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6; VENKATESH YP, 1984, J IMMUNOL, V132, P1435; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; Vogel U, 2004, J CLIN MICROBIOL, V42, P2898, DOI 10.1128/JCM.42.7.2898-2901.2004; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Vogel U, 1999, INFECT IMMUN, V67, P954, DOI 10.1128/IAI.67.2.954-957.1999; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	67	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8297	8307		10.1074/jbc.M110.184838	http://dx.doi.org/10.1074/jbc.M110.184838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21245150	hybrid, Green Published			2022-12-25	WOS:000288013300059
J	Zimmermann, E; Skogstrand, K; Hougaard, DM; Astrup, A; Hansen, T; Pedersen, O; Sorensen, TIA; Jess, T				Zimmermann, Esther; Skogstrand, Kristin; Hougaard, David M.; Astrup, Arne; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.; Jess, Tine			Influences of the Common FTO rs9939609 Variant on Inflammatory Markers Throughout a Broad Range of Body Mass Index	PLOS ONE			English	Article							OBESITY; GENE; PREVALENCE; BIOMARKERS; OVERWEIGHT; CHILDHOOD; MORTALITY; DISEASE; RISK	Background: A recent study reported that the fatness associated A-allele of FTO rs9939609 increased plasma high sensitivity C-reactive protein ( hs-CRP) levels independent of fatness. We aimed to investigate if this gene variant had fatness-independent effects on plasma hs-CRP and 10 additional circulating obesity-related adipokines throughout a broad range of body mass index ( BMI) among Danish men. Methodology/Principal Findings: In a population of 362,200 young men, examined for military service between 1943 and 1977, two groups were identified: 1) a random 1% sample and 2) all obese men ( BMI = 31.0 kg/m(2), all of whom were above the 99(th) percentile of this population). At an average age of 49 years ( range: 39 through 65 years), 551 men, hereof 231 of the obese, were re-examined, including genotyping and measurement of the fasting circulating inflammatory markers hs-CRP, IL-1 beta, IL-6, IL-10, IL-18, mip1 alpha, mip1 beta, sTNF alpha-R1, TGF-beta, TNF-alpha and leptin. Men with known disease were excluded from the examination. All the inflammatory markers were log-transformed to approximate a normal distribution. Genotype-phenotype relationships were studied using linear regression analyses with the inflammatory markers as the response variable. Significant positive associations between hs-CRP, leptin and a broad range of BMI were observed, but the associations did not significantly differ across FTO rs9939609 genotype. There were no significant associations between the other inflammatory markers, FTO rs9939609 genotype or BMI, respectively. Conclusion: No fatness-independent effects of the FTO rs9939609 A-allele on a series of inflammatory markers were observed in this cohort of healthy middle-aged men representing a broad range of fatness.	[Zimmermann, Esther; Sorensen, Thorkild I. A.; Jess, Tine] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Zimmermann, Esther] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Skogstrand, Kristin; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, Copenhagen, Denmark; [Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Aarhus University	Zimmermann, E (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	ez@ipm.regionh.dk	Hougaard, David/AAD-6368-2019; Pedersen, Oluf/AAG-8015-2020; Astrup, Arne/B-1407-2015	Skogstrand, Kristin/0000-0002-0026-3711; Astrup, Arne/0000-0001-8968-8996; Zimmermann, Esther/0000-0001-5854-0542	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission [LSHM-CT-2005-018734]; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]; Danish Council for Independent Research	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The work was supported by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark. The work is also part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme [Contract LSHM-CT-2005-018734], and part of the research program of the Danish Obesity Research Centre (DanORC, see www.danorc.dk). DanORC is supported by the Danish Council for Strategic Research (Grant 2101-06-0005). Also, Dr. Tine Jess is funded by a Female Researcher Leader grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P.K., 2010, REGRESSION LINEAR PR, DOI [DOI 10.1007/978-1-4419-7170-8, 10.1007/978-1-4419-7170-8]; APPLEYARD M, 1989, SCAND J SOC MED S41, V70, P1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doney ASF, 2009, CIRC-CARDIOVASC GENE, V2, P255, DOI 10.1161/CIRCGENETICS.108.822320; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fisher E, 2009, OBESITY, V17, P330, DOI 10.1038/oby.2008.465; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gnacinska M, 2009, ADV MED SCI-POLAND, V54, P150, DOI 10.2478/v10039-009-0035-2; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2009, DIS MARKERS, V26, P247, DOI [10.1155/2009/757683, 10.3233/DMA-2009-0634]; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Skogstrand K, 2008, J IMMUNOL METHODS, V336, P78, DOI 10.1016/j.jim.2008.04.006; SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	26	27	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15958	10.1371/journal.pone.0015958	http://dx.doi.org/10.1371/journal.pone.0015958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246032	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511200028
J	Turque, AS; Batista, D; Silveira, CB; Cardoso, AM; Vieira, RP; Moraes, FC; Clementino, MM; Albano, RM; Paranhos, R; Martins, OB; Muricy, G				Turque, Aline S.; Batista, Daniela; Silveira, Cynthia B.; Cardoso, Alexander M.; Vieira, Ricardo P.; Moraes, Fernando C.; Clementino, Maysa M.; Albano, Rodolpho M.; Paranhos, Rodolfo; Martins, Orlando B.; Muricy, Guilherme			Environmental Shaping of Sponge Associated Archaeal Communities	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; RIO-DE-JANEIRO; GUANABARA BAY; MARINE SPONGES; FLOW-CYTOMETRY; DIVERSITY; BACTERIAL; QUALITY; DNA; MICROORGANISMS	Background: Archaea are ubiquitous symbionts of marine sponges but their ecological roles and the influence of environmental factors on these associations are still poorly understood. Methodology/Principal Findings: We compared the diversity and composition of archaea associated with seawater and with the sponges Hymeniacidon heliophila, Paraleucilla magna and Petromica citrina in two distinct environments: Guanabara Bay, a highly impacted estuary in Rio de Janeiro, Brazil, and the nearby Cagarras Archipelago. For this we used metagenomic analyses of 16S rRNA and ammonia monooxygenase (amoA) gene libraries. Hymeniacidon heliophila was more abundant inside the bay, while P. magna was more abundant outside and P. citrina was only recorded at the Cagarras Archipelago. Principal Component Analysis plots (PCA) generated using pairwise unweighted UniFrac distances showed that the archaeal community structure of inner bay seawater and sponges was different from that of coastal Cagarras Archipelago. Rarefaction analyses showed that inner bay archaeaoplankton were more diverse than those from the Cagarras Archipelago. Only members of Crenarchaeota were found in sponge libraries, while in seawater both Crenarchaeota and Euryarchaeota were observed. Although most amoA archaeal genes detected in this study seem to be novel, some clones were affiliated to known ammonia oxidizers such as Nitrosopumilus maritimus and Cenarchaeum symbiosum. Conclusion/Significance: The composition and diversity of archaeal communities associated with pollution-tolerant sponge species can change in a range of few kilometers, probably influenced by eutrophication. The presence of archaeal amoA genes in Porifera suggests that Archaea are involved in the nitrogen cycle within the sponge holobiont, possibly increasing its resistance to anthropogenic impacts. The higher diversity of Crenarchaeota in the polluted area suggests that some marine sponges are able to change the composition of their associated archaeal communities, thereby improving their fitness in impacted environments.	[Turque, Aline S.; Silveira, Cynthia B.; Vieira, Ricardo P.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Batista, Daniela] Pontificia Univ Catolica Rio de Janeiro, Lab Estudos Marinhos & Ambientais, Dept Quim, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] Inst Nacl Metrol Normalizacao & Qualidade Ind, Inmetro Diretoria Programa, Rio De Janeiro, Brazil; [Moraes, Fernando C.; Muricy, Guilherme] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz, INCQS, Lab Microrganismos Referencia, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Paranhos, Rodolfo] Univ Fed Rio de Janeiro, Dept Biol Marinha, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Pontificia Universidade Catolica do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Turque, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	muricy@mn.ufrj.br	Muricy, Guilherme/O-2012-2015; Cardoso, Alexander/S-6687-2017; Silveira, Cynthia/D-6829-2013; Paranhos, Rodolfo/F-1927-2011; Clementino, Maysa/C-1944-2009; Cardoso, Alexander/AAX-2505-2021	Muricy, Guilherme/0000-0002-1705-3673; Cardoso, Alexander/0000-0003-2974-0232; Silveira, Cynthia/0000-0002-9533-5588; Albano, Rodolpho/0000-0002-0643-901X; Batista, Daniela/0000-0001-5624-132X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478925/2007-7]; Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ) [E-26/152.841/2006]; Petrobras/UFRJ [21-0050.0023462.06.4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Petrobras/UFRJ	This study benefited from funding by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant Number 478925/2007-7; www.cnpq.br), Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ Grant number E-26/152.841/2006; www.faperj.br) and Petrobras/UFRJ (Grant number 21-0050.0023462.06.4; www.petrobras.com.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado Pedro M., 2007, V28, P3; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Britto ER, 1978, MONITORAGEM EMISSARI; Chong SC, 2002, ANTON LEEUW INT J G, V81, P263, DOI 10.1023/A:1020535222281; Clementino MM, 2007, J APPL MICROBIOL, V103, P141, DOI 10.1111/j.1365-2672.2006.03230.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Finks RH, 1970, S ZOOL SOC LONDON, V25, P331; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Godoy JM, 1998, J RADIOANAL NUCL CH, V227, P157, DOI 10.1007/BF02386450; Gonzalez AM, 2000, BRAZ ARCH BIOL TECHN, V43, P493, DOI 10.1590/S1516-89132000000500008; Grasshoff K, 1999, METHODS SEAWATER ANA; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ionescu D, 2009, FEMS MICROBIOL ECOL, V69, P425, DOI 10.1111/j.1574-6941.2009.00721.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margot H, 2002, MAR BIOL, V140, P739, DOI 10.1007/s00227-001-0740-2; Menezes CBA, 2010, MICROBIOL RES, V165, P466, DOI 10.1016/j.micres.2009.09.005; Meniconi MDG, 2002, ENVIRON FORENSICS, V3, P303, DOI 10.1006/enfo.2002.0101; Muricy G., 2006, SERIE LIVROS, V17; Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04; PARANHOS R, 1993, ARQ BIOL TECNOL, V36, P685; Paranhos R, 1998, ENVIRON MONIT ASSESS, V50, P131, DOI 10.1023/A:1005855914215; Perez T, 2000, B SOC ZOOL FR, V125, P17; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	55	63	66	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15774	10.1371/journal.pone.0015774	http://dx.doi.org/10.1371/journal.pone.0015774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209889	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600036
J	Weber, MS; Benkhoucha, M; Lehmann-Horn, K; Hertzenberg, D; Sellner, J; Santiago-Raber, ML; Chofflon, M; Hemmer, B; Zamvil, SS; Lalive, PH				Weber, Martin S.; Benkhoucha, Mahdia; Lehmann-Horn, Klaus; Hertzenberg, Deetje; Sellner, Johann; Santiago-Raber, Marie-Laure; Chofflon, Michel; Hemmer, Bernhard; Zamvil, Scott S.; Lalive, Patrice H.			Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; MYCOBACTERIUM-TUBERCULOSIS; GLATIRAMER ACETATE; CROSS-REACTIVITY; IMMUNE-RESPONSES; DENDRITIC CELLS; PROTECTS MICE; INDUCTION; RECEPTOR	Bacterial and viral infections have long been implicated in pathogenesis and progression of multiple sclerosis (MS). Incidence and severity of its animal model experimental autoimmune encephalomyelitis (EAE) can be enhanced by concomitant administration of pertussis toxin (PTx), the major virulence factor of Bordetella pertussis. Its adjuvant effect at the time of immunization with myelin antigen is attributed to an unspecific activation and facilitated migration of immune cells across the blood brain barrier into the central nervous system (CNS). In order to evaluate whether recurring exposure to bacterial antigen may have a differential effect on development of CNS autoimmunity, we repetitively administered PTx prior to immunization. Mice weekly injected with PTx were largely protected from subsequent EAE induction which was reflected by a decreased proliferation and pro-inflammatory differentiation of myelin-reactive T cells. Splenocytes isolated from EAE-resistant mice predominantly produced IL-10 upon re-stimulation with PTx, while non-specific immune responses were unchanged. Longitudinal analyses revealed that repetitive exposure of mice to PTx gradually elevated serum levels for TGF-beta and IL-10 which was associated with an expansion of peripheral CD4(+)CD25(+)FoxP3(+) regulatory T cells (Treg). Increased frequency of Treg persisted upon immunization and thereafter. Collectively, these data suggest a scenario in which repetitive PTx treatment protects mice from development of CNS autoimmune disease through upregulation of regulatory cytokines and expansion of CD4(+)CD25(+)FoxP3(+) Treg. Besides its therapeutic implication, this finding suggests that encounter of the immune system with microbial products may not only be part of CNS autoimmune disease pathogenesis but also of its regulation.	[Weber, Martin S.; Lehmann-Horn, Klaus; Hertzenberg, Deetje; Sellner, Johann; Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, Munich, Germany; [Weber, Martin S.; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Benkhoucha, Mahdia; Santiago-Raber, Marie-Laure; Chofflon, Michel; Lalive, Patrice H.] Univ Hosp Geneva, Dept Neurosci, Div Neurol, Geneva, Switzerland; [Benkhoucha, Mahdia; Santiago-Raber, Marie-Laure; Chofflon, Michel; Lalive, Patrice H.] Univ Geneva, Fac Med, Geneva, Switzerland; [Benkhoucha, Mahdia; Lalive, Patrice H.] Univ Hosp Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Lalive, Patrice H.] Univ Geneva, Univ Hosp Geneva, Fac Med, Dept Genet & Lab Med, Geneva, Switzerland	Technical University of Munich; University of California System; University of California San Francisco; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Weber, MS (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.	m.weber@lrz.tu-muenchen.de; zamvil@ucsf.neuroimmunol.org	Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021; Selllner, Johann/AAB-1263-2019; Weber, Martin/GPW-6095-2022; Lalive, Patrice/AAM-5861-2020	Hemmer, Bernhard/0000-0001-5985-6784; 	Deutsche Forschungsgemeinschaft (DFG) [WE 3547/4-1]; National Multiple Sclerosis Society (NMSS) [RG 445A1/T, RG 3622, 3913]; Else Kroner Fresenius Stiftung [A69/2010]; TEVA; Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen; Novartis; Bayer Schering; Biogen Idec; Merck-Serono; Roche; Micromet; Metanomics; Protagen; National Institutes of Health (NIH [RO1 AI073737, RO1 AI059709, RO1 NS063008]; Maisin Foundation; Swiss National Foundation [310000-132705]; Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059709, R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Else Kroner Fresenius Stiftung; TEVA(Teva Pharmaceutical Industries); Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen; Novartis(Novartis); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck-Serono(Merck & Company); Roche(Roche Holding); Micromet(Amgen); Metanomics; Protagen; National Institutes of Health (NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maisin Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.S.W. received grant support from the Deutsche Forschungsgemeinschaft (DFG; WE 3547/4-1), the National Multiple Sclerosis Society (NMSS; RG 445A1/T), the Else Kroner Fresenius Stiftung (A69/2010), TEVA and the Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen. K.L-H. and J.S. were supported by fellowships from the KKF of the Technische Universitat Munchen. B.H. has received board membership and/or consulting fees from Novartis, Bayer Schering, Biogen Idec, Merck-Serono, Roche, Micromet and Novartis. B.H. received grant support from Novartis, Bayer Schering, Biogen Idec, Metanomics, Protagen and Merck-Serono. S.S.Z. was supported by the National Institutes of Health (NIH; RO1 AI073737, RO1 AI059709, and RO1 NS063008), the NMSS (RG 3622 and 3913) and the Maisin Foundation. P.H.L. was supported by the Swiss National Foundation (#310000-132705) and the Swiss Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RK, 2002, J NEUROIMMUNOL, V129, P133, DOI 10.1016/S0165-5728(02)00203-5; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Arimoto H, 2000, J NEUROIMMUNOL, V104, P15, DOI 10.1016/S0165-5728(99)00242-8; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bager P, 2004, BRAIN, V127, P2491, DOI 10.1093/brain/awh283; BENNUN A, 1995, J IMMUNOL, V154, P2939; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; Bruckener KE, 2003, J CELL SCI, V116, P1837, DOI 10.1242/jcs.00378; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Burnette W N, 1997, Behring Inst Mitt, P434; Cassan C, 2006, J IMMUNOL, V177, P1552, DOI 10.4049/jimmunol.177.3.1552; Cermelli C, 2003, J INFECT DIS, V187, P1377, DOI 10.1086/368166; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Gardell JL, 2006, J CLIN VIROL, V37, pS11, DOI 10.1016/S1386-6532(06)70005-1; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; HANDEL AE, PLOS ONE, V5; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hofstetter HH, 2007, CYTOKINE, V40, P35, DOI 10.1016/j.cyto.2007.07.192; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINTHICUM DS, 1982, IMMUNOBIOLOGY, V162, P211, DOI 10.1016/S0171-2985(11)80001-X; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; MUNOZ JJ, 1984, CELL IMMUNOL, V83, P92, DOI 10.1016/0008-8749(84)90228-4; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; RADVANYI LG, 1993, J IMMUNOL, V150, P5704; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Robbinson D, 1996, CELL IMMUNOL, V168, P165, DOI 10.1006/cimm.1996.0063; SCHIFFENBAUER J, 1993, P NATL ACAD SCI USA, V90, P8543, DOI 10.1073/pnas.90.18.8543; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; SOOS JM, 1993, J NEUROIMMUNOL, V43, P39, DOI 10.1016/0165-5728(93)90073-8; Stephens LA, 2005, P NATL ACAD SCI USA, V102, P17418, DOI 10.1073/pnas.0507454102; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Su SB, 2001, J IMMUNOL, V167, P250, DOI 10.4049/jimmunol.167.1.250; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; WESSELBORG S, 1993, J IMMUNOL, V150, P4338; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029	53	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16009	10.1371/journal.pone.0016009	http://dx.doi.org/10.1371/journal.pone.0016009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209857	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600057
J	Yoder, MJ; Miko, I; Seltmann, KC; Bertone, MA; Deans, AR				Yoder, Matthew J.; Miko, Istvan; Seltmann, Katja C.; Bertone, Matthew A.; Deans, Andrew R.			A Gross Anatomy Ontology for Hymenoptera	PLOS ONE			English	Article							GENOMICS; IMAGES	Hymenoptera is an extraordinarily diverse lineage, both in terms of species numbers and morphotypes, that includes sawflies, bees, wasps, and ants. These organisms serve critical roles as herbivores, predators, parasitoids, and pollinators, with several species functioning as models for agricultural, behavioral, and genomic research. The collective anatomical knowledge of these insects, however, has been described or referred to by labels derived from numerous, partially overlapping lexicons. The resulting corpus of information-millions of statements about hymenopteran phenotypes-remains inaccessible due to language discrepancies. The Hymenoptera Anatomy Ontology (HAO) was developed to surmount this challenge and to aid future communication related to hymenopteran anatomy. The HAO was built using newly developed interfaces within mx, a Web-based, open source software package, that enables collaborators to simultaneously contribute to an ontology. Over twenty people contributed to the development of this ontology by adding terms, genus differentia, references, images, relationships, and annotations. The database interface returns an Open Biomedical Ontology (OBO) formatted version of the ontology and includes mechanisms for extracting candidate data and for publishing a searchable ontology to the Web. The application tools are subject-agnostic and may be used by others initiating and developing ontologies. The present core HAO data constitute 2,111 concepts, 6,977 terms (labels for concepts), 3,152 relations, 4,361 sensus (links between terms, concepts, and references) and over 6,000 text and graphical annotations. The HAO is rooted with the Common Anatomy Reference Ontology (CARO), in order to facilitate interoperability with and future alignment to other anatomy ontologies, and is available through the OBO Foundry ontology repository and BioPortal. The HAO provides a foundation through which connections between genomic, evolutionary developmental biology, phylogenetic, taxonomic, and morphological research can be actualized. Inherent mechanisms for feedback and content delivery demonstrate the effectiveness of remote, collaborative ontology development and facilitate future refinement of the HAO.	[Yoder, Matthew J.; Miko, Istvan; Seltmann, Katja C.; Bertone, Matthew A.; Deans, Andrew R.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Yoder, MJ (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	andy_deans@ncsu.edu	Deans, Andrew R./AAG-4166-2021; Seltmann, Katja/AAC-9120-2020	Deans, Andrew R./0000-0002-2119-4663; Seltmann, Katja/0000-0001-5354-6048; Miko, Istvan/0000-0001-9719-0215; Bertone, Matt/0000-0001-7985-1913	National Science Foundation [DBI-0850223, DEB-0328922, EF-0905606]; OBO ontology; International Society of Hymenopterist; Direct For Biological Sciences [1261346] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0850223] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); OBO ontology; International Society of Hymenopterist; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation funded this research through its Advances in Biological Informatics program (grant DBI-0850223), PEET program (DEB-0328922), and NESCent (EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Fredrik Ronquist for encouraging the development of the HAO, Gary Gibson and Lars Vilhelmsen for their feedback on content and the OBO ontology and International Society of Hymenopterist for support and feedback. Ontology development was significantly enhanced by colleagues at the National Evolutionary Synthesis Center (NESCent). Roberto Keller and two anonymous reviewers provided many useful comments and suggestions to improve the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balhoff JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010500; BARD J, 2008, COMPUT BIOL SER, V6, P3; BECK D. ELDEN, 1933, PROC UTAH ACAD SCI, V10, P89; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Burger A., 2008, ANATOMY ONTOLOGIES B; Cote RG, 2008, NUCLEIC ACIDS RES, V36, pW372, DOI 10.1093/nar/gkn252; *CREAT COMM, CREAT COMM BY NC SA; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Deans AR, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1787.1.2; Drysdale R, 2001, Brief Bioinform, V2, P68, DOI 10.1093/bib/2.1.68; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; La Salle J, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2217.1.3; LEOPOLD J, 2009, P WORLD ACAD SCI ENG, V52, P369; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Miko I, 2009, ZOOKEYS, P127, DOI 10.3897/zookeys.20.119; Musen M A, 2008, AMIA Annu Symp Proc, P1223; Ramirez MJ, 2007, SYST BIOL, V56, P283, DOI 10.1080/10635150701313848; Smith B., 2005, 10 INT C LOG METH PH, P505; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Topalis P, 2008, INSECT MOL BIOL, V17, P87, DOI 10.1111/j.1365-2583.2008.00781.x; Verhoeff CW, 1893, ZOOL ANZ, V16, P407; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wharton RA, 2010, ZOOKEYS, P35, DOI 10.3897/zookeys.37.313; WHEELER WM, 1910, COLUMBIA BIOL SERIES, V9; Yoder M, 2007, ZOOTAXA, P47; Yu AC, 2006, J BIOMED INFORM, V39, P252, DOI 10.1016/j.jbi.2005.11.006; MX COLLABORATIVE WEB	36	236	257	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15991	10.1371/journal.pone.0015991	http://dx.doi.org/10.1371/journal.pone.0015991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209921	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200077
J	Valluet, A; Hmitou, I; Davis, S; Druillennec, S; Larcher, M; Laroche, S; Eychene, A				Valluet, Agathe; Hmitou, Isabelle; Davis, Sabrina; Druillennec, Sabine; Larcher, Magalie; Laroche, Serge; Eychene, Alain			B-raf Alternative Splicing Is Dispensable for Development but Required for Learning and Memory Associated with the Hippocampus in the Adult Mouse	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACIO-CUTANEOUS SYNDROME; ELEMENT-BINDING PROTEIN; EARLY GENE ZIF268; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; REGULATED KINASE; MAP KINASE; IN-VIVO; ACTIVATION	The B-raf proto-oncogene exerts essential functions during development and adulthood. It is required for various processes, such as placental development, postnatal nervous system myelination and adult learning and memory. The mouse B-raf gene encodes several isoforms resulting from alternative splicing of exons 8b and 9b located in the hinge region upstream of the kinase domain. These alternative sequences modulate the biochemical and biological properties of B-Raf proteins. To gain insight into the physiological importance of B-raf alternative splicing, we generated two conditional knockout mice of exons 8b and 9b. Homozygous animals with a constitutive deletion of either exon are healthy and fertile, and survive up to 18 months without any visible abnormalities, demonstrating that alternative splicing is not essential for embryonic development and brain myelination. However, behavioural analyses revealed that expression of exon 9b-containing isoforms is required for B-Raf function in hippocampal-dependent learning and memory. In contrast, mice mutated on exon 8b are not impaired in this function. Interestingly, our results suggest that exon 8b is present only in eutherians and its splicing is differentially regulated among species.	[Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Inst Curie, F-91405 Orsay, France; [Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Ctr Univ Orsay, INSERM, U1021, F-91405 Orsay, France; [Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Ctr Univ Orsay, CNRS, UMR 3347, F-91405 Orsay, France; [Davis, Sabrina; Laroche, Serge] Univ Paris 11, Ctr Neurosci Paris Sud, Orsay, France; [Davis, Sabrina; Laroche, Serge] CNRS, UMR 8195, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Valluet, A (corresponding author), Inst Curie, F-91405 Orsay, France.	eychene@curie.fr	DRUILLENNEC, Sabine/B-2572-2019; Eychene, Alain/M-8838-2017; Hmitou, Isabelle/H-8341-2017	DRUILLENNEC, Sabine/0000-0003-0237-1465; Hmitou, Isabelle/0000-0001-7320-6075; EYCHENE, Alain/0000-0002-6818-7225	Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer (Comite de l'Essonne); Ministere Francais de la Recherche; Association pour la Recherche sur le Cancer (ARC); Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise); Institut National du Cancer (INCa)	Institut Curie; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (Comite de l'Essonne); Ministere Francais de la Recherche(Ministry of Research, France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was funded by the Institut Curie, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), and by grants from the Ligue Nationale Contre le Cancer (Comite de l'Essonne). A. V. and I. H. were supported by fellowships from the Ministere Francais de la Recherche, the Association pour la Recherche sur le Cancer (ARC) and the Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise). M.L. was supported by the Institut National du Cancer (INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; EYCHENE A, 1992, ONCOGENE, V7, P1315; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Hmitou I, 2007, MOL CELL BIOL, V27, P31, DOI 10.1128/MCB.01265-06; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kelly A, 2003, J NEUROSCI, V23, P5354; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; MARX M, 1988, EMBO J, V7, P3369, DOI 10.1002/j.1460-2075.1988.tb03209.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Selcher JC, 2002, NEUROSCIENTIST, V8, P122, DOI 10.1177/107385840200800208; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	36	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15272	10.1371/journal.pone.0015272	http://dx.doi.org/10.1371/journal.pone.0015272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203559	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000027
J	Christie, MR; Tissot, BN; Albins, MA; Beets, JP; Jia, YL; Ortiz, DM; Thompson, SE; Hixon, MA				Christie, Mark R.; Tissot, Brian N.; Albins, Mark A.; Beets, James P.; Jia, Yanli; Ortiz, Delisse M.; Thompson, Stephen E.; Hixon, Mark A.			Larval Connectivity in an Effective Network of Marine Protected Areas	PLOS ONE			English	Article							CORAL-REEF FISH; ZEBRASOMA-FLAVESCENS; SELF-RECRUITMENT; YELLOW TANG; POPULATIONS; PATTERNS; RETENTION; ACANTHURIDAE; MANAGEMENT; DISPERSAL	Acceptance of marine protected areas (MPAs) as fishery and conservation tools has been hampered by lack of direct evidence that MPAs successfully seed unprotected areas with larvae of targeted species. For the first time, we present direct evidence of large-scale population connectivity within an existing and effective network of MPAs. A new parentage analysis identified four parent-offspring pairs from a large, exploited population of the coral-reef fish Zebrasoma flavescens in Hawai'i, revealing larval dispersal distances ranging from 15 to 184 km. In two cases, successful dispersal was from an MPA to unprotected sites. Given high adult abundances, the documentation of any parent-offspring pairs demonstrates that ecologically-relevant larval connectivity between reefs is substantial. All offspring settled at sites to the north of where they were spawned. Satellite altimetry and oceanographic models from relevant time periods indicated a cyclonic eddy that created prevailing northward currents between sites where parents and offspring were found. These findings empirically demonstrate the effectiveness of MPAs as useful conservation and management tools and further highlight the importance of coupling oceanographic, genetic, and ecological data to predict, validate and quantify larval connectivity among marine populations.	[Christie, Mark R.; Albins, Mark A.; Hixon, Mark A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Tissot, Brian N.] Washington State Univ, Sch Earth & Environm Sci, Vancouver, WA USA; [Beets, James P.] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA; [Jia, Yanli] Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Ortiz, Delisse M.] Natl Marine Fisheries Serv, Highly Migratory Species Management Div, Silver Spring, MD USA; [Thompson, Stephen E.] Marine Environm Res, Kailua, HI USA	Oregon State University; Washington State University; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA	Christie, MR (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	christim@science.oregonstate.edu	Langhamer, Olivia/J-3425-2012	Tissot, Brian/0000-0003-0398-2241	Conservation International; Marine Environmental Research; National Science Foundation [05-50709, 08-51162]; National Oceanic and Atmospheric Association	Conservation International; Marine Environmental Research; National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Association(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by grants from Conservation International (MAH), Marine Environmental Research (MAH, JPB, and BNT), and Jim and Kayla Paul (MAH), with supplemental funding from the National Science Foundation (05-50709, 08-51162) (MAH). YJ was supported by the National Oceanic and Atmospheric Association through a grant to the International Pacific Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; BELKHIR K, 2002, 5000 CNR SUMR U MONT; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Christie MR, 2010, MOL ECOL RESOUR, V10, P115, DOI 10.1111/j.1755-0998.2009.02687.x; Christie MR, 2009, MOL ECOL RESOUR, V9, P544, DOI 10.1111/j.1755-0998.2008.02354.x; Claisse JT, 2009, CORAL REEFS, V28, P95, DOI 10.1007/s00338-008-0447-7; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; EBLE JA, 2011, MAR ECOL PR IN PRESS; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; LEIS JM, 1976, MAR BIOL, V36, P359, DOI 10.1007/BF00389198; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MILLER JM, 1973, EARLY LIFE HIST FISH; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Ortiz DM, 2008, MAR ECOL PROG SER, V365, P217, DOI 10.3354/meps07492; Palumbi SR, 2003, ECOL APPL, V13, pS146; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sancho G, 1997, MAR ECOL PROG SER, V153, P311, DOI 10.3354/meps153311; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; STEVENSON TC, ICES J MARI IN PRESS; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorrold SR, 2002, B MAR SCI, V70, P291; Thresher R. E., 1984, REPROD REEF FISHES, P273; WALSH WJ, 1987, ENVIRON BIOL FISH, V18, P257, DOI 10.1007/BF00004879; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029	42	158	159	0	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15715	10.1371/journal.pone.0015715	http://dx.doi.org/10.1371/journal.pone.0015715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203576	gold, Green Published			2022-12-25	WOS:000285576900036
J	Xiao, JY; Liu, C; Hou, JJ; Cui, C; Wu, DD; Fan, HY; Sun, XH; Meng, J; Yang, FQ; Wang, EH; Yu, BZ				Xiao, Jianying; Liu, Chao; Hou, Junjie; Cui, Cheng; Wu, Didi; Fan, Huiyu; Sun, Xiaohan; Meng, Jun; Yang, Fuquan; Wang, Enhua; Yu, Bingzhi			Ser(149) Is Another Potential PKA Phosphorylation Target of Cdc25B in G(2)/M Transition of Fertilized Mouse Eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; IN-VITRO; MEIOTIC RESUMPTION; XENOPUS OOCYTES; CAMP; PHOSPHATASE; ACTIVATION; MEIOSIS; MITOSIS; ARREST	It is well documented that protein kinase A (PKA) acts as a negative regulator of M phase promoting factor (MPF) by phosphorylating cell division cycle 25 homolog B (Cdc25B) in mammals. However, the molecular mechanism remains unclear. In this study, we identified PKA phosphorylation sites in vitro by LC-MS/MS analysis, including Ser(149), Ser(229), and Ser(321) of Cdc25B, and explored the role of Ser(149) in G(2)/M transition of fertilized mouse eggs. The results showed that the overexpressed Cdc25B-S149A mutant initiated efficient MPF activation by direct dephosphorylation of Cdc2-Tyr(15), resulting in triggering mitosis prior to Cdc25B-WT. Conversely, overexpression of the phosphomimic Cdc25B-S149D mutant showed no significant difference in comparison with the control groups. Furthermore, we found that Cdc25B-Ser(149) was phosphorylated at G(1) and S phases, whereas dephosphorylated at G(2) and M phases, and the phosphorylation of Cdc25B-Ser(149) was modulated by PKA in vivo. In addition, we examined endogenous and exogenous Cdc25B, which were expressed mostly in the cytoplasm at the G(1) and S phases and translocated to the nucleus at the G(2) phase. Collectively, our findings provide evidence that Ser(149) may be another potential PKA phosphorylation target of Cdc25B in G(2)/M transition of fertilized mouse eggs and Cdc25B as a direct downstream substrate of PKA in mammals, which plays important roles in the regulation of early development of mouse embryos.	[Xiao, Jianying; Liu, Chao; Cui, Cheng; Wu, Didi; Meng, Jun; Yu, Bingzhi] China Med Univ, Dept Biochem & Mol Biol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Wang, Enhua; Yu, Bingzhi] China Med Univ, Inst Pathol & Pathopysiol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Yu, Bingzhi] China Med Univ, Key Lab Med Cell Biol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Xiao, Jianying; Liu, Chao; Fan, Huiyu; Sun, Xiaohan] Liaoning Medial Univ, Dept Biochem & Mol Biol, Jinzhou 121001, Liaoning Prov, Peoples R China; [Hou, Junjie; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	China Medical University; Ministry of Education, China; China Medical University; Ministry of Education, China; China Medical University; Ministry of Education, China; Jinzhou Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yu, BZ (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ China, 92 Bei Er Rd, Shenyang 110001, Liaoning Prov, Peoples R China.	ybzbiochem@yeah.net			National Nature Science Foundation of China [30900514]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China Grant 30900514.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bouche JP, 2008, J PROTEOME RES, V7, P1264, DOI 10.1021/pr700623p; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eyers PA, 2005, J BIOL CHEM, V280, P24339, DOI 10.1074/jbc.M412442200; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Gallicano GI, 1997, MOL REPROD DEV, V46, P587, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;587::AID-MRD16&gt;3.0.CO;2-T; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; GRIECO D, 1994, P NATL ACAD SCI USA, V91, P9896, DOI 10.1073/pnas.91.21.9896; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; HOGAN B, 1986, MANIPULATING MOUSE E, P249; Jiang XN, 2008, J PROTEOME RES, V7, P1640, DOI 10.1021/pr700675j; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kovo M, 2006, REPRODUCTION, V132, P33, DOI 10.1530/rep.1.00824; Lammer C, 1998, J CELL SCI, V111, P2445; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Schultz R, 2009, CELL CYCLE, V8, P516; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Woo ES, 1999, ONCOGENE, V18, P2770, DOI 10.1038/sj.onc.1202614; Yamada K, 2006, PATHOBIOLOGY, V73, P1, DOI 10.1159/000093086; Yu BZ, 2005, DEV DYNAM, V232, P98, DOI 10.1002/dvdy.20205; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799; Zhang Z, 2007, MOL REPROD DEV, V74, P1247, DOI 10.1002/mrd.20703	41	13	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10356	10366		10.1074/jbc.M110.150524	http://dx.doi.org/10.1074/jbc.M110.150524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21212267	hybrid, Green Published			2022-12-25	WOS:000288547000052
J	Balsera, M; Buey, RM; Li, XD				Balsera, Monica; Buey, Ruben M.; Li, Xiao-Dan			Quaternary Structure of the Oxaloacetate Decarboxylase Membrane Complex and Mechanistic Relationships to Pyruvate Carboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY COUPLING MECHANISM; SMALL-ANGLE SCATTERING; X-RAY SOLUTION; NA+ PUMP; BETA-SUBUNIT; KLEBSIELLA-PNEUMONIAE; BIOLOGICAL MACROMOLECULES; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; COENZYME-A	The oxaloacetate decarboxylase primary Na+ pump (OAD) is an essential membrane protein complex that functions in the citrate fermentation pathway of some pathogenic bacteria under anaerobic conditions. OAD contains three different subunits: Oad-alpha, a biotinylated extrinsic protein that catalyzes the alpha-ketodecarboxylation of oxaloacetate; Oad-gamma, a structural bitopic membrane protein whose cytosolic tail (named as Oad-gamma') binds tightly to Oad-alpha; and Oad-beta, a multispan transmembrane alpha-helical protein that constitutes the Na+ channel. How OAD is organized structurally at the membrane and what the molecular determinants are that lead to an efficient energy coupling mechanism remain elusive. In the present work, we elucidate the stoichiometry of the native complex as well as the low resolution structure of the peripheral components of OAD (Oad-alpha and Oad-gamma') by small angle x-ray scattering. Our results point to a quaternary assembly similar to the pyruvate carboxylase complex organization. Herein, we propose a model in which the association in pairs of Oad-alpha dimers, mediated by Oad-gamma, results in the acquisition of a functional oligomeric state at the bacterial membrane. New structural insights for the conformational rearrangements associated with the carboxylbiotin transfer reaction within OAD are provided.	[Balsera, Monica; Buey, Ruben M.; Li, Xiao-Dan] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Balsera, Monica] CSIC, Dept Estres Abiot, Inst Recursos Nat & Agrobiol Salamanca, Salamanca 37008, Spain; [Buey, Ruben M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Li, XD (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	xiao.li@psi.ch	Balsera, Monica/K-2877-2014; Martinez-Buey, Ruben/K-4296-2014	Balsera, Monica/0000-0002-5586-6050; Martinez-Buey, Ruben/0000-0003-1263-0221; li, xiaodan/0000-0001-8647-7317	Swiss National Science Foundation [1122.0036 NF]; Consejo Superior de Investigaciones Cientificas [200940I204]; Federation of European Biochemical Societies; Juan de la Cierva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Consejo Superior de Investigaciones Cientificas; Federation of European Biochemical Societies; Juan de la Cierva(Instituto de Salud Carlos III)	This work was supported by Swiss National Science Foundation Grant 1122.0036 NF (to X.-D.L.).; Supported by Consejo Superior de Investigaciones Cientificas Grant 200940I204.; Supported by a Federation of European Biochemical Societies fellowship and a contract from the Juan de la Cierva program.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8191, DOI 10.1021/bi00373a011; Dahinden P, 2005, FEBS J, V272, P846, DOI 10.1111/j.1742-4658.2004.04524.x; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; DIBERARDINO M, 1995, EUR J BIOCHEM, V231, P790; DiBerardino M, 1996, EMBO J, V15, P1842, DOI 10.1002/j.1460-2075.1996.tb00534.x; DIMROTH P, 1982, EUR J BIOCHEM, V121, P435, DOI 10.1111/j.1432-1033.1982.tb05806.x; DIMROTH P, 1980, FEBS LETT, V122, P234, DOI 10.1016/0014-5793(80)80446-7; Dimroth P, 2001, BBA-BIOENERGETICS, V1505, P1, DOI 10.1016/S0005-2728(00)00272-3; DIMROTH P, 1984, BIOCHEMISTRY-US, V23, P5360, DOI 10.1021/bi00317a039; DIMROTH P, 1993, BIOCHEMISTRY-US, V32, P1734, DOI 10.1021/bi00058a006; DIMROTH P, 1983, EUR J BIOCHEM, V137, P107, DOI 10.1111/j.1432-1033.1983.tb07802.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Jockel P, 2000, BIOCHEMISTRY-US, V39, P2307, DOI 10.1021/bi992261v; Jockel P, 2000, BIOCHEMISTRY-US, V39, P4320, DOI 10.1021/bi992817e; Jockel P, 1999, BIOCHEMISTRY-US, V38, P13461, DOI 10.1021/bi990303+; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lasso G, 2010, STRUCTURE, V18, P1300, DOI 10.1016/j.str.2010.07.008; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schmid M, 2002, EUR J BIOCHEM, V269, P2997, DOI 10.1046/j.1432-1033.2002.02983.x; Schmid M, 2002, BIOCHEMISTRY-US, V41, P1285, DOI 10.1021/bi015764l; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wild MR, 2003, BIOCHEMISTRY-US, V42, P11615, DOI 10.1021/bi034753k; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008	33	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9457	9467		10.1074/jbc.M110.197442	http://dx.doi.org/10.1074/jbc.M110.197442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209096	hybrid, Green Published			2022-12-25	WOS:000288247700073
J	Bettaieb, A; Liu, SM; Xi, YN; Nagata, N; Matsuo, K; Matsuo, I; Chahed, S; Bakke, J; Keilhack, H; Tiganis, T; Haj, FG				Bettaieb, Ahmed; Liu, Siming; Xi, Yannan; Nagata, Naoto; Matsuo, Kosuke; Matsuo, Izumi; Chahed, Samah; Bakke, Jesse; Keilhack, Heike; Tiganis, Tony; Haj, Fawaz G.			Differential Regulation of Endoplasmic Reticulum Stress by Protein Tyrosine Phosphatase 1B and T Cell Protein Tyrosine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANSLATIONAL CONTROL; ER STRESS; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; DIABETES-MELLITUS; INDUCED APOPTOSIS; MICE; KINASE; ACTIVATION	Protein-tyrosine phosphatase 1B (PTP1B) and T cell protein-tyrosine phosphatase (TCPTP) are closely related intracellular phosphatases implicated in the control of glucose homeostasis. PTP1B and TCPTP can function coordinately to regulate protein tyrosine kinase signaling, and PTP1B has been implicated previously in the regulation of endoplasmic reticulum (ER) stress. In this study, we assessed the roles of PTP1B and TCPTP in regulating ER stress in the endocrine pancreas. PTP1B and TCPTP expression was determined in pancreases from chow and high fat fed mice and the impact of PTP1B and TCPTP over-or underexpression on palmitate- or tunicamycin-induced ER stress signaling assessed in MIN6 insulinoma beta cells. PTP1B expression was increased, and TCPTP expression decreased in pancreases of mice fed a high fat diet, as well as in MIN6 cells treated with palmitate. PTP1B overexpression or TCPTP knockdown in MIN6 cells mitigated palmitate- or tunicamycin-induced PERK/eIF2 alpha ER stress signaling, whereas PTP1B deficiency enhanced ER stress. Moreover, PTP1B deficiency increased ER stress-induced cell death, whereas TCPTP deficiency protected MIN6 cells from ER stress-induced death. ER stress coincided with the inhibition of Src family kinases (SFKs), which was exacerbated by PTP1B overexpression and largely prevented by TCPTP knockdown. Pharmacological inhibition of SFKs ameliorated the protective effect of TCPTP deficiency on ER stress-induced cell death. These results demonstrate that PTP1B and TCPTP play nonredundant roles in modulating ER stress in pancreatic beta cells and suggest that changes in PTP1B and TCPTP expression may serve as an adaptive response for the mitigation of chronic ER stress.	[Bettaieb, Ahmed; Liu, Siming; Xi, Yannan; Nagata, Naoto; Matsuo, Kosuke; Matsuo, Izumi; Chahed, Samah; Bakke, Jesse; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keilhack, Heike] Merck Res Labs, Boston, MA 02115 USA; [Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of California System; University of California Davis; Merck & Company; Monash University	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Tiganis, Tony/AAV-3495-2020; NAGATA, Naoto/D-9261-2012	Tiganis, Tony/0000-0002-8065-9942; NAGATA, Naoto/0000-0002-2389-2334; Bakke, Jesse/0000-0003-0305-5165	National Institutes of Health [R56 DK084317]; Juvenile Diabetes Research Foundation [1-2009-337]; American Diabetes Association [7-06-JF-28]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56 (R56 DK084317 to F.G.H.). This work was also supported by Research Grant 1-2009-337 from the Juvenile Diabetes Research Foundation, Junior Faculty Award 7-06-JF-28 from the American Diabetes Association, and the National Health and Medical Research Council of Australia (to T.T.).	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; Dalgarno D, 2006, CHEM BIOL DRUG DES, V67, P46, DOI 10.1111/j.1747-0285.2005.00316.x; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Hellemans KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007266; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	53	50	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9225	9235		10.1074/jbc.M110.186148	http://dx.doi.org/10.1074/jbc.M110.186148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216966	Green Published, hybrid			2022-12-25	WOS:000288247700053
J	Kakiashvili, E; Dan, QH; Vandermeer, M; Zhang, YQ; Waheed, F; Pham, M; Szaszi, K				Kakiashvili, Eli; Dan, Qinghong; Vandermeer, Matthew; Zhang, Yuqian; Waheed, Faiza; Pham, Monica; Szaszi, Katalin			The Epidermal Growth Factor Receptor Mediates Tumor Necrosis Factor-alpha-induced Activation of the ERK/GEF-H1/RhoA Pathway in Tubular Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; NUCLEOTIDE-EXCHANGE FACTORS; SRC FAMILY KINASES; TNF-ALPHA; EGF RECEPTOR; C-SRC; PARACELLULAR PERMEABILITY; AMPHIREGULIN RELEASE; ENDOTHELIAL-CELLS; CONVERTING-ENZYME	Tumor necrosis factor (TNF)-alpha induces cytoskeleton and intercellular junction remodeling in tubular epithelial cells; the underlying mechanisms, however, are incompletely explored. We have previously shown that ERK-mediated stimulation of the RhoA GDP/GTP exchange factor GEF-H1/Lfc is critical for TNF-alpha-induced RhoA stimulation. Here we investigated the upstream mechanisms of ERK/GEF-H1 activation. Surprisingly, TNF-alpha-induced ERK and RhoA stimulation in tubular cells were prevented by epidermal growth factor receptor (EGFR) inhibition or silencing. TNF-alpha also enhanced phosphorylation of the EGFR. EGF treatment mimicked the effects of TNF-alpha, as it elicited potent, ERK-dependent GEF-H1 and RhoA activation. Moreover, EGF-induced RhoA activation was prevented by GEF-H1 silencing, indicating that GEF-H1 is a key downstream effector of the EGFR. The TNF-alpha-elicited EGFR, ERK, and RhoA stimulation were mediated by the TNF-alpha convertase enzyme (TACE) that can release EGFR ligands. Further, EGFR transactivation also required the tyrosine kinase Src, as Src inhibition prevented TNF-alpha-induced activation of the EGFR/ERK/GEF-H1/RhoA pathway. Importantly, a bromodeoxyuridine (BrdU) incorporation assay and electric cell substrate impedance-sensing (ECIS) measurements revealed that TNF-alpha stimulated cell growth in an EGFR-dependent manner. In contrast, TNF-alpha-induced NF kappa B activation was not prevented by EGFR or Src inhibition, suggesting that TNF-alpha exerts both EGFR-dependent and -independent effects. In summary, in the present study we show that the TNF-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular cells is mediated through Src- and TACE-dependent EGFR activation. Such a mechanism could couple inflammatory and proliferative stimuli and, thus, may play a key role in the regulation of wound healing and fibrogenesis.	[Szaszi, Katalin] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Szaszi, K (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St,LKSKI Rm 622, Toronto, ON M5B 1W8, Canada.	szaszik@smh.ca	Vandermeer, Matthew/AAY-8637-2020; Szaszi, Katalin/J-7522-2012	Vandermeer, Matthew/0000-0002-8797-6713; Szaszi, Katalin/0000-0002-2490-8422	Kidney Foundation of Canada; Canadian Institutes of Health Research [MOP-97774]; Natural Sciences and Engineering Research Council of Canada [480619]; Canadian Nephrology Society	Kidney Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Nephrology Society	This work was supported in part by grants from the Kidney Foundation of Canada, Canadian Institutes of Health Research Grant MOP-97774, and Natural Sciences and Engineering Research Council of Canada Grant 480619.; Supported by a Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award.; Recipient of a KRESCENT New Investigator Award (a joint award of the Kidney Foundation of Canada, Canadian Nephrology Society, and Canadian Institute of Health Research). To whom correspondence should be addressed: St. Michael's Hospital, 30 Bond St., LKSKI Rm. 622, Toronto, ON M5B 1W8, Canada. Tel.: 416-847-1752; Fax: 416-864-5167; E-mail: szaszik@smh.ca.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Belsches A P, 1997, Front Biosci, V2, pd501; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Chokki M, 2006, LIFE SCI, V78, P3051, DOI 10.1016/j.lfs.2005.12.023; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; GAEEFAMATA R, 2006, METHOD ENZYMOL, V406, P425; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; GSTRAUNTHALER G, 1985, AM J PHYSIOL, V248, pF536, DOI 10.1152/ajprenal.1985.248.4.F536; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hirota K, 2001, J BIOL CHEM, V276, P25953, DOI 10.1074/jbc.M011021200; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; IZUMI H, 1994, EXP CELL RES, V214, P654, DOI 10.1006/excr.1994.1303; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P431, DOI 10.1016/j.bcp.2009.09.016; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; MARETZKY T, 2010, ONCOGENE IN PRESS; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Papakonstanti EA, 2004, MOL BIOL CELL, V15, P1273, DOI 10.1091/mbc.E03-07-0491; Pascher A, 2005, BIODRUGS, V19, P211, DOI 10.2165/00063030-200519040-00002; Patrick David M, 2006, BMC Physiol, V6, P2, DOI 10.1186/1472-6793-6-2; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Puls A, 1999, J CELL SCI, V112, P2983; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Shah BH, 2006, TRENDS PHARMACOL SCI, V27, P235, DOI 10.1016/j.tips.2006.03.010; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Smith PC, 2009, J PERIODONTAL RES, V44, P73, DOI 10.1111/j.1600-0765.2007.01081.x; Soler AP, 1996, AM J PHYSIOL-RENAL, V270, pF869, DOI 10.1152/ajprenal.1996.270.5.F869; Taub M, 1979, Methods Enzymol, V58, P552; Tsapara A, 2010, MOL BIOL CELL, V21, P860, DOI 10.1091/mbc.E09-07-0567; Ueno Y, 2005, BRIT J CANCER, V92, P1690, DOI 10.1038/sj.bjc.6602548; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Waheed F, 2010, AM J PHYSIOL-CELL PH, V298, pC1376, DOI 10.1152/ajpcell.00408.2009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Ziv E, 2008, J CELL BIOCHEM, V104, P606, DOI 10.1002/jcb.21650	79	54	55	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9268	9279		10.1074/jbc.M110.179903	http://dx.doi.org/10.1074/jbc.M110.179903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212278	Green Published, hybrid			2022-12-25	WOS:000288247700057
J	Mikula, M; Bomsztyk, K				Mikula, Michal; Bomsztyk, Karol			Direct Recruitment of ERK Cascade Components to Inducible Genes Is Regulated by Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; RECEPTOR TYROSINE KINASES; ACTIVATED PROTEIN-KINASE; MAP-KINASE; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CYTOPLASMIC ACCUMULATION; INSULIN-RECEPTOR; TARGET GENES; IN-VIVO	Components of the ERK cascade are recruited to genes, but it remains unknown how they are regulated at these sites. The RNA-binding protein heterogeneous nuclear ribonucleoprotein (hnRNP) K interacts with kinases and is found along genes including the mitogen-inducible early response gene EGR-1. Here, we used chromatin immunoprecipitations to study co-recruitment of hnRNP K and ERK cascade activity along the EGR-1 gene. These measurements revealed that the spatiotemporal binding patterns of ERK cascade transducers (GRB2, SOS, B-Raf, MEK, and ERK) at the EGR-1 locus resemble both hnRNP K and RNA polymerase II (Pol II). Inhibition of EGR-1 transcription with either serum-responsive factor knockdown or 5,6-di-chloro-1-beta-D-ribofuranosylbenzimidazole altered recruitment of all of the above ERK cascade components along this locus that mirrored the changes in Pol II and hnRNP K profiles. siRNA knockdown of hnRNP K decreased the levels of active MEK and ERK at the EGR-1, changes associated with decreased levels of elongating pre-mRNA and less efficient splicing. The hnRNP K dependence and pattern of ERK cascade activation at the c-MYC locus were different from at EGR-1. Ribonucleoprotein immunoprecipitations revealed that hnRNP K was associated with the EGR-1 but not c-MYC mRNAs. These data suggest a model where Pol II transcription-driven recruitment of hnRNP K along the EGR-1 locus compartmentalizes activation of the ERK cascade at these genes, events that regulate synthesis of mature mRNA.	[Mikula, Michal; Bomsztyk, Karol] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Mikula, Michal] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, PL-02781 Warsaw, Poland; [Mikula, Michal] Inst Oncol, PL-02781 Warsaw, Poland	University of Washington; University of Washington Seattle; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Bomsztyk, K (corresponding author), Univ Washington, Dept Med, Seattle, WA 98109 USA.	karolb@u.washington.edu	Mikula, Michal/G-8276-2011	Mikula, Michal/0000-0003-3447-7328	National Institutes of Health [R37-DK45978, RO-1 GM45134]; Polish Ministry of Education and Science [16/MOB/2007/0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Education and Science(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK45978 and RO-1 GM45134 (to K. B.).; Supported by Polish Ministry of Education and Science Program "Support for the International Mobility of Researchers" Grant 16/MOB/2007/0.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; BEZANCON A, 2002, J BIOL CHEM, V277, P16614; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Chang JW, 2009, INT IMMUNOL, V21, P1351, DOI 10.1093/intimm/dxp106; Chen LC, 2009, ONCOGENE, V28, P1904, DOI 10.1038/onc.2009.55; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; George R, 2009, CELL MOL LIFE SCI, V66, P711, DOI 10.1007/s00018-009-8667-8; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kim SJ, 1997, BIOCHEM J, V323, P621, DOI 10.1042/bj3230621; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kocher HM, 2005, NEPHROL DIAL TRANSPL, V20, P886, DOI 10.1093/ndt/gfh744; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Laury-Kleintop LD, 2005, J CELL BIOCHEM, V95, P1042, DOI 10.1002/jcb.20486; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-4; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito M, 2009, J AM SOC NEPHROL, V20, P1787, DOI 10.1681/ASN.2009010118; Nelson JD, 2011, DIABETES, V60, P127, DOI 10.2337/db09-1806; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; OLAH Z, 1991, EXP BRAIN RES, V84, P403; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; PODLECKI DA, 1987, J BIOL CHEM, V262, P3362; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reiterer G, 2010, CELL CYCLE, V9, P3297, DOI 10.4161/cc.9.16.12631; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Romero F, 1998, J BIOL CHEM, V273, P7776, DOI 10.1074/jbc.273.13.7776; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SETH A, 1992, J BIOL CHEM, V267, P24796; SHILATIFARD A, 2003, ANN REV BIOCH; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wei CC, 2006, J BIOL CHEM, V281, P25344, DOI 10.1074/jbc.M601945200; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	83	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9763	9775		10.1074/jbc.M110.213330	http://dx.doi.org/10.1074/jbc.M110.213330			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233203	Green Published, hybrid			2022-12-25	WOS:000288247700099
J	Ogunbayo, OA; Zhu, YM; Rossi, D; Sorrentino, V; Ma, JJ; Zhu, MX; Evans, AM				Ogunbayo, Oluseye A.; Zhu, Yingmin; Rossi, Daniela; Sorrentino, Vincenzo; Ma, Jianjie; Zhu, Michael X.; Evans, A. Mark			Cyclic Adenosine Diphosphate Ribose Activates Ryanodine Receptors, whereas NAADP Activates Two-pore Domain Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; ADENINE-DINUCLEOTIDE PHOSPHATE; ADP-RIBOSE; CA2+ RELEASE; SKELETAL-MUSCLE; INOSITOL TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; RAT VENTRICLE; SMOOTH-MUSCLE; CADP-RIBOSE	The mechanism by which cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) mobilize intracellular Ca2+ stores remains controversial. It is open to question whether cADPR regulates ryanodine receptors (RyRs) directly, as originally proposed, or indirectly by promoting Ca2+ uptake into the sarco/endoplasmic reticulum by sarco/endoplasmic reticulum Ca2+-ATPases. Conversely, although we have proposed that NAADP mobilizes endolysosomal Ca2+ stores by activating two-pore domain channels (TPCs), others suggest that NAADP directly activates RyRs. We therefore assessed Ca2+ signals evoked by intracellular dialysis from a patch pipette of cADPR and NAADP into HEK293 cells that stably overexpress either TPC1, TPC2, RyR1, or RyR3. No change in intracellular Ca2+ concentration was triggered by cADPR in either wild-type HEK293 cells (which are devoid of RyRs) or in cells that stably overexpress TPC1 and TPC2, respectively. By contrast, a marked Ca2+ transient was triggered by cADPR in HEK293 cells that stably expressed RyR1 and RyR3. The Ca2+ transient was abolished following depletion of endoplasmic reticulum stores by thapsigargin and block of RyRs by dantrolene but not following depletion of acidic Ca2+ stores by bafilomycin. By contrast, NAADP failed to evoke a Ca2+ transient in HEK293 cells that expressed RyR1 or RyR3, but it induced robust Ca2+ transients in cells that stably overexpressed TPC1 or TPC2 and in a manner that was blocked following depletion of acidic stores by bafilomycin. We conclude that cADPR triggers Ca2+ release by activating RyRs but not TPCs, whereas NAADP activates TPCs but not RyRs.	[Ogunbayo, Oluseye A.; Evans, A. Mark] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Yingmin; Zhu, Michael X.] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Rossi, Daniela; Sorrentino, Vincenzo] Univ Siena, Dept Pharmacol, I-53100 Siena, Italy; [Rossi, Daniela; Sorrentino, Vincenzo] Univ Siena, Dept Neurosci, I-53100 Siena, Italy; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of Siena; University of Siena; Rutgers State University New Brunswick; Rutgers State University Medical Center	Evans, AM (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk	Rossi, Daniela/G-7764-2012; Sorrentino, Vincenzo/A-4793-2014	Rossi, Daniela/0000-0003-0463-7327; Sorrentino, Vincenzo/0000-0002-8573-8631	National Institutes of Health; British Heart Foundation [PG/05/128]; Telethon [GGP08153]; British Heart Foundation [PG/10/95/28657] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Telethon(Fondazione Telethon); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants (to M. X. Z. and J. M.). This work was also supported by British Heart Foundation Project Grant PG/05/128 (to A. M. E.). Telethon Grant GGP08153 (to V. S.).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Cui Y, 1999, BIOCHEM J, V342, P269, DOI 10.1042/0264-6021:3420269; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Dipp M, 2001, CIRC RES, V89, P77, DOI 10.1161/hh1301.093616; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; GYORKE S, 2008, NATURE, V459, P596; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Jin HF, 2010, J ALZHEIMERS DIS, V20, P261, DOI 10.3233/JAD-2010-1360; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Macgregor AT, 2007, CELL CALCIUM, V41, P537, DOI 10.1016/j.ceca.2006.10.005; MORRISSETTE J, 1993, FEBS LETT, V330, P270, DOI 10.1016/0014-5793(93)80886-Y; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Rossi D, 2002, J CELL SCI, V115, P2497; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Yamasaki-Mann M, 2010, J BIOL CHEM, V285, P25053, DOI 10.1074/jbc.M109.095257; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	32	66	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9136	9140		10.1074/jbc.M110.202002	http://dx.doi.org/10.1074/jbc.M110.202002			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216967	Green Published, hybrid			2022-12-25	WOS:000288247700044
J	Bulow, MH; Aebersold, R; Pankratz, MJ; Junger, MA				Buelow, Margret H.; Aebersold, Ruedi; Pankratz, Michael J.; Juenger, Martin A.			The Drosophila FoxA Ortholog Fork Head Regulates Growth and Gene Expression Downstream of Target of Rapamycin	PLOS ONE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; CELL-GROWTH; C-ELEGANS; INSULIN; RNAI; METABOLISM; MELANOGASTER; RESTRICTION	Forkhead transcription factors of the FoxO subfamily regulate gene expression programs downstream of the insulin signaling network. It is less clear which proteins mediate transcriptional control exerted by Target of rapamycin (TOR) signaling, but recent studies in nematodes suggest a role for FoxA transcription factors downstream of TOR. In this study we present evidence that outlines a similar connection in Drosophila, in which the FoxA protein Fork head (FKH) regulates cellular and organismal size downstream of TOR. We find that ectopic expression and targeted knockdown of FKH in larval tissues elicits different size phenotypes depending on nutrient state and TOR signaling levels. FKH overexpression has a negative effect on growth under fed conditions, and this phenotype is not further exacerbated by inhibition of TOR via rapamycin feeding. Under conditions of starvation or low TOR signaling levels, knockdown of FKH attenuates the size reduction associated with these conditions. Subcellular localization of endogenous FKH protein is shifted from predominantly cytoplasmic on a high-protein diet to a pronounced nuclear accumulation in animals with reduced levels of TOR or fed with rapamycin. Two putative FKH target genes, CG6770 and cabut, are transcriptionally induced by rapamycin or FKH expression, and silenced by FKH knockdown. Induction of both target genes in heterozygous TOR mutant animals is suppressed by mutations in fkh. Furthermore, TOR signaling levels and FKH impact on transcription of the dFOXO target gene d4E-BP, implying a point of crosstalk with the insulin pathway. In summary, our observations show that an alteration of FKH levels has an effect on cellular and organismal size, and that FKH function is required for the growth inhibition and target gene induction caused by low TOR signaling levels.	[Buelow, Margret H.; Aebersold, Ruedi; Juenger, Martin A.] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Buelow, Margret H.; Pankratz, Michael J.] Univ Bonn, Dept Mol Brain Physiol & Behav, Life & Med Sci LIMES Inst, D-5300 Bonn, Germany; [Buelow, Margret H.; Aebersold, Ruedi] Swiss Fed Inst Technol, CC SPMD, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bulow, MH (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	pankratz@uni-bonn.de; juenger@imsb.biol.ethz.ch	Bülow, Margret/P-3641-2019; Bülow, Margret H/U-8001-2018; Jünger, Martin A./A-8010-2011	Bülow, Margret/0000-0001-6006-8507; Bülow, Margret H/0000-0001-6006-8507; 	Swiss Federal Institute of Technology (ETH) Zurich [TH-17 07-1]; Swiss National Science Foundation (SNF); Deutsche Forschungsgemeinschaft (DFG)	Swiss Federal Institute of Technology (ETH) Zurich(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a research grant of the Swiss Federal Institute of Technology (ETH) Zurich (TH-17 07-1), the Swiss National Science Foundation (SNF) and the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giordano E, 2002, GENETICS, V160, P637; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lee HH, 2004, DEV DYNAM, V229, P357, DOI 10.1002/dvdy.10443; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu Y, 2008, INSECT MOL BIOL, V17, P91, DOI 10.1111/j.1365-2583.2007.00785.x; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	42	29	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15171	10.1371/journal.pone.0015171	http://dx.doi.org/10.1371/journal.pone.0015171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217822	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900015
J	Fenk, LM; Heidlmayr, K; Lindner, P; Schmid, A				Fenk, Lisa M.; Heidlmayr, Karin; Lindner, Philipp; Schmid, Axel			Pupil Size in Spider Eyes Is Linked to Post-Ecdysal Lens Growth	PLOS ONE			English	Article							PRINCIPAL EYES; ARANEAE; SALTICIDAE; OPTICS	In this study we describe a distinctive pigment ring that appears in spider eyes after ecdysis and successively decreases in size in the days thereafter. Although pigment stops in spider eyes are well known, size variability is, to our knowledge, reported here for the first time. Representative species from three families (Ctenidae, Sparassidae and Lycosidae) are investigated and, for one of these species (Cupiennius salei, Ctenidae), the progressive increase in pupil diameter is monitored. In this species the pupil occupies only a fourth of the total projected lens surface after ecdysis and reaches its final size after approximately ten days. MicroCT images suggest that the decrease of the pigment ring is linked to the growth of the corneal lens after ecdysis. The pigment rings might improve vision in the immature eye by shielding light rays that would otherwise enter the eye via peripheral regions of the cornea, beside the growing crystalline lens.	[Fenk, Lisa M.; Heidlmayr, Karin; Lindner, Philipp; Schmid, Axel] Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria	University of Vienna	Fenk, LM (corresponding author), Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria.	lisa.fenk@univie.ac.at			Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna	Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna	LMF is recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLEST AD, 1985, J COMP PHYSIOL A, V157, P391, DOI 10.1007/BF00618129; BLEST AD, 1977, PROC R SOC SER B-BIO, V196, P197, DOI 10.1098/rspb.1977.0037; Browning HC, 1942, PROC R SOC SER B-BIO, V131, P65, DOI 10.1098/rspb.1942.0018; CARRICAB.P, 1970, VISION RES, V10, P943, DOI 10.1016/0042-6989(70)90072-6; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Fenk LM, 2010, J EXP BIOL, V213, P3111, DOI 10.1242/jeb.041939; HOMANN H, 1971, Z MORPHOL TIERE, V69, P201, DOI 10.1007/BF00277623; Insausti TC, 2000, MEM I OSWALDO CRUZ, V95, P743, DOI 10.1590/S0074-02762000000500024; Land M.F., 1985, P53; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1992, J EXP BIOL, V164, P227; Melchers M., 1963, Zoologische Jahrbuecher Systematik, V91, P1; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Muller J, 1826, VERGLEICHENDEN PHYSI; Neuhofer D, 2009, J EXP BIOL, V212, P2819, DOI 10.1242/jeb.027136; OPELL BD, 1987, J MORPHOL, V192, P87, DOI 10.1002/jmor.1051920202; Paulus H.F., 1979, P299; Wagner W, 1888, ANN SCI NAT, VAnn Sci Nat Zool, p[6, 281]; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; WILSON M, 1975, NATURE, V258, P603, DOI 10.1038/258603a0	21	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15838	10.1371/journal.pone.0015838	http://dx.doi.org/10.1371/journal.pone.0015838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209876	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900041
J	Grad, I; Cederroth, CR; Walicki, J; Grey, C; Barluenga, S; Winssinger, N; De Massy, B; Nef, S; Picard, D				Grad, Iwona; Cederroth, Christopher R.; Walicki, Joel; Grey, Corinne; Barluenga, Sofia; Winssinger, Nicolas; De Massy, Bernard; Nef, Serge; Picard, Didier			The Molecular Chaperone Hsp90 alpha Is Required for Meiotic Progression of Spermatocytes beyond Pachytene in the Mouse	PLOS ONE			English	Article							MALE GERM-CELLS; HSP90 INHIBITORS; MALE-INFERTILITY; IN-VIVO; MEIOSIS; EXPRESSION; CYCLE; MICE; HSP70-2; FKBP52	The molecular chaperone Hsp90 has been found to be essential for viability in all tested eukaryotes, from the budding yeast to Drosophila. In mammals, two genes encode the two highly similar and functionally largely redundant isoforms Hsp90 alpha and Hsp90 beta. Although they are co-expressed in most if not all cells, their relative levels vary between tissues and during development. Since mouse embryos lacking Hsp90 beta die at implantation, and despite the fact that Hsp90 inhibitors being tested as anti-cancer agents are relatively well tolerated, the organismic functions of Hsp90 in mammals remain largely unknown. We have generated mouse lines carrying gene trap insertions in the Hsp90 alpha gene to investigate the global functions of this isoform. Surprisingly, mice without Hsp90 alpha are apparently normal, with one major exception. Mutant male mice, whose Hsp90 beta levels are unchanged, are sterile because of a complete failure to produce sperm. While the development of the male reproductive system appears to be normal, spermatogenesis arrests specifically at the pachytene stage of meiosis I. Over time, the number of spermatocytes and the levels of the meiotic regulators and Hsp90 interactors Hsp70-2, NASP and Cdc2 are reduced. We speculate that Hsp90 alpha may be required to maintain and to activate these regulators and/or to disassemble the synaptonemal complex that holds homologous chromosomes together. The link between fertility and Hsp90 is further supported by our finding that an Hsp90 inhibitor that can cross the blood-testis barrier can partially phenocopy the genetic defects.	[Grad, Iwona; Walicki, Joel; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland; [Cederroth, Christopher R.; Nef, Serge] Univ Geneva, Dept Med Genet & Dev, Ctr Med Univ, Geneva, Switzerland; [Grey, Corinne; De Massy, Bernard] IGH CNRS, Inst Genet Humaine, Montpellier, France; [Barluenga, Sofia; Winssinger, Nicolas] Univ Strasbourg, Inst Sci & Ingn Supramol, Strasbourg, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grad, I (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland.	didier.picard@unige.ch	Grad, Iwona/D-1222-2012; Cederroth, Christopher/B-9932-2011; Nef, Serge/AAV-6445-2020; Cederroth, Christopher R./AAO-9501-2020; Winssinger, Nicolas/B-6710-2017	Grad, Iwona/0000-0003-4379-5950; Nef, Serge/0000-0001-5462-0676; Winssinger, Nicolas/0000-0003-1636-7766; Cederroth, Christopher/0000-0001-7267-5136	Swiss National Science Foundation; Canton de Geneve; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [06-BLAN-0160-01, 09-BLAN-0269-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton de Geneve; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in the DP and SN laboratories was supported by the Swiss National Science Foundation and the Canton de Geneve. CG and BdM were supported by the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (06-BLAN-0160-01 and 09-BLAN-0269-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Allen JW, 1996, CHROMOSOMA, V104, P414, DOI 10.1007/BF00352265; Barluenga S, 2008, ANGEW CHEM INT EDIT, V47, P4432, DOI 10.1002/anie.200800233; Barluenga S, 2009, CHEMBIOCHEM, V10, P2753, DOI 10.1002/cbic.200900494; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cederroth CR, 2007, ENDOCRINOLOGY, V148, P5507, DOI 10.1210/en.2007-0689; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Drabent B, 2000, HISTOCHEM CELL BIOL, V113, P433; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LEE SJ, 1990, MOL CELL BIOL, V10, P3239, DOI 10.1128/MCB.10.6.3239; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; MacLean MJ, 2005, BIOCHEM BIOPH RES CO, V337, P133, DOI 10.1016/j.bbrc.2005.09.025; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Munoz MJ, 1999, MOL GEN GENET, V261, P242, DOI 10.1007/s004380050963; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Nickerson HD, 2007, DEV BIOL, V306, P725, DOI 10.1016/j.ydbio.2007.04.009; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; RUBIN MR, 1986, SCIENCE, V233, P663, DOI 10.1126/science.3726554; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Saribek B, 2006, BIOCHEM BIOPH RES CO, V349, P1190, DOI 10.1016/j.bbrc.2006.08.143; Sreedhar AS, 2004, FEBS LETT, V562, P11; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tash JS, 2008, BIOL REPROD, V78, P1139, DOI 10.1095/biolreprod.107.062679; Vanmuylder N, 2002, ANAT EMBRYOL, V205, P301, DOI 10.1007/s00429-002-0258-5; Voss AK, 2000, DEVELOPMENT, V127, P1; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang CH, 2009, BIOORG MED CHEM LETT, V19, P3836, DOI 10.1016/j.bmcl.2009.04.030; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wolgemuth DJ, 2004, INT J ANDROL, V27, P192, DOI 10.1111/j.1365-2605.2004.00480.x; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Yue L, 1999, GENETICS, V151, P1065; Zhu DH, 1997, DEVELOPMENT, V124, P3007	61	115	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15770	10.1371/journal.pone.0015770	http://dx.doi.org/10.1371/journal.pone.0015770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209834	Green Published, gold			2022-12-25	WOS:000285838900030
J	Arinaminpathy, N; Grenfell, B				Arinaminpathy, Nimalan; Grenfell, Bryan			Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza	PLOS ONE			English	Article							A VIRUS; LINKED GLYCOSYLATION; RECEPTOR-BINDING; ANTIGENIC DRIFT; HEMAGGLUTININ; PHENOTYPE; TURKEYS; GLYCANS; DOMAIN; SITES	Background: Influenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity. Methodology/Principal Findings: We test the role of glycoprotein charge on sequence data from the three major subtypes of influenza A in humans, using a simple method of calculating net glycoprotein charge. Of all subtypes, H3N2 in humans shows a striking pattern of increasing positive charge since its introduction in 1968. Notably, this trend applies to both hemagglutinin and neuraminidase glycoproteins. In the late 1980s hemagglutinin charge reached a plateau, while neuraminidase charge started to decline. We identify key groups of amino acid sites involved in this charge trend. Conclusions/Significance: To our knowledge these are the first indications that, for human H3N2, net glycoprotein charge covaries strongly with antigenic drift on a global scale. Further work is needed to elucidate how such charge interacts with other immune escape mechanisms, such as glycosylation, and we discuss important questions arising for future study.	[Arinaminpathy, Nimalan; Grenfell, Bryan] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Arinaminpathy, N (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	nimpathy@princeton.edu		Arinaminpathy, Nimalan/0000-0001-9502-6876	National Institutes of Health [R01 GM083983-01]; National Science Foundation [EF-0742373]; Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health grant R01 GM083983-01 (www.nih.gov). Bryan Grenfell was also supported by the National Science Foundation grant EF-0742373 and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNTHSEN A, 2003, NEW AGE INT; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; CORNELISSEN M, 1995, AIDS RES HUM RETROV, V11, P1169, DOI 10.1089/aid.1995.11.1169; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Schulze IT, 1997, J INFECT DIS S1, V176, P24; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Wagner R, 2002, J GEN VIROL, V83, P601, DOI 10.1099/0022-1317-83-3-601; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; 2010, INFLUENZA VIRUS RESO	25	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15674	10.1371/journal.pone.0015674	http://dx.doi.org/10.1371/journal.pone.0015674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209885	Green Published, gold			2022-12-25	WOS:000285793600025
J	Lescault, PJ; Thompson, AB; Patil, V; Lirussi, D; Burton, A; Margarit, J; Bond, J; Matrajt, M				Lescault, Pamela J.; Thompson, Ann B.; Patil, Veerupaxagouda; Lirussi, Dario; Burton, Amanda; Margarit, Juan; Bond, Jeffrey; Matrajt, Mariana			Genomic Data Reveal Toxoplasma gondii Differentiation Mutants Are Also Impaired with Respect to Switching into a Novel Extracellular Tachyzoite State	PLOS ONE			English	Article							DEVELOPMENTALLY-REGULATED GENES; VIRULENCE FACTORS; TISSUE CYSTS; EXPRESSION; IDENTIFICATION; BRADYZOITES; KINASES; BIOLOGY; STAGE; PERSISTENCE	Toxoplasma gondii pathogenesis includes the invasion of host cells by extracellular parasites, replication of intracellular tachyzoites, and differentiation to a latent bradyzoite stage. We present the analysis of seven novel T. gondii insertional mutants that do not undergo normal differentiation to bradyzoites. Microarray quantification of the variation in genome-wide RNA levels for each parasite line and times after induction allowed us to describe states in the normal differentiation process, to analyze mutant lines in the context of these states, and to identify genes that may have roles in initiating the transition from tachyzoite to bradyzoite. Gene expression patterns in wild-type parasites undergoing differentiation suggest a novel extracellular state within the tachyzoite stage. All mutant lines exhibit aberrant regulation of bradyzoite gene expression and notably some of the mutant lines appear to exhibit high proportions of the intracellular tachyzoite state regardless of whether they are intracellular or extracellular. In addition to the genes identified by the insertional mutagenesis screen, mixture model analysis allowed us to identify a small number of genes, in mutants, for which expression patterns could not be accounted for using the three parasite states - genes that may play a mechanistic role in switching from the tachyzoite to bradyzoite stage.	[Lescault, Pamela J.; Thompson, Ann B.; Patil, Veerupaxagouda; Lirussi, Dario; Burton, Amanda; Margarit, Juan; Bond, Jeffrey; Matrajt, Mariana] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Lescault, PJ (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	mmatrajt@uvm.edu	Patil, Veerupaxagouda/ACB-8475-2022	Lirussi, Dario/0000-0002-3054-2586; Burton, Amanda/0000-0002-8080-5081	National Center for Research Resources (NCRR) of the NIH [1 P20 RR16462]; American Heart Association [AHA 0535047N]; NIH [P20 RR021905]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462, P20RR021905] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Vermont Genetics Network (VGN) through National Institutes of Health grant 1 P20 RR16462 from the BRIN program of the National Center for Research Resources (NCRR) of the NIH; The American Heart Association AHA 0535047N; and the NIH P20 RR021905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2009, EUKARYOT CELL, V8, P398, DOI 10.1128/EC.00329-08; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bengtesson H, 2008, 745 U CAL; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; de Felipe MMC, 2008, MOL BIOCHEM PARASIT, V157, P22, DOI 10.1016/j.molbiopara.2007.09.003; DeChamps C, 1997, J PARASITOL, V83, P152, DOI 10.2307/3284336; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DUBEY JP, 1994, J AM VET MED ASSOC, V205, P1593; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; FICHERA ME, 1995, ANTIMICROB AGENTS CH, V39, P1530, DOI 10.1128/AAC.39.7.1530; Frankel MB, 2007, P NATL ACAD SCI USA, V104, P10181, DOI 10.1073/pnas.0701893104; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh D, 2004, BIOINFORMATICS, V20, P1663, DOI 10.1093/bioinformatics/bth139; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Hartigan J., 1975, CLUSTERING ALGORITHM; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Matrajt M, 2002, MOL MICROBIOL, V44, P735, DOI 10.1046/j.1365-2958.2002.02904.x; Matrajt M, 2010, MOL BIOCHEM PARASIT, V174, P1, DOI 10.1016/j.molbiopara.2010.06.002; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; PARMLEY SF, 1994, MOL BIOCHEM PARASIT, V66, P283, DOI 10.1016/0166-6851(94)90155-4; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Possenti A, 2010, INT J PARAS IN PRESS; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1997, METHODS, V13, P112, DOI 10.1006/meth.1997.0504; Lopes FMR, 2007, BRAZ J INFECT DIS, V11, P496, DOI 10.1590/S1413-86702007000500011; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; SOETE M, 1993, EXP PARASITOL, V76, P259, DOI 10.1006/expr.1993.1031; Team RDC, 2009, R LANG ENV STAT COMP; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5	51	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14463	10.1371/journal.pone.0014463	http://dx.doi.org/10.1371/journal.pone.0014463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209930	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793600006
J	Latasa, MU; Gil-Puig, C; Fernandez-Barrena, MG; Rodriguez-Ortigosa, CM; Banales, JM; Urtasun, R; Goni, S; Mendez, M; Arcelus, S; Juanarena, N; Recio, JA; Lotersztajn, S; Prieto, J; Berasain, C; Corrales, FJ; Lecanda, J; Avila, MA				Latasa, M. Ujue; Gil-Puig, Carmen; Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Urtasun, Raquel; Goni, Saioa; Mendez, Miriam; Arcelus, Sara; Juanarena, Nerea; Recio, Juan A.; Lotersztajn, Sophie; Prieto, Jesus; Berasain, Carmen; Corrales, Fernando J.; Lecanda, Jon; Avila, Matias A.			Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice	PLOS ONE			English	Article							N-TERMINAL KINASE; MONOCYTE CHEMOTACTIC PROTEIN-1; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; S-ADENOSYLMETHIONINE; ADENOSINE RECEPTOR; RAT HEPATOCYTES; MOLECULAR-MECHANISMS; BILIARY FIBROSIS; GENE-EXPRESSION	Background: Inflammation and fibrogenesis are directly related to chronic liver disease progression, including hepatocellular carcinoma (HCC) development. Currently there are few therapeutic options available to inhibit liver fibrosis. We have evaluated the hepatoprotective and anti-fibrotic potential of orally-administered 59-methylthioadenosine (MTA) in Mdr2(-/-) mice, a clinically relevant model of sclerosing cholangitis and spontaneous biliary fibrosis, followed at later stages by HCC development. Methodology: MTA was administered daily by gavage to wild type and Mdr2(-/-) mice for three weeks. MTA anti-inflammatory and anti-fibrotic effects and potential mechanisms of action were examined in the liver of Mdr2(-/-) mice with ongoing fibrogenesis and in cultured liver fibrogenic cells (myofibroblasts). Principal Findings: MTA treatment reduced hepatomegaly and liver injury. alpha-Smooth muscle actin immunoreactivity and collagen deposition were also significantly decreased. Inflammatory infiltrate, the expression of the cytokines IL6 and Mcp-1, pro-fibrogenic factors like TGF beta 2 and tenascin-C, as well as pro-fibrogenic intracellular signalling pathways were reduced by MTA in vivo. MTA inhibited the activation and proliferation of isolated myofibroblasts and down-regulated cyclin D1 gene expression at the transcriptional level. The expression of JunD, a key transcription factor in liver fibrogenesis, was also reduced by MTA in activated myofibroblasts. Conclusions/Significance: Oral MTA administration was well tolerated and proved its efficacy in reducing liver inflammation and fibrosis. MTA may have multiple molecular and cellular targets. These include the inhibition of inflammatory and profibrogenic cytokines, as well as the attenuation of myofibroblast activation and proliferation. Downregulation of JunD and cyclin D1 expression in myofibroblasts may be important regarding the mechanism of action of MTA. This compound could be a good candidate to be tested for the treatment of (biliary) liver fibrosis.	[Latasa, M. Ujue; Gil-Puig, Carmen; Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Urtasun, Raquel; Goni, Saioa; Mendez, Miriam; Juanarena, Nerea; Prieto, Jesus; Berasain, Carmen; Corrales, Fernando J.; Lecanda, Jon; Avila, Matias A.] Univ Navarra, Div Hepatol & Gene Therapy, CIMA, E-31080 Pamplona, Spain; [Gil-Puig, Carmen; Lecanda, Jon] Digna Biotech, Madrid, Spain; [Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Arcelus, Sara; Prieto, Jesus] Univ Navarra, CIBERehd, Univ Clin, E-31080 Pamplona, Spain; [Recio, Juan A.] Inst Oncol & Hosp, Vall Hebron Res Inst, Barcelona, Spain; [Lotersztajn, Sophie] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Lotersztajn, Sophie] Univ Paris Est, Fac Med, UMR S955, Creteil, France	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Latasa, MU (corresponding author), Univ Navarra, Div Hepatol & Gene Therapy, CIMA, E-31080 Pamplona, Spain.	maavila@unav.es	Berasain, Carmen/E-4139-2016; Avila, Matias A/Y-6342-2019; Rodriguez-Ortigosa, Carlos/K-9895-2014; Gil, Carmen/K-3759-2017; Fernandez-Barrena, Maite G/J-8040-2014; URTASUN, RAQUEL/AAD-1590-2021; Banales, Jesus M/R-9739-2019; Lotersztajn, Sophie/K-9160-2017; Goñi Irigoyen, Saioa/M-6330-2015; Latasa, Maria Ujue/Z-2178-2019	Berasain, Carmen/0000-0001-7075-2476; Avila, Matias A/0000-0001-6570-3557; Rodriguez-Ortigosa, Carlos/0000-0002-4931-4719; Gil, Carmen/0000-0002-8867-4442; Fernandez-Barrena, Maite G/0000-0003-0375-6236; Goñi Irigoyen, Saioa/0000-0002-2368-7373; Latasa, Maria Ujue/0000-0002-0878-1337; Banales, Jesus/0000-0002-5224-2373; URTASUN, RAQUEL/0000-0003-2332-5361; Corrales, Fernando/0000-0002-0231-5159; lotersztajn, Sophie/0000-0002-0053-7807; Recio, Juan Angel/0000-0002-7320-3832; Prieto, Jesus/0000-0002-1091-9593	FIMA; UTE project CIMA; CiberEhd [FIS-PI070392, PI070402]; Instituto de Salud Carlos III Fellowship; Ramon y Cajal Program; Torres Quevedo Program; INSERM; Universite Paris-Est; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale;  [RTICC-RD06 00200061];  [SAF2008-01540]	FIMA; UTE project CIMA; CiberEhd; Instituto de Salud Carlos III Fellowship; Ramon y Cajal Program(Spanish Government); Torres Quevedo Program; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Est; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; 	This work was supported by the agreement between FIMA and the "UTE project CIMA"; RTICC-RD06 00200061 (CB, FJC, MAA), CiberEhd (MGF-B, JB, CRO, JP), FIS-PI070392 and PI070402 (CB, MAA); SAF2008-01540 (FJC); Instituto de Salud Carlos III Fellowship (SG); Ramon y Cajal Program (MUL) and Torres Quevedo Program (CG-P, RU); INSERM, Universite Paris-Est, the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE CM, 2010, BIOCHIM BIOPHYS 0527; Andreu-Perez P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-265; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Ansorena E, 2006, AM J PHYSIOL-GASTR L, V290, pG1186, DOI 10.1152/ajpgi.00282.2005; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Baghdasaryan A, 2010, GUT, V59, P521, DOI 10.1136/gut.2009.186528; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berasain C, 2004, BBA-MOL BASIS DIS, V1690, P276, DOI 10.1016/j.bbadis.2004.08.002; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; El-Karef A, 2007, J PATHOL, V211, P86, DOI 10.1002/path.2099; El-Karef A, 2007, J HEPATOL, V46, P664, DOI 10.1016/j.jhep.2006.10.011; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; IGLESIAS AA, 2008, HEPATOLOGY, V47, P1655; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kawada N, 1999, J HEPATOL, V30, P1057, DOI 10.1016/S0168-8278(99)80260-8; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Kruglov EA, 2006, AM J PHYSIOL-GASTR L, V290, pG765, DOI 10.1152/ajpgi.00308.2005; Li LY, 2003, GASTROENTEROLOGY, V125, P460, DOI 10.1016/S0016-5085(03)00906-5; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Mann J, 2009, ADV DRUG DELIVER REV, V61, P497, DOI 10.1016/j.addr.2009.03.011; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Marra F, 1998, AM J PATHOL, V152, P423; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; MORATTI E, 1998, Patent No. 5753213; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; MUNSHI R, 1988, BIOCHEM PHARMACOL, V37, P2085, DOI 10.1016/0006-2952(88)90560-6; Nakken KE, 2007, SCAND J GASTROENTERO, V42, P1245, DOI 10.1080/00365520701320521; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Nieto N, 2005, J BIOL CHEM, V280, P30963, DOI 10.1074/jbc.M503569200; Pascale RM, 2002, ALCOHOL, V27, P193, DOI 10.1016/S0741-8329(02)00227-6; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Ryzhov S, 2008, J PHARMACOL EXP THER, V324, P694, DOI 10.1124/jpet.107.131540; Schuppan D, 2009, GASTROEN CLIN BIOL, V33, P949, DOI 10.1016/j.gcb.2009.07.021; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Spirli C, 2003, GASTROENTEROLOGY, V124, P737, DOI 10.1053/gast.2003.50100; Stramentinoli G, 1984, Patent No. [4454122, US4454122A]; Tao JC, 1999, J BIOL CHEM, V274, P23761, DOI 10.1074/jbc.274.34.23761; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007	69	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15690	10.1371/journal.pone.0015690	http://dx.doi.org/10.1371/journal.pone.0015690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209952	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200038
J	Shen, L; Spector, DJ				Shen, Li; Spector, David J.			Read-through Activation of Transcription in a Cellular Genomic Context	PLOS ONE			English	Article							RIBOSOMAL-RNA TRANSCRIPTION; MEDIATED GENE-TRANSFER; ADENOVIRUS TYPE-5; DNA TRANSFER; DROSOPHILA-MELANOGASTER; READTHROUGH ACTIVATION; LYMPHOID-CELLS; E1B GENE; EXPRESSION; REGION	Read-through transcription from the adjacent E1a gene region is required for wild-type wt) activity of the downstream adenovirus E1b promoter early after infection read-through activation). However, whether a cellular chromosomal template can support read-through activation is not known. To address this issue, read-through activation was evaluated in the context of stably expressed templates in transfected cells. Inhibition of read-through transcription by insertion of a transcription termination sequence between the E1a and E1b promoters reduced downstream gene expression from stably integrated templates. The results indicate that the mechanism of read-through activation does not depend on the structure of early adenovirus nucleoprotein complexes, a structure that is likely to be different from that of cellular chromatin. Accordingly, this regulatory interaction could participate in the coordinated control of the expression of closely linked cellular genes.	[Shen, Li; Spector, David J.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Intercoll Grad Degree Program Genet, Hershey, PA USA; [Spector, David J.] Penn State Univ, Coll Med, Program Cell & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shen, L (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	dspector@psu.edu			National Institute of General Medical Sciences [GM058214]; Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058214] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The initial stages of this work were funded by Public Health Service grant GM058214 from the National Institute of General Medical Sciences. There is no current external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; ARTELT P, 1991, GENE, V99, P249, DOI 10.1016/0378-1119(91)90134-W; BABISS LE, 1984, J VIROL, V52, P389, DOI 10.1128/JVI.52.2.389-395.1984; BATEMAN E, 1988, CELL, V54, P985, DOI 10.1016/0092-8674(88)90113-4; CASSIDY BG, 1987, MOL CELL BIOL, V7, P2388, DOI 10.1128/MCB.7.7.2388; Cook WJ, 1996, VIROLOGY, V218, P193, DOI 10.1006/viro.1996.0179; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Esperet C, 2000, J BIOL CHEM, V275, P25831, DOI 10.1074/jbc.M001757200; FALCKPEDERSEN E, 1985, CELL, V40, P897, DOI 10.1016/0092-8674(85)90349-6; FEDOROFF NV, 1979, CELL, V16, P697, DOI 10.1016/0092-8674(79)90086-2; GRIMALDI G, 1990, MOL CELL BIOL, V10, P4667, DOI 10.1128/MCB.10.9.4667; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; JASTREBOFF MM, 1987, EXP CELL RES, V171, P513, DOI 10.1016/0014-4827(87)90184-4; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Maxfield LF, 1997, J VIROL, V71, P8321, DOI 10.1128/JVI.71.11.8321-8329.1997; MONTELL C, 1983, NATURE, V305, P600, DOI 10.1038/305600a0; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PAALMAN MH, 1995, MOL CELL BIOL, V15, P4648; PARKS CL, 1988, J VIROL, V62, P54, DOI 10.1128/JVI.62.1.54-67.1988; PARKS CL, 1990, J VIROL, V64, P2780, DOI 10.1128/JVI.64.6.2780-2787.1990; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Shen L, 2003, J VIROL, V77, P9266, DOI 10.1128/JVI.77.17.9266-9277.2003; SPECTOR DJ, 1993, VIROLOGY, V194, P128, DOI 10.1006/viro.1993.1242; SPECTOR DJ, 1983, VIROLOGY, V130, P533, DOI 10.1016/0042-6822(83)90107-1; Steinwaerder DS, 2000, GENE THER, V7, P556, DOI 10.1038/sj.gt.3301139; SUSSENBACH JS, 1984, ADENOVIRUSES, P35; THOMAS GP, 1980, CELL, V22, P523; TONEGUZZO F, 1986, P NATL ACAD SCI USA, V83, P3496, DOI 10.1073/pnas.83.10.3496; TONEGUZZO F, 1986, MOL CELL BIOL, V6, P703, DOI 10.1128/MCB.6.2.703; TONEGUZZO F, 1988, NUCLEIC ACIDS RES, V16, P5515, DOI 10.1093/nar/16.12.5515; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; WILSON MC, 1981, J MOL BIOL, V148, P231, DOI 10.1016/0022-2836(81)90537-4	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15704	10.1371/journal.pone.0015704	http://dx.doi.org/10.1371/journal.pone.0015704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209942	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500037
J	Huang, HC; Mitchison, TJ; Shi, J				Huang, Hsiao-Chun; Mitchison, Timothy J.; Shi, Jue			Stochastic Competition between Mechanistically Independent Slippage and Death Pathways Determines Cell Fate during Mitotic Arrest	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CANCER-CELLS; ANTIMITOTIC DRUGS; APOPTOSIS; PACLITAXEL; PROGRESSION; INHIBITORS; KINESIN-5; RESPONSES; MITOSIS	Variability in cell-to-cell behavior within clonal populations can be attributed to the inherent stochasticity of biochemical reactions. Most single-cell studies have examined variation in behavior due to randomness in gene transcription. Here we investigate the mechanism of cell fate choice and the origin of cell-to-cell variation during mitotic arrest, when transcription is silenced. Prolonged mitotic arrest is commonly observed in cells treated with anti-mitotic drugs. Cell fate during mitotic arrest is determined by two alternative pathways, one promoting cell death, the other promoting cyclin B1 degradation, which leads to mitotic slippage and survival. It has been unclear whether these pathways are mechanistically coupled or independent. In this study we experimentally uncoupled these two pathways using zVAD-fmk to block cell death or Cdc20 knockdown to block slippage. We then used time-lapse imaging to score the kinetics of single cells adopting the remaining fate. We also used kinetic simulation to test whether the behaviors of death versus slippage in cell populations where both pathways are active can be quantitatively recapitulated by a model that assumes stochastic competition between the pathways. Our data are well fit by a model where the two pathways are mechanistically independent, and cell fate is determined by a stochastic kinetic competition between them that results in cell-to-cell variation.	[Huang, Hsiao-Chun; Mitchison, Timothy J.; Shi, Jue] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Huang, Hsiao-Chun] Harvard Univ, Sch Med, Grad Program Syst Biol, Boston, MA USA; [Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Kowloon Tong, Hong Kong, Peoples R China; [Shi, Jue] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hong Kong Baptist University; Hong Kong Baptist University	Huang, HC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jshi@hkbu.eduk.hk	Shi, Jue/J-9714-2014	Shi, Jue/0000-0003-4061-3496	National Cancer Institute [CA139980]; Hong Kong Research Grant Council [261310]; NATIONAL CANCER INSTITUTE [P01CA139980] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA139980) to T.J. Mitchison, and the Hong Kong Research Grant Council(#261310) to J. Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Blagosklonny MV, 2002, CANCER BIOL THER, V1, P113, DOI 10.4161/cbt.53; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; McEleny KR, 2002, PROSTATE, V51, P133, DOI 10.1002/pros.10061; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	26	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15724	10.1371/journal.pone.0015724	http://dx.doi.org/10.1371/journal.pone.0015724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203573	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900038
J	Domingues, HS; Mues, M; Lassmann, H; Wekerle, H; Krishnamoorthy, G				Domingues, Helena S.; Mues, Marsilius; Lassmann, Hans; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy			Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; VASCULAR ENDOTHELIAL-CELLS; IFN-GAMMA; T-CELLS; CUTTING EDGE; INDUCTION; MICE; EXPRESSION; CYTOKINE	Background: There is consensus that experimental autoimmune encephalomyelitis (EAE) can be mediated by myelin specific T cells of Th1 as well as of Th17 phenotype, but the contribution of either subset to the pathogenic process has remained controversial. In this report, we compare functional differences and pathogenic potential of "monoclonal" T cell lines that recognize myelin oligodendrocyte glycoprotein (MOG) with the same transgenic TCR but are distinguished by an IFN-gamma producing Th1-like and IL-17 producing Th17-like cytokine signature. Methods and Findings: CD4(+) T cell lines were derived from the transgenic mouse strain 2D2, which expresses a TCR recognizing MOG peptide 35-55 in the context of I-A(b). Adoptive transfer of Th1 cells into lymphopenic (Rag2(-/-)) recipients, predominantly induced "classic" paralytic EAE, whereas Th17 cells mediated "atypical" ataxic EAE in approximately 50% of the recipient animals. Combination of Th1 and Th17 cells potentiated the encephalitogenicity inducing classical EAE exclusively. Th1 and Th17 mediated EAE lesions differed in their composition but not in their localization within the CNS. While Th1 lesions contained IFN-gamma, but no IL-17 producing T cells, the T cells in Th17 lesions showed plasticity, substantially converting to IFN-gamma producing Th1-like cells. Th1 and Th17 cells differed drastically by their lytic potential. Th1 but not Th17 cells lysed autoantigen presenting astrocytes and fibroblasts in vitro in a contact-dependent manner. In contrast, Th17 cells acquired cytotoxic potential only after antigenic stimulation and conversion to IFN-gamma producing Th1 phenotype. Conclusions: Our data demonstrate that both Th1 and Th17 lineages possess the ability to induce CNS autoimmunity but can function with complementary as well as differential pathogenic mechanisms. We propose that Th17-like cells producing IL-17 are required for the generation of atypical EAE whereas IFN-gamma producing Th1 cells induce classical EAE.	[Domingues, Helena S.] Univ Coimbra, PhD Program Expt Biol & Biomed, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Domingues, Helena S.; Mues, Marsilius; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany	Universidade de Coimbra; Medical University of Vienna; Max Planck Society	Domingues, HS (corresponding author), Inst Mol & Cellular Biol IBMC, Div Basic & Clin Neurobiol, Oporto, Portugal.	guru@neuro.mpg.de	Krishnamoorthy, Gurumoorthy/O-1650-2013; Domingues, Sofia/A-9842-2011; Lassmann, Hans/Z-2269-2019	Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707; Domingues, Sofia/0000-0003-1230-2682; Lassmann, Hans/0000-0001-8617-5052	Max Planck society, Deutsche Forschungsgemeinschaft [SFB 571, B6]; ARSEP [AO 2009]; Portuguese Foundation for Science and Tecnology (FCT) [SFRH/BD/15885/2005]	Max Planck society, Deutsche Forschungsgemeinschaft(Max Planck SocietyGerman Research Foundation (DFG)); ARSEP; Portuguese Foundation for Science and Tecnology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported in part by the Max Planck society, Deutsche Forschungsgemeinschaft (SFB 571, Project B6), ARSEP (AO 2009) and by a PhD fellowship to H. S. D. (Portuguese Foundation for Science and Tecnology (FCT), reference SFRH/BD/15885/2005). Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEN DM, 1994, J NEUROIMMUNOL, V51, P123, DOI 10.1016/0165-5728(94)90074-4; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; FALLIS RJ, 1989, J IMMUNOL, V143, P2160; Ferber IA, 1996, J IMMUNOL, V156, P5; FONTANA A, 1984, NATURE, V307, P273, DOI 10.1038/307273a0; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Ichikawa M, 2000, J NEUROIMMUNOL, V102, P56, DOI 10.1016/S0165-5728(99)00153-8; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lees JR, 2008, J IMMUNOL, V180, P8066, DOI 10.4049/jimmunol.180.12.8066; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; MCCARRON RM, 1991, J IMMUNOL, V147, P503; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; RANSOHOFF RM, 1991, ARCH NEUROL-CHICAGO, V48, P1244, DOI 10.1001/archneur.1991.00530240048017; RONCHESE F, 1987, J IMMUNOL, V139, P629; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; SEDGWICK JD, 1990, J IMMUNOL, V145, P2474; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; SUN D, 1986, NATURE, V320, P70, DOI 10.1038/320070a0; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153	51	159	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15531	10.1371/journal.pone.0015531	http://dx.doi.org/10.1371/journal.pone.0015531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21209700	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500046
J	Low, JSW; Tao, Q; Ng, KM; Goh, HK; Shu, XS; Woo, WL; Ambinder, RF; Srivastava, G; Shamay, M; Chan, ATC; Popescu, NC; Hsieh, WS				Low, J. S. W.; Tao, Q.; Ng, K. M.; Goh, H. K.; Shu, X-S; Woo, W. L.; Ambinder, R. F.; Srivastava, G.; Shamay, M.; Chan, A. T. C.; Popescu, N. C.; Hsieh, W-S			A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors	ONCOGENE			English	Article						DLC1; RhoGAP; methylation; tumor suppressor gene; carcinoma; p53	GTPASE-ACTIVATING PROTEIN; STRESS-RESPONSIVE GENE; TRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; MORPHOLOGICAL-CHANGES; RHOGAP PROTEIN; CELL-GROWTH; CANCER; NASOPHARYNGEAL; METHYLATION	The critical 8p22 tumor suppressor deleted in liver cancer 1 (DLC1) is frequently inactivated by aberrant CpG methylation and/or genetic deletion and implicated in tumorigeneses of multiple tumor types. Here, we report the identification and characterization of its new isoform, DLC1 isoform 4 (DLC1-i4). This novel isoform encodes an 1125-aa (amino acid) protein with distinct N-terminus as compared with other known DLC1 isoforms. Similar to other isoforms, DLC1-i4 is expressed ubiquitously in normal tissues and immortalized normal epithelial cells, suggesting a role as a major DLC1 transcript. However, differential expression of the four DLC1 isoforms is found in tumor cell lines: Isoform 1 (longest) and 3 (short thus probably nonfunctional) share a promoter and are silenced in almost all cancer and immortalized cell lines, whereas isoform 2 and 4 utilize different promoters and are frequently downregulated. DLC1-i4 is significantly downregulated in multiple carcinoma cell lines, including 2/4 nasopharyngeal, 8/16 (50%) esophageal, 4/16 (25%) gastric, 6/9 (67%) breast, 3/4 colorectal, 4/4 cervical and 2/8(25%) lung carcinoma cell lines. The functional DLC1-i4 promoter is within a CpG island and is activated by wild-type p53. CpG methylation of the DLC1-i4 promoter is associated with its silencing in tumor cells and was detected in 38-100% of multiple primary tumors. Treatment with 5-aza-20-deoxycytidine or genetic double knockout of DNMT1 and DNMT3B led to demethylation of the promoter and reactivation of its expression, indicating a predominantly epigenetic mechanism of silencing. Ectopic expression of DLC1-i4 in silenced tumor cells strongly inhibited their growth and colony formation. Thus, we identified a new isoform of DLC1 with tumor suppressive function. The differential expression of various DLC1 isoforms suggests interplay in modulating the complex activities of DLC1 during carcinogenesis. Oncogene (2011) 30, 1923-1935; doi: 10.1038/onc.2010.576; published online 10 January 2011	[Low, J. S. W.; Tao, Q.; Goh, H. K.; Woo, W. L.; Ambinder, R. F.; Shamay, M.; Hsieh, W-S] Johns Hopkins Singapore, Div Biomed Sci, Singapore, Singapore; [Low, J. S. W.; Goh, H. K.; Ambinder, R. F.; Hsieh, W-S] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Tao, Q.; Ambinder, R. F.; Shamay, M.; Hsieh, W-S] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Tao, Q.; Ng, K. M.; Shu, X-S; Chan, A. T. C.] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol S China, Sir YK Pao Ctr Canc,Hong Kong Canc Inst,Canc Epig, Shatin, Hong Kong, Peoples R China; [Tao, Q.] Chinese Univ Hong Kong, PWH, Ctr Canc, Dept Clin Oncol,Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Srivastava, G.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Popescu, N. C.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; National University of Singapore; Johns Hopkins University; Johns Hopkins Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tao, Q (corresponding author), Chinese Univ Hong Kong, PWH, Ctr Canc, Dept Clin Oncol,Li Ka Shing Inst Hlth Sci, Rm 315, Shatin, Hong Kong, Peoples R China.	qtao@clo.cuhk.edu.hk; whsieh1@jhem.jhmi.edu	Woo, Wai Lok/T-3662-2018; Tao, Qian/T-4743-2018; Chan, Anthony Tak Cheung/R-3940-2018	Woo, Wai Lok/0000-0002-8698-7605; Tao, Qian/0000-0001-5383-4808; Chan, Anthony Tak Cheung/0000-0002-6912-8091	A*STAR; Chinese University of Hong Kong; Singapore National Research Foundation; Ministry of Education; NATIONAL CANCER INSTITUTE [ZIABC010038, P50CA096888] Funding Source: NIH RePORTER	A*STAR(Agency for Science Technology & Research (A*STAR)); Chinese University of Hong Kong(Chinese University of Hong Kong); Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by an A*STAR grant (Johns Hopkins Singapore, QT/WS/RA), a Chinese University of Hong Kong grant (QT) and a grant from Singapore National Research Foundation and the Ministry of Education under the Research Center of Excellence Program (WS/RA). We thank Drs Bert Vogelstein, George Tsao, (Dolly Huang), Michael Obster and Guiyuan Li for some cell lines; and DSMZ (German Collection of Microorganisms & Cell Cultures) for the KYSE cell lines (Shimada et al., Cancer 69: 277-284, 1992). We also thank Drs Wenling Han, Thomas Putti, Luke Tan for some tumor samples.	AKIYAMA Y, 1995, TFSEARCH SEARC UNPUB; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHEUNG WY, 1993, AM J CLIN PATHOL, V100, P502, DOI 10.1093/ajcp/100.5.502; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; HORII A, 1993, HUM MOL GENET, V2, P283, DOI 10.1093/hmg/2.3.283; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Ng IOL, 2000, CANCER RES, V60, P6581; Pang JCS, 2005, HUM PATHOL, V36, P36, DOI 10.1016/j.humpath.2004.09.021; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sabbir MG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-17; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Takai Daiya, 2003, In Silico Biology, V3, P235; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Wong CM, 2003, CANCER RES, V63, P7646; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yuan BZ, 2007, EXP CELL RES, V313, P3868, DOI 10.1016/j.yexcr.2007.08.009; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246; Zhou XL, 1999, CANCER RES, V59, P843	66	44	49	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1923	1935		10.1038/onc.2010.576	http://dx.doi.org/10.1038/onc.2010.576			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21217778	Green Accepted			2022-12-25	WOS:000289777700008
J	Murray, LM; Comley, LH; Gillingwater, TH; Parson, SH				Murray, Lyndsay M.; Comley, Laura H.; Gillingwater, Thomas H.; Parson, Simon H.			The response of neuromuscular junctions to injury is developmentally regulated	FASEB JOURNAL			English	Article						hypoxia; vulnerability; motor neuron; Wallerian degeneration	SPINAL MUSCULAR-ATROPHY; AFFINITY NEUROTROPHIN RECEPTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; GUILLAIN-BARRE-SYNDROME; SCHWANN-CELL APOPTOSIS; MOTOR-NERVE TERMINALS; SELECTIVE VULNERABILITY; WALLERIAN DEGENERATION; SYNAPTIC VULNERABILITY; MOTONEURON DEATH	It is well established that developmental maturity is a key factor regulating the response of lower motor neurons to injury. The influence of age on the survival of motor neuron cell somata following axotomy is well documented, but it remains unclear whether maturity also influences the degeneration of axonal and synaptic compartments at the neuromuscular junction. Such information is important for our interpretation of data suggesting that neonatal neuromuscular junctions are particularly vulnerable in neurodegenerative conditions that affect the developing postnatal nervous system, such as spinal muscular atrophy. Here, we have examined the role of development in regulating the vulnerability of mouse neuromuscular junctions to two mechanistically distinct degenerative insults: hypoxia and peripheral nerve injury. We report that neuromuscular junctions in neonatal mice are significantly more resistant to both hypoxia and nerve injury than those in adult mice, with a transition from the neonatal to adult phenotype occurring at 2-3 wk of age. We also demonstrate that the reduced vulnerability of neuromuscular junctions observed in neonatal mice is not determined by the maturity of the synapse per se, suggesting that properties associated with the neonatal environment and/or age of the neuron are responsible for modulating vulnerability. Our results are in stark contrast to previous studies showing that motor neuron cell somata are markedly more vulnerable to axotomy in neonatal mice. We conclude that neonatal neuromuscular junctions are resistant to a range of neurodegenerative insults in vivo and that this resistance is developmentally regulated.-Murray, L. M., Comley, L. H., Gillingwater, T. H., Parson, S. H. The response of neuromuscular junctions to injury is developmentally regulated. FASEB J. 25, 1306-1313 (2011). www.fasebj.org	Univ Edinburgh, Sch Med, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Sch Med, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Parson, SH (corresponding author), Univ Edinburgh, Old Med Sch, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	s.h.parson@ed.ac.uk	Gillingwater, Thomas/G-2880-2011	Gillingwater, Thomas/0000-0002-0306-5577; Parson, Simon/0000-0002-8848-8738	Euan MacDonald Centre for Motor Neurone Disease Research (Edinburgh, UK); Biotechnology and Biological Sciences Research Council; SMA Trust; Wellcome Trust	Euan MacDonald Centre for Motor Neurone Disease Research (Edinburgh, UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SMA Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Derek Thomson for assistance with animals and members of the S. H. P. and T. H. G. laboratories for helpful advice on the current study. L. M. M. and S. H. P. were supported by Seedcorn funds from the Euan MacDonald Centre for Motor Neurone Disease Research (Edinburgh, UK). L. H. C. is supported by a Biotechnology and Biological Sciences Research Council Ph.D. studentship. T. H. G. is supported by The SMA Trust and The Wellcome Trust.	Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Baxter B, 2008, J ANAT, V212, P827, DOI 10.1111/j.1469-7580.2008.00909.x; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BROWN MC, 1978, J PHYSIOL-LONDON, V278, P325, DOI 10.1113/jphysiol.1978.sp012307; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gillingwater TH, 2002, J PHYSIOL-LONDON, V543, P739, DOI 10.1113/jphysiol.2002.022343; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Kapoukranidou D, 2005, MED SCI MONITOR, V11, pBR373; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Li LX, 1998, J COMP NEUROL, V396, P158; LICHTMAN JW, 1996, SEMIN DEV BIOL, V6, P195; LOWRIE MB, 1994, DEV NEUROSCI-BASEL, V16, P279, DOI 10.1159/000112120; Malik RQ, 2000, J PHYSIOL-LONDON, V528P, p79P; Murray LM, 2010, NEUROMUSCULAR DISORD, V20, P740, DOI 10.1016/j.nmd.2010.06.013; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Petratos S, 2003, J NEUROPATH EXP NEUR, V62, P398, DOI 10.1093/jnen/62.4.398; POLLIN MM, 1991, DEVELOPMENT, V112, P83; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SAUNDERS KC, 1979, CLIN ORTHOP RELAT R, P194; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; THOMPSON W, 1977, NEUROSCIENCE, V2, P523, DOI 10.1016/0306-4522(77)90049-5; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Willison HJ, 2008, J NEUROIMMUNOL, V201, P172, DOI 10.1016/j.jneuroim.2008.05.028; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4	32	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1306	1313		10.1096/fj.10-171934	http://dx.doi.org/10.1096/fj.10-171934			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21228222	Green Accepted			2022-12-25	WOS:000288982800019
J	Ni, CL; Shi, HP; Yu, HM; Chang, YC; Chen, YR				Ni, Chun-Lun; Shi, Hoi-Ping; Yu, Hui-Ming; Chang, Yun-Chorng; Chen, Yun-Ru			Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization	FASEB JOURNAL			English	Article						Alzheimer's disease; protein aggregation; protein conformation; natively unfolded	HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; AGGREGATION PROPERTIES; DUTCH TYPE; WILD-TYPE; FIBRILS; PEPTIDE; MUTATION; MECHANISM	Amyloid formation is initiated by protein misfolding, followed by self-association to ultimately form amyloid fibrils. The discovery of toxic prefibrillar oligomers in many amyloidosis underscores the importance of understanding the folding mechanism prior to such aggregation. Here, we investigated the folding properties of the natively unfolded amyloid-beta (A beta) peptide and the familial variants (A21G, E22Q, E22G, E22K, and D23N) in Alzheimer's disease (AD). In combinations of native electrophoresis, analytical ultracentrifugation, fluorescence emission, and far-UV circular dichroism, we showed that all A beta 40 variants are predominantly monomeric with similar residual secondary structures, but distinct hydrophobic-exposed protein surfaces. Guanidine hydrochloride (GdnHCl) denaturation in the absence and presence of trifluoroethanol (TFE) showed that A beta variants adopt an apparent 2-state equilibrium model with different stabilities, in which wild type is less stable than A21G but more stable than D23N and E22 mutants. By correlating the folding stability with the nucleation phase in fibrillization, we found the more stable the variant, the slower the nucleation, except for D23N. Besides, the unfolding of A beta conformation leads to reduced formation of mature fibrils, but an increase in nonfibrillar, amorphous type of aggregates. Overall, we demonstrated that folding stability of A beta is an important determinant of the nucleation kinetics.-Ni, C.-L., Shi, H.-P., Yu, H.-M., Chang, Y.-C., and Chen, Y.-R. Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization. FASEB J. 25, 1390-1401 (2011). www.fasebj.org	[Ni, Chun-Lun; Shi, Hoi-Ping; Yu, Hui-Ming; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Yun-Chorng] Natl Cheng Kung Univ, Inst Electroopt Sci & Engn, Tainan 70101, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chang, Yun-Chorng/A-5832-2011; Chen, Yun-Ru/C-9304-2014	Chang, Yun-Chorng/0000-0002-2862-9789; Chen, Yun-Ru/0000-0002-6596-6338; Ni, Chun-Lun/0000-0002-6960-3972	Genomics Research Center, Academia Sinica, Taiwan; National Science Council, Taiwan [NSC 96-2113-M-001-030-MY2]	Genomics Research Center, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Dr. Ming-Dow Tsai (Institute of Biochemical Science, Academia Sinica) and Dr. An-Suei Yang (Genomics Research Center, Academia Sinica) for critical reading. The authors thank Dr. Leonid Breydo (University of California, Irvine, CA, USA) for suggestions. This work was supported by the Genomics Research Center, Academia Sinica, Taiwan, and the National Science Council, Taiwan (NSC 96-2113-M-001-030-MY2).	Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bibl M, 2007, J NEUROCHEM, V103, P467, DOI 10.1111/j.1471-4159.2007.04763.x; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bornebroek M, 1996, BRAIN PATHOL, V6, P111, DOI 10.1111/j.1750-3639.1996.tb00793.x; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Ferrao-Gonzales AD, 2005, J BIOL CHEM, V280, P34747, DOI 10.1074/jbc.M501651200; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Guo JT, 2004, PROTEINS, V57, P357, DOI 10.1002/prot.20222; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Kajava AV, 2010, FASEB J, V24, P1311, DOI 10.1096/fj.09-145979; KAMINO K, 1992, AM J HUM GENET, V51, P998; Krone MG, 2008, J MOL BIOL, V381, P221, DOI 10.1016/j.jmb.2008.05.069; Kumar-Singh S, 2002, NEUROBIOL DIS, V11, P330, DOI 10.1006/nbdi.2002.0529; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Povey JF, 2007, J STRUCT BIOL, V157, P329, DOI 10.1016/j.jsb.2006.07.008; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Rossi G, 1998, NEUROLOGY, V50, P688, DOI 10.1212/WNL.50.3.688; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	54	32	32	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1390	1401		10.1096/fj.10-175539	http://dx.doi.org/10.1096/fj.10-175539			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21209058				2022-12-25	WOS:000288982800028
J	Patrick, M; Korotkov, KV; Hol, WGJ; Sandkvist, M				Patrick, Marcella; Korotkov, Konstantin V.; Hol, Wim G. J.; Sandkvist, Maria			Oligomerization of EpsE Coordinates Residues from Multiple Subunits to Facilitate ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; PILUS RETRACTION MOTOR; VIBRIO-CHOLERAE; PROTEIN-SECRETION; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; CYTOPLASMIC DOMAIN; OUTER-MEMBRANE; IV SECRETION; IDENTIFICATION	EpsE is an ATPase that powers transport of cholera toxin and hydrolytic enzymes through the Type II secretion (T2S) apparatus in the Gram-negative bacterium, Vibrio cholerae. On the basis of structures of homologous Type II/IV secretion ATPases and our biochemical data, we believe that EpsE is active as an oligomer, likely a hexamer, and the binding, hydrolysis, and release of nucleotide cause EpsE to undergo dynamic structural changes, thus converting chemical energy to mechanical work, ultimately resulting in extracellular secretion. The conformational changes that occur as a consequence of nucleotide binding would realign conserved arginines (Arg(210), Arg(225), Arg(320), Arg(324), Arg(336), and Arg(369)) from adjoining domains and subunits to complete the active site around the bound nucleotide. Our data suggest that these arginines are essential for ATP hydrolysis, although their roles in shaping the active site of EpsE are varied. Specifically, we have shown that replacements of these arginine residues abrogate the T2S process due to a reduction of ATPase activity yet do not have any measurable effect on nucleotide binding or oligomerization of EpsE. We have further demonstrated that point mutations in the EpsE intersubunit interface also reduce ATPase activity without disrupting oligomerization, strengthening the idea that residues from multiple subunits must precisely interact in order for EpsE to be sufficiently active to support T2S. Our findings suggest that the action of EpsE is similar to that of other Type II/IV secretion ATPase family members, and thus these results may be widely applicable to the family as a whole.	[Patrick, Marcella; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48105 USA; [Korotkov, Konstantin V.; Hol, Wim G. J.] Univ Washington, Dept Biochem, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Sandkvist, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48105 USA.	mariasan@umich.edu		Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health [RO1AI049294]; NIAID [RO1AI34501]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R01AI049294, R56AI034501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI049294 (to M. S.) and RO1AI34501 (to W. G. J. H.) from the NIAID.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Hare S, 2007, EMBO J, V26, P4926, DOI 10.1038/sj.emboj.7601904; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; POSSOT O, 1994, MOL MICROBIOL, V12, P287, DOI 10.1111/j.1365-2958.1994.tb01017.x; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shiue SJ, 2007, MOL MICROBIOL, V65, P401, DOI 10.1111/j.1365-2958.2007.05795.x; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Thomsen ND, 2008, MOL MICROBIOL, V69, P1071, DOI 10.1111/j.1365-2958.2008.06364.x; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	36	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10378	10386		10.1074/jbc.M110.167031	http://dx.doi.org/10.1074/jbc.M110.167031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209100	Green Published, hybrid			2022-12-25	WOS:000288547000054
J	He, P; Laidlaw, T; Maekawa, A; Kanaoka, Y; Xu, KY; Lam, BK				He, Ping; Laidlaw, Tanya; Maekawa, Akiko; Kanaoka, Yoshihide; Xu, Kongyi; Lam, Bing K.			Oxidative Stress Suppresses Cysteinyl Leukotriene Generation by Mouse Bone Marrow-derived Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MOLECULAR-CLONING; 5-LIPOXYGENASE; GLUTATHIONE; PROTEIN; EXPRESSION; ACID; PURIFICATION; INFLAMMATION; MEDIATORS	Cysteinyl leukotrienes and oxidative stress have both been implicated in bronchial asthma; however, there is no previous study that focused on the ability of oxidative stress to alter cysteinyl leukotriene generation. In this study, treatment of bone marrow-derived mast cells with prostaglandin D-2 reduced their ability to generate leukotriene (LT) C-4 upon calcium ionophore stimulation but had little effect on LTB4 generation. This effect could be reproduced by a selective agonist of the DP2 receptor, 15R-methyl prostaglandin D-2 (15R-D-2). 15R-D-2 dose-dependently inhibited LTC4 generation with an IC50 of 2 mu M, and the effect was not altered by a DP2/thromboxane antagonist or by a peroxisome proliferator-activated receptor-gamma antagonist. 15R-D-2 exerted its suppressive effect via a reduction in intracellular GSH, a mechanism that involved the conjugation of its non-enzymatic breakdown product to GSH. At 10 mu M, 15R-D-2 reduced LTC4 generation to 10%, intracellular GSH to 50%, and LTC4 synthase (LTC4S) activity to 33.5% of untreated cells without altering immunoreactive LTC4S protein expression or 5-lipoxygenase activity. The effects of 15R-D-2 on LTC4S activity could be partially reversed by reducing reagent. The sulfhydryl-reactive oxidative agent diamide suppressed LTC4S activity and induced a reversible formation of covalent dimer LTC4S. LTC4S bearing a C56S mutation was resistant to the effect of diamide. Covalent dimer LTC4S was observed in nasal polyp biopsies, indicating that dimerization and inactivation of LTC4S can occur at the site of inflammation. These results suggest a cellular redox regulation of LTC4S function through a post-translational mechanism.	[Lam, Bing K.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lam, BK (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg,Rm 628,1 Jimmy Fund Way, Boston, MA 02115 USA.	blam@rics.bwh.harvard.edu			National Institutes of Health [HL36110, HL082695, HL090630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090630, P01HL036110, R01HL082695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL36110, HL082695, and HL090630.	Adamjee J, 2006, J PATHOL, V209, P392, DOI 10.1002/path.1979; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ATSMON J, 1990, CANCER RES, V50, P1879; Banu SK, 2008, ENDOCRINOLOGY, V149, P219, DOI 10.1210/en.2007-1087; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Diamant Z, 1997, AM J RESP CRIT CARE, V155, P1247, DOI 10.1164/ajrccm.155.4.9105062; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P6677, DOI 10.1073/pnas.84.19.6677; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; HATZELMANN A, 1987, EUR J BIOCHEM, V169, P175, DOI 10.1111/j.1432-1033.1987.tb13595.x; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hevko JM, 2002, J BIOL CHEM, V277, P7037, DOI 10.1074/jbc.M108942200; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; Mesquita-Santos FP, 2006, J IMMUNOL, V176, P1326, DOI 10.4049/jimmunol.176.3.1326; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; NICHOLSON DW, 1993, P NATL ACAD SCI USA, V90, P2015, DOI 10.1073/pnas.90.5.2015; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; PENROSE JF, 1992, P NATL ACAD SCI USA, V89, P11603, DOI 10.1073/pnas.89.23.11603; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200	38	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8277	8286		10.1074/jbc.M110.205567	http://dx.doi.org/10.1074/jbc.M110.205567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233206	Green Published, hybrid			2022-12-25	WOS:000288013300057
J	Vigetti, D; Clerici, M; Deleonibus, S; Karousou, E; Viola, M; Moretto, P; Heldin, P; Hascall, VC; De Luca, G; Passi, A				Vigetti, Davide; Clerici, Moira; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Heldin, Paraskevi; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Hyaluronan Synthesis Is Inhibited by Adenosine Monophosphate-activated Protein Kinase through the Regulation of HAS2 Activity in Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS; INTRACELLULAR HYALURONAN; GLUCOSE DEHYDROGENASE; CHONDROITIN-SULFATE; MOLECULAR-CLONING; SYNTHASE 2; CYCLIN D3; ATHEROSCLEROSIS; PROLIFERATION; EXPRESSION	Hyaluronan (HA) is an extracellular matrix glycosaminoglycan (GAG) involved in cell motility, proliferation, tissue remodeling, development, differentiation, inflammation, tumor progression, and invasion and controls vessel thickening in cardiovascular diseases. Therefore, the control of HA synthesis could permit the fine-tuning of cell behavior, but the mechanisms that regulate HA synthesis are largely unknown. Recent studies suggest that the availability of the nucleotide-sugar precursors has a critical role. Because the formation of UDP-sugars is a highly energetically demanding process, we have analyzed whether the energy status of the cell could control GAG production. AMP-activated protein kinase (AMPK) is the main ATP/AMP sensor of mammalian cells, and we mimicked an energy stress by treating human aortic smooth muscle cells (AoSMCs) with the AMPK activators 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin. Under these conditions, HA synthesis, but not that of the other GAGs, was greatly reduced. We confirmed the inhibitory effect of AMPK using a specific inhibitor and knock-out cell lines. We found that AMPK phosphorylated Thr-110 of human HAS2, which inhibits its enzymatic activity. In contrast, the other two HAS isoenzymes (HAS1 and HAS3) were not modified by the kinase. The reduction of HA decreased the ability of AoSMCs to proliferate, migrate, and recruit immune cells, thereby reducing the pro-atherosclerotic AoSMC phenotype. Interestingly, such effects were not recovered by treatment with exogenous HA, suggesting that AMPK can block the pro-atherosclerotic signals driven by HA by interaction with its receptors.	[Vigetti, Davide; Clerici, Moira; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Heldin, Paraskevi] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Ludwig Institute for Cancer Research; Uppsala University; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011; Vigetti, Davide/C-9861-2010	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; Vigetti, Davide/0000-0002-6339-8453	Fondazione Comunitaria del Varesotto-ONLUS; Fondo di Ateneo per la Ricerca; Centro Insubre di Biotecnologie per la Salute Umana	Fondazione Comunitaria del Varesotto-ONLUS; Fondo di Ateneo per la Ricerca; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by the Fondazione Comunitaria del Varesotto-ONLUS, PRIN 2007 (to G. D. L.), Fondo di Ateneo per la Ricerca, and a Centro Insubre di Biotecnologie per la Salute Umana young researcher award (to D. V.).	Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; BALDUINI C, 1973, BIOCHEM J, V133, P243, DOI 10.1042/bj1330243; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de Dios ST, 2007, J DIABETES COMPLICAT, V21, P108, DOI 10.1016/j.jdiacomp.2006.03.003; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nardini M, 2004, GENE EXPR PATTERNS, V4, P303, DOI 10.1016/j.modgep.2003.10.006; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; TIMAR J, 1995, INT J CANCER, V62, P755, DOI 10.1002/ijc.2910620618; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2008, ELECTROPHORESIS, V29, P3168, DOI 10.1002/elps.200700855; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	46	82	86	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7917	7924		10.1074/jbc.M110.193656	http://dx.doi.org/10.1074/jbc.M110.193656			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21228273	hybrid, Green Published			2022-12-25	WOS:000288013300022
J	Yadav, P; Tran, H; Ebegbe, R; Gottlieb, P; Wei, H; Lewis, RH; Mumbey-Wafula, A; Kaplan, A; Kholdarova, E; Spatz, L				Yadav, Pragya; Tran, Hoa; Ebegbe, Roland; Gottlieb, Paul; Wei, Hui; Lewis, Rita H.; Mumbey-Wafula, Alice; Kaplan, Atira; Kholdarova, Elina; Spatz, Linda			Antibodies Elicited in Response to EBNA-1 May Cross-React with dsDNA	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALTERED IMMUNE-RESPONSE; BARR NUCLEAR ANTIGEN-1; ORIGIN-BINDING-PROTEIN; ANTI-DNA ANTIBODIES; DOUBLE-STRANDED DNA; B-CELLS; AUTOANTIBODIES; PEPTIDE; EPITOPE	Background: Several genetic and environmental factors have been linked to Systemic Lupus Erythematosus (SLE). One environmental trigger that has a strong association with SLE is the Epstein Barr Virus (EBV). Our laboratory previously demonstrated that BALB/c mice expressing the complete EBNA-1 protein can develop antibodies to double stranded DNA (dsDNA). The present study was undertaken to understand why anti-dsDNA antibodies arise during the immune response to EBNA-1. Methodology/Principal Findings: In this study, we demonstrated that mouse antibodies elicited in response to EBNA-1 cross-react with dsDNA. First, we showed that adsorption of sera reactive with EBNA-1 and dsDNA, on dsDNA cellulose columns, diminished reactivity with EBNA-1. Next, we generated mononclonal antibodies (MAbs) to EBNA-1 and showed, by several methods, that they also reacted with dsDNA. Examination of two cross-reactive MAbs-3D4, generated in this laboratory, and 0211, a commercial MAb-revealed that 3D4 recognizes the carboxyl region of EBNA-1, while 0211 recognizes both the amino and carboxyl regions. In addition, 0211 binds moderately well to the ribonucleoprotein, Sm, which has been reported by others to elicit a cross-reactive response with EBNA-1, while 3D4 binds only weakly to Sm. This suggests that the epitope in the carboxyl region may be more important for cross-reactivity with dsDNA while the epitope in the amino region may be more important for cross-reactivity with Sm. Conclusions/Significance: In conclusion, our results demonstrate that antibodies to the EBNA-1 protein cross-react with dsDNA. This study is significant because it demonstrates a direct link between the viral antigen and the development of anti-dsDNA antibodies, which are the hallmark of SLE. Furthermore, it illustrates the crucial need to identify the epitopes in EBNA-1 responsible for this cross-reactivity so that therapeutic strategies can be designed to mask these regions from the immune system following EBV exposure.	[Yadav, Pragya] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Yadav, Pragya; Gottlieb, Paul; Spatz, Linda] CUNY, Grad Ctr, New York, NY USA; [Yadav, Pragya; Gottlieb, Paul; Spatz, Linda] CUNY City Coll, PhD Program Biochem, New York, NY 10031 USA; [Tran, Hoa; Ebegbe, Roland; Gottlieb, Paul; Lewis, Rita H.; Spatz, Linda] CUNY City Coll, Grad Sch Biol, New York, NY 10031 USA; [Gottlieb, Paul; Wei, Hui; Mumbey-Wafula, Alice; Kaplan, Atira; Kholdarova, Elina; Spatz, Linda] CUNY City Coll, Dept Microbiol & Immunol, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Yadav, P (corresponding author), CUNY City Coll, Dept Chem, New York, NY 10031 USA.	lspatz@med.cuny.edu			National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE) [SO6 GM 08168]; National Center for Research Resources Centers in Minority Institutions [NIH/NCRR/RCMI 5G12 RR03060]; Professional Staff Congress at the City University of New York (PSC-CUNY) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008168] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Professional Staff Congress at the City University of New York (PSC-CUNY) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants SO6 GM 08168 from the National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE), NIH/NCRR/RCMI 5G12 RR03060 from the National Center for Research Resources Centers in Minority Institutions and the Professional Staff Congress at the City University of New York (PSC-CUNY) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi F, 2001, CLIN IMMUNOL, V98, P293, DOI 10.1006/clim.2000.4970; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Ceccarelli DFJ, 2000, J VIROL, V74, P4939, DOI 10.1128/JVI.74.11.4939-4948.2000; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; EVANS AS, 1989, VIRAL INFECT HUMANS, P265; FAWCETT PT, 1990, AUTOIMMUNITY, V6, P249, DOI 10.3109/08916939008998417; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; Gottlieb P, 2002, VIROLOGY, V295, P266, DOI 10.1006/viro.2002.1436; Harley JB, 2000, MOLECULAR MIMICRY, MICROBES, AND AUTOIMMUNITY, P109; ILIEV A, 1994, J IMMUNOL, V153, P3551; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jiang C, 2010, J IMMUNOL, V184, P1085, DOI 10.4049/jimmunol.0902670; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; MARCHINI B, 1994, J AUTOIMMUN, V7, P179, DOI 10.1006/jaut.1994.1014; McClain MT, 2006, ARTHRITIS RHEUM-US, V54, P360, DOI 10.1002/art.21682; PETERSEN J, 1990, ARTHRITIS RHEUM, V33, P993, DOI 10.1002/art.1780330711; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Poole BD, 2008, J AUTOIMMUN, V31, P362, DOI 10.1016/j.jaut.2008.08.007; RANA FR, 1990, FEBS LETT, V261, P464, DOI 10.1016/0014-5793(90)80616-Q; Riemekasten G, 1998, J CLIN INVEST, V102, P754, DOI 10.1172/JCI2749; SABBATINI A, 1993, EUR J IMMUNOL, V23, P1146, DOI 10.1002/eji.1830230525; Sharma A, 2001, J AUTOIMMUN, V16, P479, DOI 10.1006/jaut.2001.0514; SHOENFELD Y, 1986, CLIN EXP IMMUNOL, V66, P255; Summers H, 1996, J VIROL, V70, P1228, DOI 10.1128/JVI.70.2.1228-1231.1996; Sun YJ, 2001, INT IMMUNOL, V13, P223, DOI 10.1093/intimm/13.2.223; Sundar K, 2004, J AUTOIMMUN, V23, P127, DOI 10.1016/j.jaut.2004.06.001; Takeda I, 1999, J AUTOIMMUN, V13, P423, DOI 10.1006/jaut.1999.0330; Taylor DK, 2006, MOL IMMUNOL, V43, P1776, DOI 10.1016/j.molimm.2005.11.003; Workman CJ, 1998, J PROTEIN CHEM, V17, P599, DOI 10.1007/BF02780961; ZACK DJ, 1995, J IMMUNOL, V154, P1987; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang W, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/683489	37	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14488	10.1371/journal.pone.0014488	http://dx.doi.org/10.1371/journal.pone.0014488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245919	Green Published, gold			2022-12-25	WOS:000286510500005
J	Corbi, N; Batassa, EM; Pisani, C; Onori, A; Di Certo, MG; Strimpakos, G; Fanciulli, M; Mattei, E; Passananti, C				Corbi, Nicoletta; Batassa, Enrico Maria; Pisani, Cinzia; Onori, Annalisa; Di Certo, Maria Grazia; Strimpakos, Georgios; Fanciulli, Maurizio; Mattei, Elisabetta; Passananti, Claudio			The eEF1 gamma Subunit Contacts RNA Polymerase II and Binds Vimentin Promoter Region	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; YEAST; INTERACTS; MEDIATOR; RPB3; IDENTIFICATION; LOCALIZATION; ARCHITECTURE; DOXORUBICIN; ACTIVATION	Here, we show that the eukaryotic translation elongation factor 1 gamma (eEF1 gamma) physically interacts with the RNA polymerase II (pol II) core subunit 3 (RPB3), both in isolation and in the context of the holo-enzyme. Importantly, eEF1 gamma has been recently shown to bind Vimentin mRNA. By chromatin immunoprecipitation experiments, we demonstrate, for the first time, that eEF1 gamma is also physically present on the genomic locus corresponding to the promoter region of human Vimentin gene. The eEF1 gamma depletion causes the Vimentin protein to be incorrectly compartmentalised and to severely compromise cellular shape and mitochondria localisation. We demonstrate that eEF1 gamma partially colocalises with the mitochondrial marker Tom20 and that eEF1 gamma depletion increases mitochondrial superoxide generation as well as the total levels of carbonylated proteins. Finally, we hypothesise that eEF1 gamma, in addition to its role in translation elongation complex, is involved in regulating Vimentin gene by contacting both pol II and the Vimentin promoter region and then shuttling/nursing the Vimentin mRNA from its gene locus to its appropriate cellular compartment for translation.	[Corbi, Nicoletta; Batassa, Enrico Maria; Pisani, Cinzia; Onori, Annalisa; Passananti, Claudio] Regina Elena Inst Canc Res, CNR, Ist Biol & Patol Mol, Rome, Italy; [Pisani, Cinzia] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Di Certo, Maria Grazia; Strimpakos, Georgios; Mattei, Elisabetta] IRCCS Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, Rome, Italy; [Fanciulli, Maurizio] Regina Elena Inst Canc Res, Dept Therapeut Programs Dev, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Corbi, N (corresponding author), Regina Elena Inst Canc Res, CNR, Ist Biol & Patol Mol, Rome, Italy.	passananti@ifo.it	Passananti, Claudio/K-9593-2016; Maria Grazia, Di Certo/AAW-8769-2020; Pisani, Cinzia/AAM-1890-2020; Corbi, Nicoletta/K-2313-2014; Corbi, Nicoletta/AAW-8835-2020; fanciulli, maurizio/ABH-6745-2020	Pisani, Cinzia/0000-0002-8673-3891; PASSANANTI, CLAUDIO/0000-0002-9288-5736; CORBI, NICOLETTA/0000-0002-4505-1632; STRIMPAKOS, GEORGIOS/0000-0002-6021-9704	Paul Blumel Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 2009, IG 5697]; Telethon [GGP07177]; Progetto PRIN	Paul Blumel Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Progetto PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by Paul Blumel Foundation; by Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 2009 and IG 5697; by Telethon project GGP07177; Progetto PRIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Bermano G, 2001, FEBS LETT, V497, P77, DOI 10.1016/S0014-5793(01)02438-3; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; Corbi N, 2002, FASEB J, V16, P1639, DOI 10.1096/fj.02-0123fje; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Fanciulli M, 1998, FEBS LETT, V427, P236, DOI 10.1016/S0014-5793(98)00431-1; Fanciulli M, 1996, FEBS LETT, V384, P48, DOI 10.1016/0014-5793(96)00277-3; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; Katsumoto T, 1990, BIOL CELL, V168, P139; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Klein C, 2007, NAT GENET, P3986; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Merrick WC, 2000, PROTEIN SYNTHESIS EL; Mimori K, 1996, GUT, V38, P66, DOI 10.1136/gut.38.1.66; Monaco L, 2003, GENE, V321, P57, DOI 10.1016/S0378-1119(03)00834-5; Morris EJ, 2000, J CELL SCI, V113, P2433; Muller M, 2007, CELL MOL LIFE SCI, V64, P171, DOI 10.1007/s00018-006-6286-1; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Passananti C, 2007, BIOCHEM CELL BIOL, V85, P477, DOI 10.1139/O07-062; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Sarnowska E, 2007, NUCLEIC ACIDS RES, V35, P5499, DOI 10.1093/nar/gkm502; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Tan Q, 2000, GENE DEV, V14, P339; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	47	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14481	10.1371/journal.pone.0014481	http://dx.doi.org/10.1371/journal.pone.0014481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217813	Green Submitted, gold, Green Published			2022-12-25	WOS:000285838900010
J	Zhang, YA; Duan, S; Lin, XP; Zhang, W; Meng, N; Zhao, LP; Zhao, Y; Han, DM; Zhang, L				Zhang, Yuan; Duan, Su; Lin, Xiaoping; Zhang, Wei; Meng, Na; Zhao, Liping; Zhao, Yan; Han, Demin; Zhang, Luo			SNPs in the FCER1A Gene Region Show No Association with Allergic Rhinitis in a Han Chinese Population	PLOS ONE			English	Article							SERUM IGE LEVELS; RI-ALPHA GENE; PROMOTER POLYMORPHISMS; ASTHMA; EPSILON; EPISTASIS; DISEASES; VARIANTS; CHAIN; SUSCEPTIBILITY	Background: Immunoglobulin E (IgE) is a central player in the allergic response, and raised total IgE levels are considered as an indicator of atopy or potential development of atopy. A recent genome-wide scan in a German population-based cohort of adults identified the gene encoding the alpha chain of the high affinity receptor for IgE (FCER1A) as a susceptibility locus influencing total serum IgE levels. The aim of this study was to investigate whether the polymorphisms in the FCER1A gene are associated with allergic rhinitis (AR) in a Han Chinese population. Methodology/Principal Findings: A population of 378 patients with AR and 288 healthy controls was studied. Precise phenotyping of patients was accomplished by means of a questionnaire and clinical examination. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE) measurement. A total of 16 single nucleotide polymorphisms (SNPs) in FCER1A were selected and individually genotyped. None of the SNPs in the FCER1A showed an association with AR. Similarly, the lack of association was also evident in subgroup analysis for the presence of different allergen sensitivities. None of the selected SNPs in FCER1A was associated with total IgE level. Conclusions: Although FCER1A presents itself as a good candidate for contributing to total serum IgE, this study failed to find an association between SNPs in the FCER1A gene region and IgE level or AR susceptibility.	[Zhang, Yuan; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otorhinolaryngol, Minist Educ China, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Zhang, Yuan; Duan, Su; Zhao, Yan; Han, Demin; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Lin, Xiaoping] Gen Hosp Shenyang Mil Command, Ctr Allergy & Immunotherapy, Shenyang, Peoples R China	Ministry of Education, China; Capital Medical University	Zhang, YA (corresponding author), Beijing Inst Otorhinolaryngol, Minist Educ China, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	Ministry of Science and Technology of the People's Republic of China [2007BAI18B15]; National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30872846, 30973282]; Beijing Natural Science Foundation [7072017]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Key Technology Research and Development Program from the Ministry of Science and Technology of the People's Republic of China (2007BAI18B15), National Science Fund for Distinguished Young Scholars (81025007), National Natural Science Foundation of China (30872846 and 30973282), and Beijing Natural Science Foundation (7072017) to DH and LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bae JS, 2007, J ALLERGY CLIN IMMUN, V119, P449, DOI 10.1016/j.jaci.2006.10.006; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chen CM, 2009, ALLERGY, V64, P1327, DOI 10.1111/j.1398-9995.2009.02005.x; DREBORG S, 1993, ALLERGY, V47, pS48; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hasegawa M, 2003, J IMMUNOL, V171, P1927, DOI 10.4049/jimmunol.171.4.1927; Jacobsen HP, 2001, J ALLERGY CLIN IMMUN, V107, P659; John JMM, 2010, ALLERGY, V65, P875, DOI 10.1111/j.1398-9995.2009.02297.x; Kanada S, 2008, J IMMUNOL, V180, P8204, DOI 10.4049/jimmunol.180.12.8204; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Limb SL, 2005, J ALLERGY CLIN IMMUN, V115, P61, DOI 10.1016/j.jaci.2004.09.032; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Musilova P, 2005, ANIM GENET, V36, P507, DOI 10.1111/j.1365-2052.2005.01348.x; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Potaczek DP, 2008, INT J IMMUNOGENET, V35, P339, DOI 10.1111/j.1744-313X.2008.00784.x; Potaczek DP, 2006, ALLERGY, V61, P1230, DOI 10.1111/j.1398-9995.2006.01195.x; Potaczek DP, 2007, ANN ALLERG ASTHMA IM, V98, P500, DOI 10.1016/S1081-1206(10)60770-3; Potaczek DP, 2009, IMMUNOGENETICS, V61, P649, DOI 10.1007/s00251-009-0391-x; Shikanai T, 2002, J APPL PHYSIOL, V93, P37, DOI 10.1152/japplphysiol.00993.2001; Strachan DR, 2001, J ALLERGY CLIN IMMUN, V108, P901, DOI 10.1067/mai.2001.119408; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vychodilova-Krenkova L, 2005, INT J IMMUNOGENET, V32, P277, DOI 10.1111/j.1744-313X.2005.00522.x; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhang M, 2007, IMMUNOL RES, V37, P1, DOI 10.1007/BF02686092	36	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15792	10.1371/journal.pone.0015792	http://dx.doi.org/10.1371/journal.pone.0015792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209833	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900034
J	Cui, T; Hurtig, M; Elgue, G; Li, SC; Veronesi, G; Essaghir, A; Demoulin, JB; Pelosi, G; Alimohammadi, M; Oberg, K; Giandomenico, V				Cui, Tao; Hurtig, Monica; Elgue, Graciela; Li, Su-Chen; Veronesi, Giulia; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Pelosi, Giuseppe; Alimohammadi, Mohammad; Oberg, Kjell; Giandomenico, Valeria			Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors	PLOS ONE			English	Article							NEUROLOGICAL SYNDROMES; POOR-PROGNOSIS; CANCER; LUNG; CARCINOMAS; MANAGEMENT; PATHOLOGY; SURVIVAL; DISEASE; CELLS	Background: Small intestine neuroendocrine tumors (SI-NETs) belong to a rare group of cancers. Most patients have developed metastatic disease at the time of diagnosis, for which there is currently no cure. The delay in diagnosis is a major issue in the clinical management of the patients and new markers are urgently needed. We have previously identified paraneoplastic antigen Ma2 (PNMA2) as a novel SI-NET tissue biomarker. Therefore, we evaluated whether Ma2 autoantibodies detection in the blood stream is useful for the clinical diagnosis and recurrence of SI-NETs. Methodology/Principal Findings: A novel indirect ELISA was set up to detect Ma2 autoantibodies in blood samples of patients with SI-NET at different stages of disease. The analysis was extended to include typical and atypical lung carcinoids (TLC and ALC), to evaluate whether Ma2 autoantibodies in the blood stream become a general biomarker for NETs. In total, 124 blood samples of SI-NET patients at different stages of disease were included in the study. The novel Ma2 autoantibody ELISA showed high sensitivity, specificity and accuracy with ROC curve analysis underlying an area between 0.734 and 0.816. Ma2 autoantibodies in the blood from SI-NET patients were verified by western blot and sequential immunoprecipitation. Serum antibodies of patients stain Ma2 in the tumor tissue and neurons. We observed that SI-NET patients expressing Ma2 autoantibody levels below the cutoff had a longer progression and recurrence-free survival compared to those with higher titer. We also detected higher levels of Ma2 autoantibodies in blood samples from TLC and ALC patients than from healthy controls, as previously shown in small cell lung carcinoma samples. Conclusion: Here we show that high Ma2 autoantibody titer in the blood of SI-NET patients is a sensitive and specific biomarker, superior to chromogranin A (CgA) for the risk of recurrence after radical operation of these tumors.	[Cui, Tao; Li, Su-Chen; Giandomenico, Valeria] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hurtig, Monica; Alimohammadi, Mohammad; Oberg, Kjell] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Elgue, Graciela] Uppsala Univ, Div Clin Immunol, Uppsala, Sweden; [Veronesi, Giulia] European Inst Oncol, Div Thorac Surg, Milan, Italy; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Pelosi, Giuseppe] European Inst Oncol, Div Pathol & Lab Med, Milan, Italy; [Pelosi, Giuseppe] Univ Milan, Sch Med, Milan, Italy; [Oberg, Kjell; Giandomenico, Valeria] Univ Uppsala Hosp, Dept Med Sci, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; IRCCS European Institute of Oncology (IEO); Universite Catholique Louvain; IRCCS European Institute of Oncology (IEO); University of Milan; Uppsala University; Uppsala University Hospital	Cui, T (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	valeria.giandomenico@medsci.uu.se	Veronesi, Giulia/AAA-6327-2021; Oberg, Kjell/AAG-7118-2019; Demoulin, Jean-Baptiste/E-5847-2010; Pelosi, Giuseppe/F-5073-2012	Veronesi, Giulia/0000-0001-9032-1278; Pelosi, Giuseppe/0000-0003-4725-4692; Demoulin, Jean-Baptiste/0000-0002-8016-6689	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse	This work was supported by funding from the Lions Cancerforskningsfond, Tore Nilssons Stiftelse for Medicinsk Forskning and Erik, Karin och Gosta Selander Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Behr R, 2007, DEV BIOL, V306, P636, DOI 10.1016/j.ydbio.2007.03.525; Creutzfeldt W, 1996, WORLD J SURG, V20, P126, DOI 10.1007/s002689900020; Dong J, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-81; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P1638, DOI 10.1002/cncr.24180; Eichmuller SB, 2007, CURR MED CHEM, V14, P2489, DOI 10.2174/092986707782023668; Eriksson B, 2008, NEUROENDOCRINOLOGY, V87, P8, DOI 10.1159/000111034; Gozzard Paul, 2010, Pract Neurol, V10, P260, DOI 10.1136/jnnp.2010.224105; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Hoffmann LA, 2008, J NEUROL NEUROSUR PS, V79, P767, DOI 10.1136/jnnp.2007.118588; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Jiang BH, 2010, AM J PATHOL, V177, P1095, DOI 10.2353/ajpath.2010.091178; Kaltsas G, 2010, ENDOCR-RELAT CANCER, V17, pR173, DOI 10.1677/ERC-10-0024; Klimstra DS, 2010, AM J SURG PATHOL, V34, P300, DOI 10.1097/PAS.0b013e3181ce1447; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Ludbrook J, 2008, ANZ J SURG, V78, P204, DOI 10.1111/j.1445-2197.2007.04405.x; Modlin IM, 2008, JNCI-J NATL CANCER I, V100, P1282, DOI 10.1093/jnci/djn275; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Monstad SE, 2009, CANCER IMMUNOL IMMUN, V58, P1797, DOI 10.1007/s00262-009-0690-y; Moran CA, 2009, AM J CLIN PATHOL, V131, P206, DOI 10.1309/AJCP9H1OTMUCSKQW; Oberg K, 2009, CURR OPIN ENDOCRINOL, V16, P72, DOI 10.1097/MED.0b013e328320d845; Pujol JL, 2007, J THORAC ONCOL, V2, P168, DOI 10.1097/JTO.0b013e31802f1c9d; Rosner B, 1999, STAT MED, V18, P1387, DOI 10.1002/(SICI)1097-0258(19990615)18:11<1387::AID-SIM126>3.0.CO;2-V; Schuller M, 2005, J NEUROIMMUNOL, V169, P172, DOI 10.1016/j.jneuroim.2005.08.019; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Stich O, 2007, J NEUROIMMUNOL, V183, P220, DOI 10.1016/j.jneuroim.2006.11.008; Syrigos KN, 1996, INT J CANCER, V66, P624, DOI 10.1002/(SICI)1097-0215(19960529)66:5<624::AID-IJC7>3.0.CO;2-V; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Tschernatsch M, 2008, EUR J NEUROL, V15, P1390, DOI 10.1111/j.1468-1331.2008.02328.x; TSUTA K, 2010, LUNG CANC; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; Voltz R, 1999, NEW ENGL J MED, V340, P1788, DOI 10.1056/NEJM199906103402303; Welin S, 2009, NEUROENDOCRINOLOGY, V89, P302, DOI 10.1159/000179900; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	37	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16010	10.1371/journal.pone.0016010	http://dx.doi.org/10.1371/journal.pone.0016010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209860	Green Published, gold			2022-12-25	WOS:000285793600058
J	Gao, CM; Yam, AY; Wang, XM; Magdangal, E; Salisbury, C; Peretz, D; Zuckermann, RN; Connolly, MD; Hansson, O; Minthon, L; Zetterberg, H; Blennow, K; Fedynyshyn, JP; Allauzen, S				Gao, Carol Man; Yam, Alice Y.; Wang, Xuemei; Magdangal, Erika; Salisbury, Cleo; Peretz, David; Zuckermann, Ronald N.; Connolly, Michael D.; Hansson, Oskar; Minthon, Lennart; Zetterberg, Henrik; Blennow, Kaj; Fedynyshyn, Joseph P.; Allauzen, Sophie			A beta 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; A-BETA; CEREBROVASCULAR LESIONS; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PREVALENCE; PATHOGENESIS; BRAIN; NEURODEGENERATION; AGGREGATION	Alzheimer's Disease (AD) is the most prevalent form of dementia worldwide, yet the development of therapeutics has been hampered by the absence of suitable biomarkers to diagnose the disease in its early stages prior to the formation of amyloid plaques and the occurrence of irreversible neuronal damage. Since oligomeric A beta species have been implicated in the pathophysiology of AD, we reasoned that they may correlate with the onset of disease. As such, we have developed a novel misfolded protein assay for the detection of soluble oligomers composed of A beta x-40 and x-42 peptide (hereafter A beta 40 and A beta 42) from cerebrospinal fluid (CSF). Preliminary validation of this assay with 36 clinical samples demonstrated the presence of aggregated A beta 40 in the CSF of AD patients. Together with measurements of total A beta 42, diagnostic sensitivity and specificity greater than 95% and 90%, respectively, were achieved. Although larger sample populations will be needed to confirm this diagnostic sensitivity, our studies demonstrate a sensitive method of detecting circulating A beta 40 oligomers from AD CSF and suggest that these oligomers could be a powerful new biomarker for the early detection of AD.	[Gao, Carol Man; Yam, Alice Y.; Wang, Xuemei; Magdangal, Erika; Salisbury, Cleo; Peretz, David; Zuckermann, Ronald N.; Connolly, Michael D.; Fedynyshyn, Joseph P.; Allauzen, Sophie] Novartis Vaccines & Diagnost, Res & Dev, Emeryville, CA USA; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Dept Neurosci & Physiol, Molndal, Sweden; [Hansson, Oskar; Minthon, Lennart] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Malmo, Sweden	Novartis; Sahlgrenska University Hospital; Lund University	Gao, CM (corresponding author), Novartis Vaccines & Diagnost, Res & Dev, Emeryville, CA USA.	joseph.fedynyshyn@novartis.com	Hansson, Oskar/A-7134-2013; Zuckermann, Ronald/P-3436-2019; Wang, Xuemei/GXF-3702-2022; Zuckermann, Ronald N/A-7606-2014	Hansson, Oskar/0000-0001-8467-7286; Zuckermann, Ronald/0000-0002-3055-8860; Zuckermann, Ronald N/0000-0002-3055-8860	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was funded by Novartis Vaccines and Diagnostics. Several of the authors are or were employed by the funder and, as such, the funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Caroli A, 2009, EXPERT REV MED DEVIC, V6, P569, DOI [10.1586/erd.09.35, 10.1586/ERD.09.35]; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FUKUMOTO H, 2010, FASEB J; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haglund M, 2006, ACTA NEUROPATHOL, V111, P430, DOI 10.1007/s00401-006-0054-z; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018; Jellinger KA, 2010, NEURODEGENER DIS, V7, P112, DOI 10.1159/000285518; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nguyen JT, 2000, CHEM BIOL, V7, P463, DOI 10.1016/S1074-5521(00)00130-7; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Portelius E, 2010, ACTA NEUROPATHOL; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Urbanelli Lorena, 2009, Recent Pat CNS Drug Discov, V4, P160; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weller RO, 2003, NEUROL RES, V25, P611, DOI 10.1179/016164103101202057	38	70	75	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15725	10.1371/journal.pone.0015725	http://dx.doi.org/10.1371/journal.pone.0015725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209907	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600030
J	Perrin, FE; Boniface, G; Serguera, C; Lonjon, N; Serre, A; Prieto, M; Mallet, J; Privat, A				Perrin, Florence E.; Boniface, Guillaume; Serguera, Che; Lonjon, Nicolas; Serre, Angeline; Prieto, Monica; Mallet, Jacques; Privat, Alain			Grafted Human Embryonic Progenitors Expressing Neurogenin-2 Stimulate Axonal Sprouting and Improve Motor Recovery after Severe Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; TRAUMATIC INJURY; MOUSE MODEL; AUTOFLUORESCENCE; REPAIR; RATS; PROMOTES; BRAIN; DIFFERENTIATION	Background: Spinal cord injury (SCI) is a widely spread pathology with currently no effective treatment for any symptom. Regenerative medicine through cell transplantation is a very attractive strategy and may be used in different non-exclusive ways to promote functional recovery. We investigated functional and structural outcomes after grafting human embryonic neural progenitors (hENPs) in spinal cord-lesioned rats. Methods and Principal Findings: With the objective of translation to clinics we have chosen a paradigm of delayed grafting, i.e., one week after lesion, in a severe model of spinal cord compression in adult rats. hENPs were either naive or engineered to express Neurogenin 2 (Ngn2). Moreover, we have compared integrating and non-integrating lentiviral vectors, since the latter present reduced risks of insertional mutagenesis. We show that transplantation of hENPs transduced to express Ngn2 fully restore weight support and improve functional motor recovery after severe spinal cord compression at thoracic level. This was correlated with partial restoration of serotonin innervations at lumbar level, and translocation of 5HT1A receptors to the plasma membrane of motoneurons. Since hENPs were not detectable 4 weeks after grafting, transitory expression of Ngn2 appears sufficient to achieve motor recovery and to permit axonal regeneration. Importantly, we also demonstrate that transplantation of naive hENPs is detrimental to functional recovery. Conclusions and Significance: Transplantation and short-term survival of Ngn2-expressing hENPs restore weight support after SCI and partially restore serotonin fibers density and 5HT1A receptor pattern caudal to the lesion. Moreover, grafting of naive-hENPs was found to worsen the outcome versus injured only animals, thus pointing to the possible detrimental effect of stem cell-based therapy per se in SCI. This is of major importance given the increasing number of clinical trials involving cell grafting developed for SCI patients.	[Perrin, Florence E.; Privat, Alain] Univ Basque Country UPV EHU, Dept Neurosci, IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Perrin, Florence E.; Boniface, Guillaume; Lonjon, Nicolas; Privat, Alain] St Eloi Hosp, INSERM, U583, Inst Neurosci Montpellier Pathophysiol & Therapy, Montpellier, France; [Boniface, Guillaume; Lonjon, Nicolas] Gui de Chauliac Hosp, Dept Neurosurg, Montpellier, France; [Serguera, Che; Serre, Angeline; Mallet, Jacques] Univ Paris 06, INSERM UMRS 975, Inst Cerveau & Moelle Epiniere, Hop La Pitie Salpetriere,Ctr Rech,CNRS UMR 7225, Paris, France; [Serguera, Che] CEA INSERM, MIRCen, Fontenay Aux Roses, France; [Prieto, Monica; Privat, Alain] St Eloi Hosp, Neureva Inc INM, Montpellier, France	Basque Foundation for Science; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier	Perrin, FE (corresponding author), Univ Basque Country UPV EHU, Dept Neurosci, IKERBASQUE Basque Fdn Sci, Bilbao, Spain.	f.perrin@ikerbasque.org	Serguera, Ché/J-8918-2012; PERRIN, Florence/AAY-6815-2021	Serguera, Che/0000-0002-9210-0636; PERRIN, Florence/0000-0002-7630-0515	European Union; Institut pour la Recherche sur la Moelle Epiniere; Academie de Medecine; Societe Francaise de Neurochirurgie; Verticale; Association Demain Debout Aquitaine	European Union(European Commission); Institut pour la Recherche sur la Moelle Epiniere; Academie de Medecine; Societe Francaise de Neurochirurgie; Verticale; Association Demain Debout Aquitaine	This study was supported by the European Union FP6 "RESCUE" STREP; the "Institut pour la Recherche sur la Moelle Epiniere"; the "Academie de Medecine"; the "Societe Francaise de Neurochirurgie"; "Verticale" and the "Association Demain Debout Aquitaine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; BUCCARON MH, 1995, NEUROBIOL DIS, V2, P37, DOI 10.1006/nbdi.1995.0004; Buchet D, 2002, MOL CELL NEUROSCI, V19, P389, DOI 10.1006/mcne.2001.1086; CAVALIERI B, 1635, CERTAIN METHOD DEV N, P1; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Gaviria M, 2002, J NEUROTRAUM, V19, P205, DOI 10.1089/08977150252806965; HAVENITH CEG, 1993, J LEUKOCYTE BIOL, V53, P504, DOI 10.1002/jlb.53.5.504; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LONJON N, 2010, SPINAL CORD IN PRESS; Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989; Lonjon N, 2009, J NEUROSCI RES, V87, P403, DOI 10.1002/jnr.21871; MALLEY A, 1988, J LEUKOCYTE BIOL, V43, P557, DOI 10.1002/jlb.43.6.557; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; NICOD LP, 1989, J LEUKOCYTE BIOL, V45, P458, DOI 10.1002/jlb.45.5.458; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Ribotta MG, 2002, PROG BRAIN RES, V137, P191; RIBOTTA MGY, 1995, J NEUROSCI RES, V41, P79, DOI 10.1002/jnr.490410110; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Sarkis C, 2008, CURR GENE THER, V8, P430, DOI 10.2174/156652308786848012; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Sedy J, 2007, J NEUROTRAUM, V24, P1487, DOI 10.1089/neu.2006.0252; SHAPIRO S, 1995, J SURG RES, V59, P393, DOI 10.1006/jsre.1995.1181; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115	37	34	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15914	10.1371/journal.pone.0015914	http://dx.doi.org/10.1371/journal.pone.0015914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209909	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600050
J	Krijger, PHL; Wit, N; van den Berk, PCM; Jacobs, H				Krijger, Peter H. L.; Wit, Niek; van den Berk, Paul C. M.; Jacobs, Heinz			The Fanconi Anemia Core Complex Is Dispensable during Somatic Hypermutation and Class Switch Recombination	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; IMMUNOGLOBULIN GENE HYPERMUTATION; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; REPAIR; MICE; REV1; MUTAGENESIS; MECHANISM; PATHWAY	To generate high affinity antibodies during an immune response, B cells undergo somatic hypermutation (SHM) of their immunoglobulin genes. Error-prone translesion synthesis (TLS) DNA polymerases have been reported to be responsible for all mutations at template A/T and at least a fraction of G/C transversions. In contrast to A/T mutations which depend on PCNA ubiquitination, it remains unclear how G/C transversions are regulated during SHM. Several lines of evidence indicate a mechanistic link between the Fanconi Anemia (FA) pathway and TLS. To investigate the contribution of the FA pathway in SHM we analyzed FancG-deficient B cells. B cells deficient for FancG, an essential member of the FA core complex, were hypersensitive to treatment with cross-linking agents. However, the frequencies and nucleotide exchange spectra of SHM remained comparable between wild-type and FancG-deficient B cells. These data indicate that the FA pathway is not involved in regulating the outcome of SHM in mammals. In addition, the FA pathway appears dispensable for class switch recombination.	[Krijger, Peter H. L.; Wit, Niek; van den Berk, Paul C. M.; Jacobs, Heinz] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Krijger, PHL (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	h.jacobs@nki.nl		Jacobs, Heinz/0000-0001-6227-9850; Krijger, Peter/0000-0003-1702-348X	Netherlands Organisation for Scientific Research; Dutch Cancer Foundation [NWO 917.56.328, NKI-2008-4112]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Foundation(KWF Kankerbestrijding)	This work was funded by the Netherlands Organisation for Scientific Research (http://www.nwo.nl) and the Dutch Cancer Foundation (www.kwf.nl) (VIDI program NWO 917.56.328 and KWF grant NKI-2008-4112 to HJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Faili A, 2009, J IMMUNOL, V182, P6353, DOI 10.4049/jimmunol.0900177; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Martomo SA, 2005, P NATL ACAD SCI USA, V102, P8656, DOI 10.1073/pnas.0501852102; Masuda K, 2009, J IMMUNOL, V183, P1846, DOI 10.4049/jimmunol.0901240; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15236	10.1371/journal.pone.0015236	http://dx.doi.org/10.1371/journal.pone.0015236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209924	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200021
J	Radtke, AL; Wilson, JW; Sarker, S; Nickerson, CA				Radtke, Andrea L.; Wilson, James W.; Sarker, Shameema; Nickerson, Cheryl A.			Analysis of Interactions of Salmonella Type Three Secretion Mutants with 3-D Intestinal Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 1; FLAGELLAR PROTEIN EXPORT; ROTATING-WALL VESSEL; III SECRETION; COLONIZATION FACTORS; FIMBRIAL OPERONS; MOLECULAR-BASIS; MASTER OPERON; ANIMAL-MODELS	The prevailing paradigm of Salmonella enteropathogenesis based on monolayers asserts that Salmonella pathogenicity island-1 Type Three Secretion System (SPI-1 T3SS) is required for bacterial invasion into intestinal epithelium. However, little is known about the role of SPI-1 in mediating gastrointestinal disease in humans. Recently, SPI-1 deficient nontyphoidal Salmonella strains were isolated from infected humans and animals, indicating that SPI-1 is not required to cause enteropathogenesis and demonstrating the need for more in vivo-like models. Here, we utilized a previously characterized 3-D organotypic model of human intestinal epithelium to elucidate the role of all characterized Salmonella enterica T3SSs. Similar to in vivo reports, the Salmonella SPI-1 T3SS was not required to invade 3-D intestinal cells. Additionally, Salmonella strains carrying single (SPI-1 or SPI-2), double (SPI-1/2) and complete T3SS knockout (SPI-1/SPI-2:flhDC) also invaded 3-D intestinal cells to wildtype levels. Invasion of wildtype and TTSS mutants was a Salmonella active process, whereas noninvasive bacterial strains, bacterial size beads, and heat-killed Salmonella did not invade 3-D cells. Wildtype and T3SS mutants did not preferentially target different cell types identified within the 3-D intestinal aggregates, including M-cells/M-like cells, enterocytes, or Paneth cells. Moreover, each T3SS was necessary for substantial intracellular bacterial replication within 3-D cells. Collectively, these results indicate that T3SSs are dispensable for Salmonella invasion into highly differentiated 3-D models of human intestinal epithelial cells, but are required for intracellular bacterial growth, paralleling in vivo infection observations and demonstrating the utility of these models in predicting in vivo-like pathogenic mechanisms.	[Radtke, Andrea L.; Wilson, James W.; Sarker, Shameema; Nickerson, Cheryl A.] Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Wilson, James W.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Arizona State University; Arizona State University-Tempe; Villanova University	Radtke, AL (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	cheryl.nickerson@asu.edu			NASA [NNJ06HE92, NNX09AH40G]; NIH [R21MH080702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080702] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by NASA grants NNJ06HE92 and NNX09AH40G and NIH grant R21MH080702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Baumler AJ, 1997, J BACTERIOL, V179, P317; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bevins CL, 2004, CURR OPIN GASTROEN, V20, P572, DOI 10.1097/00001574-200411000-00012; Bishop A, 2008, MICROBIOL-SGM, V154, P1914, DOI 10.1099/mic.0.2008/016998-0; Brayden DJ, 2005, DRUG DISCOV TODAY, V10, P1145, DOI 10.1016/S1359-6446(05)03536-1; Bueno SM, 2010, IMMUNOLOGY, V130, P273, DOI 10.1111/j.1365-2567.2009.03233.x; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; Clark MA, 1998, INFECT IMMUN, V66, P724, DOI 10.1128/IAI.66.2.724-731.1998; CLARK MA, 1994, RES MICROBIOL, V145, P543, DOI 10.1016/0923-2508(94)90031-0; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Edwards RA, 2000, P NATL ACAD SCI USA, V97, P1258, DOI 10.1073/pnas.97.3.1258; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Folkesson A, 1999, MOL MICROBIOL, V33, P612, DOI 10.1046/j.1365-2958.1999.01508.x; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Frost AJ, 1997, VET PATHOL, V34, P369, DOI 10.1177/030098589703400501; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1992, J BACTERIOL, V174, P4338; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641, DOI 10.1128/IAI.62.10.4641-4645.1994; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; HENLE G, 1957, J IMMUNOL, V79, P54; Henry-Stanley MJ, 2006, CYTOKINE, V34, P252, DOI 10.1016/j.cyto.2006.05.008; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hjelm BE, 2010, BIOL REPROD, V82, P617, DOI 10.1095/biolreprod.109.080408; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; HORIUCHI S, 1992, MICROBIOL IMMUNOL, V36, P593, DOI 10.1111/j.1348-0421.1992.tb02059.x; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Humphries AD, 2001, FEMS MICROBIOL LETT, V201, P121, DOI 10.1016/S0378-1097(01)00250-6; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Keshav S, 2006, J LEUKOCYTE BIOL, V80, P500, DOI 10.1189/jlb.1005556; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lee FKM, 2006, FEMS MICROBIOL LETT, V261, P41, DOI 10.1111/j.1574-6968.2006.00338.x; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Lim JS, 2009, BIOCHEM BIOPH RES CO, V390, P1322, DOI 10.1016/j.bbrc.2009.10.145; MACBETH KJ, 1993, INFECT IMMUN, V61, P1544, DOI 10.1128/IAI.61.4.1544-1546.1993; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Misselwitz B, 2010, INFECT IMMUN; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nevalainen TJ, 2001, APMIS, V109, P295, DOI 10.1034/j.1600-0463.2001.d01-123.x; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schenk M, 2008, BEST PRACT RES CL GA, V22, P391, DOI 10.1016/j.bpg.2007.11.002; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Westphal V, 2000, AM J PATHOL, V157, P1917, DOI 10.1016/S0002-9440(10)64830-4; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105	85	44	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15750	10.1371/journal.pone.0015750	http://dx.doi.org/10.1371/journal.pone.0015750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206750	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793200050
J	Wang, Z; Du, JA; Sun, HM; Wu, H; Xiao, ZP; Zhao, M				Wang, Zhen; Du, Jiang; Sun, Haiming; Wu, Helen; Xiao, Zeping; Zhao, Min			Patterns of Childhood Trauma and Psychological Distress among Injecting Heroin Users in China	PLOS ONE			English	Article							SUBSTANCE-ABUSE TREATMENT; COCAINE RELAPSE OUTCOMES; PHYSICAL ABUSE; SEXUAL-ABUSE; COMMUNITY SAMPLE; HEALTH CONSEQUENCES; COPING STRATEGIES; WOMEN; IMPACT; MEN	Background: Childhood trauma has been reported as a possible cause of future substance abuse in some countries. This study reports the prevalence of childhood trauma and examines its association with psychological distress among injecting drug users from mainland China. Methodology: The study was conducted in three government-operated drug rehabilitation facilities in Shanghai, China in 2007. The Early Trauma Inventory Self Report-Short Form (ETISR-SF) was used to evaluate 4 types (general, emotional, physical and sexual) and severity of childhood trauma, and the Symptom Checklist-90-Revised (SCL-90-R) to evaluate psychological distress. Principal Findings: Among 341 injecting drug users who completed the study, about 80% reported one or more types of childhood trauma, specifically 53% general trauma, 56% physical abuse, 36% emotional abuse and 26% sexual abuse. Compared to female injecting drug users, males reported significantly higher scores of general trauma and physical abuse, but lower sexual abuse scores. Hierarchical linear regression analyses showed that greater physical and emotional abuse in childhood predict greater current psychopathological distress among these injecting drug users in China. Conclusions: The results reveal a high prevalence of childhood trauma among injecting drug users in China, and it is comparable to other similar studies in Western countries. It is important to consider the role of childhood trauma in the prevention and treatment of substance abuse.	[Wang, Zhen; Du, Jiang; Sun, Haiming; Xiao, Zeping; Zhao, Min] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Wu, Helen] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA	Shanghai Jiao Tong University; University of Texas System; University of Texas Medical Branch Galveston	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China.	xiaozeping@gmail.com; drzhaomin@gmail.com	Wang, Zhen/A-2389-2011	Wang, Zhen/0000-0003-4319-5314	NIH [R01-TW007279]; FOGARTY INTERNATIONAL CENTER [R01TW007279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding for this study was provided by NIH grant R01-TW007279. The NIH had no role in the study design, collection, analysis, or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Bifulco A, 2000, SOC PSYCH PSYCH EPID, V35, P264, DOI 10.1007/s001270050238; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Brems C, 2004, AM J DRUG ALCOHOL AB, V30, P799, DOI 10.1081/ADA-200037546; BRIERE J, 1990, CHILD ABUSE NEGLECT, V14, P357, DOI 10.1016/0145-2134(90)90007-G; Burnette ML, 2008, J SUBST ABUSE TREAT, V35, P217, DOI 10.1016/j.jsat.2007.10.002; [陈树林 Chen Shulin], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P323; Chen ZL, 2007, INT J OFFENDER THER, V51, P98, DOI 10.1177/0306624X06295717; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; DEROGATIS LR, 1983, ARCH GEN PSYCHIAT, V40, P1152; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Feldman MB, 2007, INT J EAT DISORDER, V40, P418, DOI 10.1002/eat.20378; Goeders N, 2003, EUR NEUROPSYCHOPHARM, V13, pS5, DOI 10.1016/S0924-977X(03)90003-4; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heffernan K, 2000, ADDICT BEHAV, V25, P797, DOI 10.1016/S0306-4603(00)00066-6; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Hyman SM, 2006, AM J DRUG ALCOHOL AB, V32, P655, DOI 10.1080/10623320600919193; Michels II, 2007, ACTA PHARMACOL SIN, V28, P1505, DOI 10.1111/j.1745-7254.2007.00633.x; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Klein H, 2007, CHILD ABUSE NEGLECT, V31, P39, DOI 10.1016/j.chiabu.2006.08.005; LI C, 2002, CHINESE J DRUG DEPEN, V11, P133; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; MacMillan HL, 1997, JAMA-J AM MED ASSOC, V278, P131, DOI 10.1001/jama.278.2.131; Medrano MA, 2002, AM J DRUG ALCOHOL AB, V28, P1, DOI 10.1081/ADA-120001278; Medrano MA, 1999, AM J DRUG ALCOHOL AB, V25, P449, DOI 10.1081/ADA-100101872; Merrill LL, 2001, J CONSULT CLIN PSYCH, V69, P992, DOI 10.1037//0022-006X.69.6.992; Min M, 2007, J TRAUMA STRESS, V20, P833, DOI 10.1002/jts.20250; Plotzker RE, 2007, AM J ADDICTION, V16, P431, DOI 10.1080/10550490701643161; Rodgers CS, 2004, CHILD ABUSE NEGLECT, V28, P575, DOI 10.1016/j.chiabu.2004.01.002; ROSS CA, 1990, AM J PSYCHIAT, V147, P1698; Sacks JY, 2008, J SUBST ABUSE TREAT, V34, P90, DOI 10.1016/j.jsat.2007.01.010; Schaaf KK, 1998, CHILD ABUSE NEGLECT, V22, P1119, DOI 10.1016/S0145-2134(98)00090-8; Schafer M, 2000, PSYCHOTHER PSYCH MED, V50, P38, DOI 10.1055/s-2000-13235; Scher CD, 2004, CHILD ABUSE NEGLECT, V28, P167, DOI 10.1016/j.chiabu.2003.09.012; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Vaddiparti K, 2006, ARCH SEX BEHAV, V35, P451, DOI 10.1007/s10508-006-9044-4; [王振 WANG Zhen], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P956; Wong DFK, 2002, SOC WORK HEALTH CARE, V35, P479, DOI 10.1300/J010v35n01_08; WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388	42	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15882	10.1371/journal.pone.0015882	http://dx.doi.org/10.1371/journal.pone.0015882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209959	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200063
J	Yan, TT; Yin, WJ; Zhou, LH; Jiang, YW; Shen, ZZ; Shao, ZM; Lu, JS				Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong			Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; RECURRENCE; CARCINOMA; SURVIVAL; MICE	Background: Postoperative fever may serve as an indirect sign to reflect the alterations of the host milieu caused by surgery. It still remains open to investigation whether postoperative fever has a bearing on prognosis in patients with lymph node negative breast cancers. Methods: We performed a retrospective study of 883 female unilateral patients with lymph node negative breast cancer. Fever was defined as an oral temperature >= 38 in one week postoperation. Survival curves were performed with Kaplan-Meier method, and annual relapse hazard was estimated by hazard function. Findings: The fever patients were older than those without fever (P<0.0001). Hypertensive patients had a propensity for fever after surgery (P=0.011). A statistically significant difference was yielded in the incidence of fever among HR+/ERBB2-, ERBB2+, HR-/ERBB2-subgroups (P=0.012). In the univariate survival analysis, we observed postoperative fever patients were more likely to recur than those without fever (P=0.0027). The Cox proportional hazards regression analysis showed that postoperative fever (P=0.044, RR=1.89, 95%CI 1.02-3.52) as well as the HR/ERBB2 subgroups (P=0.013, HR=1.60, 95%CI 1.09-2.31) was an independent prognostic factor for relapse-free survival. Conclusion: Postoperative fever may contribute to relapse in node negative breast cancer patients, which suggests that changes in host milieu related to fever might accelerate the growth of micro-metastatic foci. It may be more precise to integrate both tumor-and host-related factors for the evaluation of relapse risk.	[Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yan, TT (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	lujjss@yahoo.com.cn	Li-Mei, Cheng/L-2214-2013; Yin, Wenjin/L-6020-2019	Yin, Wenjin/0000-0002-2129-7443				Bull SB, 2004, J CLIN ONCOL, V22, P86, DOI 10.1200/JCO.2004.09.128; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Conze D, 2001, CANCER RES, V61, P8851; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER B, 1989, CANCER RES, V49, P1996; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kumar Satish, 2007, Indian Heart J, V59, P316; Majetschak M, 2000, CRIT CARE MED, V28, P1847, DOI 10.1097/00003246-200006000-00027; Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007; McCarter MD, 1998, SURGERY, V123, P96, DOI 10.1016/S0039-6060(98)70234-X; Mirza AN, 2002, ANN SURG, V235, P10, DOI 10.1097/00000658-200201000-00003; Mitchell JD, 2007, CYTOKINE, V38, P37, DOI 10.1016/j.cyto.2007.04.009; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; *NAT AC ENG CTR EN, 2006, EXPL FED REG HUM S 1; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; NOWACKI MP, 1983, DIS COLON RECTUM, V26, P263, DOI 10.1007/BF02562495; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pile James C, 2006, Cleve Clin J Med, V73 Suppl 1, pS62; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Schootman M, 2004, BREAST CANCER RES TR, V85, P219, DOI 10.1023/B:BREA.0000025410.41220.67; TEUCHER G, 1987, Archiv fuer Geschwulstforschung, V57, P309; Turek Z, 2009, SEMIN CARDIOTHORAC V, V13, P249, DOI 10.1177/1089253209353134; Vacek PM, 2002, CANCER, V94, P2160, DOI 10.1002/cncr.10459; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2005, J CLIN ONCOL, V23, P1631, DOI 10.1200/JCO.2005.12.005; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; 2002, CANC INDCIDENCE 5 CO, V8, P1	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15903	10.1371/journal.pone.0015903	http://dx.doi.org/10.1371/journal.pone.0015903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209958	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200072
J	Kucejova, B; Sunny, NE; Nguyen, AD; Hallac, R; Fu, X; Pena-Llopis, S; Mason, RP; DeBerardinis, RJ; Xie, XJ; DeBose-Boyd, R; Kodibagkar, VD; Burgess, SC; Brugarolas, J				Kucejova, B.; Sunny, N. E.; Nguyen, A. D.; Hallac, R.; Fu, X.; Pena-Llopis, S.; Mason, R. P.; DeBerardinis, R. J.; Xie, X-J; DeBose-Boyd, R.; Kodibagkar, V. D.; Burgess, S. C.; Brugarolas, J.			Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death	ONCOGENE			English	Article						Vhl; Hif; liver steatosis; mitochondrial respiration	LINDAU TUMOR-SUPPRESSOR; RENAL-CELL CARCINOMA; CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; FATTY-ACID OXIDATION; RETINOID-X-RECEPTOR; HEPATIC GLUCONEOGENESIS; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; HIF-ALPHA; IN-VIVO	As the ultimate electron acceptor in oxidative phosphorylation, oxygen plays a critical role in metabolism. When oxygen levels drop, heterodimeric hypoxia-inducible factor (Hif) transcription factors become active and facilitate adaptation to hypoxia. Hif regulation by oxygen requires the protein von Hippel-Lindau (pVhl) and pVhl disruption results in constitutive Hif activation. The liver is a critical organ for metabolic homeostasis, and Vhl inactivation in hepatocytes results in a Hif-dependent shortening in life span. While albumin-Cre; Vhl(F/F) mice develop hepatic steatosis and impaired fatty acid oxidation, the variable penetrance and unpredictable life expectancy has made the cause of death elusive. Using a system in which Vhl is acutely disrupted and a combination of ex vivo liver perfusion studies and in vivo oxygen measurements, we demonstrate that Vhl is essential for mitochondrial respiration in vivo. Adenovirus-Cre mediated acute Vhl disruption in the liver caused death within days. Deprived of pVhl, livers accumulated tryglicerides and circulating ketone and glucose levels dropped. The phenotype was reminiscent of inborn defects in fatty acid oxidation and of fasted PPAR alpha-deficient mice and while death was unaffected by pharmacologic PPAR alpha activation, it was delayed by glucose administration. Ex vivo liver perfusion analyses and acylcarnitine profiles showed mitochondrial impairment and a profound inhibition of liver ketone and glucose production. By contrast, other mitochondrial functions, such as ureagenesis, were unaffected. Oxygen consumption studies revealed a marked suppression of mitochondrial respiration, which, as determined by magnetic resonance oximetry in live mice, was accompanied by a corresponding increase in liver pO(2). Importantly, simultaneous inactivation of Hif-1 beta suppressed liver steatosis and rescued the mice from death. These data demonstrate that constitutive Hif activation in mice is sufficient to suppress mitochondrial respiration in vivo and that no other pathway exists in the liver that can allow oxygen utilization when Hif is active precluding thereby metabolic collapse. Oncogene (2011) 30, 2147-2160; doi:10.1038/onc.2010.587; published online 10 January 2011	[Kucejova, B.; Pena-Llopis, S.; Brugarolas, J.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Kucejova, B.; Pena-Llopis, S.; Brugarolas, J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Oncol, Dallas, TX 75390 USA; [Kucejova, B.; Pena-Llopis, S.; Xie, X-J; Brugarolas, J.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Sunny, N. E.; Fu, X.; Burgess, S. C.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Nguyen, A. D.; DeBose-Boyd, R.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hallac, R.; Mason, R. P.; Kodibagkar, V. D.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [DeBerardinis, R. J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Xie, X-J] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brugarolas, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.brugarolas@utsouthwestern.edu	Peña-Llopis, Samuel/ABH-2358-2020; Mason, Ralph/C-8472-2012	Mason, Ralph/0000-0001-7517-3721; Pena-Llopis, Samuel/0000-0003-3847-1353; Kucejova, Blanka/0000-0002-5058-330X; Hallac, Rami/0000-0001-9025-399X; Nguyen, Andrew/0000-0002-9492-9472	American Cancer Society [115739, RO1CA129387]; Generalitat Valenciana (Spain);  [K08NS051843];  [RO1DK078184]; NATIONAL CANCER INSTITUTE [U24CA126608, R21CA132096, R01CA139043, R01CA129387] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051843] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs Frank J Gonzalez, Volker H Haase, William Y Kim and William G Kaelin Jr for mouse strains and reagents, Dr Michael Brown for discussions, and Dr Jay D Horton for critically reading the manuscript, TianTeng He for help with liver perfusion experiments, and members of the Brugarolas lab for discussions. This work was supported by the following grants to J.B: K08NS051843, American Cancer Society Research Scholar Grant (115739) and RO1CA129387 as well as an RO1DK078184 to S.B. MRI was performed in conjunction with R01CA139043 (R.P.M.) R21CA132096 (V.D.K.) and the UT Southwestern small animal imaging research program U24 CA126608 and P41 RR02584. S.P.-L. was supported in part by a fellowship from the Generalitat Valenciana (Spain). J.B. is a Virginia Murchison Linthicum Scholar in Medical Research at UT Southwestern.	Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen SF, 2010, ANGIOGENESIS, V13, P59, DOI 10.1007/s10456-010-9164-2; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; DOHM GL, 1972, AM J PHYSIOL, V223, P783, DOI 10.1152/ajplegacy.1972.223.4.783; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEBHARD RL, 1987, J LIPID RES, V28, P1177; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hong SB, 2006, LAB INVEST, V86, P664, DOI 10.1038/labinvest.3700431; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MASON RP, 1994, ARTIF CELL BLOOD SUB, V22, P1141, DOI 10.3109/10731199409138809; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonald JM, 2009, J ANIM SCI, V87, P3105, DOI 10.2527/jas.2009-1935; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Park SK, 2007, INT J ONCOL, V30, P341; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Tosi MR, 2004, INT J MOL MED, V14, P93; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; WILSON CA, 1992, EXP EYE RES, V55, P119, DOI 10.1016/0014-4835(92)90099-E; Wood PA, 1999, CURR OPIN LIPIDOL, V10, P107, DOI 10.1097/00041433-199904000-00004; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zambrano NR, 1999, J UROLOGY, V162, P1246, DOI 10.1016/S0022-5347(05)68259-6; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	65	38	41	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	18					2147	2160		10.1038/onc.2010.587	http://dx.doi.org/10.1038/onc.2010.587			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21217781	Green Accepted			2022-12-25	WOS:000290249600006
J	Langelier, MF; Planck, JL; Roy, S; Pascal, JM				Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.			Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA STRUCTURAL AND FUNCTIONAL INSIGHTS INTO DNA-DEPENDENT PARP-1 ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE-III; CHROMATIN-STRUCTURE; BINDING; ENZYME; DOMAIN; IDENTIFICATION; PROTEINS; BREAKS; RECRUITMENT; MODULATION	Poly(ADP-ribose) polymerase-1 (PARP-1) has two homologous zinc finger domains, Zn1 and Zn2, that bind to a variety of DNA structures to stimulate poly(ADP-ribose) synthesis activity and to mediate PARP-1 interaction with chromatin. The structural basis for interaction with DNA is unknown, which limits our understanding of PARP-1 regulation and involvement in DNA repair and transcription. Here, we have determined crystal structures for the individual Zn1 and Zn2 domains in complex with a DNA double strand break, providing the first views of PARP-1 zinc fingers bound to DNA. The Zn1-DNA and Zn2-DNA structures establish a novel, bipartite mode of sequence-independent DNA interaction that engages a continuous region of the phosphodiester backbone and the hydrophobic faces of exposed nucleotide bases. Biochemical and cell biological analysis indicate that the Zn1 and Zn2 domains perform distinct functions. The Zn2 domain exhibits high binding affinity to DNA compared with the Zn1 domain. However, the Zn1 domain is essential for DNA-dependent PARP-1 activity in vitro and in vivo, whereas the Zn2 domain is not strictly required. Structural differences between the Zn1-DNA and Zn2-DNA complexes, combined with mutational and structural analysis, indicate that a specialized region of the Zn1 domain is re-configured through the hydrophobic interaction with exposed nucleotide bases to initiate PARP-1 activation.	[Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), 233 S 10th St,BLSB 804, Philadelphia, PA 19107 USA.	John.Pascal@KimmelCancerCenter.org			American Cancer Society [RSG0918301DMC, IRG0806001]; Emerald Foundation, Inc.,; Ladies of Port Richmond; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Emerald Foundation, Inc.,; Ladies of Port Richmond; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Grants RSG0918301DMC and IRG0806001, The Emerald Foundation, Inc., and The Ladies of Port Richmond.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kulczyk AW, 2004, J MOL BIOL, V341, P723, DOI 10.1016/j.jmb.2004.06.035; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrucco S, 2003, NUCLEIC ACIDS RES, V31, P6689, DOI 10.1093/nar/gkg890; Petrucco S, 2002, J BIOL CHEM, V277, P23675, DOI 10.1074/jbc.M201411200; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	45	148	151	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10690	10701		10.1074/jbc.M110.202507	http://dx.doi.org/10.1074/jbc.M110.202507			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233213	hybrid, Green Published			2022-12-25	WOS:000288547000083
J	Comstock, CES; Augello, MA; Schiewer, MJ; Karch, J; Burd, CJ; Ertel, A; Knudsen, ES; Jessen, WJ; Aronow, BJ; Knudsen, KE				Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Karch, Jason; Burd, Craig J.; Ertel, Adam; Knudsen, Erik S.; Jessen, Walter J.; Aronow, Bruce J.; Knudsen, Karen E.			Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; GENE-EXPRESSION; CELL-PROLIFERATION; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; RESPONSIVE GENES; KINASE-ACTIVITY; CO-REPRESSOR; ACTIVATION; NUCLEAR	D-type cyclins regulate cellular outcomes in part through cyclin-dependent, kinase-independent mechanisms that modify transcription factor action, and recent in vivo studies showed that cyclin D1 associates with a large number of transcriptional regulators in cells of the retina and breast. Given the frequency of cyclin D1 alterations in cancer, it is imperative to delineate the molecular mechanisms by which cyclin D1 controls key transcription factor networks in human disease. Prostate cancer was used as a paradigm because this tumor type is reliant at all stages of the disease on androgen receptor (AR) signaling, and cyclin D1 has been shown to negatively modulate AR-dependent expression of prostate-specific antigen (KLK3/PSA). Strategies were employed to control cyclin D1 expression under conditions of hormone depletion, and the effect of cyclin D1 on subsequent androgen-dependent gene expression was determined using unbiased gene expression profiling. Modulating cyclin D1 conferred widespread effects on androgen signaling and revealed cyclin D1 to be a selective effector of hormone action. A subset of androgen-induced target genes, known to be directly regulated by AR, was strongly suppressed by cyclin D1. Analyses of AR occupancy at target gene regulatory loci of clinical relevance demonstrated that cyclin D1 limits AR residence after hormone stimulation. Together, these findings reveal a new function for cyclin D1 in controlling hormone-dependent transcriptional outcomes and demonstrate a pervasive role for cyclin D1 in regulating transcription factor dynamics.	[Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Ertel, Adam; Knudsen, Erik S.; Knudsen, Karen E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Ertel, Adam; Knudsen, Erik S.; Knudsen, Karen E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Knudsen, Karen E.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Knudsen, Karen E.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Karch, Jason] Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45221 USA; [Burd, Craig J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Jessen, Walter J.] Covance Biomarker Ctr Excellence, Greenfield, IN 46140 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Covance; Cincinnati Children's Hospital Medical Center	Knudsen, KE (corresponding author), 233 S 10th St,BLSB 1008A, Philadelphia, PA 19107 USA.	Karen.Knudsen@kimmelcancercenter.org	Comstock, Clay/B-6122-2008; Aronow, Bruce J/F-8438-2012	Comstock, Clay/0000-0001-5867-1489; Jessen, Walter/0000-0003-3840-4337; Burd, Craig/0000-0002-6899-6751; Schiewer, Matthew/0000-0002-2325-4228; Knudsen, Karen/0000-0002-1301-890X	National Institutes of Health [CA099996]; Department of Defense [PC094507, PC094195, PC094596]; NATIONAL CANCER INSTITUTE [R01CA099996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA099996 (to K. E. K.). This work was also supported by Department of Defense New Investigator Award PC094507 (to C. E. S. C.) and Department of Defense Predoctoral Fellowships PC094195 (to M. J. S.) and PC094596 (to M. A. A.).	Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; BATES S, 1994, ONCOGENE, V9, P71; BERNARDS R, 1999, BIOCHIM BIOPHYS ACTA, V1424, P17; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Burd CJ, 2006, ENDOCR-RELAT CANCER, V13, P979, DOI 10.1677/erc.1.01115; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Ciemerych MA, 2008, INT J DEV BIOL, V52, P299, DOI 10.1387/ijdb.072336mc; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; Comstock CES, 2008, CONTEMP ENDOCRINOL S, P83, DOI 10.1007/978-1-59745-309-7_5; Comstock CES, 2009, CLIN CANCER RES, V15, P5338, DOI 10.1158/1078-0432.CCR-08-2865; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DELAUNOIT Y, 1991, CANCER RES, V51, P5165; DePrimo SE, 2002, GENOME BIOL, V3; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gan L, 2009, CELL DEATH DIFFER, V16, P1408, DOI 10.1038/cdd.2009.86; Henrique R, 2006, J MOL MED, V84, P911, DOI 10.1007/s00109-006-0099-4; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Knudsen KE, 1999, CANCER RES, V59, P2297; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacombe L, 2001, INT J CANCER, V95, P135, DOI 10.1002/1097-0215(20010520)95:3<135::AID-IJC1023>3.0.CO;2-3; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Lin BY, 1999, CANCER RES, V59, P4180; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Muller I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-297; Mullany LK, 2008, CELL CYCLE, V7, P2215, DOI 10.4161/cc.7.14.6274; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Olshavsky NA, 2008, ONCOGENE, V27, P3111, DOI 10.1038/sj.onc.1210981; Omar EA, 2001, PROSTATE, V49, P191, DOI 10.1002/pros.1134; PENDAS AM, 1994, CYTOGENET CELL GENET, V66, P263, DOI 10.1159/000133708; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Rigaud J, 2004, PROSTATE, V58, P269, DOI 10.1002/pros.10329; Sarkar FH, 1999, PROSTATE, V40, P256; Schiewer MJ, 2009, ONCOGENE, V28, P1016, DOI 10.1038/onc.2008.446; Shi XB, 2008, PROSTATE, V68, P1816, DOI 10.1002/pros.20849; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wetherill YB, 2002, MOL CANCER THER, V1, P515; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; WONG CI, 1993, J BIOL CHEM, V268, P19004; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	92	28	28	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8117	8127		10.1074/jbc.M110.170720	http://dx.doi.org/10.1074/jbc.M110.170720			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212260	Green Published, hybrid			2022-12-25	WOS:000288013300042
J	Bover, P; Alcover, JA; Michaux, JJ; Hautier, L; Hutterer, R				Bover, Pere; Alcover, Josep A.; Michaux, Jacques J.; Hautier, Lionel; Hutterer, Rainer			Body Shape and Life Style of the Extinct Balearic Dormouse Hypnomys (Rodentia, Gliridae): New Evidence from the Study of Associated Skeletons	PLOS ONE			English	Article							MASS ESTIMATION; MALLORCA; SIZE; POPULATIONS; ADAPTATIONS; EVOLUTION; APODEMUS; ISLANDS; MAMMALS; BATE	Hypnomys is a genus of Gliridae (Rodentia) that occurred in the Balearic Islands until Late Holocene. Recent finding of a complete skeleton of the chronospecies H. morpheus (Late Pleistocene-Early Holocene) and two articulated skeletons of H. cf. onicensis (Late Pliocene) allowed the inference of body size and the calculation of several postcranial indexes. We also performed a Factorial Discriminant Analysis (FDA) in order to evaluate locomotory behaviour and body shape of the taxa. Using allometric models based on skull and tooth measurements, we calculated a body weight between 173 and 284 g for H. morpheus, and direct measurements of articulated skeletons yielded a Head and Body Length (HBL) of 179 mm and a Total Body Length of 295 mm for this species. In addition to the generally higher robustness of postcranial bones already recorded by previous authors, H. morpheus, similar to Canariomys tamarani, another extinct island species, displayed elongated zygopodium bones of the limbs and a wider distal humerus and femur than in an extant related taxon, Eliomys quercinus. Indexes indicated that Hypnomys was more terrestrial and had greater fossorial abilities than E. quercinus. This was also corroborated by a Discriminant Analysis, although no clear additional inference of locomotory abilities could be calculated.	[Bover, Pere; Alcover, Josep A.] Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain; [Bover, Pere; Alcover, Josep A.; Hutterer, Rainer] Amer Museum Nat Hist, Div Vertebrate Zool Mammal, New York, NY 10024 USA; [Michaux, Jacques J.] Univ Montpellier 2, EPHE, Montpellier, France; [Michaux, Jacques J.] Univ Montpellier 2, CNRS, ISEM, UMR 5554, Montpellier, France; [Michaux, Jacques J.] Univ Montpellier, F-34059 Montpellier, France; [Hautier, Lionel] Univ Cambridge, Dept Zool, Cambridge, England; [Hutterer, Rainer] Zool Forsch Museum Alexander Koenig, Bonn, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); American Museum of Natural History (AMNH); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Cambridge; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Bover, P (corresponding author), Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain.	pere.bover@uib.es	; Alcover, Josep Antoni/Y-3796-2018	Bover Arbos, Pedro/0000-0003-2942-2840; Alcover, Josep Antoni/0000-0001-9905-2588; Hautier, Lionel/0000-0001-8701-5421	Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain) [CGL2007-62047/BTE]	Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is included in the project CGL2007-62047/BTE of the Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUSTI J, 1982, Geobios (Villeurbanne), V15, P783, DOI 10.1016/S0016-6995(82)80008-9; Alcover J.A., 1997, Endins, V21, P79; Alcover J. A., 1975, SPELEON, V22, P81; Alcover J. A., 1981, QUIMERES PASSAT ELS; Alcover JA, 1983, THESIS U BARCELONA; ANGERBJORN A, 1986, OIKOS, V47, P47, DOI 10.2307/3565918; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Bate DMA, 1918, P ZOOL SOC LOND, V1918, P209, DOI [10.1111/j.1096-3642.1918. tb02091.x, DOI 10.1111/J.1096-3642.1918.TB02091.X]; Biknevicius A.R., 1993, American Museum Novitates, V3079, P1; Biknevicius AR, 1999, J ZOOL, V248, P179, DOI 10.1111/j.1469-7998.1999.tb01194.x; Bover P, 2003, J BIOGEOGR, V30, P771, DOI 10.1046/j.1365-2699.2003.00872.x; Bover P, 2007, LIBR RES 7 S INT ZOO; Bover P, 2008, J BIOGEOGR, V35, P1112, DOI 10.1111/j.1365-2699.2007.01839.x; Bover P, 2010, GEOL MAG, V147, P871, DOI 10.1017/S0016756810000336; BOYE P, 1992, Z SAUGETIERKD, V57, P29; Burjachs F., 1994, TRABAJOS PALINOLOGIA, P199; Damuth J., 1990, BODY SIZE MAMMALIAN; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; Elissamburu A, 2004, J ZOOL, V262, P145, DOI 10.1017/S0952836903004485; Ginard Antelm, 2009, Endins, V33, P105; GINGERICH P D, 1990, Contributions from the Museum of Paleontology University of Michigan, V28, P79; GINGERICH PD, 1982, AM J PHYS ANTHROPOL, V58, P81, DOI 10.1002/ajpa.1330580110; Gracia Francesc, 2009, Endins, V33, P35; Hautier L, 2009, ACTA PALAEONTOL POL, V54, P181, DOI 10.4202/app.2008.0001; Holden ME, 2009, SYSTEMATIC REVISIO 2; Hopkins SSB, 2008, J MAMMAL, V89, P232, DOI 10.1644/06-MAMM-A-306.1; KAHMANN H, 1973, Saeugetierkundliche Mitteilungen, V21, P65; Kahmann H., 1974, Boletin Soc Hist nat Baleares, V19, P57; Kahmann H, 1972, VEROFF ZOOL STAATS M, V16, P20; Kahmann H, 1970, VEROFF ZOOL STAATS M, V14, P75; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Lopez-Martinez N, 1987, NUEVO MURIDO GIGANTE; MAEMPEL GZ, 1982, P K NED AKAD B PHYS, V85, P113; Michaux JR, 2002, GLOBAL ECOL BIOGEOGR, V11, P427, DOI 10.1046/j.1466-822x.2002.00301.x; Mihlbachler MC, 2002, QUATERNARY RES, V58, P289, DOI 10.1006/qres.2002.2385; Millien V, 2008, P ROY SOC B-BIOL SCI, V275, P1953, DOI 10.1098/rspb.2008.0087; Millien V, 2010, J MAMMAL, V91, P11, DOI 10.1644/08-MAMM-A-347R1.1; Millien-Parra V, 2000, MAMMALIA, V64, P221, DOI 10.1515/mamm.2000.64.2.221; Mills DH, 1976, PUB PAL I U UPPSALA, V4, P1; MOYA-SOLA S, 1984, Acta Geologica Hispanica, V19, P33; Parra V, 1998, CR ACAD SCI II A, V326, P79, DOI 10.1016/S1251-8050(97)83207-7; Perez-Obiol R, 1996, PALEOAMBIENTE CUATER, P87; Quintana J., 1995, Paleontologia i Evolucio, V26-27, P271; Quintana J, 2010, J VERTEBR P IN PRESS; Quintana J, 2010, GEOBIOS IN PRESS; Quintana Josep, 2004, Endins, V26, P7; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Renaud S, 2001, BIOL J LINN SOC, V74, P557, DOI 10.1006/bijl.2001.0595; Rinderknecht A, 2008, P ROY SOC B-BIOL SCI, V275, P923, DOI 10.1098/rspb.2007.1645; Rose J, 1999, BRIT GEOMOR, P91; Rose J, 1999, J GEOL SOC LONDON, V156, P435, DOI 10.1144/gsjgs.156.2.0435; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Sanchez-Villagra MR, 2003, SCIENCE, V301, P1708, DOI 10.1126/science.1089332; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Storch G., 1978, HDB SAUGETIERE EUROP, V1, P201; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; THUNELL RC, 1979, SEDIMENT GEOL, V23, P67, DOI 10.1016/0037-0738(79)90006-X; Thunell RC, 1983, UTRECHT MICROPALEONT, V30, P111; Tuccimei P., 2000, ENDINS, V23, P59; Vesica PL, 2000, QUATERNARY SCI REV, V19, P865, DOI 10.1016/S0277-3791(99)00026-8	60	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15817	10.1371/journal.pone.0015817	http://dx.doi.org/10.1371/journal.pone.0015817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209820	Green Published, gold			2022-12-25	WOS:000285838900038
J	Cizkova, M; Cizeron-Clairac, G; Vacher, S; Susini, A; Andrieu, C; Lidereau, R; Bieche, I				Cizkova, Magdalena; Cizeron-Clairac, Geraldine; Vacher, Sophie; Susini, Aurelie; Andrieu, Catherine; Lidereau, Rosette; Bieche, Ivan			Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CELL-GROWTH; TRANSCRIPTION FACTORS; STEM-CELLS; CARCINOMAS; SIGNATURE; PTEN; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	Background: The PI3K/AKT pathway plays a pivotal role in breast cancer development and maintenance. PIK3CA, encoding the PI3K catalytic subunit, is the oncogene exhibiting a high frequency of gain-of-function mutations leading to PI3K/AKT pathway activation in breast cancer. PIK3CA mutations have been observed in 30% to 40% of ER alpha-positive breast tumors. However the physiopathological role of PIK3CA mutations in breast tumorigenesis remains largely unclear. Methodology/Principal Findings: To identify relevant downstream target genes and signaling activated by aberrant PI3K/AKT pathway in breast tumors, we first analyzed gene expression with a pangenomic oligonucleotide microarray in a series of 43 ER alpha-positive tumors with and without PIK3CA mutations. Genes of interest were then investigated in 249 ER alpha-positive breast tumors by real-time quantitative RT-PCR. A robust collection of 19 genes was found to be differently expressed in PIK3CA-mutated tumors. PIK3CA mutations were associated with over-expression of several genes involved in the Wnt signaling pathway (WNT5A, TCF7L2, MSX2, TNFRSF11B), regulation of gene transcription (SEC14L2, MSX2, TFAP2B, NRIP3) and metal ion binding (CYP4Z1, CYP4Z2P, SLC40A1, LTF, LIMCH1). Conclusion/Significance: This new gene set should help to understand the behavior of PIK3CA-mutated cancers and detailed knowledge of Wnt signaling activation could lead to novel therapeutic strategies.	[Cizkova, Magdalena; Cizeron-Clairac, Geraldine; Vacher, Sophie; Susini, Aurelie; Andrieu, Catherine; Lidereau, Rosette; Bieche, Ivan] Hop Rene Huguenin, Lab Oncogenet, Inst Natl Sante & Rech, Inst Curie,U745, St Cloud, France; [Cizkova, Magdalena] Palacky Univ, Expt Med Lab, Dept Paediat, Fac Med & Dent, CR-77147 Olomouc, Czech Republic; [Cizkova, Magdalena] Univ Hosp Olomouc, Olomouc, Czech Republic	Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Palacky University Olomouc; University Hospital Olomouc	Cizkova, M (corresponding author), Hop Rene Huguenin, Lab Oncogenet, Inst Natl Sante & Rech, Inst Curie,U745, St Cloud, France.	i.bieche@stcloud-huguenin.org	Bièche, Ivan/O-7399-2017	Bièche, Ivan/0000-0002-2430-5429; VACHER, Sophie/0000-0002-0042-6023	INCA (Institut National du CAncer); Ile de France; Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer; Cartes d'Identite des Tumeurs (CIT) program	INCA (Institut National du CAncer)(Institut National du Cancer (INCA) France); Ile de France; Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer; Cartes d'Identite des Tumeurs (CIT) program	This work was supported by INCA (Institut National du CAncer), Programme Canceropoles 2003-2007 Ile de France, and Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer. This work is part of the Cartes d'Identite des Tumeurs (CIT) program (http://cit.ligue-cancer.net/index.php/en) launched and directed by the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Andre F, 2008, BREAST CANCER RES TR, V108, P183, DOI 10.1007/s10549-007-9594-8; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; Bieche I, 1999, CLIN CHEM, V45, P1148; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Carnero A, 2009, EXPERT OPIN INV DRUG, V18, P1265, DOI 10.1517/13543780903066798; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Esseghir S, 2007, CLIN CANCER RES, V13, P3164, DOI 10.1158/1078-0432.CCR-07-0224; Ford CE, 2009, CELL CYCLE, V8, P1838, DOI 10.4161/cc.8.12.8863; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Johnykutty S, 2009, MODERN PATHOL, V22, P770, DOI 10.1038/modpathol.2009.24; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Katoh M, 2005, ONCOL REP, V14, P1583; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Leris ACA, 2005, ANTICANCER RES, V25, P731; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Nteliopoulos G, 2009, BRIT J HAEMATOL, V146, P637, DOI 10.1111/j.1365-2141.2009.07823.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rieger MA, 2004, CANCER RES, V64, P2357, DOI 10.1158/0008-5472.CAN-03-0849; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Satoh K, 2004, J MAMMARY GLAND BIOL, V9, P195, DOI 10.1023/B:JOMG.0000037162.84758.b5; Shan L, 2003, AM J PATHOL, V163, P2495, DOI 10.1016/S0002-9440(10)63604-8; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wu F, 2009, J MOL ENDOCRINOL, V42, P19, DOI 10.1677/JME-08-0088; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	48	44	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15647	10.1371/journal.pone.0015647	http://dx.doi.org/10.1371/journal.pone.0015647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209903	Green Submitted, gold, Green Published			2022-12-25	WOS:000285793600024
J	Jelassi, B; Chantome, A; Alcaraz-Perez, F; Baroja-Mazo, A; Cayuela, ML; Pelegrin, P; Surprenant, A; Roger, S				Jelassi, B.; Chantome, A.; Alcaraz-Perez, F.; Baroja-Mazo, A.; Cayuela, M. L.; Pelegrin, P.; Surprenant, A.; Roger, S.			P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness	ONCOGENE			English	Article						P2X(7) receptors; migration; SK3 channels; cancer cell invasion; cystein cathepsins	GATED SODIUM-CHANNELS; EPITHELIAL-CELLS; P2X7 RECEPTOR; ATP RECEPTOR; EXPRESSION; CALCIUM; POLYMORPHISM; MACROPHAGES; PROGRESSION; MECHANISM	ATP-gated P2X(7) receptors (P2X(7)R) are unusual plasma membrane ion channels that have been extensively studied in immune cells. More recently, P2X(7)R have been described as potential cancer cell biomarkers. However, mechanistic links between P2X(7)R and cancer cell processes are unknown. Here, we show, in the highly aggressive human breast cancer cell line MDA-MB-435s, that P2X(7) receptor is highly expressed and fully functional. Its activation is responsible for the extension of neurite-like cellular prolongations, of the increase in cell migration by 35% and in cell invasion through extracellular matrix by 150%. The change in cancer cell morphology and the increased migration appeared to be due to the activation of Ca2+-activated SK3 potassium channels. The enhanced invasion through the extracellular matrix was related to the increase of mature forms of cysteine cathepsins in the extracellular medium, which was independent of SK3 channel activity and not associated with cell death. Pharmacological targeting of P2X(7)R in vivo was crucial for cell invasiveness in a zebrafish model of metastases. Our results demonstrate a novel mechanistic link between P2X(7)R functionality in cancer cells and invasiveness, a key parameter in tumour growth and in the development of metastases. They also suggest a potential therapeutic role for the newly developed P2X(7)R antagonists. Oncogene (2011) 30, 2108-2122; doi:10.1038/onc.2010.593; published online 17 January 2011	[Jelassi, B.; Chantome, A.; Roger, S.] Univ Tours, INSERM, U921, F-37032 Tours, France; [Alcaraz-Perez, F.; Cayuela, M. L.] Univ Hosp Virgen Arrixaca FFIS, Canc & Aging Grp, Carretera Palmar, Murcia, Spain; [Baroja-Mazo, A.; Pelegrin, P.] Univ Hosp Virgen Arrixaca FFIS, Inflammat & Expt Surg Grp, Carretera Palmar, Murcia, Spain; [Pelegrin, P.; Surprenant, A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Manchester	Roger, S (corresponding author), Univ Tours, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, France.	sebastien.roger@univ-tours.fr	Pelegrin, Pablo/M-2007-2014; Baroja-Mazo, Alberto/E-6270-2016; cayuela, maria l/S-1148-2019	Pelegrin, Pablo/0000-0002-9688-1804; Baroja-Mazo, Alberto/0000-0001-5212-5006; Roger, Sebastien/0000-0002-9852-5248; Alcaraz Perez, Francisca/0000-0003-1802-4943	Biotechnology and Biological Sciences Research Council; Ligue Nationale Contre le Cancer Region Centre; Association CANCEN; Ministere de la Recherche et des Technologies; 'Institut National de la Sante et de la Recherche Medicale' (INSERM); 'Partenariat Hubert Curien-Alliance' from the French Foreign and European Ministry; French Embassy in the United Kingdom; Institut National du Cancer (INCa)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ligue Nationale Contre le Cancer Region Centre(Ligue nationale contre le cancer); Association CANCEN; Ministere de la Recherche et des Technologies; 'Institut National de la Sante et de la Recherche Medicale' (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); 'Partenariat Hubert Curien-Alliance' from the French Foreign and European Ministry; French Embassy in the United Kingdom; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	We thank Pr Jean-Christophe Pages, Dr Christine Collin and Dr Virginie Joulin for the development of small hairpin RNA cell lines, Elizabeth Martin, Mari C. Banos, Encarnacion Sanchez and Isabelle Domingo for technical assistance. We are grateful to Pr Gilles Lalmanach for helpful discussions and Pierre-Yves Sizaret for his help with confocal microscopy. We thank Dr Michael Jarvis (Abbott Laboratories, USA) for the generous gift of A740003. This work was supported by the Biotechnology and Biological Sciences Research Council, by a grant from the 'Ligue Nationale Contre le Cancer Region Centre', the 'Association CANCEN', the 'Ministere de la Recherche et des Technologies', the 'Institut National de la Sante et de la Recherche Medicale' (INSERM) and the 'Partenariat Hubert Curien-Alliance' from the French Foreign and European Ministry and the French Embassy in the United Kingdom. A C was funded by the 'Institut National du Cancer (INCa)'.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Deli T, 2007, INT J CANCER, V121, P55, DOI 10.1002/ijc.22621; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Frosch BA, 1999, APMIS, V107, P28, DOI 10.1111/j.1699-0463.1999.tb01523.x; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Li X, 2006, CANCER EPIDEM BIOMAR, V15, P1906, DOI 10.1158/1055-9965.EPI-06-0407; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Potier M, 2010, BIOCHEM BIOPH RES CO, V397, P42, DOI 10.1016/j.bbrc.2010.05.046; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; Roger S, 2006, CURR PHARM DESIGN, V12, P3681, DOI 10.2174/138161206778522047; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Slater M, 2005, J MOL HISTOL, V36, P159, DOI 10.1007/s10735-004-6166-7; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Zhang XJ, 2004, LEUKEMIA RES, V28, P1313, DOI 10.1016/j.leukres.2004.04.001	43	154	157	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	18					2108	2122		10.1038/onc.2010.593	http://dx.doi.org/10.1038/onc.2010.593			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21242969				2022-12-25	WOS:000290249600003
J	Xu, S; Feng, Z; Zhang, M; Wu, Y; Sang, Y; Xu, H; Lv, X; Hu, K; Cao, J; Zhang, R; Chen, L; Liu, M; Yun, JP; Zeng, YX; Kang, T				Xu, S.; Feng, Z.; Zhang, M.; Wu, Y.; Sang, Y.; Xu, H.; Lv, X.; Hu, K.; Cao, J.; Zhang, R.; Chen, L.; Liu, M.; Yun, J-P; Zeng, Y-X; Kang, T.			hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas	ONCOGENE			English	Article						cell cycle; hSSB1; p21; ubiquitin; hepatocellular; carcinomas	HUMAN BREAST-CARCINOMA; P21(WAF1/CIP1) EXPRESSION; DNA-DAMAGE; CELL-CYCLE; GENOMIC STABILITY; INHIBITION; P53; PROTEASOME; APOPTOSIS; SURVIVAL	Downregulation of hSSB1, a single-stranded DNA-binding protein, causes increased radiosensitivity, defective checkpoint activation and genomic instability. However, the mechanisms of hSSB1 function in these responses remain to be uncovered. Here, we present evidence that hSSB1 directly binds p21 and this interaction may prevent p21 from ubiquitin-mediated degradation. Furthermore, both promotion of the G1/S transition and abrogation of the G2/M checkpoints induced by hSSB1 knockdown are partially dependent on p21. Most importantly, hSSB1 and p21 levels are positively correlated in human hepatocellular carcinomas (HCC), as determined by immuno-staining. Therefore, hSSB1 may positively modulate p21 to regulate cell cycle progression and DNA damage response, implicating hSSB1 as a novel, promising therapeutic target for cancers such as HCC. Oncogene (2011) 30, 2219-2229; doi:10.1038/onc.2010.596; published online 17 January 2011	[Xu, S.; Wu, Y.; Sang, Y.; Lv, X.; Hu, K.; Cao, J.; Zhang, R.; Chen, L.; Zeng, Y-X; Kang, T.] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Xu, S.; Feng, Z.; Zhang, M.; Wu, Y.; Sang, Y.; Xu, H.; Lv, X.; Hu, K.; Cao, J.; Zhang, R.; Chen, L.; Liu, M.; Yun, J-P; Zeng, Y-X; Kang, T.] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Feng, Z.; Xu, H.; Liu, M.] Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, M.; Yun, J-P] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Kang, T (corresponding author), Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, 651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	kangtb@mail.sysu.edu.cn	Lv, Xiao-Bin/T-7607-2019; Feng, Zizhen/G-2322-2014	Sang, Yi/0000-0001-6534-0741; Feng, Zizhen/0000-0002-7763-1869	NSFC [30772492, 30973506, U0732005, 30930045]; 863 project [2006AA02A404]; 973 project [2010CB912201]	NSFC(National Natural Science Foundation of China (NSFC)); 863 project(National High Technology Research and Development Program of China); 973 project(National Basic Research Program of China)	We thank the members of the laboratory for their helpful comments on the manuscript. This work was supported by grants from NSFC (30772492 and 30973506 to J-PY, U0732005 to Y-XZ, and 30930045 to TK), from the 863 project (2006AA02A404 to Y-XZ), and from the 973 project (2010CB912201 to TK).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Brustmann H, 2005, GYNECOL ONCOL, V98, P396, DOI 10.1016/j.ygyno.2005.04.035; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fukuchi K, 1999, BBA-MOL CELL RES, V1451, P206, DOI 10.1016/S0167-4889(99)00081-6; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 2006, MOL CANCER THER, V5, P1385, DOI 10.1158/1535-7163.MCT-06-0163; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Inagaki Y, 2008, CANCER GENET CYTOGEN, V180, P30, DOI 10.1016/j.cancergencyto.2007.09.013; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kao JT, 2007, LIVER INT, V27, P772, DOI 10.1111/j.1478-3231.2007.01499.x; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lee YH, 2009, MODERN PATHOL, V22, P1121, DOI 10.1038/modpathol.2009.76; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Li XS, 1996, CANCER RES, V56, P5055; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MICHIELI P, 1994, CANCER RES, V54, P3391; Miyazaki M, 2004, CANCER RES, V64, P4155, DOI 10.1158/0008-5472.CAN-03-2750; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; O'Reilly MA, 2005, ANTIOXID REDOX SIGN, V7, P108, DOI 10.1089/ars.2005.7.108; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Qin LF, 1998, INT J CANCER, V79, P424, DOI 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Schoniger-Hekele M, 2005, LIVER INT, V25, P62, DOI 10.1111/j.1478-3231.2004.0997.x; SHEIKH MS, 1994, ONCOGENE, V9, P3407; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Shiraki K, 2006, LIVER INT, V26, P1018, DOI 10.1111/j.1478-3231.2006.01320.x; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Tanaka H, 2002, J CELL BIOL, V158, P321, DOI 10.1083/jcb.200202071; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Xiao JY, 2009, CELL CYCLE, V8, P889, DOI 10.4161/cc.8.6.7898; Xu SB, 2009, J CANCER RES CLIN, V135, P1791, DOI 10.1007/s00432-009-0627-z; Zhang F, 2009, J BIOL CHEM, V284, P30408, DOI 10.1074/jbc.M109.039404; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	48	44	52	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	19					2219	2229		10.1038/onc.2010.596	http://dx.doi.org/10.1038/onc.2010.596			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242961				2022-12-25	WOS:000290514600005
J	Downer, EJ; Clifford, E; Gran, B; Nel, HJ; Fallon, PG; Moynagh, PN				Downer, Eric J.; Clifford, Eileen; Gran, Bruno; Nel, Hendrik J.; Fallon, Padraic G.; Moynagh, Paul N.			Identification of the Synthetic Cannabinoid R(+) WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-beta Expression RELEVANCE TO THERAPEUTIC EFFECTS IN MODELS OF MULTIPLE SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TNF-ALPHA; INFLAMMATORY DEMYELINATION; SIGNALING PATHWAY; RECEPTOR AGONIST; INNATE IMMUNITY; DOUBLE-BLIND; CELLS; INDUCTION; SYSTEM	beta-Interferons (IFN-beta s) represent one of the first line treatments for relapsing-remitting multiple sclerosis, slowing disease progression while reducing the frequency of relapses. Despite this, more effective, well tolerated therapeutic strategies are needed. Cannabinoids palliate experimental autoimmune encephalomyelitis (EAE) symptoms and have therapeutic potential in MS patients although the precise molecular mechanism for these effects is not understood. Toll-like receptor (TLR) signaling controls innate immune responses and TLRs are implicated in MS. Here we demonstrate that the synthetic cannabinoid R(+) WIN55,212-2 is a novel regulator of TLR3 and TLR4 signaling by inhibiting the pro-inflammatory signaling axis triggered by TLR3 and TLR4, whereas selectively augmenting TLR3-induced activation of IFN regulatory factor 3 (IRF3) and expression of IFN-beta. We present evidence that R(+) WIN55,212-2 strongly promotes the nuclear localization of IRF3. The potentiation of IFN-beta expression by R(+) WIN55,212-2 is critical for manifesting its protective effects in the murine MS model EAE as evidenced by its reduced therapeutic efficacy in the presence of an anti-IFN-beta antibody. R(+) WIN55,212-2 also induces IFN-beta expression in MS patient peripheral blood mononuclear cells, whereas down-regulating inflammatory signaling in these cells. These findings identify R(+) WIN55,212-2 as a novel regulator of TLR3 signaling to IRF3 activation and IFN-beta expression and highlights a new mechanism that may be open to exploitation in the development of new therapeutics for the treatment of MS.	[Downer, Eric J.; Clifford, Eileen; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Co Kildare, Ireland; [Gran, Bruno] Univ Nottingham, Div Clin Neurol, Nottingham NG7 2RD, England; [Nel, Hendrik J.; Fallon, Padraic G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin 8, Ireland	Maynooth University; University of Nottingham; Trinity College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Co Kildare, Ireland.	Paul.Moynagh@nuim.ie	Gran, Bruno/A-2288-2013; Fallon, Padraic/Y-2711-2019; Tuluc, Petronel/C-2527-2011	Gran, Bruno/0000-0001-6384-2342; Fallon, Padraic/0000-0002-8401-7293; Downer, Eric/0000-0002-6012-2291; Moynagh, Paul/0000-0002-4139-3061	Science Foundation Ireland; IRCSET; MS Society of Great Britain and Northern Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET(Irish Research Council for Science, Engineering and Technology); MS Society of Great Britain and Northern Ireland	This work was supported by Science Foundation Ireland (to P. N. M.), an IRCSET postdoctoral fellowship (to E. J. D.), and a research grant from the MS Society of Great Britain and Northern Ireland (to B. G.).	Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Germain N, 2002, INT IMMUNOPHARMACOL, V2, P537, DOI 10.1016/S1567-5769(01)00200-4; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kraus J, 2008, MULT SCLER J, V14, P843, DOI 10.1177/1352458508088940; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Ni X, 2004, MULT SCLER J, V10, P158, DOI 10.1191/1352458504ms1009oa; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; O'Brien K, 2008, CURR MED CHEM, V15, P1105, DOI 10.2174/092986708784221458; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rizzo V, 2009, NEUROSCI LETT, V462, P135, DOI 10.1016/j.neulet.2009.07.014; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Smith SR, 2001, EUR J PHARMACOL, V432, P107, DOI 10.1016/S0014-2999(01)01477-7; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Wandinger KP, 1997, J NEUROL SCI, V149, P87, DOI 10.1016/S0022-510X(97)05383-5; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Wraith DC, 2009, P NATL ACAD SCI USA, V106, P15466, DOI 10.1073/pnas.0903360106	51	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10316	10328		10.1074/jbc.M110.188599	http://dx.doi.org/10.1074/jbc.M110.188599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245146	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000288547000049
J	Gentilella, A; Khalili, K				Gentilella, Antonio; Khalili, Kamel			BAG3 Expression in Glioblastoma Cells Promotes Accumulation of Ubiquitinated Clients in an Hsp70-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR-1; PROTEASOME INHIBITION; FAMILY PROTEINS; CANCER-CELLS; ACTIVATION; APOPTOSIS; GENE; HEAT-SHOCK-PROTEIN-70; MACROAUTOPHAGY; DEGRADATION	Disposal of damaged proteins and protein aggregates is a prerequisite for the maintenance of cellular homeostasis and impairment of this disposal can lead to a broad range of pathological conditions, most notably in brain-associated disorders including Parkinson and Alzheimer diseases, and cancer. In this respect, the Protein Quality Control (PQC) pathway plays a central role in the clearance of damaged proteins. The Hsc/Hsp70-co-chaperone BAG3 has been described as a new and critical component of the PQC in several cellular contexts. For example, the expression of BAG3 in the rodent brain correlates with the engagement of protein degradation machineries in response to proteotoxic stress. Nevertheless, little is known about the molecular events assisted by BAG3. Here we show that ectopic expression of BAG3 in glioblastoma cells leads to the activation of an HSF1-driven stress response, as attested by transcriptional activation of BAG3 and Hsp70. BAG3 overexpression determines an accumulation of ubiquitinated proteins and this event requires the N-terminal region, WW domain of BAG3 and the association of BAG3 with Hsp70. The ubiquitination mainly occurs on BAG3-client proteins and the inhibition of proteasomal activity results in a further accumulation of ubiquitinated clients. At the cellular level, overexpression of BAG3 in glioblastoma cell lines, but not in non-glial cells, results in a remarkable decrease in colony formation capacity and this effect is reverted when the binding of BAG3 to Hsp70 is impaired. These observations provide the first evidence for an involvement of BAG3 in the ubiquitination and turnover of its partners.	[Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ, Sch Med, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA.	kamel.khalili@temple.edu	Gentilella, Antonio/AAA-9864-2020		National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants awarded by the National Institutes of Health (to K. K.).	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Du ZX, 2009, J CELL PHYSIOL, V218, P631, DOI 10.1002/jcp.21634; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Gentilella A, 2009, J CELL BIOCHEM, V108, P1117, DOI 10.1002/jcb.22343; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Jung SE, 2010, BRAIN RES, V1349, P1, DOI 10.1016/j.brainres.2010.06.043; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schneider L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-14; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Wang HQ, 2008, BIOCHEM BIOPH RES CO, V365, P381, DOI 10.1016/j.bbrc.2007.11.001; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916	31	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9205	9215		10.1074/jbc.M110.175836	http://dx.doi.org/10.1074/jbc.M110.175836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233200	Green Published, hybrid			2022-12-25	WOS:000288247700051
J	Huo, LH; Li, DW; Sun, XO; Shi, XJ; Karna, P; Yang, W; Liu, M; Qiao, WT; Aneja, R; Zhou, J				Huo, Lihong; Li, Dengwen; Sun, Xiaoou; Shi, Xingjuan; Karna, Prasanthi; Yang, Wei; Liu, Min; Qiao, Wentao; Aneja, Ritu; Zhou, Jun			Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-associated Deacetylase HDAC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT; CYCLIN T1; PROTEIN; LOOP; APOPTOSIS; INTERACTS; SEQUENCE; REQUIRES; BINDING; PCAF	Reversible acetylation of Tat is critical for its transactivation activity toward HIV-1 transcription. However, the enzymes involved in the acetylation/deacetylation cycles have not been fully characterized. In this study, by yeast two-hybrid assay, we have discovered the histone deacetylase HDAC6 to be a binding partner of Tat. Our data show that HDAC6 interacts with Tat in the cytoplasm in a microtubule-dependent manner. In addition, HDAC6 deacetylates Tat at Lys-28 and thereby suppresses Tat-mediated transactivation of the HIV-1 promoter. Inactivation of HDAC6 promotes the interaction of Tat with cyclin T1 and leads to an increase in Tat transactivation activity. These findings establish HDAC6 as a Tat deacetylase and support a model in which Lys-28 deacetylation decreases Tat transactivation activity through affecting the ability of Tat to form a ribonucleoprotein complex with cyclin T1 and the transactivation-responsive RNA.	[Huo, Lihong; Li, Dengwen; Sun, Xiaoou; Shi, Xingjuan; Yang, Wei; Qiao, Wentao; Zhou, Jun] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Key Lab Mol Microbiol & Biotechnol,Minist Educ, Tianjin 300071, Peoples R China; [Karna, Prasanthi; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Liu, Min] Tianjin Med Univ, Dept Biochem, Key Lab Cellular & Mol Immunol Tianjin, Basic Med Coll, Tianjin 300070, Peoples R China	Nankai University; University System of Georgia; Georgia State University; Tianjin Medical University	Zhou, J (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Key Lab Mol Microbiol & Biotechnol,Minist Educ, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Huo, Lihong/ABI-4909-2020; Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260; Huo, Lihong/0000-0001-7901-6758	National Science and Technology Major Project [2008ZX10001-002]; Tianjin Natural Science Foundation [09JCYBJC08900]; National Basic Research Program of China [2007CB914802]; National Natural Science Foundation of China [30825022, 90913021, 30800565]; Fok Ying Tung Education Foundation [111036]	National Science and Technology Major Project; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by National Science and Technology Major Project Grant 2008ZX10001-002, Tianjin Natural Science Foundation Grant 09JCYBJC08900, National Basic Research Program of China Grant 2007CB914802, National Natural Science Foundation of China Grants 30825022, 90913021, and 30800565, and Fok Ying Tung Education Foundation Grant 111036.	BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; De Marco A, 2010, AMINO ACIDS, V38, P1583, DOI 10.1007/s00726-009-0378-9; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Egele C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-62; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gautier VW, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-47; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	28	52	55	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9280	9286		10.1074/jbc.M110.208884	http://dx.doi.org/10.1074/jbc.M110.208884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220424	hybrid, Green Published			2022-12-25	WOS:000288247700058
J	Kandasamy, P; Zarini, S; Chan, ED; Leslie, CC; Murphy, RC; Voelker, DR				Kandasamy, Pitchaimani; Zarini, Simona; Chan, Edward D.; Leslie, Christina C.; Murphy, Robert C.; Voelker, Dennis R.			Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); INNATE IMMUNE-RESPONSES; NUCLEAR-ENVELOPE; ASTHMA; ACTIVATION; CELLS; TRANSLOCATION; INFLAMMATION; PROTEIN; KINASE	Mycoplasma pneumoniae is a human pathogen causing respiratory infections that are also associated with serious exacerbations of chronic lung diseases. Membranes and lipoproteins from M. pneumoniae induced a 4-fold increase in arachidonic acid (AA) release from RAW264.7 and a 2-fold increase in AA release from primary human alveolar macrophages. The bacterial lipoprotein mimic and TLR2/1 agonist Pam3Cys and the TLR2/6 agonist MALP-2 produced effects similar to those elicited by M. pneumoniae in macrophages by inducing the phosphorylation of p38(MAPK) and p44/42(ERK1/2) MAP kinases and cyclooxygenase-2 (COX-2) expression. M. pneumoniae induced the generation of prostaglandins PGD(2) and PGE(2) from RAW264.7 cells and thromboxane B-2 (TXB2) from human alveolar macrophages. Anti-TLR2 antibody completely abolished M. pneumoniae-induced AA release and TNF alpha secretion from RAW264.7 cells and human alveolar macrophages. Disruption of the phosphorylation of p44/42(ERK1/2) or inactivation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) completely inhibited M. pneumoniae-induced AA release from macrophages. The minor pulmonary surfactant phospholipid, palmitoyl-oleoyl-phosphatidylglycerol (POPG), antagonized the proinflammatory actions of M. pneumoniae, Pam3Cys, and MALP-2 by reducing the production of AA metabolites from macrophages. The effect of POPG was specific, insofar as saturated PG, and saturated and unsaturated phosphatidylcholines did not have significant effect on M. pneumoniae-induced AA release. Collectively, these data demonstrate that M. pneumoniae stimulates the production of eicosanoids from macrophages through TLR2, and POPG suppresses this pathogen-induced response.	[Kandasamy, Pitchaimani; Chan, Edward D.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Zarini, Simona; Leslie, Christina C.; Murphy, Robert C.] Univ Colorado Denver Sch Med, Dept Pharmacol, Aurora, CO 80011 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St,K601, Denver, CO 80206 USA.	voelkerd@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Zarini, Simona/0000-0002-7460-3299	National Institutes of Health [HL094629, HL073907, HL34303, M01 RR00051]; Clinical and Translational Science Award (CTSA) [1UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303, R01HL094629, P01HL073907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094629, HL073907 (to D. R. V.), HL34303 (to C. C. L. and R. C. M.), and infrastructure Grants M01 RR00051, and Clinical and Translational Science Award (CTSA) 1UL1 RR025780.	Aizawa H, 1996, CHEST, V109, P338, DOI 10.1378/chest.109.2.338; Allen IC, 2006, AM J PHYSIOL-LUNG C, V290, pL526, DOI 10.1152/ajplung.00340.2005; BESKIND DL, 1994, ANN EMERG MED, V23, P1375, DOI 10.1016/S0196-0644(94)70365-5; Chan ED, 1999, CHEST, V115, P1188, DOI 10.1378/chest.115.4.1188; Chmura K, 2008, AM J PHYSIOL-LUNG C, V295, pL220, DOI 10.1152/ajplung.90204.2008; Christie PE, 1996, THORAX, V51, P1171, DOI 10.1136/thx.51.12.1171; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Diaz N. A., 1996, ANAL CHIM ACTA, V327, P161; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; GIL JC, 1993, ANN ALLERGY, V70, P23; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hashimoto M, 2003, J BIOL CHEM, V278, P44205, DOI 10.1074/jbc.M306735200; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V103, P1054, DOI 10.1016/S0091-6749(99)70179-X; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Moore ML, 2006, J ALLERGY CLIN IMMUN, V117, P1036, DOI 10.1016/j.jaci.2005.12.1314; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OBYRNE PM, 1989, EUR RESPIR J, V2, P782; Oosaki R, 1997, INT ARCH ALLERGY IMM, V114, P373, DOI 10.1159/000237697; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Rawadi G, 1998, J IMMUNOL, V160, P1330; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2008, INFECT IMMUN, V76, P270, DOI 10.1128/IAI.00955-07; Shin HD, 2003, J ALLERGY CLIN IMMUN, V112, P454, DOI 10.1067/mai.2003.1641; Singh AM, 2006, THORAX, V61, P809, DOI 10.1136/thx.2005.045179; Stamm B, 2008, EMERG INFECT DIS, V14, P641, DOI 10.3201/eid1404.061366; Tanaka F, 1997, Respirology, V2, P119, DOI 10.1111/j.1440-1843.1997.tb00064.x; TAYLOR IK, 1991, AM REV RESPIR DIS, V143, P119, DOI 10.1164/ajrccm/143.1.119; Tonks A, 2001, CLIN EXP IMMUNOL, V124, P86, DOI 10.1046/j.1365-2249.2001.01479.x; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Wieslander Ake, 1992, P93; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002	55	54	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7841	7853		10.1074/jbc.M110.170241	http://dx.doi.org/10.1074/jbc.M110.170241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205826	hybrid, Green Published			2022-12-25	WOS:000288013300015
J	Stranzl, GR; Santelli, E; Bankston, LA; La Clair, C; Bobkov, A; Schwarzenbacher, R; Godzik, A; Perego, M; Grynberg, M; Liddington, RC				Stranzl, Gudrun R.; Santelli, Eugenio; Bankston, Laurie A.; La Clair, Chandra; Bobkov, Andrey; Schwarzenbacher, Robert; Godzik, Adam; Perego, Marta; Grynberg, Marcin; Liddington, Robert C.			Structural Insights into Inhibition of Bacillus anthracis Sporulation by a Novel Class of Non-heme Globin Sensor Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN GENE-EXPRESSION; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; VIRULENCE PLASMIDS; CAPSULE SYNTHESIS; BINDING DOMAIN; REGULATOR; TRANSCRIPTION; SEQUENCE; CHLORIDE	Pathogenesis by Bacillus anthracis requires coordination between two distinct activities: plasmid-encoded virulence factor expression (which protects vegetative cells from immune surveillance during outgrowth and replication) and chromosomally encoded sporulation (required only during the final stages of infection). Sporulation is regulated by at least five sensor histidine kinases that are activated in response to various environmental cues. One of these kinases, BA2291, harbors a sensor domain that has similar to 35% sequence identity with two plasmid proteins, pXO1-118 and pXO2-61. Because overexpression of pXO2-61 (or pXO1-118) inhibits sporulation of B. anthracis in a BA2291-dependent manner, and pXO2-61 expression is strongly up-regulated by the major virulence gene regulator, AtxA, it was suggested that their function is to titrate out an environmental signal that would otherwise promote untimely sporulation. To explore this hypothesis, we determined crystal structures of both plasmid-encoded proteins. We found that they adopt a dimeric globin fold but, most unusually, do not bind heme. Instead, they house a hydrophobic tunnel and hydrophilic chamber that are occupied by fatty acid, which engages a conserved arginine and chloride ion via its carboxyl head group. In vivo, these domains may therefore recognize changes in fatty acid synthesis, chloride ion concentration, and/or pH. Structure-based comparisons with BA2291 suggest that it binds ligand and dimerizes in an analogous fashion, consistent with the titration hypothesis. Analysis of newly sequenced bacterial genomes points to the existence of a much broader family of non-heme, globin-based sensor domains, with related but distinct functionalities, that may have evolved from an ancestral heme-linked globin.	[Stranzl, Gudrun R.; Santelli, Eugenio; Bankston, Laurie A.; Bobkov, Andrey; Schwarzenbacher, Robert; Godzik, Adam; Grynberg, Marcin; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [La Clair, Chandra; Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Grynberg, Marcin] Inst Biochem & Biophys PAS, PL-02106 Warsaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org	Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Grynberg, Marcin/0000-0003-1887-7209	National Institutes of Health [AI055789, AI055860]; Department of Defense [W81XWH-10-1-0093]; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; Austrian Science Fund; Polish State Committee for Scientific Research [2 PO4B 026 28]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); Austrian Science Fund(Austrian Science Fund (FWF)); Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860. This work was also supported by Department of Defense Grant W81XWH-10-1-0093. The Brookhaven National Synchrotron Light Source is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences Contract DE-AC02-98CH10886.; Received an Erwin Schrodinger fellowship from the Austrian Science Fund.; Supported in part by Grant 2 PO4B 026 28 from the Polish State Committee for Scientific Research.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Bongiorni C, 2006, J BACTERIOL, V188, P487, DOI 10.1128/JB.188.2.487-498.2006; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunsing RL, 2005, J BACTERIOL, V187, P6972, DOI 10.1128/JB.187.20.6972-6981.2005; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Contreras-Martel C, 2007, BIOPHYS CHEM, V125, P388, DOI 10.1016/j.bpc.2006.09.014; DAI ZH, 1995, MOL MICROBIOL, V16, P1171, DOI 10.1111/j.1365-2958.1995.tb02340.x; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Giardina B, 2004, ACTA PHYSIOL SCAND, V182, P229, DOI 10.1111/j.1365-201X.2004.01360.x; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lodish H., 2000, MOL CELL BIOL, P640; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nogi Y, 2005, INT J SYST EVOL MICR, V55, P2309, DOI 10.1099/ijs.0.63649-0; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perego M, 2008, TRENDS MICROBIOL, V16, P215, DOI 10.1016/j.tim.2008.01.010; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sakurai H, 2010, PHOTOSYNTH RES, V104, P163, DOI 10.1007/s11120-010-9531-2; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; Song YF, 2009, J MOL BIOL, V387, P840, DOI 10.1016/j.jmb.2009.01.038; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; White AK, 2006, J BACTERIOL, V188, P6354, DOI 10.1128/JB.00656-06; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	44	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8448	8458		10.1074/jbc.M110.207126	http://dx.doi.org/10.1074/jbc.M110.207126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216948	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000288013300073
J	Yang, ZY; Chi, XL; Funabashi, M; Baba, S; Nonaka, K; Pahari, P; Unrine, J; Jacobsen, JM; Elliott, GI; Rohr, J; Van Lanen, SG				Yang, Zhaoyong; Chi, Xiuling; Funabashi, Masanori; Baba, Satoshi; Nonaka, Koichi; Pahari, Pallab; Unrine, Jason; Jacobsen, Jesse M.; Elliott, Gregory I.; Rohr, Juergen; Van Lanen, Steven G.			Characterization of LipL as a Non-heme, Fe(II)-dependent alpha-Ketoglutarate:UMP Dioxygenase That Generates Uridine-5 '-aldehyde during A-90289 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; GENE-CLUSTER; STREPTOMYCES SP; ESCHERICHIA-COLI; PEPTIDOGLYCAN SYNTHESIS; NUCLEOSIDE ANTIBIOTICS; CLAVAMINATE SYNTHASE; CRYSTAL-STRUCTURE; 2 ISOZYMES; IDENTIFICATION	Fe(II)- and alpha-ketoglutarate (alpha-KG)-dependent dioxygenases are a large and diverse superfamily of mononuclear, non-heme enzymes that perform a variety of oxidative transformations typically coupling oxidative decarboxylation of alpha-KG with hydroxylation of a prime substrate. The biosynthetic gene clusters for several nucleoside antibiotics that contain a modified uridine component, including the lipopeptidyl nucleoside A-90289 from Streptomyces sp. SANK 60405, have recently been reported, revealing a shared open reading frame with sequence similarity to proteins annotated as alpha-KG:taurine dioxygenases (TauD), a well characterized member of this dioxygenase superfamily. We now provide in vitro data to support the functional assignment of LipL, the putative TauD enzyme from the A-90289 gene cluster, as a non-heme, Fe(II)- dependent alpha-KG: UMP dioxygenase that produces uridine-5`-aldehyde to initiate the biosynthesis of the modified uridine component of A-90289. The activity of LipL is shown to be dependent on Fe(II), alpha-KG, and O-2, stimulated by ascorbic acid, and inhibited by several divalent metals. In the absence of the prime substrate UMP, LipL is able to catalyze oxidative decarboxylation of alpha-KG, although at a significantly reduced rate. The steady-state kinetic parameters using optimized conditions were determined to be K-m(alpha-KG) = 7.5 mu M, K-m(UMP) = 14 mu M, and k(cat) approximate to 80 min(-1). The discovery of this new activity not only sets the stage to explore the mechanism of LipL and related dioxygenases further but also has critical implications for delineating the biosynthetic pathway of several related nucleoside antibiotics.	[Yang, Zhaoyong; Chi, Xiuling; Pahari, Pallab; Jacobsen, Jesse M.; Elliott, Gregory I.; Rohr, Juergen; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Funabashi, Masanori; Baba, Satoshi; Nonaka, Koichi] Daiichi Sankyo Co Ltd, Biopharmaceut Res Grp 1, Biopharmaceut Technol Res Labs, Pharmaceut Technol Div, Iwaki, Fukushima 9718183, Japan; [Unrine, Jason] Univ Kentucky, Coll Agr, Dept Plant & Soil Sci, Lexington, KY 40536 USA	University of Kentucky; Daiichi Sankyo Company Limited; University of Kentucky	Van Lanen, SG (corresponding author), 789 S Limestone, Lexington, KY 40539 USA.	svanlanen@uky.edu	Pahari, Pallab/AAF-5664-2019; Funabashi, Masanori/GQZ-8735-2022; Rohr, Jurgen/G-5375-2014	Rohr, Jurgen/0000-0001-6447-5951; Pahari, Pallab/0000-0003-3662-2015; Unrine, Jason/0000-0003-3012-5261	Kentucky Science and Technology Corporation; National Science Foundation	Kentucky Science and Technology Corporation; National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Kentucky Science and Technology Corporation (S. G. V. L.) and a National Science Foundation predoctoral fellowship (J. J.).	Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; BUSBY RW, 1995, J BIOL CHEM, V270, P4262, DOI 10.1074/jbc.270.9.4262; CHEN RH, 1989, J ANTIBIOT, V42, P512, DOI 10.7164/antibiotics.42.512; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; FISHER DK, 1994, PHARMACEUT RES, V11, P759, DOI 10.1023/A:1018996817529; Funabashi M, 2010, NAT CHEM BIOL, V6, P581, DOI [10.1038/NCHEMBIO.393, 10.1038/nchembio.393]; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holt A, 1997, ANAL BIOCHEM, V244, P384, DOI 10.1006/abio.1996.9911; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO F, 1991, ANTIMICROB AGENTS CH, V35, P234, DOI 10.1128/AAC.35.2.234; ISONO K, 1978, J AM CHEM SOC, V100, P3937, DOI 10.1021/ja00480a052; IWASA T, 1977, J ANTIBIOT, V30, P1; JONES GH, 1979, J ORG CHEM, V44, P1309, DOI 10.1021/jo01322a025; Ju JH, 2004, CHEMBIOCHEM, V5, P1281, DOI 10.1002/cbic.200400136; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; KNAPP S, 1994, J ORG CHEM, V59, P946, DOI 10.1021/jo00084a005; LINDBLAD B, 1970, J AM CHEM SOC, V92, P7446, DOI 10.1021/ja00728a032; Luo LS, 2006, ANAL BIOCHEM, V353, P69, DOI 10.1016/j.ab.2006.03.033; MARSH EN, 1992, BIOCHEMISTRY-US, V31, P12648, DOI 10.1021/bi00165a015; McCusker KP, 2009, P NATL ACAD SCI USA, V106, P19791, DOI 10.1073/pnas.0910660106; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; Murakami R, 2008, J ANTIBIOT, V61, P537, DOI 10.1038/ja.2008.71; Murakami R, 2007, J ANTIBIOT, V60, P690, DOI 10.1038/ja.2007.88; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; PFITZNER KE, 1963, J AM CHEM SOC, V85, P3027, DOI 10.1021/ja00902a035; Rackham EJ, 2010, CHEMBIOCHEM, V11, P1700, DOI 10.1002/cbic.201000200; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; TAKAHASHI S, 1985, J ANTIBIOT, V38, P830, DOI 10.7164/antibiotics.38.830; TAMURA G, 1976, AGR BIOL CHEM TOKYO, V40, P447, DOI 10.1080/00021369.1976.10862071; Tsvetanova BC, 2002, J BIOL CHEM, V277, P35289, DOI 10.1074/jbc.M201345200; Unrine JM, 2006, ENVIRON TOXICOL CHEM, V25, P1864, DOI 10.1897/05-598R.1; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	45	40	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7885	7892		10.1074/jbc.M110.203562	http://dx.doi.org/10.1074/jbc.M110.203562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216959	hybrid, Green Published			2022-12-25	WOS:000288013300019
J	Kaminitz, A; Askenasy, EM; Yaniv, I; Stein, J; Askenasy, N				Kaminitz, Ayelet; Askenasy, Enosh M.; Yaniv, Isaac; Stein, Jerry; Askenasy, Nadir			Apoptosis of Purified CD4(+) T Cell Subsets Is Dominated by Cytokine Deprivation and Absence of Other Cells in New Onset Diabetic NOD Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; MARROW IN-VIVO; INTERLEUKIN-2 PRODUCTION; HEMATOPOIETIC-CELLS; LYMPHOCYTES; HOMEOSTASIS; ACTIVATION; DEATH; IL-2; SUPPRESSION	Background: Regulatory T cells (Treg) play a significant role in immune homeostasis and self-tolerance. Excessive sensitivity of isolated Treg to apoptosis has been demonstrated in NOD mice and humans suffering of type 1 diabetes, suggesting a possible role in the immune dysfunction that underlies autoimmune insulitis. In this study the sensitivity to apoptosis was measured in T cells from new onset diabetic NOD females, comparing purified subsets to mixed cultures. Principal Findings: Apoptotic cells are short lived in vivo and death occurs primarily during isolation, manipulation and culture. Excessive susceptibility of CD25(+) T cells to spontaneous apoptosis is characteristic of isolated subsets, however disappears when death is measured in mixed splenocyte cultures. In variance, CD25(-) T cells display balanced sensitivity to apoptosis under both conditions. The isolation procedure removes soluble factors, IL-2 playing a significant role in sustaining Treg viability. In addition, pro-and anti-apoptotic signals are transduced by cell-to-cell interactions: CD3 and CD28 protect CD25(+) T cells from apoptosis, and in parallel sensitize naive effector cells to apoptosis. Treg viability is modulated both by other T cells and other subsets within mixed splenocyte cultures. Variations in sensitivity to apoptosis are often hindered by fast proliferation of viable cells, therefore cycling rates are mandatory to adequate interpretation of cell death assays. Conclusions: The sensitivity of purified Treg to apoptosis is dominated by cytokine deprivation and absence of cell-to-cell interactions, and deviate significantly from measurements in mixed populations. Balanced sensitivity of naive/effector and regulatory T cells to apoptosis in NOD mice argues against the concept that differential susceptibility affects disease evolution and progression.	[Kaminitz, Ayelet; Yaniv, Isaac; Stein, Jerry; Askenasy, Nadir] Schneider Childrens Med Ctr Israel, Ctr Stem Cell Res, Frankel Lab, Petah Tiqwa, Israel; [Stein, Jerry] Schneider Childrens Med Ctr Israel, Bone Marrow Transplant Unit, Petah Tiqwa, Israel; [Yaniv, Isaac] Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, Petah Tiqwa, Israel; [Kaminitz, Ayelet] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Askenasy, Enosh M.] Ben Gurion Univ Negev, Soroka Med Sch, IL-84105 Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center	Kaminitz, A (corresponding author), Schneider Childrens Med Ctr Israel, Ctr Stem Cell Res, Frankel Lab, Petah Tiqwa, Israel.	anadir@012.net.il			Leah and Edward M. Frankel Trust	Leah and Edward M. Frankel Trust	This study was supported by a generous grant from the Leah and Edward M. Frankel Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Askenasy N, 2003, EXP HEMATOL, V31, P1292, DOI 10.1016/j.exphem.2003.09.006; Askenasy N, 2002, STEM CELLS, V20, P501, DOI 10.1634/stemcells.20-6-501; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Asquith B, 2009, TRENDS IMMUNOL, V30, P182, DOI 10.1016/j.it.2009.01.003; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Colucci F, 1996, J AUTOIMMUN, V9, P271, DOI 10.1006/jaut.1996.0034; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Glisic-Milosavljevic S, 2007, CLIN EXP IMMUNOL, V150, P75, DOI 10.1111/j.1365-2249.2007.03475.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Jiang N, 2003, BLOOD, V102, P2243, DOI 10.1182/blood-2002-10-3312; Kaminitz A, 2010, J AUTOIMMUN, V35, P145, DOI 10.1016/j.jaut.2010.06.002; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mellanby RJ, 2007, IMMUNOLOGY, V121, P15, DOI 10.1111/j.1365-2567.2007.02546.x; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pearl-Yafe M, 2007, STEM CELLS, V25, P1448, DOI 10.1634/stemcells.2007-0013; Pearl-Yafe M, 2006, AUTOIMMUN REV, V5, P338, DOI 10.1016/j.autrev.2006.02.005; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Radosevic K, 1999, J AUTOIMMUN, V13, P373, DOI 10.1006/jaut.1999.0338; Raimondi G, 2007, CRIT REV IMMUNOL, V27, P61, DOI 10.1615/CritRevImmunol.v27.i1.50; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Yarkoni S, 2010, DIABETOLOGIA, V53, P356, DOI 10.1007/s00125-009-1604-4; Yarkoni S, 2008, BIOESSAYS, V30, P875, DOI 10.1002/bies.20812; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15684	10.1371/journal.pone.0015684	http://dx.doi.org/10.1371/journal.pone.0015684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209873	gold, Green Submitted, Green Published			2022-12-25	WOS:000285838900026
J	Wurtzel, O; Dori-Bachash, M; Pietrokovski, S; Jurkevitch, E; Sorek, R				Wurtzel, Omri; Dori-Bachash, Mally; Pietrokovski, Shmuel; Jurkevitch, Edouard; Sorek, Rotem			Mutation Detection with Next-Generation Resequencing through a Mediator Genome	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS	The affordability of next generation sequencing (NGS) is transforming the field of mutation analysis in bacteria. The genetic basis for phenotype alteration can be identified directly by sequencing the entire genome of the mutant and comparing it to the wild-type (WT) genome, thus identifying acquired mutations. A major limitation for this approach is the need for an a-priori sequenced reference genome for the WT organism, as the short reads of most current NGS approaches usually prohibit de-novo genome assembly. To overcome this limitation we propose a general framework that utilizes the genome of relative organisms as mediators for comparing WT and mutant bacteria. Under this framework, both mutant and WT genomes are sequenced with NGS, and the short sequencing reads are mapped to the mediator genome. Variations between the mutant and the mediator that recur in the WT are ignored, thus pinpointing the differences between the mutant and the WT. To validate this approach we sequenced the genome of Bdellovibrio bacteriovorus 109J, an obligatory bacterial predator, and its prey-independent mutant, and compared both to the mediator species Bdellovibrio bacteriovorus HD100. Although the mutant and the mediator sequences differed in more than 28,000 nucleotide positions, our approach enabled pinpointing the single causative mutation. Experimental validation in 53 additional mutants further established the implicated gene. Our approach extends the applicability of NGS-based mutant analyses beyond the domain of available reference genomes.	[Wurtzel, Omri; Pietrokovski, Shmuel; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Dori-Bachash, Mally; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Wurtzel, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rotem.sorek@weizmann.ac.il	Wurtzel, Omri/AAG-3985-2019	Wurtzel, Omri/0000-0002-6865-5914; Pietrokovski, Shmuel/0000-0001-8573-5863	Crown Human Genome Center; M.D. Moross Institute for Cancer Research; Israel Science Foundation [1615/09, 1290/08]; NIH [R01AI082376-01]; EMBO; Minerva Foundation; Yeda-Sela Center for Basic Research; Kahn Center for Systems Biology of the Human Cell; Azrieli Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082376] Funding Source: NIH RePORTER	Crown Human Genome Center; M.D. Moross Institute for Cancer Research; Israel Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Minerva Foundation; Yeda-Sela Center for Basic Research; Kahn Center for Systems Biology of the Human Cell; Azrieli Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sequencing was partially supported by The Crown Human Genome Center and the M.D. Moross Institute for Cancer Research. R. S. was supported, in part, by the Israel Science Foundation FIRST program (grant 1615/09), NIH R01AI082376-01, the EMBO Young Investigator program, the Minerva Foundation, and the Yeda-Sela Center for Basic Research. O.W. was supported by the Kahn Center for Systems Biology of the Human Cell, and is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. This project was also supported by the Israel Science Foundation grant number 1290/08 to E.J.. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; Dashiff Aliza, 2009, Open Microbiol J, V3, P87, DOI 10.2174/1874285800903000087; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Klockgether J, 2009, J BACTERIOL; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tettelin H, 2009, METHODS MOL BIOL, V551, P231, DOI 10.1007/978-1-60327-999-4_18	20	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15628	10.1371/journal.pone.0015628	http://dx.doi.org/10.1371/journal.pone.0015628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209874	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900024
J	Mandalia, S; Mandalia, R; Lo, G; Chadborn, T; Sharott, P; Youle, M; Anderson, J; Baily, G; Brettle, R; Fisher, M; Gompels, M; Kinghorn, G; Johnson, M; McCarron, B; Pozniak, A; Tang, A; Walsh, J; White, D; Williams, I; Gazzard, B; Beck, EJ				Mandalia, Sundhiya; Mandalia, Roshni; Lo, Gary; Chadborn, Tim; Sharott, Peter; Youle, Mike; Anderson, Jane; Baily, Guy; Brettle, Ray; Fisher, Martin; Gompels, Mark; Kinghorn, George; Johnson, Margaret; McCarron, Brendan; Pozniak, Anton; Tang, Alan; Walsh, John; White, David; Williams, Ian; Gazzard, Brian; Beck, Eduard J.		NPMS-HHC Steering Grp	Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY	Background: The number of people living with HIV (PLHIV) is increasing in the UK. This study estimated the annual population cost of providing HIV services in the UK, 1997-2006 and projected them 2007-2013. Methods: Annual cost of HIV treatment for PLHIV by stage of HIV infection and type of ART was calculated (UK pounds, 2006 prices). Population costs were derived by multiplying the number of PLHIV by their annual cost for 1997-2006 and projected 2007-2013. Results: Average annual treatment costs across all stages of HIV infection ranged from 17,034 pound in 1997 to 18,087 pound in 2006 for PLHIV on mono-therapy and from 27,649 pound in 1997 to 32,322 pound in 2006 for those on quadruple-or-more ART. The number of PLHIV using NHS services rose from 16,075 to 52,083 in 2006 and was projected to increase to 78,370 by 2013. Annual population cost rose from 104 pound million in 1997 to 483 pound million in 2006, with a projected annual cost between 721 pound and 758 pound million by 2013. When including community care costs, costs increased from 164 pound million in 1997, to 683 pound million in 2006 and between 1,019 pound and 1,065 pound million in 2013. Conclusions: Increased number of PLHIV using NHS services resulted in rising UK population costs. Population costs are expected to continue to increase, partly due to PLHIV's longer survival on ART and the relative lack of success of HIV preventing programs. Where possible, the cost of HIV treatment and care needs to be reduced without reducing the quality of services, and prevention programs need to become more effective. While high income countries are struggling to meet these increasing costs, middle- and lower-income countries with larger epidemics are likely to find it even more difficult to meet these increasing demands, given that they have fewer resources.	[Mandalia, Sundhiya; Mandalia, Roshni; Lo, Gary; Youle, Mike; Gazzard, Brian; Beck, Eduard J.] NPMS HHC Coordinating & Analyt Ctr, London, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Mandalia, Sundhiya; Lo, Gary; Pozniak, Anton; Gazzard, Brian; Beck, Eduard J.] Chelsea & Westminster Hosp, London, England; [Chadborn, Tim] Hlth Protect Agcy, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England; [Baily, Guy] London & Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [Kinghorn, George] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Tang, Alan] Royal Berkshire Hosp, Reading, Berks, England; [Walsh, John] St Marys Hosp, London, England; [White, David] Birmingham Heartlands Hosp, London, England; [Williams, Ian] Mortimer Market Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Imperial College London; Health Protection Agency; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Brighton; Southmead Hospital; University of Sheffield; James Cook University Hospital; Royal Berkshire Hospital; Imperial College London; Heart of England NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Mandalia, S (corresponding author), NPMS HHC Coordinating & Analyt Ctr, London, England.	becke@unaids.org	Kinghorn, George/AAO-1425-2021; Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Kinghorn, George/0000-0001-6608-5076	Tibotec	Tibotec	During 2008/2009, the NPMS-HHC was financially supported through a non-restrictive grant from Tibotec, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich J, 2005, STAT SCI, V20, P401, DOI 10.1214/088342305000000331; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BALETA A, 2010, LANCET; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 2004, AIDS, V18, P2411; Beck EJ, 2003, BRIT J SEX MED, V27, P21; BECK EJ, 2010, 18 INT AIDS C VIENN; BECK EJ, 2003, BRIT J SEX MED, V27, P19; BECK EJ, 2008, USE COST HIV SERVICE; *EUR CTR DIS PREV, 2009, HIV AIDS SURV EUR 20, P24; Grant RM, 2010, NEW ENGL J MED, V363, P1; Hall HI, 2010, JAIDS-J ACQ IMM DEF, V55, P271, DOI 10.1097/QAI.0b013e3181e8f90c; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Health Protection Agency, 2010, SURV PREV HIV INF DI; Health Protection Agency, 2009, HIV UK 2009 REP; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; *HLTH PROT AG, 2009, HLTH PROT AG SURV PR; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; MONTANER JS, 2010, LANCET; POATE D, 2009, UNAIDS 2 INDEPENDENT; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P1; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; *UN, 2010, 64 SESS GEN ASS AG I; WHO, 2010, ANT THER HIV INF AD; World Health Organization (WHO), 2010, MOR 5 MILL PEOPL REC; 2010, BMJ, V341, pC3977	28	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15677	10.1371/journal.pone.0015677	http://dx.doi.org/10.1371/journal.pone.0015677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209893	Green Published, Green Accepted, gold			2022-12-25	WOS:000285793600027
J	Brown, RM; Short, JL; Lawrence, AJ				Brown, Robyn Mary; Short, Jennifer Lynn; Lawrence, Andrew John			Identification of Brain Nuclei Implicated in Cocaine-Primed Reinstatement of Conditioned Place Preference: A Behaviour Dissociable from Sensitization	PLOS ONE			English	Article							STRESS-INDUCED REINSTATEMENT; MEDIAL PREFRONTAL CORTEX; CORTICOTROPIN-RELEASING-FACTOR; OPIATE-SEEKING BEHAVIOR; C-FOS EXPRESSION; LATERAL HABENULA; STRIA TERMINALIS; BED NUCLEUS; PSYCHOLOGICAL STRESS; PAIRED ENVIRONMENT	Relapse prevention represents the primary therapeutic challenge in the treatment of drug addiction. As with humans, drug-seeking behaviour can be precipitated in laboratory animals by exposure to a small dose of the drug (prime). The aim of this study was to identify brain nuclei implicated in the cocaine-primed reinstatement of a conditioned place preference (CPP). Thus, a group of mice were conditioned to cocaine, had this place preference extinguished and were then tested for primed reinstatement of the original place preference. There was no correlation between the extent of drug-seeking upon reinstatement and the extent of behavioural sensitization, the extent of original CPP or the extinction profile of mice, suggesting a dissociation of these components of addictive behaviour with a drug-primed reinstatement. Expression of the protein product of the neuronal activity marker c-fos was assessed in a number of brain regions of mice that exhibited reinstatement (R mice) versus those which did not (NR mice). Reinstatement generally conferred greater Fos expression in cortical and limbic structures previously implicated in drug-seeking behaviour, though a number of regions not typically associated with drug-seeking were also activated. In addition, positive correlations were found between neural activation of a number of brain regions and reinstatement behaviour. The most significant result was the activation of the lateral habenula and its positive correlation with reinstatement behaviour. The findings of this study question the relationship between primed reinstatement of a previously extinguished place preference for cocaine and behavioural sensitization. They also implicate activation patterns of discrete brain nuclei as differentiators between reinstating and non-reinstating mice.	[Brown, Robyn Mary; Short, Jennifer Lynn; Lawrence, Andrew John] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Brown, Robyn Mary; Short, Jennifer Lynn] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Lawrence, Andrew John] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Brown, RM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	Andrew.Lawrence@florey.edu.au	Short, Jennifer/AAC-7385-2019; Brown, Robyn M/AAO-3694-2021	Brown, Robyn M/0000-0003-4167-3634	NHMRC; Besen/Pratt Foundations; Victorian Government	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Besen/Pratt Foundations; Victorian Government	This study was supported by an NHMRC Fellowship to AJL, the Besen/Pratt Foundations and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Biala G, 2006, EUR J PHARMACOL, V537, P85, DOI 10.1016/j.ejphar.2006.03.017; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Blanchard RJ, 1998, NEUROSCI BIOBEHAV R, V23, P179, DOI 10.1016/S0149-7634(98)00019-0; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; BROWN EE, 1992, J NEUROSCI, V12, P4112; Brown RM, 2009, NEUROCHEM RES, V34, P1876, DOI 10.1007/s11064-009-9967-y; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; BROWN SA, 1995, J STUD ALCOHOL, V56, P538, DOI 10.15288/jsa.1995.56.538; Childress A, 1988, NIDA Res Monogr, V81, P74; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; CRAWFORD CA, 1995, PSYCHOPHARMACOLOGY, V120, P392, DOI 10.1007/BF02245810; Cruz FC, 2008, NEUROSCIENCE, V151, P313, DOI 10.1016/j.neuroscience.2007.10.019; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; Dayas CV, 2007, BIOL PSYCHIAT, V61, P979, DOI 10.1016/j.biopsych.2006.07.034; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; DEJONG W, 1994, INT J ADDICT, V29, P681, DOI 10.3109/10826089409047904; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Erb S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0006.1999; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Floyd NS, 2001, J COMP NEUROL, V432, P307, DOI 10.1002/cne.1105; Font L, 2008, PHYSIOL BEHAV, V93, P733, DOI 10.1016/j.physbeh.2007.11.026; Franklin TR, 2000, EUR J NEUROSCI, V12, P2097, DOI 10.1046/j.1460-9568.2000.00071.x; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; GOSSOP M, 1989, BRIT J PSYCHIAT, V154, P348, DOI 10.1192/bjp.154.3.348; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Hamlin AS, 2008, NEUROSCIENCE, V151, P659, DOI 10.1016/j.neuroscience.2007.11.018; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hebert MA, 1999, PHARMACOL BIOCHEM BE, V63, P349, DOI 10.1016/S0091-3057(98)00255-X; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kufahl PR, 2009, SYNAPSE, V63, P823, DOI 10.1002/syn.20666; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Leri F, 2002, J NEUROSCI, V22, P5713; Lu L, 2001, EUR J PHARMACOL, V415, P203, DOI 10.1016/S0014-2999(01)00840-8; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McDougall SJ, 2004, EUR J NEUROSCI, V20, P2430, DOI 10.1111/j.1460-9568.2004.03707.x; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2001, J NEUROSCI, V21, P8655; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Mueller D, 2000, BEHAV BRAIN RES, V115, P39, DOI 10.1016/S0166-4328(00)00239-4; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; O'Brien C, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p66A; OBrien CP, 1997, AM J PSYCHIAT, V154, P1195; Paredes RG, 2003, SCAND J PSYCHOL, V44, P203, DOI 10.1111/1467-9450.00337; Parker LA, 2000, PHARMACOL BIOCHEM BE, V66, P559, DOI 10.1016/S0091-3057(00)00222-7; Paxinos G., MOUSE BRAIN STEREOTA; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rhodes SEV, 2007, EUR J NEUROSCI, V25, P2498, DOI 10.1111/j.1460-9568.2007.05486.x; Rhodes SEV, 2004, LEARN MEMORY, V11, P611, DOI 10.1101/lm.79704; Robinson TE, 2000, ADDICTION, V95, pS91; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Sanchez CJ, 2001, BRAIN RES, V908, P86, DOI 10.1016/S0006-8993(01)02638-5; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1996, PSYCHOPHARMACOLOGY, V125, P385, DOI 10.1007/BF02246022; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Spanagel R, 2000, J NEURAL TRANSM, V107, P669, DOI 10.1007/s007020070068; SUTHERLAND RJ, 1981, J COMP PHYSIOL PSYCH, V95, P781, DOI 10.1037/h0077833; TAKAGISHI M, 1991, BRAIN RES, V566, P26, DOI 10.1016/0006-8993(91)91677-S; Touzani K, 2009, NEUROBIOL LEARN MEM, V92, P464, DOI 10.1016/j.nlm.2009.06.006; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; VACHON MP, 1992, BEHAV NEUROSCI, V106, P981, DOI 10.1037/0735-7044.106.6.981; Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; Zavala AR, 2007, NEUROSCIENCE, V145, P438, DOI 10.1016/j.neuroscience.2006.12.038; Zavala AR, 2003, BRAIN RES, V990, P157, DOI 10.1016/S0006-8993(03)03452-8; Zhang FQ, 2005, NEUROSCI LETT, V386, P133, DOI 10.1016/j.neulet.2005.06.008	83	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15889	10.1371/journal.pone.0015889	http://dx.doi.org/10.1371/journal.pone.0015889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209913	gold, Green Published			2022-12-25	WOS:000285793200068
J	Kotz, A; Wagener, J; Engel, J; Routier, FH; Echtenacher, B; Jacobsen, I; Heesemann, J; Ebel, F				Kotz, Andrea; Wagener, Johannes; Engel, Jakob; Routier, Francoise H.; Echtenacher, Bernd; Jacobsen, Ilse; Heesemann, Juergen; Ebel, Frank			Approaching the Secrets of N-Glycosylation in Aspergillus fumigatus: Characterization of the AfOch1 Protein	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; MANNOSYLTRANSFERASE; OCH1; LOCALIZATION; GLUCOAMYLASE; DEFICIENT; VIRULENCE; ENCODES; GLYCANS; HOC1	The mannosyltransferase Och1 is the key enzyme for synthesis of elaborated protein N-glycans in yeast. In filamentous fungi genes implicated in outer chain formation are present, but their function is unclear. In this study we have analyzed the Och1 protein of Aspergillus fumigatus. We provide first evidence that poly-mannosylated N-glycans exist in A. fumigatus and that their synthesis requires AfOch1 activity. This implies that AfOch1 plays a similar role as S. cerevisiae ScOch1 in the initiation of an N-glycan outer chain. A Delta afoch1 mutant showed normal growth under standard and various stress conditions including elevated temperature, cell wall and oxidative stress. However, sporulation of this mutant was dramatically reduced in the presence of high calcium concentrations, suggesting that certain proteins engaged in sporulation require N-glycan outer chains to be fully functional. A characteristic feature of AfOch1 and Och1 homologues from other filamentous fungi is a signal peptide that clearly distinguishes them from their yeast counterparts. However, this difference does not appear to have consequences for its localization in the Golgi. Replacing the signal peptide of AfOch1 by a membrane anchor had no impact on its ability to complement the sporulation defect of the Delta afoch1 strain. The mutant triggered a normal cytokine response in infected murine macrophages, arguing against a role of outer chains as relevant Aspergillus pathogen associated molecular patterns. Infection experiments provided no evidence for attenuation in virulence; in fact, according to our data the Delta afoch1 mutant may even be slightly more virulent than the control strains.	[Kotz, Andrea; Wagener, Johannes; Heesemann, Juergen; Ebel, Frank] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Engel, Jakob; Routier, Francoise H.] Hannover Med Sch, Dept Cellular Chem, Hannover, Germany; [Echtenacher, Bernd] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Jacobsen, Ilse] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany; [Heesemann, Juergen] Univ Munich, Fac Med, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Munich; Hannover Medical School; University of Regensburg; Hans Knoll Institute (HKI); University of Munich	Kotz, A (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.	ebel@mvp.uni-muenchen.de	Routier, Francoise/O-1611-2019; Ebel, Frank/AAF-2303-2022; Jacobsen, Ilse/B-3155-2011; Ebel, Frank/AFH-1488-2022; Wagener, Johannes/K-5904-2012; Wagener, Johannes/AAN-1359-2021	Ebel, Frank/0000-0002-1027-1440; Jacobsen, Ilse/0000-0002-6033-9984; Ebel, Frank/0000-0002-1027-1440; Wagener, Johannes/0000-0002-5952-9422; Routier, Francoise/0000-0002-7163-0590	Center of Integrated Protein Science Munich (CIPSM); Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 576, TP B8]	Center of Integrated Protein Science Munich (CIPSM); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Center of Integrated Protein Science Munich (CIPSM), and by a grant of the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich 576, TP B8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; Goto M, 1997, APPL ENVIRON MICROB, V63, P2940, DOI 10.1128/AEM.63.7.2940-2943.1997; GRAHAM TR, 1995, MOL BIOL CELL, V6, P809, DOI 10.1091/mbc.6.7.809; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Kotz A, 2010, FUNGAL GENET BIOL, V47, P169, DOI 10.1016/j.fgb.2009.10.001; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301; Lambou K, 2010, YEAST, V27, P625, DOI 10.1002/yea.1798; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Maras M, 1999, GLYCOCONJUGATE J, V16, P99, DOI 10.1023/A:1026436424881; McCormick A, 2010, CELL MICROB IN PRESS; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; NAGASU T, 1992, YEAST, V8, P535, DOI 10.1002/yea.320080705; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Neiman AM, 1997, GENETICS, V145, P637; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schwienbacher M, 2005, MED MYCOL, V43, P623, DOI 10.1080/13693780500089216; TAKAYANAGI T, 1994, CARBOHYD RES, V256, P149, DOI 10.1016/0008-6215(94)84234-5; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zanni E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-86	31	34	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15729	10.1371/journal.pone.0015729	http://dx.doi.org/10.1371/journal.pone.0015729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206755	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200046
J	Santander, J; Xin, W; Yang, Z; Curtiss, R				Santander, Javier; Xin, Wei; Yang, Zhao; Curtiss, Roy			The Aspartate-Semialdehyde Dehydrogenase of Edwardsiella ictaluri and Its Use as Balanced-Lethal System in Fish Vaccinology	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM VACCINE; RECOMBINANT PNEUMOCOCCAL PSPA; INDISPENSABLE AMINO-ACIDS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CHANNEL CATFISH; ENTERIC SEPTICEMIA; STREPTOCOCCUS-MUTANS; STABLE MAINTENANCE; IMMUNE-RESPONSES	asdA mutants of Gram-negative bacteria have an obligate requirement for diaminopimelic acid (DAP), which is an essential constituent of the peptidoglycan layer of the cell wall of these organisms. In environments deprived of DAP, i.e., animal tissues, they will undergo lysis. Deletion of the asdA gene has previously been exploited to develop antibiotic-sensitive strains of live attenuated recombinant bacterial vaccines. Introduction of an Asd(+) plasmid into a Delta asdA mutant makes the bacterial strain plasmid-dependent. This dependence on the Asd(+) plasmid vector creates a balanced-lethal complementation between the bacterial strain and the recombinant plasmid. E. ictaluri is an enteric Gram-negative fish pathogen that causes enteric septicemia in catfish. Because E. ictaluri is a nasal/oral invasive intracellular pathogen, this bacterium is a candidate to develop a bath/oral live (r) under bar ecombinant (a) under bar ttenuated (E) under bar dwardsiella (v) under bar accine (RAEV) for the catfish aquaculture industry. As a first step to develop an antibiotic-sensitive RAEV strain, we characterized and deleted the E. ictaluri asdA gene. E. ictaluri Delta asdA01 mutants exhibit an absolute requirement for DAP to grow. The asdA gene of E. ictaluri was complemented by the asdA gene from Salmonella. Several Asd(+) expression vectors with different origins of replication were transformed into E. ictaluri Delta asdA01. Asd(+) vectors were compatible with the pEI1 and pEI2 E. ictaluri native plasmids. The balanced-lethal system was satisfactorily evaluated in vivo. Recombinant GFP, PspA, and LcrV proteins were synthesized by E. ictaluri Delta asdA01 harboring Asd(+) plasmids. Here we constructed a balanced-lethal system, which is the first step to develop an antibiotic-sensitive RAEV for the aquaculture industry.	[Santander, Javier; Xin, Wei; Yang, Zhao; Curtiss, Roy] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Yang, Zhao] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Arizona State University; Arizona State University-Tempe; East China University of Science & Technology	Santander, J (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Santander, Javier/AAU-9423-2020		United States Deparment of Agriculture (USDA) [CRIS-ARZR-2009-01801]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile	United States Deparment of Agriculture (USDA)(United States Department of Agriculture (USDA)); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by United States Deparment of Agriculture (USDA) grant CRIS-ARZR-2009-01801 and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Gestion Propia Fellowship, Chile.	Anderson D. P., 1984, FISH IMMUNOLOGY, P110; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BRANGER CG, 2010, VACCINE IN PRESS; Branger CG, 2007, ADV EXP MED BIOL, V603, P387; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P45, DOI 10.1099/00207713-34-1-45; BurnsKeliher LL, 1997, J BACTERIOL, V179, P3604, DOI 10.1128/jb.179.11.3604-3612.1997; CARDINEAU GA, 1987, J BIOL CHEM, V262, P3344; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; CURTISS R, 1965, J BACTERIOL, V89, P28, DOI 10.1128/JB.89.1.28-40.1965; CURTISS RI, 2007, INDUCTION HOST IMMUN; DUPREE HK, 1970, T AM FISH SOC, V99, P90, DOI 10.1577/1548-8659(1970)99<90:AAEFTG>2.0.CO;2; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Fernandez DH, 2001, PLASMID, V45, P52, DOI 10.1006/plas.2000.1499; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HALVER JE, 1960, J NUTR, V72, P340, DOI 10.1093/jn/72.3.340; HALVER JE, 1957, J NUTR, V63, P95, DOI 10.1093/jn/63.1.95; Harb OS, 1998, INFECT IMMUN, V66, P1898, DOI 10.1128/IAI.66.5.1898-1903.1998; HAWKE JP, 1981, INT J SYST BACTERIOL, V31, P396, DOI 10.1099/00207713-31-4-396; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; JAGUSZTYNKRYNICKA EK, 1982, J GEN MICROBIOL, V128, P1135; Kang HY, 2003, FEMS IMMUNOL MED MIC, V37, P99, DOI 10.1016/S0928-8244(03)00063-4; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lawrence ML, 2001, J AQUAT ANIM HEALTH, V13, P291, DOI 10.1577/1548-8667(2001)013&lt;0291:PAVOAT&gt;2.0.CO;2; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; Li MH, 1998, AQUACULTURE, V163, P297, DOI 10.1016/S0044-8486(98)00239-7; Maurer KJ, 2001, J AQUAT ANIM HEALTH, V13, P163, DOI 10.1577/1548-8667(2001)013&lt;0163:EAOOAD&gt;2.0.CO;2; MAZID MA, 1978, B JPN SOC SCI FISH, V44, P739; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; NOSE T, 1974, B JPN SOC SCI FISH, V40, P903; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; Russo R, 2009, FISH SHELLFISH IMMUN, V26, P543, DOI 10.1016/j.fsi.2009.02.011; Sambrook J, 2001, MOL CLONING LAB MANU; Santander J, 2007, INFECT IMMUN, V75, P1382, DOI 10.1128/IAI.00888-06; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shi HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011142; Shoemaker CA, 1999, AQUACULTURE, V176, P189, DOI 10.1016/S0044-8486(99)00116-7; Shoemaker CA, 2007, VACCINE, V25, P1126, DOI 10.1016/j.vaccine.2006.09.055; Shoemaker CA, 2009, J WORLD AQUACULT SOC, V40, P573, DOI 10.1111/j.1749-7345.2009.00279.x; Thune RL, 2007, APPL ENVIRON MICROB, V73, P7934, DOI 10.1128/AEM.01115-07; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Viola RE, 2008, ACTA CRYSTALLOGR D, V64, P321, DOI 10.1107/S0907444907068552; VOGEL HJ, 1959, P NATL ACAD SCI USA, V45, P1717, DOI 10.1073/pnas.45.12.1717; Walakira JK, 2008, J APPL MICROBIOL, V105, P2133, DOI 10.1111/j.1365-2672.2008.03933.x; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; WIENTJES FB, 1985, J BACTERIOL, V164, P331, DOI 10.1128/JB.164.1.331-337.1985; Williams ML, 2005, VET MICROBIOL, V108, P281, DOI 10.1016/j.vetmic.2005.04.017; Williams ML, 2003, J AQUAT ANIM HEALTH, V15, P264, DOI 10.1577/H03-051.1; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Xin W, 2008, INFECT IMMUN, V76, P3241, DOI 10.1128/IAI.01623-07	61	19	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15944	10.1371/journal.pone.0015944	http://dx.doi.org/10.1371/journal.pone.0015944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209920	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200076
J	Dube, DH; Li, B; Greenblatt, EJ; Nimer, S; Raymond, AK; Kohler, JJ				Dube, Danielle H.; Li, Bin; Greenblatt, Ethan J.; Nimer, Sadeieh; Raymond, Amanda K.; Kohler, Jennifer J.			A Two-Hybrid Assay to Study Protein Interactions within the Secretory Pathway	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; LINKED OLIGOSACCHARIDES; CRYSTAL-STRUCTURE; OUTER CHAIN; IN-VIVO; YEAST; GLYCOSYLATION; SYSTEM; GENE	Interactions of transcriptional activators are difficult to study using transcription-based two-hybrid assays due to potent activation resulting in false positives. Here we report the development of the Golgi two-hybrid (G2H), a method that interrogates protein interactions within the Golgi, where transcriptional activators can be assayed with negligible background. The G2H relies on cell surface glycosylation to report extracellularly on protein-protein interactions occurring within the secretory pathway. In the G2H, protein pairs are fused to modular domains of the reporter glycosyltransferase, Och1p, and proper cell wall formation due to Och1p activity is observed only when a pair of proteins interacts. Cells containing interacting protein pairs are identified by selectable phenotypes associated with Och1p activity and proper cell wall formation: cells that have interacting proteins grow under selective conditions and display weak wheat germ agglutinin (WGA) binding by flow cytometry, whereas cells that lack interacting proteins display stunted growth and strong WGA binding. Using this assay, we detected the interaction between transcription factor MyoD and its binding partner Id2. Interfering mutations along the MyoD: Id2 interaction interface ablated signal in the G2H assay. Furthermore, we used the G2H to detect interactions of the activation domain of Gal4p with a variety of binding partners. Finally, selective conditions were used to enrich for cells encoding interacting partners. The G2H detects protein-protein interactions that cannot be identified via traditional two-hybrid methods and should be broadly useful for probing previously inaccessible subsets of the interactome, including transcriptional activators and proteins that traffic through the secretory pathway.	[Dube, Danielle H.] Bowdoin Coll, Dept Chem & Biochem, Brunswick, ME 04011 USA; [Dube, Danielle H.; Greenblatt, Ethan J.; Raymond, Amanda K.; Kohler, Jennifer J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Li, Bin; Nimer, Sadeieh; Kohler, Jennifer J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Greenblatt, Ethan J.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Bowdoin College; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Dube, DH (corresponding author), Bowdoin Coll, Dept Chem & Biochem, Brunswick, ME 04011 USA.	Jennifer.Kohler@UTSouthwestern.edu	Kohler, Jennifer J./B-6589-2009	Kohler, Jennifer J./0000-0001-5373-3329; Raymond, Amanda/0000-0001-8284-1265; Greenblatt, Ethan/0000-0002-3805-0113	Stanford Office of Technology Licensing; National Science Foundation [CAREER-MCB 0834336]; Welch Foundation [I-1686]; Stanford University; University of Texas Southwestern Medical Center	Stanford Office of Technology Licensing(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Stanford University(Stanford University); University of Texas Southwestern Medical Center	This work was supported by grants from the Stanford Office of Technology Licensing, the National Science Foundation (CAREER-MCB 0834336), the Welch Foundation (I-1686), a Walter and Idun Berry Postdoctoral Fellowship (Stanford University) to D.H.D., and a Bing Fellowship (Stanford University) to A.K.R. Additional funds were supplied by Stanford University and the University of Texas Southwestern Medical Center. J. J. K. is an Alfred P. Sloan Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo DW, 2004, NAT BIOTECHNOL, V22, P888, DOI 10.1038/nbt985; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hennecke F, 2005, PROTEIN ENG DES SEL, V18, P477, DOI 10.1093/protein/gzi053; HILL K, 1992, GENETICS, V130, P273; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim SY, 2004, MOL BIOTECHNOL, V27, P1, DOI 10.1385/MB:27:1:01; Kohler JJ, 2004, CHEMBIOCHEM, V5, P1455, DOI 10.1002/cbic.200400156; Kohler JJ, 2003, CHEM BIOL, V10, P1303, DOI 10.1016/j.chembiol.2003.11.018; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Melcher K, 2000, J MOL BIOL, V301, P1097, DOI 10.1006/jmbi.2000.4034; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang W, 1996, EUR J CELL BIOL, V71, P53; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723	37	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15648	10.1371/journal.pone.0015648	http://dx.doi.org/10.1371/journal.pone.0015648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209940	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500034
J	Lajoie, P; Snapp, EL				Lajoie, Patrick; Snapp, Erik Lee			Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INTRANUCLEAR NEURONAL INCLUSIONS; AMYLOID-LIKE FIBRILS; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASES; TRANSLATIONAL DIFFUSION; NEUROLOGICAL PHENOTYPE; EXPANSION PROTEINS; MAMMALIAN-CELLS	Background: Aggregation and cytotoxicity of mutant proteins containing an expanded number of polyglutamine (polyQ) repeats is a hallmark of several diseases, including Huntington's disease (HD). Within cells, mutant Huntingtin (mHtt) and other polyglutamine expansion mutant proteins exist as monomers, soluble oligomers, and insoluble inclusion bodies (IBs). Determining which of these forms constitute a toxic species has proven difficult. Recent studies support a role for IBs as a cellular coping mechanism to sequester levels of potentially toxic soluble monomeric and oligomeric species of mHtt. Methodology/Principal Findings: When fused to a fluorescent reporter (GFP) and expressed in cells, the soluble monomeric and oligomeric polyglutamine species are visually indistinguishable. Here, we describe two complementary biophysical fluorescence microscopy techniques to directly detect soluble polyglutamine oligomers (using Httexon 1 or Htt(ex1)) and monitor their fates in live cells. Photobleaching analyses revealed a significant reduction in the mobilities of mHtt ex1 variants consistent with their incorporation into soluble microcomplexes. Similarly, when fused to split-GFP constructs, both wildtype and mHtt(ex1) formed oligomers, as evidenced by the formation of a fluorescent reporter. Only the mHtt(ex1) split-GFP oligomers assembled into IBs. Both FRAP and split-GFP approaches confirmed the ability of mHtt(ex1) to bind and incorporate wildtype Htt into soluble oligomers. We exploited the irreversible binding of split-GFP fragments to forcibly increase levels of soluble oligomeric mHtt(ex1). A corresponding increase in the rate of IBs formation and the number formed was observed. Importantly, higher levels of soluble mHtt(ex1) oligomers significantly correlated with increased mutant cytotoxicity, independent of the presence of IBs. Conclusions/Significance: Our study describes powerful and sensitive tools for investigating soluble oligomeric forms of expanded polyglutamine proteins, and their impact on cell viability. Moreover, these methods should be applicable for the detection of soluble oligomers of a wide variety of aggregation prone proteins.	[Lajoie, Patrick; Snapp, Erik Lee] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Lajoie, P (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	erik-lee.snapp@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Lajoie, Patrick/0000-0002-1614-176X	CHDI; NIA [R21 1R21AG032544-01]; NIGMS [RO1GM086530-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	CHDI; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by an Early Discovery Initiative grant from CHDI to ELS. In addition, ELS was an Ellison Medical Foundation New Scholar in Aging and is supported by NIA R21 1R21AG032544-01 and NIGMS RO1GM086530-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrio-Dupont M, 2000, BIOPHYS J, V78, P901, DOI 10.1016/S0006-3495(00)76647-1; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhola PD, 2009, J CELL SCI, V122, P4296, DOI 10.1242/jcs.055590; Brooks Elizabeth, 2004, V277, P103; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Cong SY, 2006, EXP NEUROL, V199, P257, DOI 10.1016/j.expneurol.2005.11.008; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goncalves SA, TRENDS BIOCH SCI, V35, P643; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Legleiter J, J BIOL CHEM; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Luo SQ, 2008, HUM MOL GENET, V17, P895, DOI 10.1093/hmg/ddm362; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Rubinsztein DC, 2006, EXP NEUROL, V199, P243, DOI 10.1016/j.expneurol.2006.03.006; Rubinsztein David C, 2003, Sci Aging Knowledge Environ, V2003, pPE26, DOI 10.1126/sageke.2003.37.pe26; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Villalobos Victor, 2008, V439, P339, DOI 10.1007/978-1-59745-188-8_23; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; WOUTERS FS, 2001, CURR PROTOC PROTEIN, pCH19	83	80	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15245	10.1371/journal.pone.0015245	http://dx.doi.org/10.1371/journal.pone.0015245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209946	Green Published, gold			2022-12-25	WOS:000285792500026
J	Belgiovine, C; Frapolli, R; Bonezzi, K; Chiodi, I; Favero, F; Mello-Grand, M; Dei Tos, AP; Giulotto, E; Taraboletti, G; D'Incalci, M; Mondello, C				Belgiovine, Cristina; Frapolli, Roberta; Bonezzi, Katiuscia; Chiodi, Ilaria; Favero, Francesco; Mello-Grand, Maurizia; Dei Tos, Angelo P.; Giulotto, Elena; Taraboletti, Giulia; D'Incalci, Maurizio; Mondello, Chiara			Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells	PLOS ONE			English	Article							RHO-GTPASES; IN-VIVO; INVASION; MIGRATION; MOTILITY; MECHANISMS; PLASTICITY; SARCOMA; ACTIVATION; MODES	Background: Mesenchymal and amoeboid movements are two important mechanisms adopted by cancer cells to invade the surrounding environment. Mesenchymal movement depends on extracellular matrix protease activity, amoeboid movement on the RhoA-dependent kinase ROCK. Cancer cells can switch from one mechanism to the other in response to different stimuli, limiting the efficacy of antimetastatic therapies. Methodology and Principal Findings: We investigated the acquisition and molecular regulation of the invasion capacity of neoplastically transformed human fibroblasts, which were able to induce sarcomas and metastases when injected into immunocompromised mice. We found that neoplastic transformation was associated with a change in cell morphology (from fibroblastic to polygonal), a reorganization of the actin cytoskeleton, a decrease in the expression of several matrix metalloproteases and increases in cell motility and invasiveness. In a three-dimensional environment, sarcomagenic cells showed a spherical morphology with cortical actin rings, suggesting a switch from mesenchymal to amoeboid movement. Accordingly, cell invasion decreased after treatment with the ROCK inhibitor Y27632, but not with the matrix protease inhibitor Ro 28-2653. The increased invasiveness of tumorigenic cells was associated with reduced expression of Rnd3 (also known as RhoE), a cellular inhibitor of ROCK. Indeed, ectopic Rnd3 expression reduced their invasive ability in vitro and their metastatic potential in vivo. Conclusions: These results indicate that, during neoplastic transformation, cells of mesenchymal origin can switch from a mesenchymal mode of movement to an amoeboid one. In addition, they point to Rnd3 as a possible regulator of mesenchymal tumor cell invasion and to ROCK as a potential therapeutic target for sarcomas.	[Belgiovine, Cristina; Chiodi, Ilaria; Mondello, Chiara] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Frapolli, Roberta; D'Incalci, Maurizio] Ist Ric Farmacol Mario Negri, Milan, Italy; [Bonezzi, Katiuscia; Taraboletti, Giulia] Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Favero, Francesco; Mello-Grand, Maurizia] Fdn Edo Elvo Tempia, Canc Genom Lab, Biella, Italy; [Dei Tos, Angelo P.] Osped Gen Treviso, Treviso, Italy; [Giulotto, Elena] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Pavia	Belgiovine, C (corresponding author), CNR, Ist Genet Mol, I-27100 Pavia, Italy.	mondello@igm.cnr.it	Frapolli, Roberta/AAA-6729-2020; Taraboletti, Giulia/J-4089-2018; Mondello, Chiara/B-8305-2015; Belgiovine, Cristina/E-4575-2015; Dei Tos, Angelo/AAN-3244-2020; D'Incalci, Maurizio/AAA-9021-2020	Frapolli, Roberta/0000-0003-2907-273X; Taraboletti, Giulia/0000-0001-8780-5001; Mondello, Chiara/0000-0002-8379-9246; Belgiovine, Cristina/0000-0002-6986-9594; Dei Tos, Angelo/0000-0002-1228-8940; D'Incalci, Maurizio/0000-0001-8784-1360; CHIODI, ILARIA/0000-0002-4734-4017; Favero, Francesco/0000-0003-3684-2659; GIULOTTO, ELENA/0000-0002-4705-2049	Fondazione Cariplo [2006-0734]	Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Fondazione Cariplo (grant 2006-0734). I.C. post-doctoral fellowship has been supported by Fondazione Cariplo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Deaglio S, 2007, BLOOD, V110, p244B; Farina KL, 1998, CANCER RES, V58, P2528; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; MICUDA S, CURR CANC DRUG TARGE, V10, P127; Molloy TJ, 2008, BREAST CANCER RES TR, V112, P297, DOI 10.1007/s10549-007-9872-5; Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Taraboletti G, 2004, EUR J CANCER, V40, P881, DOI 10.1016/j.ejca.2004.01.002; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Weinberg RA, 2008, CANCER CELL, V14, P283, DOI 10.1016/j.ccr.2008.09.009; Weinberg RA, 2008, APMIS, V116, P548, DOI 10.1111/j.1600-0463.2008.001168.x; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	47	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14154	10.1371/journal.pone.0014154	http://dx.doi.org/10.1371/journal.pone.0014154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21209796	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100032
J	Hamel, B; Monaghan-Benson, E; Rojas, RJ; Temple, BRS; Marston, DJ; Burridge, K; Sondek, J				Hamel, Brant; Monaghan-Benson, Elizabeth; Rojas, Rafael J.; Temple, Brenda R. S.; Marston, Daniel J.; Burridge, Keith; Sondek, John			SmgGDS Is a Guanine Nucleotide Exchange Factor That Specifically Activates RhoA and RhoC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; BOVINE BRAIN CYTOSOL; C-TERMINAL REGION; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SMALL GTPASES; RAS; MECHANISM; RAC1	SmgGDS is an atypical guanine nucleotide exchange factor (GEF) that promotes both cell proliferation and migration and is up-regulated in several types of cancer. SmgGDS has been previously shown to activate a wide variety of small GTPases, including the Ras family members Rap1a, Rap1b, and K-Ras, as well as the Rho family members Cdc42, Rac1, Rac2, RhoA, and RhoB. In contrast, here we show that SmgGDS exclusively activates RhoA and RhoC among a large panel of purified GTPases. Consistent with the well known properties of GEFs, this activation is catalytic, and SmgGDS preferentially binds to nucleotide-depleted RhoA relative to either GDP- or GTP gamma S-bound forms. However, mutational analyses indicate that SmgGDS utilizes a distinct exchange mechanism compared with canonical GEFs and in contrast to known GEFs requires RhoA to retain a polybasic region for activation. A homology model of SmgGDS highlights an electronegative surface patch and a highly conserved binding groove. Mutation of either area ablates the ability of SmgGDS to activate RhoA. Finally, the in vitro specificity of SmgGDS for RhoA and RhoC is retained in cells. Together, these results indicate that SmgGDS is a bona fide GEF that specifically activates RhoA and RhoC through a unique mechanism not used by other Rho family exchange factors.	[Rojas, Rafael J.; Marston, Daniel J.; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hamel, Brant; Temple, Brenda R. S.; Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Monaghan-Benson, Elizabeth; Burridge, Keith] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 4009 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM062299, R01-GM029860]; American Cancer Society [PF-09-119-01-CSM]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, R01GM062299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM062299 (to J. S.) and R01-GM029860 (to K. B.). This work was also supported by American Cancer Society Grant PF-09-119-01-CSM (to E. M.-B.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HIROYOSHI M, 1991, J BIOL CHEM, V266, P2962; HORI Y, 1991, ONCOGENE, V6, P515; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; ISOMURA M, 1990, BIOCHEM BIOPH RES CO, V169, P652, DOI 10.1016/0006-291X(90)90380-6; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	40	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191122	http://dx.doi.org/10.1074/jbc.M110.191122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21242305	Green Published, hybrid			2022-12-25	WOS:000289077500029
J	Kario, E; Amar, N; Elazar, Z; Navon, A				Kario, Edith; Amar, Nira; Elazar, Zvulun; Navon, Ami			A New Autophagy-related Checkpoint in the Degradation of an ERAD-M Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; HMG-COA REDUCTASE; CRYSTALLOID ENDOPLASMIC-RETICULUM; E3 UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; MOLECULAR CHAPERONES; MEMBRANE-PROTEIN	The endoplasmic reticulum (ER) harbors elaborate quality control mechanisms to ensure proper folding and post-translational modifications of polypeptides targeted to this organelle. Once an aberrant protein is detected, it is dislocated from the ER and routed to the proteasome for destruction. Autophagy has been recently implicated in the elevation of the ER stress response; however, the involvement of this pathway in selective removal of ER-associated degradation (ERAD) substrates has not been demonstrated. In the present study, we show that an ER membrane lesion, associated with the accumulation of the yeast ERAD-M substrate 6Myc-Hmg2p elicits the recruitment of Atg8 and elements of the cytosol to vacuole targeting (CVT) to the membrane, leading to attenuation in the degradation process. Deletion of peptide: N-glycanase (PNG1) stabilizes this association, a process accompanied by slowdown of 6MycHmg2p degradation. Truncation of the unstructured C-terminal 23 amino acids of 6Myc-Hmg2p rendered its degradation PNG1-independent and allowed its partial delivery to the vacuole in an autophagy-dependent manner. These findings demonstrate a new conduit for the selective vacuolar/lysosomal removal of ERAD misfolded proteins by an autophagy-related machinery acting concomitantly with the proteasome.	[Kario, Edith; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Amar, Nira; Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Elazar, Z (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	zvulun.elazar@weizmann.ac.il; ami.navon@weizmann.ac.il			Israel Science Foundation; Israeli Cancer Research Foundation; Weizmann Institute Minerva Center; Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development	Israel Science Foundation(Israel Science Foundation); Israeli Cancer Research Foundation; Weizmann Institute Minerva Center; Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	Supported in part by the Israel Science Foundation, the Israeli Cancer Research Foundation, and the Weizmann Institute Minerva Center. Incumbent of the Harold Korda Chair of Biology.; Incumbent of the Recanati career development chair of cancer research. Research in the laboratory of A. N. is supported by the Israel Science Foundation, the Minerva Foundation (Germany), the German-Israeli Foundation for Scientific Research and Development, and a special gift from Rolando Uziel.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jakob CA, 2001, EMBO REP, V2, P423; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stolz A, 2010, TRAFFIC, V11, P1363, DOI 10.1111/j.1600-0854.2010.01093.x; Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	80	11	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11479	11491		10.1074/jbc.M110.177618	http://dx.doi.org/10.1074/jbc.M110.177618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21228276	Green Published, hybrid			2022-12-25	WOS:000288797100059
J	Klaus-Heisen, D; Nurisso, A; Pietraszewska-Bogiel, A; Mbengue, M; Camut, S; Timmers, T; Pichereaux, C; Rossignol, M; Gadella, TWJ; Imberty, A; Lefebvre, B; Cullimore, JV				Klaus-Heisen, Doerte; Nurisso, Alessandra; Pietraszewska-Bogiel, Anna; Mbengue, Malick; Camut, Sylvie; Timmers, Ton; Pichereaux, Carole; Rossignol, Michel; Gadella, Theodorus W. J.; Imberty, Anne; Lefebvre, Benoit; Cullimore, Julie V.			Structure-Function Similarities between a Plant Receptor-like Kinase and the Human Interleukin-1 Receptor-associated Kinase-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDICAGO-TRUNCATULA; TYROSINE PHOSPHORYLATION; PROTEIN-KINASES; IRAK-4 KINASE; ACTIVATION; DOMAIN; GENE; AUTOPHOSPHORYLATION; COMPLEX; FAMILY	Phylogenetic analysis has previously shown that plant receptor-like kinases (RLKs) are monophyletic with respect to the kinase domain and share an evolutionary origin with the animal interleukin-1 receptor-associated kinase/Pellesoluble kinases. The lysin motif domain-containing receptorlike kinase-3 (LYK3) of the legume Medicago truncatula shows 33% amino acid sequence identity with human IRAK-4 over the kinase domain. Using the structure of this animal kinase as a template, homology modeling revealed that the plant RLK contains structural features particular to this group of kinases, including the tyrosine gatekeeper and the N-terminal extension alpha-helix B. Functional analysis revealed the importance of these conserved features for kinase activity and suggests that kinase activity is essential for the biological role of LYK3 in the establishment of the root nodule nitrogen-fixing symbiosis with rhizobia bacteria. The kinase domain of LYK3 has dual serine/threonine and tyrosine specificity, and mass spectrometry analysis identified seven serine, eight threonine, and one tyrosine residue as autophosphorylation sites in vitro. Three activation loop serine/threonine residues are required for biological activity, and molecular dynamics simulations suggest that Thr-475 is the prototypical phosphorylated residue that interacts with the conserved arginine in the catalytic loop, whereas Ser-471 and Thr-472 may be secondary sites. A threonine in the juxtamembrane region and two threonines in the C-terminal lobe of the kinase domain are important for biological but not kinase activity. We present evidence that the structure-function similarities that we have identified between LYK3 and IRAK-4 may be more widely applicable to plant RLKs in general.	[Klaus-Heisen, Doerte; Mbengue, Malick; Camut, Sylvie; Timmers, Ton; Lefebvre, Benoit; Cullimore, Julie V.] INRA, CNRS, Lab Plant Microbe Interact, F-31326 Castanet Tolosan, France; [Nurisso, Alessandra; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble 9, France; [Nurisso, Alessandra; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble 9, France; [Pietraszewska-Bogiel, Anna; Gadella, Theodorus W. J.] Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Pichereaux, Carole; Rossignol, Michel] Univ Toulouse, Inst Pharmacol & Biol Struct, Inst Federatif Rech, IFR40, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Amsterdam; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Cullimore, JV (corresponding author), INRA, CNRS, Lab Plant Microbe Interact, BP 52627, F-31326 Castanet Tolosan, France.	julie.cullimore@toulouse.inra.fr	Mbengue, Malick/G-4837-2012; lefebvre, benoit/G-2028-2012; Imberty, Anne/P-6451-2018	Mbengue, Malick/0000-0002-7723-7757; Lefebvre, Benoit/0000-0002-3810-605X; Pichereaux, Carole/0000-0002-7559-5358; Cullimore, Julie/0000-0001-8804-4849; Imberty, Anne/0000-0001-6825-9527; Gadella, Theodorus/0000-0002-7639-219X	European Community [MRTN-CT-2006-035546]; Fondation pour la Recherche Medicale; Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council [CR07003760]; French National Research Agency	European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council(Region Occitanie); French National Research Agency(French National Research Agency (ANR))	This work was supported in part by the European Community Marie Curie Research Training Network Programme Contract MRTN-CT-2006-035546 "NODPERCEPTION," French National Research Agency Contracts "NodBindsLysM" and "Sympasignal," Fondation pour la Recherche Medicale Contract "Grands Equipements," the Toulouse Midi-Pyrenees Genopole, and the Midi-Pyrenees Regional Council Grant CR07003760.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Catoira R, 2001, DEVELOPMENT, V128, P1507; Chen XW, 2010, J BIOL CHEM, V285, P10454, DOI 10.1074/jbc.M109.093427; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200	37	44	44	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11202	11210		10.1074/jbc.M110.186171	http://dx.doi.org/10.1074/jbc.M110.186171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21205819	Green Published, hybrid			2022-12-25	WOS:000288797100031
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Monoacylated Cellular Prion Protein Modifies Cell Membranes, Inhibits Cell Signaling, and Reduces Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SCRAPIE ISOFORM; CHOLESTEROL; DISEASE; PRP; ACCUMULATION; TRAFFICKING; RESISTANT	Prion diseases occur following the conversion of the cellular prion protein (PrPC) into a disease related, protease-resistant isoform (PrPSc). In these studies, a cell painting technique was used to introduce PrPC to prion-infected neuronal cell lines (ScGT1, ScN2a, or SMB cells). The addition of PrPC resulted in increased PrPSc formation that was preceded by an increase in the cholesterol content of cell membranes and increased activation of cytoplasmic phospholipase A(2) (cPLA(2)). In contrast, although PrPC lacking one of the two acyl chains from its glycosylphosphatidylinositol (GPI) anchor (PrPC-G-lyso-PI) bound readily to cells, it did not alter the amount of cholesterol in cell membranes, was not found within detergent-resistant membranes (lipid rafts), and did not activate cPLA(2). It remained within cells for longer than PrPC with a conventional GPI anchor and was not converted to PrPSc. Moreover, the addition of high amounts of PrPC-G-lyso-PI displaced cPLA(2) from PrPSc-containing lipid rafts, reduced the activation of cPLA(2), and reduced PrPSc formation in all three cell lines. In addition, ScGT1 cells treated with PrPC-G-lyso-PI did not transmit infection following intracerebral injection to mice. We propose that that the chemical composition of the GPI anchor attached to PrPC modified the local membrane microenvironments that control cell signaling, the fate of PrPC, and hence PrPSc formation. In addition, our observations raise the possibility that pharmacological modification of GPI anchors might constitute a novel therapeutic approach to prion diseases.	[Bate, Clive; Williams, Alun] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence.	Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GOCZE PM, 1992, ENDOCRINOLOGY, V131, P2972, DOI 10.1210/en.131.6.2972; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200	34	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8752	8758		10.1074/jbc.M110.186833	http://dx.doi.org/10.1074/jbc.M110.186833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212283	Green Published, hybrid			2022-12-25	WOS:000288247700006
J	Oh, MK; Park, HJ; Kim, NH; Park, SJ; Park, IY; Kim, IS				Oh, Mi-Kyung; Park, Hyo-Jung; Kim, Nam-Hoon; Park, Seon-Joo; Park, In-Yang; Kim, In-Sook			Hypoxia-inducible Factor-1 alpha Enhances Haptoglobin Gene Expression by Improving Binding of STAT3 to the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE-LIKE SITE; RESPONSE ELEMENT; DNA-BINDING; REGULATORY FACTOR; VEGF EXPRESSION; CELL-MIGRATION; JUNB PROMOTER; TUMOR-GROWTH; PROTEIN; IDENTIFICATION	Haptoglobin (Hp) is known to play a role in angiogenesis as well as in anti-inflammation. STAT3 is a major transcription factor for expression of human Hp. We investigated whether hypoxia-inducible factor-1 alpha (HIF-1 alpha), a key mediator of angiogenesis, participates in Hp gene expression. HIF-1 alpha overexpression by gene transfection or hypoxia augmented Hp transcription in HepG2 human hepatoma cells. Conversely, knockdown of HIF-1 alpha by specific siRNA transfection diminished Hp expression, although the level of STAT3 phosphorylation remained unchanged. A luciferase reporter assay using mutant Hp promoters demonstrated that two adjacent DNA elements, a STAT3-binding element (SBE) and a cAMP-response element (CRE)-like site in human Hp promoter - 120/ - 97, were required for HIF-1 alpha-stimulated transactivation of the Hp gene. HIF-1 alpha, STAT3, and p300/CBP were simultaneously bound to the SBE/CRE as a complex form. When HIF-1 alpha was knocked down, STAT3 binding to the SBE in the Hp promoter was attenuated. Our findings suggest that HIF-1 alpha assists STAT3 in strong binding to the proximal SBE in the Hp promoter. The CRE-like site located near the SBE may contribute to the formation of a stable complex of STAT3, HIF-1 alpha, and p300/CBP, which leads to maximum transcription of the Hp gene.	[Oh, Mi-Kyung; Park, Hyo-Jung; Kim, Nam-Hoon; Park, Seon-Joo; Kim, In-Sook] Catholic Univ Korea, Dept Med Lifesci, Coll Med, Seoul 137701, South Korea; [Park, In-Yang] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, IS (corresponding author), Catholic Univ Korea, Dept Med Lifesci, Coll Med, Seoul 137701, South Korea.	ikim@catholic.ac.kr		Park, Hyo-Jung/0000-0002-1601-7638	Korea Research Foundation from the Korean Government [KRF-2007-313-E00095]; Ministry of Health and Welfare, Republic of Korea [A050209]	Korea Research Foundation from the Korean Government; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2007-313-E00095 from the Korean Government and by Korea Health 21 R&D Project Grant A050209 from the Ministry of Health and Welfare, Republic of Korea.	Ahmed N, 2004, BRIT J CANCER, V91, P129, DOI 10.1038/sj.bjc.6601882; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BAUMANN H, 1994, BLOOD, V15, P764; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Dasqupta A, 2009, EUR J CANCER, V45, P677, DOI 10.1016/j.ejca.2008.11.027; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Gariboldi MB, 2010, BIOCHEM PHARMACOL, V80, P455, DOI 10.1016/j.bcp.2010.05.011; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grigorov I, 2000, MOL BIOL REP, V27, P81, DOI 10.1023/A:1007177605135; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Kim NH, 2007, IMMUNOLOGY, V122, P607, DOI 10.1111/j.1365-2567.2007.02679.x; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Kojima H, 1996, ONCOGENE, V12, P547; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; Lohr NL, 2005, AM J PHYSIOL-HEART C, V288, pH1389, DOI 10.1152/ajpheart.00938.2004; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; Park SJ, 2008, BRIT J PHARMACOL, V154, P1196, DOI 10.1038/bjp.2008.197; Park SJ, 2009, FEBS LETT, V583, P3235, DOI 10.1016/j.febslet.2009.09.014; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Ruas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	43	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8857	8865		10.1074/jbc.M110.150557	http://dx.doi.org/10.1074/jbc.M110.150557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224490	hybrid, Green Published			2022-12-25	WOS:000288247700016
J	Yu, YL; Chou, RH; Chen, LT; Shyu, WC; Hsieh, SC; Wu, CS; Zeng, HJ; Yeh, SP; Yang, DM; Hung, SC; Hung, MC				Yu, Yung-Luen; Chou, Ruey-Hwang; Chen, Ling-Tzu; Shyu, Woei-Cherng; Hsieh, Su-Ching; Wu, Chen-Shiou; Zeng, Hong-Jie; Yeh, Su-Peng; Yang, De-Ming; Hung, Shih-Chieh; Hung, Mien-Chie			EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BONE-MARROW; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; LIPID KINASE FAMILY; GROUP PROTEIN EZH2; INTRACEREBRAL TRANSPLANTATION; 4-PHOSPHATE 5-KINASE; POLYCOMB COMPLEXES; MOUSE DEVELOPMENT; PHOSPHATE KINASE; SKELETAL-MUSCLE	Enhancer of zeste homolog 2 (EZH2) regulates stem cells renewal, maintenance, and differentiation into different cell lineages including neuron. Changes in intracellular Ca2+ concentration play a critical role in the differentiation of neurons. However, whether EZH2 modulates intracellular Ca2+ signaling in regulating neuronal differentiation from human mesenchymal stem cells (hMSCs) still remains unclear. When hMSCs were treated with a Ca2+ chelator or a PLC inhibitor to block IP3-mediated Ca2+ signaling, neuronal differentiation was disrupted. EZH2 bound to the promoter region of PIP5K1C to suppress its transcription in proliferating hMSCs. Interestingly, knockdown of EZH2 enhanced the expression of PIP5K1C, which in turn increased the amount of PI(4,5)P-2, a precursor of IP3, and resulted in increasing the intracellular Ca2+ level, suggesting that EZH2 negatively regulates intracellular Ca2+ through suppression of PIP5K1C. Knockdown of EZH2 also enhanced hMSCs differentiation into functional neuron both in vitro and in vivo. In contrast, knockdown of PIP5K1C significantly reduced PI(4,5)P-2 contents and intracellular Ca2+ release in EZH2-silenced cells and resulted in the disruption of neuronal differentiation from hMSCs. Here, we provide the first evidence to demonstrate that after induction to neuronal differentiation, decreased EZH2 activates the expression of PIP5K1C to evoke intracellular Ca2+ signaling, which leads hMSCs to differentiate into functional neuron lineage. Activation of intracellular Ca2+ signaling by repressing or knocking down EZH2 might be a potential strategy to promote neuronal differentiation from hMSCs for application to neurological dysfunction diseases.	[Yu, Yung-Luen; Chou, Ruey-Hwang; Hsieh, Su-Ching; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 404, Taiwan; [Yeh, Su-Peng] China Med Univ Hosp, Div Hematol & Oncol, Dept Med, Taichung 404, Taiwan; [Yu, Yung-Luen; Zeng, Hong-Jie; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung 404, Taiwan; [Yu, Yung-Luen; Wu, Chen-Shiou] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung 404, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang; Chen, Ling-Tzu] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Stem Cell Lab, Dept Med Res & Educ Orthopaed & Traumatol, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Inst Pharmacol, Taipei 112, Taiwan; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Texas System; UTMD Anderson Cancer Center	Yu, YL (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.	ylyu@mail.cmu.edu.tw; mhung@mdanderson.org	Chou, Ruey-Hwang/K-8541-2013; Yang, De-Ming/AAW-9886-2020; Hung, Mien-Chie/ABD-5911-2021	Chou, Ruey-Hwang/0000-0002-2297-2180; Yang, De-Ming/0000-0002-6923-4855; Hung, Mien-Chie/0000-0003-4317-4740; Wu, Chen-Shiou/0000-0003-0791-1483	National Institutes of Health [R01 CA109311, P01 CA099031]; The University of Texas M.D. Anderson-China Medical University; Hospital Sister Institution; Cancer Center Research of Excellence [DOH-99-TDC-111-05, NSC-2632-B-039-001-MY3, NSC-2320-B-039-032-MY3, NSC-3111-B-039]; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas M.D. Anderson-China Medical University; Hospital Sister Institution; Cancer Center Research of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grants R01 CA109311 and P01 CA099031. This work was also supported by The University of Texas M.D. Anderson-China Medical University and Hospital Sister Institution Fund, Cancer Center Research of Excellence DOH-99-TDC-111-05 (to M. C. H.); NSC-2632-B-039-001-MY3 (to M. C. H.); NSC-2320-B-039-032-MY3 (to Y. L. Y.); and NSC-3111-B-039 (to M. C. H., and Y. L. Y.).	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Banerjee S, 2005, BIOESSAYS, V27, P1035, DOI 10.1002/bies.20298; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; de la Cruz CC, 2005, CHROMOSOMA, V114, P183, DOI 10.1007/s00412-005-0008-6; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; Hung SC, 2004, STEM CELLS, V22, P1321, DOI 10.1634/stemcells.2003-0176; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jackson M B, 1999, Adv Neurol, V79, P511; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	55	46	46	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9657	9667		10.1074/jbc.M110.185124	http://dx.doi.org/10.1074/jbc.M110.185124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216957	Green Published, hybrid			2022-12-25	WOS:000288247700090
J	Song, F; Zhang, X; Ren, XB; Zhu, P; Xu, J; Wang, L; Li, YF; Zhong, N; Ru, Q; Zhang, DW; Jiang, JL; Xia, B; Chen, ZN				Song, Fei; Zhang, Xin; Ren, Xiao-Bai; Zhu, Ping; Xu, Jing; Wang, Li; Li, Yi-Fei; Zhong, Nan; Ru, Qiang; Zhang, Da-Wei; Jiang, Jian-Li; Xia, Bin; Chen, Zhi-Nan			Cyclophilin A (CyPA) Induces Chemotaxis Independent of Its Peptidylprolyl Cis-Trans Isomerase Activity DIRECT BINDING BETWEEN CyPA AND THE ECTODOMAIN OF CD147	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOSPORINE-A BINDING; SIGNAL-TRANSDUCTION; CD147; ISOMERIZATION; CANCER; CATALYSIS; PROTEIN; CELLS; IDENTIFICATION; HAB18G/CD147	Cyclophilin A (CyPA) is a ubiquitously distributed peptidylprolyl cis-transisomerase (PPIase) that possesses diverse biological functions. Extracellular CyPA is a potent chemokine, which can directly induce leukocyte chemotaxis and contribute to the pathogenesis of inflammation-mediated diseases. Although it has been identified that the chemotaxis activity of CyPA is mediated through its cell surface signaling receptor CD147, the role of CyPA PPIase activity in this process is disputable, and the underlying molecular mechanism is still poorly understood. In this study, we present the first evidence that CyPA induces leukocyte chemotaxis through a direct binding with the ectodomain of CD147 (CD147(ECT)), independent of its PPIase activity. Although NMR study indicates that the CD147(ECT) binding site on CyPA overlaps with the PPIase active site, the PPIase inactive mutant CyPA(R55A) exhibits similar CD147(ECT) binding ability and chemotaxis activity to those of CyPAWT. Furthermore, we have identified three key residues of CyPA involved in CD147(ECT) binding and found that mutations H70A, T107A, and R69A result in similar levels of reduction in CD147(ECT) binding ability and chemotaxis activity for CyPA, without affecting the PPIase activity. Our findings indicate that there exists a novel mechanism for CyPA to regulate cellular signaling processes, shedding new light on its applications in drug development and providing a new targeting site for drug design.	[Ren, Xiao-Bai; Li, Yi-Fei; Xia, Bin] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ren, Xiao-Bai; Zhong, Nan; Xia, Bin] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Li, Yi-Fei; Xia, Bin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhu, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China; [Zhang, Da-Wei; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Xijing Hosp, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Zhang, Da-Wei; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Xijing Hosp, Dept Cell Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Peking University; Peking University; Peking University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Xia, B (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	binxia@pku.edu.cn; znchen@fmmu.edu.cn	Xu, Jing/AAX-7869-2020; Li, Yifei/GYA-2567-2022; Xia, Bin/O-1160-2016	Xu, Jing/0000-0002-2035-3482; Xia, Bin/0000-0002-2197-6403	National Natural Science Foundation of China [30900234]; 973 Program [2009CB521700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by Grant 30900234 from the National Natural Science Foundation of China and Grant 2009CB521700 from the 973 Program.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Calhoun CC, 2009, MOL CELL BIOCHEM, V320, P35, DOI 10.1007/s11010-008-9896-0; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; CLARDY J, 1995, P NATL ACAD SCI USA, V92, P56, DOI 10.1073/pnas.92.1.56; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Elbaz B, 2010, BIOCHEMISTRY-US, V49, P7634, DOI 10.1021/bi1008722; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hur S, 2002, J AM CHEM SOC, V124, P7303, DOI 10.1021/ja020222s; Ke HM, 2004, FRONT BIOSCI-LANDMRK, V9, P2285, DOI 10.2741/1396; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li M, 2006, CANCER-AM CANCER SOC, V106, P2284, DOI 10.1002/cncr.21862; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MOSS ML, 1992, J BIOL CHEM, V267, P22054; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; Obchoei S, 2009, MED SCI MONITOR, V15, pRA221; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Yang HR, 2007, BIOCHEM BIOPH RES CO, V361, P763, DOI 10.1016/j.bbrc.2007.07.085; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	40	51	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8197	8203		10.1074/jbc.C110.181347	http://dx.doi.org/10.1074/jbc.C110.181347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21245143	hybrid, Green Published			2022-12-25	WOS:000288013300050
J	Mori, T; Hirai, M; Kuroiwa, T; Miyagishima, S				Mori, Toshiyuki; Hirai, Makoto; Kuroiwa, Tsuneyoshi; Miyagishima, Shin-ya			The Functional Domain of GCS1-Based Gamete Fusion Resides in the Amino Terminus in Plant and Parasite Species	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLASMODIUM-BERGHEI; FERTILIZATION; CHLAMYDOMONAS; CELL; FERTILITY; ENDOSPERM; FUS1; GCS1	Fertilization is one of the most important processes in all organisms utilizing sexual reproduction. In a previous study, we succeeded in identifying a novel male gametic transmembrane protein GCS1 (GENERATIVE CELL SPECIFIC 1), also called HAP2 (HAPLESS 2) in the male-sterile Arabidopsis thaliana mutants, as a factor critical to gamete fusion in flowering plants. Interestingly, GCS1 is highly conserved among various eukaryotes covering plants, protists and invertebrates. Of these organisms, Chlamydomonas (green alga) and Plasmodium (malaria parasite) GCS1s similarly show male gametic expression and gamete fusion function. Since it is generally believed that protein factors controlling gamete fusion have rapidly evolved and different organisms utilize species-specific gamete fusion factors, GCS1 may be an ancient fertilization factor derived from the common ancestor of those organisms above. And therefore, its molecular structure and function are important to understanding the common molecular mechanics of eukaryotic fertilization. In this study, we tried to detect the central functional domain(s) of GCS1, using complementation assay of ArabidopsisGCS1 mutant lines expressing modified GCS1. As a result, the positively-charged C-terminal sequence of this protein is dispensable for gamete fusion, while the highly conserved N-terminal domain is critical to GCS1 function. In addition, in vitro fertilization assay of Plasmodium berghei (mouse malaria parasite) knock-in lines expressing partly truncated GCS1 showed similar results. Those findings above indicate that the extracellular N-terminus alone is sufficient for GCS1-based gamete fusion.	[Mori, Toshiyuki; Miyagishima, Shin-ya] RIKEN, Adv Sci Inst, Miyagishima Initiat Res Unit, Saitama, Japan; [Hirai, Makoto] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma, Japan; [Kuroiwa, Tsuneyoshi] Rikkyo Univ, Res Informat Ctr Extremophile, Coll Sci, Dept Life Sci, Tokyo 171, Japan	RIKEN; Gunma University; Rikkyo University	Mori, T (corresponding author), RIKEN, Adv Sci Inst, Miyagishima Initiat Res Unit, Saitama, Japan.	moritoshi@riken.jp	Mori, Toshiyuki/F-8488-2013	Miyagishima, Shin-ya/0000-0002-9111-0832; Berger, Frederic/0000-0002-3609-8260	Sumitomo Foundation [090356, 080354];  [21112008];  [22112519];  [21022044];  [20590426]; Grants-in-Aid for Scientific Research [21112008] Funding Source: KAKEN	Sumitomo Foundation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	1. Sumitomo Foundation to TM (090356) and MH (080354). http://www.sumitomo.or.jp/html/kiso/kisokagaku.htm 2. Grant-in-Aid for Scientific Research on Innovative Areas to T. M. (21112008) and M. H. (22112519). http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html 3. Grant-in-Aid for Scientific Research on Priority Areas to H. M. (21022044) http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html 4. Grant-in-Aid for Scientific Research (C) to H. M. (20590426) http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Chen Z, 2008, DEVELOPMENT, V135, P65, DOI 10.1242/dev.010108; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Ferris PJ, 1996, MOL BIOL CELL, V7, P1235, DOI 10.1091/mbc.7.8.1235; Frank AC, 2009, PLANT PHYSIOL, V151, P1390, DOI 10.1104/pp.109.144204; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; Hirai M, 2010, ACTA TROP, V114, P157, DOI 10.1016/j.actatropica.2009.08.005; Ingouff M, 2009, CURR BIOL, V19, pR19, DOI 10.1016/j.cub.2008.11.025; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Liu YJ, 2010, DEVELOPMENT, V137, P1473, DOI 10.1242/dev.044743; Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680; Suzuki G, 2009, PLANT CELL PHYSIOL, V50, P1857, DOI 10.1093/pcp/pcp142; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000882; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	25	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15957	10.1371/journal.pone.0015957	http://dx.doi.org/10.1371/journal.pone.0015957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209845	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900052
J	Zhang, L; Xiao, H; Karlan, S; Zhou, H; Gross, J; Elashoff, D; Akin, D; Yan, XM; Chia, D; Karlan, B; Wong, DT				Zhang, Lei; Xiao, Hua; Karlan, Scott; Zhou, Hui; Gross, Jenny; Elashoff, David; Akin, David; Yan, Xinmin; Chia, David; Karlan, Beth; Wong, David T.			Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer	PLOS ONE			English	Article							NIPPLE ASPIRATE FLUID; FLIGHT MASS-SPECTROMETRY; ANHYDRASE-IX EXPRESSION; GENE-EXPRESSION; CLINICAL UTILITY; DNA METHYLATION; GROWTH-FACTOR; WOMEN; MARKERS; SERUM	Background: A sensitive assay to identify biomarkers using non-invasively collected clinical specimens is ideal for breast cancer detection. While there are other studies showing disease biomarkers in saliva for breast cancer, our study tests the hypothesis that there are breast cancer discriminatory biomarkers in saliva using de novo discovery and validation approaches. This is the first study of this kind and no other study has engaged a de novo biomarker discovery approach in saliva for breast cancer detection. In this study, a case-control discovery and independent preclinical validations were conducted to evaluate the performance and translational utilities of salivary transcriptomic and proteomic biomarkers for breast cancer detection. Methodology/Principal Findings: Salivary transcriptomes and proteomes of 10 breast cancer patients and 10 matched controls were profiled using Affymetrix HG-U133-Plus-2.0 Array and two-dimensional difference gel electrophoresis (2D-DIGE), respectively. Preclinical validations were performed to evaluate the discovered biomarkers in an independent sample cohort of 30 breast cancer patients and 63 controls using RT-qPCR (transcriptomic biomarkers) and quantitative protein immunoblot (proteomic biomarkers). Transcriptomic and proteomic profiling revealed significant variations in salivary molecular biomarkers between breast cancer patients and matched controls. Eight mRNA biomarkers and one protein biomarker, which were not affected by the confounding factors, were pre-validated, yielding an accuracy of 92% (83% sensitive, 97% specific) on the preclinical validation sample set. Conclusions: Our findings support that transcriptomic and proteomic signatures in saliva can serve as biomarkers for the non-invasive detection of breast cancer. The salivary biomarkers possess discriminatory power for the detection of breast cancer, with high specificity and sensitivity, which paves the way for prediction model validation study followed by pivotal clinical validation.	[Zhang, Lei; Xiao, Hua; Zhou, Hui; Akin, David; Yan, Xinmin; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhang, Lei; Xiao, Hua; Zhou, Hui; Akin, David; Yan, Xinmin; Wong, David T.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Karlan, Scott] Cedars Sinai Med Ctr, Saul & Joyce Brandman Breast Ctr, Los Angeles, CA 90048 USA; [Gross, Jenny; Karlan, Beth] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Elashoff, David] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Chia, David] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg Otolaryngol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Zhang, L (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	leizhang@ucla.edu; dtww@ucla.edu	Xiao, Hua/I-7429-2013; Lester, Jenny/B-5933-2012	Xiao, Hua/0000-0002-2831-0436; 	National Institutes of Health [UO1DE016275, R21CA126733]; California Breast Cancer Research [16IB-0004]; NATIONAL CANCER INSTITUTE [R21CA126733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170, U01DE016275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Institutes of Health (UO1DE016275 and R21CA126733) to DTW; and Innovative, Exploratory & Developmental Awards (IDEA) from California Breast Cancer Research Program (16IB-0004) to LZ. URLs: http://www.nih.gov and http://www.cbcrp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, BREAST CANC RES, V12, pR7; Abba MC, 2009, CANCER PREV RES, V2, P175, DOI 10.1158/1940-6207.CAPR-08-0104; Anderson KS, 2008, J PROTEOME RES, V7, P1490, DOI 10.1021/pr700804c; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Bigler LR, 2009, CLIN LAB MED, V29, P71, DOI 10.1016/j.cll.2009.01.004; Bigler LR, 2002, J ORAL PATHOL MED, V31, P421, DOI 10.1034/j.1600-0714.2002.00123.x; Brooks MN, 2008, MOL MED REP, V1, P375; Brown NM, 2006, BREAST CANCER RES TR, V97, P41, DOI 10.1007/s10549-005-9085-8; Buehring GC, 2006, BREAST CANCER RES TR, V98, P63, DOI 10.1007/s10549-005-9132-5; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cheang MCU, 2008, ANNU REV PATHOL-MECH, V3, P67, DOI 10.1146/annurev.pathmechdis.3.121806.151505; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Davis MA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1619; Drukier AK, 2006, J PROTEOME RES, V5, P1906, DOI 10.1021/pr0600834; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Gast MCW, 2009, INT J BIOL MARKER, V24, P130, DOI 10.1177/172460080902400302; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Jotwani AC, 2009, MOL DIAGN THER, V13, P349, DOI 10.2165/11318220-000000000-00000; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kuopio T, 1998, CANCER RES, V58, P432; Levenson VV, 2007, BBA-GEN SUBJECTS, V1770, P847, DOI 10.1016/j.bbagen.2007.01.017; Li JN, 2005, CLIN CANCER RES, V11, P8312, DOI 10.1158/1078-0432.CCR-05-1538; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Lonneborg A, 2009, EXPERT REV ANTICANC, V9, P1115, DOI [10.1586/era.09.31, 10.1586/ERA.09.31]; Lyakhov IG, 2008, NUCLEIC ACIDS RES, V36, P3828, DOI 10.1093/nar/gkn189; Martens JWM, 2009, FUTURE ONCOL, V5, P1245, DOI [10.2217/fon.09.89, 10.2217/FON.09.89]; Melnikov AA, 2008, J MOL DIAGN, V10, P93, DOI 10.2353/jmoldx.2008.070077; Mikhitarian K, 2005, CLIN CANCER RES, V11, P3697, DOI 10.1158/1078-0432.CCR-04-2164; Morris SR, 2007, CURR OPIN ONCOL, V19, P547, DOI 10.1097/CCO.0b013e3282f0ada3; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Navarro MA, 1997, BREAST CANCER RES TR, V42, P83, DOI 10.1023/A:1005755928831; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pawlik TM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-68; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Sauter ER, 2005, EXPERT REV MOL DIAGN, V5, P873, DOI 10.1586/14737159.5.6.873; Span PN, 2007, BRIT J CANCER, V96, P1309, DOI 10.1038/sj.bjc.6603715; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Streckfus C, 2005, Adv Dent Res, V18, P17; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Streckfus CF, 2006, J ORAL PATHOL MED, V35, P292, DOI 10.1111/j.1600-0714.2006.00427.x; Streckfus CF, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.1o834.x; Streckfus CF, 2008, CANCER INVEST, V26, P159, DOI 10.1080/07357900701783883; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vlahou Antonia, 2003, Clin Breast Cancer, V4, P203, DOI 10.3816/CBC.2003.n.026; Voskuil DW, 2004, BREAST CANCER RES TR, V84, P225, DOI 10.1023/B:BREA.0000019954.59130.d3; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhang L, 2009, MOL DIAGN THER, V13, P245, DOI 10.2165/11317160-000000000-00000	57	133	144	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15573	10.1371/journal.pone.0015573	http://dx.doi.org/10.1371/journal.pone.0015573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217834	gold, Green Published, Green Submitted			2022-12-25	WOS:000285838900022
J	Inoue, M; Yasuda, K; Uemura, H; Yasaka, N; Inoue, H; Sei, Y; Horikoshi, N; Fukuma, T				Inoue, Masahiro; Yasuda, Kouichi; Uemura, Haruki; Yasaka, Natsumi; Inoue, Hiroshi; Sei, Yoshitatsu; Horikoshi, Nobuo; Fukuma, Toshihide			Phosphorylation-Dependent Protein Interaction with Trypanosoma brucei 14-3-3 Proteins that Display Atypical Target Recognition	PLOS ONE			English	Article							14-3-3-PROTEINS; BINDING; ISOFORMS; CYTOKINESIS; SPECIFICITY; GENOME; KINASE; ZETA	Background: The 14-3-3 proteins are structurally conserved throughout eukaryotes and participate in protein kinase signaling. All 14-3-3 proteins are known to bind to evolutionally conserved phosphoserine-containing motifs (modes 1 and/or 2) with high affinity. In Trypanosoma brucei, 14-3-3I and II play pivotal roles in motility, cytokinesis and the cell cycle. However, none of the T. brucei 14-3-3 binding proteins have previously been documented. Methodology/Principal Findings: Initially we showed that T. brucei 14-3-3 proteins exhibit far lower affinity to those peptides containing RSxpSxP (mode 1) and RxY/FxpSxP (mode 2) (where x is any amino acid residue and pS is phosphoserine) than human 14-3-3 proteins, demonstrating the atypical target recognition by T. brucei 14-3-3 proteins. We found that the putative T. brucei protein phosphatase 2C (PP2c) binds to T. brucei 14-3-3 proteins utilizing its mode 3 motif (-pS/pTx(1-2)-COOH, where x is not Pro). We constructed eight chimeric PP2c proteins replacing its authentic mode 3 motif with potential mode 3 sequences found in Trypanosoma brucei genome database, and tested their binding. As a result, T. brucei 14-3-3 proteins interacted with three out of eight chimeric proteins including two with high affinity. Importantly, T. brucei 14-3-3 proteins co-immunoprecipitated with an uncharacterized full-length protein containing identified high-affinity mode 3 motif, suggesting that both proteins form a complex in vivo. In addition, a synthetic peptide derived from this mode 3 motif binds to T. brucei 14-3-3 proteins with high affinity. Conclusion/Significance: Because of the atypical target recognition of T. brucei 14-3-3 proteins, no 14-3-3-binding proteins have been successfully identified in T. brucei until now whereas over 200 human 14-3-3-binding proteins have been identified. This report describes the first discovery of the T. brucei 14-3-3-binding proteins and their binding motifs. The high-affinity phosphopeptide will be a powerful tool to identify novel T. brucei 14-3-3-binding proteins.	[Inoue, Masahiro; Yasuda, Kouichi; Yasaka, Natsumi; Inoue, Hiroshi; Fukuma, Toshihide] Kurume Univ, Sch Med, Dept Infect Med, Div Eukaryot Microbiol, Kurume, Fukuoka 830, Japan; [Uemura, Haruki] Nagasaki Univ, Inst Trop Med, Dept Protozool, Nagasaki 852, Japan; [Sei, Yoshitatsu] NIDDK, Gastroenterol Sect, Digest Dis Branch, Bethesda, MD USA; [Horikoshi, Nobuo] SW Texas State Univ, Div Mol Radiat Biol, Dept Radiat Oncol, Sch Med, Dallas, TX USA	Kurume University; Nagasaki University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Texas State University System; Texas State University San Marcos	Inoue, M (corresponding author), Kurume Univ, Sch Med, Dept Infect Med, Div Eukaryot Microbiol, Kurume, Fukuoka 830, Japan.	inouedna@med.kurume-u.ac.jp	Horikoshi, Nobuo/Y-8245-2019	Horikoshi, Nobuo/0000-0001-8464-8178	Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research [2009, 20590434]; Institute of Tropical Medicine, Nagasaki University [2008-20-D-2, 2009-21-E-8]; Ishibashi Foundation for the Promotion of Science	Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute of Tropical Medicine, Nagasaki University; Ishibashi Foundation for the Promotion of Science	This research was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 2009, 20590434, by the Cooperative Research Grant(s) (2008-20-D-2, 2009-21-E-8, 9) of the Institute of Tropical Medicine, Nagasaki University, and by a grant from the Ishibashi Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; DAS A, 1994, J CELL SCI, V107, P3477; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Inoue M, 2005, J BIOL CHEM, V280, P14085, DOI 10.1074/jbc.M412336200; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Manak MS, 2007, BIOCHEMISTRY-US, V46, P1055, DOI 10.1021/bi061366c; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wu M, 2006, ANAL BIOCHEM, V349, P186, DOI 10.1016/j.ab.2005.11.030; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe Michael B, 2004, Biochem J, V379, pe1, DOI 10.1042/BJ20040284	23	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15566	10.1371/journal.pone.0015566	http://dx.doi.org/10.1371/journal.pone.0015566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203569	Green Submitted, Green Published, gold			2022-12-25	WOS:000285576900032
J	Feng, M; Li, Z; Aau, M; Wong, CH; Yang, X; Yu, Q				Feng, M.; Li, Z.; Aau, M.; Wong, C. H.; Yang, X.; Yu, Q.			Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation	ONCOGENE			English	Article						Myc; miR-378; TOB2; cyclin D1	C-MYC; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; CANCER METASTASIS; MIR-200 FAMILY; E-CADHERIN; MICRORNA; TARGET; RAS; APOPTOSIS	The c-Myc transcription factor activates a cascade of downstream targets to form a complex transcriptional program that ultimately leads to cellular transformation. Although a large number of protein-encoding genes as well as non-coding RNAs were identified as Myc targets, only a few have been validated to be functionally important for c-Myc-driven transformation. Here, we identify a microRNA (miRNA), miR-378, as a novel target of the c-Myc oncoprotein that is able to cooperate with activated Ras or HER2 to promote cellular transformation. Mechanistically, miR-378 achieves this oncogenic effect, at least in part, by targeting and inhibiting the anti-proliferative BTG family member, TOB2, which is further elucidated as a candidate tumor suppressor to transcriptionally repress proto-oncogene cyclin D1. Therefore, our study identifies miR-378-TOB2-cyclin D1 as a functional module to mediate the cross talk between Myc and Ras signaling in cellular transformation. Oncogene (2011) 30, 2242-2251; doi:10.1038/onc.2010.602; published online 17 January 2011	[Feng, M.; Li, Z.; Aau, M.; Wong, C. H.; Yang, X.; Yu, Q.] ASTAR, Dept Canc Biol & Pharmacol, Genome Inst Singapore, Biopolis 138672, Singapore; [Yu, Q.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Yu, Q.] DUKE NUS Med Sch, Dept Canc & Stem Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Yu, Q (corresponding author), ASTAR, Dept Canc Biol & Pharmacol, Genome Inst Singapore, 60 Biopolis St, Biopolis 138672, Singapore.	yuq@gis.a-star.edu.sg	Yang, Xiaojing/G-9201-2012	Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology & Research (A*Star) of Singapore	Agency for Science, Technology & Research (A*Star) of Singapore(Agency for Science Technology & Research (A*STAR))	We thank Dr William Hahn for the HMLE and HMLER cells. This work was supported by Agency for Science, Technology & Research (A*Star) of Singapore.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuttler F, 2001, ONCOGENE, V20, P6084, DOI 10.1038/sj.onc.1204827; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Stacey D, 2002, CURR OPIN GENET DEV, V12, P44, DOI 10.1016/S0959-437X(01)00262-3; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	29	68	69	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	19					2242	2251		10.1038/onc.2010.602	http://dx.doi.org/10.1038/onc.2010.602			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21242960				2022-12-25	WOS:000290514600007
J	Lindsay, AJ; McCaffrey, MW				Lindsay, Andrew J.; McCaffrey, Mary W.			Myosin Va Is Required for P Body but Not Stress Granule Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC PROCESSING BODIES; MESSENGER-RNA TRANSLATION; MOTOR PROTEIN; COMPLEX; TRANSPORT; MICROTUBULE; CELLS; DECAY; GENE; IDENTIFICATION	In the present study we demonstrate an association between mammalian myosin Va and cytoplasmic P bodies, microscopic ribonucleoprotein granules that contain components of the 5'-3' mRNA degradation machinery. Myosin Va colocalizes with several P body markers and its RNAi-mediated knockdown results in the disassembly of P bodies. Overexpression of a dominant-negative mutant of myosin Va reduced the motility of P bodies in living cells. Co-immunoprecipitation experiments demonstrate that myosin Va physically associates with eIF4E, an mRNA binding protein that localizes to P bodies. In contrast, we find that myosin Va does not play a role in stress granule formation. Stress granules are ribonucleoprotein structures that are involved in translational silencing and are spatially, functionally, and compositionally linked to P bodies. Myosin Va is found adjacent to stress granules in stressed cells but displays minimal localization within stress granules, and myosin Va knockdown has no effect on stress granule assembly or disassembly. Combined with recently published reports demonstrating a role for Drosophila and mammalian class V myosins in mRNA transport and the involvement of the yeast myosin V orthologue Myo2p in P body assembly, our results provide further evidence that the class V myosins serve an important role in the transport and turnover of mRNA.	[Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland	University College Cork	Lindsay, AJ (corresponding author), Inst Curie, CNRS, Unite Mixte Rech 144, Lab Mol Mechanisms Intracellular Transport, F-75248 Paris 05, France.	Andrew.Lindsay@curie.fr	Lindsay, Andrew J/P-9778-2017	Lindsay, Andrew J/0000-0001-9693-7022	Health Research Board, Ireland [PD/2005/25]; Health Research Board/Marie-Curie [HRB MCPD/2009/6]; SFI [05/IN.3/B859]	Health Research Board, Ireland; Health Research Board/Marie-Curie(European Commission); SFI(Science Foundation Ireland)	This work was supported by Health Research Board, Ireland Career Development Fellowship PD/2005/25 and Joint Health Research Board/Marie-Curie Postdoctoral Mobility Fellowship HRB MCPD/2009/6 (to A. J. L.) and SFI Programme Grant 05/IN.3/B859 (to M. W. M.).	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Anderson P, 2005, DEV CELL, V9, P311, DOI 10.1016/j.devcel.2005.08.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gonsalvez GB, 2004, J BIOL CHEM, V279, P46286, DOI 10.1074/jbc.M406086200; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sloane JA, 2007, J NEUROSCI, V27, P11366, DOI 10.1523/JNEUROSCI.2326-07.2007; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	49	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11519	11528		10.1074/jbc.M110.182808	http://dx.doi.org/10.1074/jbc.M110.182808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21245139	Green Published, hybrid			2022-12-25	WOS:000288797100062
J	Shakibaei, M; Buhrmann, C; Mobasheri, A				Shakibaei, Mehdi; Buhrmann, Constanze; Mobasheri, Ali			Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-kappa B Ligand (RANKL) Activation of NF-kappa B Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTES IN-VITRO; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; LIFE-SPAN; ACETYLATION; MICE; TRANSCRIPTION; OSTEOPOROSIS; MECHANISMS; TRANCE/RANKL	Resveratrol is a polyphenolic phytoestrogen that has been shown to exhibit potent anti-oxidant, anti-inflammatory, and anti-catabolic properties. Increased osteoclastic and decreased osteoblastic activities result in bone resorption and loss of bone mass. These changes have been implicated in pathological processes in rheumatoid arthritis and osteoporosis. Receptor activator of NF-kappa B ligand (RANKL), a member of the TNF superfamily, is a major mediator of bone loss. In this study, we investigated the effects of resveratrol on RANKL during bone morphogenesis in high density bone cultures in vitro. Untreated bone-derived cell cultures produced well organized bone-like structures with a bone-specific matrix. Treatment with RANKL induced formation of tartrate-resistant acid phosphatase-positive multinucleated cells that exhibited morphological features of osteoclasts. RANKL induced NF-kappa B activation, whereas pretreatment with resveratrol completely inhibited this activation and suppressed the activation of I kappa B alpha kinase and I kappa B alpha phosphorylation and degradation. RANKL up-regulated p300 (a histone acetyltransferase) expression, which, in turn, promoted acetylation of NF-kappa B. Resveratrol inhibited RANKL-induced acetylation and nuclear translocation of NF-kappa B in a time-and concentration-dependent manner. In addition, activation of Sirt-1 (a histone deacetylase) by resveratrol induced Sirt-1-p300 association in bone-derived and preosteoblastic cells, leading to deacetylation of RANKL-induced NF-kappa B, inhibition of NF-kappa B transcriptional activation, and osteoclastogenesis. Co-treatment with resveratrol activated the bone transcription factors Cbfa-1 and Sirt-1 and induced the formation of Sirt-1-Cbfa-1 complexes. Overall, these results demonstrate that resveratrol-activated Sirt-1 plays pivotal roles in regulating the balance between the osteoclastic versus osteoblastic activity result in bone formation in vitro thereby highlighting its therapeutic potential for treating osteoporosis and rheumatoid arthritis-related bone loss.	[Shakibaei, Mehdi; Buhrmann, Constanze] Univ Munich, Musculoskeletal Res Grp, Inst Anat, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Musculoskeletal Res Grp, Div Vet Med, Sch Vet Med & Sci, Loughborough LE12 5RD, England	University of Munich; University of Nottingham	Shakibaei, M (corresponding author), Univ Munich, Musculoskeletal Res Grp, Inst Anat, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Mobasheri, Ali/D-5770-2011	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Mobasheri, Ali/0000-0001-6261-1286; Buhrmann, Constanze/0000-0002-0786-0463	Wellcome Trust (United Kingdom)	Wellcome Trust (United Kingdom)(Wellcome Trust)	Supported by the Wellcome Trust (United Kingdom).	Aggarwal BB, 2004, ANN NY ACAD SCI, V1030, P434, DOI 10.1196/annals.1329.054; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JANOWSKAWIECZOREK A, 1991, BLOOD, V77, P1796; Jimi E, 1999, J IMMUNOL, V163, P434; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Leiro J, 2004, DIS AQUAT ORGAN, V59, P171, DOI 10.3354/dao059171; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; LOBO RA, 1995, AM J OBSTET GYNECOL, V173, P982, DOI 10.1016/0002-9378(95)90247-3; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; ROBINSON RA, 1979, JOHNS HOPKINS MED J, V145, P10; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P463; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	62	157	173	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11492	11505		10.1074/jbc.M110.198713	http://dx.doi.org/10.1074/jbc.M110.198713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21239502	Green Published, hybrid			2022-12-25	WOS:000288797100060
J	Schmidt, J; Smith, NJ; Christiansen, E; Tikhonova, IG; Grundmann, M; Hudson, BD; Ward, RJ; Drewke, C; Milligan, G; Kostenis, E; Ulven, T				Schmidt, Johannes; Smith, Nicola J.; Christiansen, Elisabeth; Tikhonova, Irina G.; Grundmann, Manuel; Hudson, Brian D.; Ward, Richard J.; Drewke, Christel; Milligan, Graeme; Kostenis, Evi; Ulven, Trond			Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists IDENTIFICATION OF THE STRUCTURAL AND CHEMICAL REQUIREMENTS FOR SELECTIVE ACTIVATION OF FFA2 VERSUS FFA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; NICOTINIC-ACID; FUNCTIONAL-CHARACTERIZATION; LIGAND EFFICIENCY; 7TM RECEPTORS; PUMA-G; BINDING; PHARMACOLOGY; EFFICACY	Free fatty acid receptor 2 (FFA2; GPR43) is a G protein-coupled seven-transmembrane receptor for short-chain fatty acids (SCFAs) that is implicated in inflammatory and metabolic disorders. The SCFA propionate has close to optimal ligand efficiency for FFA2 and can hence be considered as highly potent given its size. Propionate, however, does not discriminate between FFA2 and the closely related receptor FFA3 (GPR41). To identify FFA2-selective ligands and understand the molecular basis for FFA2 selectivity, a targeted library of small carboxylic acids was examined using holistic, label-free dynamic mass redistribution technology for primary screening and the receptor-proximal G protein [S-35] guanosine 5'-(3-O-thio) triphosphate activation, inositol phosphate, and cAMP accumulation assays for hit confirmation. Structure-activity relationship analysis allowed formulation of a general rule to predict selectivity for small carboxylic acids at the orthosteric binding site where ligands with substituted sp(3)-hybridized alpha-carbons preferentially activate FFA3, whereas ligands with sp(2)- or sp-hybridized alpha-carbons prefer FFA2. The orthosteric binding mode was verified by site-directed mutagenesis: replacement of orthosteric site arginine residues by alanine in FFA2 prevented ligand binding, and molecular modeling predicted the detailed mode of binding. Based on this, selective mutation of three residues to their non-conserved counterparts in FFA3 was sufficient to transfer FFA3 selectivity to FFA2. Thus, selective activation of FFA2 via the orthosteric site is achievable with rather small ligands, a finding with significant implications for the rational design of therapeutic compounds selectively targeting the SCFA receptors.	[Smith, Nicola J.; Hudson, Brian D.; Ward, Richard J.; Milligan, Graeme] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Schmidt, Johannes; Grundmann, Manuel; Drewke, Christel; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, D-53115 Bonn, Germany; [Christiansen, Elisabeth; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Glasgow; University of Bonn; University of Southern Denmark; Queens University Belfast	Milligan, G (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk; kostenis@uni-bonn.de; ulven@ifk.sdu.dk	Hudson, B. D./H-4845-2013; Milligan, Graeme/F-9426-2011; Rexen Ulven, Elisabeth/S-2026-2017; Ulven, Trond/H-5500-2015	Hudson, B. D./0000-0001-7059-0091; Milligan, Graeme/0000-0002-6946-3519; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Ulven, Trond/0000-0002-8135-1755; Smith, Nicola J/0000-0002-7247-9562	Danish Council for Independent Research Technology and Production [09-070364]; Danish Medical Research Council; Wellcome Trust [089600/Z/09/Z]	Danish Council for Independent Research Technology and Production(Det Frie Forskningsrad (DFF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Danish Council for Independent Research Technology and Production Grant 09-070364, the Danish Medical Research Council, and Wellcome Trust Grant 089600/Z/09/Z.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Coyne AG, 2010, CURR OPIN CHEM BIOL, V14, P299, DOI 10.1016/j.cbpa.2010.02.010; de Kloe GE, 2009, DRUG DISCOV TODAY, V14, P630, DOI 10.1016/j.drudis.2009.03.009; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Kenakin T, 2008, COMB CHEM HIGH T SCR, V11, P337, DOI 10.2174/138620708784534824; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2010, NAT BIOTECHNOL, V28, P928, DOI 10.1038/nbt0910-928; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Rocheville M, 2009, CURR OPIN PHARMACOL, V9, P643, DOI 10.1016/j.coph.2009.06.015; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; *SCHROD LLC, 2009, GLID VERS 5; *SCHROD LLC, 2009, MAESTR 8 5 VERS 5 5; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Smith NJ, 2011, MOL CELL ENDOCRINOL, V331, P241, DOI 10.1016/j.mce.2010.07.009; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	42	86	88	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10628	10640		10.1074/jbc.M110.210872	http://dx.doi.org/10.1074/jbc.M110.210872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21220428	Green Published, hybrid			2022-12-25	WOS:000288547000077
J	Buntru, A; Kopp, K; Voges, M; Frank, R; Bachmann, V; Hauck, CR				Buntru, Alexander; Kopp, Kathrin; Voges, Maike; Frank, Ronald; Bachmann, Verena; Hauck, Christof R.			Phosphatidylinositol 3 '-Kinase Activity Is Critical for Initiating the Oxidative Burst and Bacterial Destruction during CEACAM3-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; CARCINOEMBRYONIC ANTIGENS CD66; GONOCOCCAL OPACITY PROTEINS; NEISSERIA-GONORRHOEAE; ADHESION MOLECULE; EPITHELIAL-CELLS; NADPH OXIDASE; OPA PROTEINS; PATHOGENIC NEISSERIAE; EXCHANGE FACTOR	Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) is an immunoglobulin-related receptor expressed on human granulocytes. CEACAM3 functions as a single chain phagocytotic receptor recognizing Gram-negative bacteria such as Neisseria gonorrhoeae, which possess CEACAM-binding adhesins on their surface. The cytoplasmic domain of CEACAM3 contains an immunoreceptor tyrosine-based activation motif (ITAM)-like sequence that is phosphorylated upon receptor engagement. Here we show that the SH2 domains of the regulatory subunit of phosphatidylinositol 3'-kinase (PI3K) bind to tyrosine residue 230 of CEACAM3 in a phosphorylation-dependent manner. PI3K is rapidly recruited and directly associates with CEACAM3 upon bacterial binding as shown by FRET analysis. Although PI3K activity is not required for efficient uptake of the bacteria by CEACAM3-transfected cells or primary human granulocytes, it is critical for the stimulated production of reactive oxygen species by infected phagocytes and the intracellular degradation of CEACAM-binding bacteria. Together, our results highlight the ability of CEACAM3 to coordinate signaling events that not only mediate bacterial uptake, but also trigger the killing of internalized pathogens.	[Buntru, Alexander; Kopp, Kathrin; Voges, Maike; Bachmann, Verena; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Buntru, Alexander; Voges, Maike; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, Dept Biol Chem, D-38124 Braunschweig, Germany	University of Konstanz; University of Konstanz; Helmholtz Association; Helmholtz-Center for Infection Research	Hauck, CR (corresponding author), Postfach X908, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de			Landesstiftung BW [LS-Prot-66]; Ministry of Science, Research; Arts of Baden-Wurttemberg	Landesstiftung BW; Ministry of Science, Research; Arts of Baden-Wurttemberg	This work was supported by Landesstiftung BW (LS-Prot-66) and a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (to C. R. H.).	Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Bos MP, 1998, P NATL ACAD SCI USA, V95, P9584, DOI 10.1073/pnas.95.16.9584; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DEWALD B, 1988, J BIOL CHEM, V263, P16179; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Marrazzo J, 2010, PRINCIPLES PRACTICE, P2753; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; MEYER TF, 1990, ANNU REV MICROBIOL, V44, P451; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Sarantis H, 2007, CELL MICROBIOL, V9, P2167, DOI 10.1111/j.1462-5822.2007.00947.x; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9555	9566		10.1074/jbc.M110.216085	http://dx.doi.org/10.1074/jbc.M110.216085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216968	Green Published, hybrid			2022-12-25	WOS:000288247700081
J	Liu, IJ; Chiu, CY; Chen, YC; Wu, HC				Liu, I-Ju; Chiu, Chien-Yu; Chen, Yun-Ching; Wu, Han-Chung			Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE ELEVATED GENE-1; HEMORRHAGIC-FEVER; MONOCLONAL-ANTIBODIES; SYSTEMIC-SCLEROSIS; PEPTIDE LIBRARIES; DRUG-DELIVERY; IN-VITRO; INFECTION; APOPTOSIS; EPITOPE	The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural protein 1) polyclonal antibodies cross-reacted with human umbilical vein endothelial cells (HUVECs). We further identified a complex-specific mAb, DB16-1, which could recognize DV NS1 and cross-react with HUVECs and human blood vessels. The target protein of DB16-1 was further purified by immunoaffinity chromatography. LC-MS/MS analysis and co-immunoprecipitation revealed that the target protein of DB16-1 was human LYRIC (lysine-rich CEACAM1 co-isolated). Our newly generated anti-LYRIC mAbs bound to HUVECs in a pattern similar to that of DB16-1. The B-cell epitope of DB16-1 displayed a consensus motif, Lys-X-Trp-Gly (KXWG), which corresponded to amino acid residues 116-119 of DV NS1 and mimicked amino acid residues 334-337 in LYRIC. Moreover, the binding activity of DB16-1 in NS1 of DV-2 and in LYRIC disappeared after the KXWG epitope was deleted in each. In conclusion, DB16-1 targeted the same epitope in DV NS1 and LYRIC protein on human endothelial cells, suggesting that it might play a role in the pathogenesis of DHF/DSS. Future studies on the role of the anti-NS1 antibody in causing vascular permeability will undoubtedly be performed on sera collected from individuals before, during, and after the endothelial cell malfunction phase of a dengue illness.	[Liu, I-Ju; Wu, Han-Chung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Liu, I-Ju; Chiu, Chien-Yu; Chen, Yun-Ching; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Wu, HC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Academia Sinica; National Science Council, Taiwan [NSC-98-3111-B-001-004, NSC-98-2323-B-001-001]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica (to H.-C. W.) and National Science Council, Taiwan, Grants NSC-98-3111-B-001-004 and NSC-98-2323-B-001-001 (to H.-C. W.).	Avirutnan P, 1998, J IMMUNOL, V161, P6338; BANKI K, 1992, P NATL ACAD SCI USA, V89, P1939, DOI 10.1073/pnas.89.5.1939; BielefeldtOhmann H, 1997, TRENDS MICROBIOL, V5, P409, DOI 10.1016/S0966-842X(97)01126-8; Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261; Bowditch RD, 1996, BLOOD, V88, P4579, DOI 10.1182/blood.V88.12.4579.bloodjournal88124579; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Di Rosa F, 1998, IMMUNOL REV, V164, P17; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; FUJINAMI RS, 1983, P NATL ACAD SCI-BIOL, V80, P2346, DOI 10.1073/pnas.80.8.2346; Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1984, J IMMUNOL, V132, P1529; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; KAPLAN C, 1992, SEMIN HEMATOL, V29, P34; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KURANE I, 1989, J CLIN INVEST, V83, P506, DOI 10.1172/JCI113911; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lunardi C, 2006, PLOS MED, V3, P94, DOI 10.1371/journal.pmed.0030002; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Namboodiri AM, 2004, AUTOIMMUNITY, V37, P241, DOI 10.1080/08916930410001710046; Nechansky A, 2009, J PHARMACEUT BIOMED, V49, P1014, DOI 10.1016/j.jpba.2009.01.029; QUERY CC, 1987, CELL, V51, P211, DOI 10.1016/0092-8674(87)90148-6; Rhodes GH, 1997, J AUTOIMMUN, V10, P447, DOI 10.1006/jaut.1997.9996; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rose AL, 2002, BLOOD, V100, P1765, DOI 10.1182/blood.V100.5.1765.h81702001765_1765_1773; Sibille P, 1997, EUR J IMMUNOL, V27, P1221, DOI 10.1002/eji.1830270525; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001	44	73	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9726	9736		10.1074/jbc.M110.170993	http://dx.doi.org/10.1074/jbc.M110.170993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233208	hybrid, Green Published			2022-12-25	WOS:000288247700096
J	Anaya, ZEA; Savistchenko, J; Massonneau, V; Lacroux, C; Andreoletti, O; Vilette, D				Anaya, Zaira E. Arellano; Savistchenko, Jimmy; Massonneau, Veronique; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier			Recovery of Small Infectious PrPres Aggregates from Prion-infected Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; SHEEP SCRAPIE; PROTEIN; DISEASE; NEURODEGENERATION; PROPAGATION; PARTICLES; AGENT	Prion diseases are characterized by deposits of abnormal conformers of the PrP protein. Although large aggregates of proteinase K-resistant PrP (PrPres) are infectious, the precise relationships between aggregation state and infectivity remain to be established. In this study, we have fractionated detergent lysates from prion-infected cultured cells by differential ultracentrifugation and ultrafiltration and have characterized a previously unnoticed PrP species. This abnormal form is resistant to proteinase K digestion but, in contrast to typical aggregated PrPres, remains in the soluble fraction at intermediate centrifugal forces and is not retained by filters of 300-kDa cutoff. Cell-based assay and inoculation to animals demonstrate that these entities are infectious. The finding that cell-derived small infectious PrPres aggregates can be recovered in the absence of strong in vitro denaturating treatments now gives a biological basis for investigating the role of small PrP aggregates in the pathogenicity and/or the multiplication cycle of prions.	[Anaya, Zaira E. Arellano; Savistchenko, Jimmy; Massonneau, Veronique; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,UMR 1225, F-31076 Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Vilette, D (corresponding author), Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,UMR 1225, F-31076 Toulouse, France.	d.vilette@envt.fr			Agence Nationale de la Recherche (France) [ANR-08-MIEN-010]; Department for Environment, Food and Rural Affairs (United Kingdom)	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Department for Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported in part by Agence Nationale de la Recherche Grant ANR-08-MIEN-010 (France) and the Department for Environment, Food and Rural Affairs (United Kingdom).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Berardi VA, 2006, TRANSFUSION, V46, P652, DOI 10.1111/j.1537-2995.2006.00763.x; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Deleault AM, 2008, J GEN VIROL, V89, P2642, DOI 10.1099/vir.0.2008/002303-0; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Manousis T, 2000, J GEN VIROL, V81, P1615, DOI 10.1099/0022-1317-81-6-1615; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Soto C, 2008, DEV CELL, V15, P339, DOI 10.1016/j.devcel.2008.09.001; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025	38	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8141	8148		10.1074/jbc.M110.165233	http://dx.doi.org/10.1074/jbc.M110.165233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212268	Green Published, hybrid			2022-12-25	WOS:000288013300044
J	Bianchi, R; Kastrisianaki, E; Giambanco, I; Donato, R				Bianchi, Roberta; Kastrisianaki, Eirini; Giambanco, Ileana; Donato, Rosario			S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; NEURITE OUTGROWTH; NITRIC-OXIDE; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; GROWTH-FACTOR; RHO-GTPASES; IN-VITRO; RECEPTOR; ACTIVATION	The Ca2+-binding protein of the EF-hand type, S100B, is abundantly expressed in and secreted by astrocytes, and release of S100B from damaged astrocytes occurs during the course of acute and chronic brain disorders. Thus, the concept has emerged that S100B might act an unconventional cytokine or a damage-associated molecular pattern protein playing a role in the pathophysiology of neurodegenerative disorders and inflammatory brain diseases. S100B proinflammatory effects require relatively high concentrations of the protein, whereas at physiological concentrations S100B exerts trophic effects on neurons. Most if not all of the extracellular (trophic and toxic) effects of S100B in the brain are mediated by the engagement of RAGE (receptor for advanced glycation end products). We show here that high S100B stimulates murine microglia migration in Boyden chambers via RAGE-dependent activation of Src kinase, Ras, PI3K, MEK/ERK1/2, RhoA/ROCK, Rac1/JNK/AP-1, Rac1/NF-kappa B, and, to a lesser extent, p38 MAPK. Recruitment of the adaptor protein, diaphanous-1, a member of the formin protein family, is also required for S100B/RAGE-induced migration of microglia. The S100B/RAGE-dependent activation of diaphanous-1/Rac1/JNK/AP-1, Ras/Rac1/NF-kappa B and Src/Ras/PI3K/RhoA/diaphanous-1 results in the up-regulation of expression of the chemokines, CCL3, CCL5, and CXCL12, whose release and activity are required for S100B to stimulate microglia migration. Lastly, RAGE engagement by S100B in microglia results in up-regulation of the chemokine receptors, CCR1 and CCR5. These results suggests that S100B might participate in the pathophysiology of brain inflammatory disorders via RAGE-dependent regulation of several inflammation-related events including activation and migration of microglia.	[Bianchi, Roberta; Kastrisianaki, Eirini; Giambanco, Ileana; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, Sect Anat, I-06122 Perugia, Italy	University of Perugia	Donato, R (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Sect Anat, Via Giochetto, I-06122 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Giambanco, Ileana/0000-0003-0286-6302	Associazione Italiana per la Ricerca sul Cancro [6021]; Fondazione Cassa di Risparmio di Perugia [2007.0218.020, 2009.020.0021]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project 6021 and Fondazione Cassa di Risparmio di Perugia Grants 2007.0218.020 and 2009.020.0021 (to R. D.).	Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Batra RK, 1999, AM J RESP CELL MOL, V21, P238, DOI 10.1165/ajrcmb.21.2.3470; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BLASI E, 1995, J NEUROIMMUNOL, V58, P111, DOI 10.1016/0165-5728(95)00016-U; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Chen X, 2007, CURR MOL MED, V7, P735; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Jong EK, 2008, J NEUROCHEM, V105, P1726, DOI 10.1111/j.1471-4159.2008.05267.x; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim SH, 2004, NEUROBIOL AGING, V25, P431, DOI 10.1016/S0197-4580(03)00126-X; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; LEVI G, 1993, P NATL ACAD SCI USA, V90, P1541, DOI 10.1073/pnas.90.4.1541; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Okamoto T, 2002, FASEB J, V16, P1928, DOI 10.1096/fj.02-0030fje; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Polk WW, 2007, AM J PHYSIOL-CELL PH, V293, pC1160, DOI 10.1152/ajpcell.00578.2006; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riuzzi F, 2007, AM J PATHOL, V171, P947, DOI 10.2353/ajpath.2007.070049; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2000, NEUROSCIENCE, V99, P773, DOI 10.1016/S0306-4522(00)00238-4; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wainwright MS, 2004, ANN NEUROL, V56, P61, DOI 10.1002/ana.20142; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; Xu DZ, 2003, J BIOL CHEM, V278, P39349, DOI 10.1074/jbc.M302771200; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	83	170	180	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7214	7226		10.1074/jbc.M110.169342	http://dx.doi.org/10.1074/jbc.M110.169342			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209080	Green Published, hybrid			2022-12-25	WOS:000287737300038
J	Cummings, V; Hewitt, J; Van Rooyen, A; Currie, K; Beard, S; Thrush, S; Norkko, J; Barr, N; Heath, P; Halliday, NJ; Sedcole, R; Gomez, A; McGraw, C; Metcalf, V				Cummings, Vonda; Hewitt, Judi; Van Rooyen, Anthony; Currie, Kim; Beard, Samuel; Thrush, Simon; Norkko, Joanna; Barr, Neill; Heath, Philip; Halliday, N. Jane; Sedcole, Richard; Gomez, Antony; McGraw, Christina; Metcalf, Victoria			Ocean Acidification at High Latitudes: Potential Effects on Functioning of the Antarctic Bivalve Laternula elliptica	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; SOUTHERN-OCEAN; TEMPERATURE; IMPACT; EVOLUTIONARY; DISSOLUTION; GROWTH; KING; VULNERABILITY; ADAPTATION	Ocean acidification is a well recognised threat to marine ecosystems. High latitude regions are predicted to be particularly affected due to cold waters and naturally low carbonate saturation levels. This is of concern for organisms utilising calcium carbonate (CaCO3) to generate shells or skeletons. Studies of potential effects of future levels of pCO(2) on high latitude calcifiers are at present limited, and there is little understanding of their potential to acclimate to these changes. We describe a laboratory experiment to compare physiological and metabolic responses of a key benthic bivalve, Laternula elliptica, at pCO(2) levels of their natural environment (430 mu atm, pH 7.99; based on field measurements) with those predicted for 2100 (735 mu atm, pH 7.78) and glacial levels (187 mu atm, pH 8.32). Adult L. elliptica basal metabolism (oxygen consumption rates) and heat shock protein HSP70 gene expression levels increased in response both to lowering and elevation of pH. Expression of chitin synthase (CHS), a key enzyme involved in synthesis of bivalve shells, was significantly up-regulated in individuals at pH 7.78, indicating L. elliptica were working harder to calcify in seawater undersaturated in aragonite (Omega(Ar) = 0.71), the CaCO3 polymorph of which their shells are comprised. The different response variables were influenced by pH in differing ways, highlighting the importance of assessing a variety of factors to determine the likely impact of pH change. In combination, the results indicate a negative effect of ocean acidification on whole-organism functioning of L. elliptica over relatively short terms (weeks-months) that may be energetically difficult to maintain over longer time periods. Importantly, however, the observed changes in L. elliptica CHS gene expression provides evidence for biological control over the shell formation process, which may enable some degree of adaptation or acclimation to future ocean acidification scenarios.	[Cummings, Vonda; Barr, Neill; Heath, Philip] Natl Inst Water & Atmospher Res, Mahanga Bay Aquaculture Facil, Wellington, New Zealand; [Hewitt, Judi; Thrush, Simon] Natl Inst Water & Atmospher Res, Hillcrest, New Zealand; [Van Rooyen, Anthony; Beard, Samuel; Sedcole, Richard; Metcalf, Victoria] Lincoln Univ, Dept Wine Food & Mol Biosci, Lincoln, New Zealand; [Currie, Kim] Natl Inst Water & Atmospher Res, Dunedin, New Zealand; [Norkko, Joanna] Abo Akad Univ, Turku, Finland; [McGraw, Christina] Univ Otago, Dept Chem, Dunedin, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Lincoln University - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Abo Akademi University; University of Otago	Cummings, V (corresponding author), Natl Inst Water & Atmospher Res, Mahanga Bay Aquaculture Facil, Wellington, New Zealand.	v.cummings@niwa.co.nz	Metcalf, Victoria/C-1933-2013	Halliday, Jane/0000-0002-9718-0348; Metcalf, Victoria/0000-0002-0833-7965; Norkko, Joanna/0000-0001-9885-8408; McGraw, Christina/0000-0001-5841-0748; Thrush, Simon/0000-0002-4005-3882; Cummings, Vonda/0000-0003-1076-3995	New Zealand Foundation for Research, Science and Technology [COX01707]; National Institute of Water and Atmospheric Research	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); National Institute of Water and Atmospheric Research	This research was funded by the New Zealand Foundation for Research, Science and Technology International Polar Year project COX01707, and the National Institute of Water and Atmospheric Research Capital Expenditure fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2001, ANTARCT SCI, V13, P111, DOI 10.1017/S0954102001000189; Ahn In-Young, 2001, Ocean and Polar Research, V23, P419; AHN IY, 1993, J EXP MAR BIOL ECOL, V171, P75, DOI 10.1016/0022-0981(93)90141-A; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Brockington S, 2001, POLAR BIOL, V24, P523, DOI 10.1007/s003000100251; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Chang ES, 2005, INTEGR COMP BIOL, V45, P43, DOI 10.1093/icb/45.1.43; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; CLARKE A, 1987, MAR ECOL PROG SER, V38, P89, DOI 10.3354/meps038089; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Cummings V, 2006, ANTARCT SCI, V18, P633, DOI 10.1017/S0954102006000666; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Ellis JI, 1997, ENVIRON MONIT ASSESS, V48, P157, DOI 10.1023/A:1005752603707; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Fabbri E., 2008, ISJ, V5, P135; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Harper EM, 2006, ZOOL J LINN SOC-LOND, V148, P395, DOI 10.1111/j.1096-3642.2006.00260.x; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Hauton C, 2009, BIOGEOSCI DISCUSS, V6, P919, DOI DOI 10.5194/BGD-6-919-2009; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Heilmayer O, 2003, MAR BIOL, V143, P477, DOI 10.1007/s00227-003-1079-7; HOEGHGULDBERG O, 1995, J EXP BIOL, V198, P19; Ishimatsu A, 2004, J OCEANOGR, V60, P731, DOI 10.1007/s10872-004-5765-y; Kleypas JA, 2006, WORKSH HELD 18 20 AP; Langenbuch M, 2003, J EXP BIOL, V206, P3895, DOI 10.1242/jeb.00620; Lenton A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038227; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; MCGRAW CM, LIMNOL OCEA IN PRESS; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; MORELY SA, 2009, COMP BIOCH PHYSL A, V153, P154; Morley SA, 2007, OECOLOGIA, V153, P29, DOI 10.1007/s00442-007-0720-4; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Norkko J, 2006, J EXP MAR BIOL ECOL, V337, P38, DOI 10.1016/j.jembe.2006.06.003; Norkko J, 2005, J EXP MAR BIOL ECOL, V326, P144, DOI 10.1016/j.jembe.2005.05.014; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Portner HO, 1999, COMP BIOCHEM PHYS A, V124, P179, DOI 10.1016/S1095-6433(99)00105-1; Raven J.A., 2005, 1205 ROYAL SOC, DOI DOI 10.1080/02688690801911598; Revelle R., 1957, GEOL SOC AM MEM, V67, P239; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; ROPER DS, 1991, MAR ENVIRON RES, V31, P197, DOI 10.1016/0141-1136(91)90011-V; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Somerfield PJ, 2002, J ANIM ECOL, V71, P581, DOI 10.1046/j.1365-2656.2002.00624.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; TAYLOR AC, 1995, COMP BIOCHEM PHYS A, V112, P333, DOI 10.1016/0300-9629(95)00106-9; Tomanek L, 1999, J EXP BIOL, V202, P2925; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; Urban HJ, 1998, ANTARCT SCI, V10, P153, DOI 10.1017/S0954102098000200; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2006, J STRUCT BIOL, V153, P264, DOI 10.1016/j.jsb.2005.11.006; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3	77	121	122	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16069	10.1371/journal.pone.0016069	http://dx.doi.org/10.1371/journal.pone.0016069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245932	Green Published, gold			2022-12-25	WOS:000286511200033
J	Logie, JJ; Ali, S; Marshall, KM; Heck, MMS; Walker, BR; Hadoke, PWF				Logie, James J.; Ali, Sadaf; Marshall, Kathryn M.; Heck, Margarete M. S.; Walker, Brian R.; Hadoke, Patrick W. F.			Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR GENE; IN-VITRO; ANGIOSTATIC STEROIDS; DEXAMETHASONE; RAT; EXPRESSION; MECHANISM; MATRIX; VIVO	Background: Glucocorticoid-mediated inhibition of angiogenesis is important in physiology, pathophysiology and therapy. However, the mechanisms through which glucocorticoids inhibit growth of new blood vessels have not been established. This study addresses the hypothesis that physiological levels of glucocorticoids inhibit angiogenesis by directly preventing tube formation by endothelial cells. Methodology/Principal Findings: Cultured human umbilical vein (HUVEC) and aortic (HAoEC) endothelial cells were used to determine the influence of glucocorticoids on tube-like structure (TLS) formation, and on cellular proliferation (5-bromo-2'-deoxyuridine (BrdU) incorporation), viability (ATP production) and migration (Boyden chambers). Dexamethasone or cortisol (at physiological concentrations) inhibited both basal and prostaglandin F(2 alpha) (PGF(2 alpha))-induced and vascular endothelial growth factor (VEGF) stimulated TLS formation in endothelial cells (ECs) cultured on Matrigel, effects which were blocked with the glucocorticoid receptor antagonist RU38486. Glucocorticoids had no effect on EC viability, migration or proliferation. Time-lapse imaging showed that cortisol blocked VEGF-stimulated cytoskeletal reorganisation and initialisation of tube formation. Real time PCR suggested that increased expression of thrombospodin-1 contributed to glucocorticoid-mediated inhibition of TLS formation. Conclusions/Significance: We conclude that glucocorticoids interact directly with glucocorticoid receptors on vascular ECs to inhibit TLS formation. This action, which was conserved in ECs from two distinct vascular territories, was due to alterations in cell morphology rather than inhibition of EC viability, migration or proliferation and may be mediated in part by induction of thrombospodin-1. These findings provide important insights into the anti-angiogenic action of endogenous glucocorticoids in health and disease.	[Logie, James J.; Ali, Sadaf; Marshall, Kathryn M.; Heck, Margarete M. S.; Walker, Brian R.; Hadoke, Patrick W. F.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Logie, JJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	phadoke@staffmail.ed.ac.uk		Marshall, Kathryn/0000-0002-3645-1909	Medical Research Council; Medical Research Scotland; Wellcome Trust; British Heart Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Scotland; Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation)	JJL was funded by a Medical Research Council studentship and KMM was funded by a postdoctoral fellowship from Medical Research Scotland. MMSH is a Wellcome Trust University Award holder. PWFH and BRW are funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banciu M, 2006, J CONTROL RELEASE, V113, P1, DOI 10.1016/j.jconrel.2006.03.019; BERK BC, 1988, J CELL PHYSIOL, V137, P391, DOI 10.1002/jcp.1041370302; BLEI F, 1993, J CELL PHYSIOL, V155, P568, DOI 10.1002/jcp.1041550315; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen WL, 2006, OCUL IMMUNOL INFLAMM, V14, P215, DOI 10.1080/09273940600732380; Christy C, 2003, HYPERTENSION, V42, P580, DOI 10.1161/01.HYP.0000088855.06598.5B; COLVILLENASH PR, 1992, ANN RHEUM DIS, V51, P919, DOI 10.1136/ard.51.7.919; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; FOLKMAN J, 1987, ANN SURG, V206, P374, DOI 10.1097/00000658-198709000-00016; Gille J, 2001, J INVEST DERMATOL, V117, P1581, DOI 10.1046/j.0022-202x.2001.01573.x; GREEN JP, 1965, BRIT J SURG, V52, P523, DOI 10.1002/bjs.1800520710; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Harada I, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P763; Hasan Q, 2000, PEDIATRICS, V105, P117, DOI 10.1542/peds.105.1.117; Kraling BM, 1999, J CELL SCI, V112, P1599; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; LONGENECKER JP, 1982, J CELL PHYSIOL, V113, P197, DOI 10.1002/jcp.1041130203; Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Matsuda S, 2005, INVEST OPHTH VIS SCI, V46, P1062, DOI 10.1167/iovs.04-0761; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Oberleithner H, 2003, J MEMBRANE BIOL, V196, P163, DOI 10.1007/s00239-003-0635-6; Pross C, 2002, J VASC SURG, V35, P1253, DOI 10.1067/mva.2002.123332; Pufe T, 2003, BONE, V33, P869, DOI 10.1016/j.bone.2003.08.002; Rae M, 2009, J CLIN ENDOCR METAB, V94, P1443, DOI 10.1210/jc.2008-1879; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; STOKES CL, 1990, MICROVASC RES, V40, P279, DOI 10.1016/0026-2862(90)90025-M; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3504, DOI 10.1210/jc.87.7.3504; Wang YS, 2002, GRAEF ARCH CLIN EXP, V240, P42, DOI 10.1007/s00417-001-0398-y; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; Wilasrusmee C, 2003, CLIN TRANSPLANT, V17, P6, DOI 10.1034/j.1399-0012.17.s9.1.x; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zou YH, 2006, J OCUL PHARMACOL TH, V22, P19, DOI 10.1089/jop.2006.22.19	43	67	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14476	10.1371/journal.pone.0014476	http://dx.doi.org/10.1371/journal.pone.0014476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217824	Green Published, gold			2022-12-25	WOS:000285838900005
J	Eriksen, M; Porneki, AD; Skov, V; Burns, JS; Beck-Nielsen, H; Glintborg, D; Gaster, M				Eriksen, Mette; Porneki, Ann Dorte; Skov, Vibe; Burns, Jorge S.; Beck-Nielsen, Henning; Glintborg, Dorte; Gaster, Michael			Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GLYCOGEN-SYNTHASE ACTIVITY; SKELETAL-MUSCLE CELLS; TYPE-2 DIABETIC SUBJECTS; REDUCED LIPID OXIDATION; GLUCOSE-METABOLISM; ACQUIRED DEFECTS; GENETIC-ORIGIN; PIOGLITAZONE; PREVALENCE	Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among premenopausal women, who often develop insulin resistance. We tested the hypothesis that insulin resistance in skeletal muscle of patients with polycystic ovary syndrome (PCOS) is an intrinsic defect, by investigating the metabolic characteristics and gene expression of in vitro differentiated myotubes established from well characterized PCOS subjects. Methods: Using radiotracer techniques, RT-PCR and enzyme kinetic analysis we examined myotubes established from PCOS subjects with or without pioglitazone treatment, versus healthy control subjects who had been extensively metabolically characterized in vivo. Results Myotubes established from PCOS and matched control subjects comprehensively expressed all insulin-sensitive biomarkers; glucose uptake and oxidation, glycogen synthesis and lipid uptake. There were no significant differences between groups either at baseline or during acute insulin stimulation, although in vivo skeletal muscle was insulin resistant. In particular, we found no evidence for defects in insulin-stimulated glycogen synthase activity between groups. Myotubes established from PCOS patients with or without pioglitazone treatment also showed no significant differences between groups, neither at baseline nor during acute insulin stimulation, although in vivo pioglitazone treatment significantly improved insulin sensitivity. Consistently, the myotube cultures failed to show differences in mRNA levels of genes previously demonstrated to differ in PCOS patients with or without pioglitazone treatment (PLEK, SLC22A16, and TTBK). Conclusion: These results suggest that the mechanisms governing insulin resistance in skeletal muscle of PCOS patients in vivo are not primary, but rather adaptive. Trial Registration: ClinicalTrials.gov NCT00145340	[Eriksen, Mette; Beck-Nielsen, Henning; Glintborg, Dorte; Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Porneki, Ann Dorte; Burns, Jorge S.; Gaster, Michael] Univ So Denmark, Clin Mol Endocrinol, Dept Endocrinol, Odense Univ Hosp, Odense, Denmark; [Porneki, Ann Dorte; Burns, Jorge S.; Gaster, Michael] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark; [Skov, Vibe] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Human MicroArray Ctr, DK-5000 Odense, Denmark; [Skov, Vibe] Odense Univ Hosp, Dept Clin Genet, Human MicroArray Ctr, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Eriksen, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	Michael.Gaster@ouh.regionsyddanmark.dk	Burns, Jorge S./J-3395-2012; Glintborg, Dorte/AAE-3676-2019; Burns, Jorge/AAF-5291-2019	Burns, Jorge S./0000-0002-8602-1536; Glintborg, Dorte/0000-0002-8338-8025; Brandt Eriksen, Mette/0000-0001-6785-261X	Danish Council for Independent Research; Novo Nordisk Foundation; Danish Diabetes Association; Region of Southern Denmark [09/13388]; Augustinus Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Region of Southern Denmark; Augustinus Foundation	The Danish Council for Independent Research (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/medical-sciences/medical-sciences), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/), the Danish Diabetes Association (http://www.diabetes.dk/Forskning.aspx), Region of Southern Denmark grant no. 09/13388 (http://www.regionsyddanmark.dk/wm157175) and the Augustinus Foundation (no URL) are thanked for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004274; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Baig A, 2009, PROTEOMICS, V9, P4254, DOI 10.1002/pmic.200900060; Ban A, 2008, J VET MED SCI, V70, P761, DOI 10.1292/jvms.70.761; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjorntorp P, 1996, J INTERN MED, V239, P105, DOI 10.1046/j.1365-2796.1996.364690000.x; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; Book CB, 1999, J CLIN ENDOCR METAB, V84, P3110, DOI 10.1210/jc.84.9.3110; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ciaraldi TP, 2009, J CLIN ENDOCR METAB, V94, P157, DOI 10.1210/jc.2008-1492; Ciaraldi TP, 1998, METABOLISM, V47, P940, DOI 10.1016/S0026-0495(98)90348-1; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Corbould A, 2007, METABOLISM, V56, P716, DOI 10.1016/j.metabol.2006.12.021; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Deligeoroglou E, 2009, GYNECOL ENDOCRINOL, V25, P603, DOI 10.1080/09513590903015619; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Frederiksen CM, 2008, DIABETOLOGIA, V51, P2068, DOI 10.1007/s00125-008-1122-9; Gaster M, 2006, BBA-MOL CELL BIOL L, V1761, P100, DOI 10.1016/j.bbalip.2005.12.003; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Gaster M, 2004, BBA-MOL BASIS DIS, V1690, P85, DOI 10.1016/j.bbadis.2004.05.006; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, BBA-MOL BASIS DIS, V1537, P211, DOI 10.1016/S0925-4439(01)00071-0; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Gaster M, 2007, BBA-MOL BASIS DIS, V1772, P755, DOI 10.1016/j.bbadis.2007.03.007; Gaster M, 2007, J LIPID RES, V48, P207, DOI 10.1194/jlr.M600319-JLR200; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Gaster M, 2009, BIOCHEM BIOPH RES CO, V382, P766, DOI 10.1016/j.bbrc.2009.03.102; Glintborg D, 2004, FERTIL STERIL, V82, P1570, DOI 10.1016/j.fertnstert.2004.06.040; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P3618, DOI 10.1210/jc.2008-0760; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Glintborg D, 2008, CLIN ENDOCRINOL, V68, P165, DOI 10.1111/j.1365-2265.2007.03015.x; Glintborg D, 2006, FERTIL STERIL, V86, P385, DOI 10.1016/j.fertnstert.2005.12.067; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Henry RR, 1996, J CLIN INVEST, V98, P1231, DOI 10.1172/JCI118906; Henry RR, 1996, DIABETES, V45, P400, DOI 10.2337/diabetes.45.4.400; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Hother-Nielsen O, 1995, ENDOCRINOL METAB, V2, P275; Kahsar-Miller MD, 2001, FERTIL STERIL, V75, P53, DOI 10.1016/S0015-0282(00)01662-9; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011272; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYKKESFELDT G, 1985, CLIN ENDOCRINOL, V23, P385, DOI 10.1111/j.1365-2265.1985.tb01096.x; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Venkatesan AM, 2001, RECENT PROG HORM RES, V56, P295, DOI 10.1210/rp.56.1.295; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757; Xita N, 2002, EUR J ENDOCRINOL, V147, P717, DOI 10.1530/eje.0.1470717; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Zhuo GC, 2010, BIOCHEM GENET, V48, P157, DOI 10.1007/s10528-009-9308-5	69	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14469	10.1371/journal.pone.0014469	http://dx.doi.org/10.1371/journal.pone.0014469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209881	gold, Green Submitted, Green Published			2022-12-25	WOS:000285793600011
J	Sborgi, L; Barrera-Vilarmau, S; Obregon, P; de Alba, E				Sborgi, Lorenzo; Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva			Characterization of a Novel Interaction between Bcl-2 Members Diva and Harakiri	PLOS ONE			English	Article							CELL-DEATH; BH3-ONLY PROTEINS; BH3 DOMAINS; APOPTOSIS; FAMILY; RECOGNITION; REGULATORS; MECHANISM; SURVIVAL; LIGANDS	Interactions within proteins of the Bcl-2 family are key in the regulation of apoptosis. The death-inducing members control apoptotic mechanisms partly by antagonizing the prosurvival proteins through heterodimer formation. Structural and biophysical studies on these complexes are providing important clues to understand their function. To help improve our knowledge on protein-protein interactions within the Bcl-2 family we have studied the binding between two of its members: mouse Diva and human Harakiri. Diva has been shown to perform both prosurvival and killing activity. In contrast, Harakiri induces cell death by interacting with antiapoptotic Bcl-2 members. Here we show using ELISA and NMR that Diva and Harakiri can interact in vitro. Combining the NMR data with the previously reported three-dimensional structure of Diva we find that Harakiri binds to a specific region in Diva. This interacting surface is equivalent to the known binding area of prosurvival Bcl-2 members from the reported structures of the complexes, suggesting that Diva could function at the structural level similarly to the antiapoptotic proteins of the Bcl-2 family. We illustrate this result by building a structural model of the heterodimer using molecular docking and the NMR data as restraints. Moreover, combining circular dichroism and NMR we also show that Harakiri is largely unstructured with residual (13%) alpha-helical conformation. This result agrees with intrinsic disorder previously observed in other Bcl-2 members. In addition, Harakiri constructs of different length were studied to identify the region critical for the interaction. Differential affinity for Diva of these constructs suggests that the amino acid sequence flanking the interacting region could play an important role in binding.	[Sborgi, Lorenzo; Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sborgi, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	dealbae@cib.csic.es	Barrera-Vilarmau, Susana/ABD-1039-2020	Barrera-Vilarmau, Susana/0000-0003-4868-6593	European Commission [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03278, CSD2009-00088]; Comunidad de Madrid and Agencia CSIC IV PRICIT [CCG08-CSIC/SAL-3777]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid and Agencia CSIC IV PRICIT	This work was supported by the European Commission Marie Curie International Reintegration Grant [IRG-046412 to EDA], by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramon y Cajal to EDA, and Plan Nacional I+D+I (grant BFU2008-03278 to EDA), by Comunidad de Madrid and Agencia CSIC IV PRICIT (grant CCG08-CSIC/SAL-3777 to EDA), and by Spanish Ministerio de Ciencia e Innovacion through the Consolider-Ingenio 2010 program (grant CSD2009-00088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bernabeu A, 2007, BBA-BIOMEMBRANES, V1768, P1659, DOI 10.1016/j.bbamem.2007.02.023; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; DAVID CS, 2000, CELL, V103, P839; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Fernandez-Luna JL, 2008, CELL SIGNAL, V20, P1921, DOI 10.1016/j.cellsig.2008.04.015; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MEYERS JK, 1997, BIOCHEMISTRY-US, V36, P10923; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Rautureau GJP, 2010, PROTEINS, V78, P2181, DOI 10.1002/prot.22728; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sborgi Lorenzo, 2010, Biomol NMR Assign, V4, P65, DOI 10.1007/s12104-010-9208-y; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2010, STRUCTURE, V18, P1069, DOI 10.1016/j.str.2010.08.003; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15575	10.1371/journal.pone.0015575	http://dx.doi.org/10.1371/journal.pone.0015575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209886	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600020
J	Jayadev, S; Case, A; Eastman, AJ; Nguyen, H; Pollak, J; Wiley, JC; Moller, T; Morrison, RS; Garden, GA				Jayadev, Suman; Case, Amanda; Eastman, Alison J.; Nguyen, Huy; Pollak, Julia; Wiley, Jesse C.; Moeller, Thomas; Morrison, Richard S.; Garden, Gwenn A.			Presenilin 2 Is the Predominant gamma-Secretase in Microglia and Modulates Cytokine Release	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSES; INTERFERON-GAMMA; RECEPTOR; ACTIVATION; EXPRESSION; ALPHA; NOTCH; TRANSDUCTION; MUTATIONS	Presenilin 1 (PS1) and Presenilin 2 (PS2) are the enzymatic component of the gamma-secretase complex that cleaves amyloid precursor protein (APP) to release amyloid beta (Ab) peptide. PS deficiency in mice results in neuroinflammation and neurodegeneration in the absence of accumulated Ab. We hypothesize that PS influences neuroinflammation through its gamma-secretase action in CNS innate immune cells. We exposed primary murine microglia to a pharmacological gamma-secretase inhibitor which resulted in exaggerated release of TNF alpha and IL-6 in response to lipopolysaccharide. To determine if this response was mediated by PS1, PS2 or both we used shRNA to knockdown each PS in a murine microglia cell line. Knockdown of PS1 did not lead to decreased gamma-secretase activity while PS2 knockdown caused markedly decreased gamma-secretase activity. Augmented proinflammatory cytokine release was observed after knockdown of PS2 but not PS1. Proinflammatory stimuli increased microglial PS2 gene transcription and protein in vitro. This is the first demonstration that PS2 regulates CNS innate immunity. Taken together, our findings suggest that PS2 is the predominant gamma-secretase in microglia and modulates release of proinflammatory cytokines. We propose PS2 may participate in a negative feedback loop regulating inflammatory behavior in microglia.	[Jayadev, Suman; Case, Amanda; Eastman, Alison J.; Moeller, Thomas; Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Nguyen, Huy] Univ Iowa, Dept Neurosci, Iowa City, IA USA; [Pollak, Julia] Univ Washington, Dept Neurobiol & Behav, Seattle, WA 98195 USA; [Wiley, Jesse C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Morrison, Richard S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jayadev, S (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	sumie@u.washington.edu	Garden, Gwenn/CAF-9344-2022; Jayadev, Suman/B-6362-2019; Nguyen, Huy/AAF-9560-2019; Möller, Thomas/W-8974-2019; Nguyen, Huy/GWQ-6433-2022	Nguyen, Huy/0000-0002-5896-9661; Garden, Gwenn/0000-0002-8753-6515	National Institutes of Health (NIH) [NS055652, NS056031, NS062269]; American Federation for Aging Research [RAG08083]; Alzheimer Association New Investigator Grant [NIRG-06-26411]; Friends of Alzheimer Disease; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055652, R01NS056031, R21NS062269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Alzheimer Association New Investigator Grant; Friends of Alzheimer Disease; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: National Institutes of Health (NIH) NS055652 (S.J.), American Federation for Aging Research RAG08083 (S.J.), Alzheimer Association New Investigator Grant NIRG-06-26411 (S.J.), NIH NS056031 (R. S. M.), NIH NS062269 (G. A. G.) and a grant from the Friends of Alzheimer Disease (G. A. G.). Human brain autopsy tissue was procured from the Alzheimer Disease Research Center NIH AG05136. Alzheimer disease patient autopsy tissue was provided by the Alzheimer Disease Research Center, University of Washington Medical Center (P50 AG05136). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Balcaitis S, 2005, GLIA, V50, P48, DOI 10.1002/glia.20146; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Blasko I, 2001, J NEUROIMMUNOL, V116, P1, DOI 10.1016/S0165-5728(01)00279-X; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Chakrabarty P, 2010, J IMMUNOL; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Elzinga BM, 2009, J BIOL CHEM, V284, P1394, DOI 10.1074/jbc.M803108200; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; GIFFORD GE, 1987, J NATL CANCER I, V78, P121, DOI 10.1093/jnci/78.1.121; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grandbarbe L, 2007, GLIA, V55, P1519, DOI 10.1002/glia.20553; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heilig EA, 2010, J BIOL CHEM; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; HUBERMAN M, 1994, J NEUROIMMUNOL, V52, P147, DOI 10.1016/0165-5728(94)90108-2; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2002, NEUROMOL MED, V2, P29; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee SM, 2006, FASEB J, V20, pA173; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pennypacker KR, 1998, MOL BRAIN RES, V56, P57, DOI 10.1016/S0169-328X(98)00028-X; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Saban MR, 2002, AM J PATHOL, V160, P2095, DOI 10.1016/S0002-9440(10)61159-5; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Terai K, 1996, BRAIN RES, V739, P343, DOI 10.1016/S0006-8993(96)01073-6; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yagi T, 2008, P NATL ACAD SCI USA, V105, P979, DOI 10.1073/pnas.0707755105; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	70	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15743	10.1371/journal.pone.0015743	http://dx.doi.org/10.1371/journal.pone.0015743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206757	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793200049
J	Cha, B; Kim, W; Kim, YK; Hwang, BN; Park, SY; Yoon, JW; Park, WS; Cho, JW; Bedford, MT; Jho, EH				Cha, B.; Kim, W.; Kim, Y. K.; Hwang, B. N.; Park, S. Y.; Yoon, J. W.; Park, W. S.; Cho, J. W.; Bedford, M. T.; Jho, E-h			Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling	ONCOGENE			English	Article						Axin; PRMT1; Wnt; protein methylation; GSK3 beta	BETA-CATENIN; COLORECTAL-CANCER; PATHWAY; PHOSPHORYLATION; UBIQUITINATION; ACTIVATION; COMPLEX; BINDING; PRMT1; INHIBITION	Axin, a negative regulator of Wnt signaling, is a key scaffold protein for the beta-catenin destruction complex. It has been previously shown that multiple post-translational modification enzymes regulate the level of Axin. Here, we provide evidence that protein arginine methyltransferase 1 (PRMT1) directly interacts with and methylates the 378th arginine residue of Axin both in vitro and in vivo. We found that the transient expression of PRMT1 led to an increased level of Axin and that knockdown of endogenous PRMT1 by short hairpin RNA reduced the level of Axin. These results suggest that methylation by PRMT1 enhanced the stability of Axin. Methylation of Axin by PRMT1 also seemingly enhanced the interaction between Axin and glycogen synthase kinase 3 beta, leading to decreased ubiquitination of Axin. Consistent with the role of PRMT1 in the regulation of Axin, knockdown of PRMT1 enhanced the level of cytoplasmic beta-catenin as well as beta-catenin-dependent transcription activity. In summary, we show that the methylation of Axin occurred in vivo and controlled the stability of Axin. Therefore, methylation of Axin by PRMT1 may serve as a finely tuned regulation mechanism for Wnt/beta-catenin signaling. Oncogene (2011) 30, 2379-2389; doi: 10.1038/onc.2010.610; published online 17 January 2011	[Cha, B.; Kim, W.; Hwang, B. N.; Jho, E-h] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea; [Kim, Y. K.; Bedford, M. T.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA; [Park, S. Y.; Cho, J. W.] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Park, S. Y.; Cho, J. W.] Yonsei Univ, Dept Integrated OMICS Biomed Sci, World Class Univ Program, Seoul 120749, South Korea; [Yoon, J. W.; Park, W. S.] Catholic Univ Korea, Dept Pathol, Coll Med, Seoul, South Korea	University of Seoul; University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University; Catholic University of Korea	Jho, EH (corresponding author), Univ Seoul, Dept Life Sci, 90 Jeonnong Dong, Seoul 130743, South Korea.	ej70@uos.ac.kr	Bedford, Mark T/E-7856-2011	Jho, Eek-hoon/0000-0003-2414-6234	Korea Research Foundation [C00339]; Ministry for Health and Welfare, Republic of Korea [1020240]; Brain Korea 21 program; Seoul Science Fellowship	Korea Research Foundation(National Research Foundation of Korea); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science Fellowship	This work was supported by grants from the Korea Research Foundation (C00339) and the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1020240) to E Jho B Cha, W Kim and B Hwang were supported by the Brain Korea 21 program. B Cha and W Kim were recipients of the Seoul Science Fellowship.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Gupta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002658; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jernigan KK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000647; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Jung H, 2009, EXP MOL MED, V41, P695, DOI 10.3858/emm.2009.41.10.076; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Polakis P, 2000, GENE DEV, V14, P1837; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shimizu Y, 2002, GENE CHROMOSOME CANC, V33, P73, DOI 10.1002/gcc.1226; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	51	53	53	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	20					2379	2389		10.1038/onc.2010.610	http://dx.doi.org/10.1038/onc.2010.610			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21242974				2022-12-25	WOS:000290789200009
J	Luo, Y; Zhou, H; Liu, L; Shen, T; Chen, W; Xu, B; Han, X; Zhang, F; Scott, RS; Alexander, JS; Alam, A; Huang, S				Luo, Y.; Zhou, H.; Liu, L.; Shen, T.; Chen, W.; Xu, B.; Han, X.; Zhang, F.; Scott, R. S.; Alexander, J. S.; Alam, A.; Huang, S.			The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway	ONCOGENE			English	Article						ciclopirox; lymphatic endothelial cells; tube formation; VEGFR-3; ERK	TUMOR LYMPHANGIOGENESIS; CANDIDA-ALBICANS; VEGF RECEPTOR-3; GROWTH; METASTASIS; PROMOTES; PHOSPHORYLATION; ANGIOGENESIS; LYMPHEDEMA; ACTIVATION	Ciclopirox olamine (CPX), an off-patent antifungal agent used to treat mycoses of skin and nails, has recently been demonstrated to be a potential anticancer agent. However, the underlying mechanism is not well understood. Here, for the first time, we show that CPX inhibited lymphangiogenesis in an in vitro model (tube formation). This effect was, in part, associated with inhibition of vascular endothelial growth factor receptor-3 (VEGFR-3) expression, as overexpression of VEGFR-3 conferred partial resistance to CPX inhibitory effect on tube formation in lymphatic endothelial cells (LECs), whereas downregulation of VEGFR-3 mimicked the effect of CPX, blocking the tube formation. Further study revealed that CPX did not alter mRNA level, but inhibited protein synthesis and promoted protein degradation of VEGFR-3. In addition, we found that CPX inhibited phosphorylation of the extracellular signal-related kinase 1/2 (ERK1/2), a downstream effector of VEGFR-3. Overexpression of VEGFR-3 attenuated CPX inhibition of ERK1/2 phosphorylation, whereas downregulation of VEGFR-3 inhibited ERK1/2 phosphorylation in LECs. Ectopic expression of constitutively active mitogen-activated protein kinase kinase 1 (MKK1) resulted in activation of ERK1/2 and partially prevented CPX inhibition of LEC tube formation. The results suggest that CPX inhibits LEC tube formation at least, in part, through inhibiting VEGFR-3-mediated ERK signaling pathway. Oncogene (2011) 30, 2098-2107; doi:10.1038/onc.2010.590; published online 10 January 2011	[Luo, Y.; Zhou, H.; Liu, L.; Shen, T.; Chen, W.; Xu, B.; Han, X.; Huang, S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Luo, Y.] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Zhang, F.; Scott, R. S.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA; [Alam, A.] Sanofi Aventis R&D, Toulouse, France; [Huang, S.] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Sichuan University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Sanofi-Aventis; Sanofi France; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Huang, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	shuan1@lsuhsc.edu	Xu, Baoshan/H-6435-2011; luo, yan/I-5305-2015; Chen, Wenxing/GSI-9910-2022; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072; Xu, Baoshan/0000-0001-8902-1243; Chen, Wenxing/0000-0003-4571-7622	NIH [CA115414]; Louisiana Board of Regents [LEQSF (2006-09)-RD-A-18]; American Cancer Society [RSG-08-135-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the NIH grant CA115414 (SH), Louisiana Board of Regents grant (LEQSF (2006-09)-RD-A-18) (SH), and American Cancer Society grant RSG-08-135-01-CNE (SH). We thank Dr Natalie Ahn for providing MKK1 constructs.	Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Clement PMJ, 2002, INT J CANCER, V100, P491, DOI 10.1002/ijc.10515; Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464; DITTMAR W, 1973, ARZNEIMITTEL-FORSCH, V23, P670; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Fang Changge, 2009, Lymphatic Research and Biology, V7, P189, DOI 10.1089/lrb.2009.0033; Fournier E, 1999, ONCOGENE, V18, P507, DOI 10.1038/sj.onc.1202315; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Jin DH, 2008, CARDIOVASC RES, V80, P339, DOI 10.1093/cvr/cvn228; JUE SG, 1985, DRUGS, V29, P330, DOI 10.2165/00003495-198529040-00002; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010578; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Ruggeri B, 2003, CANCER RES, V63, P5978; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Sigle HC, 2005, J ANTIMICROB CHEMOTH, V55, P663, DOI 10.1093/jac/dki089; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Sunavala-Dossabhoy G, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-1; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255	43	27	27	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	18					2098	2107		10.1038/onc.2010.590	http://dx.doi.org/10.1038/onc.2010.590			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21217783	Green Accepted			2022-12-25	WOS:000290249600002
J	Ravindran, S; Gao, Q; Ramachandran, A; Blond, S; Predescu, SA; George, A				Ravindran, Sriram; Gao, Qi; Ramachandran, Amsaveni; Blond, Sylvie; Predescu, Sanda A.; George, Anne			Stress Chaperone GRP-78 Functions in Mineralized Matrix Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-TRANSCRIPTION; SURFACE EXPRESSION; COXSACKIEVIRUS A9; IN-VITRO; DENTIN; PROTEIN-1; CELLS; DMP1; BIP; IDENTIFICATION	Mineralized matrix formation is a well orchestrated event requiring several players. Glucose-regulated protein-78 (GRP-78) is an endoplasmic reticulum chaperone protein that has been implicated in functional roles ranging from involvement in cancer biology to serving as a receptor for viruses. In the present study we explored the role of GRP-78 in mineralized matrix formation. Differential expression of GRP-78 mRNA and protein was observed upon in vitro differentiation of primary mouse calvarial cells. An interesting observation was that GRP-78 was identified in the secretome of these cells and in the bone matrix, suggesting an extracellular function during matrix formation. In vitro nucleation experiments under physiological concentrations of calcium and phosphate ions indicated that GRP-78 can induce the formation of calcium phosphate polymorphs by itself, when bound to immobilized type I collagen and on demineralized collagen wafers. We provide evidence that GRP-78 can bind to DMP1 and type I collagen independent of each other in a simulated extracellular environment. Furthermore, we demonstrate the cell surface localization of GRP-78 and provide evidence that it functions as a receptor for DMP1 endocytosis in pre-osteoblasts and primary calvarial cells. Overall, this study represents a paradigm shift in the biological function of GRP-78.	[Ravindran, Sriram; Gao, Qi; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Blond, Sylvie] Univ Illinois, Dept Pharmaceut Biotechnol, Chicago, IL 60612 USA; [Predescu, Sanda A.] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		Predescu, Sanda/0000-0002-9386-6756; GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657]; Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 11657. This work was also supported by the Brodie Endowment Fund.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Ravindran S, 2004, THROMB HAEMOSTASIS, V92, P1277, DOI 10.1160/TH04-01-0008; Stan RV, 1997, MOL BIOL CELL, V8, P595, DOI 10.1091/mbc.8.4.595; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	27	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8729	8739		10.1074/jbc.M110.179341	http://dx.doi.org/10.1074/jbc.M110.179341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239500	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000288247700004
J	Yang, Y; Yamashita, T; Nakamaru-Ogiso, E; Hashimoto, T; Murai, M; Igarashi, J; Miyoshi, H; Mori, N; Matsuno-Yagi, A; Yagi, T; Kosaka, H				Yang, Yu; Yamashita, Tetsuo; Nakamaru-Ogiso, Eiko; Hashimoto, Takeshi; Murai, Masatoshi; Igarashi, Junsuke; Miyoshi, Hideto; Mori, Nozomu; Matsuno-Yagi, Akemi; Yagi, Takao; Kosaka, Hiroaki			Reaction Mechanism of Single Subunit NADH-Ubiquinone Oxidoreductase (Ndi1) from Saccharomyces cerevisiae EVIDENCE FOR A TERNARY COMPLEX MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ELECTRON-TRANSFER; QUINONE OXIDOREDUCTASE; LATERAL DIFFUSION; CRYSTAL-STRUCTURE; BOUND UBIQUINONE; DT-DIAPHORASE; CIBACRON BLUE; INHIBITOR; BINDING	The flavoprotein rotenone-insensitive internal NADH-ubiquinone (UQ) oxidoreductase (Ndi1) is a member of the respiratory chain in Saccharomyces cerevisiae. We reported previously that bound UQ in Ndi1 plays a key role in preventing the generation of reactive oxygen species. Here, to elucidate this mechanism, we investigated biochemical properties of Ndi1 and its mutants in which highly conserved amino acid residues (presumably involved in NADH and/or UQ binding sites) were replaced. We found that wild-type Ndi1 formed a stable charge transfer (CT) complex (around 740 nm) with NADH, but not with NADPH, under anaerobic conditions. The intensity of the CT absorption band was significantly increased by the presence of bound UQ or externally added n-decylbenzoquinone. Interestingly, however, when Ndi1 was exposed to air, the CT band transiently reached the same maximum level regardless of the presence of UQ. This suggests that Ndi1 forms a ternary complex with NADH and UQ, but the role of UQ in withdrawing an electron can be substitutable with oxygen. Proteinase K digestion analysis showed that NADH (but not NADPH) binding induces conformational changes in Ndi1. The kinetic study of wild-type and mutant Ndi1 indicated that there is no overlap between NADH and UQ binding sites. Moreover, we found that the bound UQ can reversibly dissociate from Ndi1 and is thus replaceable with other quinones in the membrane. Taken together, unlike other NAD(P)H-UQ oxidoreductases, the Ndi1 reaction proceeds through a ternary complex (not a ping-pong) mechanism. The bound UQ keeps oxygen away from the reduced flavin.	[Yang, Yu; Yamashita, Tetsuo; Hashimoto, Takeshi; Igarashi, Junsuke; Kosaka, Hiroaki] Kagawa Univ, Dept Cardiovasc Physiol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Mori, Nozomu] Kagawa Univ, Dept Otolaryngol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Nakamaru-Ogiso, Eiko] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA; [Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Yang, Yu] China Med Univ, Fac Basic Med, Dept Physiol, Shenyang 110001, Peoples R China	Kagawa University; Kagawa University; University of Pennsylvania; Kyoto University; Scripps Research Institute; China Medical University	Yamashita, T (corresponding author), Kagawa Univ, Dept Cardiovasc Physiol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tyama@med.kagawa-u.ac.jp		Murai, Masatoshi/0000-0001-6601-2854	National Institutes of Health [R01GM033712]; Japan Society for the Promotion of Science [19870016]; Kagawa University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590933] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 (to T. Yagi). This work was also supported by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) 19870016 (to T. Yamashita) and by the fund for Kagawa University Young Scientists 2007 (to T. Yamashita).	Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Chen SA, 1999, MOL PHARMACOL, V56, P272, DOI 10.1124/mol.56.2.272; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; ERNSTER L, 1957, BIOCHIM BIOPHYS ACTA, V26, P408, DOI 10.1016/0006-3002(57)90023-9; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; GARTEN S, 1971, BIOCHEM PHARMACOL, V20, P1661, DOI 10.1016/0006-2952(71)90294-2; HOSODA S, 1974, J BIOL CHEM, V249, P6416; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kozlov AV, 1998, BIOORG CHEM, V26, P334, DOI 10.1006/bioo.1998.1109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; MASSEY V, 1963, BIOCHEM Z, V338, P474; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; NONAKA Y, 1986, J BIOCHEM-TOKYO, V99, P803, DOI 10.1093/oxfordjournals.jbchem.a135540; PRESTERA T, 1992, BIOCHEMISTRY-US, V31, P824, DOI 10.1021/bi00118a027; PROCHASKA HJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P529, DOI 10.1016/0003-9861(88)90060-4; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; SCHIRMER RH, 1987, COENZYMES COFACTOR B, V2, P333; Schmid R, 2004, FEBS LETT, V578, P163, DOI 10.1016/j.febslet.2004.10.093; SCHNEIDER H, 1980, J BIOL CHEM, V255, P3748; SCHNEIDER H, 1982, J BIOL CHEM, V257, P789; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Velazquez I, 2001, ARCH BIOCHEM BIOPHYS, V389, P7, DOI 10.1006/abbi.2001.2293; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; YAGI T, 2004, RESP ARCHAEA BACTERI, P15; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	40	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9287	9297		10.1074/jbc.M110.175547	http://dx.doi.org/10.1074/jbc.M110.175547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220430	hybrid, Green Published			2022-12-25	WOS:000288247700059
J	Sakamoto, K; Bu, GJ; Chen, S; Takei, Y; Hibi, K; Kodera, Y; McCormick, LM; Nakao, A; Noda, M; Muramatsu, T; Kadomatsu, K				Sakamoto, Kazuma; Bu, Guojun; Chen, Sen; Takei, Yoshifumi; Hibi, Kenji; Kodera, Yasuhiro; McCormick, Lynn M.; Nakao, Akimasa; Noda, Masaharu; Muramatsu, Takashi; Kadomatsu, Kenji			Premature Ligand-Receptor Interaction during Biosynthesis Limits the Production of Growth Factor Midkine and Its Receptor LDL Receptor-related Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; ALZHEIMER-DISEASE; DIFFERENTIAL FUNCTIONS; MOLECULAR CHAPERONE; AUTOCRINE SECRETION; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; BETA-PEPTIDE; BINDING	Protein production within the secretory pathway is accomplished by complex but organized processes. Here, we demonstrate that the growth factor midkine interacts with LDL receptor-related protein 1 (LRP1) at high affinity (K-d value, 2.7 nM) not only at the cell surface but also within the secretory pathway during biosynthesis. The latter premature ligand-receptor interaction resulted in aggregate formation and consequently suppressed midkine secretion and LRP1 maturation. We utilized an endoplasmic reticulum (ER) retrieval signal and an LRP1 fragment, which strongly bound to midkine and the LRP1-specialized chaperone receptor-associated protein (RAP), to construct an ER trapper. The ER trapper efficiently trapped midkine and RAP and mimicked the premature ligand-receptor interaction, i.e. suppressed maturation of the ligand and receptor. The ER trapper also diminished the inhibitory function of LRP1 on platelet-derived growth factor-mediated cell migration. Complementary to these results, an increased expression of RAP was closely associated with midkine expression in human colorectal carcinomas (33 of 39 cases examined). Our results suggest that the premature ligand-receptor interaction plays a role in protein production within the secretory pathway.	[Sakamoto, Kazuma; Chen, Sen; Takei, Yoshifumi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Aichi 4668550, Japan; [Hibi, Kenji; Kodera, Yasuhiro; Nakao, Akimasa] Nagoya Univ, Grad Sch Med, Dept Surg, Showa Ku, Aichi 4668550, Japan; [Bu, Guojun; McCormick, Lynn M.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bu, Guojun; McCormick, Lynn M.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Muramatsu, Takashi] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Aichi 4800195, Japan	Nagoya University; Nagoya University; Washington University (WUSTL); Washington University (WUSTL); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Aichi Gakuin University	Kadomatsu, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	TAKEI, Yoshifumi/I-7260-2014; Kodera, Yasuhiro/M-4912-2014; Noda, Masaharu/D-7146-2016; Sakamoto, Kazuma/B-7347-2016; Kadomatsu, Kenji/G-8083-2012	Noda, Masaharu/0000-0002-3796-524X; 	National Institutes of Health [R01 AG027924]; Ministry of Education, Culture, Sports, Science and Technology, Japan [20390092]; Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University); NATIONAL INSTITUTE ON AGING [R01AG027924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG027924 (to G. B.). This work was also supported by Grant-in-aid 20390092 from Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. K.) and by the Global Center of Excellence program from Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University).	BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; DUNBAR CE, 1989, SCIENCE, V245, P1493, DOI 10.1126/science.2789432; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Ikematsu S, 2003, BRIT J CANCER, V88, P1522, DOI 10.1038/sj.bjc.6600938; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KOJIMA S, 1995, J BIOL CHEM, V270, P9590, DOI 10.1074/jbc.270.16.9590; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Mashour GA, 2001, ONCOGENE, V20, P97, DOI 10.1038/sj.onc.1204026; Muramatsu H, 2000, BIOCHEM BIOPH RES CO, V270, P936, DOI 10.1006/bbrc.2000.2549; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; REBECK GW, 1993, NEURON, V11, P575; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; SPORN MB, 1992, ANN INTERN MED, V117, P408, DOI 10.7326/0003-4819-117-5-408; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takei Y, 2001, CANCER RES, V61, P8486; Takei Y, 2006, CANCER, V107, P864, DOI 10.1002/cncr.22068; Tamamizu-Kato S, 2008, BIOCHEMISTRY-US, V47, P5225, DOI 10.1021/bi702097s; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; TSUTSUI J, 1993, CANCER RES, V53, P1281; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; YASUHARA O, 1993, BIOCHEM BIOPH RES CO, V192, P246, DOI 10.1006/bbrc.1993.1406; Ye C, 1999, BRIT J CANCER, V79, P179, DOI 10.1038/sj.bjc.6690030	46	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8405	8413		10.1074/jbc.M110.176479	http://dx.doi.org/10.1074/jbc.M110.176479			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212259	hybrid, Green Published			2022-12-25	WOS:000288013300069
J	Copsel, S; Garcia, C; Diez, F; Vermeulem, M; Baldi, A; Bianciotti, LG; Russel, FGM; Shayo, C; Davio, C				Copsel, Sabrina; Garcia, Corina; Diez, Federico; Vermeulem, Monica; Baldi, Alberto; Bianciotti, Liliana G.; Russel, Frans G. M.; Shayo, Carina; Davio, Carlos			Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; SIGNALING MOLECULES; MRP4 ABCC4; EFFLUX PUMP; NUCLEOTIDES; EXPRESSION; TRANSPORT; DRUGS; U937; RECEPTORS	Increased intracellular cAMP concentration plays a well established role in leukemic cell maturation. We previously reported that U937 cells stimulated by H2 receptor agonists, despite a robust increase in cAMP, fail to mature because of rapid H2 receptor desensitization and phosphodiesterase (PDE) activation. Here we show that intracellular cAMP levels not only in U937 cells but also in other acute myeloid leukemia cell lines are also regulated by multidrug resistance-associated proteins (MRPs), particularly MRP4. U937, HL-60, and KG-1a cells, exposed to amthamine (H2-receptor agonist), augmented intracellular cAMP concentration with a concomitant increase in the efflux. Extrusion of cAMP was ATP-dependent and probenecid-sensitive, supporting that the transport was MRP-mediated. Cells exposed to amthamine and the PDE4 inhibitor showed enhanced cAMP extrusion, but this response was inhibited by MRP blockade. Amthamine stimulation, combined with PDE4 and MRP inhibition, induced maximal cell arrest proliferation. Knockdown strategy by shRNA revealed that this process was mediated by MRP4. Furthermore, blockade by probenecid or MRP4 knockdown showed that increased intracellular cAMP levels induce maturation in U937 cells. These findings confirm the key role of intracellular cAMP levels in leukemic cell maturation and provide the first evidence that MRP4 may represent a new potential target for leukemia differentiation therapy.	[Copsel, Sabrina; Garcia, Corina; Diez, Federico; Davio, Carlos] Univ Buenos Aires, Lab Farmacol Receptores, Catedra Quim Med, Dept Farmacol,Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina; [Copsel, Sabrina; Baldi, Alberto; Shayo, Carina] Inst Biol & Med Expt, Lab Patol & Farmacol Mol, RA-1428 Buenos Aires, DF, Argentina; [Copsel, Sabrina; Garcia, Corina; Vermeulem, Monica; Baldi, Alberto; Bianciotti, Liliana G.; Shayo, Carina; Davio, Carlos] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Vermeulem, Monica] Acad Nacl Med Buenos Aires, Dept Inmunol, Inst Invest Hematol, RA-1425 Buenos Aires, DF, Argentina; [Bianciotti, Liliana G.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiopatol, Dept Ciencias Biol, RA-1113 Buenos Aires, DF, Argentina; [Russel, Frans G. M.] Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 HP Nijmegen, Netherlands	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires; Radboud University Nijmegen	Davio, C (corresponding author), Junin 956 PP 1113, Buenos Aires, DF, Argentina.	cardavio@ffyb.uba.ar	Copsel, Sabrina/I-2245-2019; Baldi, Alfonso/ABG-2397-2021; Russel, Frans G.M./B-3184-2014	Copsel, Sabrina/0000-0001-5465-9052; Russel, Frans G.M./0000-0002-7959-2314; Bianciotti, Liliana Graciela/0000-0001-5410-4516	Universidad de Buenos Aires [UBACyT B0-50]; Consejo Nacional de Investigaciones Cientificas y Tecnologica [PIP 6110]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 38318, 01725]; National Institutes of Health, NCI [NO2-CO-41101]; Union for International Cancer Control International Cancer Technology; NATIONAL CANCER INSTITUTE [R01CA041101] Funding Source: NIH RePORTER	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Union for International Cancer Control International Cancer Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Universidad de Buenos Aires (Grant UBACyT B0-50); Consejo Nacional de Investigaciones Cientificas y Tecnologica (PIP 6110), and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 38318 and 01725). This work was supported, in whole or in part, by National Institutes of Health Contract NO2-CO-41101 from the NCI (to S. C.), and this work was also supported by a Union for International Cancer Control International Cancer Technology Transfer Fellowship (to S. C.).	Adachi M, 2002, ADV DRUG DELIVER REV, V54, P1333, DOI 10.1016/S0169-409X(02)00166-7; Andric SA, 2006, ENDOCRINOLOGY, V147, P3435, DOI 10.1210/en.2006-0091; Bankir L, 2002, AM J PHYSIOL-RENAL, V282, pF376, DOI 10.1152/ajprenal.00202.2001; Burg M, 1996, J IMMUNOL, V157, P5574; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Chou WC, 2005, BLOOD, V106, P304, DOI 10.1182/blood-2005-01-0241; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Fernandez N, 2002, MOL PHARMACOL, V62, P1506, DOI 10.1124/mol.62.6.1506; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YP, 2009, CLIN CANCER RES, V15, P1762, DOI 10.1158/1078-0432.CCR-08-0442; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; HENDRIE PC, 1994, INT J IMMUNOPHARMACO, V16, P547, DOI 10.1016/0192-0561(94)90106-6; HONMA Y, 1978, BIOCHEM BIOPH RES CO, V82, P1246, DOI 10.1016/0006-291X(78)90321-2; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Kobsar A, 2008, STEM CELLS DEV, V17, P81, DOI 10.1089/scd.2007.0060; Lee AW, 1999, BLOOD, V93, P537, DOI 10.1182/blood.V93.2.537.402k30_537_553; Legnazzi BL, 2000, BIOCHEM PHARMACOL, V60, P159, DOI 10.1016/S0006-2952(00)00295-1; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Monczor F, 2006, BIOCHEM PHARMACOL, V71, P1219, DOI 10.1016/j.bcp.2005.12.037; Negrotto S, 2006, EXP HEMATOL, V34, P1420, DOI 10.1016/j.exphem.2006.05.017; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oevermann L, 2009, INT J CANCER, V124, P2303, DOI 10.1002/ijc.24207; PINTO A, 1992, P NATL ACAD SCI USA, V89, P8884, DOI 10.1073/pnas.89.19.8884; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Sassi Y, 2009, CELL CYCLE, V8, P962; SCAVENNEC J, 1981, CANCER RES, V41, P3222; Shayo C, 1997, MOL PHARMACOL, V51, P983, DOI 10.1124/mol.51.6.983; Shayo C, 2004, BIOCHEM BIOPH RES CO, V314, P798, DOI 10.1016/j.bbrc.2003.12.166; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	40	120	129	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6979	6988		10.1074/jbc.M110.166868	http://dx.doi.org/10.1074/jbc.M110.166868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21205825	Green Published, hybrid			2022-12-25	WOS:000287737300014
J	Yuan, F; Xie, Q; Wu, JB; Bai, YJ; Mao, BB; Dong, YL; Bi, WZ; Ji, GJ; Tao, WF; Wang, Y; Yuan, ZQ				Yuan, Fang; Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Dong, Yongli; Bi, Wenzhi; Ji, Guangju; Tao, Wufan; Wang, Yan; Yuan, Zengqiang			MST1 Promotes Apoptosis through Regulating Sirt1-dependent p53 Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; HISTONE DEACETYLASE; CELL-PROLIFERATION; CALORIE RESTRICTION; STERILE-20 KINASE; PHOSPHORYLATION; ACTIVATION; CASPASE; SIRT1; SURVIVAL	Mammalian Sterile 20-like kinase 1 (MST1) protein kinase plays an important role in the apoptosis induced by a variety of stresses. The MST1 is a serine/threonine kinase that is activated upon apoptotic stimulation, which in turn activates its downstream targets, JNK/p38, histone H2B and FOXO. It has been reported that overexpression of MST1 initiates apoptosis by activating p53. However, the molecular mechanisms underlying MST1-p53 signaling during apoptosis are unclear. Here, we report that MST1 promotes genotoxic agent-induced apoptosis in a p53-dependent manner. We found that MST1 increases p53 acetylation and transactivation by inhibiting the deacetylation of Sirtuin 1 (Sirt1) and its interaction with p53 and that Sirt1 can be phosphorylated by MST1 leading to the inhibition of Sirt1 activity. Collectively, these findings define a novel regulatory mechanism involving the phosphorylation of Sirt1 by MST1 kinase which leads to p53 activation, with implications for our understanding of signaling mechanisms during DNA damage-induced apoptosis.	[Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Yuan, Zengqiang] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Ji, Guangju; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Yuan, Fang] Third Mil Med Univ, Chongqing 400030, Peoples R China; [Bi, Wenzhi; Wang, Yan] Chinese People Liberty Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China; [Dong, Yongli; Tao, Wufan] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Army Medical University; Chinese People's Liberation Army General Hospital; Fudan University	Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.	yanwang301@yahoo.com; zqyuan@ibp.ac.cn	Dong, Yongli/K-1222-2016	Ji, Guangju/0000-0001-8626-3490; Xie, Qi/0000-0002-2370-2078; Yuan, Zengqiang/0000-0001-5739-2867	National Science Foundation of China [30870792, 81030025]; Ministry of Science and Technology of China [973-2009CB918704, 2006CB910903]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science Foundation of China Grants 30870792 and 81030025 and the Ministry of Science and Technology of China Grants 973-2009CB918704 and 2006CB910903.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; GOLLIEB S, 1989, CELL, V56, P771; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	41	64	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6940	6945		10.1074/jbc.M110.182543	http://dx.doi.org/10.1074/jbc.M110.182543			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21212262	hybrid, Green Published			2022-12-25	WOS:000287737300009
J	Baandrup, JD; Markvardsen, LH; Peters, CD; Schou, UK; Jensen, JL; Magnusson, NE; Orntoft, TF; Kruhoffer, M; Simonsen, U				Baandrup, Jonas D.; Markvardsen, Lars H.; Peters, Christian D.; Schou, Uffe K.; Jensen, Jens L.; Magnusson, Nils E.; Orntoft, Torben F.; Kruhoffer, Mogens; Simonsen, Ulf			Pressure Load: The Main Factor for Altered Gene Expression in Right Ventricular Hypertrophy in Chronic Hypoxic Rats	PLOS ONE			English	Article							MONOAMINE-OXIDASE-A; PULMONARY-HYPERTENSION; CARDIAC-HYPERTROPHY; MICROARRAY ANALYSIS; HEART-FAILURE; MESSENGER-RNA; RECEPTOR; ENDOTHELIN; TISSUE; CELL	Background: The present study investigated whether changes in gene expression in the right ventricle following pulmonary hypertension can be attributed to hypoxia or pressure loading. Methodology/Principal Findings: To distinguish hypoxia from pressure-induced alterations, a group of rats underwent banding of the pulmonary trunk (PTB), sham operation, or the rats were exposed to normoxia or chronic, hypobaric hypoxia. Pressure measurements were performed and the right ventricle was analyzed by Affymetrix GeneChip, and selected genes were confirmed by quantitative PCR and immunoblotting. Right ventricular systolic blood pressure and right ventricle to body weight ratio were elevated in the PTB and the hypoxic rats. Expression of the same 172 genes was altered in the chronic hypoxic and PTB rats. Thus, gene expression of enzymes participating in fatty acid oxidation and the glycerol channel were downregulated. mRNA expression of aquaporin 7 was downregulated, but this was not the case for the protein expression. In contrast, monoamine oxidase A and tissue transglutaminase were upregulated both at gene and protein levels. 11 genes (e.g. insulin-like growth factor binding protein) were upregulated in the PTB experiment and downregulated in the hypoxic experiment, and 3 genes (e.g. c-kit tyrosine kinase) were downregulated in the PTB and upregulated in the hypoxic experiment. Conclusion/Significance: Pressure load of the right ventricle induces a marked shift in the gene expression, which in case of the metabolic genes appears compensated at the protein level, while both expression of genes and proteins of importance for myocardial function and remodelling are altered by the increased pressure load of the right ventricle. These findings imply that treatment of pulmonary hypertension should also aim at reducing right ventricular pressure.	[Baandrup, Jonas D.; Markvardsen, Lars H.; Magnusson, Nils E.; Simonsen, Ulf] Aarhus Univ, Dept Pharmacol, DK-8000 Aarhus, Denmark; [Peters, Christian D.; Schou, Uffe K.] Aarhus Univ, Water & Salt Res Ctr, Dept Anat, Aarhus, Denmark; [Jensen, Jens L.] Aarhus Univ, Inst Math, Dept Theoret Stat, DK-8000 Aarhus, Denmark; [Orntoft, Torben F.; Kruhoffer, Mogens] Aarhus Univ Hosp, Mol Diagnost Lab, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Baandrup, JD (corresponding author), Aarhus Univ, Dept Pharmacol, Univ Pk 240, DK-8000 Aarhus, Denmark.	us@farm.au.dk	Jensen, Jens Ledet/B-7172-2008	Jensen, Jens Ledet/0000-0002-8776-5764; Magnusson, Nils Erik/0000-0002-9614-0133; Markvardsen, Lars Hoj/0000-0002-5562-9768; Love, Uffe Schou/0000-0002-2409-0499; Peters, Christian Daugaard/0000-0002-4917-1535	Danish Heart Foundation; Danish Lung Foundation; Danish Research Council	Danish Heart Foundation; Danish Lung Foundation; Danish Research Council(Det Frie Forskningsrad (DFF))	Jonas Baandrup was supported by the Danish Heart Foundation, and Ulf Simonsen was supported by the Danish Lung Foundation and the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Bianchi P, 2005, CIRCULATION, V112, P3297, DOI 10.1161/CIRCULATIONAHA.104.528133; Bianchi P, 2005, FASEB J, V19, P641, DOI 10.1096/fj.04-2518fje; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bull Todd M, 2007, Proc Am Thorac Soc, V4, P117, DOI 10.1513/pats.200605-128JG; Butler TL, 2006, AM J PHYSIOL-HEART C, V291, pH705, DOI 10.1152/ajpheart.00090.2006; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen SJ, 1995, J APPL PHYSIOL, V79, P2122, DOI 10.1152/jappl.1995.79.6.2122; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Ecarnot-Laubriet A, 2002, BBA-MOL BASIS DIS, V1586, P233, DOI 10.1016/S0925-4439(01)00101-6; Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Faber JE, 2007, AM J PHYSIOL-HEART C, V292, pH2316, DOI 10.1152/ajpheart.00792.2006; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gaynor SL, 2005, CIRCULATION, V112, pI212, DOI 10.1161/CIRCULATIONAHA.104.517789; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Gharib SA, 2005, PHYSIOL GENOMICS, V22, P14, DOI 10.1152/physiolgenomics.00265.2004; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Hwang DM, 2000, GENOMICS, V66, P1, DOI 10.1006/geno.2000.6171; Iglarz M, 2010, CLIN SCI, V119, P453, DOI 10.1042/CS20100222; Jiang YL, 2007, ACTA BIOCH BIOPH SIN, V39, P73, DOI 10.1111/j.1745-7270.2007.00249.x; Kisch-Wedel H, 2003, INTENS CARE MED, V29, P1574, DOI 10.1007/s00134-003-1891-z; Kogler H, 2003, CIRC RES, V93, P230, DOI 10.1161/01.RES.0000085042.89656.C7; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Montalescot G, 1998, AM J CARDIOL, V82, P749, DOI 10.1016/S0002-9149(98)00439-1; Mulder P, 1997, CIRCULATION, V96, P1976, DOI 10.1161/01.CIR.96.6.1976; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Park HK, 2001, PHARMACOL RES, V43, P265, DOI 10.1006/phrs.2000.0777; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Rodriguez MJ, 2001, CELL TISSUE RES, V304, P215, DOI 10.1007/s004410100361; Schou Uffe K., 2007, Journal of Experimental Animal Science, V43, P237, DOI 10.1016/j.jeas.2006.10.004; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Sivasubramaniam SD, 2003, CELL TISSUE RES, V313, P291, DOI 10.1007/s00441-003-0765-6; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Wakayama Y, 2004, CELL TISSUE RES, V316, P123, DOI 10.1007/s00441-004-0857-y	47	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15859	10.1371/journal.pone.0015859	http://dx.doi.org/10.1371/journal.pone.0015859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246034	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511200023
J	Danilova, N; Kumagai, A; Lin, J				Danilova, Nadia; Kumagai, Asako; Lin, Jenny			p53 Upregulation Is a Frequent Response to Deficiency of Cell-Essential Genes	PLOS ONE			English	Article							DNA-DAMAGE; RIBOSOME BIOGENESIS; ZEBRAFISH; ACTIVATION; APOPTOSIS; LEADS; MUTATIONS; MODEL; MICE; IDENTIFICATION	Background: The role of p53 in the prevention of development of embryos damaged by genotoxic factors is well recognized. However, whether p53 plays an analogous role in preventing birth defects from genetic mutations remains an unanswered question. Genetic screens for mutations affecting development show that only a fraction of developmentally lethal mutations leads to specific phenotypes while the majority results in similar recurrent phenotypes characterized by neuronal apoptosis and developmental delay. Mutations in cell-essential genes typically fall into this group. The observation that mutations in diverse housekeeping genes lead to a similar phenotype suggests a common mechanism underlying this phenotype. For some mutants, p53 inhibition was shown to attenuate the phenotype. Methodology/Principal Findings: To find out how common p53 involvement is in this phenotype, we analyzed zebrafish mutants from various categories of cell essential genes. Several thousand zebrafish mutants have been identified; many of them are kept at stock centers and available for the research community. We selected mutants for genes functioning in DNA replication, transcription, telomere maintenance, ribosome biogenesis, splicing, chaperoning, endocytosis, and cellular transport. We found that mutants have similar phenotypes including neural apoptosis, failure to develop structures originated from the neural crest cells, and hematopoietic defects. All mutants share p53 upregulation and similar changes in several p53-dependent and independent molecular pathways. Conclusion/Significance: Our results suggest that mutations in housekeeping genes often canalize on the p53-mediated phenotype. p53 prevents the development of embryos with defects in such genes. p53-mediated changes in gene expression may also contribute to many human congenital malformations.	[Danilova, Nadia; Kumagai, Asako; Lin, Jenny] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Danilova, N (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	ndanilova@ucla.edu			Diamond Blackfan Anemia Foundation; National Institutes of Health [R01HL97561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	Diamond Blackfan Anemia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Diamond Blackfan Anemia Foundation and the National Institutes of Health research grant R01HL97561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Danilova N, 2011, BRIT J HAEMATOL, V152, P217, DOI 10.1111/j.1365-2141.2010.08396.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Danilova Nadia, 2008, Birth Defects Research, V84, P215, DOI 10.1002/bdrc.20129; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Driever W, 1996, DEVELOPMENT, V123, P37; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; HAFTER P, 1996, DEVELOPMENT, V123, P1; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall PA, 1997, CURR BIOL, V7, pR144, DOI 10.1016/S0960-9822(97)70074-5; Heyer BS, 2000, GENE DEV, V14, P2072; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; THISSE C, 1993, DEVELOPMENT, V119, P1203; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2	35	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15938	10.1371/journal.pone.0015938	http://dx.doi.org/10.1371/journal.pone.0015938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209837	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900051
J	Palstra, AP; Tudorache, C; Rovira, M; Brittijn, SA; Burgerhout, E; van den Thillart, GEEJM; Spaink, HP; Planas, JV				Palstra, Arjan P.; Tudorache, Christian; Rovira, Mireia; Brittijn, Sebastiaan A.; Burgerhout, Erik; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.; Planas, Josep V.			Establishing Zebrafish as a Novel Exercise Model: Swimming Economy, Swimming-Enhanced Growth and Muscle Growth Marker Gene Expression	PLOS ONE			English	Article							SKELETAL-MUSCLE; DANIO-RERIO; BRACHYDANIO-RERIO; HUMAN-DISEASE; SYSTEM; ADULT; TROUT; RECEPTORS; MYOSTATIN; PERFORMANCE	Background: Zebrafish has been largely accepted as a vertebrate multidisciplinary model but its usefulness as a model for exercise physiology has been hampered by the scarce knowledge on its swimming economy, optimal swimming speeds and cost of transport. Therefore, we have performed individual and group-wise swimming experiments to quantify swimming economy and to demonstrate the exercise effects on growth in adult zebrafish. Methodology/Principal Findings: Individual zebrafish (n = 10) were able to swim at a critical swimming speed (U-crit) of 0.548+/-0.007 m s(-1) or 18.0 standard body lengths (BL) s(-1). The optimal swimming speed (U-opt) at which energetic efficiency is highest was 0.396+/-0.019 m s(-1) (13.0 BL s(-1)) corresponding to 72.26+/-0.29% of U-crit. The cost of transport at optimal swimming speed (COTopt) was 25.23+/-4.03 mu mol g(-1) m(-1). A group-wise experiment was conducted with zebrafish (n = 83) swimming at U-opt for 6 h day(-1) for 5 days week(-1) for 4 weeks vs. zebrafish (n = 84) that rested during this period. Swimming zebrafish increased their total body length by 5.6% and body weight by 41.1% as compared to resting fish. For the first time, a highly significant exercise-induced growth is demonstrated in adult zebrafish. Expression analysis of a set of muscle growth marker genes revealed clear regulatory roles in relation to swimming-enhanced growth for genes such as growth hormone receptor b (ghrb), insulin-like growth factor 1 receptor a (igf1ra), troponin C (stnnc), slow myosin heavy chain 1 (smyhc1), troponin I2 (tnni2), myosin heavy polypeptide 2 (myhz2) and myostatin (mstnb). Conclusions/Significance: From the results of our study we can conclude that zebrafish can be used as an exercise model for enhanced growth, with implications in basic, biomedical and applied sciences, such as aquaculture.	[Palstra, Arjan P.; Rovira, Mireia; Planas, Josep V.] Univ Barcelona, IBUB, Fac Biol, Dept Fisiol, Barcelona, Spain; [Palstra, Arjan P.; Tudorache, Christian; Brittijn, Sebastiaan A.; Burgerhout, Erik; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] Leiden Univ IBL, Inst Biol, Sylvius Lab, Leiden, Netherlands	University of Barcelona; Leiden University; Leiden University - Excl LUMC	Palstra, AP (corresponding author), Univ Barcelona, IBUB, Fac Biol, Dept Fisiol, Barcelona, Spain.	palstra@ub.edu	Palstra, Arjan/B-4122-2013; Burgerhout, Erik/AAI-4527-2020; Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Rovira, Mireia/0000-0003-4050-1662; Tudorache, Christian/0000-0002-6208-9608; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [CSD2007-0002]; European Commission (REPRO-SWIM) [219971]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission (REPRO-SWIM)(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 to J. V. Planas). A. P. Palstra was supported by a Marie Curie Intra-European Fellowship from the European Commission (REPRO-SWIM) with Grant Agreement number 219971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amali AA, 2004, DEV DYNAM, V229, P847, DOI 10.1002/dvdy.10454; [Anonymous], 2003, STRENGTH POWER SPORT; Batt J, 2005, FASEB J, DOI [10.1096/04-3640fje, DOI 10.1096/04-3640FJE]; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; DAVISON W, 1977, J EXP BIOL, V70, P1; DAVISON W, 1989, COMP BIOCHEM PHYS A, V94, P1, DOI 10.1016/0300-9629(89)90775-5; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; de Vocht A, 1999, BASISHANDBOEK SPSS 8; Di Prinzio CM, 2010, GENE EXPR PATTERNS, V10, P214, DOI 10.1016/j.gep.2010.03.001; Duan CM, 1997, AM ZOOL, V37, P491; EAST P, 1987, CAN J ZOOL, V65, P843, DOI 10.1139/z87-134; Fox BK, 2010, GEN COMP ENDOCR, V166, P573, DOI 10.1016/j.ygcen.2009.11.012; Gerhard GS, 2003, EXP GERONTOL, V38, P1333, DOI 10.1016/j.exger.2003.10.022; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; KAUFMANN R, 1990, J EXP BIOL, V150, P343; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LeMoine CMR, 2010, J COMP PHYSIOL B, V180, P151, DOI 10.1007/s00360-009-0398-5; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCAS MC, 1992, J FISH BIOL, V41, P175, DOI 10.1111/j.1095-8649.1992.tb02648.x; Martin CI, 2005, J EXP BIOL, V208, P2083, DOI 10.1242/jeb.01605; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Morales R, 2001, ELEC J BIOTECH, V4, P51; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; PLAUT I, 1994, J EXP BIOL, V194, P209; Plaut I, 2000, J EXP BIOL, V203, P813; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; TOTLAND GK, 1987, AQUACULTURE, V66, P299, DOI 10.1016/0044-8486(87)90115-3; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Tudorache C, 2007, J FISH BIOL, V71, P1630, DOI 10.1111/j.1095-8649.2007.01620.x; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.0022-1112.2004.00447.x; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; VANRAAMSDONK W, 1983, ANAT EMBRYOL, V167, P125; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; WALKER MG, 1978, J FISH BIOL, V13, P475, DOI 10.1111/j.1095-8649.1978.tb03457.x; Xu C, 2003, J EXP BIOL, V206, P4067, DOI 10.1242/jeb.00635; Xu XP, 2008, VIROLOGY, V376, P1, DOI 10.1016/j.virol.2007.12.026	56	87	90	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14483	10.1371/journal.pone.0014483	http://dx.doi.org/10.1371/journal.pone.0014483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217817	Green Published, gold			2022-12-25	WOS:000285838900012
J	Voelz, K; Johnston, SA; Rutherford, JC; May, RC				Voelz, Kerstin; Johnston, Simon A.; Rutherford, Julian C.; May, Robin C.			Automated Analysis of Cryptococcal Macrophage Parasitism Using GFP-Tagged Cryptococci	PLOS ONE			English	Article							INTRACELLULAR PARASITISM; ALVEOLAR MACROPHAGES; FLUORESCENT PROTEINS; PULMONARY CRYPTOCOCCOSIS; MONONUCLEAR PHAGOCYTES; NEOFORMANS INFECTION; MURINE MACROPHAGES; BRITISH-COLUMBIA; VANCOUVER-ISLAND; HUMAN-MONOCYTES	The human fungal pathogens Cryptococcus neoformans and C. gattii cause life-threatening infections of the central nervous system. One of the major characteristics of cryptococcal disease is the ability of the pathogen to parasitise upon phagocytic immune effector cells, a phenomenon that correlates strongly with virulence in rodent models of infection. Despite the importance of phagocyte/Cryptococcus interactions to disease progression, current methods for assaying virulence in the macrophage system are both time consuming and low throughput. Here, we introduce the first stable and fully characterised GFP-expressing derivatives of two widely used cryptococcal strains: C. neoformans serotype A type strain H99 and C. gattii serotype B type strain R265. Both strains show unaltered responses to environmental and host stress conditions and no deficiency in virulence in the macrophage model system. In addition, we report the development of a method to effectively and rapidly investigate macrophage parasitism by flow cytometry, a technique that preserves the accuracy of current approaches but offers a four-fold improvement in speed.	[Voelz, Kerstin; Johnston, Simon A.; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Rutherford, Julian C.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Birmingham; Newcastle University - UK	Voelz, K (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	R.C.May@bham.ac.uk	Voelz, Kerstin/A-8888-2011; Johnston, Simon/G-4515-2010; May, Robin Charles/ABA-9266-2021	Voelz, Kerstin/0000-0003-0973-4353; May, Robin Charles/0000-0001-5364-1838; Johnston, Simon/0000-0002-3429-9536	Medical Research Council [G0601171]; Wellcome Trust [088148MF]; Darwin Trust; Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council [BB/H006605/1] Funding Source: researchfish; BBSRC [BB/H006605/1] Funding Source: UKRI; MRC [G0601171] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Darwin Trust; Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by grants from the Medical Research Council, grant G0601171 (http://www.mrc.ac.uk/), the Wellcome Trust, grant 088148MF (http://www.wellcome.ac.uk) and a Darwin Trust PhD studentship to KV. The A1R confocal used in this research was obtained through Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West Midlands (AWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2008, CELL MICROBIOL, V10, P1622, DOI 10.1111/j.1462-5822.2008.01152.x; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Alvarez M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-51; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; BOBAK DA, 1988, J IMMUNOL, V141, P592; BOLANOS B, 1989, J MED VET MYCOL, V27, P203; BRUMMER E, 1994, CELL IMMUNOL, V157, P1, DOI 10.1006/cimm.1994.1200; BULMER GS, 1967, J BACTERIOL, V94, P1480, DOI 10.1128/JB.94.5.1480-1483.1967; BULMER GS, 1975, INFECT IMMUN, V11, P73, DOI 10.1128/IAI.11.1.73-79.1975; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; CAMPBELL GD, 1966, AM REV RESPIR DIS, V94, P236; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cross CE, 1997, IMMUNOLOGY, V91, P289, DOI 10.1046/j.1365-2567.1997.00238.x; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; DIAMOND RD, 1973, INFECT IMMUN, V7, P231, DOI 10.1128/IAI.7.2.231-236.1973; Dong XL, 2004, NUCLEIC ACIDS RES, V32, pW660, DOI 10.1093/nar/gkh410; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Geunes-Boyer S, 2009, INFECT IMMUN, V77, P2783, DOI 10.1128/IAI.00088-09; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GRIFFIN FM, 1981, P NATL ACAD SCI-BIOL, V78, P3853, DOI 10.1073/pnas.78.6.3853; Hu GG, 2010, EUKARYOT CELL, V9, P74, DOI 10.1128/EC.00289-09; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Knodler LA, 2005, INFECT IMMUN, V73, P7027, DOI 10.1128/IAI.73.10.7027-7031.2005; KOZEL TR, 1988, INFECT IMMUN, V56, P2794, DOI 10.1128/IAI.56.11.2794-2800.1988; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Levitz SM, 1997, J CLIN INVEST, V100, P1640, DOI 10.1172/JCI119688; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; MILLER MF, 1991, INFECT IMMUN, V59, P24, DOI 10.1128/IAI.59.1.24-28.1991; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; MITCHELL TG, 1972, INFECT IMMUN, V5, P491, DOI 10.1128/IAI.5.4.491-498.1972; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Monari C, 2003, EUR J IMMUNOL, V33, P1041, DOI 10.1002/eji.200323388; Nadrous HF, 2003, CHEST, V124, p95S, DOI 10.1016/S0012-3692(16)60136-8; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; RALPH P, 1975, J IMMUNOL, V114, P898; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Voelz K, 2009, INFECT IMMUN	60	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15968	10.1371/journal.pone.0015968	http://dx.doi.org/10.1371/journal.pone.0015968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209844	Green Published, gold, Green Accepted			2022-12-25	WOS:000285838900055
J	Binder, M; Lechenne, B; Ummanni, R; Scharf, C; Balabanov, S; Trusch, M; Schluter, H; Braren, I; Spillner, E; Trepel, M				Binder, Mascha; Lechenne, Barbara; Ummanni, Ramesh; Scharf, Christan; Balabanov, Stefan; Trusch, Maria; Schlueter, Hartmut; Braren, Ingke; Spillner, Edzard; Trepel, Martin			Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN GENES; RHEUMATOID-ARTHRITIS; VIMENTIN; ANTIBODIES; LYMPHOMAS; CLL; CALRETICULIN; SPECIFICITY; EXPRESSION; APOPTOSIS	Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Survival of CLL cells depends on their close contact with stromal cells in lymphatic tissues, bone marrow and blood. This microenvironmental regulation of CLL cell survival involves the stromal secretion of chemo- and cytokines as well as the expression of adhesion molecules. Since CLL survival may also be driven by antigenic stimulation through the B-cell antigen receptor (BCR), we explored the hypothesis that these processes may be linked to each other. We tested if stromal cells could serve as an antigen reservoir for CLL cells, thus promoting CLL cell survival by stimulation through the BCR. As a proof of principle, we found that two CLL BCRs with a common stereotyped heavy chain complementarity-determining region 3 (previously characterized as "subset 1") recognize antigens highly expressed in stromal cells - vimentin and calreticulin. Both antigens are well-documented targets of autoantibodies in autoimmune disorders. We demonstrated that vimentin is displayed on the surface of viable stromal cells and that it is present and bound by the stereotyped CLL BCR in CLL-stroma co-culture supernatant. Blocking the vimentin antigen by recombinant soluble CLL BCR under CLL-stromal cell co-culture conditions reduces stroma-mediated anti-apoptotic effects by 20-45%. We therefore conclude that CLL BCR stimulation by stroma-derived antigens can contribute to the protective effect that the stroma exerts on CLL cells. This finding sheds a new light on the understanding of the pathobiology of this so far mostly incurable disease.	[Binder, Mascha; Lechenne, Barbara; Ummanni, Ramesh; Balabanov, Stefan; Trepel, Martin] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol, Hamburg, Germany; [Scharf, Christan] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol, Greifswald, Germany; [Trusch, Maria; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Braren, Ingke; Spillner, Edzard] Univ Hamburg, Dept Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Binder, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol, Hamburg, Germany.	m.trepel@uke.de	Balabanov, Stefan/E-9765-2014; Riedner, Maria/W-5546-2019; Scharf, Christian/A-7931-2011; Schluter, Hartmut/D-1371-2015; Spillner, E./G-3799-2010	Scharf, Christian/0000-0001-6806-6450; Schluter, Hartmut/0000-0002-9358-7036; spillner, edzard/0000-0003-0999-5254; Binder, Mascha/0000-0003-0663-3004	German Jose Carreras International Leukemia Foundation [R07/29f]; German Cancer Aid [108239]	German Jose Carreras International Leukemia Foundation; German Cancer Aid(Deutsche Krebshilfe)	This study was funded by the German Jose Carreras International Leukemia Foundation (grant R07/29f to MT) and the German Cancer Aid (grant 108239 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOHN W, 1992, EXP CELL RES, V201, P1, DOI 10.1016/0014-4827(92)90341-5; Braren I, 2007, BIOTECHNOL APPL BIOC, V47, P205, DOI 10.1042/BA20060170; Braren I, 2007, CLIN CHEM, V53, P837, DOI 10.1373/clinchem.2006.078360; BUCHNER M, 2009, BLOOD, V114, P2356; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; DIGHIERO G, 1991, BLOOD, V78, P581; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; MATUTES E, 1994, LEUKEMIA, V8, P1640; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; MYHRINDER AL, 2008, BLOOD; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nijenhuis S, 2004, CLIN CHIM ACTA, V350, P17, DOI 10.1016/j.cccn.2004.07.016; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Pedersen IM, 2002, BLOOD, V100, P1795, DOI 10.1182/blood.V100.5.1795.h81702001795_1795_1801; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; QUIROGA MP, 2008, BLOOD, V112, P2064; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Stamatopoulos K, 2005, BLOOD, V106, P3575, DOI 10.1182/blood-2005-04-1511; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227; Tobin G, 2005, UPSALA J MED SCI, V110, P97, DOI 10.3109/2000-1967-075; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Tobin G, 2007, LEUKEMIA LYMPHOMA, V48, P1081, DOI 10.1080/10428190701342034; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; VERRECK FAW, 1995, TISSUE ANTIGENS, V45, P270, DOI 10.1111/j.1399-0039.1995.tb02451.x; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	57	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15992	10.1371/journal.pone.0015992	http://dx.doi.org/10.1371/journal.pone.0015992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209908	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793600053
J	Enell, LE; Kapan, N; Soderberg, JAE; Kahsai, L; Nassel, DR				Enell, Lina E.; Kapan, Neval; Soderberg, Jeannette A. E.; Kahsai, Lily; Nassel, Dick R.			Insulin Signaling, Lifespan and Stress Resistance Are Modulated by Metabotropic GABA Receptors on Insulin Producing Cells in the Brain of Drosophila	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; RECTIFYING K+ CHANNELS; PANCREATIC BETA-CELLS; IN-VITRO; MUSHROOM BODIES; ANTENNAL LOBE; DIABETIC RATS; B RECEPTORS; BODY-SIZE; NEURONS	Insulin-like peptides (ILPs) regulate growth, reproduction, metabolic homeostasis, life span and stress resistance in worms, flies and mammals. A set of insulin producing cells (IPCs) in the Drosophila brain that express three ILPs (DILP2, 3 and 5) have been the main focus of interest in hormonal DILP signaling. Little is, however, known about factors that regulate DILP production and release by these IPCs. Here we show that the IPCs express the metabotropic GABA(B) receptor (GBR), but not the ionotropic GABA(A) receptor subunit RDL. Diminishing the GBR expression on these cells by targeted RNA interference abbreviates life span, decreases metabolic stress resistance and alters carbohydrate and lipid metabolism at stress, but not growth in Drosophila. A direct effect of diminishing GBR on IPCs is an increase in DILP immunofluorescence in these cells, an effect that is accentuated at starvation. Knockdown of irk3, possibly part of a G protein-activated inwardly rectifying K+ channel that may link to GBRs, phenocopies GBR knockdown in starvation experiments. Our experiments suggest that the GBR is involved in inhibitory control of DILP production and release in adult flies at metabolic stress and that this receptor mediates a GABA signal from brain interneurons that may convey nutritional signals. This is the first demonstration of a neurotransmitter that inhibits insulin signaling in its regulation of metabolism, stress and life span in an invertebrate brain.	[Enell, Lina E.; Kapan, Neval; Soderberg, Jeannette A. E.; Kahsai, Lily; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Enell, LE (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se			Swedish Research Council [621-2001-1605]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (Grant 621-2001-1605, D.R.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong H, 2006, DIABETOLOGIA, V49, P697, DOI 10.1007/s00125-005-0123-1; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FELDMAN JM, 1970, ENDOCRINOLOGY, V86, P66; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Harrison JB, 1996, CELL TISSUE RES, V284, P269, DOI 10.1007/s004410050587; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Liu X, 2009, J NEUROSCI, V29, P1573, DOI 10.1523/JNEUROSCI.4763-08.2009; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Peschke E, 1997, J PINEAL RES, V23, P156, DOI 10.1111/j.1600-079X.1997.tb00349.x; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang Y, 2004, ARTERIOSCL THROM VAS, V24, pE23; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Yamanaka N, 2006, P NATL ACAD SCI USA, V103, P8622, DOI 10.1073/pnas.0511196103; Yamanaka N, 2010, P NATL ACAD SCI USA, V107, P2060, DOI 10.1073/pnas.0907471107; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	72	56	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15780	10.1371/journal.pone.0015780	http://dx.doi.org/10.1371/journal.pone.0015780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209905	Green Published, gold			2022-12-25	WOS:000285793600039
J	Verhulst, NO; Andriessen, R; Groenhagen, U; Kiss, GB; Schulz, S; Takken, W; van Loon, JJA; Schraa, G; Smallegange, RC				Verhulst, Niels O.; Andriessen, Rob; Groenhagen, Ulrike; Kiss, Gabriella Bukovinszkine; Schulz, Stefan; Takken, Willem; van Loon, Joop J. A.; Schraa, Gosse; Smallegange, Renate C.			Differential Attraction of Malaria Mosquitoes to Volatile Blends Produced by Human Skin Bacteria	PLOS ONE			English	Article							GAMBIAE-SENSU-STRICTO; HUMAN AXILLARY ODOR; L-LACTIC ACID; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; PSEUDOMONAS-AERUGINOSA; DIPTERA-CULICIDAE; ELECTROPHYSIOLOGICAL RESPONSES; PYRUVATE FERMENTATION; OVIPOSITION RESPONSES	The malaria mosquito Anopheles gambiae sensu stricto is mainly guided by human odour components to find its blood host. Skin bacteria play an important role in the production of human body odour and when grown in vitro, skin bacteria produce volatiles that are attractive to A. gambiae. The role of single skin bacterial species in the production of volatiles that mediate the host-seeking behaviour of mosquitoes has remained largely unknown and is the subject of the present study. Headspace samples were taken to identify volatiles that mediate this behaviour. These volatiles could be used as mosquito attractants or repellents. Five commonly occurring species of skin bacteria were tested in an olfactometer for the production of volatiles that attract A. gambiae. Odour blends produced by some bacterial species were more attractive than blends produced by other species. In contrast to odours from the other bacterial species tested, odours produced by Pseudomonas aeruginosa were not attractive to A. gambiae. Headspace analysis of bacterial volatiles in combination with behavioural assays led to the identification of six compounds that elicited a behavioural effect in A. gambiae. Our results provide, to our knowledge, the first evidence for a role of selected bacterial species, common on the human skin, in determining the attractiveness of humans to malaria mosquitoes. This information will be used in the further development of a blend of semiochemicals for the manipulation of mosquito behaviour.	[Verhulst, Niels O.; Andriessen, Rob; Kiss, Gabriella Bukovinszkine; Takken, Willem; van Loon, Joop J. A.; Smallegange, Renate C.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Groenhagen, Ulrike; Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-3300 Braunschweig, Germany; [Schraa, Gosse] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands	Wageningen University & Research; Braunschweig University of Technology; Wageningen University & Research	Verhulst, NO (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	niels.verhulst@wur.nl	Verhulst, Niels/AAH-4288-2019; Smallegange, Renate C./L-1566-2019; van Loon, Joop J.A./B-3744-2009	Smallegange, Renate C./0000-0002-6946-9777; Schulz, Stefan/0000-0002-4810-324X; Verhulst, Niels/0000-0002-1106-9711; van Loon, Joop J.A./0000-0002-4260-0501	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH) [121]; Deutsche Forschungsgemeinschaft	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by a grant from the Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH#121) and by the Deutsche Forschungsgemeinschaft (U. G. and S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2006, J VECTOR ECOL, V31, P71, DOI 10.3376/1081-1710(2006)31[71:AOMTVA]2.0.CO;2; ANTHONY RM, 1992, CLIN EXP DERMATOL, V17, P102, DOI 10.1111/j.1365-2230.1992.tb00174.x; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2003, J MED ENTOMOL, V40, P653, DOI 10.1603/0022-2585-40.5.653; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bojar RA, 2002, WORLD J MICROB BIOT, V18, P889, DOI 10.1023/A:1021271028979; Boland W., 1984, ANAL VOLATILES, P371; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Braks MAH, 2001, PHYSIOL ENTOMOL, V26, P142, DOI 10.1046/j.1365-3032.2001.00227.x; COLLINS MD, 1983, INT J SYST BACTERIOL, V33, P870, DOI 10.1099/00207713-33-4-870; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Dickschat JS, 2005, CHEM BIODIVERS, V2, P837, DOI 10.1002/cbdv.200590062; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Knols BGJ, 1997, B ENTOMOL RES, V87, P151, DOI 10.1017/S0007485300027292; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Maxwell CA, 1998, MED VET ENTOMOL, V12, P325, DOI 10.1046/j.1365-2915.1998.00108.x; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Noble W, 2004, SKIN MICROFLORA MICR; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; Posey KH, 1998, J MED ENTOMOL, V35, P330, DOI 10.1093/jmedent/35.3.330; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; RENNIE PJ, 1990, INT J COSMETIC SCI, V12, P197, DOI 10.1111/j.1467-2494.1990.tb00535.x; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; SARKANY I, 1962, ARCH DERMATOL, V85, P578, DOI 10.1001/archderm.1962.01590050008002; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; STOTZKY G, 1976, Critical Reviews in Microbiology, V4, P333, DOI 10.3109/10408417609102303; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; TOMITA B, 1987, APPL ENVIRON MICROB, V53, P1541, DOI 10.1128/AEM.53.7.1541-1547.1987; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Verhulst N. O., 2008, P NETH ENTOMOL SOC, V19, P129; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wauters G, 1998, J CLIN MICROBIOL, V36, P1430, DOI 10.1128/JCM.36.5.1430-1432.1998; WELSCH M., 1948, AN TONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V14, P193, DOI 10.1007/BF02272692; Wilson M., 2008, BACTERIOLOGY HUMANS; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	68	96	101	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15829	10.1371/journal.pone.0015829	http://dx.doi.org/10.1371/journal.pone.0015829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209854	Green Published, gold			2022-12-25	WOS:000285793600045
J	Chung, HR; Dunkel, I; Heise, F; Linke, C; Krobitsch, S; Ehrenhofer-Murray, AE; Sperling, SR; Vingron, M				Chung, Ho-Ryun; Dunkel, Ilona; Heise, Franziska; Linke, Christian; Krobitsch, Sylvia; Ehrenhofer-Murray, Ann E.; Sperling, Silke R.; Vingron, Martin			The Effect of Micrococcal Nuclease Digestion on Nucleosome Positioning Data	PLOS ONE			English	Article							HISTONE-DNA INTERACTIONS; CHROMATIN-STRUCTURE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC GENOME; HIGH-RESOLUTION; YEAST; ORGANIZATION; CLEAVAGE; REVEALS	Eukaryotic genomes are packed into chromatin, whose basic repeating unit is the nucleosome. Nucleosome positioning is a widely researched area. A common experimental procedure to determine nucleosome positions involves the use of micrococcal nuclease (MNase). Here, we show that the cutting preference of MNase in combination with size selection generates a sequence-dependent bias in the resulting fragments. This strongly affects nucleosome positioning data and especially sequence-dependent models for nucleosome positioning. As a consequence we see a need to re-evaluate whether the DNA sequence is a major determinant of nucleosome positioning in vivo. More generally, our results show that data generated after MNase digestion of chromatin requires a matched control experiment in order to determine nucleosome positions.	[Chung, Ho-Ryun; Vingron, Martin] MPI Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Dunkel, Ilona; Sperling, Silke R.] MPI Mol Genet, Grp Cardiovasc Genet, Dept Vertebrate Genom, Berlin, Germany; [Heise, Franziska; Ehrenhofer-Murray, Ann E.] Univ Duisburg Essen, Genet Abt, ZMB, Essen, Germany; [Linke, Christian; Krobitsch, Sylvia] MPI Mol Genet, Neurodegenerat Disorder Grp, Otto Warburg Lab, Berlin, Germany	University of Duisburg Essen	Chung, HR (corresponding author), MPI Mol Genet, Dept Computat Mol Biol, Berlin, Germany.	chung@molgen.mpg.de		Rickert-Sperling, Silke/0000-0002-7135-3298				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; AXEL R, 1975, BIOCHEMISTRY-US, V14, P2921, DOI 10.1021/bi00684a020; Cartwright IL, 1999, METHOD ENZYMOL, V304, P462; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; CLARK RJ, 1971, NATURE-NEW BIOL, V229, P101, DOI 10.1038/newbio229101a0; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEFFAK IM, 1981, BIOCHIM BIOPHYS ACTA, V656, P86, DOI 10.1016/0005-2787(81)90030-7; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; LOHR D, 1984, NUCLEIC ACIDS RES, V12, P8457, DOI 10.1093/nar/12.22.8457; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; OOHARA I, 1987, J MOL BIOL, V196, P399, DOI 10.1016/0022-2836(87)90700-5; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; STEIN A, 2009, NUCL ACIDS RES; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WORCEL A, 1983, NUCLEIC ACIDS RES, V11, P421, DOI 10.1093/nar/11.2.421; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zaret KS, 1999, METHOD ENZYMOL, V304, P612; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	50	86	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15754	10.1371/journal.pone.0015754	http://dx.doi.org/10.1371/journal.pone.0015754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206756	gold, Green Published, Green Accepted			2022-12-25	WOS:000285793200051
J	James, SW; Porco, D; Decaens, T; Richard, B; Rougerie, R; Erseus, C				James, Samuel W.; Porco, David; Decaens, Thibaud; Richard, Benoit; Rougerie, Rodolphe; Erseus, Christer			DNA Barcoding Reveals Cryptic Diversity in Lumbricus terrestris L., 1758 (Clitellata): Resurrection of L. herculeus (Savigny, 1826)	PLOS ONE			English	Article							MITOCHONDRIAL; FORESTS; OLIGOCHAETA; DEFOLIATION	The widely studied and invasive earthworm, Lumbricus terrestris L., 1758 has been the subject of nomenclatural debate for many years. However these disputes were not based on suspicions of heterogeneity, but rather on the descriptions and nomenclatural acts associated with the species name. Large numbers of DNA barcode sequences of the cytochrome oxidase I obtained for nominal L. terrestris and six congeneric species reveal that there are two distinct lineages within nominal L. terrestris. One of those lineages contains the Swedish population from which the name-bearing specimen of L. terrestris was obtained. The other contains the population from which the syntype series of Enterion herculeum Savigny, 1826 was collected. In both cases modern and old representatives yielded barcode sequences allowing us to clearly establish that these are two distinct species, as different from one another as any other pair of congeners in our data set. The two are morphologically indistinguishable, except by overlapping size-related characters. We have designated a new neotype for L. terrestris. The newly designated neotype and a syntype of L. herculeus yielded DNA adequate for sequencing part of the cytochrome oxidase I gene (COI). The sequence data make possible the objective determination of the identities of earthworms morphologically identical to L. terrestris and L. herculeus, regardless of body size and segment number. Past work on nominal L. terrestris could have been on either or both species, although L. herculeus has yet to be found outside of Europe.	[James, Samuel W.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Porco, David; Rougerie, Rodolphe] Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON, Canada; [James, Samuel W.; Porco, David; Decaens, Thibaud; Richard, Benoit; Rougerie, Rodolphe] Univ Rouen, Ecol Lab, UPRES EA ECODIV 1293, FED SCALE,UFR Sci & Tech, Mont St Aignan, France; [Erseus, Christer] Univ Gothenburg, Dept Zool, Gothenburg, Sweden	University of Kansas; Universite de Rouen Normandie; University of Gothenburg	James, SW (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	sjames@ku.edu	Richard, Benoit/H-2967-2012; Porco, David/D-7781-2011; Decaens, Thibaud/AAA-5287-2020; James, Samuel/T-2190-2019; James, Samuel/D-6010-2013; Rougerie, Rodolphe/D-2930-2009	Richard, Benoit/0000-0003-4522-027X; James, Samuel/0000-0001-6758-5726; Rougerie, Rodolphe/0000-0003-0937-2815	Natural Science and Engineering Research Council of Canada (NSERC); Genome Canada; United States National Science Foundation [DEB 0516439]; Region Haute Normandie; Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques; SCiences Appliquees a L'Environnment research federation; ArtDatabanken (Swedish Taxonomy Initiative); Royal Society of Arts and Sciences in Goteborg; NSERC	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); United States National Science Foundation(National Science Foundation (NSF)); Region Haute Normandie(Region Normandie); Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques(Region Normandie); SCiences Appliquees a L'Environnment research federation; ArtDatabanken (Swedish Taxonomy Initiative); Royal Society of Arts and Sciences in Goteborg; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Most of this research was supported through grants from Natural Science and Engineering Research Council of Canada (NSERC) and Genome Canada to Paul Hebert (Biodiversity Institute of Ontario). S. W. James was supported by United States National Science Foundation Grant DEB 0516439 and by a Marie Curie France Regions grant from the Region Haute Normandie. R. Rougerie and D. Porco were supported by post-doctoral fellowship grant from the Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques. T. Decaens, B. Richard, R. Rougerie, D. Porco, and S. James were supported by the SCiences Appliquees a L'Environnment research federation through the Functions and Determinants of BIODIVersity program. C. Erseus was supported by ArtDatabanken (Swedish Taxonomy Initiative) and The Royal Society of Arts and Sciences in Goteborg. None of these funding agencies had any role in the conducting of the study or in the preparation of the manuscript. It is fair to say than until this work is published, most of them remain unaware of its existence. Paul Hebert, as director of the Canadian Centre for DNA Barcoding at the Biodiversity Institute of Ontario, made it a priority to direct the necessary resources toward the study, but the resources were ultimately derived from grants by NSERC and Genome Canada. Dr. Hebert cannot be cast in the role of a funding agency, but rather in the role of a laboratory director making decisions about how to use existing support.	Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; BOORE JL, 1995, GENETICS, V141, P305; BOUCHE M B, 1972, Revue d'Ecologie et de Biologie du Sol, V9, P697; Chang CH, 2007, ORG DIVERS EVOL, V7, P231, DOI 10.1016/j.ode.2006.06.001; DARWIN C, 1881, FORMATION VEGETABLE; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hale CM, 2005, ECOSYSTEMS, V8, P911, DOI 10.1007/s10021-005-0066-x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrix PF, 2008, ANNU REV ECOL EVOL S, V39, P593, DOI 10.1146/annurev.ecolsys.39.110707.173426; International Commision on Zoological Nomenclature, 1999, INT COD ZOOL NOM; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LANDSBERG J, 1989, TRENDS ECOL EVOL, V4, P96, DOI 10.1016/0169-5347(89)90054-2; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; Michaelsen W., 1900, Das Tierreich, VLief. x, pUnpaginated; Muzika RM, 2001, USDA NE EXP, V277, P117; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richard B, 2010, MOL ECOL RESOUR, V10, P606, DOI 10.1111/j.1755-0998.2009.02822.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savigny JC, 1826, MEM ACAD SCI I FRANC, V5, P176; Sims R.W., 1973, Bulletin of Zoological Nomenclature, V30, P27; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomlin A. D., 1983, Earthworm ecology - from Darwin to vermiculture, P331	27	129	137	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15629	10.1371/journal.pone.0015629	http://dx.doi.org/10.1371/journal.pone.0015629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206917	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200031
J	Schafer, I; von Leitner, EC; Schon, G; Koller, D; Hansen, H; Kolonko, T; Kaduszkiewicz, H; Wegscheider, K; Glaeske, G; van den Bussche, H				Schaefer, Ingmar; von Leitner, Eike-Christin; Schoen, Gerhard; Koller, Daniela; Hansen, Heike; Kolonko, Tina; Kaduszkiewicz, Hanna; Wegscheider, Karl; Glaeske, Gerd; van den Bussche, Hendrik			Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK PROFILE; POPULATION; PREVALENCE; SYMPTOMS; DEPRESSION; DEMENTIA; ANXIETY; COMORBIDITY; STROKE	Objective: Multimorbidity is a common problem in the elderly that is significantly associated with higher mortality, increased disability and functional decline. Information about interactions of chronic diseases can help to facilitate diagnosis, amend prevention and enhance the patients' quality of life. The aim of this study was to increase the knowledge of specific processes of multimorbidity in an unselected elderly population by identifying patterns of statistically significantly associated comorbidity. Methods: Multimorbidity patterns were identified by exploratory tetrachoric factor analysis based on claims data of 63,104 males and 86,176 females in the age group 65+. Analyses were based on 46 diagnosis groups incorporating all ICD-10 diagnoses of chronic diseases with a prevalence >= 1%. Both genders were analyzed separately. Persons were assigned to multimorbidity patterns if they had at least three diagnosis groups with a factor loading of 0.25 on the corresponding pattern. Results: Three multimorbidity patterns were found: 1) cardiovascular/metabolic disorders [prevalence female: 30%; male: 39%], 2) anxiety/depression/somatoform disorders and pain [34%; 22%], and 3) neuropsychiatric disorders [6%; 0.8%]. The sampling adequacy was meritorious (Kaiser-Meyer-Olkin measure: 0.85 and 0.84, respectively) and the factors explained a large part of the variance (cumulative percent: 78% and 75%, respectively). The patterns were largely age-dependent and overlapped in a sizeable part of the population. Altogether 50% of female and 48% of male persons were assigned to at least one of the three multimorbidity patterns. Conclusion: This study shows that statistically significant co-occurrence of chronic diseases can be subsumed in three prevalent multimorbidity patterns if accounting for the fact that different multimorbidity patterns share some diagnosis groups, influence each other and overlap in a large part of the population. In recognizing the full complexity of multimorbidity we might improve our ability to predict needs and achieve possible benefits for elderly patients who suffer from multimorbidity.	[Schaefer, Ingmar; von Leitner, Eike-Christin; Hansen, Heike; Kolonko, Tina; Kaduszkiewicz, Hanna; van den Bussche, Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Schoen, Gerhard; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Koller, Daniela; Glaeske, Gerd] Univ Bremen, Div Hlth Econ Hlth Policy & Hlth Serv Res, Ctr Social Policy Res, Bremen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bremen	Schafer, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany.	in.schaefer@uke.uni-hamburg.de			German Federal Ministry of Education and Research [01ET0725, 01ET0731]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (http://www.bmbf.bund.de/; grant numbers 01ET0725 and 01ET0731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Busse R., 2007, WISSENSCHAFTLICHES G; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Crue BL, 2009, PAIN MED, V10, P6, DOI 10.1111/j.1526-4637.2008.00536.x; Federal Association of SHI Physicians in Germany, 2007, BAS DAT SHI CAR GERM; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hallman WK, 2003, AM J PUBLIC HEALTH, V93, P624, DOI 10.2105/AJPH.93.4.624; Hartman TCO, 2008, FAM PRACT, V25, P266, DOI 10.1093/fampra/cmn041; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Haug TT, 2002, SCAND J GASTROENTERO, V37, P294, DOI 10.1080/003655202317284192; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; John R, 2003, GERONTOLOGIST, V43, P649, DOI 10.1093/geront/43.5.649; Knibb RC, 1999, J PSYCHOSOM RES, V47, P545, DOI 10.1016/S0022-3999(99)00055-0; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Locatelli F, 2001, KIDNEY INT, V60, P741, DOI 10.1046/j.1523-1755.2001.060002741.x; LYNESS JM, 1995, J AM GERIATR SOC, V43, P216, DOI 10.1111/j.1532-5415.1995.tb07325.x; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; O'Hara R, 2003, ANN GEN HOSP PSYCHIA, V2, P11; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Rho YH, 2005, J KOREAN MED SCI, V20, P1029, DOI 10.3346/jkms.2005.20.6.1029; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Schellevis FG, 1993, CHRONIC DIS GEN PRAC; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; van den Bussche H, 2010, BMC PUBLIC IN PRESS; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zentralinstitut fur die kassenarztliche Versorgung, 2007, DAT ADT PAN ZENTR KA	34	96	98	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15941	10.1371/journal.pone.0015941	http://dx.doi.org/10.1371/journal.pone.0015941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209965	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200075
J	Bonfiglio, S; Achilli, A; Olivieri, A; Negrini, R; Colli, L; Liotta, L; Ajmone-Marsan, P; Torroni, A; Ferretti, L				Bonfiglio, Silvia; Achilli, Alessandro; Olivieri, Anna; Negrini, Riccardo; Colli, Licia; Liotta, Luigi; Ajmone-Marsan, Paolo; Torroni, Antonio; Ferretti, Luca			The Enigmatic Origin of Bovine mtDNA Haplogroup R: Sporadic Interbreeding or an Independent Event of Bos primigenius Domestication in Italy?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; CONTROL REGION; CATTLE; PHYLOGEOGRAPHY; SEQUENCE; ANCIENT; TAURUS; LINEAGES; AFRICAN	Background: When domestic taurine cattle diffused from the Fertile Crescent, local wild aurochsen (Bos primigenius) were still numerous. Moreover, aurochsen and introduced cattle often coexisted for millennia, thus providing potential conditions not only for spontaneous interbreeding, but also for pastoralists to create secondary domestication centers involving local aurochs populations. Recent mitochondrial genomes analyses revealed that not all modern taurine mtDNAs belong to the shallow macro-haplogroup T of Near Eastern origin, as demonstrated by the detection of three branches (P, Q and R) radiating prior to the T node in the bovine phylogeny. These uncommon haplogroups represent excellent tools to evaluate if sporadic interbreeding or even additional events of cattle domestication occurred. Methodology: The survey of the mitochondrial DNA (mtDNA) control-region variation of 1,747 bovine samples (1,128 new and 619 from previous studies) belonging to 37 European breeds allowed the identification of 16 novel non-T mtDNAs, which after complete genome sequencing were confirmed as members of haplogroups Q and R. These mtDNAs were then integrated in a phylogenetic tree encompassing all available P, Q and R complete mtDNA sequences. Conclusions: Phylogenetic analyses of 28 mitochondrial genomes belonging to haplogroups P (N=2), Q (N=16) and R (N=10) together with an extensive survey of all previously published mtDNA datasets revealed major similarities between haplogroups Q and T. Therefore, Q most likely represents an additional minor lineage domesticated in the Near East together with the founders of the T subhaplogroups. Whereas, haplogroup R is found, at least for the moment, only in Italy and nowhere else, either in modern or ancient samples, thus supporting an origin from European aurochsen. Haplogroup R could have been acquired through sporadic interbreeding of wild and domestic animals, but our data do not rule out the possibility of a local and secondary event of B. primigenius domestication in Italy.	[Bonfiglio, Silvia; Achilli, Alessandro; Olivieri, Anna; Torroni, Antonio; Ferretti, Luca] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Negrini, Riccardo; Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Piacenza, Italy; [Liotta, Luigi] Univ Messina, Dipartimento Morfol Biochim Fisiol & Prod Anim, Messina, Italy	University of Pavia; University of Perugia; Catholic University of the Sacred Heart; University of Messina	Bonfiglio, S (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	luca.ferretti@unipv.it	Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Bonfiglio, Silvia/AAC-1988-2019; OLIVIERI, ANNA/I-9235-2012; Colli, Licia/AAC-2985-2021; Ferretti, Luca/D-2337-2013; AJMONE MARSAN, Paolo/M-2466-2018	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Ferretti, Luca/0000-0001-5044-8442; NEGRINI, Riccardo/0000-0002-8735-0286; Liotta, Luigi/0000-0002-3242-1817; Bonfiglio, Silvia/0000-0002-4422-1580; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies); Italian Ministry of the University; Fondazione Alma Mater Ticinensis	Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies); Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR)); Fondazione Alma Mater Ticinensis	This research received support from Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies) (to LF), Progetti Ricerca Interesse Nazionale 2007 (Italian Ministry of the University) (to AT, LF and PA-M), FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO), and Fondazione Alma Mater Ticinensis (to AT and LF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P317; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brugal J.-P., 1987, Actes du Congres National des Societes Savantes Section des Sciences, V112, P53; CAESAR, COMMENTARIES GALLIC, V6, pCH28; Cai X, 2007, GENETICA, V131, P175, DOI 10.1007/s10709-006-9129-y; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; CLUTTONBROCK J, 1989, WALKING LARDER PATTE, V22, P368; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Gou X, 2010, J ANIM BREED GENET, V127, P154, DOI 10.1111/j.1439-0388.2009.00807.x; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Helmer Daniel, 2005, P86; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Kim E, 2010, J ANIM SCI, V88, P2551, DOI 10.2527/jas.2009-2235; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2006, ANIM GENET, V37, P579, DOI 10.1111/j.1365-2052.2006.01524.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; MASON H, 1984, EVOLUTION DOMESTIC A, V12, P452; Meadow R.H., 1993, HARAPPAN CIVILIZATIO, V2nd, P295; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Priskin K, 2007, ACTA BIOL HUNG, V58, P131, DOI 10.1556/ABiol.58.2007.Suppl.10; Randi E, 2004, MOL ECOL, V13, P3071, DOI 10.1111/j.1365-294X.2004.02279.x; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; VANVUURE CT, OEROS SPOOR TERUG; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; VIRGIL, GEORGICS, V3, P531; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	45	68	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15760	10.1371/journal.pone.0015760	http://dx.doi.org/10.1371/journal.pone.0015760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209945	gold, Green Published, Green Submitted			2022-12-25	WOS:000285792500038
J	Pan, RL; Wang, P; Xiang, LX; Shao, JZ				Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong			Delta-like 1 Serves as a New Target and Contributor to Liver Fibrosis Down-regulated by Mesenchymal Stem Cell Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL CELLS; HEPATIC DIFFERENTIATION; MECHANISMS; INJURY; PROGRESSION; HEPATOCYTES; PREF-1	Chronic liver injury always progresses to fibrosis and eventually to cirrhosis, a massive health care burden worldwide. Deltalike 1 (Dlk1) is well known as an inhibitor of adipocyte differentiation. However, whether it is involved in liver fibrosis remains unclear. Here, we provide the first evidence that Dlk1 is a critical contributor to liver fibrosis through promoting activation of hepatic stellate cells (HSCs) during chronic liver injury. We found that upon liver injury, Dlk1 was dramatically induced and initially expressed in hepatocytes and then into the HSCs by a paracrine manner. It leads to the activation of HSCs, which is considered to be a pivotal event in liver fibrogenesis. Two forms (similar to 50 and similar to 25 kDa) of the Dlk1 protein were detected by Western blot analysis. In vitro administration of Dlk1 significantly promoted HSC activation, whereas in vivo knockdown of Dlk1 dramatically inhibited HSC activation and the subsequent fibrosis. The large soluble form (similar to 50 kDa) of Dlk1 was shown to contribute to HSC activation. We were encouraged to find the Dlk1-promoted HSC activation and liver fibrosis can be depressed by transplantation of bone marrow-mesenchymal stem cells (BM-MSCs). Furthermore, we demonstrated that FGF2 was up-regulated in BM-MSCs under injury stimulation, and it probably participated in the inhibition of Dlk1 by BM-MSCs. Our findings provide a novel role of Dlk1 in liver fibrosis leading to a better understanding of the molecular basis in fibrosis and cirrhosis and also give insights into the cellular and molecular mechanisms of MSC biology in liver repair.	[Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong] Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xiang, LX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xianglx@zju.edu.cn; shaojz@zju.edu.cn			Science and Technology Foundation of the Ministry of Health of China [WKJ2007-2-037]	Science and Technology Foundation of the Ministry of Health of China	This work was supported by Science and Technology Foundation of the Ministry of Health of China Grant WKJ2007-2-037.	Almeida-Porada G, 2010, EXP HEMATOL, V38, P574, DOI 10.1016/j.exphem.2010.04.007; Andersen DC, 2009, STEM CELLS, V27, P898, DOI 10.1634/stemcells.2008-0826; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Chen Y, 2009, J CELL MOL MED, V13, P2582, DOI 10.1111/j.1582-4934.2008.00471.x; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Huang CC, 2004, J PATHOL, V202, P172, DOI 10.1002/path.1505; Ishikawa T, 2007, CELL TISSUE RES, V327, P463, DOI 10.1007/s00441-006-0334-x; JinNo K, 1997, J GASTROENTEROL, V32, P119; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Muddu AK, 2007, INT J BIOCHEM CELL B, V39, P695, DOI 10.1016/j.biocel.2006.10.006; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Pan RL, 2008, CYTOTHERAPY, V10, P668, DOI 10.1080/14653240802360704; Peng Xiaodong, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P166; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105	38	45	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194498	http://dx.doi.org/10.1074/jbc.M110.194498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21239501	Green Published, hybrid			2022-12-25	WOS:000289077500048
J	Genin, EC; Geillon, F; Gondcaille, C; Athias, A; Gambert, P; Trompier, D; Savary, S				Genin, Emmanuelle C.; Geillon, Flore; Gondcaille, Catherine; Athias, Anne; Gambert, Philippe; Trompier, Doriane; Savary, Stephane			Substrate Specificity Overlap and Interaction between Adrenoleukodystrophy Protein (ALDP/ABCD1) and Adrenoleukodystrophy-related Protein (ALDRP/ABCD2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; PEROXISOMAL ABCD2 TRANSPORTER; POLYUNSATURATED FATTY-ACIDS; ENDOPLASMIC-RETICULUM; DOCOSAHEXAENOIC ACID; MEMBRANE-PROTEIN; BETA-OXIDATION; GENE-THERAPY; EXPRESSION; ALDP	X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder caused by mutations in the ABCD1 gene, which encodes a peroxisomal member of the ATP-binding cassette (ABC) transporter subfamily D called ALDP. ALDP is supposed to function as a homodimer allowing the entry of CoA-esters of very-long chain fatty acids (VLCFA) into the peroxisome, the unique site of their beta-oxidation. ALDP deficiency can be corrected by overexpression of ALDRP, its closest homolog. However, the exact nature of the substrates transported by ALDRP and its relationships with ALDP still remain unclear. To gain insight into the function of ALDRP, we used cell models allowing the induction in a dose-dependent manner of a wild type or a mutated non-functional ALDRP-EGFP fusion protein. We explored the consequences of the changes of ALDRP expression levels on the fatty acid content (saturated, monounsaturated, and polyunsaturated fatty acids) in phospholipids as well as on the levels of beta-oxidation of 3 suspected substrates:C26:0, C24:0, and C22:6n-3 (DHA). We found an inverse correlation between the fatty acid content of saturated (C26:0, C24:0) and monounsaturated (C26:1, C24:1) VLCFA and the expression level of ALDRP. Interestingly, we obtained a transdominant-negative effect of the inactive ALDRP-EGFP on ALDP function. This effect is due to a physical interaction between ALDRP and ALDP that we evidenced by proximity ligation assays and coimmunoprecipitation. Finally, the beta-oxidation assays demonstrate a role of ALDRP in the metabolism of saturated VLCFA (redundant with that of ALDP) but also a specific involvement of ALDRP in the metabolism of DHA.	[Savary, Stephane] Univ Bourgogne, LBMN, UMR866, INSERM,GDRCNRS 2583, F-21000 Dijon, France; [Genin, Emmanuelle C.; Geillon, Flore; Gondcaille, Catherine; Trompier, Doriane; Savary, Stephane] INSERM, UMR866, Ctr Rech Lipides, F-21000 Dijon, France; [Athias, Anne; Gambert, Philippe] Hop Bocage, Plateforme Lipid IFR100, F-21000 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Savary, S (corresponding author), Univ Bourgogne, LBMN, UMR866, INSERM,GDRCNRS 2583, 6 Bd Gabriel, F-21000 Dijon, France.	stsavary@u-bourgogne.fr	Savary, Stephane/C-8137-2011; TROMPIER, Doriane/D-5862-2017	Savary, Stephane/0000-0002-9237-1727; Genin, Emmanuelle C./0000-0003-3039-7101; Trompier, Doriane/0000-0002-0746-1753	European Association Against Leukodystrophies (ELA Foundation, Nancy, France); regional council of Burgundy	European Association Against Leukodystrophies (ELA Foundation, Nancy, France); regional council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the European Association Against Leukodystrophies (ELA Foundation, Nancy, France) and grants from the regional council of Burgundy.	Araseki M, 2005, BIOSCI BIOTECH BIOCH, V69, P483, DOI 10.1271/bbb.69.483; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Bons JAP, 2008, CLIN CHIM ACTA, V387, P59, DOI 10.1016/j.cca.2007.09.002; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ferdinandusse S, 2003, J LIPID RES, V44, P1992, DOI 10.1194/jlr.M300223-JLR200; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fouquet F, 1997, NEUROBIOL DIS, V3, P271, DOI 10.1006/nbdi.1997.0127; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Genin EC, 2009, J STEROID BIOCHEM, V116, P37, DOI 10.1016/j.jsbmb.2009.04.006; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Leclercq S, 2008, BIOCHIMIE, V90, P1602, DOI 10.1016/j.biochi.2008.05.022; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Unterrainer G, 2000, HUM MOL GENET, V9, P2609, DOI 10.1093/hmg/9.18.2609; Van Roermund C. W., 2010, BIOCH BIOPHYS ACTA M, V1811, P148; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434	35	38	39	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8075	8084		10.1074/jbc.M110.211912	http://dx.doi.org/10.1074/jbc.M110.211912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209459	Green Published, hybrid			2022-12-25	WOS:000288013300038
J	Wang, Q; Traynor, JR				Wang, Qin; Traynor, John R.			Opioid-induced Down-Regulation of RGS4 ROLE OF UBIQUITINATION AND IMPLICATIONS FOR RECEPTOR CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLASTOMA SH-SY5Y CELLS; MESSENGER-RNA; DIFFERENTIAL MODULATION; ADENYLYL-CYCLASE; NEUROPATHIC PAIN; ENDOGENOUS RGS4; UP-REGULATION; RAT-BRAIN; PROTEIN; MU	Regulator of G protein signaling protein 4 (RGS4) acts as a GTPase accelerating protein to modulate mu- and delta- opioid receptor (MOR and DOR, respectively) signaling. In turn, exposure to MOR agonists leads to changes in RGS4 at the mRNA and/or protein level. Here we have used human neuroblastoma SH-SY5Y cells that endogenously express MOR, DOR, and RGS4 to study opioid-mediated down-regulation of RGS4. Overnight treatment of SH-SY5Y cells with the MOR agonist DAMGO or the DOR agonist DPDPE decreased RGS4 protein by similar to 60% accompanied by a profound loss of opioid receptors but with no change in RGS4 mRNA. The decrease in RGS4 protein was prevented by the pretreatment with pertussis toxin or the opioid antagonist naloxone. The agonist-induced down-regulation of RGS4 proteins was completely blocked by treatment with the proteasome inhibitors MG132 or lactacystin or high concentrations of leupeptin, indicating involvement of ubiquitin-proteasome and lysosomal degradation. Polyubiquitinated RGS4 protein was observed in the presence of MG132 or the specific proteasome inhibitor lactacystin and promoted by opioid agonist. The loss of opioid receptors was not prevented by MG132, demonstrating a different degradation pathway. RGS4 is a GTPase accelerating protein for both G alpha(i/o) and G alpha(q) proteins. After overnight treatment with DAMGO to reduce RGS4 protein, signaling at the G alpha(i/o)-coupled DOR and the G alpha(q)-coupled M-3 muscarinic receptor (M3R) was increased but not signaling of the alpha(2) adrenergic receptor or bradykinin BK2 receptor, suggesting the development of cross-talk between the DOR and M3R involving RGS4.	[Wang, Qin; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Substance Abuse Res Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Traynor, JR (corresponding author), Univ Michigan, Dept Pharmacol, 1301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu			National Institutes of Health [DA04087]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA04087 (to J. R. T.).	Alt A, 2002, BRIT J PHARMACOL, V135, P217, DOI 10.1038/sj.bjp.0704430; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bradbury FA, 2009, J NEUROCHEM, V109, P1526, DOI 10.1111/j.1471-4159.2009.06082.x; Bushlin I, 2010, CURR OPIN PHARMACOL, V10, P80, DOI 10.1016/j.coph.2009.09.009; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHENG J, 1995, J NEUROCHEM, V65, P170; Connor M, 1996, BRIT J PHARMACOL, V117, P333, DOI 10.1111/j.1476-5381.1996.tb15195.x; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J COMP NEUROL, V385, P491, DOI 10.1002/(SICI)1096-9861(19970908)385:4<491::AID-CNE1>3.0.CO;2-Z; Han MH, 2010, BIOL PSYCHIAT, V67, P761, DOI 10.1016/j.biopsych.2009.08.041; HEIKKILA J, 1991, EUR J PHARM-MOLEC PH, V208, P9, DOI 10.1016/0922-4106(91)90045-J; HIRST RA, 1995, BIOCHEM PHARMACOL, V49, P1633, DOI 10.1016/0006-2952(95)00075-B; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; KAZMI SMI, 1986, BIOCHEM BIOPH RES CO, V137, P813, DOI 10.1016/0006-291X(86)91152-6; KAZMI SMI, 1989, BIOCHEM BIOPH RES CO, V158, P921, DOI 10.1016/0006-291X(89)92810-6; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; LAMBERT DG, 1989, EUR J PHARMACOL, V165, P71, DOI 10.1016/0014-2999(89)90771-1; Lan KL, 2000, J BIOL CHEM, V275, P33497, DOI 10.1074/jbc.M005785200; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Lopez-Gimenez JF, 2008, MOL PHARMACOL, V74, P1278, DOI 10.1124/mol.108.048272; MCDONALD RL, 1994, BIOCHEM PHARMACOL, V48, P23; Nakagawa T, 2001, EUR J PHARMACOL, V433, P29, DOI 10.1016/S0014-2999(01)01485-6; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Pagano M, 2008, CELL SIGNAL, V20, P1190, DOI 10.1016/j.cellsig.2008.02.008; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Schwendt M, 2007, NEUROREPORT, V18, P1261, DOI 10.1097/WNR.0b013e328240507a; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Talbot JN, 2010, J NEUROCHEM, V112, P1026, DOI 10.1111/j.1471-4159.2009.06519.x; Taymans JM, 2004, EUR J NEUROSCI, V19, P2249, DOI 10.1111/j.0953-816X.2004.03336.x; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zhang WJ, 2009, BRAIN, V132, P778, DOI 10.1093/brain/awn330	48	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7854	7864		10.1074/jbc.M110.160911	http://dx.doi.org/10.1074/jbc.M110.160911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209077	Green Published, hybrid			2022-12-25	WOS:000288013300016
J	Sanchis-Moysi, J; Idoate, F; Dorado, C; Alayon, S; Calbet, JAL				Sanchis-Moysi, Joaquin; Idoate, Fernando; Dorado, Cecilia; Alayon, Santiago; Calbet, Jose A. L.			Large Asymmetric Hypertrophy of Rectus Abdominis Muscle in Professional Tennis Players	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; TRUNK MUSCLES; MRI; STRENGTH; MASS; ACTIVATION; WRESTLERS; STIFFNESS; SYMMETRY; ANATOMY	Purpose: To determine the volume and degree of asymmetry of the musculus rectus abdominis (RA) in professional tennis players. Methods: The volume of the RA was determined using magnetic resonance imaging (MRI) in 8 professional male tennis players and 6 non-active male control subjects. Results: Tennis players had 58% greater RA volume than controls (P = 0.01), due to hypertrophy of both the dominant (34% greater volume, P = 0.02) and non-dominant (82% greater volume, P = 0.01) sides, after accounting for age, the length of the RA muscle and body mass index (BMI) as covariates. In tennis players, there was a marked asymmetry in the development of the RA, which volume was 35% greater in the non-dominant compared to the dominant side (P<0.001). In contrast, no side-to-side difference in RA volume was observed in the controls (P = 0.75). The degree of side-to-side asymmetry increased linearly from the first lumbar disc to the pubic symphysis (r = 0.97, P<0.001). Conclusions: Professional tennis is associated with marked hypertrophy of the musculus rectus abdominis, which achieves a volume that is 58% greater than in non-active controls. Rectus abdominis hypertrophy is more marked in the non-dominant than in the dominant side, particularly in the more distal regions. Our study supports the concept that humans can differentially recruit both rectus abdominis but also the upper and lower regions of each muscle. It remains to be determined if this disequilibrium raises the risk of injury.	[Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Idoate, Fernando] Clin San Miguel, Dept Radiol, Pamplona, Spain; [Alayon, Santiago] Hosp San Roque Maspalomas, Dept Diagnost Imaging, Grp San Roque, Maspalomas, Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Sanchis-Moysi, J (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.	jsanchis@def.ulpgc.es	Cecilia, Dorado-Garcia/B-4586-2010; Idoate Saralegui, Fernando/K-7485-2013; Sanchis-Moysi, Joaquin/B-5561-2012; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Dorado García, Cecilia/ABC-2792-2021; Calbet, Jose A L/H-6693-2015	Cecilia, Dorado-Garcia/0000-0001-6616-6810; Idoate Saralegui, Fernando/0000-0001-5600-6055; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885	Catedra Real Madrid Club de Futbol [2009/04RM]	Catedra Real Madrid Club de Futbol	This study was granted by Catedra Real Madrid Club de Futbol (2009/04RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyas F, 2007, BRIT J SPORT MED, V41, P836, DOI 10.1136/bjsm.2007.037747; ANDERSSON E, 1988, MED SCI SPORT EXER, V20, P587; ASKAR OM, 1977, ANN ROY COLL SURG, V59, P313; Bancroft LW, 2007, SEMIN MUSCULOSKEL R, V11, P16, DOI 10.1055/s-2007-984410; Barker KL, 2004, SPINE, V29, pE515, DOI 10.1097/01.brs.0000144405.11661.eb; Barker PJ, 2006, SPINE, V31, P397, DOI 10.1097/01.brs.0000195869.18844.56; Calbet JAL, 1998, CALCIFIED TISSUE INT, V62, P491, DOI 10.1007/s002239900467; Chow John W, 2009, Sports Med Arthrosc Rehabil Ther Technol, V1, P24, DOI 10.1186/1758-2555-1-24; Connell D, 2006, AM J ROENTGENOL, V187, P1457, DOI 10.2214/AJR.04.1929; David P, 2008, J STRENGTH COND RES, V22, P1855, DOI 10.1519/JSC.0b013e31817bd529; Ellenbecker T.S., 1996, ISOKINET EXERC SCI, V6, P15, DOI 10.3233/IES-1996-6103; Elliott B, 2006, BRIT J SPORT MED, V40, P392, DOI 10.1136/bjsm.2005.023150; HAINLINE B, 1995, CLIN SPORT MED, V14, P241; Hides J, 2006, SPINE, V31, pE175, DOI 10.1097/01.brs.0000202740.86338.df; Hides J, 2008, BRIT J SPORT MED, V42, P809, DOI 10.1136/bjsm.2007.044024; Hides JA, 2007, SPINE, V32, P1687, DOI 10.1097/BRS.0b013e318074c386; Hodges PW, 2005, J BIOMECH, V38, P1873, DOI 10.1016/j.jbiomech.2004.08.016; HUTCHINSON MR, 1995, MED SCI SPORT EXER, V27, P826; Ikeda Y, 2009, J STRENGTH COND RES, V23, P2231, DOI 10.1519/JSC.0b013e3181b8676f; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Knudson D, 2000, INT J SPORTS MED, V21, P321, DOI 10.1055/s-2000-3776; Kubo J, 2007, J STRENGTH COND RES, V21, P1251; Kubo T, 2010, J STRENGTH COND RES, V24, P1472, DOI 10.1519/JSC.0b013e3181d32eb1; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; LEHMAN RC, 1988, CLIN SPORT MED, V7, pR11; Maquirriain J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036129; Mirka G, 1997, CLIN BIOMECH, V12, P172, DOI 10.1016/S0268-0033(97)00061-2; Moreside JM, 2008, J ELECTROMYOGR KINES, V18, P527, DOI 10.1016/j.jelekin.2007.01.003; Norris C M, 1993, Br J Sports Med, V27, P19; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rankin G, 2006, MUSCLE NERVE, V34, P320, DOI 10.1002/mus.20589; Sanchis-Moysi J, 2010, INT J SPORTS MED, V31, P416, DOI 10.1055/s-0030-1248331; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; TIMM KE, 1995, ISOKINET EXERC SCI, V5, P43; Urquhart DM, 2005, MANUAL THER, V10, P144, DOI 10.1016/j.math.2004.08.011	37	39	39	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15858	10.1371/journal.pone.0015858	http://dx.doi.org/10.1371/journal.pone.0015858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209832	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900043
J	Sproule, TJ; Sled, JG; Wentzell, J; Wang, B; Henkelman, RM; Roopenian, DC; Burgess, RW				Sproule, Thomas J.; Sled, John G.; Wentzell, Jill; Wang, Bing; Henkelman, R. Mark; Roopenian, Derry C.; Burgess, Robert W.			A Mouse Model of Heritable Cerebrovascular Disease	PLOS ONE			English	Article							BINDING-PROTEIN; MUTATIONS; GENE; MALFORMATIONS; KRIT1	The study of animal models of heritable cerebrovascular diseases can improve our understanding of disease mechanisms, identify candidate genes for related human disorders, and provide experimental models for preclinical trials. Here we describe a spontaneous mouse mutation that results in reproducible, adult-onset, progressive, focal ischemia in the brain. The pathology is not the result of hemorrhage, embolism, or an anatomical abnormality in the cerebral vasculature. The mutation maps as a single site recessive locus to mouse Chromosome 9 at 105 Mb, a region of shared synteny with human chromosome 3q22. The genetic interval, defined by recombination mapping, contains seven protein-coding genes and one processed transcript, none of which are changed in their expression level, splicing, or sequence in affected mice. Targeted resequencing of the entire interval did not reveal any provocative changes; thus, the causative molecular lesion has not been identified.	[Sproule, Thomas J.; Wentzell, Jill; Wang, Bing; Roopenian, Derry C.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Sled, John G.; Henkelman, R. Mark] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Jackson Laboratory; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Sproule, TJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Robert.burgess@jax.org	HENKELMAN, MARK/W-6847-2019; Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Burgess, Robert/0000-0002-9229-3407	National Institutes of Health [R21 NS051338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health, R21 NS051338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; CORTELL S, 1969, J APPL PHYSIOL, V26, P158, DOI 10.1152/jappl.1969.26.1.158; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389	14	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15327	10.1371/journal.pone.0015327	http://dx.doi.org/10.1371/journal.pone.0015327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217823	Green Published, gold, Green Submitted			2022-12-25	WOS:000285838900019
J	Williams, DS; Bird, MJ; Jorissen, RN; Yu, YL; Walker, F; Zhang, HH; Nice, EC; Burgess, AW				Williams, David S.; Bird, Matthew J.; Jorissen, Robert N.; Yu, Yen Lin; Walker, Franscesa; Zhang, Hui Hua; Nice, Edouard C.; Burgess, Antony W.			Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; FRAMESHIFT-MUTATION; DNA-REPAIR; DATABASE; IDENTIFICATION; ESTABLISHMENT; SURVEILLANCE; INHIBITION; PEPTIDES	Background: Frameshift mutations in microsatellite instability high (MSI-High) colorectal cancers are a potential source of targetable neo-antigens. Many nonsense transcripts are subject to rapid degradation due to nonsense-mediated decay (NMD), but nonsense transcripts with a cMS in the last exon or near the last exon-exon junction have intrinsic resistance to nonsense-mediated decay (NMD). NMD-resistant transcripts are therefore a likely source of expressed mutant proteins in MSI-High tumours. Methods: Using antibodies to the conserved N-termini of predicted mutant proteins, we analysed MSI-High colorectal cancer cell lines for examples of naturally expressed mutant proteins arising from frameshift mutations in coding microsatellites (cMS) by immunoprecipitation and Western Blot experiments. Detected mutant protein bands from NMD-resistant transcripts were further validated by gene-specific short-interfering RNA (siRNA) knockdown. A genome-wide search was performed to identify cMS-containing genes likely to generate NMD-resistant transcripts that could encode for antigenic expressed mutant proteins in MSI-High colon cancers. These genes were screened for cMS mutations in the MSI-High colon cancer cell lines. Results: Mutant protein bands of expected molecular weight were detected in mutated MSI-High cell lines for NMD-resistant transcripts (CREBBP, EP300, TTK), but not NMD-sensitive transcripts (BAX, CASP5, MSH3). Expression of the mutant CREBBP and EP300 proteins was confirmed by siRNA knockdown. Five cMS-bearing genes identified from the genome-wide search and without existing mutation data (SFRS12IP1, MED8, ASXL1, FBXL3 and RGS12) were found to be mutated in at least 5 of 11 (45%) of the MSI-High cell lines tested. Conclusion: NMD-resistant transcripts can give rise to expressed mutant proteins in MSI-High colon cancer cells. If commonly expressed in primary MSI-High colon cancers, MSI-derived mutant proteins could be useful as cancer specific immunological targets in a vaccine targeting MSI-High colonic tumours.	[Williams, David S.; Bird, Matthew J.; Yu, Yen Lin; Walker, Franscesa; Zhang, Hui Hua; Nice, Edouard C.; Burgess, Antony W.] Ludwig Inst Canc Res, Epithelial Biochem Lab, Melbourne Branch, Parkville, Vic, Australia; [Williams, David S.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, David S.] Melbourne Hlth, Dept Anat Pathol, Parkville, Vic, Australia; [Jorissen, Robert N.; Burgess, Antony W.] Ludwig Inst Canc Res, Ludwig Colon Canc Initiat Lab, Melbourne Branch, Parkville, Vic, Australia	Ludwig Institute for Cancer Research; University of Melbourne; Ludwig Institute for Cancer Research	Williams, DS (corresponding author), Ludwig Inst Canc Res, Epithelial Biochem Lab, Melbourne Branch, Parkville, Vic, Australia.	David.Williams@austin.org.au; Tony.Burgess@ludwig.edu.au	Nice, Edouard C/B-1026-2011	Bird, Matthew/0000-0003-3185-0780; Jorissen, Robert/0000-0001-9634-2803	NHMRC Program [487922]; CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant; Cancer Council Victoria; Royal College of Pathologists of Australasia of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant; Victorian Government, Australia	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Royal College of Pathologists of Australasia of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant; Victorian Government, Australia	This project was partially funded by NHMRC Program Grant number 487922. Funding support for this work was also provided by a CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant (DSW, AWB, ECN), the Cancer Council Victoria (EN) and a Royal College of Pathologists of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant (DSW). This work was also supported by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SM, 1990, CANCER RES, V50, P5225; Bader SA, 2007, BRIT J CANCER, V96, P660, DOI 10.1038/sj.bjc.6603592; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Chang EY, 2009, ARCH SURG-CHICAGO, V144, P511, DOI 10.1001/archsurg.2009.40; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; Des Guetz G, 2009, EUR J CANCER, V45, P1890, DOI 10.1016/j.ejca.2009.04.018; DREWINKO B, 1976, CANCER RES, V36, P467; Duval A, 2002, ANN GENET-PARIS, V45, P71, DOI 10.1016/S0003-3995(02)01115-2; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Engel C, 2010, CLIN GASTROENTEROL H, V8, P174, DOI 10.1016/j.cgh.2009.10.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ionov Y, 2004, P NATL ACAD SCI USA, V101, P1273, DOI 10.1073/pnas.0307276101; Ishikawa T, 2003, CANCER RES, V63, P5564; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; KIRKLAND SC, 1985, CANCER RES, V45, P3790; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Linnebacher M, 2001, INT J CANCER, V93, P6, DOI 10.1002/ijc.1298; Linnebacher M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/841451; Lynch HT, 2008, GASTROENTEROLOGY, V134, P1246, DOI 10.1053/j.gastro.2008.02.008; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Niv Y, 2007, WORLD J GASTROENTERO, V13, P1767; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Reuschenbach M, 2009, FAM CANC; Ripberger E, 2003, J CLIN IMMUNOL, V23, P415, DOI 10.1023/A:1025329819121; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Saeterdal I, 2001, CANCER IMMUNOL IMMUN, V50, P469, DOI 10.1007/s002620100222; Schuler Mathias M., 2007, V409, P75; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Schwitalle Yvette, 2004, Cancer Immun, V4, P14; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Speetjens FM, 2008, INT J CANCER, V123, P838, DOI 10.1002/ijc.23570; Stoffel EM, 2008, CANCER PREV RES, V1, P470, DOI 10.1158/1940-6207.CAPR-08-0098; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; WHITEHEAD RH, 1991, INT J CANCER, V48, P693, DOI 10.1002/ijc.2910480511; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289	57	44	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e16012	10.1371/journal.pone.0016012	http://dx.doi.org/10.1371/journal.pone.0016012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209843	Green Published, gold			2022-12-25	WOS:000285838900056
J	Pellegatti, P; Falzoni, S; Donvito, G; Lemaire, I; Di Virgilio, F				Pellegatti, Patrizia; Falzoni, Simonetta; Donvito, Giovanna; Lemaire, Irma; Di Virgilio, Francesco			P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration	FASEB JOURNAL			English	Article						purinergic receptors; cell fusion; giant cells; bone metabolism; inflammation	GIANT-CELL FORMATION; P2X(7) RECEPTOR; MACROPHAGE FUSION; PLASMA-MEMBRANE; IN-VITRO; BONE; ATP; DIFFERENTIATION; ACTIVATION; EXPRESSION	Defects in bone homeostasis are a major health problem. Osteoclast differentiation and activation have a crucial role in bone remodeling in health and disease. Osteoclasts are bone-resorbing cells derived from mononuclear phagocyte progenitors. The key event in osteoclast formation is fusion of mononucleate precursors to form mature multinucleated osteclasts. Here we provide evidence of an absolute requirement for the P2X7 receptor, ATP release, and adenosine signaling in human osteoclast formation, as shown by the following findings: macrophage-colony stimulating factor/receptor activator for nuclear factor-kappa B ligand (M-CSF/RANKL)-stimulated fusion of human monocytes is fully prevented by an anti-P2X7 mAb, by specific P2X7 pharmacological antagonists, or by inhibition of CD39/NTPDase; fusion-competent monocytes release ATP via the P2X7 receptor; accelerated degradation of released ATP by addition of either apyrase or hexokinase strongly increases fusion; removal of extracellular adenosine by adenosine deaminase blocks, while addition of exogenous adenosine strongly potentiates, fusion; and pharmacologic stimulation of the adenosine A2A receptor increases, while selective A2A blockade inhibits, fusion. These results show that the purinergic axis plays a crucial and as yet undescribed role in osteoclast formation and reconcile previous evidence advocating a key role for either ATP or adenosine receptors in multinucleated giant cell formation.-Pellegatti, P., Falzoni, S., Donvito, G., Lemaire, I., Di Virgilio, F. P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. FASEB J. 25, 1264-1274 (2011). www.fasebj.org	[Pellegatti, Patrizia; Falzoni, Simonetta; Donvito, Giovanna; Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Lemaire, Irma] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ferrara; University of Ottawa	Di Virgilio, F (corresponding author), Univ Ferrara, Interdisciplinary Ctr Study Inflammat, Dept Expt & Diagnost Med, Sect Gen Pathol, Via Borsari 46, I-44100 Ferrara, Italy.	fdv@unife.it	Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Falzoni, Simonetta/0000-0002-6594-0357	Italian Association for Cancer Research [IG 5354]; Telethon of Italy [GGP06070]; Italian Space Agency (ASI-OSMA); Commission of European Communities [HEALTH-F2-2007-202231]; Regione Emilia Romagna; University of Ferrara	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); Italian Space Agency (ASI-OSMA)(Agenzia Spaziale Italiana (ASI)); Commission of European Communities(European Commission); Regione Emilia Romagna(Regione Emilia Romagna); University of Ferrara	This research was supported by grants from the Italian Association for Cancer Research (IG 5354), Telethon of Italy (GGP06070), the Italian Space Agency (ASI-OSMA), the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231), the Regione Emilia Romagna (Innovative Approaches to the Diagnosis of Inflammatory Diseases and Moniter research programs), and institutional funds from the University of Ferrara. F. D. V. acts as a consultant of Cordex Pharma and Affectis Pharma, biotech companies involved in the development of ATP-based drugs.	Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Falzoni S, 2000, MOL BIOL CELL, V11, P3169, DOI 10.1091/mbc.11.9.3169; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gartland A, 2003, CRIT REV EUKAR GENE, V13, P243, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i24.150; Gartland A, 2003, CALCIFIED TISSUE INT, V73, P361, DOI 10.1007/s00223-002-2098-y; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hiken JF, 2004, AM J PHYSIOL-CELL PH, V287, pC403, DOI 10.1152/ajpcell.00361.2003; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; Kara FM, 2010, FASEB J, V24, P2325, DOI 10.1096/fj.09-147447; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; MARKS SC, 1988, AM J ANAT, V183, P1, DOI 10.1002/aja.1001830102; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Merrill JT, 1997, ARTHRITIS RHEUM, V40, P1308, DOI 10.1002/1529-0131(199707)40:7<1308::AID-ART16>3.0.CO;2-M; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Westfall TD, 1997, EUR J PHARMACOL, V329, P169, DOI 10.1016/S0014-2999(97)89178-9; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	43	73	73	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1264	1274		10.1096/fj.10-169854	http://dx.doi.org/10.1096/fj.10-169854			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21233486				2022-12-25	WOS:000288982800015
J	Wang, JH; Ma, J; Charboneau, R; Barke, R; Roy, S				Wang, Jinghua; Ma, Jing; Charboneau, Rick; Barke, Roderick; Roy, Sabita			Morphine Inhibits Murine Dendritic Cell IL-23 Production by Modulating Toll-like Receptor 2 and Nod2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL INFECTION; ANTIBACTERIAL DEFENSE; HOST-DEFENSE; T-CELLS; MACROPHAGES; PNEUMOLYSIN; TLR; INDUCTION; RECOGNITION	IL-23, produced by dendritic cells (DCs) and macrophages, plays a critical role in innate immunity against bacterial infection. Our previous studies show that morphine disrupts the IL-23/IL-17 mediated pulmonary mucosal host defense and increases susceptibility to Streptococcus pneumoniae lung infection. To determine the mechanism by which morphine modulates IL-23 production, mouse bone marrow-derived dendritic cells (BMDCs) and macrophages (BMDMs) were treated with morphine, and infected with S. pneumoniae or stimulated with Toll-like receptor (TLR) and Nod2 ligands. We found that a significant increase in IL-23 protein production was observed in S. pneumoniae, TLR2 ligand lipoteichoic acid (LTA), and TLR4 ligand pneumolysin (PLY) stimulated BMDCs and BMDMs. Interestingly, although Nod2 ligand muramyldipeptide (MDP) alone had no effect on IL-23 production, it potentiated LTA induced IL-23 production to the same level as that observed following S. pneumoniae infection, suggesting that S. pneumoniae induced IL-23 production in DCs involves activation of both TLR2 and Nod2 signaling mechanisms. Furthermore, pretreatment of DCs with MyD88 (myeloid differentiation primary response gene 88) and IL-1 receptor-associated kinase (IRAK) 1/4 inhibitors, or TLR2 antibody diminished the S. pneumoniae induced IL-23 and abolished the inhibitory effects of morphine, indicating that S. pneumoniae induced IL-23 production depends on activation of the TLR2-MyD88-IRAK1/4 signaling pathway. Moreover, morphine decreased S. pneumoniae induced phosphorylation of interferon regulatory factor 3 (IRF3) and activating transcription factor 2 in DCs. Taken together, our study shows that morphine impairs S. pneumoniae induced IL-23 production through MyD88-IRAK1/4-dependent TLR2 and Nod2 signaling in DCs.	[Wang, Jinghua; Ma, Jing; Roy, Sabita] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Charboneau, Rick; Barke, Roderick] Vet Affairs Med Ctr, Dept Surg, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, MMC 195,420 Delaware St SE, Minneapolis, MN 55455 USA.	royxx002@umn.edu	ma, jing/B-5493-2013		National Institutes of Health [R03 DA023353, R01 DA12104, K02 DA015349, R01 DA022935, P50 DA11806]; Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA015349, R01DA022935, P50DA011806, R01DA012104, R03DA023353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R03 DA023353 (to J. W.) and R01 DA12104, K02 DA015349, R01 DA022935, and P50 DA11806 (to S. R.). This work was also supported by funds from the Minneapolis Veterans Affairs Medical Center (to R. B.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Alifrangis C, 2006, INT J STD AIDS, V17, P779, DOI 10.1258/095646206778691130; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dighe SV, 2009, PHARMACOL BIOCHEM BE, V92, P537, DOI 10.1016/j.pbb.2009.02.004; Garrelts JC, 1996, PHARMACOECONOMICS, V10, P36, DOI 10.2165/00019053-199610010-00005; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Kelschenbach J, 2008, J IMMUNOL, V180, P3670, DOI 10.4049/jimmunol.180.6.3670; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Li XL, 2004, ARTHRITIS RES THER, V6, pR273, DOI 10.1186/ar1175; Ma J, 2010, INFECT IMMUN, V78, P830, DOI 10.1128/IAI.00914-09; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Picard C, 2007, IMMUNOL RES, V38, P347, DOI 10.1007/s12026-007-0006-2; Reimer T, 2007, J IMMUNOL, V179, P1166, DOI 10.4049/jimmunol.179.2.1166; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; TISEO PJ, 1995, PAIN, V61, P47, DOI 10.1016/0304-3959(94)00148-8; Wang JH, 2005, J IMMUNOL, V174, P426, DOI 10.4049/jimmunol.174.1.426; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zola TA, 2008, J IMMUNOL, V181, P7909, DOI 10.4049/jimmunol.181.11.7909	34	33	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10225	10232		10.1074/jbc.M110.188680	http://dx.doi.org/10.1074/jbc.M110.188680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245149	Green Published, hybrid			2022-12-25	WOS:000288547000039
J	Bretones, G; Acosta, JC; Caraballo, JM; Ferrandiz, N; Gomez-Casares, MT; Albajar, M; Blanco, R; Ruiz, P; Hung, WC; Albero, MP; Perez-Roger, I; Leon, J				Bretones, Gabriel; Acosta, Juan C.; Caraballo, Juan M.; Ferrandiz, Nuria; Teresa Gomez-Casares, M.; Albajar, Marta; Blanco, Rosa; Ruiz, Paula; Hung, Wen-Chun; Pilar Albero, M.; Perez-Roger, Ignacio; Leon, Javier			SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27(KIP1) through SKP2 in Human Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; C-MYC; CYCLE PROGRESSION; BCR-ABL; NEGATIVE AUTOREGULATION; GENOMIC TARGETS; HUMAN CANCER; DEGRADATION; P27	SKP2 is the ubiquitin ligase subunit that targets p27(KIP1) (p27) for degradation. SKP2 is induced in the G(1)-S transit of the cell cycle, is frequently overexpressed in human cancer, and displays transformation activity in experimental models. Here we show that MYC induces SKP2 expression at the mRNA and protein levels in human myeloid leukemia K562 cells with conditional MYC expression. Importantly, in these systems, induction of MYC did not activate cell proliferation, ruling out SKP2 up-regulation as a consequence of cell cycle entry. MYC-dependent SKP2 expression was also detected in other cell types such as lymphoid, fibroblastic, and epithelial cell lines. MYC induced SKP2 mRNA expression in the absence of protein synthesis and activated the SKP2 promoter in luciferase reporter assays. With chromatin immunoprecipitation assays, MYC was detected bound to a region of human SKP2 gene promoter that includes E-boxes. The K562 cell line derives from human chronic myeloid leukemia. In a cohort of chronic myeloid leukemia bone marrow samples, we found a correlation between MYC and SKP2 mRNA levels. Analysis of cancer expression databases also indicated a correlation between MYC and SKP2 expression in lymphoma. Finally, MYC-induced SKP2 expression resulted in a decrease in p27 protein in K562 cells. Moreover, silencing of SKP2 abrogated the MYC-mediated down-regulation of p27. Our data show that SKP2 is a direct MYC target gene and that MYC-mediated SKP2 induction leads to reduced p27 levels. The results suggest the induction of SKP2 oncogene as a new mechanism for MYC-dependent transformation.	[Leon, Javier] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria,Fac Med, SODERCAN Soc Desarrollo Cantabria,CSIC,IBBTEC, Santander 39011, Spain; [Teresa Gomez-Casares, M.] Hosp Dr Negrin, Serv Hematol, Las Palmas Gran Canaria 35020, Spain; [Albajar, Marta] Hosp Univ Marques de Valdecilla, Serv Hematol, Inst Invest & Formac Marques de Valdecilla, Santander 39009, Spain; [Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Pilar Albero, M.; Perez-Roger, Ignacio] Cardenal Herrera CEU Univ, Dept Chem Biochem & Mol Biol, Moncada 46113, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Hospital Universitario Marques de Valdecilla (HUMV); National Sun Yat Sen University; Universidad CEU Cardenal Herrera	Leon, J (corresponding author), Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria,Fac Med, SODERCAN Soc Desarrollo Cantabria,CSIC,IBBTEC, Cardenal Herrera Oria S-N, Santander 39011, Spain.	leonj@unican.es	Pérez Roger, Ignacio/K-1346-2014; Bretones, Gabriel/AAB-4637-2021; Hung, Wen-Chun/F-4846-2011; Acosta, Juan/AAE-6320-2021; Ferrandiz-Diaz, Nuria/V-4071-2017; Leon, Javier/K-4615-2014; CASARES, MARIA TERESA GOMEZ/R-6060-2018	Pérez Roger, Ignacio/0000-0002-5564-6912; Bretones, Gabriel/0000-0002-1521-5544; Acosta, Juan/0000-0002-7989-7329; Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Leon, Javier/0000-0001-5803-0112	Spanish Ministerio de Ciencia e Innovacion [PN-SAF08-01581]; Spanish Ministerio de Sanidad y Consumo [ISCIII-RETIC RD06/0020/0017]; University of Cantabria-IFIMAV; Proyecto Universidad Cardenal Herrera-Santander;  [PI06-0285]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); University of Cantabria-IFIMAV; Proyecto Universidad Cardenal Herrera-Santander; 	This study was supported by Grant PN-SAF08-01581 from the Spanish Ministerio de Ciencia e Innovacion, Grant ISCIII-RETIC RD06/0020/0017 from the Spanish Ministerio de Sanidad y Consumo, a grant from University of Cantabria-IFIMAV (to J. L.), and Grants PI06-0285 and Proyecto Universidad Cardenal Herrera-Santander (to I. P.-R.).	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Ceballos E, 2000, ONCOGENE, V19, P2194, DOI 10.1038/sj.onc.1203541; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Chen JY, 2009, LEUKEMIA RES, V33, P1520, DOI 10.1016/j.leukres.2009.03.007; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gomez-Casares MT, 2004, HAEMATOLOGICA, V89, P241; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Huang YC, 2006, J CELL PHYSIOL, V209, P363, DOI 10.1002/jcp.20741; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Lerga A, 1999, CELL GROWTH DIFFER, V10, P639; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	71	64	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9815	9825		10.1074/jbc.M110.165977	http://dx.doi.org/10.1074/jbc.M110.165977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245140	hybrid, Green Published			2022-12-25	WOS:000288247700104
J	Kreisman, LSC; Cobb, BA				Kreisman, Lori S. C.; Cobb, Brian A.			Glycoantigens Induce Human Peripheral Tr1 Cell Differentiation with Gut-homing Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTOR 9; BACTEROIDES-FRAGILIS; ZWITTERIONIC POLYSACCHARIDES; CAPSULAR POLYSACCHARIDE; SYMBIOTIC BACTERIA; ABSCESS FORMATION; IMMUNE-RESPONSES; DENDRITIC CELLS; ANTIGEN	The carbohydrate antigen (glycoantigen) PSA from an intestinal commensal bacteria is able to down-regulate inflammatory bowel disease in model mice, suggesting that stimulation with PSA results in regulatory T cell (Treg) generation. However, mechanisms of how peripheral human T cells respond and home in response to commensal antigens are still not understood. Here, we demonstrate that a single exposure to PSA induces differentiation of human peripheral CD4(+) T cells into type-Tr1 Tregs. This is in contrast to mouse models where PSA induced the production of Foxp3(+) iTregs. The human PSA-induced Tr1 cells are profoundly anergic and exhibit nonspecific bystander suppression mediated by IL-10 secretion. Most surprisingly, glycoantigen exposure provoked expression of gut homing receptors on their surface. These findings reveal a mechanism for immune homeostasis in the gut whereby exposure to commensal glycoantigens provides the requisite information to responding T cells for proper tissue localization (gut) and function (anti-inflammatory/regulatory).	[Kreisman, Lori S. C.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Cobb, BA (corresponding author), 10900 Euclid Ave,WRB 6532, Cleveland, OH 44106 USA.	brian.cobb@case.edu			National Institutes of Health [K22AI062707, DP2OD004225, R01GM082916]; American Asthma Foundation; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI062707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants K22AI062707, DP2OD004225, and R01GM082916. This work was also supported by the American Asthma Foundation Early Excellence Award and the Mt. Sinai Health Care Foundation Scholars Program award (to B. A. C.).	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Allakhverdi Z, 2006, J ALLERGY CLIN IMMUN, V118, P1342, DOI 10.1016/j.jaci.2006.07.034; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Asseman C, 1998, GUT, V42, P157, DOI 10.1136/gut.42.2.157; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Brubaker JO, 1999, J IMMUNOL, V162, P2235; Brun V, 2009, INT IMMUNOPHARMACOL, V9, P609, DOI 10.1016/j.intimp.2009.01.032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi YH, 2002, BIOCHEMISTRY-US, V41, P15144, DOI 10.1021/bi020491v; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Chung DR, 2002, J EXP MED, V195, P1471, DOI 10.1084/jem.20020028; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Di Nunzio S, 2009, BLOOD, V114, P4138, DOI 10.1182/blood-2009-04-214593; Elson CO, 2002, IMMUNOL RES, V26, P87, DOI 10.1385/IR:26:1-3:087; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hadley GA, 1997, J IMMUNOL, V159, P3748; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Kreisman LSC, 2007, GLYCOBIOLOGY, V17, P46, DOI 10.1093/glycob/cwl056; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; OCHOAREPARAZ J, 2010, MUCOSAL IMMUNOL, V185, P4101; Papadakis KA, 2003, J IMMUNOL, V171, P159, DOI 10.4049/jimmunol.171.1.159; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Serafini G, 2009, HAEMATOL-HEMATOL J, V94, P1415, DOI 10.3324/haematol.2008.003129; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stephen TL, 2005, INFECT IMMUN, V73, P2184, DOI 10.1128/IAI.73.4.2184-2189.2005; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; WANG R, 2009, AM J IMMUNOL, V5, P101; Wang Y, 2000, P NATL ACAD SCI USA, V97, P13478, DOI 10.1073/pnas.97.25.13478; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	49	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8810	8818		10.1074/jbc.M110.206011	http://dx.doi.org/10.1074/jbc.M110.206011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228275	hybrid, Green Published			2022-12-25	WOS:000288247700011
J	Varshney, AK; Wang, XB; Cook, E; Dutta, K; Scharff, MD; Goger, MJ; Fries, BC				Varshney, Avanish K.; Wang, Xiaobo; Cook, Emily; Dutta, Kaushik; Scharff, Matthew D.; Goger, Michael J.; Fries, Bettina C.			Generation, Characterization, and Epitope Mapping of Neutralizing and Protective Monoclonal Antibodies against Staphylococcal Enterotoxin B-induced Lethal Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SUPERANTIGENS; CRYSTAL-STRUCTURE; BINDING PROTEIN; TRANSGENIC MICE; TOXIC-SHOCK; IN-VITRO; VACCINATION; VACCINES; MUTANTS; SEPSIS	T-cell stimulating activity of Staphylococcal enterotoxin B (SEB) is an important factor in the pathogenesis of certain staphylococcal diseases including SEB mediated shock. SEB is one of the most potent superantigens known and treatment of SEB induced shock remains a challenge. We generated and characterized murine monoclonal antibodies (mAbs) to SEB in mice. We tested mAbs neutralize mitogenic effects of SEB in vitro and in vivo with T-cell proliferation assays and 2 murine models for SEB induced lethal shock (SEBILS). Epitope mapping suggests that all these mAbs recognize conformational epitopes that are destroyed by deleting the C terminus of the protein. Further site-directed mutagenesis identified potential residues involved in binding to SEB that differ between Methicillin resistant and sensitive Staphylococcus aureus strains. Only mAb 20B1 was effective as a monotherapy in treating SEBILS in HLA DR3 transgenic mice, which exhibit enhanced sensitivity to SEB. It is noteworthy that mAbs, 14G8 and 6D3 were not protective when given alone in the HLA DR3 mice but their efficacy of protection could be greatly enhanced when mAbs were co-administered simultaneously. Our data suggest combinations of defined mAbs may constitute a better treatment strategy and provide a new insight for the development of passive immunotherapy.	[Varshney, Avanish K.; Wang, Xiaobo; Cook, Emily; Fries, Bettina C.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10461 USA; [Scharff, Matthew D.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Dutta, Kaushik; Goger, Michael J.] New York Struct Biol Ctr, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fries, BC (corresponding author), Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, 1300 Morris Pk Ave,Ullmann 1223, Bronx, NY 10461 USA.	Bettina.Fries@einstein.yu.edu	Varshney, Avanish/E-8500-2012		National Institutes of Health [U54-AI057158-Lipkin, 5T32AI007506-Casadevall]; U.S. Dept. of Defense [W911NF0710053]; New York Structural Biology Center (NYSBC); New York State Office of Science, Technology, and Academic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, T32AI007506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Defense(United States Department of Defense); New York Structural Biology Center (NYSBC); New York State Office of Science, Technology, and Academic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U54-AI057158-Lipkin and 5T32AI007506-Casadevall, the U.S. Dept. of Defense Grant W911NF0710053; and the New York Structural Biology Center (NYSBC). NYSBC is a STAR center supported by the New York State Office of Science, Technology, and Academic Research.	ALAKHOV VY, 1990, BIOTECHNOL APPL BIOC, V12, P94; ALAKHOV VY, 1992, EUR J BIOCHEM, V209, P823, DOI 10.1111/j.1432-1033.1992.tb17353.x; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Arad G, 2004, IMMUNOL LETT, V91, P141, DOI 10.1016/j.imlet.2003.11.003; Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Bavari S, 1999, J INFECT DIS, V180, P1365, DOI 10.1086/314977; Bavari S, 1996, J INFECT DIS, V174, P338, DOI 10.1093/infdis/174.2.338; Boles JW, 2003, VACCINE, V21, P2791, DOI 10.1016/S0264-410X(03)00222-6; Casadevall A, 2002, NAT BIOTECHNOL, V20, P114, DOI 10.1038/nbt0202-114; Caughey B, 2003, NAT MED, V9, P819, DOI 10.1038/nm0703-819; Cheng S, 2003, J AUTOIMMUN, V21, P195, DOI 10.1016/S0896-8411(03)00120-3; Cook E, 2007, CLIN VACCINE IMMUNOL, V14, P1094, DOI 10.1128/CVI.00183-07; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Dattamajumdar AK, 1996, IMMUNOGENETICS, V43, P141, DOI 10.1007/BF00176675; DELGARCIASUAREZ MM, 2004, INFECT IMMUN, V72, P4534; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; HAMAD ARA, 1994, J EXP MED, V180, P615, DOI 10.1084/jem.180.2.615; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13; IANDOLO JJ, 1977, INFECT IMMUN, V16, P610, DOI 10.1128/IAI.16.2.610-616.1977; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LeClaire RD, 2001, ANTIMICROB AGENTS CH, V45, P460, DOI 10.1128/AAC.45.2.460-463.2001; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li HY, 2003, SHOCK, V20, P257, DOI 10.1097/00024382-200309000-00010; Liu Tao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P63; MacCarthy T, 2009, DNA REPAIR, V8, P137, DOI 10.1016/j.dnarep.2008.09.006; METZROTH B, 1993, INFECT IMMUN, V61, P2445, DOI 10.1128/IAI.61.6.2445-2452.1993; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Nishi JI, 1997, J IMMUNOL, V158, P247; NORMANN SJ, 1970, J IMMUNOL, V104, P673; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Rajagopalan G, 2004, INFECT IMMUN, V72, P6733, DOI 10.1128/IAI.72.11.6733-6737.2004; Rajagopalan G, 2003, TISSUE ANTIGENS, V62, P149, DOI 10.1034/j.1399-0039.2003.00088.x; Rajagopalan G, 2006, SHOCK, V25, P647, DOI 10.1097/01.shk.0000209565.92445.7d; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; Rossi RJ, 2004, INT IMMUNOL, V16, P1751, DOI 10.1093/intimm/dxh176; Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Ulrich R. G., 2001, TXB MILITARY MED MED; Ulrich RG, 1998, TRENDS MICROBIOL, V6, P134, DOI 10.1016/S0966-842X(98)01247-5; Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5; Vabulas R, 1996, INFECT IMMUN, V64, P4567, DOI 10.1128/IAI.64.11.4567-4573.1996; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Woody MA, 1997, VACCINE, V15, P133, DOI 10.1016/S0264-410X(96)00166-1	50	48	53	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9737	9747		10.1074/jbc.M110.212407	http://dx.doi.org/10.1074/jbc.M110.212407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233204	hybrid, Green Published			2022-12-25	WOS:000288247700097
J	Zaarour, N; Defontaine, N; Demaretz, S; Azroyan, A; Cheval, L; Laghmani, K				Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel			Secretory Carrier Membrane Protein 2 Regulates Exocytic Insertion of NKCC2 into the Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; CORE VESICLE EXOCYTOSIS; RECYCLING ENDOSOMES; SURFACE EXPRESSION; CHLORIDE CHANNEL; EPITHELIAL-CELLS; NA+-K+-2CL(-) COTRANSPORTER; SORTING ENDOSOMES; APICAL MEMBRANE; PLASMA-MEMBRANE	The renal-specific Na-K-2Cl co-transporter, NKCC2, plays a pivotal role in regulating body salt levels and blood pressure. NKCC2 mutations lead to type I Bartter syndrome, a life-threatening kidney disease. Regulation of NKCC2 trafficking behavior serves as a major mechanism in controlling NKCC2 activity across the plasma membrane. However, the identities of the protein partners involved in cell surface targeting of NKCC2 are largely unknown. To gain insight into these processes, we used a yeast two-hybrid system to screen a kidney cDNA library for proteins that interact with the NKCC2 C terminus. One binding partner we identified was SCAMP2 (secretory carrier membrane protein 2). Microscopic confocal imaging and co-immunoprecipitation assays confirmed NKCC2-SCAMP2 interaction in renal cells. SCAMP2 associated also with the structurally related co-transporter NCC, suggesting that the interaction with SCAMP2 is a common feature of sodium-dependent chloride co-transporters. Heterologous expression of SCAMP2 specifically decreased cell surface abundance as well as transport activity of NKCC2 across the plasma membrane. Co-immunolocalization experiments revealed that intracellularly retained NKCC2co-localizes with SCAMP2 in recycling endosomes. The rate of NKCC2 endocytic retrieval, assessed by the sodium 2-mercaptoethane sulfonate cleavage assay, was not affected by SCAMP2. The surface-biotinylatable fraction of newly inserted NKCC2 in the plasma membrane was reduced by SCAMP2, demonstrating that SCAMP2-induced decrease in surface NKCC2 is due to decreased exocytotic trafficking. Finally, a single amino acid mutation, cysteine 201 to alanine, within the conserved cytoplasmic E peptide of SCAMP2, which is believed to regulate exocytosis, abolished SCAMP2-mediated down-regulation of the co-transporter. Taken together, these data are consistent with a model whereby SCAMP2 regulates NKCC2 transit through recycling endosomes and limits the cell surface targeting of the co-transporter by interfering with its exocytotic trafficking.	[Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] CNRS, INSERM, Ctr Rech Cordeliers, UMRS 872,ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France; [Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] Univ Paris 05, Fac Med, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Laghmani, K (corresponding author), UMRS 872 Equipe 3 ERL7226, 15 Rue Ecole Med, F-752270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766; CHEVAL, LYDIE/0000-0003-2957-6487	INSERM (Paris, France); Fondation pour la Recherche Medicale; la Societe de Neprologie	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); la Societe de Neprologie	This work was supported by grants from INSERM (Paris, France).; Recipient of a thesis fellowship from the Fondation pour la Recherche Medicale and from la Societe de Neprologie.	Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Ashton N, 2006, J HYPERTENS, V24, P2355, DOI 10.1097/HJH.0b013e3280104dd1; Bartz R, 2003, BIOCHEM BIOPH RES CO, V312, P663, DOI 10.1016/j.bbrc.2003.10.172; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Diering GH, 2009, J BIOL CHEM, V284, P13892, DOI 10.1074/jbc.M807055200; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; Ellis MA, 2006, AM J PHYSIOL-RENAL, V291, pF707, DOI 10.1152/ajprenal.00161.2006; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Green EG, 1997, BIOCHEM BIOPH RES CO, V239, P612, DOI 10.1006/bbrc.1997.7520; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Han CF, 2009, J IMMUNOL, V182, P2986, DOI 10.4049/jimmunol.0802002; Hannemann A, 2009, J BIOL CHEM, V284, P35348, DOI 10.1074/jbc.M109.060004; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Hubbard C, 2000, MOL BIOL CELL, V11, P2933, DOI 10.1091/mbc.11.9.2933; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Liao H, 2008, AM J PHYSIOL-CELL PH, V294, pC797, DOI 10.1152/ajpcell.00493.2007; Liao H, 2007, BIOCHEMISTRY-US, V46, P10909, DOI 10.1021/bi701121j; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Thakker RV, 2000, KIDNEY INT, V57, P787, DOI 10.1046/j.1523-1755.2000.00916.x; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Yang XJ, 2000, AM J PHYSIOL-CELL PH, V279, pC410, DOI 10.1152/ajpcell.2000.279.2.C410; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhu J, 2003, BIOCHEM J, V375, P761, DOI 10.1042/BJ20030885	69	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9489	9502		10.1074/jbc.M110.166546	http://dx.doi.org/10.1074/jbc.M110.166546			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21205824	Green Published, hybrid			2022-12-25	WOS:000288247700076
J	Yuan, W; Xu, M; Huang, C; Liu, N; Chen, S; Zhu, B				Yuan, Wen; Xu, Mo; Huang, Chang; Liu, Nan; Chen, She; Zhu, Bing			H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; TRITHORAX-GROUP PROTEIN; EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; DROSOPHILA-MELANOGASTER; POLYCOMB COMPLEXES; ACTIVE GENES; IN-VIVO; CHROMATIN	H3K27 methylation mediated by the histone methyltransferase complex PRC2 is critical for transcriptional regulation, Polycomb silencing, Drosophila segmentation, mammalian X chromosome inactivation, and cancer. PRC2-mediated H3K27 methylation can spread along the chromatin and propagate the repressive chromatin environment; thus, chromatin components that antagonize the activity of PRC2 are important for restraining Polycomb silencing. Here we report that in HeLa cells, H3 histones unmethylated at Lys-36 are mostly methylated at Lys-27, with the exception of newly synthesized H3. In addition, K27me3 rarely co-exists with K36me2 or K36me3 on the same histone H3 polypeptide. Moreover, PRC2 activity is greatly inhibited on nucleosomal substrates with preinstalled H3K36 methylation. These findings collectively identify H3K36 methylation as a chromatin component that restricts the PRC2-mediated spread of H3K27 methylation. Finally, we provide evidence that the controversial histone lysine methyltransferase Ash1, a known Trithorax group protein that antagonizes Polycomb silencing in vivo, is an H3K36-specific dimethylase, not an H3K4 methylase, further supporting the role of H3K36 methylation in antagonizing PRC2-mediated H3K27 methylation.	[Yuan, Wen; Xu, Mo; Huang, Chang; Liu, Nan; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yuan, Wen; Huang, Chang] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xu, Mo] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Liu, Nan] Beijing Normal Univ, Life Sci Coll, Beijing 100875, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Normal University	Zhu, B (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhubing@nibs.ac.cn		yuan, wen/0000-0003-0029-2544	Chinese Ministry of Science and Technology [2011CB965300, 2007AA02Z1A6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Chinese Ministry of Science and Technology Grants 2011CB965300 and 2007AA02Z1A6 (to B.Z.).	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Allis CD, 2006, EPIGENETICS, P23; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Jia GS, 2009, CELL RES, V19, P1217, DOI 10.1038/cr.2009.110; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; SHEARN A, 1989, GENETICS, V121, P517; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784	44	349	358	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7983	7989		10.1074/jbc.M110.194027	http://dx.doi.org/10.1074/jbc.M110.194027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239496	hybrid, Green Published			2022-12-25	WOS:000288013300029
J	Ritner, C; Wong, SSY; King, FW; Mihardja, SS; Liszewski, W; Erle, DJ; Lee, RJ; Bernstein, HS				Ritner, Carissa; Wong, Sharon S. Y.; King, Frank W.; Mihardja, Shirley S.; Liszewski, Walter; Erle, David J.; Lee, Randall J.; Bernstein, Harold S.			An Engineered Cardiac Reporter Cell Line Identifies Human Embryonic Stem Cell-Derived Myocardial Precursors	PLOS ONE			English	Article							CARDIOMYOCYTES; DIFFERENTIATION; EXPRESSION; HEART; ANTIGEN-1; BIOLOGY	Unlike some organs, the heart is unable to repair itself after injury. Human embryonic stem cells (hESCs) grow and divide indefinitely while maintaining the potential to develop into many tissues of the body. As such, they provide an unprecedented opportunity to treat human diseases characterized by tissue loss. We have identified early myocardial precursors derived from hESCs (hMPs) using an alpha-myosin heavy chain (alpha MHC)-GFP reporter line. We have demonstrated by immunocytochemistry and quantitative real-time PCR (qPCR) that reporter activation is restricted to hESC-derived cardiomyocytes (CMs) differentiated in vitro, and that hMPs give rise exclusively to muscle in an in vivo teratoma formation assay. We also demonstrate that the reporter does not interfere with hESC genomic stability. Importantly, we show that hMPs give rise to atrial, ventricular and specialized conduction CM subtypes by qPCR and microelectrode array analysis. Expression profiling of hMPs over the course of differentiation implicate Wnt and transforming growth factor-beta signaling pathways in CM development. The identification of hMPs using this alpha MHC-GFP reporter line will provide important insight into the pathways regulating human myocardial development, and may provide a novel therapeutic reagent for the treatment of cardiac disease.	[Ritner, Carissa; Wong, Sharon S. Y.; King, Frank W.; Mihardja, Shirley S.; Liszewski, Walter; Erle, David J.; Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Erle, David J.; Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ritner, C (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	harold.bernstein@ucsf.edu		Ritner, Carissa/0000-0002-4968-6838; Erle, David/0000-0002-2171-0648	NHLBI [HL085377, HL007544]; California Institute for Regenerative Medicine [RC1-00104]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085377, T32HL007544] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Public Health Service Grant (HL085377) from NHLBI, a Comprehensive Research Grant (RC1-00104) from the California Institute for Regenerative Medicine, and a gift from the Pollin Foundation to H.S.B., and funds from an NIH/NCRR UCSF-CTSI Grant (UL1 RR024131) to D.J.E. S.S.Y.W. and F.W.K. were supported by a National Research Service Award (HL007544) from NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Epting CL, 2004, J CELL SCI, V117, P6185, DOI 10.1242/jcs.01548; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Gaur M, 2010, CYTOTHERAPY, V12, P807, DOI 10.3109/14653249.2010.491821; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; GULICK J, 1991, J BIOL CHEM, V266, P9180; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Poelmann RE, 2000, CELL TISSUE RES, V301, P43, DOI 10.1007/s004410000227; RITNER C, 2010, JOVE-J VIS EXP, V42, pE2036, DOI DOI 10.3791/2036; SANCHEZ A, 1991, J BIOL CHEM, V266, P22419; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Wong SSY, 2010, REGEN MED, V5, P763, DOI 10.2217/RME.10.52; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu XQ, 2008, CYTOTHERAPY, V10, P376, DOI 10.1080/14653240802105307; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x	35	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e16004	10.1371/journal.pone.0016004	http://dx.doi.org/10.1371/journal.pone.0016004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245908	Green Published, gold, Green Submitted			2022-12-25	WOS:000286510500008
J	Sipos, M; Jeraldo, P; Chia, N; Qu, AI; Dhillon, AS; Konkel, ME; Nelson, KE; White, BA; Goldenfeld, N				Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Qu, Ani; Dhillon, A. Singh; Konkel, Michael E.; Nelson, Karen E.; White, Bryan A.; Goldenfeld, Nigel			Robust Computational Analysis of rRNA Hypervariable Tag Datasets	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MICROBIAL DIVERSITY; SPECIES RICHNESS; PHYLOGENETIC ANALYSES; SECONDARY STRUCTURE; COMMUNITIES; ALGORITHMS; EVOLUTION; DATABASE; NUMBER	Next-generation DNA sequencing is increasingly being utilized to probe microbial communities, such as gastrointestinal microbiomes, where it is important to be able to quantify measures of abundance and diversity. The fragmented nature of the 16S rRNA datasets obtained, coupled with their unprecedented size, has led to the recognition that the results of such analyses are potentially contaminated by a variety of artifacts, both experimental and computational. Here we quantify how multiple alignment and clustering errors contribute to overestimates of abundance and diversity, reflected by incorrect OTU assignment, corrupted phylogenies, inaccurate species diversity estimators, and rank abundance distribution functions. We show that straightforward procedural optimizations, combining preexisting tools, are effective in handling large (10(5)-10(6)) 16S rRNA datasets, and we describe metrics to measure the effectiveness and quality of the estimators obtained. We introduce two metrics to ascertain the quality of clustering of pyrosequenced rRNA data, and show that complete linkage clustering greatly outperforms other widely used methods.	[Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Qu, Ani; White, Bryan A.; Goldenfeld, Nigel] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Goldenfeld, Nigel] Univ Illinois, Loomis Lab Phys, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Dhillon, A. Singh] Washington State Univ, Avian Hlth & Food Safety Lab, Puyallup, WA USA; [Konkel, Michael E.] Washington State Univ, Sch Mol Biosci, Puyallup, WA USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington State University; Washington State University; J. Craig Venter Institute	Sipos, M (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	nigel@uiuc.edu	Jeraldo, Patricio/H-8178-2019	Jeraldo, Patricio/0000-0003-0282-4217; Konkel, Michael/0000-0002-8950-0903; Chia, Nicholas/0000-0001-9652-691X	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2005-35212-15287]; Department of Energy [DOE-2005-05818]; National Science Foundation [NSF-EF-0526747]; Institute of Genomic Biology; L.S. Edelheit Family Biological Physics Fellowship	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Institute of Genomic Biology; L.S. Edelheit Family Biological Physics Fellowship	These studies were supported by the Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant number 2005-35212-15287. Other support was provided by the Department of Energy through grant number DOE-2005-05818 and the National Science Foundation through grant number NSF-EF-0526747. N.C. acknowledges support from the Institute of Genomic Biology Fellows Program. P.J. acknowledges support from the L.S. Edelheit Family Biological Physics Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huse SM, 2010, ENV MICROBIOLOGY; Krznaric D, 1998, DISCRETE COMPUT GEOM, V19, P131, DOI 10.1007/PL00009332; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; May ACW, 2004, STRUCTURE, V12, P737, DOI 10.1016/j.str.2004.04.001; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Mouillot D, 1999, RES POPUL ECOL, V41, P203; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15220	10.1371/journal.pone.0015220	http://dx.doi.org/10.1371/journal.pone.0015220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217830	Green Published, Green Submitted, gold			2022-12-25	WOS:000285838900017
J	Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Balaggan, KS; Mowat, F; West, EL; Munro, PMG; Thrasher, AJ; Matter, K; Balda, MS; Ali, RR				Georgiadis, Anastasios; Tschernutter, Marion; Bainbridge, James W. B.; Balaggan, Kamaljit S.; Mowat, Freya; West, Emma L.; Munro, Peter M. G.; Thrasher, Adrian J.; Matter, Karl; Balda, Maria S.; Ali, Robin R.			The Tight Junction Associated Signalling Proteins ZO-1 and ZONAB Regulate Retinal Pigment Epithelium Homeostasis in Mice	PLOS ONE			English	Article							BOX-BINDING PROTEIN; MESENCHYMAL TRANSITION; PROLIFERATIVE VITREORETINOPATHY; DIABETIC-RETINOPATHY; CELL-PROLIFERATION; GENE-EXPRESSION; E-CADHERIN; TRANSCRIPTION; BARRIER; DIFFERENTIATION	Cell-cell adhesion regulates the development and function of epithelia by providing mechanical support and by guiding cell proliferation and differentiation. The tight junction (TJ) protein zonula occludens (ZO)-1 regulates cell proliferation and gene expression by inhibiting the activity of the Y-box transcription factor ZONAB in cultured epithelial cells. We investigated the role of this TJ-associated signalling pathway in the retinal pigment epithelium (RPE) in vivo by lentivirally-mediated overexpression of ZONAB, and knockdown of its cellular inhibitor ZO-1. Both overexpression of ZONAB or knockdown of ZO-1 resulted in increased RPE proliferation, and induced ultrastructural changes of an epithelial-mesenchymal transition (EMT)-like phenotype. Electron microscopy analysis revealed that transduced RPE monolayers were disorganised with increased pyknosis and monolayer breaks, correlating with increased expression of several EMT markers. Moreover, fluorescein angiography analysis demonstrated that the increased proliferation and EMT-like phenotype induced by overexpression of ZONAB or downregulation of ZO-1 resulted in RPE dysfunction. These findings demonstrate that ZO-1 and ZONAB are critical for differentiation and homeostasis of the RPE monolayer and may be involved in RPE disorders such as proliferative vitroretinopathy and atrophic age-related macular degeneration.	[Georgiadis, Anastasios; Tschernutter, Marion; Bainbridge, James W. B.; Balaggan, Kamaljit S.; Mowat, Freya; West, Emma L.; Ali, Robin R.] UCL, Dept Genet, UCL Inst Ophthalmol, London, England; [Matter, Karl; Balda, Maria S.] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London, England; [Munro, Peter M. G.] UCL, Electron Microscopy Unit, UCL Inst Ophthalmol, London, England; [Thrasher, Adrian J.; Ali, Robin R.] UCL, Mol Immunol Unit, UCL Inst Child Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Georgiadis, A (corresponding author), UCL, Dept Genet, UCL Inst Ophthalmol, London, England.	m.balda@ucl.ac.uk; r.ali@ucl.ac.uk	Matter, Karl/C-4880-2008; MOWAT, FREYA/AAD-5102-2021; West, Emma L/C-5252-2013; Georgiadis, Anastasios/G-8777-2012	Matter, Karl/0000-0001-8026-7220; Georgiadis, Anastasios/0000-0001-5079-3588; West, Emma/0000-0002-7006-3686; Ali, Robin/0000-0003-3126-6517; Mowat, Freya/0000-0002-8726-8768; /0000-0002-8427-6746; Thrasher, Adrian/0000-0002-6097-6115; Bainbridge, James/0000-0003-1318-8201	European Union [LSHG-CT-2005-512036]; Medical Research Council; National Institute for Health Research Biomedical Centre for Ophthalmology; BBSRC [BB/H002294/1] Funding Source: UKRI; MRC [G0900098, G0700743, G0400678] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002294/1] Funding Source: researchfish; Medical Research Council [G0900098, G0700743, G0400678] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Centre for Ophthalmology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	This project was supported by the European Union (Integrated Project EVI-GENORET: LSHG-CT-2005-512036), Medical Research Council and the National Institute for Health Research Biomedical Centre for Ophthalmology. JWBB is a Wellcome Trust Advanced Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Arakawa Y, 2004, BIOCHEM BIOPH RES CO, V322, P297, DOI 10.1016/j.bbrc.2004.04.208; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, TRENDS CELL BIOL, V13, P310, DOI 10.1016/S0962-8924(03)00105-3; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Buchert M, 2009, GASTROENTEROLOGY, V137, P156, DOI 10.1053/j.gastro.2009.03.037; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Defoe DM, 2007, MOL VIS, V13, P273; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kroll P, 2007, OPHTHALMOLOGICA, V221, P78, DOI 10.1159/000098253; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lima WR, 2010, J AM SOC NEPHROL, V21, P478, DOI 10.1681/ASN.2009070698; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Pannequin J, 2007, MOL CANCER RES, V5, P1147, DOI 10.1158/1541-7786.MCR-07-0198; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tsapara A, 2006, MOL BIOL CELL, V17, P1322, DOI 10.1091/mbc.E05-06-0507; Tschernutter M, 2005, GENE THER, V12, P694, DOI 10.1038/sj.gt.3302460; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	40	81	84	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15730	10.1371/journal.pone.0015730	http://dx.doi.org/10.1371/journal.pone.0015730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209887	Green Published, Green Submitted, gold			2022-12-25	WOS:000285793600031
J	Peters, R; Wolf, MJ; van den Broek, M; Nuvolone, M; Dannenmann, S; Stieger, B; Rapold, R; Konrad, D; Rubin, A; Bertino, JR; Aguzzi, A; Heikenwalder, M; Knuth, AK				Peters, Rowayda; Wolf, Monika J.; van den Broek, Maries; Nuvolone, Mario; Dannenmann, Stefanie; Stieger, Bruno; Rapold, Reto; Konrad, Daniel; Rubin, Arnold; Bertino, Joseph R.; Aguzzi, Adriano; Heikenwalder, Mathias; Knuth, Alexander K.			Efficient Generation of Multipotent Mesenchymal Stem Cells from Umbilical Cord Blood in Stroma-Free Liquid Culture	PLOS ONE			English	Article							EX-VIVO EXPANSION; MOBILIZED PERIPHERAL-BLOOD; HUMAN-BONE-MARROW; PROGENITOR CELLS; CRITICAL PARAMETERS; UNRELATED DONOR; SELF-RENEWAL; ADULT; TRANSPLANTATION; EXPRESSION	Background: Haematopoiesis is sustained by haematopoietic (HSC) and mesenchymal stem cells (MSC). HSC are the precursors for blood cells, whereas marrow, stroma, bone, cartilage, muscle and connective tissues derive from MSC. The generation of MSC from umbilical cord blood (UCB) is possible, but with low and unpredictable success. Here we describe a novel, robust stroma-free dual cell culture system for long-term expansion of primitive UCB-derived MSC. Methods and Findings: UCB-derived mononuclear cells (MNC) or selected CD34(+) cells were grown in liquid culture in the presence of serum and cytokines. Out of 32 different culture conditions that have been tested for the efficient expansion of HSC, we identified one condition (DMEM, pooled human AB serum, Flt-3 ligand, SCF, MGDF and IL-6; further denoted as D7) which, besides supporting HSC expansion, successfully enabled long-term expansion of stromal/MSC from 8 out of 8 UCB units (5 MNC-derived and 3 CD34(+) selected cells). Expanded MSC displayed a fibroblast-like morphology, expressed several stromal/MSC-related antigens (CD105, CD73, CD29, CD44, CD133 and Nestin) but were negative for haematopoietic cell markers (CD45, CD34 and CD14). MSC stemness phenotype and their differentiation capacity in vitro before and after high dilution were preserved throughout long-term culture. Even at passage 24 cells remained Nestin(+), CD133(+) and > 95% were positive for CD105, CD73, CD29 and CD44 with the capacity to differentiate into mesodermal lineages. Similarly we show that UCB derived MSC express pluripotency stem cell markers despite differences in cell confluency and culture passages. Further, we generated MSC from peripheral blood (PB) MNC of 8 healthy volunteers. In all cases, the resulting MSC expressed MSC-related antigens and showed the capacity to form CFU-F colonies. Conclusions: This novel stroma-free liquid culture overcomes the existing limitation in obtaining MSC from UCB and PB enabling so far unmet therapeutic applications, which might substantially affect clinical practice.	[Peters, Rowayda; van den Broek, Maries; Dannenmann, Stefanie; Knuth, Alexander K.] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Wolf, Monika J.; Nuvolone, Mario; Aguzzi, Adriano; Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Stieger, Bruno] Univ Zurich Hosp, Dept Med, Inst Clin Pharmacol, CH-8091 Zurich, Switzerland; [Stieger, Bruno] Univ Zurich Hosp, Dept Med, Inst Toxicol, CH-8091 Zurich, Switzerland; [Rapold, Reto; Konrad, Daniel] Univ Childrens Hosp, Div Diabetol & Endocrinol, Zurich, Switzerland; [Rubin, Arnold; Bertino, Joseph R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Nuvolone, Mario] Univ Pavia, Dept Internal Med, Amyloid Ctr, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; IRCCS Fondazione San Matteo; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Peters, R (corresponding author), Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland.	rowayda.peters@gmail.com	knuth, alexander/H-2608-2014; Stieger, Bruno/U-6323-2017; Aguzzi, Adriano/A-3351-2008; van den Broek, Maries/L-6532-2019; Heikenwalder, Mathias/AAA-2269-2020; Nuvolone, Mario/K-4763-2018; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Stieger, Bruno/0000-0002-7190-5785; Nuvolone, Mario/0000-0001-8334-1684; Konrad, Daniel/0000-0001-9067-4356; Aguzzi, Adriano/0000-0002-0344-6708; van den Broek, Maries/0000-0002-9489-3692	Oncosuisse [OCS 02113-08-2007]; Roche Research Foundation; Atlantic Philanthropies, Cancer Research Institute; Stiftung fur Forschung der Onkologie (SFO); Collegio Ghislieri, Pavia, Italy; European Research Council; Novartis Research Foundation	Oncosuisse; Roche Research Foundation; Atlantic Philanthropies, Cancer Research Institute; Stiftung fur Forschung der Onkologie (SFO); Collegio Ghislieri, Pavia, Italy; European Research Council(European Research Council (ERC)European Commission); Novartis Research Foundation	This work was supported by Prof. Dr. Max-Cloetta, the Oncosuisse (OCS 02113-08-2007) (M.H.), the Roche Research Foundation (M.J.W.), Atlantic Philanthropies, Cancer Research Institute and Stiftung fur Forschung der Onkologie (SFO). M.N. was partly supported by an investigator fellowship of Collegio Ghislieri, Pavia, Italy. A.A. was supported by an Advanced Grant of the European Research Council and by a generous grant of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bron D, 2008, B CANCER, V95, P314, DOI 10.1684/bdc.2008.0589; BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Fang BJ, 2009, ANN HEMATOL, V88, P261, DOI 10.1007/s00277-008-0599-0; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hough R, 2009, BRIT J HAEMATOL, V147, P593, DOI 10.1111/j.1365-2141.2009.07841.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Loges S, 2004, STEM CELLS DEV, V13, P229, DOI 10.1089/154732804323099163; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mareschi K, 2001, HAEMATOLOGICA, V86, P1099; Nguyen VA, 2009, J CELL MOL MED, V13, P522, DOI 10.1111/j.1582-4934.2008.00340.x; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Oda M, 2009, INT J HEMATOL, V89, P374, DOI 10.1007/s12185-009-0266-9; Perdikogianni C, 2008, CYTOTHERAPY, V10, P452, DOI 10.1080/14653240701883079; Perey L, 1998, BRIT J HAEMATOL, V103, P618, DOI 10.1046/j.1365-2141.1998.01062.x; Peters R, 1998, BLOOD, V92, P2041, DOI 10.1182/blood.V92.6.2041.418k34_2041_2052; Peters R, 2002, BRIT J HAEMATOL, V119, P792, DOI 10.1046/j.1365-2141.2002.03873.x; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Poloni A, 2008, CYTOTHERAPY, V10, P690, DOI 10.1080/14653240802419310; Pozzi S, 2006, EXP HEMATOL, V34, P934, DOI 10.1016/j.exphem.2006.03.007; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Rocha V, 2004, CURR OPIN HEMATOL, V11, P375, DOI 10.1097/01.moh.0000145933.36985.eb; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solves P, 2008, CRYOBIOLOGY, V56, P152, DOI 10.1016/j.cryobiol.2008.02.002; Stieger B, 2006, SWISS MED WKLY, V136, P552; Sueblinvong V, 2009, CURR OPIN PHARMACOL, V9, P268, DOI 10.1016/j.coph.2009.03.002; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yao CL, 2004, EXP HEMATOL, V32, P720, DOI 10.1016/j.exphem.2004.05.021; Zeddou M, 2010, CELL BIOL INT, V34, P693, DOI 10.1042/CBI20090414	52	22	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15689	10.1371/journal.pone.0015689	http://dx.doi.org/10.1371/journal.pone.0015689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209896	gold, Green Published, Green Accepted			2022-12-25	WOS:000285793600028
J	Schwank, S; Sutherland, CJ; Drakeley, CJ				Schwank, Samana; Sutherland, Colin J.; Drakeley, Chris J.			Promiscuous Expression of alpha-Tubulin II in Maturing Male and Female Plasmodium falciparum Gametocytes	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; SEX-RATIO; SEQUENCE-ANALYSIS; COMMITMENT; PROTEIN; PFG377; GENES; STAGE; DENSITY	Background: Antimalarial interventions designed to impact on the transmissible sexual stages of Plasmodium falciparum are evaluated by measurement of peripheral gametocyte carriage in vivo and infectivity to mosquitoes. Drug or vaccine-elicited effects may differentially affect the relative abundance of mature male and female sexual forms, and this can be measured by estimation of sex ratios before and after intervention in vivo and in vitro. Measuring the impact of anti-gametocyte drugs on sexual commitment of immature gametocyte stages in vitro is not currently possible as male and female parasites cannot be distinguished by morphology alone prior to stage IV. Methodology/Principal Findings: We have modified an existing immunofluorescence-based approach for distinguishing male and female gametocytes during development in vitro, by using highly synchronised magnetically-enriched gametocyte preparations at different stages of maturity. Antibodies recognising alpha-tubulin II ( males) and Pfg377 ( females) were used to attempt to discriminate the sexes. Transcription of these two proteins was not coordinated during in vitro development, with pfg377 transcripts accumulating only late in development, immediately prior to immunofluorescent signals from the PfG377 protein appearing in stage IV gametocytes. Contrary to previous descriptions of this protein as male-specific in P. falciparum, alpha-tubulin II recognised both male and female gametocytes at stages I to IV, but evidence of differential expression levels of this protein in late stage male and female gametocytes was found. Using antibodies recognising PfG377 as the primary marker and alpha-tubulin II as a secondary marker, robust estimates of sex ratio in in vitro cultures were obtained for gametocytes at stage IV or later, and validated by light microscopic counts. However, sex ratio estimation was not possible for early stage gametocytes due to the promiscuity of alpha-tubulin II protein expression, and the relatively late accumulation of PfG377 during the development process. Conclusions/Significance: This approach is a feasible method for the evaluation of drug impacts on late-stage gametocyte sex ratio in in vitro studies. Additional sex-specific antigens need to be evaluated for sex ratio estimation in early stage gametocyte preparations.	[Schwank, Samana; Sutherland, Colin J.; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Schwank, S (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407	Europaeischer Landersverein der Industrie; UK Health Protection Agency; Wellcome Trust [063516]	Europaeischer Landersverein der Industrie; UK Health Protection Agency; Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by a PhD Studentship to SS, awarded by the Europaeischer Landersverein der Industrie. CJS was supported by the UK Health Protection Agency. CJD was supported by Wellcome Trust grant #063516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano P, 1995, MOL BIOCHEM PARASIT, V74, P143, DOI 10.1016/0166-6851(95)02491-3; BAKER DA, 1995, MOL BIOCHEM PARASIT, V72, P193, DOI 10.1016/0166-6851(95)00073-A; Bell A, 1998, PARASITOL TODAY, V14, P234, DOI 10.1016/S0169-4758(98)01246-0; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Carter R, 1993, Methods Mol Biol, V21, P67; de Koning-Ward TF, 2008, MOL MICROBIOL, V67, P278, DOI 10.1111/j.1365-2958.2007.06039.x; DELVES CJ, 1990, MOL BIOCHEM PARASIT, V43, P271, DOI 10.1016/0166-6851(90)90151-B; Drew DR, 2007, MOL BIOCHEM PARASIT, V156, P199, DOI 10.1016/j.molbiopara.2007.08.004; Fennell BJ, 2008, INT J PARASITOL, V38, P527, DOI 10.1016/j.ijpara.2007.09.005; Field J., 1956, MICROSCOPIC DIAGNOSI, V2; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; HOLLOWAY SP, 1990, MOL BIOCHEM PARASIT, V43, P257, DOI 10.1016/0166-6851(90)90150-K; HOLLOWAY SP, 1989, MOL MICROBIOL, V3, P1501, DOI 10.1111/j.1365-2958.1989.tb00136.x; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kooij TWA, 2005, MOL BIOCHEM PARASIT, V144, P16, DOI 10.1016/j.molbiopara.2005.07.003; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Mitri C, 2009, P ROY SOC B-BIOL SCI, V276, P3721, DOI 10.1098/rspb.2009.0962; Peatey CL, 2009, J INFECT DIS, V200, P1518, DOI 10.1086/644645; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Severini C, 1999, MOL BIOCHEM PARASIT, V100, P247, DOI 10.1016/S0166-6851(99)00050-X; Silvestrini F, 2000, PARASITOLOGY, V121, P465, DOI 10.1017/S0031182099006691; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265; Sowunmi A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-297; Sowunmi A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-169; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700	34	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14470	10.1371/journal.pone.0014470	http://dx.doi.org/10.1371/journal.pone.0014470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209927	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000285793600012
J	Lu, Y; Li, XQ; Lu, HQ; Fan, Z				Lu, Yang; Li, Xinqun; Lu, Haiquan; Fan, Zhen			1, 9-Pyrazoloanthrones Downregulate HIF-1 alpha and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTATIC COLORECTAL-CANCER; INDUCIBLE FACTOR 1-ALPHA; N-TERMINAL KINASE; PLATINUM-BASED CHEMOTHERAPY; PHASE-II MULTICENTER; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; MUTATION STATUS; KRAS MUTATIONS	Cetuximab, a monoclonal antibody that blocks the epidermal growth factor receptor (EGFR), is currently approved for the treatment of several types of solid tumors. We previously showed that cetuximab can inhibit hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein synthesis by inhibiting the activation of EGFR downstream signaling pathways including Erk, Akt, and mTOR. 1, 9-pyrazoloanthrone (1, 9 PA) is an anthrapyrazolone compound best known as SP600125 that specifically inhibits c-jun N-terminal kinase (JNK). Here, we report 1, 9 PA can downregulate HIF-1 alpha independently of its inhibition of JNK. This downregulatory effect was abolished when the oxygen-dependent domain (ODD) of HIF-1 alpha (HIF-1 alpha-DODD, the domain responsible for HIF-1 alpha degradation) was experimentally deleted or when the activity of HIF-1a prolyl hydroxylase (PHD) or the 26S proteasomal complex was inhibited, indicating that the 1, 9 PA downregulates HIF-1 alpha by promoting PHD-dependent HIF-1 alpha degradation. We found that the combination of 1, 9 PA and cetuximab worked synergistically to induce apoptosis in cancer cells in which cetuximab or 1, 9 PA alone had no or only weak apoptotic activity. This synergistic effect was substantially decreased in cancer cells transfected with HIF-1 alpha-DODD, indicating that downregulation of HIF-1 alpha was the mechanism of this synergistic effect. More importantly, 1, 9 PA can downregulate HIF-1 alpha in cancer cells that are insensitive to cetuximab-induced inhibition of HIF-1 alpha expression due to overexpression of oncogenic Ras (RasG12V). Our findings suggest that 1, 9 PA is a lead compound of a novel class of drugs that may be used to enhance the response of cancer cells to cetuximab through a complementary effect on the downregulation of HIF-1 alpha.	[Lu, Yang; Li, Xinqun; Lu, Haiquan; Fan, Zhen] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lu, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	zfan@mdanderson.org			National Institutes of Health [5R01CA129036]; Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA129036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a National Institutes of Health award 5R01CA129036 (to Z.F.) and a grant from the Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center (to Z.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Karashima T, 2002, CLIN CANCER RES, V8, P1253; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lee E, 2002, MOL CELLS, V14, P9; Li X, 2006, ONCOGENE, V25, P525, DOI 10.1038/sj.onc.1209075; Li XQ, 2008, MOL CANCER THER, V7, P1207, DOI 10.1158/1535-7163.MCT-07-2187; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang K, 2003, MOL CANCER THER, V2, P1113; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Liu B, 2000, BRIT J CANCER, V82, P1991; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391; 2009, N ENGL J MED, V360, P1408; 2007, BR J CANC, V96, P1166	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15823	10.1371/journal.pone.0015823	http://dx.doi.org/10.1371/journal.pone.0015823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209911	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793200059
J	Singaravelu, K; Nelson, C; Bakowski, D; de Brito, OM; Ng, SW; Di Capite, J; Powell, T; Scorrano, L; Parekh, AB				Singaravelu, Karthika; Nelson, Charmaine; Bakowski, Daniel; de Brito, Olga Martins; Ng, Siaw-Wei; Di Capite, Joseph; Powell, Trevor; Scorrano, Luca; Parekh, Anant B.			Mitofusin 2 Regulates STIM1 Migration from the Ca2+ Store to the Plasma Membrane in Cells with Depolarized Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CRAC CHANNELS; CURRENT I-CRAC; ACTIVATED CALCIUM CURRENT; MAST-CELLS; T-LYMPHOCYTES; ENDOPLASMIC-RETICULUM; RBL-1 CELLS; DEPLETION; ORAI1; INFLUX	Store-operated Ca2+ channels in the plasma membrane (PM) are activated by the depletion of Ca2+ from the endoplasmic reticulum (ER) and constitute a widespread and highly conserved Ca2+ influx pathway. After store emptying, the ER Ca2+ sensor STIM1 forms multimers, which then migrate to ER-PM junctions where they activate the Ca2+ release-activated Ca2+ channel Orai1. Movement of an intracellular protein to such specialized sites where it gates an ion channel is without precedence, but the fundamental question of how STIM1 migrates remains unresolved. Here, we show that trafficking of STIM1 to ER-PM junctions and subsequent Ca2+ release-activated Ca2+ channel activity is impaired following mitochondrial depolarization. We identify the dynamin-related mitochondrial protein mitofusin 2, mutations of which causes the inherited neurodegenerative disease Charcot-Marie-Tooth IIa in humans, as an important component of this mechanism. Our results reveal a molecular mechanism whereby a mitochondrial fusion protein regulates protein trafficking across the endoplasmic reticulum and reveals a homeostatic mechanism whereby mitochondrial depolarization can inhibit store-operated Ca2+ entry, thereby reducing cellular Ca2+ overload.	[Singaravelu, Karthika; Nelson, Charmaine; Bakowski, Daniel; Ng, Siaw-Wei; Di Capite, Joseph; Powell, Trevor; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [de Brito, Olga Martins; Scorrano, Luca] Dulbecco Telethon Inst, Venetian Inst Mol Med, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Med, CH-1211 Geneva, Switzerland	University of Oxford; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	Medical Research Council (United Kingdom); British Heart Foundation; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom) and the British Heart Foundation.	Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chvanov M, 2008, PFLUG ARCH EUR J PHY, V457, P505, DOI 10.1007/s00424-008-0529-y; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; MOHR FC, 1990, AM J PHYSIOL, V258, pC217, DOI 10.1152/ajpcell.1990.258.2.C217; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh A, 2009, CURR BIOL, V19, pR200, DOI 10.1016/j.cub.2009.01.012; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Parekh AB, 2007, CELL CALCIUM, V42, P111, DOI 10.1016/j.ceca.2007.02.012; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Rojo M, 2002, J CELL SCI, V115, P1663; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; SILVERMAN HS, 1994, AM J PHYSIOL, V266, pC222, DOI 10.1152/ajpcell.1994.266.1.C222; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoon E, 2004, BIOCHEM BIOPH RES CO, V325, P117, DOI 10.1016/j.bbrc.2004.09.216; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	65	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.174029	http://dx.doi.org/10.1074/jbc.M110.174029			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21220420	hybrid, Green Published			2022-12-25	WOS:000289077500034
J	Barbash, O; Lee, EK; Diehl, JA				Barbash, O.; Lee, E. K.; Diehl, J. A.			Phosphorylation-dependent regulation of SCFFbx4 dimerization and activity involves a novel component, 14-3-3 epsilon	ONCOGENE			English	Article						cdk4; cyclin D1; Fbx4; 14-3-3	CYCLIN D1; STRUCTURAL BASIS; 14-3-3 PROTEINS; KINASE-ACTIVITY; NUCLEAR EXPORT; UBIQUITINATION; ACTIVATION; 14-3-3-PROTEINS; LOCALIZATION; PROTEOLYSIS	Fbx4 is an F-box constituent of Skp-Cullin-F-box (SCF) ubiquitin ligases that directs ubiquitylation of cyclin D1. Ubiquitylation of cyclin D1 requires phosphorylation of both cyclin D1 and Fbx4 by GSK3 beta. GSK3 beta-mediated phosphorylation of Fbx4 Ser12 during the G1/S transition regulates Fbx4 dimerization, which in turn governs Fbx4-driven E3 ligase activity. In esophageal carcinomas that overexpress cyclin D1, Fbx4 is subject to inactivating mutations that specifically disrupt dimerization, highlighting the biological significance of this regulatory mechanism. In an effort to elucidate the mechanisms that regulate dimerization, we sought to identify proteins that differentially bind to wild-type Fbx4 versus a cancer-derived dimerization-deficient mutant. We provide evidence that phosphorylation of Ser12 generates a docking site for 14-3-3 epsilon. 14-3-3 epsilon binds to endogenous Fbx4 and this association is impaired by mutations that target either Ser8 or Ser12 in Fbx4, suggesting that this N-terminal motif in Fbx4 directs its interaction with 14-3-3 epsilon. Knockdown of 14-3-3 epsilon inhibited Fbx4 dimerization, reduced SCFFbx4 E3 ligase activity and stabilized cyclin D1. Collectively, the current results suggest a model wherein 14-3-3 epsilon binds to Ser12-phosphorylated Fbx4 to mediate dimerization and function. Oncogene (2011) 30, 1995-2002; doi:10.1038/onc.2010.584; published online 17 January 2011	[Barbash, O.; Lee, E. K.; Diehl, J. A.] Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Barbash, O.; Lee, E. K.; Diehl, J. A.] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; [Barbash, O.; Lee, E. K.; Diehl, J. A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Diehl, JA (corresponding author), Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, 454 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu			NIH [P01-CA098101]; Leukemia & Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [P01CA098101, R01CA133154, P30CA016520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Margarita Romero for excellent technical assistance. This work was supported by a grant from the NIH (P01-CA098101) and a Leukemia & Lymphoma Scholar award (JAD).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Barbash O, 2009, ONCOGENE, V28, P4317, DOI 10.1038/onc.2009.287; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Konishi H, 2002, CANCER RES, V62, P271; KORCHEVA VB, 2010, APPL IMMUNOHISTOCHEM; Li YF, 2010, J BIOL CHEM, V285, P13896, DOI 10.1074/jbc.M110.111518; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pignataro L, 2005, Acta Otorhinolaryngol Ital, V25, P75; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeng ZX, 2010, DEV CELL, V18, P214, DOI 10.1016/j.devcel.2010.01.007; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	35	27	27	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					1995	2002		10.1038/onc.2010.584	http://dx.doi.org/10.1038/onc.2010.584			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21242966	Green Accepted			2022-12-25	WOS:000289977400003
J	Fernandez, RMH; Ruiz-Miro, M; Dolcet, X; Aldea, M; Gari, E				Fernandez, R. M. H.; Ruiz-Miro, M.; Dolcet, X.; Aldea, M.; Gari, E.			Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility	ONCOGENE			English	Article						cyclin D1; Ral GTPases; exocyst; cell motility cell adhesion; tumor spreading	MIGRATION; PHOSPHORYLATION; ACTIVATION; EXOCYST; CANCER; INDUCTION; COMPLEXES; INVASION; FILAMIN; NUMBER	Alterations in the levels of adhesion and motility of cells are critical events in the development of metastasis. Cyclin D1 (CycD1) is one of the most frequently amplified oncogenes in many types of cancers and it is also associated with the development of metastasis. Despite this, we still do not know which are all the relevant pathways by which CycD1 induces oncogenic processes. CycD1 functions can be either dependent or independent of the cyclin-dependent kinase Cdk4, and they affect several cellular aspects such as proliferation, cell attachment and migration. In this work, we reveal a novel function of CycD1 that fosters our understanding of the oncogenic potential of CycD1. We show that CycD1 binds to the small GTPases Ral A and B, which are involved, through exocyst regulation, in the progression of metastatic cancers, inducing anchorage-independent growth and cell survival of transformed cells. We show that CycD1 binds active Ral complexes and the exocyst protein Sec6, and co-localizes with Ral GTPases in trans-Golgi and exocyst-rich regions. We have also observed that CycD1-Cdk4 phosphorylates the Ral GEF Rgl2 'in vitro' and that CycD1-Cdk4 activity stimulates accumulation of the Ral GTP active forms. In accordance with this, our data suggest that CycD1-Cdk4 enhances cell detachment and motility in collaboration with Ral GTPases. This new function may help explain the contribution of CycD1 to tumor spreading. Oncogene (2011) 30, 1936-1946; doi: 10.1038/onc.2010.577; published online 17 January 2011	[Fernandez, R. M. H.; Ruiz-Miro, M.; Dolcet, X.; Aldea, M.; Gari, E.] Univ Lleida, Fac Med, Dept Ciencies Med Basiques, IRBLleida, Lleida 25008, Catalonia, Spain; [Dolcet, X.] IRBLleida, Oncol Pathol Grp, Catalonia, Spain; [Aldea, M.] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gari, E (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques, IRBLleida, Montserrat Roig 2, Lleida 25008, Catalonia, Spain.	eloi.gari@cmb.udl.cat	Fernández Hernández, Rita María/C-4477-2011; Aldea, Marti/K-3962-2014; Dolcet, Xavi/B-5665-2009; Garí, Eloi/A-5996-2010	Aldea, Marti/0000-0002-8710-5336; Dolcet, Xavi/0000-0003-1921-0449; Garí, Eloi/0000-0002-3505-4901	Ministry of Education and Science of Spain [BFU2007-65640/BMC, BFU2007-67929-C02- 01]; Consolider-Ingenio [CSD2007-00015]	Ministry of Education and Science of Spain(Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank N Agell, C Yeaman, JL Bos, M Matsuda, X Bustelo, P Crespo, MA del Pozo and J Herreros for the gift of plasmids and reagents, and also N Eritja, MBozic, JM Valdivielso, Lluis Fajas, Eloi Montanez and SaraWickstrom for technical advice. We are grateful to J Odajima and P Sicinski for providing CCND1<SUP>-/-</SUP> and CCND1<SUP>+/+</SUP> immortalized MEFs, and M Hendrix and E Seftor for providing R3327-50A cells. We thank S Rius, I Navarro, I Montoliu and MA Cornado for their technical assistance and the members of CYC lab for helpful discussions. This work was funded by the Ministry of Education and Science of Spain BFU2007-65640/BMC (Eloi Gari) and BFU2007-67929-C02- 01 (Marti Aldea) and Consolider-Ingenio 2010 (CSD2007-00015). RMH Fernandez and M Ruiz-Miro were supported by predoctoral fellowships from the Ministry of Education and Science of Spain.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-7; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kono K, 2008, MOL BIOL CELL, V19, P1763, DOI 10.1091/mbc.E07-09-0950; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lu FM, 2003, CANCER RES, V63, P7056; Luo Jan, 1997, Pathol Oncol Res, V3, P264; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi JH, 2006, EXP CELL RES, V312, P3432, DOI 10.1016/j.yexcr.2006.07.016; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	48	18	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1936	1946		10.1038/onc.2010.577	http://dx.doi.org/10.1038/onc.2010.577			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21242975				2022-12-25	WOS:000289777700009
J	Mochmann, LH; Bock, J; Ortiz-Tanchez, J; Schlee, C; Bohne, A; Neumann, K; Hofmann, WK; Thiel, E; Baldus, CD				Mochmann, L. H.; Bock, J.; Ortiz-Tanchez, J.; Schlee, C.; Bohne, A.; Neumann, K.; Hofmann, W. K.; Thiel, E.; Baldus, C. D.			Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG	ONCOGENE			English	Article						ETS-related gene (ERG); WNT11; acute leukemia; ERG target genes; 6-bromoindirubin-3-oxime (BIO); morphological transformation	ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; T-LYMPHOBLASTIC LEUKEMIA; PROSTATE-CANCER; FAMILY; EXPRESSION; DIFFERENTIATION; TUMORIGENESIS; OVEREXPRESSION; TRANSFORMATION	E26 transforming sequence-related gene (ERG) is a transcription factor involved in normal hematopoiesis and is dysregulated in leukemia. ERG mRNA overexpression was associated with poor prognosis in a subset of patients with T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML). Herein, a genome-wide screen of ERG target genes was conducted by chromatin immunoprecipitation-on-chip (ChIP-chip) in Jurkat cells. In this screen, 342 significant annotated genes were derived from this global approach. Notably, ERG-enriched targets included WNT signaling genes: WNT11, WNT2, WNT9A, CCND1 and FZD7. Furthermore, chromatin immunoprecipitation (ChIP) of normal and primary leukemia bone marrow material also confirmed WNT11 as a target of ERG in six of seven patient samples. A larger sampling of patient diagnostic material revealed that ERG and WNT11 mRNA were co-expressed in 80% of AML (n = 30) and 40% in T-ALL (n = 30) bone marrow samples. Small interfering RNA (siRNA)-mediated knockdown of ERG confirmed down-regulation of WNT11 transcripts. Conversely, in a tet-on ERG-inducible assay, WNT11 transcripts were co-stimulated. A WNT pathway agonist, 6-bromoindirubin-3-oxime (BIO), was used to determine the effect of cell growth on the ERG-inducible cells. The addition of BIO resulted in an ERG-dependent proliferative growth advantage over ERG-uninduced cells. Finally, ERG induction prompted morphological transformation whereby round unpolarized K562 cells developed elongated protrusions and became polarized. This morphological transformation could effectively be inhibited with BIO and with siRNA knockdown of WNT11. In conclusion, ERG transcriptional networks in leukemia converge on WNT signaling targets. Specifically, WNT11 emerged as a direct target of ERG. Potent ERG induction promoted morphological transformation through WNT11 signals. The findings in this study unravel new ERG-directed molecular signals that may contribute to the resistance of current therapies in acute leukemia patients with poor prognosis characterized by high ERG mRNA expression. Oncogene (2011) 30, 2044-2056; doi:10.1038/onc.2010.582; published online 17 January 2011	[Mochmann, L. H.; Bock, J.; Ortiz-Tanchez, J.; Schlee, C.; Bohne, A.; Thiel, E.; Baldus, C. D.] Charite, Dept Hematol & Oncol, D-12203 Berlin, Germany; [Neumann, K.] Charite, Inst Biometr & Clin Epidemiol, Berlin, Germany; [Hofmann, W. K.] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg	Baldus, CD (corresponding author), Charite, Dept Hematol & Oncol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.	claudia.baldus@charite.de			Deutsche Krebshilfe (Max Eder Nachwuchsforderung)	Deutsche Krebshilfe (Max Eder Nachwuchsforderung)(Deutsche Krebshilfe)	This study was supported by a grant from the Deutsche Krebshilfe (Max Eder Nachwuchsforderung) to CDB. We thank Dr Martin Neumann (Department of Hematology and Oncology, Charite, Berlin, Germany) for his critical reading of the manuscript. We also thank Dr Anja Kuhl (Research Center ImmunoSciences, Charite, Berlin, Germany) for helpful advice and fluorescence microscopy assistance.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Baldus CD, 2004, P NATL ACAD SCI USA, V101, P3915, DOI 10.1073/pnas.0400272101; Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Bastian LS, 1996, J BIOL CHEM, V271, P18554, DOI 10.1074/jbc.271.31.18554; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bohne A, 2009, LEUKEMIA RES, V33, P817, DOI 10.1016/j.leukres.2008.11.012; Brandon C, 2000, BLOOD, V96, P4132, DOI 10.1182/blood.V96.13.4132.h8004132_4132_4141; CHIANG J, 2009, P NATL ACAD SCI USA, V106, P3396; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Ellett F, 2009, MECH DEVELOP, V126, P220, DOI 10.1016/j.mod.2008.11.001; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; GOMEZ JR, 2007, BLOOD, V109, P3462; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong XT, 1997, BLOOD, V90, P1192; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; LELINEK J, 2008, LEUKEMIA, V22, P1529; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; MARTIN V, 2009, CANCER SCI, V3, P1; Narod SA, 2008, BRIT J CANCER, V99, P847, DOI 10.1038/sj.bjc.6604558; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Rainis L, 2005, CANCER RES, V65, P7596, DOI 10.1158/0008-5472.CAN-05-0147; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Soda M, 2008, CELL SIGNAL, V20, P2317, DOI 10.1016/j.cellsig.2008.09.001; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Stankiewicz MJ, 2009, BLOOD, V113, P3337, DOI 10.1182/blood-2008-08-174813; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; WU D, 2009, TREND BIOCH SCI, V722, P1; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704	50	30	31	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2044	2056		10.1038/onc.2010.582	http://dx.doi.org/10.1038/onc.2010.582			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21242973	Green Submitted			2022-12-25	WOS:000289977400008
J	Materia, S; Cater, MA; Klomp, LWJ; Mercer, JFB; La Fontaine, S				Materia, Stephanie; Cater, Michael A.; Klomp, Leo W. J.; Mercer, Julian F. B.; La Fontaine, Sharon			Clusterin (Apolipoprotein J), a Molecular Chaperone That Facilitates Degradation of the Copper-ATPases ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; WILSON-DISEASE PROTEIN; HEAT-SHOCK PROTEINS; MENKES PROTEIN; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRAFFICKING; EXPRESSION; MUTATIONS	The copper-transporting P1B-type ATPases (Cu-ATPases) ATP7A and ATP7B are key regulators of physiological copper levels. They function to maintain intracellular copper homeostasis by delivering copper to secretory compartments and by trafficking toward the cell periphery to export excess copper. Mutations in the genes encoding ATP7A and ATP7B lead to copper deficiency and toxicity disorders, Menkes and Wilson diseases, respectively. This report describes the interaction between the Cu-ATPases and clusterin and demonstrates a chaperone-like role for clusterin in facilitating their degradation. Clusterin interacted with both ATP7A and ATP7B in mammalian cells. This interaction increased under conditions of oxidative stress and with mutations in ATP7B that led to its misfolding and mislocalization. A Wilson disease patient mutation (G85V) led to enhanced ATP7B turnover, which was further exacerbated when cells overexpressed clusterin. We demonstrated that clusterin-facilitated degradation of mutant ATP7B is likely to involve the lysosomal pathway. The knockdown and overexpression of clusterin increased and decreased, respectively, the Cu-ATPase-mediated copper export capacity of cells. These results highlight a new role for intracellular clusterin in mediating Cu-ATPase quality control and hence in the normal maintenance of copper homeostasis, and in promoting cell survival in the context of disease. Based on our findings, it is possible that variations in clusterin expression and function could contribute to the variable clinical expression of Menkes and Wilson diseases.	[Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Cater, Michael A.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Klomp, Leo W. J.] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands	Deakin University; Deakin University; Peter Maccallum Cancer Center; Utrecht University; Utrecht University Medical Center	La Fontaine, S (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	Mercer, Julian/R-8583-2019; La Fontaine, Sharon/G-7113-2018	La Fontaine, Sharon/0000-0002-9948-074X	National Health and Medical Research Council of Australia (NHMRC); Dutch Digestive Disease Foundation [WS02-34]; Netherlands Organisation for Scientific Research (NWO) [912.04.106]; NWO Earth and Life Sciences [817.02.022]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Dutch Digestive Disease Foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Earth and Life Sciences	This work was supported by grants from The National Health and Medical Research Council of Australia (NHMRC; to S. L. and J. F. B. M.), an NHMRC biomedical research fellowship (to M. A. C.), and Dutch Digestive Disease Foundation Grant WS02-34, The Netherlands Organisation for Scientific Research (NWO) Program Grant 912.04.106, and NWO Earth and Life Sciences Grant 817.02.022 (to L. W. J. K.).	[Anonymous], 1995, METABOLIC BASIS INHE; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Borm B, 2004, J PEDIATR-US, V145, P119, DOI 10.1016/j.jpeds.2004.04.033; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Duc HH, 1998, EUR J HUM GENET, V6, P616; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Nagasaka H, 2009, J TOXICOL SCI, V34, pSP229, DOI 10.2131/jts.34.SP229; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rice RH, 2009, CHEM-BIOL INTERACT, V181, P359, DOI 10.1016/j.cbi.2009.08.007; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; van de Sluis BJA, 1999, HUM MOL GENET, V8, P501, DOI 10.1093/hmg/8.3.501; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	40	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10073	10083		10.1074/jbc.M110.190546	http://dx.doi.org/10.1074/jbc.M110.190546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21242307	Green Published, hybrid			2022-12-25	WOS:000288547000022
J	Vukelic, S; Stojadinovic, O; Pastar, I; Rabach, M; Krzyzanowska, A; Lebrun, E; Davis, SC; Resnik, S; Brem, H; Tomic-Canic, M				Vukelic, Sasa; Stojadinovic, Olivera; Pastar, Irena; Rabach, Morgan; Krzyzanowska, Agata; Lebrun, Elizabeth; Davis, Stephen C.; Resnik, Sydney; Brem, Harold; Tomic-Canic, Marjana			Cortisol Synthesis in Epidermis Is Induced by IL-1 and Tissue Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; HUMAN SKIN; GLUCOCORTICOID SYNTHESIS; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ADIPOSE-TISSUE; GROWTH-FACTORS; RETINOIC ACID	Glucocorticoids (GCs) are known inhibitors of wound healing. In this study we report the novel finding that both keratinocytes in vitro and epidermis in vivo synthesize cortisol and how this synthesis regulates wound healing. We show that epidermis expresses enzymes essential for cortisol synthesis, including steroid 11 beta-hydroxylase (CYP11B1), and an enzyme that controls negative feedback mechanism, 11 beta-hydroxysteroid dehydrogenase 2 (11 beta HSD2). We also found that cortisol synthesis in keratinocytes and skin can be stimulated by ACTH and inhibited by metyrapone (CYP11B1 enzyme inhibitor). Interestingly, IL-1 beta, the first epidermal signal of tissue injury, induces the expression of CYP11B1 and increases cortisol production by keratinocytes. Additionally, we found induction of CYP11B1 increased production of cortisol and activation of GR pathway during wound healing ex vivo and in vivo using human and porcine wound models, respectively. Conversely, inhibition of cortisol synthesis during wound healing increases IL-1 beta production, suggesting that cortisol synthesis in epidermis may serve as a local negative feedback to proinflammatory cytokines. Local GCs synthesis, therefore, may provide control of the initial proinflammatory response, preventing excessive inflammation upon tissue injury. Inhibition of GC synthesis accelerated wound closure in vivo, providing the evidence that modulation of cortisol synthesis in epidermis may be an important regulatory mechanism during wound healing.	[Stojadinovic, Olivera; Pastar, Irena; Lebrun, Elizabeth; Davis, Stephen C.; Resnik, Sydney; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Vukelic, Sasa] Lenox Hill Hosp, Dept Med, New York, NY 10075 USA; [Rabach, Morgan] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA; [Krzyzanowska, Agata] Hosp Special Surg, New York, NY 10021 USA; [Brem, Harold] NYU, Sch Med, Dept Surg, Helen L & Martin S Kimmel Div,Wound Healing Ctr, New York, NY 10016 USA	University of Miami; Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, 1600 NW 10th Ave,RMSB,Rm 2023-A, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [NR008029]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grant NR008029. Drs. Tomic-Canic and Brem have submitted a patent application "De novo synthesis of glucocorticoids in the epidermis and its uses and applications." This application has not yet been approved.	ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chabre O, 2000, J CLIN ENDOCR METAB, V85, P4060, DOI 10.1210/jc.85.11.4060; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; DAVIDSON VL, 1994, BIOCHEMISTRY-US, P433; Davis SC, 2008, OSTOMY WOUND MANAG, V54, P16; DEFAYE G, 1982, MOL CELL ENDOCRINOL, V27, P157, DOI 10.1016/0303-7207(82)90105-8; Ermak G, 1997, J INVEST DERMATOL, V108, P160, DOI 10.1111/1523-1747.ep12332925; Fallo F, 2002, EUR J ENDOCRINOL, V147, P795, DOI 10.1530/eje.0.1470795; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; Haselbeck RJ, 1997, DEV DYNAM, V208, P447, DOI 10.1002/(SICI)1097-0177(199704)208:4<447::AID-AJA1>3.0.CO;2-I; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jho SH, 2005, J INVEST DERMATOL, V124, P1034, DOI 10.1111/j.0022-202X.2005.23691.x; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kondo S, 1999, J INVEST DERM SYMP P, V4, P177, DOI 10.1038/sj.jidsp.5640205; Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O; KUPPER TS, 1990, J INVEST DERMATOL, V94, pS146, DOI 10.1111/1523-1747.ep12876130; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; LEE B, 2002, MOL MECH ACTION STER, P1; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Pastar Irena, 2008, Surg Technol Int, V17, P105; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2384, DOI 10.1210/jc.2003-030138; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x; Rogoff D, 2001, J STEROID BIOCHEM, V78, P77, DOI 10.1016/S0960-0760(01)00076-0; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2000, BBA-GEN SUBJECTS, V1474, P1, DOI 10.1016/S0304-4165(99)00215-9; SLOMINSKI A, 1995, FEBS LETT, V374, P113, DOI 10.1016/0014-5793(95)01090-2; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Tomic-Canic M, 2004, DERM CLIN BAS SCI, P25; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121; Zhou ZF, 1998, MOL CELL ENDOCRINOL, V138, P61, DOI 10.1016/S0303-7207(98)00052-5; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807; Zouboulis CC, 2000, HORM RES, V54, P230, DOI 10.1159/000053265	68	140	141	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10265	10275		10.1074/jbc.M110.188268	http://dx.doi.org/10.1074/jbc.M110.188268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239489	Green Published, hybrid			2022-12-25	WOS:000288547000044
J	Watanabe, N; Lam, E				Watanabe, Naohide; Lam, Eric			Calcium-dependent Activation and Autolysis of Arabidopsis Metacaspase 2d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; PORPHYROMONAS-GINGIVALIS; CYSTEINE PROTEINASE; CRYSTAL-STRUCTURE; APOPTOSIS; PROTEASE; YEAST; PURIFICATION; GINGIPAIN; THALIANA	Metacaspases (MCPs) are members of a new family of cysteine proteases found in plants, fungi, and protozoa that are structurally related to metazoan caspases. Recent studies showed that plant MCPs are arginine/lysine-specific cysteine proteases with caspase-like processing activities in vitro and in vivo, and some of the plant type II MCPs exhibit Ca2+ dependence for their endopeptidase activity in vitro. However, the mechanisms and biological relevance of Ca2+ dependence and self-processing of plant MCPs remains unclear. Here we show that recombinant AtMCP2d, the most abundantly expressed member of Arabidopsis type II MCPs at the transcriptional level, exhibits a strict Ca2+ dependence for its catalytic activation that is apparently mediated by intramolecular self-cleavage mechanism. However, rapid inactivation of AtMCP2d activity concomitant with Ca2+ induced self-processing at multiple internal sites was observed. Because active AtMCP2d can cleave its inactive form, intermolecular cleavage (autolysis) of AtMCP2d could also occur under our assay conditions. Ca2+-induced self-processing of recombinant AtMCP2d was found to correlate with the sequential appearance of at least six intermediates, including self-cleaved forms, during the proenzyme purification process. Six of these peptides were characterized, and the cleavage sites were mapped through N-terminal protein sequencing. Mutation analysis of AtMCP2d revealed that cleavage after Lys-225, which is a highly conserved residue among the six Arabidopsis type II MCPs, is critical for the catalytic activation by Ca2+, and we demonstrate that this residue is essential for AtMCP2d activation of H2O2-induced cell death in yeast. Together, our results provide clues to understand the mode of regulation for this class of proteases.	[Watanabe, Naohide; Lam, Eric] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lam, E (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	lam@aesop.rutgers.edu			National Science Foundation [IOS-0744709]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0744709.	Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; KAHN S, 2010, J PLANT PHYSL, V167, P855; Koeplinger KA, 2000, PROTEIN EXPRES PURIF, V18, P378, DOI 10.1006/prep.2000.1205; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Margetts MB, 2000, PROTEIN EXPRES PURIF, V18, P262, DOI 10.1006/prep.2000.1193; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; REDDY ASN, 1994, BIOCHEM BIOPH RES CO, V199, P1089, DOI 10.1006/bbrc.1994.1342; Safadi F, 1997, ARCH BIOCHEM BIOPHYS, V348, P143, DOI 10.1006/abbi.1997.0361; Sanmartin M, 2005, PLANT PHYSIOL, V137, P841, DOI 10.1104/pp.104.058552; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Wang CX, 2003, J BIOL CHEM, V278, P34467, DOI 10.1074/jbc.M300745200; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	40	63	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10027	10040		10.1074/jbc.M110.194340	http://dx.doi.org/10.1074/jbc.M110.194340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209078	Green Published, hybrid			2022-12-25	WOS:000288547000017
J	Miner, JJ; Shao, BJ; Wang, Y; Chichili, GR; Liu, ZH; Klopocki, AG; Yago, T; McDaniel, JM; Rodgers, W; Xia, LJ; McEver, RP				Miner, Jonathan J.; Shao, Bojing; Wang, Ying; Chichili, Gurunadh R.; Liu, Zhenghui; Klopocki, Arkadiusz G.; Yago, Tadayuki; McDaniel, J. Michael; Rodgers, William; Xia, Lijun; McEver, Rodger P.			Cytoplasmic Domain of P-selectin Glycoprotein Ligand-1 Facilitates Dimerization and Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DERIVED O-GLYCANS; MYELOID CELLS; ERYTHROPOIETIN RECEPTOR; LINKED OLIGOSACCHARIDES; TRANSMEMBRANE DOMAIN; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; 1 PSGL-1; IN-VIVO; EXPRESSION	P-selectin glycoprotein ligand-1 (PSGL-1) is a homodimeric transmembrane mucin on leukocytes. During inflammation, reversible interactions of PSGL-1 with selectins mediate leukocyte rolling on vascular surfaces. The transmembrane domain of PSGL-1 is required for dimerization, and the cytoplasmic domain propagates signals that activate beta(2) integrins to slow rolling on integrin ligands. Leukocytes from knock-in "Delta CD" mice express a truncated PSGL-1 that lacks the cytoplasmic domain. Unexpectedly, they have 10-fold less PSGL-1 on their surfaces than WT leukocytes. Using glycosidases, proteases, Western blotting, confocal microscopy, cell-surface cross-linking, FRET, and pulse-chase metabolic labeling, we demonstrate that deleting the cytoplasmic domain impaired dimerization and delayed export of PSGL-1 from the endoplasmic reticulum (ER), markedly increasing a monomeric precursor in the ER and decreasing mature PSGL-1 on the cell surface. A monomeric full-length PSGL-1 made by substituting the transmembrane domain with that of CD43 exited the ER normally, revealing that dimerization was not required for ER export. Thus, the transmembrane and cytoplasmic domains cooperate to promote dimerization of PSGL-1. Furthermore, the cytoplasmic domain provides a key signal to export precursors of PSGL-1 from the ER to the Golgi apparatus en route to the cell surface.	[Chichili, Gurunadh R.; Liu, Zhenghui; Klopocki, Arkadiusz G.; Yago, Tadayuki; McDaniel, J. Michael; Rodgers, William; Xia, Lijun; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Miner, Jonathan J.; Shao, Bojing; Wang, Ying; Xia, Lijun; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	McEver, RP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org			National Institutes of Health [HL 03463, HL 085607]; Oklahoma Center for the Advancement of Science and Technology [HR08-084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363, P01HL085607, K08HL003463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 03463 (to R. P. M.) and HL 085607 (to R. P. M. and L. X.). This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR08-084 (to W. R.).	BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; Chichili GR, 2010, J BIOL CHEM, V285, P14737, DOI 10.1074/jbc.M109.097311; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kawar ZS, 2008, GLYCOBIOLOGY, V18, P441, DOI 10.1093/glycob/cwn020; Kobzdej MMA, 2002, BLOOD, V100, P4485, DOI 10.1182/blood-2002-06-1799; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; ROSE MC, 1984, J BIOL CHEM, V259, P3167; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xia LJ, 1998, BLOOD, V91, P1625, DOI 10.1182/blood.V91.5.1625.1625_1625_1632; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang J, 1996, BLOOD, V87, P4176, DOI 10.1182/blood.V87.10.4176.bloodjournal87104176; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	58	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9577	9586		10.1074/jbc.M110.208777	http://dx.doi.org/10.1074/jbc.M110.208777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220419	Green Published, hybrid			2022-12-25	WOS:000288247700083
J	Yano, J; Walker, LM; Strickler, MA; Service, RJ; Yachandra, VK; Debus, RJ				Yano, Junko; Walker, Lee M.; Strickler, Melodie A.; Service, Rachel J.; Yachandra, Vittal K.; Debus, Richard J.			Altered Structure of the Mn4Ca Cluster in the Oxygen-evolving Complex of Photosystem II by a Histidine Ligand Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; ECHO ENVELOPE MODULATION; FTIR DIFFERENCE SPECTROSCOPY; MANGANESE CLUSTER; D1 POLYPEPTIDE; THERMOSYNECHOCOCCUS-ELONGATUS; PHOTOSYNTHETIC APPARATUS; NITROGEN LIGATION; STRONTIUM EXAFS; PULSED EPR	The effect of replacing a histidine ligand on the properties of the oxygen-evolving complex (OEC) and the structure of the Mn4Ca cluster in Photosystem II (PSII) is studied by x-ray absorption spectroscopy using PSII core complexes from the Synechocystis sp. PCC 6803 D1 polypeptide mutant H332E. In the x-ray crystallographic structures of PSII, D1-His(332) has been assigned as a direct ligand of a manganese ion, and the mutation of this histidine ligand to glutamate has been reported to prevent the advancement of the OEC beyond the S(2)Yz(center dot) intermediate state. The manganese K-edge (1s core electron to 4p) absorption spectrum of D1-H332E shifts to a lower energy compared with that of the native WT samples, suggesting that the electronic structure of the manganese cluster is affected by the presence of the additional negative charge on the OEC of the mutant. The extended x-ray absorption spectrum shows that the geometric structure of the cluster is altered substantially from that of the native WT state, resulting in an elongation of manganese-ligand and manganese-manganese interactions in the mutant. The strontium-H332E mutant, in which calcium is substituted by strontium, confirms that strontium (calcium) is a part of the altered cluster. The structural perturbations caused by the D1-H332E mutation are much larger than those produced by any biochemical treatment or mutation examined previously with x-ray absorption spectroscopy. The substantial structural changes provide an explanation not only for the altered properties of the D1-H332E mutant but also the importance of the histidine ligand for proper assembly of the Mn4Ca cluster.	[Yano, Junko; Yachandra, Vittal K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Walker, Lee M.; Strickler, Melodie A.; Service, Rachel J.; Debus, Richard J.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Riverside	Yano, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, MS 66-0200,1 Cyclotron Rd, Berkeley, CA 94720 USA.	JYano@lbl.gov; richard.debus@ucr.edu			National Institutes of Health [GM 55302, GM 076232]; Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-05CH11231]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM055302, R01GM076232, R01GM055302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 55302 (to V.K.Y.) and GM 076232 (to R.J.D.). This work was also supported by the Department of Energy, Director, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences under Contract DE-AC02-05CH11231 (to J.Y. and V.K.Y.). Portions of this research were carried out at Stanford Synchrotron Radiation Laboratory, operated by Stanford University for the Department of Energy, Office of Basic Energy Sciences and supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources.	Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BRITT RD, 1989, J AM CHEM SOC, V111, P3522, DOI 10.1021/ja00192a006; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5859, DOI 10.1021/bi00017a017; Cinco RM, 1999, INORG CHEM, V38, P5988, DOI 10.1021/ic991003j; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; DAU H, 1995, BIOCHEMISTRY-US, V34, P5274, DOI 10.1021/bi00015a043; Dau H, 2005, PHYS SCRIPTA, VT115, P844; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2000, BIOCHEMISTRY-US, V39, P470, DOI 10.1021/bi9917737; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; DEROSE VJ, 1994, J AM CHEM SOC, V116, P5239, DOI 10.1021/ja00091a031; DEROSE VJ, 1991, BIOCHEMISTRY-US, V30, P1335, DOI 10.1021/bi00219a025; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; George G. N., 2000, EXAFSPAK EDG FIT STA; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GILCHRIST ML, 1996, THESIS U CALIFORNIA; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; LATIMER MJ, 1995, BIOCHEMISTRY-US, V34, P10898, DOI 10.1021/bi00034a024; LIANG W, 1994, BIOCHEMISTRY-US, V33, P4923, DOI 10.1021/bi00182a022; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MCCARRICK RM, 2008, STRUCTURE PHOTOSYNTH; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Strickler MA, 2007, BIOCHEMISTRY-US, V46, P3151, DOI 10.1021/bi062195e; Sugiura M, 2009, BIOCHEMISTRY-US, V48, P7856, DOI 10.1021/bi901067b; TANG XS, 1994, P NATL ACAD SCI USA, V91, P704, DOI 10.1073/pnas.91.2.704; YACHANDRA VK, 2005, PHOTOSYSTEM, V2; Yano J, 2007, PHOTOSYNTH RES, V91, P173; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yeagle GJ, 2008, INORG CHEM, V47, P1803, DOI 10.1021/ic701680c; Yeagle GJ, 2008, PHILOS T R SOC B, V363, P1157, DOI 10.1098/rstb.2007.2211; ZIMMERMANN JL, 1993, BIOCHEMISTRY-US, V32, P4831, DOI 10.1021/bi00069a019	53	10	10	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9257	9267		10.1074/jbc.M110.205740	http://dx.doi.org/10.1074/jbc.M110.205740			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233216	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000288247700056
J	Tanaka, N; Shuman, S				Tanaka, Naoko; Shuman, Stewart			RtcB Is the RNA Ligase Component of an Escherichia coli RNA Repair Operon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; LACTIS GAMMA-TOXIN; POLYNUCLEOTIDE KINASE-PHOSPHATASE; CLOSTRIDIUM-THERMOCELLUM; MESSENGER-RNA; ANTICODON NUCLEASE; PHOSPHODIESTERASE ACTIVITIES; DEINOCOCCUS-RADIODURANS; CYTOTOXIC RIBONUCLEASE; CRYSTAL-STRUCTURE	RNA 2`,3`-cyclic phosphate ends play important roles in RNA metabolism as substrates for RNA ligases during tRNA restriction-repair and tRNA splicing. Diverse bacteria from multiple phyla encode a two-component RNA repair cassette, comprising Pnkp (polynucleotide kinase-phosphatase-ligase) and Hen1 (RNA 3`-terminal ribose 2`-O-methyltransferase), that heals and then seals broken tRNAs with 2`,3`-cyclic phosphate and 5`-OH ends. The Pnkp-Hen1 repair operon is absent in the majority of bacterial species, thereby raising the prospect that other RNA repair systems might be extant. A candidate component is RNA 3`-phosphate cyclase, a widely distributed enzyme that transforms RNA 3`-monophosphate termini into 2`,3`-cyclic phosphates but cannot seal the ends it produces. Escherichia coli RNA cyclase (RtcA) is encoded in a sigma(54)-regulated operon with RtcB, a protein of unknown function. Taking a cue from Pnkp-Hen1, we purified E. coli RtcB and tested it for RNA ligase activity. We report that RtcB per se seals broken tRNA-like stem-loop structures with 2`,3`-cyclic phosphate and 5`-OH ends to form a splice junction with a 2`-OH, 3`,5`-phosphodiester. We speculate that: (i) RtcB might afford bacteria a means to recover from stress-induced RNA damage; and (ii) RtcB homologs might catalyze tRNA repair or splicing reactions in archaea and eukarya.	[Tanaka, Naoko; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330 (to S.S.).	AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Blanga-Kanfi S, 2006, NUCLEIC ACIDS RES, V34, P3209, DOI 10.1093/nar/gkl415; Brooks MA, 2008, PROTEIN SCI, V17, P1336, DOI 10.1110/ps.035493.108; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Jain R, 2010, RNA, V16, P316, DOI 10.1261/rna.1926510; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Keppetipola N, 2006, RNA, V12, P73, DOI 10.1261/rna.2196406; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P3624, DOI 10.1093/nar/gkm110; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Keppetipola N, 2009, RNA, V15, P1036, DOI 10.1261/rna.1637809; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Lu J, 2008, NUCLEIC ACIDS RES, V36, P1072, DOI 10.1093/nar/gkm1121; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Martins A, 2004, J BIOL CHEM, V279, P50654, DOI 10.1074/jbc.M407657200; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; Raymond A, 2007, NUCLEIC ACIDS RES, V35, P839, DOI 10.1093/nar/gkl1090; REINBERG D, 1985, J BIOL CHEM, V260, P6088; Schwer B, 2004, P NATL ACAD SCI USA, V101, P2788, DOI 10.1073/pnas.0305859101; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tanaka N, 2009, RNA, V15, P1865, DOI 10.1261/rna.1771509; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Torchia C, 2008, NUCLEIC ACIDS RES, V36, P6218, DOI 10.1093/nar/gkn602; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	45	103	107	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7727	7731		10.1074/jbc.C111.219022	http://dx.doi.org/10.1074/jbc.C111.219022			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224389	hybrid, Green Published			2022-12-25	WOS:000288013300003
J	Rahaman, SO; Swat, W; Febbraio, M; Silverstein, RL				Rahaman, S. Ohidar; Swat, Wojciech; Febbraio, Maria; Silverstein, Roy L.			Vav Family Rho Guanine Nucleotide Exchange Factors Regulate CD36-mediated Macrophage Foam Cell Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; ATHEROSCLEROTIC LESION DEVELOPMENT; MONOCYTE-DERIVED MACROPHAGES; E-DEFICIENT MICE; OXIDATIVE BURST; OXIDIZED LDL; LIPID UPTAKE; REQUIRE VAV; PLATELET; PROTEINS	Lipid-laden macrophages or "foam cells" are the primary components of the fatty streak, the earliest atherosclerotic lesion. Although Vav family guanine nucleotide exchange factors impact processes highly relevant to atherogenesis and are involved in pathways common to scavenger receptor CD36 signaling, their role in CD36-dependent macrophage foam cell formation remains unknown. The goal of the present study was to determine the contribution of Vav proteins to CD36-dependent foam cell formation and to identify the mechanisms by which Vavs participate in the process. We found that CD36 contributes to activation of Vav-1, -2, and -3 in aortae from hyperlipidemic mice and that oxidatively modified LDL (oxLDL) induces activation of macrophage Vav in vitro in a CD36 and Src family kinase-dependent manner. CD36-dependent uptake of oxLDL in vitro and foam cell formation in vitro and in vivo was significantly reduced in Vav null macrophages. These studies for the first time link CD36 and Vavs in a signaling pathway required for macrophage foam cell formation.	[Rahaman, S. Ohidar; Silverstein, Roy L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Febbraio, Maria] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Swat, Wojciech] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Febbraio, Maria; Silverstein, Roy L.] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Washington University (WUSTL); Case Western Reserve University; Cleveland Clinic Foundation	Rahaman, SO (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	rahamao@ccf.org; silverr2@ccf.org			National Institutes of Health [HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL087018.	Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Curtis BR, 1996, TRANSFUSION, V36, P331, DOI 10.1046/j.1537-2995.1996.36496226147.x; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Guy E, 2007, ATHEROSCLEROSIS, V192, P123, DOI 10.1016/j.atherosclerosis.2006.07.015; Harb D, 2009, CARDIOVASC RES, V83, P42, DOI 10.1093/cvr/cvp081; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Knowles JW, 2007, AM HEART J, V154, P1052, DOI 10.1016/j.ahj.2007.05.021; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Marleau Sylvie, 2005, FASEB J, V19, P1869; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; YAMAMOTO N, 1990, BLOOD, V76, P1698; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9	34	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7010	7017		10.1074/jbc.M110.192450	http://dx.doi.org/10.1074/jbc.M110.192450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209086	Green Published, hybrid			2022-12-25	WOS:000287737300017
J	Wang, J; Grishin, N; Kinch, L; Cohen, JC; Hobbs, HH; Xie, XS				Wang, Jin; Grishin, Nick; Kinch, Lisa; Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song			Sequences in the Nonconsensus Nucleotide-binding Domain of ABCG5/ABCG8 Required for Sterol Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY CHOLESTEROL SECRETION; ABC-TRANSPORTERS; ATP-BINDING; DIETARY-CHOLESTEROL; MUTATIONS; RECONSTITUTION; ACCUMULATION; MECHANISM; MICE; LOOP	ATP-binding cassette transporters ABCG5 (G5) and ABCG8 (G8) form a heterodimer that transports cholesterol and plant sterols from hepatocytes into bile. Mutations that inactivate G5 or G8 cause hypercholesterolemia and premature atherosclerosis. We showed previously that the two nucleotide-binding domains (NBDs) in the heterodimer are not functionally equivalent; sterol transport is abolished by mutations in the consensus residues of NBD2 but not of NBD1. Here, we examined the structural requirements of NBD1 for sterol transport. Substitutions of the D-loop aspartate and Q-loop glutamine in either NBD did not impair sterol transport. The H-loop histidine of NBD2 (but not NBD1) was required for sterol transport. Exchange of the signature motifs between the NBDs did not interfere with sterol transport, whereas swapping the Walker A, Walker B, and signature motifs together resulted in failure to transport sterols. Selected substitutions within NBD1 altered substrate specificity: transport of plant sterols by the heterodimer was preserved, whereas transport of cholesterol was abolished. In summary, these data indicate that NBD1, although not required for ATP hydrolysis, is essential for normal function of G5G8 in sterol transport. Both the position and structural integrity of NBD2 are essential for sterol transport activity.	[Wang, Jin; Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Grishin, Nick; Kinch, Lisa; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, MC8591, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; xiao-song.xie@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [HL72304]; NHLBI [RO1 HL72304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL072304, R01HL072304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72304 and RO1 HL72304 from NHLBI.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Wang J, 2008, BIOCHEMISTRY-US, V47, P5194, DOI 10.1021/bi800292v; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2004, J LIPID RES, V45, P301, DOI 10.1194/jlr.M300377-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200	23	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7308	7314		10.1074/jbc.M110.210880	http://dx.doi.org/10.1074/jbc.M110.210880			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209088	hybrid, Green Published			2022-12-25	WOS:000287737300047
J	Guo, JE; Hall, KD				Guo, Juen; Hall, Kevin D.			Predicting Changes of Body Weight, Body Fat, Energy Expenditure and Metabolic Fuel Selection in C57BL/6 Mice	PLOS ONE			English	Article							THERMOGENESIS; OBESITY; MASS	The mouse is an important model organism for investigating the molecular mechanisms of body weight regulation, but a quantitative understanding of mouse energy metabolism remains lacking. Therefore, we created a mathematical model of mouse energy metabolism to predict dynamic changes of body weight, body fat, energy expenditure, and metabolic fuel selection. Based on the principle of energy balance, we constructed ordinary differential equations representing the dynamics of body fat mass (FM) and fat-free mass (FFM) as a function of dietary intake and energy expenditure (EE). The EE model included the cost of tissue deposition, physical activity, diet-induced thermogenesis, and the influence of FM and FFM on metabolic rate. The model was calibrated using previously published data and validated by comparing its predictions to measurements in five groups of male C57/BL6 mice (N = 30) provided ad libitum access to either chow or high fat diets for varying time periods. The mathematical model accurately predicted the observed body weight and FM changes. Physical activity was predicted to decrease immediately upon switching from the chow to the high fat diet and the model coefficients relating EE to FM and FFM agreed with previous independent estimates. Metabolic fuel selection was predicted to depend on a complex interplay between diet composition, the degree of energy imbalance, and body composition. This is the first validated mathematical model of mouse energy metabolism and it provides a quantitative framework for investigating energy balance relationships in mouse models of obesity and diabetes.	[Guo, Juen; Hall, Kevin D.] NIDDKD, Lab Biol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Guo, JE (corresponding author), NIDDKD, Lab Biol Modeling, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013038] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; Gregory P., 2005, BAYESIAN LOGICAL DAT; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, IEEE ENG MED BIOL, V29, P36, DOI 10.1109/MEMB.2009.935465; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2009, CELL METAB, V9, P3, DOI 10.1016/j.cmet.2008.12.006; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Longo KA, 2010, AM J PHYSIOL-REG I, V298, pR747, DOI 10.1152/ajpregu.00476.2009; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; TAM J, 2008, CELL METABOLISM	27	46	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15961	10.1371/journal.pone.0015961	http://dx.doi.org/10.1371/journal.pone.0015961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246038	gold, Green Submitted, Green Published			2022-12-25	WOS:000286511200029
J	Bellistri, GM; Casabianca, A; Merlini, E; Orlandi, C; Ferrario, G; Meroni, L; Galli, M; Magnani, M; Monforte, AD; Marchetti, G				Bellistri, Giusi Maria; Casabianca, Anna; Merlini, Esther; Orlandi, Chiara; Ferrario, Giulio; Meroni, Luca; Galli, Massimo; Magnani, Mauro; Monforte, Antonella d'Arminio; Marchetti, Giulia			Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+Gain on Antiviral Therapy	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS-1; CD8 T-CELLS; INFECTED PATIENTS; CD127 EXPRESSION; GENE-EXPRESSION; IN-VIVO; CD4(+); SUPPRESSION; RECEPTOR	Background: The bone marrow (BM) cytokine milieu might substantially affect T-lymphocyte homeostasis in HIV-positive individuals. Interleukin-7 (IL-7) is a bone marrow-derived cytokine regulating T-cell homeostasis through a CD4+-driven feedback loop. CD4+ T-lymphopenia is associated with increased free IL-7 levels and reduced IL-7R expression/function, which are only partially reverted by highly active antiretroviral therapy (HAART). We investigated the BM production, peripheral expression and signaling (pStat5+ and Bcl-2+ CD4+/CD8+ T cells) of IL-7/IL-7R alpha in 30 HAART-treated HIV-positive patients who did not experience CD4+ recovery (CD4+ <= 200/mu l) and who had different levels of HIV viremia; these patients included 18 immunological nonresponders (INRs; HIV-RNA <= 50), 12 complete failures (CFs; HIV-RNA > 1000), and 23 HIV-seronegative subjects. Methods: We studied plasma IL-7 levels, IL-7R alpha+CD4+/CD8+ T-cell proportions, IL-7R alpha mRNA expression in PBMCs, spontaneous IL-7 production by BM mononuclear cells (BMMCs), and IL-7 mRNA/IL-7R alpha mRNA in BMMC-derived stromal cells (SCs). We also studied T-cell responsiveness to IL-7 by measuring the proportions of pStat5+ and Bcl-2+ CD4+/CD8+ T cells. Results: Compared to HIV-seronegative controls, CFs and INRs presented elevated plasma IL-7 levels and lower IL-7R alpha CD4+/CD8+ cell-surface expression and peripheral blood production, confirming the most relevant IL-7/IL-7R disruption. Interestingly, BM investigation revealed a trend of higher spontaneous IL-7 production in INRs (p = .09 vs. CFs) with a nonsignificant trend toward higher IL-7-R alpha mRNA levels in BMMC-derived stromal cells. However, upon IL-7 stimulation, the proportion of pStat5+ CD4+ T cells did not increase in INRs despite higher constitutive levels (p = .06); INRs also displayed lower Bcl-2+ CD8+ T-cell proportions than controls (p = .04). Conclusions: Despite severe CD4+ T-lymphopenia and a disrupted IL-7/IL-7R profile in the periphery, INRs display elevated BM IL-7/IL-7R alpha expression but impaired T-cell responsiveness to IL-7, suggesting the activity of a central compensatory pathway targeted to replenish the CD4+ compartment, which is nevertheless inappropriate to compensate the dysfunctional signaling through IL-7 receptor.	[Bellistri, Giusi Maria; Merlini, Esther; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, Dept Med Surg & Dent, Milan, Italy; [Ferrario, Giulio; Meroni, Luca; Galli, Massimo] Univ Milan, Luigi Sacco Hosp, Chair Infect Dis & Trop Med, Dept Clin Sci, Milan, Italy; [Casabianca, Anna; Orlandi, Chiara; Magnani, Mauro] Univ Urbino, Inst Biol Chem Giorgio Fornaini, I-61029 Urbino, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; Luigi Sacco Hospital; University of Urbino	Bellistri, GM (corresponding author), Univ Milan, San Paolo Hosp, Clin Infect Dis, Dept Med Surg & Dent, Milan, Italy.	giulia.marchetti@unimi.it	Gori, Andrea/AAC-6078-2022; Marchetti, Giulia/GPX-7655-2022; Magnani, Mauro/A-1919-2008; GALLI, MASSIMO/L-7282-2017; MARCHETTI, GIULIA CARLA/K-4384-2018	orlandi, chiara/0000-0003-3288-7286; Magnani, Mauro/0000-0001-6456-6626; GALLI, MASSIMO/0000-0001-8887-6215; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) - Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy [30G.50, 30G.63, 50G]	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) - Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy	Financial support was provided by a grant from Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) 2009 - Universita degli Studi di Milano, and from Istituto Superiore di Sanita, "National research program on AIDS", 30G.50; 30G.63, 50G; 2006, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; Badolato R, 2008, CLIN INFECT DIS, V46, P1911, DOI 10.1086/588481; Bahner I, 1997, BLOOD, V90, P1787, DOI 10.1182/blood.V90.5.1787; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; DELUCA A, 1993, BRIT J HAEMATOL, V85, P20, DOI 10.1111/j.1365-2141.1993.tb08640.x; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Isgro A, 1999, AIDS, V13, P2486, DOI 10.1097/00002030-199912030-00027; Isgro A, 2008, CLIN INFECT DIS, V46, P1902, DOI 10.1086/588480; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; MacPherson J, 2001, J ACQ IMMUN DEF SYND, V28, P454; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Neuhaus T, 2003, CELL PROLIFERAT, V36, P75, DOI 10.1046/j.1365-2184.2003.00262.x; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	41	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15663	10.1371/journal.pone.0015663	http://dx.doi.org/10.1371/journal.pone.0015663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209878	gold, Green Published			2022-12-25	WOS:000285838900025
J	Li, MX; Sham, PC; Cherny, SS; Song, YQ				Li, Miao-Xin; Sham, Pak C.; Cherny, Stacey S.; Song, You-Qiang			A Knowledge-Based Weighting Framework to Boost the Power of Genome-Wide Association Studies	PLOS ONE			English	Article							FALSE DISCOVERY RATE; INTERACTION NETWORK; ALZHEIMERS-DISEASE; PROTEIN; PRIORITIZATION; INTERACTOME; INFERENCE; DATABASE; TRAITS; GENES	Background: We are moving to second-wave analysis of genome-wide association studies (GWAS), characterized by comprehensive bioinformatical and statistical evaluation of genetic associations. Existing biological knowledge is very valuable for GWAS, which may help improve their detection power particularly for disease susceptibility loci of moderate effect size. However, a challenging question is how to utilize available resources that are very heterogeneous to quantitatively evaluate the statistic significances. Methodology/Principal Findings: We present a novel knowledge-based weighting framework to boost power of the GWAS and insightfully strengthen their explorative performance for follow-up replication and deep sequencing. Built upon diverse integrated biological knowledge, this framework directly models both the prior functional information and the association significances emerging from GWAS to optimally highlight single nucleotide polymorphisms (SNPs) for subsequent replication. In the theoretical calculation and computer simulation, it shows great potential to achieve extra over 15% power to identify an association signal of moderate strength or to use hundreds of whole-genome subjects fewer to approach similar power. In a case study on late-onset Alzheimer disease (LOAD) for a proof of principle, it highlighted some genes, which showed positive association with LOAD in previous independent studies, and two important LOAD related pathways. These genes and pathways could be originally ignored due to involved SNPs only having moderate association significance. Conclusions/Significance: With user-friendly implementation in an open-source Java package, this powerful framework will provide an important complementary solution to identify more true susceptibility loci with modest or even small effect size in current GWAS for complex diseases.	[Li, Miao-Xin; Song, You-Qiang] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.; Song, You-Qiang] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Li, MX (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	songy@hkucc.hku.hk	Song, You-Qiang/E-5207-2011; Cherny, Stacey S/B-3315-2008; Li, Miaoxin/B-7079-2013; Song, You-qiang/C-4401-2009	Cherny, Stacey S/0000-0002-0269-3352; Song, You-Qiang/0000-0001-9407-2256	Research Grant Council of Hong Kong [HKU7688/05M, HKU7752/08M]; Research Fund for the Control of Infectious Diseases (RFCID) [08070652]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Research Fund for the Control of Infectious Diseases (RFCID)	This work was supported by the Research Grant Council of Hong Kong (HKU7688/05M and HKU7752/08M, YQS) and the Research Fund for the Control of Infectious Diseases (RFCID) (no. 08070652, YQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hemminger BM, 2006, BIOINFORMATICS, V22, P626, DOI 10.1093/bioinformatics/btk025; HOLM S, 1979, SCAND J STAT, V6, P65; Hua JP, 2007, BIOINFORMATICS, V23, P57, DOI 10.1093/bioinformatics/btl536; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kulkarni V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S3; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li QZ, 2009, J STAT PLAN INFER, V139, P2431, DOI 10.1016/j.jspi.2008.11.007; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pahl R, 2009, BIOSTATISTICS, V10, P297, DOI 10.1093/biostatistics/kxn036; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Schjeide BMM, 2009, ARCH NEUROL-CHICAGO, V66, P250, DOI 10.1001/archneurol.2008.552; Seripa D, 2005, NEUROBIOL AGING, V26, P455, DOI 10.1016/j.neurobiolaging.2004.04.001; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Taguchi K, 2005, ANN NEUROL, V57, P585, DOI 10.1002/ana.20433; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; WASSERMAN L, 2006, WEIGHTED HYPOTHESIS; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27	54	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14480	10.1371/journal.pone.0014480	http://dx.doi.org/10.1371/journal.pone.0014480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217833	Green Submitted, Green Published, gold			2022-12-25	WOS:000285838900009
J	Ayuni, EL; Gazdhar, A; Giraud, MN; Kadner, A; Gugger, M; Cecchini, M; Caus, T; Carrel, TP; Schmid, RA; Tevaearai, HT				Ayuni, Erick L.; Gazdhar, Amiq; Giraud, Marie Noelle; Kadner, Alexander; Gugger, Mathias; Cecchini, Marco; Caus, Thierry; Carrel, Thierry P.; Schmid, Ralph A.; Tevaearai, Hendrik T.			In Vivo Electroporation Mediated Gene Delivery to the Beating Heart	PLOS ONE			English	Article							IMMEDIATE-EARLY PROMOTER; SKELETAL-MUSCLE; THERAPEUTIC ANGIOGENESIS; ELECTRIC PULSES; EXPRESSION; ELECTROTRANSFER; EFFICACY; DISEASE; LIVER; LUNG	Gene therapy may represent a promising alternative strategy for cardiac muscle regeneration. In vivo electroporation, a physical method of gene transfer, has recently evolved as an efficient method for gene transfer. In the current study, we investigated the efficiency and safety of a protocol involving in vivo electroporation for gene transfer to the beating heart. Adult male rats were anesthetised and the heart exposed through a left thoracotomy. Naked plasmid DNA was injected retrograde into the transiently occluded coronary sinus before the electric pulses were applied. Animals were sacrificed at specific time points and gene expression was detected. Results were compared to the group of animals where no electric pulses were applied. No post-procedure arrhythmia was observed. Left ventricular function was temporarily altered only in the group were high pulses were applied; CK-MB (Creatine kinase) and TNT (Troponin T) were also altered only in this group. Histology showed no signs of toxicity. Gene expression was highest at day one. Our results provide evidence that in vivo electroporation with an optimized protocol is a safe and effective tool for nonviral gene delivery to the beating heart. This method may be promising for clinical settings especially for perioperative gene delivery.	[Ayuni, Erick L.; Giraud, Marie Noelle; Kadner, Alexander; Caus, Thierry; Carrel, Thierry P.; Tevaearai, Hendrik T.] Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland; [Gazdhar, Amiq; Schmid, Ralph A.] Univ Hosp Bern, Div Gen Thorac Surg, CH-3010 Bern, Switzerland; [Gugger, Mathias] Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland; [Cecchini, Marco] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Ayuni, EL (corresponding author), Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland.	ralph.schmid@insel.ch	Gazdhar, Amiq/AAJ-6835-2020; Kadner, Alexander/ADL-0427-2022; Kadner, Alexander/GYJ-0985-2022; Caus, Thierry/AFD-3883-2022; Gazdhar, Amiq/AAN-6024-2020; gf, mn/N-1593-2016; Carrel, Thierry/AAI-5910-2021	Gazdhar, Amiq/0000-0002-4807-8785; Kadner, Alexander/0000-0003-3024-6514; Caus, Thierry/0000-0001-9120-9026; gf, mn/0000-0003-3228-6827; Schmid, Ralph Alexander/0000-0003-0699-079X	Olga Mayenfisch Foundation, Zurich Switzerland; Swiss National Science Foundation [3200-068304-2006, 310000-118270-2007]	Olga Mayenfisch Foundation, Zurich Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Olga Mayenfisch Foundation, Zurich Switzerland and by two grants from the Swiss National Science Foundation (3200-068304-2006 to RAS and 310000-118270-2007 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Blair-Parks K, 2002, J GENE MED, V4, P92, DOI 10.1002/jgm.231; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Fromes Y, 1999, GENE THER, V6, P683, DOI 10.1038/sj.gt.3300853; Gazdhar A, 2006, J GENE MED, V8, P910, DOI 10.1002/jgm.911; Gehl J, 1999, BBA-GEN SUBJECTS, V1428, P233, DOI 10.1016/S0304-4165(99)00094-X; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Heller R, 1996, FEBS LETT, V389, P225, DOI 10.1016/0014-5793(96)00590-X; Lin CR, 2002, GENE THER, V9, P1247, DOI 10.1038/sj.gt.3301790; Lin CR, 2002, NEUROSCI LETT, V317, P1; Loser P, 1998, J VIROL, V72, P180; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; MARSHALL WG, GENE THER, V17, P419; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Neumann E., 1989, ELECTROPORATION ELEC; Nikolski VP, 2005, EUROPACE, V7, pS146, DOI 10.1016/j.eupc.2005.04.011; Nunamaker EA, 2003, AM J PHYSIOL-HEART C, V285, pH2240, DOI 10.1152/ajpheart.00350.2003; Parsa CJ, 2005, J GENE MED, V7, P595, DOI 10.1002/jgm.704; Rubenstrunk A, 2004, CELL BIOL TOXICOL, V20, P25, DOI 10.1023/B:CBTO.0000021079.69089.4f; Tavakoli R, 2006, J GENE MED, V8, P242, DOI 10.1002/jgm.859; Vale PR, 2000, CIRCULATION, V102, P965, DOI 10.1161/01.CIR.102.9.965; Wang YN, 2001, AM J TRANSPLANT, V1, P334, DOI 10.1034/j.1600-6143.2001.10408.x; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Wright MJ, 2001, GENE THER, V8, P1833, DOI 10.1038/sj.gt.3301614	33	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14467	10.1371/journal.pone.0014467	http://dx.doi.org/10.1371/journal.pone.0014467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209934	Green Published, gold			2022-12-25	WOS:000285793600010
J	Di Stefano, B; Buecker, C; Ungaro, F; Prigione, A; Chen, HH; Welling, M; Eijpe, M; Mostoslavsky, G; Tesar, P; Adjaye, J; Geijsen, N; Broccoli, V				Di Stefano, Bruno; Buecker, Christa; Ungaro, Federica; Prigione, Alessandro; Chen, Hsu-Hsin; Welling, Maaike; Eijpe, Maureen; Mostoslavsky, Gustavo; Tesar, Paul; Adjaye, James; Geijsen, Niels; Broccoli, Vania			An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; SELF-RENEWAL; FIBROBLASTS; EPIBLAST; KLF4; INDUCTION; OCT4	Recent data demonstrates that stem cells can exist in two morphologically, molecularly and functionally distinct pluripotent states; a naive LIF-dependent pluripotent state which is represented by murine embryonic stem cells (mESCs) and an FGF-dependent primed pluripotent state represented by murine and rat epiblast stem cells (EpiSCs). We find that derivation of induced pluripotent stem cells (iPSCs) under EpiSC culture conditions yields FGF-dependent iPSCs from hereon called FGF-iPSCs) which, unexpectedly, display naive ES-like/ICM properties. FGF-iPSCs display X-chromosome activation, multi-lineage differentiation, teratoma competence and chimera contribution in vivo. Our findings suggest that in 129 and Bl6 mouse strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor conditions. Characterization of the key molecular signalling pathways revealed FGF-iPSCs to depend on the Activin/Nodal and FGF pathways, while signalling through the JAK-STAT pathway is not required for FGF-iPS cell maintenance. Our findings suggest that in 129 and Bl6 mouse strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor conditions.	[Di Stefano, Bruno; Ungaro, Federica; Broccoli, Vania] Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, I-20132 Milan, Italy; [Buecker, Christa; Chen, Hsu-Hsin; Welling, Maaike; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA USA; [Buecker, Christa; Chen, Hsu-Hsin; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Prigione, Alessandro; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Eijpe, Maureen] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Stem Cell Biol & Regenerat Med, Boston, MA 02118 USA; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Welling, Maaike; Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Di Stefano, Bruno] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Geijsen, Niels] Univ Utrecht, Sch Vet, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Boston University; Case Western Reserve University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); IRCCS Fondazione San Matteo; Utrecht University	Di Stefano, B (corresponding author), Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, I-20132 Milan, Italy.	ngeijsen@mgh.harvard.edu; broccoli.vania@hsr.it	Di Stefano, Bruno/K-5020-2017; Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014; Di Stefano, Bruno/H-7232-2015; Ungaro, Federica/J-6047-2018; Broccoli, Vania/K-3464-2016; Prigione, Alessandro/ABA-1584-2021; Alessandro, Prigione/B-2959-2013	Di Stefano, Bruno/0000-0003-2532-3087; Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Di Stefano, Bruno/0000-0003-2532-3087; Ungaro, Federica/0000-0001-5395-7795; Broccoli, Vania/0000-0003-4050-0926; Alessandro, Prigione/0000-0001-9457-1952; Buecker, Christa/0000-0003-3055-2642; Welling, Maaike/0000-0003-3253-3410; Mostoslavsky, Gustavo/0000-0002-0784-2169	Telethon [GGP07181]; Italian Ministry of Health; National Institutes of Health and Dutch Science Organization (NWO); Bundesministerium fur Bildung und Forschung [01GN0807]; Max Planck Society; Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)	Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health and Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan)	This work was supported by funding from Telethon (GGP07181) and Italian Ministry of Health (Young Research Award) to V.B., from National Institutes of Health and Dutch Science Organization (NWO) to N.G., and from the Bundesministerium fur Bildung und Forschung (01GN0807) and the Max Planck Society to J.A. C.B. was supported by the Gottlieb Daimler- and Karl Benz-Foundation. H.H.C. was supported by the National Science Council (Taiwan, ROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	20	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16092	10.1371/journal.pone.0016092	http://dx.doi.org/10.1371/journal.pone.0016092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209851	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000285793600060
J	Oguey, C; Foloppe, N; Hartmann, B				Oguey, Christophe; Foloppe, Nicolas; Hartmann, Brigitte			Understanding the Sequence-Dependence of DNA Groove Dimensions: Implications for DNA Interactions	PLOS ONE			English	Article							B-II TRANSITIONS; NF-KAPPA-B; MINOR-GROOVE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; HELIX GEOMETRY; NUCLEIC-ACIDS; PROTEIN; RECOGNITION; COMPLEXES	Background: The B-DNA major and minor groove dimensions are crucial for DNA-protein interactions. It has long been thought that the groove dimensions depend on the DNA sequence, however this relationship has remained elusive. Here, our aim is to elucidate how the DNA sequence intrinsically shapes the grooves. Methodology/Principal Findings: The present study is based on the analysis of datasets of free and protein-bound DNA crystal structures, and from a compilation of NMR P-31 chemical shifts measured on free DNA in solution on a broad range of representative sequences. The P-31 chemical shifts can be interpreted in terms of the BI <-> BII backbone conformations and dynamics. The grooves width and depth of free and protein-bound DNA are found to be clearly related to the BI/BII backbone conformational states. The DNA propensity to undergo BI <-> BII backbone transitions is highly sequence-dependent and can be quantified at the dinucleotide level. This dual relationship, between DNA sequence and backbone behavior on one hand, and backbone behavior and groove dimensions on the other hand, allows to decipher the link between DNA sequence and groove dimensions. It also firmly establishes that proteins take advantage of the intrinsic DNA groove properties. Conclusions/Significance: The study provides a general framework explaining how the DNA sequence shapes the groove dimensions in free and protein-bound DNA, with far-reaching implications for DNA-protein indirect readout in both specific and non specific interactions.	[Oguey, Christophe] CNRS, Lab Phys Theor & Modelisat, UMR 8089, Cergy Pontoise, France; [Oguey, Christophe] Univ Cergy Pontoise, Cergy Pontoise, France; [Foloppe, Nicolas; Hartmann, Brigitte] INSERM, UMR S665, Paris, France; [Foloppe, Nicolas; Hartmann, Brigitte] Univ Paris Diderot, Inst Natl Transfus Sanguine, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CY Cergy Paris Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Oguey, C (corresponding author), CNRS, Lab Phys Theor & Modelisat, UMR 8089, Cergy Pontoise, France.	nf_research@hotmail.com; brigitte.hartmann@univ-paris-diderot.fr	oguey, christophe/A-4168-2012		INSERM UMR [S665]; CNRS; Institut National de la Transfusion Sanguine (INTS)	INSERM UMR; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Transfusion Sanguine (INTS)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was funded by INSERM UMR S665, CNRS, Institut National de la Transfusion Sanguine (INTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Crothers DM, 1999, DNA BENDING ADENINE, P445; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DICKERSON RE, 1994, P NATL ACAD SCI USA, V91, P3579, DOI 10.1073/pnas.91.9.3579; Djuranovic D, 2005, BIOPHYS J, V89, P2542, DOI 10.1529/biophysj.104.057109; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Dostal L, 2004, BIOCHEMISTRY-US, V43, P9600, DOI 10.1021/bi049192r; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Gorenstein DG, 1984, PHOSPHORUS 31 NMR PR; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Hartmann B, 1996, Q REV BIOPHYS, V29, P309, DOI 10.1017/S0033583500005874; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Huang DB, 2005, J MOL BIOL, V346, P147, DOI 10.1016/j.jmb.2004.11.042; Isaacs RJ, 2001, J MOL BIOL, V311, P149, DOI 10.1006/jmbi.2001.4855; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Moravek Z, 2002, NUCLEIC ACIDS RES, V30, P1182, DOI 10.1093/nar/30.5.1182; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Prabakaran P, 2006, STRUCTURE, V14, P1355, DOI 10.1016/j.str.2006.06.018; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SRINIVASAN AR, 1987, J BIOMOL STRUCT DYN, V4, P895, DOI 10.1080/07391102.1987.10507690; STOFER E, 1994, BIOPOLYMERS, V34, P337, DOI 10.1002/bip.360340305; Suck Dietrich, 1994, Journal of Molecular Recognition, V7, P65, DOI 10.1002/jmr.300070203; Suzuki M, 1996, J MOL BIOL, V255, P677, DOI 10.1006/jmbi.1996.0055; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Tian Y, 2009, J PHYS CHEM B, V113, P2596, DOI 10.1021/jp711203m; Tisne C, 1999, J MOL BIOL, V293, P139, DOI 10.1006/jmbi.1999.3157; Tolstorukov MY, 2004, J MOL BIOL, V337, P65, DOI 10.1016/j.jmb.2004.01.011; van Dam L, 2000, J MOL BIOL, V304, P541, DOI 10.1006/jmbi.2000.4194; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680; Wellenzohn B, 2002, BIOCHEMISTRY-US, V41, P4088, DOI 10.1021/bi015642t; Winger RH, 1999, J BIOMOL STRUCT DYN, V17, P223, DOI 10.1080/07391102.1999.10508355; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; YOUNG MA, 1995, BIOPHYS J, V68, P2454, DOI 10.1016/S0006-3495(95)80427-3; Zacharias M, 2006, BIOPHYS J, V91, P882, DOI 10.1529/biophysj.106.083816	46	56	56	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15931	10.1371/journal.pone.0015931	http://dx.doi.org/10.1371/journal.pone.0015931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209967	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200074
J	Carraro, V; Maurin, AC; Lambert-Langlais, S; Averous, J; Chaveroux, C; Parry, L; Jousse, C; Ord, D; Ord, T; Fafournoux, P; Bruhat, A				Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Chaveroux, Cedric; Parry, Laurent; Jousse, Celine; Oerd, Daima; Oerd, Tonis; Fafournoux, Pierre; Bruhat, Alain			Amino Acid Availability Controls TRB3 Transcription in Liver through the GCN2/eIF2 alpha/ATF4 Pathway	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; UNFOLDED PROTEIN RESPONSE; C/EBP-BETA; CELL-DEATH; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; HISTONE ACETYLATION; INSULIN-RESISTANCE; TRIBBLES HOMOLOG; LIPID-METABOLISM	In mammals, plasma amino acid concentrations are markedly affected by dietary or pathological conditions. It has been well established that amino acids are involved in the control of gene expression. Up to now, all the information concerning the molecular mechanisms involved in the regulation of gene transcription by amino acid availability has been obtained in cultured cell lines. The present study aims to investigate the mechanisms involved in transcriptional activation of the TRB3 gene following amino acid limitation in mice liver. The results show that TRB3 is up-regulated in the liver of mice fed a leucine-deficient diet and that this induction is quickly reversible. Using transient transfection and chromatin immunoprecipitation approaches in hepatoma cells, we report the characterization of a functional Amino Acid Response Element (AARE) in the TRB3 promoter and the binding of ATF4, ATF2 and C/EBP beta to this AARE sequence. We also provide evidence that only the binding of ATF4 to the AARE plays a crucial role in the amino acid-regulated transcription of TRB3. In mouse liver, we demonstrate that the GCN2/eIF2 alpha/ATF4 pathway is essential for the induction of the TRB3 gene transcription in response to a leucine-deficient diet. Therefore, this work establishes for the first time that the molecular mechanisms involved in the regulation of gene transcription by amino acid availability are functional in mouse liver.	[Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Parry, Laurent; Jousse, Celine; Fafournoux, Pierre; Bruhat, Alain] INRA, UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France; [Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Parry, Laurent; Jousse, Celine; Fafournoux, Pierre; Bruhat, Alain] Univ Clermont 1, UMR Nutr Humaine 1019, UFR Med, Clermont Ferrand, France; [Chaveroux, Cedric] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Oerd, Daima; Oerd, Tonis] Estonian Bioctr, Tartu, Estonia	INRAE; Universite Clermont Auvergne (UCA); McGill University; Estonian Biocentre	Carraro, V (corresponding author), INRA, UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France.	pierre.fafournoux@clermont.inra.fr; alain.bruhat@clermont.inra.fr	Örd, Tõnis/G-8113-2012; Örd, Daima/H-4467-2012	Örd, Tõnis/0000-0001-8778-2508; Chaveroux, Cedric/0000-0002-4116-3354	Institut National de la Recherche Agronomique (INRA, France); Estonian Science Foundation [7683]	Institut National de la Recherche Agronomique (INRA, France); Estonian Science Foundation	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA, France). T. Ord is supported by Grant 7683 from the Estonian Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Bruhat A, 2009, BIOFACTORS, V35, P249, DOI 10.1002/biof.40; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kimball Scot R, 2004, Nutr Metab (Lond), V1, P3, DOI 10.1186/1743-7075-1-3; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ord T, 2009, GENE, V444, P24, DOI 10.1016/j.gene.2009.06.001; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S, 2009, J CLIN ENDOCR METAB, V94, P190, DOI 10.1210/jc.2008-1365; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; SHAN J, PHYSL GENOMICS; SIERRA F, 1990, MOL BIOL MED, V7, P131; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	48	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15716	10.1371/journal.pone.0015716	http://dx.doi.org/10.1371/journal.pone.0015716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203563	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900037
J	Kovtun, O; Mureev, S; Johnston, W; Alexandrov, K				Kovtun, Oleksiy; Mureev, Sergey; Johnston, Wayne; Alexandrov, Kirill			Towards the Construction of Expressed Proteomes Using a Leishmania tarentolae Based Cell-Free Expression System	PLOS ONE			English	Article							PROTEIN; EVOLUTION; PHOSPHATASE; DISEASE	The adaptation of organisms to a parasitic life style is often accompanied by the emergence of novel biochemical pathways absent in free-living organisms. As a result, the genomes of specialized parasitic organisms often code for a large number (> 50%) of proteins with no detectable homology or predictable function. Although understanding the biochemical properties of these proteins and their roles in parasite biogenesis is the next challenge of molecular parasitology, analysis tools developed for free-living organisms are often inadequate for this purpose. Here we attempt to solve some of these problems by developing a methodology for the rapid production of expressed proteomes in cell-free systems based on parasitic organisms. To do so we take advantage of Species Independent Translational Sequences (SITS), which can efficiently mediate translation initiation in any organism. Using these sequences we developed a single-tube in vitro translation system based on the parasitic protozoan Leishmania tarentolae. We demonstrate that the system can be primed directly with SITS containing templates constructed by overlap extension PCR. To test the systems we simultaneously amplified 31 of L. tarentolae's putative translation initiation factors and phosphatases directly from the genomic DNA and subjected them to expression, purification and activity analysis. All of the amplified products produced soluble recombinant proteins, and putative phosphatases could be purified to at least 50% purity in one step. We further compared the ability of L. tarentolae and E. coli based cell-free systems to express a set of mammalian, L. tarentolae and Plasmodium falciparum Rab GTPases in functional form. We demonstrate that the L. tarentolae cell-free system consistently produced higher quality proteins than E. coli-based system. The differences were particularly pronounced in the case of open reading frames derived from P. falciparum. The implications of these developments are discussed.	[Kovtun, Oleksiy; Mureev, Sergey; Johnston, Wayne; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Kovtun, O (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au	Mureev, Sergey/ABB-4757-2020; Kovtun, Oleksiy/F-7443-2015; Alexandrov, Kirill/A-5830-2013; Kovtun, Oleksiy/AAE-5397-2019; mureev, sergey/K-3521-2014; Johnston, Wayne/D-2095-2017	Kovtun, Oleksiy/0000-0001-6374-7863; Alexandrov, Kirill/0000-0002-0957-6511; Kovtun, Oleksiy/0000-0001-6374-7863; mureev, sergey/0000-0001-9999-3150; Johnston, Wayne/0000-0002-7485-8363	ARC [DP003363, FT0991611]; University of Queensland	ARC(Australian Research Council); University of Queensland(University of Queensland)	This work was supported in part by grant ARC grants DP003363 and FT0991611 to K. A. O.K was supported by a fellowship of the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Azizi H, 2009, PARASITOLOGY, V136, P723, DOI 10.1017/S0031182009005873; BAI GE, 1988, FASEB J, V2, P3010, DOI 10.1096/fasebj.2.14.2846396; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Dursina B, 2002, BIOCHEMISTRY-US, V41, P6805, DOI 10.1021/bi016067w; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirano N, 2006, PROTEINS, V64, P343, DOI 10.1002/prot.21008; Hoffmann Michael, 2004, Biotechnol Annu Rev, V10, P1, DOI 10.1016/S1387-2656(04)10001-X; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; SARABHAI A, 1967, J MOL BIOL, V27, P145, DOI 10.1016/0022-2836(67)90357-9; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Waldo Geoffrey S., 2003, V230, P343; ZHUO S, 1993, J BIOL CHEM, V268, P17754	22	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14388	10.1371/journal.pone.0014388	http://dx.doi.org/10.1371/journal.pone.0014388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203562	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900006
J	Li, YH; Lu, WY; King, TD; Liu, CC; Bijur, GN; Bu, GJ				Li, Yonghe; Lu, Wenyan; King, Taj D.; Liu, Chia-Chen; Bijur, Gautam N.; Bu, Guojun			Dkk1 Stabilizes Wnt Co-Receptor LRP6: Implication for Wnt Ligand-Induced LRP6 Down-Regulation	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-6; KREMEN PROTEINS; WINGLESS; INTERNALIZATION; DICKKOPF-1; MECHANISM; ENDOCYTOSIS; ACTIVATION; INDUCTION; PATHWAYS	Background: The low density lipoprotein receptor-related protein-6 (LRP6) is an essential co-receptor for canonical Wnt signaling. Dickkopf 1 (Dkk1), a major secreted Wnt signaling antagonist, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. Previous studies have demonstrated that Dkk1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen. Methodology/Principal Findings: In the present study, we found that transfected Dkk1 induces LRP6 accumulation while inhibiting Wnt/LRP6 signaling. Treatment with Dkk1-conditioned medium or recombinant Dkk1 protein stabilized LRP6 with a prolonged half-life and induces LRP6 accumulation both at the cell surface and in endosomes. We also demonstrated that Kremen2 co-expression abrogated the effect of Dkk1 on LRP6 accumulation, indicating that the effect of Kremen2 is dominant over Dkk1 regulation of LRP6. Furthermore, we found that Wnt3A treatment induces LRP6 down-regulation, an effect paralleled with a Wnt/LRP6 signaling decay, and that Dkk1 treatment blocked Wnt3A-induced LRP6 down-regulation. Finally, we found that LRP6 turnover was blocked by an inhibitor of caveolae-mediated endocytosis. Conclusions/Significance: Our results reveal a novel role for Dkk1 in preventing Wnt ligand-induced LRP6 down-regulation and contribute significantly to our understanding of Dkk1 function in Wnt/LRP6 signaling.	[Li, Yonghe; Lu, Wenyan; King, Taj D.] So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Li, Yonghe; Liu, Chia-Chen; Bu, Guojun] Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Li, YH (corresponding author), So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA.	y.li@sri.org; bu@wustl.edu		Du, Hanjian/0000-0002-2353-8802	National Institutes of Health [CA124531, AG031784, AG027924]; NATIONAL CANCER INSTITUTE [R01CA124531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG027924, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by grants from the National Institutes of Health CA124531 (to Y.L.), and AG031784 and AG027924 (to G. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	40	93	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11014	10.1371/journal.pone.0011014	http://dx.doi.org/10.1371/journal.pone.0011014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543981	Green Published, gold, Green Submitted			2022-12-25	WOS:000278494900026
J	Tang, YQ; Jaganath, IB; Sekaran, SD				Tang, Yin-Quan; Jaganath, Indu Bala; Sekaran, Shamala Devi			Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of Apoptosis	PLOS ONE			English	Article							PROSTATE-CANCER; AMARUS; EXPRESSION; ACID; EXTRACT; PLANTS	Background: Phyllanthus is a traditional medicinal plant that has been used in the treatment of many diseases including hepatitis and diabetes. The main aim of the present work was to investigate the potential cytotoxic effects of aqueous and methanolic extracts of four Phyllanthus species (P. amarus, P. niruri, P. urinaria and P. watsonii) against skin melanoma and prostate cancer cells. Methodology/Principal Findings: Phyllanthus plant appears to possess cytotoxic properties with half-maximal inhibitory concentration (IC50) values of 150-300 mu g/ml for aqueous extract and 50-150 mu g/ml for methanolic extract that were determined using the MTS reduction assay. In comparison, the plant extracts did not show any significant cytotoxicity on normal human skin (CCD-1127Sk) and prostate (RWPE-1) cells. The extracts appeared to act by causing the formation of a clear "ladder'' fragmentation of apoptotic DNA on agarose gel, displayed TUNEL-positive cells with an elevation of caspase-3 and -7 activities. The Lactate Dehydrogenase (LDH) level was lower than 15% in Phyllanthus treated-cancer cells. These indicate that Phyllanthus extracts have the ability to induce apoptosis with minimal necrotic effects. Furthermore, cell cycle analysis revealed that Phyllanthus induced a Go/G1-phase arrest on PC-3 cells and a S-phase arrest on MeWo cells and these were accompanied by accumulation of cells in the Sub-G1 (apoptosis) phase. The cytotoxic properties may be due to the presence of polyphenol compounds such as ellagitannins, gallotannins, flavonoids and phenolic acids found both in the water and methanol extract of the plants. Conclusions/Significance: Phyllanthus plant exerts its growth inhibition effect in a selective manner towards cancer cells through the modulation of cell cycle and induction of apoptosis via caspases activation in melanoma and prostate cancer cells. Hence, Phyllanthus may be sourced for the development of a potent apoptosis-inducing anticancer agent.	[Tang, Yin-Quan; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Jaganath, Indu Bala] MARDI, Ctr Biotechnol, Serdang, Malaysia	Universiti Malaya; Institute Penyelidikan Dan Kemajuan Pertanian	Tang, YQ (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	tang, yin/GXZ-6989-2022; Devi, Shamala Devi/B-9735-2010; Tang, Yin-Quan/J-5859-2013; Sekaran, Shamala Devi/B-8482-2008; Tang, Yin-Quan/K-5725-2017	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Tang, Yin-Quan/0000-0001-7327-2830; Jaganath, Indu/0000-0002-3272-9598	University Malaya [UM PS183/2009B]; Malaysian Agricultural and Research Development Institute (MARDI) [53-02-03-1002]	University Malaya(Universiti Malaya); Malaysian Agricultural and Research Development Institute (MARDI)	This study was funded by the Postgraduate Research Grant, University Malaya (UM PS183/2009B)(www.um.edu.my) and Malaysian Agricultural and Research Development Institute (MARDI) (53-02-03-1002)(www.mardi.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2009, CANC FACTS FIG 2009, P19; Asha VV, 2007, FITOTERAPIA, V78, P134, DOI 10.1016/j.fitote.2006.10.009; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; BLUMBERG BS, 1990, VACCINE, V8, pS86, DOI 10.1016/0264-410X(90)90225-B; *CANC RES UK, 2010, SKIN CANC UK INC STA; Che XH, 2010, BASIC CLIN PHARMACOL, V106, P30, DOI 10.1111/j.1742-7843.2009.00465.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; CRAGG GM, 2007, BIOACTIVE NATURAL PR; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Faried A, 2007, INT J ONCOL, V30, P605; Guchelaar H J, 1992, Clin Oncol (R Coll Radiol), V4, P388, DOI 10.1016/S0936-6555(05)81134-3; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Huang ST, 2004, LIFE SCI, V75, P339, DOI 10.1016/j.lfs.2003.12.013; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kloucek P, 2005, J ETHNOPHARMACOL, V99, P309, DOI 10.1016/j.jep.2005.01.062; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Lee CD, 1996, EUR J CLIN INVEST, V26, P1069, DOI 10.1046/j.1365-2362.1996.410595.x; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Maecker HL, 2000, CANCER RES, V60, P4638; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; Mazumder A, 2006, NAT PROD RES, V20, P323, DOI 10.1080/14786410600650404; Mazunder UK, 2005, EURO B DRUG RES, V13, P15; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ott M, 1997, EUR J CLIN INVEST, V27, P908, DOI 10.1046/j.1365-2362.1997.2020749.x; Prakash A, 1995, PHYTOTHER RES, V9, P594, DOI 10.1002/ptr.2650090813; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; Rajeshkumar NV, 2000, J ETHNOPHARMACOL, V73, P215, DOI 10.1016/S0378-8741(00)00311-1; Rajeshkumar NV, 2002, J ETHNOPHARMACOL, V81, P17, DOI 10.1016/S0378-8741(01)00419-6; RAPHAEL KR, 2002, J EXP BIOL, V40, P905; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; VARMA A, 2009, ECAM IN PRESS; VENKATESWARAN PS, 1997, P NATL ACAD SCI USA, V84, P274; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zhou S, 1997, Zhongguo Zhong Yao Za Zhi, V22, P109	47	105	108	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12644	10.1371/journal.pone.0012644	http://dx.doi.org/10.1371/journal.pone.0012644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838625	Green Published, gold, Green Submitted			2022-12-25	WOS:000281687100013
J	Chen, SL; Yao, H; Han, JP; Liu, C; Song, JY; Shi, LC; Zhu, YJ; Ma, XY; Gao, T; Pang, XH; Luo, K; Li, Y; Li, XW; Jia, XC; Lin, YL; Leon, C				Chen, Shilin; Yao, Hui; Han, Jianping; Liu, Chang; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Luo, Kun; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin; Leon, Christine			Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species	PLOS ONE			English	Article							LAND PLANTS; AUTHENTICATION; IDENTIFICATION; TAXONOMY; PHYLOGENETICS; COMPLEMENTS; RBCL; TOOL	Background: The plant working group of the Consortium for the Barcode of Life recommended the two-locus combination of rbcL + matK as the plant barcode, yet the combination was shown to successfully discriminate among 907 samples from 550 species at the species level with a probability of 72%. The group admits that the two-locus barcode is far from perfect due to the low identification rate, and the search is not over. Methodology/Principal Findings: Here, we compared seven candidate DNA barcodes (psbA-trnH, matK, rbcL, rpoC1, ycf5, ITS2, and ITS) from medicinal plant species. Our ranking criteria included PCR amplification efficiency, differential intra-and inter-specific divergences, and the DNA barcoding gap. Our data suggest that the second internal transcribed spacer (ITS2) of nuclear ribosomal DNA represents the most suitable region for DNA barcoding applications. Furthermore, we tested the discrimination ability of ITS2 in more than 6600 plant samples belonging to 4800 species from 753 distinct genera and found that the rate of successful identification with the ITS2 was 92.7% at the species level. Conclusions: The ITS2 region can be potentially used as a standard DNA barcode to identify medicinal plants and their closely related species. We also propose that ITS2 can serve as a novel universal barcode for the identification of a broader range of plant taxa.	[Chen, Shilin; Yao, Hui; Han, Jianping; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin] Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China; [Liu, Chang] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Kun] Hubei Univ Chinese Med, Dept Pharm, Wuhan, Hubei, Peoples R China; [Leon, Christine] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; University of Hong Kong; Hubei University of Chinese Medicine; Royal Botanic Gardens, Kew	Chen, SL (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China.	slchen@implad.ac.cn; songjingyuan@hotmail.com	xiwen, li/W-1990-2019; Zhu, Yingjie/W-3315-2017; Yao, hui/AAM-2391-2021; Yang, Pengcheng/N-1037-2014; Wei, Yuanyuan/H-7963-2014	Zhu, Yingjie/0000-0003-1849-6019; Yang, Pengcheng/0000-0001-5496-8357; Kang, Le/0000-0003-4262-2329; Han, Jianping/0000-0002-7976-6708; Jiang, Feng/0000-0002-7407-7604; Wei, Yuanyuan/0000-0003-0635-6879	International Cooperation Program of Science and Technology [2007DFA30990]; Special Foundation of Ministry of Health [200802043]; Hong Kong Research Grant Council (HKU) [7526/06M]	International Cooperation Program of Science and Technology; Special Foundation of Ministry of Health; Hong Kong Research Grant Council (HKU)(University of Hong KongHong Kong Research Grants Council)	This work is supported by the International Cooperation Program of Science and Technology ( No. 2007DFA30990) and the Special Foundation of Ministry of Health ( No. 200802043) granted to S. L. C. This work is also supported by grants from the Hong Kong Research Grant Council (HKU 7526/06M) to C. L. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miao M, 2008, PROTIST, V159, P519, DOI 10.1016/j.protis.2008.05.002; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, MOL ECOL NOTES, V7, P365, DOI 10.1111/j.1471-8286.2007.01698.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385	41	1050	1384	21	299	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8613	10.1371/journal.pone.0008613	http://dx.doi.org/10.1371/journal.pone.0008613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	21209894	gold, Green Published, Green Submitted			2022-12-25	WOS:000273414100007
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; WHO, 2004, POL LAB MAN; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400031
